<SEC-DOCUMENT>0001725160-21-000220.txt : 20211110
<SEC-HEADER>0001725160-21-000220.hdr.sgml : 20211110
<ACCEPTANCE-DATETIME>20211110075200
ACCESSION NUMBER:		0001725160-21-000220
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		104
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211110
DATE AS OF CHANGE:		20211110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zentalis Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001725160
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39263
		FILM NUMBER:		211394460

	BUSINESS ADDRESS:	
		STREET 1:		530 SEVENTH AVENUE, SUITE 2201
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018
		BUSINESS PHONE:		(212) 433-3791

	MAIL ADDRESS:	
		STREET 1:		530 SEVENTH AVENUE, SUITE 2201
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Zentalis Pharmaceuticals, LLC
		DATE OF NAME CHANGE:	20200107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Zeno Pharma, LLC
		DATE OF NAME CHANGE:	20171212
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>zntl-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:ec330f09-1704-42bb-8fbc-efe747c127bc,g:cceb589a-52db-4380-936c-762192d75fd3,d:359d7483f88b44aba6df295b4be37cde--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:zntl="http://www.zentalis.com/20210930" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>zntl-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80L2ZyYWc6ZTgwMTkyMjczYWNiNGUxNDlhOTdlNDg5ZTQxYTdlOTgvdGFibGU6MTU3Y2Y1ODZiNTViNGY2YTlkMDJjZDZlYzg4YzIyZjMvdGFibGVyYW5nZToxNTdjZjU4NmI1NWI0ZjZhOWQwMmNkNmVjODhjMjJmM18wLTEtMS0xLTE0NzQ1_a6e94eaf-3a9a-4b5d-b793-40f2ef4ad019">0001725160</ix:nonNumeric><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" format="ixt:fixed-false" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80L2ZyYWc6ZTgwMTkyMjczYWNiNGUxNDlhOTdlNDg5ZTQxYTdlOTgvdGFibGU6MTU3Y2Y1ODZiNTViNGY2YTlkMDJjZDZlYzg4YzIyZjMvdGFibGVyYW5nZToxNTdjZjU4NmI1NWI0ZjZhOWQwMmNkNmVjODhjMjJmM18xLTEtMS0xLTE0NzQ1_273f3ba1-709b-4369-91b2-c73918070db7">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80L2ZyYWc6ZTgwMTkyMjczYWNiNGUxNDlhOTdlNDg5ZTQxYTdlOTgvdGFibGU6MTU3Y2Y1ODZiNTViNGY2YTlkMDJjZDZlYzg4YzIyZjMvdGFibGVyYW5nZToxNTdjZjU4NmI1NWI0ZjZhOWQwMmNkNmVjODhjMjJmM18yLTEtMS0xLTE0NzQ1_d53229ea-c822-4c2b-847a-cde1b35acc35">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" format="ixt:date-month-day" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80L2ZyYWc6ZTgwMTkyMjczYWNiNGUxNDlhOTdlNDg5ZTQxYTdlOTgvdGFibGU6MTU3Y2Y1ODZiNTViNGY2YTlkMDJjZDZlYzg4YzIyZjMvdGFibGVyYW5nZToxNTdjZjU4NmI1NWI0ZjZhOWQwMmNkNmVjODhjMjJmM18zLTEtMS0xLTE0NzQ1_944dd580-d697-4156-9a95-a017c0fabc7c">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80L2ZyYWc6ZTgwMTkyMjczYWNiNGUxNDlhOTdlNDg5ZTQxYTdlOTgvdGFibGU6MTU3Y2Y1ODZiNTViNGY2YTlkMDJjZDZlYzg4YzIyZjMvdGFibGVyYW5nZToxNTdjZjU4NmI1NWI0ZjZhOWQwMmNkNmVjODhjMjJmM180LTEtMS0xLTE0NzQ1_429adb74-6b2f-481d-b1ea-15d87cea9b0f">2021</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="zntl-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i686a0fdf3788449f8f91bd94b936f1fb_I20211109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c8ce9f01da84935a62e807401cc9cae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66bf6807e17f4804bb968d10045ac403_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5479652c5e8948eea76ed85f21cb8d7e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibce0517364924372a750c28c212342ce_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05e61bfa32a14e3187bb570193bd427c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib42d2e50a19640fd98f9685c1637127d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73b610735c7347e8aaac83b4f7bc7c43_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21152b916121449d97e5409f0cbc25b2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7c1a20b82134c2996172b95f893e5d4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab511672603b4a81a03caf2ab30bcf7c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f0fe3d7eeb04c7899bcb9ae2088bdf4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4021c98173a4dcba140ad00a72d452c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98f6ab579d534d1bb65c5fe26ac9a269_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8acbfe477b1c4f3a815b95163a1b9152_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id08f2fc2050a4c44943d2e4a295e9e4b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a274b3c002d4c999b3d4c6415451551_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ee68a808a09462ab4fa007d6b40a836_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6caad814d88b42158fdc2cd280aab0ed_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49952e4f44cf4702824e413a479ed8e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08713a361b1540acb0726229b81829e1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a86486294184f18889f9a3725de48f1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i609623d6091f4576a93d91b6acb32ee7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc6dc347950a4b29af9da5a02d804ca9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if397f6a7f90548bcaa33a5c5cf1f88cb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65a26d388f63425cb3a2dc35e2a31a4b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1f3ce1f164345ed9ee96c629cc01c5d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie71fb05f111f4be48d0ccef2861d630f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib93e31ca1184485f94ea42f971abc9e0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefaca15d6a7d4345a23fd191b8e32d62_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadec20410c96469aaee44c0c733e3dc4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaac40f72e56c4a298f6c8a19b70d2903_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4922676e6be541f3872e64b2464fb137_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ab4533a3be14806b3b04f091b9ee6f3_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4aa9cf16c10047e38ad6329f8dc98d18_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28c684747f014fc580d4d13ca452e467_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if603d442707c4674b05711009d838f40_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfc558dbb30841d4b077a7adf6dba4a8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica7568cfa246420a8555ccc29e4641d5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b6093af831e491297bdfb820eba1bb4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae5a70bb484d47a5966a3232feabc0a3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b4a788eaa8d424898851941377c7408_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9bfd239f78a4d1c9687ea22e1413f42_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i401925c54aed4e27af6b9f7bae761633_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieea94c1751ea4ca9aafb6ed451e8026c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84f4ac54c0c4412cad1de8c39c9f465f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb096e42e3894e489f301e40bd55a89a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37dfc4263719434b9b05fe487d9d50df_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4589566e63f84b7b9cccea38766a0eb1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dffd747f1e14c5498e5f8b92e2018d7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i205664e670624f0d9706e05dfcffde81_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72b30c6cbd624852b0a41e4ef1b61c9b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b164794b9d4478db7c7a1f24b1a53e1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36b0ac5aa6b94994b62d1befce371046_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fafba9138604e4582aa3c16d8ca83cb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i172924960c934f48b9b4f68bfc2f1c46_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0020419724ac422c834b41878fbbf94b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3d8bceefc7b40dc839ef2d3d293a13c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie807a0e24c7b451dae314257f1dd00e0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20dba144ba4b4cc586cce30c51aaa503_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5015e220e18d463eab535a4b2752b5c2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bcb52b9ccef496eb3fcb0a88b4d38ea_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i171029a8b8344ffcb4c0653ce2b78593_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1d6083038da45c5aadfdf0aefeda452_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd1fdb349c73430aa944980282c11963_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eb313acd05f42ae9d92268c78a67bd4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i44bca96b50f545e98c95ba466913be25_D20171221-20171221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-21</xbrli:startDate><xbrli:endDate>2017-12-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53b0d350827a4825b36838126a07429a_I20200402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdac556512264baba2e3c86be867069c_D20200402-20200402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-02</xbrli:startDate><xbrli:endDate>2020-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0daa24d503d64a52a0b1fa592bd6c4e8_D20200402-20200402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-02</xbrli:startDate><xbrli:endDate>2020-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1b99cb5cf7d4b9bb0f68ae4525eab72_D20200407-20200407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-07</xbrli:startDate><xbrli:endDate>2020-04-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8cad8b83d3f432cafaa0e90fa7125e0_D20200407-20200407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-07</xbrli:startDate><xbrli:endDate>2020-04-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib67a09c2cc4e4165b391d6ef5419f1b7_I20200407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88c5a60307524479aa90649174075824_D20200407-20200407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-07</xbrli:startDate><xbrli:endDate>2020-04-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59959a77c7aa43129b028607068148f6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">zntl:ZenteraTherapeuticsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a09ec80921740a8a5b68eddc9671099_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">zntl:ZenteraTherapeuticsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36e1e114412b4a85a123b6bacd5ba04e_D20171221-20171221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">zntl:KalyraPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-21</xbrli:startDate><xbrli:endDate>2017-12-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe080c8b70bb4349ac04f51678c3abf1_I20171221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">zntl:KalyraPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3da75022cc3d428d9e0424e542c47954_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadfc04fccb134988b9f947350d9c04c9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2389c0a608534740bdcad0e2fa9bfcec_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie38dad6ada064a56894e848a9616b856_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b8f9142cb4543f0a263ce89556879f5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa5cb2304d0444b389a997ad08e0c71e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia868940f58cc42b5b13f0fc8b51e01da_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ad029fd87124e22a93cabf53bf1d8ad_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec9f78113384472a9c1cd4490522fa4f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cbe2ea503f244c28efc38eaf91c8231_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37fa66f18165423bb7d922609186b948_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc5bcd3985e645c3a401476d670729d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic46f09a640544a46acc118a2e3a87c79_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e4e6113e81b488f98011e1738519d49_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6170a569b9745a5ac1f31b8c185a532_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89d1dfe44e99408ea6d011b126cf6fef_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b74220aedf04b8caee6df508ef0f7ce_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e82dd52a30f41459848f3a6b6b17f8e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42e57e64fbf34e6da8033002ed837bad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5fd90709dc74fd5a0cc52f2f2b7c1c0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30534ad685e4405c91d0e95f607be899_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96de234042a644fbab1614f7b8d810b0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86bdaabffa344b98af6e3b49d1f8e9dd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ec4099481c540d7af1b813bfb7d9ceb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c547910054f4a26851d64a99c8cf16c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9732f080c4174fc4b7b9ebf4ed2bb7c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ecc7e181acf44b4a83f0b3df2cdf533_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ebb15d5ad9e487694cef2cce04f74cc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib30cfbc3f8684fdaa1394520152b8204_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32c0dcc014f347b3b166110a2b441716_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c8984afd47b4dd1b6aa58ef930f6c50_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60a9b4ad23f4455bbd5483f1f3ba42b4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47888dd151434e169157684d400b27a8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i315772c54c624f278fe0ed2cba140fa2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideda6fd6619d423cacd820c6cb596396_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd8cecb43fce44fabe382da208c94b9a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2424305fc33c47e180bdcca355f56217_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0249ef610edf412a8b7c3986cb8f4198_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec4ba4b40d1a4678a41ebfca352cd0cb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i197f8be1dab94341ab3cb7bec4da51ee_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9459160646db459cbb327815f2c0dfad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b05eb2946574576b40669621fb77cff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3044630795146b99483f1baf0d571ee_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a5070fbecb84ab58845fe8229eb4e37_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49e62a87a0124d07b9b303e1965c458e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i817a4309217c44a8b8dc4c083d2b3c28_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc264132dfe94434b23a32e250ea3637_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zntl:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61d571892c00485fac3e8c5f93914a1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zntl:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69b3c5acd4d04eb0ad0b6255c633e023_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zntl:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cdc5a844c7741f88f2ffc72efd90024_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zntl:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic372449226be422d8b31116aa2375ce9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47a6b58f9a6844d89050368b6375eeb3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic01a05364dea4804a256c0dc000120f3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90612704ec3a46e591ec1d86c1621300_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d749128b5cc4c058432e3008374c9f5_D20150901-20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-09-01</xbrli:startDate><xbrli:endDate>2015-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i791e20e9521c44e28152d01ddac1222b_I20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf2c9428be0742a0a000254f1421fc0d_I20160331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8997c29134c6485eb8e9deb026d07200_D20160201-20160331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-02-01</xbrli:startDate><xbrli:endDate>2016-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dac0c6c83624d678d99d838917cfa5e_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e885190922f4e1d806613f4bfce9ffe_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15fe047b039c40dfa459cd498a30878a_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i561f11c86d154f968f0d7b64cfa9bb70_D20180101-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4f7f71c7cf34041890690bb8f1b4f55_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cfdd80dc235471f94d955162c41ea8d_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ae8f32d20e94dec87f494ef073bbaa1_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id660983397b24d43bf35134f4a0c0395_D20200201-20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic748b33ae7394b2b9c1ebfeb481ad01c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i662b4e7ea6f842119f8206ee5b4516c7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bad6ea4eda8467f8d5d6a4850fc03d0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2494c11e1f6b40a3866cf410bc8a7cb8_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0473a06af7ec44a996f1bca35660558f_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69a08aa6ff634f5caab3972d78e1ddfa_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b2b52f5efb3462d8683dfdb2d599eac_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia401f69705414c51916b97151f480785_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6829f239f3964fc5b73c9f115f4efd4a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i773376c6e0a4414fba9a40b0fa6f57eb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85105ad976e44ee3a9e3b01e44eee367_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if256d2dc23e54899b1bcec809c82546d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90fe1d00c583463bb71b163aa4946d4b_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc382a9f642a48919cda5bcaa7020bfb_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a0fb89c534046e2a6262b44710848a6_D20200402-20200402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">zntl:CorporateConversionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-02</xbrli:startDate><xbrli:endDate>2020-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i398696456f95488dbba235847304fab6_I20200402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibac774a69e7b4afb9ca8e9498d26c25a_I20200407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i550ef246d4114b12b5ec6d79c50b321c_D20200407-20200407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-07</xbrli:startDate><xbrli:endDate>2020-04-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie530cc1b51e14d3da1b54feb7ef48e78_D20200803-20200803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">zntl:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-03</xbrli:startDate><xbrli:endDate>2020-08-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia99692ba60b24412a1dab4423fbdcce9_D20200803-20200803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-03</xbrli:startDate><xbrli:endDate>2020-08-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59f99ff806c9400aa93e53bd0e0c2163_I20200803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">zntl:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i303787d7706b449b8fd82484ea7a63e8_D20200803-20200803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">zntl:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-03</xbrli:startDate><xbrli:endDate>2020-08-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6ddf0384ce84914b02bcf5b8a9a975f_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">zntl:FollowOnPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i462230a27f80426bb97a31bcd0bd3a57_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i599720d743104c59928244998d2e982a_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">zntl:FollowOnPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26c9395499914bb6915eb0b50eb6531e_I20171221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zntl:A2017ProfitInterestPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i788f376ae39641539c7ea4298ff33b65_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zntl:A2020IncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40102d77fe8f40fa92901924ead82975_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zntl:A2020IncentiveAwardPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9da50ea1ee9c4df0b7b30adef3d8867a_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zntl:A2020IncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia728d556059a440da6322b57d7154e71_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zntl:A2020IncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i181d83080b3f41ccb6787320f7d2229c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4e4e5dca01c4b329a93274f8d739507_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a7273c96f564c1e865eeb7eb0a5402f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94593153cf8c498c8b518d4df370e8d5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a677277d96a48bab6eb887dca74a45e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i607b537a79654bcfa5b76e79200ad79e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie98b88c9c000461eab4ed9980e58de2c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e645d2454e44e4c90ab99b885f15b90_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e9fbea9de0a48f9a2fd97d698309e42_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zntl:ZenteraStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabd570ef2f9345599b057ad29b52f338_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zntl:ZenteraStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf9822acfb464a6d891585e7be3a5ca0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:ProfitInterestAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i744b23fd24c6491ba42985404b428ca4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:ProfitInterestAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2ec8dacbd2c4cc28e92de70f1d60be4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:ProfitInterestAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:ProfitInterestAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22afa5cbdf1a42a4b3d45f2baa46d20a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4497e0e0b4ec4f1a8b88d44070441e38_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9c306d1d813469a8be5c195343bbcce_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i587d0a5af8bc44d2be7b3c8da9f39a3f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id66b9433de164aa588c8902b962f4437_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie80c09b9267b4debab194f8e3b070f1d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i585f906916e24788950b045daf6006d0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:RestrictedStockAwardsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1dc9e958a3743ed897181a2bcab4d8b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:RestrictedStockAwardsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c866a3da3ee4c01869b06d7863723bb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:RestrictedStockAwardsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c3c44f5e0b242eba976e925ee1e833c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:RestrictedStockAwardsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20f31a36244b4706ade54e9ea17fc52f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:ProfitInterestAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i146ec30e5c904ad4934dfa43202cd322_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3721dc48f90f43aaaedb4b9e4701785a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63c6b196f1234c5a926349599c036d07_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d7f255a3d184998b0bc0e47acd7a4bf_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i660a769e8c324a2cbb4a2c3aaaf0e8ba_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1ff576aa6cd420c9c34c4a3796b36df_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f1a54d8ee624903a58ab6e4a97f47c3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i782b4959ffc945c6b1b065f0b433ec10_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5aa816b1a8094167b4936dcee3a759ea_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc74194e61cc4c73a3ce9cb7361dcc5f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeb7a874665d45dea6e7487809034f00_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3578222b355449619cf1a71155f3985c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>zntl:lease</xbrli:measure></xbrli:unit><xbrli:context id="i356de632612e431284fab49bb34efaca_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i004976abe339457d8797c8a3f4268c32_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia727e9eb512a4899be678569e4be9e04_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia84faaa12cb04eed88b3628a273183ce_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida8eb8260bb84fffa3c3fc02e85ac4f2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8cbc6c76d0e4128b4e08d37495dc609_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie48938e7777e45829bfd62b464670e1d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5379b3f1fc91468e8557d8d058d3aaa3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f09d3ed0755408fa8b8594c78bbc16d_I20171221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">zntl:KalyraPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05c84f48e4c9416e9b68315685186678_I20171221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">zntl:KalyraPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2765153e500b4c2ea94087220a2f2cd0_D20171221-20171221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">zntl:KalyraPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-21</xbrli:startDate><xbrli:endDate>2017-12-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c0b35a7a7664cf0a904ddb853e834d5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">zntl:KalyraPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffe291a882a04056a3a61eec999af54f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:LicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10842b54d0d24a489e994b1893949958_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:LicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0db2a4af26634c05ae218afec38b427f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18d34a087a6f45069ed7552aa3fc34b1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf33597aac934769b0e7dc53e6692e7c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b68177d9165436bb2788988bec1574e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifedec654804d4a048412181632ffca4d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f9253d63b8a4572ac7ef410befd9a0b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17387c8daecd44fd832424bd3dff82a8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0625dd931fe6420b9f8753010dae2784_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001725160</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i359d7483f88b44aba6df295b4be37cde_1"></div><div style="min-height:0pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:21.250%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjgy_f90e1073-d8d6-4096-bbcb-f5d97d7851c9">10-Q</ix:nonNumeric></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:21.250%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjgz_f68bad6e-e786-4f2d-affc-d0be4503236f">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjQ_1aaa4e30-fa69-48f0-8e3c-c800334f3af0">September&#160;30, 2021</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjgw_d58cf542-7eba-4862-837c-6eb96820a549">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ___________________ to ___________________</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: </span><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjg5_196b6e51-7f90-4316-acd1-c5b1914430af">001-39263</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:21.250%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjg1_9b672d61-f908-4db2-a39f-248775dbb297">Zentalis Pharmaceuticals, Inc.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:21.250%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6YzhhYTEwNzdjMWIxNDk0ZDg4YjgxNjEwMTA3MGUwZTkvdGFibGVyYW5nZTpjOGFhMTA3N2MxYjE0OTRkODhiODE2MTAxMDcwZTBlOV8wLTAtMS0xLTE0NzQ1_dacf04bc-cc4d-4168-bad7-a6b30521121a">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6YzhhYTEwNzdjMWIxNDk0ZDg4YjgxNjEwMTA3MGUwZTkvdGFibGVyYW5nZTpjOGFhMTA3N2MxYjE0OTRkODhiODE2MTAxMDcwZTBlOV8wLTEtMS0xLTE0NzQ1_5d20e10c-dca8-4b69-88a8-e919f711882b">82-3607803</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(State or other jurisdiction of</span></div><div style="margin-bottom:0.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6YzhhYTEwNzdjMWIxNDk0ZDg4YjgxNjEwMTA3MGUwZTkvdGFibGVyYW5nZTpjOGFhMTA3N2MxYjE0OTRkODhiODE2MTAxMDcwZTBlOV8zLTAtMS0xLTE0NzQ1_29f6b004-e7cf-4e60-8df6-5c63be984809">530 Seventh Avenue,</ix:nonNumeric> </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6YzhhYTEwNzdjMWIxNDk0ZDg4YjgxNjEwMTA3MGUwZTkvdGFibGVyYW5nZTpjOGFhMTA3N2MxYjE0OTRkODhiODE2MTAxMDcwZTBlOV80LTAtMS0xLTE0NzQ1_0a6b1f8d-4c23-49a8-93ee-726823a04d27">Suite 2201</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6YzhhYTEwNzdjMWIxNDk0ZDg4YjgxNjEwMTA3MGUwZTkvdGFibGVyYW5nZTpjOGFhMTA3N2MxYjE0OTRkODhiODE2MTAxMDcwZTBlOV81LTAtMS0xLTE0NzQ1_2f11b608-de18-4e6b-a517-de544fbb212f">New York,</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;<ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6YzhhYTEwNzdjMWIxNDk0ZDg4YjgxNjEwMTA3MGUwZTkvdGFibGVyYW5nZTpjOGFhMTA3N2MxYjE0OTRkODhiODE2MTAxMDcwZTBlOV82LTAtMS0xLTE0NzQ1_54babf15-3e1d-4ed8-af5e-646413c280cd">New York</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6YzhhYTEwNzdjMWIxNDk0ZDg4YjgxNjEwMTA3MGUwZTkvdGFibGVyYW5nZTpjOGFhMTA3N2MxYjE0OTRkODhiODE2MTAxMDcwZTBlOV82LTEtMS0xLTE0NzQ1_1990820d-76d7-4e36-8b2a-c6afd14e2bdb">10018</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjkw_6e2b78ab-ddaf-47f9-b566-c6cc34164809">212</ix:nonNumeric>) <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjkx_a26ba223-93db-4200-a65b-5c3b7068e21b">433-3791</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:21.250%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6NTM2YWMzMDQ4ZGU5NDBkYzkwNDkwNzdjYWQ2ZWRmOWQvdGFibGVyYW5nZTo1MzZhYzMwNDhkZTk0MGRjOTA0OTA3N2NhZDZlZGY5ZF8xLTAtMS0xLTE0NzQ1_4f29187b-8704-478f-8fdd-f4dd4e99480a"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common Stock,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$0.001 par value per share</span></div></ix:nonNumeric></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6NTM2YWMzMDQ4ZGU5NDBkYzkwNDkwNzdjYWQ2ZWRmOWQvdGFibGVyYW5nZTo1MzZhYzMwNDhkZTk0MGRjOTA0OTA3N2NhZDZlZGY5ZF8xLTEtMS0xLTE0NzQ1_34395100-d7a5-44bf-aefb-f1df13784aa7">ZNTL</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6NTM2YWMzMDQ4ZGU5NDBkYzkwNDkwNzdjYWQ2ZWRmOWQvdGFibGVyYW5nZTo1MzZhYzMwNDhkZTk0MGRjOTA0OTA3N2NhZDZlZGY5ZF8xLTItMS0xLTE0NzQ1L3RleHRyZWdpb246ZThlNjY1NGVmNGVkNDI5MzlmMmZlYjRhMWUwYzQ0MzBfMjE5OTAyMzI1NTYzMw_f4d9c73a-cf2e-418f-9c2a-65f336517363">The Nasdaq Stock Market LLC</ix:nonNumeric> (Nasdaq Global Market)</span></div></td></tr></table></div><div style="margin-bottom:6pt;text-indent:28.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjky_8e3280fb-160c-44e3-96b4-6516c91cd225">Yes</ix:nonNumeric> &#9746;  &#160;No  &#9744;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjkz_bf61a475-7e56-4103-83f3-9da74a2cac14">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-bottom:3pt;text-indent:28.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.722%"><tr><td style="width:1.0%"></td><td style="width:34.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.995%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6M2E1MTAyZGI5OGFkNDRlMzg5NThmZGE5MDJmZDc2YTkvdGFibGVyYW5nZTozYTUxMDJkYjk4YWQ0NGUzODk1OGZkYTkwMmZkNzZhOV8xLTAtMS0xLTE0NzQ1_2cb5636c-8479-4a75-bcf6-73679b96e821">Non-accelerated Filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6M2E1MTAyZGI5OGFkNDRlMzg5NThmZGE5MDJmZDc2YTkvdGFibGVyYW5nZTozYTUxMDJkYjk4YWQ0NGUzODk1OGZkYTkwMmZkNzZhOV8xLTQtMS0xLTE0NzQ1_bc95c1b2-016c-4a57-b1d0-5f1ad1e814cc">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6M2E1MTAyZGI5OGFkNDRlMzg5NThmZGE5MDJmZDc2YTkvdGFibGVyYW5nZTozYTUxMDJkYjk4YWQ0NGUzODk1OGZkYTkwMmZkNzZhOV8yLTQtMS0xLTE0NzQ1_0090e636-334c-44b2-9e3a-0c62a9763528">&#9746;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-indent:28.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjg2_4c46b167-90c9-44a7-b221-7fc58de2a954">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-indent:28.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjgx_f2392daa-332f-44e3-81e0-44676928a4c8">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="margin-bottom:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of November 9, 2021, the registrant had <ix:nonFraction unitRef="shares" contextRef="i686a0fdf3788449f8f91bd94b936f1fb_I20211109" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjEy_7c60aadc-67b8-493b-bbd3-8bd3faa6223d">45,305,544</ix:nonFraction> shares of common stock, $0.001 par value per share, outstanding.</span></div><div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:0pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_16">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_16">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_19">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_19">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_22">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_22">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_25">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_25">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_28">Condensed Consolidated Statements of Comprehensive Loss</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_28">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_31">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_31">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_34">Condensed Consolidated Statement of Members&#8217; Equity (Deficit) and Changes in Redeemable Convertible Preferred Stock </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_34">9</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_37">Notes to Condensed Consolidated Financial Statements </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_37">13</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_79">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_79">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_82">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_82">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_85">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_85">48</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_88">OTHER INFORMATION</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_88">49</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_91">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_91">49</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_94">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_94">49</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_97">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_97">111</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_100">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_100">111</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_103">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_103">111</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_106">Other Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_106">111</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_109">Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_109">111</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_112">Signatures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i359d7483f88b44aba6df295b4be37cde_112">113</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. All statements other than statements of historical facts contained in this Quarterly Report are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. All statements other than statements of historical fact contained in this Quarterly Report, including without limitation statements regarding our future results of operations and financial position, the anticipated impact of the COVID-19 pandemic on our business, the sufficiency of our cash and cash equivalents to fund our operations, business strategy, prospective products and product candidates, clinical trial timelines and expected timing for the release of data, research and development costs, future revenue, timing and likelihood of success, activities under our existing collaborations and potential collaboration opportunities, and plans and objectives of management are forward-looking statements.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements in this Quarterly Report are only predictions and are based largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this Quarterly Report and are subject to a number of known and unknown risks, uncertainties, assumptions and other important factors, including those described under &#8220;Summary Risk Factors&#8221; below and in the sections in this Quarterly Report entitled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and elsewhere in this Quarterly Report.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY RISK FACTORS</span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to numerous risk and uncertainties, including those described in Part II, Item 1A. &#8220;Risk Factors&#8221; in this Quarterly Report on Form 10-Q. You should carefully consider these risk and uncertainties when investing in our common stock. These principal risks and uncertainties affecting our business include the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;We have a limited operating history, have not completed any clinical trials and have no products approved for commercial sale, which may make it difficult for you to evaluate our current business and predict our future success and viability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;We have incurred significant net losses since inception and we expect to continue to incur significant net losses for the foreseeable future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;We will require substantial additional capital to finance our operations. If we are unable to raise such capital when needed, or on acceptable terms, we may be forced to delay, reduce or eliminate one or more of our research and drug development programs or future commercialization efforts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;We are substantially dependent on the success of our lead product candidates, ZN-c3 and ZN-c5, which are currently in clinical trials. If we are unable to complete development of, obtain approval for and commercialize ZN-c3 and/or ZN-c5 in a timely manner, our business will be harmed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;The outcome of preclinical testing and early clinical trials may not be predictive of the success of later clinical trials, and the results of our clinical trials may not satisfy the requirements of the FDA, EMA or other comparable foreign regulatory authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;We may face additional risks associated with the development of ZN-c3, ZN-c5, ZN-d5, ZN-e4 and potentially other product candidates in combination with other therapies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;The clinical trial and regulatory approval processes are lengthy, time-consuming and inherently unpredictable, and we may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of our product candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;The competition for qualified personnel is particularly intense in our industry. If we are unable to retain or hire key personnel, then we may not be able to sustain or grow our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;We face significant competition and, if our competitors develop and market technologies or products more rapidly than we do or that are more effective, safer or less expensive than the product candidates we develop, our commercial opportunities will be negatively impacted.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;Our success depends on our ability to protect our intellectual property and our proprietary platform. If we are unable to adequately protect our intellectual property and our proprietary platform, or to obtain and maintain issued patents which are sufficient to protect our product candidates, then others could compete against us more directly, which would negatively impact our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;Our existing collaborations are important to our business and future licenses may also be important to us and, if we are unable to maintain any of these collaborations, or if these arrangements are not successful, our business could be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;We rely, and expect to continue to rely, on third parties, including independent clinical investigators and CROs, to conduct certain aspects of our preclinical studies and clinical trials. If these third parties do not successfully carry out their contractual duties, comply with applicable regulatory requirements or meet expected deadlines, we may not be able to obtain regulatory approval for or commercialize our product candidates and our business could be substantially harmed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;Our commercial success depends significantly on our ability to operate without infringing the patents and other proprietary rights of third parties. Claims by third parties that we infringe their proprietary rights may result in liability for damages or prevent or delay our development and commercialization efforts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;The COVID-19 pandemic has adversely impacted, and we expect will continue to adversely impact, our business, including our preclinical studies and clinical trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;Risks related to our ceasing to qualify as an emerging growth company after December 31, 2021.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_13"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BASIS OF PRESENTATION</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this Quarterly Report on Form 10-Q, unless the context otherwise requires, references to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company,&#8221; &#8220;Zentalis&#8221; and similar references refer: (1) following the consummation of our statutory conversion to a Delaware corporation on April 2, 2020 in connection with our initial public offering, to Zentalis Pharmaceuticals, Inc., and (2) prior to the completion of such conversion, to Zentalis Pharmaceuticals, LLC. See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations &#8212; Corporate Conversion&#8221; in this Quarterly Report on Form 10-Q for further information.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_16"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements.</span></div><div id="i359d7483f88b44aba6df295b4be37cde_22"></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zentalis Pharmaceuticals, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share amounts and par value)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNC0xLTEtMS0xNDc0NQ_9a1d5fbc-6a26-40e7-a04e-8748d70f9bd2">40,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNC0zLTEtMS0xNDc0NQ_c6d1898d-bc14-4def-a7be-6caf76338325">54,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities, available-for-sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNS0xLTEtMS0xNDc0NQ_b3f69078-ee33-430c-9bd5-48b6b7fb0307">325,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNS0zLTEtMS0xNDc0NQ_c389cfed-30ae-435b-a7d6-c032b368a605">283,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable from government grants, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNi0xLTEtMS0xNDc0NQ_80ace361-5347-454f-8087-8389712e1d26">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNi0zLTEtMS0xNDc0NQ_61773737-d157-4f7f-ae60-1b3345445879">417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNy0xLTEtMS0xNDc0NQ_8292ac3a-81bb-42e9-9c9e-34feffc41043">10,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNy0zLTEtMS0xNDc0NQ_07b35918-540f-47f1-8366-e7e73384ba63">6,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfOC0xLTEtMS0xNDc0NQ_a5bb74ea-a31a-4268-8707-d58c4c33bea0">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfOC0zLTEtMS0xNDc0NQ_d839ec51-d526-4305-bba3-c75146d5c64a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfOS0xLTEtMS0xNDc0NQ_9ddf0a15-3dee-458f-84de-a4d8ec7765df">377,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfOS0zLTEtMS0xNDc0NQ_13bb204c-4a0a-44da-b2cb-8a28eae92a40">345,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTAtMS0xLTEtMTQ3NDU_bef24cd6-5bee-40c3-b799-14761943ad51">4,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTAtMy0xLTEtMTQ3NDU_ae4131fb-b131-4828-a68a-7d5b7338138a">1,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease&#160;right-of-use&#160;assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTEtMS0xLTEtMTQ3NDU_5dd287b3-4fec-417b-bd6d-20e4350e3768">693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTEtMy0xLTEtMTQ3NDU_c42f12e1-a7b6-4a3c-9dce-2cc30669e41a">2,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTItMS0xLTEtMTQ3NDU_2cb543a3-f319-4965-bcf0-4175be868576">6,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTItMy0xLTEtMTQ3NDU_01c1c32b-646e-4ad6-b15c-114203f5660e">2,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTQtMS0xLTEtMTQ3NDU_1c5f8666-63f0-4f18-843c-0f25a14854d1">3,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTQtMy0xLTEtMTQ3NDU_0be75ae2-e76c-4892-8a76-6d0c35a52836">3,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process&#160;research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTUtMS0xLTEtMTQ3NDU_160b4a26-28ab-4d1c-8299-ff7e35f3e59f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTUtMy0xLTEtMTQ3NDU_812a8e9d-e03d-4a99-8746-90a86417e155">8,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment in Zentera Therapeutics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTYtMS0xLTEtMTg2NTI_7b581748-ae02-487f-a0c7-2172c50e70e5">39,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTYtMy0xLTEtMTg2NTI_74e6a322-22e0-4417-af64-f994a0e28adb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTYtMS0xLTEtMTQ3NDU_c598e7ab-2a1d-4c0b-b401-5f3ccb857462">3,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTYtMy0xLTEtMTQ3NDU_64c91e65-eff2-43c9-8d12-2a5672298db0">1,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTctMS0xLTEtMTQ3NDU_ca824d8d-38b2-4d90-bfe7-6de7b21c6e1c">435,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTctMy0xLTEtMTQ3NDU_f259581b-2b9e-4eb6-9003-427fcf52f6e3">365,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIABILITIES&#160;AND&#160;STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjAtMS0xLTEtMTQ3NDU_13665f63-1803-4a96-8cd0-893cd4033166">8,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjAtMy0xLTEtMTQ3NDU_e7d70a8e-db1b-4fbf-b1ce-d03cdc9334ae">8,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjEtMS0xLTEtMTQ3NDU_99388628-8bd7-481e-b0a0-c4e74a83a529">31,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjEtMy0xLTEtMTQ3NDU_17f80cab-109b-4d49-a889-59a5afbb7e4c">19,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjItMS0xLTEtMTQ3NDU_83a7c6ee-fbd6-4ca2-99ce-d8f677764894">39,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjItMy0xLTEtMTQ3NDU_92639f9e-0d97-4c44-8a00-391aa583d57e">28,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjMtMS0xLTEtMTQ3NDU_04b8a829-ecc0-43be-804c-e97a2c41005e">1,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjMtMy0xLTEtMTQ3NDU_297c4ac8-d7bd-47c5-9d0e-8e5cfffd93de">2,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjQtMS0xLTEtMTQ3NDU_fb462883-87c7-4311-9003-80a2ac4659ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjQtMy0xLTEtMTQ3NDU_b40adc68-2558-41f4-bb3f-7a22bfb89849">1,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjUtMS0xLTEtMTQ3NDU_c9021c16-6f3d-485c-aa35-6bff3a0b3267">41,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjUtMy0xLTEtMTQ3NDU_cf14046c-d76d-4e2c-8260-f29c8ffab951">32,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjYtMS0xLTEtMTQ3NDU_bd8e36a9-7a28-4007-ab17-3e57927be3ef"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjYtMy0xLTEtMTQ3NDU_c430a6ee-d3ac-479f-9aac-6ef3c687a15a"></ix:nonFraction></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N18yMQ_376f5282-b172-4cd5-8e04-67a2ec944c81"><ix:nonFraction unitRef="usdPerShare" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N18yMQ_3be04851-43a5-4480-87e8-904d7185457a">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N18zNQ_44413d30-e9aa-4215-abeb-0b599f5a85d9"><ix:nonFraction unitRef="shares" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N18zNQ_b21aff87-66e3-4c6d-bd29-e1b49f53fe7b">10,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N181Nw_7c2e00e8-25f1-4f7d-b38c-e22955b9c116"><ix:nonFraction unitRef="shares" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N181Nw_aaa082f4-0ac3-40ed-afdd-86355a6c63fe"><ix:nonFraction unitRef="shares" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N181Nw_d7863ad4-2272-49fa-b008-3bdae87de3b4"><ix:nonFraction unitRef="shares" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N181Nw_f8270dc6-60fc-47c6-830d-a68a515945c8">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at September&#160;30, 2021 and December 31, 2020 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMS0xLTEtMTQ3NDU_b5ea6d29-7d58-42c7-a4ec-e20ecc975f13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMy0xLTEtMTQ3NDU_fc2bba37-79f8-4d98-afa2-29c92ae74f34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl8xOA_b2a90d3f-49f3-47e2-9766-0366cff5fcb4"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl8xOA_d469acb2-60c8-4a9c-8132-f9af62134e69">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl8zMg_1404a944-26d9-4712-bc22-d4f34dc5fda1"><ix:nonFraction unitRef="shares" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl8zMg_3b85beab-fd23-4952-bb69-f25bd2359f24">250,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl81NA_711b1c6a-4a6c-467d-bbce-88eb0dc9a337"><ix:nonFraction unitRef="shares" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl81NA_7bb9f660-57ab-4643-b5a7-3c6f0998328c">45,198,528</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl82MQ_f17c97a2-61db-4847-aada-45771e6477da"><ix:nonFraction unitRef="shares" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl82MQ_fec00b92-0956-4eaf-842d-63926158d904">41,040,286</ix:nonFraction></ix:nonFraction> shares issued and outstanding at September&#160;30, 2021 and December 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMS0xLTEtMTQ3NDU_20f6c75f-fd5b-4416-9fee-b3ef097cf00a">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMy0xLTEtMTQ3NDU_1b26066d-56e4-470e-95e9-28f25d11d688">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzMtMS0xLTEtMTQ3NDU_373bfff4-bcf9-4f12-b04a-0051f7778d50">702,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzMtMy0xLTEtMTQ3NDU_ecc48dd4-f57f-45e8-9c30-10cf5fd3923c">509,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzQtMS0xLTEtMTQ3NDU_5d7b2a21-933a-4854-98a2-f8edadd5432c">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzQtMy0xLTEtMTQ3NDU_9451a3a5-21c0-423c-9bcb-86be8c994687">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzUtMS0xLTEtMTQ3NDU_f824944d-c22f-498c-98b3-8f0f2765645b">309,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzUtMy0xLTEtMTQ3NDU_95636bd8-ea79-499e-8212-ebb5c8606487">200,834</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzYtMS0xLTEtMTQ3NDU_ac3574e1-e930-456d-ba49-7787196af85c">393,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzYtMy0xLTEtMTQ3NDU_62379c68-acc6-48c8-a9b4-d56227fea2be">308,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzctMS0xLTEtMTQ3NDU_91c757fc-a030-4775-9d18-4bb284a3d603">564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzctMy0xLTEtMTQ3NDU_7883bf9f-a172-4e97-91ee-a0f257f7cc00">24,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzgtMS0xLTEtMTQ3NDU_ee05580a-3b3b-4308-8b6e-4e64e124a16e">393,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzgtMy0xLTEtMTQ3NDU_af5ab65f-2cb3-4d19-826e-ac1baf71356e">333,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzktMS0xLTEtMTQ3NDU_3faa6c0c-e0bc-4c14-ac7d-226807b57c8e">435,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzktMy0xLTEtMTQ3NDU_a0887cf9-9dc3-4788-bb86-e076af38b311">365,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zentalis Pharmaceuticals, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except per share amounts)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMy0xLTEtMS0xNDc0NQ_e9d61928-e7c6-4060-b8d0-b96aae228c1b">53,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMy0zLTEtMS0xNDc0NQ_bea7bfa7-4e6f-4879-8083-1432056bfa1f">24,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMy01LTEtMS0xNDc0NQ_0f7d2e57-0fa8-4091-8019-a959e2985cc0">137,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMy03LTEtMS0xNDc0NQ_becc6651-3a78-4c0b-99d1-0fbe6afc14bb">55,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNC0xLTEtMS0xNDc0NQ_3d53eda9-3c2c-439f-b6c7-15f521e77f22">8,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNC0zLTEtMS0xNDc0NQ_6ea0e3a7-bb03-4aef-950a-d995f94e6e4d">10,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNC01LTEtMS0xNDc0NQ_85c36a3d-3e36-440b-ba83-ace628163590">31,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNC03LTEtMS0xNDc0NQ_0371ac7a-c1a7-4051-9bb5-15f1762f9318">23,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNS0xLTEtMS0xNDc0NQ_7f4cf3ed-0d67-4356-888b-439a61caa093">62,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNS0zLTEtMS0xNDc0NQ_bab71868-d276-4be0-a0c9-fdac518c5d7a">34,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNS01LTEtMS0xNDc0NQ_013a4b3d-91d3-4441-97c8-6d66f4ac88cd">168,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNS03LTEtMS0xNDc0NQ_c11eae79-0e75-439c-9972-cc24af7a5ac0">78,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNi0xLTEtMS0xNDc0NQ_54c068cc-00d9-4cd7-914a-2d78da0149e9">62,870</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNi0zLTEtMS0xNDc0NQ_c4e11e3c-e021-4a3a-a3c3-77dd2b29a2d4">34,767</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNi01LTEtMS0xNDc0NQ_e8741745-5e6a-469a-b686-d70446e34031">168,349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNi03LTEtMS0xNDc0NQ_da284065-a311-4ebc-a000-5c7fb4f21549">78,542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Income (Expense)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfOC0xLTEtMS0xNDc0NQ_50af70bb-d46b-4456-9d41-a42144457054">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfOC0zLTEtMS0xNDc0NQ_b0b7c9b3-6b45-4eff-a188-db065ccf7155">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfOC01LTEtMS0xNDc0NQ_8f9e4553-ee92-4a95-88ae-65310e63fbfe">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfOC03LTEtMS0xNDc0NQ_8bc2b0c9-2f76-4070-98ca-1258e2d49365">368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on deconsolidation of Zentera</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeconsolidationGainOrLossAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtMS0xLTEtMjIwNDU_40a88a0f-c330-4cf4-b3a1-511b7939ed4b">51,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DeconsolidationGainOrLossAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtMy0xLTEtMjIwNDU_e74bdc95-5b8a-45de-9864-2f13d2d31aae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeconsolidationGainOrLossAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtNS0xLTEtMjIwNDU_7dd73cf0-ece2-4c6e-a992-35c18eb4e5d4">51,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DeconsolidationGainOrLossAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtNy0xLTEtMjIwNDU_b6b5cefd-936e-4ed9-91b7-63f4052a0c03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtMS0xLTEtMTQ3NDU_b806bc5c-54ae-4739-80be-f2302d7b1160">11,189</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtMy0xLTEtMTQ3NDU_46979cec-7930-4954-95db-fbb684f1b503">34,647</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtNS0xLTEtMTQ3NDU_de67936a-dc5f-4601-bb31-3cd66fefeeea">116,454</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtNy0xLTEtMTQ3NDU_199db44e-f3be-41dd-b48a-2df0f161dfcc">78,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTEtMS0xLTEtMTQ3NDU_23cb8926-441c-4578-9a91-d98b0a3c8a22">697</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTEtMy0xLTEtMTQ3NDU_97529ea4-251e-49e2-821c-1ce6835c19de">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTEtNS0xLTEtMTQ3NDU_52b06729-cc21-44dc-b02e-55b9dd1ca90e">456</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTEtNy0xLTEtMTQ3NDU_2599104d-0c9f-4282-83ea-7b5f402cb397">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTItMS0xLTEtMTQ3NDU_27aa6c4c-b4e4-4915-9b1f-9c017d958879">10,492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTItMy0xLTEtMTQ3NDU_88e546e8-3d77-418f-8658-4f5fdd39e0a4">34,665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTItNS0xLTEtMTQ3NDU_683ab1a1-d21a-4b72-b6b8-2765a1e17324">115,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTItNy0xLTEtMTQ3NDU_abaf28f6-5fea-4f77-b99b-3a6efd09151f">78,192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTMtMS0xLTEtMTQ3NDU_8bcd180d-6667-4486-89ef-17ed02386d92">6,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTMtMy0xLTEtMTQ3NDU_9d89abc9-44bd-4a6f-bb58-9457cd877467">110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTMtNS0xLTEtMTQ3NDU_be315c56-f6bc-4356-b71e-d4efaa7260ca">7,332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTMtNy0xLTEtMTQ3NDU_1e6bc51f-e6cd-457c-9cba-797a47f0b59c">654</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Zentalis </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTQtMS0xLTEtMTQ3NDU_f13bff4d-1e65-479b-88e4-a37ce93b12b9">4,191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTQtMy0xLTEtMTQ3NDU_49a1920f-ce94-44af-88a8-89ec12e5a88b">34,555</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTQtNS0xLTEtMTQ3NDU_b916f6dd-5996-4323-8749-ceec7e480970">108,666</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTQtNy0xLTEtMTQ3NDU_d2359ef9-6b76-4ca8-a5a6-da17a3e45bf4">77,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share outstanding, basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtMS0xLTEtMTQ3NDU_2b0b978e-174a-4107-bc17-3a5cc4f3f3a5"><ix:nonFraction unitRef="usdPerShare" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtMS0xLTEtMTQ3NDU_b6ebfc08-94fd-47dc-9524-19b00a84af9e">0.09</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtMy0xLTEtMTQ3NDU_84a090c6-1bc7-42a5-9dce-17bc429dfd56"><ix:nonFraction unitRef="usdPerShare" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtMy0xLTEtMTQ3NDU_989aa5d0-c338-447b-a174-7b2bbf7fb781">0.91</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtNS0xLTEtMTQ3NDU_11bb3597-2cd1-4bf9-84e8-a07c74d6e8ab"><ix:nonFraction unitRef="usdPerShare" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtNS0xLTEtMTQ3NDU_d3adbdf9-625b-4ddb-b0ac-fe1ad30b750b">2.59</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtNy0xLTEtMTQ3NDU_21ecf7e9-a45c-441b-a25a-183d70213732"><ix:nonFraction unitRef="usdPerShare" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtNy0xLTEtMTQ3NDU_92d88857-ecda-494a-9184-9b29176d07fd">3.21</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares used in computing net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctMS0xLTEtMTQ3NDU_251943e7-c4ff-4e30-aceb-e0b0b097569a"><ix:nonFraction unitRef="shares" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctMS0xLTEtMTQ3NDU_7e48f6f3-6f3b-43db-9fc9-de74c5be139d">44,609</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctMy0xLTEtMTQ3NDU_3b3feb87-0aba-4163-84ed-cb50991b3450"><ix:nonFraction unitRef="shares" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctMy0xLTEtMTQ3NDU_9774cd21-b11f-4141-a589-6f99c8effb38">37,959</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctNS0xLTEtMTQ3NDU_6343a55f-ccd8-4a85-abf2-5eb87ae5eca4"><ix:nonFraction unitRef="shares" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctNS0xLTEtMTQ3NDU_d963b575-0235-4329-b4ba-7bb051189ddd">41,918</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctNy0xLTEtMTQ3NDU_06eec7e6-084b-466a-aa6b-58faafb27330"><ix:nonFraction unitRef="shares" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctNy0xLTEtMTQ3NDU_87eea78e-68f4-4fe4-a6e9-618aa37a2db4">24,143</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zentalis Pharmaceuticals, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfMi0xLTEtMS0xNDc0NQ_27aa6c4c-b4e4-4915-9b1f-9c017d958879">10,492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfMi0zLTEtMS0xNDc0NQ_88e546e8-3d77-418f-8658-4f5fdd39e0a4">34,665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfMi01LTEtMS0xNDc0NQ_683ab1a1-d21a-4b72-b6b8-2765a1e17324">115,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfMi03LTEtMS0xNDc0NQ_abaf28f6-5fea-4f77-b99b-3a6efd09151f">78,192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation effects</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNC0xLTEtMS0xNDc0NQ_e12c1e32-eb3b-4de5-93af-fe9e5faed0a9">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNC0zLTEtMS0xNDc0NQ_06199c77-9602-4161-b420-3a824cd4fa1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNC01LTEtMS0xNDc0NQ_28aced20-f677-4695-bec2-c4c90e4e6895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNC03LTEtMS0xNDc0NQ_e0d1e94a-5770-44c6-898d-14a96ef28ad5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNS0xLTEtMS0xNDc0NQ_a9bb767b-8493-4db0-ada2-4af0bf9356e8">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNS0zLTEtMS0xNDc0NQ_f0bef178-68b7-4594-a9f3-7d0b08524f51">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNS01LTEtMS0xNDc0NQ_a80f1ab6-fde8-479e-9402-7e041bec4f3e">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNS03LTEtMS0xNDc0NQ_5fba4d91-3065-48e8-8cf9-6f6c65b0e049">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNi0xLTEtMS0xNDc0NQ_f4c43b5b-0cea-4001-909e-199adb983fce">10,554</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNi0zLTEtMS0xNDc0NQ_3abc958c-2d65-433b-b014-852780d6bcc7">34,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNi01LTEtMS0xNDc0NQ_24ad24ca-b599-469d-b230-8d0eaaf783bc">116,002</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNi03LTEtMS0xNDc0NQ_22445d4d-ee79-4c5a-b279-c2e85d82fa96">78,169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNy0xLTEtMS0xNDc0NQ_9802bde4-3562-438b-947f-962e761c3822">6,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNy0zLTEtMS0xNDc0NQ_ada79f2e-193f-40fd-bd20-61f0243a7890">110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNy01LTEtMS0xNDc0NQ_f9c8bbc9-7142-424b-9279-cd27872fcd34">7,332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNy03LTEtMS0xNDc0NQ_9af60984-666e-4149-814f-700dd5a028ca">654</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss attributable to Zentalis</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfOC0xLTEtMS0xNDc0NQ_9e9c500c-aa6a-4d6c-a3bb-7030fdf1db72">4,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfOC0zLTEtMS0xNDc0NQ_15905471-5f20-4247-9d56-7967942e9e9f">34,536</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfOC01LTEtMS0xNDc0NQ_97092440-1f60-42b3-983b-cd59bf513975">108,670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfOC03LTEtMS0xNDc0NQ_39034b85-55ce-4445-a2bd-86664beb4cd4">77,515</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_31"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zentalis Pharmaceuticals, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="margin-bottom:1pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMy0xLTEtMS0xNDc0NQ_97ab0bfa-fb46-4eb8-8fab-24debc07be70">115,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMy0zLTEtMS0xNDc0NQ_3ae128d3-dcca-4a0b-a75a-359debb9ae22">78,192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNS0xLTEtMS0xNDc0NQ_53279301-e5ca-4d3a-b8a1-b1e91abd82fe">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNS0zLTEtMS0xNDc0NQ_c285ff90-fee6-49d3-9700-f0c0b64fddd0">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNi0xLTEtMS0yMDcwMg_72db40d7-e60d-4a3e-ae49-8b2001551de4">8,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNi0zLTEtMS0yMDcwMg_6f34133d-08bc-4cd1-8c2e-34e044790285">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized tax gain on IPR&amp;D impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="zntl:RecognizedTaxGainOnIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNy0xLTEtMS0yMDcyOA_25771027-1c54-4698-8daf-3a1a2d6566b4">2,462</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="zntl:RecognizedTaxGainOnIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNy0zLTEtMS0yMDcyOA_ceaa69cd-315e-4974-9643-92b9db81a5b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on deconsolidation of Zentera, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="zntl:DeconsolidationGainLossAmountNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfOC0xLTEtMS0yMDcyOA_f0a9d5d3-3a88-45cb-a3ad-b859b21dfd30">49,930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="zntl:DeconsolidationGainLossAmountNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfOC0zLTEtMS0yMDcyOA_f33b68f1-d885-4ef7-88e5-a2560fcace73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNi0xLTEtMS0xNDc0NQ_38b8c23e-278f-415f-9105-d28b4f38bb8a">27,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNi0zLTEtMS0xNDc0NQ_fbea398d-63b6-4d5e-a5e1-fbb3b0d89e24">15,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNy0xLTEtMS0xNDc0NQ_c9b0fd88-e43a-41a4-a61c-688085acd1dd">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNy0zLTEtMS0xNDc0NQ_06b0131f-7602-43c8-94b4-30eb881a530b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of premiums on marketable securities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfOC0xLTEtMS0xNDc0NQ_5515e6c9-9401-431d-b8b7-22cfc2767e90">712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfOC0zLTEtMS0xNDc0NQ_8346fff7-d4af-45de-a74e-e34e95b55aad">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTAtMS0xLTEtMTQ3NDU_70f235c0-8cbb-4c19-9826-fb95b10d256f">309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTAtMy0xLTEtMTQ3NDU_02a99458-c807-4d7d-8f71-4bdbbb05a6a6">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTEtMS0xLTEtMTQ3NDU_75ada077-1b6b-4ce1-92cc-e9eef1444f34">1,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTEtMy0xLTEtMTQ3NDU_c1e89f90-43a5-40ce-9abd-e1ab9dd2f491">5,784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTItMS0xLTEtMTQ3NDU_d1d11daa-6e3a-4f7b-8f11-d57bc15e9285">12,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTItMy0xLTEtMTQ3NDU_0843cd12-6c6b-4efe-b2c0-227d8804aee9">9,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets and liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" name="zntl:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTMtMS0xLTEtMTQ3NDU_7c06fb20-d492-486d-a7ff-cc66fb733b20">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" name="zntl:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTMtMy0xLTEtMTQ3NDU_b31337af-abc4-4baf-8092-46c74cb8c50c">169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTQtMS0xLTEtMTQ3NDU_449201fd-6714-40d8-aabf-c995cb1e5bca">117,072</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTQtMy0xLTEtMTQ3NDU_1a55bac2-1a5f-4d99-ad69-b49b6df4256b">59,468</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTYtMS0xLTEtMTQ3NDU_28d07dc8-0cc2-41bc-ad0c-a79eebf843b8">280,285</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTYtMy0xLTEtMTQ3NDU_a91799f9-004b-4534-a914-89f24f2cc99f">304,085</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from maturities of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTctMS0xLTEtMTQ3NDU_5373d9d9-048b-4b41-989e-373a4b57da62">237,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTctMy0xLTEtMTQ3NDU_aec2f067-9ccf-48c6-bb21-86980daf751e">29,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deconsolidation of Zentera cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashDivestedFromDeconsolidation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjEtMS0xLTEtMjIxMDY_5073af31-9bb8-47f2-9bee-4935b2db285d">14,320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashDivestedFromDeconsolidation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjEtMy0xLTEtMjIxMDg_dd2873df-ad0f-4335-a04e-c4ee02b94e06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTgtMS0xLTEtMTQ3NDU_89b4a9a3-350a-4568-8ac0-6c2c99c40bdd">3,916</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTgtMy0xLTEtMTQ3NDU_5dbecfaf-d32f-4022-bb9d-79974c19de01">97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTktMS0xLTEtMTQ3NDU_f0496607-f35a-47e8-bc44-782372453ddb">61,382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTktMy0xLTEtMTQ3NDU_59d79458-52a6-4648-9f7d-5ae861aa7f5e">275,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock in initial public offering, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjEtMS0xLTEtMTQ3NDU_d0a6a0d6-88f7-4fbf-9586-b775c0235e16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjEtMy0xLTEtMTQ3NDU_60fdc34d-c7cb-46df-8145-68706d3fd0ed">172,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock under equity incentive plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjItMS0xLTEtMTQ3NDU_1912b122-d4c4-476a-978f-30d0d381bb19">4,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjItMy0xLTEtMTQ3NDU_486a73ad-661a-4dd6-97f9-8823f1ce5740">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions from noncontrolling interest owners, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjMtMS0xLTEtMTQ3NDU_f3fdc842-c4eb-4d7c-a4c6-16b6c6db68d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjMtMy0xLTEtMTQ3NDU_d2036ea3-393a-4ae4-b3fc-4cdd3e6027cc">18,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjctMS0xLTEtMjEzMzA_967c035c-346c-469b-a7bb-80d0fdbd8dd9">162,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjctMy0xLTEtMjEzMzA_092f1d0f-9309-46e6-9a49-d9f2d1f09d41">155,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from the issuance of Series C convertible preferred units, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjQtMS0xLTEtMTQ3NDU_2961488d-494f-41d5-990d-59d89ae50217">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjQtMy0xLTEtMTQ3NDU_3c1b8046-75bc-4b10-b8eb-387edc7018c3">14,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjYtMS0xLTEtMTQ3NDU_ec2dbd18-d133-4c09-8975-fdc9d5db583a">166,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjYtMy0xLTEtMTQ3NDU_845ad266-d18b-46ad-84f8-23f7df572818">361,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase/(decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjctMS0xLTEtMTQ3NDU_dfb085cd-c751-4a13-9903-42321a1a95f9">12,200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjctMy0xLTEtMTQ3NDU_44e1c683-6f00-4817-a99e-dc5730bb0684">26,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjgtMS0xLTEtMTQ3NDU_ef5373e8-43c2-43b1-9bf3-5ae180b00679">56,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8ce9f01da84935a62e807401cc9cae_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjgtMy0xLTEtMTQ3NDU_89633d10-4b3c-4c5a-94e1-f8da58f10f80">67,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjktMS0xLTEtMTQ3NDU_85c032aa-8e0a-4453-973a-a9b12b9c020a">44,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bf6807e17f4804bb968d10045ac403_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjktMy0xLTEtMTQ3NDU_b9d28641-585e-4b6e-9e57-5410f10c9e40">93,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosure of&#160;non-cash&#160;investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred in connection with initial public offering included in accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="zntl:StockIssuanceCostsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMzMtMS0xLTEtMTQ3NDU_fa277454-98b2-4c16-8299-bd2034adfcdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" name="zntl:StockIssuanceCostsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMzMtMy0xLTEtMTQ3NDU_5a4c575f-19f0-4489-99d8-41e012353ee1">594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:7pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:7pt;text-indent:18pt"><span><br/></span></div><div style="margin-top:7pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the Consolidated Statements of Cash Flows for the periods presented:</span></div><div style="margin-bottom:1pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmM0ZDhmMWY3ODY1NTQ2OWY4OGY4Y2YwMjVkM2Y3ODY1L3RhYmxlcmFuZ2U6YzRkOGYxZjc4NjU1NDY5Zjg4ZjhjZjAyNWQzZjc4NjVfMi0xLTEtMS0xNDc0NQ_775db411-2bfe-4720-97d8-722887f1d24d">40,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bf6807e17f4804bb968d10045ac403_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmM0ZDhmMWY3ODY1NTQ2OWY4OGY4Y2YwMjVkM2Y3ODY1L3RhYmxlcmFuZ2U6YzRkOGYxZjc4NjU1NDY5Zjg4ZjhjZjAyNWQzZjc4NjVfMi0zLTEtMS0xNDc0NQ_156e4837-770c-483f-a7d6-94f18fcf378f">92,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmM0ZDhmMWY3ODY1NTQ2OWY4OGY4Y2YwMjVkM2Y3ODY1L3RhYmxlcmFuZ2U6YzRkOGYxZjc4NjU1NDY5Zjg4ZjhjZjAyNWQzZjc4NjVfMy0xLTEtMS0xNDc0NQ_449f145b-2069-46f7-a084-3e493111da38">3,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bf6807e17f4804bb968d10045ac403_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmM0ZDhmMWY3ODY1NTQ2OWY4OGY4Y2YwMjVkM2Y3ODY1L3RhYmxlcmFuZ2U6YzRkOGYxZjc4NjU1NDY5Zjg4ZjhjZjAyNWQzZjc4NjVfMy0zLTEtMS0xNDc0NQ_99bdcb84-7b96-40a2-9ba8-496e7abc1163">1,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash reported in the Condensed Consolidated Statement of Cash Flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmM0ZDhmMWY3ODY1NTQ2OWY4OGY4Y2YwMjVkM2Y3ODY1L3RhYmxlcmFuZ2U6YzRkOGYxZjc4NjU1NDY5Zjg4ZjhjZjAyNWQzZjc4NjVfNC0xLTEtMS0xNDc0NQ_a2e99c4b-b942-4a19-9e28-61cb67011202">44,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bf6807e17f4804bb968d10045ac403_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmM0ZDhmMWY3ODY1NTQ2OWY4OGY4Y2YwMjVkM2Y3ODY1L3RhYmxlcmFuZ2U6YzRkOGYxZjc4NjU1NDY5Zjg4ZjhjZjAyNWQzZjc4NjVfNC0zLTEtMS0xNDc0NQ_10c6ea5c-57d7-4d0a-8532-2234c56cd673">93,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_34"></div><hr style="page-break-after:always"/><div style="min-height:0pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zentalis Pharmaceuticals, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Members&#8217;/Stockholders&#8217; Equity(Deficit) and Changes in Redeemable Convertible Preferred Units</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.925%"><tr><td style="width:1.0%"></td><td style="width:34.071%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.606%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.481%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.249%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Noncontrolling</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5479652c5e8948eea76ed85f21cb8d7e_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNC0xLTEtMS0xNDc0NQ_a2d31575-99ca-478c-9908-10fdd70f7dcc">41,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5479652c5e8948eea76ed85f21cb8d7e_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNC0zLTEtMS0xNDc0NQ_eb54d6d1-7b7a-4df9-a2d9-231ab3d25d74">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce0517364924372a750c28c212342ce_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNC01LTEtMS0xNDc0NQ_8c211389-af9d-441d-830e-d6bcb2d3a16d">529,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05e61bfa32a14e3187bb570193bd427c_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNC03LTEtMS0xNDc0NQ_6c48fdf8-3286-4120-adf4-0c9339740ece">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib42d2e50a19640fd98f9685c1637127d_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNC05LTEtMS0xNDc0NQ_ca5f1025-b864-4d6b-a996-1db4f15b725b">305,309</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73b610735c7347e8aaac83b4f7bc7c43_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNC0xMS0xLTEtMTQ3NDU_79c9ef15-a520-471f-b8ef-68ae5fa48671">23,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21152b916121449d97e5409f0cbc25b2_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNC0xMy0xLTEtMTQ3NDU_2cfc6d87-d7a3-4fa3-ab5c-3758da89d1a0">247,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c1a20b82134c2996172b95f893e5d4_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNS01LTEtMS0xNDc0NQ_537c8d24-27cb-431d-8ef5-f3c5bc9e85b9">7,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNS0xMy0xLTEtMTQ3NDU_83aa391e-32ed-458e-8393-adde55f1a2e1">7,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab511672603b4a81a03caf2ab30bcf7c_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNi03LTEtMS0xNDc0NQ_4eaf4b1e-8fe7-4b31-9e7e-9f3119a6efa6">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNi0xMy0xLTEtMTQ3NDU_aade61c7-9016-4c6d-ae82-e482a5ebd312">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in connection with an equity offering, net of underwriting discounts, commissions and offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f0fe3d7eeb04c7899bcb9ae2088bdf4_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNy0xLTEtMS0xODgyNQ_e65ec44b-0853-46c5-b107-14be671ca69c">3,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f0fe3d7eeb04c7899bcb9ae2088bdf4_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNy0zLTEtMS0xODgyNQ_6cdc7521-e69c-4e5c-89cd-e2180f206ef1">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c1a20b82134c2996172b95f893e5d4_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNy01LTEtMS0xODgzMg_dc747c98-9982-4679-a3f2-65d4a2b44e8e">162,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNy0xMy0xLTEtMTg4Mzk_cbab7f58-5eeb-4e4b-a1a2-dacd3bfbf18e">162,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in connection with restricted stock unit vesting</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f0fe3d7eeb04c7899bcb9ae2088bdf4_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNy0xLTEtMS0xNDc0NQ_e9c461e3-776d-4e46-8ce0-a00e554192ea">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deconsolidation event</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4021c98173a4dcba140ad00a72d452c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfOS0xMS0xLTEtMjA4Nzg_7c2564a6-9300-487d-b414-57451f32e203">16,899</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfOS0xMy0xLTEtMjA4Nzg_11a55479-f612-4f46-9e95-836693695077">16,899</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f0fe3d7eeb04c7899bcb9ae2088bdf4_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfOC0xLTEtMS0xNDc0NQ_76e8c319-737e-4637-bf84-bc55ad81b24c">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c1a20b82134c2996172b95f893e5d4_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfOC01LTEtMS0xNDc0NQ_b2260288-2057-4595-b999-e292ed7bb71e">3,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfOC0xMy0xLTEtMTQ3NDU_e9f9c25a-8340-4ca1-b60f-b928610eb40b">3,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f0fe3d7eeb04c7899bcb9ae2088bdf4_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTAtMS0xLTEtMTkxNzM_99397e6d-20ea-4d22-8ec7-2f9274bc7f1c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c1a20b82134c2996172b95f893e5d4_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTAtNS0xLTEtMTkxODA_facc7572-0f6f-434f-aaf3-9c0b67d24dc2">545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTAtMTMtMS0xLTE5MTgw_88f644f9-1137-484d-b33b-64fbb32e2d94">545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cancellation of restricted stock awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3f0fe3d7eeb04c7899bcb9ae2088bdf4_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfOS0xLTEtMS0xNDc0NQ_06cd6bc9-5a7f-4575-bc58-59a3678c2329">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4021c98173a4dcba140ad00a72d452c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTAtMTEtMS0xLTE0NzQ1_12f3aa1a-670f-4749-a587-bb9d462df4b7">6,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTAtMTMtMS0xLTE0NzQ1_7ec8b9c8-e67b-49c4-bf43-79a3e1170f33">6,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss attributable to Zentalis </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98f6ab579d534d1bb65c5fe26ac9a269_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTEtOS0xLTEtMTQ3NDU_fac8ec1a-8d38-42b0-86b2-951334059ada">4,191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTEtMTMtMS0xLTE0NzQ1_69a80db4-5b68-4a11-a856-767e74f5de7a">4,191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8acbfe477b1c4f3a815b95163a1b9152_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTItMS0xLTEtMTQ3NDU_a0bc64b3-577f-47fa-a5ae-b8a84804276f">45,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8acbfe477b1c4f3a815b95163a1b9152_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTItMy0xLTEtMTQ3NDU_f3993440-db00-437f-bb78-412a3404a7d3">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id08f2fc2050a4c44943d2e4a295e9e4b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTItNS0xLTEtMTQ3NDU_3927a831-984c-4b7d-8ef1-a254530004ef">702,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a274b3c002d4c999b3d4c6415451551_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTItNy0xLTEtMTQ3NDU_bb57ffc4-9383-4c97-8c6a-b9f0c77d5979">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ee68a808a09462ab4fa007d6b40a836_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTItOS0xLTEtMTQ3NDU_a7a8acf2-9f11-485f-b992-94706b7a71ac">309,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6caad814d88b42158fdc2cd280aab0ed_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTItMTEtMS0xLTE0NzQ1_ff8cd371-042d-432b-b334-16653378f8c5">564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTItMTMtMS0xLTE0NzQ1_60f0feda-3218-4c21-be21-9839640a099f">393,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="height:0pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:0pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.776%"><tr><td style="width:1.0%"></td><td style="width:31.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.327%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.846%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.327%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.846%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.278%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Noncontrolling</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i49952e4f44cf4702824e413a479ed8e3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNC0xLTEtMS0xNDc0NQ_5240450c-859a-434d-ba4c-2df2a198fdec">41,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49952e4f44cf4702824e413a479ed8e3_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNC0zLTEtMS0xNDc0NQ_a232bdc1-1d90-4ebe-b232-cf36ddcee637">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08713a361b1540acb0726229b81829e1_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNC02LTEtMS0xNDc0NQ_c1e4ba49-db21-4724-a31b-a2301be7e16c">509,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a86486294184f18889f9a3725de48f1_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNC04LTEtMS0xNDc0NQ_f5a8fc03-6b10-44a6-b9fa-06ea0f5a52b1">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i609623d6091f4576a93d91b6acb32ee7_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNC0xMC0xLTEtMTQ3NDU_8c9f3204-8794-40a8-941e-8f534d304002">200,834</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc6dc347950a4b29af9da5a02d804ca9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNC0xMi0xLTEtMTQ3NDU_9bdbfeb3-b916-4d32-a7ac-69ef73f5bed8">24,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNC0xNC0xLTEtMTQ3NDU_4c3d9125-7e7a-4d69-bd14-4e79d01d8bad">333,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if397f6a7f90548bcaa33a5c5cf1f88cb_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNS02LTEtMS0xNDc0NQ_a71bfc3b-02d9-42ed-9e04-c533d484f8d2">27,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNS0xNC0xLTEtMTQ3NDU_c8845cc7-25ce-4683-ad3e-c780dbe1d2ce">27,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65a26d388f63425cb3a2dc35e2a31a4b_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNi04LTEtMS0xNDc0NQ_bdc0290a-7a9e-42dc-9a14-1db31a669421">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNi0xNC0xLTEtMTQ3NDU_fd710705-e796-4b7d-abb1-b05f62d4038f">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in connection with an equity offering, net of underwriting discounts, commissions and offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1f3ce1f164345ed9ee96c629cc01c5d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNy0xLTEtMS0xODg0Ng_12eef558-d9b3-4bc7-a470-f0f6cbcc5762">3,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1f3ce1f164345ed9ee96c629cc01c5d_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNy0zLTEtMS0xODg0Ng_7b0f1475-4c13-4e70-be15-529b7e4d8e6e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if397f6a7f90548bcaa33a5c5cf1f88cb_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNy02LTEtMS0xODg1Mw_2deb80a9-e444-4a0d-8414-00c63f43a5be">162,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNy0xNC0xLTEtMTg4NTM_ae4c6fb9-8fe7-44b8-b70d-3eb27be52b21">162,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in connection with restricted stock unit vesting</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1f3ce1f164345ed9ee96c629cc01c5d_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNy0xLTEtMS0xNDc0NQ_fa07c006-ecae-4b90-80d4-1e1410901030">442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deconsolidation event</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71fb05f111f4be48d0ccef2861d630f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfOS0xMS0xLTEtMjA5NTA_bc9cb730-aaa6-4a2e-8cab-989aca98b722">16,899</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfOS0xMy0xLTEtMjA5NTA_ba2e85bb-4dc9-4045-978c-1f9c51e1fc25">16,899</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1f3ce1f164345ed9ee96c629cc01c5d_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfOC0xLTEtMS0xNDc0NQ_e153d7ac-992f-4004-86dc-e11ec0842a9a">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if397f6a7f90548bcaa33a5c5cf1f88cb_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfOC02LTEtMS0xNDc0NQ_a238a2fa-1f9b-4843-a43d-1d4c66ddd66d">3,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfOC0xNC0xLTEtMTQ3NDU_20af8168-7eb1-4306-a641-3a25687b7801">3,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1f3ce1f164345ed9ee96c629cc01c5d_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTAtMS0xLTEtMTkxODc_70cebb8c-e845-4a12-b6a0-65e2c809a1a3">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if397f6a7f90548bcaa33a5c5cf1f88cb_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTAtNi0xLTEtMTkxOTQ_1224ab3b-15b2-4112-aa8b-72e5d22a8faf">545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTAtMTQtMS0xLTE5MTk0_5877edf2-b342-42cc-981b-f3f4e449c1ce">545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cancellation of restricted stock awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if1f3ce1f164345ed9ee96c629cc01c5d_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfOS0xLTEtMS0xNDc0NQ_7e9b1bf7-6826-40ca-bfc3-6c83b625f047">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71fb05f111f4be48d0ccef2861d630f_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTAtMTItMS0xLTE0NzQ1_6389528a-b5c3-4d96-bb68-c98a479806e4">7,332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTAtMTQtMS0xLTE0NzQ1_1d180fba-36f4-4df2-82a4-925ffcaea647">7,332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss attributable to Zentalis</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib93e31ca1184485f94ea42f971abc9e0_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTEtMTAtMS0xLTE0NzQ1_f62e90ff-ee0d-4488-aa7b-fff5502a845c">108,666</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTEtMTQtMS0xLTE0NzQ1_f955d073-cfce-4ee6-9378-0b7429f6569c">108,666</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8acbfe477b1c4f3a815b95163a1b9152_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTItMS0xLTEtMTQ3NDU_94a9ed15-5d78-43f0-9e32-35b26449dc65">45,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8acbfe477b1c4f3a815b95163a1b9152_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTItMy0xLTEtMTQ3NDU_0643aa34-4587-4ab3-93a0-51c2761b0f3f">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id08f2fc2050a4c44943d2e4a295e9e4b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTItNi0xLTEtMTQ3NDU_d1934ff0-1e40-40fb-8a56-47ffc09a0d74">702,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a274b3c002d4c999b3d4c6415451551_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTItOC0xLTEtMTQ3NDU_969e7620-5dd6-4268-a3de-3b2a922ce7d6">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ee68a808a09462ab4fa007d6b40a836_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTItMTAtMS0xLTE0NzQ1_38079dba-29bf-4f6c-9b3d-204c966e7665">309,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6caad814d88b42158fdc2cd280aab0ed_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTItMTItMS0xLTE0NzQ1_fd5911e4-095f-4854-9b61-32a548b702b1">564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTItMTQtMS0xLTE0NzQ1_3361080a-31b1-445a-a8eb-fb25e3179305">393,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:0pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:0pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.839%"><tr><td style="width:1.0%"></td><td style="width:27.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Zentalis Stockholders</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Noncontrolling</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity<br/>(Deficit)</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefaca15d6a7d4345a23fd191b8e32d62_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNC0xOC0xLTEtMTQ3NDU_a4b9e72f-5969-49aa-a52e-39d23767bf4f">35,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefaca15d6a7d4345a23fd191b8e32d62_I20200630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNC0yMC0xLTEtMTQ3NDU_fb26dd29-7099-4297-b28d-3b84f4463d5d">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadec20410c96469aaee44c0c733e3dc4_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNC0yMi0xLTEtMTQ3NDU_30e64be8-e694-4e24-a701-90f0c6b708c6">339,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaac40f72e56c4a298f6c8a19b70d2903_I20200630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNC0yNC0xLTEtMTQ3NDU_1c7fb2b1-6e92-4b4d-99a8-4a3eddad1836">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4922676e6be541f3872e64b2464fb137_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNC0yNi0xLTEtMTQ3NDU_3e0b1df0-9ee5-44d8-a3ad-01e13ef4a352">125,976</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ab4533a3be14806b3b04f091b9ee6f3_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNC0yOC0xLTEtMTQ3NDU_361f9996-dc6f-4684-aa49-3323172b9f91">24,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aa9cf16c10047e38ad6329f8dc98d18_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNC0zMC0xLTEtMTQ3NDU_c3befeda-f13d-4af0-9184-89a5ebbedb7c">237,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28c684747f014fc580d4d13ca452e467_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNS0yMi0xLTEtMTQ3NDU_d76fafa7-0ada-49a5-9626-a9ea570a613f">7,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNS0zMC0xLTEtMTQ3NDU_48010f39-110d-4260-8e7b-c90f7b9b3166">7,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in connection with an equity offering, net of underwriting discounts, commissions and offering costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if603d442707c4674b05711009d838f40_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNi0xOC0xLTEtMTQ3NDU_9684f1ae-1e89-4e4f-9b29-78d808c2e17d">4,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if603d442707c4674b05711009d838f40_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNi0yMC0xLTEtMTQ3NDU_b12872ee-a35c-410b-8723-53991bd14303">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28c684747f014fc580d4d13ca452e467_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNi0yMi0xLTEtMTQ3NDU_89df5f9b-6c7c-485d-ad3a-8d7a62d03856">155,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNi0zMC0xLTEtMTQ3NDU_a761e78e-e63c-4cc6-8add-49fa4dda7390">155,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cancellation of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if603d442707c4674b05711009d838f40_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNy0xOC0xLTEtMTQ3NDU_25e09a30-d907-41b9-8005-57207ba45119">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfc558dbb30841d4b077a7adf6dba4a8_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfOC0yNC0xLTEtMTQ3NDU_5f86a0b7-0b00-4cfe-b9ba-30354c405dc3">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfOC0zMC0xLTEtMTQ3NDU_04e01ad2-974d-4053-be4d-195a0c753b52">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss attributable to&#160;non-controlling&#160;interest</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28c684747f014fc580d4d13ca452e467_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTEtMjItMS0xLTE0NzQ1_94613dc7-e5f0-42c6-9841-4e89092b55d2">187</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica7568cfa246420a8555ccc29e4641d5_D20200701-20200930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTEtMjgtMS0xLTE0NzQ1_da9e6bae-2ff8-48f4-ac8c-8cc09bcfbd6f">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTEtMzAtMS0xLTE0NzQ1_a363acd4-6bf0-4877-9f08-866b993c08b3">110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss attributable to Zentalis </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b6093af831e491297bdfb820eba1bb4_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTItMjYtMS0xLTE0NzQ1_88029d4b-d6ca-4816-8e0c-d2d2aec58ffc">34,555</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTItMzAtMS0xLTE0NzQ1_12bc6844-5985-472c-9761-cd5d5498de8b">34,555</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae5a70bb484d47a5966a3232feabc0a3_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTMtMTgtMS0xLTE0NzQ1_2af3f6f5-8550-43a4-9f72-413918c661a5">40,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae5a70bb484d47a5966a3232feabc0a3_I20200930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTMtMjAtMS0xLTE0NzQ1_dc1034ad-2fa6-4a6a-841c-936ac41f852a">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4a788eaa8d424898851941377c7408_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTMtMjItMS0xLTE0NzQ1_14556de6-341b-47cb-ae71-63a94f0317d3">501,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9bfd239f78a4d1c9687ea22e1413f42_I20200930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTMtMjQtMS0xLTE0NzQ1_e9f11ad6-909d-4437-86d3-2d89b1b2b22e">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i401925c54aed4e27af6b9f7bae761633_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTMtMjYtMS0xLTE0NzQ1_277f77ff-0b39-4ccf-a70f-031269c82d63">160,531</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea94c1751ea4ca9aafb6ed451e8026c_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTMtMjgtMS0xLTE0NzQ1_96ff620a-7b42-4ded-86d4-b3a9f274a108">24,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bf6807e17f4804bb968d10045ac403_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTMtMzAtMS0xLTE0NzQ1_75323082-daee-4154-9c8b-2f6611dc1381">365,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:0pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:0pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.919%"><tr><td style="width:1.0%"></td><td style="width:16.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.078%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.078%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.078%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.272%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:3.078%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.272%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:3.078%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.272%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:3.078%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.272%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:3.078%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.078%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.985%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.272%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:5.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.996%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="90" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="63" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Zentalis Members/Stockholders</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:32pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Convertible<br/>Preferred&#160;Units</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Convertible<br/>Preferred&#160;Units</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Class&#160;A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Common&#160;Units</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Class&#160;B</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Common&#160;Units</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Noncontrolling</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity<br/>(Deficit)</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84f4ac54c0c4412cad1de8c39c9f465f_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0xLTEtMS0xNDc0NQ_318cd4ef-13f2-4c26-80e1-528d3b9373c8">9,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f4ac54c0c4412cad1de8c39c9f465f_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0zLTEtMS0xNDc0NQ_606640dc-73da-4d3d-a8de-3d51d96a0329">141,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb096e42e3894e489f301e40bd55a89a_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonUnitOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0xMC0xLTEtMTQ3NDU_cd5a3f6d-311a-4fa2-858e-2a6f7e277557">5,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb096e42e3894e489f301e40bd55a89a_I20191231" decimals="-3" name="us-gaap:CommonUnitIssuanceValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0xMi0xLTEtMTQ3NDU_e2417f8f-e43b-41f9-b736-e41fb023fb2c">709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37dfc4263719434b9b05fe487d9d50df_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonUnitOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0xNC0xLTEtMTQ3NDU_53636111-1366-4429-999a-8a83cc822226">2,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37dfc4263719434b9b05fe487d9d50df_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonUnitIssuanceValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0xNi0xLTEtMTQ3NDU_5f074a04-cf96-4a35-9f94-159b5b52379b">2,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4589566e63f84b7b9cccea38766a0eb1_I20191231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0xOC0xLTEtMTQ3NDU_b644ee1d-ad85-4aa7-959b-dcdfe6a0a20c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4589566e63f84b7b9cccea38766a0eb1_I20191231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0yMC0xLTEtMTQ3NDU_54b9b2fd-dead-4948-8884-16faef5dd504">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dffd747f1e14c5498e5f8b92e2018d7_I20191231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0yMi0xLTEtMTQ3NDU_c7ee385a-ec19-4a05-8297-952a2f048d66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205664e670624f0d9706e05dfcffde81_I20191231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0yNC0xLTEtMTQ3NDU_a6e2b2ba-c946-4aa1-bb0c-9b5b5480ff1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72b30c6cbd624852b0a41e4ef1b61c9b_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0yNi0xLTEtMTQ3NDU_f2775f9a-1653-4ca2-b858-1693157f79c5">82,993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b164794b9d4478db7c7a1f24b1a53e1_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0yOC0xLTEtMTQ3NDU_dfd49c39-bbc5-453a-82cd-9545bb92a00c">6,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8ce9f01da84935a62e807401cc9cae_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0zMC0xLTEtMTQ3NDU_3826a03e-d5a9-462a-a0af-af0fef126c15">73,285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of Series C convertible preferred units at $<ix:nonFraction unitRef="usdPerShare" contextRef="i36b0ac5aa6b94994b62d1befce371046_I20200930" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNS0wLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjVhMmI1YWUyZDY5NDQ0YTRhYjhjNGFiZTU4YTg0OThlXzU2_ca828861-84dd-4b4d-b045-b15aea36f097">17.50</ix:nonFraction> per unit net of issuance costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7fafba9138604e4582aa3c16d8ca83cb_D20200101-20200930" decimals="-3" name="zntl:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNS0xLTEtMS0xNDc0NQ_4510edb8-d963-47af-a7c5-25047cb6c83f">867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fafba9138604e4582aa3c16d8ca83cb_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNS0zLTEtMS0xNDc0NQ_07027f82-c9c2-409d-bb13-5029003fb419">14,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cancellation of profit interest awards, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i172924960c934f48b9b4f68bfc2f1c46_D20200101-20200930" decimals="-3" name="zntl:StockCancelledDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNi0xNC0xLTEtMTQ3NDU_720f7f41-f7fb-44ec-bab9-e9c78ff18fa5">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in connection with an initial public offering, net of underwriting discounts, commissions and offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0020419724ac422c834b41878fbbf94b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNy0xOC0xLTEtMTQ3NDU_9a72a95d-0945-4d87-a60e-9fa5f58f01bb">10,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0020419724ac422c834b41878fbbf94b_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNy0yMC0xLTEtMTQ3NDU_3d0fdf81-2c30-4555-aed8-110956e6c2db">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d8bceefc7b40dc839ef2d3d293a13c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNy0yMi0xLTEtMTQ3NDU_f4483705-d7b8-4842-835e-e8b8560ca88c">172,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie807a0e24c7b451dae314257f1dd00e0_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNy0zMC0xLTEtMTQ3NDU_8cd9ece7-9546-428b-a3f1-a251619e28a0">172,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions from noncontrolling interest owners</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20dba144ba4b4cc586cce30c51aaa503_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfOC0yOC0xLTEtMTQ3NDU_361c8170-9bde-406e-b767-b26460b63023">18,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfOC0zMC0xLTEtMTQ3NDU_8d42a04a-cf25-4e3b-953c-a7408b280586">18,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i172924960c934f48b9b4f68bfc2f1c46_D20200101-20200930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfOS0xNi0xLTEtMTQ3NDU_1cc5e53c-b671-4983-ac90-87bc62d44cdd">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5015e220e18d463eab535a4b2752b5c2_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfOS0yMi0xLTEtMTQ3NDU_bea0dade-c526-497a-8fab-95e2608e68b5">14,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfOS0zMC0xLTEtMTQ3NDU_50e3a60a-2bc0-4982-b301-eba10b75ffe4">15,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Conversion of convertible preferred units to common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7fafba9138604e4582aa3c16d8ca83cb_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="zntl:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTAtMS0xLTEtMTQ3NDU_49653451-fefc-4ed9-a4d8-f614ef77107c">10,817</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fafba9138604e4582aa3c16d8ca83cb_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTAtMy0xLTEtMTQ3NDU_81735eea-063a-425b-96f6-57860f8fcd73">155,934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="zntl:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTAtMTgtMS0xLTE0NzQ1_6c6cdf46-7c7b-4ecd-b3ea-5c70f4c7ec7f">15,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930" decimals="-3" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTAtMjAtMS0xLTE0NzQ1_d83c7abe-f4eb-41fe-883d-c5b2cfe4be96">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5015e220e18d463eab535a4b2752b5c2_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTAtMjItMS0xLTE0NzQ1_0373ed4a-c134-4ff6-abf1-5a79ed67df10">155,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTAtMzAtMS0xLTE0NzQ1_ff9dd71a-457a-46f3-b15d-d534e25615a3">155,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Conversion of common and incentive units to common and restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5bcb52b9ccef496eb3fcb0a88b4d38ea_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMTAtMS0xLTE0NzQ1_9f5cbdb5-26bf-4365-a00f-92090e846b91">5,601</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bcb52b9ccef496eb3fcb0a88b4d38ea_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMTItMS0xLTE0NzQ1_58ad2fcf-c791-4466-8ebe-6c049be1c63f">709</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i172924960c934f48b9b4f68bfc2f1c46_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMTQtMS0xLTE0NzQ1_f61eadc6-aaa4-4a6a-a9ee-d529c46f2834">2,607</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i172924960c934f48b9b4f68bfc2f1c46_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMTYtMS0xLTE0NzQ1_f73d4b85-ae2a-47ad-a7c4-3b92336af9eb">2,507</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMTgtMS0xLTE0NzQ1_aa0b20c6-efea-428b-a62f-d3249250cdf1">10,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMjAtMS0xLTE0NzQ1_ec3fce94-f14e-47ec-a0a9-03bfb57524af">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5015e220e18d463eab535a4b2752b5c2_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMjItMS0xLTE0NzQ1_07ca6741-c25c-4b7d-a857-aff07ecf5b76">3,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMzAtMS0xLTE0NzQ1_288e0485-0c32-457e-9fe9-a3e7981089a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in connection with an equity offering, net of underwriting discounts, commissions and offering costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTItMTgtMS0xLTE5NTYz_581b3088-8660-474e-a459-d2ea9f4d43f3">4,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTItMjAtMS0xLTE5NTYz_358bcef1-48ee-4867-a143-8caa15532922">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5015e220e18d463eab535a4b2752b5c2_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTItMjItMS0xLTE5NTg4_ea82dbaf-a398-417c-a152-7bea8a484597">155,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTItMzAtMS0xLTE5NjI1_be450e7d-d36e-430f-b63f-38e223aa1040">155,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cancellation of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTMtMTgtMS0xLTE5NTYz_378732f1-72ed-4ffd-9656-d8448c67086d">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171029a8b8344ffcb4c0653ce2b78593_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTItMjQtMS0xLTE0NzQ1_71dd312a-81c5-419e-afef-3beefaf9b119">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTItMzAtMS0xLTE0NzQ1_69e87a5e-550e-4cc0-aa74-ae8bbea6c554">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss attributable to&#160;non-controlling&#160;interest</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5015e220e18d463eab535a4b2752b5c2_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTMtMjItMS0xLTE0NzQ1_e17e1c7d-479f-4a69-98e7-1ad783f94345">187</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20dba144ba4b4cc586cce30c51aaa503_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTMtMjgtMS0xLTE0NzQ1_670c5139-d32c-4848-a061-0eeb9dc92dc3">467</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTMtMzAtMS0xLTE0NzQ1_ed1a2399-21b2-4810-b80e-5b96da4ad222">654</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss attributable to Zentalis </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1d6083038da45c5aadfdf0aefeda452_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTQtMjYtMS0xLTE0NzQ1_613c28a2-800c-4c11-97d6-ac9133262bf1">77,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTQtMzAtMS0xLTE0NzQ1_acf1dbbe-6c09-4302-b48b-9b11964063ca">77,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i36b0ac5aa6b94994b62d1befce371046_I20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMS0xLTEtMTQ3NDU_a277bb84-0f6c-42c6-935f-607fdc0803fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b0ac5aa6b94994b62d1befce371046_I20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMy0xLTEtMTQ3NDU_44753443-a432-4653-a972-d8968d84bfcb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifd1fdb349c73430aa944980282c11963_I20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CommonUnitOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMTAtMS0xLTE0NzQ1_f89995d0-3379-4324-af33-295a8efc1037">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd1fdb349c73430aa944980282c11963_I20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CommonUnitIssuanceValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMTItMS0xLTE0NzQ1_b0d5342e-37d2-4c3d-85f0-284b6d0004a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6eb313acd05f42ae9d92268c78a67bd4_I20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CommonUnitOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMTQtMS0xLTE0NzQ1_7c04cd0f-3b13-4a31-8ac9-4cd3bb4f5847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eb313acd05f42ae9d92268c78a67bd4_I20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CommonUnitIssuanceValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMTYtMS0xLTE0NzQ1_76fcc854-336d-4a1c-8a8e-a8861ddab0dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae5a70bb484d47a5966a3232feabc0a3_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMTgtMS0xLTE0NzQ1_3cf363fb-9652-479f-915b-7895e71c38d0">40,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae5a70bb484d47a5966a3232feabc0a3_I20200930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMjAtMS0xLTE0NzQ1_64d1858a-a725-4562-bdfa-d9aa9119de29">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4a788eaa8d424898851941377c7408_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMjItMS0xLTE0NzQ1_3b80a403-c729-4b32-ad2b-41c73f00d014">501,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9bfd239f78a4d1c9687ea22e1413f42_I20200930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMjQtMS0xLTE0NzQ1_8c3984cd-ff8d-47f4-a567-da2b9a0a62cc">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i401925c54aed4e27af6b9f7bae761633_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMjYtMS0xLTE0NzQ1_83d957a0-4b51-4a44-8254-c8f4c4f90b99">160,531</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea94c1751ea4ca9aafb6ed451e8026c_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMjgtMS0xLTE0NzQ1_668d3124-3977-4fdc-9967-447746a45569">24,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bf6807e17f4804bb968d10045ac403_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMzAtMS0xLTE0NzQ1_ce7a8217-998b-40e5-95be-9773d91c4c72">365,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:0pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_37"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="i359d7483f88b44aba6df295b4be37cde_40"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMzUzMQ_db64421d-cd37-4bdd-990f-124937efe199" continuedAt="i485e7550a50249ea824f00c641e5c23d" escape="true">Organization and Business</ix:nonNumeric></span></div><ix:continuation id="i485e7550a50249ea824f00c641e5c23d" continuedAt="i855c1f8d5d39444cbf4e0228dac051ac"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Organization</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zentalis Pharmaceuticals, Inc. (&#8220;Zentalis&#8221;, &#8220;We&#8221; or the &#8220;Company&#8221;) is a clinical-stage pharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. All of the Company&#8217;s tangible assets are held in the United States.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was formed and incorporated in the state of Delaware as Zeno Pharmaceuticals, Inc. on December&#160;23, 2014. Effective November&#160;21, 2017, Zeno Pharma, LLC was formed by the shareholders of Zeno Pharmaceuticals, Inc. On December&#160;21, 2017, Zeno Pharmaceuticals, Inc. became a wholly owned subsidiary of Zeno Pharma, LLC. In connection with this restructuring, the rights and preferences of the Preferred Stock of Zeno Pharmaceuticals, Inc. were exchanged for preferred units with similar rights and preferences of Zeno Pharma, LLC. As part of the restructuring, the employees, consultants and board members of Zeno Pharmaceuticals, Inc. exchanged their equity grants in Zeno Pharmaceuticals, Inc. stock for Class&#160;B common units in Zeno Pharma, LLC. Additionally, existing common stockholders of Zeno Pharmaceuticals, Inc. exchanged their common stock for Class&#160;A common units in Zeno Pharma, LLC. All exchanges were made on a&#160;<ix:nonFraction unitRef="number" contextRef="i44bca96b50f545e98c95ba466913be25_D20171221-20171221" decimals="INF" format="ixt-sec:numwordsen" name="zntl:CommonStockConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMTQ0Nw_e9c6b5e1-3788-4ba0-8860-797896c64858">one</ix:nonFraction>-for-one&#160;basis. The restructuring was accounted for as a common control transaction. In December 2019, the Company was renamed to Zentalis Pharmaceuticals, LLC. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to the effectiveness of the registration statement pertaining to the Company&#8217;s initial public offering (&#8220;IPO&#8221;) on April 2, 2020, the Company converted from a Delaware limited liability company into a Delaware corporation, and changed its name to Zentalis Pharmaceuticals, Inc. Pursuant to the statutory corporate conversion, all of the outstanding units of Zentalis Pharmaceuticals, LLC converted into shares of common stock of Zentalis Pharmaceuticals, Inc. based upon the value of Zentalis Pharmaceuticals, Inc. at the time of the IPO with a value implied by the price of the shares of common stock sold in the IPO. Based on the IPO price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i53b0d350827a4825b36838126a07429a_I20200402" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjI3Mw_9b4e4058-a4e9-43ab-aee5-913cae9ae708">18.00</ix:nonFraction> per share, the outstanding converted units converted into <ix:nonFraction unitRef="shares" contextRef="ibdac556512264baba2e3c86be867069c_D20200402-20200402" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesIssued1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjMzNA_f3e587ac-2cbe-4d92-9744-d8dab6fc9e64">25,288,854</ix:nonFraction> shares of common stock (including <ix:nonFraction unitRef="shares" contextRef="i0daa24d503d64a52a0b1fa592bd6c4e8_D20200402-20200402" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesIssued1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjM3MQ_33630794-b82a-4d8f-ba4b-16bd9f129fd0">1,160,277</ix:nonFraction> shares of restricted common stock).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 7, 2020, the Company completed the IPO in which the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="id1b99cb5cf7d4b9bb0f68ae4525eab72_D20200407-20200407" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjQ5NQ_5e990466-d839-4d98-b6aa-88e2ed8486b0">10,557,000</ix:nonFraction> shares&#160;of common stock (including <ix:nonFraction unitRef="shares" contextRef="ie8cad8b83d3f432cafaa0e90fa7125e0_D20200407-20200407" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjUzMg_842c8527-8931-446f-acd8-45da437bed4e">1,377,000</ix:nonFraction> shares of common stock in connection with the full exercise of the underwriters&#8217; option to purchase additional shares) at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib67a09c2cc4e4165b391d6ef5419f1b7_I20200407" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjY4NA_bac551d9-eb61-48fe-a39e-d97ba72378c8">18.00</ix:nonFraction> per share. The Company&#8217;s aggregate gross proceeds from the sale of shares in the IPO, including the sale of shares pursuant to the full exercise of the underwriters&#8217; option to purchase additional shares, was $<ix:nonFraction unitRef="usd" contextRef="i88c5a60307524479aa90649174075824_D20200407-20200407" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjg5NQ_f52f3d87-45f0-432b-a874-f8a7fa65817e">190.0</ix:nonFraction>&#160;million before fees and expenses of $<ix:nonFraction unitRef="usd" contextRef="i88c5a60307524479aa90649174075824_D20200407-20200407" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjkyNg_56048be7-1868-4bcc-bcc5-750a7161ff15">17.6</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i855c1f8d5d39444cbf4e0228dac051ac">Substantial doubt about an entity&#8217;s ability to continue as a going concern exists when relevant conditions and events, considered in the aggregate, indicate that it is probable that the entity will be unable to meet its obligations as they become due within one year from the financial statement issuance date. The Company determined that there are no conditions or events that raise substantial doubt about its ability to continue as a going concern within one year after the date that the interim unaudited condensed consolidated financial statements for the quarter ended September&#160;30, 2021 are issued.</ix:continuation> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_43"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80My9mcmFnOjM1MzA2YjAzNDZmNTRlY2M4ZTk5MzQ2NTJkYTQ0NWEyL3RleHRyZWdpb246MzUzMDZiMDM0NmY1NGVjYzhlOTkzNDY1MmRhNDQ1YTJfMjU2Mg_6cc04c03-9d5a-47e8-924b-5f2dc2d9bc5d" continuedAt="ibde29056ae194fce8983ec624c53b32a" escape="true">Interim Unaudited Financial Statements </ix:nonNumeric></span></div><ix:continuation id="ibde29056ae194fce8983ec624c53b32a" continuedAt="id6578ca775c44df894756d841194cae5"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80My9mcmFnOjM1MzA2YjAzNDZmNTRlY2M4ZTk5MzQ2NTJkYTQ0NWEyL3RleHRyZWdpb246MzUzMDZiMDM0NmY1NGVjYzhlOTkzNDY1MmRhNDQ1YTJfMjU2NA_cb9f146e-8635-4c3a-b74b-48e2035ef8b9" continuedAt="i5bce91bd31664e7e9e44968c18ba6b96" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5bce91bd31664e7e9e44968c18ba6b96">The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and with the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) related to a quarterly report on Form 10-Q. The year-end condensed consolidated balance sheet data was derived from the Company&#8217;s audited financial statements but does not include all disclosures required by U.S. GAAP. These condensed consolidated financial statements and notes thereto should be read in conjunction with the Company&#8217;s audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on March 25, 2021. The unaudited financial information for the interim periods presented herein reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of the financial condition and results of operation for the periods presented, with such adjustments consisting only of normal recurring adjustments.</ix:continuation> </span></div><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80My9mcmFnOjM1MzA2YjAzNDZmNTRlY2M4ZTk5MzQ2NTJkYTQ0NWEyL3RleHRyZWdpb246MzUzMDZiMDM0NmY1NGVjYzhlOTkzNDY1MmRhNDQ1YTJfMjU2NQ_d001237c-d80d-4df6-8db3-125d9a2ec826" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include our accounts and our wholly-owned subsidiaries and variable interest entity (&#8220;VIE&#8221;) for which we are the primary beneficiary. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our ownership, contractual and other interests in entities that are not wholly-owned by us to determine if these entities are VIEs, and, if so, whether we are the primary beneficiary of the VIE. In determining whether we are the primary beneficiary of a VIE and therefore required to consolidate the VIE, we apply a qualitative approach that determines whether we have both (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the rights to receive benefits from, the VIE that could potentially be significant to that VIE. We continuously assess whether we are the primary beneficiary of a VIE as changes to existing relationships or future transactions may result in the consolidation or deconsolidation, as the case may be, of such VIE.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The equity method is used to account for investments in which we have the ability to exercise significant influence, but not control, over the investee. Such investments are recorded on the balance sheet, and the share of net income or losses of equity investments is recognized on a one quarter lag in investment and other income (expense), net.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80My9mcmFnOjM1MzA2YjAzNDZmNTRlY2M4ZTk5MzQ2NTJkYTQ0NWEyL3RleHRyZWdpb246MzUzMDZiMDM0NmY1NGVjYzhlOTkzNDY1MmRhNDQ1YTJfMjU2Ng_88783c68-eb4e-430f-9a35-298e30e81a2b" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates and judgments, which are based on historical and anticipated results and trends and on various other assumptions that management believes to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management&#8217;s estimates.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Though the impact of the COVID-19 pandemic to our business and operating results presents additional uncertainty, we continue to use the best information available to inform our critical accounting estimates.</span></div></ix:nonNumeric><div style="margin-bottom:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, there have been no changes to the Company&#8217;s significant accounting policies as described in its Annual Report on Form 10-K for the fiscal year ended December 31, 2020 outside of the equity method accounting for investments and adoption and pending adoption of recent accounting pronouncements mentioned below.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80My9mcmFnOjM1MzA2YjAzNDZmNTRlY2M4ZTk5MzQ2NTJkYTQ0NWEyL3RleHRyZWdpb246MzUzMDZiMDM0NmY1NGVjYzhlOTkzNDY1MmRhNDQ1YTJfMjE5OTAyMzI2OTQxMg_ea4149f2-a7d0-4740-bf55-ac7e0c388c7a" continuedAt="i84bb1c76d22f477ab242880539e217c6" escape="true">Equity Method Accounting</ix:nonNumeric></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="id6578ca775c44df894756d841194cae5"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i84bb1c76d22f477ab242880539e217c6">We have significant influence, but not a controlling interest, in Zentera. From the deconsolidation of Zentera during July 2021 prospectively, this investment is accounted for using the equity method. Our share of earnings or losses of the investment entity are reported on the consolidated statement of operations through investment and other income, net, with a corresponding increase or decrease to the equity investment carried on the statement of financial position. This information is generally not received sufficiently timely for us to record our portion of earnings or loss in the current financial statements and therefore we report our portion of earnings or loss on a one quarter lag.</ix:continuation></span></div><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80My9mcmFnOjM1MzA2YjAzNDZmNTRlY2M4ZTk5MzQ2NTJkYTQ0NWEyL3RleHRyZWdpb246MzUzMDZiMDM0NmY1NGVjYzhlOTkzNDY1MmRhNDQ1YTJfMjU2MA_729a10c3-79cf-4571-a113-86b709c480f7" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adoption and Pending Adoption of Recent Accounting Pronouncements </span></div><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80My9mcmFnOjM1MzA2YjAzNDZmNTRlY2M4ZTk5MzQ2NTJkYTQ0NWEyL3RleHRyZWdpb246MzUzMDZiMDM0NmY1NGVjYzhlOTkzNDY1MmRhNDQ1YTJfMjU2MQ_e3661b5e-f9ae-4dd8-8d26-fc13db9efcbd" escape="true"><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a brief description of recently issued accounting standards, those adopted in the current period and those not yet adopted:</span></div><div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.717%"><tr><td style="width:1.0%"></td><td style="width:14.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.854%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.774%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.774%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Financial<br/>Statements or Other<br/>Significant Matters</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In January 2020, the FASB issued ASU 2020-01, Investments &#8211; Equity Securities (Topic 321)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This standard clarifies the interaction between accounting standards related to equity securities (ASC 321), equity method investments (ASC 323), and certain derivatives (ASC 815).&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 1, 2021, we did not hold equity securities, equity method investments or derivatives. The impact of this new accounting guidance in 2021 did not have a material impact to our consolidated financial statements at the time of adoption.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of July 2021, we hold an equity method investment which is accounted for under ASC 323. The investment is recorded on the consolidated statement of financial position at fair value as of the date of deconsolidation. The Company&#8217;s share of earnings or losses of the investment entity are reported on the consolidated statement of operations through investment and other income, net with a corresponding increase or decrease to the equity investment. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div id="i359d7483f88b44aba6df295b4be37cde_2748779069827"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNzQ4Nzc5MDY5ODI3L2ZyYWc6MTc1NzIzZTdiZDZiNGZiOWI2OTNjYjJkN2RkMzdkNTYvdGV4dHJlZ2lvbjoxNzU3MjNlN2JkNmI0ZmI5YjY5M2NiMmQ3ZGQzN2Q1Nl8yNzQ4Nzc5MDc3MjMz_3b818d3c-e6a5-4fea-a7a9-e3db443ada3b" continuedAt="i895ec1866f9c43d3999da634773997ae" escape="true">Significant Transactions</ix:nonNumeric></span></div><ix:continuation id="i895ec1866f9c43d3999da634773997ae" continuedAt="i204e0fb512334a0da5ea9b85f3614ba0"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zentera Therapeutics</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we became a majority common shareholder of Zentera Therapeutics, Ltd., a Shanghai-based clinical-stage biopharmaceutical company focused on developing cancer therapeutics (&#8220;Zentera&#8221;), concurrent with its Series A convertible preferred stock offering. The financial position and results of operations of Zentera have been included in our consolidated financial statements from the date of the initial investment as a result of our control of the entity. In July 2021, Zentera completed a Series B convertible preferred stock offering which diluted our investment to a position of less than majority owned. Upon review of the facts and circumstances, together with the authoritative accounting literature, we determined that consolidation of Zentera is no longer appropriate. After the July 2021 Series B convertible preferred offering in which we did not participate, our review concluded that we ceased to have a controlling financial interest in Zentera, an additional board member was added to the Zentera </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i204e0fb512334a0da5ea9b85f3614ba0" continuedAt="idab218e3d81d40e9a58832f8acbadcd0"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">board of directors and we concluded that we no longer have the power to direct the activities that most significantly affect Zentera&#8217;s economic performance nor are we the primary beneficiary of Zentera.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in July 2021, the financial position and results of operations of Zentera are no longer included in our consolidated financial statements. An equity method investment of $<ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNzQ4Nzc5MDY5ODI3L2ZyYWc6MTc1NzIzZTdiZDZiNGZiOWI2OTNjYjJkN2RkMzdkNTYvdGV4dHJlZ2lvbjoxNzU3MjNlN2JkNmI0ZmI5YjY5M2NiMmQ3ZGQzN2Q1Nl8xMDk5NTExNjM1Njgy_a99e07a8-ccc8-4a7d-9327-33979a2efd72">39.3</ix:nonFraction> million was recorded on our balance sheet representing the fair value of our common stock investment using the backsolve method with consideration for a lack of marketability at the time of deconsolidation. A corresponding deferred tax liability of $<ix:nonFraction unitRef="usd" contextRef="i59959a77c7aa43129b028607068148f6_I20210930" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNzQ4Nzc5MDY5ODI3L2ZyYWc6MTc1NzIzZTdiZDZiNGZiOWI2OTNjYjJkN2RkMzdkNTYvdGV4dHJlZ2lvbjoxNzU3MjNlN2JkNmI0ZmI5YjY5M2NiMmQ3ZGQzN2Q1Nl8xMDk5NTExNjM5NDkw_6f7e0b0b-7001-4489-8e22-6edef1a68c64">1.7</ix:nonFraction> million representing the tax impact of the unrealized gain on deconsolidation was recorded during the three months ended September 30, 2021. A gain of $<ix:nonFraction unitRef="usd" contextRef="i3a09ec80921740a8a5b68eddc9671099_D20210701-20210930" decimals="-5" name="us-gaap:DeconsolidationGainOrLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNzQ4Nzc5MDY5ODI3L2ZyYWc6MTc1NzIzZTdiZDZiNGZiOWI2OTNjYjJkN2RkMzdkNTYvdGV4dHJlZ2lvbjoxNzU3MjNlN2JkNmI0ZmI5YjY5M2NiMmQ3ZGQzN2Q1Nl8xMDk5NTExNjM1NzE1_863a4258-1072-4377-949b-eb0072349d3a">51.6</ix:nonFraction> million, measured as the difference between the fair value of our retained noncontrolling interest together with the carrying amount of the Zentera noncontrolling interest, and the carrying amount of Zentera&#8217;s assets and liabilities was recognized during the third quarter of 2021.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, each of our subsidiaries Zeno Alpha, Inc., K-Group Alpha, Inc., Zeno Management Inc., and K-Group Beta, Inc. entered into a collaboration and royalty-bearing license agreement with Zentera, which we refer to as the &#8220;Zentera Sublicenses,&#8221; pursuant to which we collaborate with Zentera on the development and commercialization of ZN-c3, ZN-c5 and ZN-d5, respectively, in the People&#8217;s Republic of China, Macau, Hong Kong and Taiwan, which is referred to as the &#8220;Zentera Collaboration Territory.&#8221; Under each Zentera Sublicense, Zentera will lead development, and upon regulatory approval, the commercialization, of the collaboration products in the Zentera Collaboration Territory. </span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idab218e3d81d40e9a58832f8acbadcd0">Under the terms of the Zentera Sublicenses, Zentera is responsible for the costs of developing the Collaboration Products in the Zentera Collaboration Territory, and we are responsible for the costs of developing the Collaboration Products outside the Zentera Collaboration Territory, provided that Zentera will reimburse us for a portion of the costs for global data management, pharmacovigilance, safety database management, and chemistry, manufacturing and controls activities with respect to each Collaboration Product. Prior to the deconsolidation of Zentera, these costs were eliminated in consolidation. For the period subsequent to deconsolidation to September 30, 2021, the amounts incurred under this arrangement totaled $<ix:nonFraction unitRef="usd" contextRef="i3a09ec80921740a8a5b68eddc9671099_D20210701-20210930" decimals="-5" name="zntl:ResearchAndDevelopmentExpenseReimbursements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNzQ4Nzc5MDY5ODI3L2ZyYWc6MTc1NzIzZTdiZDZiNGZiOWI2OTNjYjJkN2RkMzdkNTYvdGV4dHJlZ2lvbjoxNzU3MjNlN2JkNmI0ZmI5YjY5M2NiMmQ3ZGQzN2Q1Nl8xMDk5NTExNjM1NzM1_43dbc703-15ba-4522-9ec2-17ae23cda3e4">2.9</ix:nonFraction> million and are presented as contra-research and development expense in the consolidated statement of operations. A corresponding receivable is recorded within prepaid expenses and other current assets on the consolidated balance sheet.</ix:continuation> </span></div><div id="i359d7483f88b44aba6df295b4be37cde_46"></div><div style="margin-bottom:12pt;margin-top:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMTgyOA_5ad182b2-25d2-44d0-8f83-9deecd13636f" continuedAt="ifc949aaae47641f6866d2b86c6bcb527" escape="true">Business Combinations</ix:nonNumeric></span></div><ix:continuation id="ifc949aaae47641f6866d2b86c6bcb527" continuedAt="icb5607ec23e049fc89119850d6892e34"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Kalyra Pharmaceuticals, Inc.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;21, 2017, we acquired $<ix:nonFraction unitRef="usd" contextRef="i36e1e114412b4a85a123b6bacd5ba04e_D20171221-20171221" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfOTM_c4a02e29-534a-45b7-a46a-0dcd3c0cebdb">4.5</ix:nonFraction>&#160;million of Kalyra&#8217;s Series B Preferred Stock representing a <ix:nonFraction unitRef="number" contextRef="ibe080c8b70bb4349ac04f51678c3abf1_I20171221" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMTQ4_3c1914cf-f183-48b6-810d-d534e74af253">25</ix:nonFraction>% equity interest in Kalyra for purposes of entering the analgesics therapeutic research space. The acquisition price was paid entirely in cash.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the authoritative guidance, we concluded that Kalyra is a business consisting of inputs, employees, intellectual property and processes capable of producing outputs. Additionally, we have concluded that Kalyra is a variable interest entity, we are the primary beneficiary and have the power to direct the activities that most significantly affect Kalyra&#8217;s economic performance through common management and our board representation. Prior to the change of control, the Company and Kalyra transacted for the delivery of research and development services and support. The financial position and results of operations of Kalyra have been included in our consolidated financial statements from the date of the initial investment.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant with authoritative guidance, we have recorded the identifiable assets, liabilities and noncontrolling interests in the VIE at their fair value upon initial consolidation. The identified goodwill is comprised of the workforce and expected synergies from combining the entities. During the third quarter of 2021, Kalyra determined that they will no longer pursue the development of Kalyra&#8217;s lead product candidate and ceased the associated clinical trial. The in-process research and development costs (&#8220;IPR&amp;D&#8221;) recorded on Kalyra&#8217;s balance sheet exclusively relates to this candidate. Management recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i3da75022cc3d428d9e0424e542c47954_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMjc0ODc3OTA4Mzg4NA_fcfdba02-4e84-410e-81a9-d49f55a3611d">8.8</ix:nonFraction>&#160;million within the research and </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="icb5607ec23e049fc89119850d6892e34"><div style="margin-bottom:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development expense line item on the consolidated statement of operations during the third quarter of 2021, which resulted in a reduction of the IPR&amp;D asset from $<ix:nonFraction unitRef="usd" contextRef="iadfc04fccb134988b9f947350d9c04c9_I20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMjc0ODc3OTA4Mzg3MA_0207db94-a534-473c-a8e8-2bf6f37ccc9c">8.8</ix:nonFraction>&#160;million to <ix:nonFraction unitRef="usd" contextRef="i2389c0a608534740bdcad0e2fa9bfcec_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMjc0ODc3OTA4Mzg5Nw_c1848802-cef5-43ab-8426-6275c22f26d5">zero</ix:nonFraction>. The impairment of IPR&amp;D resulted in a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> reversal of the associated deferred tax liability of $<ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMjE5OTAyMzI3MTI0OQ_6de1292a-cf00-43f9-a3ef-e42e274de175">2.4</ix:nonFraction> million during the third quarter of 2021. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMTgyNg_47d3dae0-d98d-4ddf-ae5d-0766d4922156" continuedAt="ibb063afd35ee4ab683fdf811070cf143" escape="true">Total assets and liabilities of Kalyra as of September&#160;30, 2021 and December&#160;31, 2020 are as follows (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:18pt"><ix:continuation id="ibb063afd35ee4ab683fdf811070cf143"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="background-color:#cdffcc;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38dad6ada064a56894e848a9616b856_I20210930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfMi0xLTEtMS0xNDc0NQ_b9df5f8e-e651-4961-ba6a-34ac3aec533f">556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfMi0zLTEtMS0xNDc0NQ_8838fb8e-329d-4173-8ef1-524c1ed6098f">417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38dad6ada064a56894e848a9616b856_I20210930" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfMy0xLTEtMS0xNDc0NQ_e7a63ee4-bca9-4a1d-9500-1613e4f14104">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfMy0zLTEtMS0xNDc0NQ_993e000e-9b2d-49e9-9f3e-a3d71b7b5d74">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process&#160;research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38dad6ada064a56894e848a9616b856_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfNC0xLTEtMS0xNDc0NQ_a3918868-ee55-4807-b753-2f5a06a73222">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfNC0zLTEtMS0xNDc0NQ_d962f764-b69e-4143-8129-5182d877464d">8,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38dad6ada064a56894e848a9616b856_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfNS0xLTEtMS0xNDc0NQ_320d4811-f8da-485b-9efc-22d97c75fa5d">3,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfNS0zLTEtMS0xNDc0NQ_992cb0c5-bd15-4235-8efb-bea96a0be127">3,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38dad6ada064a56894e848a9616b856_I20210930" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfNy0xLTEtMS0xNDc0NQ_c8bdaa23-4884-42ca-bc57-eff9f0c7c54c">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfNy0zLTEtMS0xNDc0NQ_5d7a0170-19ac-4595-bc9e-f28b4807d29d">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38dad6ada064a56894e848a9616b856_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfOC0xLTEtMS0xNDc0NQ_e2a46b2d-ee12-4363-9f54-a29fc38a4f74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfOC0zLTEtMS0xNDc0NQ_2847d6e3-1a0a-420c-a4de-bed33a1be4c0">2,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38dad6ada064a56894e848a9616b856_I20210930" decimals="-3" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfOS0xLTEtMS0xNDc0NQ_fcbab775-5444-413c-a449-8c2b2e8da8eb">564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfOS0zLTEtMS0xNDc0NQ_87fe0542-ea5a-4521-bb8c-bd031fe2957e">6,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liabilities recognized as a result of consolidating Kalyra do not represent additional claims on our general assets. Pursuant to the authoritative guidance, the equity interest in Kalyra not owned by Zentalis is reported as a noncontrolling interest on our condensed consolidated balance sheets.</span></div><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="zntl:ReconciliationOfNoncontrollingInterestTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMTgyNw_f110f72a-f498-4d6b-bbc5-a4fc563216b4" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of equity (net assets) attributable to the noncontrolling interest (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.416%"><tr><td style="width:1.0%"></td><td style="width:82.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.223%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOmMyM2IyOGMzNDUyNDQwOTQ4YmEwNzIzZjNlOTIxOWZiL3RhYmxlcmFuZ2U6YzIzYjI4YzM0NTI0NDA5NDhiYTA3MjNmM2U5MjE5ZmJfMi0xLTEtMS0xNDc0NQ_39c37b87-b3d1-4dff-bba2-b7418ca485ff">6,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa5cb2304d0444b389a997ad08e0c71e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOmMyM2IyOGMzNDUyNDQwOTQ4YmEwNzIzZjNlOTIxOWZiL3RhYmxlcmFuZ2U6YzIzYjI4YzM0NTI0NDA5NDhiYTA3MjNmM2U5MjE5ZmJfMy0xLTEtMS0xNDc0NQ_1865384f-be7d-4106-a658-13707c057c53">6,141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38dad6ada064a56894e848a9616b856_I20210930" decimals="-3" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOmMyM2IyOGMzNDUyNDQwOTQ4YmEwNzIzZjNlOTIxOWZiL3RhYmxlcmFuZ2U6YzIzYjI4YzM0NTI0NDA5NDhiYTA3MjNmM2U5MjE5ZmJfNC0xLTEtMS0xNDc0NQ_c3e55625-f32a-4efb-997f-77a5ac1647f6">564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i359d7483f88b44aba6df295b4be37cde_49"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RleHRyZWdpb246ZDM5NjNlMWUzY2VjNDY3YTkxMDVhYzBmYmE2YjMxNjlfMTQyNQ_aa05dc4e-99f7-4cb4-9cc1-644332c488d4" continuedAt="i733ac2bc3da643278bba232a33a06cfe" escape="true">Fair Value Measurement</ix:nonNumeric></span></div><ix:continuation id="i733ac2bc3da643278bba232a33a06cfe" continuedAt="i3466813bb6784471a9142fca4ebc8c4e"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RleHRyZWdpb246ZDM5NjNlMWUzY2VjNDY3YTkxMDVhYzBmYmE2YjMxNjlfMTQyNg_3290add7-41af-4c8b-a72f-24511bdc3426" continuedAt="ie6fee3cf92d44714b75eaa1e59995646" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale marketable securities consisted of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.775%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia868940f58cc42b5b13f0fc8b51e01da_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMi0xLTEtMS0xNDc0NQ_14cd29d9-defb-4e50-9195-04a7669d1446">239,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia868940f58cc42b5b13f0fc8b51e01da_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMi0zLTEtMS0xNDc0NQ_ecf4affa-fc08-40bb-bb65-d61ff8fa9252">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia868940f58cc42b5b13f0fc8b51e01da_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMi01LTEtMS0xNDc0NQ_028edc3e-8ca7-4421-a0b5-884b04675504">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia868940f58cc42b5b13f0fc8b51e01da_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMi03LTEtMS0xNDc0NQ_93b9e0db-864d-4844-8408-2ff5f3161e34">239,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad029fd87124e22a93cabf53bf1d8ad_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMy0xLTEtMS0xNDc0NQ_9587c614-a1db-4eb2-861b-c2c5d2bf7333">10,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad029fd87124e22a93cabf53bf1d8ad_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMy0zLTEtMS0xNDc0NQ_8f88a201-14b3-44d3-aebc-f4c62fc31df3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad029fd87124e22a93cabf53bf1d8ad_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMy01LTEtMS0xNDc0NQ_e563b649-9214-452a-9e95-6ead5eadebc7">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad029fd87124e22a93cabf53bf1d8ad_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMy03LTEtMS0xNDc0NQ_312b1863-4e26-42f8-b0c1-70a68cc9592e">10,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Government Agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f78113384472a9c1cd4490522fa4f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNC0xLTEtMS0xNDc0NQ_b5bf4ed0-721e-44a9-81d1-e9c6412f33cb">35,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f78113384472a9c1cd4490522fa4f_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNC0zLTEtMS0xNDc0NQ_2aa4a67b-7d2a-41d6-9779-010a3ebef552">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f78113384472a9c1cd4490522fa4f_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNC01LTEtMS0xNDc0NQ_d98e944c-97c3-4be0-99ac-daf91b7ce5dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f78113384472a9c1cd4490522fa4f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNC03LTEtMS0xNDc0NQ_f2c30418-acfe-4e12-8e41-bc42c75df93a">35,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Treasury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cbe2ea503f244c28efc38eaf91c8231_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNS0xLTEtMS0xNDc0NQ_da0983e6-eb49-4545-bb54-a4626e3f7613">40,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cbe2ea503f244c28efc38eaf91c8231_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNS0zLTEtMS0xNDc0NQ_8661f488-972d-4ff5-9a12-7de98940b7fd">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cbe2ea503f244c28efc38eaf91c8231_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNS01LTEtMS0xNDc0NQ_b11ccfc3-a963-46c0-91e1-50e339015a2e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cbe2ea503f244c28efc38eaf91c8231_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNS03LTEtMS0xNDc0NQ_082be041-03ca-4677-acd3-7d7b2aa18c74">40,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNi0xLTEtMS0xNDc0NQ_90eb7d83-5175-4a5d-8b69-17a1780cda20">325,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNi0zLTEtMS0xNDc0NQ_04584493-91d2-43ce-b73d-5ab4dd02b82d">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNi01LTEtMS0xNDc0NQ_5ec1b2df-5fd6-4474-9b81-c5435e2ebde5">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNi03LTEtMS0xNDc0NQ_8c45bd62-b62f-4aa0-b37e-a43721de6ece">325,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i3466813bb6784471a9142fca4ebc8c4e" continuedAt="i6f27b5596abb4de9a7d0bace953065f6"><div style="margin-bottom:12pt;text-indent:18pt"><ix:continuation id="ie6fee3cf92d44714b75eaa1e59995646"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.775%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37fa66f18165423bb7d922609186b948_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMi0xLTEtMS0xNDc0NQ_be70a868-9811-4340-a439-80ac62ca0ba5">147,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37fa66f18165423bb7d922609186b948_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMi0zLTEtMS0xNDc0NQ_96db6966-adae-41f3-9350-854751a16fb8">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37fa66f18165423bb7d922609186b948_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMi01LTEtMS0xNDc0NQ_88483bbd-08c9-41de-856b-338d64c9ac6c">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37fa66f18165423bb7d922609186b948_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMi03LTEtMS0xNDc0NQ_dca47de2-9c00-4bb9-a495-186ad9ee881c">147,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5bcd3985e645c3a401476d670729d9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMy0xLTEtMS0xNDc0NQ_b0dd7434-5705-4128-96e5-fb68572c9cb9">23,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5bcd3985e645c3a401476d670729d9_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMy0zLTEtMS0xNDc0NQ_2c5198b7-3c13-4f94-ab25-74293a6a8316">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc5bcd3985e645c3a401476d670729d9_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMy01LTEtMS0xNDc0NQ_0c394936-05fb-4548-bd51-f333c2831990">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5bcd3985e645c3a401476d670729d9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMy03LTEtMS0xNDc0NQ_08289697-0cf2-4ec4-96d2-0524605a82e5">23,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Government Agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic46f09a640544a46acc118a2e3a87c79_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNC0xLTEtMS0xNDc0NQ_63cd1cf8-0b61-4f22-a45d-b965c365013b">81,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic46f09a640544a46acc118a2e3a87c79_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNC0zLTEtMS0xNDc0NQ_5743fdd2-f7bd-45bd-ad67-3ad706aac1d8">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic46f09a640544a46acc118a2e3a87c79_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNC01LTEtMS0xNDc0NQ_0a1aa61c-19ec-4c57-b721-dd20c4287ced">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic46f09a640544a46acc118a2e3a87c79_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNC03LTEtMS0xNDc0NQ_931398fd-d19d-403a-bc7e-fdec7f74f75f">81,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Treasury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e4e6113e81b488f98011e1738519d49_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNS0xLTEtMS0xNDc0NQ_d4bc011d-acef-420d-a91a-fde6a8a3b514">31,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e4e6113e81b488f98011e1738519d49_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNS0zLTEtMS0xNDc0NQ_880fae72-29c5-4cca-9018-1df30dc598c2">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e4e6113e81b488f98011e1738519d49_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNS01LTEtMS0xNDc0NQ_cab826d1-c1f4-4817-844a-996b19431639">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e4e6113e81b488f98011e1738519d49_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNS03LTEtMS0xNDc0NQ_89a90ff9-e5ff-430d-a97a-709bae5d5be6">31,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNi0xLTEtMS0xNDc0NQ_518e5b47-aa57-4219-9158-75d2a1ffe645">283,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNi0zLTEtMS0xNDc0NQ_83233bf3-a2e5-4e69-89cd-0fa7d0b137e9">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNi01LTEtMS0xNDc0NQ_abda31af-7670-4706-9d2b-3784c86e97d3">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNi03LTEtMS0xNDc0NQ_3a68e233-a4ad-4d46-8dce-c94dec7a32b0">283,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></ix:continuation></div><div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company regularly reviews the securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as the severity of the impairment, changes in underlying credit ratings, forecasted recovery, our intent to sell or the likelihood that we would be required to sell the investment before its anticipated recovery in market value and the probability that the scheduled cash payments will continue to be made. Based on our review of these marketable securities, we believe none of the unrealized loss is as a result of a credit loss as of September&#160;30, 2021, because we do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of their amortized cost basis. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RleHRyZWdpb246ZDM5NjNlMWUzY2VjNDY3YTkxMDVhYzBmYmE2YjMxNjlfMTQyMg_a0e0da6b-dbaa-4c5a-812a-4df44bdd3c15" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of available-for-sale debt securities are as follows (in thousands):</span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.044%"><tr><td style="width:1.0%"></td><td style="width:51.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.362%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.256%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjk5NDliMzlmOGM1YjRjZTFiNjlmMjZlY2U4MjM0NmYwL3RhYmxlcmFuZ2U6OTk0OWIzOWY4YzViNGNlMWI2OWYyNmVjZTgyMzQ2ZjBfMy0xLTEtMS0xNDc0NQ_9d180bfc-8ac7-4620-94d4-2787f79d5137">315,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjk5NDliMzlmOGM1YjRjZTFiNjlmMjZlY2U4MjM0NmYwL3RhYmxlcmFuZ2U6OTk0OWIzOWY4YzViNGNlMWI2OWYyNmVjZTgyMzQ2ZjBfMy0zLTEtMS0xNDc0NQ_df21e2de-ac53-4175-980c-292d7e4ee9a2">247,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one but within five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjk5NDliMzlmOGM1YjRjZTFiNjlmMjZlY2U4MjM0NmYwL3RhYmxlcmFuZ2U6OTk0OWIzOWY4YzViNGNlMWI2OWYyNmVjZTgyMzQ2ZjBfNC0xLTEtMS0xNDc0NQ_960a14b8-b563-4afd-a5bf-01c23c1d77f7">9,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjk5NDliMzlmOGM1YjRjZTFiNjlmMjZlY2U4MjM0NmYwL3RhYmxlcmFuZ2U6OTk0OWIzOWY4YzViNGNlMWI2OWYyNmVjZTgyMzQ2ZjBfNC0zLTEtMS0xNDc0NQ_26ac2bfd-9ca7-4072-ade3-9faf33ea0285">36,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjk5NDliMzlmOGM1YjRjZTFiNjlmMjZlY2U4MjM0NmYwL3RhYmxlcmFuZ2U6OTk0OWIzOWY4YzViNGNlMWI2OWYyNmVjZTgyMzQ2ZjBfNS0xLTEtMS0xNDc0NQ_706d7d4d-1437-46f8-83ef-d928cfd7dd14">325,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjk5NDliMzlmOGM1YjRjZTFiNjlmMjZlY2U4MjM0NmYwL3RhYmxlcmFuZ2U6OTk0OWIzOWY4YzViNGNlMWI2OWYyNmVjZTgyMzQ2ZjBfNS0zLTEtMS0xNDc0NQ_a118c8c0-2335-4b2f-8581-0740018239ca">283,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RleHRyZWdpb246ZDM5NjNlMWUzY2VjNDY3YTkxMDVhYzBmYmE2YjMxNjlfMTQyMw_26365223-133a-4d30-a094-7c9c8925848f" continuedAt="i9ab194c810a948bb96656184faae0387" escape="true">The following table summarizes, by major security type, our cash equivalents and available-for-sale marketable securities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i6f27b5596abb4de9a7d0bace953065f6"><div style="margin-bottom:12pt;text-indent:18pt"><ix:continuation id="i9ab194c810a948bb96656184faae0387"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:18.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total estimated fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total estimated fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6170a569b9745a5ac1f31b8c185a532_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMy0xLTEtMS0xNDc0NQ_dc2519e7-1888-4fdd-b51f-02d19df7c407">25,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89d1dfe44e99408ea6d011b126cf6fef_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMy0zLTEtMS0xNDc0NQ_c4773ff5-a8d2-4fef-be98-df604f6f984b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b74220aedf04b8caee6df508ef0f7ce_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMy01LTEtMS0xNDc0NQ_36da52fe-8045-4cfa-8779-cdc52950fd6b">25,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e82dd52a30f41459848f3a6b6b17f8e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMy03LTEtMS0xNDc0NQ_3abb2cac-0564-4156-b9a9-bdeb85888d9a">24,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e57e64fbf34e6da8033002ed837bad_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMy05LTEtMS0xNDc0NQ_ac88d188-4e50-4344-87a0-a62a28cd2418">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd90709dc74fd5a0cc52f2f2b7c1c0_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMy0xMS0xLTEtMTQ3NDU_e98a1850-1b52-4061-a764-f20218846f76">24,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30534ad685e4405c91d0e95f607be899_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNi0xLTEtMS0xNDc0NQ_3769a814-a265-45c2-a532-e051b4967b6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96de234042a644fbab1614f7b8d810b0_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNi0zLTEtMS0xNDc0NQ_8d969ae4-2232-4c3f-9839-b2400845a7b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86bdaabffa344b98af6e3b49d1f8e9dd_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNi01LTEtMS0xNDc0NQ_d538e48c-7ee5-4e39-a369-e332fe5a7750">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec4099481c540d7af1b813bfb7d9ceb_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNi03LTEtMS0xNDc0NQ_ef25fae3-42e3-4929-acc6-fe866398439b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c547910054f4a26851d64a99c8cf16c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNi05LTEtMS0xNDc0NQ_3c98aeac-1c64-49ac-8e12-4a5a199967ac">4,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9732f080c4174fc4b7b9ebf4ed2bb7c1_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNi0xMS0xLTEtMTQ3NDU_d8b76acd-d6e7-4033-a0de-bb835b128f89">4,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents:</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ecc7e181acf44b4a83f0b3df2cdf533_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNy0xLTEtMS0xNDc0NQ_3505ee9d-8768-407f-be84-7657f41b7cd3">25,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ebb15d5ad9e487694cef2cce04f74cc_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNy0zLTEtMS0xNDc0NQ_34af03c0-c21d-42f5-9855-7b793dd39f30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNy01LTEtMS0xNDc0NQ_724b0340-9adb-434b-ac39-4486b18aeb91">25,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib30cfbc3f8684fdaa1394520152b8204_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNy03LTEtMS0xNDc0NQ_d29992bb-90a7-4017-85bd-98ea5d14bd6b">24,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32c0dcc014f347b3b166110a2b441716_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNy05LTEtMS0xNDc0NQ_77242606-2064-4882-828e-c9de3f4c6a80">4,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNy0xMS0xLTEtMTQ3NDU_1bf163f1-c45e-47c4-81e4-3d33d7dff24f">29,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c8984afd47b4dd1b6aa58ef930f6c50_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTAtMS0xLTEtMTQ3NDU_55b02467-d18c-4ac7-a4c5-02c80f230a72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60a9b4ad23f4455bbd5483f1f3ba42b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTAtMy0xLTEtMTQ3NDU_23ce1d9d-91c0-49ff-9f58-da12385641b7">239,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia868940f58cc42b5b13f0fc8b51e01da_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTAtNS0xLTEtMTQ3NDU_cd038f41-897b-4c8b-9b85-d7d0a1bda802">239,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47888dd151434e169157684d400b27a8_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTAtNy0xLTEtMTQ3NDU_431c08fe-40c3-4087-8ff1-75e07a7f89e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315772c54c624f278fe0ed2cba140fa2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTAtOS0xLTEtMTQ3NDU_2a5e1097-0f7c-48c5-b510-2cf900784933">147,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37fa66f18165423bb7d922609186b948_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTAtMTEtMS0xLTE0NzQ1_f60217fa-a402-4f8a-a1ff-e772e5376f55">147,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideda6fd6619d423cacd820c6cb596396_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTEtMS0xLTEtMTQ3NDU_186276ca-286c-4d82-886a-a6f4ab0da21c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8cecb43fce44fabe382da208c94b9a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTEtMy0xLTEtMTQ3NDU_a04403b6-e119-40c9-b664-6a45037f8af6">10,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad029fd87124e22a93cabf53bf1d8ad_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTEtNS0xLTEtMTQ3NDU_f14bf57a-9294-4fdc-9bc2-0a8da315fbf5">10,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2424305fc33c47e180bdcca355f56217_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTEtNy0xLTEtMTQ3NDU_bbd9c6bf-4cb5-4788-a690-c2ac78ba1c15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0249ef610edf412a8b7c3986cb8f4198_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTEtOS0xLTEtMTQ3NDU_5aac36e7-519e-4a3b-ad22-a9c7f3248302">23,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5bcd3985e645c3a401476d670729d9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTEtMTEtMS0xLTE0NzQ1_3e9cdcc5-dddc-4f96-823b-1e97763ba955">23,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Government Agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec4ba4b40d1a4678a41ebfca352cd0cb_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTItMS0xLTEtMTQ3NDU_104097ab-f9f3-46bb-974a-88b85f13354e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197f8be1dab94341ab3cb7bec4da51ee_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTItMy0xLTEtMTQ3NDU_32ed6ac4-1561-421a-8bab-235f39165cb3">35,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9f78113384472a9c1cd4490522fa4f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTItNS0xLTEtMTQ3NDU_0dc59f06-2fd4-4bca-bd68-8c19e7436d0e">35,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9459160646db459cbb327815f2c0dfad_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTItNy0xLTEtMTQ3NDU_fb7f5f65-7db6-44dc-be5c-ce9412bdf69f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b05eb2946574576b40669621fb77cff_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTItOS0xLTEtMTQ3NDU_ba8a86b4-7ed2-4f13-a1da-97ebf6f15042">81,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic46f09a640544a46acc118a2e3a87c79_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTItMTEtMS0xLTE0NzQ1_2696bc37-ab44-4f31-aef4-53dfc984f90e">81,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3044630795146b99483f1baf0d571ee_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTMtMS0xLTEtMTQ3NDU_bbf84daa-eafb-4991-8673-e10694278edf">40,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a5070fbecb84ab58845fe8229eb4e37_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTMtMy0xLTEtMTQ3NDU_89330a51-1dd4-41b3-a4e6-ec4b028c3f3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cbe2ea503f244c28efc38eaf91c8231_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTMtNS0xLTEtMTQ3NDU_0c34846f-24a5-4bc3-b58f-f2bb9aaa87e0">40,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49e62a87a0124d07b9b303e1965c458e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTMtNy0xLTEtMTQ3NDU_f0b7f20a-9982-4799-83a7-288bc93377f9">31,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i817a4309217c44a8b8dc4c083d2b3c28_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTMtOS0xLTEtMTQ3NDU_b4bd1871-88f2-42b7-85f3-2c9a9b7b7c11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e4e6113e81b488f98011e1738519d49_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTMtMTEtMS0xLTE0NzQ1_799c9c35-2c88-4576-9bcd-8cbcfdf08fc1">31,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale marketable securities:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ecc7e181acf44b4a83f0b3df2cdf533_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTQtMS0xLTEtMTQ3NDU_20dcd1f4-adf9-41ac-8170-e2c21389ffdf">40,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ebb15d5ad9e487694cef2cce04f74cc_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTQtMy0xLTEtMTQ3NDU_ef2c8c71-275f-4d75-bfef-275bc21af92f">285,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTQtNS0xLTEtMTQ3NDU_f7845371-ce2d-4fe5-a475-d1fc434b3e98">325,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib30cfbc3f8684fdaa1394520152b8204_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTQtNy0xLTEtMTQ3NDU_d7527320-432b-48fa-bd0b-ba7a7e75ec26">31,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32c0dcc014f347b3b166110a2b441716_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTQtOS0xLTEtMTQ3NDU_971b0aa8-b360-4565-b399-0ac97e90941a">252,445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTQtMTEtMS0xLTE0NzQ1_0b4d6d52-860e-444a-adfe-7ea7a86d11e1">283,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value<br/></span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ecc7e181acf44b4a83f0b3df2cdf533_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTYtMS0xLTEtMTQ3NDU_c743320d-f487-4ac9-b276-2b4a16fc54af">66,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ebb15d5ad9e487694cef2cce04f74cc_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTYtMy0xLTEtMTQ3NDU_3e3202d0-06de-43a5-806f-eccefef1596b">285,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTYtNS0xLTEtMTQ3NDU_ca4da5ec-e0f2-403c-bf4c-99b10d4d58e6">351,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib30cfbc3f8684fdaa1394520152b8204_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTYtNy0xLTEtMTQ3NDU_e6002d41-0cf5-4bdd-b08b-498db13caab0">55,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32c0dcc014f347b3b166110a2b441716_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTYtOS0xLTEtMTQ3NDU_58e890a4-0cf6-4ec9-b6f1-a3f414cab97c">257,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTYtMTEtMS0xLTE0NzQ1_045f61bf-e56d-45c7-9842-b71a3b3aea80">312,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between Level&#160;1 and Level&#160;2 of the fair value hierarchy during the nine months ended September&#160;30, 2021. We had no instruments that were classified within Level&#160;3 as of September&#160;30, 2021 or December&#160;31, 2020.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_52"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:OtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RleHRyZWdpb246ODM0MmUwZGExMDcxNGI0Nzg5ZTVjNmU0YjI0NjU2ZGJfMTIw_9a3bce96-1b77-4ed4-8398-fadb6ae82da4" continuedAt="i44ef7dc0c64846989dc8be3136052dc3" escape="true">Prepaid Expenses and Other Assets</ix:nonNumeric></span></div><ix:continuation id="i44ef7dc0c64846989dc8be3136052dc3"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RleHRyZWdpb246ODM0MmUwZGExMDcxNGI0Nzg5ZTVjNmU0YjI0NjU2ZGJfMTIx_1b0e41af-b2ba-423e-b1d5-cea6bbeebb26" escape="true"><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other assets consisted of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidInsurance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfMi0xLTEtMS0xNDc0NQ_f3ca2ba8-e540-43e0-aae9-0ea5d8567255">1,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidInsurance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfMi0zLTEtMS0xNDc0NQ_3ba0a707-2c7d-4dbc-a86c-8c8249d1d356">1,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid software licenses and maintenance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="zntl:PrepaidSoftwareLicenseAndMaintenance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfMy0xLTEtMS0xNDc0NQ_f9d8b5b7-c6af-4df3-a42f-0ab56d70cb28">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" name="zntl:PrepaidSoftwareLicenseAndMaintenance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfMy0zLTEtMS0xNDc0NQ_76f9de9b-b0f5-4c56-815e-7e77a9e8977e">563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign R&amp;D credit refund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="zntl:ForeignResearchAndDevelopmentCreditRefund" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNC0xLTEtMS0xNDc0NQ_8d1118cd-020d-4210-b773-3e63c3c0e288">1,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" name="zntl:ForeignResearchAndDevelopmentCreditRefund" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNC0zLTEtMS0xNDc0NQ_fcfda1cd-3d2c-4019-aff5-94ff9517388b">692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="zntl:PrepaidResearchAndDevelopmentCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNS0xLTEtMS0xNDc0NQ_d4e49012-aa4a-4f86-a352-f567329bf8fd">9,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="zntl:PrepaidResearchAndDevelopmentCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNS0zLTEtMS0xNDc0NQ_d36a4f07-5926-4532-9837-a2123b1cf883">5,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:InterestReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNi0xLTEtMS0xNDc0NQ_f57a6140-e7b6-4d94-a7be-45de0a563fad">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" name="us-gaap:InterestReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNi0zLTEtMS0xNDc0NQ_b6b73c66-65a0-4c00-bcca-9d4945d27fd9">478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zentera receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DueFromRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNy0xLTEtMS0yMTAwMA_4ca8f4bb-30bf-481a-9f1e-2fccf7b3df1a">2,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DueFromRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNy0zLTEtMS0yMTAwMA_15c77ede-28b4-4f27-8872-54cc98cd6b3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="zntl:OtherPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNy0xLTEtMS0xNDc0NQ_798d550f-b102-4be7-b848-77371ea40f1d">888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" name="zntl:OtherPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNy0zLTEtMS0xNDc0NQ_016103c8-300a-4219-86a5-d6eeb2a6207d">441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfOC0xLTEtMS0xNDc0NQ_0defc1d0-5579-4cba-a780-8a0b48089731">16,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfOC0zLTEtMS0xNDc0NQ_6f723c38-9aa0-4ff3-831a-725120f1b3b0">9,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less long-term portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfOS0xLTEtMS0xNDc0NQ_e1a161d6-69a9-4201-b17b-33d023be9e83">6,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfOS0zLTEtMS0xNDc0NQ_bbc2c6ae-f7c0-4f5a-ad2a-20ff99151f59">2,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other assets, current</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfMTAtMS0xLTEtMTQ3NDU_a063e037-5f20-4e9a-80f0-05d32f7ad925">10,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfMTAtMy0xLTEtMTQ3NDU_af8697a8-4ab3-4858-8ed2-768139ac28c4">6,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i359d7483f88b44aba6df295b4be37cde_55"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RleHRyZWdpb246MDVkZGM4NmE0YWM1NGNmNmE2MTljNzVlZmQxM2U0YjlfMzc4_e15c6856-b84e-4ed5-87da-cd5be0adcb53" continuedAt="i625a096469ec40ef88121f211fde41cf" escape="true">Property and Equipment, net</ix:nonNumeric></span></div><ix:continuation id="i625a096469ec40ef88121f211fde41cf" continuedAt="ie39ed49db5d844f792f482923294e4c1"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RleHRyZWdpb246MDVkZGM4NmE0YWM1NGNmNmE2MTljNzVlZmQxM2U0YjlfMzc3_159ec5fb-0c15-456f-8872-c0ab7d5addf1" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and Office Equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc264132dfe94434b23a32e250ea3637_I20210930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfMi0xLTEtMS0xNDc0NQ_4f813354-d1d1-4e3e-9ff9-70ec6ad11f5b">563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61d571892c00485fac3e8c5f93914a1f_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfMi0zLTEtMS0xNDc0NQ_4e954d96-e854-4b99-88be-89250ac979e5">529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69b3c5acd4d04eb0ad0b6255c633e023_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfMy0xLTEtMS0xNDc0NQ_94eca40c-2485-435b-9a2d-52d20eb1dc8a">1,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cdc5a844c7741f88f2ffc72efd90024_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfMy0zLTEtMS0xNDc0NQ_53cf435a-93b5-4319-99e3-4d7fd124fdb5">424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold Improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic372449226be422d8b31116aa2375ce9_I20210930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNC0xLTEtMS0xNDc0NQ_c28a1866-2989-4f80-beb3-b7cf0df8174d">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47a6b58f9a6844d89050368b6375eeb3_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNC0zLTEtMS0xNDc0NQ_53398081-1f6f-44c7-9258-6dfb973bb0bb">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in Progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic01a05364dea4804a256c0dc000120f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNS0xLTEtMS0xNDc0NQ_794a9a6b-e781-4bbb-86b6-a9063b5d9332">2,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90612704ec3a46e591ec1d86c1621300_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNS0zLTEtMS0xNDc0NQ_dc7be4df-0812-4aa1-b2d0-8e4c051c3364">347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNi0xLTEtMS0xNDc0NQ_627d1621-bfb2-4819-81c5-f16a3239d076">5,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNi0zLTEtMS0xNDc0NQ_22922beb-dbed-436a-a2fe-2ed3472bb781">1,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNy0xLTEtMS0xNDc0NQ_158fff6a-341f-480b-a97a-f5d40f3cd401">584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNy0zLTEtMS0xNDc0NQ_d8600281-fea0-47d6-b7dd-8d4ea8ef42de">250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfOC0xLTEtMS0xNDc0NQ_08fe767f-cbf8-41aa-a85f-67ac8f8ba0cc">4,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfOC0zLTEtMS0xNDc0NQ_ecb09e33-efdb-48b1-bc5b-139bb5d73f60">1,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><ix:continuation id="ie39ed49db5d844f792f482923294e4c1" continuedAt="i75c4a4e6585946499b1982382c0294ae"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense for the three months ended September&#160;30, 2021 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was approximately $<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RleHRyZWdpb246MDVkZGM4NmE0YWM1NGNmNmE2MTljNzVlZmQxM2U0YjlfMjAy_c9e2f84d-f765-410f-aac1-87fc96001780">137</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RleHRyZWdpb246MDVkZGM4NmE0YWM1NGNmNmE2MTljNzVlZmQxM2U0YjlfMjE4_5fa6b046-609d-4d72-b253-7b3b04e13e83">51</ix:nonFraction> thousand, respectively. Depreciation and amortization expense for the nine months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i75c4a4e6585946499b1982382c0294ae"> and 2020 was approximately $<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RleHRyZWdpb246MDVkZGM4NmE0YWM1NGNmNmE2MTljNzVlZmQxM2U0YjlfMzM1_a25188f5-ee95-4d9b-a7a6-1c440c8741fa">335</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RleHRyZWdpb246MDVkZGM4NmE0YWM1NGNmNmE2MTljNzVlZmQxM2U0YjlfMzUx_10f4a9e1-3ca8-4519-9270-c7e9af415a71">127</ix:nonFraction> thousand, respectively.</ix:continuation> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_58"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RleHRyZWdpb246ZmEzOGQ4NjY1M2U3NDM3MGFmODEwYmQ1ZTZhOTQ3NmVfODQ_05ea0fd9-837a-4227-aa6a-2d8b14a07d50" continuedAt="ic5e03db9364b493d9e0de3f50a65bab0" escape="true">Accrued Expenses</ix:nonNumeric></span></div><ix:continuation id="ic5e03db9364b493d9e0de3f50a65bab0"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RleHRyZWdpb246ZmEzOGQ4NjY1M2U3NDM3MGFmODEwYmQ1ZTZhOTQ3NmVfODM_1ec9a76a-495f-4ccc-9448-6a3a310bb647" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="zntl:AccruedResearchAndDevelopmentCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfMi0xLTEtMS0xNDc0NQ_4c7b8b2b-1454-4f02-9da8-d2f3d135e014">19,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="zntl:AccruedResearchAndDevelopmentCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfMi0zLTEtMS0xNDc0NQ_69fa943c-0c0d-417f-b5d6-17c6edf6bf16">11,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfMy0xLTEtMS0xNDc0NQ_c4a9e554-df65-4cd8-a1e9-c5e3efe8f9f4">7,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfMy0zLTEtMS0xNDc0NQ_61fa9647-a597-466b-9200-10dafb441f5e">5,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="zntl:AccruedGeneralAndAdministrativeCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfNS0xLTEtMS0xNDc0NQ_56edc88f-528b-4396-822c-b4332de0c890">2,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" name="zntl:AccruedGeneralAndAdministrativeCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfNS0zLTEtMS0xNDc0NQ_32d276dd-f288-4f1e-a028-ead73ab37da7">996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfNi0xLTEtMS0xNDc0NQ_d66538e4-8c8a-47e5-93d5-1a5acbcfa9aa">862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfNi0zLTEtMS0xNDc0NQ_6eafad93-5691-4109-9967-6e68f3233476">902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfNy0xLTEtMS0xNDc0NQ_f968cdd6-dbc4-43ef-bbee-118c46bc40ed">767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfNy0zLTEtMS0xNDc0NQ_cd76a2bc-84f2-4559-a7dc-1d0f2a16a9a2">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfOC0xLTEtMS0xNDc0NQ_bd3b7cb2-f67c-4317-b7bb-471bbd8e92d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfOC0zLTEtMS0xNDc0NQ_54ca7b9f-0622-4ddd-9149-64b633c31001">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfOS0xLTEtMS0xNDc0NQ_040beff2-cb92-41e7-9551-ea1a3e8e90e3">31,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfOS0zLTEtMS0xNDc0NQ_bb746de2-61cb-4a30-a8c6-0b04ad8b8a41">19,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i359d7483f88b44aba6df295b4be37cde_61"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="zntl:TemporaryEquityTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfODY0Mg_bbd3a882-289d-4dac-bdeb-989d3a441df7" continuedAt="ic77fff7e258f4a5bb4bb77ce94efdda3" escape="true">Convertible Preferred Units</ix:nonNumeric></span></div><ix:continuation id="ic77fff7e258f4a5bb4bb77ce94efdda3" continuedAt="ie4caf23bef9246e1ae6ae163bc64b026"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series A Convertible Preferred Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, Zeno Pharmaceuticals, Inc. entered into a Series A Preferred Stock Purchase Agreement (the &#8220;Series A Preferred Agreement&#8221;). Under the terms of the Series A Preferred Agreement, Zeno Pharmaceuticals, Inc. issued <ix:nonFraction unitRef="shares" contextRef="i9d749128b5cc4c058432e3008374c9f5_D20150901-20150930" decimals="INF" format="ixt:num-dot-decimal" name="zntl:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzAz_796cad98-1fb2-4e76-be7c-8865bd80dfe5">1,293,104</ix:nonFraction> shares of Series A convertible preferred stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="i791e20e9521c44e28152d01ddac1222b_I20150930" decimals="2" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzU2_c99b6f4f-37cd-44a4-8338-82446b031144">11.60</ix:nonFraction> per share for gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i9d749128b5cc4c058432e3008374c9f5_D20150901-20150930" decimals="-5" format="ixt:num-dot-decimal" name="zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzkx_1a494363-cd5e-4086-b7d8-82490757bbbc">15.0</ix:nonFraction>&#160;million. The net proceeds of this financing were $<ix:nonFraction unitRef="usd" contextRef="i9d749128b5cc4c058432e3008374c9f5_D20150901-20150930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNDM1_729e8fab-4d31-48da-aee3-4580c2e99ddf">14.9</ix:nonFraction>&#160;million after issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i9d749128b5cc4c058432e3008374c9f5_D20150901-20150930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNDYy_a055d5c5-b1d4-46ff-8416-9e11c5b4e083">0.1</ix:nonFraction>&#160;million. In February and March 2016, Zeno Pharmaceuticals, Inc. issued an aggregate of <ix:nonFraction unitRef="shares" contextRef="ibf2c9428be0742a0a000254f1421fc0d_I20160331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNTQ0_37ed9c05-3836-4be4-8949-ca222f0512c7">286,205</ix:nonFraction> additional shares of Series A convertible preferred stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="ibf2c9428be0742a0a000254f1421fc0d_I20160331" decimals="2" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNjA4_dd8dab72-d98d-40b1-a034-dc699f564e56">11.60</ix:nonFraction> per share for additional gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i8997c29134c6485eb8e9deb026d07200_D20160201-20160331" decimals="-5" format="ixt:num-dot-decimal" name="zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNjU0_80898d42-70d4-4771-a68e-57f7a336a600">3.3</ix:nonFraction>&#160;million. The issuance costs of this additional financing were approximately <ix:nonFraction unitRef="usd" contextRef="i8997c29134c6485eb8e9deb026d07200_D20160201-20160331" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNzI1_29782a25-49f0-42ac-8bda-468122f99a01">thirty-nine thousand</ix:nonFraction> dollars. All Series A convertible preferred stock issued and outstanding by Zeno Pharmaceuticals, Inc. was converted into Series A convertible preferred units of Zentalis Pharmaceuticals, LLC in conjunction with the corporate restructuring and merger.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Convertible Preferred Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, Zentalis Pharmaceuticals, LLC entered into a Series B Preferred Unit Purchase Agreement (the &#8220;Series B Preferred Agreement&#8221;). Under the terms of the Series B Preferred Agreement, Zentalis Pharmaceuticals, LLC issued <ix:nonFraction unitRef="shares" contextRef="i2dac0c6c83624d678d99d838917cfa5e_I20171231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTI1MQ_8af4d82a-b5d5-43da-a6f1-e7ea1a43ffc8">2,735,320</ix:nonFraction> Series B preferred units at $<ix:nonFraction unitRef="usdPerShare" contextRef="i2dac0c6c83624d678d99d838917cfa5e_I20171231" decimals="2" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTI4Mg_1e417521-722d-4b9a-a2cc-cf0adda7aac8">12.43</ix:nonFraction> per unit for gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i7e885190922f4e1d806613f4bfce9ffe_D20171201-20171231" decimals="-5" format="ixt:num-dot-decimal" name="zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTMxNg_f52862be-9e42-489a-9f8f-26632cf6f4b4">34.0</ix:nonFraction>&#160;million. The net proceeds of this financing were $<ix:nonFraction unitRef="usd" contextRef="i7e885190922f4e1d806613f4bfce9ffe_D20171201-20171231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTM2MA_0d57660f-2059-4162-8489-1d852a5819e8">32.1</ix:nonFraction>&#160;million after issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i7e885190922f4e1d806613f4bfce9ffe_D20171201-20171231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTM4Nw_bb1ae05d-d142-45d1-9210-be14e8c8a757">1.9</ix:nonFraction>&#160;million. In January and August 2018, Zentalis Pharmaceuticals, LLC issued an aggregate of <ix:nonFraction unitRef="shares" contextRef="i15fe047b039c40dfa459cd498a30878a_I20180831" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTQ3Mg_b2ee0ec0-ee60-4583-9bfc-e64631ba9910">788,419</ix:nonFraction> additional shares of Series B preferred units at $<ix:nonFraction unitRef="usdPerShare" contextRef="i15fe047b039c40dfa459cd498a30878a_I20180831" decimals="2" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTUyNA_d3d28b19-76f1-416b-a22e-5f287ba7d433">12.43</ix:nonFraction> per unit for additional gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i561f11c86d154f968f0d7b64cfa9bb70_D20180101-20180831" decimals="-5" format="ixt:num-dot-decimal" name="zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTU2OQ_06c5fca6-a70c-4c41-820d-f4b1a28d885d">9.8</ix:nonFraction>&#160;million. The net proceeds of this additional financing were $<ix:nonFraction unitRef="usd" contextRef="i561f11c86d154f968f0d7b64cfa9bb70_D20180101-20180831" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTYyNA_be7b1ad7-cbb2-4b02-8070-dfcb7bcbf920">9.5</ix:nonFraction>&#160;million after issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i561f11c86d154f968f0d7b64cfa9bb70_D20180101-20180831" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTY1MQ_8f710d6e-0c39-4dd4-a9dc-2606e32d0e23">0.3</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series C Convertible Preferred Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, Zentalis Pharmaceuticals, LLC entered into a Series C Preferred Unit Purchase Agreement (the &#8220;Series C Preferred Agreement&#8221;). Under the terms of the Series C Preferred Agreement, Zentalis Pharmaceuticals, LLC issued <ix:nonFraction unitRef="shares" contextRef="if4f7f71c7cf34041890690bb8f1b4f55_I20190930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTkyNw_80cd71e0-d211-4df6-ab89-caf7ac138bc2">4,847,106</ix:nonFraction> units of Series C convertible preferred units at $<ix:nonFraction unitRef="usdPerShare" contextRef="if4f7f71c7cf34041890690bb8f1b4f55_I20190930" decimals="2" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTk3OQ_10ea0814-31b6-4be1-847f-73a9519a86a4">17.50</ix:nonFraction> per unit for gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i6cfdd80dc235471f94d955162c41ea8d_D20190901-20190930" decimals="-5" format="ixt:num-dot-decimal" name="zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjAxMw_e0f05e32-33d1-4d67-95f2-7999dc1e2d9e">84.8</ix:nonFraction>&#160;million. The net proceeds of this financing were $<ix:nonFraction unitRef="usd" contextRef="i6cfdd80dc235471f94d955162c41ea8d_D20190901-20190930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjA1Nw_a9166c6a-93fa-45ae-ba23-df03ada92716">81.9</ix:nonFraction>&#160;million after issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i6cfdd80dc235471f94d955162c41ea8d_D20190901-20190930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjA4NA_987f2558-06ce-4216-8787-5bab5b159f06">2.9</ix:nonFraction>&#160;million. In February 2020, Zentalis Pharmaceuticals, LLC issued <ix:nonFraction unitRef="shares" contextRef="i4ae8f32d20e94dec87f494ef073bbaa1_I20200229" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjE0Mw_aba7286f-11be-4c5a-8cc4-3617e16279d6">867,194</ix:nonFraction> additional units of Series C preferred units under the Series C Preferred Agreement. The units were issued for $<ix:nonFraction unitRef="usdPerShare" contextRef="i4ae8f32d20e94dec87f494ef073bbaa1_I20200229" decimals="2" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjI1Nw_2b2a8368-e933-44db-a0de-d431b0c545df">17.50</ix:nonFraction> per unit for gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="id660983397b24d43bf35134f4a0c0395_D20200201-20200229" decimals="-5" format="ixt:num-dot-decimal" name="zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjI5MQ_d709fd5e-7ee3-40d9-bba9-41282195f511">15.2</ix:nonFraction>&#160;million. The net proceeds of this financing were $<ix:nonFraction unitRef="usd" contextRef="id660983397b24d43bf35134f4a0c0395_D20200201-20200229" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjMzNQ_80a76af2-722a-45c9-ad9f-8d1edefe0a16">14.2</ix:nonFraction>&#160;million after issuance costs of $<ix:nonFraction unitRef="usd" contextRef="id660983397b24d43bf35134f4a0c0395_D20200201-20200229" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjM2Mg_a85b67af-b62d-4f5d-8ac9-b84b8f91abc9">1.0</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="ie4caf23bef9246e1ae6ae163bc64b026" continuedAt="ie6f17b55c9534193a7a3094c910af8ad"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjM3Nw_004fe5b8-c7a3-4029-8398-e350aa40ec9d"><ix:nonFraction unitRef="shares" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjM3Nw_1a75bbef-2b0e-4460-83d9-0122bd2e5e4a"><ix:nonFraction unitRef="shares" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjM3Nw_3ad8ba79-1540-43f3-a7ab-edea776e6780"><ix:nonFraction unitRef="shares" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjM3Nw_761c4482-c287-4dac-9c25-a5a8cfc82f8d"><ix:nonFraction unitRef="shares" contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjM3Nw_7bc02c0e-fd4c-4954-9656-5f77ba6ef8d9"><ix:nonFraction unitRef="shares" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjM3Nw_d131cb4d-ba95-4eaa-82b1-918b6a24ca79">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> authorized, issued, or outstanding shares of convertible preferred units at September&#160;30, 2021 and December&#160;31, 2020. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2020, we reclassified the convertible preferred units from members&#8217; equity to temporary equity because, in conjunction with the Series C convertible preferred units issuance, all units were now deemed to contain contingent liquidation features that are not solely within our control. During the year ended December&#160;31, 2020, we did not adjust the carrying values of the convertible preferred units to the deemed redemption values of such units since a liquidation event was not probable. </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends are payable if and when declared by the Board of Directors. <ix:nonFraction unitRef="usdPerShare" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="zntl:ConvertiblePreferredStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzAyNw_0e33e916-f247-4312-a17b-2aed123afbc5">No</ix:nonFraction> dividends have been declared through September&#160;30, 2021. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Series A preferred unit, Series B preferred unit and Series C preferred unit was convertible at the option of the holder thereof, at any time after the issuance of such unit, into Class&#160;A common units at a conversion price equal to the original purchase price (subject to anti-dilution adjustments, discussed below) which was $<ix:nonFraction unitRef="usdPerShare" contextRef="ic748b33ae7394b2b9c1ebfeb481ad01c_I20210930" decimals="INF" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzQxNA_5e27dd4e-dbcc-4021-8c3d-e17a5d2dfe5a">11.60</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i662b4e7ea6f842119f8206ee5b4516c7_I20210930" decimals="INF" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzQxOA_3f5a7eec-9e2a-481d-992a-72e28bed910b">12.43</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i6bad6ea4eda8467f8d5d6a4850fc03d0_I20210930" decimals="INF" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzQyNQ_1acea364-3dc0-4769-a25b-3498d8c01a8b">17.50</ix:nonFraction> per unit, respectively. The convertible preferred units automatically converted at the then applicable conversion rate upon the closing of a firm commitment underwritten public offering of shares of a successor corporations&#8217; common stock, at a public offering price per share of equal to or greater than the Series C original purchase price (as adjusted for any stock splits, stock dividends, combinations or other similar recapitalization) resulting in aggregate gross cash proceeds of at least $<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="zntl:TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzkyNA_bd1d2366-56d1-4336-b3f7-df267af29149">75.0</ix:nonFraction>&#160;million (a &#8220;Qualified IPO&#8221;). Additionally, the convertible preferred unit would have automatically converted into common stock, at the then applicable conversion rate, upon written consent of a majority of the then outstanding Series A, Series B and Series C convertible preferred units (voting as a separate class on an as converted to Common Unit basis). In conjunction with our IPO on April 2, 2020, which constituted a Qualified IPO, all convertible preferred units were converted to common stock. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-dilution protection</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the convertible preferred units had proportional anti-dilution protection for unit splits, unit dividends and similar recapitalizations. Subject to certain exclusions, anti-dilution price protection for additional sales of securities by us for consideration per unit less than the applicable conversion price per unit of any series of convertible preferred stock, was on a broad-based weighted average basis.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective rights</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the convertible preferred units had certain protective rights, including, without limitation, regarding the authorization, alteration, redemption, or sale of Class&#160;B common units; commencement of a liquidation or deemed liquidation event; entrance into a joint venture or partnership; any incurrence of indebtedness; certain transactions that exceed a certain dollar threshold; changes to our governing documents; or the declaration of any dividends. Such actions were required to be approved by a majority of the then outstanding Series A, Series B and Series C convertible preferred unit holders (voting as a single class and on an&#160;as-converted&#160;basis), as specified in the amended and restated LLC agreement. An increase or decrease in the authorized number of Directors constituting the Board or the creation of a membership interest or equity security senior to or pari passu with Series C convertible preferred units was required to be approved by a majority of the then outstanding Series C convertible preferred Units (voting as a separate class on an as converted basis).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series A, Series B and Series C convertible preferred units were not redeemable except in the event of certain effected deemed liquidation events. As of immediately prior to our IPO on April 2, 2020, we had classified convertible preferred units as temporary equity in accordance with authoritative guidance for the classification and </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="ie6f17b55c9534193a7a3094c910af8ad"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measurement of potentially redeemable securities whose redemption is based upon certain change in control events outside of our control, including liquidation, sale or transfer of control of the Company. We did not adjust the carrying value of the convertible preferred units to the deemed redemption values of such units since a liquidation event was not probable.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidation preference</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of the dissolution, liquidation, merger or winding up of the Company, the holders of Series C convertible preferred units were entitled to receive, on a pro rata basis in respect of each such Series C convertible preferred unit, a preference amount of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6bad6ea4eda8467f8d5d6a4850fc03d0_I20210930" decimals="INF" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNjk4OA_26b95b96-2a70-49f4-a993-6108aadaf7ad">17.50</ix:nonFraction> per Series C convertible unit (as adjusted for any unit splits, dividends, combinations, recapitalizations or the like).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the payment of the Series C convertible preferred unit preferences, Series A and Series B convertible preferred units were entitled to receive, on a pro rata basis in respect of each convertible preferred unit in proportion to the relative preference amount of each preferred unit, a preference amount of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic748b33ae7394b2b9c1ebfeb481ad01c_I20210930" decimals="INF" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNzQzMQ_5e69eeba-0e6d-40a5-9f29-ec9d2b81c00e">11.60</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i662b4e7ea6f842119f8206ee5b4516c7_I20210930" decimals="INF" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNzQzOA_41e07d3a-0d5c-409e-adbf-e0363d477658">12.43</ix:nonFraction> per unit of Series A and Series B convertible preferred units (as adjusted for any units splits, dividend, combinations, recapitalizations of the like), respectively.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the payment of the Series C, Series A and Series B convertible preferred unit preferences, Series A, Series B and Series C convertible preferred units are entitled to receive, on an as converted to common unit pro rata basis, an amount equal to distributions made to Class&#160;A common units prior to all unit classes sharing in distributions on a pro rata basis. Thereafter, Series A, Series B and Series C convertible preferred units and Series A and Series B common units were entitled to receive the remaining assets of the Company available for distribution to its unit holders pro rata based on the number of common units held by each holder, treating for these purposes as if all units had been converted to common.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of all units other than Class&#160;B common units that were unvested were to vote together as a single class. Each holder of Series A, Series B and Series C convertible preferred units were entitled to the number of votes calculated on an as converted to Class&#160;A common unit basis.</span></div></ix:continuation><div id="i359d7483f88b44aba6df295b4be37cde_64"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="zntl:ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTEwNjY_c4fdfc18-cfb3-4f65-a338-08b73026affd" continuedAt="i7fefdca7878644f6af3b3d88243ea498" escape="true">Members&#8217; Equity </ix:nonNumeric></span></div><ix:continuation id="i7fefdca7878644f6af3b3d88243ea498" continuedAt="i70c28bb9b06a4207a3a3d6623f7cef43"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, Zentalis Pharmaceuticals, LLC was formed in the state of Delaware. In conjunction with a corporate restructuring, Zeno Pharmaceuticals, Inc., a Delaware corporation formed in 2014, was acquired by the Company pursuant to a merger agreement and became a wholly owned subsidiary of the Company. Per the terms of the merger agreement, each share of Zeno Pharmaceuticals, Inc. common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive one Class&#160;A common unit and each share of Zeno Pharmaceuticals, Inc. Series A preferred stock issued and outstanding immediately prior to the effective date of the merger converted into the right to receive one Series A preferred unit. As of the effective time of the merger agreement, all outstanding options to purchase shares of Zeno Pharmaceuticals, Inc. common stock were cancelled and replaced with profits interest awards in the LLC.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the December 2017 corporate restructuring, we amended and restated the LLC agreement, and as amended, the capital units of the Company consisted of <ix:nonFraction unitRef="shares" contextRef="i2494c11e1f6b40a3866cf410bc8a7cb8_I20171231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredUnitsAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTE1NA_2f084b67-d20c-402d-b1f5-6d53a0c8e9cd">1,638,000</ix:nonFraction> authorized Series A preferred units, <ix:nonFraction unitRef="shares" contextRef="i2dac0c6c83624d678d99d838917cfa5e_I20171231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredUnitsAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTE5NA_cba0fd85-f23d-406e-baf8-4af331a58d39">3,621,000</ix:nonFraction> authorized Series B preferred units, <ix:nonFraction unitRef="shares" contextRef="i0473a06af7ec44a996f1bca35660558f_I20171231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonUnitAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTIzNA_c2847e59-4cf1-4d8b-9224-0af7c877dd38">15,000,000</ix:nonFraction> authorized Class&#160;A common units and <ix:nonFraction unitRef="shares" contextRef="i69a08aa6ff634f5caab3972d78e1ddfa_I20171231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonUnitAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTI3Mw_ca777176-4d16-4f32-9ac7-bd9da8ba4327">872,620</ix:nonFraction> authorized Class&#160;B common units.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class&#160;A Common Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the corporate restructuring in December 2017, <ix:nonFraction unitRef="shares" contextRef="i7b2b52f5efb3462d8683dfdb2d599eac_I20171231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTM5Ng_4de6eb38-87a7-4d19-8821-eb57498feb98"><ix:nonFraction unitRef="shares" contextRef="i7b2b52f5efb3462d8683dfdb2d599eac_I20171231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTM5Ng_e072b66f-51c3-494a-ab1a-bf6f1a448772">5,187,554</ix:nonFraction></ix:nonFraction> shares of common stock issued and outstanding and <ix:nonFraction unitRef="shares" contextRef="i7b2b52f5efb3462d8683dfdb2d599eac_I20171231" decimals="INF" format="ixt:num-dot-decimal" name="zntl:CommonStockSharesSubjectToFutureVestingProvisions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTQ0OQ_3fd0c3ea-0db8-44fe-b8bd-93f90fed1118">406,831</ix:nonFraction> shares of common stock subject to future vesting provisions of Zeno Pharmaceuticals, Inc. were converted into an equal number of Class&#160;A common units of Zentalis Pharmaceuticals, LLC. In September </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i70c28bb9b06a4207a3a3d6623f7cef43" continuedAt="i7c2c2c65b5414311b27db76755d8df61"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019, the number of authorized Class&#160;A common units was increased to <ix:nonFraction unitRef="shares" contextRef="ia401f69705414c51916b97151f480785_I20190930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonUnitAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTcxOA_0a23a5ea-6be7-4fe1-9d66-8ea76c6fa2a6">20,000,000</ix:nonFraction>. During the nine months ended September&#160;30, 2021 and 2020, we did <ix:nonFraction unitRef="shares" contextRef="i6829f239f3964fc5b73c9f115f4efd4a_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTc2OA_09726f65-84b4-4c30-8b42-41cf246b8925"><ix:nonFraction unitRef="shares" contextRef="i773376c6e0a4414fba9a40b0fa6f57eb_D20200101-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTc2OA_2adc9d17-bef3-439e-aaaf-c52bdbb44b44">no</ix:nonFraction></ix:nonFraction>t issue any Class A common units. As of September&#160;30, 2021 and 2020, there were <ix:nonFraction unitRef="shares" contextRef="i85105ad976e44ee3a9e3b01e44eee367_I20200930" decimals="INF" format="ixt:fixed-zero" name="zntl:CommonUnitOutstandingSubjectToFutureVestingConditions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTgzMg_ef4a8c31-8d8a-4843-bafd-11cb88f02978"><ix:nonFraction unitRef="shares" contextRef="if256d2dc23e54899b1bcec809c82546d_I20210930" decimals="INF" format="ixt:fixed-zero" name="zntl:CommonUnitOutstandingSubjectToFutureVestingConditions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTgzMg_fd837a84-4b00-4c2f-a467-9c430c2bb996">no</ix:nonFraction></ix:nonFraction> Class A common units subject to future vesting conditions.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class&#160;B Common Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the corporate restructuring in December 2017, <ix:nonFraction unitRef="shares" contextRef="i90fe1d00c583463bb71b163aa4946d4b_D20171201-20171231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTk4MQ_ae9ac8f5-c737-49e3-9c3f-4c2332b99a6a">703,000</ix:nonFraction> options exercisable into Zeno Pharmaceuticals, Inc. common stock were converted into an equal number of Class&#160;B Common Units of Zentalis Pharmaceuticals, LLC. In September 2019, the number of authorized Class&#160;B common units was increased to <ix:nonFraction unitRef="shares" contextRef="ibc382a9f642a48919cda5bcaa7020bfb_I20190930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonUnitAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMjIyNQ_9c297798-3309-4819-aa3e-f33f8348f91a">3,458,522</ix:nonFraction>.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IPO and Follow-on Offerings</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 2, 2020 and immediately prior to the effectiveness of the Company&#8217;s IPO, Zentalis Pharmaceuticals, LLC converted from a Delaware limited liability company into a Delaware corporation pursuant to a statutory conversion, and changed its name to Zentalis Pharmaceuticals, Inc. In order to consummate the corporate conversion, a certificate of conversion was filed with the Secretary of State of the State of Delaware. All of the outstanding units of Zentalis Pharmaceuticals, LLC converted into shares of common stock of Zentalis Pharmaceuticals, Inc. based upon the value of Zentalis Pharmaceuticals, Inc. at the time of the IPO with a value implied by the price of the shares of common stock sold in the IPO. <ix:nonFraction unitRef="shares" contextRef="i9a0fb89c534046e2a6262b44710848a6_D20200402-20200402" decimals="INF" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMjk3Mw_05e3725d-db10-4588-9e25-6c8218f925c5">No</ix:nonFraction> cash or fractional shares of common stock were issued in connection with the corporate conversion. Based on the IPO price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib67a09c2cc4e4165b391d6ef5419f1b7_I20200407" decimals="INF" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzEwMg_be9eaa5c-c2c6-4c3c-ac77-4cba0dda83a5">18.00</ix:nonFraction> per share of common stock, all of the outstanding units converted into an aggregate of <ix:nonFraction unitRef="shares" contextRef="ibdac556512264baba2e3c86be867069c_D20200402-20200402" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzE5Mg_d00d65a9-89fe-4790-9c42-857e422681d7">25,288,854</ix:nonFraction> shares of common stock (including <ix:nonFraction unitRef="shares" contextRef="i0daa24d503d64a52a0b1fa592bd6c4e8_D20200402-20200402" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzIyOQ_b7f1d5bf-332c-4fc4-a898-77b33611d596">1,160,277</ix:nonFraction> shares of restricted common stock).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the completion of the IPO, the board and stockholders approved the certificate of incorporation to provide for <ix:nonFraction unitRef="shares" contextRef="i398696456f95488dbba235847304fab6_I20200402" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzM5OA_4b3524cb-7038-4f47-9623-bc268a513fc4">250,000,000</ix:nonFraction> authorized shares of common stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i398696456f95488dbba235847304fab6_I20200402" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzQ1NQ_1e6cd625-1c77-473e-bf7c-22449243db43">0.001</ix:nonFraction> per share and <ix:nonFraction unitRef="shares" contextRef="i398696456f95488dbba235847304fab6_I20200402" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzQ3Mg_f83d2e44-cba7-4840-898b-ffb44bcef052">10,000,000</ix:nonFraction> authorized shares of preferred stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i398696456f95488dbba235847304fab6_I20200402" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzUzMg_6ddb2ab7-d7f1-4110-947f-3f7152cd0f38">0.001</ix:nonFraction> per share.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 7, 2020, the Company completed an IPO in which the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="id1b99cb5cf7d4b9bb0f68ae4525eab72_D20200407-20200407" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzYzMA_f6d3e894-529b-44b0-aa2e-b64e1e8501d8">10,557,000</ix:nonFraction> shares of common stock (including <ix:nonFraction unitRef="shares" contextRef="ie8cad8b83d3f432cafaa0e90fa7125e0_D20200407-20200407" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzY2Nw_ac87c09e-8b1d-4577-9064-0b65bfeb4889">1,377,000</ix:nonFraction> shares of common stock in connection with the full exercise of the underwriters&#8217; option to purchase additional shares) at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ibac774a69e7b4afb9ca8e9498d26c25a_I20200407" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzgwMw_6b0e7194-48b8-47bf-a18d-bd9b6682f8f1">18.00</ix:nonFraction> per share. The Company&#8217;s aggregate gross proceeds from the sale of shares in the IPO, including the sale of shares pursuant to the full exercise of the underwriters&#8217; option to purchase additional shares, was $<ix:nonFraction unitRef="usd" contextRef="i550ef246d4114b12b5ec6d79c50b321c_D20200407-20200407" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDAxNA_3fae32b0-f01c-4910-9e39-97492802a264">190.0</ix:nonFraction>&#160;million before fees and expenses of $<ix:nonFraction unitRef="usd" contextRef="i550ef246d4114b12b5ec6d79c50b321c_D20200407-20200407" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDA0NQ_a49bed56-3999-445c-9dbf-7134d5bc61c6">17.6</ix:nonFraction>&#160;million.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 3, 2020, the Company completed a follow-on offering in which the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="ie530cc1b51e14d3da1b54feb7ef48e78_D20200803-20200803" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDE0OA_d774b108-f0b9-4921-ba28-fdb0388adbe6">4,743,750</ix:nonFraction> shares of common stock (including <ix:nonFraction unitRef="shares" contextRef="ia99692ba60b24412a1dab4423fbdcce9_D20200803-20200803" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDE4NQ_e0c673ce-84dc-4865-9e62-c8147e91b0bd">618,750</ix:nonFraction> shares of common stock in connection with the full exercise of the underwriters&#8217; option to purchase additional shares) at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i59f99ff806c9400aa93e53bd0e0c2163_I20200803" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDMzNw_221c1f28-9dd0-45bd-a67c-54481f9afa39">35.00</ix:nonFraction> per share. The Company&#8217;s aggregate gross proceeds from the sale of shares in the follow-on offering, including the sale of shares pursuant to the full exercise of the underwriters&#8217; option to purchase additional shares, was $<ix:nonFraction unitRef="usd" contextRef="i303787d7706b449b8fd82484ea7a63e8_D20200803-20200803" decimals="-5" format="ixt:num-dot-decimal" name="zntl:ProceedsFromIssuanceOfCommonStockGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDU2Mw_2d0c8329-48cd-4ace-a4e3-e876516bcc7a">166.0</ix:nonFraction>&#160;million before fees and expenses of $<ix:nonFraction unitRef="usd" contextRef="i303787d7706b449b8fd82484ea7a63e8_D20200803-20200803" decimals="-5" format="ixt:num-dot-decimal" name="zntl:ExpensesAndFeesFromTheIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDU5NA_8ffbf744-9a31-445b-bf4e-ca8b786a3140">10.8</ix:nonFraction>&#160;million.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed a follow-on offering in which the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="ia6ddf0384ce84914b02bcf5b8a9a975f_D20210701-20210701" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMjc0ODc3OTA4MTY4Mw_e5d8ae2e-87a8-4e30-a627-39f3139b463a">3,565,000</ix:nonFraction> shares of common stock (including <ix:nonFraction unitRef="shares" contextRef="i462230a27f80426bb97a31bcd0bd3a57_D20210701-20210701" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMjc0ODc3OTA4MTY5NA_4cc693f4-eba4-4da1-93fd-43f52841593e">465,000</ix:nonFraction> shares of common stock in connection with the full exercise of the underwriters&#8217; option to purchase additional shares) at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i599720d743104c59928244998d2e982a_I20210701" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMjc0ODc3OTA4MTcxOQ_bf33062e-4dfd-44e5-aaea-ffc4164d2d88">48.50</ix:nonFraction> per share. The Company&#8217;s aggregate gross proceeds from the sale of shares in the follow-on offering, including the sale of shares pursuant to the full exercise of the underwriters&#8217; option to purchase additional shares, was $<ix:nonFraction unitRef="usd" contextRef="ia6ddf0384ce84914b02bcf5b8a9a975f_D20210701-20210701" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMjc0ODc3OTA4MTcwMw_4d18d5f7-530b-4fdd-afe4-95a6f375b273">172.9</ix:nonFraction>&#160;million before fees and expenses of $<ix:nonFraction unitRef="usd" contextRef="ia6ddf0384ce84914b02bcf5b8a9a975f_D20210701-20210701" decimals="INF" name="zntl:ExpensesAndFeesFromTheIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTA5OTUxMTY0MDU5Ng_0814031f-61ca-43a9-95ed-31b1f79f7a87">10.7</ix:nonFraction> million.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i7c2c2c65b5414311b27db76755d8df61" continuedAt="i6f364fcf469a4577bf89c10ffe14341e"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Company&#8217;s 2017 Profits Interest Plan (&#8220;the Plan&#8221;) as approved and adopted by the Board of Directors on December 21, 2017, the Company was authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="i26c9395499914bb6915eb0b50eb6531e_I20171221" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDkxMQ_684998a9-eb7c-4878-b9b8-ae639ae0b384">3,458,522</ix:nonFraction> shares of Class B common units, (&#8220;profits interest award units&#8221;), subject to restrictions as described in the Plan. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In April 2020, the Plan was terminated and the Company&#8217;s board of directors adopted, and the Company&#8217;s stockholders approved the 2020 Incentive Award Plan (&#8220;the 2020 Plan&#8221;), which became effective upon the corporate conversion and allows for grants to selected employees, consultants and non-employee members of the Board of Directors. We currently grant stock options and restricted stock units under the 2020 Plan. The number of common shares available for issuance under the 2020 Plan is the sum of (1) <ix:nonFraction unitRef="shares" contextRef="i788f376ae39641539c7ea4298ff33b65_I20200430" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNTUzNw_3cfce593-9f02-430f-b51b-d93a792307b5">5,600,000</ix:nonFraction> shares of common stock; plus (2) any shares forfeited from the unvested restricted shares of our common stock issued upon conversion of unvested Class B common units (up to <ix:nonFraction unitRef="shares" contextRef="i40102d77fe8f40fa92901924ead82975_I20200430" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNTcxMw_93d91e41-0477-4b18-8982-51edc4a2a1ba">1,250,000</ix:nonFraction> shares); plus (3) an annual increase on the first day of each fiscal year beginning with the fiscal year ending December 31, 2021 and continuing to, and including, the fiscal year ending December 31, 2030, equal to the lesser of (a) <ix:nonFraction unitRef="number" contextRef="i9da50ea1ee9c4df0b7b30adef3d8867a_D20200401-20200430" decimals="INF" name="zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNTk0OQ_32089459-6d5f-4d63-9629-7fc2746ab203">5</ix:nonFraction>% of the shares of common stock outstanding on the final day of the immediately preceding calendar year and (b) such smaller number of shares as determined by our board of directors. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, <ix:nonFraction unitRef="shares" contextRef="ia728d556059a440da6322b57d7154e71_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNjE0Mg_2f9cb229-fe7b-46bb-ae93-0849d98f0775">4,418,484</ix:nonFraction> shares were subject to outstanding awards and <ix:nonFraction unitRef="shares" contextRef="ia728d556059a440da6322b57d7154e71_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNjE5MQ_c38dd377-9132-44d7-b4d5-6ffc86fa5b95">2,237,052</ix:nonFraction> shares were available for future grants of share-based awards. </span></div><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTEwNjI_f7d85b7d-8063-40f1-a9bf-01a771f78798" continuedAt="i6818d2ef36f140c688aec1c50d463672" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense related to share based awards was comprised of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i181d83080b3f41ccb6787320f7d2229c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMi0xLTEtMS0xNDc0NQ_079a3fc6-34fb-4544-8fce-8c6422bdda3f">3,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e4e5dca01c4b329a93274f8d739507_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMi0zLTEtMS0xNDc0NQ_f2bee85b-8be7-41cd-a3e6-85c168f028f5">2,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a7273c96f564c1e865eeb7eb0a5402f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMi01LTEtMS0xNDc0NQ_295b585e-b1a1-4ad8-a44e-955a3d5486ab">10,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94593153cf8c498c8b518d4df370e8d5_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMi03LTEtMS0xNDc0NQ_13142bbd-a2d1-4a33-b805-3e95e2a7cad7">4,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a677277d96a48bab6eb887dca74a45e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMy0xLTEtMS0xNDc0NQ_a44d6296-c9a0-4a03-ae6d-768c18910c29">3,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i607b537a79654bcfa5b76e79200ad79e_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMy0zLTEtMS0xNDc0NQ_215ffffb-1680-4b50-b3cf-bc0e8aae74fa">5,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b88c9c000461eab4ed9980e58de2c_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMy01LTEtMS0xNDc0NQ_28112286-cd13-4765-9757-86c678c238b9">16,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e645d2454e44e4c90ab99b885f15b90_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMy03LTEtMS0xNDc0NQ_bf45565d-d349-40f0-b022-e099c89b6641">10,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfNC0xLTEtMS0xNDc0NQ_7c5122ec-e664-4c80-9a7d-3d65b20a1ace">7,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfNC0zLTEtMS0xNDc0NQ_97da84c5-4ef1-4e87-b914-c19bcfb262c6">7,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfNC01LTEtMS0xNDc0NQ_3a178572-2ff6-44f4-849e-4d86761f0d9b">27,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfNC03LTEtMS0xNDc0NQ_0e89953a-f401-4a65-b3cf-d34c175dd2f6">15,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the deconsolidation during the third quarter of 2021, total share-based compensation expense includes $<ix:nonFraction unitRef="usd" contextRef="i0e9fbea9de0a48f9a2fd97d698309e42_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNjQyNA_5dcf8c79-24d7-47d2-840c-ade9f3b9ef52">138</ix:nonFraction>&#160;thousand of share-based compensation expense for employees, consultants and directors of Zentera, for the nine months ended September&#160;30, 2021, compared to $<ix:nonFraction unitRef="usd" contextRef="iabd570ef2f9345599b057ad29b52f338_D20200101-20200930" decimals="-3" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNjY4OQ_d8a2bc9f-865d-4d32-b449-f3a7749957fa">187</ix:nonFraction> thousand for the same period in 2020.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><ix:continuation id="i6818d2ef36f140c688aec1c50d463672"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by type of share-based award (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit Interest Award Units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf9822acfb464a6d891585e7be3a5ca0_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMi0xLTEtMS0xNDc0NQ_36558fa2-a449-42dd-a7ec-28449bc21f58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744b23fd24c6491ba42985404b428ca4_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMi0zLTEtMS0xNDc0NQ_9a235163-4a8b-438a-8c1f-493fc353a19d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2ec8dacbd2c4cc28e92de70f1d60be4_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMi01LTEtMS0xNDc0NQ_79ee3d01-ac6b-4878-a7e5-1288b627f5cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMi03LTEtMS0xNDc0NQ_f14da5c9-d64b-428f-a492-2ef3c0967778">329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22afa5cbdf1a42a4b3d45f2baa46d20a_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMy0xLTEtMS0xNDc0NQ_b3b49150-fe3e-4499-ba14-b223b3ba1832">5,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4497e0e0b4ec4f1a8b88d44070441e38_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMy0zLTEtMS0xNDc0NQ_6e1dc116-6dff-4f9b-8808-a54eaa2d695f">2,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMy01LTEtMS0xNDc0NQ_162a7276-f30a-4a62-a473-f73caefc5077">14,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9c306d1d813469a8be5c195343bbcce_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMy03LTEtMS0xNDc0NQ_e82ee125-d111-41ba-a6ac-fcc59e52a0e8">3,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i587d0a5af8bc44d2be7b3c8da9f39a3f_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNC0xLTEtMS0xNDc0NQ_41e347f6-6ea7-4c3b-b6ab-a4901b1d4df5">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id66b9433de164aa588c8902b962f4437_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNC0zLTEtMS0xNDc0NQ_42c0816c-69bb-49b1-9f87-672a699cf01b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNC01LTEtMS0xNDc0NQ_2c2f1a3a-f80f-45db-8152-339db535170d">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie80c09b9267b4debab194f8e3b070f1d_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNC03LTEtMS0xNDc0NQ_22aef35f-e21a-4319-9553-fd31f4cc1e5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs and RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i585f906916e24788950b045daf6006d0_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNS0xLTEtMS0xNDc0NQ_a4e8b54d-9ea0-492d-b2c3-6b5be242daa6">1,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1dc9e958a3743ed897181a2bcab4d8b_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNS0zLTEtMS0xNDc0NQ_80a44a77-f267-4bb9-8856-cceff40b3692">5,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c866a3da3ee4c01869b06d7863723bb_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNS01LTEtMS0xNDc0NQ_19ec3e91-250b-441f-9d9f-66b4b9d06f33">12,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3c44f5e0b242eba976e925ee1e833c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNS03LTEtMS0xNDc0NQ_897e240b-6c23-4fc3-ad14-b8e9fb13ba42">11,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNi0xLTEtMS0xNDc0NQ_66b4f393-d758-445d-8609-f3277bd4261d">7,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNi0zLTEtMS0xNDc0NQ_ffb4c2f2-5d10-480d-9193-ebb0bc58fef1">7,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNi01LTEtMS0xNDc0NQ_5aa00415-5274-49ad-a266-732fa9d8f633">27,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNi03LTEtMS0xNDc0NQ_dc3ab970-7dae-4b08-afdf-a59c24a98eca">15,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTEwNjE_69995932-251b-404f-b6b9-fd941138d4e7" continuedAt="i018a54977f714a83810c38d7646b23d0" escape="true"></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i6f364fcf469a4577bf89c10ffe14341e" continuedAt="if6d00a0981ea49008ea4f8c020e17938"><ix:continuation id="i018a54977f714a83810c38d7646b23d0" continuedAt="ie65ebe2e9a4445aaba75537eb3f42af8"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the profits interest awards is estimated using an option pricing model with the following assumptions:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:77.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.880%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Members&#8217; equity value (in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f31a36244b4706ade54e9ea17fc52f_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MembersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjhjYjc5ODc0ZTEyMTRmMzRhNTExMTk1MTM0ZjA1NmRiL3RhYmxlcmFuZ2U6OGNiNzk4NzRlMTIxNGYzNGE1MTExOTUxMzRmMDU2ZGJfMi0yLTEtMS0xNDc0NQ_8ca02148-8e20-4aaf-8fb5-55c7288307db">271,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Threshold amounts (in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjhjYjc5ODc0ZTEyMTRmMzRhNTExMTk1MTM0ZjA1NmRiL3RhYmxlcmFuZ2U6OGNiNzk4NzRlMTIxNGYzNGE1MTExOTUxMzRmMDU2ZGJfMy0yLTEtMS0xNDc0NQ_ab4bf645-6ee0-4dc5-9b23-6a52ed039528">309,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjhjYjc5ODc0ZTEyMTRmMzRhNTExMTk1MTM0ZjA1NmRiL3RhYmxlcmFuZ2U6OGNiNzk4NzRlMTIxNGYzNGE1MTExOTUxMzRmMDU2ZGJfNC0yLTEtMS0xNDc0NQ_ebca9da5-4e20-447b-b4e0-85767e3f5fa9">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjhjYjc5ODc0ZTEyMTRmMzRhNTExMTk1MTM0ZjA1NmRiL3RhYmxlcmFuZ2U6OGNiNzk4NzRlMTIxNGYzNGE1MTExOTUxMzRmMDU2ZGJfNS0yLTEtMS0xNDc0NQ_79bb9b16-f355-4a4b-909c-df7481bf4166">75.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to liquidity (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930" format="ixt-sec:duryear" name="zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjhjYjc5ODc0ZTEyMTRmMzRhNTExMTk1MTM0ZjA1NmRiL3RhYmxlcmFuZ2U6OGNiNzk4NzRlMTIxNGYzNGE1MTExOTUxMzRmMDU2ZGJfNi0yLTEtMS0xNDc0NQ_fd448663-7757-4fc0-b4f8-52ebda36de3d">1.1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lack of marketability discount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930" decimals="3" name="zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjhjYjc5ODc0ZTEyMTRmMzRhNTExMTk1MTM0ZjA1NmRiL3RhYmxlcmFuZ2U6OGNiNzk4NzRlMTIxNGYzNGE1MTExOTUxMzRmMDU2ZGJfNy0yLTEtMS0xNDc0NQ_836b42b9-5ffc-4723-819b-cc800b24dd12">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjhjYjc5ODc0ZTEyMTRmMzRhNTExMTk1MTM0ZjA1NmRiL3RhYmxlcmFuZ2U6OGNiNzk4NzRlMTIxNGYzNGE1MTExOTUxMzRmMDU2ZGJfOC0yLTEtMS0xNDc0NQ_d5a9f50d-0511-43d4-ad6c-3ca0299c187a">3.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of each profits interest award on the date of grant. The members&#8217; equity value was based on a recent enterprise valuation analysis performed. The threshold amounts are based on the discretion of the Board of Directors at the time of grant. The expected life of the Class&#160;B Common Unit awards granted during the period presented was determined based on an expected liquidation event under the plan. We apply the risk-free interest rate based on the U.S. Treasury yield in effect at the time of the grant consistent with the life of the award. The expected volatility is based on a peer group in the industry in which the Company does business consistent with the expected time to liquidity. The dividend yield was set at zero as the underlying security does not and is not expected to pay a dividend. The Finnerty model and the Asian Protective Put Model methods were used to estimate the discount for lack of marketability inherent to the awards.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class&#160;B common units issued have been classified as equity awards, and share-based compensation expense is based on the grant date fair value of the award. During the nine months ended September&#160;30, 2021 and 2020, we issued <ix:nonFraction unitRef="shares" contextRef="i146ec30e5c904ad4934dfa43202cd322_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfODE1OA_f8e3de76-c754-4425-a6d5-b60357890034">zero</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i3721dc48f90f43aaaedb4b9e4701785a_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfODE2NQ_65a9faa8-3927-4cc5-bc6c-dc34df88540f">70,000</ix:nonFraction> Class B common units, respectively. As of September&#160;30, 2021 and December&#160;31, 2020, there were no Class B common units outstanding. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options and Restricted Stock Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exercise price of stock options granted is equal to the closing price of the common stock on the date of grant. The fair value of each option award is estimated on the date of grant using the Black-Scholes model. Due to the Company&#8217;s limited operating history and a lack of company specific historical and implied volatility data, the Company estimates expected volatility based on the historical volatility of a group of similar companies that are publicly traded. The historical volatility data was computed using the daily closing prices for the selected companies&#8217; shares during the equivalent period of the calculated expected term of the stock-based awards. The Company uses the &#8220;simplified method&#8221; for estimating the expected term of employee options, whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option (generally <ix:nonNumeric contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930" format="ixt-sec:duryear" name="zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfOTIwOQ_3b9c8962-0d08-4a70-898a-6c842e721d74">10</ix:nonNumeric> years). The risk-free interest rate is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The Company has not issued any dividends and does not expect to issue dividends over the life of the options. As a result, the Company has estimated the dividend yield to be <ix:nonFraction unitRef="number" contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMjc0ODc3OTA4MTcyNg_ecc76c38-8d8a-4dbc-8ab5-21674264ec69">zero</ix:nonFraction>. <ix:continuation id="ie65ebe2e9a4445aaba75537eb3f42af8" continuedAt="ie38dfba3842f47aba892a88872d55504">The fair value of the stock options granted during the nine months ended September&#160;30, 2021 and September&#160;30, 2020 was determined with the following assumptions:</ix:continuation></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="if6d00a0981ea49008ea4f8c020e17938" continuedAt="i933a322cde8749ca9186dcb2388b758a"><div style="margin-bottom:12pt;text-indent:18pt"><ix:continuation id="ie38dfba3842f47aba892a88872d55504"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.839%"><tr><td style="width:1.0%"></td><td style="width:44.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.452%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMS0xLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjA2MDVmYTc1Yjg2ZDQ0Y2ZiNjZhM2ZmOGNiYWFkMmZhXzIxOTkwMjMyNTU1NzQ_a6252d83-5ab2-4c0b-9bee-239ce8e067bb">73.9</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMS0xLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjA2MDVmYTc1Yjg2ZDQ0Y2ZiNjZhM2ZmOGNiYWFkMmZhXzIxOTkwMjMyNTU1ODI_78f2b5eb-8c43-4fb7-a344-84636ccde367">76.6</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib9c306d1d813469a8be5c195343bbcce_D20200101-20200930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMS0zLTEtMS0xNDc0NS90ZXh0cmVnaW9uOmQ2ZjFmZWY0ODkyNTRmNjZiZjk1YTQzZmU5ODliOWRjXzIxOTkwMjMyNTU1NzQ_e79349bf-087a-4ff2-9296-d58a35d04632">76.6</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ib9c306d1d813469a8be5c195343bbcce_D20200101-20200930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMS0zLTEtMS0xNDc0NS90ZXh0cmVnaW9uOmQ2ZjFmZWY0ODkyNTRmNjZiZjk1YTQzZmU5ODliOWRjXzIxOTkwMjMyNTU1ODI_0cbf5d12-f6e5-4c0a-b73d-6945fb790a59">78.2</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i63c6b196f1234c5a926349599c036d07_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMi0xLTEtMS0xNDc0NS90ZXh0cmVnaW9uOmU2YjJhZDY2NDdmNjRkNGM4ZTU0YTA0MWE4NGU2OTliXzEwOTk1MTE2Mjc3ODY_3df07c2d-d457-4b09-a4e1-9f6a6166ade0">5.2</ix:nonNumeric> - <ix:nonNumeric contextRef="i7d7f255a3d184998b0bc0e47acd7a4bf_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMi0xLTEtMS0xNDc0NS90ZXh0cmVnaW9uOmU2YjJhZDY2NDdmNjRkNGM4ZTU0YTA0MWE4NGU2OTliXzIxOTkwMjMyNTU1NzY_715e8ebb-674f-4507-8408-f56b1d4834bd">6.2</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i660a769e8c324a2cbb4a2c3aaaf0e8ba_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMi0zLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjQ1YjBkOTc2ODA0ZjRmYTJiMWY2NGEyOWM4NTUwZWMwXzIxOTkwMjMyNTU1Njg_db53bed8-9545-45f0-ba77-47d543805c1e">5.7</ix:nonNumeric> - <ix:nonNumeric contextRef="if1ff576aa6cd420c9c34c4a3796b36df_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMi0zLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjQ1YjBkOTc2ODA0ZjRmYTJiMWY2NGEyOWM4NTUwZWMwXzIxOTkwMjMyNTU1NzQ_c256ac31-3e6e-44ce-8d05-091517d8f577">6.0</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMy0xLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjZjMTAxMGIzMzMzYTQ5MjZhZGI3MjczOWFiM2IyZmRhXzQ5NDc4MDIzMjUwMTE_c904cf06-b03b-4338-99fa-49c72db87a89">0.5</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMy0xLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjZjMTAxMGIzMzMzYTQ5MjZhZGI3MjczOWFiM2IyZmRhXzQ5NDc4MDIzMjUwMTg_ce749e09-4dc9-443e-8471-84548f459050">1.1</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib9c306d1d813469a8be5c195343bbcce_D20200101-20200930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMy0zLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjdjOTg2N2NmNzMxYzRjZGU4MjIxMWI5YTk3Y2NkZjllXzQ5NDc4MDIzMjUwMTE_01f6a488-33f9-40c1-bfe2-10c263f0f72e">0.4</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ib9c306d1d813469a8be5c195343bbcce_D20200101-20200930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMy0zLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjdjOTg2N2NmNzMxYzRjZGU4MjIxMWI5YTk3Y2NkZjllXzQ5NDc4MDIzMjUwMTg_e065f07a-f738-42e0-86c7-8dc01b2a1a64">0.5</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfNC0xLTEtMS0xNDc0NQ_64344223-3b93-470b-8224-faf9566bd6df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib9c306d1d813469a8be5c195343bbcce_D20200101-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfNC0zLTEtMS0xNDc0NQ_b6b7e521-511a-4044-b507-a2851b731b8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTEwNjU_91155fee-9e4b-49bc-b7ec-c11c44f2def2" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average assumptions used to estimate the fair value of stock purchase rights under the employee stock purchase plan (&#8220;ESPP&#8221;) are as follows:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.782%"><tr><td style="width:1.0%"></td><td style="width:30.055%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.055%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.059%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjkyYzc1ZWEyODZmYzQ5OWE4MDQ0NTM3YzhhMmU3NDRlL3RhYmxlcmFuZ2U6OTJjNzVlYTI4NmZjNDk5YTgwNDQ1MzdjOGEyZTc0NGVfMy0zLTEtMS0xNDc0NQ_0709a167-158f-4100-87b7-aed2ce8bc9a7">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie80c09b9267b4debab194f8e3b070f1d_D20200101-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjkyYzc1ZWEyODZmYzQ5OWE4MDQ0NTM3YzhhMmU3NDRlL3RhYmxlcmFuZ2U6OTJjNzVlYTI4NmZjNDk5YTgwNDQ1MzdjOGEyZTc0NGVfMy01LTEtMS0xNDc0NQ_d69c5563-e451-4ce9-8884-e332fd27f378">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjkyYzc1ZWEyODZmYzQ5OWE4MDQ0NTM3YzhhMmU3NDRlL3RhYmxlcmFuZ2U6OTJjNzVlYTI4NmZjNDk5YTgwNDQ1MzdjOGEyZTc0NGVfNC0zLTEtMS0xNDc0NQ_a6c7c56e-904a-4150-ba1b-fc53c088dd36">0.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjkyYzc1ZWEyODZmYzQ5OWE4MDQ0NTM3YzhhMmU3NDRlL3RhYmxlcmFuZ2U6OTJjNzVlYTI4NmZjNDk5YTgwNDQ1MzdjOGEyZTc0NGVfNS0zLTEtMS0xNDc0NQ_9bdbab22-05c5-4a20-8a60-81a32147ceeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie80c09b9267b4debab194f8e3b070f1d_D20200101-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjkyYzc1ZWEyODZmYzQ5OWE4MDQ0NTM3YzhhMmU3NDRlL3RhYmxlcmFuZ2U6OTJjNzVlYTI4NmZjNDk5YTgwNDQ1MzdjOGEyZTc0NGVfNS01LTEtMS0xNDc0NQ_8a1b566f-50da-4cc5-b39d-276e492cb41b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjkyYzc1ZWEyODZmYzQ5OWE4MDQ0NTM3YzhhMmU3NDRlL3RhYmxlcmFuZ2U6OTJjNzVlYTI4NmZjNDk5YTgwNDQ1MzdjOGEyZTc0NGVfNi0zLTEtMS0xNDc0NQ_4d908738-6290-49bd-858a-6d122c1b8cf1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie80c09b9267b4debab194f8e3b070f1d_D20200101-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjkyYzc1ZWEyODZmYzQ5OWE4MDQ0NTM3YzhhMmU3NDRlL3RhYmxlcmFuZ2U6OTJjNzVlYTI4NmZjNDk5YTgwNDQ1MzdjOGEyZTc0NGVfNi01LTEtMS0xNDc0NQ_7e6f6392-3006-44f6-ae8f-5eb495911dfd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the ESPP, the Company&#8217;s employees may elect to have up to <ix:nonFraction unitRef="number" contextRef="i3f1a54d8ee624903a58ab6e4a97f47c3_I20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfOTk1OA_7688659f-4abb-4c77-af7a-7c8492399953">20</ix:nonFraction>% of their compensation, up to a maximum of $<ix:nonFraction unitRef="usd" contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTAwMDM_f7a6a148-1575-47a9-94a6-90e0496221ee">21,250</ix:nonFraction> per calendar year, withheld to purchase shares of the Company&#8217;s common stock for a purchase price equal to <ix:nonFraction unitRef="number" contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTAxMTM_213b380f-020a-4170-a4ff-b48824786773">85</ix:nonFraction>% of the lower of the fair market value per share (at closing) of the Company&#8217;s common stock on (i) the first trading day of a <ix:nonNumeric contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930" format="ixt-sec:durwordsen" name="zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTEwNjA_c67c8330-5043-4b4a-a6e4-2ebe050e46c6">six-month</ix:nonNumeric> offering period, or (ii) the applicable purchase date, defined as the last trading day of the <ix:nonNumeric contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930" format="ixt-sec:durwordsen" name="zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTEwNjg_d0d5e99b-0e11-4b22-ad7a-e282f8a8a84e">six-month</ix:nonNumeric> offering period.</span></div><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTEwNjk_9356dc20-74e6-43af-abd9-65aa9ab06e8c" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unrecognized estimated compensation cost by type of award and the weighted average requisite service period over which such expense is expected to be recognized (in thousands, unless otherwise noted):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.256%"><tr><td style="width:1.0%"></td><td style="width:31.878%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.878%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.881%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized <br/>Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining <br/>Weighted-Average Recognition Period <br/>(years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i782b4959ffc945c6b1b065f0b433ec10_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOmY0NmJlMTVlZTJjNDQwYzM4YjEwMjczZTg4ZDIxYWM0L3RhYmxlcmFuZ2U6ZjQ2YmUxNWVlMmM0NDBjMzhiMTAyNzNlODhkMjFhYzRfMi0xLTEtMS0xNDc0NQ_ca0c1838-4c97-467e-9b9f-b380b845d512">65,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOmY0NmJlMTVlZTJjNDQwYzM4YjEwMjczZTg4ZDIxYWM0L3RhYmxlcmFuZ2U6ZjQ2YmUxNWVlMmM0NDBjMzhiMTAyNzNlODhkMjFhYzRfMi0zLTEtMS0xNDc0NQ_0775f512-36f0-4538-8339-b545e3fe0831">3.05</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5aa816b1a8094167b4936dcee3a759ea_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOmY0NmJlMTVlZTJjNDQwYzM4YjEwMjczZTg4ZDIxYWM0L3RhYmxlcmFuZ2U6ZjQ2YmUxNWVlMmM0NDBjMzhiMTAyNzNlODhkMjFhYzRfMy0xLTEtMS0xNDc0NQ_071ead9e-2409-4ea9-90c8-9f7ead9bd349">1,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icc74194e61cc4c73a3ce9cb7361dcc5f_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOmY0NmJlMTVlZTJjNDQwYzM4YjEwMjczZTg4ZDIxYWM0L3RhYmxlcmFuZ2U6ZjQ2YmUxNWVlMmM0NDBjMzhiMTAyNzNlODhkMjFhYzRfMy0zLTEtMS0xNDc0NQ_46691fbe-35e7-4c10-98fc-bf7273ded575">1.84</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb7a874665d45dea6e7487809034f00_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOmY0NmJlMTVlZTJjNDQwYzM4YjEwMjczZTg4ZDIxYWM0L3RhYmxlcmFuZ2U6ZjQ2YmUxNWVlMmM0NDBjMzhiMTAyNzNlODhkMjFhYzRfNC0xLTEtMS0xNDc0NQ_a73daded-3969-4ef3-92fb-e189f5cb075b">7,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3578222b355449619cf1a71155f3985c_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOmY0NmJlMTVlZTJjNDQwYzM4YjEwMjczZTg4ZDIxYWM0L3RhYmxlcmFuZ2U6ZjQ2YmUxNWVlMmM0NDBjMzhiMTAyNzNlODhkMjFhYzRfNC0zLTEtMS0xNDc0NQ_36fb7b3b-9dcd-485c-958d-4c0e543256a1">2.29</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f1a54d8ee624903a58ab6e4a97f47c3_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOmY0NmJlMTVlZTJjNDQwYzM4YjEwMjczZTg4ZDIxYWM0L3RhYmxlcmFuZ2U6ZjQ2YmUxNWVlMmM0NDBjMzhiMTAyNzNlODhkMjFhYzRfNS0xLTEtMS0xNDc0NQ_b85eda11-df72-415c-bf76-2fa60e1f4176">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, we issued <ix:nonFraction unitRef="shares" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTA5OTUxMTY0MDQ5NQ_bb109aa5-d90a-4f4c-933e-9feeb611666e">0.1</ix:nonFraction>&#160;million shares of common stock in connection with the exercises of stock options. For the nine months ended September&#160;30, 2021, <ix:nonFraction unitRef="shares" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTA3NDk_7908ca49-c30c-466f-a9b9-b9a8e1813a3d">0.3</ix:nonFraction> million shares of </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i933a322cde8749ca9186dcb2388b758a">common stock issued in conjunction with certain restricted stock awards vested. Outstanding stock options, unvested restricted stock awards, and unvested restricted stock units totaling approximately <ix:nonFraction unitRef="shares" contextRef="i782b4959ffc945c6b1b065f0b433ec10_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTA5NjI_955d81ec-be27-469b-b01f-c4f698abb86a">4.1</ix:nonFraction>&#160;million shares, <ix:nonFraction unitRef="shares" contextRef="i5aa816b1a8094167b4936dcee3a759ea_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTA5NzQ_7d583cd9-03eb-42cd-9a46-19a2ff41d9f3">0.4</ix:nonFraction>&#160;million shares and <ix:nonFraction unitRef="shares" contextRef="ieeb7a874665d45dea6e7487809034f00_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTA5ODg_08ff0988-05db-45c1-85b7-1eab4d86afdc">0.4</ix:nonFraction>&#160;million shares of our common stock, respectively, were outstanding as of September&#160;30, 2021.</ix:continuation> </span></div><div id="i359d7483f88b44aba6df295b4be37cde_67"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RleHRyZWdpb246ZDZlNGRmZGI2MjEyNDRjZGIxMWQ3ZDEwNmQ2ZDhlZDZfMjE0OA_000d68c8-2fb8-4513-ac42-1a6d5735afee" continuedAt="id2d9469b6b744f6ab547f7ba09994423" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="id2d9469b6b744f6ab547f7ba09994423" continuedAt="i5702b2089f514254be15a8f1b4a16e9b"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Contingencies </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we may be involved in various disputes, including lawsuits and claims arising in the ordinary course of business, including actions with respect to intellectual property, employment, and contractual matters. Any of these claims could subject us to costly legal expenses. The Company records a liability in its consolidated financial statements for these matters when a loss is known or considered probable and the amount can be reasonably estimated. The Company reviews these estimates each accounting period as additional information is known and adjusts the loss provision when appropriate. If a matter is both probable to result in a liability and the amounts of loss can be reasonably estimated, the Company estimates and discloses the possible loss or range of loss to the extent necessary to make the consolidated financial statements not misleading. If the loss is not probable or cannot be reasonably estimated, a liability is not recorded in our consolidated financial statements. While we do generally believe that we have adequate insurance to cover many different types of liabilities, our insurance carriers may deny coverage, or our policy limits may be inadequate to fully satisfy any damage awards or settlement. If this were to happen, the payment of any such awards could have a material adverse effect on our consolidated results of operations and financial position. Additionally, any such claims, whether or not successful, could damage our reputation and business. We are currently not a party to any legal proceedings.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commitments include payments related to operating leases. <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RleHRyZWdpb246ZDZlNGRmZGI2MjEyNDRjZGIxMWQ3ZDEwNmQ2ZDhlZDZfMjE0OQ_d6f11a82-9182-4268-9fee-c3d9f7645b60" continuedAt="i31a39a9d328f403ba7139f10a59f5d53" escape="true">Approximate annual future minimum operating lease payments as of September&#160;30, 2021 are as follows (in thousands): </ix:nonNumeric></span></div><div style="margin-bottom:12pt"><ix:continuation id="i31a39a9d328f403ba7139f10a59f5d53"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RhYmxlOmQ0ZWVlOGNlZTQ1YTQyY2ZhMDFlZmRlOWVlYzZlMjg2L3RhYmxlcmFuZ2U6ZDRlZWU4Y2VlNDVhNDJjZmEwMWVmZGU5ZWVjNmUyODZfMS0yLTEtMS0xNDc0NQ_bdd3f9ba-f6ac-476c-a516-3334cadc5b79">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RhYmxlOmQ0ZWVlOGNlZTQ1YTQyY2ZhMDFlZmRlOWVlYzZlMjg2L3RhYmxlcmFuZ2U6ZDRlZWU4Y2VlNDVhNDJjZmEwMWVmZGU5ZWVjNmUyODZfMi0yLTEtMS0xNDc0NQ_5e0b1d84-284f-42f2-aeba-82e684c2839e">637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RhYmxlOmQ0ZWVlOGNlZTQ1YTQyY2ZhMDFlZmRlOWVlYzZlMjg2L3RhYmxlcmFuZ2U6ZDRlZWU4Y2VlNDVhNDJjZmEwMWVmZGU5ZWVjNmUyODZfNS0yLTEtMS0xNDc0NQ_267b0c72-cd36-43e0-ac4f-b84aeecd2c90">908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RhYmxlOmQ0ZWVlOGNlZTQ1YTQyY2ZhMDFlZmRlOWVlYzZlMjg2L3RhYmxlcmFuZ2U6ZDRlZWU4Y2VlNDVhNDJjZmEwMWVmZGU5ZWVjNmUyODZfNi0yLTEtMS0xNDc0NQ_7af4559b-3872-4be4-bba1-69614080b093">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RhYmxlOmQ0ZWVlOGNlZTQ1YTQyY2ZhMDFlZmRlOWVlYzZlMjg2L3RhYmxlcmFuZ2U6ZDRlZWU4Y2VlNDVhNDJjZmEwMWVmZGU5ZWVjNmUyODZfNy0yLTEtMS0xNDc0NQ_ec9b164a-1681-4af7-95f3-950df825a706">862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5702b2089f514254be15a8f1b4a16e9b">The weighted-average remaining lease term of our operating leases is approximately <ix:nonNumeric contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RleHRyZWdpb246ZDZlNGRmZGI2MjEyNDRjZGIxMWQ3ZDEwNmQ2ZDhlZDZfMTg3Nw_4414cf96-6db2-4e96-8e2b-9095d956c809">0.8</ix:nonNumeric> years. As of September&#160;30, 2021, we had entered into <ix:nonFraction unitRef="lease" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="zntl:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RleHRyZWdpb246ZDZlNGRmZGI2MjEyNDRjZGIxMWQ3ZDEwNmQ2ZDhlZDZfMTkxMQ_17cb6015-fd0a-440d-a3cd-d2780593e065">two</ix:nonFraction> additional leases for real estate that have not yet commenced with total minimum lease payments of approximately $<ix:nonFraction unitRef="usd" contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="zntl:LesseeOperatingLeaseLeaseNotYetCommencedLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RleHRyZWdpb246ZDZlNGRmZGI2MjEyNDRjZGIxMWQ3ZDEwNmQ2ZDhlZDZfMjAyNw_2f89f040-9767-45c0-ad2d-5a37c9bec7eb">74.6</ix:nonFraction> million. These leases are expected to commence in the fourth quarter of 2021 and have lease terms of <ix:nonNumeric contextRef="i356de632612e431284fab49bb34efaca_I20210930" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RleHRyZWdpb246ZDZlNGRmZGI2MjEyNDRjZGIxMWQ3ZDEwNmQ2ZDhlZDZfMjEyMw_7417b91a-2d82-4b04-b1c3-9cc3e42aa4f6">10</ix:nonNumeric> years and <ix:nonNumeric contextRef="i004976abe339457d8797c8a3f4268c32_I20210930" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RleHRyZWdpb246ZDZlNGRmZGI2MjEyNDRjZGIxMWQ3ZDEwNmQ2ZDhlZDZfMjEzMA_6b8924ef-eb93-465c-aec5-c6caf139721b">11</ix:nonNumeric> years, respectively.</ix:continuation> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_70"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RleHRyZWdpb246M2I5ZWQ1NmEyNjIxNGMyOGE3Mjk0NDMyZjE5ODFmMjFfNjEw_e7c3bfd3-6fe4-408f-9745-8f24c98eef9c" continuedAt="i3b3e19f545c74873842b69f509a4df64" escape="true">Net Loss Per Common Share/Class&#160;A Common Unit </ix:nonNumeric></span></div><ix:continuation id="i3b3e19f545c74873842b69f509a4df64"><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RleHRyZWdpb246M2I5ZWQ1NmEyNjIxNGMyOGE3Mjk0NDMyZjE5ODFmMjFfNjEy_24b0c9f6-b8a8-48f7-bc93-27f84b722cbb" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per common share/Class&#160;A common unit were calculated as follows (in thousands except per share and per unit amounts):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Zentalis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfMy0xLTEtMS0xNDc0NQ_f13bff4d-1e65-479b-88e4-a37ce93b12b9">4,191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfMy0zLTEtMS0xNDc0NQ_49a1920f-ce94-44af-88a8-89ec12e5a88b">34,555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfMy01LTEtMS0xNDc0NQ_b916f6dd-5996-4323-8749-ceec7e480970">108,666</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfMy03LTEtMS0xNDc0NQ_d2359ef9-6b76-4ca8-a5a6-da17a3e45bf4">77,538</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS0xLTEtMS0xNDc0NQ_251943e7-c4ff-4e30-aceb-e0b0b097569a"><ix:nonFraction unitRef="shares" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS0xLTEtMS0xNDc0NQ_7e48f6f3-6f3b-43db-9fc9-de74c5be139d">44,609</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS0zLTEtMS0xNDc0NQ_3b3feb87-0aba-4163-84ed-cb50991b3450"><ix:nonFraction unitRef="shares" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS0zLTEtMS0xNDc0NQ_9774cd21-b11f-4141-a589-6f99c8effb38">37,959</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS01LTEtMS0xNDc0NQ_6343a55f-ccd8-4a85-abf2-5eb87ae5eca4"><ix:nonFraction unitRef="shares" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS01LTEtMS0xNDc0NQ_d963b575-0235-4329-b4ba-7bb051189ddd">41,918</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS03LTEtMS0xNDc0NQ_06eec7e6-084b-466a-aa6b-58faafb27330"><ix:nonFraction unitRef="shares" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS03LTEtMS0xNDc0NQ_87eea78e-68f4-4fe4-a6e9-618aa37a2db4">24,143</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi0xLTEtMS0xNDc0NQ_91216124-d3ab-474d-aa1d-522b52db9bc9"><ix:nonFraction unitRef="usdPerShare" contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi0xLTEtMS0xNDc0NQ_e6af426f-b8c3-4b42-a340-0966725302ef">0.09</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi0zLTEtMS0xNDc0NQ_13b36549-ce06-44ac-9ff8-6c705d42d23b"><ix:nonFraction unitRef="usdPerShare" contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi0zLTEtMS0xNDc0NQ_cad090c2-068c-4149-94c0-c0f6468db205">0.91</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi01LTEtMS0xNDc0NQ_05645293-a602-490e-bb2f-c28e594e0f13"><ix:nonFraction unitRef="usdPerShare" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi01LTEtMS0xNDc0NQ_b1d9dab1-5563-4864-879a-379c9f9acd0c">2.59</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi03LTEtMS0xNDc0NQ_434ebcf0-d8b1-424d-832c-31a346456f86"><ix:nonFraction unitRef="usdPerShare" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi03LTEtMS0xNDc0NQ_b699dde8-19b8-4480-9602-dba53a4107bd">3.21</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our potential and dilutive securities, which include outstanding stock options, unvested RSAs and unvested RSUs have been excluded from the computation of diluted net loss per common share as the effect would be anti-dilutive. </span></div><ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RleHRyZWdpb246M2I5ZWQ1NmEyNjIxNGMyOGE3Mjk0NDMyZjE5ODFmMjFfNjE0_f6c57b44-bad2-4f50-9629-290b18e277fe" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents have been excluded from the calculations of diluted net loss per common share because their inclusion would be antidilutive (in thousands).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.153%"><tr><td style="width:1.0%"></td><td style="width:58.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia727e9eb512a4899be678569e4be9e04_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfMi0xLTEtMS0xNDc0NQ_dcd351ec-ed9d-489a-864c-31376b50fbcd">4,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia84faaa12cb04eed88b3628a273183ce_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfMi0zLTEtMS0xNDc0NQ_b7b71ce7-78ff-4f5e-990c-759ed92d0095">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSAs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida8eb8260bb84fffa3c3fc02e85ac4f2_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfMy0xLTEtMS0xNDc0NQ_5dea2100-08d4-4b45-8543-8d6c2c62f5fd">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8cbc6c76d0e4128b4e08d37495dc609_D20200101-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfMy0zLTEtMS0xNDc0NQ_01dcfdbe-72ef-4181-8609-2561987da2b8">845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSUs </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie48938e7777e45829bfd62b464670e1d_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfNC0xLTEtMS0xNDc0NQ_11c56b7b-e4c2-4842-ba22-112a3f82da5c">364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5379b3f1fc91468e8557d8d058d3aaa3_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfNC0zLTEtMS0xNDc0NQ_f836a35e-9a22-4a5a-a700-006b3da5fc5a">1,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfNS0xLTEtMS0xNDc0NQ_6709dfa4-c6ac-4f87-bf86-4b2589121559">4,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfNS0zLTEtMS0xNDc0NQ_6f471e79-614b-4464-8c55-8fdda16db219">4,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i359d7483f88b44aba6df295b4be37cde_73"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMzE2Ng_0bfa9104-fcfa-4941-8358-7d16b88ce28a" continuedAt="i1c5072df82e849fabcafa462174a7ec6" escape="true">Related Party Disclosures</ix:nonNumeric></span></div><ix:continuation id="i1c5072df82e849fabcafa462174a7ec6" continuedAt="i46b1e6e5c97e4bb68ce11814d05e2b49"><div style="text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kalyra Pharmaceuticals, Inc. and Recurium IP Holdings, LLC</span></div><div style="text-indent:24.5pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;21, 2017, we acquired <ix:nonFraction unitRef="shares" contextRef="i2f09d3ed0755408fa8b8594c78bbc16d_I20171221" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTI5_f20f34cf-618c-4800-af71-a86a6911b128">17,307,692</ix:nonFraction> shares of Series B preferred stock of Kalyra Pharmaceuticals, Inc. for a per share price of&#160;twenty-six&#160;cents ($<ix:nonFraction unitRef="usdPerShare" contextRef="i05c84f48e4c9416e9b68315685186678_I20171221" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMjQy_285ea577-a74d-47a2-b1aa-9014641bdf0c">0.26</ix:nonFraction>) or approximately $<ix:nonFraction unitRef="usd" contextRef="i2765153e500b4c2ea94087220a2f2cd0_D20171221-20171221" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMjYz_8905abf5-1f1a-453e-917e-b26d916e3447">4.5</ix:nonFraction>&#160;million. The management team and stockholders of Kalyra are also stockholders of the Company.</span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the investment, we entered into a license agreement and a master services agreement with Kalyra. The license agreement was signed and commenced on December&#160;31, 2014 for the exclusive rights to develop and commercialize products derived from Kalyra&#8217;s technology in the initial area of oncology. The license agreement and all rights were subsequently sold from Kalyra to Recurium IP Holdings, LLC (&#8220;Recurium IP&#8221;), an entity with common ownership to Kalyra prior to the Zentalis investment. Under the agreement, we have agreed to make payments to Recurium IP based on specific milestones. In addition, the Company shall pay mid to&#160;high-single&#160;digit percentage royalties on net product sales to Recurium IP and sublicense fees on any consideration paid to us by a sublicensor. All payments are based on Recurium Equity, LLC&#8217;s, an affiliate company of Recurium IP, equity ownership stake in us as of December 2020. The license agreement will terminate upon the later of the last expiration of the patent rights or <ix:nonNumeric contextRef="i4c0b35a7a7664cf0a904ddb853e834d5_D20210101-20210930" format="ixt-sec:duryear" name="zntl:RelatedPartyAgreementTerm" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTM3MA_a7d50359-596f-4a98-b40d-4280f800fa40">15</ix:nonNumeric> years from the date of commencement. For the nine months ended </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i46b1e6e5c97e4bb68ce11814d05e2b49"><div style="margin-bottom:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we paid $<ix:nonFraction unitRef="usd" contextRef="iffe291a882a04056a3a61eec999af54f_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTQ2MQ_86764860-1f50-4e85-8d7a-14370623a826">10.0</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="usd" contextRef="i10842b54d0d24a489e994b1893949958_D20200101-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTQ2OA_918e4e01-2466-4e46-8101-8ce2787f1975">zero</ix:nonFraction>, respectively, in milestone payments to Recurium IP in connection with the commencement of Phase 2 trials for ZN-c3 and ZN-c5.</span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Master Services Agreement (&#8220;MSA&#8221;) was entered into in January 2015 and states that Kalyra may provide research and development services to us and that we shall reimburse such expenses on a time and materials basis based on the initial statements of work. For each of the three months ended September&#160;30, 2021 and 2020, we did <ix:nonFraction unitRef="usd" contextRef="i0db2a4af26634c05ae218afec38b427f_D20210701-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTgzNg_648cb0c3-4c32-4f77-8f7a-8d6fd2cb2d43"><ix:nonFraction unitRef="usd" contextRef="i18d34a087a6f45069ed7552aa3fc34b1_D20200701-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTgzNg_ea988af6-9ecf-4fcc-b5eb-0eac8fb71b2a">no</ix:nonFraction></ix:nonFraction>t incur any expense with Kalyra. For the nine months ended September&#160;30, 2021 and 2020, we incurred approximately <ix:nonFraction unitRef="usd" contextRef="ibf33597aac934769b0e7dc53e6692e7c_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTkzMg_74fc50c5-0d8e-410f-8bb0-3c93ef75f0e2">zero</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="i9b68177d9165436bb2788988bec1574e_D20200101-20200930" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTkzOQ_5a8f90d0-6b8c-4b22-a970-ec4eed98a206">seventeen thousand</ix:nonFraction> dollars of expense with Kalyra, respectively, that was eliminated in consolidation for research and development services provided. As of September&#160;30, 2021 and 2020, there was <ix:nonFraction unitRef="usd" contextRef="ifedec654804d4a048412181632ffca4d_I20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMjEwMA_5e66da83-3a12-4dcc-909c-f91e57e3b722"><ix:nonFraction unitRef="usd" contextRef="i2f9253d63b8a4572ac7ef410befd9a0b_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMjEwMA_be220812-cb12-43ce-a207-6b6635588667">no</ix:nonFraction></ix:nonFraction> balance due to Kalyra.</span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into an Intercompany Services Agreement (&#8220;ISA&#8221;) with Kalyra in January 2018 which states that we may provide research and development services to Kalyra and that Kalyra shall reimburse such expenses on a time and materials basis. For the three and nine months ended September&#160;30, 2021 and 2020, we provided immaterial research and development services to Kalyra that were eliminated in consolidation, respectively. As of September&#160;30, 2021 and 2020, an immaterial amount was due from Kalyra and eliminated in consolidation, respectively.</span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tempus</span></div><div style="text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kimberly Blackwell, M.D., is a member of the Company's board of directors and is also the Chief Medical Officer of Tempus Labs, Inc. ("Tempus"). The Company entered into a Master Services Agreement with Tempus in December 2020 to provide data licensing and research services. There were $<ix:nonFraction unitRef="usd" contextRef="i17387c8daecd44fd832424bd3dff82a8_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMzA2MA_c9a744de-b635-4482-83cd-fdda545a47f3">1.0</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="usd" contextRef="i0625dd931fe6420b9f8753010dae2784_I20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMzA2Nw_e21b24a5-f20c-40b6-abbe-8aa0e11474b1">zero</ix:nonFraction> fees incurred for services performed by Tempus for the nine months ended September&#160;30, 2021 and 2020, respectively.</span></div><div style="text-indent:24.5pt"><span><br/></span></div><div style="text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Zentera</span></div><div style="text-indent:24.5pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony Y. Sun, M.D., our President and Chief Executive Officer, serves as Chief Executive Officer and a member of the board of directors of Zentera, and Kevin D. Bunker, Ph.D., our Chief Operating Officer, serves as a member of the board of directors of Zentera. Accordingly, the Company identifies Zentera as a related party.</span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we entered into the Zentera Sublicenses, pursuant to which we collaborate with Zentera on the development and comm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ercialization of ZN-c3, ZN-c5 and ZN-d5, respectively, in the Zentera Collaboration Territory. Under the terms of the Zentera Sublicenses, Zentera is responsible for the costs of developing the Collaboration Products in the Zentera Collaboration Territory, and we are responsible for the costs of developing the Collaboration Products outside the Zentera Collaboration Territory, provided that Zentera will reimburse us for a portion of its costs for global data management, pharmacovigilance, safety database management, and chemistry, manufacturing and controls activities with respect to each Collaboration Product. Prior to the deconsolidation of Zentera during the three months ended September 30, 2021, these costs were eliminated in consolidation. For the three months ended September 30, 2021, the amounts incurred under this arrangement totaled $<ix:nonFraction unitRef="usd" contextRef="i3a09ec80921740a8a5b68eddc9671099_D20210701-20210930" decimals="-5" name="zntl:ResearchAndDevelopmentExpenseReimbursements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTA5OTUxMTYzNDk1OA_43dbc703-15ba-4522-9ec2-17ae23cda3e4">2.9</ix:nonFraction> million and are presented as contra-research and development expense in the consolidated statement of operations.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:24.5pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_79"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis of financial condition and operating results should be read together with our consolidated financial statements and the related notes and other financial information included elsewhere in this Quarterly Report on Form 10-Q, as well as our audited consolidated financial statements and the related notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020. Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report on Form 10-Q contains forward-looking statements that involve risks and uncertainties. As a result of many important factors, such as those set forth in the &#8220;Risk Factors&#8221; section of this Quarterly Report on Form 10-Q, our actual results may differ materially from those anticipated in these forward-looking statements. For convenience of presentation some of the numbers have been rounded in the text below.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. We use our highly efficient drug discovery engine, which we refer to as our &#8220;Integrated Discovery Engine&#8221;, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that we believe could result in potentially differentiated product profiles. Our discovery engine combines our extensive experience and capabilities across cancer biology and medicinal chemistry. We believe our product candidates are differentiated from current programs targeting similar pathways and, if approved, have the potential to significantly impact clinical outcomes of patients with cancer. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are developing a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. We currently have two (2) lead product candidates - ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, and ZN-c5, an oral selective estrogen receptor degrader, or SERD. Our other clinical product candidates include ZN-d5, a selective inhibitor of B-cell lymphoma 2, or BCL-2, and ZN-e4, an irreversible inhibitor of mutant epidermal growth factor receptor, or EGFR. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ZN-c3 (WEE1 Inhibitor)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ZN-c3 is currently being evaluated in multiple ongoing clinical trials, including a Phase 2 monotherapy clinical trial for the treatment of women with recurrent or persistent uterine serous carcinoma, or USC.  The study was initiated following an end-of-Phase 1 meeting with the U.S. Food and Drug Administration, or FDA, which concurred in principle with the proposal that ZN-c3 has the potential for an accelerated approval pathway based on the proposed global study design. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, ZN-c3 in combination with chemotherapy has received orphan drug designation and rare pediatric disease designation from the FDA for pediatric osteosarcoma. We initiated a Phase 1/2 clinical trial of ZN-c3 in combination with chemotherapy in pediatric and adult patients with osteosarcoma during the third quarter of 2021. We expect to report initial results from this trial in the second half of 2022. If ZN-c3 were to obtain approval for the designated indication, we believe it may be eligible for a rare pediatric disease priority voucher upon approval.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ZN-c3 is also being evaluated in an ongoing Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ongoing Phase 1b clinical trial in combination with chemotherapy in patients with advanced ovarian cancer.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In the fourth quarter of 2021, we intend to initiate a Phase 2 monotherapy trial for a tumor agnostic, predictive biomarker, subject to FDA feedback. This Phase 2 tumor agnostic trial planned with registrational intent would investigate ZN-c3 in patients with solid tumors that express the identified predictive biomarker.  We also intend to initiate a Phase 1/2 clinical trial evaluating ZN-c3 in combination with GlaxoSmithKline&#8217;s PARP inhibitor niraparib (ZEJULA&#174;), as part of a clinical research collaboration in ovarian cancer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreed to support two planned additional investigator-initiated trials that we expect to initiate in 2022: a trial with the Ivy Brain Center in glioblastoma multiforme and a trial in combination with immunotherapy with Dana Farber in triple negative breast cancer.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ZN-c5 (Oral SERD)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ongoing Phase 1/2 clinical trial evaluating ZN-c5 in combination with Pfizer&#8217;s CDK4/6 palbociclib, and the</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase 1b clinical trial evaluating ZN-c5 in combination with Lilly&#8217;s CDK4/6 abemaciclib, the safety and tolerability data suggested ZN-c5 has the potential to be a promising candidate for further evaluation in combinations. We continue to enroll patients in the two separate combination trials and expect to report initial results in the first half of 2022 from these trials.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ZN-d5 (BCL-2 Inhibitor)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing Phase 1 monotherapy dose escalation trial for ZN-d5 is enrolling patients with relapsed/refractory Non-Hodgkin&#8217;s Lymphoma and additionally began enrolling patients with acute myeloid leukemia in the third quarter of 2021. We intend to report initial results from this Phase 1 trial in the first half of 2022.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ZN-e4 (EGFR Inhibitor)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing Phase 1/2 dose escalation trial for ZN-e4 in patients with advanced non-small cell lung cancer (NSCLC) is enrolling both osimertinib-na&#239;ve and experienced patients. We intend to report initial results from the Phase 1/2 trial in the fourth quarter of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Zentera Therapeutics</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our China joint venture, Zentera, is also advancing corresponding clinical trials in China for ZN-c3, ZN-c5 and ZN-d5. See &#8220;Zentera Therapeutics&#8221; below and Notes 3 and 13 to our interim unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Liquidity Overview</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, our operations have been limited to organizing and staffing our company, business planning, raising capital, establishing our intellectual property portfolio and performing research and development of our product pipeline. We do not have any products approved for commercial sale and have not generated any revenues from product sales. In April 2020, we completed our IPO and issued and sold approximately 10.6 million shares of our common stock at a public offering price of $18.00 per share, including approximately 1.4 million shares in connection with the full exercise of the underwriters&#8217; option to purchase additional shares, resulting in net proceeds of approximately $172.4 million, after deducting underwriting discounts and commissions and offering expenses. In August 2020, we completed a follow-on offering of our common stock and issued and sold approximately 4.7 million shares of our common stock at a public offering price of $35.00 per share, including approximately 0.6 million shares in connection with the full exercise of the underwriters&#8217; option to purchase additional shares, resulting in net proceeds of approximately $155.2 million, after deducting underwriting discounts and commissions and offering expenses. On July 1, 2021, we completed a follow-on offering of our common stock and issued and sold approximately 3.6 million shares of our common stock at a public offering price of $48.50 per share, including approximately 0.5 million shares in connection with the full exercise of the underwriters&#8217; option to purchase additional shares, resulting in net proceeds of approximately $162.2 million, after deducting underwriting discounts and commissions and offering expenses.  </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had cash, cash equivalents and marketable securities of $366.8 million as of September&#160;30, 2021. We believe that our existing cash, cash equivalents and marketable securities as of September&#160;30, 2021 will enable us to fund our operating expenses and capital expenditure requirements into the third quarter of 2023. We have based these estimates on assumptions that may prove to be imprecise, and we could utilize our available capital resources sooner than we expect. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have incurred significant operating losses. Our net losses were $118.5 million for the year ended December 31, 2020, and $116.0 million and $78.2 million for the nine months ended September&#160;30, 2021 and September&#160;30, 2020, respectively. Our net losses were $10.5 million and $34.7 million for the three months ended September&#160;30, 2021 and September&#160;30, 2020, respectively. We had an accumulated deficit of $309.5 million as of </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021. We expect to continue to incur significant expenses and operating losses for the foreseeable future. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will not generate revenue from product sales unless and until we successfully complete clinical development and obtain regulatory approval for our product candidates. In addition, if we obtain regulatory approval for any of our product candidates, we expect to incur significant expenses related to developing our commercialization capabilities to support product sales, marketing and distribution activities, either alone or in collaboration with others. Furthermore, we expect to incur additional costs associated with operating as a public company, particularly after we are no longer an emerging growth company, including significant legal, accounting, investor relations and other expenses that we did not incur as a private company. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we will need to raise substantial additional capital to support our continuing operations and pursue our growth strategy. Until such time as we can generate significant revenue from product sales, if ever, we plan to finance our operations through the sale of equity, debt financings or other capital sources, which may include collaborations with other companies or other strategic transactions. There are no assurances that we will be successful in obtaining an adequate level of financing as and when needed to finance our operations on terms acceptable to us or at all. If we are unable to secure adequate additional funding as and when needed, we may have to significantly delay, scale back or discontinue the development and commercialization of one or more product candidates or delay our pursuit of potential in-licenses or acquisitions.  </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Conversion</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our IPO, we converted from a Delaware limited liability company into a Delaware corporation pursuant to a statutory conversion, and changed our name from Zentalis Pharmaceuticals, LLC to Zentalis Pharmaceuticals, Inc. We refer to all transactions related to our conversion to a corporation as the Corporate Conversion. As a result of the Corporate Conversion, all holders of units of Zentalis Pharmaceuticals, LLC became holders of shares of common stock of Zentalis Pharmaceuticals, Inc.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Corporate Conversion, our outstanding Series A convertible preferred units, Series B convertible preferred units, Series C convertible preferred units, Class A common units and Class B common units, or Units, converted into an aggregate of 25,288,854 shares of our common stock (including 1,160,277 shares of restricted common stock) based on the IPO price of $18.00 per share of common stock.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to monitor how the COVID-19 pandemic is affecting our employees, business, preclinical studies and clinical trials. In response to the spread of COVID-19, we have closed our executive offices with our administrative employees continuing their work outside of our offices and limited the number of staff in any given research and development laboratory by operating on rotational schedules. Disruptions caused by the COVID-19 pandemic have resulted in difficulties including delays in initiating new trial sites and certain supply chain activities, suspension of enrollment at some of our existing trial sites, and the incurrence of additional costs as a result of preclinical study and clinical trial delays and adjustments and supply chain delays. Limited operations at our laboratory facilities have also resulted in delays in our research-stage programs. As a result, we expect that the COVID-19 pandemic will continue to impact our business, results of operations, clinical development timelines and financial condition. At this time, there is significant uncertainty relating to the trajectory of the COVID-19 pandemic and impact of related responses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of COVID-19 on our future results will largely depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the duration of the pandemic, the impact of variants, travel restrictions and social distancing in the United States and other countries, business closures or business disruptions, the continued impact on financial markets and the global economy, the adoption and effectiveness of vaccines and vaccine distribution efforts, and the effectiveness of the global response to contain and treat the disease. See &#8220;Risk Factors&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has adversely impacted and we expect will continue to adversely impact our business, including our preclinical studies and clinical trials.&#8221; in Part II, Item 1A. of this Quarterly Report on Form 10-Q.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">License Agreements and Strategic Collaborations Agreements</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recurium IP Holdings, LLC</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2014, and as amended and restated effective as of December 2017 and September 2019 and as amended in May 2020, we entered into a license agreement, or the Recurium Agreement, with Recurium IP Holdings, LLC, or Recurium IP, under which we were granted an exclusive worldwide license to certain intellectual property rights owned or controlled by Recurium IP to develop and commercialize pharmaceutical products for the treatment or prevention of disease, other than for pain. In connection with the May 2020 amendment, we clarified certain aspects of the sublicensing payment provisions. We have the right to sublicense our rights under the Recurium Agreement, subject to certain conditions. We are required to use commercially reasonable efforts to develop and commercialize at least one product that comprises or contains a licensed compound and to execute certain development activities. </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Recurium Agreement, we are obligated to make development and regulatory milestone payments, pay royalties for net sales and make sublicensing payments with respect to certain licensed products directed to one of ten specific biological targets, including ZN-c3, ZN-c5, ZN-e4 and ZN-d5. We are obligated to make development and regulatory milestone payments for such licensed products of up to $44.5 million. In addition, we are obligated to make milestone payments up to $150,000 for certain licensed products used in animals. We are also obligated to pay royalties on sales of such licensed products at a mid- to high-single digit percentage. In addition, if we choose to sublicense or assign to any third parties our rights under the Recurium Agreement with respect to such licensed products, we must pay to Recurium&#160;IP 20% of sublicensing income received in connection with such transaction. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mayo Foundation for Medical Education and Research </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, and as amended in April 2017 and December 2017, we entered into an option agreement, or the Mayo Agreement, with Mayo Foundation for Medical Education and Research under which we were granted an exclusive option to obtain a nonexclusive worldwide license to know-how and an exclusive worldwide license to related patent rights created by Mayo under the Mayo Agreement. The Mayo Agreement provided that it will expire on the date of the last to expire of the Mayo patent rights or, if no Mayo patent rights arise, on February 11, 2021. No Mayo patent rights were created under the Mayo Agreement; therefore the agreement expired on February 11, 2021. In consideration for the grant of know-how we provided grants of common stock on the first anniversary and Class A common units on the second and third anniversaries following entry into the Mayo Agreement. As of September&#160;30, 2021, we have granted equity securities which amount to 15,435 shares of common stock under the Mayo Agreement.   </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SciClone Pharmaceuticals International (Cayman) Development Ltd. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2014, and as amended in December 2016 and December 2017, we entered into a collaboration and license agreement, or the SciClone Agreement, with SciClone Pharmaceuticals International (Cayman) Development Ltd., or SciClone, under which we granted an exclusive license certain intellectual property rights in the People&#8217;s Republic of China (including the territories of Macao and Hong Kong), South Korea, Taiwan and Vietnam, or the SciClone Territory, for SciClone to develop and commercialize a licensed product for the treatment or prevention of oncologic diseases and an exclusive option to obtain a similar license for up to two (2) additional licensed products. Under the SciClone Agreement, SciClone is responsible for clinical development activities required in order to obtain regulatory approval in the SciClone Territory. SciClone paid to us a one-time upfront payment of $1.0&#160;million upon entering into the SciClone Agreement, and $4.0 million in aggregate milestone payments. No additional development or commercial milestones or reimbursement for research and development expenses are payable under the SciClone Agreement, as amended. We are entitled to receive a mid-single digit royalty on net sales of licensed products in the SciClone Territory, which royalty is subject to certain reductions in the event that SciClone is unable to achieve certain gross margins or if generic products are sold or if technology covering a licensed product is licensed from a third party. We have also agreed to pay SciClone tiered royalties pursuant to the terms of the SciClone Agreement, the applicable rate of which are determined based on whether a compound is developed to a </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">successful dual IND submission and the costs incurred by SciClone for the development of such product candidate. Following the December 2016 amendment to the SciClone Agreement, SciClone retains the exclusive license to develop and commercialize our EGFR inhibitor product candidate, ZN-e4, in the SciClone Territory, and the exclusive option to obtain an exclusive license to develop up to two (2) specified compounds under the SciClone Agreement for which we submit an IND by providing notice and paying $5 million to us. SciClone&#8217;s and our royalty obligations will expire on a licensed product-by-licensed product and country-by-country basis on the later of fifteen years from the date of first commercial sale or when there is no longer a valid patent claim covering such licensed product in such country. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pfizer Clinical Trial Collaboration and Supply Agreement </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we entered into a clinical trial collaboration and supply agreement with Pfizer, Inc. to evaluate the safety, tolerability and efficacy of ZN-c5 in combination with their CDK4/6 inhibitor, palbociclib, in our ongoing Phase 1/2 clinical trial of ZN-c5. Pursuant to this agreement, we will be responsible for the conduct and cost of the relevant studies, under the supervision of a joint development committee made up of our representatives and representatives of Pfizer that meets quarterly. Pfizer will supply palbociclib for use in the trial, at no cost to us. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eli Lilly and Company Clinical Trial Collaboration and Supply Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">In July 2020, we entered into a clinical trial collaboration and supply agreement with Eli Lilly and Company, or Lilly, to evaluate the safety, tolerability and efficacy of ZN-c5 in combination with their CDK4/6 inhibitor, abemaciclib, in a Phase 1b open label multi-center clinical trial that we initiated in November 2020.  Pursuant to this agreement, we will be responsible for the conduct and cost of the relevant studies. Lilly is obligated to supply abemaciclib for use in the trial, at no cost to us. We are required to provide to Lilly clinical data and other reports at major decision points during the trial and no later than 60 days following completion of the planned Phase 1b clinical trial.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">This agreement does not grant any right of first negotiation to participate in future clinical trials, and each of the parties retains all rights and ability to evaluate their respective compounds in any clinical studies, either as monotherapy or in combination with any other product or compound, in any therapeutic area.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The agreement with Lilly will expire upon completion of all obligations of the parties thereunder or upon termination by either party. We and Lilly each have the right to terminate the agreement for material breach by the other party. In addition, the agreement may be terminated by either party due to safety considerations or if either party decides to discontinue development of its own compound for medical, scientific, legal or other reasons or if a regulatory authority takes any action preventing that party from supplying its compound for the study. Lilly also has the right to terminate this agreement if it notifies us in writing that it reasonably and in good faith believes that abemaciclib is being used in an unsafe manner, and we fail to incorporate changes to address such issue, and the issue is unable to be resolved following elevation to appropriate parties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">GlaxoSmithKline Clinical Trial Collaboration and Supply Agreement</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In April 2021, we entered into a clinical trial collaboration and supply agreement with GlaxoSmithKline plc, or GSK, in which we will evaluate the combination of ZN-c3, our oral WEE1 inhibitor product candidate, and niraparib, GSK&#8217;s poly (ADP-ribose) polymerase (PARP) inhibitor, in patients with advanced epithelial ovarian cancer. We are currently conducting clinical studies with ZN-c3 both as a monotherapy and in combination with certain standard of care therapies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to this agreement, we will be responsible for the conduct and cost of the relevant studies, under the supervision of a joint development committee made up of our representatives and representatives of GSK that meets quarterly. GSK will supply niraparib for use in the collaboration, at no cost to us. We are required to provide to GSK clinical data and other reports upon completion of the study. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This agreement does not grant any right of first negotiation to participate in future clinical trials, and each of the parties retains all rights and ability to evaluate their respective compounds in any clinical studies, either as monotherapy or in combination with any other product or compound, in any therapeutic area. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The agreement with GSK will expire upon completion of all obligations of the parties thereunder or upon termination by either party. We and GSK each have the right to terminate the agreement for material breach by the other party. In addition, the agreement may be terminated by either party due to safety considerations or if either party decides to discontinue development of its own compound for medical, scientific, legal or other reasons or if a regulatory authority takes any action preventing that party from supplying its compound for the study or in the event the other party is subject to specified bankruptcy, insolvency or similar circumstances. GSK also has the right to terminate this agreement if it notifies us in writing that it reasonably and in good faith believes that niraparib is being used in an unsafe manner, and we fail to incorporate changes to address such issue, and the issue is unable to be resolved following elevation to appropriate parties. </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Zentera Therapeutics</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, each of our subsidiaries Zeno Alpha, Inc., K-Group Alpha, Inc. Zeno Management, Inc. and K-Group Beta, Inc. entered into a collaboration and license agreement with our joint venture, Zentera, which we refer to as the &#8220;Zentera Sublicenses&#8221;, pursuant to which we collaborate with Zentera on the development and commercialization of ZN-c3, ZN-c5 and ZN-d5, respectively, whether alone or in a licensed product, or the Collaboration Products, in each case for the treatment or prevention of disease, other than for pain, which is referred to as the Zentera Field, in the People&#8217;s Republic of China, Macau, Hong Kong and Taiwan, which is referred to as the &#8220;Zentera Collaboration Territory&#8221;. Under each Zentera Sublicense, Zentera will lead development, and upon regulatory approval, the commercialization, of the Collaboration Products in the Zentera Collaboration Territory. On May 19, 2020, Zentera issued an aggregate of 60.2% of its issued shares of common stock to Zeno Alpha, Inc., K-Group Alpha, Inc., K-Group Beta, Inc., Zeno Management, Inc. and Zeno Beta, Inc. In July 2021, Zentera entered into a Series B Preference Shares Purchase Agreement, pursuant to which it raised $75.0 million in gross proceeds. As of September 30, 2021, we hold a 40.3% equity interest in Zentera. Anthony Y. Sun, M.D., our President and Chief Executive Officer, serves as Chief Executive Officer and a member of the board of directors of Zentera, and Kevin D. Bunker, Ph.D., our Chief Operating Officer, serves as a member of the board of directors of Zentera. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under each Zentera Sublicense, we granted Zentera an exclusive, royalty-bearing license under certain of our technology, including technology licensed from Recurium under the Recurium Agreement, to develop and commercialize the Collaboration Products in the Zentera Field and in the Zentera Collaboration Territory, subject to certain rights that we retain, and upon a successful manufacturing transfer, a non-exclusive license under certain of our manufacturing technology to manufacture Collaboration Products in the Zentera Field and in the Zentera Collaboration Territory. Zentera has the right to sublicense its rights under the Zentera Sublicenses subject to certain conditions.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Zentera Sublicenses, Zentera is responsible for the costs of developing the Collaboration Products in the Zentera Collaboration Territory, and we are responsible for the costs of developing the Collaboration Products outside the Zentera Collaboration Territory, provided that Zentera will reimburse us for a portion of its costs for global data management, pharmacovigilance, safety database management, and chemistry, manufacturing and controls activities with respect to each Collaboration Product. Under the Zentera Sublicenses, we will be eligible to receive future development and regulatory milestones of up to $4.45 million per Collaboration Product. Zentera will pay us royalties on net sales of Collaboration Products in the Zentera Collaboration Territory at a mid- to high-single digit percentage, subject to certain reductions. In addition, if Zentera or its affiliate chooses to sublicense or assign to any third parties its rights under the Zentera Sublicenses with respect to any Collaboration Product, Zentera must pay to us 20% of sublicensing income received by Zentera or its affiliates in connection with such transaction.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zentera&#8217;s royalty obligations will expire on a Collaboration Product-by-Collaboration Product and region-by-region basis upon the later of the date on which such product is no longer covered by a valid claim of a licensed patent and the 15th anniversary of the first commercial sale of such product in such region.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zentera filed four Clinical Trial Applications, or CTAs (China equivalent of IND), and four have been approved in China to date for ZN-c3, ZN-c5, ZN-d5 and ZN-c3 in combination. Zentera has begun enrolling four clinical trials for ZN-c3, ZN-c5 and ZN-d5. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Our Results of Operations</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have not generated any revenue, and we do not expect to generate any revenue in the foreseeable future from product sales. We have generated, and may in the future generate, revenue from payments received under our collaboration agreements, which includes payments of upfront fees, license fees, milestone-based payments and reimbursements for research and development efforts. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist primarily of costs incurred for our research activities, including our discovery efforts, and the development of our product candidates, and include: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">salaries, benefits and other related costs, including stock-based compensation expense, for personnel engaged in research and development functions; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">expenses incurred under agreements with third parties, including contract research organizations, or CROs, and other third parties that conduct research, preclinical activities and clinical trials on our behalf as well as contract manufacturing organizations, or CMOs, that manufacture drug material for use in our preclinical studies and clinical trials; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">costs of outside consultants, including their fees, stock-based compensation and related travel expenses; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the costs of laboratory supplies and acquiring, developing and manufacturing preclinical study and clinical trial materials; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">license payments made for intellectual property used in research and development activities; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">allocated expenses for rent and maintenance of facilities and other operating costs.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense research and development costs as incurred. Reimbursed research and development costs under government grants and certain collaborative arrangements are recorded as a reduction to research and development expenses and are recognized in the period in which the related costs are incurred. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We track external development costs by product candidate or development program, but we do not allocate personnel costs, general license payments made under our licensing arrangements or other internal costs to specific development programs or product candidates. These costs are included in unallocated research and development expenses in the table below. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our research and development expenses by product candidate or development program:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.711%"><tr><td style="width:1.0%"></td><td style="width:44.077%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.153%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.227%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZN-c3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZN-c5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZN-d5</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZN-e4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated research and development expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,998</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,162</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,380&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development activities are central to our business model. Product candidates in later stages of clinical development generally have a higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. We expect that our research and development expenses will continue to increase substantially for the foreseeable future and will comprise a larger percentage of our total expenses as we complete our ongoing clinical trials, initiate new clinical trials, continue to discover and develop additional product candidates and prepare regulatory filings for any product candidates that successfully complete clinical development. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The successful development of our product candidates is highly uncertain. At this time, we cannot determine with certainty the duration and costs of our existing and future clinical trials of our product candidates or any other product candidate we may develop or if, when, or to what extent we will generate revenue from the commercialization and sale of any product candidate for which we obtain marketing approval. We may never succeed in obtaining marketing approval for any product candidate. The duration, costs and timing of clinical trials and development of our product candidates and any other product candidate we may develop in the future will depend on a variety of factors, including:</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">per patient trial costs; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the number of patients who enroll in each trial; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the number of trials required for approval; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the number of sites included in the trials; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the countries in which the trials are conducted; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the length of time required to enroll eligible patients; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the drop-out or discontinuation rates of patients; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">any delays in clinical trials as a result of the COVID-19 pandemic;</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">potential additional safety monitoring requested by regulatory agencies; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the duration of patient participation in the trials and follow-up; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the phase of development of the product candidate; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the efficacy and safety profile of the product candidate. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">uncertainties in clinical trial design and patient enrollment rates; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the actual probability of success for our product candidates, including the safety and efficacy, early clinical data, competition, manufacturing capability and commercial viability; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">significant and changing government regulation and regulatory guidance; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the timing and receipt of any marketing approvals; and</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the expense of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A change in the outcome of any of these variables with respect to the development of a product candidate could mean a significant change in the costs and timing associated with the development of that product candidate. For example, if the FDA or another regulatory authority were to require us to conduct clinical trials beyond those that we anticipate will be required for the completion of clinical development of a product candidate, or if we experience significant delays in our clinical trials due to patient enrollment or other reasons, we would be required to expend significant additional financial resources and time on the completion of clinical development.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of salaries and other related costs, including stock-based compensation, for personnel in our executive, finance, business development and administrative functions. General and administrative expenses also include legal fees relating to intellectual property and corporate matters; professional fees for accounting, auditing, tax and consulting services; insurance costs; travel expenses; and facility-related expenses, which include direct depreciation costs and allocated expenses for rent and maintenance of facilities and other operating costs. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our general and administrative expenses will increase in the future as we increase our personnel headcount to support increased research and development activities relating to ZN-c3, ZN-c5, ZN-d5, ZN-e4, and any other product candidate we may develop. We also expect to incur increased expenses associated with being a public company, particularly after we are no longer an emerging growth company, including costs of accounting, audit, legal, regulatory and tax-related services associated with maintaining compliance with Nasdaq and SEC requirements; director and officer insurance costs; and investor and public relations costs. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists of interest earned on cash, cash equivalents and available-for-sale marketable securities.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we and our corporate subsidiaries have generated cumulative federal, state and foreign net operating loss in certain jurisdictions for which we have not recorded any net tax benefit due to uncertainty around utilizing these tax attributes within their respective carryforward periods.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of Three Months Ended September 30, 2021 to Three Months Ended September 30, 2020 </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the periods indicated, together with the changes in those items in dollars:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.442%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase<br/>(Decrease)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="24" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,767&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,103&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,870)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,767)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,103)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on deconsolidation of Zentera</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,189)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,647)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,458&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(697)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(715)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,492)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,665)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,173&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Zentalis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,191)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,555)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,364&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not generate any revenue for the three months ended September&#160;30, 2021 and September&#160;30, 2020. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three months ended September&#160;30, 2021 were $54.0 million, compared to $24.7 million for the three months ended September&#160;30, 2020. The increase of $29.3 million was primarily due to increases in external research and development expenses related to our clinical product candidates as we advanced our clinical pipeline. In addition, in the three months ended September&#160;30, 2021, we conducted additional preclinical studies, incurred additional manufacturing costs and incurred increased costs for study and lab materials. Unallocated research and development expenses increased by $18.8 million due to an impairment charge of $8.8 million recorded on Kalyra&#8217;s IPR&amp;D, $8.2 million of additional employee related costs associated with increased headcount to support our platform development and $1.8 million of additional allocable overhead expenses. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses for the three months ended September&#160;30, 2021 were $8.9 million, compared to $10.1 million during the three months ended September&#160;30, 2020. This decrease of $1.2 million was primarily attributable to an increase in allocable overhead expenses to research and development expenses of $1.7 million and a decrease of $0.6 million in legal fees, partially offset by an increase of $1.1 million of facilities and related permits/fees and licenses expenses. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment and Other Income, Net </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment and other income, net was $0.1 million for the three months ended September&#160;30, 2021, compared to $0.1 million for the three months ended September&#160;30, 2020. The decrease of $21,000 was a result of lower effective interest earned on invested cash and marketable securities balances. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain on Deconsolidation of Zentera</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2021 Zentera was deconsolidated, resulting in a gain of $51.6 million. There was no comparable event during the corresponding period in 2020.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Provision (benefit)</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes was $(0.7) million for the three months ended September&#160;30, 2021, compared to $18,000 for the three months ended September 30, 2020. The decrease in provision for income taxes for the three months ended September&#160;30, 2021 is primarily attributable to the reversal of a deferred tax liability of $2.4 million associated with the in-process research and development impairment, partially offset by a deferred tax liability of $1.7 million recognized in connection with the unrealized tax gain on the deconsolidation of Zentera. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss was $10.5 million for the three months ended September&#160;30, 2021, compared to $34.7 million for the three months ended September&#160;30, 2020. The $24.2 million decrease in net loss was primarily the result of the gain on deconsolidation recognized during the three months ended September 30, 2021, partially offset by increases in research and development expenses discussed above.  </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of Nine Months Ended September 30, 2021 to Nine Months Ended September 30, 2020</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the periods indicated, together with the changes in those items in dollars:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:56.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.886%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.886%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.507%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,349&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,542&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,807&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168,349)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,542)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89,807)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on deconsolidation of Zentera</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,454)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,174)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,280)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,998)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,192)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,332)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,678)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Zentalis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108,666)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,538)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,128)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not generate any revenue for the nine months ended September&#160;30, 2021 and September&#160;30, 2020. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the nine months ended September&#160;30, 2021 were $137.2 million, compared to $55.4 million for the nine months ended September&#160;30, 2020. The increase of $81.8 million was primarily due to increases in external research and development expenses related to our clinical product candidates, as we advanced our clinical pipeline. In addition, in the nine months ended September&#160;30, 2021, we conducted additional preclinical studies, incurred additional manufacturing costs, and incurred increased costs for study and lab materials. Unallocated research and development expenses increased by $47.4 million primarily due to $18.9 million of additional employee related costs, $11.5 million of research supplies and services, an impairment charge of $8.8 million recorded on Kalyra&#8217;s IPR&amp;D, increases in facilities and other allocable overhead expenses of $5.3 million and increases in reimbursable expenses from collaborative partners of $2.9 million.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses for the nine months ended September&#160;30, 2021 were $31.2 million, compared to $23.2 million during the nine months ended September&#160;30, 2020. This increase of $8.0 million was primarily attributable to an increase of $10.7 million in employee-related costs of which $6.2 million was driven by non-cash stock-based compensation from incentive grants issued during the period and increased headcount to support our growth. Other increased expenses included allocable facilities and information technology costs of $2.9 million, insurance costs of $0.8 million and recruiting costs of $0.7 million.  These increased costs were offset by a reduction of $1.6 million of legal fees and $0.4 million of consulting fees. These amounts were partially offset by a decrease in allocable overhead expenses.  </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment and Other Income, Net </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment and other income was $0.3 million for the nine months ended September&#160;30, 2021, compared to $0.4 million for the nine months ended September&#160;30, 2020. The decrease of $0.1 million was primarily the result of lower effective interest earned on the invested marketable securities balances.  </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain on Deconsolidation of Zentera</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021 Zentera was deconsolidated, resulting in a gain of $51.6 million. There was no comparable event during the comparable period of 2020.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Provision (benefit)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes was $(0.5) million for the nine months ended September&#160;30, 2021. The decrease in provision for income taxes for the nine months ended September&#160;30, 2021 is primarily attributable to the reversal of a deferred tax liability of $2.4 million associated with the in-process research and development impairment, partially offset by a deferred tax liability of $1.7 million recognized in connection with the unrealized tax gain on the deconsolidation of Zentera, and $0.3 million of expense attributable to our Australian subsidiary. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss was $116.0 million for the nine months ended September&#160;30, 2021, compared to $78.2 million for the nine months ended September&#160;30, 2020. The $37.8 million increase in net loss was primarily attributable to increases in research and development and general and administrative expenses discussed above, partially offset by the gain on the deconsolidation of Zentera.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, our operations have been limited to organizing and staffing our company, business planning, raising capital, establishing our intellectual property portfolio and performing research and development of our product pipeline. We do not have any products approved for commercial sale and have not generated any revenues from product sales and we have incurred significant operating losses. We expect to incur significant expenses and operating losses for the foreseeable future as we advance the preclinical and clinical development of our research programs and product candidates. We expect that our research and development and general and administrative costs will increase in connection with conducting additional preclinical studies and clinical trials for our current and future research programs and product candidates, contracting with CMOs to support preclinical studies and clinical trials, expanding our intellectual property portfolio, and providing general and administrative support for our operations. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we will need to raise substantial additional capital to support our continuing operations and pursue our growth strategy. Until such time as we can generate significant revenue from product sales, if ever, we plan to finance our operations through the sale of equity, debt financings or other capital sources, which may include collaborations with other companies or other strategic transactions. There are no assurances that we will be successful in obtaining an adequate level of financing as and when needed to finance our operations on terms acceptable to us or at all, particularly in light of the economic downturn and ongoing uncertainty related to the COVID-19 pandemic. The COVID-19 pandemic could adversely affect the economies and financial markets of the global economy, resulting in an economic downturn that could also affect our operations, our ability to conduct our clinical trials, our ability to raise additional funds through public offerings and the volatility of our stock price and trading in our stock. Even after the COVID-19 pandemic has subsided, we expect we will continue to experience adverse impacts to our business as a result of any economic recession or depression that has occurred or may occur in the future. If we are unable to secure adequate additional funding as and when needed, we may have to significantly delay, scale back or discontinue the development and commercialization of one or more product candidates or delay our pursuit of potential in-licenses or acquisitions. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the numerous risks and uncertainties associated with developing and commercializing therapeutics, we are unable to predict the timing or amount of increased expenses or when or if we will be able to achieve or maintain profitability. Even if we are able to generate revenue from product sales, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently have any approved products and have never generated any revenue from product sales. To date, we have financed our operations primarily through the sale of equity securities. From inception through September&#160;30, 2021, we raised a total of $691 million in gross proceeds from the sale of our Series A, B and C convertible preferred units and from the sale of shares of our common stock through our IPO in April 2020 and follow-on public offerings of common stock in August 2020 and July 2021. As of September&#160;30, 2021, we had cash, cash equivalents, and marketable securities of $366.8 million, and an accumulated deficit of $309.5 million. We had no indebtedness as of September&#160;30, 2021. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ATM Program</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, we entered into a sales agreement, or the Sales Agreement, with SVB Leerink LLC, or SVB Leerink, as sales agent, pursuant to which we may, from time to time, issue and sell common stock with an aggregate value of up to $200.0 million in &#8220;at-the-market&#8221; offerings, or the ATM, under our Registration Statement on Form S-3 (File No. 333-255769) filed with the SEC on May 4, 2021. Sales of common stock, if any, pursuant to the Sales Agreement, may be made in sales deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415(a) of the Securities Act, including sales made directly through the Nasdaq Global Market or any other existing trading market for our common stock. No securities have been issued pursuant to the Sales Agreement. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">July 2021 Follow-On Offering</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we completed a follow-on offering of our common stock in which we issued and sold 3,565,000 shares of our common stock (including 465,000 shares of common stock in connection with the full exercise of the underwriters&#8217; option to purchase additional shares) at a public offering price of $48.50 per share, resulting in aggregate gross proceeds of $172.9 million, before deducting underwriting discounts and commissions and offering expenses of $10.7 million.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Cash Flows </span></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our sources and uses of cash for the period presented: </span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,072)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase/(decrease) in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,200)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,383&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred losses since inception. Net cash used in operating activities for the nine months ended September&#160;30, 2021 was $117.1 million, consisting primarily of our net loss of $116.0 million as we incurred expenses associated with research activities for our lead product candidates and incurred general and administrative expenses, as well as changes in operating assets and liabilities of $14.2 million, partially offset by non-cash adjustments of $15.3 million.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities for the nine months ended September&#160;30, 2020 was $59.5 million, consisting primarily of our net loss of $78.2 million as we incurred expenses associated with research activities for our lead product candidates and incurred general and administrative expenses, partially offset by changes in operating assets and liabilities of $3.1 million and non-cash adjustments of $15.6 million.  </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the nine months ended September&#160;30, 2021 of $61.4 million was attributable to the proceeds from maturities of marketable securities of $237.1 million, offset by net investment of excess cash of $280.3 million and the purchases of property and equipment of $3.9 million.      </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the nine months ended September&#160;30, 2020 of $275.2 million was attributable to the net investment of excess cash of $275.1 million and the purchase of property and equipment of $0.1 million. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the nine months ended September&#160;30, 2021 of $166.3 million primarily relates to the July 2021 follow-on offering which provided net cash of $162.2 million. An additional $4.0 million was provided from the issuance of common stock under equity incentive plans. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the nine months ended September&#160;30, 2020 of $361.0 million primarily relates to net proceeds from the completion of our initial public offering of $172.5 million, net proceeds from our follow-on offering of $155.9 million, net proceeds from the issuance of our Series C convertible preferred units of $14.2 million, and contributions from noncontrolling interest owners of $18.4 million. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Funding Requirements </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses have increased substantially in 2020 and to date in 2021 and are expected to increase substantially in the future in connection with our ongoing activities. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, our expenses will increase as we:</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">advance the clinical development of ZN-c3, ZN-c5, ZN-d5 and ZN-e4 for the treatment of oncology indications; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">pursue the preclinical and clinical development of other current and future research programs and product candidates;</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">in-license or acquire the rights to other products, product candidates or technologies; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">maintain, expand and protect our intellectual property portfolio; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">hire additional personnel in research, manufacturing and regulatory and clinical development as well as management personnel; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">seek regulatory approval for any product candidates that successfully complete clinical development; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">expand our operational, financial and management systems and increase personnel, including personnel to support our operations as a public company.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash, cash equivalents and marketable securities as of September&#160;30, 2021 will enable us to fund our operating expenses and capital expenditure requirements into the third quarter of 2023.  We have </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based these estimates on assumptions that may prove to be imprecise, and we could utilize our available capital resources sooner than we expect. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the numerous risks and uncertainties associated with research, development and commercialization of pharmaceutical drugs, it is difficult to estimate with certainty the amount of our working capital requirements. Our future funding requirements will depend on many factors, including:</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the progress, costs and results of our clinical trials for our programs for ZN-c3, ZN-c5, ZN-d5 and ZN-e4;</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the progress, costs and results of additional research and preclinical studies in other research programs we initiate in the future; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the costs and timing of process development and manufacturing scale-up activities associated with our product candidates and other programs we advance them through preclinical and clinical development; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to establish and maintain strategic collaborations, licensing or other agreements and the financial terms of such agreements; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the extent to which we in-license or acquire rights to other products, product candidates or technologies; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and protecting our intellectual property rights and defending against any intellectual property-related claims.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the magnitude and duration of the COVID-19 pandemic and its impact on our liquidity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and future funding requirements is uncertain as of the filing date of this Quarterly Report on Form 10-Q, as the pandemic continues to evolve globally. We have considered and will continue to consider the availability of relief provided by such legislative actions as the Families First Act and the CARES Act, and have opted to pursue certain, but not all measures including the deferral of employer payroll taxes, but not including Payroll Protection Plan loans. See &#8220;Impact of COVID-19 Pandemic&#8221; and &#8220;Risk Factors&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has adversely impacted and we expect will continue to adversely impact our business, including our preclinical studies and clinical trials&#8221;. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, our operating results may change in the future, and we may need additional funds to meet operational needs and capital requirements associated with such operating plans. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until such time, if ever, that we can generate product revenue sufficient to achieve profitability, we expect to finance our cash needs through a combination of equity offerings, debt financings, collaboration agreements, other third-party funding, strategic alliances, licensing arrangements and marketing and distribution arrangements. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have no credit facility or committed sources of capital. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a common stockholder. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise additional funds through other third-party funding, collaboration agreements, strategic alliances, licensing arrangements or marketing and distribution arrangements, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">future commercialization efforts or grant rights to develop and market products or product candidates that we would otherwise prefer to develop and market ourselves. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">We have not entered into any off-balance sheet arrangements.  </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Use of Estimates </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes to our critical accounting policies from our disclosure reported in &#8220;Critical Accounting Policies and Estimates&#8221; in the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, except as disclosed below.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Accounting</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant influence, but not a controlling interest, in Zentera. From the deconsolidation of Zentera during July 2021 prospectively, this investment is accounted for using the equity method. Our share of earnings or losses of the investment entity are reported on the consolidated statement of operations through investment and other income, net, with a corresponding increase or decrease to the equity investment carried on the statement of financial position. This information is generally not received sufficiently timely for us to record our portion of earnings or loss in the current financial statements and therefore we report our portion of earnings or loss on a one quarter lag.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Emerging Growth Company Status </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, and we may take advantage of reduced reporting requirements that are otherwise applicable to public companies. Section 107 of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with those standards. We have elected to take advantage of the extended transition period for complying with new or revised accounting standards; and as a result of this election, our financial statements may not be comparable to companies that comply with public company effective dates. The JOBS Act also exempts us from having to provide an auditor attestation of internal control over financial reporting under Sarbanes-Oxley Act Section 404(b). </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will remain an &#8220;emerging growth company&#8221; until December 31, 2021. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of recent accounting pronouncements that may potentially impact our financial position, results of operations or cash flows is disclosed in Note 2 to our interim unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not entered into any off-balance sheet arrangements.</span></div><div id="i359d7483f88b44aba6df295b4be37cde_82"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_85"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitations on Effectiveness of Controls and Procedures</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated, as of the end of the period covered by this Quarterly Report on Form 10-Q, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of September&#160;30, 2021.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in management&#8217;s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act that occurred during the quarter ended September&#160;30, 2021 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div id="i359d7483f88b44aba6df295b4be37cde_91"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not subject to any material legal proceedings.</span></div><div id="i359d7483f88b44aba6df295b4be37cde_94"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should carefully consider the risks and uncertainties described below and the other information in this Quarterly Report on Form 10-Q, including our interim unaudited condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and in the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; before deciding whether to invest in our common stock. Such risks and uncertainties may be amplified by the COVID-19 pandemic and its potential impact on our business and the global economy. Our business, financial condition, results of operations or prospects could be materially and adversely affected if any of these risks occurs, and as a result, the market price of our common stock could decline and you could lose all or part of your investment. This Quarterly Report on Form 10-Q also contains forward-looking statements that involve risks and uncertainties. See &#8220;Cautionary Note Regarding Forward-Looking Statements.&#8221; Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations. Our actual results could differ materially and adversely from those anticipated in these forward-looking statements as a result of certain important factors, including those set forth below. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Financial Position and Need for Additional Capital </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have a limited operating history, have not completed any clinical trials, and have no products approved for commercial sale, which may make it difficult for you to evaluate our current business and predict our future success and viability. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical stage biopharmaceutical company with a limited operating history upon which you can evaluate our business and prospects. We have no products approved for commercial sale and have not generated any revenue from product sales. To date, we have devoted substantially all of our resources and efforts to organizing and staffing our company, business planning, executing partnerships, raising capital, discovering, identifying and developing potential product candidates, securing related intellectual property rights and conducting preclinical studies and clinical trials of our product candidates, including the ongoing clinical trials of ZN-c3, ZN-c5, ZN-d5 and ZN-e4. We have not yet demonstrated our ability to successfully complete any clinical trials, obtain marketing approvals, manufacture a commercial-scale product or arrange for a third party to do so on our behalf, or conduct sales and marketing activities necessary for successful product commercialization. As a result, it may be more difficult for you to accurately predict our future success or viability than it could be if we had a longer operating history. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors and risks frequently experienced by clinical stage biopharmaceutical companies in rapidly evolving fields. We also may need to transition from a company with a research focus to a company capable of supporting commercial activities. If we do not adequately address these risks and difficulties or successfully make such a transition, our business will suffer. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred significant net losses since inception and we expect to continue to incur significant net losses for the foreseeable future. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred net losses in each reporting period since our inception, have not generated any revenue from product sales to date and have financed our operations principally through private financings, our initial public offering, or IPO, and follow-on public offerings of our common stock. We have incurred net losses of $118.5 million for the year ended December&#160;31, 2020, and $116.0 million and $78.2 million for the nine months ended September&#160;30, 2021 and September&#160;30, 2020, respectively. As of September&#160;30, 2021, we had an accumulated deficit of $309.5 million. Our losses have resulted principally from expenses incurred in research and development of our product candidates and from management and administrative costs and other expenses that we have incurred while building our business infrastructure. Four of our product candidates, ZN-c3, ZN-c5, ZN-d5 and ZN-e4, are in clinical trials. Our other programs are in preclinical research. As a result, we expect that it will be several years, if ever, before we have a commercialized product and generate revenue from product sales. Even if we succeed in receiving marketing approval for and commercializing one or more of our product candidates, we expect that we will continue to incur substantial research and development and other expenses as we discover, develop and market additional potential products. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to incur significant expenses and increasing operating losses for the foreseeable future as we continue our research and development efforts and seek to obtain regulatory approval and commercialization of our product candidates. The net losses we incur may fluctuate significantly from quarter to quarter such that a period-to-period comparison of our results of operations may not be a good indication of our future performance. The size of our future net losses will depend, in part, on the rate of future growth of our expenses and our ability to generate revenue. Our prior losses and expected future losses have had and will continue to have an adverse effect on our working capital and our ability to achieve and maintain profitability. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to generate revenue and achieve profitability depends significantly on our ability to achieve a number of objectives. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business depends entirely on the successful discovery, development and commercialization of our product candidates. We currently generate no revenues from sales of any products. We have no products approved for commercial sale and do not anticipate generating any revenue from product sales for the next several years, if ever. Our ability to generate revenue and achieve profitability depends significantly on our ability, or any future collaborator&#8217;s ability, to achieve a number of objectives, including: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">successful and timely completion of preclinical and clinical development of our product candidates, including ZN-c3, ZN-c5, ZN-d5 and ZN-e4 and any other future product candidates, as well as the associated costs, including any unforeseen costs we have incurred and may continue to incur as a result of preclinical study or clinical trial delays due to the COVID-19 pandemic or other causes; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">establishing and maintaining relationships with contract research organizations, or CROs, and clinical sites for the clinical development, both in the United States and internationally, of our product candidates, including ZN-c3, ZN-c5, ZN-d5 and ZN-e4 and any other future product candidates; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">timely receipt of marketing approvals from applicable regulatory authorities for any product candidates for which we successfully complete clinical development; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">making any required post-marketing approval commitments to applicable regulatory authorities; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">developing an efficient and scalable manufacturing process for our product candidates, including obtaining finished products that are appropriately packaged for sale; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">establishing and maintaining commercially viable supply and manufacturing relationships with third parties that can provide adequate, in both amount and quality, products and services to support clinical development and meet the market demand for product candidates that we develop, if approved; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">successful commercial launch following any marketing approval, including the development of a commercial infrastructure, whether in-house or with one or more collaborators; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">a continued acceptable safety profile following any marketing approval of our product candidates; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">commercial acceptance of our product candidates by patients, the medical community and third-party payors; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">identifying, assessing and developing new product candidates; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">obtaining, maintaining and expanding patent protection, trade secret protection and regulatory exclusivity, both in the United States and internationally; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">protecting our rights in our intellectual property portfolio; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">defending against third-party interference or infringement claims, if any; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">negotiating favorable terms in any collaboration, licensing or other arrangements that may be necessary or desirable to develop, manufacture or commercialize our product candidates; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">obtaining coverage and adequate reimbursement by hospitals, government and third-party payors for product candidates that we develop; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">addressing any competing therapies and technological and market developments; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">attracting, hiring and retaining qualified personnel.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may never be successful in achieving our objectives and, even if we do, may never generate revenue that is significant or large enough to achieve profitability. If we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable would decrease the value of our company and could impair our ability to maintain or further our research and development efforts, raise additional necessary capital, grow our business and continue our operations. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will require substantial additional capital to finance our operations. If we are unable to raise such capital when needed, or on acceptable terms, we may be forced to delay, reduce and/or eliminate one or more of our research and drug development programs or future commercialization efforts. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developing pharmaceutical products, including conducting preclinical studies and clinical trials, is a very time-consuming, expensive and uncertain process that takes years to complete. Our operations have consumed substantial amounts of cash since inception, and we expect our expenses to increase in connection with our ongoing activities, particularly as we initiate and conduct clinical trials of, and seek marketing approval for, ZN-c3, ZN-c5, ZN-d5, ZN-e4 and our other product candidates. Even if one or more of the product candidates that we develop is approved for commercial sale, we anticipate incurring significant costs associated with commercializing any approved product candidate. Our expenses could increase beyond expectations if we are required by the FDA, the European Medicines Agency, or the EMA, or other regulatory agencies to perform clinical trials or preclinical studies in addition to those that we currently anticipate. Other unanticipated costs may also arise. In addition, if we obtain marketing approval for any of our product candidates, including ZN-c3, ZN-c5, ZN-d5 and ZN-e4, we expect to incur significant commercialization expenses related to drug sales, marketing, manufacturing and distribution. Because the design and outcome of our planned and anticipated clinical trials are highly uncertain, we cannot reasonably estimate the actual amounts necessary to successfully complete the development and commercialization of any product candidate we develop. We have also incurred, and expect to continue to incur, additional costs associated with operating as a public company, particularly after we are no longer an emerging growth company. Accordingly, we will need to obtain substantial additional funding in order to maintain our continuing operations. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we had cash and cash equivalents and marketable securities of $366.8 million. Based on current business plans, we believe that our existing cash, cash equivalents and marketable securities as of September&#160;30, 2021 will be sufficient to fund our operating expenses and capital expenditures requirements into the third quarter of 2023, but will not be sufficient to fund all of the activities that are necessary to complete the development of our product candidates. This estimate is based on assumptions that may prove to be wrong, and we could use our available capital resources sooner than we currently expect. Changing circumstances, some of which may be beyond our control, could cause us to consume capital significantly faster than we currently anticipate, and we may need to seek additional funds sooner than planned. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be required to obtain further funding through public or private equity offerings, debt financings, collaborations and licensing arrangements or other sources, which may dilute our stockholders or restrict our operating activities. We do not have any committed external source of funds. Adequate additional financing may not be available to us on acceptable terms, or at all. Market volatility resulting from the COVID-19 pandemic or other factors could also adversely impact our ability to access capital as and when needed. Our failure to raise capital as and when needed or on acceptable terms would have a negative impact on our financial condition and our ability to pursue our business strategy, and we may have to delay, reduce the scope of, suspend or eliminate one or more of our research-stage programs, clinical trials or future commercialization efforts. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Discovery, Development and Commercialization of Our Product Candidates </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are substantially dependent on the success of our lead product candidates, ZN-c3, and/or ZN-c5, which are currently in clinical trials. If we are unable to complete development of, obtain approval for and commercialize these product candidates in a timely manner, our business will be harmed. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success is dependent on our ability to timely complete clinical trials, obtain marketing approval for and successfully commercialize our lead product candidates. We are investing significant efforts and financial resources in the research and development of ZN-c3 and ZN-c5. ZN-c3 and ZN-c5 will require additional clinical development, evaluation of clinical, preclinical and manufacturing activities, marketing approval from government regulators, substantial investment and significant marketing efforts before we can generate any revenues from product sales. We are not permitted to market or promote ZN-c3 or ZN-c5, or any other product candidate, before we receive marketing approval from the FDA and comparable foreign regulatory authorities, and we may never receive such marketing approvals. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our lead product candidates will depend on several factors, including the following: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the successful and timely completion of our ongoing clinical trials of ZN-c3 and ZN-c5;</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the initiation and successful patient enrollment and completion of additional clinical trials of ZN-c3 and ZN-c5 on a timely basis; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">maintaining and establishing relationships with CROs and clinical sites for the clinical development of ZN-c3 and ZN-c5 both in the United States and internationally; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the frequency and severity of adverse events in the clinical trials; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the efficacy, safety and tolerability profiles that are satisfactory to the FDA, EMA or any comparable foreign regulatory authority for marketing approval; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the timely receipt of marketing approvals for ZN-c3 and ZN-c5 from applicable regulatory authorities; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the extent of any required post-marketing approval commitments to applicable regulatory authorities; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the maintenance of existing or the establishment of new supply arrangements with third-party drug product suppliers and manufacturers for clinical development of ZN-c3 and ZN-c5;</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the maintenance of existing, or the establishment of new, scaled production arrangements with third-party manufacturers to obtain finished products that are appropriate for commercial sale of ZN-c3 and ZN-c5 if approved, including for supplies of drugs that we are testing in combination with ZN-c3 and ZN-c5; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">obtaining and maintaining patent protection, trade secret protection and regulatory exclusivity, both in the United States and internationally; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the protection of our rights in our intellectual property portfolio; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the successful launch of commercial sales following any marketing approval; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">a continued acceptable safety profile following any marketing approval; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">commercial acceptance by patients, the medical community and third-party payors; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to compete with other therapies.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have complete control over many of these factors, including certain aspects of clinical development and the regulatory submission process, potential threats to our intellectual property rights and the manufacturing, marketing, distribution and sales efforts of any future collaborator. If we are not successful with respect to one or more of these factors in a timely manner or at all, we could experience significant delays or an inability to successfully commercialize ZN-c3 and ZN-c5, which would materially harm our business. If we do not receive marketing approvals for ZN-c3 and ZN-c5, we may not be able to continue our operations. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect to depend on collaborations with third parties for the research, development and commercialization of certain of the product candidates we may develop. If any of these collaborations are not successful, we may not be able to capitalize on the market potential of those product candidates. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We anticipate seeking third-party collaborators for the research, development and commercialization of some of our product candidates. Our likely collaborators in any future collaboration arrangements we may enter into include large and mid-size pharmaceutical companies and biotechnology companies. If we were to enter into any collaboration arrangements with third parties, those agreements may limit our control over the amount and timing of resources that our collaborators dedicate to the development and commercialization of any product candidates we may seek to develop with them. We cannot predict the success of any collaboration in which we have entered or may enter. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaborations involving our research programs or any product candidates we may develop pose the following risks to us: </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Collaborators have significant discretion in determining the efforts and resources that they will apply to these collaborations. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;             Collaborators may not pursue development and commercialization of any product candidates we may develop or may elect not to continue or renew development or commercialization programs based on clinical trial results, changes in the collaborator's strategic focus or market considerations or available funding or external factors such as an acquisition or business combination that diverts resources or creates competing priorities. If this were to happen, we may need additional capital to pursue further development or commercialization of the applicable product candidates. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;              Collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;              Collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our products or product candidates if the collaborators believe that competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than ours. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;              Subject to certain diligence obligations, collaborators with marketing and distribution rights to one (1) or more products may not commit sufficient resources to the marketing and distribution of such product or products.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;              Collaborators may not properly obtain, maintain, enforce or defend our intellectual property or proprietary rights or may use proprietary information in a way that could jeopardize or invalidate our proprietary information or expose us to potential litigation. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;              Collaborators may own or co-own intellectual property covering our products that results from our collaborating with them, and in cases where that applies, we would not have the exclusive right to commercialize the collaboration intellectual property. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;              Disputes may arise between our collaborators and us that result in the delay or termination of the research, development or commercialization of our products or product candidates or that result in costly litigation or arbitration that diverts management attention and resources. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;              We may lose certain valuation rights under circumstances identified in our collaborations, including if we undergo a change of control. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;               Collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;              Collaboration agreements may not lead to development or commercialization of product candidates in the most efficient manner or at all. If a present or future collaborator of ours were to be involved in a business combination, the continued pursuit and emphasis on our product development or commercialization program under such collaboration could be delayed, diminished or terminated. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;               Collaborators may be unable to maintain compliance with GLP and GCP requirements or to secure approval for clinical development plans from the FDA or foreign regulatory authorities. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not receive the funding we expect under these agreements, our development of product candidates could be delayed and we may need additional resources to develop our product candidates. In addition, if one of our collaborators terminates its agreement with us, we may find it more difficult to find a suitable replacement collaborator or attract new collaborators and our development programs may be delayed or the perception of us in the business and financial communities could be adversely affected. All of the risks relating to product development, marketing approval and commercialization described in this annual report apply to the activities of our collaborators. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We may in the future decide to collaborate with pharmaceutical and biotechnology companies for the development and potential commercialization of any product candidates we may develop. These and other similar relationships may require us to incur non-recurring and other charges, increase our near- and long-term expenditures, issue securities that dilute our existing stockholders or disrupt our management and business. In addition, we could face significant competition in seeking appropriate collaborators and the negotiation process is time-consuming and complex. Our ability to reach a definitive collaboration agreement will depend, among other things, upon our assessment of the collaborator's resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator's evaluation of several factors. If we license rights to any product candidates we or our collaborators may develop, we may not be able to realize the benefit of those transactions if we are unable to successfully integrate them with our existing operations and company culture.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There is currently no FDA-approved oral SERD, and our development of ZN-c5 may never lead to a marketable product. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are developing ZN-c5 as an oral SERD. There is currently no FDA-approved oral SERD. We have not received regulatory approval for ZN-c5 and cannot be certain that our approach will lead to the development of an approvable or marketable product, alone or in combination with other therapies. We may not succeed in demonstrating safety and efficacy of ZN-c5 in our ongoing Phase 1/2 clinical trial or in larger-scale clinical trials. Advancing ZN-c5 as an oral SERD creates significant challenges for us, including: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">obtaining marketing approval, as the FDA or other regulatory authorities have never approved an orally available SERD; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">if ZN-c5 is approved, educating medical personnel regarding the potential efficacy and safety benefits, as well as the challenges, of incorporating our ZN-c5 into existing treatment regimens, including in combination with other treatments for breast cancer; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">establishing the sales and marketing capabilities upon obtaining any marketing approvals to gain market acceptance.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our long-term prospects depend in part upon discovering, developing and commercializing additional product candidates, which may fail in development or suffer delays that adversely affect their commercial viability. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future operating results are dependent on our ability to successfully discover, develop, obtain regulatory approval for and commercialize product candidates beyond those we currently have in clinical development. A product candidate can unexpectedly fail at any stage of preclinical and clinical development. The historical failure rate for product candidates is high due to risks relating to safety, efficacy, clinical execution, changing standards of medical care and other unpredictable variables. The results from preclinical testing or early clinical trials of a product candidate may not be predictive of the results that will be obtained in later stage clinical trials of the product candidate. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of other product candidates we may develop will depend on many factors, including the following: </span></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:68.5pt">generating sufficient data to support the initiation or continuation of clinical trials; </span></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:68.5pt">obtaining regulatory permission to initiate clinical trials; </span></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:68.5pt">contracting with the necessary parties to conduct clinical trials; </span></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:68.5pt">successful enrollment of patients in, and the completion of, clinical trials on a timely basis; </span></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:68.5pt">the timely manufacture of sufficient quantities of the product candidate for use in clinical trials; and </span></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:68.5pt">adverse events in the clinical trials.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we successfully advance any other product candidates into clinical development, their success will be subject to all of the clinical, regulatory and commercial risks described elsewhere in this &#8220;Risk Factors&#8221; section. Accordingly, we cannot assure you that we will ever be able to discover, develop, obtain regulatory approval of, commercialize or generate significant revenue from our other product candidates. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The regulatory approval processes of the FDA and other comparable foreign regulatory authorities are lengthy, time consuming and inherently unpredictable. If we are ultimately unable to obtain regulatory approval for our product candidates, we will be unable to generate product revenue and our business will be substantially harmed. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not permitted to commercialize, market, promote or sell any product candidate in the United States without obtaining marketing approval from the FDA. Foreign regulatory authorities impose similar requirements. The time required to obtain approval by the FDA and other comparable foreign regulatory authorities is unpredictable, typically takes many years following the commencement of clinical trials and depends upon numerous factors, including the type, complexity and novelty of the product candidates involved. In addition, approval policies, regulations or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate&#8217;s clinical development and may vary among jurisdictions, which may cause delays in the approval or the decision not to approve an application. Regulatory authorities have substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient for approval and require additional preclinical, clinical or other data. Even if we eventually complete clinical testing and receive approval of any regulatory filing for our product candidates, the FDA and other comparable foreign regulatory authorities may approve our product candidates for a more limited indication or a narrower patient population than we originally requested. We have not submitted for, or obtained, regulatory approval for any product candidate, and it is possible that none of our existing product candidates or any product candidates we may seek to develop in the future will ever obtain regulatory approval. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, development of our product candidates and/or regulatory approval may be delayed for reasons beyond our control. For example, a U.S. federal government shutdown or budget sequestration, such as ones that occurred </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during 2013, 2018 and 2019, may result in significant reductions to the FDA&#8217;s budget, employees and operations, which may lead to slower response times and longer review periods, potentially affecting our ability to progress development of our product candidates or obtain regulatory approval for our product candidates. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applications for our product candidates could fail to receive regulatory approval for many reasons, including the following: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the FDA or other comparable foreign regulatory authorities may disagree with the design, implementation or results of our clinical trials; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the FDA or other comparable foreign regulatory authorities may determine that our product candidates are not safe and effective, only moderately effective or have undesirable or unintended side effects, toxicities or other characteristics that preclude our obtaining marketing approval or prevent or limit commercial use; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the population studied in the clinical trial may not be sufficiently broad or representative to assure efficacy and safety in the full population for which we seek approval; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the FDA or other comparable foreign regulatory authorities may disagree with our interpretation of data from preclinical studies or clinical trials; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the data collected from clinical trials of our product candidates may not be sufficient to support the submission of a New Drug Application, or NDA, or other submission or to obtain regulatory approval in the United States or elsewhere; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">we may be unable to demonstrate to the FDA or other comparable foreign regulatory authorities that a product candidate&#8217;s risk-benefit ratio for its proposed indication is acceptable; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the FDA or other comparable foreign regulatory authorities may fail to approve the manufacturing processes, test procedures and specifications or facilities of third-party manufacturers with which we contract for clinical and commercial supplies; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the approval policies or regulations of the FDA or other comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This lengthy approval process, as well as the unpredictability of the results of clinical trials, may result in our failing to obtain regulatory approval to market any of our product candidates, which would significantly harm our business, results of operations and prospects. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, even if we obtain approval of our product candidates, regulatory authorities may approve any of our product candidates for fewer or more limited indications than we request, may impose significant limitations in the form of narrow indications, warnings, or a Risk Evaluation and Mitigation Strategy, or REMS. Regulatory authorities may not approve the price we intend to charge for products we may develop, may grant approval contingent on the performance of costly post-marketing clinical trials, or may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of that product candidate. Any of the foregoing scenarios could seriously harm our business. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The clinical trials of our product candidates may not demonstrate safety and efficacy to the satisfaction of the FDA, EMA or other comparable foreign regulatory authorities or otherwise produce positive results. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before obtaining marketing approval from the FDA or other comparable foreign regulatory authorities for the sale of our product candidates, we must complete preclinical development and extensive clinical trials to demonstrate the safety and efficacy of our product candidates. Clinical testing is expensive, difficult to design and implement, can take many years to complete and its ultimate outcome is uncertain. A failure of one or more clinical trials can occur </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at any stage of the process. The outcome of preclinical studies and early-stage clinical trials may not be predictive of the success of later clinical trials. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their drugs. The outcome of preclinical studies and early-stage clinical trials may not be predictive of the success of later clinical trials. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their drugs. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may rely in part on preclinical, clinical and quality data generated by CROs and other third parties for regulatory submissions for our product candidates. While we have or will have agreements governing these third parties&#8217; services, we have limited influence over their actual performance. If these third parties do not make data available to us, or, if applicable, make regulatory submissions in a timely manner, in each case pursuant to our agreements with them, our development programs may be significantly delayed, and we may need to conduct additional studies or collect additional data independently. In either case, our development costs would increase. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not know whether our future clinical trials will begin on time or enroll patients on time, or whether our ongoing and/or future clinical trials will be completed on schedule or at all. Clinical trials can be delayed for a variety of reasons, including delays related to: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the FDA or comparable foreign regulatory authorities disagreeing as to the design or implementation of our clinical studies; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">obtaining regulatory authorizations to commence a trial or reaching a consensus with regulatory authorities on trial design; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">any failure or delay in reaching an agreement with CROs and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">obtaining approval from one or more institutional review boards, or IRBs, or ethics committees; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">IRBs or ethics committees refusing to approve, suspending or terminating the trial at an investigational site, precluding enrollment of additional subjects, or withdrawing their approval of the trial; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">changes to clinical trial protocol; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">clinical sites deviating from trial protocol or dropping out of a trial; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">manufacturing sufficient quantities of product candidate or obtaining sufficient quantities of combination therapies for use in clinical trials; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">subjects failing to enroll or remain in our trial at the rate we expect, or failing to return for post- treatment follow-up;</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">subjects choosing an alternative treatment for the indication for which we are developing our product candidates, or participating in competing clinical trials; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">lack of adequate funding to continue the clinical trial; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">subjects experiencing severe or unexpected drug-related adverse effects; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">occurrence of serious adverse events in trials of the same class of agents conducted by other companies; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">selection of clinical end points that require prolonged periods of clinical observation or analysis of the resulting data; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">a facility manufacturing our product candidates or any of their components being ordered by the FDA or comparable foreign regulatory authorities to temporarily or permanently shut down due to violations of current good manufacturing practice, or cGMP, regulations or similar foreign requirements or other applicable requirements, or infections or cross-contaminations of product candidates in the manufacturing process; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">any changes to our manufacturing process that may be necessary or desired; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">third-party clinical investigators losing the licenses or permits necessary to perform our clinical trials, not performing our clinical trials on our anticipated schedule or consistent with the clinical trial protocol, good clinical practices, or GCP, or other regulatory requirements; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">third-party contractors not performing data collection or analysis in a timely or accurate manner; or </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">third-party contractors becoming debarred or suspended or otherwise penalized by the FDA or other government or regulatory authorities for violations of regulatory requirements, in which case we may need to find a substitute contractor, and we may not be able to use some or all of the data produced by such contractors in support of our marketing applications.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, disruptions caused by the COVID-19 pandemic have caused and we expect will continue to cause difficulties or delays in initiating, enrolling, conducting or completing our planned and ongoing clinical trials. We could also encounter delays if a clinical trial is suspended or terminated by us, by the IRBs of the institutions in which such trials are being conducted, by a Data Safety Monitoring Board for such trial or by the FDA or comparable foreign regulatory authorities. Such authorities may impose such a suspension or termination due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA or comparable foreign regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a drug, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. In addition, changes in regulatory requirements and policies may occur, and we may need to amend clinical trial protocols to comply with these changes. Amendments may require us to resubmit our clinical trial protocols to IRBs or ethics committees for reexamination, which may impact the costs, timing or successful completion of a clinical trial. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, conducting clinical trials in foreign countries, as we may do for our product candidates, presents additional risks that may delay completion of our clinical trials. These risks include the failure of enrolled patients in foreign countries to adhere to clinical protocol as a result of differences in healthcare services or cultural customs, managing additional administrative burdens associated with foreign regulatory schemes, as well as political and economic risks relevant to such foreign countries. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA or comparable foreign regulatory authorities. The FDA or comparable foreign regulatory authority may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected interpretation of the study. The FDA or comparable foreign regulatory authority may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or rejection, of our marketing applications by the FDA or comparable foreign regulatory authority, as the case may be, and may ultimately lead to the denial of marketing approval of one or more of our product candidates. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we experience delays in the completion of, or termination of, any clinical trial of our product candidates, the commercial prospects of our product candidates will be harmed, and our ability to generate product revenues from any of these product candidates will be delayed. Moreover, any delays in completing our clinical trials will increase our costs, slow down our product candidate development and approval process and jeopardize our ability to commence product sales and generate revenues. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, many of the factors that cause, or lead to, termination or suspension of, or a delay in the commencement or completion of, clinical trials may also ultimately lead to the denial of regulatory approval of a product candidate. Any delays to our clinical trials that occur as a result could shorten any period during which we may have the exclusive right to commercialize our product candidates and our competitors may be able to bring products to market before we do, and the commercial viability of our product candidates could be significantly reduced. Any of these occurrences may harm our business, financial condition and prospects significantly. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The outcome of preclinical testing and early clinical trials may not be predictive of the success of later clinical trials, and the results of our clinical trials may not satisfy the requirements of the FDA, EMA or other comparable foreign regulatory authorities. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before obtaining regulatory approvals for the commercial sale of any of our product candidates, we will be required to demonstrate with substantial evidence through well-controlled clinical trials that our product candidates are safe and effective for their intended uses. Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the clinical trial process. Success in preclinical studies and early-stage clinical trials does not mean that future clinical trials will be successful. We do not know whether ZN-c3, ZN-c5, ZN-d5 and ZN-e4 will perform in current or future clinical trials as ZN-c3, ZN-c5, ZN-d5 and ZN-e4 have performed in preclinical studies, or, with respect to ZN-c3, ZN-c5 and ZN-e4, ongoing clinical trials to date. Product candidates in later-stage clinical trials may fail to demonstrate sufficient safety and efficacy to the satisfaction of the FDA, EMA and other comparable foreign regulatory authorities despite having progressed through preclinical studies and early-stage clinical trials. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some instances, there can be significant variability in safety and efficacy results between different clinical trials of the same product candidate due to numerous factors, including changes in trial protocols, differences in size and type of the patient populations, differences in and adherence to the dosing regimen and other trial protocols and the rate of dropout among clinical trial participants. Patients treated with our product candidates may also be undergoing surgical, radiation and chemotherapy treatments and may be using other approved products or investigational new drugs, which can cause side effects or adverse events that are unrelated to our product candidate. As a result, assessments of efficacy can vary widely for a particular patient, and from patient to patient and site to site within a clinical trial. This subjectivity can increase the uncertainty of, and adversely impact, our clinical trial outcomes. We do not know whether any clinical trials we may conduct will demonstrate consistent or adequate efficacy and safety sufficient to obtain marketing approval to market our product candidates. Most product candidates that begin clinical trials are never approved by regulatory authorities for commercialization. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have limited experience in designing clinical trials and may be unable to design and execute a clinical trial to support marketing approval. We cannot be certain that our planned clinical trials or any other future clinical trials will be successful. Additionally, any safety concerns observed in any one of our clinical trials in our targeted indications could limit the prospects for regulatory approval of our product candidates in those and other indications, which could seriously harm our business. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses and many companies that believed their product candidates performed satisfactorily in preclinical studies and clinical trials nonetheless failed to obtain FDA or comparable foreign regulatory authority approval. We cannot guarantee that the FDA or foreign regulatory authorities will interpret trial results as we do, and more trials could be required before we are able to submit applications seeking approval of our product candidates. To the extent that the results of the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">trials are not satisfactory to the FDA or foreign regulatory authorities for support of a marketing application, we may be required to expend significant resources, which may not be available to us, to conduct additional trials in support of potential approval of our product candidates. Even if regulatory approval is secured for any of our product candidates, the terms of such approval may limit the scope and use of our product candidate, which may also limit its commercial potential. Furthermore, the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval, which may lead to the FDA or comparable foreign regulatory authorities delaying, limiting or denying approval of our product candidates. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interim, initial, &#8220;topline&#8221;, and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may publicly disclose preliminary or topline data from our preclinical studies and clinical trials, which is based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular study or trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the topline or preliminary results that we report may differ from future results of the same studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Topline data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, topline data should be viewed with caution until the final data are available. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may also disclose interim data from our preclinical studies and clinical trials. Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available or as patients from our clinical trials continue other treatments for their disease. Adverse differences between preliminary or interim data and final data could significantly harm our business prospects. Further, disclosure of interim data by us or by our competitors could result in volatility in the price of our common stock. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of the particular product candidate or product and our company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is based on what is typically extensive information, and you or others may not agree with what we determine is material or otherwise appropriate information to include in our disclosure. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the interim, topline, or preliminary data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, our product candidates may be harmed, which could harm our business, operating results, prospects or financial condition. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if approved, our product candidates may not achieve adequate market acceptance among physicians, patients, healthcare payors and others in the medical community necessary for commercial success. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if our product candidates receive regulatory approval, they may not gain adequate market acceptance among physicians, patients, healthcare payors and others in the medical community. The degree of market acceptance of any of our approved product candidates will depend on a number of factors, including: </span></div><div style="margin-bottom:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">the efficacy and safety profile as demonstrated in clinical trials compared to alternative treatments; </span></div><div style="margin-bottom:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">the timing of market introduction of the product candidate as well as competitive products; </span></div><div style="margin-bottom:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">the clinical indications for which the product candidate is approved; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">restrictions on the use of our product candidates, such as boxed warnings or contraindications in labeling, or a REMS, if any, which may not be required of alternative treatments and competitor products; </span></div><div style="margin-bottom:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">the potential and perceived advantages of product candidates over alternative treatments; </span></div><div style="margin-bottom:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">the cost of treatment in relation to alternative treatments; </span></div><div style="margin-bottom:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">the availability of coverage and adequate reimbursement, as well as pricing, by third-party payors, including government authorities; </span></div><div style="margin-bottom:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">the availability of the approved product candidate for use as a combination therapy; </span></div><div style="margin-bottom:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">relative convenience and ease of administration; </span></div><div style="margin-bottom:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies; </span></div><div style="margin-bottom:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">the effectiveness of sales and marketing efforts; </span></div><div style="margin-bottom:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">unfavorable publicity relating to our products or product candidates or similar approved products or product candidates in development by third parties; and </span></div><div style="margin-bottom:12pt;padding-left:67.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">the approval of other new therapies for the same indications.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our product candidates is approved but does not achieve an adequate level of acceptance by physicians, hospitals, healthcare payors and patients, we may not generate or derive sufficient revenue from that product candidate and our financial results could be negatively impacted. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we experience delays or difficulties in the enrollment and/or maintenance of patients in clinical trials, our clinical development activities could be delayed or otherwise adversely affected. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient enrollment is a significant factor in the timing of clinical trials, and the timing of our clinical trials depends, in part, on the speed at which we can recruit patients to participate in our trials, as well as completion of required follow-up periods. We may not be able to initiate or continue clinical trials for our product candidates if we are unable to locate and enroll a sufficient number of eligible patients to participate in these trials to such trial&#8217;s conclusion as required by the FDA or other comparable foreign regulatory authorities. Additionally, certain clinical trials for future product candidates may be focused on indications with relatively small patient populations, which may further limit enrollment of eligible patients or may result in slower enrollment than we anticipate. The eligibility criteria of our clinical trials, once established, may further limit the pool of available trial participants. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient enrollment may also be affected if our competitors have ongoing clinical trials for product candidates that are under development for the same indications as our product candidates, and patients who would otherwise be eligible for our clinical trials instead enroll in clinical trials of our competitors&#8217; product candidates. Patient enrollment for any of our clinical trials may be affected by other factors, including: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">size and nature of the patient population; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">severity of the disease under investigation; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">availability and efficacy of approved drugs for the disease under investigation; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">patient eligibility criteria for the trial in question as defined in the protocol; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">perceived risks and benefits of the product candidate under study; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">clinicians&#8217; and patients&#8217; perceptions as to the potential advantages of the product candidate being studied in relation to other available therapies, including any new products that may be approved for the indications we are investigating; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">efforts to facilitate timely enrollment in clinical trials; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">patient referral practices of physicians; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the ability to monitor patients adequately during and after treatment; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">proximity and availability of clinical trial sites for prospective patients; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">continued enrollment of prospective patients by clinical trial sites; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the risk that patients enrolled in clinical trials will drop out of the trials before completion or, because they may be late-stage cancer patients, will not survive the full terms of the clinical trials.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our inability to enroll a sufficient number of patients for our clinical trials would result in significant delays or may require us to abandon one or more clinical trials altogether. Enrollment delays in our clinical trials may result in increased development costs for our product candidates and jeopardize our ability to obtain marketing approval for the sale of our product candidates. Furthermore, even if we are able to enroll a sufficient number of patients for our clinical trials, we may have difficulty maintaining enrollment of such patients in our clinical trials. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We intend to develop ZN-c3, ZN-c5, ZN-d5, ZN-e4 and potentially other product candidates in combination with other therapies, which exposes us to additional risks. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to develop ZN-c3, ZN-c5, ZN-d5, ZN-e4 and likely other future product candidates in combination with one or more other approved or unapproved therapies to treat cancer or other diseases. For example, we are currently evaluating ZN-c3 in combination with the approved agent niraparib, and ZN-c5 in combination with certain approved agents including palbociclib and abemaciclib. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if any product candidate we develop were to receive marketing approval or be commercialized for use in combination with other existing therapies, we would continue to be subject to the risks that the FDA or comparable foreign regulatory authorities outside of the United States could revoke approval of the therapy used in combination with our product or that safety, efficacy, manufacturing or supply issues could arise with any of those existing therapies. If the therapies we use in combination with our product candidates are replaced as the standard of care for the indications we choose for any of our product candidates, the FDA or comparable foreign regulatory authorities may require us to conduct additional clinical trials. The occurrence of any of these risks could result in our own products, if approved, being removed from the market or being less successful commercially. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also may choose to evaluate ZN-c3, ZN-c5, ZN-d5, ZN-e4 or any other future product candidates in combination with one or more cancer therapies that have not yet been approved for marketing by the FDA or comparable foreign regulatory authorities. We will not be able to market and sell ZN-c3, ZN-c5, ZN-d5, ZN-e4 or any product candidate we develop in combination with an unapproved cancer therapy for a combination indication if that unapproved therapy does not ultimately obtain marketing approval either alone or in combination with our product. In addition, unapproved cancer therapies face the same risks described with respect to our product candidates currently in development and clinical trials, including the potential for serious adverse effects, delay in their clinical trials and lack of FDA approval. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA or comparable foreign regulatory authorities do not approve these other drugs or revoke their approval of, or if safety, efficacy, quality, manufacturing or supply issues arise with, the drugs we choose to evaluate in </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">combination with our product candidate we develop, we may be unable to obtain approval of or market such combination therapy. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the market opportunity for any product candidate that we or our strategic partners develop is smaller than we believe, our revenue may be adversely affected and our business may suffer. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to initially focus our product candidate development on treatments for various oncology indications. Our projections of addressable patient populations that may benefit from treatment with our product candidates are based on our estimates. These estimates, which have been derived from a variety of sources, including scientific literature, surveys of clinics, patient foundations and market research, may prove to be incorrect. Further, new studies may change the estimated incidence or prevalence of these cancers. Additionally, the potentially addressable patient population for our product candidates may not ultimately be amenable to treatment with our product candidates. Our market opportunity may also be limited by future competitor treatments that enter the market. If any of our estimates prove to be inaccurate, the market opportunity for any product candidate that we or our strategic partners develop could be significantly diminished and have an adverse material impact on our business. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face significant competition, and if our competitors develop and market technologies or products more rapidly than we do or that are more effective, safer or less expensive than the product candidates we develop, our commercial opportunities will be negatively impacted. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The biotechnology and pharmaceutical industries are characterized by rapidly advancing technologies, intense competition and a strong emphasis on proprietary and novel products and product candidates. Our competitors have developed, are developing or may develop products, product candidates and processes competitive with our product candidates. Any product candidates that we successfully develop and commercialize will compete with existing therapies and new therapies that may become available in the future. We believe that a significant number of products are currently under development, and may become commercially available in the future, for the treatment of conditions for which we may attempt to develop product candidates. In addition, our products may need to compete with off-label drugs used by physicians to treat the indications for which we seek approval. This may make it difficult for us to replace existing therapies with our products. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, there is intense competition in the fields of oncology we are pursuing. We have competitors both in the United States and internationally, including major multinational pharmaceutical companies, established biotechnology companies, specialty pharmaceutical companies, emerging and start-up companies, universities and other research institutions. We also compete with these organizations to recruit management, scientists and clinical development personnel, which could negatively affect our level of expertise and our ability to execute our business plan. We will also face competition in establishing clinical trial sites, enrolling subjects for clinical trials and in identifying and in-licensing new product candidates. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have chosen to initially address well-validated biochemical targets, and therefore expect to face competition from existing products and products in development for each of our product candidates. There are a large number of companies developing or marketing treatments for cancer, including many major pharmaceutical and biotechnology companies. Many of these current and potential competitors have significantly greater financial, manufacturing, marketing, drug development, technical and human resources and commercial expertise than we do. Large pharmaceutical and biotechnology companies, in particular, have extensive experience in clinical testing, obtaining regulatory approvals, recruiting patients and manufacturing biotechnology products. These companies also have significantly greater research and marketing capabilities than we do and may also have products that have been approved or are in late stages of development, and collaborative arrangements in our target markets with leading companies and research institutions. Established pharmaceutical and biotechnology companies may also invest heavily to accelerate discovery and development of novel compounds or to in-license novel compounds that could make the product candidates that we develop obsolete. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies, as well as in acquiring technologies complementary to, or necessary for, our programs. As a result of all of these factors, our competitors may succeed in obtaining approval from the FDA or other comparable foreign regulatory authorities or in discovering, developing and commercializing products in our field before we do. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe effects, are more convenient, have a broader label, are marketed more effectively, are reimbursed or are less expensive than any products that we may develop. Our competitors also may obtain marketing approval from the FDA or other comparable foreign regulatory authorities for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. Even if the product candidates we develop achieve marketing approval, they may be priced at a significant premium over competitive products if any have been approved by then, resulting in reduced competitiveness. Technological advances or products developed by our competitors may render our technologies or product candidates obsolete, less competitive or not economical. If we are unable to compete effectively, our opportunity to generate revenue from the sale of our products we may develop, if approved, could be adversely affected. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may expend our limited resources to pursue a particular product candidate or indication and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we have limited financial and managerial resources, we focus on research programs, therapeutic platforms and product candidates that we identify for specific indications. As a result, we may forego or delay pursuit of opportunities with other therapeutic platforms or product candidates or for other indications that later prove to have greater commercial potential or a greater likelihood of success. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs, therapeutic platforms and product candidates for specific indications may not yield any commercially viable products. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in methods of product candidate manufacturing or formulation may result in additional costs or delay. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As product candidates progress through preclinical and clinical trials to marketing approval and commercialization, it is common that various aspects of the development program, such as manufacturing methods and formulation, are altered along the way in an effort to optimize yield and manufacturing batch size, minimize costs and achieve consistent quality and results. Such changes carry the risk that they will not achieve these intended objectives. Any of these changes could cause our product candidates to perform differently and affect the results of planned clinical trials or other future clinical trials conducted with the altered materials. This could delay completion of clinical trials, require the conduct of bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay approval of our product candidates and jeopardize our ability to commercialize our product candidates, if approved, and generate revenue. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business entails a significant risk of product liability and if we are unable to obtain sufficient insurance coverage such inability could have an adverse effect on our business and financial condition. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business exposes us to significant product liability risks inherent in the development, testing, manufacturing and marketing of therapeutic treatments. Product liability claims could delay or prevent completion of our development programs. If we succeed in marketing products, such claims could result in an FDA or other regulatory authority investigation of the safety and effectiveness of our products, our manufacturing processes and facilities or our marketing programs. FDA or other regulatory authority investigations could potentially lead to a recall of our products or more serious enforcement action, limitations on the approved indications for which they may be used or suspension or withdrawal of approvals. Regardless of the merits or eventual outcome, liability claims may also result in decreased demand for our products, injury to our reputation, costs to defend the related litigation, a diversion of management&#8217;s time and our resources and substantial monetary awards to trial participants or patients. We currently have product liability insurance that we believe is appropriate for our stage of development and may need to obtain higher levels prior to marketing any of our product candidates, if approved. Any insurance we have or may obtain may not provide sufficient coverage against potential liabilities. Furthermore, clinical trial and product liability insurance is becoming increasingly expensive. As a result, we may be unable to obtain sufficient insurance at a reasonable cost to protect us against losses caused by product liability claims that could have an adverse effect on our business and financial condition. Similar challenges to obtaining coverage and reimbursement, applicable to pharmaceutical or biological products, will apply to companion diagnostics that we or our collaborators may develop. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any product candidates we develop may become subject to unfavorable third-party coverage and reimbursement practices, as well as pricing regulations. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability and extent of coverage and adequate reimbursement by third-party payors, including government health administration authorities, private health coverage insurers, managed care organizations and other third-party payors is essential for most patients to be able to afford expensive treatments. Sales of any of our product candidates that receive marketing approval will depend substantially, both in the United States and internationally, on the extent to which the costs of our product candidates will be covered and reimbursed by third-party payors. If reimbursement is not available, or is available only to limited levels, we may not be able to successfully commercialize our product candidates. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize an adequate return on our investment. Coverage and reimbursement may impact the demand for, or the price of, any product candidate for which we obtain marketing approval. If coverage and reimbursement are not available or reimbursement is available only to limited levels, we may not successfully commercialize any product candidate for which we obtain marketing approval. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is significant uncertainty related to third-party payor coverage and reimbursement of newly approved products. In the United States, for example, principal decisions about reimbursement for new products are typically made by the Centers for Medicare&#160;&amp; Medicaid Services, or CMS, an agency within the U.S. Department of Health and Human Services, or HHS. CMS decides whether and to what extent a new product will be covered and reimbursed under Medicare, and private third-party payors often follow CMS&#8217;s decisions regarding coverage and reimbursement to a substantial degree. However, one third-party payor&#8217;s determination to provide coverage for a product candidate does not assure that other payors will also provide coverage for the product candidate. As a result, the coverage determination process is often time-consuming and costly. This process will require us to provide scientific and clinical support for the use of our products to each third-party payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the prices charged for medical products. Further, such payors are increasingly challenging the price, examining the medical necessity and reviewing the cost effectiveness of medical product candidates. There may be especially significant delays in obtaining coverage and reimbursement for newly approved drugs. Third-party payors may limit coverage to specific product candidates on an approved list, known as a formulary, which might not include all FDA-approved drugs for a particular indication. We may need to conduct expensive pharmaco-economic studies to demonstrate the medical necessity and cost effectiveness of our products. Nonetheless, our product candidates may not be considered medically necessary or cost effective. We cannot be sure that coverage and reimbursement will be available for any product that we commercialize and, if reimbursement is available, what the level of reimbursement will be. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the United States, international operations are generally subject to extensive governmental price controls and other market regulations, and we believe the increasing emphasis on cost containment initiatives in Europe, Canada and other countries has and will continue to put pressure on the pricing and usage of therapeutics such as our product candidates. In many countries, particularly the member states of the European Union, or EU, medical product prices are subject to varying price control mechanisms as part of national health systems. In these countries, pricing negotiations with governmental authorities can take considerable time after a product receives marketing authorization. To obtain reimbursement or pricing approval in some countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of our product candidate to other available therapies. In general, product prices under such systems are substantially lower than in the United States. Other countries allow companies to fix their own prices for products, but monitor and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our product candidates. Accordingly, in markets outside the United States, the reimbursement for our products may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenue and profits. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to establish or sustain coverage and adequate reimbursement for any future product candidates from third-party payors, the adoption of those products and sales revenue will be adversely affected, which, in turn, could adversely affect the ability to market or sell those product candidates, if approved. Coverage policies and third-party payor reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Regulatory Approval and Other Legal Compliance Matters </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to obtain U.S. or foreign regulatory approvals and, as a result, may be unable to commercialize our product candidates. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidates are subject to extensive governmental regulations relating to, among other things, research, testing, development, manufacturing, safety, efficacy, approval, recordkeeping, reporting, labeling, storage, packaging, advertising and promotion, pricing, marketing and distribution of drugs. Rigorous preclinical testing and clinical trials and an extensive regulatory approval process must be successfully completed in the United States and in many foreign jurisdictions before a new drug can be marketed. Satisfaction of these and other regulatory requirements is costly, time consuming, uncertain and subject to unanticipated delays. We cannot provide any assurance that any product candidate we may develop will progress through required clinical testing and obtain the regulatory approvals necessary for us to begin selling them. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not conducted, managed or completed large-scale or pivotal clinical trials nor managed the regulatory approval process with the FDA or any other regulatory authority. The time required to obtain approvals from the FDA and other regulatory authorities is unpredictable, and requires successful completion of extensive clinical trials which typically takes many years, depending upon the type, complexity and novelty of the product candidate. The standards that the FDA and its foreign counterparts use when evaluating clinical trial data can and often changes during drug development, which makes it difficult to predict with any certainty how they will be applied. We may also encounter unexpected delays or increased costs due to new government regulations, including future legislation or administrative action, or changes in FDA policy during the period of drug development, clinical trials and FDA regulatory review. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any delay or failure in seeking or obtaining required approvals would have a material and adverse effect on our ability to generate revenue from the particular product candidate for which we developing and seeking approval. Furthermore, any regulatory approval to market a drug may be subject to significant limitations on the approved uses or indications for which we may market the drug or the labeling or other restrictions. In addition, the FDA has the authority to require a REMS as part of approving a NDA, or after approval, which may impose further requirements or restrictions on the distribution or use of an approved drug. These requirements or restrictions might include limiting prescribing to certain physicians or medical centers that have undergone specialized training, limiting treatment to patients who meet certain safe-use criteria and requiring treated patients to enroll in a registry. These limitations and restrictions may significantly limit the size of the market for the drug and affect reimbursement by third-party payors. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to numerous foreign regulatory requirements governing, among other things, the conduct of clinical trials, manufacturing and marketing authorization, pricing and third-party reimbursement. The foreign regulatory approval process varies among countries, and generally includes all of the risks associated with FDA approval described above as well as risks attributable to the satisfaction of local regulations in foreign jurisdictions. Moreover, the time required to obtain approval may differ from that required to obtain FDA approval. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our current or future product candidates may cause significant adverse events, toxicities or other undesirable side effects when used alone or in combination with other approved products or investigational new drugs that may result in a safety profile that could inhibit regulatory approval, prevent market acceptance, limit their commercial potential or result in significant negative consequences. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As is the case with pharmaceuticals generally, it is likely that there may be side effects and adverse events associated with our product candidates&#8217; use. Results of our clinical trials could reveal a high and unacceptable severity and prevalence of side effects or unexpected characteristics. Undesirable side effects caused by our product candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or comparable foreign regulatory authorities. The drug-related side effects could affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability claims. Any of these occurrences may harm our business, financial condition and prospects significantly. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our product candidates are associated with undesirable side effects or have unexpected characteristics in preclinical studies or clinical trials when used alone or in combination with other approved products or investigational new drugs we may need to interrupt, delay or abandon their development or limit development to more narrow uses or subpopulations in which the undesirable side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective. Treatment-related side effects could also affect patient recruitment or the ability of enrolled subjects to complete the trial, or result in potential product liability claims. Any of these occurrences may prevent us from achieving or maintaining market acceptance of the affected product candidate and may harm our business, financial condition and prospects significantly. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patients in our ongoing and planned clinical trials may in the future suffer significant adverse events or other side effects not observed in our preclinical studies or previous clinical trials. Some of our product candidates, may be used as chronic therapies or be used in pediatric populations, for which safety concerns may be particularly scrutinized by regulatory agencies. In addition, if our product candidates are used in combination with other therapies, our product candidates may exacerbate adverse events associated with the therapy. Patients treated with our product candidates may also be undergoing surgical, radiation and chemotherapy treatments, which can cause side effects or adverse events that are unrelated to our product candidate, but may still impact the success of our clinical trials. The inclusion of critically ill patients in our clinical trials may result in deaths or other adverse medical events due to other therapies or medications that such patients may be using or due to the gravity of such patients&#8217; illnesses. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If significant adverse events or other side effects are observed in any of our current or future clinical trials, we may have difficulty recruiting patients to the clinical trials, patients may drop out of our trials, or we may be required to abandon the trials or our development efforts of that product candidate altogether. We, the FDA, other comparable regulatory authorities or an IRB may suspend clinical trials of a product candidate at any time for various reasons, including a belief that subjects in such trials are being exposed to unacceptable health risks or adverse side effects. Some potential therapeutics developed in the biotechnology industry that initially showed therapeutic promise in early-stage trials have later been found to cause side effects that prevented their further development. Even if the side effects do not preclude the product candidate from obtaining or maintaining marketing approval, undesirable side effects may inhibit market acceptance due to its tolerability versus other therapies. Any of these developments could materially harm our business, financial condition and prospects. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, if any of our product candidates obtains marketing approval, toxicities associated with such product candidates and not seen during clinical testing may also develop after such approval and lead to a requirement to conduct additional clinical safety trials, additional contraindications, warnings and precautions being added to the drug label, significant restrictions on the use of the product or the withdrawal of the product from the market. We cannot predict whether our product candidates will cause toxicities in humans that would preclude or lead to the revocation of regulatory approval based on preclinical studies or early-stage clinical trials. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The FDA, EMA and other comparable foreign regulatory authorities may not accept data from trials conducted in locations outside of their jurisdiction. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may choose to conduct international clinical trials in the future. The acceptance of study data by the FDA, EMA or other comparable foreign regulatory authority from clinical trials conducted outside of their respective jurisdictions may be subject to certain conditions. In cases where data from foreign clinical trials are intended to serve as the basis for marketing approval in the United States, the FDA will generally not approve the application on the basis of foreign data alone unless (1)&#160;the data are applicable to the United States population and United States medical practice; (2)&#160;the trials are performed by clinical investigators of recognized competence and pursuant to current GCP requirements; and (3)&#160;the FDA is able to validate the data through an on-site inspection or other appropriate mean. Additionally, the FDA&#8217;s clinical trial requirements, including the adequacy of the patient population studied and statistical powering, must be met. In addition, such foreign trials would be subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA, EMA or any applicable foreign regulatory authority will accept data from trials conducted outside of its applicable jurisdiction. If the FDA, EMA or any applicable foreign regulatory authority does not accept such data, it would result in the need for additional trials, which would be costly and time-consuming and delay aspects of our business plan, and which may result in our product candidates not receiving approval for commercialization in the applicable jurisdiction. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of our product candidates in other jurisdictions. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory approval in any other jurisdiction. For example, even if the FDA grants marketing approval of a product candidate, comparable regulatory authorities in foreign jurisdictions must also approve the manufacturing, marketing and promotion and reimbursement of the product candidate in those countries. However, a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory approval process in others. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from those in the United States, including additional preclinical studies or clinical trials as clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the United States, a product candidate must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we intend to charge for our products is also subject to approval. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Obtaining foreign regulatory approvals and establishing and maintaining compliance with foreign regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of our products in certain countries. If we or any future collaborator fail to comply with the regulatory requirements in international markets or fail to receive applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of our product candidates will be harmed. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if our product candidates receive regulatory approval, they will be subject to significant post-marketing regulatory requirements and oversight. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any regulatory approvals that we may receive for our product candidates will require the submission of reports to regulatory authorities and surveillance to monitor the safety and efficacy of the product candidate, may contain significant limitations related to use restrictions for specified age groups, warnings, precautions or contraindications, and may include burdensome post-approval study or risk management requirements. For example, the FDA may require a REMS in order to approve our product candidates, which could entail requirements for a medication guide, physician training and communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. In addition, if the FDA or foreign regulatory authorities approve our product candidates, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion, import, export and recordkeeping for our product candidates will be subject to extensive and ongoing regulatory requirements. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as on-going compliance with cGMPs or similar foreign requirements and GCP for any clinical trials that we conduct post-approval. In addition, manufacturers of drug products and their facilities are subject to continual review and periodic, unannounced inspections by the FDA and other regulatory authorities for compliance with cGMP regulations or similar foreign requirements and standards. If we or a regulatory agency discover previously unknown problems with a product, such as adverse events of unanticipated severity or frequency, or problems with the facilities where the product is manufactured, a regulatory agency may impose restrictions on that product, the manufacturing facility or us, including requiring recall or withdrawal of the product from the market or suspension of manufacturing. In addition, failure to comply with FDA and other comparable foreign regulatory requirements may subject our company to administrative or judicially imposed sanctions, including: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">delays in or the rejection of product approvals; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">restrictions on our ability to conduct clinical trials, including full or partial clinical holds on ongoing or planned trials; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">restrictions on the products, manufacturers or manufacturing process; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">warning or untitled letters; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">civil and criminal penalties; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">injunctions; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">suspension or withdrawal of regulatory approvals; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">product seizures, detentions or import bans; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">voluntary or mandatory product recalls and publicity requirements; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">total or partial suspension of production; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">imposition of restrictions on operations, including costly new manufacturing requirements.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any event or penalty described above may inhibit our ability to commercialize our product candidates and generate revenue and could require us to expend significant time and resources in response and could generate negative publicity. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA&#8217;s and other regulatory authorities&#8217; policies may change, and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. For example, the results of the 2020 U.S. Presidential Election may impact our business and industry. Namely, the previous administration took several executive actions, including the issuance of a number of Executive Orders, that could impose significant burdens on, or otherwise materially delay, the FDA&#8217;s ability to engage in routine oversight activities such as implementing statutes through rulemaking, issuance of guidance, and review and approval of marketing applications. It is difficult to predict whether or how these orders will be implemented, or whether they will be rescinded and replaced under the current administration. The policies and priorities of the new administration are unknown and could materially impact the regulations governing our product candidates. In addition, the EU has adopted the Clinical Trials Regulation, or CTR, in April 2014, which is expected to become applicable by early 2022. The CTR will be directly applicable in all EU member states, repealing the current Clinical Trials Directive. Conduct of all clinical trials performed in the European Union will continue to be bound by currently applicable provisions until the new CTR becomes applicable. The extent to which ongoing clinical trials will be governed by the CTR will depend on when the CTR becomes applicable and on the duration of the individual clinical trial. If a clinical trial continues for more than three years from the day on which the CTR becomes applicable the CTR will at that time begin to apply to the clinical trial. The CTR harmonizes the assessment and supervision processes for clinical trials throughout the EU via a Clinical Trials Information System, which will notably contain a centralized EU portal and database. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may be subject to enforcement action and we may not achieve or sustain profitability.  </span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The FDA and other regulatory agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our product candidates are approved and we are found to have improperly promoted off-label uses of those products, we may become subject to significant liability. The FDA and other regulatory agencies strictly regulate the promotional claims that may be made about prescription products, such as our product candidates, if approved. In particular, a product may not be promoted for uses that are not approved by the FDA or such other regulatory agencies as reflected in the product&#8217;s approved labeling. If we receive marketing approval for a product candidate, physicians may nevertheless prescribe it to their patients in a manner that is inconsistent with the approved label. If we are found to have promoted such off-label uses, we may become subject to significant liability. The U.S. federal government has levied large civil and criminal fines against companies for alleged improper promotion of off-label use and has enjoined several companies from engaging in off-label promotion. The&#160;FDA has also requested that companies enter into consent decrees or permanent injunctions under which specified promotional conduct is </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">changed or curtailed. If we cannot successfully manage the promotion of our product candidates, if approved, we could become subject to significant liability, which would materially adversely affect our business and financial condition. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are required by the FDA or similar regulatory authorities to obtain approval (or clearance, or certification) of a companion diagnostic test in connection with approval of any of our product candidates, and we do not obtain or face delays in obtaining approval (or clearance, or certification) of a diagnostic device, we will not be able to commercialize such product candidate and our ability to generate revenue will be materially impaired. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If safe and effective use of any of our product candidates depends on an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic that is not otherwise commercially available, then the FDA generally will require approval or clearance of that diagnostic, known as a companion diagnostic, at the same time that the FDA approves our product candidates if at all. According to FDA guidance, if the FDA determines that a companion diagnostic device is essential to the safe and effective use of a novel therapeutic product or indication, the FDA generally will not approve the therapeutic product or new therapeutic product indication if the companion diagnostic is not also approved or cleared for that indication. If a satisfactory companion diagnostic is not commercially available, we may be required to create or obtain one that would be subject to regulatory approval requirements. The process of obtaining or creating such diagnostic is time consuming and costly. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companion diagnostics are developed in conjunction with clinical programs for the associated product and are subject to regulation as medical devices by the FDA and comparable regulatory authorities, and, to date, the FDA has generally required premarket approval of all companion diagnostics for cancer therapies. The approval of a companion diagnostic as part of the therapeutic product&#8217;s labeling limits the use of the therapeutic product to only those patients who express the specific genetic alteration that the companion diagnostic was developed to detect. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA or a comparable regulatory authority requires approval, clearance or certification of a companion diagnostic for any of our product candidates, whether before or after it obtains marketing approval, we, and/or future collaborators, may encounter difficulties in developing and obtaining approval for such product candidate. Any delay or failure by us or third-party collaborators to develop or obtain regulatory approval, clearance or certification of a companion diagnostic could delay or prevent approval or continued marketing of such product candidate. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also experience delays in developing a sustainable, reproducible and scalable manufacturing process for the companion diagnostic or in transferring that process to commercial partners or negotiating insurance reimbursement plans, all of which may prevent us from completing our clinical trials or commercializing our product candidate, if approved, on a timely or profitable basis, if at all. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Approval, clearance or certification of companion diagnostics may be subject to further legislative or regulatory reforms notably in the EU. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 25, 2017, the new In Vitro Medical Devices Regulation (2017/746, or IVDR) entered into force. The IVDR repeals and replaces the EU In Vitro Diagnostic Medical Devices Directive. Unlike directives, which must be implemented into the national laws of the EU member, regulations are directly applicable, i.e., without the need for adoption of EU member states laws implementing them, in all EU member states and are intended to eliminate current differences in the regulation of medical devices among EU member states. The IVDR, among other things, is intended to establish a uniform, transparent, predictable and sustainable regulatory framework across the EU for medical devices and ensure a high level of safety and health while supporting innovation. The IVDR will, however, only become applicable in May 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The regulation of companion diagnostics will be subject to further requirements as of May 2022. The IVDR introduces a new classification system for companion diagnostics which are now specifically defined as diagnostic tests that support the safe and effective use of a specific medicinal product, by identifying patients that are suitable or unsuitable for treatment. Companion diagnostics will have to undergo a conformity assessment by a notified body. Before it can issue a CE certificate, the notified body must seek a scientific opinion from the EMA on the suitability of the companion diagnostic to the medicinal product concerned if the medicinal product falls exclusively within the scope of the centralized procedure for the authorization of medicines, or the medicinal product is already </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">authorized through the centralized procedure, or a marketing authorization application for the medicinal product has been submitted through the centralized procedure. For other substances, the notified body can seek the opinion from a national competent authorities or the EMA.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These modifications may make it more difficult and costly for us to obtain regulatory clearances or approvals or certifications for our companion diagnostics or to manufacture, market or distribute our products after clearance or approval or certification is obtained.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruptions at the FDA, the SEC and other government agencies caused by funding shortages or global health concerns could hinder their ability to hire and retain key leadership and other personnel, or otherwise prevent new or modified products from being developed, approved or commercialized in a timely manner or at all, or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability of the FDA and other regulatory authorities to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes, and other events that may otherwise affect the FDA&#8217;s ability to perform routine functions. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the Securities and Exchange Commission, or the SEC, and other government agencies on which our operations may rely, including those that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Disruptions at the FDA and other agencies may also slow the time necessary for new drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, in recent years, including in 2018 and 2019, the U.S. government shut down several times and certain regulatory agencies, such as the FDA and the SEC, had to furlough critical employees and stop critical activities. Separately, in response to the COVID-19 pandemic, on March&#160;10, 2020 the FDA announced its intention to postpone most inspections of foreign manufacturing facilities and products, and on March&#160;18, 2020, the FDA temporarily postponed routine surveillance inspections of domestic manufacturing facilities. Subsequently, on July 10, 2020, the FDA announced its intention to resume certain on-site inspections of domestic manufacturing facilities subject to a risk-based prioritization system. The FDA intends to use this risk-based assessment system to identify the categories of regulatory activity that can occur within a given geographic area, ranging from mission critical inspections to resumption of all regulatory activities. Additionally, on April 15, 2021, the FDA issued a guidance document in which the FDA described its plans to conduct voluntary remote interactive evaluations of certain drug manufacturing facilities and clinical research sites. According to the guidance, the FDA intends to request such remote interactive evaluations in situations where an in-person inspection would not be prioritized, deemed mission-critical, or where direct inspection is otherwise limited by travel restrictions, but where the FDA determines that remote evaluation would be appropriate. Regulatory authorities outside the United States may adopt similar restrictions or other policy measures in response to the COVID-19 pandemic. If a prolonged government shutdown occurs, or if global health concerns continue to prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, in our operations as a public company, future government shutdowns or delays could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations. </span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may attempt to secure approval from the FDA or comparable foreign regulatory authorities through the use of accelerated approval pathways. If we are unable to obtain such approval, we may be required to conduct additional preclinical studies or clinical trials beyond those that we contemplate, which could increase the expense of obtaining, and delay the receipt of, necessary marketing approvals. Even if we receive accelerated approval from the FDA, if our confirmatory trials do not verify clinical benefit, or if we do not comply with rigorous post-marketing requirements, the FDA may seek to withdraw accelerated approval. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may in the future seek an accelerated approval for our one or more of our product candidates. Under the accelerated approval program, the FDA may grant accelerated approval to a product candidate designed to treat a serious or life-threatening condition that provides meaningful therapeutic benefit over available therapies upon a </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determination that the product candidate has an effect on a surrogate endpoint or intermediate clinical endpoint that is reasonably likely to predict clinical benefit. The FDA considers a clinical benefit to be a positive therapeutic effect that is clinically meaningful in the context of a given disease, such as irreversible morbidity or mortality. For the purposes of accelerated approval, a surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign, or other measure that is thought to predict clinical benefit, but is not itself a measure of clinical benefit. An intermediate clinical endpoint is a clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit. The accelerated approval pathway may be used in cases in which the advantage of a new drug over available therapy may not be a direct therapeutic advantage, but is a clinically important improvement from a patient and public health perspective. If granted, accelerated approval is usually contingent on the sponsor&#8217;s agreement to conduct, in a diligent manner, additional post-approval confirmatory studies to verity and describe the drug&#8217;s clinical benefit. If such post-approval studies fail to confirm the drug&#8217;s clinical benefit, the FDA may withdraw its approval of the drug. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to seeking accelerated approval for any of our product candidates, we intend to seek feedback from the FDA and will otherwise evaluate our ability to seek and receive accelerated approval. There can be no assurance that after our evaluation of the feedback and other factors we will decide to pursue or submit an NDA for accelerated approval or any other form of expedited development, review or approval. Similarly, there can be no assurance that after subsequent FDA feedback we will continue to pursue or apply for accelerated approval or any other form of expedited development, review or approval, even if we initially decide to do so. Furthermore, if we decide to submit an application for accelerated approval or receive an expedited regulatory designation (e.g., breakthrough therapy designation) for our product candidates, there can be no assurance that such submission or application will be accepted or that any expedited development, review or approval will be granted on a timely basis, or at all. The FDA or other comparable foreign regulatory authorities could also require us to conduct further studies prior to considering our application or granting approval of any type. A failure to obtain accelerated approval or any other form of expedited development, review or approval for our product candidate would result in a longer time period to commercialization of such product candidate, could increase the cost of development of such product candidate and could harm our competitive position in the marketplace. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may face difficulties from changes to current regulations and future legislation. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Existing regulatory policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For example, in March 2010, the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively the ACA, was passed, which substantially changes the way healthcare is financed by both the government and private insurers, and significantly impacts the U.S. pharmaceutical industry. Since its enactment, there have been judicial, executive and Congressional challenges to certain aspects of the ACA. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA without specifically ruling on the constitutionality of the ACA. Prior to the Supreme Court&#8217;s decision,</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> President Biden issued an executive order to initiate a special enrollment period from February 15, 2021 through August 15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is unclear how other healthcare reform measures of the Biden administration or other efforts, if any, to challenge, repeal or replace the ACA will impact the ACA or our business. We are continuing to monitor any changes to the ACA that, in turn, may potentially impact our business in the future. </span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, other legislative changes have been proposed and adopted in the United States since the ACA was enacted. These changes included aggregate reductions to Medicare payments to providers of 2% per fiscal year, effective April&#160;1, 2013, which, due to subsequent legislative amendments, will stay in effect through 2030, with the exception of a temporary suspension from May 1, 2020 through December 31, 2021 unless additional congressional action is taken. In January 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, reduced Medicare payments to several providers, and increased the statute of limitations period for the government to recover overpayments to providers from three (3) to five (5) years. These new laws may result in additional reductions in Medicare and other healthcare funding, which could have a material adverse effect on customers for our drugs, if approved, and accordingly, our financial operations. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, there has been heightened governmental scrutiny recently over the manner in which drug manufacturers set prices for their marketed products, which has resulted in several Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drug products. The likelihood of success of these and other measures proposed by the former administration is unclear, particularly in light of the current administration. At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and in additional downward pressure on the price that we receive for any approved product. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our product candidates. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, on May&#160;30, 2018, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Beilina Right to Try Act of 2017, or the Right to Try Act, was signed into law. The law, among other things, provides a federal framework for certain patients to access certain investigational new product candidates that have completed a Phase 1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a drug manufacturer to make its products available to eligible patients as a result of the Right to Try Act. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for biotechnology products. We cannot be sure whether additional legislative changes will be enacted, or whether FDA regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals of our product candidates, if any, may be. In addition, increased scrutiny by Congress of the FDA&#8217;s approval process may significantly delay or prevent marketing approval, as well as subject us to more stringent product labeling and post-marketing testing and other requirements. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our relationships with healthcare professionals, clinical investigators, CROs and third party payors in connection with our current and future business activities may be subject to federal and state healthcare fraud and abuse laws, false claims laws, transparency laws, government price reporting, and health information privacy and security laws, which could expose us to, among other things, criminal sanctions, civil penalties, contractual damages, exclusion from governmental healthcare programs, reputational harm, administrative burdens and diminished profits and future earnings. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare providers and third-party payors play a primary role in the recommendation and prescription of any product candidates for which we obtain marketing approval. Our current and future arrangements with healthcare professionals, clinical investigators, CROs, third-party payors and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain the business or financial arrangements and relationships through which we market, sell and distribute our products for which we obtain marketing approval. Restrictions under applicable federal and state healthcare laws and regulations include the following: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the federal Anti-Kickback Statute prohibits, among other things, persons and entities from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made under a federal </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">healthcare program such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it in order to have committed a violation.  </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the federal false claims laws, including the civil False Claims Act, which can be enforced by private citizens through civil whistleblower or qui tam actions, prohibit individuals or entities from, among other things, knowingly presenting, or causing to be presented, to the federal government, claims for payment that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government. In addition, the government may assert that a claim including items or services resulting from a violation of the U.S. federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, prohibits, among other things, executing or attempting to execute a scheme to defraud any healthcare benefit program or making false statements relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act and their implementing regulations, also imposes obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the federal Physician Payments Sunshine Act requires applicable manufacturers of covered drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program, with specific exceptions, to annually report to CMS information regarding payments and other transfers of value to physicians, as defined by such law, certain other healthcare providers starting in 2022 and teaching hospitals, as well as information regarding ownership and investment interests held by physicians and their immediate family members. The information reported is publicly available on a searchable website, with disclosure required annually; and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">analogous state and foreign laws and regulations, such as state anti-kickback and false claims laws, may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some state laws require biotechnology companies to comply with the biotechnology industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government and may require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures. Some state laws require biotechnology companies to report information on the pricing of certain drug products. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">State and foreign laws also govern the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. For instance, the collection and use of health data in the European Union is governed by the General Data Protection Regulation, or the GDPR, which went into effect in May 2018 and which extends the geographical scope of European Union data protection law to non-European Union entities under certain conditions, tightens existing European Union data protection principles, creates new obligations for companies and new rights for individuals. The GDPR also applies to the European Economic Area, or the EEA (which consists of the 27 EU member states plus Iceland, Liechtenstein and Norway). Failure to comply with the GDPR may result in substantial fines, which can be up to &#8364;20 million or 4% of the annual global revenues of the noncompliant company, whichever is greater and other administrative penalties. The GDPR may increase our responsibility and liability in relation to personal data that we process and we may be required to put in place additional mechanisms ensuring compliance with the GDPR. This may be onerous and if our efforts to comply with GDPR or other applicable European Union laws and regulations are not successful, it could adversely affect our business in the European Union. Moreover, the United Kingdom leaving the EU could also lead to further legislative and regulatory changes. Following the United Kingdom&#8217;s withdrawal from the EEA and the EU, and the expiration of the transition period, from January 1, 2021, companies have to comply with both the GDPR and the GDPR as incorporated into United Kingdom national law, the latter regime having the ability to separately fine up to the greater of &#163;17.5 million or 4% of global turnover. On January 1, 2021, the United Kingdom became a third country for the purposes of the GDPR. It remains unclear how the United Kingdom data protection laws or regulations will develop in the medium to longer term. On June 28, 2021, the European Commission adopted an adequacy decision in favor of the United Kingdom, enabling data transfers from member states in the European Union to the United Kingdom without additional safeguards. However, the United Kingdom adequacy decision will automatically expire in June 2025 unless the European Commission renews or extends that decision and remains under review by the Commission during this period. In addition, on June&#160;28, 2018, the State of California enacted the California Consumer Privacy Act, or CCPA, which went into effect on January&#160;1, 2020. The CCPA creates individual privacy rights for California consumers and increases the privacy and security obligations of entities handling certain personal information. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. The CCPA may increase our compliance costs and potential liability, and similar laws have been proposed at the federal level and in other states. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Efforts to ensure that our current and future business arrangements with third parties will comply with applicable healthcare laws and regulations will involve on-going substantial costs. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant penalties, including civil, criminal and administrative penalties, damages, fines, disgorgement, individual imprisonment, exclusion from participation in government funded healthcare programs, such as Medicare and Medicaid, integrity oversight and reporting obligations, contractual damages, reputational harm, diminished profits and future earnings and the curtailment or restructuring of our operations. Defending against any such actions can be costly, time-consuming and may require significant financial and personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired. Further, if any of the physicians or other healthcare providers or entities with whom we expect to do business is found to be not in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our employees, independent contractors, consultants, commercial collaborators, principal investigators, CROs, suppliers and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the risk that our employees, independent contractors, consultants, commercial collaborators, principal investigators, CROs, suppliers and vendors may engage in misconduct or other improper activities. Misconduct by these parties could include failures to comply with FDA and other foreign authorities regulations, provide accurate information to the FDA, comply with federal and state health care fraud and abuse laws and regulations, accurately report financial information or data or disclose unauthorized activities to us. In particular, sales, marketing and business arrangements in the health care industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Misconduct by these parties could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter misconduct by these parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant penalties, including civil, criminal and administrative penalties, damages, fines, disgorgement, individual imprisonment, exclusion from participation in government funded healthcare programs, such as Medicare and Medicaid, integrity oversight and reporting obligations, contractual damages, reputational harm, diminished profits and future earnings and the curtailment or restructuring of our operations. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on our business. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and biological materials. Our operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us in connection with our storage or disposal of hazardous and flammable materials, including chemicals and biological materials. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our research, development or commercialization efforts. Failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our research and development activities could be affected or delayed as a result of possible restrictions on animal testing. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain laws and regulations require us to test our product candidates on animals before initiating clinical trials involving humans. Animal testing activities have been the subject of controversy and adverse publicity. Animal rights groups and other organizations and individuals have attempted to stop animal testing activities by pressing for legislation and regulation in these areas and by disrupting these activities through protests and other means. To the extent the activities of these groups are successful, our research and development activities may be interrupted, delayed or become more expensive. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business activities may be subject to the U.S. Foreign Corrupt Practices Act, or the FCPA, and similar anti-bribery and anti-corruption laws of other countries in which we operate, as well as U.S. and certain foreign export controls, trade sanctions, and import laws and regulations. Compliance with these legal requirements could limit our ability to compete in foreign markets and subject us to liability if we violate them. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we further expand our operations outside of the United States, we must dedicate additional resources to comply with numerous laws and regulations in each jurisdiction in which we plan to operate. Our business activities may be subject to the FCPA and similar anti-bribery or anti-corruption laws, regulations or rules of other countries in which we operate. The FCPA generally prohibits companies and their employees and third party intermediaries from offering, promising, giving or authorizing the provision of anything of value, either directly or indirectly, to a non-U.S. government official in order to influence official action or otherwise obtain or retain business. The FCPA also requires public companies to make and keep books and records that accurately and fairly reflect the transactions of the corporation and to devise and maintain an adequate system of internal accounting controls. Our business is heavily regulated and therefore involves significant interaction with public officials, including officials of non-U.S. governments. Additionally, in many other countries, hospitals owned and operated by the government, and doctors and other hospital employees would be considered foreign officials under the FCPA. Recently the SEC and Department of Justice have increased their FCPA enforcement activities with respect to biotechnology and pharmaceutical companies. There is no certainty that all of our employees, agents or contractors, or those of our affiliates, will comply with all applicable laws and regulations, particularly given the high level of complexity of these laws. Violations of these laws and regulations could result in fines, criminal sanctions against us, our officers or our employees, disgorgement, and other sanctions and remedial measures, and prohibitions on the conduct of our business. Any such violations could include prohibitions on our ability to offer our products in one or more countries and could materially damage our reputation, our brand, our international activities, our ability to attract and retain employees and our business, prospects, operating results and financial condition. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our products and activities may be subject to U.S. and foreign export controls, trade sanctions and import laws and regulations. Governmental regulation of the import or export of our products, or our failure to obtain any required import or export authorization for our products, when applicable, could harm our international sales and adversely affect our revenue. Compliance with applicable regulatory requirements regarding the export of our products may create delays in the introduction of our products in international markets or, in some cases, prevent the export of our products to some countries altogether. Furthermore, U.S. export control laws and economic sanctions prohibit the shipment of certain products and services to countries, governments, and persons targeted by U.S. sanctions. If we fail to comply with export and import regulations and such economic sanctions, penalties could be imposed, including fines and/or denial of certain export privileges. Moreover, any new export or import restrictions, new legislation or shifting approaches in the enforcement or scope of existing regulations, or in the countries, persons, or products targeted by such regulations, could result in decreased use of our products by, or in our decreased ability to export our products to existing or potential customers with international operations. Any decreased use of our products or limitation on our ability to export or sell access to our products would likely adversely affect our business. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Employee Matters, Managing Our Growth and Other Risks Related to Our Business </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The COVID-19 pandemic has adversely impacted and we expect will continue to adversely impact our business, including our preclinical studies and clinical trials. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, a strain of the novel coronavirus disease, COVID-19, was declared a pandemic and spread across the world, including throughout the United States, Europe and Asia. The pandemic and government measures taken in response have also had a significant impact, both direct and indirect, on businesses and commerce, as worker shortages have occurred; supply chains have been disrupted; facilities and production have been suspended; and demand for certain goods and services, such as medical services and supplies, has spiked, while demand for other goods and services, such as travel, has fallen. In response to the spread of COVID-19, we have closed our executive offices with our administrative employees continuing their work outside of our offices and limited the number of staff in any given research and development laboratory. As a result of the COVID-19 pandemic, we have experienced and we expect to continue to experience disruptions that could severely impact our business, preclinical studies and clinical trials, including: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">continued delays or difficulties in enrolling patients in our clinical trials; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">continued delays or difficulties in clinical site initiation, including difficulties in recruiting clinical site investigators and clinical site staff; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">delays in receiving authorizations from regulatory authorities to initiate our planned clinical trials; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">diversion of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals serving as our clinical trial sites and hospital staff supporting the conduct of our clinical trials; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">interruption of key clinical trial activities, such as clinical trial site data monitoring, due to limitations on travel imposed or recommended by federal or state or foreign governments, employers and others or interruption of clinical trial subject visits and study procedures (such as endoscopies that are deemed non-essential), which may impact the integrity of subject data and clinical study endpoints; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">risk that participants enrolled in our clinical trials will contract COVID-19 while the clinical trial is ongoing, which could impact the results of the clinical trial, including by increasing the number of observed adverse events;</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">risk that we are unable to enroll participants in our clinical trials in adequate numbers;</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">interruption or delays in the operations of the FDA or other regulatory authorities, which may impact review and approval timelines; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">interruption of, or delays in receiving, supplies of our product candidates from our contract manufacturing organizations due to staffing shortages, production slowdowns or stoppages and disruptions in delivery systems; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">interruptions in preclinical studies due to restricted or limited operations at our laboratory facility; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">delays in necessary interactions with local regulators, ethics committees and other important agencies and contractors due to limitations in employee resources or forced furlough of government employees;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">changes in local regulations as part of a response to the COVID-19 pandemic, which may require us to change the ways in which our clinical trials are conducted, which may result in unexpected costs, or to discontinue such clinical trials altogether;</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">limitations on employee resources that would otherwise be focused on the conduct of our preclinical studies and clinical trials, including because of sickness of employees or their families or the desire of employees to avoid contact with large groups of people;</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">interruption or delays to our sourced discovery and clinical activities; and</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">refusal of the FDA to accept data from clinical trials in affected geographies outside the United States.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to rapidly evolve. The extent to which the pandemic impacts our business, preclinical studies and clinical trials will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the duration of the pandemic, the impact of variants, travel restrictions and social distancing in the United States and other countries, business closures or business disruptions and the adoption and effectiveness of vaccination efforts and other actions taken in the United States and other countries to contain and treat the disease. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success is highly dependent on our ability to attract and retain highly skilled executive officers and employees. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To succeed, we must recruit, retain, manage and motivate qualified clinical, scientific, technical and management personnel, and we face significant competition for experienced personnel. We are highly dependent on the principal members of our management and scientific and medical staff. If we do not succeed in attracting and retaining qualified personnel, particularly at the management level, it could adversely affect our ability to execute our business plan and harm our operating results. In particular, the loss of one or more of our executive officers could be detrimental to us if we cannot recruit suitable replacements in a timely manner. The competition for qualified personnel in the biotechnology field is intense and as a result, we may be unable to continue to attract and retain qualified personnel necessary for the future success of our business. We could in the future have difficulty attracting experienced personnel to our company and may be required to expend significant financial resources in our employee recruitment and retention efforts. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the other biotechnology companies that we compete against for qualified personnel have greater financial and other resources, different risk profiles and a longer history in the industry than we do. They also may provide more diverse opportunities and better prospects for career advancement. Some of these characteristics may be more appealing to high-quality candidates than what we have to offer. If we are unable to continue to attract and retain high-quality personnel, the rate and success at which we can discover, develop and commercialize our product candidates will be limited and the potential for successfully growing our business will be harmed. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to establish sales or marketing capabilities or enter into agreements with third parties to sell or market our product candidates, we may not be able to successfully sell or market our product candidates that obtain regulatory approval. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently do not have and have never had a marketing or sales team. In order to commercialize any product candidates, if approved, we must build marketing, sales, distribution, managerial and other non-technical capabilities or make arrangements with third parties to perform these services for each of the territories in which we may have approval to sell or market our product candidates. We may not be successful in accomplishing these required tasks. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Establishing an internal sales or marketing team with technical expertise and supporting distribution capabilities to commercialize our product candidates will be expensive and time-consuming, and will require significant attention of our executive officers to manage. Any failure or delay in the development of our internal sales, marketing and distribution capabilities could adversely impact the commercialization of any of our product candidates that we </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">obtain approval to market, if we do not have arrangements in place with third parties to provide such services on our behalf. Alternatively, if we choose to collaborate, either globally or on a territory-by-territory basis, with third parties that have direct sales forces and established distribution systems, either to augment our own sales force and distribution systems or in lieu of our own sales force and distribution systems, we will be required to negotiate and enter into arrangements with such third parties relating to the proposed collaboration. If we are unable to enter into such arrangements when needed, on acceptable terms, or at all, we may not be able to successfully commercialize any of our product candidates that receive regulatory approval or any such commercialization may experience delays or limitations. If we are unable to successfully commercialize our approved product candidates, either on our own or through collaborations with one or more third parties, our future product revenue will suffer and we may incur significant additional losses. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have never commercialized a product candidate before and may lack the necessary expertise, personnel and resources to successfully commercialize any products on our own or together with suitable collaborators. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never commercialized a product candidate, and we currently have no sales force, marketing or distribution capabilities. To achieve commercial success for the product candidates, which we may license to others, we will rely on the assistance and guidance of those collaborators. For product candidates for which we retain commercialization rights, we will have to develop our own sales, marketing and supply organization or outsource these activities to a third party. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors that may affect our ability to commercialize our product candidates on our own include recruiting and retaining adequate numbers of effective sales and marketing personnel, obtaining access to or persuading adequate numbers of physicians to prescribe our product candidates and other unforeseen costs associated with creating an independent sales and marketing organization. Developing a sales and marketing organization will be expensive and time-consuming and could delay the launch of our product candidates. We may not be able to build an effective sales and marketing organization. If we are unable to build our own distribution and marketing capabilities or to find suitable partners for the commercialization of our product candidates, we may not generate revenues from them or be able to reach or sustain profitability. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In order to successfully implement our plans and strategies, we will need to grow the size of our organization, and we may experience difficulties in managing this growth. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to successfully implement our development and commercialization plans and strategies, and as we transition into operating as a public company, we expect to need additional managerial, operational, sales, marketing, financial and other personnel. Future growth would impose significant added responsibilities on members of management, including: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">identifying, recruiting, integrating, maintaining and motivating additional employees; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">managing our internal development efforts effectively, including the clinical, FDA, EMA and other comparable foreign regulatory agencies&#8217; review process for ZN-c3, ZN-c5, ZN-d5 and ZN-e4 and any other future product candidates, while complying with any contractual obligations to contractors and other third parties we may have; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">improving our operational, financial and management controls, reporting systems and procedures.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our future financial performance and our ability to successfully develop and, if approved, commercialize, ZN-c3, ZN-c5, ZN-d5 and ZN-e4 and any other future product candidates will depend, in part, on our ability to effectively manage any future growth, and our management may also have to divert a disproportionate amount of its attention away from day-to-day activities in order to devote a substantial amount of time to managing these growth activities. Furthermore, certain of our employees, including members of our management team perform services from time to time, on behalf of Kalyra Pharmaceuticals, Inc., and Zentera Therapeutics, Ltd., pursuant to intercompany and collaborative service agreements, respectively. As a result, such individuals do not allocate all of their time and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">resources to us and our other subsidiaries which, coupled with the need to manage growth activities, could further limit their ability to devote a sufficient amount of attention to day-to-day activities of our business. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently rely, and for the foreseeable future will continue to rely, in substantial part on certain independent organizations, advisors and consultants to provide certain services, including key aspects of clinical development and manufacturing. We cannot assure you that the services of independent organizations, advisors and consultants will continue to be available to us on a timely basis when needed, or that we can find qualified replacements. In addition, if we are unable to effectively manage our outsourced activities or if the quality or accuracy of the services provided by third party service providers is compromised for any reason, our clinical trials may be extended, delayed or terminated, and we may not be able to obtain marketing approval of ZN-c3, ZN-c5, ZN-d5 and ZN-e4 and any other future product candidates or otherwise advance our business. We cannot assure you that we will be able to manage our existing third party service providers or find other competent outside contractors and consultants on economically reasonable terms, or at all. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not able to effectively expand our organization by hiring new employees and/or engaging additional third party service providers, we may not be able to successfully implement the tasks necessary to further develop and commercialize ZN-c3, ZN-c5, ZN-d5 and ZN-e4 and any other future product candidates and, accordingly, may not achieve our research, development and commercialization goals. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our internal computer systems, or those of any of our CROs, manufacturers, other contractors, consultants, collaborators or potential future collaborators, may fail or suffer security or data privacy breaches or other unauthorized or improper access to, use of, or destruction of our proprietary or confidential data, employee data, or personal data, which could result in additional costs, loss of revenue, significant liabilities, harm to our brand and material disruption of our operations. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the implementation of security measures, our internal computer systems and those of our current and any future CROs and other contractors, consultants, collaborators and third-party service providers, are vulnerable to damage from computer viruses, cybersecurity threats, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failure. If such an event were to occur and cause interruptions in our operations or result in the unauthorized acquisition of or access to personally identifiable information or individually identifiable health information (violating certain privacy laws such as HIPAA, Health Information Technology for Economic and Clinical Health Act and GDPR), it could result in a material disruption of our drug discovery and development programs and our business operations, whether due to a loss of our trade secrets or other similar disruptions. Some of the federal, state and foreign government requirements include obligations of companies to notify individuals of security breaches involving particular personally identifiable information, which could result from breaches experienced by us or by our vendors, contractors, or organizations with which we have formed strategic relationships. Notifications and follow-up actions related to a security breach could impact our reputation, cause us to incur significant costs, including legal expenses and remediation costs. For example, the loss of clinical trial data from completed or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the lost data. We also rely on third parties to manufacture our product candidates, and similar events relating to their computer systems could also have a material adverse effect on our business. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data, or inappropriate disclosure of confidential or proprietary information, we could be exposed to litigation and governmental investigations, the further development and commercialization of our product candidates could be delayed, and we could be subject to significant fines or penalties for any noncompliance with certain state, federal and/or international privacy and security laws. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our insurance policies may not be adequate to compensate us for the potential losses arising from any such disruption, failure or security breach. In addition, such insurance may not be available to us in the future on economically reasonable terms, or at all. Further, our insurance may not cover all claims made against us and could have high deductibles in any event, and defending a suit, regardless of its merit, could be costly and divert management attention. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EU drug marketing and reimbursement regulations may materially affect our ability to market and receive coverage for our products in the European member states. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to seek approval to market our product candidates in both the United States and in selected foreign jurisdictions. If we obtain approval in one or more foreign jurisdictions for our product candidates, we will be subject to rules and regulations in those jurisdictions. In some foreign countries, particularly those in the European Union, the pricing of drugs is subject to governmental control and other market regulations which could put pressure on the pricing and usage of our product candidates. In these countries, pricing negotiations with governmental authorities can take considerable time after obtaining marketing approval of a product candidate. In&#160;addition, market acceptance and sales of our product candidates will depend significantly on the availability of adequate coverage and reimbursement from third-party payors for our product candidates and may be affected by existing and future healthcare reform measures. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Much like the federal Anti-Kickback Statute prohibition in the United States, the provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal products is also prohibited in the European Union. The provision of benefits or advantages to physicians is governed by the national laws of EU member states, such as the UK Bribery Act 2010. Infringement of these laws could result in substantial fines and imprisonment. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments made to physicians in certain EU member states must be publicly disclosed. Moreover, agreements with physicians often must be the subject of prior notification and/or approval by the physician&#8217;s employer, his or her competent professional organization and/or the regulatory authorities of the individual EU member states. These requirements are provided in the national laws, industry codes or professional codes of conduct, applicable in the EU member states. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in most foreign countries, including the EU and the EEA, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing and reimbursement vary widely from country to country. For example, the European Union provides options for its member states to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. Reference pricing used by various EU member states and parallel distribution, or arbitrage between low-priced and high-priced member states, can further reduce prices. A member state may approve a specific price for the medicinal product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. In some countries, we may be required to conduct a clinical study or other studies that compare the cost-effectiveness of any of our product candidates to other available therapies in order to obtain or maintain reimbursement or pricing approval. There can be no assurance that any country that has price controls or reimbursement limitations for biopharmaceutical products will allow favorable reimbursement and pricing arrangements for any of our products. Historically, products launched in the European Union do not follow price structures of the United States and generally prices tend to be significantly lower. Publication of discounts by third-party payors or authorities may lead to further pressure on the prices or reimbursement levels within the country of publication and other countries. If pricing is set at unsatisfactory levels or if reimbursement of our products is unavailable or limited in scope or amount, our revenues from sales and the potential profitability of any of our product candidates in those countries would be negatively affected. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A portion of our manufacturing of our lead product candidates takes place in China through third-party manufacturers. A significant disruption in the operation of those manufacturers, a trade war or political unrest in China could materially adversely affect our business, financial condition and results of operations. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently contract manufacturing operations to third parties, and clinical quantities of our lead product candidates are manufactured by these third parties outside the United States, including in China, and we expect to continue to use such third-party manufacturers for such product candidates. Any disruption in production or inability of our manufacturers in China to produce adequate quantities to meet our needs, whether as a result of a natural disaster or other causes, could impair our ability to operate our business on a day-to-day basis and to continue our </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development of our product candidates. Furthermore, since these manufacturers are located in China, we are exposed to the possibility of product supply disruption and increased costs in the event of changes in the policies of the United States or Chinese governments, political unrest or unstable economic conditions in China. For example, a trade war could lead to tariffs on the chemical intermediates we use that are manufactured in China. Any of these matters could materially and adversely affect our business and results of operations. Any recall of the manufacturing lots or similar action regarding our product candidates used in clinical trials could delay the trials or detract from the integrity of the trial data and its potential use in future regulatory filings. In addition, manufacturing interruptions or failure to comply with regulatory requirements by any of these manufacturers could significantly delay clinical development of potential products and reduce third-party or clinical researcher interest and support of proposed trials. These interruptions or failures could also impede commercialization of our product candidates and impair our competitive position. Further, we may be exposed to fluctuations in the value of the local currency in China. Future appreciation of the local currency could increase our costs. In addition, our labor costs could continue to rise as wage rates increase due to increased demand for skilled laborers and the availability of skilled labor declines in China. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operations are vulnerable to interruption by fire, severe weather conditions, power loss, telecommunications failure, terrorist activity and other events beyond our control, which could harm our business. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our facility is located in a region which experiences severe weather from time to time. We have not undertaken a systematic analysis of the potential consequences to our business and financial results from a major tornado, flood, fire, earthquake, power loss, terrorist activity or other disasters and do not have a recovery plan for such disasters. In addition, we do not carry sufficient insurance to compensate us for actual losses from interruption of our business that may occur, and any losses or damages incurred by us could harm our business. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of December 31, 2020, we had available federal net operating loss, or NOL, carryforwards of approximately $183.0 million for federal income tax purposes, of which $162.0 million were generated in taxable years beginning after December 31, 2017 and can be carried forward indefinitely, but may only be used to offset 80% of our taxable income in taxable years beginning after December 31, 2020. This limitation may require us to pay U.S. federal income taxes in future years despite generating federal NOLs in prior years. Our federal NOLs generated in tax years beginning prior to January 1, 2018 are not subject to this limitation, but are only permitted to be carried forward for 20 taxable years under applicable U.S. federal tax law, and will start to expire in 2033 if not utilized.</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our NOL carryforwards could expire unused, to the extent subject to expiration, or otherwise be unavailable to offset future taxable income because of their limited duration or because of restrictions under applicable tax law.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under Sections&#160;382 and 383 of the Code, if a corporation undergoes an &#8220;ownership change&#8221; (generally defined as a cumulative change in our ownership by one or more &#8220;5-percent shareholders&#8221; that exceeds 50 percentage points over a rolling three-year period), the corporation&#8217;s ability to use its pre-change federal NOLs and certain other pre-change tax attributes to offset its post-change taxable income and income tax liabilities may be limited. Similar rules may apply under state tax laws. We may have experienced such ownership changes in the past and we may experience ownership changes in the future as a result of shifts in our stock ownership, some of which are outside our control. We have not conducted any studies to determine whether any such ownership changes have occurred or the annual limitations, if any, that could result from such ownership changes. Our ability to utilize those NOLs could be limited by an ownership change as described above and consequently, we may not be able to utilize a material portion of our NOLs and certain other tax attributes, which could have a material adverse effect on our cash flows and results of operations. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A variety of risks associated with marketing our product candidates internationally could materially adversely affect our business. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to seek regulatory approval of our product candidates outside of the United States and, accordingly, we expect that we will be subject to additional risks related to operating in foreign countries if we obtain the necessary approvals, including: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">differing regulatory requirements and reimbursement regimes in foreign countries; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">unexpected changes in tariffs, trade barriers, price and exchange controls and other regulatory requirements; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">economic weakness, including inflation, or political instability in particular foreign economies and markets; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">foreign taxes, including withholding of payroll taxes; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business in another country; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">difficulties staffing and managing foreign operations; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">workforce uncertainty in countries where labor unrest is more common than in the United States; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">potential liability under the FCPA or comparable foreign regulations; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">challenges enforcing our contractual and intellectual property rights, especially in those foreign countries that do not respect and protect intellectual property rights to the same extent as the United States; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">business interruptions resulting from geo-political actions, including war and terrorism.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These and other risks associated with our international operations may materially adversely affect our ability to attain or maintain profitable operations. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success depends on our ability to protect our intellectual property and our proprietary platform. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends in part on our ability to obtain and maintain patent protection and trade secret protection for our product candidates, proprietary technologies and their uses as well as our and our licensors&#8217; ability to operate without infringing the proprietary rights of others. If we or our licensors are unable to protect our intellectual property rights or if our intellectual property rights are inadequate for our technology or our product candidates, our competitive position could be harmed. We and our licensors generally seek to protect our proprietary position by filing patent applications in the United States and abroad related to our product candidates, proprietary technologies and their uses that are important to our business. Our patent applications cannot be enforced against third parties practicing the technology claimed in such applications unless, and until, patents issue from such applications, and then only to the extent the issued claims cover the technology. There can be no assurance that our patent applications will result in patents being issued or that issued patents will afford sufficient protection against competitors with similar technology, nor can there be any assurance that the patents, if issued, will not be infringed, designed around, invalidated or rendered unenforceable by third parties. Even issued patents may later be found invalid or unenforceable or may be modified or revoked in proceedings instituted by third parties before various patent offices or in courts. The degree of future protection for our and our licensors&#8217; proprietary rights is uncertain. Only limited protection may be available and may not adequately protect our or our licensors&#8217; rights or permit us or our licensors to gain or keep any competitive advantage. These uncertainties and/or limitations in our and our licensors&#8217; ability to properly protect the intellectual property rights relating to our product candidates could have a material adverse effect on our financial condition and results of operations. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we license issued patents in the United States and foreign countries, we cannot be certain that the claims in our other U.S. pending patent applications, corresponding international patent applications and patent applications in certain foreign countries will be considered patentable by the United States Patent and Trademark Office, or USPTO, courts in the United States or by the patent offices and courts in foreign countries, nor can we be certain that the claims in our issued patents will not be found invalid or unenforceable if challenged. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The patent application process is subject to numerous risks and uncertainties, and there can be no assurance that we or our licensors or any of our potential future collaborators will be successful in protecting our product candidates by obtaining and defending patents. These risks and uncertainties include the following: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other provisions during the patent process, the noncompliance with which can result in abandonment or lapse of a patent or patent application, and partial or complete loss of patent rights in the relevant jurisdiction; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">patent applications may not result in any patents being issued; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">patents may be challenged, invalidated, modified, revoked, circumvented, found to be unenforceable or otherwise may not provide any competitive advantage; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our competitors, many of whom have substantially greater resources than we or our licensors do and many of whom have made significant investments in competing technologies, may seek or may have already obtained patents that will limit, interfere with or block our ability to make, use and sell our product candidates; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">there may be significant pressure on the U.S. government and international governmental bodies to limit the scope of patent protection both inside and outside the United States for disease treatments that prove successful, as a matter of public policy regarding worldwide health concerns; and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">countries other than the United States may have patent laws less favorable to patentees than those upheld by U.S. courts, allowing foreign competitors a better opportunity to create, develop and market competing products.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The patent prosecution process is also expensive and time-consuming, and we or our licensors may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner or in all jurisdictions where protection may be commercially advantageous. It is also possible that we or our licensors may not identify patentable aspects of our research and development output before it is too late to obtain patent protection. Moreover, in some circumstances, we do not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the patents, directed to technology that we license, including those from our licensors and from third parties. We also may require the cooperation of our licensors in order to enforce the licensed patent rights, and such cooperation may not be provided. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business. We cannot be certain that patent prosecution and maintenance activities by our licensors have been or will be conducted in compliance with applicable laws and regulations, which may affect the validity and enforceability of such patents or any patents that may issue from such applications. If they fail to do so, this could cause us to lose rights in any applicable intellectual property that we in-license, and, as a result, our ability to develop and commercialize products or product candidates may be adversely affected and we may be unable to prevent competitors from making, using and selling competing products. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, although we enter into non-disclosure and confidentiality agreements with parties who have access to patentable aspects of our research and development output, such as our employees, outside scientific collaborators, CROs, third-party manufacturers, consultants, advisors, licensors, and other third parties, any of these parties may breach such agreements and disclose such output before a patent application is filed, thereby jeopardizing our ability to seek patent protection. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with our obligations in the agreements under which we license intellectual property rights from our licensors and third parties or otherwise experience disruptions to our business relationships with our licensors, we could lose license rights that are important to our business. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to a number of license agreements under which we are granted rights to intellectual property that are important to our business and we may enter into additional license agreements in the future. For example, in September 2019, we entered into an exclusive license agreement with Recurium IP Holdings, LLC, or Recurium&#160;IP, to obtain an exclusive license to certain intellectual property rights to develop and commercialize ZN-e5, ZN-c3 and ZN-e4. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This and our other existing license agreements impose on us, and we expect that any future license agreements where we in-license intellectual property will impose on us, various development, regulatory and/or commercial diligence obligations, payment of milestones and/or royalties and other obligations. If we fail to comply with our obligations under these agreements, or we are subject to bankruptcy-related proceedings, the licensors may have the right to terminate the licenses, in which event we would not be able to market products covered by the licenses. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may need to obtain licenses from third parties to advance our research or allow commercialization of our product candidates, and we cannot provide any assurances that third-party patents do not exist that might be enforced against our product candidates in the absence of such a license. We may fail to obtain any of these licenses on commercially reasonable terms, if at all. Even if we are able to obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In that event, we may be required to expend significant time and resources to develop or license replacement technology. If we are unable to do so, we may be unable to develop or commercialize the affected product candidates, which could materially harm our business and the third parties owning such intellectual property rights could seek either an injunction prohibiting our sales, or, with respect to our sales, an obligation on our part to pay royalties and/or other forms of compensation. Licensing of intellectual property is of critical importance to our business and involves complex legal, business and scientific issues. Disputes may arise between us and our licensors regarding intellectual property subject to a license agreement, including: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the scope of rights granted under the license agreement and other interpretation-related issues; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">whether and the extent to which our technology and processes infringe intellectual property of the licensor that is not subject to the licensing agreement; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our right to sublicense patents and other rights to third parties; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our diligence obligations with respect to the use of the licensed technology in relation to our development and commercialization of our product candidates, and what activities satisfy those diligence obligations; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our right to transfer or assign the license; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensors and its affiliates and sublicensees and by us and our partners and sublicensees.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on acceptable terms, we may not be able to successfully develop and commercialize the affected product candidates, which would have a material adverse effect on our business. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain of our agreements may limit or delay our ability to consummate certain transactions, may impact the value of those transactions, or may limit our ability to pursue certain activities. For example, if we choose to sublicense or assign to any third parties our rights under our existing license agreement with Recurium with respect to any licensed product, we may be required to pay to Recurium a specified percentage of all revenue to be received in connection with such transaction. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the scope of any patent protection our licensors obtain is not sufficiently broad, or if our licensors lose any of the patent protection we license, our ability to prevent our competitors from commercializing similar or identical product candidates would be adversely affected. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The patent position of biopharmaceutical companies generally is highly uncertain, involves complex legal and factual questions, and has been the subject of much litigation in recent years. As a result, the existence, issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issued that protect our product candidates or that effectively prevent others from commercializing competitive product candidates. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, the scope of claims in a patent application can be significantly reduced before any claims in a patent issue, and claim scope can be reinterpreted after issuance. Even if patent applications we license currently or in the future issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors or other third parties from competing with us, or otherwise provide us with any competitive advantage. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any patents that we license may be challenged or circumvented by third parties or may be narrowed or invalidated as a result of challenges by third parties. Consequently, we do not know whether our product candidates will be protectable or remain protected by valid and enforceable patents. Our competitors or other third parties may be able to circumvent our patents by developing similar or alternative technologies or products in a non-infringing manner, which could materially adversely affect our business, financial condition, results of operations and prospects. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our licensed-in patents may not cover our product candidates or may be challenged in the courts or patent offices in the United States and abroad. We may be subject to a third party pre-issuance submission of prior art to the USPTO, or become involved in opposition, derivation, revocation, reexamination, post-grant review, or PGR, and inter partes review, or IPR, or other similar proceedings in the USPTO or foreign patent offices challenging our patent rights. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to validity of our patents, for example, we cannot be certain that there is no invalidating prior art, of which we or our licensors and the patent examiner were unaware during prosecution. There is no assurance that all potentially relevant prior art relating to our patents and patent applications or those of our licensors has been found. There is also no assurance that there is not prior art of which we or licensors were or are aware, but which we do not believe affects the validity or enforceability of a claim in our patents and patent applications or those of our licensors, which may, nonetheless, ultimately be found to affect the validity or enforceability of a claim. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate or render unenforceable, our patent rights, allow third parties to commercialize our product candidates and compete directly with us, without payment to us. Such loss of in-licensed patent rights, loss of exclusivity or in patent claims being narrowed, invalidated or held unenforceable could limit our ability to stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of our product candidates. Such proceedings also may result in substantial cost and require significant time from our scientists and management, even if the eventual outcome is favorable to us. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The patent protection and patent prosecution for some of our product candidates may be dependent on our licensors and third parties. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We or our licensors may fail to identify patentable aspects of inventions made in the course of development and commercialization activities before it is too late to obtain patent protection on them. Therefore, we may miss potential opportunities to strengthen our patent position. It is possible that defects as to form in the preparation or filing of our patents or patent applications may exist, or may arise in the future, for example with respect to proper priority claims, inventorship, claim scope, or requests for patent term adjustments. If we or our licensors, whether current or future, fail to establish, maintain or protect such patents and other intellectual property rights, such rights may be reduced or eliminated. If our licensors are not fully cooperative or disagree with us as to the prosecution, maintenance or enforcement of any patent rights, such patent rights could be compromised. If there are material defects in the form, preparation, prosecution, or enforcement of our in-licensed patents or patent applications, such patents may be invalid and/or unenforceable, and such applications may never result in valid, enforceable patents. Any of these outcomes could impair our ability to prevent competition from third parties, which may have an adverse impact on our business. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a licensee of third parties, we rely on third parties to file and prosecute patent applications and maintain patents and otherwise protect the licensed intellectual property under some of our license agreements. We have not had and do not have primary control over these activities for certain of our patents or patent applications and other intellectual property rights. We cannot be certain that such activities by third parties have been or will be conducted in compliance with applicable laws and regulations or will result in valid and enforceable patents or other intellectual property rights. Pursuant to the terms of the license agreements with some of our licensors, the licensors may have the right to control enforcement of our licensed patents or defense of any claims asserting the invalidity of these patents and even if we are permitted to pursue such enforcement or defense, we will require the cooperation of our licensors. We cannot be certain that our licensors will allocate sufficient resources or prioritize their or our enforcement of such patents or defense of such claims to protect our interests in the licensed patents. Even if we are </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not a party to these legal actions, an adverse outcome could harm our business because it might prevent us from continuing to license intellectual property that we may need to operate our business. If any of our licensors or any of our future licensors or future collaborators fails to appropriately prosecute and maintain patent protection for patents covering any of our product candidates, our ability to develop and commercialize those product candidates may be adversely affected and we may not be able to prevent competitors from making, using and selling competing products. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, even where we have the right to control patent prosecution of patents and patent applications we have acquired or licensed from third parties, we may still be adversely affected or prejudiced by actions or inactions of our licensors and their counsel that took place prior to us assuming control over patent prosecution. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology acquired or licensed from various third parties, including our licensors, may be subject to retained rights. Our licensors often retain certain rights under their agreements with us, including the right to use the underlying technology for use in fields other than the fields licensed to us or for use in noncommercial academic and research use, to publish general scientific findings from research related to the technology, and to make customary scientific and scholarly disclosures of information relating to the technology. It is difficult to monitor whether our licensors limit their use of the technology to these uses, and we could incur substantial expenses to enforce our rights to our licensed technology in the event of misuse. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are limited in our ability to utilize acquired or licensed technologies, or if we lose our rights to critical licensed technology, we may be unable to successfully develop, out-license, market and sell our products, which could prevent or delay new product introductions. Our business strategy depends on the successful development of licensed and acquired technologies into commercial products. Therefore, any limitations on our ability to utilize these technologies may impair our ability to develop, out-license or market and sell our product candidate. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our intellectual property has been discovered through government-funded programs and thus may be subject to federal regulations such as &#8220;march-in&#8221; rights, certain reporting requirements and a preference for U.S.-based companies. Compliance with such regulations may limit our exclusive rights, and limit our ability to contract with non-U.S. manufacturers. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the intellectual property rights we have acquired or licensed or may acquire or license in the future may have been generated through the use of U.S. government funding and may therefore be subject to certain federal regulations. These U.S. government rights include a non-exclusive, non-transferable, irrevocable worldwide license to use inventions for any governmental purpose. In addition, the U.S. government has the right, under certain limited circumstances, to require us to grant exclusive, partially exclusive, or non-exclusive licenses to any of these inventions to a third party if it determines that: (i)&#160;adequate steps have not been taken to commercialize the invention; (ii)&#160;government action is necessary to meet public health or safety needs; or (iii)&#160;government action is necessary to meet requirements for public use under federal regulations (also referred to as &#8220;march-in rights&#8221;). The U.S. government also has the right to take title to these inventions if the grant recipient fails to disclose the invention to the government or fails to file an application to register the intellectual property within specified time limits. Intellectual property generated under a government funded program is also subject to certain reporting requirements, compliance with which may require us to expend substantial resources. In addition, the U.S. government requires that any products embodying any of these inventions or produced through the use of any of these inventions be manufactured substantially in the United States. This preference for U.S. industry may be waived by the federal agency that provided the funding if the owner or assignee of the intellectual property can show that reasonable but unsuccessful efforts have been made to grant licenses on similar terms to potential licensees that would be likely to manufacture substantially in the United States or that under the circumstances domestic manufacture is not commercially feasible. This preference for U.S. industry may limit our ability to contract with non-U.S. product manufacturers for products relating to such intellectual property. To the extent any of our future intellectual property is also generated through the use of U.S. government funding, the provisions of the Bayh-Dole Act may similarly apply. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual property rights do not necessarily address all potential threats to our competitive advantage. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations, and may not adequately protect our business or permit us to maintain our competitive advantage. For example: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">others may be able to develop products that are similar to our product candidates but that are not covered by the claims of the patents that we own or license; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">we or our licensors might not have been the first to make the inventions covered by the issued patents or patent application that we own or license; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">we or our licensors might not have been the first to file patent applications covering certain of our inventions; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">it is possible that our licensors&#8217; pending patent applications will not lead to issued patents; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">issued patents that we own or license may be held invalid or unenforceable, as a result of legal challenges by our competitors; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our competitors might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">we may not develop additional proprietary technologies that are patentable; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the patents of others may have an adverse effect on our business.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should any of these events occur, it could significantly harm our business, results of operations and prospects. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our commercial success depends significantly on our ability to operate without infringing the patents and other proprietary rights of third parties. Claims by third parties that we infringe their proprietary rights may result in liability for damages or prevent or delay our developmental and commercialization efforts. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends in part on avoiding infringement of the patents and proprietary rights of third parties. However, our research, development and commercialization activities may be subject to claims that we infringe or otherwise violate patents or other intellectual property rights owned or controlled by third parties. Other entities may have or obtain patents or proprietary rights that could limit our ability to make, use, sell, offer for sale or import our product candidates and products that may be approved in the future, or impair our competitive position. There is a substantial amount of litigation, both within and outside the United States, involving patent and other intellectual property rights in the biopharmaceutical industry, including patent infringement lawsuits, oppositions, reexaminations, IPR proceedings and PGR proceedings before the USPTO and/or foreign patent offices. Numerous third-party U.S. and foreign issued patents and pending patent applications exist in the fields in which we are developing product candidates. There may be third-party patents or patent applications with claims to materials, formulations, methods of manufacture or methods for treatment related to the use or manufacture of our product candidates. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the biopharmaceutical industry expands and more patents issue, the risk increases that our product candidates may be subject to claims of infringement of the patent rights of third parties. Because patent applications are maintained as confidential for a certain period of time, until the relevant application is published we may be unaware of third-party patents that may be infringed by commercialization of any of our product candidates, and we cannot be certain that we were the first to file a patent application related to a product candidate or technology. Moreover, because patent applications can take many years to issue, there may be currently pending patent applications that may later result in issued patents that our product candidates may infringe. In addition, identification of third-party patent rights that may be relevant to our technology is difficult because patent searching is imperfect due to differences in terminology among patents, incomplete databases and the difficulty in assessing the meaning of patent claims. In addition, third parties may obtain patents in the future and claim that use of our technologies infringes these patents. Any claims of patent infringement asserted by third parties would be time consuming and could: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">result in costly litigation that may cause negative publicity; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">divert the time and attention of our technical personnel and management; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">cause development delays; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">prevent us from commercializing any of our product candidates until the asserted patent expires or is held finally invalid or unenforceable or not infringed in a court of law; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">require us to develop non-infringing technology, which may not be possible on a cost-effective basis; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">subject us to significant liability to third parties; or </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">require us to enter into royalty or licensing agreements, which may not be available on commercially reasonable terms, or at all, or which might be non-exclusive, which could result in our competitors gaining access to the same technology.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although no third party has asserted a claim of patent infringement against us as of the date of this Quarterly Report on Form 10-Q, others may hold proprietary rights that could prevent our product candidates from being marketed. Any patent-related legal action against us claiming damages and seeking to enjoin activities relating to our product candidates or processes could subject us to potential liability for damages, including treble damages if we were determined to willfully infringe, and require us to obtain a license to manufacture or develop our product candidates. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of management and employee resources from our business. We cannot predict whether we would prevail in any such actions or that any license required under any of these patents would be made available on commercially acceptable terms, if at all. Moreover, even if we or our future strategic partners were able to obtain a license, the rights may be nonexclusive, which could result in our competitors gaining access to the same intellectual property. In addition, we cannot be certain that we could redesign our product candidates or processes to avoid infringement, if necessary. Accordingly, an adverse determination in a judicial or administrative proceeding, or the failure to obtain necessary licenses, could prevent us from developing and commercializing our product candidates, which could harm our business, financial condition and operating results. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Parties making claims against us may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation or administrative proceedings, there is a risk that some of our confidential information could be compromised by disclosure. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise additional funds or otherwise have a material adverse effect on our business, results of operations, financial condition and prospects. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be involved in lawsuits to protect or enforce our patents or the patents of our licensors, which could be expensive, time-consuming and unsuccessful. Further, our issued patents could be found invalid or unenforceable if challenged in court. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors may infringe our intellectual property rights or those of our licensors. To prevent infringement or unauthorized use, we and/or our licensors may be required to file infringement claims, which can be expensive and time-consuming. Further, our licensors may need to file infringement claims, and our licensors may elect not file such claims. In addition, in a patent infringement proceeding, a court may decide that a patent we own or license is not valid, is unenforceable and/or is not infringed. If we or any of our licensors or potential future collaborators were to initiate legal proceedings against a third party to enforce a patent directed at one of our product candidates, the defendant could counterclaim that our patent is invalid and/or unenforceable in whole or in part. In patent litigation, defendant counterclaims alleging invalidity and/or unenforceability are commonplace. Grounds for a validity challenge include an alleged failure to meet any of several statutory requirements, including lack of novelty or written description, obviousness or non-enablement. Grounds for an unenforceability assertion could include an allegation that someone connected with prosecution of the patent intentionally withheld material information from the USPTO or made a misleading statement during prosecution. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability, we would lose at least part, and perhaps all, of the patent protection on such product candidate. In addition, if the breadth or strength of protection provided by our patents and patent applications or those of our licensors is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates. Such a loss of patent protection would have a material adverse impact on our business. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if resolved in our favor, litigation or other legal proceedings relating to our intellectual property rights may cause us to incur significant expenses, and could distract our technical and management personnel from their normal responsibilities. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could compromise our ability to compete in the marketplace. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation or other legal proceedings relating to our intellectual property rights, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation or other proceedings. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual property litigation may lead to unfavorable publicity that harms our reputation and causes the market price of our common shares to decline. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the course of any intellectual property litigation, there could be public announcements of the initiation of the litigation as well as results of hearings, rulings on motions, and other interim proceedings in the litigation. If securities analysts or investors regard these announcements as negative, the perceived value of our existing products, programs or intellectual property could be diminished. Accordingly, the market price of shares of our common stock may decline. Such announcements could also harm our reputation or the market for our future products, which could have a material adverse effect on our business. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivation or interference proceedings may be necessary to determine priority of inventions, and an unfavorable outcome may require us to cease using the related technology or to attempt to license rights from the prevailing party. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivation or interference proceedings provoked by third parties or brought by us or our licensors, or declared by the USPTO or similar proceedings in foreign patent offices may be necessary to determine the priority of inventions with respect to our or our licensors&#8217; patents or patent applications. An unfavorable outcome could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms. Our or our licensors&#8217; defense of such proceedings may fail and, even if successful, may result in substantial costs and distract our management and other employees. In addition, the uncertainties associated with such proceedings could have a material adverse effect on our ability to raise the funds necessary to continue our clinical trials, continue our research programs, license necessary technology from third parties or enter into development or manufacturing partnerships that would help us bring our product candidates to market. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patent reform legislation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2011, the Leahy-Smith America Invents Act, or Leahy-Smith Act, was signed into law. The Leahy-Smith Act includes a number of significant changes to U.S. patent law. These include provisions that affect the way patent applications are prosecuted and also affect patent litigation. In particular, under the Leahy-Smith Act, the United States transitioned in March 2013 to a &#8220;first inventor to file&#8221; system in which, assuming that other requirements of patentability are met, the first inventor to file a patent application will be entitled to the patent regardless of whether a third party was first to invent the claimed invention. A third party that files a patent application in the USPTO after March 2013 but before us could therefore be awarded a patent covering an invention of ours even if we had made the invention before it was made by such third party. This will require us to be cognizant going forward of the time from invention to filing of a patent application. Furthermore, our ability to obtain and maintain valid and enforceable patents depends on whether the differences between our technology and the prior art allow our technology to be patentable over the prior art. Since patent applications in the United States and most other countries are confidential for a period of time after filing or until issuance, we cannot be certain that we were the first to either (1)&#160;file any patent application related to our product candidates or (2)&#160;invent any of the inventions claimed in our patents or patent applications. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Leahy-Smith Act also includes a number of significant changes that affect the way patent applications are prosecuted and also affect patent litigation. These include allowing third-party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent by USPTO administered post-grant proceedings, including PGR, IPR, and derivation proceedings. An adverse determination in any such submission or proceeding could reduce the scope or enforceability of, or invalidate, our patent rights, which could adversely affect our competitive position. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standard in United States federal courts necessary to invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action. Accordingly, a third party may attempt to use the USPTO procedures to invalidate our patent claims that would not have been invalidated if first challenged by the third party as a defendant in a district court action. Thus, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our or licensors&#8217; patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in U.S. patent law, or laws in other countries, could diminish the value of patents in general, thereby impairing our ability to protect our product candidates. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As is the case with other biopharmaceutical companies, our success is heavily dependent on intellectual property, particularly patents. Obtaining and enforcing patents in the biopharmaceutical industry involve a high degree of technological and legal complexity. Therefore, obtaining and enforcing biopharmaceutical patents is costly, time-consuming and inherently uncertain. Changes in either the patent laws or in the interpretations of patent laws in the United States and other countries may diminish the value of our intellectual property and may increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. We cannot predict the breadth of claims that may be allowed or enforced in our patents or in third-party patents. In addition, Congress or other foreign legislative bodies may pass patent reform legislation that is unfavorable to us. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, the U.S. Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our or our licensors&#8217; ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the U.S. federal courts, the USPTO, or similar authorities in foreign jurisdictions, the laws and regulations governing patents could change in unpredictable ways that would weaken our or our licensors&#8217; ability to obtain new patents or to enforce our existing patents and patents we might obtain in the future. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We or our licensors may be subject to claims challenging the inventorship or ownership of our or our patents and other intellectual property. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also be subject to claims that former employees or other third parties have an ownership interest in our patents or other intellectual property. Litigation may be necessary to defend against these and other claims challenging inventorship or ownership. If we or our licensors fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights. Such an outcome could have a material adverse effect on our business. Even if we or our licensors are successful in defending against such claims, litigation could result in substantial costs and distraction to management and other employees. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patent terms may be inadequate to protect our competitive position on our product candidates for an adequate amount of time. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional filing date. Various extensions may be available, but the term of a patent, and the protection it affords, is limited. Even if patents directed to our product candidates are obtained, once the patent term has expired, we may be open to competition from competitive products. Given the amount of time required for the development, testing and regulatory review of product candidates, patents directed to our product candidates might expire before or shortly after such candidates are commercialized. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our licensors do not obtain patent term extension for our product candidates, our business may be materially harmed. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending upon the timing, duration and specifics of FDA marketing approval of our product candidates, one or more of our U.S. patents may be eligible for limited patent term restoration under the Drug Price Competition and Patent Term Restoration Act of 1984, or the Hatch-Waxman Amendments. The Hatch- Waxman Amendments permit a patent restoration term of up to five years as compensation for patent term lost during product development and the FDA regulatory review process. A maximum of one patent may be extended per FDA-approved product as compensation for the patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval and only those claims covering such approved drug product, a method for using it or a method for manufacturing it may be extended. Patent term extension may also be available in certain foreign countries upon regulatory approval of our product candidates. However, we or our licensors may not be granted an extension because of, for example, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we or our licensors are unable to obtain patent term extension or restoration or the term of any such extension is less than we request, our competitors may obtain approval of competing products following our patent expiration, and our revenue could be reduced, possibly materially. Further, if this occurs, our competitors may take advantage of our investment in development and trials by referencing our clinical and preclinical data and launch their product earlier than might otherwise be the case. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to protect our intellectual property rights throughout the world. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have issued patents and pending patent applications in the United States and certain other countries, filing, prosecuting and defending patents in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we or our licensors have patent protection but enforcement is not as strong as that in the United States. These products may compete with our product candidates, and our or our licensors patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of many foreign countries do not favor the enforcement of patents and other intellectual property protection, which could make it difficult for us to stop the infringement of our or our licensors&#8217; patents or marketing of competing products in violation of our proprietary rights. Proceedings to enforce our or our licensors&#8217; patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our or our licensors&#8217; patents at risk of being invalidated or interpreted narrowly and our or our licensors&#8217; patent applications at risk of not issuing and could provoke third parties to assert claims against us. We or our licensors may not prevail in any lawsuits that we or our licensors initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our or our licensors&#8217; efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we or our licensors are forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be impaired, and our business, financial condition, results of operations and prospects may be adversely affected. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Obtaining and maintaining our patent protection depends on compliance with various procedural, documentary, fee payment and other requirements imposed by regulations and governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on patents and/or applications will be due to the USPTO and various foreign patent offices at various points over the lifetime of our patents and/or applications. We have systems in place to remind us to pay these fees, and we rely on third parties to pay these fees when due. Additionally, the USPTO and various foreign patent offices require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. We employ reputable law firms and other professionals to help us comply, and in many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with rules applicable to the particular jurisdiction. However, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. If such an event were to occur, it could have a material adverse effect on our business. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we rely on the protection of our trade secrets, including unpatented know-how, technology and other proprietary information to maintain our competitive position. Although we have taken steps to protect our trade secrets and unpatented know-how, including entering into confidentiality agreements with third parties, and confidential information and inventions agreements with employees, consultants, licensors and advisors, we cannot provide any assurances that all such agreements have been duly executed, and any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, third parties may still obtain this information or may come upon this or similar information independently, and we would have no right to prevent them from using that technology or information to compete with us. If any of these events occurs or if we otherwise lose protection for our trade secrets, the value of this information may be greatly reduced and our competitive position would be harmed. If we or our licensors do not apply for patent protection prior to such publication or if we cannot otherwise maintain the confidentiality of our proprietary technology and other confidential information, then our ability to obtain patent protection or to protect our trade secret information may be jeopardized. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to claims that we have wrongfully hired an employee from a competitor or that we or our employees have wrongfully used or disclosed alleged confidential information or trade secrets of their former employers. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As is common in the biopharmaceutical industry, in addition to our employees, we engage the services of consultants to assist us in the development of our product candidates. Many of these consultants, and many of our employees, were previously employed at, or may have previously provided or may be currently providing consulting services to, other biopharmaceutical companies including our competitors or potential competitors. We may become subject to claims that we, our employees or a consultant inadvertently or otherwise used or disclosed trade secrets or other information proprietary to their former employers or their former or current clients. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel, which could adversely affect our business. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to our management team and other employees. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Dependence on Third Parties </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely, and expect to continue to rely, on third parties, including independent clinical investigators and CROs, to conduct certain aspects of our preclinical studies and clinical trials. If these third parties do not successfully carry out their contractual duties, comply with applicable regulatory requirements or meet expected deadlines, we may not be able to obtain regulatory approval for or commercialize our product candidates and our business could be substantially harmed. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have relied upon and plan to continue to rely upon third parties, including independent clinical investigators and third-party CROs, to conduct certain aspects of our preclinical studies and clinical trials and to monitor and manage data for our ongoing preclinical and clinical programs. We rely on these parties for execution of our preclinical studies and clinical trials, and control only certain aspects of their activities. Nevertheless, we are responsible for ensuring that each of our studies and trials is conducted in accordance with the applicable protocol, legal, regulatory and scientific standards, and our reliance on these third parties does not relieve us of our regulatory responsibilities. We and our third-party contractors and CROs are required to comply with GCP requirements, which are regulations and guidelines enforced by the FDA and comparable foreign regulatory authorities for all of our product candidates in clinical development. Regulatory authorities enforce these GCPs through periodic inspections of trial sponsors, principal investigators and trial sites. If we or any of these third parties or our CROs fail to comply with applicable GCPs, the clinical data generated in our clinical trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. We cannot assure you that upon inspection by a given regulatory authority, such regulatory authority will determine that any of our clinical trials comply with GCP regulations. In addition, our clinical trials must be conducted with product produced under cGMP regulations and similar foreign requirements. Our failure to comply with these regulations may require us to repeat clinical trials, which would delay the regulatory approval process. Moreover, our business may be adversely affected if any of these third parties violates federal, state or foreign fraud and abuse or false claims laws and regulations or healthcare privacy and security laws. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, these investigators and CROs are not our employees and we will not be able to control, other than by contract, the amount of resources, including time, which they devote to our product candidates and clinical trials. These third parties may also have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical trials or other product development activities, which could affect their performance on our behalf. If independent investigators or CROs fail to devote sufficient resources to the development of our product candidates, or if CROs do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our clinical protocols, regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated and we may not be able to obtain regulatory approval for or successfully commercialize our product candidates. As a result, our results of operations and the commercial prospects for our product candidates would be harmed, our costs could increase and our ability to generate revenues could be delayed or precluded entirely. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CROs have the right to terminate their agreements with us in the event of an uncured material breach. In addition, some of our CROs have an ability to terminate their respective agreements with us if it can be reasonably demonstrated that the safety of the subjects participating in our clinical trials warrants such termination, if we make a general assignment for the benefit of our creditors or if we are liquidated. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and government measures taken in response have also had a significant impact on our CROs, and we expect that they will face further disruption which may affect our ability to initiate and complete our preclinical studies and clinical trials. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our relationships with these third-party CROs terminate, we may not be able to enter into arrangements with alternative CROs or to do so on commercially reasonable terms. Switching or adding additional CROs involves additional cost and requires management time and focus. In addition, there is a natural transition period when a new CRO commences work. As a result, delays occur, which can materially impact our ability to meet our desired clinical development timelines. Additionally, CROs may lack the capacity to absorb higher workloads or take on additional capacity to support our needs. Though we carefully manage our relationships with our CROs, there can be no assurance that we will not encounter similar challenges or delays in the future or that these delays or challenges will not have a material adverse impact on our business, financial condition and prospects. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We contract with third parties for the manufacture of our product candidates for preclinical studies and our ongoing clinical trials, and expect to continue to do so for additional clinical trials and ultimately for commercialization. This reliance on third parties increases the risk that we will not have sufficient quantities of our product candidates or drugs or such quantities at an acceptable cost, which could delay, prevent or impair our development or commercialization efforts. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently have the infrastructure or internal capability to manufacture supplies of our product candidates for use in development and commercialization. We rely, and expect to continue to rely, on third-party manufacturers for the production of our product candidates for preclinical studies and clinical trials under the guidance of members of our organization. We do not have long-term supply agreements. Furthermore, the raw materials for our product candidates are sourced, in some cases, from a single-source supplier. If we were to experience an unexpected loss of supply of any of our product candidates or any of our future product candidates for any reason, whether as a result of manufacturing, supply or storage issues or otherwise, we could experience delays, disruptions, suspensions or terminations of, or be required to restart or repeat, any pending or ongoing clinical trials. For example, the extent to which the COVID-19 pandemic impacts our ability to procure sufficient supplies for the development of our products and product candidates will depend on the severity and duration of the spread of the virus, and the actions undertaken to contain COVID-19 or treat its effects. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to rely on third-party manufacturers for the commercial supply of any of our product candidates for which we obtain marketing approval. We may be unable to maintain or establish required agreements with third-party manufacturers or to do so on acceptable terms. Even if we are able to establish agreements with third-party manufacturers, reliance on third-party manufacturers entails additional risks, including: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the failure of the third party to manufacture our product candidates according to our schedule, or at all, including if our third-party contractors give greater priority to the supply of other products over our product candidates or otherwise do not satisfactorily perform according to the terms of the agreements between us and them; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the reduction or termination of production or deliveries by suppliers, or the raising of prices or renegotiation of terms; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the termination or nonrenewal of arrangements or agreements by our third-party contractors at a time that is costly or inconvenient for us; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the breach by the third-party contractors of our agreements with them; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the failure of third-party contractors to comply with applicable regulatory requirements; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the failure of the third party to manufacture our product candidates according to our specifications; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the mislabeling of clinical supplies, potentially resulting in the wrong dose amounts being supplied or active drug or placebo not being properly identified; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">clinical supplies not being delivered to clinical sites on time, leading to clinical trial interruptions, or of drug supplies not being distributed to commercial vendors in a timely manner, resulting in lost sales; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the misappropriation of our proprietary information, including our trade secrets and know-how.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have complete control over all aspects of the manufacturing process of, and are dependent on, our contract manufacturing partners for compliance with cGMP regulations or similar foreign requirements for manufacturing both active drug substances and finished drug products. Third-party manufacturers may not be able to comply with cGMP regulations or similar regulatory requirements outside of the United States. If our contract manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or others, they will not be able to secure and/or maintain marketing approval for their manufacturing facilities. In addition, we do not have control over the ability of our contract manufacturers to maintain adequate quality control, quality assurance and qualified personnel. If the FDA or a comparable foreign regulatory authority does not approve these facilities for the manufacture of our product candidates or if it withdraws any such approval in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain marketing approval for or market our product candidates, if approved. Our failure, or the failure of our third-party manufacturers, to comply with applicable regulations could result in sanctions being imposed on us, including fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates or drugs, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our product candidates or drugs and harm our business and results of operations. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current and anticipated future dependence upon others for the manufacture of our product candidates or drugs may adversely affect our future profit margins and our ability to commercialize any product candidates that receive marketing approval on a timely and competitive basis. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The manufacture of drugs is complex and our third-party manufacturers may encounter difficulties in production. If any of our third-party manufacturers encounter such difficulties, our ability to provide adequate supply of our product candidates for clinical trials or our products for patients, if approved, could be delayed or prevented. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing drugs, especially in large quantities, is complex and may require the use of innovative technologies. Each lot of an approved drug product must undergo thorough testing for identity, strength, quality, purity and potency. Manufacturing drugs requires facilities specifically designed for and validated for this purpose, and sophisticated quality assurance and quality control procedures are necessary. Slight deviations anywhere in the manufacturing process, including filling, labeling, packaging, storage and shipping and quality control and testing, may result in lot failures, product recalls or spoilage. When changes are made to the manufacturing process, we may be required to provide preclinical and clinical data showing the comparable identity, strength, quality, purity or potency of the products before and after such changes. If microbial, viral or other contaminations are discovered at the facilities of our manufacturer, such facilities may need to be closed for an extended period of time to investigate and remedy the contamination, which could delay clinical trials and adversely harm our business. The use of biologically derived ingredients can also lead to allegations of harm, including infections or allergic reactions, or closure of product facilities due to possible contamination. If our manufacturers are unable to produce sufficient quantities for clinical trials or for commercialization as a result of these challenges, or otherwise, our development and commercialization efforts would be impaired, which would have an adverse effect on our business, financial condition, results of operations and growth prospects. </span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we decide to establish collaborations in the future, but are not able to establish those collaborations on commercially reasonable terms, we may have to alter our development and commercialization plans. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our drug development programs and the potential commercialization of our product candidates will require substantial additional cash to fund expenses. We may continue to seek to selectively form collaborations to expand our capabilities, potentially accelerate research and development activities and provide for commercialization activities by third parties. Any of these relationships may require us to incur non-recurring and other charges, increase our near and long-term expenditures, issue securities that dilute our existing stockholders, or disrupt our management and business. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We would face significant competition in seeking appropriate collaborators and the negotiation process is time-consuming and complex. Whether we reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#8217;s evaluation of a number of factors. Those factors may include the design or results of clinical trials, the likelihood of approval by the FDA or comparable foreign regulatory authorities, the potential market for the subject product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients, the potential of competing drugs, the existence of uncertainty with respect to our ownership of intellectual property and industry and market conditions generally. The&#160;potential collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such collaboration could be more attractive than the one with us for our product candidate. Further, we may not be successful in our efforts to establish a collaboration or other alternative arrangements for future product candidates because they may be deemed to be at too early of a stage of development for collaborative effort and third parties may not view them as having the requisite potential to demonstrate safety and efficacy. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators. Even if we are successful in entering into a collaboration, the terms and conditions of that collaboration may restrict us from entering into future agreements on certain terms with potential collaborators. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If and when we seek to enter into collaborations, we may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of a product candidate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop our product candidates or bring them to market and generate product revenue. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have and in the future may enter into collaborations with third parties for the development and commercialization of product candidates. If those collaborations are not successful, we may not be able to capitalize on the market potential of these product candidates. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have and may in the future seek third-party collaborators for the development and commercialization of one or more of our product candidates. Our likely collaborators for any future collaboration arrangements include large and mid-size pharmaceutical companies, regional and national pharmaceutical companies and biotechnology companies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may have limited control over the amount and timing of resources that our collaborators dedicate to the development or commercialization of our product candidates. Our ability to generate revenues from these arrangements will depend on our collaborators&#8217; abilities and efforts to successfully perform the functions assigned to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">them in these arrangements. Collaborations involving our product candidates could pose numerous risks to us, including the following: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">collaborators have significant discretion in determining the efforts and resources that they will apply to these collaborations and may not perform their obligations as expected; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">collaborators may deemphasize or not pursue development and commercialization of our product candidates or may elect not to continue or renew development or commercialization programs based on clinical trial results, changes in the collaborators&#8217; strategic focus, including as a result of a sale or disposition of a business unit or development function, or available funding or external factors such as an acquisition that diverts resources or creates competing priorities; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our product candidates if the collaborators believe that competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than ours; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">a collaborator with marketing and distribution rights to multiple products may not commit sufficient resources to the marketing and distribution of our product relative to other products; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">collaborators may not properly obtain, maintain, defend or enforce our intellectual property rights or may use our proprietary information and intellectual property in such a way as to invite litigation or other intellectual property related proceedings that could jeopardize or invalidate our proprietary information and intellectual property or expose us to potential litigation or other intellectual property related proceedings; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">disputes may arise between the collaborators and us that result in the delay or termination of the research, development or commercialization of our product candidates or that result in costly litigation or arbitration that diverts management attention and resources; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">collaboration agreements may not lead to development or commercialization of product candidates in the most efficient manner or at all; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">if a collaborator of ours were to be involved in a business combination, the continued pursuit and emphasis on our drug development or commercialization program could be delayed, diminished or terminated.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of Our Common Stock </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The price of our stock may be volatile, and you could lose all or part of your investment. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our common stock is likely to be highly volatile and subject to wide fluctuations in response to various factors, some of which we cannot control. The stock market in general, and pharmaceutical and biotechnology companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating performance. In addition to the factors discussed in this &#8220;Risk Factors&#8221; section, these factors include: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the timing and results of preclinical studies and clinical trials of our product candidates or those of our competitors; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the success of competitive products or announcements by potential competitors of their product development efforts; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">regulatory actions with respect to our products or our competitors&#8217; products; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">actual or anticipated changes in our growth rate relative to our competitors; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">regulatory or legal developments in the United States and other countries; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">developments or disputes concerning patent applications, issued patents or other proprietary rights; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the recruitment or departure of key personnel; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">announcements by us or our competitors of significant acquisitions, strategic collaborations, joint ventures, collaborations or capital commitments; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">actual or anticipated changes in estimates as to financial results, development timelines or recommendations by securities analysts; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">fluctuations in the valuation of companies perceived by investors to be comparable to us; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">market conditions in the pharmaceutical and biotechnology sector; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">changes in the structure of healthcare payment systems; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">speculative trading in and short sales of our common stock, as well as trading phenomena such as the &#8220;short squeeze&#8221;;</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">share price and volume fluctuations attributable to inconsistent trading volume levels of our shares; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">announcement or expectation of additional financing efforts; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">sales of our common stock by us, our insiders or our other stockholders; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">expiration of market stand-off or lock-up agreements; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">general economic, industry and market conditions.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the trading prices for common stock of other biopharmaceutical companies have been highly volatile as a result of the COVID-19 pandemic. The COVID-19 pandemic continues to rapidly evolve. The extent to which the pandemic may impact our business, preclinical studies and clinical trials will depend on future developments, which are highly uncertain and cannot be predicted with confidence. The realization of any of the above risks or any of a broad range of other risks, including those described in this &#8220;Risk Factors&#8221; section, could have a dramatic and adverse impact on the market price of our common stock. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our quarterly operating results may fluctuate significantly or may fall below the expectations of investors or securities analysts, each of which may cause our stock price to fluctuate or decline. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our operating results to be subject to quarterly fluctuations. Our net loss and other operating results will be affected by numerous factors, including: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">variations in the level of expense related to the ongoing development of our product candidates or future development programs; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">results of clinical trials, or the addition or termination of clinical trials or funding support by us or potential future partners; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our execution of any collaboration, licensing or similar arrangements, and the timing of payments we may make or receive under potential future arrangements or the termination or modification of any such potential future arrangements; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">any intellectual property infringement, misappropriation or violation lawsuit or opposition, interference or cancellation proceeding in which we may become involved; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">additions and departures of key personnel; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">strategic decisions by us or our competitors, such as acquisitions, divestitures, spin-offs, joint ventures, strategic investments or changes in business strategy; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">if any of our product candidates receives regulatory approval, the terms of such approval and market acceptance and demand for such product candidates; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">regulatory developments affecting our product candidates or those of our competitors; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">changes in general market and economic conditions.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our quarterly operating results fall below the expectations of investors or securities analysts, the price of our common stock could decline substantially. Furthermore, any quarterly fluctuations in our operating results may, in turn, cause the price of our stock to fluctuate substantially. We believe that quarterly comparisons of our financial results are not necessarily meaningful and should not be relied upon as an indication of our future performance. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current beneficial owners of 5% or more of our common stock and management own a significant percentage of our stock and are able to exert significant influence over matters subject to stockholder approval.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, our executive officers, directors, holders of 5% or more of our capital stock and their respective affiliates beneficially own approximately</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 59.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6% of our outstanding common stock. As a result, these stockholders will be able to significantly influence us through this ownership position. These stockholders may be able to determine all matters requiring stockholder approval. For example, these stockholders may be able to control elections of directors, amendments of our organizational documents or approval of any merger, sale of assets or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may feel are in your best interest as one of our stockholders. The interests of this group of stockholders may not always coincide with your interests or the interests of other stockholders and they may act in a manner that advances their best interests and not necessarily those of other stockholders, including seeking a premium value for their common stock, and might affect the prevailing market price for our common stock.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales of a substantial number of shares of our common stock in the public market could cause our stock price to fall. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of a substantial number of shares of our common stock in the public market, or the perception in the market that the holders of a large number of shares of common stock intend to sell shares, could reduce the market price of our common stock. Outstanding shares of our common stock may be freely sold in the public market at any time to the extent permitted by Rules 144 and 701 under the Securities Act, or to the extent that such shares have already been registered under the Securities Act and are held by non-affiliates of ours. Moreover, holders of a substantial number of shares of our common stock have rights, subject to certain conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. We also have registered all shares of common stock that we may issue under our equity compensation plans or that are issuable upon exercise of outstanding options. These shares can be freely sold in the public market upon issuance and once vested, subject to volume limitations applicable to affiliates. If any of these additional shares are sold, or if it is perceived that they will be sold, in the public market, the market price of our common stock could decline.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Raising additional capital may cause dilution to our existing stockholders, restrict our operations or require us to relinquish rights to our product candidates on unfavorable terms to us. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek additional capital through a variety of means, including through public or private equity, debt financings or other sources, including up-front payments and milestone payments from strategic collaborations. For example, in August 2020 and July 2021, we completed underwritten public offerings of our common stock. To the extent that we raise additional capital through the sale of equity or convertible debt or equity securities, your ownership interest will be diluted, and the terms may include liquidation or other preferences that adversely affect your rights as a stockholder. Such financing may result in dilution to stockholders, imposition of debt covenants, increased fixed payment obligations or other restrictions that may affect our business. If we raise additional funds through up-front payments or milestone payments pursuant to strategic collaborations with third parties, we may have to relinquish valuable rights to our product candidates, or grant licenses on terms that are not favorable to us. In addition, we may seek additional capital due to favorable market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are an &#8220;emerging growth company,&#8221; and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies will make our common stock less attractive to investors. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act and will remain an emerging growth company until December 31, 2021. For as long as we continue to be an emerging growth company, we intend to take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">reduced disclosure obligations regarding executive compensation; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">exemptions from the requirements of holding nonbinding advisory stockholder votes on executive compensation and stockholder approval of any golden parachute payments not previously approved.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We intend to take advantage of the extended transition period for adopting new or revised accounting standards under the JOBS Act as an emerging growth company. As a result of this election, our financial statements may not be comparable to companies that comply with public company effective dates. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions in our certificate of incorporation and bylaws and Delaware law might discourage, delay or prevent a change in control of our company or changes in our management and, therefore, depress the market price of our common stock. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation and bylaws contain provisions that could depress the market price of our common stock by acting to discourage, delay or prevent a change in control of our company or changes in our management that the stockholders of our company may deem advantageous. These provisions, among other things: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">establish a classified board of directors so that not all members of our board are elected at one time; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">permit only the board of directors to establish the number of directors and fill vacancies on the board; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">provide that directors may only be removed &#8220;for cause&#8221; and only with the approval of two-thirds of our stockholders; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">authorize the issuance of &#8220;blank check&#8221; preferred stock that our board could use to implement a stockholder rights plan (also known as a &#8220;poison pill&#8221;); </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">eliminate the ability of our stockholders to call special meetings of stockholders; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">prohibit stockholder action by written consent, which requires all stockholder actions to be taken at a meeting of our stockholders; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">prohibit cumulative voting; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">authorize our board of directors to amend the bylaws; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">establish advance notice requirements for nominations for election to our board or for proposing matters that can be acted upon by stockholders at annual stockholder meetings; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">require a super-majority vote of stockholders to amend some provisions described above.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Section&#160;203 of the General Corporation Law of the State of Delaware, or the DGCL, prohibits a publicly-held Delaware corporation from engaging in a business combination with an interested stockholder, generally a person which together with its affiliates owns, or within the last three (3) years has owned, 15% of our voting stock, for a period of three (3) years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of our certificate of incorporation, bylaws or Delaware law that has the effect of delaying or preventing a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our capital stock and could also affect the price that some investors are willing to pay for our common stock. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;Our certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for: </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">any derivative action or proceeding brought on our behalf; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">any action asserting a claim of breach of fiduciary duty; </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">any action asserting a claim against us arising under the DGCL, our certificate of incorporation or our bylaws; and </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">any action asserting a claim against us that is governed by the internal-affairs doctrine.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This exclusive-forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees. Any person or entity purchasing or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented to this provision. If a court were to find this exclusive-forum provision in our certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving the dispute in other jurisdictions, which could seriously harm our business. Nothing in our certificate of incorporation precludes stockholders that assert claims under the Securities Act or the Exchange Act from bringing such claims in state or federal court, subject to applicable law. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not currently intend to pay dividends on our common stock and, consequently, your ability to achieve a return on your investment will depend on appreciation of the value of our common stock.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid any cash dividends on our equity securities. We currently anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. Any return to stockholders will therefore be limited to any appreciation in the value of our common stock, which is not certain. </span></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we engage in future acquisitions or strategic partnerships, this may increase our capital requirements, dilute our stockholders, cause us to incur debt or assume contingent liabilities, and subject us to other risks. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may evaluate various acquisition opportunities and strategic partnerships, including licensing or acquiring complementary products, intellectual property rights, technologies or businesses. Any potential acquisition or strategic partnership may entail numerous risks, including: </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; increased operating expenses and cash requirements; </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; the assumption of additional indebtedness or contingent liabilities; </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; the issuance of our equity securities; </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; assimilation of operations, intellectual property and products of an acquired company, including difficulties associated with integrating new personnel; </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="padding-left:27pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; the diversion of our management&#8217;s attention from our existing programs and initiatives in pursuing such a strategic merger or acquisition; </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; retention of key employees, the loss of key personnel and uncertainties in our ability to maintain key business relationships; </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; risks and uncertainties associated with the other party to such a transaction, including the prospects of that party and their existing products or product candidates and marketing approvals; and </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226; our inability to generate revenue from acquired technology and/or products sufficient to meet our objectives in undertaking the acquisition or even to offset the associated acquisition and maintenance costs. In addition, if we undertake acquisitions or pursue partnerships in the future, we may issue dilutive securities, assume or incur debt obligations, incur large one-time expenses and acquire intangible assets that could result in significant future amortization expense. Moreover, we may not be able to locate suitable acquisition opportunities, and this inability could impair our ability to grow or obtain access to technology or products that may be important to the development of our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish research or reports, or if they publish adverse or misleading research or reports, regarding us, our business or our market, our stock price and trading volume could decline. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common stock will be influenced by the research and reports that securities or industry analysts publish about us, our business or our market. If any of the analysts who cover us issue adverse or misleading research or reports regarding us, our business model, our intellectual property, our stock performance or our market, or if our operating results fail to meet the expectations of analysts, our stock price would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The requirements of being a public company may strain our resources, result in more litigation and divert management&#8217;s attention. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we are and will continue to be subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, the listing requirements of Nasdaq and other applicable securities rules and regulations. Complying with these rules and regulations has increased and will increase our legal and financial compliance costs, make some activities more difficult, time consuming or costly and increase demand on our systems and resources. The Exchange Act requires, among other things, that we file annual, quarterly and current reports with respect to our business and operating results. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are required to disclose changes made in our internal control over financial reporting on a quarterly basis. In order to maintain and, if required, improve our disclosure controls and procedures and internal control over financial reporting to meet this standard, significant resources and management oversight may be required. As a result, management&#8217;s attention may be diverted from other business concerns, which could adversely affect our business and operating results. We may also need to hire additional employees or engage outside consultants to comply with these requirements, which will increase our costs and expenses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, changing laws, regulations and standards relating to corporate governance and public disclosure are creating uncertainty for public companies, increasing legal and financial compliance costs and making some activities more time consuming. These laws, regulations and standards are subject to varying interpretations, in many cases due to their lack of specificity and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have invested and intend to continue to invest in resources to comply with evolving laws, regulations and standards, and this investment may result in increased general and administrative expenses and a diversion of management&#8217;s time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be adversely affected. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These new rules and regulations may make it more expensive for us to obtain director and officer liability insurance and, in the future, we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and retain qualified members of our board of directors, particularly to serve on our audit committee and compensation committee, and qualified executive officers. By disclosing information in filings required of us as a public company, our business and financial condition will continue to become more visible, which we believe may result in threatened or actual litigation, including by competitors and other third parties. If those claims are successful, our business could be seriously harmed. Even if the claims do not result in litigation or are resolved in our favor, the time and resources needed to resolve them could divert our management&#8217;s resources and seriously harm our business. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, stockholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our common stock. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our stock. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to disclose changes made in our internal controls and procedures on a quarterly basis and our management is required to assess the effectiveness of these controls annually. However, for as long as we are an emerging growth company, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting pursuant to Section 404. We will remain an emerging growth company until December 31, 2021. An independent assessment of the effectiveness of our internal controls over financial reporting could detect problems that our management&#8217;s assessment might not. Undetected material weaknesses in our internal controls over financial reporting could lead to restatements of our financial statements and require us to incur the expense of remediation.</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to securities litigation, which is expensive and could divert management attention.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our common stock may be volatile and, in the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert our management&#8217;s attention from other business concerns, which could seriously harm our business.  </span></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_97"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Proceeds</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 7, 2020, we completed our IPO and issued and sold 10,557,000 shares of our common stock (including 1,377,000 shares of our common stock in connection with the full exercise of the underwriters&#8217; option to purchase additional shares) at a price to the public of $18.00 per share. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, net proceeds of approximately $172.4 million from our IPO have been invested in investment grade, interest-bearing instruments. There has been no material change in the expected use of the net proceeds from our IPO as described in our final prospectus, dated April 2, 2020, filed with the SEC pursuant to Rule 424(b) relating to our registration statement on Form S-1 (Registration No. 333-236959), as amended, filed in connection with our IPO.</span></div><div id="i359d7483f88b44aba6df295b4be37cde_100"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities.</span></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-49pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i359d7483f88b44aba6df295b4be37cde_103"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures.</span></div><div style="margin-top:12pt;padding-left:24.5pt;text-indent:-24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i359d7483f88b44aba6df295b4be37cde_106"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information.</span></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-49pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i359d7483f88b44aba6df295b4be37cde_109"></div><div style="-sec-extract:summary;margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits.</span></div><div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:10.172%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.161%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:36.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing<br/>Date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed/Furnished Herewith</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1725160/000172516020000007/zentalis-eleaxplanofconv.htm">Plan of Conversion Converting Zentalis Pharmaceuticals, LLC (a Delaware limited liability company) into Zentalis Pharmaceuticals, Inc. (a Delaware corporation)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-39263</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">05/15/2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1725160/000172516020000007/zntl-certificateofconver.htm">Certificate of Conversion Converting Zentalis Pharmaceuticals, LLC (a Delaware limited liability company) into Zentalis Pharmaceuticals, Inc. (a Delaware corporation)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-39263</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">05/15/2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1725160/000119312520100536/d914800dex41.htm">Certificate of Incorporation of Zentalis Pharmaceuticals, Inc.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-237593</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">04/07/2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001725160/000172516021000063/exhibit-31xzntlxamendedres.htm">Bylaws of Zentalis Pharmaceuticals, Inc.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-39263</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/19/2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-healthpeakhcpxz.htm">Partial Lease Termination Agreement and First Amendment to Lease, effective September 16, 2021, by and between Zentalis Pharmaceuticals, Inc. and TPSC IX, LLC</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="zentalis10-qq32021ex3111.htm">Certification of Chief Executive Officer pursuant to Exchange Act Rule&#160;13a-14(a).</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="zentalis10-qq32021ex312.htm">Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a).</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:10.172%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.161%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:36.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing<br/>Date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed/Furnished Herewith</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="zentalis10-qq32021ex3211.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="zentalis10-qq32021ex3221.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data file (formatted as inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:15.865%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div style="padding-left:36pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><div id="i359d7483f88b44aba6df295b4be37cde_112"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.222%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zentalis Pharmaceuticals, Inc.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: November 10, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;Anthony Y. Sun, M.D.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anthony Y. Sun, M.D.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer, President and Chairman</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(principal executive officer)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: November 10, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;Melissa B. Epperly</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Melissa B. Epperly</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(principal financial and accounting officer)</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101-healthpeakhcpxz.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i1857427c06e5452983070f6ff36fd01d_1"></div><div style="min-height:55pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Exhibit 10.1 </font></div></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:111.6pt;padding-right:111.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">PARTIAL LEASE TERMINATION AGREEMENT AND</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">FIRST AMENDMENT TO LEASE</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:42pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">This PARTIAL LEASE TERMINATION AGREEMENT AND FIRST AMENDMENT</font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">TO LEASE (this &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">First Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;) is entered into as of the 16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> day of September, 2021 (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;), by and between TPSC IX, LLC, a Delaware limited liability company (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Landlord</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;), and ZENTALIS PHARMACEUTICALS, INC., a Delaware corporation (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;).</font></div><div><font><br></font></div><div style="margin-top:9.05pt;padding-left:111.6pt;padding-right:111.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">L</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> &#58;</font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">A.&#160;&#160;&#160;&#160;Landlord and Tenant entered into that certain Lease (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;) dated September 30, 2020, whereby Landlord leased to Tenant, and Tenant leased from Landlord, that certain building located at 10275 Science Center Drive, San Diego, California (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">10275 Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;) and that certain building located at 10285 Science Center Drive, San Diego, California (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">10285 Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;), as more particularly described in the Lease. A copy of the Lease is attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">and is incorporated herein by this reference.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">B.&#160;&#160;&#160;&#160;Tenant and Landlord desire to enter into this First Amendment in order to terminate Tenant&#8217;s lease of the 10285 Building and to release one another from their respective obligations thereunder with respect to the 10285 Building, except as otherwise provided herein. Each capitalized term when used herein shall have the same respective meaning as is given such term in the Lease, unless expressly provided otherwise in this First Amendment.</font></div><div><font><br></font></div><div style="margin-top:9.05pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">A G R E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">M E N T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> &#58;</font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">NOW, THEREFORE, in consideration of the foregoing recitals and the conditions and the covenants hereinafter contained, and for other consideration hereinafter set forth, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant hereby agree as follows.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Effectiveness of this First Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Notwithstanding anything to the contrary contained in this First Amendment, this First Amendment shall not be effective until Landlord enters into a new lease with &#34;Arcturus Therapeutics, Inc.&#34; (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Arcturus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) for the 10285 Building, in a form acceptable to Landlord in its sole and absolute discretion (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Arcturus Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Termination of the 10285 Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Landlord and Tenant hereby agree that conditioned upon the performance by the parties of the provisions of this First Amendment, the obligations that relate to only the 10285 Building under the Lease, including but not limited to Tenant's obligations to pay Rent for the 10285 Building, any Rent Abatement associated therewith and any Tenant Improvement Allowance associated therewith, shall terminate and be of no further force or effect as of the date Landlord and Arcturus fully execute and deliver the Arcturus Lease (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;). Accordingly, effective as of the Termination Date, (i) the 10285 Building shall not be a part of the Premises, and Landlord and Tenant shall be relieved of their</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:27.188%"><div style="margin-top:0.15pt"><font><br></font></div></div><div style="display:inline-block;max-width:45.622%;min-width:44.622%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:27.190%"><div><font><br></font></div></div></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_4"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:5.95pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">respective obligations under the Lease with respect to the 10285 Building, and (ii) the &#34;Premises&#34; shall consist of the 10275 Building only.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Possession of 10285 Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Landlord and Tenant hereby acknowledge that Tenant is not currently in possession of the 10285 Building and Tenant hereby releases Landlord from any obligation to deliver possession of the 10285 Building to Tenant on or before the Termination Date in accordance with the provisions of the Lease.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:78pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Modifications to Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Base Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Section 4 of the Summary is hereby amended and restated in its entirety as follows&#58;</font></div><div style="margin-bottom:0.05pt;margin-top:0.4pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:9.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.925%"><tr><td style="width:1.0%"></td><td style="width:50.304%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">&#8220;4.&#160;&#160;&#160;&#160;Base Rent (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%;text-decoration:underline">Article 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">)&#58;</font></div></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">Monthly</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5pt;padding-left:30.85pt;padding-right:11.6pt;text-indent:2.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Approximate Monthly Base</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 155.9pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Annual</font></td><td colspan="3" style="padding:2px 1pt 2px 30.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Installment</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.87pt;padding-right:10.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">Rent per Rentable</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:28.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%;text-decoration:underline">Lease Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%;text-decoration:underline">Base Rent</font></div></td><td colspan="3" style="padding:2px 22.15pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">of Base Rent</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt;padding-right:10.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%;text-decoration:underline">Square Foot*</font></div></td></tr><tr><td colspan="3" style="padding:2px 26.65pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1**&#160;&#160;&#160;&#160;$4,750,602.00</font></td><td colspan="3" style="padding:2px 23.2pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$395,883.50</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:10.85pt;padding-right:10.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$5.30</font></div></td></tr><tr><td colspan="3" style="padding:2px 26.65pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2**&#160;&#160;&#160;&#160;$4,893,120.12</font></td><td colspan="3" style="padding:2px 23.2pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$407,760.01</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:10.85pt;padding-right:10.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$5.46</font></div></td></tr><tr><td colspan="3" style="padding:2px 26.65pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3&#160;&#160;&#160;&#160;$5,039,913.72</font></td><td colspan="3" style="padding:2px 23.2pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$419,992.81</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:10.85pt;padding-right:10.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$5.62</font></div></td></tr><tr><td colspan="3" style="padding:2px 26.65pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4&#160;&#160;&#160;&#160;$5,191,111.08</font></td><td colspan="3" style="padding:2px 23.2pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$432,592.59</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:10.85pt;padding-right:10.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$5.79</font></div></td></tr><tr><td colspan="3" style="padding:2px 26.65pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">5&#160;&#160;&#160;&#160;$5,346,844.44</font></td><td colspan="3" style="padding:2px 23.2pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$445,570.37</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:10.85pt;padding-right:10.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$5.97</font></div></td></tr><tr><td colspan="3" style="padding:2px 26.65pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">6&#160;&#160;&#160;&#160;$5,507,249.76</font></td><td colspan="3" style="padding:2px 23.2pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$458,937.48</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:10.85pt;padding-right:10.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$6.14</font></div></td></tr><tr><td colspan="3" style="padding:2px 26.65pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">7&#160;&#160;&#160;&#160;$5,672,467.20</font></td><td colspan="3" style="padding:2px 23.2pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$472,705.60</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:10.85pt;padding-right:10.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$6.33</font></div></td></tr><tr><td colspan="3" style="padding:2px 26.65pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">8&#160;&#160;&#160;&#160;$5,842,641.24</font></td><td colspan="3" style="padding:2px 23.2pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$486,886.77</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:10.85pt;padding-right:10.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$6.52</font></div></td></tr><tr><td colspan="3" style="padding:2px 26.65pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">9&#160;&#160;&#160;&#160;$6,017,920.44</font></td><td colspan="3" style="padding:2px 23.2pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$501,493.37</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:10.85pt;padding-right:10.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$6.71</font></div></td></tr><tr><td colspan="3" style="padding:2px 26.65pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">10&#160;&#160;&#160;&#160;$6,198,458.04</font></td><td colspan="3" style="padding:2px 23.2pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$516,538.17</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:10.85pt;padding-right:10.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$6.92</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-right:25.6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">11 (eight months)&#160;&#160;&#160;&#160;$6,384,411.84</font></div></td><td colspan="3" style="padding:2px 23.15pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$532,034.32</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:10.87pt;padding-right:10.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">$7.12</font></div></td></tr></table></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:11.4pt;padding-right:53.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">* The calculation of the Approximate Monthly Base Rent per Rentable Square Foot reflects an annual increase of 3%, rounded to the nearest cent, after the previous Lease Year.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="height:52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><font><br></font></div></div><div style="padding-left:11.35pt;padding-right:53.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">** Tenant's obligation to pay Monthly Installment of Base Rent for (i) the second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">) through ninth (9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">) full calendar months following the Lease Commencement Date with respect to the 10275 Building shall be subject to the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Section 3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> of the Lease.&#8221;</font></div><div style="height:52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_7"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Tenant's Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. As of the Termination Date, all references to Tenant's Share of the 10285 Building shall be deleted in its entirety and of no further force or effect.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">First Month&#8217;s Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Landlord hereby acknowledges that pursuant to Section 3.1 of the Lease Tenant has paid to Landlord the Base Rent and Tenant's Share of the estimated Direct Expenses for the first full month of the Lease Term in an amount equal to</font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$810,172.70 (i.e., $625,023.70 for the Base Rent and $185,149.00 for Tenant's Share of the estimated Direct Expenses). Landlord shall pay to Tenant an amount equal to $297,017.75 as a refund to Tenant of the Base Rent and Tenant's Share of the estimated Direct Expenses for the first full month of the Lease Term with respect to the 10285 Building.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Base Rent Abatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Section 3.2 of the Lease is hereby amended and restated in its entirety as follows&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:77.95pt;padding-right:47.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8220;3.2   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Abated Base Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Provided that Tenant is not then in default of this Lease beyond applicable notice and cure periods, then during the second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">) through ninth (9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">) full calendar months following the Lease Commencement Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Rent Abatement Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), Tenant shall not be obligated to pay Base Rent otherwise attributable to the Premises during such Rent Abatement Period (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Rent Abatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;). Landlord and Tenant acknowledge that the aggregate amount of the Rent Abatement equals $3,167,068.00. Tenant acknowledges and agrees that the foregoing Rent Abatement has been granted to Tenant as additional consideration for entering into this Lease, and for agreeing to pay the rental and performing the terms and conditions otherwise required under this Lease. If Tenant shall be in default under this Lease, and shall fail to cure such default within the notice and cure period, if any, permitted for cure pursuant to terms and conditions of the Lease, or if this Lease is terminated for any reason other than Landlord&#8217;s breach of this Lease or an event of casualty or condemnation, at any time prior to the expiration of the Rent Abatement Period, then the dollar amount of the unapplied portion of the Rent Abatement as of the date of such default or termination, as the case may be, shall be converted to a credit to be applied to the Base Rent applicable at the end of the Lease Term and Tenant shall immediately be obligated to begin paying Base Rent for the Premises in full.&#8221;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Section 8 of the Summary is hereby amended and restated in its entirety as follows&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:47.4pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">8.&#160;&#160;&#160;&#160;Letter of Credit</font></div><div style="padding-left:47.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Article 21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">)&#58;&#160;&#160;&#160;&#160;$682,151.00.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Landlord shall reasonably cooperate with Tenant in connection with the reduction of the L-C Amount of the L-C currently held by Landlord to the amount set forth herein.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Reduction of Parking Spaces</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. As of the Effective Date, Tenant's parking spaces shall be reduced by One Hundred Eleven (111) parking spaces, and the total unreserved parking spaces shall be deemed to be One Hundred Ninety-One (191). Tenant shall have no further right to use any parking spaces associated with the 10285 Building.</font></div><div style="height:52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_10"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Reduction of Tenant Improvement Allowance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. As of the Effective Date, the Tenant Improvement Allowance associated with the 10285 Building shall be deleted in its entirety and of no further force or effect. Furthermore, as of the Effective Date, the Tenant Improvement Allowance (i.e., the Tenant Improvement Allowance for the 10275 Building) shall be reduced by Five Hundred Thousand and 00&#47;100 ($500,000.00), resulting in the total Tenant Improvement Allowance amount being equal to $17,426,800.00.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Generator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. As of the Effective Date, the Emergency Generator shall exclude the emergency electrical generator and related equipment serving the 10285 Building.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Signage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. As of the Effective Date, Tenant's Signage shall exclude (i) the exclusive Building top identification sign on the 10285 Building, and (ii) identification signage on the Project's monument sign for the 10285 Building.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Release of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.&#160;&#160;&#160;&#160;Except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Sections 4, 6 and 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> hereof, and conditioned on the performance by the parties of the provisions of this First Amendment&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">5.1.&#160;&#160;&#160;&#160;Landlord and Tenant shall, as of the Termination Date, be fully and unconditionally released and discharged from their respective obligations from or connected with the provisions of the Lease with respect to the 10285 Building&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:115%">5.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">this First Amendment shall fully and finally settle all demands, charges, claims, accounts or causes of action of any nature, including, without limitation, both known and unknown claims and causes of action that may arise out of or in connection with the obligations of the parties under the Lease with respect to the 10285 Building.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Each of the parties expressly waives the provisions of California Civil Code Section 1542, which provides&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:78pt;padding-right:119.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&#34;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Each party acknowledges that it has received the advice of legal counsel with respect to the aforementioned waiver and understands the terms thereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:78pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Representations of Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Tenant represents and warrants to Landlord that</font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(a) Tenant has not heretofore assigned or sublet all or any portion of its interest in the Lease&#59; (b) no other person, firm or entity has any right, title or interest in the Lease&#59; (c) Tenant has the full right, legal power and actual authority to enter into this First Amendment and to terminate the Lease with respect to the 10285 Building, without the consent of any person, firm or entity&#59; and</font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(d) Tenant has the full right, legal power and actual authority to bind Tenant to the terms and conditions hereof. Tenant further represents and warrants to Landlord that as of the date hereof there are no, and as of the Termination Date there shall not be any, mechanic's liens or other liens</font></div><div style="height:52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_13"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:6pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">encumbering all or any portion of the 10285 Building, by virtue of any act or omission on the part of Tenant, its predecessors, contractors, agents, employees, successors or assigns. Notwithstanding the termination of the Lease with respect to the 10285 Building, and the release of liability provided for herein, the representations and warranties set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> shall survive the Termination Date and Tenant shall be liable to Landlord for any inaccuracy or any breach thereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Continuing Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Notwithstanding the termination of the Lease with respect to the 10285 Building and the release of liability provided for herein, Tenant shall remain liable for the performance of all of its obligations under the Lease with respect to the 10275 Building and Landlord shall have all the rights and remedies with respect to such obligations as set forth in the Lease.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Attorneys' Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Should any dispute arise between the parties hereto or their legal representatives, successors and assigns concerning any provision of this First Amendment or the rights and duties of any person in relation thereto, the party prevailing in such dispute shall be entitled, in addition to such other relief that may be granted, to recover reasonable attorneys' fees and legal costs in connection with such dispute.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. This First Amendment shall be governed and construed under the laws of the State of California.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Counterparts&#59; Signatures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. This First Amendment may be executed in counterparts, each of which shall be deemed an original, but such counterparts, when taken together, shall constitute one agreement. Signatures of the parties transmitted by telefacsimile or electronic mail PDF format shall be deemed to constitute originals and may be relied upon, for all purposes, as binding the transmitting party hereto. The parties intend to be bound by the signatures transmitted by telefacsimile or electronic mail PDF format, are aware that the other party will rely on such signature, and hereby waive any defenses to the enforcement of the terms of this First Amendment based on the form of signature.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Binding Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. This First Amendment shall inure to the benefit of, and shall be binding upon, the parties hereto and their respective legal representatives, successors and assigns.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Time of the Essence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Time is of the essence of this First Amendment and the provisions contained herein.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Landlord and Tenant hereby agree to execute such further documents or instruments as may be necessary or appropriate to carry out the intention of this First Amendment.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Voluntary Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. The parties have read this First Amendment and mutual release as contained herein, and on the advice of counsel they have freely and voluntarily entered into this First Amendment.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:154.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#91;SIGNATURE PAGE FOLLOWS&#93;</font></div><div style="height:52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_16"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:112%">IN WITNESS WHEREOF, Landlord and Tenant have executed this First Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:112%">as</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:112%">of the day and year first above written.</font></div><div><font><br></font></div><div style="text-indent:242pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;LANDLORD&#8221;</font></div><div><font><br></font></div><div style="text-indent:242pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">TPSC IX, LLC,</font></div><div style="text-indent:242pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">a Delaware limited liability company</font></div><div><font><br></font></div><div style="text-indent:242pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">By&#58;      HCP Estates USA Inc.,</font></div><div style="text-indent:278pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">a Delaware corporation, Its Managing Member</font></div><div><font><br></font></div><div style="text-indent:277.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline"> &#47;s&#47; Michael Dorris                    </font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:277.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:186%">Name&#58;  Michael Dorris</font></div><div style="text-indent:277.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:186%">Title&#58; Senior Vice President</font></div><div style="text-indent:277.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:186%">&#8220;TENANT&#8221;</font></div><div style="padding-left:36pt;text-indent:242pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ZENTALIS PHARMACEUTICALS, INC.,</font></div><div style="padding-left:36pt;text-indent:242pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">a Delaware corporation</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:242pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline"> &#47;s&#47; Kevin Bunker                      </font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:288pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Kevin Bunker</font></div><div style="padding-left:288pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Print Name</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Its&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">COO                  </font></div><div style="padding-left:288pt;text-indent:36pt"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-indent:242pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">                                                  </font></div><div style="padding-left:324pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Print Name</font></div><div><font><br></font></div><div style="text-indent:242pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Its&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">                                                   </font></div><div id="i1857427c06e5452983070f6ff36fd01d_19"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.808%"><div style="margin-top:0.5pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.383%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.809%"></div></div><div style="height:52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_22"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:111.6pt;padding-right:111.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT A</font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:222.92pt;padding-right:222.92pt;text-align:center;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:217%;text-decoration:underline">THE LEASE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:217%"> &#91;ATTACHED&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div id="i1857427c06e5452983070f6ff36fd01d_25"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.808%"><div style="margin-top:5.85pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">EXHIBIT A</font></div></div><div style="display:inline-block;max-width:0.383%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.809%"></div></div><div style="height:35pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_28"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">THE BOARDWALK</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">LEASE</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This Lease (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), dated as of the date set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Summary of Basic Lease Information (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Summary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), below, is made by and between TPSC IX, LLC, a Delaware limited liability company (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Landlord</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), and ZENTALIS PHARMACEUTICALS, INC., a Delaware corporation (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:132.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">SUMMARY OF BASIC LEASE INFORMATION</font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:11.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">TERMS OF LEASE&#160;&#160;&#160;&#160;DESCRIPTION</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:47.35pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.&#160;&#160;&#160;&#160;Date&#58;&#160;&#160;&#160;&#160;September 30, 2020.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:47.35pt;padding-right:430.05pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.&#160;&#160;&#160;&#160;Premises (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:245.35pt;padding-right:53.25pt;text-align:justify;text-indent:-198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.1&#160;&#160;&#160;&#160;Building&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">10275 Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58; That certain building to be constructed by Landlord and to be located at 10275 Science Center Drive, San Diego, California (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">10275 Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:245.35pt;padding-right:53.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">10285 Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58; That certain building to be constructed by Landlord and to be located at 10285 Science Center Drive, San Diego, California (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">10285 Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:245.35pt;padding-right:53.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As used herein, the 10275 Building and the 10285 Building shall be known collectively as the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.&#34;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:245.35pt;padding-right:53pt;text-align:justify;text-indent:-198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2&#160;&#160;&#160;&#160;Premises&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Approximately 117,929 rentable square feet of space consisting of (i) approximately 74,695 rentable square feet of space located on a portion of the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) floor and the entire second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) floor of the 10275 Building and which is all of the leasable space in the 10275 Building, and (ii) approximately 43,234 rentable square feet of space located on the entire first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) floor and the entire second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) floor of the 10285 Building and which is all of the leasable space the 10285 Building, as further set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to the Lease.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:47.35pt;padding-right:426.85pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.&#160;&#160;&#160;&#160;Lease Term (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:83.4pt;text-indent:-36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.1&#160;&#160;&#160;&#160;Length of Term&#58;&#160;&#160;&#160;&#160;Ten (10) years and eight (8) months.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_31"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.969%"><div style="margin-top:4.6pt;padding-left:83.35pt;padding-right:1.9pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.2&#160;&#160;&#160;&#160;Lease Commencement Date&#58;</font></div><div style="margin-top:4.6pt;padding-left:47.35pt;padding-right:39.5pt"><font><br></font></div></div><div style="display:inline-block;max-width:4.061%;min-width:3.061%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.970%"><div style="padding-left:47.35pt;padding-right:39.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The earlier to occur of (i) the date upon which Tenant first commences to conduct business in the Premises and</font></div><div style="padding-left:47.35pt;padding-right:45.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(ii) the Possession Date (as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1.1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease).</font></div></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:83.4pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.3&#160;&#160;&#160;&#160;Lease Expiration Date&#58;&#160;&#160;&#160;&#160;If the Lease Commencement Date shall be the first day</font></div><div style="margin-top:0.05pt;padding-left:245.4pt;padding-right:53.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of a calendar month, then the day immediately preceding the ten (10) year eight (8) month anniversary of the Lease Commencement Date&#59; or, if the Lease</font></div><div style="height:53.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_34"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:245.35pt;padding-right:53.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commencement Date shall be other than the first day of a calendar month, then the last day of the month in which the ten (10) year eight (8) month anniversary of the Lease Commencement Date occurs.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:47.35pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.&#160;&#160;&#160;&#160;Base Rent (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)&#58;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:26.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"><tr><td style="width:1.0%"></td><td style="width:21.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.853%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div><font><br></font></div><div style="margin-top:8.8pt;padding-left:12.9pt;padding-right:12.9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Lease Year</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:35.9pt;padding-right:40.4pt;text-indent:5.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Annual </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Base Rent</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:28.65pt;padding-right:28.65pt;text-align:center;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Monthly Installment </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">of Base Rent</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:14.92pt;padding-right:14.92pt;text-align:center;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Approximate Monthly Base Rent per Rentable </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Square Foot*</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.8pt;padding-left:12.92pt;padding-right:12.92pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1**</font></div></td><td colspan="3" style="padding:2px 1pt 2px 28.55pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$7,500,284.40</font></td><td colspan="3" style="padding:2px 29.35pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$625,023.70</font></td><td colspan="3" style="padding:2px 28.4pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$5.30</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.8pt;padding-left:12.92pt;padding-right:12.92pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2**</font></div></td><td colspan="3" style="padding:2px 1pt 2px 28.55pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$7,725,292.92</font></td><td colspan="3" style="padding:2px 29.35pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$643,774.41</font></td><td colspan="3" style="padding:2px 28.4pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$5.46</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:11.25pt;padding-right:11.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</font></div></td><td colspan="3" style="padding:2px 1pt 2px 28.55pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$7,957,051.68</font></td><td colspan="3" style="padding:2px 29.35pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$663,087.64</font></td><td colspan="3" style="padding:2px 28.4pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$5.62</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.8pt;padding-left:11.25pt;padding-right:11.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</font></div></td><td colspan="3" style="padding:2px 1pt 2px 28.55pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$8,195,763.24</font></td><td colspan="3" style="padding:2px 29.35pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$682,980.27</font></td><td colspan="3" style="padding:2px 28.4pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$5.79</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:11.25pt;padding-right:11.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</font></div></td><td colspan="3" style="padding:2px 1pt 2px 28.55pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$8,441,636.16</font></td><td colspan="3" style="padding:2px 29.35pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$703,469.68</font></td><td colspan="3" style="padding:2px 28.4pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$5.97</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.8pt;padding-left:11.25pt;padding-right:11.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</font></div></td><td colspan="3" style="padding:2px 1pt 2px 28.55pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$8,694,885.24</font></td><td colspan="3" style="padding:2px 29.35pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$724,573.77</font></td><td colspan="3" style="padding:2px 28.4pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$6.14</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.8pt;padding-left:11.25pt;padding-right:11.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</font></div></td><td colspan="3" style="padding:2px 1pt 2px 28.55pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$8,955,731.76</font></td><td colspan="3" style="padding:2px 29.35pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$746,310.98</font></td><td colspan="3" style="padding:2px 28.4pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$6.33</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:11.25pt;padding-right:11.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</font></div></td><td colspan="3" style="padding:2px 1pt 2px 28.55pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$9,224,403.72</font></td><td colspan="3" style="padding:2px 29.35pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$768,700.31</font></td><td colspan="3" style="padding:2px 28.4pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$6.52</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.8pt;padding-left:11.25pt;padding-right:11.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</font></div></td><td colspan="3" style="padding:2px 1pt 2px 28.55pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$9,501,135.84</font></td><td colspan="3" style="padding:2px 29.35pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$791,761.32</font></td><td colspan="3" style="padding:2px 28.4pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$6.71</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.8pt;padding-left:12.95pt;padding-right:12.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</font></div></td><td colspan="3" style="padding:2px 1pt 2px 28.55pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$9,786,169.92</font></td><td colspan="3" style="padding:2px 29.35pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$815,514.16</font></td><td colspan="3" style="padding:2px 28.4pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$6.92</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:12.95pt;padding-right:12.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">11 (eight months)</font></div></td><td colspan="3" style="padding:2px 1pt 2px 26.05pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$10,079,755.08</font></td><td colspan="3" style="padding:2px 29.3pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$839,979.59</font></td><td colspan="3" style="padding:2px 28.35pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$7.12</font></td></tr></table></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:11.35pt;padding-right:53.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">* The calculation of the Approximate Monthly Base Rent per Rentable Square Foot reflects an annual increase of 3%, rounded to the nearest cent, after the previous Lease Year.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:11.35pt;padding-right:53.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">** Tenant's obligation to pay Monthly Installment of Base Rent for (i) the second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) through ninth (9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) full calendar months following the Lease Commencement Date with respect to the 10275 Building, and (ii) the second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) through fourteenth (14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) full calendar months following the Lease Commencement Date with respect to the 10285 Building, shall be subject to the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Lease.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:47.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.&#160;&#160;&#160;&#160;Tenant Improvement Allowance (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)&#58;&#160;&#160;&#160;&#160;An amount equal to $240.00 per rentable square foot of</font></div><div style="margin-top:0.05pt;padding-left:246.75pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the Premises (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, $28,302,960.00 based upon 117,929 rentable square feet in the Premises).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:47.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.&#160;&#160;&#160;&#160;Tenant's Share</font></div><div style="margin-top:0.05pt;padding-left:47.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">10275 Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58; One hundred percent (100%).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:246.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">10285 Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58; One hundred percent (100%).</font></div><div style="height:66.3pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_37"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:47.4pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.&#160;&#160;&#160;&#160;Permitted Use</font></div><div style="margin-top:0.05pt;padding-left:246.75pt;padding-right:53.15pt;text-align:justify;text-indent:-199.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)&#58;&#160;&#160;&#160;&#160;The Premises shall be used only for general office, research and development, engineering, laboratory, storage and&#47;or warehouse uses, including, but not limited to, administrative offices and other lawful uses reasonably related to or incidental to such specified uses, all (i) consistent with first class life sciences projects in the La Jolla area of San Diego, California (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">First Class Life Sciences Projects</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), and (ii) in compliance with, and subject to, Applicable Laws (as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) and the terms of this Lease.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:47.4pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.&#160;&#160;&#160;&#160;Letter of Credit</font></div><div style="padding-left:47.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)&#58;&#160;&#160;&#160;&#160;$1,076,985.00.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:47.4pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9.&#160;&#160;&#160;&#160;Parking</font></div><div style="padding-left:246.75pt;padding-right:53.15pt;text-align:justify;text-indent:-199.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 28</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)&#58;&#160;&#160;&#160;&#160;Three hundred two (302) unreserved parking spaces, provided that (i) Tenant shall have the right to convert up to fifteen (15) of Tenant's unreserved parking spaces to reserved parking spaces near the main entrance to the 10275 Building or in the 10275 Building's subterranean parking garage (subject to Landlord's reasonable designation of the location of such spaces), and (ii) such unreserved parking spaces shall include the exclusive use of all of the parking spaces associated with the 10285 Building, for Tenant&#8217;s guests, visitors and employees, subject to the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 28</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Lease.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:47.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10.&#160;&#160;&#160;&#160;Address of Tenant</font></div><div style="padding-left:47.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 29.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)&#58;&#160;&#160;&#160;&#160;Zentalis Pharmaceuticals, Inc.</font></div><div style="padding-left:246.75pt;padding-right:135.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10835 Road to the Cure, Suite 205 San Diego, CA 92121</font></div><div style="padding-left:246.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Attention&#58; Legal Department</font></div><div style="padding-left:246.75pt;padding-right:122.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:236%">(Prior to Lease Commencement Date) and</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:246.75pt;padding-right:153.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Zentalis Pharmaceuticals, Inc. 10285 Science Center Drive San Diego, California 92121 Attention&#58; Legal Department</font></div><div style="padding-left:246.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(After Lease Commencement Date)</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:47.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11.&#160;&#160;&#160;&#160;Address of Landlord</font></div><div style="padding-left:47.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 29.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)&#58;&#160;&#160;&#160;&#160;See </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 29.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Lease.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:47.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12.&#160;&#160;&#160;&#160;Broker(s)</font></div><div style="margin-top:0.05pt;padding-left:47.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 29.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58; Cushman &#38; Wakefield</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:69.6pt;padding-right:69.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Landlord</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58; CBRE</font></div><div style="height:66.3pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_40"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:41.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1.&#160;&#160;&#160;&#160;PREMISES, BUILDING, PROJECT, AND COMMON AREAS</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:78pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Premises, Building, Project and Common Areas</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">The Premises&#59; Tender of Possession</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord hereby leases to Tenant and Tenant hereby leases from Landlord the premises set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Summary (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). The outline of the Premises is set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">attached hereto. The outline of the &#34;Building&#34; and the &#34;Project,&#34; as those terms are defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1.1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> below, are further depicted on the Site Plan attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit A-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The parties hereto agree that the lease of the Premises is upon and subject to the terms, covenants and conditions herein set forth, and Tenant covenants as a material part of the consideration for this Lease to keep and perform each and all of such terms, covenants and conditions by it to be kept and performed and that this Lease is made upon the condition of such performance. The parties hereto hereby acknowledge that the purpose of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">is to show the approximate location of the Premises only, and such Exhibit is not meant to constitute an agreement, representation or warranty as to the construction of the Premises, the precise area thereof or the specific location of the &#34;Common Areas,&#34; as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1.1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below, or the elements thereof or of the accessways to the Premises or the &#34;Project,&#34; as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1.1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below. Except as specifically set forth in this Lease and in the Tenant Work Letter attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant Work Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), Landlord shall tender possession of the Premises to Tenant in its then existing, &#34;as is&#34; condition, and Landlord shall not be obligated to provide or pay for any improvement work or services related to the improvement of the Premises. Landlord shall be deemed to have tendered possession of the Premises to Tenant upon the date of delivery of the Substantial Completion Certificate to Tenant in connection with the Tenant Improvements, as those terms are defined in the Tenant Work Letter (the &#34;&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Possession Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), and no action by Tenant shall be required therefor. Except as expressly set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1.1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below, if for any reason, Landlord is delayed in tendering possession of the Premises to Tenant by any particular date, Landlord shall not be subject to any liability for such failure, and the validity of this Lease shall not be impaired. Neither Landlord nor any agent of Landlord has made any representation or warranty regarding the condition of the Premises, the Building or the Project or with respect to the suitability of any of the foregoing for the conduct of Tenant's business, except as specifically set forth in this Lease and the Tenant Work Letter.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">The Building and The Project</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Premises constitutes the space set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Summary. The Building is part of an office&#47;laboratory project currently known as &#34;The Boardwalk.&#34; The term &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Project</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,&#34; as used in this Lease, shall mean (i) the Building (including the 10275 Building and the 10285 Building) and the Common Areas, (ii) the land (which is improved with landscaping, parking facilities and other improvements) upon which the Building and the Common Areas are located, (iii) the other office&#47;laboratory buildings located at 10265 Science Center Drive (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">10265 Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), and the land upon which such adjacent office&#47;laboratory building are located, and (iv) at Landlord's discretion, any additional real property, areas, land, buildings or other improvements added thereto outside of the Project (provided that the addition of such additional area does not materially increase Tenant's cost hereunder).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Common Areas</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall have the non-exclusive right to use in common with other tenants in the Project, and subject to the rules and regulations referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, those portions of the Project which are provided, from time to time, for use in common by Landlord, Tenant and any other tenants of the Project (such areas, together with such other portions of the Project designated by Landlord, in its discretion, are collectively referred to herein as the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Common Areas</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). The manner in which the Common Areas are maintained and operated shall be at the sole discretion of Landlord and the use thereof shall be subject to such rules, regulations and restrictions as Landlord may make from time to time. Landlord reserves the right to close temporarily, make alterations or additions to, or change the location of elements of the Project and the Common Areas, provided that, in connection therewith, Landlord shall perform such closures, alterations, additions or changes in a commercially reasonable manner and, in connection therewith, shall use commercially reasonable efforts to minimize any material interference with Tenant's use of and access to the Premises.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Landlord's Twelve Month Warranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Upon the Lease Commencement Date, the Building Systems (as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below) and the roof (including roof membrane) of each Building (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Warrantied Improvements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) shall be in good working order, condition and repair (collectively, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Good Working Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) and Landlord hereby covenants that the Warrantied Improvements shall remain in Good Working Order for the period (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Warranty Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) commencing on the Lease Commencement Date and</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_43"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">continuing until the first (1st) anniversary of the Lease Commencement Date. Landlord shall, at Landlord's sole cost and expense (which shall not be deemed an Operating Expense, as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4.2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> below), repair or replace any portion of such Warrantied Improvements which is not in Good Working Order during such Warranty Period (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Landlord&#8217;s Twelve Month Warranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), provided that the need to repair or replace was not caused by (A) the misuse, misconduct, damage, destruction, omissions, and&#47;or negligence of Tenant, its subtenants and&#47;or assignees, if any (collectively, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant Damage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), or (B) any modifications, Alterations or other improvements constructed by or on behalf of Tenant (collectively, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). Landlord's Twelve Month Warranty shall neither (i) be deemed to require Landlord to replace any portion of any Warrantied Improvements, as opposed to repair such portion of such Warrantied Improvements, nor (ii) extend to the costs of normal and customary preventive maintenance relating to the Warrantied Improvements (the responsibility and cost for which will be handled in accordance with other provisions of this Lease). To the extent repairs which Landlord is required to make pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1.1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> are necessitated by Tenant Damage or Tenant Modification, then Tenant shall reimburse Landlord for the cost of such repair (provided that if such repairs are necessitated in part by Tenant Damage or Tenant Modification, then Tenant shall reimburse Landlord for an equitable portion of the cost of such repair). If it is determined that the Warrantied Improvements are not then in Good Working Order prior to the first (1st) anniversary of the Lease Commencement Date, then Landlord shall not be liable to Tenant for any damages, but, as Tenant's sole remedy, Landlord, at no cost to Tenant (subject to any repair or replacement necessitated by Tenant Damage or Tenant Modification), shall promptly commence such work or take such other action as may be necessary to place the same in Good Working Order, and shall thereafter diligently and continuously pursue the same to completion.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Occurrence of Lease Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Landlord shall use its commercially reasonable, good faith efforts to cause the Lease Commencement Date to occur on or before November 1, 2021.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.1.5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Outside Date of Lease Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If Landlord does not cause the Lease Commencement Date to occur on or before July 1, 2022 (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Outside Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), then the sole remedy of Tenant for such failure shall be the right to deliver a notice to Landlord (a &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Termination Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) electing to terminate this Lease effective upon the date occurring five (5) business days following receipt by Landlord of the Termination Notice (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). The Termination Notice must be delivered by Tenant to Landlord, if at all, not earlier than the Outside Date (as the same may be extended pursuant to the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1.1.5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below) nor later than five (5) business days after the Outside Date. The effectiveness of any such Termination Notice delivered by Tenant to Landlord shall be governed by the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1.1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.1.5.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Extension of Outside Date After Delivery of the Termination Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If Tenant delivers a Termination Notice to Landlord, then Landlord shall have the right to suspend the occurrence of the Effective Date for a period ending thirty (30) days after the Effective Date by delivering written notice to Tenant, prior to the Effective Date, that, in Landlord's reasonable, good faith judgment, the Lease Commencement Date will occur within thirty (30) days after the Effective Date (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Termination Extension Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). If the Lease Commencement Date occurs within such thirty (30) day suspension period, then the Termination Notice shall be of no force or effect, but if the Lease Commencement Date does not occur within such thirty (30) day suspension period, then this Lease shall terminate upon the expiration of such thirty (30) day suspension period.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.1.5.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Extension of Outside Date Prior to the Delivery of Termination Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If, prior to the Outside Date, Landlord determines that the Lease Commencement Date will not occur by the Outside Date, then Landlord shall have the right to deliver a written notice to Tenant stating Landlord's opinion as to the date by which the Lease Commencement Date will occur, and Tenant shall be required, within five (5) business days after receipt of such notice, to deliver a notice to Landlord pursuant to which Tenant shall elect either (i) to terminate this Lease, in which case this Lease shall terminate and be of no further force or effect upon Landlord's receipt of such notice, or (ii) to agree to extend the Outside Date to that date set forth in Landlord's notice to Tenant. Failure by Tenant to deliver such notice or to make such election shall be deemed to be Tenant's agreement to extend the Outside Date to that date set forth in Landlord's notice to Tenant. If Tenant agrees or is deemed to have agreed to extend the Outside Date, then Landlord shall have a continuing right to deliver a notice to Tenant which requests Tenant to elect either to terminate this Lease or to further extend the Outside Date as set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1.1.5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above, until the occurrence of the Lease Commencement Date or until this Lease is terminated. Upon the delivery of a Termination Notice by Tenant pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1.1.5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> above in connection with an Outside Date extended pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1.1.5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Landlord shall also have the same right to deliver the Termination Extension Notice as to the new Outside Date, as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1.1.5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_46"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.1.5.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Other Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Effective Date and the Outside Date shall be extended to the extent of any delays beyond the reasonable control of Landlord, including any delay or delays caused by &#34;Force Majeure,&#34; as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 29.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, any Tenant delays pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Tenant Work Letter, and any delay or delays encountered by Landlord affecting the construction of the Tenant Improvements due to waiting periods for obtaining governmental permits or approvals in excess of the time periods normally required to obtain such permits or approvals for newly constructed, similarly improved space in office and laboratory buildings in the Torrey Pines market area of San Diego, California. Upon any termination as set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1.1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Landlord and Tenant shall be relieved from any and all liability to each other resulting hereunder except that Landlord shall return to Tenant any prepaid rent and the letter of credit. Tenant's rights to terminate this Lease, as set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 1.1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, shall be Tenant's sole and exclusive remedy at law or in equity for the failure of the Lease Commencement Date to occur as set forth above.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Rentable Square Feet of Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The rentable square footage of the Premises is hereby deemed to be as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Summary, and shall not be subject to measurement or adjustment during the Lease Term.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Temporary Space</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">In addition to the Premises, commencing as of the substantial completion of the tenant improvements in the Temporary Building (as that term is defined below), which is anticipated to occur on or about November 1, 2020, and continuing until the date that occurs thirty (30) day following the Lease Commencement Date (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%">Temporary Space Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">&#34;), Tenant shall lease from </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">HCP University Center East LLC, a Delaware limited liability company </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">(&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%">Affiliate Landlord</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">&#34;), an affiliate of Landlord, and Affiliate Landlord shall lease to Tenant approximately 13,251 rentable square feet of space located on the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.82pt;font-weight:400;line-height:115%;position:relative;top:-3.67pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">) floor of that certain building located at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9381 Judicial Drive, San Diego, California (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Temporary Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">, as more particularly set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit A-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">attached hereto (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%">Temporary Space</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">&#34;). Tenant shall lease the Temporary Space on all of the same terms and conditions as apply to the Premises pursuant to this Lease </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(including, without limitation, Tenant's indemnity and insurance obligations, pursuant to the terms and conditions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, below, with respect to the Temporary Space)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">, except that (i) Tenant shall not be obligated to pay any Base Rent with respect to the Temporary Space, (ii) for purposes of determining the terms and conditions applicable to the Temporary Space, Affiliate Landlord shall be deemed to be Landlord and the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Temporary Building shall be deemed to be the Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">, (iii) Tenant shall have no right to sublease or assign the Temporary Space, (iv) Tenant shall have no right to construct any Alterations or other improvements in the Temporary Space, (v) Affiliate Landlord shall construct improvements in the Temporary Space </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">which are a logical extension of the space plan attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit A-3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">, and Tenant shall accept the Temporary Space in its then existing, &#34;as-is&#34; condition without the payment of any improvement allowance&#59; provided, however, Landlord shall deduct One Hundred Fifty-Nine Thousand and No&#47;100 Dollars ($159,000.00) from the Tenant Improvement Allowance in order to reimburse Landlord for certain improvement work requested by Tenant in the Temporary Space, and (vi) Tenant shall be allowed to use up to thirty-six (36) parking spaces in the parking facility associated with the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Temporary Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">. Notwithstanding the foregoing or anything to the contrary set forth in this Lease, Tenant shall be required to pay Tenant's Share of Direct Expenses attributable to the Temporary Space and all other Additional Rent (as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;text-decoration:underline">Section 3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">, below) due pursuant to the terms of this Lease during the Temporary Space Term, provided that Tenant's Share shall be equal to 14.23%. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tenant hereby acknowledges that neither Landlord, Affiliate Landlord nor any agent of Landlord or Affiliate Landlord has made any representation or warranty regarding the condition of the Temporary Space with respect to the suitability of such space for the conduct of Tenant's business&#59; provided that Landlord represents and warrants, to its actual knowledge without a duty to investigate, that&#58; (a) the Temporary Space is not in violation of any applicable laws that would prevent Tenant from occupying the Temporary Space once the improvements are complete, and (b) there are no damages or defect with respect to the Temporary Space that would not be discoverable during a visual inspection&#59; provided that if any such damages or defects are discovered the repair shall be governed by the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">Tenant shall vacate and surrender the Temporary Space to Affiliate Landlord on or before the expiration of the Temporary Space Term (provided that if Tenant surrenders the Temporary Space early, Tenant shall provide at least thirty (30) days' prior notice to Affiliate Landlord of such surrender) empty of all furniture and personal property of Tenant, &#34;broom clean&#34;, and in as good condition as when it was delivered to Tenant, reasonable wear and tear and casualty damage excepted. If Tenant fails to timely vacate and surrender the Temporary Space, the terms of Article 16 of this Lease shall apply to such holdover, as if the Base Rent payable</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_49"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">for the Temporary Space was at the same rate per square foot as is then applicable to the Premises (without considering any free rent attributable to the Premises).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:42pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2.&#160;&#160;&#160;&#160;LEASE TERM&#59; OPTION TERM</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Lease Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The terms and provisions of this Lease shall be effective as of the date of this Lease. The term of this Lease (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lease Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) shall be as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Summary, shall commence on the date set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Summary (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lease Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), and shall terminate on the date set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Summary (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lease Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) unless this Lease is sooner terminated as hereinafter provided. For purposes of this Lease, the term &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lease Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; shall mean each consecutive twelve (12) month period during the Lease Term. At any time during the Lease Term, Landlord may deliver to Tenant a notice in the form as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, attached hereto, as a confirmation only of the information set forth therein, which Tenant shall execute and return to Landlord within ten (10) business days of receipt thereof.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:78pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Option Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Option Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord hereby grants to the originally named Tenant herein (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Original Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) and any &#34;Permitted Transferee Assignee&#34;, as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> below, two (2) options to extend the Lease Term for a period of five (5) years each (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Option Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). The options to extend shall be exercisable only by notice delivered by Tenant to Landlord as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below, the following conditions </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Option Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) are satisfied&#58; (i) as of the date of delivery of such notice, Tenant is not in default beyond any applicable notice and cure period under this Lease&#59; (ii) Tenant is not in default beyond any applicable notice and cure period under this Lease at the time Landlord and Tenant execute an amendment to this Lease extending the Lease Term for the applicable Option Term&#59; and (iii) Tenant has not previously been in default with respect to any monetary obligation or material non-monetary obligation beyond any applicable notice and cure period under this Lease more than twice in the preceding twelve (12) month period. Landlord may, at Landlord's option, exercised in Landlord's sole and absolute discretion, waive any of the Option Conditions in which case the option, if otherwise properly exercised by Tenant, shall remain in full force and effect. Upon the proper exercise of an option to extend, the Lease Term shall be extended for a period of five (5) years. The rights contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall be personal to the Original Tenant and any Permitted Transferee Assignee and may only be exercised by the Original Tenant or a Permitted Transferee Assignee (and not any other assignee or sublessee or &#34;Transferee,&#34; as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below, of Tenant&#8217;s interest in this Lease) if the Original Tenant or a Permitted Transferee Assignee, as applicable, occupies the entire Premises. In the event that Tenant fails to timely and appropriately exercise its initial option to extend the Lease Term, or its second option to extend the Lease Term, as the case may be, in accordance with the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, then such option (and any other then-remaining option to extend the Lease Term, if applicable) shall automatically terminate and shall be of no further force or effect.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Option Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Rent payable by Tenant during an Option Term (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Option Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) shall be equal to the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Market Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,&#34; as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, attached hereto, as such Market Rent is determined pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, attached hereto. The calculation of the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Market Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; shall be derived from a review of, and comparison to, the &#34;Net Equivalent Lease Rates&#34; of the &#34;Comparable Transactions,&#34; as provided for in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and, thereafter, the Market Rent shall be stated as a &#34;Net Equivalent Lease Rate&#34; for the applicable Option Term&#59; provided the Option Rent shall increase by three percent (3%) on each anniversary of the comment of the Option Term.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exercise of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Such options to extend shall be exercisable only by written notice delivered by Tenant to Landlord not more than twelve (12) months nor less than nine (9) months prior to the expiration of the initial Lease Term (or initial Option Term, as the case may be), stating that Tenant is thereby irrevocably exercising its option to lease the Premises during the Option Term (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Option Exercise Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). Landlord shall, within thirty (30) days following Landlord's receipt of the Option Exercise Notice, deliver notice (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Option Rent Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) to Tenant setting forth the Option Rent&#59; and (iii) Tenant may, on or before the date occurring fifteen (15) business days after Tenant's receipt of the Option Rent Notice, deliver written notice to Landlord and accept or reject the Option Rent set forth in the Option Rent Notice. If Tenant exercises its option to extend the Lease but fails to accept or reject the Option Rent set forth in the Option Rent Notice, then Tenant shall be deemed to have accepted the Option Rent set forth in the Option Rent Notice.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_52"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Determination of Option Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In the event Tenant timely and appropriately exercises its option to extend the Lease but rejects the Option Rent set forth in the Option Rent Notice pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above, then Landlord and Tenant shall attempt to agree upon the Option Rent using their best good-faith efforts. If Landlord and Tenant fail to reach agreement upon the Option Rent applicable to the Option Term on or before the date that is ninety (90) days prior to the expiration of the initial Lease Term (or initial Option Term, as the case may be) (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Outside Agreement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), then the Option Rent shall be determined by arbitration pursuant to the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Each party shall make a separate determination of the Option Rent, within five (5) business days following the Outside Agreement Date, and such determinations shall be submitted to arbitration in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Sections 2.2.4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">2.2.4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.1&#160;&#160;&#160;&#160;Landlord and Tenant shall each appoint one arbitrator who shall by profession be a MAI appraiser, real estate broker or real estate lawyer who shall have been active over the five (5) year period ending on the date of such appointment in the appraising and&#47;or leasing of first class office and laboratory properties in the vicinity of the Building. The determination of the arbitrators shall be limited solely to the issue area of whether Landlord&#8217;s or Tenant&#8217;s submitted Option Rent is the closest to the actual Option Rent as determined by the arbitrators, taking into account the requirements of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease. Each such arbitrator shall be appointed within fifteen (15) days after the Outside Agreement Date. Landlord and Tenant may consult with their selected arbitrators prior to appointment and may select an arbitrator who is favorable to their respective positions (including an arbitrator who has previously represented Landlord and&#47;or Tenant, as applicable). The arbitrators so selected by Landlord and Tenant shall be deemed &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Advocate Arbitrators</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.&#34;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.2&#160;&#160;&#160;&#160;The two (2) Advocate Arbitrators so appointed shall be specifically required pursuant to an engagement letter within ten (10) days of the date of the appointment of the last appointed Advocate Arbitrator to agree upon and appoint a third arbitrator (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Neutral Arbitrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) who shall be qualified under the same criteria set forth hereinabove for qualification of the two Advocate Arbitrators except that (i) neither the Landlord or Tenant or either parties' Advocate Arbitrator may, directly or indirectly, consult with the Neutral Arbitrator prior or subsequent to his or her appearance, and (ii) the Neutral Arbitrator cannot be someone who has represented Landlord and&#47;or Tenant during the five (5) year period prior to such appointment. The Neutral Arbitrator shall be retained via an engagement letter jointly prepared by Landlord&#8217;s counsel and Tenant&#8217;s counsel.</font></div><div><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3&#160;&#160;&#160;&#160;Within ten (10) days following the appointment of the Arbitrator, Landlord and Tenant shall enter into an arbitration agreement (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Arbitration Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) which shall set forth the following&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.1&#160;&#160;&#160;&#160;Each of Landlord's and Tenant's best and final and binding determination of the Option Rent exchanged by the parties pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.2&#160;&#160;&#160;&#160;An agreement to be signed by the Neutral Arbitrator, the form of which agreement shall be attached as an exhibit to the Arbitration Agreement, whereby the Neutral Arbitrator shall agree to undertake the arbitration and render a decision in accordance with the terms of this Lease, as modified by the Arbitration Agreement, and shall require the Neutral Arbitrator to demonstrate to the reasonable satisfaction of the parties that the Neutral Arbitrator has no conflicts of interest with either Landlord or Tenant&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:185.9pt;text-indent:-35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.3&#160;&#160;&#160;&#160;Instructions to be followed by the Neutral Arbitrator when conducting</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">such arbitration&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.4&#160;&#160;&#160;&#160;That Landlord and Tenant shall each have the right to submit to the Neutral Arbitrator (with a copy to the other party), on or before the date that occurs fifteen (15) days following the appointment of the Neutral Arbitrator, an advocate statement (and any other information such party deems relevant) prepared by or on behalf of Landlord or Tenant, as the case may be, in support of Landlord's or Tenant's respective determination of Option Rent (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Briefs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.5&#160;&#160;&#160;&#160;That within five (5) business days following the exchange of Briefs, Landlord and Tenant shall each have the right to provide the Neutral Arbitrator (with a copy to the other party) with a written rebuttal to the other party's Brief (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">First Rebuttals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;)&#59; provided, however, such First Rebuttals shall be limited to the facts and arguments raised in the other party's Brief and shall identify clearly which argument or fact of the other party's Brief is intended to be rebutted&#59;</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_55"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.6&#160;&#160;&#160;&#160;That within five (5) business days following the parties' receipt of each other's First Rebuttal, Landlord and Tenant, as applicable, shall each have the right to provide the Neutral Arbitrator (with a copy to the other party) with a written rebuttal to the other party's First Rebuttal (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Second Rebuttals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;)&#59; provided, however, such Second Rebuttals shall be limited to the facts and arguments raised in the other party's First Rebuttal and shall identify clearly which argument or fact of the other party's First Rebuttal is intended to be rebutted&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.7&#160;&#160;&#160;&#160;The date, time and location of the arbitration, which shall be mutually and reasonably agreed upon by Landlord and Tenant, taking into consideration the schedules of the Neutral Arbitrator, the Advocate Arbitrators, Landlord and Tenant, and each party's applicable consultants, which date shall in any event be within forty-five (45) days following the appointment of the Neutral Arbitrator&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:143.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.8&#160;&#160;&#160;&#160;That no discovery shall take place in connection with the arbitration, other than to verify the factual information that is presented by Landlord or Tenant&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.9&#160;&#160;&#160;&#160;That the Neutral Arbitrator shall not be allowed to undertake an independent investigation or consider any factual information other than presented by Landlord or Tenant, except that the Neutral Arbitrator shall be permitted to visit the Project and the buildings containing the Comparable Transactions&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:221.9pt;text-indent:-71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.10&#160;&#160;&#160;&#160;The specific persons that shall be allowed to attend the</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">arbitration&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.11&#160;&#160;&#160;&#160;Tenant shall have the right to present oral arguments to the Neutral Arbitrator at the arbitration for a period of time not to exceed three (3) hours (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant's Initial Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;)&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.12&#160;&#160;&#160;&#160;Following Tenant's Initial Statement, Landlord shall have the right to present oral arguments to the Neutral Arbitrator at the arbitration for a period of time not to exceed three (3) hours (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Landlord's Initial Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.13&#160;&#160;&#160;&#160;Following Landlord's Initial Statement, Tenant shall have up to two (2) additional hours to present additional arguments and&#47;or to rebut the arguments of Landlord (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant's Rebuttal Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.85pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.14&#160;&#160;&#160;&#160;Following Tenant's Rebuttal Statement, Landlord shall have up to two (2) additional hours to present additional arguments and&#47;or to rebut the arguments of Tenant (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Landlord's Rebuttal Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.15&#160;&#160;&#160;&#160;That, not later than ten (10) days after the date of the arbitration, the Neutral Arbitrator shall render a decision (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Ruling</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) indicating whether Landlord's or Tenant's submitted Option Rent is closer to the Option Rent&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.85pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.16&#160;&#160;&#160;&#160;That following notification of the Ruling, Landlord's or Tenant's submitted Option Rent determination, whichever is selected by the Neutral Arbitrator as being closer to the Option Rent shall become the then applicable Option Rent&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:221.9pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.3.17&#160;&#160;&#160;&#160;That the decision of the Neutral Arbitrator shall be binding on</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Landlord and Tenant.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47pt;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If a date by which an event described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.2.4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above, is to occur falls on a weekend or a holiday, the date shall be deemed to be the next business day.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4.4&#160;&#160;&#160;&#160;In the event that the Option Rent shall not have been determined pursuant to the terms hereof prior to the commencement of the Option Term, Tenant shall be required to pay the Option Rent, initially provided by Landlord to Tenant, and upon the final determination of the Option Rent, the payments made by Tenant shall be reconciled with the actual amounts due, and the appropriate party shall make any corresponding payment to the other party.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_58"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Tenant Termination Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Notwithstanding any provision to the contrary contained in this Lease, Tenant shall have two (2) options (each, a &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Termination Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) to terminate and cancel this Lease effective as of</font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i)&#160;&#160;&#160;&#160;the last day of the ninety-second (92</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) full calendar month of the Lease Term with respect to the first Termination Option, and (ii) the last day of the one hundred forth (104</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) full calendar month of the Lease Term with respect to the second Termination Option (as applicable, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), upon Tenant&#8217;s delivery of written notice to Landlord (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Termination Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), which notice shall be delivered to Landlord on or before the date which is twelve (12) full calendar months prior to the applicable Termination Date, and, concurrently with its delivery of such Termination Notice, Tenant shall deliver to Landlord the &#8220;Termination Fee,&#8221; as that term is defined hereinbelow, as consideration for and as a condition precedent to such early termination. The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Termination Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221; shall be equal to</font></div><div style="padding-left:5.95pt;padding-right:47.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(A) the total amount of Base Rent and estimated Direct Expenses which would otherwise have been paid by Tenant (as if this Lease had not been terminated) for the nine (9) calendar months following the Termination Date with respect to the first Termination Option, and (B) the total amount of Base Rent and estimated Direct Expenses which would otherwise have been paid by Tenant (as if this Lease had not been terminated) for the seven (7) calendar months following the Termination Date with respect to the second Termination Option. Subject to Landlord&#8217;s timely receipt of the Termination Notice and the Termination Fee, this Lease shall automatically terminate and be of no further force or effect, and Landlord and Tenant shall be relieved of their respective obligations under this Lease, as of the Termination Date, except with respect to those obligations set forth in this Lease, which specifically survive the expiration or earlier termination of this Lease, including, without limitation, the payment by Tenant of all amounts owed by Tenant under this Lease, up to and including the Termination Date. Each Termination Option shall automatically terminate and be of no further force or effect in the event (x) Tenant fails to properly and timely exercise such Termination Option as set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, (y) Tenant&#8217;s right to possession of the Premises has previously been terminated, or (z) Tenant is in default under this Lease (beyond the expiration of all applicable notice and cure periods), as of the date of Tenant&#8217;s delivery of the Termination Notice to Landlord. The Termination Options granted to Tenant under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> is personal to the Original Tenant and its Permitted Transferee Assignee and may not be exercised by any assignee, sublessee, or transferee of the Original Tenant&#8217;s or its Permitted Transferee Assignee' interest in this Lease.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:78pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Expansion Termination Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exercise of Termination Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If Tenant requires additional space for its business operations within the Premises, and If Landlord is unable to accommodate Tenant's need for additional space in the Project, and as a result Tenant and Landlord or an affiliate of Landlord (an entity which is controlled by, controls, or is under common control with, Landlord) fully execute and deliver a lease for space larger than the then Premises (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Expansion Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), upon terms mutually acceptable to each party in each party's sole and absolute discretion, then Tenant may terminate this Lease by delivering written notice to Landlord (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Termination Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) at least three</font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(3) business days prior to Landlord's delivery of the executed Expansion Lease to Tenant, which termination shall be effective as of the commencement date of the Expansion Lease (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), and shall be without the payment of any termination penalty or fee by Tenant.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Termination of Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Provided that Tenant timely elects to terminate this Lease in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above, this Lease shall automatically terminate and be of no further force or effect, and Landlord and Tenant shall be relieved of their respective obligations under this Lease, as of the Termination Date, except with respect to those obligations set forth in this Lease which specifically survive the expiration or earlier termination of this Lease, including, without limitation, the payment by Tenant of all amounts owed by Tenant under this Lease that accrued prior to the Termination Date. The termination right contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall be personal to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Original Tenant </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">or any Permitted Transferee Assignee, and may only be exercised by Original Tenant or any Permitted Transferee Assignee (and not by any assignee, sublessee or other Transferee of Tenant's interest in this Lease) if Original Tenant or any Permitted Transferee Assignee occupies the entire Premises.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:41.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">3.&#160;&#160;&#160;&#160;BASE RENT</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Base Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall pay, without prior notice or demand, to Landlord or Landlord's agent at the management office of the Project, or, at Landlord's option, at such other place as Landlord may from time to time designate in writing, by a check for currency which, at the time of payment, is legal tender for private or public debts </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="padding-left:6pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the United States of America, base rent (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Base Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) as set forth in Section 4 of the Summary, payable in equal monthly installments as set forth in Section 4 of the Summary in advance on or before the first day of each and every</font></div><div id="i1857427c06e5452983070f6ff36fd01d_61"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">calendar month during the Lease Term, without any setoff or deduction whatsoever. The Base Rent and Tenant's Share of the estimated Direct Expenses (as those terms are defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Sections 4.2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">4.2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease) for the first full month of the Lease Term in an amount equal to $810,172.70 (i.e., $625,023.70 for the Base Rent and $ 185,149.00 for Tenant's Share of the estimated Direct Expenses for the first full month of the Lease Term) shall be paid at the time of Tenant's execution of this Lease. If any Rent payment date (including the Lease Commencement Date) falls on a day of the month other than the first day of such month or if any payment of Rent is for a period which is shorter than one month, the Rent for any fractional month shall accrue on a daily basis for the period from the date such payment is due to the end of such calendar month or to the end of the Lease Term at a rate per day which is equal to 1&#47;365 of the applicable annual Rent. All other payments or adjustments required to be made under the terms of this Lease that require proration on a time basis shall be prorated on the same basis.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Abated Base Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Provided that Tenant is not then in default of this Lease beyond applicable notice and cure periods, then during (i) the second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) through ninth (9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) full calendar months following the Lease Commencement Date with respect to the 10275 Building, and (ii) the second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) through fourteenth (14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) full calendar months following the Lease Commencement Date with respect to the 10285 Building (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rent Abatement Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), Tenant shall not be obligated to pay Base Rent otherwise attributable to the Premises during such Rent Abatement Period (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rent Abatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;). Landlord and Tenant acknowledge that the aggregate amount of the Rent Abatement equals (a) $3,167,068.00 with respect to the 10275 Building, and (b) $2,992,571.02 with respect to the 10275 Building. Tenant acknowledges and agrees that the foregoing Rent Abatement has been granted to Tenant as additional consideration for entering into this Lease, and for agreeing to pay the rental and performing the terms and conditions otherwise required under this Lease. If Tenant shall be in default under this Lease, and shall fail to cure such default within the notice and cure period, if any, permitted for cure pursuant to terms and conditions of the Lease, or if this Lease is terminated for any reason other than Landlord&#8217;s breach of this Lease or an event of casualty or condemnation, at any time prior to the expiration of the Rent Abatement Period, then the dollar amount of the unapplied portion of the Rent Abatement as of the date of such default or termination, as the case may be, shall be converted to a credit to be applied to the Base Rent applicable at the end of the Lease Term and Tenant shall immediately be obligated to begin paying Base Rent for the Premises in full.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:41.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">4.&#160;&#160;&#160;&#160;ADDITIONAL RENT</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:77.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">General Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Direct Expenses&#59; Additional Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In addition to paying the Base Rent specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, Tenant shall pay &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant's Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; of the annual &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Direct Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,&#34; as those terms are defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Sections 4.2.6 and 4.2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, respectively. Such payments by Tenant, together with any and all other amounts payable by Tenant to Landlord pursuant to the terms of this Lease, are hereinafter collectively referred to as the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Additional Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;, and the Base Rent and the Additional Rent are herein collectively referred to as &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.&#34; All amounts due under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> as Additional Rent shall be payable for the same periods and in the same manner as the Base Rent. Without limitation on other obligations of Tenant which survive the expiration of the Lease Term, the obligations of Tenant to pay the Additional Rent provided for in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall survive the expiration of the Lease Term.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Triple Net Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord and Tenant acknowledge that, except as otherwise provided to the contrary in this Lease, it is their intent and agreement that this Lease be a &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">TRIPLE NET</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; lease and that as such, the provisions contained in this Lease are intended to pass on to Tenant or reimburse Landlord for the costs and expenses reasonably associated with this Lease, the Building and the Project, and Tenant's operation therefrom. To the extent such costs and expenses payable by Tenant cannot be charged directly to, and paid by, Tenant, such costs and expenses shall be paid by Landlord but reimbursed by Tenant as Additional Rent.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Definitions of Key Terms Relating to Additional Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. As used in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, the following terms shall have the meanings hereinafter set forth&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:114pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.2.1&#160;&#160;&#160;&#160;Intentionally Deleted.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:114pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.2.2&#160;&#160;&#160;&#160;&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Direct Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; shall mean &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Operating Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; and &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tax Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.&#34;</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_64"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.2.3&#160;&#160;&#160;&#160;&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Expense Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; shall mean each calendar year in which any portion of the Lease Term falls, through and including the calendar year in which the Lease Term expires, provided that Landlord, upon notice to Tenant, may change the Expense Year from time to time to any other twelve (12) consecutive month period, and, in the event of any such change, Tenant's Share of Direct Expenses shall be equitably adjusted for any Expense Year involved in any such change.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.2.4&#160;&#160;&#160;&#160;&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Operating Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; shall mean all expenses, costs and amounts of every kind and nature which Landlord pays or accrues during any Expense Year because of or in connection with the ownership, management, maintenance, security, repair, replacement, restoration or operation of the Project, or any portion thereof. Without limiting the generality of the foregoing, Operating Expenses shall specifically include any and all of the following&#58; (i) the cost of supplying all utilities, the cost of operating, repairing, maintaining, and renovating the utility, telephone, mechanical, sanitary, storm drainage, and elevator systems, and the cost of maintenance and service contracts in connection therewith&#59; (ii) the cost of licenses, certificates, permits and inspections and the cost of contesting any governmental enactments which may affect Operating Expenses, and the costs incurred in connection with a governmentally mandated transportation system management program or similar program&#59; (iii) the cost of all insurance carried by Landlord in connection with the Project and Premises as reasonably determined by Landlord&#59; (iv) the cost of landscaping, relamping, and all supplies, tools, equipment and materials used in the operation, repair and maintenance of the Project, or any portion thereof&#59; (v) the cost of parking area operation, repair, restoration, and maintenance&#59; (vi) fees and other costs, including management and&#47;or incentive fees, consulting fees, legal fees and accounting fees, of all contractors and consultants in connection with the management, operation, maintenance and repair of the Project&#59; (vii) payments under any equipment rental agreements and the fair rental value of any management office space&#59; (viii) subject to item (f), below, wages, salaries and other compensation and benefits, including taxes levied thereon, of all persons engaged in the operation, maintenance and security of the Project&#59; (ix) costs under any instrument pertaining to the sharing of costs by the Project&#59; (x) operation, repair, maintenance and replacement of all systems and equipment and components thereof of the Project&#59; (xi) the cost of janitorial, alarm, security and other services, replacement of wall and floor coverings, ceiling tiles and fixtures in common areas, maintenance and replacement of curbs and walkways, repair to roofs and re-roofing&#59; (xii) amortization (including interest on the unamortized cost) over such period of time as Landlord shall reasonably determine, of the cost of acquiring or the rental expense of personal property used in the maintenance, operation and repair of the Project, or any portion thereof&#59; (xiii) the cost of capital improvements or other costs incurred in connection with the Project (A) which are intended to effect economies in the operation or maintenance of the Project, or any portion thereof, or to reduce current or future Operating Expenses or to enhance the safety or security of the Project or its occupants, (B) that are required to comply with present or anticipated conservation programs, (C) which are replacements or modifications of nonstructural items located in the Common Areas required to keep the Common Areas in good order or condition, (D) that are required under any governmental law or regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">, or (E) which are repairs, replacements or modifications to the Building Systems (as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">, below)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#59; provided, however, that any capital expenditure shall be amortized (including interest on the amortized cost) over such period of time as Landlord shall reasonably determine&#59; and (xiv) costs, fees, charges or assessments imposed by, or resulting from any mandate imposed on Landlord by, any federal, state or local government for fire and police protection, trash removal, community services, or other services which do not constitute &#34;Tax Expenses&#34; as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4.2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below, (xv) cost of tenant relation programs reasonably established by Landlord, and (xvi) payments under any easement, license, operating agreement, declaration, restrictive covenant, or instrument pertaining to the sharing of costs by the Building, including, without limitation, any covenants, conditions and restrictions affecting the property, and reciprocal easement agreements affecting the property, any parking licenses, and any agreements with transit agencies affecting the Property (collectively, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Underlying Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). Notwithstanding the foregoing, for purposes of this Lease, Operating Expenses shall not, however, include&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;costs, including legal fees, space planners' fees, advertising and promotional expenses (except as otherwise set forth above), and brokerage fees incurred in connection with the original construction or development, or original or future leasing of the Project, and costs, including permit, license and inspection costs, incurred with respect to the installation of tenant improvements made for new tenants initially occupying space in the Project after the Lease Commencement Date or incurred in renovating or otherwise improving, decorating, painting or redecorating vacant space for tenants or other occupants of the Project (excluding, however, such costs relating to any common areas of the Project or parking facilities)&#59;</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_67"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;except as set forth in items (xii), (xiii), and (xiv) above, depreciation, interest and principal payments on mortgages and other debt costs, if any, penalties and interest&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(c)&#160;&#160;&#160;&#160;costs for which the Landlord is reimbursed by any tenant or occupant of the Project or by insurance by its carrier or any tenant's carrier or by anyone else, and electric power costs for which any tenant directly contracts with the local public service company&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:149.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;any bad debt loss, rent loss, or reserves for bad debts or rent loss&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(e)&#160;&#160;&#160;&#160;costs associated with the operation of the business of the partnership or entity which constitutes the Landlord, as the same are distinguished from the costs of operation of the Project (which shall specifically include, but not be limited to, accounting costs associated with the operation of the Project). Costs associated with the operation of the business of the partnership or entity which constitutes the Landlord include costs of partnership accounting and legal matters, costs of defending any lawsuits with any mortgagee (except as the actions of the Tenant may be in issue), costs of selling, syndicating, financing, mortgaging or hypothecating any of the Landlord's interest in the Project, and costs incurred in connection with any disputes between Landlord and its employees, between Landlord and Project management, or between Landlord and other tenants or occupants&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(f)&#160;&#160;&#160;&#160;the wages and benefits of any employee who does not devote substantially all of his or her employed time to the Project unless such wages and benefits are prorated to reflect time spent on operating and managing the Project vis-a-vis time spent on matters unrelated to operating and managing the Project&#59; provided, that in no event shall Operating Expenses for purposes of this Lease include wages and&#47;or benefits attributable to personnel above the level of Project manager&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:149.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(g)&#160;&#160;&#160;&#160;amount paid as ground rental for the Project by the Landlord&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(h)&#160;&#160;&#160;&#160;except for a Project management fee to the extent allowed pursuant to item (l) below, overhead and profit increment paid to the Landlord or to subsidiaries or affiliates of the Landlord for services in the Project to the extent the same exceeds the costs of such services rendered by qualified, first-class unaffiliated third parties on a competitive basis&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i)&#160;&#160;&#160;&#160;any compensation paid to clerks, attendants or other persons in commercial concessions operated by the Landlord, provided that any compensation paid to any concierge at the Project shall be includable as an Operating Expense&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(j)&#160;&#160;&#160;&#160;rentals and other related expenses incurred in leasing air conditioning systems, elevators or other equipment which if purchased the cost of which would be excluded from Operating Expenses as a capital cost, except equipment not affixed to the Project which is used in providing engineering, janitorial or similar services and, further excepting from this exclusion such equipment rented or leased to remedy or ameliorate an emergency condition in the Project &#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(k)&#160;&#160;&#160;&#160;all items and services for which Tenant or any other tenant in the Project reimburses Landlord or which Landlord provides selectively to one or more tenants (other than Tenant) without reimbursement&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:149.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(l)&#160;&#160;&#160;&#160;any costs expressly excluded from Operating Expenses elsewhere in this Lease&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(m)&#160;&#160;&#160;&#160;rent for any office space occupied by Project management personnel to the extent the size or rental rate of such office space exceeds the size or fair market rental value of office space occupied by management personnel of the comparable buildings in the vicinity of the Building, with adjustment where appropriate for the size of the applicable project&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.95pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(n)&#160;&#160;&#160;&#160;costs arising from the gross negligence or willful misconduct of Landlord in connection with this Lease&#59;</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_70"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(o)&#160;&#160;&#160;&#160;costs incurred to comply with laws relating to the removal of hazardous material (as defined under Applicable Law) which was in existence in the Building or on the Project prior to the Lease Commencement Date, and was of such a nature that a federal, State or municipal governmental authority, if it had then had knowledge of the presence of such hazardous material, in the state, and under the conditions that it then existed in the Building or on the Project, would have then required the removal of such hazardous material or other remedial or containment action with respect thereto&#59; and costs incurred to remove, remedy, contain, or treat hazardous material, which hazardous material is brought into the Building or onto the Project after the date hereof by Landlord or any other tenant of the Project and is of such a nature, at that time, that a federal, State or municipal governmental authority, if it had then had knowledge of the presence of such hazardous material, in the state, and under the conditions, that it then exists in the Building or on the Project, would have then required the removal of such hazardous material or other remedial or containment action with respect thereto&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.55pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(p)&#160;&#160;&#160;&#160;costs of items considered capital repairs, replacements, improvements and equipment under sound real estate management and accounting principles consistently applied, except as expressly included in Operating Expenses pursuant to the definition above, including, without limitation, as otherwise set forth in item (xiii) of Section 4.2.4 above&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:149.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(q)&#160;&#160;&#160;&#160;charitable or political contributions and membership fees or other payments to</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">trade organizations&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:149.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(r)&#160;&#160;&#160;&#160;costs of Tenant Improvements which are to be borne by Landlord pursuant to this</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lease&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:149.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(s)&#160;&#160;&#160;&#160;the costs of acquiring investment-grade art&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:149.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(t)&#160;&#160;&#160;&#160;legal fees incurred in negotiating and enforcing tenant leases&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(u)&#160;&#160;&#160;&#160;costs (i.e., interest and penalties) incurred due to Landlord&#8217;s default of this Lease or any other lease, mortgage, or other agreement, in each case affecting the Project&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(v)&#160;&#160;&#160;&#160;interest, fines or penalties for late payment or violations of Applicable Laws by Landlord, except to the extent incurring such expense is caused by a corresponding late payment or violation of an Applicable Law by Tenant, in which event Tenant shall be responsible for the full amount of such expense&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.85pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(w)&#160;&#160;&#160;&#160;any item of expense which, if included in Operating Expenses, would result in a double collection of such item by Landlord.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to the foregoing Operating Expense exclusions, Tenant's Share of the fees for management of the Project included in Operating Expenses shall not exceed two and 75&#47;100 percent (2.75%) of the aggregate Base Rent and Tenant's Share of Direct Expenses, adjusted and grossed up to reflect Tenant paying full Rent, as contrasted with free rent, half rent and the like (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Management Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:113.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.2.5.1&#160;&#160;&#160;&#160;&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tax Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; shall mean all federal, state, county, or local governmental or municipal taxes, fees, charges or other impositions of every kind and nature, whether general, special, ordinary or extraordinary (including, without limitation, real estate taxes, general and special assessments, transit taxes, leasehold taxes or taxes based upon the receipt of rent, including gross receipts or sales taxes applicable to the receipt of rent, unless required to be paid by Tenant, personal property taxes imposed upon the fixtures, machinery, equipment, apparatus, systems and equipment, appurtenances, furniture and other personal property used in connection with the Project, or any portion thereof), which shall be paid or accrued during any Expense Year (without regard to any different fiscal year used by such governmental or municipal authority) because of or in connection with the ownership, leasing and operation of the Project, or any portion thereof.</font></div><div style="padding-right:47.75pt;text-align:justify"><font><br></font></div><div id="i1857427c06e5452983070f6ff36fd01d_73"></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.2.5.2&#160;&#160;&#160;&#160;Tax Expenses shall include, without limitation&#58; (i) any tax on the rent, right to rent or other income from the Project, or any portion thereof, or as against the business of leasing the Project, or any </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">portion thereof&#59; (ii) any assessment, tax, fee, levy or charge in addition to, or in substitution, partially or totally, of any assessment, tax, fee, levy or charge previously included within the definition of real property tax&#59; (iii) any assessment, tax, fee, levy, or charge allocable to or measured by the area of the Premises or the Rent payable hereunder, including, without limitation, any business or gross income tax or excise tax with respect to the receipt of such rent, or upon or with respect to the possession, leasing, operating, management, maintenance, alteration, repair, use or occupancy by Tenant of the Premises, or any portion thereof&#59; and (iv) any assessment, tax, fee, levy or charge, upon this transaction or any document to which Tenant is a party, creating or transferring an interest or an estate in the Premises or the improvements thereon.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.2.5.3&#160;&#160;&#160;&#160;Any costs and expenses (including, without limitation, reasonable attorneys' and consultants' fees) incurred in attempting to protest, reduce or minimize Tax Expenses shall be included in Tax Expenses in the Expense Year such expenses are incurred. Tax refunds shall be credited against Tax Expenses and refunded to Tenant regardless of when received, based on the Expense Year to which the refund is applicable, provided that in no event shall the amount to be refunded to Tenant for any such Expense Year exceed the total amount paid by Tenant as Additional Rent under this Article 4 for such Expense Year. If Tax Expenses for any period during the Lease Term or any extension thereof are increased after payment thereof for any reason, including, without limitation, error or reassessment by applicable governmental or municipal authorities, Tenant shall pay Landlord upon demand Tenant's Share of any such increased Tax Expenses. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4.2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, there shall be excluded from Tax Expenses (i) all excess profits taxes, franchise taxes, gift taxes, capital stock taxes, inheritance and succession taxes, estate taxes, federal and state income taxes, and other taxes to the extent applicable to Landlord's net income (as opposed to rents, receipts or income attributable to operations at the Project),</font></div><div style="padding-left:20.7pt;text-align:justify;text-indent:-14.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(ii)&#160;&#160;&#160;&#160;any items included as Operating Expenses, and (iii) any items paid by Tenant under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:114pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.2.6&#160;&#160;&#160;&#160;&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant's Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; shall mean the percentage set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Summary.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Allocation of Direct Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.3.1&#160;&#160;&#160;&#160;The parties acknowledge that the Building is a part of a multi-building project and that the costs and expenses incurred in connection with the Project (i.e., the Direct Expenses) should be shared between the Building and the other buildings in the Project. Accordingly, as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> above, Direct Expenses (which consist of Operating Expenses and tax Expenses) are determined annually for the Project as a whole, and a portion of the Direct Expenses, which portion shall be determined by Landlord on an equitable basis, shall be allocated to the Building (as opposed to other buildings in the Project). Such portion of Direct Expenses allocated to the Building shall include all Direct Expenses attributable solely to the Building and an equitable portion of the Direct Expenses attributable to the Project as a whole, and shall not include Direct Expenses attributable solely to other buildings in the Project.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Cost Pools</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord shall have the right, from time to time, to equitably allocate some or all of the Direct Expenses for the Project among different portions or occupants of the Project (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Cost Pools</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), in Landlord's reasonable discretion. Such Cost Pools may include, but shall not be limited to, the office space tenants of a building of the Project or of the Project, and the laboratory space tenants of a building of the Project or of the Project. The Direct Expenses within each such Cost Pool shall be allocated and charged to the tenants within such Cost Pool in an equitable manner.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Calculation and Payment of Additional Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall pay to Landlord, in the manner set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4.4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below, and as Additional Rent, Tenant's Share of Direct Expenses for each Expense Year. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, the aggregate &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Controllable Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; (as defined in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below) included in Direct Expenses in any Expense Year after the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) Lease Year shall not increase by more than five percent (5%) on an annual, cumulative and compounded basis, over the actual aggregate Controllable Expenses included in Direct Expenses for the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) Lease Year. For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Controllable Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; shall mean all Direct Expenses except&#58; (i) Tax Expenses, and any and all assessments, including assessment districts and government-mandated charges with respect to the Building or Project, or any part thereof (ii) insurance carried by Landlord with respect to Project and&#47;or the operation thereof&#59; (iii) costs of utilities, including, without limitation, electricity, water, HVAC and sewer charges, utility surcharges and assessments,</font></div><div id="i1857427c06e5452983070f6ff36fd01d_76"></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and refuse removal&#59; (iv) Permitted Capital Expenses&#59; (v) the cost of union labor (including janitorial staff and security personnel), including labor which is not union as of the date of this Lease but which unionizes after the date </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of this Lease, and increases in wages, salaries and other compensation and benefits paid to Landlord's contractors engaged in the operation, management, maintenance or security of the Building or Project, to the extent such increases are due to increases in the applicable minimum wage legally required to be paid to such personnel, (vi) costs to comply with applicable laws and other governmental requirements first enacted or made applicable to the Building after the Lease Commencement Date, and (vii) costs relating to Force Majeure.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Statement of Actual Direct Expenses and Payment by Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord shall give to Tenant following the end of each Expense Year, a statement (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) which shall state the Direct Expenses incurred or accrued for such preceding Expense Year, and which shall indicate the amount of Tenant's Share of Direct Expenses. Upon receipt of the Statement for each Expense Year commencing or ending during the Lease Term, Tenant shall pay, with its next installment of Base Rent due, the full amount of Tenant's Share of Direct Expenses for such Expense Year, less the amounts, if any, paid during such Expense Year as &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Estimated Direct Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,&#34; as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4.4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below, and if Tenant paid more as Estimated Direct Expenses than the actual Tenant's Share of Direct Expenses, Tenant shall receive a credit in the amount of Tenant's overpayment against Rent next due under this Lease. The failure of Landlord to timely furnish the Statement for any Expense Year shall not prejudice Landlord or Tenant from enforcing its rights under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Even though the Lease Term has expired and Tenant has vacated the Premises, when the final determination is made of Tenant's Share of Direct Expenses for the Expense Year in which this Lease terminates, Tenant shall immediately pay to Landlord such amount, and if Tenant paid more as Estimated Direct Expenses than the actual Tenant's Share of Direct Expenses, Landlord shall, within thirty (30) days, deliver a check payable to Tenant in the amount of the overpayment or apply such overpayment against any unpaid Rent. The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4.4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall survive the expiration or earlier termination of the Lease Term.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Statement of Estimated Direct Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In addition, Landlord shall endeavor to give Tenant a yearly expense estimate statement (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Estimate Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) which shall set forth Landlord's reasonable estimate (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Estimate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) of what the total amount of Direct Expenses for the then-current Expense Year shall be and the estimated Tenant's Share of Direct Expenses (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Estimated Direct Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). The failure of Landlord to timely furnish the Estimate Statement for any Expense Year shall not preclude Landlord from enforcing its rights to collect any Estimated Direct Expenses under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, nor shall Landlord be prohibited from revising any Estimate Statement or Estimated Direct Expenses theretofore delivered to the extent necessary. Thereafter, Tenant shall pay, with its next installment of Base Rent due, a fraction of the Estimated Direct Expenses for the then-current Expense Year (reduced by any amounts paid pursuant to the last sentence of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4.4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">). Such fraction shall have as its numerator the number of months which have elapsed in such current Expense Year, including the month of such payment, and twelve (12) as its denominator. Until a new Estimate Statement is furnished (which Landlord shall have the right to deliver to Tenant at any time), Tenant shall pay monthly, with the monthly Base Rent installments, an amount equal to one-twelfth (1&#47;12) of the total Estimated Direct Expenses set forth in the previous Estimate Statement delivered by Landlord to Tenant.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Taxes and Other Charges for Which Tenant Is Directly Responsible</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.&#160;&#160;&#160;&#160;Tenant shall be liable for and shall pay before delinquency, taxes levied against Tenant's equipment, furniture, fixtures and any other personal property located in or about the Premises. If any such taxes on Tenant's equipment, furniture, fixtures and any other personal property are levied against Landlord or Landlord's property or if the assessed value of Landlord's property is increased by the inclusion therein of a value placed upon such equipment, furniture, fixtures or any other personal property and if Landlord pays the taxes based upon such increased assessment, which Landlord shall have the right to do regardless of the validity thereof but only under proper protest if requested by Tenant, Tenant shall , within ten (10) business days of Landlord&#8217;s written demand, repay to Landlord the taxes so levied against Landlord or the proportion of such taxes resulting from such increase in the assessment, as the case may be.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">5.&#160;&#160;&#160;&#160;USE OF PREMISES</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Permitted Use</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall use the Premises solely for the Permitted Use set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Summary and Tenant shall not use or permit the Premises or the Project to be used for any other purpose or purposes whatsoever without the prior written consent of Landlord, which may be withheld in Landlord's sole discretion.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_79"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Prohibited Uses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant further covenants and agrees that Tenant shall not use, or suffer or permit any person or persons to use, the Premises or any part thereof for any use or purpose in violation of the laws of the United States of America, the State of California, or the ordinances, regulations or requirements of the local municipal or county governing body or other lawful authorities having jurisdiction over the Project) including, without limitation, any such laws, ordinances, regulations or requirements relating to hazardous materials or substances, as those terms are defined by Applicable Laws now or hereafter in effect, or any Underlying Documents. Landlord shall have the right to impose reasonable and customary rule and regulations regarding the use of the Project, as reasonably deemed necessary by Landlord with respect to the orderly operation of the Project, and Tenant shall comply with such reasonable rules and regulations to the extent such rules and regulations are provided to Tenant in writing and apply on a non-discriminatory basis to all similar tenants of the Project. Tenant shall not do or permit anything to be done in or about the Premises which will in any way damage the reputation of the Project or obstruct or interfere with the rights of other tenants or occupants of the Building, or injure or annoy them or use or allow the Premises to be used for any improper, unlawful or objectionable purpose, nor shall Tenant cause, maintain or permit any nuisance in, on or about the Premises. Tenant shall comply with, and Tenant's rights and obligations under the Lease and Tenant's use of the Premises shall be subject and subordinate to, all recorded easements, covenants, conditions, and restrictions now or hereafter affecting the Project.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:78pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Hazardous Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:114pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Tenant's Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Prohibitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. As a material inducement to Landlord to enter into this Lease with Tenant, Tenant has fully and accurately completed Landlord&#8217;s Pre-Leasing Environmental Exposure Questionnaire (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Environmental Questionnaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), which is attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant agrees that except for those chemicals or materials, and their respective quantities, specifically listed on the Environmental Questionnaire, neither Tenant nor Tenant&#8217;s employees, contractors and subcontractors of any tier, entities with a contractual relationship with Tenant (other than Landlord), or any entity acting as an agent or sub-agent of Tenant (collectively, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant's Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) will produce, use, store or generate any &#34;Hazardous Materials,&#34; as that term is defined below, on, under or about the Premises, nor cause or permit any Hazardous Material to be brought upon, placed, stored, manufactured, generated, blended, handled, recycled, used or &#34;Released,&#34; as that term is defined below, on, in, under or about the Premises. If any information provided to Landlord by Tenant on the Environmental Questionnaire, or otherwise relating to information concerning Hazardous Materials is false, incomplete, or misleading in any material respect, the same shall be deemed an Event of Default by Tenant under this Lease. Landlord&#8217;s prior written consent shall be required to any Hazardous Materials use for the Premises not described on the initial Environmental Questionnaire, such consent to be withheld in Landlord&#8217;s sole discretion. Tenant shall not install or permit any underground storage tank on the Premises. For purposes of this Lease, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Hazardous Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; means all flammable explosives, petroleum and petroleum products, waste oil, radon, radioactive materials, toxic pollutants, asbestos, polychlorinated biphenyls (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">PCBs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), medical waste, chemicals known to cause cancer or reproductive toxicity, pollutants, contaminants, hazardous wastes, toxic substances or related materials, including without limitation any chemical, element, compound, mixture, solution, substance, object, waste or any combination thereof, which is or may be hazardous to human health, safety or to the environment due to its radioactivity, ignitability, corrosiveness, reactivity, explosiveness, toxicity, carcinogenicity, infectiousness or other harmful or potentially harmful properties or effects, or defined as, regulated as or included in, the definition of &#8220;hazardous substances,&#8221; &#8220;hazardous wastes,&#8221; &#8220;hazardous materials,&#8221; or &#8220;toxic substances&#8221; under any Environmental Laws. The term &#8220;Hazardous Materials&#8221; for purposes of this Lease shall also include any mold, fungus or spores, whether or not the same is defined, listed, or otherwise classified as a &#8220;hazardous material&#8221; under any Environmental Laws, if such mold, fungus or spores would pose a risk to human health or the environment or negatively impact the value of the Premises. For purposes of this Lease, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; or &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Released</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; or &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Releases</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; shall mean any release, deposit, discharge, emission, leaking, spilling, seeping, migrating, injecting, pumping, pouring, emptying, escaping, dumping, disposing, or other movement of Hazardous Materials into the environment. Notwithstanding anything to the contrary set forth in this Lease, Tenant shall be permitted to use cleaning solvents, toner, and other items customarily used in an office setting without Landlord&#8217;s prior consent.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Notices to Landlord</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall notify Landlord in writing as soon as possible but in no event later than five (5) days after (i) Tenant becomes aware of the occurrence of any actual, alleged or threatened Release of any Hazardous Material in, on, under, from, about or in the vicinity of the Premises (whether</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_82"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">past or present), regardless of the source or quantity of any such Release, or (ii) Tenant becomes aware of any regulatory actions, inquiries, inspections, investigations, directives, or any cleanup, compliance, enforcement or abatement proceedings (including any threatened or contemplated investigations or proceedings) relating to or potentially affecting the Premises with respect to any Release, or (iii) Tenant becomes aware of any claims by any person or entity relating to any Hazardous Materials in, on, under, from, about or in the vicinity of the Premises, whether relating to damage, contribution, cost recovery, compensation, loss or injury. Collectively, the matters set forth in clauses (i), (ii) and (iii) above are hereinafter referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Hazardous Materials Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;. Tenant shall promptly forward to Landlord copies of all orders, notices, permits, applications and other communications and reports in connection with any Hazardous Materials Claims. Additionally, Tenant shall promptly advise Landlord in writing of Tenant&#8217;s discovery of any occurrence or condition on, in, under or about the Premises that could subject Tenant or Landlord to any liability, or restrictions on ownership, occupancy, transferability or use of the Premises under any &#34;Environmental Laws,&#34; as that term is defined below. Tenant shall not enter into any legal proceeding or other action, settlement, consent decree or other compromise with respect to any Hazardous Materials Claims without first notifying Landlord of Tenant&#8217;s intention to do so and affording Landlord the opportunity to join and participate, as a party if Landlord so elects, in such proceedings and in no event shall Tenant enter into any agreements which are binding on Landlord or the Premises without Landlord&#8217;s prior written consent. Landlord shall have the right to appear at and participate in, any and all legal or other administrative proceedings concerning any Hazardous Materials Claim. For purposes of this Lease, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221; means all applicable present and future laws relating to the protection of human health, safety, wildlife or the environment, including, without limitation, (i) all requirements pertaining to reporting, licensing, permitting, investigation and&#47;or remediation of emissions, discharges, Releases, or threatened Releases of Hazardous Materials, whether solid, liquid, or gaseous in nature, into the air, surface water, groundwater, or land, or relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport, or handling of Hazardous Materials&#59; and (ii) all requirements pertaining to the health and safety of employees or the public. Environmental Laws include, but are not limited to, the Comprehensive Environmental Response, Compensation and Liability Act of 1980, 42 USC &#167; 9601, et seq., the Hazardous Materials Transportation Authorization Act of 1994, 49 USC &#167; 5101, et seq., the Solid Waste Disposal Act, as amended by the Resource Conservation and Recovery Act of 1976, and Hazardous and Solid Waste Amendments of 1984, 42 USC &#167; 6901, et seq., the Federal Water Pollution Control Act, as amended by the Clean Water Act of 1977, 33 USC &#167; 1251, et seq., the Clean Air Act of 1966, 42 USC</font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#167; 7401, et seq., the Toxic Substances Control Act of 1976, 15 USC &#167; 2601, et seq., the Safe Drinking Water Act of 1974, 42 USC &#167;&#167; 300f through 300j, the Occupational Safety and Health Act of 1970, as amended, 29 USC &#167; 651 et seq., the Oil Pollution Act of 1990, 33 USC &#167; 2701 et seq., the Emergency Planning and Community Right-To-Know Act of 1986, 42 USC &#167; 11001 et seq., the National Environmental Policy Act of 1969, 42 USC &#167; 4321 et seq., the Federal Insecticide, Fungicide and Rodenticide Act of 1947, 7 USC &#167; 136 et seq., California Carpenter-Presley-Tanner Hazardous Substance Account Act, California Health &#38; Safety Code &#167;&#167; 25300 et seq., Hazardous Materials Release Response Plans and Inventory Act, California Health &#38; Safety Code, &#167;&#167; 25500 et seq., Underground Storage of Hazardous Substances provisions, California Health &#38; Safety Code, &#167;&#167; 25280 et seq., California Hazardous Waste Control Law, California Health &#38; Safety Code, &#167;&#167; 25100 et seq., and any other state or local law counterparts, as amended, as such Applicable Laws, are in effect as of the Lease Commencement Date, or thereafter adopted, published, or promulgated.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Releases of Hazardous Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If any Release of any Hazardous Material in, on, under, from or about the Premises shall occur at any time during the Lease and&#47;or if any other Hazardous Material condition exists at the Premises that requires response actions of any kind, in addition to notifying Landlord as specified above, Tenant, at its own sole cost and expense, shall promptly upon becoming aware of such condition</font></div><div style="margin-top:0.05pt;padding-left:17.95pt;text-align:justify;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i)&#160;&#160;&#160;&#160;immediately comply with any and all reporting requirements imposed pursuant to any and all Environmental Laws,</font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(ii)&#160;&#160;&#160;&#160;provide a written certification to Landlord indicating that Tenant has complied with all applicable reporting requirements, (iii) take any and all necessary investigation, corrective and remedial action in accordance with any and all applicable Environmental Laws, utilizing an environmental consultant approved by Landlord, all in accordance with the provisions and requirements of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, including, without limitation, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and (iv) take any such additional investigative, remedial and corrective actions as Landlord shall in its reasonable discretion deem necessary such that the Premises are remediated to the condition existing prior to such Release.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:150pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:4.65pt;padding-left:6pt;padding-right:47.9pt;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.1.4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Without limiting in any way Tenant&#8217;s obligations under any other provision of this Lease, Tenant shall be solely responsible for and shall protect, defend, indemnify and hold</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_85"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the Landlord Parties harmless from and against any and all claims, judgments, losses, damages, costs, expenses, penalties, enforcement actions, taxes, fines, remedial actions, liabilities (including, without limitation, actual attorneys&#8217; fees, litigation, arbitration and administrative proceeding costs, expert and consultant fees and laboratory costs) including, without limitation, consequential damages and sums paid in settlement of claims, which arise during or after the Lease Term, whether foreseeable or unforeseeable, that arise during or after the Lease Term in whole or in part, foreseeable or unforeseeable, directly or indirectly arising out of or attributable to the presence, use, generation, manufacture, treatment, handling, refining, production, processing, storage, Release or presence of Hazardous Materials in, on, under or about the Premises by Tenant or Tenant's Agents.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:143.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.1.4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Limitations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Notwithstanding anything in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.3.1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above, to the contrary, Tenant's indemnity of Landlord as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.3.1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above, shall not be applicable to claims based upon Hazardous Materials which may exist in, on or about the Premises as of the Lease Commencement Date (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Existing Hazardous Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), except to the extent that Tenant's construction activities and&#47;or Tenant's other acts or omissions (including Tenant's failure to remove, remediate or otherwise treat or &#8220;Clean-up,&#8221; as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below, the subject Existing Hazardous Materials during the tenancy of the Premises) caused or exacerbated the subject claim.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.5pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Compliance with Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Without limiting the generality of Tenant&#8217;s obligation to comply with Applicable Laws as otherwise provided in this Lease, Tenant shall, at its sole cost and expense, comply with all Environmental Laws. Tenant shall obtain and maintain any and all necessary permits, licenses, certifications and approvals appropriate or required for the use, handling, storage, and disposal of any Hazardous Materials used, stored, generated, transported, handled, blended, or recycled by Tenant on the Premises. Landlord shall have a continuing right, without obligation, to require Tenant to obtain, and to review and inspect any and all such permits, licenses, certifications and approvals, together with copies of any and all Hazardous Materials management plans and programs, any and all Hazardous Materials risk management and pollution prevention programs, and any and all Hazardous Materials emergency response and employee training programs respecting Tenant&#8217;s use of Hazardous Materials. Upon request of Landlord, Tenant shall deliver to Landlord a narrative description explaining the nature and scope of Tenant&#8217;s activities involving Hazardous Materials and showing to Landlord&#8217;s satisfaction compliance with all Environmental Laws and the terms of this Lease.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:114pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Assurance of Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Environmental Assessments In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord may, but shall not be required to, engage from time to time such contractors as Landlord determines to be appropriate to perform environmental assessments of a scope reasonably determined by Landlord (an &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Environmental Assessment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) to ensure Tenant&#8217;s compliance with the requirements of this Lease with respect to Hazardous Materials. .</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.65pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Costs of Environmental Assessments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. All costs and expenses incurred by Landlord in connection with any such Environmental Assessment initially shall be paid by Landlord&#59; provided that if any such Environmental Assessment shows that Tenant has failed to comply with the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, then all of the costs and expenses of such Environmental Assessment shall be reimbursed by Tenant as Additional Rent within ten (10) business days after receipt of written demand therefor.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Tenant&#8217;s Obligations upon Surrender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. At the expiration or earlier termination of the Lease Term, Tenant, at Tenant&#8217;s sole cost and expense, shall&#58; (i) cause an Environmental Assessment of the Premises to be conducted in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 15.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#59; (ii) cause all Hazardous Materials Released by Tenant to be removed from the Premises and disposed of in accordance with all Environmental Laws and as necessary to allow the Premises to be used for any purpose&#59; and (iii) cause to be removed all containers installed or used by Tenant or Tenant&#8217;s Agents to store any Hazardous Materials on the Premises, and cause to be repaired any damage to the Premises caused by such removal.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:114pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Clean-up</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Environmental Reports&#59; Clean-Up</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If any written report, including any report containing results of any Environmental Assessment (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Environmental Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) shall indicate (i) the presence of any Hazardous Materials as to which Tenant has a removal or remediation obligation under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_88"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(ii) that as a result of same, the investigation, characterization, monitoring, assessment, repair, closure, remediation, removal, or other clean-up (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Clean-up</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) of any Hazardous Materials is required, Tenant shall immediately prepare and submit to Landlord within thirty (30) days after receipt of the Environmental Report a comprehensive plan, subject to Landlord&#8217;s written approval, specifying the actions to be taken by Tenant to perform the Clean-up so that the Premises are restored to the conditions required by this Lease. Upon Landlord&#8217;s approval of the Clean-up plan, Tenant shall, at Tenant&#8217;s sole cost and expense, without limitation on any rights and remedies of Landlord under this Lease, immediately implement such plan with a consultant reasonably acceptable to Landlord and proceed to Clean-Up Hazardous Materials in accordance with all Applicable Laws and as required by such plan and this Lease. If, within thirty (30) days after receiving a copy of such Environmental Report, Tenant fails either (a) to complete such Clean- up, or (b) with respect to any Clean-up that cannot be completed within such thirty-day period, fails to proceed with diligence to prepare the Clean-up plan and complete the Clean-up as promptly as practicable, then Landlord shall have the right, but not the obligation, and without waiving any other rights under this Lease, to carry out any Clean-up recommended by the Environmental Report or required by any governmental authority having jurisdiction over the Premises, and recover all of the costs and expenses thereof from Tenant as Additional Rent, payable within ten</font></div><div style="padding-left:5.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(10) business days after receipt of written demand therefor.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:107.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">No Rent Abatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall continue to pay all Rent due or accruing under this Lease during any Clean-up, and shall not be entitled to any reduction, offset or deferral of any Base Rent or Additional Rent due or accruing under this Lease during any such Clean-up.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Surrender of Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall complete any Clean-up prior to surrender of the Premises upon the expiration or earlier termination of this Lease. Tenant shall obtain and deliver to Landlord a letter or other written determination from the overseeing governmental authority confirming that the Clean-up has been completed in accordance with all requirements of such governmental authority and that no further response action of any kind is required for the unrestricted use of the Premises (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Closure Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;). Upon the expiration or earlier termination of this Lease, Tenant shall also be obligated to close all permits obtained in connection with Hazardous Materials in accordance with Applicable Laws.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Failure to Timely Clean-Up</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Should any Clean-up for which Tenant is responsible not be completed, or should Tenant not receive the Closure Letter and any governmental approvals required under Environmental Laws in conjunction with such Clean-up prior to the expiration or earlier termination of this Lease, then Tenant shall be liable to Landlord as a holdover tenant (as more particularly provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) until Tenant has fully complied with its obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Unless compelled to do so by Applicable Law, Tenant agrees that Tenant shall not disclose, discuss, disseminate or copy any information, data, findings, communications, conclusions and reports regarding the environmental condition of the Premises to any Person (other than Tenant&#8217;s consultants, attorneys, property managers and employees that have a need to know such information), including any governmental authority, without the prior written consent of Landlord. In the event Tenant reasonably believes that disclosure is compelled by Applicable Law, it shall provide Landlord ten (10) days&#8217; advance notice of disclosure of confidential information so that Landlord may attempt to obtain a protective order. Tenant may additionally release such information to bona fide prospective purchasers or lenders, subject to any such parties&#8217; written agreement to be bound by the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Copies of Environmental Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Within thirty (30) days of receipt thereof, Tenant shall provide Landlord with a copy of any and all environmental assessments, audits, studies and reports regarding Tenant&#8217;s activities with respect to the Premises, or ground water beneath the Land, or the environmental condition or Clean-up thereof. Tenant shall be obligated to provide Landlord with a copy of such materials without regard to whether such materials are generated by Tenant or prepared for Tenant, or how Tenant comes into possession of such materials.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:114pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Intentionally Omitted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Signs, Response Plans, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall be responsible for posting on the Premises any signs required under applicable Environmental Laws. Tenant shall also complete and file any business response plans</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_91"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">or inventories required by any Applicable Laws. Tenant shall concurrently file a copy of any such business response plan or inventory with Landlord.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Each covenant, agreement, representation, warranty and indemnification made by Tenant set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall survive the expiration or earlier termination of this Lease and shall remain effective until all of Tenant&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> have been completely performed and satisfied.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5.95pt;padding-right:47.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%;text-decoration:underline">Outside Area</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">. Subject to the terms and conditions contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%"> and elsewhere in this Lease, and subject to Tenant obtaining and maintaining all necessary and applicable governmental approvals, commencing as of the Lease Commencement Date, Tenant shall have a license during the Lease Term for the exclusive use of certain space in the Common Area (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:115%">Outside Area</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">&#34;), the location to be mutually and reasonably agreed upon by Landlord and Tenant, for the construction (as a Tenant Improvement or an Alteration) of a shed for the storage of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Hazardous Materials </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">used in Tenant's operations from the Premises for the Permitted Use and disclosed in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Environmental Questionnaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">. The Outside Area shall not be included in the rentable square feet of the Premises for purposes of this Lease. The license to use the Outside Area granted to Tenant hereby is personal to the Original Tenant and any Permitted Transfer Assignee, and shall not be otherwise assigned, sublet or otherwise transferred in any way or manner. Tenant also acknowledges that neither Landlord nor any agent of Landlord has made any representation or warranty regarding the condition of the Outside Area or the compliance of the Outside Area with any Applicable Laws. Tenant shall have the right, at Tenant's sole cost and expense, to alter, change or make improvements to the Outside Area (as an Alteration), subject to Landlord's reasonable approval&#59; provided, however, that Tenant shall be responsible, at its sole cost and expense, for the maintenance and repair of the Outside Area. Tenant acknowledges and agrees that although Tenant shall have the exclusive license to use the Outside Area during the Lease Term, Landlord shall have no obligation to enforce Tenant's exclusive use of the Outside Area, and neither Landlord nor the Landlord Parties shall in no event be liable for, and Landlord and the Landlord Parties are hereby released from any responsibility for, any personal injury or property damage sustained by Tenant in connection with or arising from any acts or omissions with regard to the admission or exclusion from the Outside Area of any person&#59; provided, however, that Landlord hereby covenants and agrees that it shall not grant any third party the right to use the Outside Area during the Lease Term, as the same may be extended. Tenant shall keep the Outside Area clean of all trash and debris and shall also keep the surrounding areas clean of debris and trash arising from the use of the Outside Area. Tenant agrees, at its own expense, to pay for all utilities used by Tenant in the Outside Area (including, without limitation, all sales, use and other taxes (but excluding real property taxes) imposed thereon by any governmental authority). Tenant shall remove any personal property from the Outside Area upon the expiration or earlier termination of this Lease, or upon the termination of Tenant's license under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">, and shall repair any damage to the Premises and Building caused by such removal. Except as otherwise set forth in this Lease or required by Applicable Laws, Tenant shall not be permitted to display any graphics, signs or insignias or the like in the Outside Area. Tenant's use of the Outside Area shall be subject to such reasonable additional rules, regulations and restrictions as Landlord may make from time to time concerning the Outside Area. Except as expressly set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">, all of the terms, conditions, limitations and restrictions contained in this Lease pertaining to the Premises and Tenant's use thereof (excluding Tenant&#8217;s obligation to pay Base Rent) shall apply equally to the Outside Area and Tenant's use thereof, including, without limitation, Tenant's repair and maintenance obligations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">, Tenant's responsibilities and obligations with respect to Hazardous Materials set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">, Tenant's indemnity of Landlord set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;text-decoration:underline">Section 10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">, and Tenant's insurance obligations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;text-decoration:underline">Article 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">. The license to use the Outside Area granted to Tenant hereby shall be revocable by Landlord for cause upon written notice to Tenant, and Landlord thereafter shall have the right to prevent Tenant's access thereto. As used in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">, &#34;cause&#34; shall include, without limitation, any of the following&#58; (i) Landlord's good faith determination that the license granted hereby and&#47;or the use of the Outside Area threatens the safety and&#47;or security of persons or property or endangers or otherwise interferes with the use and occupancy of the Building or Project by Landlord, its employees, agents or contractors or other tenants or occupants of the Building or the Project&#59; (ii) the license granted hereby constitutes a violation of or otherwise conflicts with any law, statute, ordinance or other governmental rule, regulation or requirement now in force or which may hereafter be enacted or promulgated (unless Tenant changes its use of the Outside Area in order to comply with such law, statute, ordinance or other governmental rule, regulation or requirement),</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_94"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5.95pt;padding-right:47.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">or results in increased rates of insurance for the Building or Project (unless Tenant pays the cost of such increased rates to Landlord)&#59; (iii) this Lease is terminated for any reason&#59; or (iv) Tenant fails, after any applicable notice and cure period expressly set forth in this Lease, to comply with any of the terms, conditions, limitations or restrictions contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%"> or elsewhere in this Lease which apply to the Outside Area or Tenant's use thereof.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">6.&#160;&#160;&#160;&#160;SERVICES AND UTILITIES</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord shall provide the following services on all days (unless otherwise stated below) during the Lease Term.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.1.1&#160;&#160;&#160;&#160;Subject to limitations imposed by all governmental rules, regulations and guidelines applicable thereto, Landlord shall provide heating, ventilation and air conditioning to the office portions of the Premises (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">HVAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) when necessary for normal comfort for normal office use in the Premises, except for the date of observation of New Year's Day, President's Day, Memorial Day, Independence Day, Labor Day, Thanksgiving Day, Christmas Day and, at Landlord's discretion, other locally or nationally recognized holidays (collectively, the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Holidays</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), 24 hours per day, 7 days per week. Tenant shall cooperate fully with Landlord at all times and abide by all non-discriminatory regulations and requirements that Landlord may reasonably prescribe for the proper functioning and protection of the HVAC, electrical, mechanical and plumbing systems.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.1.2&#160;&#160;&#160;&#160;Notwithstanding anything set forth in this Lease to the contrary, electricity is separately metered (or sub-metered) at the Premises and shall be paid directly by Tenant to the applicable utility provider. If electricity is separately sub-metered (as opposed to separately metered), then Tenant shall pay to Landlord the cost of such utilities based on such sub-meter, including reimbursement for any penalties for usage or other surcharges imposed by any utility company. Within thirty (30) days after receipt of Landlord's statement of apportionment or statement setting forth the charges payable by Tenant, Tenant shall pay to Landlord, as Additional Rent, the cost of such electrical services so apportioned or so provided by Landlord. Notwithstanding anything to the contrary set forth herein, to the extent the Premises generates electricity demand on a shared resource (e.g. electricity for the central plant), the cost of such electricity shall be allocated to Tenant on a pro rata basis or other reasonable basis consistent with commercial reasonable property management practices.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.1.3&#160;&#160;&#160;&#160;Landlord shall provide city water from the regular Building outlets for drinking, kitchen, lavatory and toilet purposes in the Building Common Areas and the Premises.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.1.4&#160;&#160;&#160;&#160;Landlord shall not provide janitorial services for the Premises. Tenant shall be solely responsible for performing all janitorial services and other cleaning of the Premises, all in compliance with Applicable Laws. The janitorial and cleaning of the Premises shall be adequate to maintain the Premises in a manner consistent with First Class Life Sciences Projects.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.1.5&#160;&#160;&#160;&#160;Landlord shall provide janitorial services for the Common Areas in a manner consistent with First Class Life Sciences Projects.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.1.6&#160;&#160;&#160;&#160;Tenant may, at its own expense, install its own security system (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant&#8217;s Security System</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) in the Premises&#59; provided, however, that Tenant shall coordinate the installation and operation of Tenant&#8217;s Security System with Landlord to assure that Tenant&#8217;s Security System is compatible with Landlord&#8217;s security system and the Building systems and equipment, and to the extent that Tenant&#8217;s Security System is not compatible with Landlord&#8217;s security system and the Building systems and equipment, Tenant shall not be entitled to install or operate the Tenant&#8217;s Security System. Tenant shall be solely responsible, at Tenant&#8217;s sole cost and expense, for the installation, monitoring, operation and removal of Tenant&#8217;s Security System. Tenant&#8217;s Security System shall be installed by Tenant in accordance with terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tenant shall cooperate fully with Landlord at all times and abide by all regulations and requirements that Landlord may reasonably prescribe for the proper functioning and protection of the HVAC, electrical, mechanical and plumbing systems&#59; provided such regulations and requirements are provided to Tenant and apply in a non- discriminatory manner to similar tenants in the Project.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_97"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Interruption of Use</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant agrees that Landlord shall not be liable for damages, by abatement of Rent (except as set forth in Section 6.5 below) or otherwise, for failure to furnish or delay in furnishing any service (including telephone and telecommunication services), or for any diminution in the quality or quantity thereof, when such failure or delay or diminution is occasioned, in whole or in part, by breakage, repairs, replacements, or improvements, by any strike, lockout or other labor trouble, by inability to secure electricity, gas, water, or other fuel at the Building or Project after reasonable effort to do so, by any riot or other dangerous condition, emergency, accident or Casualty (as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> below) whatsoever, by act or default of Tenant or other parties, or by any other cause&#59; and such failures or delays or diminution shall never be deemed to constitute an eviction or disturbance of Tenant's use and possession of the Premises or relieve Tenant from paying Rent (except as set forth in Section 6.5 below) or performing any of its obligations under this Lease. Furthermore, Landlord shall not be liable under any circumstances for a loss of, or injury to, property or for injury to, or interference with, Tenant's business, including, without limitation, loss of profits, however occurring, through or in connection with or incidental to a failure to furnish any of the services or utilities as set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Generator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall have the exclusive right to use and control (i) the 550kW emergency electrical generator and related equipment serving the 10275 Building, and (ii) the 250kW emergency electrical generator and related equipment serving the 10285 Building (all such equipment defined collectively as the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Emergency Generator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), to be installed by Landlord prior to the Lease Commencement Date. Except to the extent arising from the gross negligence or willful misconduct of Landlord, Landlord shall not be liable for any damages whatsoever resulting from any failure in operation of the Emergency Generator, or the failure of the Emergency Generator to provide suitable or adequate back-up power, including but not limited to, loss of profits, loss of rents or other revenues, loss of business opportunity, loss of goodwill or loss of use, in each case, however occurring, or loss to inventory, scientific research, scientific experiments, laboratory animals, products, specimens, samples, and&#47;or scientific, business, accounting and other records of every kind and description kept at the premises and any and all income derived or derivable therefrom. Tenant shall not be charged any additional rental or other costs for the use of the location in which the Emergency Generator is located. Tenant shall maintain and repair the Emergency Generator in good condition and repair, and in compliance with all Applicable Laws (including the maintenance of all applicable permits), at Tenant's sole cost and expense during the Lease Term. Tenant's obligations with respect to the Premises, including the insurance and indemnification obligations contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below, shall apply to Tenant's use of the Emergency Generator and Tenant shall carry industry standard Boiler and Machinery insurance covering the Emergency Generator. Tenant shall surrender the Emergency Generator (and shall transfer to Landlord all permits maintained by Tenant in connection with the Emergency Generator during the Lease Term) concurrent with the surrender of the Premises to Landlord as required hereunder in the same condition as the Emergency Generator were in as of the date hereof, reasonable wear and tear excepted, with all permits current.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Energy Performance Disclosure Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant hereby acknowledges that Landlord may be required to disclose certain information concerning the energy performance of the Building pursuant to California Public Resources Code Section 25402.10 and the regulations adopted pursuant thereto (collectively the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Energy Disclosure Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;). Tenant hereby acknowledges prior receipt of the Data Verification Checklist, as defined in the Energy Disclosure Requirements (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Energy Disclosure Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), and agrees that Landlord has timely complied in full with Landlord&#8217;s obligations under the Energy Disclosure Requirements. Tenant acknowledges and agrees that (i) Landlord makes no representation or warranty regarding the energy performance of the Building or the accuracy or completeness of the Energy Disclosure Information, (ii) the Energy Disclosure Information is for the current occupancy and use of the Building and that the energy performance of the Building may vary depending on future occupancy and&#47;or use of the Building, and (iii) Landlord shall have no liability to Tenant for any errors or omissions in the Energy Disclosure Information. Further, Tenant hereby releases Landlord from any and all losses, costs, damages, expenses and&#47;or liabilities relating to, arising out of and&#47;or resulting from the Energy Disclosure Requirements, including, without limitation, any liabilities arising as a result of Landlord&#8217;s failure to disclose the Energy Disclosure Information to Tenant prior to the execution of this Lease&#59; provided that the foregoing release shall not be applicable to losses arising as a result of Landlord&#8217;s gross negligence or willful misconduct. Tenant&#8217;s acknowledgment of the AS-IS condition of the Premises pursuant to the terms of this Lease shall be deemed to include the energy performance of the Building. Tenant further acknowledges that pursuant to the Energy Disclosure Requirements, Landlord may be required in the future to disclose information concerning Tenant&#8217;s energy usage to certain third parties, including, without limitation, prospective purchasers, lenders and tenants of the Building (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant Energy Use Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;). Tenant hereby (A) consents to all such Tenant Energy Use Disclosures, and (B) acknowledges that Landlord shall not be required to notify Tenant of any Tenant Energy Use Disclosure unless</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_100"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Landlord has been informed by Tenant that such information is of a confidential nature. Further, Tenant hereby releases Landlord from any and all losses, costs, damages, expenses and liabilities relating to, arising out of and&#47;or resulting from any Tenant Energy Use Disclosure. The terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall survive the expiration or earlier termination of this Lease.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Abatement of Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In the event that Tenant is prevented from using, and does not use, the Premises or any portion thereof, as a result of (i) any repair, maintenance or alteration performed by Landlord, or which Landlord failed to perform, after the Lease Commencement Date and required by this Lease, which substantially interferes with Tenant's use of the Premises, or (ii) any failure by Landlord to provide services, utilities or access to the Premises required by this Lease to be provided by Landlord as a result of circumstances within Landlord's control (either such set of circumstances as set forth in items (i) or (ii), above, to be known as an &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Abatement Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), then Tenant shall give Landlord notice of such Abatement Event, and if such Abatement Event continues for five (5) consecutive business days after Landlord's receipt of any such notice (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eligibility Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) and Landlord does not diligently commence and pursue to completion the remedy of such Abatement Event, then the Base Rent and Tenant's Share of Direct Expenses shall be abated or reduced, as the case may be, after expiration of the Eligibility Period for such time that Tenant continues to be so prevented from using, and does not use for the normal conduct of Tenant's business, the Premises or a portion thereof, in the proportion that the rentable area of the portion of the Premises that Tenant is prevented from using, and does not use, bears to the total rentable area of the Premises&#59; provided, however, in the event that Tenant is prevented from using, and does not use, a portion of the Premises for a period of time in excess of the Eligibility Period and the remaining portion of the Premises is not sufficient to allow Tenant to effectively conduct its business therein, and if Tenant does not conduct its business from such remaining portion, then for such time after expiration of the Eligibility Period during which Tenant is so prevented from effectively conducting its business therein, the Base Rent and Tenant's Share of Direct Expenses for the entire Premises shall be abated for such time as Tenant continues to be so prevented from using, and does not use, the Premises. If, however, Tenant reoccupies any portion of the Premises during such period, the Rent allocable to such reoccupied portion, based on the proportion that the rentable area of such reoccupied portion of the Premises bears to the total rentable area of the Premises, shall be payable by Tenant from the date Tenant reoccupies such portion of the Premises. To the extent an Abatement Event is caused by an event covered by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Articles 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, then Tenant's right to abate rent shall be governed by the terms of such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 11 or 13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, as applicable, and the Eligibility Period shall not be applicable thereto. Such right to abate Base Rent and Tenant's Share of Direct Expenses shall be Tenant's sole and exclusive remedy for rent abatement at law or in equity for an Abatement Event. Except as provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, nothing contained herein shall be interpreted to mean that Tenant is excused from paying Rent due hereunder.</font></div><div><font><br></font></div><div style="padding-left:41.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">7.&#160;&#160;&#160;&#160;REPAIRS</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Tenant Repair Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall, at Tenant's own expense, keep the Premises, including all improvements, fixtures and furnishings therein, and the floor or floors of the Building on which the Premises are located, in good order, repair and condition at all times during the Lease Term, except for damage caused by ordinary wear and tear or beyond the reasonable control of Tenant or from casualty events. Landlord may, but shall not be required to, enter the Premises pursuant to the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 27</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below, to make such repairs, alterations, improvements or additions to the Premises or to the Project or to any equipment located in the Project as Landlord shall desire or deem necessary or as Landlord may be required to do by governmental or quasi-governmental authority or court order or decree. Tenant hereby waives any and all rights under and benefits of subsection 1 of Section 1932 and Sections 1941 and 1942 of the California Civil Code or under any similar law, statute, or ordinance now or hereafter in effect.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Landlord Repair Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord shall be responsible, as a part of Operating Expenses, for repairs to and routine maintenance of the Project including without limitation&#58; (1) exterior windows, window frames, window casements (including the repairing, resealing, cleaning and replacing of exterior windows)&#59; (2) exterior doors, door frames and door closers&#59; (3) the Building (as opposed to the Premises) and Project plumbing, sewer, drainage, electrical, fire protection, life safety and security systems and equipment, existing heating, ventilation and air- conditioning systems, and all other mechanical and HVAC systems and equipment serving the Building as a whole and not exclusive to a particular floor of the Premises (collectively, the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Building Systems</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), (4) the exterior glass, exterior walls, foundation and roof (including roof membrane) of the Building, the structural portions of the floors of the Building (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Building Structure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), including, without limitation, any painting, sealing, patching and waterproofing of exterior walls, and (5) repairs to the elevator in the Building and underground utilities, except to the</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_103"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">extent that any such repairs are required due to the negligence or willful misconduct of Tenant (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Landlord Repair Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;)&#59; provided, however, that if such repairs are due to the negligence or willful misconduct of Tenant, Landlord shall nevertheless make such repairs at Tenant's expense, or, if covered by Landlord's insurance, Tenant shall only be obligated to pay any deductible in connection therewith. Costs expended by Landlord in connection with the Landlord Repair Obligations shall be included in Operating Expenses to the extent allowed pursuant to the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above. Landlord shall reasonably cooperate with Tenant to enforce any warranties that Landlord holds that could reduce Tenant's maintenance obligations under this Lease.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">8.&#160;&#160;&#160;&#160;ADDITIONS AND ALTERATIONS</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Landlord's Consent to Alterations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant may not make any improvements, alterations, additions or changes to the Premises or any mechanical, plumbing or HVAC facilities or systems pertaining to the Premises (collectively, the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Alterations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) without first procuring the prior written consent of Landlord to such Alterations, which consent shall be requested by Tenant not less than thirty (30) days prior to the commencement thereof, and which consent shall not be unreasonably withheld, conditioned or delayed by Landlord, provided it shall be deemed reasonable for Landlord to withhold its consent to any Alteration which adversely affects the structural portions or the systems or equipment of the Building or is visible from the exterior of the Building. Notwithstanding the foregoing, Tenant shall be permitted to make Alterations following ten (10) business days&#8217; notice to Landlord, but without Landlord's prior consent, to the extent that such Alterations (i) do not affect the building systems or equipment,</font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(ii) are not visible from the exterior of the Building, and (iii) cost less than $75,000.00 for a particular job of work. The construction of the initial improvements to the Premises shall be governed by the terms of the Tenant Work Letter and not the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Manner of Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord may impose, as a condition of its consent to any and all Alterations or repairs of the Premises or about the Premises, such requirements as Landlord in its reasonable discretion may deem desirable, including, but not limited to, the requirement that upon Landlord's request, Tenant shall, at Tenant's expense, remove such Alterations upon the expiration or any early termination of the Lease Term. Tenant shall construct such Alterations and perform such repairs in a good and workmanlike manner, in conformance with any and all applicable federal, state, county or municipal laws, rules and regulations and pursuant to a valid building permit, issued by the city in which the Building is located (or other applicable governmental authority). Tenant shall not use (and upon notice from Landlord shall cease using) contractors, services, workmen, labor, materials or equipment that, in Landlord's reasonable judgment, would disturb labor harmony with the workforce or trades engaged in performing other work, labor or services in or about the Building or the Common Areas. Upon completion of any Alterations (or repairs), Tenant shall deliver to Landlord final lien waivers from all contractors, subcontractors and materialmen who performed such work. In addition to Tenant's obligations under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, upon completion of any Alterations, Tenant agrees to cause a Notice of Completion to be recorded in the office of the Recorder of the County of San Diego in accordance with Section 3093 of the Civil Code of the State of California or any successor statute, and Tenant shall deliver to the Project construction manager a reproducible copy of the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">as built</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; drawings of the Alterations as well as all permits, approvals and other documents issued by any governmental agency in connection with the Alterations.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Payment for Improvements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall reimburse Landlord for Landlord's reasonable, actual, out-of-pocket costs and expenses actually incurred in connection with Landlord's review of such work.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Construction Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In addition to the requirements of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, in the event that Tenant makes any Alterations, prior to the commencement of such Alterations, Tenant shall provide Landlord with evidence that Tenant carries &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Builder's All Risk</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; insurance in an amount approved by Landlord covering the construction of such Alterations, and such other insurance as Landlord may reasonably require, it being understood and agreed that all of such Alterations shall be insured by Tenant pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease immediately upon completion thereof. In addition, Tenant's contractors and subcontractors shall be required to carry</font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i)&#160;&#160;&#160;&#160;Commercial General Liability Insurance in an amount approved by Landlord, with Landlord, and, at Landlord's option, Landlord's property manager and project manager, as additional insureds in an amount approved by Landlord, and otherwise in accordance with the requirements of Article 10 of this Lease, and (ii) workers compensation insurance with a waiver of subrogation in favor of Landlord . Landlord may, in its discretion, require Tenant to obtain a lien and completion bond or some alternate form of security satisfactory to Landlord in an amount sufficient to ensure the lien-free completion of such Alterations and naming Landlord as a co-obligee.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_106"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Landlord's Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. All Alterations, improvements, fixtures, equipment and&#47;or appurtenances which may be installed or placed in or about the Premises, from time to time, shall be at the sole cost of Tenant and shall be and become the property of Landlord and remain in place at the Premises following the expiration or earlier termination of this Lease&#59; provided that the foregoing shall not apply to Tenant&#8217;s trade fixtures. Notwithstanding the foregoing, Landlord may, by written notice to Tenant prior to the end of the Lease Term, or given following any earlier termination of this Lease, require Tenant, at Tenant's expense, to remove any Alterations and&#47;or improvements and&#47;or systems and equipment within the Premises and to repair any damage to the Premises and Building caused by such removal and return the affected portion of the Premises to a building standard tenant improved condition as determined by Landlord, provided further, however, notwithstanding the foregoing, upon request by Tenant at the time of Tenant's request for Landlord's consent to any Alteration or improvement, or at the time of Tenant's notice for any Alteration that does not require Landlord's consent, Landlord shall notify Tenant whether the applicable Alteration or improvement will be required to be removed pursuant to the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If Tenant fails to complete such removal and&#47;or to repair any damage caused by the removal of any Alterations and&#47;or improvements and&#47;or systems and equipment in the Premises and return the affected portion of the Premises to a building standard tenant improved condition as reasonably determined by Landlord, Landlord may do so and may charge the cost thereof to Tenant. Tenant hereby protects, defends, indemnifies and holds Landlord harmless from any liability, cost, obligation, expense or claim of lien in any manner relating to the installation, placement, removal or financing of any such Alterations, improvements, fixtures and&#47;or equipment in, on or about the Premises, which obligations of Tenant shall survive the expiration or earlier termination of this Lease.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">9.&#160;&#160;&#160;&#160;COVENANT AGAINST LIENS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tenant shall keep the Project and Premises free from any liens or encumbrances arising out of the work performed, materials furnished or obligations incurred by or on behalf of Tenant, and shall protect, defend, indemnify and hold Landlord harmless from and against any claims, liabilities, judgments or costs (including, without limitation, reasonable attorneys' fees and costs) arising out of same or in connection therewith. Tenant shall give Landlord notice at least twenty (20) days prior to the commencement of any such work on the Premises (or such additional time as may be necessary under Applicable Laws) to afford Landlord the opportunity of posting and recording appropriate notices of non-responsibility (to the extent applicable pursuant to then Applicable Laws). Tenant shall remove any such lien or encumbrance by bond or otherwise within ten (10) business days after notice by Landlord, and if Tenant shall fail to do so, Landlord may pay the amount necessary to remove such lien or encumbrance, without being responsible for investigating the validity thereof.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">10.&#160;&#160;&#160;&#160;INSURANCE</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Indemnification and Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Except to the extent arising from the gross negligence or willful misconduct of Landlord, Tenant hereby assumes all risk of damage to property or injury to persons in, upon or about the Premises from any cause whatsoever and agrees that Landlord, its partners, subpartners and their respective officers, agents, servants, employees, lenders, any property manager and independent contractors (collectively, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Landlord Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) shall not be liable for, and are hereby released from any responsibility for, any damage either to person or property or resulting from the loss of use thereof, which damage is sustained by Tenant or by other persons claiming through Tenant. Except to the extent arising from the gross negligence or willful misconduct of Landlord, Tenant shall indemnify, defend, protect, and hold harmless the Landlord Parties from any and all claims, loss, cost, damage, injury, expense and liability (including without limitation court costs and reasonable attorneys' fees) incurred in connection with or arising from any cause in, on or about the Premises, any acts, omissions or negligence of Tenant or of any person claiming by, through or under Tenant, or of the contractors, agents, servants, employees, invitees, guests or licensees of Tenant or any such person, in, on or about the Project or any breach of the terms of this Lease, either prior to, during, or after the expiration of the Lease Term, provided that the terms of the foregoing indemnity shall not apply if and from the time that a final adjudication has resulted in a finding of willful misconduct of Landlord. Landlord shall indemnify, defend, protect, and hold harmless Tenant from any and all loss, cost, damage, expense and liability (including without limitation reasonable attorneys' fees) arising from the gross negligence or willful misconduct of Landlord in, on or about the Project, except to the extent caused by the negligence or willful misconduct of the Tenant Parties. Should either party be named as a defendant in any suit brought against the other party in connection with or arising out of this Lease, the indemnifying party shall pay to indemnified party its reasonable costs and expenses incurred in such suit, including without limitation, its actual professional fees such as reasonable appraisers', accountants' and attorneys' fees. The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall survive the expiration or sooner termination of this Lease with respect to any claims or liability arising in connection with any event occurring prior to such expiration or termination.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_109"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Tenant's Compliance With Landlord's Property Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord shall insure the Building during the Lease Term against loss or damage under an &#34;all risk&#34; property insurance policy. Such coverage shall be in such amounts, from such companies, and on such other terms and conditions, as Landlord may from time to time reasonably determine. Additionally, at the option of Landlord, such insurance coverage may include the risks of earthquakes and&#47;or flood damage and additional hazards, a rental loss endorsement and one or more loss payee endorsements in favor of the holders of any mortgages or deeds of trust encumbering the interest of Landlord in the Building or the ground or underlying lessors of the Building, or any portion thereof. Tenant shall, at Tenant's expense, comply with all insurance company requirements pertaining to the use of the Premises. If Tenant's conduct or use of the Premises causes any increase in the premium for such insurance policies then Tenant shall reimburse Landlord for any such increase. Tenant, at Tenant's expense, shall comply with all rules, orders, regulations or requirements of the American Insurance Association (formerly the National Board of Fire Underwriters) and with any similar body. Tenant shall also provide Landlord and Landlord&#8217;s insurer(s) with such information regarding the use of the Premises and any damage to the Premises as they may require in connection with the placement of insurance for the Premises or the adjusting of any losses to the Premises.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:77.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Tenant's Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall maintain the following coverages in the following amounts.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10.3.1&#160;&#160;&#160;&#160;Commercial General Liability Insurance on an occurrence form covering the insured against claims of bodily injury, personal injury and property damage (including loss of use thereof) arising out of Tenant's operations, and contractual liabilities including a contractual coverage, and including products and completed operations coverage, for limits of liability on a per location basis of not less than&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div id="i1857427c06e5452983070f6ff36fd01d_112"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:43.669%"><div style="margin-top:4.6pt;padding-left:40.65pt;padding-right:1.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Bodily Injury and Property Damage Liability</font></div><div style="margin-top:4.6pt;padding-left:40.65pt"><font><br></font></div></div><div style="display:inline-block;max-width:12.660%;min-width:11.660%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:43.671%"><div style="padding-left:40.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$5,000,000 each occurrence</font></div><div style="margin-top:0.05pt;padding-left:40.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$5,000,000 annual aggregate</font></div></div></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-right:152.95pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Personal Injury Liability&#160;&#160;&#160;&#160;$3,000,000 each occurrence</font></div><div style="padding-right:149.65pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$3,000,000 annual aggregate</font></div><div><font><br></font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These amounts may be satisfied by a combination of primary and excess or umbrella liability insurance providing additional limits of coverage.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10.3.2&#160;&#160;&#160;&#160;Property Insurance covering (i) all office furniture, business and trade fixtures, office equipment, free-standing cabinet work, movable partitions, merchandise and all other items of Tenant's property on the Premises installed by, for, or at the expense of Tenant, (ii) the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant Improvements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,&#34; as that term is defined in the Tenant Work Letter, and any other improvements which exist in the Premises as of the Lease Commencement Date (excluding the Base Building) (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Original Improvements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), and (iii) all other improvements, alterations and additions to the Premises. Such insurance shall be written on an &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">all risks</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; of physical loss or damage basis, for the full replacement cost value (subject to reasonable deductible amounts) new without deduction for depreciation of the covered items and in amounts that meet any co-insurance clauses of the policies of insurance and shall include coverage for damage or other loss caused by fire or other peril including, but not limited to, vandalism and malicious mischief, theft, water damage of any type, including sprinkler leakage, bursting or stoppage of pipes, and explosion.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10.3.3&#160;&#160;&#160;&#160;Business Income Interruption for one (1) year plus Extra Expense insurance in such amounts as will reimburse Tenant for actual direct or indirect loss of earnings attributable to the risks outlined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 10.3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> above.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10.3.4&#160;&#160;&#160;&#160;Worker's Compensation and Employer's Liability or other similar insurance pursuant to all applicable state and local statutes and regulations. The policy shall include a waiver of subrogation in favor of Landlord, its employees, Lenders and any property manager or partners.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Form of Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The minimum limits of policies of insurance required of Tenant under this Lease shall in no event limit the liability of Tenant under this Lease. Such insurance shall (i) name Landlord, its subsidiaries and affiliates, its property manager (if any) and any other party the Landlord so specifies, as an additional insured or loss payee, as applicable, including Landlord's managing agent, if any&#59; (ii) be issued by an insurance company having</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_115"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a rating of not less than A&#58;IX in Best's Insurance Guide or which is otherwise acceptable to Landlord and licensed to do business in the State of California&#59; (iv) be primary insurance as to all claims thereunder and provide that any insurance carried by Landlord is excess and is non-contributing with any insurance required of Tenant&#59; and (v) be in form and content reasonably acceptable to Landlord. Tenant shall provide Landlord and any mortgagee of Landlord with written notice if said insurance is expected to be canceled or coverage changed at least thirty (30) days' prior to such cancelation or modification. Tenant shall deliver said policy or policies or certificates thereof to Landlord on or before the Lease Commencement Date and at least ten (10) days before the expiration dates thereof. In the event Tenant shall fail to procure such insurance, or to deliver such policies or certificate, Landlord may, at its option, procure such policies for the account of Tenant, and the cost thereof shall be paid to Landlord within five (5) business days after delivery to Tenant of bills therefor.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Subrogation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord and Tenant hereby agree to look solely to, and seek recovery only from, their respective insurance carriers in the event of a property or business interruption loss to the extent that such coverage is agreed to be provided hereunder. The parties each hereby waive all rights and claims against each other for such losses, and waive all rights of subrogation of their respective insurers, provided such waiver of subrogation shall not affect the right to the insured to recover thereunder. The parties agree that their respective insurance policies do now, or shall, contain the waiver of subrogation.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Additional Insurance Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall carry and maintain during the entire Lease Term, at Tenant's sole cost and expense, increased amounts of the insurance required to be carried by Tenant pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and such other reasonable types of insurance coverage and in such reasonable amounts covering the Premises and Tenant's operations therein, as may be reasonably requested by Landlord or Landlord's lender, but in no event in excess of the amounts and types of insurance then being required by landlords of buildings comparable to and in the vicinity of the Building.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">11.&#160;&#160;&#160;&#160;DAMAGE AND DESTRUCTION</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Repair of Damage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall promptly notify Landlord of any damage to the Premises resulting from fire or any other casualty to the extent Tenant is actually aware of such damage (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Casualty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). If the Premises or any Common Areas serving or providing access to the Premises shall be damaged by Casualty, Landlord shall promptly and diligently, subject to reasonable delays for insurance adjustment or other matters beyond Landlord's reasonable control, and subject to all other terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, restore the Base Building and such Common Areas. Such restoration shall be to substantially the same condition of the Base Building and the Common Areas prior to the Casualty, except for modifications required by zoning and building codes and other laws or by the holder of a mortgage on the Building or Project or any other modifications to the Common Areas deemed desirable by Landlord, which are consistent with the character of the Project, provided that access to the Premises shall not be materially impaired. Subject to the terms of Section 11.2, below, Tenant shall, at its sole cost and expense, repair any injury or damage to the Tenant Improvements and the Original Improvements installed in the Premises and shall return such Tenant Improvements and Original Improvements to their original condition except for modifications required by zoning and building codes and other Applicable Laws. Whether or not Landlord delivers a &#34;Landlord Repair Notice,&#34; as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> below, prior to the commencement of construction, Tenant shall submit to Landlord, for Landlord's review and approval, all plans, specifications and working drawings relating thereto, and Landlord shall select the contractors to perform such improvement work. Tenant shall in addition cooperate with requests for information regarding any repairs from Landlord&#8217;s insurer(s) by providing the requested information within ten (10) business days after Tenant receives the request. Landlord shall not be liable for any inconvenience or annoyance to Tenant or its visitors, or injury to Tenant's business resulting in any way from such damage or the repair thereof&#59; provided however, that if such Casualty shall have damaged the Premises or Common Areas necessary to Tenant's occupancy, and the Premises are not occupied by Tenant as a result thereof, then during the time and to the extent the Premises are unfit for occupancy, the Rent shall be abated in proportion to the ratio that the amount of rentable square feet of the Premises which is unfit for occupancy for the purposes permitted under this Lease bears to the total rentable square feet of the Premises. In the event that Landlord shall not deliver the Landlord Repair Notice, Tenant's right to rent abatement pursuant to the preceding sentence shall terminate as of the date which is reasonably determined by Landlord to be the date Tenant should have completed repairs to the Premises assuming Tenant used reasonable due diligence in connection therewith. Notwithstanding any contrary provision of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, the parties hereby agree as follows&#58; (i) the closure of the Project, the Building, the Common Areas, or any part thereof to protect public health shall not constitute a Casualty for purposes of this Lease, (ii) Casualty covered by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall require that the</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_118"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">physical or structural integrity of the Premises, the Project, the Building, or the Common Areas is degraded as a direct result of such occurrence, and (iii) a Casualty under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall not be deemed to occur merely because Tenant is unable to productively use the Premises in the event that the physical and structural integrity of the Premises is undamaged.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Landlord's Option to Repair</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Upon the occurrence of any damage to the Premises, Landlord may, at Landlord's option, deliver a notice (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Landlord Repair Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) to Tenant, and upon receipt of a Landlord Repair Notice Tenant shall assign to Landlord (or to any party designated by Landlord) all insurance proceeds payable to Tenant under Tenant's insurance required under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 10.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, and Landlord shall repair any injury or damage to the Tenant Improvements and the Original Improvements installed in the Premises and shall return such Tenant Improvements and Original Improvements to their original condition&#59; provided that if the cost of such repair by Landlord exceeds the amount of insurance proceeds received by Landlord from Tenant's insurance carrier (including by taking into account any deductible or self-insured retention), as assigned by Tenant, the cost of such repairs shall be paid by Tenant to Landlord prior to Landlord's commencement of repair of the damage. Notwithstanding the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, Landlord may elect not to rebuild and&#47;or restore the Premises, Building and&#47;or Project, and instead terminate this Lease, by notifying Tenant in writing of such termination within sixty (60) days after the date of discovery of the damage, such notice to include a termination date giving Tenant sixty</font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(60) days to vacate the Premises, but Landlord may so elect only if the Building or Project shall be damaged by Casualty, whether or not the Premises are affected, and one or more of the following conditions is present&#58; (i) in Landlord's reasonable judgment, repairs cannot reasonably be completed within one hundred eighty (180) days after the date of discovery of the damage (when such repairs are made without the payment of overtime or other premiums)&#59;</font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(ii)&#160;&#160;&#160;&#160;the holder of any mortgage on the Building or Project or ground lessor with respect to the Building or Project shall require that the insurance proceeds or any portion thereof be used to retire the mortgage debt, or shall terminate the ground lease, as the case may be&#59; (iii) the damage is not fully covered by Landlord's insurance policies&#59; (iv) Landlord decides to rebuild the Building or Common Areas so that they will be substantially different structurally or architecturally&#59; (v) the damage occurs during the last twelve (12) months of the Lease Term&#59; or (vi) any owner of any other portion of the Project, other than Landlord, does not intend to repair the damage to such portion of the Project&#59; provided, however, that if Landlord does not elect to terminate this Lease pursuant to Landlord's termination right as provided above, and the repairs cannot, in the reasonable opinion of Landlord, be completed within one hundred eighty</font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(180) days after being commenced, Tenant may elect, no earlier than sixty (60) days after the date of the damage and not later than ninety (90) days after the date of such damage, to terminate this Lease by written notice to Landlord effective as of the date specified in the notice, which date shall not be less than thirty (30) days nor more than sixty</font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(60) days after the date such notice is given by Tenant. Notwithstanding the provisions of this Section 11.2, Tenant shall have the right to terminate this Lease under this Section 11.2 only if each of the following conditions is satisfied&#58;</font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;the damage to the Project by Casualty was not caused by the gross negligence or intentional act of Tenant or its partners or subpartners and their respective officers, agents, servants, employees, and independent contractors&#59; (b) Tenant is not then in default under this Lease&#59; (c) as a result of the damage, Tenant cannot reasonably conduct business from the Premises following such Casualty&#59; and, (d) as a result of the damage to the Project, Tenant does not occupy or use the Premises at all for the conduct of Tenant's business following such Casualty&#59; provided that storage or removal of personal property and&#47;or routine maintenance of the Premises shall not be considered use of the Premises by Tenant for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Waiver of Statutory Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The provisions of this Lease, including this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, constitute an express agreement between Landlord and Tenant with respect to any and all damage to, or destruction of, all or any part of the Premises, the Building or the Project, and any statute or regulation of the State of California, including, without limitation, Sections 1932(2) and 1933(4) of the California Civil Code, with respect to any rights or obligations concerning damage or destruction in the absence of an express agreement between the parties, and any other statute or regulation, now or hereafter in effect, shall have no application to this Lease or any damage or destruction to all or any part of the Premises, the Building or the Project.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">12.&#160;&#160;&#160;&#160;NONWAIVER </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No provision of this Lease shall be deemed waived by either party hereto unless expressly waived in a writing signed thereby. The waiver by either party hereto of any breach of any term, covenant or condition herein contained shall not be deemed to be a waiver of any subsequent breach of same or any other term, covenant or condition herein contained. The subsequent acceptance of Rent hereunder by Landlord shall not be </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">deemed to be a waiver of any preceding breach by Tenant of any term, covenant or condition of this Lease, other than the failure of Tenant to pay the particular Rent so accepted, regardless of Landlord's knowledge of such preceding breach at the</font></div><div id="i1857427c06e5452983070f6ff36fd01d_121"></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">time of acceptance of such Rent. No acceptance of a lesser amount than the Rent herein stipulated shall be deemed a waiver of Landlord's right to receive the full amount due, nor shall any endorsement or statement on any check or payment or any letter accompanying such check or payment be deemed an accord and satisfaction, and Landlord may accept such check or payment without prejudice to Landlord's right to recover the full amount due. No receipt of monies by Landlord from Tenant after the termination of this Lease shall in any way alter the length of the Lease Term or of Tenant's right of possession hereunder, or after the giving of any notice shall reinstate, continue or extend the Lease Term or affect any notice given Tenant prior to the receipt of such monies, it being agreed that after the service of notice or the commencement of a suit, or after final judgment for possession of the Premises, Landlord may receive and collect any Rent due, and the payment of said Rent shall not waive or affect said notice, suit or judgment.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">13.&#160;&#160;&#160;&#160;CONDEMNATION     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If the whole or any part of the Premises, Building or Project shall be taken by power of eminent domain or condemned by any competent authority for any public or quasi-public use or purpose, or if any adjacent property or street shall be so taken or condemned, or reconfigured or vacated by such authority in such manner as to require the use, reconstruction or remodeling of any part of the Premises, Building or Project, or if Landlord shall grant a deed or other instrument in lieu of such taking by eminent domain or condemnation, Landlord shall have the option to terminate this Lease effective as of the date possession is required to be surrendered to the authority. Tenant shall not because of such taking assert any claim against Landlord or the authority for any compensation because of such taking and Landlord shall be entitled to the entire award or payment in connection therewith, except that Tenant shall have the right to file any separate claim available to Tenant for any taking of Tenant's personal property and fixtures belonging to Tenant and removable by Tenant upon expiration of the Lease Term pursuant to the terms of this Lease, and for moving expenses, so long as such claims do not diminish the award available to Landlord, its ground lessor with respect to the Building or Project or its mortgagee, and such claim is payable separately to Tenant. All Rent shall be apportioned as of the date of such termination. If any part of the Premises shall be taken, and this Lease shall not be so terminated, the Rent shall be proportionately abated. Tenant hereby waives any and all rights it might otherwise have pursuant to Section 1265.130 of The California Code of Civil Procedure. Notwithstanding anything to the contrary contained in this Article 13, in the event of a temporary taking of all or any portion of the Premises for a period of one hundred and eighty (180) days or less, then this Lease shall not terminate but the Base Rent and the Additional Rent shall be abated for the period of such taking in proportion to the ratio that the amount of rentable square feet of the Premises taken bears to the total rentable square feet of the Premises. Landlord shall be entitled to receive the entire award made in connection with any such temporary taking. Notwithstanding any contrary provision of this Lease, the following governmental actions shall not constitute a taking or condemnation, either permanent or temporary&#58; (i) an action that requires Tenant's business or the Building or Project to close during the Lease Term, and (ii) an action taken for the purpose of protecting public safety (e.g., to protect against acts of war, the spread of communicable diseases, or an infestation), and no such governmental actions shall entitle Tenant to any compensation from Landlord or any authority, or Rent abatement or any other remedy under this Lease.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">14.&#160;&#160;&#160;&#160;ASSIGNMENT AND SUBLETTING</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Transfers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall not, without the prior written consent of Landlord, assign, mortgage, pledge, hypothecate, encumber, or permit any lien to attach to, or otherwise transfer, this Lease or any interest hereunder, permit any assignment, or other transfer of this Lease or any interest hereunder by operation of law, sublet the Premises or any part thereof, or enter into any license or concession agreements or otherwise permit the occupancy or use of the Premises or any part thereof by any persons other than Tenant and its employees and contractors (all of the foregoing are hereinafter sometimes referred to collectively as &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Transfers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; and any person to whom any Transfer is made or sought to be made is hereinafter sometimes referred to as a &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Transferee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). If Tenant desires Landlord's consent to any Transfer, Tenant shall notify Landlord in writing, which notice (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Transfer Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) shall include</font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i) the proposed effective date of the Transfer, which shall not be less than thirty (30) days nor more than one hundred eighty (180) days after the date of delivery of the Transfer Notice, (ii) a description of the portion of the Premises to be transferred (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Subject Space</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), (iii) all of the terms of the proposed Transfer and the consideration therefor, including calculation of the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Transfer Premium</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;, as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> below, in connection with such Transfer, the name and address of the proposed Transferee, and a copy of all existing executed and&#47;or proposed documentation pertaining to the proposed Transfer, and (iv) current financial statements of the </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">proposed Transferee certified by an officer, partner or owner thereof, business credit and personal references and history of the proposed Transferee and any other information reasonably required by Landlord which will enable Landlord to determine the financial responsibility, character, and reputation of the proposed Transferee, nature of such Transferee's business and</font></div><div id="i1857427c06e5452983070f6ff36fd01d_124"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">proposed use of the Subject Space. Any Transfer made without Landlord's prior written consent shall, at Landlord's option, be null, void and of no effect, and shall, at Landlord's option, constitute an Event of Default by Tenant under this Lease. Whether or not Landlord consents to any proposed Transfer, Tenant shall pay Landlord's reasonable review and processing fees, as well as any reasonable professional fees (including, without limitation, attorneys', accountants', architects', engineers' and consultants' fees) incurred by Landlord, not to exceed $3,000 for a Transfer in the ordinary course of business, within thirty (30) days after written request by Landlord.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Landlord's Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord shall not unreasonably withhold, condition or delay its consent to any proposed Transfer of the Subject Space to the Transferee on the terms specified in the Transfer Notice. Without limitation as to other reasonable grounds for withholding consent, the parties hereby agree that it shall be reasonable under this Lease and under any Applicable Law for Landlord to withhold consent to any proposed Transfer where one or more of the following apply&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.7pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.2.1&#160;&#160;&#160;&#160;The Transferee is of a character or reputation or engaged in a business which is not consistent with the quality of the Building or the Project&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:114pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.2.2&#160;&#160;&#160;&#160;The Transferee is either a governmental agency or instrumentality thereof&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.75pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.2.3&#160;&#160;&#160;&#160;The Transferee is not a party of reasonable financial worth and&#47;or financial stability in light of the responsibilities to be undertaken in connection with the Transfer on the date consent is requested&#59; or</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.2.4&#160;&#160;&#160;&#160;The proposed Transfer would cause a violation of another lease for space in the Project, or would give an occupant of the Project a right to cancel its lease.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If Landlord consents to any Transfer pursuant to the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (and does not exercise any recapture rights Landlord may have under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease), Tenant may within six (6) months after Landlord's consent, but not later than the expiration of said six-month period, enter into such Transfer of the Premises or portion thereof, upon substantially the same terms and conditions as are set forth in the Transfer Notice furnished by Tenant to Landlord pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, provided that if there are any changes in the terms and conditions from those specified in the Transfer Notice such that Landlord would initially have been entitled to refuse its consent to such Transfer under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Tenant shall again submit the Transfer to Landlord for its approval and other action under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (including Landlord's right of recapture, if any, under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease). Notwithstanding anything to the contrary in this Lease, if Tenant or any proposed Transferee claims that Landlord has unreasonably withheld or delayed its consent under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> or otherwise has breached or acted unreasonably under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, their sole remedies shall be a suit for contract damages (other than damages for injury to, or interference with, Tenant's business including, without limitation, loss of profits, however occurring) or declaratory judgment and an injunction for the relief sought, and Tenant hereby waives all other remedies, including, without limitation, any right at law or equity to terminate this Lease, on its own behalf and, to the extent permitted under all Applicable Laws, on behalf of the proposed Transferee.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Transfer Premium</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If Landlord consents to a Transfer, as a condition thereto which the parties hereby agree is reasonable, Tenant shall pay to Landlord fifty percent (50%) of any &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Transfer Premium</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,&#34; as that term is defined in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, received by Tenant from such Transferee. &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Transfer Premium</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; shall mean all rent, additional rent or other consideration attributable to rent and payable by such Transferee in connection with the Transfer in excess of the Rent and Additional Rent payable by Tenant under this Lease during the term of the Transfer on a per rentable square foot basis if less than all of the Premises is transferred, and after deduction of (i) any costs of improvements made to the Subject Space in connection with such Transfer, (ii) brokerage commissions paid in connection with such Transfer, and (iii) reasonable legal fees incurred in connection with such Transfer. &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Transfer Premium</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; shall also include, but not be limited to, key money, bonus money or other cash consideration paid by Transferee to Tenant solely in connection with such Transfer which consideration is made in connection with this Lease (as opposed to other portions of Tenant&#8217;s business such as consideration paid to acquire Tenant&#8217;s business assets including personal property, goodwill, intellectual property, general intangibles, etc. so long as such allocation is not intended as a subterfuge to Tenant&#8217;s obligation to pay the Transfer Premium related to Tenant&#8217;s </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="padding-left:5.95pt;padding-right:47.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">interest in this Lease), and any payment in excess of fair market value for services rendered by Tenant to Transferee or for assets, fixtures, inventory, equipment, or furniture transferred by Tenant to Transferee in connection with such Transfer. The</font></div><div id="i1857427c06e5452983070f6ff36fd01d_127"></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">determination of the amount of Landlord's applicable share of the Transfer Premium shall be made on a monthly basis as rent or other consideration is received by Tenant under the Transfer.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Landlord's Option as to Subject Space</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, in the event Tenant contemplates a Transfer which, together with all prior Transfers then remaining in effect, would cause an entire building (i.e., either the 10275 Building or the 10285 Building) or more of the Premises to be Transferred for the then remaining Lease Term (taking into account any extension of the Lease Term which has been irrevocably exercised by Tenant) (for purposes hereof, a sublease shall be deemed to be for the then remaining Lease Term if, assuming all sublease renewal or extension rights are exercised, such sublease shall expire during the final twelve (12) months of the Lease Term), Tenant shall give Landlord notice (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Intention to Transfer Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) of such contemplated Transfer (whether or not the contemplated Transferee or the terms of such contemplated Transfer have been determined). The Intention to Transfer Notice shall specify the portion of and amount of rentable square feet of the Premises which Tenant intends to Transfer (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Contemplated Transfer Space</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), the contemplated date of commencement of the Contemplated Transfer (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Contemplated Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), and the contemplated length of the term of such contemplated Transfer, and shall specify that such Intention to Transfer Notice is delivered to Landlord pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in order to allow Landlord to elect to recapture the Contemplated Transfer Space. Thereafter, Landlord shall have the option, by giving written notice to Tenant within thirty (30) days after receipt of any Intention to Transfer Notice, to recapture the Contemplated Transfer Space. Such recapture shall cancel and terminate this Lease with respect to such Contemplated Transfer Space as of the Contemplated Effective Date&#59; provided, however, if Landlord elects to recapture the Contemplated Transfer Space, and such Contemplated Transfer Space is less than one hundred percent (100%) of the Premises, Tenant may, within five (5) business days, rescind its Intention to Transfer Notice, in which case the Intention to Transfer Notice shall be of no force or effect and this Lease shall remain full force and effect. In the event of a recapture by Landlord, if this Lease shall be canceled with respect to less than the entire Premises, the Rent reserved herein shall be prorated on the basis of the number of rentable square feet retained by Tenant in proportion to the number of rentable square feet contained in the Premises, and this Lease as so amended shall continue thereafter in full force and effect, and upon request of either party, the parties shall execute written confirmation of the same. If Landlord declines, or fails to elect in a timely manner, to recapture such Contemplated Transfer Space under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, then, subject to the other terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for a period of nine (9) months (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Nine Month Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) commencing on the last day of such thirty (30) day period, Landlord shall not have any right to recapture the Contemplated Transfer Space with respect to any Transfer made during the Nine Month Period, provided that any such Transfer is substantially on the terms set forth in the Intention to Transfer Notice, and provided further that any such Transfer shall be subject to the remaining terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If such a Transfer is not so consummated within the Nine Month Period (or if a Transfer is so consummated, then upon the expiration of the term of any Transfer of such Contemplated Transfer Space consummated within such Nine Month Period), Tenant shall again be required to submit a new Intention to Transfer Notice to Landlord with respect any contemplated Transfer, as provided above in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Effect of Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If Landlord consents to a Transfer, (i) the terms and conditions of this Lease shall in no way be deemed to have been waived or modified, (ii) such consent shall not be deemed consent to any further Transfer by either Tenant or a Transferee, (iii) Tenant shall deliver to Landlord, promptly after execution, an original executed copy of all documentation pertaining to the Transfer in form reasonably acceptable to Landlord, (iv) Tenant shall furnish upon Landlord's request a complete statement, certified by an independent certified public accountant, or Tenant's chief financial officer, setting forth in detail the computation of any Transfer Premium Tenant has derived and shall derive from such Transfer, and (v) no Transfer relating to this Lease or agreement entered into with respect thereto, whether with or without Landlord's consent, shall relieve Tenant or any guarantor of the Lease from any liability under this Lease, including, without limitation, in connection with the Subject Space. Landlord or its authorized representatives shall have the right at all reasonable times to audit the books, records and papers of Tenant relating to any Transfer, and shall have the right to make copies thereof. If the Transfer Premium respecting any Transfer shall be found understated, Tenant shall, within thirty (30) days after demand, pay the deficiency, and if understated by more than two percent (2%), Tenant shall pay Landlord's costs of such audit.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Additional Transfers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. For purposes of this Lease, the term &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; shall also include (i) if Tenant is a partnership, the withdrawal or change, voluntary, involuntary or by operation of law, of fifty percent (50%) or more of the partners, or transfer of fifty percent (50%) or more of partnership interests, within a twelve </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(12)-month period, or the dissolution of the partnership without immediate reconstitution thereof, and (ii) if Tenant is a closely held corporation (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, whose stock is not publicly held and not traded through an exchange or over the counter), (A)</font></div><div id="i1857427c06e5452983070f6ff36fd01d_130"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the dissolution, merger, consolidation or other reorganization of Tenant or (B) the sale or other transfer of an aggregate of fifty percent (50%) or more of the voting shares of Tenant (other than to immediate family members by reason of gift or death), within a twelve (12)-month period, or (C) the sale, mortgage, hypothecation or pledge of an aggregate of fifty percent (50%) or more of the value of the unencumbered assets of Tenant within a twelve (12)-month period.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Occurrence of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Any Transfer hereunder shall be subordinate and subject to the provisions of this Lease, and if this Lease shall be terminated during the term of any Transfer, Landlord shall have the right to&#58;</font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i) treat such Transfer as cancelled and repossess the Subject Space by any lawful means, or (ii) require that such Transferee attorn to and recognize Landlord as its landlord under any such Transfer. If Tenant shall be in default under this Lease, Landlord is hereby irrevocably authorized, as Tenant's agent and attorney-in-fact, to direct any Transferee to make all payments under or in connection with the Transfer directly to Landlord (which Landlord shall apply towards Tenant's obligations under this Lease) until such default is cured. Such Transferee shall rely on any representation by Landlord that Tenant is in default hereunder, without any need for confirmation thereof by Tenant. Upon any assignment, the assignee shall assume in writing all obligations and covenants of Tenant thereafter to be performed or observed under this Lease. No collection or acceptance of rent by Landlord from any Transferee shall be deemed a waiver of any provision of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> or the approval of any Transferee or a release of Tenant from any obligation under this Lease, whether theretofore or thereafter accruing. In no event shall Landlord's enforcement of any provision of this Lease against any Transferee be deemed a waiver of Landlord's right to enforce any term of this Lease against Tenant or any other person. If Tenant's obligations hereunder have been guaranteed, Landlord's consent to any Transfer shall not be effective unless the guarantor also consents to such Transfer.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Non-Transfers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Notwithstanding anything to the contrary contained in this Lease, (A) an assignment or subletting of all or a portion of the Premises to an affiliate of Tenant (an entity which is controlled by, controls, or is under common control with, Tenant as of the date of this Lease), (B) a sale of corporate shares of capital stock in Tenant in connection with an initial public offering of Tenant's stock on a nationally-recognized stock exchange, (C) a an assignment of this Lease to an entity which acquires all or substantially all of the stock or assets of Tenant, or (D) an assignment of this Lease to an entity which is the resulting entity of a merger or consolidation of Tenant during the Lease Term, shall not be deemed a Transfer requiring Landlord's consent under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and shall not be subject to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Sections 14.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">14.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> above (any such assignee or sublessee described in items (A) through (D) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> hereinafter referred to as a &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Permitted Transferee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), provided that</font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i) Tenant notifies Landlord promptly upon the effective date of any such assignment or sublease and promptly supplies Landlord with any documents or information reasonably requested by Landlord regarding such transfer or transferee as set forth above, (ii) Tenant is not in default, beyond any applicable notice and cure period, and such assignment or sublease is not a subterfuge by Tenant to avoid its obligations under this Lease, (iii) such Permitted Transferee (or the Tenant entity immediately preceding the Permitted Transfer (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Prior Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), if such Prior Tenant remains the Tenant under this Lease) shall have a tangible net worth (not including goodwill as an asset) computed in accordance with generally accepted accounting principles (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Net Worth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) at least equal to the Net Worth of Tenant on the day immediately preceding the effective date of such assignment or sublease&#59; provided that if the Prior Tenant is a surviving entity of such Permitted Transfer but is no longer the Tenant under this Lease, and such Prior Tenant remains liable under this Lease, then Tenant may combine the Net Worth of the Prior Tenant and the Permitted Transferee to satisfy the foregoing Net Worth requirement&#59; provided further that, in the event of a subletting of all or a portion of the Premises to an affiliate of Tenant pursuant to item (A) above, Tenant may combine the Net Worth of Tenant and such affiliate of Tenant to satisfy the foregoing Net Worth requirement, and (iv) no assignment relating to this Lease, whether with or without Landlord's consent, shall relieve Tenant from any liability under this Lease, and, in the event of an assignment of Tenant's entire interest in this Lease, the liability of Tenant and such transferee (other than a transferee pursuant to a stock or member interest transfer whereby this Lease is not actually assigned to a new entity) shall be joint and several. An assignee of Tenant's entire interest in this Lease who qualifies as a Permitted Transferee may also be referred to herein as a &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Permitted Transferee Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.&#34; &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,&#34; as used in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 14.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, shall mean the ownership, directly or indirectly, of at least fifty-one percent (51%) of the voting securities of, or possession of the right to vote, in the ordinary direction of its affairs, of at least fifty-one percent (51%) of the voting interest in, any person or entity.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="padding-left:41.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">15.&#160;&#160;&#160;&#160;SURRENDER OF PREMISES&#59; OWNERSHIP AND REMOVAL OF TRADE FIXTURES</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Surrender of Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. No act or thing done by Landlord or any agent or employee of Landlord during the Lease Term shall be deemed to constitute an acceptance by Landlord of a surrender of the Premises unless</font></div><div id="i1857427c06e5452983070f6ff36fd01d_133"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">such intent is specifically acknowledged in writing by Landlord. The delivery of keys to the Premises to Landlord or any agent or employee of Landlord shall not constitute a surrender of the Premises or effect a termination of this Lease, whether or not the keys are thereafter retained by Landlord, and notwithstanding such delivery Tenant shall be entitled to the return of such keys at any reasonable time upon request until this Lease shall have been properly terminated. The voluntary or other surrender of this Lease by Tenant, whether accepted by Landlord or not, or a mutual termination hereof, shall not work a merger, and at the option of Landlord shall operate as an assignment to Landlord of all subleases or subtenancies affecting the Premises or terminate any or all such sublessees or subtenancies.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Removal of Tenant Property by Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Upon the expiration of the Lease Term, or upon any earlier termination of this Lease, Tenant shall, subject to the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, quit and surrender possession of the Premises to Landlord in as good order and condition as when Tenant took possession and as thereafter improved by Landlord and&#47;or Tenant, reasonable wear and tear and repairs which are specifically made the responsibility of Landlord hereunder excepted. Upon such expiration or termination, Tenant shall, without expense to Landlord, remove or cause to be removed from the Premises all debris and rubbish, and such items of furniture, equipment, free- standing cabinet work, trade fixtures, movable partitions and other articles of personal property owned by Tenant or installed or placed by Tenant at its expense in the Premises, and such similar articles of any other persons claiming under Tenant, as Landlord may, in its sole discretion, require to be removed, and Tenant shall repair at its own expense all damage to the Premises and Building resulting from such removal.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Environmental Assessment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In connection with its surrender of the Premises, Tenant shall submit to Landlord, at least thirty (30) days prior to the expiration date of this Lease (or in the event of an earlier termination of this Lease, as soon as reasonably possible following such termination), an environmental Assessment of the Premises by a competent and experienced environmental engineer or engineering firm reasonably satisfactory to Landlord (pursuant to a contract approved by Landlord and providing that Landlord can rely on the Environmental Assessment), which (i) evidences that the Premises are in a clean and safe condition and free and clear of any Hazardous Materials&#59; and (ii) includes a review of the Premises by an environmental consultant for asbestos, mold, fungus, spores, and other moisture conditions, on-site chemical use, and lead-based paint. If such Environmental Assessment reveals that remediation or Clean-up is required under any Environmental Laws, Tenant shall submit a remediation plan prepared by a recognized environmental consultant and shall be responsible for all costs of remediation and Clean-up, as more particularly provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Condition of the Building and Premises Upon Surrender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In addition to the above requirements of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, upon the expiration of the Lease Term, or upon any earlier termination of this Lease, Tenant shall, surrender the Premises and Building such that the same are in compliance with all Applicable Laws and with Tenant having complied with all of Tenant&#8217;s obligations under this Lease, including those relating to improvement, repair, maintenance, compliance with law, testing and other related obligations of Tenant set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease. In the event that the Building and Premises shall be surrendered in a condition which does not comply with the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 15.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, because Tenant failed to comply with its obligations set forth in Lease, then following thirty</font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(30) days&#8217; notice to Tenant, during which thirty (30) day period Tenant shall have the right to cure such noncompliance, Landlord shall be entitled to expend all reasonable costs in order to cause the same to comply with the required condition upon surrender and Tenant shall immediately reimburse Landlord for all such costs upon notice and Tenant shall be deemed during the period that Tenant or Landlord, as the case may be, perform obligations relating to the Surrender Improvements to be in holdover under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.6pt;text-align:justify;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">16.&#160;&#160;&#160;&#160;HOLDING OVER&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If Tenant holds over after the expiration of the Lease Term or earlier termination thereof, with the express or implied consent of Landlord, such tenancy shall be from month-to-month only, and shall not constitute a renewal hereof or an extension for any further term. If Tenant holds over after the expiration of the Lease Term of earlier termination thereof, without the express or implied consent of Landlord, such tenancy shall be deemed to be a tenancy by sufferance only, and shall not constitute a renewal hereof or an extension for any further term. In either case, Base Rent shall be payable at a monthly rate equal to (i) one hundred twenty-five percent (125%) of the Base Rent applicable during the last rental period of the Lease Term under this Lease for the first (1st) </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">month of such holdover, and (ii) one hundred fifty percent (150%) of the Base Rent applicable during the last rental period of the Lease Term under this Lease thereafter. Such month-to-month tenancy or tenancy by sufferance, as the case may be, shall be subject to every other applicable term, covenant and agreement contained herein. Nothing contained in this Article 16 shall be construed as consent by Landlord to any holding over by Tenant, and Landlord expressly</font></div><div id="i1857427c06e5452983070f6ff36fd01d_136"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">reserves the right to require Tenant to surrender possession of the Premises to Landlord as provided in this Lease upon the expiration or other termination of this Lease. The provisions of this Article 16 shall not be deemed to limit or constitute a waiver of any other rights or remedies of Landlord provided herein or at law. If Tenant fails to surrender the Premises upon the termination or expiration of this Lease, in addition to any other liabilities to Landlord accruing therefrom, Tenant shall protect, defend, indemnify and hold Landlord harmless from all loss, costs (including reasonable attorneys' fees) and liability resulting from such failure, including, without limiting the generality of the foregoing, any claims made by any succeeding tenant founded upon such failure to surrender and any lost profits to Landlord resulting therefrom.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">17.&#160;&#160;&#160;&#160;ESTOPPEL CERTIFICATES </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Within ten (10) business days following a request in writing by Landlord, Tenant shall execute, acknowledge and deliver to Landlord an estoppel certificate, which, as submitted by Landlord, shall be substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, attached hereto (or such other form as may be required by any prospective mortgagee or purchaser of the Project, or any portion thereof), indicating therein any exceptions thereto that may exist at that time, and shall also contain any other information reasonably requested by Landlord or Landlord's mortgagee or prospective mortgagee. Any such certificate may be relied upon by any prospective mortgagee or purchaser of all or any portion of the Project. Tenant shall execute and deliver whatever other instruments may be reasonably required for such purposes. At any time during the Lease Term (but not more than once in any twelve (12) month period, except in connection with a sale or refinance of the Project, if Tenant is in monetary or material non- monetary default under this Lease, or if Tenant has identified a proposed Transferee under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> above or if Tenant request Landlord consent to an Alteration), Landlord may require Tenant to provide Landlord with a current financial statement and the financial statement of the year immediately preceding the current financial statement year. Such statements shall be prepared in accordance with generally accepted accounting principles and, if such is the normal practice of Tenant, shall be audited by an independent certified public accountant. Failure of Tenant to timely execute, acknowledge and deliver such estoppel certificate or other instruments shall constitute an acceptance of the Premises and an acknowledgment by Tenant that statements included in the estoppel certificate are true and correct, without exception.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">18.&#160;&#160;&#160;&#160;SUBORDINATION </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This Lease shall be subject and subordinate to all present and future ground or underlying leases of the Building or Project and to the lien of any mortgage, trust deed or other encumbrances now or hereafter in force against the Building or Project or any part thereof, if any, and to all renewals, extensions, modifications, consolidations and replacements thereof, and to all advances made or hereafter to be made upon the security of such mortgages or trust deeds, unless the holders of such mortgages, trust deeds or other encumbrances, or the lessors under such ground lease or underlying leases, require in writing that this Lease be superior thereto (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Superior Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;)&#59; provided, however, at Tenant's sole cost and expense, Landlord shall use commercially reasonable efforts provide Tenant a subordination non-disturbance and attornment agreement in commercially reasonable form provided by any future Superior Holder, which requires such Superior Holder to accept this lease, and not to disturb tenant&#8217;s possession, so long as a default has not occurred and is not then continuing (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SNDAA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) executed by Landlord and the appropriate Superior Holder. Tenant covenants and agrees in the event any proceedings are brought for the foreclosure of any such mortgage or deed in lieu thereof (or if any ground lease is terminated), to attorn, without any deductions or set-offs whatsoever, to the lienholder or purchaser or any successors thereto upon any such foreclosure sale or deed in lieu thereof (or to the ground lessor), if so requested to do so by such purchaser or lienholder or ground lessor, and to recognize such purchaser or lienholder or ground lessor as the lessor under this Lease, provided such lienholder or purchaser or ground lessor shall agree to accept this Lease and not disturb Tenant's occupancy, so long as Tenant timely pays the rent and observes and performs the terms, covenants and conditions of this Lease to be observed and performed by Tenant. Landlord's interest herein may be assigned as security at any time to any lienholder. Tenant shall, within ten (10) business days of request by Landlord, execute such further instruments or assurances as Landlord may reasonably deem necessary to evidence or confirm the subordination or superiority of this Lease to any such mortgages, trust deeds, ground leases or underlying leases provided that in no event shall Tenant be required to execute any document or instrument that reduces Tenant&#8217;s rights under this Lease and&#47;or increases Tenant&#8217;s liabilities under this Lease except as customarily related to commercially reasonable subordination agreements. Tenant waives the provisions of any current or future statute, rule or law which may give or purport to give Tenant any right or election to terminate or </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="padding-left:6pt;padding-right:47.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">otherwise adversely affect this Lease and the obligations of the Tenant hereunder in the event of any foreclosure proceeding or sale.</font></div><div id="i1857427c06e5452983070f6ff36fd01d_139"></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:41.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">19.&#160;&#160;&#160;&#160;DEFAULTS&#59; REMEDIES</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In addition to any other Events of Default specified in this Lease, the occurrence of any of the following shall constitute a default of this Lease by Tenant (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;)&#58;</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.1.1&#160;&#160;&#160;&#160;Any failure by Tenant to pay any Rent or any other charge required to be paid under this Lease, or any part thereof, within five (5) days following the date due with respect to Base Rent and Tenant's Share of Direct Expenses, and within five (5) days following written notice of such failure with respect to any other charge required to be paid under this Lease&#59; or</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.1.2&#160;&#160;&#160;&#160;Except where a specific time period is otherwise set forth for Tenant's performance in this Lease, in which event the failure to perform by Tenant within such time period shall be a default by Tenant under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 19.1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, any failure by Tenant to observe or perform any other provision, covenant or condition of this Lease to be observed or performed by Tenant where such failure continues for thirty (30) days after written notice thereof from Landlord to Tenant&#59; provided that if the nature of such default is such that the same cannot reasonably be cured within a thirty (30) day period, Tenant shall not be deemed to be in default if it diligently commences such cure within such period and thereafter diligently proceeds to rectify and cure such default&#59; or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:114pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.1.3&#160;&#160;&#160;&#160;Abandonment (as defined by Applicable Laws) of the Premises by Tenant&#59; or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.1.4&#160;&#160;&#160;&#160;The failure by Tenant to observe or perform according to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Articles 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease or any provision of the Tenant Work Letter, where, in each instance, such failure continues for more than three (3) business days after notice from Landlord&#59; or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any notices to be provided by Landlord under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 19.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall be in lieu of, and not in addition to, any notice required under Section 1161 et seq. of the Code of Civil Procedure, and may be served on Tenant in the manner allowed for service of notices under this Lease.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Remedies Upon Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Upon the occurrence of any Event of Default by Tenant, Landlord shall have, in addition to any other remedies available to Landlord at law or in equity (all of which remedies shall be distinct, separate and cumulative), the option to pursue any one or more of the following remedies (including, without limitation, during any eviction moratorium, to the extent allowed by Applicable Law), each and all of which shall be cumulative and nonexclusive, without any notice or demand whatsoever.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.2.1&#160;&#160;&#160;&#160;Terminate this Lease, in which event Tenant shall immediately surrender the Premises to Landlord, and if Tenant fails to do so, Landlord may, without prejudice to any other remedy which it may have for possession or arrearages in rent, enter upon and take possession of the Premises and expel or remove Tenant and any other person who may be occupying the Premises or any part thereof, without being liable for prosecution or any claim or damages therefor&#59; and Landlord may recover from Tenant the following&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41.95pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i)&#160;&#160;&#160;&#160;The worth at the time of award of the unpaid rent which has been earned at the time of such termination&#59; plus</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:42pt;padding-right:47.7pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(ii)&#160;&#160;&#160;&#160;The worth at the time of award of the amount by which the unpaid rent which would have been earned after termination until the time of award exceeds the amount of such rental loss that Tenant proves could have been reasonably avoided&#59; plus</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:42pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(iii)&#160;&#160;&#160;&#160;The worth at the time of award of the amount by which the unpaid rent for the balance of the Lease Term after the time of award exceeds the amount of such rental loss that Tenant proves could have been reasonably avoided&#59; plus</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:42pt;padding-right:47.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(iv)&#160;&#160;&#160;&#160;Any other amount necessary to compensate Landlord for all the detriment proximately caused by Tenant's failure to perform its obligations under this Lease or which in the ordinary course of things would be likely to result therefrom, specifically including but not limited to, brokerage </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="padding-left:42pt;padding-right:47.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">commissions and advertising expenses incurred, expenses of remodeling the Premises or any portion thereof</font></div><div id="i1857427c06e5452983070f6ff36fd01d_142"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:41.95pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">for a new tenant, whether for the same or a different use, and any special concessions made to obtain a new tenant&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41.95pt;padding-right:47.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(v)&#160;&#160;&#160;&#160;At Landlord's election, such other amounts in addition to or in lieu of the foregoing as may be permitted from time to time by Applicable Law.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The term &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; as used in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 19.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall be deemed to be and to mean all sums of every nature required to be paid by Tenant pursuant to the terms of this Lease, whether to Landlord or to others. As used in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Sections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">19.2.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above, the &#34;worth at the time of award&#34; shall be computed by allowing interest at the rate set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, but in no case greater than the maximum amount of such interest permitted by law. As used in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 19.2.1(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> above, the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">worth at the time of award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; shall be computed by discounting such amount at the discount rate of the Federal Reserve Bank of San Francisco at the time of award plus one percent (1%).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.2.2&#160;&#160;&#160;&#160;Landlord shall have the remedy described in California Civil Code Section 1951.4 (lessor may continue lease in effect after lessee's breach and abandonment and recover rent as it becomes due, if lessee has the right to sublet or assign, subject only to reasonable limitations). Accordingly, if Landlord does not elect to terminate this Lease on account of any Event of Default by Tenant, Landlord may, from time to time, without terminating this Lease, enforce all of its rights and remedies under this Lease, including the right to recover all rent as it becomes due.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.2.3&#160;&#160;&#160;&#160;Landlord shall at all times have the rights and remedies (which shall be cumulative with each other and cumulative and in addition to those rights and remedies available under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Sections 19.2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">19.2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above, or any law or other provision of this Lease), without prior demand or notice except as required by Applicable Law, to seek any declaratory, injunctive or other equitable relief, and specifically enforce this Lease, or restrain or enjoin a violation or breach of any provision hereof.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Subleases of Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Whether or not Landlord elects to terminate this Lease on account of any Event of Default by Tenant, as set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Landlord shall have the right to terminate any and all subleases, licenses, concessions or other consensual arrangements for possession entered into by Tenant and affecting the Premises or may, in Landlord's sole discretion, succeed to Tenant's interest in such subleases, licenses, concessions or arrangements. In the event of Landlord's election to succeed to Tenant's interest in any such subleases, licenses, concessions or arrangements, Tenant shall, as of the date of notice by Landlord of such election, have no further right to or interest in the rent or other consideration receivable thereunder.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Efforts to Relet</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. No re-entry or repossession, repairs, maintenance, changes, alterations and additions, reletting, appointment of a receiver to protect Landlord's interests hereunder, or any other action or omission by Landlord shall be construed as an election by Landlord to terminate this Lease or Tenant's right to possession, or to accept a surrender of the Premises, nor shall same operate to release Tenant in whole or in part from any of Tenant's obligations hereunder, unless express written notice of such intention is sent by Landlord to Tenant. Tenant hereby irrevocably waives any right otherwise available under any law to redeem or reinstate this Lease.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Landlord Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord shall be in default under this Lease if Landlord fails to perform any of its obligations hereunder following the Lease Commencement Date and such failure continues for thirty (30) days after Tenant delivers to Landlord written notice specifying such failure&#59; however, if such failure cannot reasonably be cured within such 30-day period, but Landlord commences to cure such failure within such 30-day period and thereafter diligently pursues the curing thereof to completion, then Landlord shall not be in default hereunder or liable for damages therefor. Except where the provisions of this Lease grant Tenant an express, exclusive remedy, or expressly deny Tenant a remedy, Tenant's exclusive remedy for Landlord's failure to perform its obligations under this Lease shall be limited to damages, injunctive relief, or specific performance&#59; in each case, Landlord's liability or obligations with respect to any such remedy shall be limited as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 29.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">20.&#160;&#160;&#160;&#160;COVENANT OF QUIET ENJOYMENT </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Landlord covenants that Tenant, on paying the Rent, charges for services and other payments herein reserved and on keeping, observing and performing all the other terms, </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">covenants, conditions, provisions and agreements herein contained on the part of Tenant to be kept, observed and performed, shall, during the Lease Term, peaceably and quietly have, hold and enjoy the Premises subject to the terms,</font></div><div id="i1857427c06e5452983070f6ff36fd01d_145"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">covenants, conditions, provisions and agreements hereof without interference by any persons lawfully claiming by or through Landlord. The foregoing covenant is in lieu of any other covenant express or implied.</font></div><div><font><br></font></div><div style="padding-left:42pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">21.&#160;&#160;&#160;&#160;LETTER OF CREDIT</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Delivery of Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Concurrent with Tenant's execution and delivery of this Lease, Tenant shall deliver to Landlord concurrent with Tenant's execution of this Lease, as protection for the full and faithful performance by Tenant of all of its obligations under this Lease and for all losses and damages Landlord may suffer (or which Landlord reasonably estimates that it may suffer) as a result of any breach or default by Tenant under this Lease, an unconditional, clean, irrevocable negotiable standby letter of credit (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">L-C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) in the amount set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Summary (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">L-C Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, payable in the City of San Diego, California, running in favor of Landlord, drawn on a bank (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) reasonably approved by Landlord and which bank must have a rating from Standard and Poors Corporation of A- or better (or any equivalent rating thereto from any successor or substitute rating service selected by Lessor) and a letter of credit issuer rating from Moody&#8217;s Investor Service of A3 or better (or any equivalent rating thereto from any successor rating agency thereto) (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Credit Rating Threshold</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), and otherwise conforming in all respects to the requirements of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, including, without limitation, all of the requirements of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 21.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below, all as set forth more particularly hereinbelow. As of the date of this Lease, Landlord approved Silicon Valley Bank as the Bank. Tenant shall pay all expenses, points and&#47;or fees incurred by Tenant in obtaining and maintaining the L-C. In the event of an assignment by Tenant of its interest in the Lease (and irrespective of whether Landlord's consent is required for such assignment), the acceptance of any replacement or substitute letter of credit by Landlord from the assignee shall be subject to Landlord's prior written approval, in Landlord's reasonable discretion, and the actual out-of-pocket attorney's fees incurred by Landlord in connection with such determination shall be payable by Tenant to Landlord within ten (10) business days of billing. Tenant shall have no right to voluntarily replace the L-C without Landlord's prior written approval, in Landlord's sole and absolute discretion. Tenant shall be responsible for the payment of any and all costs incurred by Landlord relating to the review of any replacement L-C (including, without limitation, Landlord&#8217;s reasonable attorneys&#8217; fees), which replacement is required pursuant to this Section or is otherwise requested by Tenant, and such attorneys' fees shall be payable by Tenant to Landlord within ten (10) business days of billing. If Landlord approves any replacement or substitute letter of credit, Landlord shall return the L-C then held by Landlord within one hundred (100) days following Landlord receipt of the replacement or substitute L-C tendered by Tenant&#59; provided, however, if Tenant provides evidence reasonably satisfactory to Landlord that Tenant has the ability to satisfy its monetary obligations under this Lease when and as due, then Landlord shall return the L-C then held by Landlord within thirty (30) days following Landlord receipt of the replacement or substitute L-C tendered by Tenant.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The L-C shall be &#34;callable&#34; at sight, permit partial draws and multiple presentations and drawings, and be otherwise subject to the Uniform Customs and Practices for Documentary Credits (1993-Rev), International Chamber of Commerce Publication #500, or the International Standby Practices-ISP 98, International Chamber of Commerce Publication #590. The L-C must provide that presentation of a drawing under the L-C may be made by hand delivery, courier service, overnight mail, or facsimile. Tenant further covenants and warrants as follows&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21.2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Landlord Right to Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The L-C shall provide that Landlord, its successors and assigns, may, at any time and without notice to Tenant and without first obtaining Tenant's consent thereto, transfer (one or more times) all or any portion of its interest in and to the L-C to another party, person or entity, to Landlord's lender or in connection with the assignment by Landlord of its rights and interests in and to this Lease. In the event of a transfer of Landlord's interest in the Building, Landlord shall transfer the L-C, in whole or in part, to the transferee and thereupon Landlord shall, without any further agreement between the parties, be released by Tenant from all liability therefor, and it is agreed that the provisions hereof shall apply to every transfer or assignment of the whole or any portion of said L-C to a new landlord. In connection with any such transfer of the L-C by Landlord, Tenant shall, at Tenant's sole cost and expense, execute and submit to the Bank such applications, documents and instruments as may be necessary to effectuate such transfer, and Tenant shall be responsible for paying the Bank's transfer and processing fees in connection therewith.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21.2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">No Assignment by Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall neither assign nor encumber the L-C or any part thereof. Neither Landlord nor its successors or assigns will be bound by any assignment, encumbrance, attempted assignment or attempted encumbrance by Tenant in violation of this Section.</font></div><div id="i1857427c06e5452983070f6ff36fd01d_148"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21.2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Replenishment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If, as a result of any drawing by Landlord on the L-C pursuant to its rights set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 21.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> below, the amount of the L-C shall be less than the L-C Amount, Tenant shall, within the (10) business days thereafter, provide Landlord with (i) an amendment to the L-C restoring such L-C to the L-C Amount or (ii) additional L-Cs in an amount equal to the deficiency, which additional L-Cs shall comply with all of the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and if Tenant fails to comply with the foregoing, notwithstanding anything to the contrary contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 19.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> above, the same shall constitute an incurable default by Tenant under this Lease (without the need for any additional notice and&#47;or cure period).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21.2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Renewal&#59; Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If the L-C expires earlier than the date (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">LC Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) that is one hundred (100) days after the expiration of the Lease Term, Tenant shall deliver a new L-C or certificate of renewal or extension to Landlord at least sixty (60) days prior to the expiration of the L-C then held by Landlord, without any action whatsoever on the part of Landlord, which new L-C shall be irrevocable and automatically renewable through the LC Expiration Date upon the same terms as the expiring L-C or such other terms as may be acceptable to Landlord in its sole discretion. In furtherance of the foregoing, Landlord and Tenant agree that the L-C shall contain a so-called &#34;evergreen provision,&#34; whereby the L-C will automatically be renewed unless at least sixty (60) days&#8217; prior written notice of non-renewal is provided by the issuer to Landlord&#59; provided, however, that the final expiration date identified in the L-C, beyond which the L-C shall not automatically renew, shall not be earlier than the LC Expiration Date.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21.2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Bank&#8217;s Financial Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If, at any time during the Lease Term, the Bank&#8217;s long term credit rating is reduced below the Credit Rating Threshold, or if the financial condition of the Bank changes in any other materially adverse way (either, a &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Bank Credit Threat</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), then Landlord shall have the right to require that Tenant obtain from a different issuer a substitute L-C that complies in all respects with the requirements of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and Tenant&#8217;s failure to obtain such substitute L-C within ten (10) business days following Landlord&#8217;s written demand therefor (with no other notice or cure or grace period being applicable thereto, notwithstanding anything in this Lease to the contrary) shall entitle Landlord, or Landlord&#8217;s then managing agent, to immediately draw upon the then existing L- C in whole or in part, without notice to Tenant, as more specifically described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 21.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below. Tenant shall be responsible for the payment of any and all costs incurred with the review of any replacement L-C (including without limitation Landlord&#8217;s reasonable attorneys&#8217; fees), which replacement is required pursuant to this Section or is otherwise requested by Tenant.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Application of Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant hereby acknowledges and agrees that Landlord is entering into this Lease in material reliance upon the ability of Landlord to draw upon the L-C as protection for the full and faithful performance by Tenant of all of its obligations under this Lease and for all losses and damages Landlord may suffer (or which Landlord reasonably estimates that it may suffer) as a result of any breach or default by Tenant under this Lease. Landlord, or its then managing agent, shall have the right to draw down an amount up to the face amount of the L-C if any of the following shall have occurred or be applicable&#58; (A) such amount is due to Landlord under the terms and conditions of this Lease, or (B) Tenant has filed a voluntary petition under the</font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">U. S. Bankruptcy Code or any state bankruptcy code (collectively, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Bankruptcy Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), or (C) an involuntary petition has been filed against Tenant under the Bankruptcy Code, or (D) the Bank has notified Landlord that the L-C will not be renewed or extended through the LC Expiration Date, or (E) a Bank Credit Threat or Receivership (as such term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 21.6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below) has occurred and Tenant has failed to comply with the requirements of either </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 21.2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above, or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 21.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below, as applicable. If Tenant shall breach any provision of this Lease or otherwise be in default hereunder or if any of the foregoing events identified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Sections 21.3(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall have occurred, Landlord may, but without obligation to do so, and without notice to Tenant, draw upon the L-C, in part or in whole, and the proceeds may be applied by Landlord (i) to cure any breach or default of Tenant and&#47;or to compensate Landlord for any and all damages of any kind or nature sustained or which Landlord reasonably estimates that it will sustain resulting from Tenant's breach or default, (ii) against any Rent payable by Tenant under this Lease that is not paid when due and&#47;or (iii) to pay for all losses and damages that Landlord has suffered or that Landlord reasonably estimates that it will suffer as a result of any breach or default by Tenant under this Lease. The use, application or retention of the L-C, or any portion thereof, by Landlord shall not prevent Landlord from exercising any other right or remedy provided by this Lease or by any applicable law, it being intended that Landlord shall not first be required to proceed against the L-C, and shall not operate as a limitation on any recovery to which Landlord may otherwise be entitled. Tenant agrees not to interfere in any way with payment to Landlord of the </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">proceeds of the L-C, either prior to or following a &#34;draw&#34; by Landlord of any portion of the L-C, regardless of whether any dispute exists between Tenant and Landlord as to Landlord's right to draw upon the L-C. No condition or term of this Lease</font></div><div id="i1857427c06e5452983070f6ff36fd01d_151"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">shall be deemed to render the L-C conditional to justify the issuer of the L-C in failing to honor a drawing upon such L-C in a timely manner. Tenant agrees and acknowledges that (a) the L-C constitutes a separate and independent contract between Landlord and the Bank, (b) Tenant is not a third party beneficiary of such contract, (c) Tenant has no property interest whatsoever in the L-C or the proceeds thereof, and (d) in the event Tenant becomes a debtor under any chapter of the Bankruptcy Code, neither Tenant, any trustee, nor Tenant's bankruptcy estate shall have any right to restrict or limit Landlord's claim and&#47;or rights to the L-C and&#47;or the proceeds thereof by application of Section 502(b)(6) of the U. S. Bankruptcy Code or otherwise.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Letter of Credit not a Security Deposit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord and Tenant acknowledge and agree that in no event or circumstance shall the L-C or any renewal thereof or any proceeds thereof be (i) deemed to be or treated as a &#34;security deposit&#34; within the meaning of California Civil Code Section 1950.7, (ii) subject to the terms of such Section 1950.7, or (iii) intended to serve as a &#34;security deposit&#34; within the meaning of such Section 1950.7. The parties hereto (A) recite that the L-C is not intended to serve as a security deposit and such Section 1950.7 and any and all other laws, rules and regulations applicable to security deposits in the commercial context (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Security Deposit Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) shall have no applicability or relevancy thereto and (B) waive any and all rights, duties and obligations either party may now or, in the future, will have relating to or arising from the Security Deposit Laws.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Proceeds of Draw</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In the event Landlord draws down on the L-C pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Sections 21.3(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above, the proceeds of the L-C may be held by Landlord and applied by Landlord against any Rent payable by Tenant under this Lease that is not paid when due and&#47;or to pay for all losses and damages that Landlord has suffered or that Landlord reasonably estimates that it will suffer as a result of any breach or default by Tenant under this Lease. Any unused proceeds shall constitute the property of Landlord and need not be segregated from Landlord's other assets. Tenant hereby (i) agrees that (A) Tenant has no property interest whatsoever in the proceeds from any such draw, and (B) such proceeds shall not be deemed to be or treated as a &#34;security deposit&#34; under the Security Deposit Law, and (ii) waives all rights, duties and obligations either party may now or, in the future, will have relating to or arising from the Security Deposit Laws. Landlord agrees that the amount of any proceeds of the L-C received by Landlord, and not (a) applied against any Rent payable by Tenant under this Lease that was not paid when due, or</font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;used to pay for any losses and&#47;or damages suffered by Landlord (or reasonably estimated by Landlord that it will suffer) as a result of any breach or default by Tenant under this Lease (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Unused L-C Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), shall be paid by Landlord to Tenant (x) upon receipt by Landlord of a replacement L-C in the full L-C Amount, which replacement L- C shall comply in all respects with the requirements of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, or (y) within thirty (30) days after the LC Expiration Date&#59; provided, however, that if prior to the LC Expiration Date a voluntary petition is filed by Tenant, or an involuntary petition is filed against Tenant by any of Tenant's creditors, under the Bankruptcy Code, then Landlord shall not be obligated to make such payment in the amount of the Unused L-C Proceeds until either all preference issues relating to payments under this Lease have been resolved in such bankruptcy or reorganization case or such bankruptcy or reorganization case has been dismissed.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:87pt;text-indent:-45.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Bank Placed Into Receivership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21.6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Bank Placed Into Receivership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In the event the Bank is placed into receivership or conservatorship (any such event, a &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Receivership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) by the Federal Deposit Insurance Corporation or any successor or similar entity (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FDIC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), then, effective as of the date such Receivership occurs, the L-C shall be deemed to not meet the requirements of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and, within ten (10) days following Landlord's notice to Tenant of such Receivership (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">LC Replacement Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), Tenant shall replace the L-C with a substitute L-C from a different issuer reasonably acceptable to Landlord and that complies in all respects with the requirements of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If Tenant fails to replace such L-C with a substitute L-C from a different issuer pursuant to the terms and conditions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 21.6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, then, notwithstanding anything in this Lease to the contrary, Landlord shall have the right, at Landlord's option, to either (i) declare Tenant in default of this Lease for which there shall be no notice or grace or cure periods being applicable thereto other than the aforesaid ten (10) day period), in which event, Landlord shall have the right to pursue any and all remedies available to it under this Lease and at law, including, without limitation, treating any Receivership as a Bank Credit Threat and exercising Landlord&#8217;s remedies under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 21.2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above, to the extent possible pursuant to then existing FDIC policy&#59; or (ii) elect to increase the Base Rent due and owing under the terms of this Lease pursuant to the terms and conditions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 21.6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, below. </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tenant shall be responsible for the payment of any and all costs incurred with the review of any replacement L- C (including without limitation Landlord&#8217;s reasonable attorneys&#8217; fees), which replacement is required pursuant to this Section or is otherwise requested by Tenant.</font></div><div id="i1857427c06e5452983070f6ff36fd01d_154"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21.6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">FAILURE TO REPLACE L-C&#59; LIQUIDATED DAMAGES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. IN THE EVENT THAT TENANT FAILS TO REPLACE THE L-C PURSUANT TO, AND WITHIN THE TIME PERIODS SET FORTH IN, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">SECTION 21.6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> OF THIS LEASE, ABOVE, THEN TENANT'S MONTHLY INSTALLMENT OF BASE RENT SHALL BE INCREASED TO ONE HUNDRED TEN PERCENT (110%) OF ITS THEN EXISTING LEVEL DURING THE PERIOD COMMENCING ON THE DATE THAT OCCURS TEN (10) DAYS FOLLOWING THE DATE TENANT RECEIVES THE LC REPLACEMENT NOTICE AND ENDING ON THE EARLIER TO OCCUR OF (I) THE DATE SUCH REPLACEMENT L-C IS DELIVERED TO LANDLORD PURSUANT TO THE TERMS OF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">SECTION 21.6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, OR (II) THE DATE WHICH IS NINETY (90) DAYS AFTER THE DATE OF SUCH LC REPLACEMENT NOTICE. IN THE EVENT THAT TENANT FAILS, DURING SUCH NINETY (90) DAY PERIOD FOLLOWING THE DATE OF THE LC REPLACEMENT NOTICE, TO CAUSE THE REPLACEMENT L-C TO BE DELIVERED TO LANDLORD PURSUANT TO THE TERMS OF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">SECTION 21.6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, THEN TENANT'S MONTHLY INSTALLMENT OF BASE RENT SHALL BE INCREASED TO ONE HUNDRED TWENTY-FIVE PERCENT (125%) OF ITS THEN EXISTING LEVEL DURING THE PERIOD COMMENCING ON THE DATE WHICH IS NINETY (90) DAYS AFTER THE DATE OF SUCH LC REPLACEMENT NOTICE AND ENDING ON THE DATE SUCH REPLACEMENT L-C IS DELIVERED TO LANDLORD PURSUANT TO THE TERMS OF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">SECTION 21.6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, PROVIDED, HOWEVER, THAT THE TOTAL AGGREGATE AMOUNT OF BASE RENT PAID BY TENANT IN EXCESS OF THE AMOUNT OF BASE RENT THAT TENANT WOULD HAVE PAID HAD SUCH L-C REPLACEMENT FAILURE NEVER OCCURRED SHALL IN NO EVENT EXCEED THE L-C AMOUNT. THE PARTIES AGREE THAT IT WOULD BE IMPRACTICABLE AND EXTREMELY DIFFICULT TO ASCERTAIN THE ACTUAL DAMAGES SUFFERED BY LANDLORD AS A RESULT OF TENANT'S FAILURE TO TIMELY REPLACE THE L-C FOLLOWING THE LC REPLACEMENT NOTICE AS REQUIRED IN </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">SECTION 21.6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, AND THAT UNDER THE CIRCUMSTANCES EXISTING AS OF THE DATE OF THIS LEASE, THE LIQUIDATED DAMAGES PROVIDED FOR IN THIS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">SECTION 21.6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> REPRESENT A REASONABLE ESTIMATE OF THE DAMAGES WHICH LANDLORD WILL INCUR AS A RESULT OF SUCH FAILURE, PROVIDED, HOWEVER, THAT THIS PROVISION SHALL NOT WAIVE OR AFFECT LANDLORD'S RIGHTS AND TENANT'S INDEMNITY OBLIGATIONS UNDER OTHER SECTIONS OF THIS LEASE. THE PARTIES ACKNOWLEDGE THAT THE PAYMENT OF SUCH LIQUIDATED DAMAGES IS NOT INTENDED AS A FORFEITURE OR PENALTY WITHIN THE MEANING OF CALIFORNIA CIVIL CODE SECTION 3275 OR 3369, BUT IS INTENDED TO CONSTITUTE LIQUIDATED DAMAGES TO LANDLORD PURSUANT TO CALIFORNIA CIVIL CODE SECTION 1671.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">22.&#160;&#160;&#160;&#160;ROOFTOP RIGHTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant may, in accordance with, and subject to (A) reasonable construction rules and regulations promulgated by Landlord and provided to Tenant, (B) the Building standards therefor, and (C) the terms and conditions set forth in this Lease (including, without limitation, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">), Tenant may install, repair, maintain and use, at Tenant&#8217;s sole cost and expense, without the payment of Rent (other than costs allowed to be included in Direct Expenses pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease), one (1) or more antenna or other telecommunications equipment on the roofs of the Building for the receiving and transmitting of signals or broadcasts servicing the business conducted by Tenant from within the Premises or otherwise serving the Premises (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rooftop Equipment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). Tenant shall be solely responsible for any and all costs incurred or arising in connection with the Rooftop Equipment, including but not limited to costs of electricity and insurance related to the Rooftop Equipment. Landlord makes no representations or warranties whatsoever with respect to the fitness or suitability of the roof of the Building for the installation, maintenance and operation of the Rooftop Equipment, including, without limitation, with respect to the quality and clarity of any receptions and transmissions to or from the Rooftop Equipment and the presence of any interference with such signals whether emanating from the Building or otherwise. The physical appearance, size and location of the Rooftop Equipment shall be subject to Landlord&#8217;s approval, which approval shall not be unreasonably withheld, conditioned, or delayed, and Landlord may require Tenant to install screening around such Rooftop Equipment, at Tenant&#8217;s sole cost and expense. Tenant shall service, maintain and repair such Rooftop Equipment, at Tenant&#8217;s sole cost and expense. In the event Tenant elects to exercise its right to install the Rooftop Equipment, then Tenant shall give Landlord no less than ten (10) days' prior notice thereof. Tenant shall reimburse to Landlord the actual costs reasonably incurred by Landlord in approving such Rooftop Equipment, including any third-party consultant fees. Tenant's rights under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall terminate and shall be of no further force or effect upon the expiration or earlier termination of this Lease. Prior to the expiration or earlier termination of this Lease, Tenant shall remove and restore the affected portion of the </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="padding-left:5.95pt;padding-right:47.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">rooftop, the Building and the Premises to good condition and repair, free of leaks (reasonable wear and tear and damage from casualty that is Landlord's obligation to repair pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> excepted). Such Rooftop Equipment shall be installed pursuant to plans and specifications approved by Landlord (specifically including, without limitation, all mounting and waterproofing</font></div><div id="i1857427c06e5452983070f6ff36fd01d_157"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">details), which approval shall not be unreasonably withheld, conditioned or delayed. Notwithstanding any such review or approval by Landlord, Tenant shall remain solely liable for any damage arising in connection with Tenant&#8217;s installation, use, maintenance and&#47;or repair of such Rooftop Equipment, including, without limitation, any damage to any portion of the roof or roof membrane and any penetrations to the roof. Except to the extent caused by the negligence or willful misconduct of Landlord or any Landlord Party, Landlord and Tenant hereby acknowledge and agree that Landlord shall have no liability in connection with Tenant's use, maintenance and&#47;or repair of such Rooftop Equipment. The Rooftop Equipment shall, in all instances, comply with all applicable laws. Tenant shall not be entitled to license its Rooftop Equipment to any third party other than a Permitted Transferee, nor shall Tenant be permitted to receive any revenues, fees or any other consideration for the use of the Rooftop Area and&#47;or such Rooftop Equipment by any third party, in excess of the sublease rents otherwise payable in accordance with any subletting of all or a portion of the Premises. Tenant&#8217;s right to install such Rooftop Equipment shall be exclusive (other than equipment placed on the roof by Landlord which serves the Premises), and Tenant hereby expressly acknowledges Landlord&#8217;s continued right to itself utilize any portion of the rooftop of a Building.</font></div><div><font><br></font></div><div style="padding-left:41.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">23.&#160;&#160;&#160;&#160;SIGNS</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exterior Signage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Subject to Landlord's prior written approval, which shall not be unreasonably withheld, conditioned or delayed, and provided all signs are in keeping with the quality, design and style of the Building and Project, Tenant, at its sole cost and expense, may install (i) one (1) exclusive Building top identification sign on each of the 10275 Building and the 10285 Building, (ii) identification signage on the Project's monument sign shared by the tenants of the 10265 Building and the 10275 Building, and (iii) identification signage on the Project's monument sign for the 10285 Building (collectively, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant Signage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;)&#59; provided, however, in no event shall Tenant's Signage include an &#34;Objectionable Name,&#34; as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 23.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, of this Lease. All such signage shall be subject to Tenant's obtaining all required governmental approvals. All permitted signs shall be maintained by Tenant at its expense in a first-class and safe condition and appearance. Upon the expiration or earlier termination of this Lease, Tenant shall remove all of its signs at Tenant's sole cost and expense. The graphics, materials, color, design, lettering, lighting, size, illumination, specifications and exact location of Tenant's Signage (collectively, the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Sign Specifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) shall be subject to the prior written approval of Landlord, which approval shall not be unreasonably withheld, conditioned or delayed, and shall be consistent and compatible with the quality and nature of the Project. Tenant hereby acknowledges that, notwithstanding Landlord's approval of Tenant's Signage, Landlord has made no representation or warranty to Tenant with respect to the probability of obtaining all necessary governmental approvals and permits for Tenant's Signage. In the event Tenant does not receive the necessary governmental approvals and permits for Tenant's Signage, Tenant's and Landlord's rights and obligations under the remaining TCCs of this Lease shall be unaffected.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Objectionable Name</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant's Signage shall not include a name or logo which relates to an entity which is of a character or reputation, or is associated with a political faction or orientation, which is inconsistent with the quality of the Project, or which would otherwise reasonably offend a landlord of the Comparable Buildings (an &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Objectionable Name</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). The parties hereby agree that the following name, or any reasonable derivation thereof, shall be deemed not to constitute an Objectionable Name&#58; &#34;Zentalis Pharmaceuticals, Inc.&#34;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Prohibited Signage and Other Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Any signs, notices, logos, pictures, names or advertisements which are installed and that have not been separately approved by Landlord may be removed without notice by Landlord at the sole expense of Tenant. Any signs, window coverings, or blinds (even if the same are located behind the Landlord-approved window coverings for the Building), or other items visible from the exterior of the Premises or Building, shall be subject to the prior approval of Landlord, in its sole discretion.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Termination of Right to Tenant's Signage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The rights contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall be personal to Original Tenant and its Permitted Transferee Assignee, and may only be exercised and maintained by such parties (and not any other assignee, sublessee or other transferee of the Original Tenant's interest in this Lease) to the extent (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">x</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) they are not in default under this Lease (beyond any applicable notice and cure period) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(y) if they occupy the entire Premises.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">24.&#160;&#160;&#160;&#160;COMPLIANCE WITH LAW      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tenant shall not do anything or suffer anything to be done in or about the Premises or the Project which will in any way conflict with any law, statute, ordinance or other rule, directive, order, regulation, guideline or requirement of any governmental entity or governmental agency (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Applicable</font></div><div id="i1857427c06e5452983070f6ff36fd01d_160"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) now in force or which may hereafter be enacted or promulgated. At its sole cost and expense, Tenant shall promptly comply with all such governmental measures. Should any standard or regulation now or hereafter be imposed on Landlord or Tenant by a state, federal or local governmental body charged with the establishment, regulation and enforcement of occupational, health or safety standards for employers, employees, landlords or tenants, then Tenant agrees, at its sole cost and expense, to comply promptly with such standards or regulations. Tenant shall be responsible, at its sole cost and expense, to make all alterations to the Building and Premises as are required to comply with the governmental rules, regulations, requirements or standards described in this Article 24. The judgment of any court of competent jurisdiction or the admission of Tenant in any judicial action, regardless of whether Landlord is a party thereto, that Tenant has violated any of said governmental measures, shall be conclusive of that fact as between Landlord and Tenant. For purposes of Section 1938 of the California Civil Code, Landlord hereby discloses to Tenant, and Tenant hereby acknowledges, that the Project, Building and Premises have not undergone inspection by a Certified Access Specialist (CASp). As required by Section 1938(e) of the California Civil Code, Landlord hereby states as follows&#58; &#34;A Certified Access Specialist (CASp) can inspect the subject premises and determine whether the subject premises comply with all of the applicable construction-related accessibility standards under state law. Although state law does not require a CASp inspection of the subject premises, the commercial property owner or lessor may not prohibit the lessee or tenant from obtaining a CASp inspection of the subject premises for the occupancy or potential occupancy of the lessee or tenant, if requested by the lessee or tenant. The parties shall mutually agree on the arrangements for the time and manner of the CASp inspection, the payment of the fee for the CASp inspection, and the cost of making any repairs necessary to correct violations of construction-related accessibility standards within the premises.&#34; In furtherance of the foregoing, Landlord and Tenant hereby agree as follows&#58; (a) any CASp inspection requested by Tenant shall be conducted, at Tenant's sole cost and expense, by a CASp approved in advance by Landlord&#59; and (b) pursuant to Article 24 below, Tenant, at its cost, is responsible for making any repairs within the Premises to correct violations of construction-related accessibility standards&#59; and, if anything done by or for Tenant in its use or occupancy of the Premises shall require repairs to the Building (outside the Premises) to correct violations of construction-related accessibility standards, then Tenant shall, at Landlord's option, either perform such repairs at Tenant's sole cost and expense or reimburse Landlord upon demand, as Additional Rent, for the cost to Landlord of performing such repairs.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">25.&#160;&#160;&#160;&#160;LATE CHARGES&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If any installment of Rent or any other sum due from Tenant shall not be received by Landlord or Landlord's designee within five (5) business days after Tenant's receipt of written notice from Landlord that said amount is due (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Late Payment Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), then Tenant shall pay to Landlord a late charge equal to five percent (5%) of the overdue amount plus any reasonable attorneys' fees incurred by Landlord by reason of Tenant's failure to pay Rent and&#47;or other charges when due hereunder&#59; provided that such late charge shall not be incurred with respect to the first delinquent payment in any twelve (12) month period if such payment is made within ten (10) business days after Tenant's receipt of a Late Payment Notice. The late charge shall be deemed Additional Rent and the right to require it shall be in addition to all of Landlord's other rights and remedies hereunder or at law and shall not be construed as liquidated damages or as limiting Landlord's remedies in any manner. In addition to the late charge described above, any Rent or other amounts owing hereunder which are not paid within ten (10) days after the date they are due shall bear interest from the date when due until paid at a rate per annum equal to the lesser of (i) the annual &#34;Bank Prime Loan&#34; rate cited in the Federal Reserve Statistical Release Publication G.13(415), published on the first Tuesday of each calendar month (or such other comparable index as Landlord and Tenant shall reasonably agree upon if such rate ceases to be published) plus four (4) percentage points, and (ii) the highest rate permitted by Applicable Law.</font></div><div><font><br></font></div><div style="padding-left:41.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">26.&#160;&#160;&#160;&#160;LANDLORD'S RIGHT TO CURE DEFAULT&#59; PAYMENTS BY TENANT</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Landlord's Cure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. All covenants and agreements to be kept or performed by Tenant under this Lease shall be performed by Tenant at Tenant's sole cost and expense and without any reduction of Rent, except to the extent, if any, otherwise expressly provided herein. If Tenant shall fail to perform any obligation under this Lease, and such failure shall continue in excess of the time allowed under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 19.1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, above, unless a specific time period is otherwise stated in this Lease, Landlord may, but shall not be obligated to, make any such payment or perform any such act on Tenant's part without waiving its rights based upon any default of Tenant and without releasing Tenant from any obligations hereunder.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Tenant's Reimbursement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Except as may be specifically provided to the contrary in this Lease, Tenant shall pay to Landlord, upon delivery by Landlord to Tenant of statements therefor&#58; (i) sums equal to</font></div><div id="i1857427c06e5452983070f6ff36fd01d_163"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">expenditures reasonably made and obligations incurred by Landlord in connection with the remedying by Landlord of Tenant's defaults pursuant to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 26.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#59; (ii) sums equal to all losses, costs, liabilities, damages and expenses referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease&#59; and (iii) sums equal to all expenditures made and obligations incurred by Landlord in collecting or attempting to collect the Rent or in enforcing or attempting to enforce any rights of Landlord under this Lease or pursuant to law, including, without limitation, all reasonable legal fees and other amounts so expended. Tenant's obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 26.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall survive the expiration or sooner termination of the Lease Term.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">27.&#160;&#160;&#160;&#160;ENTRY BY LANDLORD&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Landlord reserves the right on at least twenty four (24) hours&#8217; notice to Tenant and during normal business hours (except in the case of an emergency) to enter the Premises to (i) inspect them&#59; (ii) show the Premises to prospective purchasers, or to current or prospective mortgagees, ground or underlying lessors or insurers or, during the last twelve (12) months of the Lease Term, to prospective tenants&#59; (iii) post notices of nonresponsibility (to the extent applicable pursuant to then Applicable Law)&#59; or (iv) alter, improve or repair the Premises or the Building, or for structural alterations, repairs or improvements to the Building or the Building's systems and equipment. Landlord may make any such entries without the abatement of Rent, except as otherwise provided in this Lease, and may take such reasonable steps as required to accomplish the stated purposes. In an emergency, Landlord shall have the right to use any means that Landlord may deem proper to open the doors in and to the Premises. Any entry into the Premises by Landlord in the manner hereinbefore described shall not be deemed to be a forcible or unlawful entry into, or a detainer of, the Premises, or an actual or constructive eviction of Tenant from any portion of the Premises. During any such access to the Premises, Landlord shall use commercially reasonable efforts to minimize interference with Tenant&#8217;s business.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">28.&#160;&#160;&#160;&#160;TENANT PARKING   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Throughout the Lease Term and any extensions thereof, Landlord shall provide, and Tenant shall have the right to use, without any additional charge (except to the extent of costs included in Direct Expenses), the amount of parking set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Summary, in each Building's subterranean parking garage and the Project's surface parking lot. Tenant shall abide by all reasonable rules and regulations which are prescribed from time to time for the orderly operation and use of the parking facility where the parking passes are located (including any sticker or other identification system established by Landlord and the prohibition of vehicle repair and maintenance activities in the parking facilities), and shall cooperate in seeing that Tenant's employees and visitors also comply with such rules and regulations. Tenant's use of the Project parking facility shall be at Tenant's sole risk and Tenant acknowledges and agrees that Landlord shall have no liability whatsoever for damage to the vehicles of Tenant, its employees and&#47;or visitors, or for other personal injury or property damage or theft relating to or connected with the parking rights granted herein or any of Tenant's, its employees' and&#47;or visitors' use of the parking facilities.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">29.&#160;&#160;&#160;&#160;MISCELLANEOUS PROVISIONS</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Terms&#59; Captions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The words &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Landlord</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; and &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; as used herein shall include the plural as well as the singular. The necessary grammatical changes required to make the provisions hereof apply either to corporations or partnerships or individuals, men or women, as the case may require, shall in all cases be assumed as though in each case fully expressed. The captions of Articles and Sections are for convenience only and shall not be deemed to limit, construe, affect or alter the meaning of such Articles and Sections.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Binding Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Subject to all other provisions of this Lease, each of the covenants, conditions and provisions of this Lease shall extend to and shall, as the case may require, bind or inure to the benefit not only of Landlord and of Tenant, but also of their respective heirs, personal representatives, successors or assigns, provided this clause shall not permit any assignment by Tenant contrary to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Article 14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">No Air Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. No rights to any view or to light or air over any property, whether belonging to Landlord or any other person, are granted to Tenant by this Lease. If at any time any windows of the Premises are temporarily darkened or the light or view therefrom is obstructed by reason of any repairs, improvements, maintenance or cleaning in or about the Project, the same shall be without liability to Landlord and without any reduction or diminution of Tenant's obligations under this Lease.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Modification of Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Should any current or prospective mortgagee or ground lessor for the Building or Project require a modification of this Lease, which modification will not cause an increased cost or expense</font></div><div id="i1857427c06e5452983070f6ff36fd01d_166"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to Tenant or in any other way materially and adversely change the rights and obligations of Tenant hereunder or modify the Premises, then and in such event, Tenant agrees that this Lease may be so modified and agrees to execute such documents as are reasonably required therefor and to deliver the same to Landlord within ten (10) business days following a request therefor. At the request of Landlord or any mortgagee or ground lessor, Tenant agrees to execute a short form of Lease and deliver the same to Landlord within ten (10) business days following the request therefor.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Transfer of Landlord's Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant acknowledges that Landlord has the right to transfer all or any portion of its interest in the Project or Building and in this Lease, and Tenant agrees that in the event of any such transfer, Landlord shall automatically be released from all liability under this Lease and Tenant agrees to look solely to such transferee for the performance of Landlord's obligations hereunder after the date of transfer and such transferee shall be deemed to have fully assumed and be liable for all obligations of this Lease to be performed by Landlord, including the return of any Security Deposit, and Tenant shall attorn to such transferee.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Prohibition Against Recording</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 29.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, neither this Lease, nor any memorandum, affidavit or other writing with respect thereto, shall be recorded by Tenant or by anyone acting through, under or on behalf of Tenant.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:48.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Landlord's Title</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord's title is and always shall be paramount to the title of Tenant. Nothing herein contained shall empower Tenant to do any act which can, shall or may encumber the title of Landlord.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Relationship of Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Nothing contained in this Lease shall be deemed or construed by the parties hereto or by any third party to create the relationship of principal and agent, partnership, joint venturer or any association between Landlord and Tenant.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Application of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord shall have the right to apply payments received from Tenant pursuant to this Lease, regardless of Tenant's designation of such payments, to satisfy any obligations of Tenant hereunder, in such order and amounts as Landlord, in its sole discretion, may elect.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Time of Essence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Time is of the essence with respect to the performance of every provision of this Lease in which time of performance is a factor.</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Partial Invalidity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If any term, provision or condition contained in this Lease shall, to any extent, be invalid or unenforceable, the remainder of this Lease, or the application of such term, provision or condition to persons or circumstances other than those with respect to which it is invalid or unenforceable, shall not be affected thereby, and each and every other term, provision and condition of this Lease shall be valid and enforceable to the fullest extent possible permitted by law.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">No Warranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In executing and delivering this Lease, Tenant has not relied on any representations, including, but not limited to, any representation as to the amount of any item comprising Additional Rent or the amount of the Additional Rent in the aggregate or that Landlord is furnishing the same services to other tenants, at all, on the same level or on the same basis, or any warranty or any statement of Landlord which is not set forth herein or in one or more of the exhibits attached hereto.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Landlord Exculpation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The liability of Landlord or the Landlord Parties to Tenant for any default by Landlord under this Lease or arising in connection herewith or with Landlord's operation, management, leasing, repair, renovation, alteration or any other matter relating to the Project or the Premises shall be limited solely and exclusively to an amount which is equal to the interest of Landlord in the Building, provided that in no event shall such liability extend to any sales or insurance proceeds received by Landlord or the Landlord Parties in connection with the Project, Building or Premises. Neither Landlord, nor any of the Landlord Parties shall have any personal liability therefor, and Tenant hereby expressly waives and releases such personal liability on behalf of itself and all persons claiming by, through or under Tenant. The limitations of liability contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 29.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> shall inure to the benefit of Landlord's and the Landlord Parties' present and future partners, beneficiaries, officers, directors, trustees, shareholders, agents and employees, and their respective partners, heirs, successors and assigns. Under no </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="padding-left:5.95pt;padding-right:47.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">circumstances shall any present or future partner of Landlord (if Landlord is a partnership), or trustee or beneficiary (if Landlord or any partner of Landlord is a trust), have any liability for the performance of Landlord's obligations</font></div><div id="i1857427c06e5452983070f6ff36fd01d_169"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">under this Lease. Notwithstanding any contrary provision herein, neither Landlord nor the Landlord Parties shall be liable under any circumstances for injury or damage to, or interference with, Tenant's business, including but not limited to, loss of profits, loss of rents or other revenues, loss of business opportunity, loss of goodwill or loss of use, in each case, however occurring, or loss to inventory, scientific research, scientific experiments, laboratory animals, products, specimens, samples, and&#47;or scientific, business, accounting and other records of every kind and description kept at the premises and any and all income derived or derivable therefrom.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. It is understood and acknowledged that there are no oral agreements between the parties hereto affecting this Lease and this Lease constitutes the parties' entire agreement with respect to the leasing of the Premises and supersedes and cancels any and all previous negotiations, arrangements, brochures, agreements and understandings, if any, between the parties hereto or displayed by Landlord to Tenant with respect to the subject matter thereof, and none thereof shall be used to interpret or construe this Lease. None of the terms, covenants, conditions or provisions of this Lease can be modified, deleted or added to except in writing signed by the parties hereto.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Right to Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord reserves the absolute right to effect such other tenancies in the Project as Landlord in the exercise of its sole business judgment shall determine to best promote the interests of the Building or Project. Tenant does not rely on the fact, nor does Landlord represent, that any specific tenant or type or number of tenants shall, during the Lease Term, occupy any space in the Building or Project.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Force Majeure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Notwithstanding anything to the contrary contained in this Lease, any prevention, delay or stoppage due to strikes, lockouts, labor disputes, acts of God, acts of war, terrorist acts, inability to obtain services, labor, or materials or reasonable substitutes therefor, governmental actions, civil commotions, Casualty, actual or threatened public health emergency (including, without limitation, epidemic, pandemic, famine, disease, plague, quarantine, and other significant public health risk), governmental edicts, actions, declarations or quarantines by a governmental entity or health organization (including, without limitation, any shelter-in-place orders, stay at home orders or any restrictions on travel related thereto that preclude Tenant, its agents, contractors or its employees from accessing the Premises, national or regional emergency), breaches in cybersecurity, and other causes beyond the reasonable control of the party obligated to perform, regardless of whether such other causes are (i) foreseeable or unforeseeable or (ii) related to the specifically enumerated events in this paragraph (collectively, a &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Force Majeure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), shall excuse the performance of such party for a period equal to any such prevention, delay or stoppage. If this Lease specifies a time period for performance of an obligation of either party, that time period shall be extended by the period of any delay in such party's performance caused by a Force Majeure. Notwithstanding anything to the contrary in this Lease, no event of Force Majeure shall (i) excuse Tenant's obligations to pay Rent and other charges due pursuant to this Lease, (ii) be grounds for Tenant to abate any portion of Rent due pursuant to this Lease, or entitle either party to terminate this Lease, except as allowed pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Articles 11 and 13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease, or (iii) excuse Tenant's obligations under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Articles 5 and 24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Lease.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Waiver of Redemption by Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant hereby waives, for Tenant and for all those claiming under Tenant, any and all rights now or hereafter existing to redeem by order or judgment of any court or by any legal process or writ, Tenant's right of occupancy of the Premises after any termination of this Lease.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. All notices, demands, statements, designations, approvals or other communications (collectively, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) given or required to be given by either party to the other hereunder or by law shall be in writing, shall be (A) sent by United States certified or registered mail, postage prepaid, return receipt requested (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Mail</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), (B) transmitted by telecopy, if such telecopy is promptly followed by a Notice sent by Mail, (C) delivered by a nationally recognized overnight courier, or (D) delivered personally. Any Notice shall be sent, transmitted, or delivered, as the case may be, to Tenant at the appropriate address set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Summary, or to such other place as Tenant may from time to time designate in a Notice to Landlord, or to Landlord at the addresses set forth below, or to such other places as Landlord may from time to time designate in a Notice to Tenant. Any Notice will be deemed given (i) three (3) days after the date it is posted if sent by Mail, (ii) the date the telecopy is transmitted,</font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(iii) the date the overnight courier delivery is made, or (iv) the date personal delivery is made. As of the date of this Lease, any Notices to Landlord must be sent, transmitted, or delivered, as the case may be, to the following addresses&#58;</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_172"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:150pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">TPSC IX, LLC</font></div><div style="padding-left:150pt;padding-right:247.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">c&#47;o Healthpeak Properties, Inc. 1920 Main Street, Suite 1200</font></div><div style="padding-left:150pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Irvine, CA 92614</font></div><div style="margin-top:0.05pt;padding-left:150pt;padding-right:262.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Attn&#58; Legal Department and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:150pt;padding-right:164.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Allen Matkins Leck Gamble Mallory &#38; Natsis LLP 1901 Avenue of the Stars, Suite 1800</font></div><div style="padding-left:150pt;padding-right:239pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Los Angeles, California 90067 Attention&#58; Anton N. Natsis, Esq.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.19&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Joint and Several</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If there is more than one tenant, the obligations imposed upon Tenant under this Lease shall be joint and several.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.20&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If Tenant is a corporation, trust or partnership, each individual executing this Lease on behalf of Tenant hereby represents and warrants that Tenant is a duly formed and existing entity qualified to do business in the State of California and that Tenant has full right and authority to execute and deliver this Lease and that each person signing on behalf of Tenant is authorized to do so.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.21&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Attorneys' Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In the event that either Landlord or Tenant should bring suit for the possession of the Premises, for the recovery of any sum due under this Lease, or because of the breach of any provision of this Lease or for any other relief against the other, then all costs and expenses, including reasonable attorneys' fees, incurred by the prevailing party therein shall be paid by the other party, which obligation on the part of the other party shall be deemed to have accrued on the date of the commencement of such action and shall be enforceable whether or not the action is prosecuted to judgment.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.22&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Governing Law&#59; WAIVER OF TRIAL BY JURY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. This Lease shall be construed and enforced in accordance with the laws of the State of California. IN ANY ACTION OR PROCEEDING ARISING HEREFROM, LANDLORD AND TENANT HEREBY CONSENT TO (I) THE JURISDICTION OF ANY COMPETENT COURT WITHIN THE STATE OF CALIFORNIA, (II) SERVICE OF PROCESS BY ANY MEANS AUTHORIZED BY CALIFORNIA LAW, AND (III) IN THE INTEREST OF SAVING TIME AND EXPENSE, TRIAL WITHOUT A JURY IN ANY ACTION TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, PROCEEDING OR COUNTERCLAIM BROUGHT BY EITHER OF THE PARTIES HERETO AGAINST THE OTHER OR THEIR SUCCESSORS IN RESPECT OF ANY MATTER ARISING OUT OF OR IN CONNECTION WITH THIS LEASE, THE RELATIONSHIP OF LANDLORD AND TENANT, TENANT'S USE OR OCCUPANCY OF THE PREMISES, AND&#47;OR ANY CLAIM FOR INJURY OR DAMAGE, OR ANY EMERGENCY OR STATUTORY REMEDY. IN THE EVENT LANDLORD COMMENCES ANY SUMMARY PROCEEDINGS OR ACTION FOR NONPAYMENT OF BASE RENT OR ADDITIONAL RENT, TENANT SHALL NOT INTERPOSE ANY COUNTERCLAIM OF ANY NATURE OR DESCRIPTION (UNLESS SUCH COUNTERCLAIM SHALL BE MANDATORY) IN ANY SUCH PROCEEDING OR ACTION, BUT SHALL BE RELEGATED TO AN INDEPENDENT ACTION AT LAW.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.23&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Submission of Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Submission of this instrument for examination or signature by Tenant does not constitute a reservation of, option for or option to lease, and it is not effective as a lease or otherwise until execution and delivery by both Landlord and Tenant.</font></div><div style="margin-top:6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.24&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Brokers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord and Tenant hereby warrant to each other that they have had no dealings with any real estate broker or agent in connection with the negotiation of this Lease, excepting only the real estate brokers or agents specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Summary (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Brokers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), and that they know of no other real estate broker or agent who is entitled to a commission in connection with this Lease. Each party agrees to indemnify and defend the other party against and hold the other party harmless from any and all claims, demands, losses, liabilities, lawsuits, judgments, costs and expenses (including without limitation reasonable attorneys' fees) with respect to any leasing commission or equivalent compensation alleged to be owing on account of any dealings with any real estate broker or agent, other than the Brokers, occurring by, through, or under the indemnifying party. The terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 29.24</font></div><div id="i1857427c06e5452983070f6ff36fd01d_175"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">shall survive the expiration or earlier termination of the Lease Term. Landlord will pay any commission owed to the Brokers on account of this Lease pursuant to a separate agreement with the Brokers.</font></div><div style="margin-top:5.95pt;padding-left:5.95pt;padding-right:47.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.25&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Independent Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. This Lease shall be construed as though the covenants herein between Landlord and Tenant are independent and not dependent and Tenant hereby expressly waives the benefit of any statute to the contrary and agrees that if Landlord fails to perform its obligations set forth herein, Tenant shall not be entitled to make any repairs or perform any acts hereunder at Landlord's expense or to any setoff of the Rent or other amounts owing hereunder against Landlord.</font></div><div style="margin-top:6.05pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.26&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Project or Building Name, Address and Signage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord shall have the right at any time to change the name and&#47;or address of the Project or Building and to install, affix and maintain any and all signs on the exterior and on the interior of the Project or Building as Landlord may, in Landlord's sole discretion, desire. Tenant shall not use the name of the Project or Building or use pictures or illustrations of the Project or Building in advertising or other publicity or for any purpose other than as the address of the business to be conducted by Tenant in the Premises, without the prior written consent of Landlord.</font></div><div style="margin-top:5.95pt;padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.27&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. This Lease may be executed in counterparts with the same effect as if both parties hereto had executed the same document. Both counterparts shall be construed together and shall constitute a single lease.</font></div><div style="margin-top:6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.28&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant acknowledges that the content of this Lease and any related documents are confidential information. Tenant shall keep such confidential information strictly confidential and shall not disclose such confidential information to any person or entity other than Tenant's financial, legal, and space planning consultants.</font></div><div style="margin-top:6.05pt;padding-left:78pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.29&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Development of the Project</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:6pt;padding-left:5.95pt;padding-right:47.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.29.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Subdivision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord reserves the right to subdivide all or a portion of the buildings and Common Areas. Tenant agrees to execute and deliver, upon demand by Landlord and in the form requested by Landlord, any additional documents needed to conform this Lease to the circumstances resulting from a subdivision and any all maps in connection therewith. Notwithstanding anything to the contrary set forth in this Lease, the separate ownership of any buildings and&#47;or Common Areas by an entity other than Landlord shall not affect the calculation of Direct Expenses or Tenant's payment of Tenant's Share of Direct Expenses.</font></div><div style="margin-top:6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.29.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Construction of Property and Other Improvements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant acknowledges that portions of the Project may be under construction following Tenant's occupancy of the Premises, and that such construction may result in levels of noise, dust, obstruction of access, etc. which are in excess of that present in a fully constructed project. Tenant hereby waives any and all rent offsets or claims of constructive eviction which may arise in connection with such construction&#59; &#59; provided, however, in undertaking any such construction, Landlord shall use commercially reasonable efforts to minimize interference with Tenant&#8217;s use and enjoyment of the Premises, Tenant&#8217;s access to the Premises, or any other rights Tenant has under this Lease.</font></div><div style="margin-top:6pt;padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.30&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">No Violation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant hereby warrants and represents that neither its execution of nor performance under this Lease shall cause Tenant to be in violation of any agreement, instrument, contract, law, rule or regulation by which Tenant is bound, and Tenant shall protect, defend, indemnify and hold Landlord harmless against any claims, demands, losses, damages, liabilities, costs and expenses, including, without limitation, reasonable attorneys' fees and costs, arising from Tenant's breach of this warranty and representation.</font></div><div style="margin-top:5.95pt;padding-left:5.95pt;padding-right:47.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.31&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Transportation Management</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall fully comply with all present or future programs reasonably implemented by Landlord to manage parking, transportation or traffic in and around the Project and&#47;or the Building, and in connection therewith, Tenant shall take responsible action for the transportation planning and management of all employees located at the Premises by working directly with Landlord, any governmental transportation management organization or any other transportation-related committees or entities. Such programs may include, without limitation&#58; (i) restrictions on the number of peak-hour vehicle trips generated by Tenant&#59; (ii) increased vehicle occupancy&#59; (iii) implementation of an in-house ridesharing program and an employee transportation coordinator&#59; (iv) working with employees and any Project, Building or area-wide ridesharing program manager&#59; (v) instituting employer-sponsored incentives (financial or in-kind) to encourage employees to rideshare&#59; and (vi) utilizing flexible work shifts for employees.</font></div><div style="margin-top:6.05pt;padding-left:6pt;padding-right:47.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.32&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Signatures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The parties hereto consent and agree that this Lease may be signed and&#47;or transmitted by facsimile, e-mail of a .pdf document or using electronic signature technology (e.g., via DocuSign or similar</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_178"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">electronic signature technology), and that such signed electronic record shall be valid and as effective to bind the party so signing as a paper copy bearing such party&#8217;s handwritten signature. The parties further consent and agree that (1) to the extent a party signs this Lease using electronic signature technology, by clicking &#8220;SIGN&#8221;, such party is signing this Lease electronically, and (2) the electronic signatures appearing on this Lease shall be treated, for purposes of validity, enforceability and admissibility, the same as handwritten signatures.</font></div><div style="margin-top:5.95pt;padding-left:6pt;padding-right:47.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.33&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Waiver of Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. As a material inducement to Landlord to enter into this Lease, Tenant hereby releases Landlord from, and hereby waives, any and all losses, costs, damages, expenses, liabilities, claims and causes of action (collectively, the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Released Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) arising from or related to Tenant's inability or limitation to conduct operations from the Premises as a result of any &#34;shelter in place&#34; orders or similar governmental directives, including, without limitation, any claims for, and&#47;or rights of, termination of this Lease and&#47;or abatement, offset and&#47;or deferral of Rent under this Lease, at law and&#47;or in equity related to the inability of Tenant to conduct operations from the Premises as a result of any &#34;shelter in place&#34; orders or similar governmental directives related thereto. With respect to the Released Claims, Tenant acknowledges that Tenant has either been advised by legal counsel or has made itself familiar with the provisions of California Civil Code section 1542, which provides as follows&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tenant, being aware of the foregoing code section, hereby expressly waives any rights Tenant may have thereunder, as well as under any other statutes or common-law principles of similar effect, pertaining to the Released Claims.</font></div><div style="margin-top:6.05pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.34&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Communications and Computer Line</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant may install, maintain, replace, remove or use any communications or computer wires and cables serving the Premises (collectively, the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), provided that Tenant shall obtain Landlord's reasonable prior written consent, use an experienced and qualified contractor approved in writing by Landlord, and comply with all of the other provisions of Articles 7 and 8 of this Lease. Tenant shall pay all costs in connection therewith. Landlord reserves the right, upon notice to Tenant prior to the expiration or earlier termination of this Lease, to require that Tenant, at Tenant's sole cost and expense, remove any Lines installed by Tenant located in or serving the Premises prior to the expiration or earlier termination of this Lease.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, Landlord and Tenant have caused this Lease to be executed the day and date first above written.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:11.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">LANDLORD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">TENANT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div id="i1857427c06e5452983070f6ff36fd01d_181"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:43.994%"><div style="margin-top:4.6pt;padding-left:11.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">TPSC IX, LLC,</font></div><div style="padding-left:11.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a Delaware limited liability company</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:11.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;&#160;&#160;&#160;&#160;HCP Estates USA Inc.,</font></div><div style="padding-left:47.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a Delaware corporation, Its Managing Member</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#47;s&#47; Mike Dorris&#160;&#160;&#160;&#160;</font></div><div style="margin-top:6.5pt;padding-left:88.7pt;padding-right:88.7pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:82%">Mike Dorris</font></div><div style="padding-left:46.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="margin-top:4.6pt;padding-left:11.4pt"><font><br></font></div></div><div style="display:inline-block;max-width:12.011%;min-width:11.011%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:43.995%"><div style="padding-left:11.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">ZENTALIS PHARMACEUTICALS, INC.,</font></div><div style="padding-left:11.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a Delaware corporation</font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:11.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#47;s&#47; Kevin Bunker&#160;&#160;&#160;&#160;</font></div><div style="margin-top:9.65pt;padding-left:68.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">Kevin Bunker</font></div><div style="margin-top:0.05pt"><img alt="image_9.jpg" src="image_9.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:232px"></div><div style="margin-top:0.6pt;padding-left:86.95pt;padding-right:86.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Print Name</font></div></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:24.719%"><div style="margin-top:0.2pt"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Title&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.373%;min-width:0.040%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:24.719%"><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:18.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">Senior Vice President</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:3pt;padding-right:-13.7pt"><img alt="image_10a.jpg" src="image_10a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:185px"></div><div style="margin-top:2.55pt;text-align:right"><font><br></font></div></div><div style="display:inline-block;max-width:0.373%;min-width:0.040%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:24.719%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Its&#58;</font></div><div style="margin-top:0.25pt;padding-left:42.9pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.373%;min-width:0.040%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:24.724%"><div style="padding-left:42.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">Chief Operating Officer</font></div><div><img alt="image_11a.jpg" src="image_11a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:209px"></div></div></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:311.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-top:0.55pt"><img alt="image_9.jpg" src="image_9.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:232px"></div><div style="margin-top:0.6pt;padding-right:92.3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Print Name</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="padding-left:311.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Its&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_184"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">THE BOARDWALK</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">OUTLINE OF PREMISES</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_187"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="padding-left:6.4pt"><img alt="image_14a.jpg" src="image_14a.jpg" style="height:484px;margin-bottom:5pt;vertical-align:text-bottom;width:622px"></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_190"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="padding-left:6.4pt"><img alt="image_15a.jpg" src="image_15a.jpg" style="height:484px;margin-bottom:5pt;vertical-align:text-bottom;width:622px"></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_193"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="padding-left:6.4pt"><img alt="image_16a.jpg" src="image_16a.jpg" style="height:484px;margin-bottom:5pt;vertical-align:text-bottom;width:622px"></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_196"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="padding-left:6.4pt"><img alt="image_17a.jpg" src="image_17a.jpg" style="height:484px;margin-bottom:5pt;vertical-align:text-bottom;width:622px"></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_199"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="padding-left:6.4pt"><img alt="image_18a.jpg" src="image_18a.jpg" style="height:484px;margin-bottom:5pt;vertical-align:text-bottom;width:622px"></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_202"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.6pt;padding-right:111.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT A-1</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">THE BOARDWALK</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">PROJECT SITE PLAN</font></div><div style="margin-top:0.35pt"><img alt="image_19a.jpg" src="image_19a.jpg" style="height:436px;margin-bottom:5pt;vertical-align:text-bottom;width:623px"></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_205"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.6pt;padding-right:111.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT A-2</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">TEMPORARY SPACE</font></div><div><font><br></font></div><div style="margin-top:0.4pt"><img alt="image_21a.jpg" src="image_21a.jpg" style="height:396px;margin-bottom:5pt;vertical-align:text-bottom;width:596px"></div><div style="height:48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_1692"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">EXHIBIT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">A-3</font></div><div><font><br></font></div><div style="text-align:center;text-indent:90.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">TEMPORARY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">SPACE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">PLAN</font><img alt="image1a.jpg" src="image1a.jpg" style="height:382px;margin-bottom:5pt;vertical-align:text-bottom;width:591px"></div><div style="height:54.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="text-align:center;text-indent:90.65pt"><img alt="imagea.jpg" src="imagea.jpg" style="height:454px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="height:54.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_214"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.55pt;padding-right:111.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">THE BOARDWALK</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">TENANT WORK LETTER</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This Tenant Work Letter shall set forth the terms and conditions relating to the construction of the Premises. This Tenant Work Letter is essentially organized chronologically and addresses the issues of the construction of the Premises, in sequence, as such issues will arise during the actual construction of the Premises. All references in this Tenant Work Letter to Articles or Sections of &#34;this Lease&#34; shall mean the relevant portions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Articles 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">29</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Office Lease to which this Tenant Work Letter is attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and all references in this Tenant Work Letter to Sections of &#34;this Tenant Work Letter&#34; shall mean the relevant portions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Sections 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Tenant Work Letter.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">SECTION 1</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:50.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">LANDLORD'S INITIAL CONSTRUCTION OF THE BASE BUILDING IMPROVEMENTS</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:6pt;padding-right:47.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.1    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Construction of Base Building Improvements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord shall construct, at its sole cost and expense, in a good workmanlike manner and without deduction from the Tenant Improvement Allowance, the Base Building improvements (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Base Building Improvements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), generally as depicted in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 1-A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, attached hereto (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Base Building Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), including the items set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 1-B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Base Building Modifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), subject to Landlord Minor Changes, as that term is defined herein below. In the event of a conflict between </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 1-A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 1-B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Schedule 1-A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">shall prevail. Landlord hereby reserves the right to modify the Base Building Plans, provided that such modifications (A) are required to comply with Applicable Laws or as a condition of any governmental or other third-party approvals or consents that are required to be obtained in connection with the Base Building Improvements, (B) will not (i) materially and adversely affect Tenant's Permitted Use of the Premises and the Project or materially increase the cost of the Tenant Improvements or decrease the functionality of the Tenant Improvements, or (ii) result in the use of materials, systems or components which are not of a materially equivalent or better quality than the materials, systems and components set forth in the Base Building Plans, or in the Lease, or</font></div><div style="padding-left:5.95pt;padding-right:47.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(C) pertain to portions of the Project located outside of the Buildings (provided that Landlord may not reduce the number of parking spaces available for Tenant's use) (collectively, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Landlord Minor Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). The Base Building Improvements, as well as the Common Areas (including the so-called &#34;path of travel&#34;) will be constructed in a good and workmanlike manner, and in compliance with Applicable Laws for unoccupied space as of the date of Substantial Completion of the Base Building Improvements to the extent required to allow Tenant, subject to the construction of the Tenant Improvements, to obtain a certificate of occupancy or its legal equivalent allowing the legal occupancy of the Premises for the Permitted Use. Within five (5) days after the Substantial Completion of the Base Building Improvements, Landlord and Tenant shall have a &#34;walk-through&#34; of the delivered Premises to jointly create a punch- list setting forth any deviations between the required Base Building Improvements and the actual condition of the Premises (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Delivery Punch List</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). Landlord shall repair or correct the items set forth on the Delivery Punch List within a commercially reasonable period after the date of such walk through.</font></div><div><font><br></font></div><div style="padding-left:175.95pt;padding-right:217.5pt;text-indent:37.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:232%">SECTION 2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:232%;text-decoration:underline">TENANT IMPROVEMENTS</font></div><div style="margin-top:0.4pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Tenant Improvement Allowance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant shall be entitled to a one-time tenant improvement allowance (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant Improvement Allowance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) in the amount set forth in Section 5 of the Summary (subject to the terms of Section 1.3 of the Lease) for the costs relating to the initial design and construction of Tenant's improvements which are permanently affixed to the Premises (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant Improvements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). In no event shall Landlord be obligated to make disbursements pursuant to this Tenant Work Letter in a total amount which exceeds the Tenant Improvement Allowance. In the event that the Tenant Improvement Allowance is not fully utilized by Tenant on or before the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) anniversary of the Lease Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#93; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">TIA Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), then such unused amounts shall revert to Landlord, and Tenant shall have no further rights with respect thereto. Any</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_217"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tenant Improvements that require the use of Building risers, raceways, shafts and&#47;or conduits, shall be subject to Landlord's reasonable rules, regulations, and restrictions, including the requirement that any cabling vendor must be selected from a list provided by Landlord, and that the amount and location of any such cabling must be approved by Landlord. All Tenant Improvements for which the Tenant Improvement Allowance has been made available shall be deemed Landlord's property under the terms of the Lease&#59; provided, however, Landlord may, by written notice to Tenant prior to the end of the Lease Term, or given following any earlier termination of this Lease, require Tenant, at Tenant's expense, to remove any Tenant Improvements and to repair any damage to the Premises and Building caused by such removal and return the affected portion of the Premises to their condition existing prior to the installment of such Tenant Improvements.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Disbursement of the Tenant Improvement Allowance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Except as otherwise set forth in this Tenant Work Letter, the Tenant Improvement Allowance shall be disbursed by Landlord (each of which disbursements shall be made pursuant to Landlord's disbursement process) only for the following items and costs (collectively, the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant Improvement Allowance Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;)&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.1&#160;&#160;&#160;&#160;Payment of the fees of the &#34;Architect&#34; and the &#34;Engineers,&#34; as those terms are defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Tenant Work Letter, which fees shall, notwithstanding anything to the contrary contained in this Tenant Work Letter, not exceed an aggregate amount equal to $3.00 per rentable square foot of the Premises, and payment of Tenant's project manager not to exceed two percent (2%) of the so called &#34;hard&#34; costs of constructing the Tenant Improvements, and payment of the fees incurred by, and the cost of documents and materials supplied by, Landlord and Landlord's consultants in connection with the preparation and review of the &#34;Construction Drawings,&#34; as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Tenant Work Letter&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.2&#160;&#160;&#160;&#160;The payment of plan check, permit and license fees relating to construction of the Tenant</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Improvements&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.3&#160;&#160;&#160;&#160;The cost of construction of the Tenant Improvements, including, without limitation, testing and inspection costs, freight elevator usage, hoisting and trash removal costs, and contractors' fees and general conditions&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.4&#160;&#160;&#160;&#160;The cost of any changes in the Base, Shell and Core when such changes are required by the Construction Drawings (including if such changes are due to the fact that such work is prepared on an unoccupied basis), such cost to include all direct architectural and&#47;or engineering fees and expenses incurred in connection therewith&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.5&#160;&#160;&#160;&#160;The cost of any changes to the Construction Drawings or Tenant Improvements required by all applicable building codes (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:113.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.6&#160;&#160;&#160;&#160;The cost of connection of the Premises to the Building's energy management systems&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.7&#160;&#160;&#160;&#160;The cost of the &#34;Landlord Supervision Fee,&#34; as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4.3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Tenant Work Letter&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:114pt;text-indent:-36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.8&#160;&#160;&#160;&#160;Sales and use taxes and Title 24 fees&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.9&#160;&#160;&#160;&#160;The cost of cabling, signage, furniture, fixtures and equipment installed by Tenant at the Premises, which costs shall, notwithstanding anything to the contrary contained in this Tenant Work Letter, not exceed an aggregate amount equal to $15.00 per rentable square foot of the Premises.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.2.10&#160;&#160;&#160;&#160;All other costs to be expended by Landlord in connection with the construction of the Tenant Improvements.</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_220"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:169.85pt;padding-right:211.3pt;text-indent:43.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:232%">SECTION 3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:232%;text-decoration:underline">CONSTRUCTION DRAWINGS</font></div><div style="margin-top:0.35pt;padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Selection of Architect&#47;Construction Drawings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord shall retain an architect reasonably approved by Tenant (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Architect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) to prepare the &#34;Construction Drawings,&#34; as that term is defined in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord shall retain (or cause the Architect to retain) engineering consultants (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Engineers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) mutually and reasonable approved by Landlord and Tenant to prepare all plans and engineering working drawings. The plans and drawings to be prepared by Architect and the Engineers hereunder shall be known collectively as the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Construction Drawings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.&#34; All Construction Drawings shall comply with the drawing format and specifications as determined by Landlord, and shall be subject to Landlord's and Tenant's approval. Tenant shall be responsible for ensuring that all elements of the design of the Construction Drawings are suitable for Tenant&#8217;s use of the Premises, and neither the preparation of the Construction Drawings by the Architect or the Engineers nor Landlord&#8217;s approval of the Construction Drawings shall relieve Tenant from such responsibility. Landlord shall cause the Architect and the Engineers to use the &#34;Required Level of Care&#34; (defined below) to cause the Construction Drawings to comply with Applicable Laws&#59; provided, however, that Tenant, not Landlord, shall be responsible for any violation of Applicable Laws by the Construction Drawings resulting from Tenant&#8217;s use of the Premises for other than general office purposes or as a result of information provided by Tenant to the Architect or Engineers. As used herein, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Required Level of Care</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221; means the level of care that reputable architects and engineers customarily use to cause drawings and specifications to comply with Applicable Laws where such drawings and specifications are prepared for spaces in buildings comparable in quality to the Building.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Initial Programming Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Within five (5) business days following the full execution and delivery of this Lease, Tenant shall furnish to Landlord all information necessary in the judgment of Landlord, the Architect and the Engineers for the preparation of a conceptual space plan for the Premises (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Space Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), including layout and designation of all offices, rooms and other partitioning, their intended use, and equipment to be contained therein, the number and sizes of workstations, number and size of kitchen, laboratory, warehouse, reception and storage areas (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Initial Programming Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;). The Initial Programming Information shall be subject to Landlord&#8217;s reasonable approval. Landlord shall provide Tenant with notice approving or reasonably disapproving the Initial Programming Information within five (5) business days after Landlord&#8217;s receipt thereof. If Landlord disapproves the Initial Programming Information, Landlord&#8217;s notice of disapproval shall describe with reasonable specificity the basis for such disapproval and the changes that would be necessary to resolve Landlord&#8217;s objections. If Landlord disapproves the Initial Programming Information, Tenant shall modify the Initial Programming Information and resubmit it for Landlord&#8217;s review and approval. Such procedure shall be repeated as necessary until Landlord has approved the Initial Programming Information.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Space Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. After approving the Initial Programming Information, Landlord shall cause the Architect to prepare and deliver to Tenant a Space Plan that conforms to the Initial Programming Information. Tenant shall approve or disapprove the Space Plan by notice to Landlord within three (3) business days after Tenant&#8217;s receipt thereof. If Tenant disapproves the Space Plan (provided, however, that Tenant may only disapprove the Space Plan to the extent it is inconsistent with the Initial Programming Information), Tenant&#8217;s notice of disapproval shall specify any revisions Tenant desires in the Space Plan. After receiving such notice of disapproval, Landlord shall cause the Architect to revise the Space Plan, taking into account the reasons for Tenant&#8217;s disapproval, and resubmit the Space Plan to Tenant for its approval. Such procedure shall be repeated as necessary until Tenant has approved the Space Plan.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Additional Programming Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Within ten (10) days after Tenant's approval of the Space Plan, Tenant shall furnish to Landlord all information that, together with the Space Plan, is necessary in the judgment of Landlord, the Architect and the Engineers to complete the architectural, engineering and final architectural working drawings for the Premises in a form that is sufficient to enable subcontractors to bid on the work and to obtain all applicable permits for the Tenant Improvements (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Final Working Drawings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), including electrical requirements, telephone requirements, special HVAC requirements, plumbing requirements, and all interior and special finishes (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Additional Programming Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;). The Additional Programming Information shall be consistent with the Space Plan and shall otherwise be subject to Landlord&#8217;s reasonable approval. Landlord shall provide Tenant with notice approving or reasonably disapproving the Additional Programming Information within five (5) business days after Landlord&#8217;s receipt thereof. If Landlord disapproves the Additional Programming</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_223"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Information, Landlord&#8217;s notice of disapproval shall describe with reasonable specificity the basis for such disapproval and the changes that would be necessary to resolve Landlord&#8217;s objections. If Landlord disapproves the Additional Programming Information, Tenant shall modify the Additional Programming Information and resubmit it for Landlord&#8217;s review and approval. Such procedure shall be repeated as necessary until Landlord has approved the Additional Programming Information.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Approved Working Drawings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. After approving the Additional Programming Information, Landlord shall cause the Architect and the Engineers to prepare and deliver to Tenant the Final Working Drawings that conform to the approved Space Plan and the approved Additional Programming Information. Within five</font></div><div style="padding-left:6pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(5)&#160;&#160;&#160;&#160;business days after Tenant's receipt thereof, Tenant shall approve or disapprove the Final Working Drawings by notice to Landlord. If Tenant disapproves the Final Working Drawings, Tenant&#8217;s notice of disapproval shall specify any revisions Tenant desires in the Final Working Drawings (provided, however, that Tenant may only disapprove the Final Working Drawings to the extent it is inconsistent with the Space Plan or the Additional Programming Information). After receiving such notice of disapproval, Landlord shall cause the Architect and&#47;or the Engineers to revise the Final Working Drawings, taking into account the reasons for Tenant&#8217;s disapproval, and resubmit the Final Working Drawings to Tenant for its approval. Such procedure shall be repeated as necessary until Tenant has approved the Final Working Drawings.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Final Working Drawings shall be approved by Tenant (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Approved Working Drawings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) prior to the commencement of the construction of the Tenant Improvements. Landlord shall immediately submit the Approved Working Drawings to the appropriate municipal authorities for issuance of applicable building permits necessary to allow &#34;Contractor,&#34; as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below, to commence the construction of the Tenant Improvements (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). No changes, modifications or alterations in the Approved Working Drawings may be made without the prior written consent of Landlord, provided that Landlord may withhold its consent, in its sole discretion, to any change in the Approved Working Drawings if such change would directly or indirectly delay the &#34;Substantial Completion&#34; of the Premises as that term is defined in Section 5.1 of this Tenant Work Letter.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Time Deadlines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord and Tenant shall each use their best, good faith, efforts and all due diligence to cooperate with the Architect, the Engineers, and each other to complete all phases of the Construction Drawings and the permitting process, and with Contractor for approval of the &#34;Cost Proposal,&#34; as that term is defined in Section 4.2 of this Tenant Work Letter, as soon as possible after the execution of the Lease. The applicable dates for approval of items, plans and drawings as described in this Section 3, Section 4, below, and in this Tenant Work Letter are set forth (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Time Deadlines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), attached hereto. Landlord and Tenant each agree to comply with the Time Deadlines.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:111.6pt;padding-right:111.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SECTION 4</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">CONSTRUCTION OF THE TENANT IMPROVEMENTS</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Contractor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. A contractor (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Contractor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) to construct the Tenant Improvements shall be selected pursuant to a competitive bid process whereby the construction of the Tenant Improvements shall be bid out to a minimum of three (3) qualified, licensed and reputable general contractors (each a &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Bidding Contractor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,&#34; and, collectively, the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Bidding Contractors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) mutually and reasonably selected by Landlord and Tenant. The Bidding Contractors shall bid on the construction of the Tenant Improvements utilizing an early set of the Final Working Drawing. Such selection shall take into account firm experience with similar projects, proposed project team and proposed commercial terms (fee, insurance, General Conditions&#47;General Requirements). Each of the Bidding Contractors shall be notified in the bidding package, which shall be prepared by Landlord and reasonably approved in advance by Tenant, of (i) the time schedule for construction of the Tenant Improvements, (ii) the requirement that, unless Landlord otherwise requires, the selected Bidding Contractor shall use the fire, life safety subcontractor designated by Landlord, (iii) the requirement that Contractor shall be required to bid each of the major subcontractors (as reasonably determined by Landlord) with at least three (3) qualified subcontractors, and (iv) the fact that such bids shall be based on a &#34;Guaranteed Maximum Price&#34; contract for the construction of the Tenant Improvements. Tenant shall, within five (5) business days following the date upon which Landlord delivers such bids to Tenant, select the Contractor from among the Bidding Contractors that have (a) submitted qualified bids which were consistent with the</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_226"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">bid assumptions and directions, and (b) have committed to Landlord's time schedule for construction of the Tenant Improvements.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Cost Proposal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. After the Approved Working Drawings are signed by Landlord and Tenant, Landlord shall provide Tenant with a cost proposal in accordance with the Approved Working Drawings, which cost proposal shall include, as nearly as possible, the cost of all Tenant Improvement Allowance Items to be incurred by Tenant in connection with the design and construction of the Tenant Improvements (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Cost Proposal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). Tenant shall approve and deliver the Cost Proposal to Landlord within five (5) business days of the receipt of the same, and upon receipt of the same by Landlord, Landlord shall be released by Tenant to purchase the items set forth in the Cost Proposal and to commence the construction relating to such items. The date by which Tenant must approve and deliver the Cost Proposal to Landlord shall be known hereafter as the &#34;Cost Proposal Delivery Date&#34;.</font></div><div><font><br></font></div><div style="padding-left:77.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Construction of Tenant Improvements by Contractor under the Supervision of Landlord</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Over-Allowance Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. On the Cost Proposal Delivery Date, Tenant shall deliver to Landlord cash in an amount (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Over-Allowance Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) equal to the difference between (i) the amount of the Cost Proposal and (ii) the amount of the Tenant Improvement Allowance. The Over-Allowance Amount shall be disbursed by Landlord prior to the disbursement of any then remaining portion of the Tenant Improvement Allowance, and such disbursement shall be pursuant to the same procedure as the Tenant Improvement Allowance. In the event that, after the Cost Proposal Delivery Date, any revisions, changes, or substitutions shall be made to the Construction Drawings or the Tenant Improvements, any additional costs which arise in connection with such revisions, changes or substitutions or any other additional costs shall be paid by Tenant to Landlord immediately upon Landlord's request as an addition to the Over-Allowance Amount.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Landlord's Retention of Contractor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Subject to Section 4.1, Landlord shall independently retain Contractor, on behalf of Tenant, to construct the Tenant Improvements in accordance with the Approved Working Drawings (subject to the following sentence) and the Cost Proposal and Landlord shall supervise the construction by Contractor, and Tenant shall pay a construction supervision and management fee (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Landlord Supervision Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) to Landlord in an amount equal to two percent (2%) of the so called &#34;hard&#34; costs of constructing the Tenant Improvements. In the event of a conflict between the Approved Working Drawings and Landlord's construction rules and regulations, Landlord, in its sole and absolute discretion, shall determine which shall prevail. Notwithstanding anything set forth in this Tenant Work Letter to the contrary, construction of the Tenant Improvements shall not commence until (a) Landlord has a fully executed and delivered contract with Contractor for the construction of the Tenant Improvements, (b) Tenant has procured and delivered to Landlord a copy of all Permits, and (c) Tenant has delivered to Landlord the Over-Allowance Amount.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Contractor's Warranties and Guaranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord hereby assigns to Tenant all warranties and guaranties by Contractor relating to the Tenant Improvements, and Tenant hereby waives all claims against Landlord relating to, or arising out of the construction of, the Tenant Improvements.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:111.6pt;padding-right:111.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SECTION 5</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:139.32pt;padding-right:139.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">COMPLETION OF THE TENANT IMPROVEMENTS&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">LEASE COMMENCEMENT DATE</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Ready for Occupancy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Premises shall be deemed </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#34;Ready for Occupancy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; upon the Substantial Completion of the Premises. For purposes of this Lease, &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Substantial Completion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; of the Premises shall occur upon the completion of construction of the Tenant Improvements in the Premises pursuant to the Approved Working Drawings, with the exception of any punch list items that do not materially interfere with Tenant&#8217;s Permitted Use and any tenant fixtures, work-stations, built-in furniture, or equipment to be installed by Tenant or under the supervision of Contractor. Upon the Substantial Completion of the Premises, Landlord shall prepare and deliver to Tenant a certificate signed by both Landlord and Architect (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Substantial Completion Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) certifying that the construction of the Tenant Improvements has been substantially completed in a good and workmanlike manner in accordance with the Approved Working Drawings in all material respects, subject only to completion of any punch list items. Landlord shall provide Tenant at least thirty (30) days prior written notice of the Substantial Completion of the Premises.</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_229"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Delay of the Substantial Completion of the Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Except as provided in this Section 5.2, the Lease Commencement Date shall occur as set forth in the Lease and Section 5.1, above. If there shall be a delay or there are delays in the Substantial Completion of the Premises or in the occurrence of any of the other conditions precedent to the Lease Commencement Date, as set forth in the Lease, as a direct, indirect, partial, or total result of&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:114pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.2.1&#160;&#160;&#160;&#160;Tenant's failure to comply with the Time Deadlines&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:114pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.2.2&#160;&#160;&#160;&#160;Tenant's failure to timely approve any matter requiring Tenant's approval&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:113.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.2.3&#160;&#160;&#160;&#160;A breach by Tenant of the terms of this Tenant Work Letter or the Lease&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.2.4&#160;&#160;&#160;&#160;Changes in any of the Construction Drawings after disapproval of the same by Landlord or because the same do not comply with Code or other applicable laws&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:113.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.2.5&#160;&#160;&#160;&#160;Tenant's request for changes in the Approved Working Drawings&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.2.6&#160;&#160;&#160;&#160;Tenant's requirement for materials, components, finishes or improvements which are not available in a commercially reasonable time given the anticipated date of Substantial Completion of the Premises, as set forth in the Lease&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:113.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.2.7&#160;&#160;&#160;&#160;Changes to the Base, Shell and Core required by the Approved Working Drawings&#59; or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:113.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.2.8&#160;&#160;&#160;&#160;Any other acts or omissions of Tenant, or its agents, or employees&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">then, notwithstanding anything to the contrary set forth in the Lease or this Tenant Work Letter and regardless of the actual date of the Substantial Completion of the Premises, the date of the Substantial Completion of the Premises shall be deemed to be the date the Substantial Completion of the Premises would have occurred if no Tenant delay or delays, as set forth above, had occurred.</font></div><div><font><br></font></div><div style="padding-left:212.72pt;padding-right:212.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:232%">SECTION 6 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:232%;text-decoration:underline">MISCELLANEOUS</font></div><div style="margin-top:0.4pt;padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Tenant's Entry Into the Premises Prior to Substantial Completion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Provided that Tenant and its agents do not interfere with Contractor's work in the Building and the Premises, Contractor shall allow Tenant access to the Premises up to sixty (60) days prior to the Substantial Completion of the Premises for the purpose of Tenant installing equipment or fixtures (including Tenant's data and telephone equipment) in the Premises and to otherwise move into the Premises. Prior to Tenant's entry into the Premises as permitted by the terms of this Section 6.1, Tenant shall submit a schedule to Landlord and Contractor, for their approval, which schedule shall detail the timing and purpose of Tenant's entry. Tenant shall hold Landlord harmless from and indemnify, protect and defend Landlord against any loss or damage to the Building or Premises and against injury to any persons caused by Tenant's actions pursuant to this Section 6.1.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Freight Elevators</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord shall make the freight elevator reasonably available to Tenant in connection with initial decorating, furnishing and moving into the Premises.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Tenant's Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Tenant has designated Sean Owsley as its sole representative with respect to the matters set forth in this Tenant Work Letter, who, until further notice to Landlord, shall have full authority and responsibility to act on behalf of the Tenant as required in this Tenant Work Letter.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Landlord's Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Landlord has designated Jeff Sobczyk of PMA, Inc. as its sole representative with respect to the matters set forth in this Tenant Work Letter, who, until further notice to Tenant, shall have full authority and responsibility to act on behalf of the Landlord as required in this Tenant Work Letter.</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_232"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Tenant's Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. All contractors, subcontractors, laborers, materialmen, and suppliers retained directly by Tenant shall be from a list of supplied by Landlord and shall all be union labor in compliance with the then existing master labor agreements.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Time of the Essence in This Tenant Work Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Unless otherwise indicated, all references herein to a &#34;number of days&#34; shall mean and refer to calendar days. In all instances where Tenant is required to approve or deliver an item, if no written notice of approval is given or the item is not delivered within the stated time period, at Landlord's sole option, at the end of such period the item shall automatically be deemed approved or delivered by Tenant and the next succeeding time period shall commence.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Tenant's Lease Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Notwithstanding any provision to the contrary contained in this Lease, if an event of default as described in the Lease, or a default by Tenant under this Tenant Work Letter, has occurred at any time on or before the TIA Expiration Date, then (i) in addition to all other rights and remedies granted to Landlord pursuant to the Lease, Landlord shall have the right to withhold payment of all or any portion of the Tenant Improvement Allowance and&#47;or Landlord may cause Contractor to cease the construction of the Premises (in which case, Tenant shall be responsible for any delay in the Substantial Completion of the Premises caused by such work stoppage as set forth in Section 5 of this Tenant Work Letter), and (ii) all other obligations of Landlord under the terms of this Tenant Work Letter shall be forgiven until such time as such default is cured pursuant to the terms of the Lease.</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_235"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:167.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">SCHEDULE 1-A TO EXHIBIT B</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.6pt;padding-right:111.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">BASE BUILDING PLANS</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:41.95pt;padding-right:80pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.&#160;&#160;&#160;&#160;Healthpeak Boardwalk Lot 15 Core &#38; Shell Issued For Construction Volume 1 PDF Package Dated 05&#47;28&#47;2020</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:41.95pt;padding-right:80pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.&#160;&#160;&#160;&#160;Healthpeak Boardwalk Lot 15 Core &#38; Shell Issued For Construction Volume 2 PDF Package Dated 05&#47;28&#47;2020</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41.95pt;padding-right:90.85pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.&#160;&#160;&#160;&#160;Healthpeak Boardwalk Lot 15 Tenant Improvement Issued For Construction PDF Package Dated 08&#47;25&#47;2020</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.&#160;&#160;&#160;&#160;Healthpeak Boardwalk Lot 16 Core &#38; Shell Issued For Construction PDF Package Dated 03&#47;18&#47;2020</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.&#160;&#160;&#160;&#160;ASI-01 - Edge of Slab Update for Lot 14 and Lot 16 dated 5&#47;14&#47;2020</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.&#160;&#160;&#160;&#160;ASI-02 - Electrical RFI's for Lot 14&#47;15 dated 5&#47;20&#47;2020</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.&#160;&#160;&#160;&#160;ASI-03 Electrical RFI's for Lot 16 dated 7&#47;31&#47;2020.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:111.6pt;padding-right:111.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">SCHEDULE 1-A TO</font></div><div style="height:44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_238"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:168pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">SCHEDULE 1-B TO EXHIBIT B</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:157.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">BASE BUILDING MODIFICATIONS</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.6pt;padding-right:111.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#91;ATTACHED&#93;</font></div><div style="height:59pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_241"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:5pt;padding-left:23.95pt"><img alt="a15shellcorea.jpg" src="a15shellcorea.jpg" style="height:858px;margin-bottom:5pt;vertical-align:text-bottom;width:664px"></div><div style="height:59pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_244"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:42pt"><img alt="image_28a.jpg" src="image_28a.jpg" style="height:474px;margin-bottom:5pt;vertical-align:text-bottom;width:612px"></div><div style="height:59pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_247"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:42pt"><img alt="image_29a.jpg" src="image_29a.jpg" style="height:494px;margin-bottom:5pt;vertical-align:text-bottom;width:640px"></div><div style="height:59pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_250"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:42pt"><img alt="image_30a.jpg" src="image_30a.jpg" style="height:494px;margin-bottom:5pt;vertical-align:text-bottom;width:640px"></div><div style="height:59pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_253"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:42pt"><img alt="image_31a.jpg" src="image_31a.jpg" style="height:494px;margin-bottom:5pt;vertical-align:text-bottom;width:640px"></div><div style="height:59pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_256"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:42pt"><img alt="image_32a.jpg" src="image_32a.jpg" style="height:494px;margin-bottom:5pt;vertical-align:text-bottom;width:640px"></div><div style="height:59pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_259"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT C</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">THE BOARDWALK</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:160.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">NOTICE OF LEASE TERM DATES</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.25pt"><img alt="image_34.jpg" src="image_34.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:153px"><img alt="image_34.jpg" src="image_34.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:153px"><img alt="image_34.jpg" src="image_34.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:153px"></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Re&#58;&#160;&#160;&#160;&#160;Lease dated</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, 20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> between</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.05pt;padding-left:77.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Landlord</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;),   and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,   a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;)</font></div><div id="i1857427c06e5452983070f6ff36fd01d_262"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:33.084%"><div style="padding-left:77.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">concerning&#160;&#160;&#160;&#160;Suite&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="padding-left:10.1pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.373%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.084%"><div style="padding-left:10.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">on&#160;&#160;&#160;&#160;floor(s)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="padding-left:10.1pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.373%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.086%"><div style="padding-left:10.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of&#160;&#160;&#160;&#160;the&#160;&#160;&#160;&#160;building&#160;&#160;&#160;&#160;located&#160;&#160;&#160;&#160;at</font></div></div></div><div style="padding-left:77.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, California.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Gentlemen&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In accordance with the Lease (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), we wish to advise you and&#47;or confirm as follows&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:78pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.&#160;&#160;&#160;&#160;The Lease Term shall commence on or has commenced on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">for a term of</font></div><div style="margin-top:0.05pt;padding-left:77.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> ending on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:77.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.&#160;&#160;&#160;&#160;Rent commenced to accrue on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, in the amount of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:77.95pt;padding-right:53.3pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.&#160;&#160;&#160;&#160;If the Lease Commencement Date is other than the first day of the month, the first billing will contain a pro rata adjustment. Each billing thereafter, with the exception of the final billing, shall be for the full amount of the monthly installment as provided for in the Lease.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:78pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.&#160;&#160;&#160;&#160;Your rent checks should be made payable to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">at</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:77.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.&#160;&#160;&#160;&#160;The exact number of rentable&#47;usable square feet within the Premises is</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">square feet.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:77.95pt;padding-right:52.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.&#160;&#160;&#160;&#160;Tenant's Share as adjusted based upon the exact number of usable square feet within the Premises is</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:245.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#34;Landlord&#34;&#58;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:245.35pt;padding-right:75.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:260.35pt;padding-right:78.55pt;text-indent:-15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Its&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_265"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:11.35pt;padding-right:402.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Agreed to and Accepted as of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, 200</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:11.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#34;Tenant&#34;&#58;</font></div><div><font><br></font></div><div style="margin-top:0.4pt"><img alt="image_37a.jpg" src="image_37a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:240px"></div><div style="margin-top:0.6pt;padding-left:11.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:23.9pt;padding-right:330.55pt;text-indent:-12.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Its&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_268"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT D</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">THE BOARDWALK</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:126.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">FORM OF TENANT'S ESTOPPEL CERTIFICATE</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The undersigned as Tenant under that certain Lease (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;) made and entered into as of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, 20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> by and between</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as Landlord, and the undersigned as Tenant, for Premises consisting of the entire office building located at</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, California, certifies as follows&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.&#160;&#160;&#160;&#160;Attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">is a true and correct copy of the Lease and all amendments and modifications thereto. The documents contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">represent the entire agreement between the parties as to the Premises.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.&#160;&#160;&#160;&#160;The undersigned currently occupies the Premises described in the Lease, the Lease Term commenced on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and the Lease Term expires on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and the undersigned has no option to terminate or cancel the Lease or to purchase all or any part of the Premises, the Building and&#47;or the Project.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:78pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.&#160;&#160;&#160;&#160;Base Rent became payable on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.&#160;&#160;&#160;&#160;The Lease is in full force and effect and has not been modified, supplemented or amended in any way except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.&#160;&#160;&#160;&#160;Tenant has not transferred, assigned, or sublet any portion of the Premises nor entered into any license or concession agreements with respect thereto except as follows&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:6.55pt;padding-left:6pt;padding-right:47.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.&#160;&#160;&#160;&#160;Tenant shall not modify the documents contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">without the prior written consent of Landlord's mortgagee.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.&#160;&#160;&#160;&#160;All monthly installments of Base Rent, all Additional Rent and all monthly installments of estimated Additional Rent have been paid when due through</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The current monthly installment of Base Rent is</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.&#160;&#160;&#160;&#160;All conditions of the Lease to be performed by Landlord necessary to the enforceability of the Lease have been satisfied and Landlord is not in default thereunder. In addition, the undersigned has not delivered any notice to Landlord regarding a default by Landlord thereunder. The Lease does not require Landlord to provide any rental concessions or to pay any leasing brokerage commissions.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9.&#160;&#160;&#160;&#160;No rental has been paid more than thirty (30) days in advance and no security has been deposited with Landlord except as provided in the Lease. Neither Landlord, nor its successors or assigns, shall in any event be liable or responsible for, or with respect to, the retention, application and&#47;or return to Tenant of any security deposit paid to any prior landlord of the Premises, whether or not still held by any such prior landlord, unless and until the party from whom the security deposit is being sought, whether it be a lender, or any of its successors or assigns, has actually received for its own account, as landlord, the full amount of such security deposit.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10.&#160;&#160;&#160;&#160;As of the date hereof, there are no existing defenses or offsets, or, to the undersigned's knowledge, claims or any basis for a claim, that the undersigned has against Landlord.</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_271"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11.&#160;&#160;&#160;&#160;If Tenant is a corporation or partnership, each individual executing this Estoppel Certificate on behalf of Tenant hereby represents and warrants that Tenant is a duly formed and existing entity qualified to do business in California and that Tenant has full right and authority to execute and deliver this Estoppel Certificate and that each person signing on behalf of Tenant is authorized to do so.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12.&#160;&#160;&#160;&#160;There are no actions pending against the undersigned under the bankruptcy or similar laws of the United States or any state.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13.&#160;&#160;&#160;&#160;To its actual knowledge, Tenant is in full compliance with all federal, state and local laws, ordinances, rules and regulations affecting its use of the Premises, including, but not limited to, those laws, ordinances, rules or regulations relating to hazardous or toxic materials. Tenant has never permitted or suffered, nor does Tenant have any knowledge of, the generation, manufacture, treatment, use, storage, disposal or discharge of any hazardous, toxic or dangerous waste, substance or material in, on, under or about the Project or the Premises or any adjacent premises or property in violation of any federal, state or local law, ordinance, rule or regulation.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.&#160;&#160;&#160;&#160;To the undersigned's knowledge, all tenant improvement work to be performed by Landlord under the Lease has been completed in accordance with the Lease and has been accepted by the undersigned and all reimbursements and allowances due to the undersigned under the Lease in connection with any tenant improvement work have been paid in full. All work (if any) in the common areas required by the Lease to be completed by Landlord has been completed and all parking spaces required by the Lease have been furnished and&#47;or all parking ratios required by the Lease have been met.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The undersigned acknowledges that this Estoppel Certificate may be delivered to Landlord or to a prospective mortgagee or prospective purchaser, and acknowledges that said prospective mortgagee or prospective purchaser will be relying upon the statements contained herein in making the loan or acquiring the property of which the Premises are a part and that receipt by it of this certificate is a condition of making such loan or acquiring such property.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Executed at</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">on the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">day of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, 20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:245.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#34;Tenant&#34;&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:245.35pt;padding-right:75.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:260.35pt;padding-right:78.55pt;text-indent:-15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Its&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:260.35pt;padding-right:78.55pt;text-indent:-15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Its&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_274"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.55pt;padding-right:111.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT E</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:150.65pt;padding-right:153.7pt;text-indent:43.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%">THE BOARDWALK </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:237%;text-decoration:underline">ENVIRONMENTAL QUESTIONNAIRE</font></div><div id="i1857427c06e5452983070f6ff36fd01d_1740"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.862%"><tr><td style="width:1.0%"></td><td style="width:19.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Tenant Name</font></td><td colspan="9" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Lease Address</font></td><td colspan="9" style="background-color:#dbdbdb;padding:0 1pt"></td></tr></table></div><div id="i1857427c06e5452983070f6ff36fd01d_280"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.659%"><div style="padding-left:6pt"><img alt="image_42.jpg" src="image_42.jpg" style="height:12px;margin-bottom:5pt;vertical-align:text-bottom;width:12px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lease Type (check correct box &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">right click to properties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">)&#58;</font></div><div style="padding-left:6pt;padding-right:161.3pt"><font><br></font></div></div><div style="display:inline-block;max-width:2.681%;min-width:1.681%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.660%"><div style="padding-left:6pt;padding-right:161.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:153%">Primary Lease&#47;Lessee Sublease from&#58;</font></div></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Instructions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58; The following questionnaire is to be completed by the Lessee representative with knowledge of the planned operations for the specified building&#47;location. Please print clearly and attach additional sheets as necessary.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">PROCESS INFORMATION</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-bottom:2.35pt;margin-top:4.6pt;padding-left:33pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Describe planned site use, including a brief description of manufacturing processes and&#47;or pilot plants planned for this site, if any.</font></div><div style="margin-bottom:6pt;padding-left:32.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.385%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#e6e5e5;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#e6e5e5;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#e6e5e5;border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:8.4pt;padding-left:32.95pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">HAZARDOUS MATERIALS &#8211; OTHER THAN WASTE</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:33.35pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Will (or are) non-waste hazardous materials be&#47;being used or stored at this site&#63; If so, continue with the next question. If not, go to Section 3.0.</font></div><div style="margin-top:6pt;padding-left:59.95pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.1&#160;&#160;&#160;&#160;</font><img alt="image_42.jpg" src="image_42.jpg" style="height:12px;margin-bottom:5pt;vertical-align:text-bottom;width:12px"><img alt="image_42.jpg" src="image_42.jpg" style="height:12px;margin-bottom:5pt;vertical-align:text-bottom;width:12px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Are any of the following materials handled on the Property&#63;&#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;&#160;No</font></div><div style="margin-top:3.75pt;padding-left:59.95pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">A material is handled if it is used, generated, processed, produced, packaged, treated, stored, emitted, discharged, or disposed.&#93; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If YES, check </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(right click to properties) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the applicable correct </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Fire Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">hazard categories</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> below.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:65.9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.206%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.3pt;padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Combustible dusts&#47;fibers</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 5.45pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Explosives</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.3pt;padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Flammable liquids</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.25pt;padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Combustible liquids </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(e.g., oils)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.25pt;padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Compressed gas - inert</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.25pt;padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Flammable solids&#47;pyrophorics</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:0.05pt;margin-top:0.4pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.6pt;padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cryogenic liquids - inert</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:0.05pt;margin-top:0.4pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Compressed gas -</font></div><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">flammable&#47;pyrophoric</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:0.05pt;margin-top:0.4pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.6pt;padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Organic peroxides</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:0.05pt;margin-top:0.4pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cryogenic liquids -</font></div><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:106%">flammable</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:0.05pt;margin-top:0.4pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.6pt;padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Compressed gas - oxidizing</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:0.05pt;margin-top:0.4pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.6pt;padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Oxidizers - solid or liquid</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.65pt;padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cryogenic liquids - oxidizing</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.65pt;padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Compressed gas - toxic</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.45pt;padding-right:23.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Reactives - unstable or water reactive</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corrosives - solid or liquid</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Compressed gas - corrosive</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Toxics - solid or liquid</font></div></td></tr></table></div><div style="margin-top:7.15pt;padding-left:60.7pt;padding-right:52.35pt;text-indent:-27.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2-2.&#160;&#160;&#160;&#160;For all materials checked in Section 2.1 above, please list the specific material(s), use(s), and quantities of each used or stored on the site in the table below&#59; or attach a separate inventory. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">NOTE&#58; If proprietary, the constituents need not be named but the hazard information and volumes are required.</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_283"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:62.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.212%"><tr><td style="width:1.0%"></td><td style="width:29.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:52.95pt;padding-right:52.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Material&#47; Chemical</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.85pt;padding-left:1.77pt;padding-right:1.77pt;text-align:center;text-indent:-0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Physical State (Solid, Liquid, or</font></div><div style="padding-left:13.22pt;padding-right:13.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Gas)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:13.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Container Size</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:13.9pt;padding-right:-0.95pt;text-indent:-12.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number of Containers Used &#38; Stored</font></div></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total Quantity</font></div></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.45pt;padding-right:2.45pt;text-align:center;text-indent:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Units (pounds for solids, gallons or liters for liquids, &#38;</font></div></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:1.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:19pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:19pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:19pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-bottom:1.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f1f1f1;border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6.65pt;padding-left:59.95pt;padding-right:38.5pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2-3.&#160;&#160;&#160;&#160;Describe the planned storage area location(s) for the materials in Section 2-2 above. Include site maps and drawings as appropriate.</font></div><div style="margin-top:0.4pt"><img alt="image_63a.jpg" src="image_63a.jpg" style="height:63px;margin-bottom:5pt;vertical-align:text-bottom;width:611px"></div><div style="margin-top:6.35pt;padding-left:33.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2-4.&#160;&#160;&#160;&#160;Other hazardous materials. Check below (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">right click to properties) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">if applicable. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">NOTE&#58; If either of the latter</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_286"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:60.7pt;padding-right:28.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">two are checked (BSL-3 and&#47;or radioisotope&#47;radiation), be advised that not all lease locations&#47;cities or lease agreements allow these hazards&#59; and if either of these hazards are planned, additional information will be required with copies of oversight agency authorizations&#47;licenses as they become available.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:65.9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.758%"><tr><td style="width:1.0%"></td><td style="width:3.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.108%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:0.05pt;margin-top:0.4pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Risk Group 2&#47;Biosafety</font></div><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Level-2 Biohazards</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:0.05pt;margin-top:0.4pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Risk Group 3&#47;Biosafety</font></div><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Level-3 Biohazards</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:0.05pt;margin-top:0.4pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><img alt="image_48.jpg" src="image_48.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:13px"></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 5.45pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Radioisotopes&#47;Radiation</font></td></tr></table></div><div style="margin-top:5.95pt;padding-left:32.95pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">3.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">HAZARDOUS WASTE (i.e., REGULATED CHEMICAL WASTE)</font></div><div style="margin-top:5.9pt;padding-left:33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Are (or will) hazardous wastes (be) generated&#63;&#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;&#160;No</font></div><div style="margin-top:3.7pt;padding-left:32.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If YES, continue with the next question. If not, skip this section and go to section 4.0.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:60pt;padding-right:65.2pt;text-indent:-27.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.1&#160;&#160;&#160;&#160;Are or will any of the following hazardous (CHEMICAL) wastes generated, handled, or disposed of (where applicable and allowed) on the property&#63;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:65.9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.206%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 5.45pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Liquids</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">Process sludges</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 5.45pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">PCBs</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 5.45pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Solids</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 5.45pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Metals</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 5.45pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">wastewater</font></td></tr></table></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3-2.&#160;&#160;&#160;&#160;List and estimate the quantities of hazardous waste identified in Question 3-1 above.</font></div><div style="margin-bottom:0.05pt;margin-top:0.35pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:60.7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.206%"><tr><td style="width:1.0%"></td><td style="width:25.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6.65pt;padding-left:12.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">WASTE TYPE</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="margin-top:5.45pt;padding-left:14.55pt;padding-right:14.25pt;text-indent:-12.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">HAZARDOUS (CHEMICAL) WASTE GENERATED</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:19.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">SOURCE</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:8.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">RCRA</font></div><div style="margin-top:0.05pt;padding-left:7.65pt;padding-right:6.05pt;text-indent:4.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">listed (federal)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:4.1pt;padding-left:6.2pt;padding-right:6.2pt;text-align:center;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Non- RCRA</font></div><div style="padding-left:1.5pt;padding-right:1.5pt;text-align:center;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(Calif- ornia ONLY or recycle)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6.6pt;padding-left:4.45pt;padding-right:9.8pt;text-indent:3.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">APPROX. MONTHLY QUANTITY</font></div><div style="padding-left:9.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">with units</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6.6pt;padding-right:-0.15pt;text-align:center;text-indent:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">DISPOSITION &#91;e.g., off-site landfill, incineration, fuel blending scrap metal&#59; wastewater neutralization (onsite or off-site)&#93;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:15.55pt"><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:13.35pt"><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:1pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:0.05pt"><font><br></font></div><div id="i1857427c06e5452983070f6ff36fd01d_289"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:33.084%"><div style="margin-top:2.5pt;padding-left:33.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3-3.&#160;&#160;&#160;&#160;Waste characterization by&#58;&#160;&#160;&#160;&#160;Process knowledge</font></div><div style="margin-top:2.5pt;padding-left:29.1pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.373%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.084%"><div style="padding-left:29.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">EPA lab analysis</font></div><div style="margin-top:2.5pt;padding-left:26.6pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.373%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.086%"><div style="padding-left:26.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Both</font></div></div></div><div style="margin-top:6pt;padding-left:60.7pt;padding-right:78.65pt;text-indent:-27.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3-4.&#160;&#160;&#160;&#160;Please include name, location, and permit number (e.g. EPA ID No.) for transporter and disposal facility if  applicable. Attach separate pages as necessary. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">If not yet known, write &#8220;TBD.&#8221;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:60.7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.350%"><tr><td style="width:1.0%"></td><td style="width:27.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:4.5pt;padding-left:4.35pt;text-indent:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Hazardous Waste Transporter&#47;Disposal Facility Name</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:47.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Facility Location</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:4.5pt;padding-left:2.2pt;padding-right:1.55pt;text-indent:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Transporter (T) or Disposal (D) Facility</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:19.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Permit Number</font></div></td></tr><tr style="height:26pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:27pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:27pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5.85pt;padding-left:60.7pt;padding-right:39pt;text-indent:-27.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3-5.&#160;&#160;&#160;&#160;Are pollution controls or monitoring employed in the process to prevent or minimize the release of wastes into the environment&#63; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">NOTE&#58; This does NOT mean fume hoods&#59; examples include air scrubbers, </font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:5.85pt;padding-left:60.7pt;padding-right:39pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">cyclones, carbon or HEPA filters at building exhaust fans, sedimentation tanks, pH neutralization systems for wastewater, etc.</font></div><div style="margin-top:6.05pt;padding-left:73.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Yes&#160;&#160;&#160;&#160;No</font></div><div style="margin-top:5.95pt;padding-left:59.95pt"><img alt="image_87a.jpg" src="image_87a.jpg" style="height:20px;margin-bottom:5pt;vertical-align:text-bottom;width:448px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If YES, please list&#47;describe&#58;</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_292"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:59.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.494%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#edebe0;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#edebe0;border-bottom:0.5pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4.15pt;padding-left:33.35pt;padding-right:54.2pt;text-indent:-27.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">4.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">OTHER REGULATED WASTE (i.e., REGULATED BIOLOGICAL WASTE, referred to as &#8220;Medical</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Waste&#8221; in California)</font></div><div style="margin-top:5.9pt;padding-left:33.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4-1.&#160;&#160;&#160;&#160;Will (or do) you generate medical waste&#63;&#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;&#160;No If NO, skip to Section 5.0.</font></div><div style="margin-top:5.95pt;padding-left:60.7pt;padding-right:63.9pt;text-indent:-27.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4-2.&#160;&#160;&#160;&#160;Check the types of waste that will be generated, all of which fall under the California Medical Waste Act&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:65.9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.206%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:6.45pt;padding-right:-1.45pt"><font><br></font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3.55pt;padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contaminated sharps (i.e., if contaminated with &#8805; Risk</font></div><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Group 2 materials)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Animal carcasses</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3.55pt;padding-left:4.45pt;padding-right:22.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pathology waste known or suspected to be contaminated</font></div><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">with &#8805; Risk Group 2 pathogens)</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:1pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:9.3pt;padding-left:4.45pt;padding-right:9.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Red bag biohazardous waste (i.e., with &#8805; Risk Group 2 materials) for autoclaving</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:1pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:7.45pt;padding-left:4.45pt;padding-right:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Human or non-human primate blood, tissues, etc.</font></div><div style="margin-top:3.7pt;padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(e.g., clinical specimens)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:1pt solid #000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3.55pt;padding-left:4.45pt;padding-right:13.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Trace Chemotherapeutic Waste and&#47;or Pharmaceutical waste NOT otherwise regulated as</font></div><div style="padding-left:4.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">RCRA chemical waste</font></div></td></tr></table></div><div style="margin-top:5.9pt;padding-left:33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4-3.&#160;&#160;&#160;&#160;What vendor will be used for off-site autoclaving and&#47;or incineration&#63;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div id="i1857427c06e5452983070f6ff36fd01d_295"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:33.084%"><div style="margin-top:4.6pt;padding-left:33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4-5.&#160;&#160;&#160;&#160;Do you have a Medical Waste Permit for this site&#63;</font></div><div style="margin-top:4.6pt;padding-left:22pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.373%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.084%"><div style="padding-left:22pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Yes</font></div><div style="margin-top:4.6pt;padding-left:19.3pt"><font><br></font></div><div style="padding-left:19.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No, not required.</font></div></div><div style="display:inline-block;max-width:0.373%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.086%"></div></div><div style="margin-top:3.65pt;padding-left:285.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No, but an application will be submitted.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">5.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">UNDERGROUND STORAGE TANKS (USTS) &#38; ABOVEGROUND STORAGE TANKS (ASTS)</font></div><div style="margin-top:5.8pt;padding-left:60.7pt;padding-right:29.55pt;text-indent:-27.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5-1.&#160;&#160;&#160;&#160;Are underground storage tanks (USTs), aboveground storage tanks (ASTs), or associated pipelines used for the storage of petroleum products, chemicals, or liquid wastes present on site (lease renewals) or required for planned operations (new tenants)&#63;&#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;&#160;No</font></div><div style="margin-top:6pt;padding-left:60.7pt;padding-right:43.25pt;text-align:justify;text-indent:-0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">NOTE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#58; If you will have your own diesel emergency power generator, then you will have at least one AST! &#91;NOTE&#58; If a backup generator services multiple tenants, then the landlord usually handles the permits.&#93;</font></div><div style="margin-top:3.95pt;padding-left:59.95pt;padding-right:82.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If NO, skip to section 6.0. If YES, please describe capacity, contents, age, type of the USTs or ASTs, as well any associated leak detection&#47;spill prevention measures. Please attach additional pages if necessary.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:60.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.350%"><tr><td style="width:1.0%"></td><td style="width:6.054%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.864%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:7.25pt;padding-left:8.25pt;padding-right:2.75pt;text-indent:-4.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">UST or AST</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:7.25pt;padding-left:8.05pt;padding-right:6.1pt;text-indent:-0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Capacity (gallons)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="margin-top:6.15pt;padding-left:46.37pt;padding-right:46.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Contents</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:7.25pt;padding-left:3.3pt;padding-right:1.85pt;text-indent:6.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Year Installed</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Type (Steel, Fiberglass, etc.)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:7.05pt;padding-left:1.45pt;text-indent:0.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:126%">Associated Leak Detection &#47; Spill Prevention Measures*</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:22pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6.3pt;padding-left:96pt;padding-right:38.5pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">*</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">NOTE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58; The following are examples of leak detection &#47; spill prevention measures&#58; integrity testing, inventory reconciliation, leak detection system, overfill spill protection, secondary containment, cathodic protection.</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.8pt;padding-left:33.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5-2.&#160;&#160;&#160;&#160;Please provide copies of written tank integrity test results and&#47;or monitoring documentation, if available.</font></div><div style="margin-top:4.55pt;padding-left:33.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5-3.&#160;&#160;&#160;&#160;Is the UST&#47;AST registered and permitted with the appropriate regulatory agencies&#63;&#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;&#160;No, not yet</font></div><div style="margin-top:5.7pt;padding-left:59.95pt;padding-right:33.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:101%">If YES, please attach a copy of the required permit(s). </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:101%">See Section 7-1 for the oversight agencies that issue permits, with the exception of those for diesel emergency power generators which are permitted by the local Air Quality District (Bay Area Air Quality Management District &#61; BAAQMD&#59; or San Diego Air Pollution Control District &#61; San Diego APCD).</font></div><div style="margin-top:4.75pt;padding-left:33.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5-4.&#160;&#160;&#160;&#160;If this Questionnaire is being completed for a lease renewal, and if any of the USTs&#47;ASTs have leaked,</font></div><div id="i1857427c06e5452983070f6ff36fd01d_298"></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:5.8pt;padding-left:60.7pt;padding-right:38.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:101%">please state the substance released, the media(s) impacted (e.g., soil, water, asphalt, etc.), the actions taken, and all remedial responses to the incident.</font></div><div style="margin-bottom:0.05pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:59.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.206%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#edebe0;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#edebe0;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#edebe0;border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:8.35pt;padding-left:59.95pt;padding-right:57.95pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5-5.&#160;&#160;&#160;&#160;If this Questionnaire is being completed for a lease renewal, have USTs&#47;ASTs been removed from the Property&#63;</font></div><div style="margin-top:3.7pt;padding-left:73.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Yes&#160;&#160;&#160;&#160;No</font></div><div style="margin-top:3.95pt;padding-left:59.95pt;padding-right:38.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If YES, please provide any official closure letters or reports and supporting documentation (e.g., analytical test results, remediation report results, etc.).</font></div><div style="margin-top:5.95pt;padding-left:59.95pt;padding-right:50.95pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5-6.&#160;&#160;&#160;&#160;For Lease renewals, are there any above or below ground pipelines on site used to transfer chemicals or wastes&#63;</font></div><div style="margin-top:3.8pt;padding-left:73.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Yes&#160;&#160;&#160;&#160;No</font></div><div style="margin-top:3.65pt;padding-left:60pt;padding-right:68.7pt;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:155%">For new tenants, are installations of this type required for the planned operations&#63;&#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;&#160;No If YES to either question in this section 5-6, please describe.</font></div><div style="margin-bottom:6pt;padding-left:59.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.206%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#edebe0;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#edebe0;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:16pt"><td colspan="3" style="background-color:#edebe0;border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6.65pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">6.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">ASBESTOS CONTAINING BUILDING MATERIALS</font></div><div style="margin-top:5.9pt;padding-left:33pt;padding-right:7.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Please be advised that an asbestos survey may have been performed at the Property. If provided, please review the information that identifies the locations of known asbestos containing material or presumed asbestos containing material. All personnel and appropriate subcontractors should be notified of the presence of these materials, and informed not to disturb these materials. Any activity that involves the disturbance or removal of these materials must be done by an appropriately trained individual&#47;contractor.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:33pt;text-indent:-27.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">7.0&#160;&#160;&#160;&#160;OTHER </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">REGULATORY PERMITS&#47;REQUIREMENTS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:59.95pt;padding-right:36.6pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7-1.&#160;&#160;&#160;&#160;Does the operation have or require an industrial wastewater permit to discharge into the local National Pollutant Discharge Elimination System (NPDES)&#63; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#91;Example&#58; This applies when wastewater from equipment cleaning is routed through a pH neutralization system prior to discharge into the sanitary or lab sewer for certain pharmaceutical manufacturing wastewater&#59; etc.&#93; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Permits are obtained from the regional sanitation district that is treating wastewater.</font></div><div style="margin-top:5.95pt;padding-left:60pt;padding-right:54.2pt;text-indent:13.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Yes&#160;&#160;&#160;&#160;No&#160;&#160;&#160;&#160;No, but one will be prepared and submitted to the Landlord property management company.</font></div><div style="margin-top:6.05pt;padding-left:60pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If so, please attach a copy of this permit or provide it later when it has been prepared.</font></div><div style="margin-top:5.95pt;padding-left:60.7pt;padding-right:30.3pt;text-indent:-27.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7-2.&#160;&#160;&#160;&#160;Has a Hazardous Materials Business Plan (HMBP) been developed for the site and submitted via the State of California Electronic Reporting System (CERS)&#63; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#91;NOTE&#58; The trigger limits for having to do this are &#8805; 200 cubic feet if any one type of compressed gas(except for carbon dioxide and inert simple asphyxiant gases, which have a higher trigger limit of &#8805; 1,000 cubic feet)&#59; &#8805; 55 gallons if any one type of hazardous chemical liquid&#59; and &#8805;500 pounds of any one type of hazardous chemical solid. So a full-sixe gas cylinder and a 260- liter of liquid nitrogen are triggers! Don&#8217;t forget the diesel fuel in a backup emergency </font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:5.95pt;padding-left:60.7pt;padding-right:30.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">generator if the diesel tank size is &#8805; 55 gallons and it is permitted under the tenant (rather than under the landlord).&#93; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">NOTE&#58; Each local Certified Unified Program Agency (CUPA) in California governs the HMBP process so start there. Examples&#58; the CUPA for cities in San Mateo County is the County Environmental Health Department&#59; the CUPA for the City of Hayward, CA is the Hayward Fire Department&#59; the CUPA for Mountain View is the Mountain View Fire Department&#59; and, the CUPA for San Diego is the County of San Diego Hazardous Materials Division (HMD),</font></div><div id="i1857427c06e5452983070f6ff36fd01d_301"></div><div style="margin-top:0.45pt"><font><br></font></div><div id="i1857427c06e5452983070f6ff36fd01d_304"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:33.084%"><div style="margin-top:4.6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Yes</font></div><div style="margin-top:4.6pt;padding-left:19.3pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.373%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.084%"><div style="padding-left:19.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No, not required.</font></div><div style="margin-top:4.6pt;padding-left:16.8pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.373%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.086%"><div style="padding-left:16.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No, but one will be prepared and submitted, and a copy will be provided</font></div></div></div><div style="padding-left:60pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to the landlord property management company.</font></div><div style="margin-top:5.95pt;padding-left:60pt;padding-right:28.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If one has been completed, please attach a copy. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Continue to provide updated versions as they are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">completed. This is a legal requirement in that State law requires that the owner&#47;operator of a business located</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">on leased or rented real property shall notify, in writing, the owner of the property that the business is subject</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">to and is in compliance with the Hazardous Materials Business Plan requirements (Health and Safety Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Chapter 6.95 Section 25505.1).</font></div><div style="margin-top:6.05pt;padding-left:60.7pt;padding-right:32pt;text-indent:-27.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7-3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">NOTE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58; Please be advised that if you are involved in any tenant improvements that require a construction permit, you will be asked to provide the local city with a Hazardous Materials Inventory Statement (HMIS) to ensure that your hazardous chemicals fall within the applicable Fire Code fire control area limits for the applicable construction occupancy of the particular building. The HMIS will include much of the information listed in Section 2-2. Neither the landlord nor the landlord&#8217;s property management company expressly warrants that the inventory provided in Section 2-2 will necessarily meet the applicable California Fire Code fire control area limits for building occupancy, especially in shared tenant occupancy situations. It is the responsibility of the tenant to ensure that a facility and site can legally handle the intended operations and hazardous materials desired&#47; needed for its operations, but the landlord is happy to assist in this determination when possible.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">CERTIFICATION</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:88.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">I am familiar with the real property described in this questionnaire. By signing below, I represent and warrant that the answers to the above questions are complete and accurate to the best of my knowledge. I also understand that Lessor will rely on the completeness and accuracy of my answers in assessing any environmental liability risks associated with the property.</font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Signature&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Title&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Date&#58;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Telephone&#58;</font></div><div style="height:47pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_307"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT F</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">MARKET RENT ANALYSIS</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:42pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">When determining Market Rent, the following rules and instructions shall be followed.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">RELEVANT FACTORS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The &#34;Market Rent,&#34; as used in this Lease, shall be derived from an analysis (as such derivation and analysis are set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) of the &#34;Net Equivalent Lease Rates,&#34; of the &#34;Comparable Transactions&#34;. The &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Market Rent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,&#34; as used in this Lease, shall be equal to the annual rent per rentable square foot as would be applicable on the commencement of the Option Term at which tenants, are, pursuant to transactions consummated within the twelve (12) month period immediately preceding the first day of the Option Term (provided that timing adjustments shall be made to reflect any perceived changes which will occur in the Market Rent following the date of any particular Comparable Transaction up to the date of the commencement of the Option Term) leasing non-sublease, non-encumbered, non-equity space comparable in location and quality to the Premises and consisting of one full floor or greater transactions, for a comparable term, in an arm's-length transaction, which comparable space is located in the &#34;Comparable Buildings,&#34; as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, below (transactions satisfying the foregoing criteria shall be known as the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Comparable Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;). The terms of the Comparable Transactions shall be calculated as a Net Equivalent Lease Rate pursuant to the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and shall take into consideration only the following terms and concessions&#58; (i) the rental rate and escalations for the Comparable Transactions, (ii) the amount of parking rent per parking permit paid in the Comparable Transactions, (iii) operating expense and tax escalation protection granted in such Comparable Transactions such as a base year or expense stop (although for each such Comparable Transaction the base rent shall be adjusted to a triple net base rent using reasonable estimates of operating expenses and taxes as determined by Landlord for each such Comparable Transaction)&#59; (iv) tenant improvements or allowances provided or to be provided for such comparable space, taking into account, the value of the existing improvements, if any, in the Premises and&#47;or improvement allowances granted to Tenant, such value of existing improvements to be based upon the age, quality and layout of the improvements and the extent to which the same could be utilized by general office users (as contrasted to the Tenant), and (v) rental abatement concessions, if any, being granted such tenants in connection with such comparable space&#59; provided, however, that no consideration shall be given to (1) the fact that Landlord is or is not required to pay a real estate brokerage commission in connection with the applicable term or the fact that the Comparable Transactions do or do not involve the payment of real estate brokerage commissions, and (2) any period of rental abatement, if any, granted to tenants in Comparable Transactions in connection with the design, permitting and construction of tenant improvements in such comparable spaces. The Market Rent shall include adjustment of the stated size of the Premises, based upon the standards of measurement utilized in the Comparable Transactions.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">TENANT SECURITY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Market Rent shall additionally include a determination as to whether, and if so to what extent, Tenant must provide Landlord with financial security, such as a letter of credit or guaranty, for Tenant's Rent obligations during the Option Term. Such determination shall be made by reviewing the extent of financial security then generally being imposed in Comparable Transactions from tenants of comparable financial condition and credit history to the then existing financial condition and credit history of Tenant (with appropriate adjustments to account for differences in the then-existing financial condition of Tenant and such other tenants).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">TENANT IMPROVEMENT ALLOWANCE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If, in determining the Market Rent for an Option Term, Tenant is entitled to a tenant improvement or comparable allowance for the improvement of the Option Space (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Option Term TI Allowance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34;), Landlord may, at Landlord&#8217;s sole option, elect to grant all or a portion of the Option Term TI Allowance in accordance with the following&#58; (A) to grant some or all of the Option Term TI Allowance to Tenant in the form as described above (i.e., as an improvement allowance), and&#47;or (B) to offset against the rental rate component of the Market Rent all or a portion of the Option Term TI Allowance (in which case such portion of the Option Term TI Allowance provided in the form of a rental offset shall not be granted to Tenant). To the extent Landlord elects not to grant the entire Option Term TI Allowance to Tenant as a tenant improvement allowance, the offset under item (B), above, shall equal the amount of the tenant improvement allowance not granted to Tenant as a tenant improvement allowance pursuant to the preceding sentence.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">COMPARABLE BUILDINGS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. For purposes of this Lease, the term &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Comparable Buildings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; shall mean the Building, the other buildings in the Project, and those other first-class institutionally-owned office and</font></div><div style="height:48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_310"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">laboratory buildings located in the Torrey Pines market area of San Diego, California that are comparable in age (based on the date of original construction or the latest major renovation) location, quality of construction, services and amenities. With respect to Comparable Transactions that are not located in the Building, the Market Rent shall be adjusted, if necessary, to take into consideration the size, age, quality of construction and appearance, scale, nature and location of the Comparable Buildings as they the relate to the Building.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">METHODOLOGY FOR REVIEWING AND COMPARING THE COMPARABLE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">TRANSACTIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In order to analyze the Comparable Transactions based on the factors to be considered in calculating Market Rent, and given that the Comparable Transactions may vary in terms of length or term, rental rate, concessions, etc., the following steps shall be taken into consideration to &#34;adjust&#34; the objective data from each of the Comparable Transactions. By taking this approach, a &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Net Equivalent Lease Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#34; for each of the Comparable Transactions shall be determined using the following steps to adjust the Comparable Transactions, which will allow for an &#34;apples to apples&#34; comparison of the Comparable Transactions.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.1&#160;&#160;&#160;&#160;The contractual rent payments for each of the Comparable Transactions should be arrayed monthly or annually over the lease term. All Comparable Transactions should be adjusted to simulate a net rent structure, wherein the tenant is responsible for the payment of all property operating expenses and taxes in a manner consistent with this Lease. This results in the estimate of Net Equivalent Rent received by each landlord for each Comparable Transaction being expressed as a periodic net rent payment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.2&#160;&#160;&#160;&#160;Any free rent or similar inducements received over time should be deducted in the time period in which they occur, resulting in the net cash flow arrayed over the lease term.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3&#160;&#160;&#160;&#160;The resultant net cash flow from the lease should be then discounted (using an annual discount rate equal to 8.0%) to the lease commencement date, resulting in a net present value estimate.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.4&#160;&#160;&#160;&#160;From the net present value, up front inducements (improvements allowances and other concessions) should be deducted. These items should be deducted directly, on a &#34;dollar for dollar&#34; basis, without discounting since they are typically incurred at lease commencement, while rent (which is discounted) is a future receipt.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.5&#160;&#160;&#160;&#160;The net present value should then amortized back over the lease term as a level monthly or annual net rent payment using the same annual discount rate of 8.0% used in the present value analysis. This calculation will result in a hypothetical level or even payment over the option period, termed the &#34;Net Equivalent Lease Rate&#34; (or constant equivalent in general financial terms).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">USE OF NET EQUIVALENT LEASE RATES FOR COMPARABLE TRANSACTIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Net Equivalent Lease Rates for the Comparable Transactions shall then be used to reconcile, in a manner usual and customary for a real estate appraisal process, to a conclusion of Market Rent which shall be stated as a Net Equivalent Lease Rate applicable the Option Term.</font></div><div style="height:48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_313"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT G</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:166.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">FORM OF LETTER OF CREDIT</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IRREVOCABLE STANDBY LETTER OF CREDIT NUMBER </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ISSUE DATE&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ISSUING BANK&#58;</font></div><div style="padding-left:6pt;padding-right:402.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">SILICON VALLEY BANK 3003 TASMAN DRIVE</font></div><div style="padding-left:6pt;padding-right:352.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2ND FLOOR, MAIL SORT HF210 SANTA CLARA, CALIFORNIA 95054</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">BENEFICIARY&#58;</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">TPSC IX, LLC</font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:343.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">C&#47;O HEALTHPEAK PROPERTIES, INC. 1920 MAIN STREET, SUITE 1200</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IRVINE, CA 92614</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ATTN&#58; LEGAL DEPARTMENT</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">APPLICANT&#58;</font></div><div style="padding-left:6pt;padding-right:342.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ZENTALIS PHARMACEUTICALS, INC. 530 SEVENTH AVE. STE 2201</font></div><div style="margin-top:0.05pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">NEW YORK, NY 10018</font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:77.95pt;padding-right:69.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">AMOUNT&#58;&#160;&#160;&#160;&#160;US$1,076,985.00 (ONE MILLION SEVENTY-SIX THOUSAND NINE HUNDRED EIGHTY-FIVE AND 00&#47;100 U.S. DOLLARS)</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">EXPIRATION DATE&#58;&#160;&#160;&#160;&#160;SEPTEMBER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, 2021 (ONE YEAR FROM DATE THE LC IS ISSUED)</font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:119pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">PLACE OF EXPIRATION&#58;&#160;&#160;&#160;&#160;ISSUING BANK&#8217;S COUNTERS AT ITS ABOVE ADDRESS DEAR SIR&#47;MADAM&#58;</font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:55.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">WE HEREBY ESTABLISH OUR IRREVOCABLE STANDBY LETTER OF CREDIT NO. SVBS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IN YOUR FAVOR FOR THE ACCOUNT OF THE APPLICANT EFFECTIVE IMMEDIATELY, FOR THE SUM NOT EXCEEDING ONE MILLION SEVENTY-SIX THOUSAND NINE HUNDRED EIGHTY-FIVE AND 00&#47;100 U.S. DOLLARS U.S. DOLLARS ($1,076,985.00) WHICH EXPIRES ON</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">AT OUR OFFICE AND AVAILABLE BY YOUR DRAFT(S) DRAWN ON US AT SIGHT IN THE FORM OF EXHIBIT &#8220;A&#8221; ATTACHED AND ACCOMPANIED BY THE FOLLOWING DOCUMENTS&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:15.95pt;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.&#160;&#160;&#160;&#160;THE ORIGINAL OF THIS LETTER OF CREDIT AND ALL AMENDMENT(S), IF ANY.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#91;Type here&#93;</font></div><div style="padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">ALL THE DETAILS SET FORTH HEREIN IN THIS LETTER OF CREDIT DRAFT IS APPROVED BY APPLICANT. IF THERE IS ANY DISCREPANCY BETWEEN THE DETAILS OF THIS LETTER OF CREDIT DRAFT AND THE LETTER OF CREDIT APPLICATION, BETWEEN APPLICANT AND SILICON VALLEY BANK, THE DETAILS HEREOF SHALL PREVAIL.</font></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.540%"><tr><td style="width:1.0%"></td><td style="width:46.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Applicants Authorized Signature</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Date</font></td></tr></table></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_316"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:75.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.&#160;&#160;&#160;&#160;BENEFICIARY&#8217;S DATED AND SIGNED STATEMENT, STATING ANY ONE OF THE FOLLOWING WITH INSTRUCTIONS IN BRACKETS THEREIN COMPLETED&#58;</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:59.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;THE UNDERSIGNED HEREBY CERTIFIES THAT BENEFICIARY, EITHER (A) UNDER THE LEASE (DEFINED BELOW), OR (B) AS A RESULT OF THE TERMINATION OF SUCH LEASE, HAS THE RIGHT TO DRAW DOWN THE AMOUNT OF USD(INSERT) IN ACCORDANCE WITH THE TERMS OF THAT CERTAIN OFFICE LEASE DATED SEPTEMBER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, 2020 BY AND BETWEEN BENEFICIARY AND APPLICANT (OR THE SUCCESSOR-IN-INTEREST TO THE ORIGINAL TENANT OF SUCH OFFICE LEASE), AS THE SAME MAY HAVE BEEN AMENDED (COLLECTIVELY, THE &#8220;LEASE&#8221;), OR SUCH AMOUNT CONSTITUTES DAMAGES OWING BY THE TENANT TO BENEFICIARY RESULTING FROM THE BREACH OF SUCH LEASE BY THE TENANT THEREUNDER, OR THE TERMINATION OF SUCH LEASE, AND SUCH AMOUNT REMAINS UNPAID AT THE TIME OF THIS DRAWING.&#8221;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">OR</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:54.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;THE UNDERSIGNED HEREBY CERTIFIES THAT BENEFICIARY HAS RECEIVED A WRITTEN NOTICE OF SILICON VALLEY BANK&#8217;S ELECTION NOT TO EXTEND ITS STANDBY LETTER OF CREDIT NO. SVBSF(INSERT) AND LESS THAN SIXTY (60) DAYS REMAIN PRIOR TO THE EXPIRATION OF SUCH LETTER OF CREDIT.&#8221;</font></div><div><font><br></font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">OR</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:50.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;THE UNDERSIGNED HEREBY CERTIFIES THAT BENEFICIARY IS ENTITLED TO DRAW DOWN THE FULL AMOUNT OF LETTER OF CREDIT NO. SVBSF(INSERT) AS THE RESULT OF THE FILING OF A VOLUNTARY PETITION UNDER THE U.S. BANKRUPTCY CODE OR A STATE BANKRUPTCY CODE BY THE TENANT UNDER THAT CERTAIN OFFICE LEASE DATED SEPTEMBER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, 2020 BY AND BETWEEN BENEFICIARY AND APPLICANT (OR THE SUCCESSOR-IN-INTEREST TO THE ORIGINAL TENANT OF SUCH OFFICE LEASE), AS THE SAME MAY HAVE BEEN AMENDED (COLLECTIVELY, THE &#8220;LEASE&#8221;), WHICH FILING HAS NOT BEEN DISMISSED AT THE TIME OF THIS DRAWING.&#8221;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">OR</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:54.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;THE UNDERSIGNED HEREBY CERTIFIES THAT BENEFICIARY IS ENTITLED TO DRAW DOWN THE FULL AMOUNT OF LETTER OF CREDIT NO. SVBSF(INSERT) AS THE RESULT OF AN INVOLUNTARY PETITION HAVING BEEN FILED UNDER THE U.S. BANKRUPTCY CODE OR A STATE BANKRUPTCY CODE AGAINST THE TENANT UNDER THAT CERTAIN OFFICE LEASE DATED SEPTEMBER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, 2020 BY AND BETWEEN BENEFICIARY AND APPLICANT (OR THE SUCCESSOR-IN-INTEREST TO THE ORIGINAL TENANT OF SUCH OFFICE LEASE), AS THE SAME MAY HAVE BEEN AMENDED (COLLECTIVELY, THE &#8220;LEASE&#8221;), WHICH FILING HAS NOT BEEN DISMISSED AT THE TIME OF THIS DRAWING.&#8221;</font></div><div><font><br></font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">OR</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:48.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;THE UNDERSIGNED HEREBY CERTIFIES THAT BENEFICIARY IS ENTITLED TO DRAW DOWN THE FULL AMOUNT OF LETTER OF CREDIT NO. SVBSF(INSERT) AS THE RESULT OF THE REJECTION, OR DEEMED REJECTION, OF THAT CERTAIN OFFICE LEASE DATED SEPTEMBER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, 2020 BY AND BETWEEN BENEFICIARY AND APPLICANT(OR THE SUCCESSOR-IN-INTEREST TO THE ORIGINAL TENANT OF SUCH OFFICE LEASE), AS THE SAME MAY HAVE BEEN AMENDED, UNDER SECTION 365 OF THE U.S. BANKRUPTCY CODE.&#8221;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#91;Type here&#93;</font></div><div style="padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">ALL THE DETAILS SET FORTH HEREIN IN THIS LETTER OF CREDIT DRAFT IS APPROVED BY APPLICANT. IF THERE IS ANY DISCREPANCY BETWEEN THE DETAILS OF THIS LETTER OF CREDIT DRAFT AND THE LETTER OF CREDIT APPLICATION, BETWEEN APPLICANT AND SILICON VALLEY BANK, THE DETAILS HEREOF SHALL PREVAIL.</font></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.540%"><tr><td style="width:1.0%"></td><td style="width:46.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Applicants Authorized Signature</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Date</font></td></tr></table></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_319"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">PARTIAL DRAWINGS AND MULTIPLE PRESENTATIONS ARE ALLOWED.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">NOTWITHSTANDING THE EXPIRATION DATE IDENTIFIED ABOVE IN THIS LETTER OF CREDIT, THIS LETTER OF CREDIT SHALL BE AUTOMATICALLY EXTENDED FOR AN ADDITIONAL PERIOD OF ONE YEAR, WITHOUT AMENDMENT, FROM THE PRESENT OR EACH FUTURE EXPIRATION DATE UNLESS AT LEAST 60 DAYS PRIOR TO THE THEN CURRENT EXPIRATION DATE WE SEND YOU A NOTICE BY REGISTERED OR CERTIFIED MAIL OR OVERNIGHT COURIER SERVICE AT THE ABOVE ADDRESS THAT THIS LETTER OF CREDIT WILL NOT BE EXTENDED BEYOND THE THEN CURRENT EXPIRATION DATE. IN NO EVENT SHALL THIS LETTER OF CREDIT BE AUTOMATICALLY EXTENDED BEYOND OCTOBER 31, 2032. IN THE EVENT WE SEND SUCH NOTICE OF NON-EXTENSION, YOU MAY DRAW HEREUNDER BY YOUR PRESENTATION TO US OF YOUR SIGNED AND DATED STATEMENT STATING THAT YOU HAVE RECEIVED A NON-EXTENSION NOTICE FROM SILICON VALLEY BANK IN RESPECT OF LETTER OF CREDIT NO. SVBSF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, YOU ARE DRAWING ON SUCH LETTER OF CREDIT FOR US$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, LESS THAN SIXTY (60) DAYS REMAIN PRIOR TO THE EXPIRATION OF THIS LETTER OF CREDIT AND YOU HAVE NOT RECEIVED A REPLACEMENT LETTER OF CREDIT ACCEPTABLE TO YOU.</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ALL DEMANDS FOR PAYMENT SHALL BE MADE BY PRESENTATION OF THE REQUIRED DOCUMENTS ON A BUSINESS DAY AT OUR OFFICE (THE &#8220;BANK&#8217;S OFFICE&#8221;) AT&#58; SILICON VALLEY BANK, 3003 TASMAN DRIVE, MAIL SORT HF 210, SANTA CLARA, CA 95054, ATTENTION&#58; GLOBAL TRADE FINANCE. AS USED IN THIS LETTER OF CREDIT, &#34;BUSINESS DAY&#34; SHALL MEAN ANY DAY OTHER THAN A SATURDAY, SUNDAY OR A DAY ON WHICH BANKING INSTITUTIONS IN THE STATE OF CALIFORNIA ARE AUTHORIZED OR REQUIRED BY LAW TO CLOSE. NOTWITHSTANDING ANY PROVISION TO THE CONTRARY IN THE ISP98 (AS HEREINAFTER DEFINED), IF THE EXPIRATION DATE OR THE FINAL EXPIRATION DATE IS NOT A BUSINESS Day THEN SUCH DATE SHALL BE AUTOMATICALLY EXTENDED TO THE NEXT SUCCEEDING DATE WHICH IS A BUSINESS DAY.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">FACSIMILE PRESENTATIONS ARE ALSO PERMITTED. EACH FACSIMILE TRANSMISSION SHALL BE MADE AT&#58; (408) 496-2418 OR (408) 969-6510</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">AND UNDER CONTEMPORANEOUS TELEPHONE ADVICE</font></div><div style="padding-left:5.95pt;padding-right:47.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">TO&#58; (408) 450-5001 OR (408) 654-7176, ATTENTION&#58; GLOBAL TRADE FINANCE. ABSENCE OF THE AFORESAID TELEPHONE ADVICE SHALL NOT AFFECT OUR OBLIGATION TO HONOR ANY DRAW REQUEST.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">THIS LETTER OF CREDIT IS TRANSFERABLE IN WHOLE BUT NOT IN PART ONE OR MORE TIMES, BUT IN EACH INSTANCE ONLY TO A SINGLE BENEFICIARY AS TRANSFEREE AND FOR THE THEN AVAILABLE AMOUNT, ASSUMING SUCH TRANSFER TO SUCH TRANSFEREE WOULD BE IN COMPLIANCE WITH THEN APPLICABLE LAW AND REGULATION, INCLUDING BUT NOT LIMITED TO THE REGULATIONS OF THE U.S. DEPARTMENT OF TREASURY AND U.S. DEPARTMENT OF COMMERCE. AT THE TIME OF TRANSFER, THE ORIGINAL LETTER OF CREDIT AND ORIGINALS OR COPIES OF ALL AMENDMENTS, IF ANY, TO THIS LETTER OF CREDIT MUST BE SURRENDERED TO US AT OUR ADDRESS INDICATED IN THIS LETTER OF CREDIT TOGETHER WITH OUR TRANSFER FORM ATTACHED HERETO AS EXHIBIT &#8220;B&#8221; DULY EXECUTED. APPLICANT SHALL PAY OUR TRANSFER FEE OF &#188; OF 1% OF THE TRANSFER AMOUNT (MINIMUM US$250.00) UNDER THIS LETTER OF CREDIT BUT SUCH PAYMENT BY APPLICANT SHALL NOT BE A CONDITION TO TRANSFER. EACH TRANSFER SHALL BE EVIDENCED BY EITHER (1) OUR ENDORSEMENT ON THE REVERSE OF THE LETTER OF CREDIT AND WE SHALL FORWARD THE ORIGINAL OF THE LETTER OF CREDIT SO ENDORSED TO THE TRANSFEREE OR (2) OUR ISSUING A REPLACEMENT LETTER OF CREDIT TO THE TRANSFEREE ON SUBSTANTIALLY THE SAME TERMS AND CONDITIONS AS THE TRANSFERRED LETTER OF CREDIT (IN WHICH EVENT THE TRANSFERRED LETTER OF CREDIT SHALL HAVE NO FURTHER EFFECT).</font></div><div style="margin-top:4.2pt;padding-left:5.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#91;Type here&#93;</font></div><div style="padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">ALL THE DETAILS SET FORTH HEREIN IN THIS LETTER OF CREDIT DRAFT IS APPROVED BY APPLICANT. IF THERE IS ANY DISCREPANCY BETWEEN THE DETAILS OF THIS LETTER OF CREDIT DRAFT AND THE LETTER OF CREDIT APPLICATION, BETWEEN APPLICANT AND SILICON VALLEY BANK, THE DETAILS HEREOF SHALL PREVAIL.</font></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.540%"><tr><td style="width:1.0%"></td><td style="width:46.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Applicants Authorized Signature</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Date</font></td></tr></table></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_322"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt;padding-right:47.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IF DEMAND FOR PAYMENT IS PRESENTED BY 10 A.M. CALIFORNIA TIME AND CONFORMS TO THE TERMS AND CONDITIONS OF THIS LETTER OF CREDIT, PAYMENT SHALL BE MADE BY ISSUING BANK TO YOU OF THE AMOUNT SPECIFIED, IN IMMEDIATELY AVAILABLE FUNDS NO LATER THAN THE NEXT FOLLOWING BUSINESS DAY AFTER THE DATE OF PRESENTMENT. IF DEMAND FOR PAYMENT IS PRESENTED BY YOU HEREUNDER AFTER THE TIME SPECIFIED ABOVE, AND CONFORMS TO THE TERMS AND CONDITIONS OF THIS LETTER OF CREDIT, PAYMENT SHALL BE MADE TO YOU, OF THE AMOUNT OF SPECIFIED, IN IMMEDIATELY AVAILABLE FUNDS NO LATER THAN THE SECOND BUSINESS DAY AFTER THE DATE OF PRESENTMENT.</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">WE HEREBY AGREE WITH THE BENEFICIARY THAT THE DRAFTS DRAWN UNDER AND IN ACCORDANCE WITH THE TERMS AND CONDITIONS OF THIS LETTER OF CREDIT SHALL BE DULY HONORED UPON PRESENTATION TO US ON OR BEFORE THE EXPIRATION DATE OF THIS LETTER OF CREDIT OR ANY AUTOMATICALLY EXTENDED EXPIRATION DATE.</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IF THE ORIGINAL AND&#47;OR ANY AMENDMENTS THERETO OF THIS STANDBY LETTER OF CREDIT NO. SVBSF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ARE LOST, STOLEN OR DESTROYED, WE WILL ISSUE YOU A &#34;CERTIFIED TRUE COPY&#34; OF THIS STANDBY LETTER OF CREDIT NO. SVBSF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">UPON OUR RECEIPT OF YOUR INDEMNITY LETTER. IF THE ORIGINAL OF THIS STANDBY LETTER OF CREDIT IS MUTILATED, WE WILL ISSUE YOU A REPLACEMENT STANDBY LETTER OF CREDIT WITH THE SAME NUMBER, DATE AND TERMS AS THE ORIGINAL UPON OUR RECEIPT OF THE MUTILATED STANDBY LETTER OF CREDIT.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IF ANY INSTRUCTIONS ACCOMPANYING A DRAWING UNDER THIS LETTER OF CREDIT REQUEST THAT PAYMENT IS TO BE MADE BY TRANSFER TO YOUR ACCOUNT WITH ANOTHER BANK, WE WILL ONLY EFFECT SUCH PAYMENT BY FED WIRE TO A U.S. REGULATED BANK, AND WE AND&#47;OR SUCH OTHER BANK MAY RELY ON AN ACCOUNT NUMBER SPECIFIED IN SUCH INSTRUCTIONS EVEN IF THE NUMBER IDENTIFIES A PERSON OR ENTITY DIFFERENT FROM THE INTENDED PAYEE.</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">THIS LETTER OF CREDIT IS SUBJECT TO THE INTERNATIONAL STANDBY PRACTICES (ISP98), INTERNATIONAL CHAMBER OF COMMERCE, PUBLICATION NO. 590.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:8.05pt;padding-left:5.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">SILICON VALLEY BANK,</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><img alt="image_123a.jpg" src="image_123a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:180px"><img alt="image_124a.jpg" src="image_124a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:180px"></div><div style="margin-top:0.05pt;padding-left:18.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">AUTHORIZED SIGNATURE&#160;&#160;&#160;&#160;AUTHORIZED SIGNATURE</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#91;Type here&#93;</font></div><div style="padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">ALL THE DETAILS SET FORTH HEREIN IN THIS LETTER OF CREDIT DRAFT IS APPROVED BY APPLICANT. IF THERE IS ANY DISCREPANCY BETWEEN THE DETAILS OF THIS LETTER OF CREDIT DRAFT AND THE LETTER OF CREDIT APPLICATION, BETWEEN APPLICANT AND SILICON VALLEY BANK, THE DETAILS HEREOF SHALL PREVAIL.</font></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_325"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:92.6pt;padding-right:92.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">EXHIBIT &#34;A&#34;</font></div><div style="padding-left:66.27pt;padding-right:66.27pt;text-align:center"><font><br></font></div><div style="margin-top:0.05pt;padding-left:90.97pt;padding-right:90.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SIGHT DRAFT</font></div><div style="margin-top:0.25pt"><img alt="image_125a.jpg" src="image_125a.jpg" style="height:418px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:144.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">GUIDELINES TO PREPARE THE DRAFT</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:24pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.&#160;&#160;&#160;&#160;DATE&#58; ISSUANCE DATE OF DRAFT.</font></div><div style="padding-left:24pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.&#160;&#160;&#160;&#160;REF. NO.&#58; BENEFICIARY'S REFERENCE NUMBER, IF ANY.</font></div><div style="margin-top:0.05pt;padding-left:23.95pt;padding-right:109.2pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.&#160;&#160;&#160;&#160;PAY TO THE ORDER OF&#58; NAME OF BENEFICIARY AS INDICATED IN THE L&#47;C (MAKE SURE BENEFICIARY ENDORSES IT ON THE REVERSE SIDE).</font></div><div style="padding-left:24pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.&#160;&#160;&#160;&#160;US$&#58; AMOUNT OF DRAWING IN FIGURES.</font></div><div style="padding-left:24pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.&#160;&#160;&#160;&#160;USDOLLARS&#58; AMOUNT OF DRAWING IN WORDS.</font></div><div style="padding-left:23.95pt;padding-right:93.8pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.&#160;&#160;&#160;&#160;LETTER OF CREDIT NUMBER&#58; SILICON VALLEY BANK'S STANDBY L&#47;C NUMBER THAT PERTAINS TO THE DRAWING.</font></div><div style="margin-top:0.05pt;padding-left:24pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.&#160;&#160;&#160;&#160;DATED&#58; ISSUANCE DATE OF THE STANDBY L&#47;C.</font></div><div style="padding-left:24pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.&#160;&#160;&#160;&#160;BENEFICIARY'S NAME&#58; NAME OF BENEFICIARY AS INDICATED IN THE L&#47;C.</font></div><div style="padding-left:24pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9.&#160;&#160;&#160;&#160;AUTHORIZED SIGNATURE&#58; SIGNED BY AN AUTHORIZED SIGNER OF BENEFICIARY.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IF YOU NEED FURTHER ASSISTANCE IN COMPLETING THIS DRAFT, PLEASE CALL OUR L&#47;C PAYMENT SECTION AT 408-654-6274 OR 408-654-7716.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#91;Type here&#93;</font></div><div style="padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">ALL THE DETAILS SET FORTH HEREIN IN THIS LETTER OF CREDIT DRAFT IS APPROVED BY APPLICANT. IF THERE IS ANY DISCREPANCY BETWEEN THE DETAILS OF THIS LETTER OF CREDIT DRAFT AND THE LETTER OF CREDIT APPLICATION, BETWEEN APPLICANT AND SILICON VALLEY BANK, THE DETAILS HEREOF SHALL PREVAIL.</font></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.540%"><tr><td style="width:1.0%"></td><td style="width:46.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Applicants Authorized Signature</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Date</font></td></tr></table></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_328"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IRREVOCABLE STANDBY LETTER OF CREDIT NUMBER </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#91;Type here&#93;</font></div><div style="padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">ALL THE DETAILS SET FORTH HEREIN IN THIS LETTER OF CREDIT DRAFT IS APPROVED BY APPLICANT. IF THERE IS ANY DISCREPANCY BETWEEN THE DETAILS OF THIS LETTER OF CREDIT DRAFT AND THE LETTER OF CREDIT APPLICATION, BETWEEN APPLICANT AND SILICON VALLEY BANK, THE DETAILS HEREOF SHALL PREVAIL.</font></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.540%"><tr><td style="width:1.0%"></td><td style="width:46.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Applicants Authorized Signature</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Date</font></td></tr></table></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_331"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">EXHIBIT &#8220;B&#8221;</font></div><div style="margin-top:0.05pt;padding-left:111.52pt;padding-right:111.52pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FORM OF TRANSFER FORM</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">DATE&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">TO&#58; SILICON VALLEY BANK</font></div><div style="margin-top:0.05pt;padding-left:21.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3003 TASMAN DRIVE&#160;&#160;&#160;&#160;RE&#58; IRREVOCABLE STANDBY LETTER OF CREDIT</font></div><div style="padding-left:21.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">SANTA CLARA, CA 95054&#160;&#160;&#160;&#160;NO.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ISSUED BY</font></div><div style="margin-top:0.05pt;padding-left:21.75pt;padding-right:131.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ATTN&#58; GLOBAL TRADE FINANCE&#160;&#160;&#160;&#160;SILICON VALLEY BANK, SANTA CLARA STANDBY LETTERS OF CREDIT&#160;&#160;&#160;&#160;L&#47;C AMOUNT&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">GENTLEMEN&#58;</font></div><div><font><br></font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">FOR VALUE RECEIVED, THE UNDERSIGNED BENEFICIARY HEREBY IRREVOCABLY TRANSFERS TO&#58;</font></div><div><font><br></font></div><div style="margin-top:0.35pt"><img alt="image_128.jpg" src="image_128.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:534px"></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(NAME OF TRANSFEREE)</font></div><div><font><br></font></div><div style="margin-top:0.35pt"><img alt="image_128.jpg" src="image_128.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:534px"></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(ADDRESS)</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:47pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ALL RIGHTS OF THE UNDERSIGNED BENEFICIARY TO DRAW UNDER THE ABOVE LETTER OF CREDIT UP TO ITS AVAILABLE AMOUNT AS SHOWN ABOVE AS OF THE DATE OF THIS TRANSFER.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:47.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">BY THIS TRANSFER, ALL RIGHTS OF THE UNDERSIGNED BENEFICIARY IN SUCH LETTER OF CREDIT ARE TRANSFERRED TO THE TRANSFEREE. TRANSFEREE SHALL HAVE THE SOLE RIGHTS AS BENEFICIARY THEREOF, INCLUDING SOLE RIGHTS RELATING TO ANY AMENDMENTS, WHETHER INCREASES OR EXTENSIONS OR OTHER AMENDMENTS, AND WHETHER NOW EXISTING OR HEREAFTER MADE. ALL AMENDMENTS ARE TO BE ADVISED DIRECTLY TO THE TRANSFEREE WITHOUT NECESSITY OF ANY CONSENT OF OR NOTICE TO THE UNDERSIGNED BENEFICIARY.</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:47.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">THE ORIGINAL OF SUCH LETTER OF CREDIT IS RETURNED HEREWITH, AND WE ASK YOU TO EITHER (1) ENDORSE THE TRANSFER ON THE REVERSE THEREOF, AND FORWARD IT DIRECTLY TO THE TRANSFEREE WITH YOUR CUSTOMARY NOTICE OF TRANSFER, OR (2) ISSUE A REPLACEMENT LETTER OF CREDIT TO THE TRANSFEREE ON SUBSTANTIALLY THE SAME TERMS AND CONDITIONS AS THE TRANSFERRED LETTER OF CREDIT (IN WHICH EVENT THE TRANSFERRED LETTER OF CREDIT SHALL HAVE NO FURTHER EFFECT).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div id="i1857427c06e5452983070f6ff36fd01d_334"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:44.248%"><div style="margin-top:4.6pt;padding-left:17.25pt;padding-right:20.6pt;text-indent:-11.3pt"><img alt="exhga.jpg" src="exhga.jpg" style="height:310px;margin-bottom:5pt;vertical-align:text-bottom;width:520px"></div></div><div style="display:inline-block;max-width:11.503%;min-width:10.503%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:44.249%"></div></div><div style="height:80pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_337"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:20.019%"><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:0.55pt"><font><br></font></div></div><div style="display:inline-block;max-width:19.971%;min-width:19.471%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:20.019%"><div><font><br></font></div></div><div style="display:inline-block;max-width:19.971%;min-width:19.471%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:20.020%"></div></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_340"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">LEASE</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">THE BOARDWALK</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">TPSC IX, LLC,</font></div><div style="padding-left:185.22pt;padding-right:185.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">a Delaware limited liability company, as Landlord,</font></div><div style="padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ZENTALIS PHARMACEUTICALS, INC.,</font></div><div style="margin-top:0.05pt;padding-left:212.75pt;padding-right:212.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:237%">a Delaware corporation, as Tenant.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:23.741%"><div style="margin-top:4.75pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%">822610.04&#47;WLA</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%">183362-00050&#47;9-30-20&#47;mem&#47;mem</font></div></div><div style="display:inline-block;max-width:52.517%;min-width:51.517%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:23.742%"><div style="margin-top:4.75pt;padding-left:29.45pt"><font><br></font></div><div style="padding-left:29.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%">&#91;THE BOARDWALK&#93;</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%">&#91;Zentalis Pharmaceuticals, Inc.&#93;</font></div></div></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_343"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.1pt;padding-left:111.6pt;padding-right:111.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">TABLE OF CONTENTS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-right:52.25pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Page</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_40" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">PREMISES, BUILDING, PROJECT, AND COMMON AREAS</a><a href="#i1857427c06e5452983070f6ff36fd01d_40" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_40" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">5</a></font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_49" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">LEASE TERM&#59; OPTION TERM</a><a href="#i1857427c06e5452983070f6ff36fd01d_49" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_49" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">6</a></font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_58" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">BASE RENT</a><a href="#i1857427c06e5452983070f6ff36fd01d_58" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_58" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">6</a></font></div><div style="margin-top:0.05pt;padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_61" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">ADDITIONAL RENT</a><a href="#i1857427c06e5452983070f6ff36fd01d_61" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_61" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">6</a></font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_76" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">USE OF PREMISES</a><a href="#i1857427c06e5452983070f6ff36fd01d_76" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_76" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">11</a></font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">SERVICES AND UTILITIES</a><a href="#i1857427c06e5452983070f6ff36fd01d_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">16</a></font></div><div style="margin-top:0.05pt;padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_100" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">REPAIRS</a><a href="#i1857427c06e5452983070f6ff36fd01d_100" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_100" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">17</a></font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_103" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">ADDITIONS AND ALTERATIONS</a><a href="#i1857427c06e5452983070f6ff36fd01d_103" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_103" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">17</a></font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9.&#160;&#160;&#160;&#160;COVENANT AGAINST LIENS&#160;&#160;&#160;&#160;19</font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">INSURANCE</a><a href="#i1857427c06e5452983070f6ff36fd01d_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">19</a></font></div><div style="margin-top:0.05pt;padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_115" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">DAMAGE AND DESTRUCTION</a><a href="#i1857427c06e5452983070f6ff36fd01d_115" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_115" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">21</a></font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12.&#160;&#160;&#160;&#160;NONWAIVER&#160;&#160;&#160;&#160;22</font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13.&#160;&#160;&#160;&#160;CONDEMNATION&#160;&#160;&#160;&#160;23</font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">ASSIGNMENT AND SUBLETTING</a><a href="#i1857427c06e5452983070f6ff36fd01d_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_121" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">23</a></font></div><div style="margin-top:0.05pt;padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_130" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">SURRENDER OF PREMISES&#59; OWNERSHIP AND REMOVAL OF TRADE FIXTURES</a><a href="#i1857427c06e5452983070f6ff36fd01d_130" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_130" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">26</a></font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16.&#160;&#160;&#160;&#160;HOLDING OVER&#160;&#160;&#160;&#160;27</font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17.&#160;&#160;&#160;&#160;ESTOPPEL CERTIFICATES&#160;&#160;&#160;&#160;27</font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18.&#160;&#160;&#160;&#160;SUBORDINATION&#160;&#160;&#160;&#160;28</font></div><div style="margin-top:0.05pt;padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_139" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">DEFAULTS&#59; REMEDIES</a><a href="#i1857427c06e5452983070f6ff36fd01d_139" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_139" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">28</a></font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20.&#160;&#160;&#160;&#160;COVENANT OF QUIET ENJOYMENT&#160;&#160;&#160;&#160;30</font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21.&#160;&#160;&#160;&#160;SECURITY DEPOSIT&#160;&#160;&#160;&#160;30</font></div><div style="margin-top:0.05pt;padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22.&#160;&#160;&#160;&#160;COMMUNICATIONS AND COMPUTER LINE&#160;&#160;&#160;&#160;30</font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_157" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">SIGNS</a><a href="#i1857427c06e5452983070f6ff36fd01d_157" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_157" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">30</a></font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24.&#160;&#160;&#160;&#160;COMPLIANCE WITH LAW&#160;&#160;&#160;&#160;31</font></div><div style="margin-top:0.05pt;padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25.&#160;&#160;&#160;&#160;LATE CHARGES&#160;&#160;&#160;&#160;31</font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_160" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">LANDLORD'S RIGHT TO CURE DEFAULT&#59; PAYMENTS BY TENANT</a><a href="#i1857427c06e5452983070f6ff36fd01d_160" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_160" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">32</a></font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">27.&#160;&#160;&#160;&#160;ENTRY BY LANDLORD&#160;&#160;&#160;&#160;32</font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">28.&#160;&#160;&#160;&#160;TENANT PARKING&#160;&#160;&#160;&#160;32</font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29.&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="#i1857427c06e5452983070f6ff36fd01d_163" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">MISCELLANEOUS PROVISIONS</a><a href="#i1857427c06e5452983070f6ff36fd01d_163" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;</a><a href="#i1857427c06e5452983070f6ff36fd01d_163" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">32</a></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">EXHIBITS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:367pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A&#160;&#160;&#160;&#160;OUTLINE OF PREMISES B&#160;&#160;&#160;&#160;TENANT WORK LETTER</font></div><div style="padding-left:42pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">C&#160;&#160;&#160;&#160;FORM OF NOTICE OF LEASE TERM DATES</font></div><div style="padding-left:6pt;padding-right:269.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">D&#160;&#160;&#160;&#160;FORM OF TENANT'S ESTOPPEL CERTIFICATE E&#160;&#160;&#160;&#160;ENVIRONMENTAL QUESTIONNAIRE</font></div><div style="padding-left:41.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">F&#160;&#160;&#160;&#160;MARKET RENT ANALYSIS</font></div><div style="margin-top:0.05pt;padding-left:42pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">G&#160;&#160;&#160;&#160;FORM OF LETTER OF CREDIT</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:37.284%"><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:116%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:116%">(i)</font></div><div style="margin-top:0.1pt"><font><br></font></div></div><div style="display:inline-block;max-width:25.431%;min-width:24.431%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:37.285%"><div><font><br></font></div></div></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_346"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.1pt;padding-left:111.57pt;padding-right:111.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">INDEX</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-right:52.35pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Page(s)</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Abatement Event&#160;&#160;&#160;&#160;24</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Advocate Arbitrators&#160;&#160;&#160;&#160;8</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Alterations&#160;&#160;&#160;&#160;25</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Arbitration Agreement&#160;&#160;&#160;&#160;8</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Base Building Improvements&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Exhibit B</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Base Building Modifications&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Exhibit B</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Base Building Plans&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Exhibit B</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Base Rent&#160;&#160;&#160;&#160;10</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Briefs&#160;&#160;&#160;&#160;8</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Brokers&#160;&#160;&#160;&#160;47</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Building&#160;&#160;&#160;&#160;1</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Casualty&#160;&#160;&#160;&#160;28</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Common Areas&#160;&#160;&#160;&#160;4</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contemplated Effective Date&#160;&#160;&#160;&#160;32</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contemplated Transfer Space&#160;&#160;&#160;&#160;32</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Controllable Expenses&#160;&#160;&#160;&#160;15</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deliver Punch List&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Exhibit B</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Direct Expenses&#160;&#160;&#160;&#160;11</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective Date&#160;&#160;&#160;&#160;5</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Eligibility Period&#160;&#160;&#160;&#160;24</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Emergency Generator&#160;&#160;&#160;&#160;23</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Estimate&#160;&#160;&#160;&#160;16</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Estimate Statement&#160;&#160;&#160;&#160;16</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Estimated Direct Expenses&#160;&#160;&#160;&#160;16</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Existing Hazardous Materials&#160;&#160;&#160;&#160;19</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Expense Year&#160;&#160;&#160;&#160;12</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">First Rebuttals&#160;&#160;&#160;&#160;8</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Force Majeure&#160;&#160;&#160;&#160;46</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Holidays&#160;&#160;&#160;&#160;22</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">HVAC&#160;&#160;&#160;&#160;22</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Intention to Transfer Notice&#160;&#160;&#160;&#160;32</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Landlord&#160;&#160;&#160;&#160;1</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Landlord Minor Changes&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Exhibit B</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Landlord Parties&#160;&#160;&#160;&#160;26</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Landlord Repair Notice&#160;&#160;&#160;&#160;29</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Landlord's Initial Statement&#160;&#160;&#160;&#160;9</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Landlord's Rebuttal Statement&#160;&#160;&#160;&#160;9</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lease&#160;&#160;&#160;&#160;1</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lease Commencement Date&#160;&#160;&#160;&#160;7</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lease Expiration Date&#160;&#160;&#160;&#160;7</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lease Term&#160;&#160;&#160;&#160;7</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lease Year&#160;&#160;&#160;&#160;7</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lines&#160;&#160;&#160;&#160;49</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Mail&#160;&#160;&#160;&#160;46</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Market Rent&#160;&#160;&#160;&#160;7</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Market Rent,&#160;&#160;&#160;&#160;7</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net Worth&#160;&#160;&#160;&#160;33</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Neutral Arbitrator&#160;&#160;&#160;&#160;8</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Nine Month Period&#160;&#160;&#160;&#160;32</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Notices&#160;&#160;&#160;&#160;46</font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:37.461%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:116%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:116%">(ii)</font></div><div><font><br></font></div></div><div style="display:inline-block;max-width:25.076%;min-width:24.076%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:37.463%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1857427c06e5452983070f6ff36fd01d_349"></div><hr style="page-break-after:always"><div style="min-height:55pt;width:100%"><div><img alt="image_20.jpg" src="image_20.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div></div><div style="margin-top:4.1pt;padding-right:47.85pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Page(s)</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Objectionable Name&#160;&#160;&#160;&#160;42</font></div><div style="margin-top:0.05pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating Expenses&#160;&#160;&#160;&#160;12</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Option Conditions&#160;&#160;&#160;&#160;7</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Option Rent&#160;&#160;&#160;&#160;7</font></div><div style="margin-top:0.05pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Option Term&#160;&#160;&#160;&#160;7</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Option Term TI Allowance&#160;&#160;&#160;&#160;1</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Original Improvements&#160;&#160;&#160;&#160;27</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outside Agreement Date&#160;&#160;&#160;&#160;8</font></div><div style="margin-top:0.05pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outside Area&#160;&#160;&#160;&#160;21</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outside Date&#160;&#160;&#160;&#160;5</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Permitted Transferee&#160;&#160;&#160;&#160;33</font></div><div style="margin-top:0.05pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Permitted Transferee Assignee&#160;&#160;&#160;&#160;33</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Possession Date&#160;&#160;&#160;&#160;4</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Premises&#160;&#160;&#160;&#160;4</font></div><div style="margin-top:0.05pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Project,&#160;&#160;&#160;&#160;4</font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Rooftop Equipment&#160;&#160;&#160;&#160;41</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Ruling&#160;&#160;&#160;&#160;9</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Second Rebuttals&#160;&#160;&#160;&#160;9</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sign Specifications&#160;&#160;&#160;&#160;42</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">SNDAA&#160;&#160;&#160;&#160;35</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Statement&#160;&#160;&#160;&#160;16</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Subject Space&#160;&#160;&#160;&#160;30</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Summary.&#160;&#160;&#160;&#160;1</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Superior Holders&#160;&#160;&#160;&#160;35</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tax Expenses&#160;&#160;&#160;&#160;14</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tenant&#160;&#160;&#160;&#160;1</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tenant Work Letter&#160;&#160;&#160;&#160;4</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tenant&#8217;s Security System&#160;&#160;&#160;&#160;22</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tenant's Initial Statement&#160;&#160;&#160;&#160;9</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tenant's Rebuttal Statement&#160;&#160;&#160;&#160;9</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tenant's Share&#160;&#160;&#160;&#160;15</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Termination Date&#160;&#160;&#160;&#160;10</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Termination Extension Notice&#160;&#160;&#160;&#160;5</font></div><div style="margin-top:0.05pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Termination Fee&#160;&#160;&#160;&#160;10</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Termination Notice&#160;&#160;&#160;&#160;5, 10</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Transfer Notice&#160;&#160;&#160;&#160;30</font></div><div style="padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Transferee&#160;&#160;&#160;&#160;30</font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:37.595%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:116%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:116%">(iii)</font></div><div><font><br></font></div></div><div style="display:inline-block;max-width:24.808%;min-width:23.808%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:37.597%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div></div></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>zentalis10-qq32021ex3111.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i70a6bb89f7f645609c0575a9c41010eb_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 31.1</font></div></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">CERTIFICATION </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">I, Anthony Y. Sun, M.D. certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Zentalis Pharmaceuticals, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">&#91;omitted&#93;&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:81pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:81pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November 10, 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47;&#160;Anthony Y. Sun, M.D.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony Y. Sun, M.D.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Chief Executive Officer, President and Chairman</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">(principal executive officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>zentalis10-qq32021ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="if1feca081fc346799e8ea2552c3f9e88_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 31.2</font></div></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">CERTIFICATION </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">I, Melissa B. Epperly, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Zentalis Pharmaceuticals, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">&#91;omitted&#93;&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November 10, 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47;&#160;Melissa B. Epperly</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Melissa B. Epperly</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Chief Financial Officer</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">principal financial officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>zentalis10-qq32021ex3211.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i410f4f610c2c4ef7980fb9fc99b50ad6_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 32.1</font></div></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In connection with the Quarterly Report on Form 10-Q of Zentalis Pharmaceuticals, Inc. (the &#8220;Company&#8221;) for the period ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt;padding-left:9pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November 10, 2021</font></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47;&#160;Anthony Y. Sun, M.D.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony Y. Sun, M.D.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Chief Executive Officer, President and Chairman</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">(principal executive officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>zentalis10-qq32021ex3221.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i2d2348b4bfad4edaaa2df1a529abab84_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 32.2</font></div></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In connection with the Quarterly Report on Form 10-Q of Zentalis Pharmaceuticals, Inc. (the &#8220;Company&#8221;) for the period ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt;padding-left:9pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November 10, 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47;&#160;Melissa B. Epperly</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Melissa B. Epperly</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Chief Financial Officer</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">principal financial officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>zntl-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:ec330f09-1704-42bb-8fbc-efe747c127bc,g:cceb589a-52db-4380-936c-762192d75fd3-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:zntl="http://www.zentalis.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.zentalis.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zntl-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zntl-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zntl-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zntl-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.zentalis.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.zentalis.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits" roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Members&#8217;/Stockholders&#8217; Equity(Deficit) and Changes in Redeemable Convertible Preferred Units</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical" roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Members&#8217;/Stockholders&#8217; Equity(Deficit) and Changes in Redeemable Convertible Preferred Units (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandBusiness" roleURI="http://www.zentalis.com/role/OrganizationandBusiness">
        <link:definition>2101101 - Disclosure - Organization and Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandBusinessDetails" roleURI="http://www.zentalis.com/role/OrganizationandBusinessDetails">
        <link:definition>2402401 - Disclosure - Organization and Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterimUnauditedFinancialStatements" roleURI="http://www.zentalis.com/role/InterimUnauditedFinancialStatements">
        <link:definition>2103102 - Disclosure - Interim Unaudited Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterimUnauditedFinancialStatementsPolicies" roleURI="http://www.zentalis.com/role/InterimUnauditedFinancialStatementsPolicies">
        <link:definition>2204201 - Disclosure - Interim Unaudited Financial Statements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterimUnauditedFinancialStatementsTables" roleURI="http://www.zentalis.com/role/InterimUnauditedFinancialStatementsTables">
        <link:definition>2305301 - Disclosure - Interim Unaudited Financial Statements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantTransactions" roleURI="http://www.zentalis.com/role/SignificantTransactions">
        <link:definition>2106103 - Disclosure - Significant Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantTransactionsDetails" roleURI="http://www.zentalis.com/role/SignificantTransactionsDetails">
        <link:definition>2407402 - Disclosure - Significant Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.zentalis.com/role/BusinessCombinations">
        <link:definition>2108104 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://www.zentalis.com/role/BusinessCombinationsTables">
        <link:definition>2309302 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativeDetails" roleURI="http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails">
        <link:definition>2410403 - Disclosure - Business Combinations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsAssetsandLiabilitiesDetails" roleURI="http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails">
        <link:definition>2411404 - Disclosure - Business Combinations - Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsRollforwardofNoncontrollingInterestDetails" roleURI="http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails">
        <link:definition>2412405 - Disclosure - Business Combinations - Rollforward of Noncontrolling Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurement" roleURI="http://www.zentalis.com/role/FairValueMeasurement">
        <link:definition>2113105 - Disclosure - Fair Value Measurement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementTables" roleURI="http://www.zentalis.com/role/FairValueMeasurementTables">
        <link:definition>2314303 - Disclosure - Fair Value Measurement (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails" roleURI="http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails">
        <link:definition>2415406 - Disclosure - Fair Value Measurement - Components of Available-for-sale Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails" roleURI="http://www.zentalis.com/role/FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails">
        <link:definition>2416407 - Disclosure - Fair Value Measurement - Contractual Maturities of Available-for-sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails" roleURI="http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails">
        <link:definition>2417408 - Disclosure - Fair Value Measurement - Fair Value of Assets Measured on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesandOtherAssets" roleURI="http://www.zentalis.com/role/PrepaidExpensesandOtherAssets">
        <link:definition>2118106 - Disclosure - Prepaid Expenses and Other Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesandOtherAssetsTables" roleURI="http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsTables">
        <link:definition>2319304 - Disclosure - Prepaid Expenses and Other Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesandOtherAssetsDetails" roleURI="http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails">
        <link:definition>2420409 - Disclosure - Prepaid Expenses and Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesandOtherAssetsDetails_1" roleURI="http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails_1">
        <link:definition>2420409 - Disclosure - Prepaid Expenses and Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentnet" roleURI="http://www.zentalis.com/role/PropertyandEquipmentnet">
        <link:definition>2121107 - Disclosure - Property and Equipment, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentnetTables" roleURI="http://www.zentalis.com/role/PropertyandEquipmentnetTables">
        <link:definition>2322305 - Disclosure - Property and Equipment, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentnetSummaryDetails" roleURI="http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails">
        <link:definition>2423410 - Disclosure - Property and Equipment, net - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentnetNarrativeDetails" roleURI="http://www.zentalis.com/role/PropertyandEquipmentnetNarrativeDetails">
        <link:definition>2424411 - Disclosure - Property and Equipment, net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpenses" roleURI="http://www.zentalis.com/role/AccruedExpenses">
        <link:definition>2125108 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesTables" roleURI="http://www.zentalis.com/role/AccruedExpensesTables">
        <link:definition>2326306 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesDetails" roleURI="http://www.zentalis.com/role/AccruedExpensesDetails">
        <link:definition>2427412 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredUnits" roleURI="http://www.zentalis.com/role/ConvertiblePreferredUnits">
        <link:definition>2128109 - Disclosure - Convertible Preferred Units</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredUnitsNarrativeDetails" roleURI="http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails">
        <link:definition>2429413 - Disclosure - Convertible Preferred Units - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MembersEquity" roleURI="http://www.zentalis.com/role/MembersEquity">
        <link:definition>2130110 - Disclosure - Members&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MembersEquityTables" roleURI="http://www.zentalis.com/role/MembersEquityTables">
        <link:definition>2331307 - Disclosure - Members&#8217; Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MembersEquityNarrativeDetails" roleURI="http://www.zentalis.com/role/MembersEquityNarrativeDetails">
        <link:definition>2432414 - Disclosure - Members&#8217; Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MembersEquitySharebasedCompensationDetails" roleURI="http://www.zentalis.com/role/MembersEquitySharebasedCompensationDetails">
        <link:definition>2433415 - Disclosure - Members&#8217; Equity - Share-based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MembersEquitySharebasedCompensationExpenseDetails" roleURI="http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails">
        <link:definition>2434416 - Disclosure - Members&#8217; Equity - Share-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails" roleURI="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails">
        <link:definition>2435417 - Disclosure - Members&#8217; Equity - Fair Value Assumptions for Profit Interest Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MembersEquityFairValueAssumptionsforStockOptionsDetails" roleURI="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails">
        <link:definition>2436418 - Disclosure - Members&#8217; Equity - Fair Value Assumptions for Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MembersEquityFairValueAssumptionsforESPPDetails" roleURI="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails">
        <link:definition>2437419 - Disclosure - Members&#8217; Equity - Fair Value Assumptions for ESPP (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MembersEquityUnrecognizedCompensationCostDetails" roleURI="http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails">
        <link:definition>2438420 - Disclosure - Members&#8217; Equity - Unrecognized Compensation Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingencies" roleURI="http://www.zentalis.com/role/CommitmentandContingencies">
        <link:definition>2139111 - Disclosure - Commitment and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesTables" roleURI="http://www.zentalis.com/role/CommitmentandContingenciesTables">
        <link:definition>2340308 - Disclosure - Commitment and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesFutureMinimumLeasePaymentsDetails" roleURI="http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails">
        <link:definition>2441421 - Disclosure - Commitment and Contingencies - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesFutureMinimumLeasePaymentsDetails_1" roleURI="http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails_1">
        <link:definition>2441421 - Disclosure - Commitment and Contingencies - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesNarrativeDetails" roleURI="http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails">
        <link:definition>2442422 - Disclosure - Commitment and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerCommonShareClassACommonUnit" roleURI="http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnit">
        <link:definition>2143112 - Disclosure - Net Loss Per Common Share/Class&#160;A Common Unit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerCommonShareClassACommonUnitTables" roleURI="http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitTables">
        <link:definition>2344309 - Disclosure - Net Loss Per Common Share/Class&#160;A Common Unit (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerCommonShareClassACommonUnitCalculationDetails" roleURI="http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitCalculationDetails">
        <link:definition>2445423 - Disclosure - Net Loss Per Common Share/Class&#160;A Common Unit - Calculation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails" roleURI="http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails">
        <link:definition>2446424 - Disclosure - Net Loss Per Common Share/Class&#160;A Common Unit - Antidilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyDisclosures" roleURI="http://www.zentalis.com/role/RelatedPartyDisclosures">
        <link:definition>2147113 - Disclosure - Related Party Disclosures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyDisclosuresDetails" roleURI="http://www.zentalis.com/role/RelatedPartyDisclosuresDetails">
        <link:definition>2448425 - Disclosure - Related Party Disclosures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="zntl_KalyraPharmaceuticalsIncMember" abstract="true" name="KalyraPharmaceuticalsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_MasterServicesAgreementMember" abstract="true" name="MasterServicesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross" abstract="false" name="ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_LaboratoryEquipmentMember" abstract="true" name="LaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_FollowOnPublicOfferingMember" abstract="true" name="FollowOnPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zntl_A2017ProfitInterestPlanMember" abstract="true" name="A2017ProfitInterestPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="zntl_AccruedGeneralAndAdministrativeCostsCurrent" abstract="false" name="AccruedGeneralAndAdministrativeCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock" abstract="false" name="ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="zntl_StockIssuanceCostsIncurredButNotYetPaid" abstract="false" name="StockIssuanceCostsIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_ProceedsFromIssuanceOfCommonStockGross" abstract="false" name="ProceedsFromIssuanceOfCommonStockGross" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_ConvertiblePreferredStockDividendsPerShareDeclared" abstract="false" name="ConvertiblePreferredStockDividendsPerShareDeclared" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="zntl_CorporateConversionMember" abstract="true" name="CorporateConversionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zntl_RecognizedTaxGainOnIntangibleAssetImpairment" abstract="false" name="RecognizedTaxGainOnIntangibleAssetImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember" abstract="true" name="RestrictedStockAwardsAndRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock" abstract="false" name="ExpensesAndFeesFromTheIssuanceOfCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_CommonUnitOutstandingSubjectToFutureVestingConditions" abstract="false" name="CommonUnitOutstandingSubjectToFutureVestingConditions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="zntl_ZenteraStockPlanMember" abstract="true" name="ZenteraStockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zntl_CommonStockSharesSubjectToFutureVestingProvisions" abstract="false" name="CommonStockSharesSubjectToFutureVestingProvisions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="zntl_LicenseAgreementMember" abstract="true" name="LicenseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zntl_PrepaidResearchAndDevelopmentCosts" abstract="false" name="PrepaidResearchAndDevelopmentCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_FollowOnOfferingMember" abstract="true" name="FollowOnOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zntl_ComputerAndOfficeEquipmentMember" abstract="true" name="ComputerAndOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zntl_CommonStockConversionRatio" abstract="false" name="CommonStockConversionRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="zntl_StockCancelledDuringPeriodShares" abstract="false" name="StockCancelledDuringPeriodShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="zntl_ProfitInterestAwardsMember" abstract="true" name="ProfitInterestAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" abstract="false" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_EarningsPerShareDenominatorAbstract" abstract="true" name="EarningsPerShareDenominatorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="zntl_AccruedResearchAndDevelopmentCostsCurrent" abstract="false" name="AccruedResearchAndDevelopmentCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_PrepaidSoftwareLicenseAndMaintenance" abstract="false" name="PrepaidSoftwareLicenseAndMaintenance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_A2020IncentiveAwardPlanMember" abstract="true" name="A2020IncentiveAwardPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="zntl_ZenteraTherapeuticsLtdMember" abstract="true" name="ZenteraTherapeuticsLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_EarningsPerShareNumeratorAbstract" abstract="true" name="EarningsPerShareNumeratorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="zntl_ResearchAndDevelopmentExpenseReimbursements" abstract="false" name="ResearchAndDevelopmentExpenseReimbursements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering" abstract="false" name="TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_ForeignResearchAndDevelopmentCreditRefund" abstract="false" name="ForeignResearchAndDevelopmentCreditRefund" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_ReconciliationOfNoncontrollingInterestTableTextBlock" abstract="false" name="ReconciliationOfNoncontrollingInterestTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="zntl_OtherPrepaidExpense" abstract="false" name="OtherPrepaidExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_TemporaryEquityTextBlock" abstract="false" name="TemporaryEquityTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="zntl_DeconsolidationGainLossAmountNet" abstract="false" name="DeconsolidationGainLossAmountNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="zntl_RelatedPartyAgreementTerm" abstract="false" name="RelatedPartyAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>zntl-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:ec330f09-1704-42bb-8fbc-efe747c127bc,g:cceb589a-52db-4380-936c-762192d75fd3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="zntl-20210930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ffa930c4-938f-46c7-86e8-99220e1e28c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_1310a7c8-ea03-40c2-94dd-4b96f7f11034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ffa930c4-938f-46c7-86e8-99220e1e28c6" xlink:to="loc_us-gaap_MinorityInterest_1310a7c8-ea03-40c2-94dd-4b96f7f11034" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_14e02ace-5f4b-4a8c-946f-8526e5dc3279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ffa930c4-938f-46c7-86e8-99220e1e28c6" xlink:to="loc_us-gaap_StockholdersEquity_14e02ace-5f4b-4a8c-946f-8526e5dc3279" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c127c7b5-8ba0-4597-8a67-2d42291d6f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_07fad85c-2aa5-406b-8a3f-5edcfd54b957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c127c7b5-8ba0-4597-8a67-2d42291d6f48" xlink:to="loc_us-gaap_AccountsPayableCurrent_07fad85c-2aa5-406b-8a3f-5edcfd54b957" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_62ee2cf1-23f1-4d75-b827-13f860562ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c127c7b5-8ba0-4597-8a67-2d42291d6f48" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_62ee2cf1-23f1-4d75-b827-13f860562ca4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e6276336-ae22-474b-bbbf-aef5ecdaa292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5a8cd5c1-e8d5-4ac3-8e58-fed461e4f1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e6276336-ae22-474b-bbbf-aef5ecdaa292" xlink:to="loc_us-gaap_CommonStockValue_5a8cd5c1-e8d5-4ac3-8e58-fed461e4f1eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4ff01a7c-99da-4293-bd66-199e07aab3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e6276336-ae22-474b-bbbf-aef5ecdaa292" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4ff01a7c-99da-4293-bd66-199e07aab3f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_e9d413b3-6009-447c-a8b0-3c042a62ecae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e6276336-ae22-474b-bbbf-aef5ecdaa292" xlink:to="loc_us-gaap_AdditionalPaidInCapital_e9d413b3-6009-447c-a8b0-3c042a62ecae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_88bb6d76-1ddb-441e-b89a-42607fa3a109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e6276336-ae22-474b-bbbf-aef5ecdaa292" xlink:to="loc_us-gaap_PreferredStockValue_88bb6d76-1ddb-441e-b89a-42607fa3a109" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dea76d36-3163-455a-ad17-b6b870bb1cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e6276336-ae22-474b-bbbf-aef5ecdaa292" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dea76d36-3163-455a-ad17-b6b870bb1cfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d9da1d75-15f6-4e49-b83c-8a4816554f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0be99306-8818-476f-93d7-b4b199b9bcef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d9da1d75-15f6-4e49-b83c-8a4816554f7c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0be99306-8818-476f-93d7-b4b199b9bcef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2c3218ef-986a-406b-97df-064c991a52e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d9da1d75-15f6-4e49-b83c-8a4816554f7c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2c3218ef-986a-406b-97df-064c991a52e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_beacf075-6a85-41e7-8f40-caa1ddf1be04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d9da1d75-15f6-4e49-b83c-8a4816554f7c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_beacf075-6a85-41e7-8f40-caa1ddf1be04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a2ddaec3-3bf2-4854-8664-1e3027ceb8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d9da1d75-15f6-4e49-b83c-8a4816554f7c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a2ddaec3-3bf2-4854-8664-1e3027ceb8dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_48fe4d52-aeed-4f23-8224-ccb4759a9eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d9da1d75-15f6-4e49-b83c-8a4816554f7c" xlink:to="loc_us-gaap_RestrictedCashCurrent_48fe4d52-aeed-4f23-8224-ccb4759a9eb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5360ee2-a852-451c-b21f-80d8c56ee3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f0de106-c335-4093-8859-441b694c1b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5360ee2-a852-451c-b21f-80d8c56ee3c7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f0de106-c335-4093-8859-441b694c1b8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_93913a98-2fec-4eae-827e-0bb27c2958ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5360ee2-a852-451c-b21f-80d8c56ee3c7" xlink:to="loc_us-gaap_CommitmentsAndContingencies_93913a98-2fec-4eae-827e-0bb27c2958ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a17d7c44-cd57-4ad8-ac97-0a1ae449d6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5360ee2-a852-451c-b21f-80d8c56ee3c7" xlink:to="loc_us-gaap_Liabilities_a17d7c44-cd57-4ad8-ac97-0a1ae449d6b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a43f21e7-3c00-4c2f-86bc-d01fe172bb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_fd355331-3aad-4e2a-8f03-2168aeee3c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a43f21e7-3c00-4c2f-86bc-d01fe172bb48" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_fd355331-3aad-4e2a-8f03-2168aeee3c8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b5fd3ca2-a90c-49a0-b417-7657926715bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a43f21e7-3c00-4c2f-86bc-d01fe172bb48" xlink:to="loc_us-gaap_AssetsCurrent_b5fd3ca2-a90c-49a0-b417-7657926715bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_44e73323-91ef-4f02-8f45-f99a49ef1eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a43f21e7-3c00-4c2f-86bc-d01fe172bb48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_44e73323-91ef-4f02-8f45-f99a49ef1eed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_981c30ec-b0f5-4bf1-8c49-1a3e4d1bd0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a43f21e7-3c00-4c2f-86bc-d01fe172bb48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_981c30ec-b0f5-4bf1-8c49-1a3e4d1bd0ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ad9a500a-d7ac-4d66-84dc-10e06a882b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a43f21e7-3c00-4c2f-86bc-d01fe172bb48" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ad9a500a-d7ac-4d66-84dc-10e06a882b7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b6320343-d8f7-46c6-a5bd-d7af52f66672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a43f21e7-3c00-4c2f-86bc-d01fe172bb48" xlink:to="loc_us-gaap_Goodwill_b6320343-d8f7-46c6-a5bd-d7af52f66672" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_b99e6498-40be-451c-923d-4c4964c2af5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a43f21e7-3c00-4c2f-86bc-d01fe172bb48" xlink:to="loc_us-gaap_EquityMethodInvestments_b99e6498-40be-451c-923d-4c4964c2af5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_b5d1f34d-f235-4a4b-921c-09c658649f91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a43f21e7-3c00-4c2f-86bc-d01fe172bb48" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_b5d1f34d-f235-4a4b-921c-09c658649f91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_97fdc9e2-e3f9-47d5-9d2a-893032806d84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_609c0627-1081-48ed-b627-7c39f56289d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_97fdc9e2-e3f9-47d5-9d2a-893032806d84" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_609c0627-1081-48ed-b627-7c39f56289d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d947d248-c067-47bf-9e96-e87c7e4100d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_97fdc9e2-e3f9-47d5-9d2a-893032806d84" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d947d248-c067-47bf-9e96-e87c7e4100d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7fd96fd6-ac9d-43f4-b77a-8fef38a9d22b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_97fdc9e2-e3f9-47d5-9d2a-893032806d84" xlink:to="loc_us-gaap_LiabilitiesCurrent_7fd96fd6-ac9d-43f4-b77a-8fef38a9d22b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="zntl-20210930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_031ad147-b775-4168-8aed-bcfb188e5ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_b959fc6a-cd65-4b5a-9966-3f90800fa6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_031ad147-b775-4168-8aed-bcfb188e5ebb" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_b959fc6a-cd65-4b5a-9966-3f90800fa6bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_67763726-26f8-4cc8-978a-4668bf84db89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_031ad147-b775-4168-8aed-bcfb188e5ebb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_67763726-26f8-4cc8-978a-4668bf84db89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4d17b45c-5d4e-4432-8e85-88ff04f5bfb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_48b4d40d-0913-4adf-be5f-a030f5425bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_4d17b45c-5d4e-4432-8e85-88ff04f5bfb2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_48b4d40d-0913-4adf-be5f-a030f5425bb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec530bcc-5140-480f-a22a-cb045bce9679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_4d17b45c-5d4e-4432-8e85-88ff04f5bfb2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec530bcc-5140-480f-a22a-cb045bce9679" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_099f6307-0028-43ca-8e52-e46d7e297f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_63e5b01b-05ba-4c79-8f22-df9924b7715f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_099f6307-0028-43ca-8e52-e46d7e297f8f" xlink:to="loc_us-gaap_InvestmentIncomeInterest_63e5b01b-05ba-4c79-8f22-df9924b7715f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_d01b18f9-f01b-4030-9fa1-9338342ef48f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_099f6307-0028-43ca-8e52-e46d7e297f8f" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_d01b18f9-f01b-4030-9fa1-9338342ef48f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_47e86213-0a53-40b1-bceb-005358a7224a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_099f6307-0028-43ca-8e52-e46d7e297f8f" xlink:to="loc_us-gaap_OperatingIncomeLoss_47e86213-0a53-40b1-bceb-005358a7224a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_adcb6669-e683-4bf1-a2ab-7b74316a9a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_5dbd33f6-e87e-4a96-9f9f-9ba50fe4c9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_adcb6669-e683-4bf1-a2ab-7b74316a9a2b" xlink:to="loc_us-gaap_OperatingExpenses_5dbd33f6-e87e-4a96-9f9f-9ba50fe4c9e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_30a0221c-3685-4147-8fd2-da1fe4097c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_32b2b5fb-1fe0-4723-8c7a-d08667d470d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_30a0221c-3685-4147-8fd2-da1fe4097c28" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_32b2b5fb-1fe0-4723-8c7a-d08667d470d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_98138e47-d391-4d0e-b15e-bfe38f6914c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_30a0221c-3685-4147-8fd2-da1fe4097c28" xlink:to="loc_us-gaap_ProfitLoss_98138e47-d391-4d0e-b15e-bfe38f6914c0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="zntl-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2f54c493-2044-48cc-99b7-2a5ab942c0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_4e17ac92-bea3-44a7-a0c2-a73485376e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2f54c493-2044-48cc-99b7-2a5ab942c0f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_4e17ac92-bea3-44a7-a0c2-a73485376e09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1f6b49d1-1d5d-4ffd-896a-d5f2cab8918b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2f54c493-2044-48cc-99b7-2a5ab942c0f0" xlink:to="loc_us-gaap_ProfitLoss_1f6b49d1-1d5d-4ffd-896a-d5f2cab8918b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_445a1ed5-2c8d-4d3e-bad8-5ccc2094f773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2f54c493-2044-48cc-99b7-2a5ab942c0f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_445a1ed5-2c8d-4d3e-bad8-5ccc2094f773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_dcc84ab4-a7d6-438c-aac6-da144ea58520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_9cdefbef-a6f5-4910-83f5-12e5395af092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_dcc84ab4-a7d6-438c-aac6-da144ea58520" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_9cdefbef-a6f5-4910-83f5-12e5395af092" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e5ad43ae-f5e0-42f8-8791-ec114a115086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_dcc84ab4-a7d6-438c-aac6-da144ea58520" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e5ad43ae-f5e0-42f8-8791-ec114a115086" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="zntl-20210930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2490c22b-7ae3-47f1-98fa-2202297b2703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cb02406-14fa-465d-b8be-7d310ff6ac4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2490c22b-7ae3-47f1-98fa-2202297b2703" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cb02406-14fa-465d-b8be-7d310ff6ac4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_469c17a8-dfb6-4ee1-bbfd-7776a4a9f028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2490c22b-7ae3-47f1-98fa-2202297b2703" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_469c17a8-dfb6-4ee1-bbfd-7776a4a9f028" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82ed6b38-af52-4a1f-848c-33b820ceccec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2490c22b-7ae3-47f1-98fa-2202297b2703" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82ed6b38-af52-4a1f-848c-33b820ceccec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79e88a41-9975-48b2-b054-550394e9bc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation_642c316e-9da8-408b-a4bc-0ba0e53117b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79e88a41-9975-48b2-b054-550394e9bc4b" xlink:to="loc_us-gaap_CashDivestedFromDeconsolidation_642c316e-9da8-408b-a4bc-0ba0e53117b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_38f2391d-cebb-4e56-bb5a-9058a2ecbf37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79e88a41-9975-48b2-b054-550394e9bc4b" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_38f2391d-cebb-4e56-bb5a-9058a2ecbf37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bb2310a3-f122-41c8-bf68-112c8901e695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79e88a41-9975-48b2-b054-550394e9bc4b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bb2310a3-f122-41c8-bf68-112c8901e695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_0da62e43-a900-4524-b120-4afff2d5b386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79e88a41-9975-48b2-b054-550394e9bc4b" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_0da62e43-a900-4524-b120-4afff2d5b386" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e4eed2-ec27-477b-923a-e9dee15ff951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_RecognizedTaxGainOnIntangibleAssetImpairment_117a7504-04a4-4495-ae3a-4ac1a7ca1e4e" xlink:href="zntl-20210930.xsd#zntl_RecognizedTaxGainOnIntangibleAssetImpairment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e4eed2-ec27-477b-923a-e9dee15ff951" xlink:to="loc_zntl_RecognizedTaxGainOnIntangibleAssetImpairment_117a7504-04a4-4495-ae3a-4ac1a7ca1e4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_75e0bda4-0e45-4e0c-99d0-ed7b4081027e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e4eed2-ec27-477b-923a-e9dee15ff951" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_75e0bda4-0e45-4e0c-99d0-ed7b4081027e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_89cc9e50-8790-4451-b9eb-a1922f992279" xlink:href="zntl-20210930.xsd#zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e4eed2-ec27-477b-923a-e9dee15ff951" xlink:to="loc_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_89cc9e50-8790-4451-b9eb-a1922f992279" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_95b30cb8-77c8-4a74-85f0-c495f6808457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e4eed2-ec27-477b-923a-e9dee15ff951" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_95b30cb8-77c8-4a74-85f0-c495f6808457" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_22d6129f-41c7-4d06-9ea9-e8552e452a39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e4eed2-ec27-477b-923a-e9dee15ff951" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_22d6129f-41c7-4d06-9ea9-e8552e452a39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6dd336ce-00a8-41c1-b304-c9cfeaac60b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e4eed2-ec27-477b-923a-e9dee15ff951" xlink:to="loc_us-gaap_ProfitLoss_6dd336ce-00a8-41c1-b304-c9cfeaac60b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_DeconsolidationGainLossAmountNet_f67040ec-14b4-4563-a201-4200a9dade41" xlink:href="zntl-20210930.xsd#zntl_DeconsolidationGainLossAmountNet"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e4eed2-ec27-477b-923a-e9dee15ff951" xlink:to="loc_zntl_DeconsolidationGainLossAmountNet_f67040ec-14b4-4563-a201-4200a9dade41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4bd4600e-e89f-40ef-b1b1-299790333daa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e4eed2-ec27-477b-923a-e9dee15ff951" xlink:to="loc_us-gaap_ShareBasedCompensation_4bd4600e-e89f-40ef-b1b1-299790333daa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_494122cc-49f0-4654-bcfb-e4b212f62535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e4eed2-ec27-477b-923a-e9dee15ff951" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_494122cc-49f0-4654-bcfb-e4b212f62535" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_a82b9d1a-176a-4229-9ef1-b9a38584ccb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e4eed2-ec27-477b-923a-e9dee15ff951" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_a82b9d1a-176a-4229-9ef1-b9a38584ccb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_055fa91b-9883-43bb-9551-1975450812d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e4eed2-ec27-477b-923a-e9dee15ff951" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_055fa91b-9883-43bb-9551-1975450812d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fac9dfeb-6abd-45de-a97e-2b148171e2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0e4eed2-ec27-477b-923a-e9dee15ff951" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fac9dfeb-6abd-45de-a97e-2b148171e2a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bda1630c-871a-4dbf-812b-ae9759643059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_f90c3904-fcbd-4e13-8a80-60d24570f412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bda1630c-871a-4dbf-812b-ae9759643059" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_f90c3904-fcbd-4e13-8a80-60d24570f412" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_0d2b449a-2ae8-4168-a66b-f4bf50c9c6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bda1630c-871a-4dbf-812b-ae9759643059" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_0d2b449a-2ae8-4168-a66b-f4bf50c9c6bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_290e22dc-10c7-4c20-a72c-c88d7845f8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bda1630c-871a-4dbf-812b-ae9759643059" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_290e22dc-10c7-4c20-a72c-c88d7845f8ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_3518e4e0-c552-49b7-9d31-20325db7f4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bda1630c-871a-4dbf-812b-ae9759643059" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_3518e4e0-c552-49b7-9d31-20325db7f4ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e4a1fa1a-393d-4cb3-8612-27d1ed1c58d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bda1630c-871a-4dbf-812b-ae9759643059" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e4a1fa1a-393d-4cb3-8612-27d1ed1c58d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_718d80c2-cbff-46f3-8a5b-4828403f5fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6f8d166c-004c-476b-b443-9f0d615b2ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_718d80c2-cbff-46f3-8a5b-4828403f5fe0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6f8d166c-004c-476b-b443-9f0d615b2ab5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_68be7b67-7d4c-41f0-994f-9a3833f65b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_718d80c2-cbff-46f3-8a5b-4828403f5fe0" xlink:to="loc_us-gaap_RestrictedCash_68be7b67-7d4c-41f0-994f-9a3833f65b76" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d06aa1aa-3aa5-4707-90ac-5d1555c0bff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4838d039-6870-4b40-832b-826407709084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d06aa1aa-3aa5-4707-90ac-5d1555c0bff1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4838d039-6870-4b40-832b-826407709084" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_729698e7-98f3-4d75-a2fa-a49d11ff3d96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d06aa1aa-3aa5-4707-90ac-5d1555c0bff1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_729698e7-98f3-4d75-a2fa-a49d11ff3d96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b005a89d-71ef-43e9-ac7b-d7e4621c3828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d06aa1aa-3aa5-4707-90ac-5d1555c0bff1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b005a89d-71ef-43e9-ac7b-d7e4621c3828" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.zentalis.com/role/FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_5dda4117-ba20-4ddf-a8ce-aa0c4288a1df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_b3d9dc40-78f6-4f84-acaf-2ec2b867591a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_5dda4117-ba20-4ddf-a8ce-aa0c4288a1df" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_b3d9dc40-78f6-4f84-acaf-2ec2b867591a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_0d826087-2424-482f-8370-95a40a8f1ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_5dda4117-ba20-4ddf-a8ce-aa0c4288a1df" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_0d826087-2424-482f-8370-95a40a8f1ab4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_108a5f62-e90a-4ba1-9a74-79ff0036771b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7be17ec3-eab7-468d-90ab-eb23682bb961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_108a5f62-e90a-4ba1-9a74-79ff0036771b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7be17ec3-eab7-468d-90ab-eb23682bb961" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_22c4665e-1ec3-4700-945b-ca7657d556c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_108a5f62-e90a-4ba1-9a74-79ff0036771b" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_22c4665e-1ec3-4700-945b-ca7657d556c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#PrepaidExpensesandOtherAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_65b969fe-24fa-419f-b1f9-c185a6e49770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_a263b2b0-660e-4f6b-862f-b9c05f9bf8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_65b969fe-24fa-419f-b1f9-c185a6e49770" xlink:to="loc_us-gaap_InterestReceivable_a263b2b0-660e-4f6b-862f-b9c05f9bf8e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_OtherPrepaidExpense_3af174b2-5fb3-434a-a422-7a64a44f0f1e" xlink:href="zntl-20210930.xsd#zntl_OtherPrepaidExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_65b969fe-24fa-419f-b1f9-c185a6e49770" xlink:to="loc_zntl_OtherPrepaidExpense_3af174b2-5fb3-434a-a422-7a64a44f0f1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_PrepaidResearchAndDevelopmentCosts_41cee6ec-e3e1-4535-881e-bfe4c6aa55ce" xlink:href="zntl-20210930.xsd#zntl_PrepaidResearchAndDevelopmentCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_65b969fe-24fa-419f-b1f9-c185a6e49770" xlink:to="loc_zntl_PrepaidResearchAndDevelopmentCosts_41cee6ec-e3e1-4535-881e-bfe4c6aa55ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_bf39c7c7-a2fc-476a-9e0e-23abd47a34e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_65b969fe-24fa-419f-b1f9-c185a6e49770" xlink:to="loc_us-gaap_PrepaidInsurance_bf39c7c7-a2fc-476a-9e0e-23abd47a34e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_0daf4d6b-6e70-4782-a7f8-b3986a8786ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_65b969fe-24fa-419f-b1f9-c185a6e49770" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_0daf4d6b-6e70-4782-a7f8-b3986a8786ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_PrepaidSoftwareLicenseAndMaintenance_21094984-ab86-4f3a-8b49-1400677295a2" xlink:href="zntl-20210930.xsd#zntl_PrepaidSoftwareLicenseAndMaintenance"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_65b969fe-24fa-419f-b1f9-c185a6e49770" xlink:to="loc_zntl_PrepaidSoftwareLicenseAndMaintenance_21094984-ab86-4f3a-8b49-1400677295a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ForeignResearchAndDevelopmentCreditRefund_432afcf1-eeea-41ca-b318-c9dabadce044" xlink:href="zntl-20210930.xsd#zntl_ForeignResearchAndDevelopmentCreditRefund"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_65b969fe-24fa-419f-b1f9-c185a6e49770" xlink:to="loc_zntl_ForeignResearchAndDevelopmentCreditRefund_432afcf1-eeea-41ca-b318-c9dabadce044" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails_1" xlink:type="simple" xlink:href="zntl-20210930.xsd#PrepaidExpensesandOtherAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_9e94c3c4-31ec-484b-b332-0030d09a1e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d6ea842d-991e-4029-8a42-59c28bf4c39a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_9e94c3c4-31ec-484b-b332-0030d09a1e47" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d6ea842d-991e-4029-8a42-59c28bf4c39a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_27f99074-bb28-414b-ab6a-4e93f4b9c591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_9e94c3c4-31ec-484b-b332-0030d09a1e47" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_27f99074-bb28-414b-ab6a-4e93f4b9c591" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#PropertyandEquipmentnetSummaryDetails"/>
  <link:calculationLink xlink:role="http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_07abb8a9-ff00-4e55-bbbc-7172ab53ea0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f873c8e9-feba-4d14-81c7-43a10dde8175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_07abb8a9-ff00-4e55-bbbc-7172ab53ea0d" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f873c8e9-feba-4d14-81c7-43a10dde8175" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4e1ae089-bdf2-4872-8cc6-97305bb21ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_07abb8a9-ff00-4e55-bbbc-7172ab53ea0d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_4e1ae089-bdf2-4872-8cc6-97305bb21ff1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#AccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.zentalis.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_261eff0d-d896-4559-8090-2dbed264c04d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_685ce39e-3f3c-4075-b263-1df546153906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_261eff0d-d896-4559-8090-2dbed264c04d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_685ce39e-3f3c-4075-b263-1df546153906" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_6f1ab1dd-b77e-4df0-9608-4a0957b5b990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_261eff0d-d896-4559-8090-2dbed264c04d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_6f1ab1dd-b77e-4df0-9608-4a0957b5b990" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_AccruedGeneralAndAdministrativeCostsCurrent_d486d993-fabb-48b4-9e01-28e02ff36484" xlink:href="zntl-20210930.xsd#zntl_AccruedGeneralAndAdministrativeCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_261eff0d-d896-4559-8090-2dbed264c04d" xlink:to="loc_zntl_AccruedGeneralAndAdministrativeCostsCurrent_d486d993-fabb-48b4-9e01-28e02ff36484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_07511381-d18c-4664-9bd9-76cde5530bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_261eff0d-d896-4559-8090-2dbed264c04d" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_07511381-d18c-4664-9bd9-76cde5530bc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_d2b2d31a-f0f7-424e-9bda-efd87eca7638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_261eff0d-d896-4559-8090-2dbed264c04d" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_d2b2d31a-f0f7-424e-9bda-efd87eca7638" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_AccruedResearchAndDevelopmentCostsCurrent_af4988c4-1d57-409a-a0ec-89ba7485ea74" xlink:href="zntl-20210930.xsd#zntl_AccruedResearchAndDevelopmentCostsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_261eff0d-d896-4559-8090-2dbed264c04d" xlink:to="loc_zntl_AccruedResearchAndDevelopmentCostsCurrent_af4988c4-1d57-409a-a0ec-89ba7485ea74" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#CommitmentandContingenciesFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cbf7c416-38ae-4d82-b4d9-d5a7ab4489a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5f036d3b-6e26-4685-a0fa-d9c6c0c8a3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cbf7c416-38ae-4d82-b4d9-d5a7ab4489a0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5f036d3b-6e26-4685-a0fa-d9c6c0c8a3f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_cdac9de9-71c4-4280-a5ed-39699bb61408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cbf7c416-38ae-4d82-b4d9-d5a7ab4489a0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_cdac9de9-71c4-4280-a5ed-39699bb61408" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="zntl-20210930.xsd#CommitmentandContingenciesFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecc028a3-eae3-4b1c-9867-1ac9f690d6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_57464279-8df6-4bb2-a8f0-f9e0ed777734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecc028a3-eae3-4b1c-9867-1ac9f690d6c7" xlink:to="loc_us-gaap_OperatingLeaseLiability_57464279-8df6-4bb2-a8f0-f9e0ed777734" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a2252841-5f06-48df-89be-cbe18d2ac613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecc028a3-eae3-4b1c-9867-1ac9f690d6c7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a2252841-5f06-48df-89be-cbe18d2ac613" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>zntl-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:ec330f09-1704-42bb-8fbc-efe747c127bc,g:cceb589a-52db-4380-936c-762192d75fd3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits" xlink:type="simple" xlink:href="zntl-20210930.xsd#CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits" xlink:type="extended" id="i11ff57eb3f6542a384d7e53b32319390_CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9e0e87c3-2412-4b3c-9346-a0fad6a87b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e0e87c3-2412-4b3c-9346-a0fad6a87b40" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1c046e35-8c6a-4dd6-837b-7528cd8a686e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1c046e35-8c6a-4dd6-837b-7528cd8a686e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_a531c0fb-34cb-4089-b6d3-57cc3390573e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_a531c0fb-34cb-4089-b6d3-57cc3390573e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_d780d11c-50e9-42b4-ac84-e3ff7f2911a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_d780d11c-50e9-42b4-ac84-e3ff7f2911a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_dc1100bf-3dbe-4c28-bc08-a99d4aaff6c1" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:to="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_dc1100bf-3dbe-4c28-bc08-a99d4aaff6c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_4b1c2233-4f8f-4593-96f0-92408aa7b909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_4b1c2233-4f8f-4593-96f0-92408aa7b909" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits_c4c24407-9c46-443d-be7a-e872770775bf" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:to="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits_c4c24407-9c46-443d-be7a-e872770775bf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_fe8a1d02-a2f8-4386-9ddb-33f6b862183e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_983bc818-3a6b-4c90-953f-f280b96a81f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9e0e87c3-2412-4b3c-9346-a0fad6a87b40" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_6a44f39c-f9da-4a09-ac38-ce6ffcf6e3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_SharesIssued_6a44f39c-f9da-4a09-ac38-ce6ffcf6e3fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_683b9b6b-7389-4a25-90e1-8f5d5d7c3390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_683b9b6b-7389-4a25-90e1-8f5d5d7c3390" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonUnitOutstanding_b7a387e5-4fec-420f-a4a7-907cdebaa545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonUnitOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_CommonUnitOutstanding_b7a387e5-4fec-420f-a4a7-907cdebaa545" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonUnitIssuanceValue_addc2d71-e40c-4c8e-98e4-63a339906f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonUnitIssuanceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_CommonUnitIssuanceValue_addc2d71-e40c-4c8e-98e4-63a339906f3f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fdb1e2a8-73cd-4b0b-b613-8129af0ee12a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fdb1e2a8-73cd-4b0b-b613-8129af0ee12a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3e39d8de-49f6-4b73-af83-548f33a09685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3e39d8de-49f6-4b73-af83-548f33a09685" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_8d85ec09-a542-4290-899b-7dc64729e256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_8d85ec09-a542-4290-899b-7dc64729e256" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_a31dafdd-4c99-4b5a-b5ce-018a31fdbc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_a31dafdd-4c99-4b5a-b5ce-018a31fdbc7a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5bb03ded-be0f-4195-bffe-36dc34871b72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5bb03ded-be0f-4195-bffe-36dc34871b72" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_016f08d6-2364-441d-ae18-ac77610767d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_016f08d6-2364-441d-ae18-ac77610767d4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_72e3e8a4-6aad-4342-a0a8-10d4a8e04650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_72e3e8a4-6aad-4342-a0a8-10d4a8e04650" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_b560d434-f549-4ae5-9e39-33f5f21caac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_b560d434-f549-4ae5-9e39-33f5f21caac0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_StockCancelledDuringPeriodShares_89c35c0f-0e4f-41c8-948b-bfd7034f11d0" xlink:href="zntl-20210930.xsd#zntl_StockCancelledDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_zntl_StockCancelledDuringPeriodShares_89c35c0f-0e4f-41c8-948b-bfd7034f11d0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_c67041c1-ec33-4fc2-a0df-70119a7446c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_c67041c1-ec33-4fc2-a0df-70119a7446c7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0de380d8-1965-4447-b7c5-2db47566bade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0de380d8-1965-4447-b7c5-2db47566bade" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d137c6a6-f8fd-45db-9b86-f05af6b6f469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d137c6a6-f8fd-45db-9b86-f05af6b6f469" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_cd8173a9-f356-4699-bd35-9a383e421435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_cd8173a9-f356-4699-bd35-9a383e421435" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits_b4be27bc-cd2d-4c40-8c76-c6d3af001743" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_a23ce0f4-69bc-4206-8776-139f6aa74931" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_6839721c-951a-4902-a41d-910c3ac7980b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_6839721c-951a-4902-a41d-910c3ac7980b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_b2d62639-e444-4adc-82f5-759f994d777c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_b2d62639-e444-4adc-82f5-759f994d777c" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f0c112fe-ba8c-48bb-a759-a127ca86bcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f0c112fe-ba8c-48bb-a759-a127ca86bcc1" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_241609c5-fb2b-4765-97bd-afdc14234d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_NetIncomeLoss_241609c5-fb2b-4765-97bd-afdc14234d82" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonUnitOutstanding_ec3a48c2-507e-4f3d-a475-870790c9ad64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonUnitOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonUnitIssuanceValue_f7f9c41f-c41e-42cf-abb3-979f2fd30657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonUnitIssuanceValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_3270e6b8-5853-4596-878d-eb34ca89b792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_02d43fd8-84ed-409b-91fd-fb9318cefae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_126c4bf3-a815-4657-aafb-fa8767e2b3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9e0e87c3-2412-4b3c-9346-a0fad6a87b40" xlink:to="loc_us-gaap_StatementTable_126c4bf3-a815-4657-aafb-fa8767e2b3f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b712b48c-bb05-4368-824e-771675477e68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_126c4bf3-a815-4657-aafb-fa8767e2b3f3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b712b48c-bb05-4368-824e-771675477e68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b712b48c-bb05-4368-824e-771675477e68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b712b48c-bb05-4368-824e-771675477e68" xlink:to="loc_us-gaap_EquityComponentDomain_b712b48c-bb05-4368-824e-771675477e68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f9734fc1-a87d-4cf8-8d60-fdb4281e6c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b712b48c-bb05-4368-824e-771675477e68" xlink:to="loc_us-gaap_EquityComponentDomain_f9734fc1-a87d-4cf8-8d60-fdb4281e6c73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f92e9b6e-fdb2-458b-ac62-b79966489e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f9734fc1-a87d-4cf8-8d60-fdb4281e6c73" xlink:to="loc_us-gaap_CommonStockMember_f92e9b6e-fdb2-458b-ac62-b79966489e11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e2ea2db8-64c3-487e-922e-ecf8ba925d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f9734fc1-a87d-4cf8-8d60-fdb4281e6c73" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e2ea2db8-64c3-487e-922e-ecf8ba925d5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5a111342-02b7-45ae-852b-5f8a440415f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f9734fc1-a87d-4cf8-8d60-fdb4281e6c73" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5a111342-02b7-45ae-852b-5f8a440415f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1ab5df49-1cd0-4260-bf03-12f9a8b8a581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f9734fc1-a87d-4cf8-8d60-fdb4281e6c73" xlink:to="loc_us-gaap_RetainedEarningsMember_1ab5df49-1cd0-4260-bf03-12f9a8b8a581" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_bf534b37-8575-415f-b1f5-1d2925a65744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f9734fc1-a87d-4cf8-8d60-fdb4281e6c73" xlink:to="loc_us-gaap_NoncontrollingInterestMember_bf534b37-8575-415f-b1f5-1d2925a65744" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_92986e1b-a73b-4b42-b2f8-fdd307cb49a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_126c4bf3-a815-4657-aafb-fa8767e2b3f3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_92986e1b-a73b-4b42-b2f8-fdd307cb49a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_92986e1b-a73b-4b42-b2f8-fdd307cb49a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_92986e1b-a73b-4b42-b2f8-fdd307cb49a3" xlink:to="loc_us-gaap_ClassOfStockDomain_92986e1b-a73b-4b42-b2f8-fdd307cb49a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_373159a3-83a0-48ff-aa0f-e22c12548e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_92986e1b-a73b-4b42-b2f8-fdd307cb49a3" xlink:to="loc_us-gaap_ClassOfStockDomain_373159a3-83a0-48ff-aa0f-e22c12548e71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_4eacb28a-a0ec-49dc-bdd1-df37a62386e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_373159a3-83a0-48ff-aa0f-e22c12548e71" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_4eacb28a-a0ec-49dc-bdd1-df37a62386e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_df75901f-8d08-4572-91ef-f876c39cc39c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_373159a3-83a0-48ff-aa0f-e22c12548e71" xlink:to="loc_us-gaap_CommonClassAMember_df75901f-8d08-4572-91ef-f876c39cc39c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_cb0a115d-9a1d-4ea9-956e-c3cb59729c03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_373159a3-83a0-48ff-aa0f-e22c12548e71" xlink:to="loc_us-gaap_CommonClassBMember_cb0a115d-9a1d-4ea9-956e-c3cb59729c03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_bee68fcf-8c32-43b9-ab24-90449e5eac7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_126c4bf3-a815-4657-aafb-fa8767e2b3f3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_bee68fcf-8c32-43b9-ab24-90449e5eac7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bee68fcf-8c32-43b9-ab24-90449e5eac7b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_bee68fcf-8c32-43b9-ab24-90449e5eac7b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bee68fcf-8c32-43b9-ab24-90449e5eac7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_be9c2b7d-60f1-4dec-9f55-7617d12a7a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_bee68fcf-8c32-43b9-ab24-90449e5eac7b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_be9c2b7d-60f1-4dec-9f55-7617d12a7a8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_1079219b-28b5-430d-9829-fa6ec4aebd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_be9c2b7d-60f1-4dec-9f55-7617d12a7a8a" xlink:to="loc_us-gaap_IPOMember_1079219b-28b5-430d-9829-fa6ec4aebd2c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical" xlink:type="simple" xlink:href="zntl-20210930.xsd#CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical" xlink:type="extended" id="i27a9bd0d4099422ba7431d6ad6300dab_CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_655b616b-7b86-46d6-84d6-b9215eb33347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_8544d031-e79f-498b-addd-eecaad573c70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_655b616b-7b86-46d6-84d6-b9215eb33347" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_8544d031-e79f-498b-addd-eecaad573c70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_7261a2be-2659-4985-9636-bfa88d87e471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_655b616b-7b86-46d6-84d6-b9215eb33347" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_7261a2be-2659-4985-9636-bfa88d87e471" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_21b88d93-ac1a-4cd8-908a-f93275de7f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_655b616b-7b86-46d6-84d6-b9215eb33347" xlink:to="loc_us-gaap_StatementTable_21b88d93-ac1a-4cd8-908a-f93275de7f1c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d2dd2ff5-7f74-447c-9e38-750e8b3d3f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_21b88d93-ac1a-4cd8-908a-f93275de7f1c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d2dd2ff5-7f74-447c-9e38-750e8b3d3f6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d2dd2ff5-7f74-447c-9e38-750e8b3d3f6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d2dd2ff5-7f74-447c-9e38-750e8b3d3f6b" xlink:to="loc_us-gaap_ClassOfStockDomain_d2dd2ff5-7f74-447c-9e38-750e8b3d3f6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3507bd57-c0d4-41b9-bcac-5325a571c395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d2dd2ff5-7f74-447c-9e38-750e8b3d3f6b" xlink:to="loc_us-gaap_ClassOfStockDomain_3507bd57-c0d4-41b9-bcac-5325a571c395" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_c15476eb-cc04-4fab-993f-6fe266e930d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3507bd57-c0d4-41b9-bcac-5325a571c395" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_c15476eb-cc04-4fab-993f-6fe266e930d3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/OrganizationandBusinessDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#OrganizationandBusinessDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/OrganizationandBusinessDetails" xlink:type="extended" id="i78dc007c613f4f258c1a2e41a755f65e_OrganizationandBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_CommonStockConversionRatio_ec33688c-7f7a-4c0f-86b7-2511c056f63c" xlink:href="zntl-20210930.xsd#zntl_CommonStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:to="loc_zntl_CommonStockConversionRatio_ec33688c-7f7a-4c0f-86b7-2511c056f63c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_036e5dfb-8fd6-457f-bd95-08cc67f49585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_036e5dfb-8fd6-457f-bd95-08cc67f49585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_46d14fea-b9b8-4755-b384-51bced6b8cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_46d14fea-b9b8-4755-b384-51bced6b8cf7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ed00cac8-b89a-4ca5-8d5f-69be7a9c78c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ed00cac8-b89a-4ca5-8d5f-69be7a9c78c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_33293067-d1d5-492a-9e34-9a53ccf33453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_33293067-d1d5-492a-9e34-9a53ccf33453" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_4ae391bf-8f75-4e67-80a4-cbd0c1c4d734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_4ae391bf-8f75-4e67-80a4-cbd0c1c4d734" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ca22658a-9f49-4765-9180-59f487c8955e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ca22658a-9f49-4765-9180-59f487c8955e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_130d2350-8220-440c-b531-8851a813b128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ca22658a-9f49-4765-9180-59f487c8955e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_130d2350-8220-440c-b531-8851a813b128" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_130d2350-8220-440c-b531-8851a813b128_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_130d2350-8220-440c-b531-8851a813b128" xlink:to="loc_us-gaap_ClassOfStockDomain_130d2350-8220-440c-b531-8851a813b128_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_595fa29e-82ee-4c61-8d34-9c06802ab962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_130d2350-8220-440c-b531-8851a813b128" xlink:to="loc_us-gaap_ClassOfStockDomain_595fa29e-82ee-4c61-8d34-9c06802ab962" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_46ee4c6d-c663-4e7d-ad3b-6da3751b01ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_595fa29e-82ee-4c61-8d34-9c06802ab962" xlink:to="loc_us-gaap_CommonStockMember_46ee4c6d-c663-4e7d-ad3b-6da3751b01ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_00444ccf-e9eb-4461-8d16-615e1ca77282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_595fa29e-82ee-4c61-8d34-9c06802ab962" xlink:to="loc_us-gaap_RestrictedStockMember_00444ccf-e9eb-4461-8d16-615e1ca77282" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_fedc1571-6945-4dca-a89f-a668525fe3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ca22658a-9f49-4765-9180-59f487c8955e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_fedc1571-6945-4dca-a89f-a668525fe3fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fedc1571-6945-4dca-a89f-a668525fe3fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fedc1571-6945-4dca-a89f-a668525fe3fb" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fedc1571-6945-4dca-a89f-a668525fe3fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3bfc0ccd-a27f-403c-9538-3ed27899ddd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fedc1571-6945-4dca-a89f-a668525fe3fb" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3bfc0ccd-a27f-403c-9538-3ed27899ddd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_e6f0fd92-22e6-4a95-9e69-3cd5554ea3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3bfc0ccd-a27f-403c-9538-3ed27899ddd1" xlink:to="loc_us-gaap_IPOMember_e6f0fd92-22e6-4a95-9e69-3cd5554ea3be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_906f3133-58db-477c-ab38-d9ab6486366c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3bfc0ccd-a27f-403c-9538-3ed27899ddd1" xlink:to="loc_us-gaap_OverAllotmentOptionMember_906f3133-58db-477c-ab38-d9ab6486366c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/SignificantTransactionsDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#SignificantTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/SignificantTransactionsDetails" xlink:type="extended" id="i206abf9e7afb42fa8f863ccda3593f0c_SignificantTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1e733741-36e1-4635-8c36-e46991ea8860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_2abc7f58-2f3b-4b7b-b6cc-cdb1ddd62918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1e733741-36e1-4635-8c36-e46991ea8860" xlink:to="loc_us-gaap_EquityMethodInvestments_2abc7f58-2f3b-4b7b-b6cc-cdb1ddd62918" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_78cc7815-f0c1-4489-9d00-8721546a9fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1e733741-36e1-4635-8c36-e46991ea8860" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_78cc7815-f0c1-4489-9d00-8721546a9fa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_1c138684-7f16-480f-8eaa-f954ac7d0c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1e733741-36e1-4635-8c36-e46991ea8860" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_1c138684-7f16-480f-8eaa-f954ac7d0c5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ResearchAndDevelopmentExpenseReimbursements_5ee22028-06ef-478b-96fa-4eea743f08dc" xlink:href="zntl-20210930.xsd#zntl_ResearchAndDevelopmentExpenseReimbursements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1e733741-36e1-4635-8c36-e46991ea8860" xlink:to="loc_zntl_ResearchAndDevelopmentExpenseReimbursements_5ee22028-06ef-478b-96fa-4eea743f08dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8b7be6d5-fc7a-483d-b33c-3c41f8809748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1e733741-36e1-4635-8c36-e46991ea8860" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8b7be6d5-fc7a-483d-b33c-3c41f8809748" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5ab588df-e195-40f8-9cfd-832d5fbef2f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8b7be6d5-fc7a-483d-b33c-3c41f8809748" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5ab588df-e195-40f8-9cfd-832d5fbef2f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5ab588df-e195-40f8-9cfd-832d5fbef2f5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5ab588df-e195-40f8-9cfd-832d5fbef2f5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5ab588df-e195-40f8-9cfd-832d5fbef2f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8982ea65-e097-4bda-b573-6c7c3ce7b2af" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5ab588df-e195-40f8-9cfd-832d5fbef2f5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8982ea65-e097-4bda-b573-6c7c3ce7b2af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ZenteraTherapeuticsLtdMember_4af4b9b3-e638-4091-9f8c-742e16dabecb" xlink:href="zntl-20210930.xsd#zntl_ZenteraTherapeuticsLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8982ea65-e097-4bda-b573-6c7c3ce7b2af" xlink:to="loc_zntl_ZenteraTherapeuticsLtdMember_4af4b9b3-e638-4091-9f8c-742e16dabecb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended" id="iad959bcba96c4b40b2b5922a6096b2a5_BusinessCombinationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_9af627bd-b9f3-4387-8ecd-da6eb4cd2363" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2235a9a7-8715-4db2-942f-dfc5ecfc8431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_9af627bd-b9f3-4387-8ecd-da6eb4cd2363" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2235a9a7-8715-4db2-942f-dfc5ecfc8431" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_23f0d9b0-323d-4ae8-8cab-f8234a4e9a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_9af627bd-b9f3-4387-8ecd-da6eb4cd2363" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_23f0d9b0-323d-4ae8-8cab-f8234a4e9a46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_ba8a1fec-acd5-427d-a63d-2aace764d253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_9af627bd-b9f3-4387-8ecd-da6eb4cd2363" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_ba8a1fec-acd5-427d-a63d-2aace764d253" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_24e1d26e-e0cd-441c-8f91-a526497940bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_9af627bd-b9f3-4387-8ecd-da6eb4cd2363" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_24e1d26e-e0cd-441c-8f91-a526497940bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_f2924cf2-5cbc-41ec-b0fe-80e27e4077f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_9af627bd-b9f3-4387-8ecd-da6eb4cd2363" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_f2924cf2-5cbc-41ec-b0fe-80e27e4077f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aecd78-bb51-462f-9233-ed85a252805e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_9af627bd-b9f3-4387-8ecd-da6eb4cd2363" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aecd78-bb51-462f-9233-ed85a252805e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bfa2395e-e4d3-4944-91e3-03bda6798fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aecd78-bb51-462f-9233-ed85a252805e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bfa2395e-e4d3-4944-91e3-03bda6798fe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bfa2395e-e4d3-4944-91e3-03bda6798fe2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bfa2395e-e4d3-4944-91e3-03bda6798fe2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bfa2395e-e4d3-4944-91e3-03bda6798fe2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cf7398a4-4697-4739-86fb-c79670feb197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bfa2395e-e4d3-4944-91e3-03bda6798fe2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cf7398a4-4697-4739-86fb-c79670feb197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_KalyraPharmaceuticalsIncMember_2226ea5d-7f9a-4eb0-a639-dd4c85fb879f" xlink:href="zntl-20210930.xsd#zntl_KalyraPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cf7398a4-4697-4739-86fb-c79670feb197" xlink:to="loc_zntl_KalyraPharmaceuticalsIncMember_2226ea5d-7f9a-4eb0-a639-dd4c85fb879f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_dc51ca87-71a4-4a69-8d42-b32e64166c84" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aecd78-bb51-462f-9233-ed85a252805e" xlink:to="loc_srt_ConsolidatedEntitiesAxis_dc51ca87-71a4-4a69-8d42-b32e64166c84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_dc51ca87-71a4-4a69-8d42-b32e64166c84_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_dc51ca87-71a4-4a69-8d42-b32e64166c84" xlink:to="loc_srt_ConsolidatedEntitiesDomain_dc51ca87-71a4-4a69-8d42-b32e64166c84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_fd10cf01-05a7-466b-8a5c-dc306bc4ec03" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_dc51ca87-71a4-4a69-8d42-b32e64166c84" xlink:to="loc_srt_ConsolidatedEntitiesDomain_fd10cf01-05a7-466b-8a5c-dc306bc4ec03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_67916c5e-4b04-44c7-b0bc-2d2f7a8ef48e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_fd10cf01-05a7-466b-8a5c-dc306bc4ec03" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_67916c5e-4b04-44c7-b0bc-2d2f7a8ef48e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e591b8f0-01d5-4d20-adcb-dae8b7ba70b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aecd78-bb51-462f-9233-ed85a252805e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e591b8f0-01d5-4d20-adcb-dae8b7ba70b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e591b8f0-01d5-4d20-adcb-dae8b7ba70b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e591b8f0-01d5-4d20-adcb-dae8b7ba70b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e591b8f0-01d5-4d20-adcb-dae8b7ba70b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f92e98b-da3c-46e1-8f9c-9e06b703a429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e591b8f0-01d5-4d20-adcb-dae8b7ba70b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f92e98b-da3c-46e1-8f9c-9e06b703a429" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_06e0d10c-9fb9-4697-93df-00f5d6f647be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f92e98b-da3c-46e1-8f9c-9e06b703a429" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_06e0d10c-9fb9-4697-93df-00f5d6f647be" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#BusinessCombinationsAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails" xlink:type="extended" id="iea7038bdb0be4743819db2feef1f7c8b_BusinessCombinationsAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_232169cb-ed4b-47a6-887a-3e33b1483789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_232169cb-ed4b-47a6-887a-3e33b1483789" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_cd4e2fac-32eb-4572-9ad9-c82b71bd732c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_OtherAssetsCurrent_cd4e2fac-32eb-4572-9ad9-c82b71bd732c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4622f0df-f463-4956-bfac-caa6341ab7af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4622f0df-f463-4956-bfac-caa6341ab7af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_37d42370-468f-4503-928e-53ce000f570e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_Goodwill_37d42370-468f-4503-928e-53ce000f570e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_8ea07f18-6ad9-420b-b9fa-081bd154d4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_8ea07f18-6ad9-420b-b9fa-081bd154d4a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_679c12bc-32a1-47cc-b783-30b7b7f2df18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_679c12bc-32a1-47cc-b783-30b7b7f2df18" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_ea62383c-ef61-403c-a86c-b30e1264b0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_MinorityInterest_ea62383c-ef61-403c-a86c-b30e1264b0fd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_768583b3-8dc6-4d7a-82f0-8cd30a08253a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_768583b3-8dc6-4d7a-82f0-8cd30a08253a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_6d8bc040-9078-4572-aa8c-0139588984db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_768583b3-8dc6-4d7a-82f0-8cd30a08253a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_6d8bc040-9078-4572-aa8c-0139588984db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_6d8bc040-9078-4572-aa8c-0139588984db_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6d8bc040-9078-4572-aa8c-0139588984db" xlink:to="loc_srt_ConsolidatedEntitiesDomain_6d8bc040-9078-4572-aa8c-0139588984db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_866aa2b9-96d8-4765-a5d9-237297560152" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6d8bc040-9078-4572-aa8c-0139588984db" xlink:to="loc_srt_ConsolidatedEntitiesDomain_866aa2b9-96d8-4765-a5d9-237297560152" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_9347683e-b0b3-4d82-8d93-e5aa4ff8b81e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_866aa2b9-96d8-4765-a5d9-237297560152" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_9347683e-b0b3-4d82-8d93-e5aa4ff8b81e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#BusinessCombinationsRollforwardofNoncontrollingInterestDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails" xlink:type="extended" id="i76a954be17c24014b9e7a9778a30dc19_BusinessCombinationsRollforwardofNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_bb82664d-d52c-4a3e-b39b-d0fe2b699f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_abb91195-acc7-42a9-99d7-d374bb1af483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_bb82664d-d52c-4a3e-b39b-d0fe2b699f0a" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_abb91195-acc7-42a9-99d7-d374bb1af483" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_131d096a-ea0c-4cbf-b277-5af5858a51db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_abb91195-acc7-42a9-99d7-d374bb1af483" xlink:to="loc_us-gaap_MinorityInterest_131d096a-ea0c-4cbf-b277-5af5858a51db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d1514ef7-2778-438e-874b-5bd418ac04a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_abb91195-acc7-42a9-99d7-d374bb1af483" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d1514ef7-2778-438e-874b-5bd418ac04a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_cccd66cb-50fb-4fe7-a4fd-fd2dcf241771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fecabc98-2e88-46ac-9ecf-2a1e256f5f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_bb82664d-d52c-4a3e-b39b-d0fe2b699f0a" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fecabc98-2e88-46ac-9ecf-2a1e256f5f63" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_94c53189-2569-483f-a6dd-b40a697b3506" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fecabc98-2e88-46ac-9ecf-2a1e256f5f63" xlink:to="loc_srt_ConsolidatedEntitiesAxis_94c53189-2569-483f-a6dd-b40a697b3506" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_94c53189-2569-483f-a6dd-b40a697b3506_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_94c53189-2569-483f-a6dd-b40a697b3506" xlink:to="loc_srt_ConsolidatedEntitiesDomain_94c53189-2569-483f-a6dd-b40a697b3506_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_72534c1c-2b89-43a5-a79b-b32d7f6c9b16" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_94c53189-2569-483f-a6dd-b40a697b3506" xlink:to="loc_srt_ConsolidatedEntitiesDomain_72534c1c-2b89-43a5-a79b-b32d7f6c9b16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_671e6c40-bbaa-49dd-af0c-4a6876c22b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_72534c1c-2b89-43a5-a79b-b32d7f6c9b16" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_671e6c40-bbaa-49dd-af0c-4a6876c22b01" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails" xlink:type="extended" id="i122de2b8cd5148e19940367f6169554f_FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6ca176f4-ff28-4e4c-b6bf-c99a0c2afb08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_40dcc858-fabb-4fe4-a502-d47c3145c8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6ca176f4-ff28-4e4c-b6bf-c99a0c2afb08" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_40dcc858-fabb-4fe4-a502-d47c3145c8d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_25e540cb-9a13-4f09-bdbe-ddd6abe5fe04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6ca176f4-ff28-4e4c-b6bf-c99a0c2afb08" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_25e540cb-9a13-4f09-bdbe-ddd6abe5fe04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a645a630-8e30-4016-8749-62d58ce28790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6ca176f4-ff28-4e4c-b6bf-c99a0c2afb08" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a645a630-8e30-4016-8749-62d58ce28790" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1fd0c57a-489c-4a5d-bb0e-12ed5036fbef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6ca176f4-ff28-4e4c-b6bf-c99a0c2afb08" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1fd0c57a-489c-4a5d-bb0e-12ed5036fbef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6bd9ae4f-cc2d-47ca-890d-89eb547a5a03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6ca176f4-ff28-4e4c-b6bf-c99a0c2afb08" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6bd9ae4f-cc2d-47ca-890d-89eb547a5a03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ec8a8742-eb7b-4ee9-9e05-ab3b0e9edc48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6bd9ae4f-cc2d-47ca-890d-89eb547a5a03" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ec8a8742-eb7b-4ee9-9e05-ab3b0e9edc48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec8a8742-eb7b-4ee9-9e05-ab3b0e9edc48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ec8a8742-eb7b-4ee9-9e05-ab3b0e9edc48" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec8a8742-eb7b-4ee9-9e05-ab3b0e9edc48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3a3b66d-fb80-464a-ac98-5127aad73cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ec8a8742-eb7b-4ee9-9e05-ab3b0e9edc48" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3a3b66d-fb80-464a-ac98-5127aad73cdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e0d87237-f646-4133-924c-79d4266be81f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3a3b66d-fb80-464a-ac98-5127aad73cdc" xlink:to="loc_us-gaap_CommercialPaperMember_e0d87237-f646-4133-924c-79d4266be81f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_bab319c2-fd53-40ad-8f0c-8f7d1f6c4a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3a3b66d-fb80-464a-ac98-5127aad73cdc" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_bab319c2-fd53-40ad-8f0c-8f7d1f6c4a92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_522b0d57-244c-414f-a625-9ae556c450ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3a3b66d-fb80-464a-ac98-5127aad73cdc" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_522b0d57-244c-414f-a625-9ae556c450ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_cf385842-cc43-4a52-bd19-09627d5bc9de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3a3b66d-fb80-464a-ac98-5127aad73cdc" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_cf385842-cc43-4a52-bd19-09627d5bc9de" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails" xlink:type="extended" id="i89efae4733db42ffa28f9cc23188f0db_FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_878f2f7a-a6cb-4b18-97de-bdeba5f642f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d07d88f1-c640-4018-ac66-67ca32351852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_878f2f7a-a6cb-4b18-97de-bdeba5f642f5" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d07d88f1-c640-4018-ac66-67ca32351852" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fc147518-6dd8-48eb-8900-bfc929c203d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_878f2f7a-a6cb-4b18-97de-bdeba5f642f5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fc147518-6dd8-48eb-8900-bfc929c203d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e6980a87-6a48-48bb-9635-58961b38a676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_878f2f7a-a6cb-4b18-97de-bdeba5f642f5" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e6980a87-6a48-48bb-9635-58961b38a676" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_78eefd75-64c7-4000-95b3-92339d851eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_878f2f7a-a6cb-4b18-97de-bdeba5f642f5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_78eefd75-64c7-4000-95b3-92339d851eb8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_57e2c8a0-1e84-4b29-b2e7-1dbf7a83103f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_78eefd75-64c7-4000-95b3-92339d851eb8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_57e2c8a0-1e84-4b29-b2e7-1dbf7a83103f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_57e2c8a0-1e84-4b29-b2e7-1dbf7a83103f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_57e2c8a0-1e84-4b29-b2e7-1dbf7a83103f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_57e2c8a0-1e84-4b29-b2e7-1dbf7a83103f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a71f5542-e8d2-4a7d-92a4-1d17c8f9baee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_57e2c8a0-1e84-4b29-b2e7-1dbf7a83103f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a71f5542-e8d2-4a7d-92a4-1d17c8f9baee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_24880e90-2797-4cd9-bfcf-9c2ed9a48f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a71f5542-e8d2-4a7d-92a4-1d17c8f9baee" xlink:to="loc_us-gaap_MoneyMarketFundsMember_24880e90-2797-4cd9-bfcf-9c2ed9a48f3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_94213d57-1fc1-4421-b8cf-0aab572c99ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a71f5542-e8d2-4a7d-92a4-1d17c8f9baee" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_94213d57-1fc1-4421-b8cf-0aab572c99ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_98be8416-6cf6-4fab-aafa-5a914bb2b535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_78eefd75-64c7-4000-95b3-92339d851eb8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_98be8416-6cf6-4fab-aafa-5a914bb2b535" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_98be8416-6cf6-4fab-aafa-5a914bb2b535_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_98be8416-6cf6-4fab-aafa-5a914bb2b535" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_98be8416-6cf6-4fab-aafa-5a914bb2b535_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad575f32-01a8-40b7-9b7f-6a66cf3bbb44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_98be8416-6cf6-4fab-aafa-5a914bb2b535" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad575f32-01a8-40b7-9b7f-6a66cf3bbb44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6b884293-78e0-439b-872e-ab4764c483d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad575f32-01a8-40b7-9b7f-6a66cf3bbb44" xlink:to="loc_us-gaap_CommercialPaperMember_6b884293-78e0-439b-872e-ab4764c483d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_1bb7ca9a-c149-498e-8c61-5ee27fc83d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad575f32-01a8-40b7-9b7f-6a66cf3bbb44" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_1bb7ca9a-c149-498e-8c61-5ee27fc83d82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_810b1cfe-d47f-4c84-b4df-acc89c1fa2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad575f32-01a8-40b7-9b7f-6a66cf3bbb44" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_810b1cfe-d47f-4c84-b4df-acc89c1fa2ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_19e5d703-4c18-4c30-a63a-11b1ea57ac88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad575f32-01a8-40b7-9b7f-6a66cf3bbb44" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_19e5d703-4c18-4c30-a63a-11b1ea57ac88" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4249d90c-c98a-4926-839a-e50e1dc9d801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_78eefd75-64c7-4000-95b3-92339d851eb8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4249d90c-c98a-4926-839a-e50e1dc9d801" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4249d90c-c98a-4926-839a-e50e1dc9d801_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4249d90c-c98a-4926-839a-e50e1dc9d801" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4249d90c-c98a-4926-839a-e50e1dc9d801_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db0ef481-0c1a-493f-825e-19ec581a63d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4249d90c-c98a-4926-839a-e50e1dc9d801" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db0ef481-0c1a-493f-825e-19ec581a63d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_6907ac6b-b4f1-4426-a7a0-61d4abb7882d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db0ef481-0c1a-493f-825e-19ec581a63d1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_6907ac6b-b4f1-4426-a7a0-61d4abb7882d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8839940a-8e7e-4c28-bdc4-04fa7a5416b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db0ef481-0c1a-493f-825e-19ec581a63d1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8839940a-8e7e-4c28-bdc4-04fa7a5416b5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#PropertyandEquipmentnetSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails" xlink:type="extended" id="i2878814303164d6ba071f94ad09a08c1_PropertyandEquipmentnetSummaryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dae44a47-6986-42b1-8f6a-273011e47d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a99bc8ec-711e-4e94-a876-fd01955daa84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dae44a47-6986-42b1-8f6a-273011e47d5f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a99bc8ec-711e-4e94-a876-fd01955daa84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_bd1c9743-51a8-4828-b35e-74abf334d078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dae44a47-6986-42b1-8f6a-273011e47d5f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_bd1c9743-51a8-4828-b35e-74abf334d078" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_689864de-fd3f-4f3d-8c7a-e74639a583cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dae44a47-6986-42b1-8f6a-273011e47d5f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_689864de-fd3f-4f3d-8c7a-e74639a583cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a76b8d7-6481-4a00-aa41-4e65085f103a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dae44a47-6986-42b1-8f6a-273011e47d5f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a76b8d7-6481-4a00-aa41-4e65085f103a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e2e03988-6bfd-4310-9eb1-1cd156b63ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a76b8d7-6481-4a00-aa41-4e65085f103a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e2e03988-6bfd-4310-9eb1-1cd156b63ea3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e2e03988-6bfd-4310-9eb1-1cd156b63ea3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e2e03988-6bfd-4310-9eb1-1cd156b63ea3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e2e03988-6bfd-4310-9eb1-1cd156b63ea3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87438353-f341-4886-b92b-c8f011ecb117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e2e03988-6bfd-4310-9eb1-1cd156b63ea3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87438353-f341-4886-b92b-c8f011ecb117" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ComputerAndOfficeEquipmentMember_87daebf6-b48f-4b61-a210-84cd64da94d6" xlink:href="zntl-20210930.xsd#zntl_ComputerAndOfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87438353-f341-4886-b92b-c8f011ecb117" xlink:to="loc_zntl_ComputerAndOfficeEquipmentMember_87daebf6-b48f-4b61-a210-84cd64da94d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_LaboratoryEquipmentMember_ea4e3651-8a1b-4f44-abb0-0c35313de04d" xlink:href="zntl-20210930.xsd#zntl_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87438353-f341-4886-b92b-c8f011ecb117" xlink:to="loc_zntl_LaboratoryEquipmentMember_ea4e3651-8a1b-4f44-abb0-0c35313de04d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_b309d0e5-33df-45b3-975a-9ec7dc4d4dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87438353-f341-4886-b92b-c8f011ecb117" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_b309d0e5-33df-45b3-975a-9ec7dc4d4dc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_c04b8d80-3c54-4813-9eb8-0642257b8ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87438353-f341-4886-b92b-c8f011ecb117" xlink:to="loc_us-gaap_ConstructionInProgressMember_c04b8d80-3c54-4813-9eb8-0642257b8ce2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#ConvertiblePreferredUnitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails" xlink:type="extended" id="i896fce16ac6e4c8aab9db6a59281bdef_ConvertiblePreferredUnitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_663bb6d8-0ac7-4d61-98e5-21c099a23b38" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_663bb6d8-0ac7-4d61-98e5-21c099a23b38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_6dceb143-0f86-4e14-bf37-9273c2723781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_6dceb143-0f86-4e14-bf37-9273c2723781" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_786bf78d-cf27-4f4d-871d-7a494c024ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_786bf78d-cf27-4f4d-871d-7a494c024ce4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross_92c3563a-c24b-4e5b-bd5e-c4209e35d381" xlink:href="zntl-20210930.xsd#zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross_92c3563a-c24b-4e5b-bd5e-c4209e35d381" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_79451d4b-6bc2-49c2-b3c6-367b6a8cf129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_79451d4b-6bc2-49c2-b3c6-367b6a8cf129" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_ed85cbb3-f3df-457c-8b1d-71660052140c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_ed85cbb3-f3df-457c-8b1d-71660052140c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_341fca33-de01-4c38-a720-753f3267632f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_341fca33-de01-4c38-a720-753f3267632f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_bde688fd-816e-4491-be78-7ee16d93e2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_bde688fd-816e-4491-be78-7ee16d93e2f3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ConvertiblePreferredStockDividendsPerShareDeclared_0c8e1333-181b-4379-9367-c40c8c403a12" xlink:href="zntl-20210930.xsd#zntl_ConvertiblePreferredStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_zntl_ConvertiblePreferredStockDividendsPerShareDeclared_0c8e1333-181b-4379-9367-c40c8c403a12" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_793e3f50-7996-4444-8bd2-c12e16da6ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_793e3f50-7996-4444-8bd2-c12e16da6ecb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering_ed0a8af4-df9b-418c-bc4f-d0970c3d9313" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering_ed0a8af4-df9b-418c-bc4f-d0970c3d9313" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare_0569157d-7142-42f4-8469-9032361b9c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare_0569157d-7142-42f4-8469-9032361b9c61" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_8593c9fe-fbd8-41b9-9b18-a29b46dda0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_8593c9fe-fbd8-41b9-9b18-a29b46dda0c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3214acae-bcf8-4194-8a77-18a482e5b37d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8593c9fe-fbd8-41b9-9b18-a29b46dda0c1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3214acae-bcf8-4194-8a77-18a482e5b37d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3214acae-bcf8-4194-8a77-18a482e5b37d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3214acae-bcf8-4194-8a77-18a482e5b37d" xlink:to="loc_us-gaap_ClassOfStockDomain_3214acae-bcf8-4194-8a77-18a482e5b37d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1e47edb6-0cc8-4cb3-ac22-6667e8d03940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3214acae-bcf8-4194-8a77-18a482e5b37d" xlink:to="loc_us-gaap_ClassOfStockDomain_1e47edb6-0cc8-4cb3-ac22-6667e8d03940" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_395c6b13-22f9-42aa-b39c-5cd34079b9eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1e47edb6-0cc8-4cb3-ac22-6667e8d03940" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_395c6b13-22f9-42aa-b39c-5cd34079b9eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_8fcca1e5-58d4-481e-901e-93614b772ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1e47edb6-0cc8-4cb3-ac22-6667e8d03940" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_8fcca1e5-58d4-481e-901e-93614b772ac4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_2f0e221e-561d-4031-ab86-fd507d8d032e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1e47edb6-0cc8-4cb3-ac22-6667e8d03940" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_2f0e221e-561d-4031-ab86-fd507d8d032e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquityNarrativeDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/MembersEquityNarrativeDetails" xlink:type="extended" id="ia79177e384514607bbcc922f410fb51f_MembersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6de213db-b1e9-4ce0-bfe6-c25935ebae50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_CommonStockSharesIssued_6de213db-b1e9-4ce0-bfe6-c25935ebae50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_38f97f60-0467-40e1-b67e-efe2ab7f4829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_38f97f60-0467-40e1-b67e-efe2ab7f4829" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_CommonStockSharesSubjectToFutureVestingProvisions_ef4d723b-d3fb-4af2-9bfa-7d5abad5c346" xlink:href="zntl-20210930.xsd#zntl_CommonStockSharesSubjectToFutureVestingProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_CommonStockSharesSubjectToFutureVestingProvisions_ef4d723b-d3fb-4af2-9bfa-7d5abad5c346" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f9a5bd7e-f216-4189-8869-fdf650264194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f9a5bd7e-f216-4189-8869-fdf650264194" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions_41d5a36f-9f81-4db4-8f13-0dc1d4319b00" xlink:href="zntl-20210930.xsd#zntl_CommonUnitOutstandingSubjectToFutureVestingConditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions_41d5a36f-9f81-4db4-8f13-0dc1d4319b00" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonUnitAuthorized_cc60cb29-515d-4c21-b69d-3dff806ca3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonUnitAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_CommonUnitAuthorized_cc60cb29-515d-4c21-b69d-3dff806ca3a8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_07df5565-b6ba-4028-933b-4841b80bd62c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_07df5565-b6ba-4028-933b-4841b80bd62c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_e38d04a0-731a-4603-9a69-4c49383bd659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_e38d04a0-731a-4603-9a69-4c49383bd659" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b18b51c1-d471-488e-9391-f91619cd3380" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b18b51c1-d471-488e-9391-f91619cd3380" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_80ca9a3c-f1d0-4be9-9bb4-f27572d6bc88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_80ca9a3c-f1d0-4be9-9bb4-f27572d6bc88" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b08969de-07a3-4d2b-92b1-6af0b769c1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b08969de-07a3-4d2b-92b1-6af0b769c1a4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ee9cd2ea-5e5b-4edb-b1b1-44955bf7ff0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ee9cd2ea-5e5b-4edb-b1b1-44955bf7ff0c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8d77de86-a785-4f52-8e03-f513c16012a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8d77de86-a785-4f52-8e03-f513c16012a8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_7af8e1e2-8a60-483a-929b-a3f6a48beb13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_7af8e1e2-8a60-483a-929b-a3f6a48beb13" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5e68e5d3-362b-44f2-8b54-35c269c9b0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5e68e5d3-362b-44f2-8b54-35c269c9b0ae" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_1a228402-e8ff-44a3-86bd-6702ca1f99fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_1a228402-e8ff-44a3-86bd-6702ca1f99fd" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ProceedsFromIssuanceOfCommonStockGross_86e73f61-a9c7-41c0-b413-7f06f35ea81b" xlink:href="zntl-20210930.xsd#zntl_ProceedsFromIssuanceOfCommonStockGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_ProceedsFromIssuanceOfCommonStockGross_86e73f61-a9c7-41c0-b413-7f06f35ea81b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock_ab91ecca-6c62-499d-bbcc-4309320a071d" xlink:href="zntl-20210930.xsd#zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock_ab91ecca-6c62-499d-bbcc-4309320a071d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_16b5ecc3-3dd7-47a3-86fd-ccb0cd5afc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_16b5ecc3-3dd7-47a3-86fd-ccb0cd5afc2c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7d63be1d-e005-4762-8121-9591aa47116d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7d63be1d-e005-4762-8121-9591aa47116d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease_552c1a72-ae34-4a31-b8e6-7eecd42d85ac" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease_552c1a72-ae34-4a31-b8e6-7eecd42d85ac" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_01c90785-8983-4192-8e6c-d9228654a46f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_01c90785-8983-4192-8e6c-d9228654a46f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_08ecb0ad-b239-471e-bd90-55fbc5a8e997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_08ecb0ad-b239-471e-bd90-55fbc5a8e997" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_7340742e-e959-4afe-a81a-e91eb993a559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_7340742e-e959-4afe-a81a-e91eb993a559" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm_3caf2415-d78f-4997-b4f5-d38bb0cd311a" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm_3caf2415-d78f-4997-b4f5-d38bb0cd311a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2836179a-bb91-49e8-9efa-3945df7cb240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2836179a-bb91-49e8-9efa-3945df7cb240" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_a9deff57-5421-4687-9b75-74ca280be273" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_a9deff57-5421-4687-9b75-74ca280be273" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1d73c226-6214-427c-8be9-16455dbcd06f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1d73c226-6214-427c-8be9-16455dbcd06f" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_4d944da1-8eca-48d8-87af-9d2c05e3e2c2" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_4d944da1-8eca-48d8-87af-9d2c05e3e2c2" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3b3c1ab3-e8b4-4841-833a-b43117265c33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3b3c1ab3-e8b4-4841-833a-b43117265c33" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_76a196b1-f1c5-4479-8d00-eea629009ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_76a196b1-f1c5-4479-8d00-eea629009ba4" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredUnitsAuthorized_239af2f3-8fc5-4180-b223-b964ec278330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredUnitsAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_PreferredUnitsAuthorized_239af2f3-8fc5-4180-b223-b964ec278330" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9136e7c4-72b7-462e-b2d3-4b804fcfdb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9136e7c4-72b7-462e-b2d3-4b804fcfdb6b" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_597c288b-7b96-43b2-86f0-faa1bbf6ebbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:to="loc_us-gaap_StatementClassOfStockAxis_597c288b-7b96-43b2-86f0-faa1bbf6ebbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_597c288b-7b96-43b2-86f0-faa1bbf6ebbe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_597c288b-7b96-43b2-86f0-faa1bbf6ebbe" xlink:to="loc_us-gaap_ClassOfStockDomain_597c288b-7b96-43b2-86f0-faa1bbf6ebbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_597c288b-7b96-43b2-86f0-faa1bbf6ebbe" xlink:to="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_81cec943-2046-4cb4-84be-40f71b8d1f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:to="loc_us-gaap_CommonClassAMember_81cec943-2046-4cb4-84be-40f71b8d1f03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_75e53ce9-c3fc-4ded-b4ed-6d20bbcfa144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:to="loc_us-gaap_CommonClassBMember_75e53ce9-c3fc-4ded-b4ed-6d20bbcfa144" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_63530549-d086-4b39-9b48-4ef68f75273a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:to="loc_us-gaap_CommonStockMember_63530549-d086-4b39-9b48-4ef68f75273a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_deeb3bf8-17c3-45e0-a407-a211d2eacc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:to="loc_us-gaap_RestrictedStockMember_deeb3bf8-17c3-45e0-a407-a211d2eacc6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_8f82991a-bc13-4b82-aee0-6434a7c14c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_8f82991a-bc13-4b82-aee0-6434a7c14c6f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_25c17fed-500f-4572-9176-a818fc3a58a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_25c17fed-500f-4572-9176-a818fc3a58a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_afc7dc97-f1be-4051-96a2-c3b5a665e455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_afc7dc97-f1be-4051-96a2-c3b5a665e455" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_afc7dc97-f1be-4051-96a2-c3b5a665e455_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_afc7dc97-f1be-4051-96a2-c3b5a665e455" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_afc7dc97-f1be-4051-96a2-c3b5a665e455_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a5ef2373-a343-4265-870d-e046c9410ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_afc7dc97-f1be-4051-96a2-c3b5a665e455" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a5ef2373-a343-4265-870d-e046c9410ae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_CorporateConversionMember_f5225c91-d49d-42c9-9a9c-611518b5dbe2" xlink:href="zntl-20210930.xsd#zntl_CorporateConversionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a5ef2373-a343-4265-870d-e046c9410ae5" xlink:to="loc_zntl_CorporateConversionMember_f5225c91-d49d-42c9-9a9c-611518b5dbe2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_e25e1142-e42c-4243-a0ce-a592763dfc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a5ef2373-a343-4265-870d-e046c9410ae5" xlink:to="loc_us-gaap_IPOMember_e25e1142-e42c-4243-a0ce-a592763dfc83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_bea85475-06eb-4b45-a635-8d0fffe93f59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a5ef2373-a343-4265-870d-e046c9410ae5" xlink:to="loc_us-gaap_OverAllotmentOptionMember_bea85475-06eb-4b45-a635-8d0fffe93f59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_FollowOnOfferingMember_5d017fe6-07a1-4fc3-9814-d2ae83bde70a" xlink:href="zntl-20210930.xsd#zntl_FollowOnOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a5ef2373-a343-4265-870d-e046c9410ae5" xlink:to="loc_zntl_FollowOnOfferingMember_5d017fe6-07a1-4fc3-9814-d2ae83bde70a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_FollowOnPublicOfferingMember_17deef26-9f0b-40c1-9619-1acf2001b237" xlink:href="zntl-20210930.xsd#zntl_FollowOnPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a5ef2373-a343-4265-870d-e046c9410ae5" xlink:to="loc_zntl_FollowOnPublicOfferingMember_17deef26-9f0b-40c1-9619-1acf2001b237" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3c59950d-d2d1-4cc5-b8e6-526b45ae9303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:to="loc_us-gaap_PlanNameAxis_3c59950d-d2d1-4cc5-b8e6-526b45ae9303" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3c59950d-d2d1-4cc5-b8e6-526b45ae9303_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3c59950d-d2d1-4cc5-b8e6-526b45ae9303" xlink:to="loc_us-gaap_PlanNameDomain_3c59950d-d2d1-4cc5-b8e6-526b45ae9303_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d5ea6125-0c2c-4725-be52-4bb93612d2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3c59950d-d2d1-4cc5-b8e6-526b45ae9303" xlink:to="loc_us-gaap_PlanNameDomain_d5ea6125-0c2c-4725-be52-4bb93612d2d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_A2017ProfitInterestPlanMember_e2381871-1521-49c7-8a8a-ba3bafdafa81" xlink:href="zntl-20210930.xsd#zntl_A2017ProfitInterestPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d5ea6125-0c2c-4725-be52-4bb93612d2d5" xlink:to="loc_zntl_A2017ProfitInterestPlanMember_e2381871-1521-49c7-8a8a-ba3bafdafa81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_A2020IncentiveAwardPlanMember_eb6685d1-eda7-43fc-8e4a-372b373d65c0" xlink:href="zntl-20210930.xsd#zntl_A2020IncentiveAwardPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d5ea6125-0c2c-4725-be52-4bb93612d2d5" xlink:to="loc_zntl_A2020IncentiveAwardPlanMember_eb6685d1-eda7-43fc-8e4a-372b373d65c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ZenteraStockPlanMember_ac8175e4-07b9-4023-b643-f832e9c567af" xlink:href="zntl-20210930.xsd#zntl_ZenteraStockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d5ea6125-0c2c-4725-be52-4bb93612d2d5" xlink:to="loc_zntl_ZenteraStockPlanMember_ac8175e4-07b9-4023-b643-f832e9c567af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a166519a-c350-4bb8-ba64-b9bbe194623f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:to="loc_srt_RangeAxis_a166519a-c350-4bb8-ba64-b9bbe194623f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a166519a-c350-4bb8-ba64-b9bbe194623f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a166519a-c350-4bb8-ba64-b9bbe194623f" xlink:to="loc_srt_RangeMember_a166519a-c350-4bb8-ba64-b9bbe194623f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b0988e6b-8f5e-4936-8317-3591005c2c0a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a166519a-c350-4bb8-ba64-b9bbe194623f" xlink:to="loc_srt_RangeMember_b0988e6b-8f5e-4936-8317-3591005c2c0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9b7e6f9c-b6dc-4faa-9fb4-aafe58dcdbbc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b0988e6b-8f5e-4936-8317-3591005c2c0a" xlink:to="loc_srt_MaximumMember_9b7e6f9c-b6dc-4faa-9fb4-aafe58dcdbbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f1d0ac00-3649-43ee-ab25-5fbb17495a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:to="loc_us-gaap_AwardTypeAxis_f1d0ac00-3649-43ee-ab25-5fbb17495a99" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1d0ac00-3649-43ee-ab25-5fbb17495a99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f1d0ac00-3649-43ee-ab25-5fbb17495a99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1d0ac00-3649-43ee-ab25-5fbb17495a99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8806f8d-17c2-4963-9822-818f2489e84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f1d0ac00-3649-43ee-ab25-5fbb17495a99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8806f8d-17c2-4963-9822-818f2489e84f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_733f9bd7-5a8a-4515-a01d-0df3cdae8725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8806f8d-17c2-4963-9822-818f2489e84f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_733f9bd7-5a8a-4515-a01d-0df3cdae8725" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_01d1602f-abd3-4508-a0b3-5e7aaa4fe5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8806f8d-17c2-4963-9822-818f2489e84f" xlink:to="loc_us-gaap_RestrictedStockMember_01d1602f-abd3-4508-a0b3-5e7aaa4fe5fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b6e2b391-2d27-409c-b0c3-483186ef1884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8806f8d-17c2-4963-9822-818f2489e84f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b6e2b391-2d27-409c-b0c3-483186ef1884" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_79806668-4f09-47b5-9bd0-23af2cf02f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8806f8d-17c2-4963-9822-818f2489e84f" xlink:to="loc_us-gaap_EmployeeStockMember_79806668-4f09-47b5-9bd0-23af2cf02f8a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquitySharebasedCompensationDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquitySharebasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/MembersEquitySharebasedCompensationDetails" xlink:type="extended" id="i44a11b841bfd44b7b6289c6ac5159b55_MembersEquitySharebasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66c21d0d-4b56-442f-97ab-8f1eb4204c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3388c6a4-66fa-46e6-b826-a10d8e48c3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66c21d0d-4b56-442f-97ab-8f1eb4204c5a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3388c6a4-66fa-46e6-b826-a10d8e48c3e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1189fa5e-ec5a-40ad-91be-06698be5ca0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66c21d0d-4b56-442f-97ab-8f1eb4204c5a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1189fa5e-ec5a-40ad-91be-06698be5ca0b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_423427ec-f2f1-43be-b0a2-b35077f0446a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1189fa5e-ec5a-40ad-91be-06698be5ca0b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_423427ec-f2f1-43be-b0a2-b35077f0446a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_423427ec-f2f1-43be-b0a2-b35077f0446a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_423427ec-f2f1-43be-b0a2-b35077f0446a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_423427ec-f2f1-43be-b0a2-b35077f0446a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d82136fc-afa7-454d-987d-d689359b3be3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_423427ec-f2f1-43be-b0a2-b35077f0446a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d82136fc-afa7-454d-987d-d689359b3be3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a861ff74-fc35-4bde-ba06-fa43ab6a61a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d82136fc-afa7-454d-987d-d689359b3be3" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a861ff74-fc35-4bde-ba06-fa43ab6a61a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3bb4f1c0-2099-4a29-abbb-58366e4f4395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d82136fc-afa7-454d-987d-d689359b3be3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3bb4f1c0-2099-4a29-abbb-58366e4f4395" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquitySharebasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails" xlink:type="extended" id="if0a8a6f558be480190f31fa0c064c8fe_MembersEquitySharebasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29de0745-9ba2-4955-b760-d1ea00488bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c0a88b80-ae48-4b14-bf75-2bab9d8e2b96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29de0745-9ba2-4955-b760-d1ea00488bdc" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c0a88b80-ae48-4b14-bf75-2bab9d8e2b96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1ce9815-3b2e-4804-ac06-3910235fd8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29de0745-9ba2-4955-b760-d1ea00488bdc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1ce9815-3b2e-4804-ac06-3910235fd8b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3c2bc8da-7147-473b-a57b-61c4c860bc59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1ce9815-3b2e-4804-ac06-3910235fd8b1" xlink:to="loc_us-gaap_AwardTypeAxis_3c2bc8da-7147-473b-a57b-61c4c860bc59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c2bc8da-7147-473b-a57b-61c4c860bc59_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3c2bc8da-7147-473b-a57b-61c4c860bc59" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c2bc8da-7147-473b-a57b-61c4c860bc59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b215d69-268c-4faf-95c0-16197b7af8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3c2bc8da-7147-473b-a57b-61c4c860bc59" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b215d69-268c-4faf-95c0-16197b7af8df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ProfitInterestAwardsMember_ee7001c8-4f39-43be-89d6-a0846586db09" xlink:href="zntl-20210930.xsd#zntl_ProfitInterestAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b215d69-268c-4faf-95c0-16197b7af8df" xlink:to="loc_zntl_ProfitInterestAwardsMember_ee7001c8-4f39-43be-89d6-a0846586db09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0114d6b7-9250-4c1f-b986-d54c7f816489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b215d69-268c-4faf-95c0-16197b7af8df" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0114d6b7-9250-4c1f-b986-d54c7f816489" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_8e74cf09-f529-47a4-8f93-42b6da1fca29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b215d69-268c-4faf-95c0-16197b7af8df" xlink:to="loc_us-gaap_EmployeeStockMember_8e74cf09-f529-47a4-8f93-42b6da1fca29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember_b89ceabf-2cc0-412d-b920-42b8a9ed4743" xlink:href="zntl-20210930.xsd#zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b215d69-268c-4faf-95c0-16197b7af8df" xlink:to="loc_zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember_b89ceabf-2cc0-412d-b920-42b8a9ed4743" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails" xlink:type="extended" id="i457dcd92821d44f496aaa1851a908652_MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MembersEquity_d8c04e08-23a0-4d5c-85ed-1824ecabec4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MembersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_us-gaap_MembersEquity_d8c04e08-23a0-4d5c-85ed-1824ecabec4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts_ef9ba394-8ad9-427d-a1a2-c4a8401fa31a" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts_ef9ba394-8ad9-427d-a1a2-c4a8401fa31a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a8ae5311-8c39-45d6-bc8b-1256c636097d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a8ae5311-8c39-45d6-bc8b-1256c636097d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dec3ebb8-c118-41c5-93d6-465e9c23f979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dec3ebb8-c118-41c5-93d6-465e9c23f979" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity_f7191b4b-bb78-4075-bddb-c1fa071b42e4" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity_f7191b4b-bb78-4075-bddb-c1fa071b42e4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount_e6718495-40d3-4f8a-be79-5e9d9d1fdc71" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount_e6718495-40d3-4f8a-be79-5e9d9d1fdc71" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7d846c4f-469b-4d11-863e-ee60608acbac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7d846c4f-469b-4d11-863e-ee60608acbac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1cfb7312-387b-40e9-9d82-0aa5c9a9736e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1cfb7312-387b-40e9-9d82-0aa5c9a9736e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a4debd26-745d-47d3-9f6f-c02b7c820094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1cfb7312-387b-40e9-9d82-0aa5c9a9736e" xlink:to="loc_us-gaap_AwardTypeAxis_a4debd26-745d-47d3-9f6f-c02b7c820094" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a4debd26-745d-47d3-9f6f-c02b7c820094_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a4debd26-745d-47d3-9f6f-c02b7c820094" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a4debd26-745d-47d3-9f6f-c02b7c820094_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1de4f414-65f1-4870-983d-bd1e83bb0391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a4debd26-745d-47d3-9f6f-c02b7c820094" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1de4f414-65f1-4870-983d-bd1e83bb0391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ProfitInterestAwardsMember_51c55d44-f8fd-40ab-975b-ded0535c81b8" xlink:href="zntl-20210930.xsd#zntl_ProfitInterestAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1de4f414-65f1-4870-983d-bd1e83bb0391" xlink:to="loc_zntl_ProfitInterestAwardsMember_51c55d44-f8fd-40ab-975b-ded0535c81b8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquityFairValueAssumptionsforStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails" xlink:type="extended" id="ia83e84239a80441580e41a9b7bb91e7e_MembersEquityFairValueAssumptionsforStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_27d00726-ac39-464e-bdc3-2535095cdf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_27d00726-ac39-464e-bdc3-2535095cdf2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_4d0d51ae-67ca-4c3b-8a54-0b42cade3c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_4d0d51ae-67ca-4c3b-8a54-0b42cade3c26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0474f25e-5d84-42e4-bcaf-a364d1de04ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0474f25e-5d84-42e4-bcaf-a364d1de04ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_5f62f453-cc0e-4885-80c7-374cc57c50b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_5f62f453-cc0e-4885-80c7-374cc57c50b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_0b0f92c0-5000-4d25-bf88-408aa79e3137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_0b0f92c0-5000-4d25-bf88-408aa79e3137" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5d05756e-65c3-44e9-b89c-63a55807637c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5d05756e-65c3-44e9-b89c-63a55807637c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_eda2aed7-46ed-49c5-9c1f-f8bf1a24d76d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_eda2aed7-46ed-49c5-9c1f-f8bf1a24d76d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7b93fe64-4ad0-44c3-9ef3-d4e280bfbde9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_eda2aed7-46ed-49c5-9c1f-f8bf1a24d76d" xlink:to="loc_us-gaap_AwardTypeAxis_7b93fe64-4ad0-44c3-9ef3-d4e280bfbde9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7b93fe64-4ad0-44c3-9ef3-d4e280bfbde9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7b93fe64-4ad0-44c3-9ef3-d4e280bfbde9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7b93fe64-4ad0-44c3-9ef3-d4e280bfbde9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c2708cc-1e9c-4e3d-93e4-525eed43d066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7b93fe64-4ad0-44c3-9ef3-d4e280bfbde9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c2708cc-1e9c-4e3d-93e4-525eed43d066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_93149a72-e5a9-4a23-b6d7-0e85f97093c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c2708cc-1e9c-4e3d-93e4-525eed43d066" xlink:to="loc_us-gaap_EmployeeStockOptionMember_93149a72-e5a9-4a23-b6d7-0e85f97093c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d0575657-26b3-4500-9132-9a303ac6f360" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_eda2aed7-46ed-49c5-9c1f-f8bf1a24d76d" xlink:to="loc_srt_RangeAxis_d0575657-26b3-4500-9132-9a303ac6f360" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d0575657-26b3-4500-9132-9a303ac6f360_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d0575657-26b3-4500-9132-9a303ac6f360" xlink:to="loc_srt_RangeMember_d0575657-26b3-4500-9132-9a303ac6f360_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9b495629-729d-46fa-97b1-59b6e6eeb9a5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d0575657-26b3-4500-9132-9a303ac6f360" xlink:to="loc_srt_RangeMember_9b495629-729d-46fa-97b1-59b6e6eeb9a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d1b357f3-3108-4650-b981-8abc44c337b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9b495629-729d-46fa-97b1-59b6e6eeb9a5" xlink:to="loc_srt_MinimumMember_d1b357f3-3108-4650-b981-8abc44c337b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bd1e29d0-077e-412f-82e1-e4ecdb84fb10" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9b495629-729d-46fa-97b1-59b6e6eeb9a5" xlink:to="loc_srt_MaximumMember_bd1e29d0-077e-412f-82e1-e4ecdb84fb10" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquityFairValueAssumptionsforESPPDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails" xlink:type="extended" id="i29ac5044002e4c89bfc0bb1efe510cef_MembersEquityFairValueAssumptionsforESPPDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3b0358fd-95aa-49b6-b6c8-832b5def0148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_baefe869-8502-43fa-9fff-d11fe4049445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3b0358fd-95aa-49b6-b6c8-832b5def0148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_baefe869-8502-43fa-9fff-d11fe4049445" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3032b195-e585-4aff-94ac-b88e324b4966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3b0358fd-95aa-49b6-b6c8-832b5def0148" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3032b195-e585-4aff-94ac-b88e324b4966" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_736ef1f7-b707-4470-b09a-6348ecd704bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3b0358fd-95aa-49b6-b6c8-832b5def0148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_736ef1f7-b707-4470-b09a-6348ecd704bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6fa16640-bca3-42fd-81dc-854f52e84529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3b0358fd-95aa-49b6-b6c8-832b5def0148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6fa16640-bca3-42fd-81dc-854f52e84529" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8cc5d8dc-c21e-487b-8305-21f86bd9a3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3b0358fd-95aa-49b6-b6c8-832b5def0148" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8cc5d8dc-c21e-487b-8305-21f86bd9a3a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8fc42a34-e577-4d48-8178-28ba36916faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8cc5d8dc-c21e-487b-8305-21f86bd9a3a0" xlink:to="loc_us-gaap_AwardTypeAxis_8fc42a34-e577-4d48-8178-28ba36916faf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fc42a34-e577-4d48-8178-28ba36916faf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8fc42a34-e577-4d48-8178-28ba36916faf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fc42a34-e577-4d48-8178-28ba36916faf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba122bb8-4312-4c1c-aa43-2b7b3a1376ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8fc42a34-e577-4d48-8178-28ba36916faf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba122bb8-4312-4c1c-aa43-2b7b3a1376ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_a38f1887-951d-4889-8468-c6f3d18727f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba122bb8-4312-4c1c-aa43-2b7b3a1376ac" xlink:to="loc_us-gaap_EmployeeStockMember_a38f1887-951d-4889-8468-c6f3d18727f8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquityUnrecognizedCompensationCostDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails" xlink:type="extended" id="i271760ea82704cc7ab61a129a01995d1_MembersEquityUnrecognizedCompensationCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6b3349b-e27d-440e-9aed-18a84fa7beb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_5c3df8ee-8c7a-4a01-a16a-c4c1b2597dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6b3349b-e27d-440e-9aed-18a84fa7beb3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_5c3df8ee-8c7a-4a01-a16a-c4c1b2597dd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_b26ec67d-1ccc-450c-b723-88d8a2769502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6b3349b-e27d-440e-9aed-18a84fa7beb3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_b26ec67d-1ccc-450c-b723-88d8a2769502" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f410874f-ec1a-4f16-a03e-b4f119fefc81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6b3349b-e27d-440e-9aed-18a84fa7beb3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f410874f-ec1a-4f16-a03e-b4f119fefc81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e2c0e53-b468-451f-addf-b69ffb05b3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6b3349b-e27d-440e-9aed-18a84fa7beb3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e2c0e53-b468-451f-addf-b69ffb05b3d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_97d0df9b-6de8-4091-9cb7-ed6526390d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e2c0e53-b468-451f-addf-b69ffb05b3d9" xlink:to="loc_us-gaap_AwardTypeAxis_97d0df9b-6de8-4091-9cb7-ed6526390d3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_97d0df9b-6de8-4091-9cb7-ed6526390d3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_97d0df9b-6de8-4091-9cb7-ed6526390d3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_97d0df9b-6de8-4091-9cb7-ed6526390d3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4cc4f5e3-8818-42ed-a8be-8fdbc61c1444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_97d0df9b-6de8-4091-9cb7-ed6526390d3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4cc4f5e3-8818-42ed-a8be-8fdbc61c1444" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_44b88d6e-2b48-4d38-a29f-d5e471869f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4cc4f5e3-8818-42ed-a8be-8fdbc61c1444" xlink:to="loc_us-gaap_EmployeeStockOptionMember_44b88d6e-2b48-4d38-a29f-d5e471869f46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_7af74760-ebad-4624-b611-31f1cfbefb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4cc4f5e3-8818-42ed-a8be-8fdbc61c1444" xlink:to="loc_us-gaap_RestrictedStockMember_7af74760-ebad-4624-b611-31f1cfbefb9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_34c0b702-ad61-4aac-98a0-b0d6fb9d9577" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4cc4f5e3-8818-42ed-a8be-8fdbc61c1444" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_34c0b702-ad61-4aac-98a0-b0d6fb9d9577" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_d30baafa-782a-43ef-aba6-3dd17e861f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4cc4f5e3-8818-42ed-a8be-8fdbc61c1444" xlink:to="loc_us-gaap_EmployeeStockMember_d30baafa-782a-43ef-aba6-3dd17e861f41" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#CommitmentandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="extended" id="i3736882fcf684ff38583c3bc2f00b8fc_CommitmentandContingenciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_c01b1f98-f7b7-4f4d-8256-2bf79fe176b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_37a3a031-6ae7-4f7a-a493-44b7b086b6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c01b1f98-f7b7-4f4d-8256-2bf79fe176b6" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_37a3a031-6ae7-4f7a-a493-44b7b086b6b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_4de402a2-85d1-4765-bdb7-14072bef16af" xlink:href="zntl-20210930.xsd#zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c01b1f98-f7b7-4f4d-8256-2bf79fe176b6" xlink:to="loc_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_4de402a2-85d1-4765-bdb7-14072bef16af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability_35055a95-3df6-48a1-9700-fbcf931bb387" xlink:href="zntl-20210930.xsd#zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c01b1f98-f7b7-4f4d-8256-2bf79fe176b6" xlink:to="loc_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability_35055a95-3df6-48a1-9700-fbcf931bb387" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_7b575ac6-3b18-481e-aa5e-add841b64281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c01b1f98-f7b7-4f4d-8256-2bf79fe176b6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_7b575ac6-3b18-481e-aa5e-add841b64281" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_e49e565f-78e3-4f68-9583-4ce27fef80b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c01b1f98-f7b7-4f4d-8256-2bf79fe176b6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_e49e565f-78e3-4f68-9583-4ce27fef80b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d4af21de-6b4a-4c1d-bfc0-3712da9c3db3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_e49e565f-78e3-4f68-9583-4ce27fef80b5" xlink:to="loc_srt_RangeAxis_d4af21de-6b4a-4c1d-bfc0-3712da9c3db3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d4af21de-6b4a-4c1d-bfc0-3712da9c3db3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d4af21de-6b4a-4c1d-bfc0-3712da9c3db3" xlink:to="loc_srt_RangeMember_d4af21de-6b4a-4c1d-bfc0-3712da9c3db3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5ff9790d-aff0-429f-bb79-0a5bac0adde8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d4af21de-6b4a-4c1d-bfc0-3712da9c3db3" xlink:to="loc_srt_RangeMember_5ff9790d-aff0-429f-bb79-0a5bac0adde8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ea484124-7b2f-47ff-b345-508a9b8c4f6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5ff9790d-aff0-429f-bb79-0a5bac0adde8" xlink:to="loc_srt_MinimumMember_ea484124-7b2f-47ff-b345-508a9b8c4f6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3acbfa6f-4163-4190-bc04-3b0a69e39e54" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5ff9790d-aff0-429f-bb79-0a5bac0adde8" xlink:to="loc_srt_MaximumMember_3acbfa6f-4163-4190-bc04-3b0a69e39e54" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails" xlink:type="extended" id="i059d408fdb404f6887335df4965b4365_NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e09553a1-010c-41b4-abb9-6ac0074109fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_76b475a6-9ccc-4b08-9831-ccc44ebe9e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e09553a1-010c-41b4-abb9-6ac0074109fc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_76b475a6-9ccc-4b08-9831-ccc44ebe9e33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e281de1b-6a4e-4aa3-acde-de77b87cab57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e09553a1-010c-41b4-abb9-6ac0074109fc" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e281de1b-6a4e-4aa3-acde-de77b87cab57" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6aa6dd67-9723-4857-9ab6-a8c3678d1a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e281de1b-6a4e-4aa3-acde-de77b87cab57" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6aa6dd67-9723-4857-9ab6-a8c3678d1a59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6aa6dd67-9723-4857-9ab6-a8c3678d1a59_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6aa6dd67-9723-4857-9ab6-a8c3678d1a59" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6aa6dd67-9723-4857-9ab6-a8c3678d1a59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b4f457a1-6504-4e9a-b20f-79f0ef7c1fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6aa6dd67-9723-4857-9ab6-a8c3678d1a59" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b4f457a1-6504-4e9a-b20f-79f0ef7c1fe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a9dd1ad0-a8d3-412c-8f0f-c0ccf1453511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b4f457a1-6504-4e9a-b20f-79f0ef7c1fe4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a9dd1ad0-a8d3-412c-8f0f-c0ccf1453511" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_99e510f9-3377-4cbf-8fcf-7196cee5d6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b4f457a1-6504-4e9a-b20f-79f0ef7c1fe4" xlink:to="loc_us-gaap_RestrictedStockMember_99e510f9-3377-4cbf-8fcf-7196cee5d6a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a86bca33-ef87-44ce-8512-08e8d706733a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b4f457a1-6504-4e9a-b20f-79f0ef7c1fe4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a86bca33-ef87-44ce-8512-08e8d706733a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/RelatedPartyDisclosuresDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#RelatedPartyDisclosuresDetails"/>
  <link:definitionLink xlink:role="http://www.zentalis.com/role/RelatedPartyDisclosuresDetails" xlink:type="extended" id="i8c64a4e4d4d4410589bfc1b979137bcb_RelatedPartyDisclosuresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_eae2613b-00a1-4662-ae13-6e2e1b656dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_us-gaap_PreferredStockSharesIssued_eae2613b-00a1-4662-ae13-6e2e1b656dea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_4787b89e-7292-4a99-87e3-ec55c2c37457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_4787b89e-7292-4a99-87e3-ec55c2c37457" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_d8739bef-a11a-4ddd-8573-82fe69f61f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_d8739bef-a11a-4ddd-8573-82fe69f61f61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_RelatedPartyAgreementTerm_88b5f3e4-cb6b-4778-9e3c-4e44d1893b83" xlink:href="zntl-20210930.xsd#zntl_RelatedPartyAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_zntl_RelatedPartyAgreementTerm_88b5f3e4-cb6b-4778-9e3c-4e44d1893b83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_4aa8b2a2-9502-4cd5-8ecb-48671794e441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_4aa8b2a2-9502-4cd5-8ecb-48671794e441" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_3bb1e06a-43f5-4ac1-827e-da8bdba067e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_3bb1e06a-43f5-4ac1-827e-da8bdba067e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ResearchAndDevelopmentExpenseReimbursements_75c2e6e7-90d0-4728-bc8b-49615905f7ab" xlink:href="zntl-20210930.xsd#zntl_ResearchAndDevelopmentExpenseReimbursements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_zntl_ResearchAndDevelopmentExpenseReimbursements_75c2e6e7-90d0-4728-bc8b-49615905f7ab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_17da879c-db58-4582-ace9-881eef1be834" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:to="loc_srt_ConsolidatedEntitiesAxis_17da879c-db58-4582-ace9-881eef1be834" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_17da879c-db58-4582-ace9-881eef1be834_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_17da879c-db58-4582-ace9-881eef1be834" xlink:to="loc_srt_ConsolidatedEntitiesDomain_17da879c-db58-4582-ace9-881eef1be834_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1d5252d4-4268-405d-85a9-5f9d960d5ebf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_17da879c-db58-4582-ace9-881eef1be834" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1d5252d4-4268-405d-85a9-5f9d960d5ebf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_a00aafc0-76f7-436f-8d9b-b99457e31b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1d5252d4-4268-405d-85a9-5f9d960d5ebf" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_a00aafc0-76f7-436f-8d9b-b99457e31b59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1d0101a2-90cb-4ec3-8157-4b7ec8d6eb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1d0101a2-90cb-4ec3-8157-4b7ec8d6eb0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1d0101a2-90cb-4ec3-8157-4b7ec8d6eb0f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1d0101a2-90cb-4ec3-8157-4b7ec8d6eb0f" xlink:to="loc_us-gaap_ClassOfStockDomain_1d0101a2-90cb-4ec3-8157-4b7ec8d6eb0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e881aee0-f830-404e-87f7-5e893306b113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1d0101a2-90cb-4ec3-8157-4b7ec8d6eb0f" xlink:to="loc_us-gaap_ClassOfStockDomain_e881aee0-f830-404e-87f7-5e893306b113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_749f361f-968f-4722-a57b-774c562c2c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e881aee0-f830-404e-87f7-5e893306b113" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_749f361f-968f-4722-a57b-774c562c2c8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_206556b9-c4b1-4a94-b991-0c8233a8f77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_206556b9-c4b1-4a94-b991-0c8233a8f77f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_206556b9-c4b1-4a94-b991-0c8233a8f77f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_206556b9-c4b1-4a94-b991-0c8233a8f77f" xlink:to="loc_us-gaap_RelatedPartyDomain_206556b9-c4b1-4a94-b991-0c8233a8f77f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_40d14cda-ce60-4bb7-ab49-68d004f05d34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_206556b9-c4b1-4a94-b991-0c8233a8f77f" xlink:to="loc_us-gaap_RelatedPartyDomain_40d14cda-ce60-4bb7-ab49-68d004f05d34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_e7ac6812-caf0-4887-94d3-cd6e44ccec49" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_40d14cda-ce60-4bb7-ab49-68d004f05d34" xlink:to="loc_srt_AffiliatedEntityMember_e7ac6812-caf0-4887-94d3-cd6e44ccec49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_f19b91c7-0e1d-4957-8790-85e5b154ca78" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_40d14cda-ce60-4bb7-ab49-68d004f05d34" xlink:to="loc_srt_DirectorMember_f19b91c7-0e1d-4957-8790-85e5b154ca78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_3928d9ac-aece-404d-b518-af08de173a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_3928d9ac-aece-404d-b518-af08de173a81" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_3928d9ac-aece-404d-b518-af08de173a81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_3928d9ac-aece-404d-b518-af08de173a81" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_3928d9ac-aece-404d-b518-af08de173a81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_52ea5167-6a6b-4ece-8f98-2f5bef872a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_3928d9ac-aece-404d-b518-af08de173a81" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_52ea5167-6a6b-4ece-8f98-2f5bef872a0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_LicenseAgreementMember_9943ca11-538c-4c37-896b-9c0c75e68d24" xlink:href="zntl-20210930.xsd#zntl_LicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_52ea5167-6a6b-4ece-8f98-2f5bef872a0c" xlink:to="loc_zntl_LicenseAgreementMember_9943ca11-538c-4c37-896b-9c0c75e68d24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_MasterServicesAgreementMember_65dea461-a89a-4ac0-b248-eb76141548a5" xlink:href="zntl-20210930.xsd#zntl_MasterServicesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_52ea5167-6a6b-4ece-8f98-2f5bef872a0c" xlink:to="loc_zntl_MasterServicesAgreementMember_65dea461-a89a-4ac0-b248-eb76141548a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ea3fd7ee-bddd-43f3-90d0-7bbb3515339e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ea3fd7ee-bddd-43f3-90d0-7bbb3515339e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea3fd7ee-bddd-43f3-90d0-7bbb3515339e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ea3fd7ee-bddd-43f3-90d0-7bbb3515339e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea3fd7ee-bddd-43f3-90d0-7bbb3515339e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e86004d-877b-4f74-8a51-0995622ad004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ea3fd7ee-bddd-43f3-90d0-7bbb3515339e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e86004d-877b-4f74-8a51-0995622ad004" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_KalyraPharmaceuticalsIncMember_1e160c94-d9ec-4fd9-9261-2b34988c7b48" xlink:href="zntl-20210930.xsd#zntl_KalyraPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e86004d-877b-4f74-8a51-0995622ad004" xlink:to="loc_zntl_KalyraPharmaceuticalsIncMember_1e160c94-d9ec-4fd9-9261-2b34988c7b48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_09db6564-298f-4d40-9d89-bf3ac2b5d938" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_09db6564-298f-4d40-9d89-bf3ac2b5d938" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_09db6564-298f-4d40-9d89-bf3ac2b5d938_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_09db6564-298f-4d40-9d89-bf3ac2b5d938" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_09db6564-298f-4d40-9d89-bf3ac2b5d938_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e9c50338-ab94-4a19-b6a1-294255096856" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_09db6564-298f-4d40-9d89-bf3ac2b5d938" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e9c50338-ab94-4a19-b6a1-294255096856" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ZenteraTherapeuticsLtdMember_caa40696-694a-4d0c-9d8f-5c7e36b50cb4" xlink:href="zntl-20210930.xsd#zntl_ZenteraTherapeuticsLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e9c50338-ab94-4a19-b6a1-294255096856" xlink:to="loc_zntl_ZenteraTherapeuticsLtdMember_caa40696-694a-4d0c-9d8f-5c7e36b50cb4" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>zntl-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:ec330f09-1704-42bb-8fbc-efe747c127bc,g:cceb589a-52db-4380-936c-762192d75fd3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_0258a8c6-fb91-4004-af79-53243949e2fe_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_02807850-190f-49ad-a440-7539ff553fe4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_2e581652-de66-476f-be6f-b68220318c34_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Zentalis</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_64277136-1916-4ac9-bf55-d29dbeb09c70_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Zentalis</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_a2b38e37-9727-4b27-84be-2a717d8e9d43_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4d9e5fc9-5343-45a0-8544-8b19329707bf_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_65d19f18-fd41-436f-80b0-fc1e775b9ad5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease&#160;right-of-use&#160;assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_A2017ProfitInterestPlanMember_f69cc84e-b6d8-4edb-acbe-dfe419a11a3f_terseLabel_en-US" xlink:label="lab_zntl_A2017ProfitInterestPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Plan</link:label>
    <link:label id="lab_zntl_A2017ProfitInterestPlanMember_label_en-US" xlink:label="lab_zntl_A2017ProfitInterestPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Profit Interest Plan [Member]</link:label>
    <link:label id="lab_zntl_A2017ProfitInterestPlanMember_documentation_en-US" xlink:label="lab_zntl_A2017ProfitInterestPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Profit Interest Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_A2017ProfitInterestPlanMember" xlink:href="zntl-20210930.xsd#zntl_A2017ProfitInterestPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_A2017ProfitInterestPlanMember" xlink:to="lab_zntl_A2017ProfitInterestPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_7be46fbc-a7d1-4687-8a70-ecfbf966bb29_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_fa7c121a-8311-40dd-9096-838b95f98eb7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued employee expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_b4793b5b-a19d-46f9-b950-e8e43b2a712c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_5eed832d-e3de-4197-b5cb-0235d0df4f0e_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_6105c753-bee4-414a-9ca4-658ae2f78354_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_8be6b253-e3d4-48e7-9f00-7dad131fc478_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8210a356-f59e-4dac-a825-47b60204abd9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashDivestedFromDeconsolidation_56831620-4ba3-45e6-9555-bbd185e6c97c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidation of Zentera cash</link:label>
    <link:label id="lab_us-gaap_CashDivestedFromDeconsolidation_label_en-US" xlink:label="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Divested from Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashDivestedFromDeconsolidation" xlink:to="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_4a3e7e5b-9bda-4a8c-8c33-a9af31a5ba17_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_df6d15b5-4757-4ece-a226-828fbe2111b4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, weighted-average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_8a04c3a2-0c78-49be-b55a-1cc8d2e585c5_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_333ad99f-4f62-4de2-8b7c-f71e6d482ae2_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_50bcdb0b-d97f-4509-a4d7-d5f423a0a474_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity_066980d9-fb4c-4cfe-8d1d-ffce408dcc26_terseLabel_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time to liquidity (in years)</link:label>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity_label_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Time to Liquidity</link:label>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity_documentation_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Time to Liquidity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity" xlink:to="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03be2d38-fee8-4dc8-bb5f-cba68900a8ee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_244ff2cc-41ac-46c5-91ad-d00f12cf9a92_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_CommonStockSharesSubjectToFutureVestingProvisions_b46a24a1-499b-4521-90e9-47dd9258fe9b_terseLabel_en-US" xlink:label="lab_zntl_CommonStockSharesSubjectToFutureVestingProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock subject to future vesting provisions (in shares)</link:label>
    <link:label id="lab_zntl_CommonStockSharesSubjectToFutureVestingProvisions_label_en-US" xlink:label="lab_zntl_CommonStockSharesSubjectToFutureVestingProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Subject to Future Vesting Provisions</link:label>
    <link:label id="lab_zntl_CommonStockSharesSubjectToFutureVestingProvisions_documentation_en-US" xlink:label="lab_zntl_CommonStockSharesSubjectToFutureVestingProvisions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Subject to Future Vesting Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_CommonStockSharesSubjectToFutureVestingProvisions" xlink:href="zntl-20210930.xsd#zntl_CommonStockSharesSubjectToFutureVestingProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_CommonStockSharesSubjectToFutureVestingProvisions" xlink:to="lab_zntl_CommonStockSharesSubjectToFutureVestingProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_2cc708de-d2c9-4f3c-9a25-d61834ddee48_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interest owners, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_a9ac95a3-4181-4cee-a481-3b8ed3c7d97d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_9a496dce-9052-4312-acdb-09a4ef464ab5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for future grants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_a5d7c39d-0acf-45a4-9f42-3bbfaf1d5d5f_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_05806244-2480-4c07-9d9a-804af2b43c03_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase/(decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0404e69b-cf60-4573-9b0c-320b733c6d29_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f74f5e51-9cc0-4eca-944a-fe2f2fe1af96_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_28f3aec1-07a0-4064-b341-adaf085fe308_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_93836032-549f-45cd-84ae-de97541a7432_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Available-for-sale Marketable Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_0be31687-6274-40d1-b4b6-4e9a257ce081_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_bbf864c4-e2e3-4158-a68e-58680d4792a3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_LaboratoryEquipmentMember_499bccc3-bd37-4653-9de0-627105fd6562_terseLabel_en-US" xlink:label="lab_zntl_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lab Equipment</link:label>
    <link:label id="lab_zntl_LaboratoryEquipmentMember_label_en-US" xlink:label="lab_zntl_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment [Member]</link:label>
    <link:label id="lab_zntl_LaboratoryEquipmentMember_documentation_en-US" xlink:label="lab_zntl_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_LaboratoryEquipmentMember" xlink:href="zntl-20210930.xsd#zntl_LaboratoryEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_LaboratoryEquipmentMember" xlink:to="lab_zntl_LaboratoryEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_aad628ac-8645-4bae-b624-3b300766ede1_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per unit (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_5d0fca82-52fb-4a9e-bb67-ce933417c28c_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_809432fb-7e3d-4457-aa0e-e60f25cb3325_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0eec1856-8d48-456e-8c8e-15e81869d709_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_d23f6242-7de9-4ae4-9abc-43e6566b636e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_8748df9c-85f0-4c75-9a80-7976caa5780d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3102befd-20de-4b08-9925-c8aa13761a00_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering_175a6bcd-6dd6-43ed-ac39-c296e7deccce_terseLabel_en-US" xlink:label="lab_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Automatic conversion feature, minimum gross cash proceeds received in a public offering</link:label>
    <link:label id="lab_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering_label_en-US" xlink:label="lab_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Automatic Conversion Feature, Gross Cash Proceeds Minimum Amount Received In A Public Offering</link:label>
    <link:label id="lab_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering_documentation_en-US" xlink:label="lab_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Automatic Conversion Feature, Gross Cash Proceeds Minimum Amount Received In A Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering" xlink:to="lab_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_13b1f097-8b45-4604-892a-1203d0fc22f5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_dd2f69ed-a8ea-4202-a81c-f3d5ac37659d_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock_acd22a9e-98d3-49d5-bb92-98134cd0c407_terseLabel_en-US" xlink:label="lab_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses and fees from the issuance of common stock</link:label>
    <link:label id="lab_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock_label_en-US" xlink:label="lab_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses and Fees from the Issuance of Common Stock</link:label>
    <link:label id="lab_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock_documentation_en-US" xlink:label="lab_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses and Fees from the Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock" xlink:href="zntl-20210930.xsd#zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock" xlink:to="lab_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_9e9ffa1f-39ed-46eb-beb9-59f3a65c5e3b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Maturities of Available-for-sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_19d69526-1060-416d-90f8-276af646757b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding at September&#160;30, 2021 and December 31, 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_aff57598-8ce2-4eb9-a65c-13fb3e1432f2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock under equity incentive plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d3ab7f9c-7cc8-48c5-afff-897748936401_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_663fd732-e3c2-46d8-90fc-496fb7425be4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_805947de-abc1-48a9-b984-507c2624a830_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_16d632e0-c9c2-4544-82a6-6820a7d2d058_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_8a448b54-ba7c-4919-8cda-6d86f364f29a_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f6c09340-aae3-4ff4-ad57-45fc765257a2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_9f0dc818-249e-4dfa-98ee-cf393b7f8a20_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases not yet commenced, term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_77544131-c5bb-47c4-91f3-52fdf256a192_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8519da29-9c40-4d8d-839d-d5ec328df996_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_08177c9d-191f-4b34-9c27-d19a1c883bd2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_CorporateConversionMember_8113ed6f-24a0-4371-9871-ce53aa720b02_terseLabel_en-US" xlink:label="lab_zntl_CorporateConversionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Conversion</link:label>
    <link:label id="lab_zntl_CorporateConversionMember_label_en-US" xlink:label="lab_zntl_CorporateConversionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Conversion [Member]</link:label>
    <link:label id="lab_zntl_CorporateConversionMember_documentation_en-US" xlink:label="lab_zntl_CorporateConversionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_CorporateConversionMember" xlink:href="zntl-20210930.xsd#zntl_CorporateConversionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_CorporateConversionMember" xlink:to="lab_zntl_CorporateConversionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_8085d8cd-29fd-4da7-8f1c-ab60d9211221_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_ef55e394-7348-4da3-88b0-b636a9650f2c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability, deconsolidation of Zentera</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investment in Noncontrolled Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeconsolidationGainOrLossAmount_ad0db0a2-0525-41e0-9483-4ab4b06c5f0a_terseLabel_en-US" xlink:label="lab_us-gaap_DeconsolidationGainOrLossAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on deconsolidation of Zentera, net of tax</link:label>
    <link:label id="lab_us-gaap_DeconsolidationGainOrLossAmount_label_en-US" xlink:label="lab_us-gaap_DeconsolidationGainOrLossAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidation, Gain (Loss), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeconsolidationGainOrLossAmount" xlink:to="lab_us-gaap_DeconsolidationGainOrLossAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_6713f4d2-899f-4c34-8631-d07b5087f8a0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP maximum percent of compensation to contribute</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_522f8a78-0cb0-4812-9415-4ddedfd49d17_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_45f3bf7e-4778-44ef-ab64-2f3b6410ccf1_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_c4552a19-039b-48df-856a-207c7ca9420a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidation event</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:to="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_f502e6db-a070-40ce-90cf-4aecad185cbd_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to related parties</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_104c92e3-c24f-4416-ab01-fab190c9fafe_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_c914c8b8-6685-4461-bfb9-37d49207e368_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share outstanding, basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsDisclosureTextBlock_de9e9072-6329-4d8c-8f95-975ec59817d0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d4254db6-d01d-414e-9a3e-c068245337ef_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonUnitIssuanceValue_5f58c919-cf2a-4ea0-ae17-5b939fd21d88_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonUnitIssuanceValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common units, beginning balance</link:label>
    <link:label id="lab_us-gaap_CommonUnitIssuanceValue_a53b09e7-760b-497b-9fd9-1f2300923af1_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonUnitIssuanceValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common units, ending balance</link:label>
    <link:label id="lab_us-gaap_CommonUnitIssuanceValue_label_en-US" xlink:label="lab_us-gaap_CommonUnitIssuanceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Unit, Issuance Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonUnitIssuanceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonUnitIssuanceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonUnitIssuanceValue" xlink:to="lab_us-gaap_CommonUnitIssuanceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_4117a915-3dbc-4d0e-a4d2-31e90a7de4b6_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_c19064b9-c133-4964-96c2-0865d6f34e50_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7df37ac7-ae05-4752-8b09-a3d2e8adc352_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized to be issued under plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_StockCancelledDuringPeriodShares_fe175117-dba3-4d61-8c4a-697bf2fa3459_negatedLabel_en-US" xlink:label="lab_zntl_StockCancelledDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation of profit interest awards, net (in shares)</link:label>
    <link:label id="lab_zntl_StockCancelledDuringPeriodShares_label_en-US" xlink:label="lab_zntl_StockCancelledDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Cancelled During Period, Shares</link:label>
    <link:label id="lab_zntl_StockCancelledDuringPeriodShares_documentation_en-US" xlink:label="lab_zntl_StockCancelledDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Cancelled During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_StockCancelledDuringPeriodShares" xlink:href="zntl-20210930.xsd#zntl_StockCancelledDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_StockCancelledDuringPeriodShares" xlink:to="lab_zntl_StockCancelledDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation_e2d8cf85-8eee-4199-a5ad-7052f6f5d0b1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefits and share-based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits and Share-based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:to="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_19643d38-264f-4775-b5a2-4721f842564a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments to acquire interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ProfitInterestAwardsMember_7d94e567-c75e-4290-aa7c-f4b32871c09c_verboseLabel_en-US" xlink:label="lab_zntl_ProfitInterestAwardsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit Interest Award Units</link:label>
    <link:label id="lab_zntl_ProfitInterestAwardsMember_bf54aa5b-a6a4-4774-9016-9c7fb059e290_terseLabel_en-US" xlink:label="lab_zntl_ProfitInterestAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit Interest Awards</link:label>
    <link:label id="lab_zntl_ProfitInterestAwardsMember_label_en-US" xlink:label="lab_zntl_ProfitInterestAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit Interest Awards [Member]</link:label>
    <link:label id="lab_zntl_ProfitInterestAwardsMember_documentation_en-US" xlink:label="lab_zntl_ProfitInterestAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit Interest Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ProfitInterestAwardsMember" xlink:href="zntl-20210930.xsd#zntl_ProfitInterestAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ProfitInterestAwardsMember" xlink:to="lab_zntl_ProfitInterestAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityRedemptionPricePerShare_bc1f3554-d9d3-4e96-afb7-2040533e870e_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityRedemptionPricePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Redemption Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="lab_us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ReconciliationOfNoncontrollingInterestTableTextBlock_14723cee-7b62-493c-a93c-1cc71fc228be_terseLabel_en-US" xlink:label="lab_zntl_ReconciliationOfNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Equity Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_zntl_ReconciliationOfNoncontrollingInterestTableTextBlock_label_en-US" xlink:label="lab_zntl_ReconciliationOfNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Noncontrolling Interest [Table Text Block]</link:label>
    <link:label id="lab_zntl_ReconciliationOfNoncontrollingInterestTableTextBlock_documentation_en-US" xlink:label="lab_zntl_ReconciliationOfNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ReconciliationOfNoncontrollingInterestTableTextBlock" xlink:href="zntl-20210930.xsd#zntl_ReconciliationOfNoncontrollingInterestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ReconciliationOfNoncontrollingInterestTableTextBlock" xlink:to="lab_zntl_ReconciliationOfNoncontrollingInterestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_e890f55b-210c-442f-8ed9-d4e402d72c42_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Par value per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_1e3e8ff9-946c-405c-80ab-482b96dc5652_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_FollowOnPublicOfferingMember_24570273-ebdd-4279-80bd-b5f137e10cc4_terseLabel_en-US" xlink:label="lab_zntl_FollowOnPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow-On Public Offering</link:label>
    <link:label id="lab_zntl_FollowOnPublicOfferingMember_label_en-US" xlink:label="lab_zntl_FollowOnPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow-On Public Offering [Member]</link:label>
    <link:label id="lab_zntl_FollowOnPublicOfferingMember_documentation_en-US" xlink:label="lab_zntl_FollowOnPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow-On Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_FollowOnPublicOfferingMember" xlink:href="zntl-20210930.xsd#zntl_FollowOnPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_FollowOnPublicOfferingMember" xlink:to="lab_zntl_FollowOnPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_58ec4ee9-c748-46e2-9f34-1f0d23c1d7de_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_37fea616-e6f5-4ee4-9624-d744e994bdbc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b88b0cfb-07d9-4593-9f96-42241603928d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_71ae5446-0705-4709-8e3e-4769f4f19df1_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_6aeb9148-cce6-4d3e-89a0-dfa397e64eb3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_1e9be794-99c7-4ba8-8582-546fb5cdde38_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_LicenseAgreementMember_d6fdbcdd-ba78-4a4a-91b2-289e13959040_terseLabel_en-US" xlink:label="lab_zntl_LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Agreement</link:label>
    <link:label id="lab_zntl_LicenseAgreementMember_label_en-US" xlink:label="lab_zntl_LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Agreement [Member]</link:label>
    <link:label id="lab_zntl_LicenseAgreementMember_documentation_en-US" xlink:label="lab_zntl_LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_LicenseAgreementMember" xlink:href="zntl-20210930.xsd#zntl_LicenseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_LicenseAgreementMember" xlink:to="lab_zntl_LicenseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_64bfa295-c5df-49f8-ba98-64e1599bcee6_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_9abfcdf9-25b2-4982-aec8-5ca9b1a4e378_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0ee657c4-35ec-473b-9fa0-f4b5200f0ca4_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_0cd09424-dfd3-464a-a3f3-c349620b5325_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f31d6234-de90-4e7e-adc2-0636dad3ff39_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES&#160;AND&#160;STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_e9d90bce-3ac0-4ab2-a4be-fe91b84023cf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock in initial public offering, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_AccruedGeneralAndAdministrativeCostsCurrent_7473486b-46d9-44fd-9c1c-12a47fde971f_terseLabel_en-US" xlink:label="lab_zntl_AccruedGeneralAndAdministrativeCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued general and administrative expenses</link:label>
    <link:label id="lab_zntl_AccruedGeneralAndAdministrativeCostsCurrent_label_en-US" xlink:label="lab_zntl_AccruedGeneralAndAdministrativeCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued General And Administrative Costs, Current</link:label>
    <link:label id="lab_zntl_AccruedGeneralAndAdministrativeCostsCurrent_documentation_en-US" xlink:label="lab_zntl_AccruedGeneralAndAdministrativeCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued General And Administrative Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_AccruedGeneralAndAdministrativeCostsCurrent" xlink:href="zntl-20210930.xsd#zntl_AccruedGeneralAndAdministrativeCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_AccruedGeneralAndAdministrativeCostsCurrent" xlink:to="lab_zntl_AccruedGeneralAndAdministrativeCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_e18a0e75-3a39-4384-bd92-e6bcb7e652b1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Common Share/Class&#160;A Common Unit</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0c840395-8785-42ce-967f-1b808f71dafe_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_60b002a3-4640-4967-8e70-3d9cf15a094d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of options, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_0662173c-fa52-4370-bebf-a71d75f69f87_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_23524322-f296-4262-9a32-406b2cf5b721_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a9f73616-e421-44a0-a9c6-f063e7bbbba4_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_f90ab7e1-7be6-4b32-803a-ee34553cbbb4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross_702384c0-bf11-4cd2-b759-5eb2181faeb4_verboseLabel_en-US" xlink:label="lab_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from issuance of convertible preferred units</link:label>
    <link:label id="lab_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross_label_en-US" xlink:label="lab_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Redeemable Convertible Preferred Stock, Gross</link:label>
    <link:label id="lab_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross_documentation_en-US" xlink:label="lab_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Redeemable Convertible Preferred Stock, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross" xlink:href="zntl-20210930.xsd#zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross" xlink:to="lab_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ff0da257-bf74-4194-8a28-794fbd5f1bac_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ce9dbc65-e1f9-45f8-b2f0-7f80aa22c296_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_5c751217-557a-4150-9988-bca7426972eb_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2d3cb1c3-a051-4f3e-8844-b91dab1c54a9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_46ed557b-d936-488c-a25e-b28c53508638_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_4fafa788-1a3b-4a8d-9c95-d38fa8a38a76_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ResearchAndDevelopmentExpenseReimbursements_2fcd45c4-e7e9-4a67-b1f3-7594c224e2d0_terseLabel_en-US" xlink:label="lab_zntl_ResearchAndDevelopmentExpenseReimbursements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contra-research and development expense</link:label>
    <link:label id="lab_zntl_ResearchAndDevelopmentExpenseReimbursements_label_en-US" xlink:label="lab_zntl_ResearchAndDevelopmentExpenseReimbursements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Reimbursements</link:label>
    <link:label id="lab_zntl_ResearchAndDevelopmentExpenseReimbursements_documentation_en-US" xlink:label="lab_zntl_ResearchAndDevelopmentExpenseReimbursements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Reimbursements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ResearchAndDevelopmentExpenseReimbursements" xlink:href="zntl-20210930.xsd#zntl_ResearchAndDevelopmentExpenseReimbursements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ResearchAndDevelopmentExpenseReimbursements" xlink:to="lab_zntl_ResearchAndDevelopmentExpenseReimbursements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_89cc1763-4aed-41eb-85e9-7dac4b01c4b0_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ZenteraStockPlanMember_b45b556b-64f4-4207-9243-1d240d565141_terseLabel_en-US" xlink:label="lab_zntl_ZenteraStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zentera Stock Plan</link:label>
    <link:label id="lab_zntl_ZenteraStockPlanMember_label_en-US" xlink:label="lab_zntl_ZenteraStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zentera Stock Plan [Member]</link:label>
    <link:label id="lab_zntl_ZenteraStockPlanMember_documentation_en-US" xlink:label="lab_zntl_ZenteraStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zentera Stock Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ZenteraStockPlanMember" xlink:href="zntl-20210930.xsd#zntl_ZenteraStockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ZenteraStockPlanMember" xlink:to="lab_zntl_ZenteraStockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_c87dc53e-b745-4990-8820-544f9be7a427_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_96693c18-72a0-47f6-9407-6ea50f81eaee_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance fees and expenses</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_16147905-f60d-4811-9185-aa3200eccc70_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance costs of financing</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7d26cf20-40a2-43ff-8f76-441e7e4de6bf_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_0b021b49-f856-4856-842e-ab41fdf2b799_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b6a592b5-594d-493e-b790-b84215ef31c4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_AccruedResearchAndDevelopmentCostsCurrent_4bb69e5e-c73c-4193-96fc-39c7ad79dfcb_terseLabel_en-US" xlink:label="lab_zntl_AccruedResearchAndDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued research and development expenses</link:label>
    <link:label id="lab_zntl_AccruedResearchAndDevelopmentCostsCurrent_label_en-US" xlink:label="lab_zntl_AccruedResearchAndDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Development Costs, Current</link:label>
    <link:label id="lab_zntl_AccruedResearchAndDevelopmentCostsCurrent_documentation_en-US" xlink:label="lab_zntl_AccruedResearchAndDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Development Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_AccruedResearchAndDevelopmentCostsCurrent" xlink:href="zntl-20210930.xsd#zntl_AccruedResearchAndDevelopmentCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_AccruedResearchAndDevelopmentCostsCurrent" xlink:to="lab_zntl_AccruedResearchAndDevelopmentCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_7cf8eacf-fedb-461d-92cd-72702de3da92_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; 250,000,000 shares authorized; 45,198,528 and 41,040,286 shares issued and outstanding at September&#160;30, 2021 and December 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeAmortizationOfPremium_c63eb800-66ea-4205-a4f2-84f7f9cf447d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premiums on marketable securities, net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeAmortizationOfPremium_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Amortization of Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:to="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_88c10059-7091-49f6-94b0-172a423c755a_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining Weighted-Average Recognition Period (years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_67856a48-82c5-4aeb-8869-0817fdcc2b6c_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_edfce633-b418-41b9-8766-6e5a92eade35_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_PrepaidSoftwareLicenseAndMaintenance_22aac46c-97e6-4cda-8272-04fa9cabcc60_terseLabel_en-US" xlink:label="lab_zntl_PrepaidSoftwareLicenseAndMaintenance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid software licenses and maintenance</link:label>
    <link:label id="lab_zntl_PrepaidSoftwareLicenseAndMaintenance_label_en-US" xlink:label="lab_zntl_PrepaidSoftwareLicenseAndMaintenance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Software License And Maintenance</link:label>
    <link:label id="lab_zntl_PrepaidSoftwareLicenseAndMaintenance_documentation_en-US" xlink:label="lab_zntl_PrepaidSoftwareLicenseAndMaintenance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Software License And Maintenance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_PrepaidSoftwareLicenseAndMaintenance" xlink:href="zntl-20210930.xsd#zntl_PrepaidSoftwareLicenseAndMaintenance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_PrepaidSoftwareLicenseAndMaintenance" xlink:to="lab_zntl_PrepaidSoftwareLicenseAndMaintenance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredUnitsAuthorized_6151c8ea-5f21-4725-979c-eca6fa9e2bfe_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredUnitsAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred units authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredUnitsAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredUnitsAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Units, Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredUnitsAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredUnitsAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredUnitsAuthorized" xlink:to="lab_us-gaap_PreferredUnitsAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4574496f-ddc7-404c-981f-0f347d1c5ba2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_cd64f38f-c7ea-41c5-8894-fb182ac1c8e2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_2c3bfe89-1462-4a38-84f2-92bf879aaf07_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_63b825bd-1ab0-4427-8156-2b85cd458764_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSAs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_75ecd623-1b73-49cc-b394-39775049a41b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_761ffc87-0c4a-478a-8133-402d0a79769b_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interest owners</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Subsidiary Equity Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_aafa05bf-b552-4a09-9fa9-b45971106f0d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e2eb7382-46d9-4de5-9e04-fbd527c05bd6_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_8e739250-a645-4415-8756-3bd937f35354_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zentera receivable</link:label>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:to="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonUnitOutstanding_c6a77273-7797-4c70-b43c-2b73e2cf4b1d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonUnitOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common units, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonUnitOutstanding_f0c6f324-7203-4b40-8be5-a937ddb6e1dc_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonUnitOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common units, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonUnitOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonUnitOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Unit, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonUnitOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonUnitOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonUnitOutstanding" xlink:to="lab_us-gaap_CommonUnitOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_65e0bcff-a371-4aab-8563-b668087b3f29_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9b68a32f-4f7c-4324-96cb-718c3a0f671c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8fdee0a8-7dfd-4f30-a8d1-15e97c7eeda3_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonUnitAuthorized_58d9fbc7-083b-4eea-92e0-d579dcc39d8c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonUnitAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common units, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonUnitAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonUnitAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Unit, Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonUnitAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonUnitAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonUnitAuthorized" xlink:to="lab_us-gaap_CommonUnitAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_d6d61be3-c6d5-4c89-8361-39a3cb88b43e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of common and incentive units to common and restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_697d97bc-8be9-421d-94ba-a82dc1dc9500_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3fc30d03-9de6-4b57-89ce-4f6f1a948f49_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total prepaid expenses and other assets, current</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_1ea2ed81-b86b-432b-a179-28be76e28fe3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments to acquire interest</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses and Interest in Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_773dc264-4b0a-47e5-b13c-4d19eba24d34_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_e03745af-e4a5-47f5-8896-e0bfc378a479_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_e2df1184-0b41-4a56-af05-a41c781cd403_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_09d52b80-342b-4108-9814-088f9908e0cc_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_24360967-902f-4e86-bd35-17f6e16b1661_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_fdb94d51-0ef0-40df-a1ea-5a346c7d66b3_terseLabel_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering period</link:label>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_label_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Offering Period</link:label>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_documentation_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Offering Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:to="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_5dc7a68b-9444-4639-8e6b-ed79faa37fe0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare_acba4bd0-a67e-471a-acf2-2cf2169cfdd6_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidation preference (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Liquidation Preference Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:to="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_c306535d-942a-4e8d-b437-2df5b2005a82_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_23352e60-a1e6-4fa6-b8e6-f0cdb7034c6b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_f4be3015-0f90-43a3-adfe-a21a34c36184_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_9a03adce-c99f-42b0-9c19-02c59f262367_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_db1d4c5e-2f38-4270-8658-196e7bf23d89_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment and other income, net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d9b23f41-2924-44ea-a309-475a9838e2a5_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0b65bc40-7d5e-4105-9a4d-aa4d925316ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_f89b6a2e-0023-493a-9915-f45a5e06a1b7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_979142c1-ac71-4329-be09-5f90797f20fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_c043910b-5ae6-4739-ad45-7f0d9bae1b6a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one but within five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bd8b29db-e18e-426a-a8aa-ee8ff3b99a1a_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_feb385d8-cf88-4a41-9305-46a5de83c8b9_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Business</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_e4e23bd5-b3b7-4af9-aba9-92dd0d0a6551_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Series C convertible preferred units at $17.50 per unit net of issuance costs</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_693a8756-2ba1-47c4-9b7e-545fcbe37b45_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ec867e2f-f277-4f5d-a6a0-8ffb7ec63ae8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_9207b5d9-683d-473a-a7f2-fa02b9dffa8d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_26c64ae9-dd49-4bf3-81eb-0a8b69b9e568_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_MasterServicesAgreementMember_152e7fcd-81e0-4ace-81a9-1fbf2e8e7329_terseLabel_en-US" xlink:label="lab_zntl_MasterServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Master Services Agreement</link:label>
    <link:label id="lab_zntl_MasterServicesAgreementMember_label_en-US" xlink:label="lab_zntl_MasterServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Master Services Agreement [Member]</link:label>
    <link:label id="lab_zntl_MasterServicesAgreementMember_documentation_en-US" xlink:label="lab_zntl_MasterServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Master Services Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_MasterServicesAgreementMember" xlink:href="zntl-20210930.xsd#zntl_MasterServicesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_MasterServicesAgreementMember" xlink:to="lab_zntl_MasterServicesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_A2020IncentiveAwardPlanMember_48a35237-4955-4fe7-b769-213d5f2e862e_terseLabel_en-US" xlink:label="lab_zntl_A2020IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Plan</link:label>
    <link:label id="lab_zntl_A2020IncentiveAwardPlanMember_label_en-US" xlink:label="lab_zntl_A2020IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Incentive Award Plan [Member]</link:label>
    <link:label id="lab_zntl_A2020IncentiveAwardPlanMember_documentation_en-US" xlink:label="lab_zntl_A2020IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Incentive Award Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_A2020IncentiveAwardPlanMember" xlink:href="zntl-20210930.xsd#zntl_A2020IncentiveAwardPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_A2020IncentiveAwardPlanMember" xlink:to="lab_zntl_A2020IncentiveAwardPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_465292cf-4305-4050-a84d-bcbaf542272c_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of common and incentive units to common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_63b60c50-1312-4968-8032-1583df27b406_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued upon conversion of units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_0968da49-5616-4ebc-a0e5-71bb1a8507a7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_ba1643e7-b699-4492-beff-cc06e758a2a7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Accounting</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_16014127-3c73-4031-908b-499bc6194aa8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued Accounting Standards Adopted and Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidInsurance_557c4aea-5921-4c98-a9c8-bafcccf0f95c_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance</link:label>
    <link:label id="lab_us-gaap_PrepaidInsurance_label_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6fe24cf0-2747-4944-8114-e09ea876064b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_29bdcd24-a7f6-4f3c-94a5-332a3e3a2fbe_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_2ef3b126-9688-48a3-91df-984f39348df6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the issuance of Series C convertible preferred units, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_c0a06c9f-6387-4141-9c4d-c215ee9b8b2b_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of convertible preferred units</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Redeemable Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_62459ca3-92cc-48fe-a2d1-46a331640860_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_fbe304e0-c616-4627-b9f8-a7b62b562c0a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_41d5baf2-3930-4bef-a955-9217b827e964_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a1834b26-1a2f-4c63-b592-18d6e3c3f2b9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d3374a68-ba0c-4ba1-9207-46a4079f5d5f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Operating Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_b16ecab9-722a-437c-9b46-ec7106c8ca30_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c42e0f2b-497d-45b1-b7f3-eaf025a6126c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_f80eaca8-c834-438c-8f15-100d1be4cf30_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_2b37c6ed-44de-4f6f-9a35-3645d662c70c_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares acquired (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_cc156d0e-f84e-428e-be3b-528cd84725e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_d112b986-62e6-45f2-8ca1-3755c796d20e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Transactions</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ZenteraTherapeuticsLtdMember_823e104f-4ebd-4f46-b170-d052f6c0a94c_terseLabel_en-US" xlink:label="lab_zntl_ZenteraTherapeuticsLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zentera</link:label>
    <link:label id="lab_zntl_ZenteraTherapeuticsLtdMember_label_en-US" xlink:label="lab_zntl_ZenteraTherapeuticsLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zentera Therapeutics Ltd. [Member]</link:label>
    <link:label id="lab_zntl_ZenteraTherapeuticsLtdMember_documentation_en-US" xlink:label="lab_zntl_ZenteraTherapeuticsLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zentera Therapeutics Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ZenteraTherapeuticsLtdMember" xlink:href="zntl-20210930.xsd#zntl_ZenteraTherapeuticsLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ZenteraTherapeuticsLtdMember" xlink:to="lab_zntl_ZenteraTherapeuticsLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_795539b8-eecb-4008-a1f8-7501ad138d4c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4399a22c-df88-422b-8628-b472ea17af1d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of&#160;non-cash&#160;investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_a7cb4439-50aa-46b1-a1ba-223b2d77f130_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, minimum (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_509c9a66-3bef-48e1-a135-d76fb8dcac6a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ForeignResearchAndDevelopmentCreditRefund_5ba35ca7-a521-47f0-b72d-f2c27f5d0b01_terseLabel_en-US" xlink:label="lab_zntl_ForeignResearchAndDevelopmentCreditRefund" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign R&amp;D credit refund</link:label>
    <link:label id="lab_zntl_ForeignResearchAndDevelopmentCreditRefund_label_en-US" xlink:label="lab_zntl_ForeignResearchAndDevelopmentCreditRefund" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Research and Development Credit Refund</link:label>
    <link:label id="lab_zntl_ForeignResearchAndDevelopmentCreditRefund_documentation_en-US" xlink:label="lab_zntl_ForeignResearchAndDevelopmentCreditRefund" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Research and Development Credit Refund</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ForeignResearchAndDevelopmentCreditRefund" xlink:href="zntl-20210930.xsd#zntl_ForeignResearchAndDevelopmentCreditRefund"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ForeignResearchAndDevelopmentCreditRefund" xlink:to="lab_zntl_ForeignResearchAndDevelopmentCreditRefund" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_54a15ca8-eef3-44f2-8c8a-12f66e5b2a15_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_48ab1943-4867-4333-8efd-2c706eea7147_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0d54174d-0caa-4d8f-8773-aea31d208a93_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_37bf90f6-8764-41cc-a88d-7f6ca1ca30a1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6e3f7358-04e7-4b8c-bdbd-ddb538c43ff4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5ddeab80-f72c-4e79-b464-27efef63606a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_TemporaryEquityTextBlock_b0cd5c1b-cda0-40f8-86ea-9c7534a26d54_terseLabel_en-US" xlink:label="lab_zntl_TemporaryEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Units</link:label>
    <link:label id="lab_zntl_TemporaryEquityTextBlock_label_en-US" xlink:label="lab_zntl_TemporaryEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Text Block]</link:label>
    <link:label id="lab_zntl_TemporaryEquityTextBlock_documentation_en-US" xlink:label="lab_zntl_TemporaryEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityTextBlock" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_TemporaryEquityTextBlock" xlink:to="lab_zntl_TemporaryEquityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_32cfc42f-9ede-4c3b-b8a6-73436cab8c50_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_5c8488cf-453c-4117-8d87-bbd60f6b3ac7_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_d46c86e7-a6b5-4318-8522-819bf3b46fab_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_6bfbe576-d66d-44b2-ae29-8f2459624974_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Zentera Therapeutics</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a90ec506-a4c0-4904-a7cf-237b66c4975a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssets_b743b713-6133-4469-99f1-b87749c95324_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_a99b5bf8-7ee9-45f9-869a-55e98725e738_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_aeac950a-2c01-4ec1-a13f-89dbb12b70ed_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with restricted stock unit vesting (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_66a7e4de-9c16-46e9-b24d-2a659d9a72c3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued upon vesting of certain RSAs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_eff4874b-9167-4dfe-b83b-b5c119515f4c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b996caa1-dc73-4503-9553-6531142d2794_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2e41670c-01af-459e-89d8-6d9eb784f3f5_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7cdd925d-357d-4618-b6d0-474a89a72695_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5ae36e07-97fa-48cb-8670-c8bb8f047c7b_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_b783a1db-bfd6-45fe-9229-ac686325814b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from government grants, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_c02931ef-5a26-4088-860e-822438d1088a_terseLabel_en-US" xlink:label="lab_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of leases not yet commenced</link:label>
    <link:label id="lab_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_label_en-US" xlink:label="lab_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease not yet Commenced, Number of Contracts</link:label>
    <link:label id="lab_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_documentation_en-US" xlink:label="lab_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease not yet Commenced, Number of Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:href="zntl-20210930.xsd#zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:to="lab_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_EarningsPerShareNumeratorAbstract_61b64b47-c93c-45ca-b229-c652b2f950a7_terseLabel_en-US" xlink:label="lab_zntl_EarningsPerShareNumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_zntl_EarningsPerShareNumeratorAbstract_label_en-US" xlink:label="lab_zntl_EarningsPerShareNumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Numerator [Abstract]</link:label>
    <link:label id="lab_zntl_EarningsPerShareNumeratorAbstract_documentation_en-US" xlink:label="lab_zntl_EarningsPerShareNumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Numerator</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_EarningsPerShareNumeratorAbstract" xlink:href="zntl-20210930.xsd#zntl_EarningsPerShareNumeratorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_EarningsPerShareNumeratorAbstract" xlink:to="lab_zntl_EarningsPerShareNumeratorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_80ff7734-f1dd-4aa6-a591-0aa3911d9806_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e0c569de-2b7a-4f2e-a0f6-f486573e67ea_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_e4587b8e-4231-4df4-bbf1-4f6a8fb9704e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_3e02dfab-0f5e-4b83-9260-f32c07520a0e_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares converted (in shares)</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:to="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_acab106d-2a9e-4a86-a803-adbda90456a4_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments:</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_f876ef84-d5d3-4066-9ba9-9808fe7d514b_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_7835e382-9943-4a8f-9c89-bfcb87628b71_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_2a8da487-8161-4c19-9608-8adb44ab4be6_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts_f3fbd8db-b08a-4a1f-9846-004bed33f861_terseLabel_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold amounts (in thousands)</link:label>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts_label_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Threshold Amounts</link:label>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts_documentation_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Threshold Amounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts" xlink:to="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_7d4f64ce-5def-45ee-9881-17f4e84fb2b4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_bf337c21-2f89-42b5-aef5-058850ce6100_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized expense, stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_f364e7e8-736f-4eb8-89ac-68e22123736f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_6bbda363-80cf-4299-973e-d76b8fed44be_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_52225b78-6657-4aca-b428-c74f8a1b0cb5_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_9f83c763-6967-4b5e-a02c-cf2de6485bf8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_36725778-9933-4099-8d9e-6a727fb64006_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized expense, other than options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_ca5a5960-e2a7-4e30-919d-d7d15a0c9a8c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3f9a8630-5601-4c0e-893a-356b333adb84_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Option equity instruments, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_84463661-f87c-4e88-904b-27a542bd8173_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7b58b38f-215f-4fdb-8bb9-cf2c9f13660c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation effects</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_989989b0-7b6e-4d6a-b045-b69a623538d9_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_197851cc-54bb-4356-a9a7-fc39aaf74e4c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a4756abb-2780-417c-8212-75663e0f8397_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_31804717-3d86-43c0-967f-b780e61c46a2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_43b6ef82-acfb-4cd8-9b9d-1c8d394fa97c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation of restricted stock awards (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_f037fe24-6f49-4cbc-8fb8-1080adca2b27_terseLabel_en-US" xlink:label="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Series C convertible preferred units at $17.50 per unit net of issuance costs (in shares)</link:label>
    <link:label id="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_6623d9fa-6e75-420f-8780-ae9fe37d8c5c_verboseLabel_en-US" xlink:label="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred units issued (in shares)</link:label>
    <link:label id="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_documentation_en-US" xlink:label="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_3d4ada69-f584-4093-a5e2-ccc9198a2674_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_e1d3b815-0c42-4921-8a1c-f03788b72468_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_dbc48152-1ef0-4781-93b7-423f9a90af9e_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Units</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_290b12af-f258-420a-ad58-055d3cf66149_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1cd97ff5-fa4a-4e1c-9fce-e7e7b83137ab_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, available-for-sale, fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions_5399a81e-87a4-4acd-8d6a-d46d8a5f3843_terseLabel_en-US" xlink:label="lab_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common units subject to future vesting conditions (in shares)</link:label>
    <link:label id="lab_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions_label_en-US" xlink:label="lab_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Unit, Outstanding, Subject to Future Vesting Conditions</link:label>
    <link:label id="lab_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions_documentation_en-US" xlink:label="lab_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Unit, Outstanding, Subject to Future Vesting Conditions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions" xlink:href="zntl-20210930.xsd#zntl_CommonUnitOutstandingSubjectToFutureVestingConditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions" xlink:to="lab_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_b146dacf-b447-42f2-99cd-e8f4dce95aeb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_57b378b4-1698-4773-8a77-69a4c510883e_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Expense by Type of Share-based Award</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_a45ac1c6-cd9f-4d9b-bcf0-ec9603dfff81_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP purchase price of common stock, percent of market price</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_077bdb67-f0f1-4371-8f7a-4f833bd7ffc3_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_79c51a43-fa9d-4235-a767-4665e50209c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6ff2f3e5-b2f9-4d89-b340-a9f4541c88e8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7a49b45a-1e32-4fa9-b2ec-9fbd352f145e_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_53114845-e7a8-4789-b247-aa96e63b4bf2_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_65d06049-8be6-478b-b3e1-e4373b89ad89_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8e17dc96-69f5-4879-b7ba-78397292eb03_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Basic and Diluted Net Loss Per Unit</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_d6aa8926-865f-44bf-8d37-b3ef58a85042_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_9b637de0-5e56-4e37-b09c-96c8236caccb_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_24934684-7232-4ec1-8ff3-b8551c5df6fa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_0ab8e925-6474-46c7-9902-a0445d81291e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_00a4dfa4-2d5c-45fc-80dd-63ba712b4504_terseLabel_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum contribution amount</link:label>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_label_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Amount</link:label>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_documentation_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:to="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_ac47cf7e-0990-48ca-95b4-2bbcd8577fd0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_99d33efc-b708-4d69-a5c6-6ff2a7673f6c_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_74d57de4-a127-4a66-85ec-bc84b80808bb_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_8af662f6-8590-4cb4-ab3a-85688fcdfc15_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_26e05322-277c-4042-88a0-dde60f3911be_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_026c7384-9917-4e39-8017-bc73d9b6b2d6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_8f9ce6dd-edc6-48c3-ae78-8c7db7f531b5_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_dcd57082-9b16-4d77-b30a-4326541dd121_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ProceedsFromIssuanceOfCommonStockGross_61258a0d-9e34-4a17-a5f5-38fc56b369b0_terseLabel_en-US" xlink:label="lab_zntl_ProceedsFromIssuanceOfCommonStockGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from issuance of common stock</link:label>
    <link:label id="lab_zntl_ProceedsFromIssuanceOfCommonStockGross_label_en-US" xlink:label="lab_zntl_ProceedsFromIssuanceOfCommonStockGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Common Stock, Gross</link:label>
    <link:label id="lab_zntl_ProceedsFromIssuanceOfCommonStockGross_documentation_en-US" xlink:label="lab_zntl_ProceedsFromIssuanceOfCommonStockGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Common Stock, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ProceedsFromIssuanceOfCommonStockGross" xlink:href="zntl-20210930.xsd#zntl_ProceedsFromIssuanceOfCommonStockGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ProceedsFromIssuanceOfCommonStockGross" xlink:to="lab_zntl_ProceedsFromIssuanceOfCommonStockGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c855a628-7651-4686-b000-e7df706d233f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a7680f1f-5881-4a7e-89ec-b227e1acd77d_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_111522eb-dd20-4eed-bc53-4c9e83596dd4_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_d25341f2-34d2-4db2-aa8c-8b6f0aca8a3d_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less long-term portion</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35b24616-c8b0-47e6-b444-89b939495191_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_fcb6073f-fe64-412d-8383-947c51cc689f_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Unaudited Financial Statements</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_c91df860-eebc-4355-bccc-422c857864ee_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1d44bb3d-b7ef-4f83-9280-cb97cb62b34b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2d84cb0d-3281-4dcd-bc2d-83d1e34a0c12_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares used in computing net loss per share, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d6463bfe-d621-4c8e-bf7a-984bf10f4b1b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_efb97852-221b-4640-bce9-bfe757832934_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share outstanding, diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_CommonStockConversionRatio_9018df0f-14b1-4570-80c4-be85a0153aba_terseLabel_en-US" xlink:label="lab_zntl_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange ratio</link:label>
    <link:label id="lab_zntl_CommonStockConversionRatio_label_en-US" xlink:label="lab_zntl_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Conversion Ratio</link:label>
    <link:label id="lab_zntl_CommonStockConversionRatio_documentation_en-US" xlink:label="lab_zntl_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_CommonStockConversionRatio" xlink:href="zntl-20210930.xsd#zntl_CommonStockConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_CommonStockConversionRatio" xlink:to="lab_zntl_CommonStockConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_f8bd2101-8974-4b28-98fe-9bd2c6e7da79_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (in dollars per sharee)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ComputerAndOfficeEquipmentMember_a00a3061-1ba1-411c-8833-324a0ca7517e_terseLabel_en-US" xlink:label="lab_zntl_ComputerAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and Office Equipment</link:label>
    <link:label id="lab_zntl_ComputerAndOfficeEquipmentMember_label_en-US" xlink:label="lab_zntl_ComputerAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer And Office Equipment [Member]</link:label>
    <link:label id="lab_zntl_ComputerAndOfficeEquipmentMember_documentation_en-US" xlink:label="lab_zntl_ComputerAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer And Office Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ComputerAndOfficeEquipmentMember" xlink:href="zntl-20210930.xsd#zntl_ComputerAndOfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ComputerAndOfficeEquipmentMember" xlink:to="lab_zntl_ComputerAndOfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_1a5da382-ce99-40f7-b823-97fc3a14319d_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_ae270596-2a73-45dd-a9ee-a3f3703d8ba0_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to Zentalis</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_d2880686-29d9-420a-9a55-3b7cbfed1fc3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2b66088e-cb26-4b00-b499-4050272bd0f6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_PrepaidResearchAndDevelopmentCosts_1f83f772-fb07-4a19-8125-12e6fee24471_terseLabel_en-US" xlink:label="lab_zntl_PrepaidResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid research and development expenses</link:label>
    <link:label id="lab_zntl_PrepaidResearchAndDevelopmentCosts_label_en-US" xlink:label="lab_zntl_PrepaidResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Research And Development Costs</link:label>
    <link:label id="lab_zntl_PrepaidResearchAndDevelopmentCosts_documentation_en-US" xlink:label="lab_zntl_PrepaidResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Research And Development Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_PrepaidResearchAndDevelopmentCosts" xlink:href="zntl-20210930.xsd#zntl_PrepaidResearchAndDevelopmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_PrepaidResearchAndDevelopmentCosts" xlink:to="lab_zntl_PrepaidResearchAndDevelopmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_bd60ba77-8382-4c2b-bb07-a265d78f43a6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_44c5c760-07ad-4e0f-b33f-bb0d1b209704_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_5d7dcef4-cd7c-4d8d-8c98-adb92ecfd455_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_3e48c8d5-b32e-4808-8c5f-943b3c93087d_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_5dd28174-455c-40c3-8213-1a8fd10cb730_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_1e4e6781-3609-4681-a0dc-a2b0c403c4e9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIE, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_320ca4b4-6995-4d1c-9a7e-bd3c340b492c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_7d2eed46-7f85-402b-afa8-95ab009bbc29_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_149ef82c-2734-419d-9abb-7a64839e91a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_6d6a0453-5aa7-4d70-978b-6a03386088db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities of VIE</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e2836a08-7479-4a57-91b5-4c2b66d058b3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_24b6e522-f141-4d2d-8751-5fbe88766e75_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred&#160;Units</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_fd9f8801-b996-49f2-9644-c5599dbb2ca4_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred&#160;Units</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6173fbc7-ca34-4af3-94b8-42f317cd5b93_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8ceda55a-5ccc-48c3-a744-434b38fa653d_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b95e69e2-a824-43ec-8082-3f22a60b8e11_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MembersEquity_67802c70-e9fc-4f73-80d2-f84aa69a6f65_terseLabel_en-US" xlink:label="lab_us-gaap_MembersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Members&#8217; equity value (in thousands)</link:label>
    <link:label id="lab_us-gaap_MembersEquity_label_en-US" xlink:label="lab_us-gaap_MembersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Members' Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MembersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MembersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MembersEquity" xlink:to="lab_us-gaap_MembersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_OtherPrepaidExpense_8217bed6-2098-429c-b72d-1c5b040b752c_terseLabel_en-US" xlink:label="lab_zntl_OtherPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other prepaid expenses</link:label>
    <link:label id="lab_zntl_OtherPrepaidExpense_label_en-US" xlink:label="lab_zntl_OtherPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense</link:label>
    <link:label id="lab_zntl_OtherPrepaidExpense_documentation_en-US" xlink:label="lab_zntl_OtherPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_OtherPrepaidExpense" xlink:href="zntl-20210930.xsd#zntl_OtherPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_OtherPrepaidExpense" xlink:to="lab_zntl_OtherPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassBMember_438879a5-e008-40ee-9ff0-7246a419f596_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class&#160;B Common&#160;Units</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cba346b9-b767-4e37-9849-c38facaf188f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_13c3c84b-c50a-49ad-8ad7-ec64d4f0d58b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_9d78537f-66a5-43ba-957e-c6e75fae9b36_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_bd540abf-2099-46c0-b688-4de8654087a7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Property and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_900afb78-da61-4707-b3f8-1ed91c3278c3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits_6b1fd616-7f37-42fa-a127-4a27230a94e1_negatedTerseLabel_en-US" xlink:label="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible preferred units to common stock (in shares)</link:label>
    <link:label id="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits_f7f0c46c-acbe-4565-be29-6004a552d27a_terseLabel_en-US" xlink:label="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible preferred units to common stock (in shares)</link:label>
    <link:label id="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits_label_en-US" xlink:label="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, Conversion Of Units</link:label>
    <link:label id="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits_documentation_en-US" xlink:label="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, Conversion Of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="lab_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_eae820cb-d7f9-4dba-9171-c8a4944d946b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_c0a0cfb5-a208-4208-a93f-8b37742929ab_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible preferred units to common stock</link:label>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_label_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications of Temporary to Permanent Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:to="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_9e26ccdc-db58-4b3e-81ca-fc79a85c8bcd_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivable_06c3d4e9-5a75-4780-917f-cc4983c6186e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable</link:label>
    <link:label id="lab_us-gaap_InterestReceivable_label_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivable" xlink:to="lab_us-gaap_InterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_0c3627d8-8d42-4882-8afb-d2c9504cc707_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:to="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_77cf24b2-ffd8-4f90-a63b-b7ed8a2910c8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_195c5fcf-7aa9-4792-9104-68916fa4afa3_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_d9bebf0d-bc48-434e-96ee-68e5e9257c04_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_3868ba8e-32b4-4273-86c3-5735c3ac0005_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_888f764d-d124-433c-95bc-8a075029b169_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock_177faace-3a46-41cf-9b29-407a884d7800_terseLabel_en-US" xlink:label="lab_zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Members&#8217; Equity</link:label>
    <link:label id="lab_zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock_label_en-US" xlink:label="lab_zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity, Share-Based Payments, And Members' Equity [Text Block]</link:label>
    <link:label id="lab_zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock_documentation_en-US" xlink:label="lab_zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity, Share-Based Payments, And Members' Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock" xlink:href="zntl-20210930.xsd#zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock" xlink:to="lab_zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability_44d4937b-d77c-40ab-8fcf-3b97ae38cb36_terseLabel_en-US" xlink:label="lab_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments on leases not yet commenced</link:label>
    <link:label id="lab_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability_label_en-US" xlink:label="lab_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability</link:label>
    <link:label id="lab_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability_documentation_en-US" xlink:label="lab_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:href="zntl-20210930.xsd#zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:to="lab_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_KalyraPharmaceuticalsIncMember_ad14348d-26cb-4385-8c0b-0f174cb8fb54_terseLabel_en-US" xlink:label="lab_zntl_KalyraPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kalyra Pharmaceuticals, Inc.</link:label>
    <link:label id="lab_zntl_KalyraPharmaceuticalsIncMember_label_en-US" xlink:label="lab_zntl_KalyraPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kalyra Pharmaceuticals, Inc. [Member]</link:label>
    <link:label id="lab_zntl_KalyraPharmaceuticalsIncMember_documentation_en-US" xlink:label="lab_zntl_KalyraPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kalyra Pharmaceuticals, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_KalyraPharmaceuticalsIncMember" xlink:href="zntl-20210930.xsd#zntl_KalyraPharmaceuticalsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_KalyraPharmaceuticalsIncMember" xlink:to="lab_zntl_KalyraPharmaceuticalsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ConvertiblePreferredStockDividendsPerShareDeclared_93536f24-7d9c-4f73-813b-6036394c546d_terseLabel_en-US" xlink:label="lab_zntl_ConvertiblePreferredStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared (in dollars per share)</link:label>
    <link:label id="lab_zntl_ConvertiblePreferredStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_zntl_ConvertiblePreferredStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Dividends Per Share, Declared</link:label>
    <link:label id="lab_zntl_ConvertiblePreferredStockDividendsPerShareDeclared_documentation_en-US" xlink:label="lab_zntl_ConvertiblePreferredStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Dividends Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ConvertiblePreferredStockDividendsPerShareDeclared" xlink:href="zntl-20210930.xsd#zntl_ConvertiblePreferredStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ConvertiblePreferredStockDividendsPerShareDeclared" xlink:to="lab_zntl_ConvertiblePreferredStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_FollowOnOfferingMember_2bfd9eae-3d53-4961-9bf4-bc2cdd51f963_terseLabel_en-US" xlink:label="lab_zntl_FollowOnOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow-On Offering</link:label>
    <link:label id="lab_zntl_FollowOnOfferingMember_label_en-US" xlink:label="lab_zntl_FollowOnOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow-On Offering [Member]</link:label>
    <link:label id="lab_zntl_FollowOnOfferingMember_documentation_en-US" xlink:label="lab_zntl_FollowOnOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow-On Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_FollowOnOfferingMember" xlink:href="zntl-20210930.xsd#zntl_FollowOnOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_FollowOnOfferingMember" xlink:to="lab_zntl_FollowOnOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_d8b9dbe4-dca7-4005-8137-1c4d9f32e8a5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_f3341bae-dc03-427a-970a-db09e0362eda_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_8a1a75f8-d2f2-4cf9-b194-ecb79b5b37f3_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_aeb7f19f-76a9-4216-8b85-fa6f9ce816be_terseLabel_en-US" xlink:label="lab_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets and liabilities, net</link:label>
    <link:label id="lab_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_label_en-US" xlink:label="lab_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Right-Of-Use Assets And Liabilities, Net</link:label>
    <link:label id="lab_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_documentation_en-US" xlink:label="lab_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Right-Of-Use Assets And Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" xlink:href="zntl-20210930.xsd#zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" xlink:to="lab_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_c5013a5e-ba4f-4f0e-88e3-a1779c4f9f72_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember_a0f986c6-8722-4ab2-b36a-cb5aa0ab90c2_terseLabel_en-US" xlink:label="lab_zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSAs and RSUs</link:label>
    <link:label id="lab_zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember_label_en-US" xlink:label="lab_zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards And Restricted Stock Units [Member]</link:label>
    <link:label id="lab_zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards And Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember" xlink:href="zntl-20210930.xsd#zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember" xlink:to="lab_zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_d0d6561a-3ca7-4959-9634-1535f15d1705_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of deferred tax liability due to IPR&amp;D impairment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_3de72b0f-8095-44cd-9f94-29791e216a1e_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Preferred Units</link:label>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesCPreferredStockMember" xlink:to="lab_us-gaap_SeriesCPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_2682d3db-bb88-48e1-b80a-9c6596c9b54b_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ccbe244c-981d-4153-a07f-7af743175a71_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_2d8e2170-228a-41e7-940d-c658aeb69c0f_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e8e7aaae-470d-404b-8671-63e1f169f740_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_08be12e4-a8be-44ce-9234-be057581bfdd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_67c5d290-5ef9-4d18-b07d-0a0b18f0a617_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_ffee32d7-1571-4c6e-8a9a-af5a4ce1de34_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Units</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_8557d263-c6dc-4303-b033-9e641b309f46_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_e4834dcc-8fd0-4b35-bd55-7e124c6f93cf_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_f6460447-2ed7-4dbc-ab25-622e41287c07_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_DeconsolidationGainLossAmountNet_a552ebbf-a538-4ade-b963-725936ecd40d_negatedTerseLabel_en-US" xlink:label="lab_zntl_DeconsolidationGainLossAmountNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on deconsolidation of Zentera, net of tax</link:label>
    <link:label id="lab_zntl_DeconsolidationGainLossAmountNet_label_en-US" xlink:label="lab_zntl_DeconsolidationGainLossAmountNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidation, Gain (Loss), Amount, Net</link:label>
    <link:label id="lab_zntl_DeconsolidationGainLossAmountNet_documentation_en-US" xlink:label="lab_zntl_DeconsolidationGainLossAmountNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidation, Gain (Loss), Amount, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_DeconsolidationGainLossAmountNet" xlink:href="zntl-20210930.xsd#zntl_DeconsolidationGainLossAmountNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_DeconsolidationGainLossAmountNet" xlink:to="lab_zntl_DeconsolidationGainLossAmountNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_0394fc28-9049-48f3-a945-6403114ce630_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_2fa56bbb-b938-4624-ac80-60dd50ce675e_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_0fe38255-1fef-44eb-bf5a-36aeb31ede5d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class&#160;A Common&#160;Units</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_41739f3b-f7eb-4766-991b-59ef567bbb86_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e37b12ec-1beb-401b-8617-5f7e320f71f8_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e2e07d8f-f0a1-483d-9861-66ea589ef148_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a8790ad3-6d90-4b93-bcd4-f2dbcd34cb12_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash reported in the Condensed Consolidated Statement of Cash Flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_ca6cd0a3-bc95-484b-bbac-9121c3d5eda0_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_74c822cc-2e32-4698-9215-923de0d63be7_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_88f2873c-c914-4b74-9612-a0cb556e9a2f_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued and sold (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_5ac0ab52-1d53-44e2-adc8-86076b7499ab_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_20370795-8436-4324-996b-b21c222db577_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, maximum (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_02801b1f-bbf0-4afc-8025-36caf26551bb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_RecognizedTaxGainOnIntangibleAssetImpairment_5e6025b9-1a9d-4794-ab65-f48cb6762159_negatedTerseLabel_en-US" xlink:label="lab_zntl_RecognizedTaxGainOnIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized tax gain on IPR&amp;D impairment</link:label>
    <link:label id="lab_zntl_RecognizedTaxGainOnIntangibleAssetImpairment_label_en-US" xlink:label="lab_zntl_RecognizedTaxGainOnIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized Tax Gain on Intangible Asset Impairment</link:label>
    <link:label id="lab_zntl_RecognizedTaxGainOnIntangibleAssetImpairment_documentation_en-US" xlink:label="lab_zntl_RecognizedTaxGainOnIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized Tax Gain on Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_RecognizedTaxGainOnIntangibleAssetImpairment" xlink:href="zntl-20210930.xsd#zntl_RecognizedTaxGainOnIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_RecognizedTaxGainOnIntangibleAssetImpairment" xlink:to="lab_zntl_RecognizedTaxGainOnIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_8b445997-9f89-4920-bde2-baa9abbbf99f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_de785893-887e-469c-9899-f7337cd6a99e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1f9fcecf-0b1c-4ca8-9c78-10de1145c3f7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_48a6e56a-3f7b-4a9c-9f38-ef192e3c18a1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of options, net (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_682588ea-4ba5-4be3-b946-3f057cd55cfa_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares used in computing net loss per share, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b4474bd5-4edd-4647-a8c8-23a5193b0cb3_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_41645911-cd08-4ddf-9a9b-65a2017eb47b_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriters</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_aaaa3d55-b78b-44e9-b54b-2f3fccde254c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_da3cfeca-bcd9-4b7c-bc6f-74d71a826a3e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c2784aeb-bf7a-4033-be9e-6413ab171a13_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Unit</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_fa74dd0b-69d4-486c-b72c-fcbbd3be659a_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_a2fc70f1-aa1f-470f-ab65-076a46d84703_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5f1ab23f-bf9f-4aba-bf04-5b36c00253e6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_283ff236-15f2-4338-9bfd-aa1eb6110a8a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9eb9832a-07d8-4cf9-8e88-1caeeb3c63c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_03eb0b42-94b8-4651-b7be-b730aedba53d_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d9c12527-8c22-4c78-a46f-ebe49320e2e1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_959d665e-d62f-4e2d-ab76-f691d00b0fb8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Prepaid Expenses and Other Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5c7edd42-ff82-4e43-88aa-d34be235d576_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_f1c7a389-178c-4fc3-b73e-42e4d295fb8e_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_1b2c46d4-9537-462d-851b-2d866f9534e0_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_20a018b9-a1c9-40d6-a89a-1315564c103b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_ecf3562b-bac6-43c0-975a-763e79f4650b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_34a1da12-626b-4def-aecf-0c64feccb0c3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_416ff2ff-1926-4d10-ba40-c15ec77d32ac_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_EarningsPerShareDenominatorAbstract_fe50f6a0-d454-4068-aa14-4b04c51e5a30_terseLabel_en-US" xlink:label="lab_zntl_EarningsPerShareDenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_zntl_EarningsPerShareDenominatorAbstract_label_en-US" xlink:label="lab_zntl_EarningsPerShareDenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Denominator [Abstract]</link:label>
    <link:label id="lab_zntl_EarningsPerShareDenominatorAbstract_documentation_en-US" xlink:label="lab_zntl_EarningsPerShareDenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Denominator</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_EarningsPerShareDenominatorAbstract" xlink:href="zntl-20210930.xsd#zntl_EarningsPerShareDenominatorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_EarningsPerShareDenominatorAbstract" xlink:to="lab_zntl_EarningsPerShareDenominatorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_a4615d88-e33e-4a14-88dd-a79ca80ecf16_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_61cf8899-5ade-4f9c-a4dd-9298b13a2870_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm_075858ce-6087-4131-a309-d9934e6b4889_terseLabel_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generally expected vesting term of the option contract (in years)</link:label>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm_label_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Generally Expected Term</link:label>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm_documentation_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Generally Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm" xlink:to="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0e90b4a5-54a4-4ed4-a4c1-4336e63f279d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_b28e7dd9-0aab-4ec0-b5cd-6b5b6341330d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_e0bff965-f717-4f6b-b237-abd988fc58b9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6e75bb7d-d743-4243-83f7-ed3c4907ded8_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption and Pending Adoption of Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount_71fb6941-7fe2-4442-8714-df937760b954_terseLabel_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lack of marketability discount (as a percent)</link:label>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount_label_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Lack of Marketability Discount</link:label>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount_documentation_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Lack of Marketability Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount" xlink:to="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_RelatedPartyAgreementTerm_41e1dbd9-292e-43bc-9498-381cdd0e09d6_terseLabel_en-US" xlink:label="lab_zntl_RelatedPartyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement term</link:label>
    <link:label id="lab_zntl_RelatedPartyAgreementTerm_label_en-US" xlink:label="lab_zntl_RelatedPartyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Agreement, Term</link:label>
    <link:label id="lab_zntl_RelatedPartyAgreementTerm_documentation_en-US" xlink:label="lab_zntl_RelatedPartyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Agreement, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_RelatedPartyAgreementTerm" xlink:href="zntl-20210930.xsd#zntl_RelatedPartyAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_RelatedPartyAgreementTerm" xlink:to="lab_zntl_RelatedPartyAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_f335a19a-724e-4822-a857-212afe88bdbc_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_e6b94f26-f21c-4cf7-a9d2-4d1fdd270d6e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process&#160;research and development</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_7870fd87-4f2c-4c81-9056-1cb13a86a7f6_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_7009cf40-bc2b-485f-b5e2-b16e5866ddd4_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_b3300dff-474d-41d5-a425-49cec367da25_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest at beginning of period</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_b340da2d-db62-499a-9932-1acbbe541cd2_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest at end of period</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease_94bf23b7-21ab-4e2f-8ff1-c1dd5c21d1f8_terseLabel_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of common stock outstanding used as threshold to calculate shares available for issuance</link:label>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease_label_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Shares Authorized, Percent Threshold Used To Calculate Increase</link:label>
    <link:label id="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease_documentation_en-US" xlink:label="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Shares Authorized, Percent Threshold Used To Calculate Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease" xlink:to="lab_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_76741e91-0c7c-40f8-bc46-26b685b617d3_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd620633-1fe2-4605-bc48-54d9cd4faa49_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_0a8894bb-dca5-4484-a875-88a6c1936b90_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_c192c773-a5cf-4795-8c10-6660aa374187_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Disclosures</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_zntl_StockIssuanceCostsIncurredButNotYetPaid_80c05b2c-a702-4edc-bd4e-8d2003be5d21_terseLabel_en-US" xlink:label="lab_zntl_StockIssuanceCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs incurred in connection with initial public offering included in accounts payable and accrued expenses</link:label>
    <link:label id="lab_zntl_StockIssuanceCostsIncurredButNotYetPaid_label_en-US" xlink:label="lab_zntl_StockIssuanceCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Costs Incurred But Not Yet Paid</link:label>
    <link:label id="lab_zntl_StockIssuanceCostsIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_zntl_StockIssuanceCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Costs Incurred But Not Yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_StockIssuanceCostsIncurredButNotYetPaid" xlink:href="zntl-20210930.xsd#zntl_StockIssuanceCostsIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zntl_StockIssuanceCostsIncurredButNotYetPaid" xlink:to="lab_zntl_StockIssuanceCostsIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_b4bf63a8-cbc1-48bb-b93d-69795ce0b8b1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Valuation Assumptions, ESPP</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>zntl-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:ec330f09-1704-42bb-8fbc-efe747c127bc,g:cceb589a-52db-4380-936c-762192d75fd3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.zentalis.com/role/Cover" xlink:type="simple" xlink:href="zntl-20210930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ff6c35e2-a6d2-4650-ac1c-7b76554941ca" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_DocumentType_ff6c35e2-a6d2-4650-ac1c-7b76554941ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_1ed5003b-272b-472c-8d6e-51222fb0ab7b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_DocumentQuarterlyReport_1ed5003b-272b-472c-8d6e-51222fb0ab7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_728e8a90-64bb-4d46-8b31-0c772a016e62" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_DocumentPeriodEndDate_728e8a90-64bb-4d46-8b31-0c772a016e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_54ffb87b-746b-459b-8d61-841b19b30e62" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_DocumentTransitionReport_54ffb87b-746b-459b-8d61-841b19b30e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a14d677a-fade-4273-b6fb-5e721013fe12" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityFileNumber_a14d677a-fade-4273-b6fb-5e721013fe12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a88e2cee-f72e-4f71-a095-2e99b0eee762" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityRegistrantName_a88e2cee-f72e-4f71-a095-2e99b0eee762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2306893a-833c-41d1-a5ea-0b690315fe83" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2306893a-833c-41d1-a5ea-0b690315fe83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2945d2c2-0659-4b2f-a460-4f362c45a333" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityTaxIdentificationNumber_2945d2c2-0659-4b2f-a460-4f362c45a333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ca226d27-000d-4322-a2e9-ba3c025db090" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityAddressAddressLine1_ca226d27-000d-4322-a2e9-ba3c025db090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_e2bf7777-c2ed-497f-94a6-7d5fc335f105" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityAddressAddressLine2_e2bf7777-c2ed-497f-94a6-7d5fc335f105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_f0dfdfe5-a54d-48f1-8fb1-259ab766ca06" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityAddressCityOrTown_f0dfdfe5-a54d-48f1-8fb1-259ab766ca06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d85121f7-c3d0-4091-ad9a-7178dec7e360" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityAddressStateOrProvince_d85121f7-c3d0-4091-ad9a-7178dec7e360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2f15a2f9-fc1e-4002-a3bf-d09a167444af" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityAddressPostalZipCode_2f15a2f9-fc1e-4002-a3bf-d09a167444af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_61a65c7c-a5f1-4b3a-b0cc-d94129b76d43" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_CityAreaCode_61a65c7c-a5f1-4b3a-b0cc-d94129b76d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_faca6430-4fe6-415f-bc48-56381c1bd547" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_LocalPhoneNumber_faca6430-4fe6-415f-bc48-56381c1bd547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7c772c9a-3490-4a99-9b7b-886feeb17323" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_Security12bTitle_7c772c9a-3490-4a99-9b7b-886feeb17323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_30b1b426-7a79-43e7-a312-2e0722728044" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_TradingSymbol_30b1b426-7a79-43e7-a312-2e0722728044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_0e4e8f39-f490-4f3a-a097-e2a37f2f02ee" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_SecurityExchangeName_0e4e8f39-f490-4f3a-a097-e2a37f2f02ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ee221b56-1240-4b74-b1bd-5a400fbe16c8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityCurrentReportingStatus_ee221b56-1240-4b74-b1bd-5a400fbe16c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5028450e-906f-4820-8e5f-9753cc19e23c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityInteractiveDataCurrent_5028450e-906f-4820-8e5f-9753cc19e23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_c0ffda4b-10b0-41c7-a20d-59226586ab3d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityFilerCategory_c0ffda4b-10b0-41c7-a20d-59226586ab3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_86fdff50-84ed-4684-9cf6-8713c5fd9ddd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntitySmallBusiness_86fdff50-84ed-4684-9cf6-8713c5fd9ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4c299df7-6ec7-4089-b799-a6dc64f59d24" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityEmergingGrowthCompany_4c299df7-6ec7-4089-b799-a6dc64f59d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_4c66006b-fd9c-4822-aa46-50de464a4849" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityExTransitionPeriod_4c66006b-fd9c-4822-aa46-50de464a4849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e5992a91-aff5-43a4-9855-f0814a0ef363" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityShellCompany_e5992a91-aff5-43a4-9855-f0814a0ef363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_416f21ef-34d0-4a2c-a785-b40e2ec11e65" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_416f21ef-34d0-4a2c-a785-b40e2ec11e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_3b88b707-ff94-4a77-8156-0852d1f1c65b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_EntityCentralIndexKey_3b88b707-ff94-4a77-8156-0852d1f1c65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6d94597d-46e6-42e9-aa02-e0cbd35e83a3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_AmendmentFlag_6d94597d-46e6-42e9-aa02-e0cbd35e83a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_85d43e9f-76f1-4ce7-aecc-646447f3559b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_DocumentFiscalPeriodFocus_85d43e9f-76f1-4ce7-aecc-646447f3559b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_fc182112-7f2d-4d7f-9426-dcffddf18054" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_CurrentFiscalYearEndDate_fc182112-7f2d-4d7f-9426-dcffddf18054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_80f43034-69c2-4f25-82f6-66e4f1b242d2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38febee3-7bb0-47e4-8c7e-4ab2c4fcf593" xlink:to="loc_dei_DocumentFiscalYearFocus_80f43034-69c2-4f25-82f6-66e4f1b242d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="zntl-20210930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d60015c8-0fa4-49ee-a759-92e0f6cf2515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ca321a82-380f-4496-be13-2a704d664d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d60015c8-0fa4-49ee-a759-92e0f6cf2515" xlink:to="loc_us-gaap_AssetsAbstract_ca321a82-380f-4496-be13-2a704d664d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_ba1c5b4f-d989-4920-8cfc-27f1f71067b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ca321a82-380f-4496-be13-2a704d664d1c" xlink:to="loc_us-gaap_AssetsCurrentAbstract_ba1c5b4f-d989-4920-8cfc-27f1f71067b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_26f24283-64f4-40b2-b161-460315f6f6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ba1c5b4f-d989-4920-8cfc-27f1f71067b6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_26f24283-64f4-40b2-b161-460315f6f6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5d96b3af-7082-4ec3-957e-9d6603f7608b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ba1c5b4f-d989-4920-8cfc-27f1f71067b6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5d96b3af-7082-4ec3-957e-9d6603f7608b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_53073afa-18d0-404c-9c15-01840c505e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ba1c5b4f-d989-4920-8cfc-27f1f71067b6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_53073afa-18d0-404c-9c15-01840c505e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fca69440-3d0e-4930-b97d-5ffe00844bee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ba1c5b4f-d989-4920-8cfc-27f1f71067b6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fca69440-3d0e-4930-b97d-5ffe00844bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_2577eb41-51ff-4df6-b08d-501ee9bced8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ba1c5b4f-d989-4920-8cfc-27f1f71067b6" xlink:to="loc_us-gaap_RestrictedCashCurrent_2577eb41-51ff-4df6-b08d-501ee9bced8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6e1b9b04-265e-46b0-bc07-0db605518b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ba1c5b4f-d989-4920-8cfc-27f1f71067b6" xlink:to="loc_us-gaap_AssetsCurrent_6e1b9b04-265e-46b0-bc07-0db605518b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5b13deb9-cd8e-48a6-9aca-3d93e4669746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ca321a82-380f-4496-be13-2a704d664d1c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5b13deb9-cd8e-48a6-9aca-3d93e4669746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_da5952c1-79e8-43cd-adda-b71f0592c006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ca321a82-380f-4496-be13-2a704d664d1c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_da5952c1-79e8-43cd-adda-b71f0592c006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_a324ee50-5c7a-40e7-a449-d7dcba200999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ca321a82-380f-4496-be13-2a704d664d1c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_a324ee50-5c7a-40e7-a449-d7dcba200999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_01d7c12a-805b-4875-80e9-98c4f7506275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ca321a82-380f-4496-be13-2a704d664d1c" xlink:to="loc_us-gaap_Goodwill_01d7c12a-805b-4875-80e9-98c4f7506275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_405e0bbe-3395-4bad-aebd-1fe79863c8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ca321a82-380f-4496-be13-2a704d664d1c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_405e0bbe-3395-4bad-aebd-1fe79863c8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_0b856166-fe5c-4028-b86c-2baabc36cb3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ca321a82-380f-4496-be13-2a704d664d1c" xlink:to="loc_us-gaap_EquityMethodInvestments_0b856166-fe5c-4028-b86c-2baabc36cb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_3599b4fa-8c38-4600-9765-8acaeaecceda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ca321a82-380f-4496-be13-2a704d664d1c" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_3599b4fa-8c38-4600-9765-8acaeaecceda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_893ffb98-38a0-4f02-8f25-e1c18ad112ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ca321a82-380f-4496-be13-2a704d664d1c" xlink:to="loc_us-gaap_Assets_893ffb98-38a0-4f02-8f25-e1c18ad112ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a323d7db-5941-4413-81a5-05eab57b9b80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d60015c8-0fa4-49ee-a759-92e0f6cf2515" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a323d7db-5941-4413-81a5-05eab57b9b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_05b1a935-6d66-4ee1-a54f-e1301705c4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a323d7db-5941-4413-81a5-05eab57b9b80" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_05b1a935-6d66-4ee1-a54f-e1301705c4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3ef39dd4-169a-485c-8576-9b5e82f29390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_05b1a935-6d66-4ee1-a54f-e1301705c4d9" xlink:to="loc_us-gaap_AccountsPayableCurrent_3ef39dd4-169a-485c-8576-9b5e82f29390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2f147874-b91a-4b95-926f-39e32d91861f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_05b1a935-6d66-4ee1-a54f-e1301705c4d9" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_2f147874-b91a-4b95-926f-39e32d91861f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1205ee84-68ae-41e2-aeed-5f5f30484809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_05b1a935-6d66-4ee1-a54f-e1301705c4d9" xlink:to="loc_us-gaap_LiabilitiesCurrent_1205ee84-68ae-41e2-aeed-5f5f30484809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_10c28e8a-1828-4e4a-9590-9fb53722a1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a323d7db-5941-4413-81a5-05eab57b9b80" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_10c28e8a-1828-4e4a-9590-9fb53722a1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_10517621-2e00-47ff-bccb-cadc1a1f528d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a323d7db-5941-4413-81a5-05eab57b9b80" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_10517621-2e00-47ff-bccb-cadc1a1f528d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0f374ebe-ecbe-4b6f-9534-38aa10dfa4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a323d7db-5941-4413-81a5-05eab57b9b80" xlink:to="loc_us-gaap_Liabilities_0f374ebe-ecbe-4b6f-9534-38aa10dfa4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_0d3a22e7-bd91-43ed-b76a-51616f29b13f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a323d7db-5941-4413-81a5-05eab57b9b80" xlink:to="loc_us-gaap_CommitmentsAndContingencies_0d3a22e7-bd91-43ed-b76a-51616f29b13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f945a383-bcdb-4b8f-9d08-6f768469fa3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a323d7db-5941-4413-81a5-05eab57b9b80" xlink:to="loc_us-gaap_EquityAbstract_f945a383-bcdb-4b8f-9d08-6f768469fa3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ef72feef-6ea4-4657-9468-37ba7900311b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f945a383-bcdb-4b8f-9d08-6f768469fa3c" xlink:to="loc_us-gaap_PreferredStockValue_ef72feef-6ea4-4657-9468-37ba7900311b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b9fd7a79-dbaa-443a-b476-f1ef37d4bf35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f945a383-bcdb-4b8f-9d08-6f768469fa3c" xlink:to="loc_us-gaap_CommonStockValue_b9fd7a79-dbaa-443a-b476-f1ef37d4bf35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_bdce1a98-201a-4cac-9503-385011cc2bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f945a383-bcdb-4b8f-9d08-6f768469fa3c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_bdce1a98-201a-4cac-9503-385011cc2bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7e313f3e-5501-4948-8ebc-3ae1b32da98f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f945a383-bcdb-4b8f-9d08-6f768469fa3c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7e313f3e-5501-4948-8ebc-3ae1b32da98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e9a0a6b5-2360-47dc-9e19-d40339be8b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f945a383-bcdb-4b8f-9d08-6f768469fa3c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e9a0a6b5-2360-47dc-9e19-d40339be8b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_eeb36128-115b-4528-bbff-78b135daab5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f945a383-bcdb-4b8f-9d08-6f768469fa3c" xlink:to="loc_us-gaap_StockholdersEquity_eeb36128-115b-4528-bbff-78b135daab5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d075e25a-8b15-4c6a-9788-7ee985163b96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f945a383-bcdb-4b8f-9d08-6f768469fa3c" xlink:to="loc_us-gaap_MinorityInterest_d075e25a-8b15-4c6a-9788-7ee985163b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d49ca3fb-ac99-4a2c-892e-69ab4273b0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f945a383-bcdb-4b8f-9d08-6f768469fa3c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d49ca3fb-ac99-4a2c-892e-69ab4273b0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a9299168-cd4a-4dc7-97f6-5050607ac82c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a323d7db-5941-4413-81a5-05eab57b9b80" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_a9299168-cd4a-4dc7-97f6-5050607ac82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="zntl-20210930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_33734920-3041-4dfd-b8cc-b39a8e07d813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_03ce85bc-e676-4818-9396-12f8b4face41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_33734920-3041-4dfd-b8cc-b39a8e07d813" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_03ce85bc-e676-4818-9396-12f8b4face41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4d7f8995-d9b5-4848-8793-caed9d1174c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_33734920-3041-4dfd-b8cc-b39a8e07d813" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_4d7f8995-d9b5-4848-8793-caed9d1174c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_a8f82d89-8e07-4399-90cc-7b982d1c1fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_33734920-3041-4dfd-b8cc-b39a8e07d813" xlink:to="loc_us-gaap_PreferredStockSharesIssued_a8f82d89-8e07-4399-90cc-7b982d1c1fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_27a4dd57-0c00-40ed-abf1-f3c0e088c613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_33734920-3041-4dfd-b8cc-b39a8e07d813" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_27a4dd57-0c00-40ed-abf1-f3c0e088c613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1179a1bb-32fa-467e-a6aa-6ca0371e6880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_33734920-3041-4dfd-b8cc-b39a8e07d813" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1179a1bb-32fa-467e-a6aa-6ca0371e6880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_d1978d3d-9ab4-4aab-b176-a0c5f92a863c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_33734920-3041-4dfd-b8cc-b39a8e07d813" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_d1978d3d-9ab4-4aab-b176-a0c5f92a863c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_789e4678-2eb6-4d79-97db-0c140f4d774e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_33734920-3041-4dfd-b8cc-b39a8e07d813" xlink:to="loc_us-gaap_CommonStockSharesIssued_789e4678-2eb6-4d79-97db-0c140f4d774e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_11570c5f-daea-4373-9fc4-555f29662d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_33734920-3041-4dfd-b8cc-b39a8e07d813" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_11570c5f-daea-4373-9fc4-555f29662d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="zntl-20210930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_7cc32c8d-abf2-4bf2-a0cf-5cb84724689e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_bfb00a27-fb8f-4de9-917c-ac8e1ad173f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7cc32c8d-abf2-4bf2-a0cf-5cb84724689e" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_bfb00a27-fb8f-4de9-917c-ac8e1ad173f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_49776e5d-625c-4394-a10c-89090125c517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_bfb00a27-fb8f-4de9-917c-ac8e1ad173f9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_49776e5d-625c-4394-a10c-89090125c517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_0b1a85f9-69b0-408e-9ce2-c0ba99609fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_bfb00a27-fb8f-4de9-917c-ac8e1ad173f9" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_0b1a85f9-69b0-408e-9ce2-c0ba99609fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_5a2e4b13-1cf6-4fe5-9546-c4b6a217e3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_bfb00a27-fb8f-4de9-917c-ac8e1ad173f9" xlink:to="loc_us-gaap_OperatingExpenses_5a2e4b13-1cf6-4fe5-9546-c4b6a217e3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_434b1935-68e0-448b-81b5-8bc3d27de46c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7cc32c8d-abf2-4bf2-a0cf-5cb84724689e" xlink:to="loc_us-gaap_OperatingIncomeLoss_434b1935-68e0-448b-81b5-8bc3d27de46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_4058d465-0195-4766-b437-ef73bf2331e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7cc32c8d-abf2-4bf2-a0cf-5cb84724689e" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_4058d465-0195-4766-b437-ef73bf2331e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_b14c0aca-1968-490b-b5a1-b9aad3e34ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_4058d465-0195-4766-b437-ef73bf2331e0" xlink:to="loc_us-gaap_InvestmentIncomeInterest_b14c0aca-1968-490b-b5a1-b9aad3e34ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_c12e089a-d37a-4670-8a01-ca9c51e46ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_4058d465-0195-4766-b437-ef73bf2331e0" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_c12e089a-d37a-4670-8a01-ca9c51e46ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6aeb8e3d-8821-4014-a635-f11531a55ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7cc32c8d-abf2-4bf2-a0cf-5cb84724689e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6aeb8e3d-8821-4014-a635-f11531a55ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_36005ca2-5332-429f-b41b-cc2fafd8e707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7cc32c8d-abf2-4bf2-a0cf-5cb84724689e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_36005ca2-5332-429f-b41b-cc2fafd8e707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_873cef5f-cf72-4084-9f37-fa0bf432130a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7cc32c8d-abf2-4bf2-a0cf-5cb84724689e" xlink:to="loc_us-gaap_ProfitLoss_873cef5f-cf72-4084-9f37-fa0bf432130a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_66f4ce6e-3ecb-4bf8-b42a-09b45853791a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7cc32c8d-abf2-4bf2-a0cf-5cb84724689e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_66f4ce6e-3ecb-4bf8-b42a-09b45853791a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4c7b4f41-6f4b-4209-ad9b-bd323a337cea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7cc32c8d-abf2-4bf2-a0cf-5cb84724689e" xlink:to="loc_us-gaap_NetIncomeLoss_4c7b4f41-6f4b-4209-ad9b-bd323a337cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_19bb4141-e250-41b2-86f3-6d97be3c3597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7cc32c8d-abf2-4bf2-a0cf-5cb84724689e" xlink:to="loc_us-gaap_EarningsPerShareBasic_19bb4141-e250-41b2-86f3-6d97be3c3597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_000f658b-9daa-4def-98c8-bc10ea4f9fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7cc32c8d-abf2-4bf2-a0cf-5cb84724689e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_000f658b-9daa-4def-98c8-bc10ea4f9fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c5b957a9-ea44-4047-b527-232b8d0d7cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7cc32c8d-abf2-4bf2-a0cf-5cb84724689e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c5b957a9-ea44-4047-b527-232b8d0d7cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_da0bea9f-74ca-471e-a5c7-7e0fcaaa0aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7cc32c8d-abf2-4bf2-a0cf-5cb84724689e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_da0bea9f-74ca-471e-a5c7-7e0fcaaa0aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="zntl-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_849ad42e-c3f4-4332-8228-fa17e8f56935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_37aefe68-1748-4db7-bad2-abf841cee9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_849ad42e-c3f4-4332-8228-fa17e8f56935" xlink:to="loc_us-gaap_ProfitLoss_37aefe68-1748-4db7-bad2-abf841cee9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ebc0932a-8da5-4bb1-8b2d-48386804cf81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_849ad42e-c3f4-4332-8228-fa17e8f56935" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ebc0932a-8da5-4bb1-8b2d-48386804cf81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_76d4386c-e4cd-45c4-b3d2-58f08af9ca44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ebc0932a-8da5-4bb1-8b2d-48386804cf81" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_76d4386c-e4cd-45c4-b3d2-58f08af9ca44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f89eb4f0-c15f-43e9-9ec8-9bdfb88c6e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ebc0932a-8da5-4bb1-8b2d-48386804cf81" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f89eb4f0-c15f-43e9-9ec8-9bdfb88c6e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_42a26a42-0775-44fb-bd0a-d0810cfe1885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_849ad42e-c3f4-4332-8228-fa17e8f56935" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_42a26a42-0775-44fb-bd0a-d0810cfe1885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f7573f57-a707-4c68-98dc-abfc5d7ec3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_849ad42e-c3f4-4332-8228-fa17e8f56935" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f7573f57-a707-4c68-98dc-abfc5d7ec3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_596b604f-4348-43c0-a0ab-a04bcaf9d924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_849ad42e-c3f4-4332-8228-fa17e8f56935" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_596b604f-4348-43c0-a0ab-a04bcaf9d924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="zntl-20210930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_effcca15-bca2-46b4-b21f-4fd63bf723eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ffc14f8-fbe3-4951-a21d-adf5b89029ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_effcca15-bca2-46b4-b21f-4fd63bf723eb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ffc14f8-fbe3-4951-a21d-adf5b89029ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f84ae8a6-a840-43e1-8733-30cac6cb6468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ffc14f8-fbe3-4951-a21d-adf5b89029ed" xlink:to="loc_us-gaap_ProfitLoss_f84ae8a6-a840-43e1-8733-30cac6cb6468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8ab14bab-605e-4671-80fc-0002a2e23329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ffc14f8-fbe3-4951-a21d-adf5b89029ed" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8ab14bab-605e-4671-80fc-0002a2e23329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_89d43dc6-418b-4fa6-a5ab-144c90faec2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8ab14bab-605e-4671-80fc-0002a2e23329" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_89d43dc6-418b-4fa6-a5ab-144c90faec2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_5cb30528-ce67-44cd-a27b-0083c2c3c199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8ab14bab-605e-4671-80fc-0002a2e23329" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_5cb30528-ce67-44cd-a27b-0083c2c3c199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_RecognizedTaxGainOnIntangibleAssetImpairment_7e2eba27-05a2-447c-bcbe-5781d9d27797" xlink:href="zntl-20210930.xsd#zntl_RecognizedTaxGainOnIntangibleAssetImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8ab14bab-605e-4671-80fc-0002a2e23329" xlink:to="loc_zntl_RecognizedTaxGainOnIntangibleAssetImpairment_7e2eba27-05a2-447c-bcbe-5781d9d27797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_DeconsolidationGainLossAmountNet_3c2d9dc1-4ef3-461f-9835-7c924f714c83" xlink:href="zntl-20210930.xsd#zntl_DeconsolidationGainLossAmountNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8ab14bab-605e-4671-80fc-0002a2e23329" xlink:to="loc_zntl_DeconsolidationGainLossAmountNet_3c2d9dc1-4ef3-461f-9835-7c924f714c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9513d0a1-5542-4efc-8778-feffd6ec94fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8ab14bab-605e-4671-80fc-0002a2e23329" xlink:to="loc_us-gaap_ShareBasedCompensation_9513d0a1-5542-4efc-8778-feffd6ec94fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_95b55150-97e0-458b-bff5-14d3ef589320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8ab14bab-605e-4671-80fc-0002a2e23329" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_95b55150-97e0-458b-bff5-14d3ef589320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_7ce1e93e-1abb-47a2-9122-15f452561627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8ab14bab-605e-4671-80fc-0002a2e23329" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_7ce1e93e-1abb-47a2-9122-15f452561627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_53b890da-fb90-483a-b426-e4481e484779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8ab14bab-605e-4671-80fc-0002a2e23329" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_53b890da-fb90-483a-b426-e4481e484779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d41d2415-7c01-4f9d-8555-bfdfa2af74c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_53b890da-fb90-483a-b426-e4481e484779" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d41d2415-7c01-4f9d-8555-bfdfa2af74c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6b9839aa-d74c-4cc2-919c-565d780e6a73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_53b890da-fb90-483a-b426-e4481e484779" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6b9839aa-d74c-4cc2-919c-565d780e6a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9b04b535-8765-4ec6-8e80-2f1c38141bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_53b890da-fb90-483a-b426-e4481e484779" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9b04b535-8765-4ec6-8e80-2f1c38141bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_126ad908-8b73-4dfe-9b78-d33071f57174" xlink:href="zntl-20210930.xsd#zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_53b890da-fb90-483a-b426-e4481e484779" xlink:to="loc_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_126ad908-8b73-4dfe-9b78-d33071f57174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_43842057-85b0-4b89-a8fa-f3f0215dd4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ffc14f8-fbe3-4951-a21d-adf5b89029ed" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_43842057-85b0-4b89-a8fa-f3f0215dd4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_24a863ba-6b77-4ba3-99e9-de6aade870d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_effcca15-bca2-46b4-b21f-4fd63bf723eb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_24a863ba-6b77-4ba3-99e9-de6aade870d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_37c0c6ec-2f13-4c7c-9a83-eddf6af87e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_24a863ba-6b77-4ba3-99e9-de6aade870d8" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_37c0c6ec-2f13-4c7c-9a83-eddf6af87e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_41e15a9a-29c1-468f-aeea-200d5c98a359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_24a863ba-6b77-4ba3-99e9-de6aade870d8" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_41e15a9a-29c1-468f-aeea-200d5c98a359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation_351d03c2-31ca-4224-aa35-6cf33670ddc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_24a863ba-6b77-4ba3-99e9-de6aade870d8" xlink:to="loc_us-gaap_CashDivestedFromDeconsolidation_351d03c2-31ca-4224-aa35-6cf33670ddc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_24b45f12-c274-4d45-8ffd-36423a55b545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_24a863ba-6b77-4ba3-99e9-de6aade870d8" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_24b45f12-c274-4d45-8ffd-36423a55b545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6d130948-fd61-402c-b71e-b73ed01f6432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_24a863ba-6b77-4ba3-99e9-de6aade870d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6d130948-fd61-402c-b71e-b73ed01f6432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a380272d-f886-4fd9-b202-50eb09766946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_effcca15-bca2-46b4-b21f-4fd63bf723eb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a380272d-f886-4fd9-b202-50eb09766946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_6ef9dcad-2d23-4d3d-9efd-d2ce627a7259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a380272d-f886-4fd9-b202-50eb09766946" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_6ef9dcad-2d23-4d3d-9efd-d2ce627a7259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_5b6965c3-9b5c-4d44-94a3-a010e7184d77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a380272d-f886-4fd9-b202-50eb09766946" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_5b6965c3-9b5c-4d44-94a3-a010e7184d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_83284344-7069-46da-85bd-72e7826dfdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a380272d-f886-4fd9-b202-50eb09766946" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_83284344-7069-46da-85bd-72e7826dfdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_9a9bb650-d385-4e2a-912c-bb35add3aa75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a380272d-f886-4fd9-b202-50eb09766946" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_9a9bb650-d385-4e2a-912c-bb35add3aa75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_d53067f7-d12e-40fc-8c83-c0b86f993f21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a380272d-f886-4fd9-b202-50eb09766946" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_d53067f7-d12e-40fc-8c83-c0b86f993f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5eb12e6e-08c9-48d6-a618-a6b791ee834a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a380272d-f886-4fd9-b202-50eb09766946" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5eb12e6e-08c9-48d6-a618-a6b791ee834a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_64a1f8cd-76fe-44ef-85e2-6aa30146d659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_effcca15-bca2-46b4-b21f-4fd63bf723eb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_64a1f8cd-76fe-44ef-85e2-6aa30146d659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f8be58bd-a665-4a4c-b423-4c59198505b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_effcca15-bca2-46b4-b21f-4fd63bf723eb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f8be58bd-a665-4a4c-b423-4c59198505b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_41dea85e-d7bd-4bac-8d07-3100f29ea70a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_effcca15-bca2-46b4-b21f-4fd63bf723eb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_41dea85e-d7bd-4bac-8d07-3100f29ea70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d091b9ef-4ec2-4b9f-8a2d-dab57faf3c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_effcca15-bca2-46b4-b21f-4fd63bf723eb" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d091b9ef-4ec2-4b9f-8a2d-dab57faf3c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_StockIssuanceCostsIncurredButNotYetPaid_3422cb59-f92e-4fb7-940c-6259fb64ac31" xlink:href="zntl-20210930.xsd#zntl_StockIssuanceCostsIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d091b9ef-4ec2-4b9f-8a2d-dab57faf3c9d" xlink:to="loc_zntl_StockIssuanceCostsIncurredButNotYetPaid_3422cb59-f92e-4fb7-940c-6259fb64ac31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_419f3c8f-bb8d-4874-bcec-bcd1331b504b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_effcca15-bca2-46b4-b21f-4fd63bf723eb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_419f3c8f-bb8d-4874-bcec-bcd1331b504b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6f0ada1a-e7cc-40d2-80bd-193642bf4aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_419f3c8f-bb8d-4874-bcec-bcd1331b504b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6f0ada1a-e7cc-40d2-80bd-193642bf4aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_46036fca-0b02-40ec-bf8a-f2d29a57d663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_419f3c8f-bb8d-4874-bcec-bcd1331b504b" xlink:to="loc_us-gaap_RestrictedCash_46036fca-0b02-40ec-bf8a-f2d29a57d663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ad847c1-4352-4a0a-9848-435b339510c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_419f3c8f-bb8d-4874-bcec-bcd1331b504b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ad847c1-4352-4a0a-9848-435b339510c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits" xlink:type="simple" xlink:href="zntl-20210930.xsd#CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7e2e1033-3e58-4c36-88e1-3b579caa2f90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_126c4bf3-a815-4657-aafb-fa8767e2b3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7e2e1033-3e58-4c36-88e1-3b579caa2f90" xlink:to="loc_us-gaap_StatementTable_126c4bf3-a815-4657-aafb-fa8767e2b3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b712b48c-bb05-4368-824e-771675477e68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_126c4bf3-a815-4657-aafb-fa8767e2b3f3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b712b48c-bb05-4368-824e-771675477e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f9734fc1-a87d-4cf8-8d60-fdb4281e6c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b712b48c-bb05-4368-824e-771675477e68" xlink:to="loc_us-gaap_EquityComponentDomain_f9734fc1-a87d-4cf8-8d60-fdb4281e6c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f92e9b6e-fdb2-458b-ac62-b79966489e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f9734fc1-a87d-4cf8-8d60-fdb4281e6c73" xlink:to="loc_us-gaap_CommonStockMember_f92e9b6e-fdb2-458b-ac62-b79966489e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e2ea2db8-64c3-487e-922e-ecf8ba925d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f9734fc1-a87d-4cf8-8d60-fdb4281e6c73" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e2ea2db8-64c3-487e-922e-ecf8ba925d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5a111342-02b7-45ae-852b-5f8a440415f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f9734fc1-a87d-4cf8-8d60-fdb4281e6c73" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5a111342-02b7-45ae-852b-5f8a440415f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1ab5df49-1cd0-4260-bf03-12f9a8b8a581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f9734fc1-a87d-4cf8-8d60-fdb4281e6c73" xlink:to="loc_us-gaap_RetainedEarningsMember_1ab5df49-1cd0-4260-bf03-12f9a8b8a581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_bf534b37-8575-415f-b1f5-1d2925a65744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f9734fc1-a87d-4cf8-8d60-fdb4281e6c73" xlink:to="loc_us-gaap_NoncontrollingInterestMember_bf534b37-8575-415f-b1f5-1d2925a65744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_92986e1b-a73b-4b42-b2f8-fdd307cb49a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_126c4bf3-a815-4657-aafb-fa8767e2b3f3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_92986e1b-a73b-4b42-b2f8-fdd307cb49a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_373159a3-83a0-48ff-aa0f-e22c12548e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_92986e1b-a73b-4b42-b2f8-fdd307cb49a3" xlink:to="loc_us-gaap_ClassOfStockDomain_373159a3-83a0-48ff-aa0f-e22c12548e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_4eacb28a-a0ec-49dc-bdd1-df37a62386e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_373159a3-83a0-48ff-aa0f-e22c12548e71" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_4eacb28a-a0ec-49dc-bdd1-df37a62386e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_df75901f-8d08-4572-91ef-f876c39cc39c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_373159a3-83a0-48ff-aa0f-e22c12548e71" xlink:to="loc_us-gaap_CommonClassAMember_df75901f-8d08-4572-91ef-f876c39cc39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_cb0a115d-9a1d-4ea9-956e-c3cb59729c03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_373159a3-83a0-48ff-aa0f-e22c12548e71" xlink:to="loc_us-gaap_CommonClassBMember_cb0a115d-9a1d-4ea9-956e-c3cb59729c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_bee68fcf-8c32-43b9-ab24-90449e5eac7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_126c4bf3-a815-4657-aafb-fa8767e2b3f3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_bee68fcf-8c32-43b9-ab24-90449e5eac7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_be9c2b7d-60f1-4dec-9f55-7617d12a7a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_bee68fcf-8c32-43b9-ab24-90449e5eac7b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_be9c2b7d-60f1-4dec-9f55-7617d12a7a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_1079219b-28b5-430d-9829-fa6ec4aebd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_be9c2b7d-60f1-4dec-9f55-7617d12a7a8a" xlink:to="loc_us-gaap_IPOMember_1079219b-28b5-430d-9829-fa6ec4aebd2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9e0e87c3-2412-4b3c-9346-a0fad6a87b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_126c4bf3-a815-4657-aafb-fa8767e2b3f3" xlink:to="loc_us-gaap_StatementLineItems_9e0e87c3-2412-4b3c-9346-a0fad6a87b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e0e87c3-2412-4b3c-9346-a0fad6a87b40" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1c046e35-8c6a-4dd6-837b-7528cd8a686e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1c046e35-8c6a-4dd6-837b-7528cd8a686e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_a531c0fb-34cb-4089-b6d3-57cc3390573e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_a531c0fb-34cb-4089-b6d3-57cc3390573e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_d780d11c-50e9-42b4-ac84-e3ff7f2911a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_d780d11c-50e9-42b4-ac84-e3ff7f2911a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_dc1100bf-3dbe-4c28-bc08-a99d4aaff6c1" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:to="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_dc1100bf-3dbe-4c28-bc08-a99d4aaff6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_4b1c2233-4f8f-4593-96f0-92408aa7b909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_4b1c2233-4f8f-4593-96f0-92408aa7b909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits_c4c24407-9c46-443d-be7a-e872770775bf" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:to="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits_c4c24407-9c46-443d-be7a-e872770775bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_fe8a1d02-a2f8-4386-9ddb-33f6b862183e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_fe8a1d02-a2f8-4386-9ddb-33f6b862183e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_983bc818-3a6b-4c90-953f-f280b96a81f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3d7df100-78d5-4b54-a214-4604c9314b70" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_983bc818-3a6b-4c90-953f-f280b96a81f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9e0e87c3-2412-4b3c-9346-a0fad6a87b40" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_6a44f39c-f9da-4a09-ac38-ce6ffcf6e3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_SharesIssued_6a44f39c-f9da-4a09-ac38-ce6ffcf6e3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_683b9b6b-7389-4a25-90e1-8f5d5d7c3390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_683b9b6b-7389-4a25-90e1-8f5d5d7c3390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonUnitOutstanding_b7a387e5-4fec-420f-a4a7-907cdebaa545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonUnitOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_CommonUnitOutstanding_b7a387e5-4fec-420f-a4a7-907cdebaa545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonUnitIssuanceValue_addc2d71-e40c-4c8e-98e4-63a339906f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonUnitIssuanceValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_CommonUnitIssuanceValue_addc2d71-e40c-4c8e-98e4-63a339906f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fdb1e2a8-73cd-4b0b-b613-8129af0ee12a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fdb1e2a8-73cd-4b0b-b613-8129af0ee12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3e39d8de-49f6-4b73-af83-548f33a09685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3e39d8de-49f6-4b73-af83-548f33a09685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_8d85ec09-a542-4290-899b-7dc64729e256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_8d85ec09-a542-4290-899b-7dc64729e256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_a31dafdd-4c99-4b5a-b5ce-018a31fdbc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_a31dafdd-4c99-4b5a-b5ce-018a31fdbc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5bb03ded-be0f-4195-bffe-36dc34871b72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5bb03ded-be0f-4195-bffe-36dc34871b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_016f08d6-2364-441d-ae18-ac77610767d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_016f08d6-2364-441d-ae18-ac77610767d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_72e3e8a4-6aad-4342-a0a8-10d4a8e04650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_72e3e8a4-6aad-4342-a0a8-10d4a8e04650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_b560d434-f549-4ae5-9e39-33f5f21caac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_b560d434-f549-4ae5-9e39-33f5f21caac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_StockCancelledDuringPeriodShares_89c35c0f-0e4f-41c8-948b-bfd7034f11d0" xlink:href="zntl-20210930.xsd#zntl_StockCancelledDuringPeriodShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_zntl_StockCancelledDuringPeriodShares_89c35c0f-0e4f-41c8-948b-bfd7034f11d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_c67041c1-ec33-4fc2-a0df-70119a7446c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_c67041c1-ec33-4fc2-a0df-70119a7446c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0de380d8-1965-4447-b7c5-2db47566bade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0de380d8-1965-4447-b7c5-2db47566bade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d137c6a6-f8fd-45db-9b86-f05af6b6f469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d137c6a6-f8fd-45db-9b86-f05af6b6f469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_cd8173a9-f356-4699-bd35-9a383e421435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_cd8173a9-f356-4699-bd35-9a383e421435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits_b4be27bc-cd2d-4c40-8c76-c6d3af001743" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits_b4be27bc-cd2d-4c40-8c76-c6d3af001743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_a23ce0f4-69bc-4206-8776-139f6aa74931" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_a23ce0f4-69bc-4206-8776-139f6aa74931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_6839721c-951a-4902-a41d-910c3ac7980b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_6839721c-951a-4902-a41d-910c3ac7980b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_b2d62639-e444-4adc-82f5-759f994d777c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_b2d62639-e444-4adc-82f5-759f994d777c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f0c112fe-ba8c-48bb-a759-a127ca86bcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f0c112fe-ba8c-48bb-a759-a127ca86bcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_241609c5-fb2b-4765-97bd-afdc14234d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_NetIncomeLoss_241609c5-fb2b-4765-97bd-afdc14234d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonUnitOutstanding_ec3a48c2-507e-4f3d-a475-870790c9ad64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonUnitOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_CommonUnitOutstanding_ec3a48c2-507e-4f3d-a475-870790c9ad64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonUnitIssuanceValue_f7f9c41f-c41e-42cf-abb3-979f2fd30657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonUnitIssuanceValue"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_CommonUnitIssuanceValue_f7f9c41f-c41e-42cf-abb3-979f2fd30657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_3270e6b8-5853-4596-878d-eb34ca89b792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_SharesIssued_3270e6b8-5853-4596-878d-eb34ca89b792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_02d43fd8-84ed-409b-91fd-fb9318cefae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a82bacea-4a0c-4501-965b-dc41b5b282e2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_02d43fd8-84ed-409b-91fd-fb9318cefae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical" xlink:type="simple" xlink:href="zntl-20210930.xsd#CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_ffc8120b-f3b7-48a5-a28c-7e7c8045eb95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_21b88d93-ac1a-4cd8-908a-f93275de7f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_ffc8120b-f3b7-48a5-a28c-7e7c8045eb95" xlink:to="loc_us-gaap_StatementTable_21b88d93-ac1a-4cd8-908a-f93275de7f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d2dd2ff5-7f74-447c-9e38-750e8b3d3f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_21b88d93-ac1a-4cd8-908a-f93275de7f1c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d2dd2ff5-7f74-447c-9e38-750e8b3d3f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3507bd57-c0d4-41b9-bcac-5325a571c395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d2dd2ff5-7f74-447c-9e38-750e8b3d3f6b" xlink:to="loc_us-gaap_ClassOfStockDomain_3507bd57-c0d4-41b9-bcac-5325a571c395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_c15476eb-cc04-4fab-993f-6fe266e930d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3507bd57-c0d4-41b9-bcac-5325a571c395" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_c15476eb-cc04-4fab-993f-6fe266e930d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_655b616b-7b86-46d6-84d6-b9215eb33347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_21b88d93-ac1a-4cd8-908a-f93275de7f1c" xlink:to="loc_us-gaap_StatementLineItems_655b616b-7b86-46d6-84d6-b9215eb33347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_8544d031-e79f-498b-addd-eecaad573c70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_655b616b-7b86-46d6-84d6-b9215eb33347" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_8544d031-e79f-498b-addd-eecaad573c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_7261a2be-2659-4985-9636-bfa88d87e471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_655b616b-7b86-46d6-84d6-b9215eb33347" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_7261a2be-2659-4985-9636-bfa88d87e471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/OrganizationandBusiness" xlink:type="simple" xlink:href="zntl-20210930.xsd#OrganizationandBusiness"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/OrganizationandBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_44147974-44d6-48a6-982d-b45d6939a6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_7c86d0f9-7982-49bf-95c0-57273c1dad5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_44147974-44d6-48a6-982d-b45d6939a6d3" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_7c86d0f9-7982-49bf-95c0-57273c1dad5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/OrganizationandBusinessDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#OrganizationandBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/OrganizationandBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0fd2767e-08a8-43e2-a5b7-181a47a433a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ca22658a-9f49-4765-9180-59f487c8955e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0fd2767e-08a8-43e2-a5b7-181a47a433a9" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ca22658a-9f49-4765-9180-59f487c8955e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_130d2350-8220-440c-b531-8851a813b128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ca22658a-9f49-4765-9180-59f487c8955e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_130d2350-8220-440c-b531-8851a813b128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_595fa29e-82ee-4c61-8d34-9c06802ab962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_130d2350-8220-440c-b531-8851a813b128" xlink:to="loc_us-gaap_ClassOfStockDomain_595fa29e-82ee-4c61-8d34-9c06802ab962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_46ee4c6d-c663-4e7d-ad3b-6da3751b01ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_595fa29e-82ee-4c61-8d34-9c06802ab962" xlink:to="loc_us-gaap_CommonStockMember_46ee4c6d-c663-4e7d-ad3b-6da3751b01ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_00444ccf-e9eb-4461-8d16-615e1ca77282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_595fa29e-82ee-4c61-8d34-9c06802ab962" xlink:to="loc_us-gaap_RestrictedStockMember_00444ccf-e9eb-4461-8d16-615e1ca77282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_fedc1571-6945-4dca-a89f-a668525fe3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ca22658a-9f49-4765-9180-59f487c8955e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_fedc1571-6945-4dca-a89f-a668525fe3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3bfc0ccd-a27f-403c-9538-3ed27899ddd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fedc1571-6945-4dca-a89f-a668525fe3fb" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3bfc0ccd-a27f-403c-9538-3ed27899ddd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_e6f0fd92-22e6-4a95-9e69-3cd5554ea3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3bfc0ccd-a27f-403c-9538-3ed27899ddd1" xlink:to="loc_us-gaap_IPOMember_e6f0fd92-22e6-4a95-9e69-3cd5554ea3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_906f3133-58db-477c-ab38-d9ab6486366c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3bfc0ccd-a27f-403c-9538-3ed27899ddd1" xlink:to="loc_us-gaap_OverAllotmentOptionMember_906f3133-58db-477c-ab38-d9ab6486366c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ca22658a-9f49-4765-9180-59f487c8955e" xlink:to="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_CommonStockConversionRatio_ec33688c-7f7a-4c0f-86b7-2511c056f63c" xlink:href="zntl-20210930.xsd#zntl_CommonStockConversionRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:to="loc_zntl_CommonStockConversionRatio_ec33688c-7f7a-4c0f-86b7-2511c056f63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_036e5dfb-8fd6-457f-bd95-08cc67f49585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_036e5dfb-8fd6-457f-bd95-08cc67f49585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_46d14fea-b9b8-4755-b384-51bced6b8cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_46d14fea-b9b8-4755-b384-51bced6b8cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ed00cac8-b89a-4ca5-8d5f-69be7a9c78c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ed00cac8-b89a-4ca5-8d5f-69be7a9c78c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_33293067-d1d5-492a-9e34-9a53ccf33453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_33293067-d1d5-492a-9e34-9a53ccf33453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_4ae391bf-8f75-4e67-80a4-cbd0c1c4d734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a05954ab-da19-429c-9ae3-45457a91f14f" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_4ae391bf-8f75-4e67-80a4-cbd0c1c4d734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/InterimUnauditedFinancialStatements" xlink:type="simple" xlink:href="zntl-20210930.xsd#InterimUnauditedFinancialStatements"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/InterimUnauditedFinancialStatements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_186f5da0-f2d2-4979-8399-a9991c4b3a57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_a6cfa3ae-4408-470d-b25a-575a424d0283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_186f5da0-f2d2-4979-8399-a9991c4b3a57" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_a6cfa3ae-4408-470d-b25a-575a424d0283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/InterimUnauditedFinancialStatementsPolicies" xlink:type="simple" xlink:href="zntl-20210930.xsd#InterimUnauditedFinancialStatementsPolicies"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/InterimUnauditedFinancialStatementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d8009006-8042-460a-a51b-46ea6e712507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_625a99c5-42dd-4ad3-96ce-260d1ca7a8be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8009006-8042-460a-a51b-46ea6e712507" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_625a99c5-42dd-4ad3-96ce-260d1ca7a8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_8d38b3bd-5793-45ed-bd11-4b1e1c004ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8009006-8042-460a-a51b-46ea6e712507" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_8d38b3bd-5793-45ed-bd11-4b1e1c004ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_ee468d41-62c9-4fa1-b9e0-77ef91e7e9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8009006-8042-460a-a51b-46ea6e712507" xlink:to="loc_us-gaap_UseOfEstimates_ee468d41-62c9-4fa1-b9e0-77ef91e7e9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_13836166-83be-4101-84d2-fc774cb75071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8009006-8042-460a-a51b-46ea6e712507" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_13836166-83be-4101-84d2-fc774cb75071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_011e0296-fb8f-4401-b4df-1d6a55fc9a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8009006-8042-460a-a51b-46ea6e712507" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_011e0296-fb8f-4401-b4df-1d6a55fc9a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/InterimUnauditedFinancialStatementsTables" xlink:type="simple" xlink:href="zntl-20210930.xsd#InterimUnauditedFinancialStatementsTables"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/InterimUnauditedFinancialStatementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4ce94cf4-7292-48ef-ae58-f2913351590e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_1530a538-92f6-410c-8119-599dc2a18a77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4ce94cf4-7292-48ef-ae58-f2913351590e" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_1530a538-92f6-410c-8119-599dc2a18a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/SignificantTransactions" xlink:type="simple" xlink:href="zntl-20210930.xsd#SignificantTransactions"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/SignificantTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_83abaf3e-b1b2-4536-8f47-dda73ee78d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_6c6e3036-7c44-42f7-b596-31fbe4690e96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_83abaf3e-b1b2-4536-8f47-dda73ee78d73" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_6c6e3036-7c44-42f7-b596-31fbe4690e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/SignificantTransactionsDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#SignificantTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/SignificantTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_8ef3beb3-a972-4666-a29c-7b0dc7575ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8b7be6d5-fc7a-483d-b33c-3c41f8809748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_8ef3beb3-a972-4666-a29c-7b0dc7575ff2" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8b7be6d5-fc7a-483d-b33c-3c41f8809748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5ab588df-e195-40f8-9cfd-832d5fbef2f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8b7be6d5-fc7a-483d-b33c-3c41f8809748" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5ab588df-e195-40f8-9cfd-832d5fbef2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8982ea65-e097-4bda-b573-6c7c3ce7b2af" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5ab588df-e195-40f8-9cfd-832d5fbef2f5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8982ea65-e097-4bda-b573-6c7c3ce7b2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ZenteraTherapeuticsLtdMember_4af4b9b3-e638-4091-9f8c-742e16dabecb" xlink:href="zntl-20210930.xsd#zntl_ZenteraTherapeuticsLtdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8982ea65-e097-4bda-b573-6c7c3ce7b2af" xlink:to="loc_zntl_ZenteraTherapeuticsLtdMember_4af4b9b3-e638-4091-9f8c-742e16dabecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1e733741-36e1-4635-8c36-e46991ea8860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8b7be6d5-fc7a-483d-b33c-3c41f8809748" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1e733741-36e1-4635-8c36-e46991ea8860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_2abc7f58-2f3b-4b7b-b6cc-cdb1ddd62918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1e733741-36e1-4635-8c36-e46991ea8860" xlink:to="loc_us-gaap_EquityMethodInvestments_2abc7f58-2f3b-4b7b-b6cc-cdb1ddd62918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_78cc7815-f0c1-4489-9d00-8721546a9fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1e733741-36e1-4635-8c36-e46991ea8860" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_78cc7815-f0c1-4489-9d00-8721546a9fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_1c138684-7f16-480f-8eaa-f954ac7d0c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1e733741-36e1-4635-8c36-e46991ea8860" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_1c138684-7f16-480f-8eaa-f954ac7d0c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ResearchAndDevelopmentExpenseReimbursements_5ee22028-06ef-478b-96fa-4eea743f08dc" xlink:href="zntl-20210930.xsd#zntl_ResearchAndDevelopmentExpenseReimbursements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1e733741-36e1-4635-8c36-e46991ea8860" xlink:to="loc_zntl_ResearchAndDevelopmentExpenseReimbursements_5ee22028-06ef-478b-96fa-4eea743f08dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/BusinessCombinations" xlink:type="simple" xlink:href="zntl-20210930.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e31544e9-f0d1-4b5d-8b56-e3e1f7a53e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_0007a75f-7996-474c-a540-a4a1a7d5de52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e31544e9-f0d1-4b5d-8b56-e3e1f7a53e2f" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_0007a75f-7996-474c-a540-a4a1a7d5de52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="zntl-20210930.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_95685576-dbf9-45c0-9f0e-c269f7095cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_0082c038-bd6f-4cd7-a53a-e9bd9cb806f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_95685576-dbf9-45c0-9f0e-c269f7095cc7" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_0082c038-bd6f-4cd7-a53a-e9bd9cb806f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ReconciliationOfNoncontrollingInterestTableTextBlock_ea42eb8a-81eb-4c1e-85c3-c222a60943bf" xlink:href="zntl-20210930.xsd#zntl_ReconciliationOfNoncontrollingInterestTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_95685576-dbf9-45c0-9f0e-c269f7095cc7" xlink:to="loc_zntl_ReconciliationOfNoncontrollingInterestTableTextBlock_ea42eb8a-81eb-4c1e-85c3-c222a60943bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_10a5de7f-cee6-4f8d-9b2f-8149e7c3535a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aecd78-bb51-462f-9233-ed85a252805e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_10a5de7f-cee6-4f8d-9b2f-8149e7c3535a" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aecd78-bb51-462f-9233-ed85a252805e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bfa2395e-e4d3-4944-91e3-03bda6798fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aecd78-bb51-462f-9233-ed85a252805e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bfa2395e-e4d3-4944-91e3-03bda6798fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cf7398a4-4697-4739-86fb-c79670feb197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bfa2395e-e4d3-4944-91e3-03bda6798fe2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cf7398a4-4697-4739-86fb-c79670feb197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_KalyraPharmaceuticalsIncMember_2226ea5d-7f9a-4eb0-a639-dd4c85fb879f" xlink:href="zntl-20210930.xsd#zntl_KalyraPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cf7398a4-4697-4739-86fb-c79670feb197" xlink:to="loc_zntl_KalyraPharmaceuticalsIncMember_2226ea5d-7f9a-4eb0-a639-dd4c85fb879f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_dc51ca87-71a4-4a69-8d42-b32e64166c84" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aecd78-bb51-462f-9233-ed85a252805e" xlink:to="loc_srt_ConsolidatedEntitiesAxis_dc51ca87-71a4-4a69-8d42-b32e64166c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_fd10cf01-05a7-466b-8a5c-dc306bc4ec03" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_dc51ca87-71a4-4a69-8d42-b32e64166c84" xlink:to="loc_srt_ConsolidatedEntitiesDomain_fd10cf01-05a7-466b-8a5c-dc306bc4ec03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_67916c5e-4b04-44c7-b0bc-2d2f7a8ef48e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_fd10cf01-05a7-466b-8a5c-dc306bc4ec03" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_67916c5e-4b04-44c7-b0bc-2d2f7a8ef48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e591b8f0-01d5-4d20-adcb-dae8b7ba70b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aecd78-bb51-462f-9233-ed85a252805e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e591b8f0-01d5-4d20-adcb-dae8b7ba70b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f92e98b-da3c-46e1-8f9c-9e06b703a429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e591b8f0-01d5-4d20-adcb-dae8b7ba70b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f92e98b-da3c-46e1-8f9c-9e06b703a429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_06e0d10c-9fb9-4697-93df-00f5d6f647be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f92e98b-da3c-46e1-8f9c-9e06b703a429" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_06e0d10c-9fb9-4697-93df-00f5d6f647be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_9af627bd-b9f3-4387-8ecd-da6eb4cd2363" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e9aecd78-bb51-462f-9233-ed85a252805e" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_9af627bd-b9f3-4387-8ecd-da6eb4cd2363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2235a9a7-8715-4db2-942f-dfc5ecfc8431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_9af627bd-b9f3-4387-8ecd-da6eb4cd2363" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2235a9a7-8715-4db2-942f-dfc5ecfc8431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_23f0d9b0-323d-4ae8-8cab-f8234a4e9a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_9af627bd-b9f3-4387-8ecd-da6eb4cd2363" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_23f0d9b0-323d-4ae8-8cab-f8234a4e9a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_ba8a1fec-acd5-427d-a63d-2aace764d253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_9af627bd-b9f3-4387-8ecd-da6eb4cd2363" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_ba8a1fec-acd5-427d-a63d-2aace764d253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_24e1d26e-e0cd-441c-8f91-a526497940bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_9af627bd-b9f3-4387-8ecd-da6eb4cd2363" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_24e1d26e-e0cd-441c-8f91-a526497940bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_f2924cf2-5cbc-41ec-b0fe-80e27e4077f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_9af627bd-b9f3-4387-8ecd-da6eb4cd2363" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_f2924cf2-5cbc-41ec-b0fe-80e27e4077f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#BusinessCombinationsAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_909d168f-1799-4b91-81d8-8b73cfcd6abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_768583b3-8dc6-4d7a-82f0-8cd30a08253a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_909d168f-1799-4b91-81d8-8b73cfcd6abd" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_768583b3-8dc6-4d7a-82f0-8cd30a08253a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_6d8bc040-9078-4572-aa8c-0139588984db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_768583b3-8dc6-4d7a-82f0-8cd30a08253a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_6d8bc040-9078-4572-aa8c-0139588984db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_866aa2b9-96d8-4765-a5d9-237297560152" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6d8bc040-9078-4572-aa8c-0139588984db" xlink:to="loc_srt_ConsolidatedEntitiesDomain_866aa2b9-96d8-4765-a5d9-237297560152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_9347683e-b0b3-4d82-8d93-e5aa4ff8b81e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_866aa2b9-96d8-4765-a5d9-237297560152" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_9347683e-b0b3-4d82-8d93-e5aa4ff8b81e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_768583b3-8dc6-4d7a-82f0-8cd30a08253a" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_232169cb-ed4b-47a6-887a-3e33b1483789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_232169cb-ed4b-47a6-887a-3e33b1483789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_cd4e2fac-32eb-4572-9ad9-c82b71bd732c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_OtherAssetsCurrent_cd4e2fac-32eb-4572-9ad9-c82b71bd732c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4622f0df-f463-4956-bfac-caa6341ab7af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4622f0df-f463-4956-bfac-caa6341ab7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_37d42370-468f-4503-928e-53ce000f570e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_Goodwill_37d42370-468f-4503-928e-53ce000f570e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_8ea07f18-6ad9-420b-b9fa-081bd154d4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_8ea07f18-6ad9-420b-b9fa-081bd154d4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_679c12bc-32a1-47cc-b783-30b7b7f2df18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_679c12bc-32a1-47cc-b783-30b7b7f2df18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_ea62383c-ef61-403c-a86c-b30e1264b0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_df37b48e-a09b-40c9-9a1a-97d582490733" xlink:to="loc_us-gaap_MinorityInterest_ea62383c-ef61-403c-a86c-b30e1264b0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#BusinessCombinationsRollforwardofNoncontrollingInterestDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_54af7f27-212a-4e34-ae56-cfb33a54f3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fecabc98-2e88-46ac-9ecf-2a1e256f5f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_54af7f27-212a-4e34-ae56-cfb33a54f3fb" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fecabc98-2e88-46ac-9ecf-2a1e256f5f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_94c53189-2569-483f-a6dd-b40a697b3506" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fecabc98-2e88-46ac-9ecf-2a1e256f5f63" xlink:to="loc_srt_ConsolidatedEntitiesAxis_94c53189-2569-483f-a6dd-b40a697b3506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_72534c1c-2b89-43a5-a79b-b32d7f6c9b16" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_94c53189-2569-483f-a6dd-b40a697b3506" xlink:to="loc_srt_ConsolidatedEntitiesDomain_72534c1c-2b89-43a5-a79b-b32d7f6c9b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_671e6c40-bbaa-49dd-af0c-4a6876c22b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_72534c1c-2b89-43a5-a79b-b32d7f6c9b16" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_671e6c40-bbaa-49dd-af0c-4a6876c22b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_bb82664d-d52c-4a3e-b39b-d0fe2b699f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fecabc98-2e88-46ac-9ecf-2a1e256f5f63" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_bb82664d-d52c-4a3e-b39b-d0fe2b699f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_abb91195-acc7-42a9-99d7-d374bb1af483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_bb82664d-d52c-4a3e-b39b-d0fe2b699f0a" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_abb91195-acc7-42a9-99d7-d374bb1af483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_131d096a-ea0c-4cbf-b277-5af5858a51db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_abb91195-acc7-42a9-99d7-d374bb1af483" xlink:to="loc_us-gaap_MinorityInterest_131d096a-ea0c-4cbf-b277-5af5858a51db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d1514ef7-2778-438e-874b-5bd418ac04a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_abb91195-acc7-42a9-99d7-d374bb1af483" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d1514ef7-2778-438e-874b-5bd418ac04a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_cccd66cb-50fb-4fe7-a4fd-fd2dcf241771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_abb91195-acc7-42a9-99d7-d374bb1af483" xlink:to="loc_us-gaap_MinorityInterest_cccd66cb-50fb-4fe7-a4fd-fd2dcf241771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="zntl-20210930.xsd#FairValueMeasurement"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/FairValueMeasurement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1dc9ca15-2fae-4263-9a70-d89542b39642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_9e79f641-7766-489d-ae4b-202c974dfb21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1dc9ca15-2fae-4263-9a70-d89542b39642" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_9e79f641-7766-489d-ae4b-202c974dfb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="zntl-20210930.xsd#FairValueMeasurementTables"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/FairValueMeasurementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9728561b-39a0-459e-a814-de10053e5e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_0f0f39d6-2911-41a4-ba7a-098079b52af8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9728561b-39a0-459e-a814-de10053e5e35" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_0f0f39d6-2911-41a4-ba7a-098079b52af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_849ef2ff-6177-4144-a96d-866c5b7d4446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9728561b-39a0-459e-a814-de10053e5e35" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_849ef2ff-6177-4144-a96d-866c5b7d4446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_91cce1e8-38ce-4e47-bd61-2388e96dfa2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9728561b-39a0-459e-a814-de10053e5e35" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_91cce1e8-38ce-4e47-bd61-2388e96dfa2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1503af89-094c-4eec-8d8b-679d8ad8af22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6bd9ae4f-cc2d-47ca-890d-89eb547a5a03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1503af89-094c-4eec-8d8b-679d8ad8af22" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6bd9ae4f-cc2d-47ca-890d-89eb547a5a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ec8a8742-eb7b-4ee9-9e05-ab3b0e9edc48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6bd9ae4f-cc2d-47ca-890d-89eb547a5a03" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ec8a8742-eb7b-4ee9-9e05-ab3b0e9edc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3a3b66d-fb80-464a-ac98-5127aad73cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ec8a8742-eb7b-4ee9-9e05-ab3b0e9edc48" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3a3b66d-fb80-464a-ac98-5127aad73cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e0d87237-f646-4133-924c-79d4266be81f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3a3b66d-fb80-464a-ac98-5127aad73cdc" xlink:to="loc_us-gaap_CommercialPaperMember_e0d87237-f646-4133-924c-79d4266be81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_bab319c2-fd53-40ad-8f0c-8f7d1f6c4a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3a3b66d-fb80-464a-ac98-5127aad73cdc" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_bab319c2-fd53-40ad-8f0c-8f7d1f6c4a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_522b0d57-244c-414f-a625-9ae556c450ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3a3b66d-fb80-464a-ac98-5127aad73cdc" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_522b0d57-244c-414f-a625-9ae556c450ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_cf385842-cc43-4a52-bd19-09627d5bc9de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d3a3b66d-fb80-464a-ac98-5127aad73cdc" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_cf385842-cc43-4a52-bd19-09627d5bc9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6ca176f4-ff28-4e4c-b6bf-c99a0c2afb08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6bd9ae4f-cc2d-47ca-890d-89eb547a5a03" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6ca176f4-ff28-4e4c-b6bf-c99a0c2afb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_40dcc858-fabb-4fe4-a502-d47c3145c8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6ca176f4-ff28-4e4c-b6bf-c99a0c2afb08" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_40dcc858-fabb-4fe4-a502-d47c3145c8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_25e540cb-9a13-4f09-bdbe-ddd6abe5fe04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6ca176f4-ff28-4e4c-b6bf-c99a0c2afb08" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_25e540cb-9a13-4f09-bdbe-ddd6abe5fe04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a645a630-8e30-4016-8749-62d58ce28790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6ca176f4-ff28-4e4c-b6bf-c99a0c2afb08" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a645a630-8e30-4016-8749-62d58ce28790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1fd0c57a-489c-4a5d-bb0e-12ed5036fbef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6ca176f4-ff28-4e4c-b6bf-c99a0c2afb08" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1fd0c57a-489c-4a5d-bb0e-12ed5036fbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_dcdcddc7-2ba8-4d7b-a4e7-4e882c85c31c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_ce6c02fa-ad07-4c68-84a3-d1792a7420e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dcdcddc7-2ba8-4d7b-a4e7-4e882c85c31c" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_ce6c02fa-ad07-4c68-84a3-d1792a7420e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_519da25d-56fb-413e-86fe-51f1396a312c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dcdcddc7-2ba8-4d7b-a4e7-4e882c85c31c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_519da25d-56fb-413e-86fe-51f1396a312c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_00fd5398-70c6-4d54-b13a-2452aba6a637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dcdcddc7-2ba8-4d7b-a4e7-4e882c85c31c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_00fd5398-70c6-4d54-b13a-2452aba6a637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_53256bab-6435-474a-bc76-0ae89565c6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_78eefd75-64c7-4000-95b3-92339d851eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_53256bab-6435-474a-bc76-0ae89565c6c9" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_78eefd75-64c7-4000-95b3-92339d851eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_57e2c8a0-1e84-4b29-b2e7-1dbf7a83103f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_78eefd75-64c7-4000-95b3-92339d851eb8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_57e2c8a0-1e84-4b29-b2e7-1dbf7a83103f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a71f5542-e8d2-4a7d-92a4-1d17c8f9baee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_57e2c8a0-1e84-4b29-b2e7-1dbf7a83103f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a71f5542-e8d2-4a7d-92a4-1d17c8f9baee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_24880e90-2797-4cd9-bfcf-9c2ed9a48f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a71f5542-e8d2-4a7d-92a4-1d17c8f9baee" xlink:to="loc_us-gaap_MoneyMarketFundsMember_24880e90-2797-4cd9-bfcf-9c2ed9a48f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_94213d57-1fc1-4421-b8cf-0aab572c99ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a71f5542-e8d2-4a7d-92a4-1d17c8f9baee" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_94213d57-1fc1-4421-b8cf-0aab572c99ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_98be8416-6cf6-4fab-aafa-5a914bb2b535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_78eefd75-64c7-4000-95b3-92339d851eb8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_98be8416-6cf6-4fab-aafa-5a914bb2b535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad575f32-01a8-40b7-9b7f-6a66cf3bbb44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_98be8416-6cf6-4fab-aafa-5a914bb2b535" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad575f32-01a8-40b7-9b7f-6a66cf3bbb44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6b884293-78e0-439b-872e-ab4764c483d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad575f32-01a8-40b7-9b7f-6a66cf3bbb44" xlink:to="loc_us-gaap_CommercialPaperMember_6b884293-78e0-439b-872e-ab4764c483d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_1bb7ca9a-c149-498e-8c61-5ee27fc83d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad575f32-01a8-40b7-9b7f-6a66cf3bbb44" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_1bb7ca9a-c149-498e-8c61-5ee27fc83d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_810b1cfe-d47f-4c84-b4df-acc89c1fa2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad575f32-01a8-40b7-9b7f-6a66cf3bbb44" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_810b1cfe-d47f-4c84-b4df-acc89c1fa2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_19e5d703-4c18-4c30-a63a-11b1ea57ac88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad575f32-01a8-40b7-9b7f-6a66cf3bbb44" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_19e5d703-4c18-4c30-a63a-11b1ea57ac88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4249d90c-c98a-4926-839a-e50e1dc9d801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_78eefd75-64c7-4000-95b3-92339d851eb8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4249d90c-c98a-4926-839a-e50e1dc9d801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db0ef481-0c1a-493f-825e-19ec581a63d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4249d90c-c98a-4926-839a-e50e1dc9d801" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db0ef481-0c1a-493f-825e-19ec581a63d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_6907ac6b-b4f1-4426-a7a0-61d4abb7882d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db0ef481-0c1a-493f-825e-19ec581a63d1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_6907ac6b-b4f1-4426-a7a0-61d4abb7882d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8839940a-8e7e-4c28-bdc4-04fa7a5416b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db0ef481-0c1a-493f-825e-19ec581a63d1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8839940a-8e7e-4c28-bdc4-04fa7a5416b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_878f2f7a-a6cb-4b18-97de-bdeba5f642f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_78eefd75-64c7-4000-95b3-92339d851eb8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_878f2f7a-a6cb-4b18-97de-bdeba5f642f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d07d88f1-c640-4018-ac66-67ca32351852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_878f2f7a-a6cb-4b18-97de-bdeba5f642f5" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d07d88f1-c640-4018-ac66-67ca32351852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fc147518-6dd8-48eb-8900-bfc929c203d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_878f2f7a-a6cb-4b18-97de-bdeba5f642f5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fc147518-6dd8-48eb-8900-bfc929c203d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e6980a87-6a48-48bb-9635-58961b38a676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_878f2f7a-a6cb-4b18-97de-bdeba5f642f5" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e6980a87-6a48-48bb-9635-58961b38a676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/PrepaidExpensesandOtherAssets" xlink:type="simple" xlink:href="zntl-20210930.xsd#PrepaidExpensesandOtherAssets"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/PrepaidExpensesandOtherAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_6f18e2b8-0651-45fa-aec2-d9344de783a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock_4e695036-ba5a-4380-b1bc-33719ad2b32f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_6f18e2b8-0651-45fa-aec2-d9344de783a7" xlink:to="loc_us-gaap_OtherAssetsDisclosureTextBlock_4e695036-ba5a-4380-b1bc-33719ad2b32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsTables" xlink:type="simple" xlink:href="zntl-20210930.xsd#PrepaidExpensesandOtherAssetsTables"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_1eaf6e31-c313-4955-979a-72ae7da29876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_4430325b-5f68-4c79-a4e6-5dab9769ce50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_1eaf6e31-c313-4955-979a-72ae7da29876" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_4430325b-5f68-4c79-a4e6-5dab9769ce50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#PrepaidExpensesandOtherAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_62cfcb4c-1416-4006-a626-f535d5b40920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_abc82a29-27fb-42e8-92c4-f5587be1911a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_62cfcb4c-1416-4006-a626-f535d5b40920" xlink:to="loc_us-gaap_PrepaidInsurance_abc82a29-27fb-42e8-92c4-f5587be1911a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_PrepaidSoftwareLicenseAndMaintenance_37a2d07a-5d8c-428a-a413-9cf484d07769" xlink:href="zntl-20210930.xsd#zntl_PrepaidSoftwareLicenseAndMaintenance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_62cfcb4c-1416-4006-a626-f535d5b40920" xlink:to="loc_zntl_PrepaidSoftwareLicenseAndMaintenance_37a2d07a-5d8c-428a-a413-9cf484d07769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ForeignResearchAndDevelopmentCreditRefund_778c1594-9e29-49d3-87b2-31a2327a6e66" xlink:href="zntl-20210930.xsd#zntl_ForeignResearchAndDevelopmentCreditRefund"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_62cfcb4c-1416-4006-a626-f535d5b40920" xlink:to="loc_zntl_ForeignResearchAndDevelopmentCreditRefund_778c1594-9e29-49d3-87b2-31a2327a6e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_PrepaidResearchAndDevelopmentCosts_abbfcef4-ca7f-4755-9d27-c0098bc40a65" xlink:href="zntl-20210930.xsd#zntl_PrepaidResearchAndDevelopmentCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_62cfcb4c-1416-4006-a626-f535d5b40920" xlink:to="loc_zntl_PrepaidResearchAndDevelopmentCosts_abbfcef4-ca7f-4755-9d27-c0098bc40a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_1b3ec0f7-a430-4d89-9984-b5d4cae89b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_62cfcb4c-1416-4006-a626-f535d5b40920" xlink:to="loc_us-gaap_InterestReceivable_1b3ec0f7-a430-4d89-9984-b5d4cae89b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_8cc00d3e-b47a-4379-9ebc-ee4d050d7997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_62cfcb4c-1416-4006-a626-f535d5b40920" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_8cc00d3e-b47a-4379-9ebc-ee4d050d7997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_OtherPrepaidExpense_85243043-d332-481c-aea6-5c158c46b0c0" xlink:href="zntl-20210930.xsd#zntl_OtherPrepaidExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_62cfcb4c-1416-4006-a626-f535d5b40920" xlink:to="loc_zntl_OtherPrepaidExpense_85243043-d332-481c-aea6-5c158c46b0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_7deb89c9-c322-4efa-b4ff-6aa5bc8e4484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_62cfcb4c-1416-4006-a626-f535d5b40920" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssets_7deb89c9-c322-4efa-b4ff-6aa5bc8e4484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_16da754e-2a18-481a-9ab2-10805d3250ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_62cfcb4c-1416-4006-a626-f535d5b40920" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_16da754e-2a18-481a-9ab2-10805d3250ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_18a9d44d-d365-4a43-8770-5c905b6e4fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_62cfcb4c-1416-4006-a626-f535d5b40920" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_18a9d44d-d365-4a43-8770-5c905b6e4fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails_1" xlink:type="simple" xlink:href="zntl-20210930.xsd#PrepaidExpensesandOtherAssetsDetails_1"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.zentalis.com/role/PropertyandEquipmentnet" xlink:type="simple" xlink:href="zntl-20210930.xsd#PropertyandEquipmentnet"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/PropertyandEquipmentnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0a81b0b7-d6ce-4793-95ee-dc963c598809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_a8da57ca-6270-4999-8665-da7aad9ca7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0a81b0b7-d6ce-4793-95ee-dc963c598809" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_a8da57ca-6270-4999-8665-da7aad9ca7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/PropertyandEquipmentnetTables" xlink:type="simple" xlink:href="zntl-20210930.xsd#PropertyandEquipmentnetTables"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/PropertyandEquipmentnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a39bcb57-05c0-4740-95d6-254331741f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_98971179-8aee-46b5-8d5e-c3f98a1bb6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a39bcb57-05c0-4740-95d6-254331741f1f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_98971179-8aee-46b5-8d5e-c3f98a1bb6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#PropertyandEquipmentnetSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ad8a9ee0-ad5a-46bd-a6c3-7c72d41333f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a76b8d7-6481-4a00-aa41-4e65085f103a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ad8a9ee0-ad5a-46bd-a6c3-7c72d41333f0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a76b8d7-6481-4a00-aa41-4e65085f103a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e2e03988-6bfd-4310-9eb1-1cd156b63ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a76b8d7-6481-4a00-aa41-4e65085f103a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e2e03988-6bfd-4310-9eb1-1cd156b63ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87438353-f341-4886-b92b-c8f011ecb117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e2e03988-6bfd-4310-9eb1-1cd156b63ea3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87438353-f341-4886-b92b-c8f011ecb117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ComputerAndOfficeEquipmentMember_87daebf6-b48f-4b61-a210-84cd64da94d6" xlink:href="zntl-20210930.xsd#zntl_ComputerAndOfficeEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87438353-f341-4886-b92b-c8f011ecb117" xlink:to="loc_zntl_ComputerAndOfficeEquipmentMember_87daebf6-b48f-4b61-a210-84cd64da94d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_LaboratoryEquipmentMember_ea4e3651-8a1b-4f44-abb0-0c35313de04d" xlink:href="zntl-20210930.xsd#zntl_LaboratoryEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87438353-f341-4886-b92b-c8f011ecb117" xlink:to="loc_zntl_LaboratoryEquipmentMember_ea4e3651-8a1b-4f44-abb0-0c35313de04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_b309d0e5-33df-45b3-975a-9ec7dc4d4dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87438353-f341-4886-b92b-c8f011ecb117" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_b309d0e5-33df-45b3-975a-9ec7dc4d4dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_c04b8d80-3c54-4813-9eb8-0642257b8ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_87438353-f341-4886-b92b-c8f011ecb117" xlink:to="loc_us-gaap_ConstructionInProgressMember_c04b8d80-3c54-4813-9eb8-0642257b8ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dae44a47-6986-42b1-8f6a-273011e47d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a76b8d7-6481-4a00-aa41-4e65085f103a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dae44a47-6986-42b1-8f6a-273011e47d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a99bc8ec-711e-4e94-a876-fd01955daa84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dae44a47-6986-42b1-8f6a-273011e47d5f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a99bc8ec-711e-4e94-a876-fd01955daa84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_bd1c9743-51a8-4828-b35e-74abf334d078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dae44a47-6986-42b1-8f6a-273011e47d5f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_bd1c9743-51a8-4828-b35e-74abf334d078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_689864de-fd3f-4f3d-8c7a-e74639a583cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dae44a47-6986-42b1-8f6a-273011e47d5f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_689864de-fd3f-4f3d-8c7a-e74639a583cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/PropertyandEquipmentnetNarrativeDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#PropertyandEquipmentnetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/PropertyandEquipmentnetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_192a31f3-74d0-4b74-a615-a140dc8ee78c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_fd93c5ef-31a1-4c15-a6fa-7f8628e49670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_192a31f3-74d0-4b74-a615-a140dc8ee78c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_fd93c5ef-31a1-4c15-a6fa-7f8628e49670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/AccruedExpenses" xlink:type="simple" xlink:href="zntl-20210930.xsd#AccruedExpenses"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/AccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_76d98631-253f-4c1a-9ee0-d5df5da61130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_d26d3bc2-4aba-45d2-bd2c-a15ee039e7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_76d98631-253f-4c1a-9ee0-d5df5da61130" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_d26d3bc2-4aba-45d2-bd2c-a15ee039e7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="zntl-20210930.xsd#AccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/AccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_43afc8e8-6c4b-413b-b0f8-d3d5ff1984bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_8a28e1c1-1aac-4cad-a03b-1a3db2ddad39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_43afc8e8-6c4b-413b-b0f8-d3d5ff1984bd" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_8a28e1c1-1aac-4cad-a03b-1a3db2ddad39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#AccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_94ded66a-f7f9-4cd8-8812-8dd33eaf8fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_AccruedResearchAndDevelopmentCostsCurrent_256aa948-9eaf-4bb9-975b-3e3f05cec38f" xlink:href="zntl-20210930.xsd#zntl_AccruedResearchAndDevelopmentCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_94ded66a-f7f9-4cd8-8812-8dd33eaf8fb4" xlink:to="loc_zntl_AccruedResearchAndDevelopmentCostsCurrent_256aa948-9eaf-4bb9-975b-3e3f05cec38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_440afd35-3ab9-4978-b17c-a6ad214e9615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_94ded66a-f7f9-4cd8-8812-8dd33eaf8fb4" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_440afd35-3ab9-4978-b17c-a6ad214e9615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_AccruedGeneralAndAdministrativeCostsCurrent_f2f1527b-0a9b-490f-926c-05fa82c2d987" xlink:href="zntl-20210930.xsd#zntl_AccruedGeneralAndAdministrativeCostsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_94ded66a-f7f9-4cd8-8812-8dd33eaf8fb4" xlink:to="loc_zntl_AccruedGeneralAndAdministrativeCostsCurrent_f2f1527b-0a9b-490f-926c-05fa82c2d987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8bd1ee36-2529-48d6-bb57-d6f6f23dac7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_94ded66a-f7f9-4cd8-8812-8dd33eaf8fb4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8bd1ee36-2529-48d6-bb57-d6f6f23dac7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_8d7fb329-57c6-428f-9f7f-cc6be91135f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_94ded66a-f7f9-4cd8-8812-8dd33eaf8fb4" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_8d7fb329-57c6-428f-9f7f-cc6be91135f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c34e6c48-9080-4e06-9e87-d5667a9251d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_94ded66a-f7f9-4cd8-8812-8dd33eaf8fb4" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c34e6c48-9080-4e06-9e87-d5667a9251d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_aa2a3a3d-9c7e-41be-958e-ca83624b1187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_94ded66a-f7f9-4cd8-8812-8dd33eaf8fb4" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_aa2a3a3d-9c7e-41be-958e-ca83624b1187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/ConvertiblePreferredUnits" xlink:type="simple" xlink:href="zntl-20210930.xsd#ConvertiblePreferredUnits"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/ConvertiblePreferredUnits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f65aac01-7626-4934-961f-037437a5304d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityTextBlock_d2c8c078-007e-4147-af86-070ddb52ac18" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f65aac01-7626-4934-961f-037437a5304d" xlink:to="loc_zntl_TemporaryEquityTextBlock_d2c8c078-007e-4147-af86-070ddb52ac18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#ConvertiblePreferredUnitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f0d950ac-1175-4fc6-aa55-2b839f94caff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_8593c9fe-fbd8-41b9-9b18-a29b46dda0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f0d950ac-1175-4fc6-aa55-2b839f94caff" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_8593c9fe-fbd8-41b9-9b18-a29b46dda0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3214acae-bcf8-4194-8a77-18a482e5b37d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8593c9fe-fbd8-41b9-9b18-a29b46dda0c1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3214acae-bcf8-4194-8a77-18a482e5b37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1e47edb6-0cc8-4cb3-ac22-6667e8d03940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3214acae-bcf8-4194-8a77-18a482e5b37d" xlink:to="loc_us-gaap_ClassOfStockDomain_1e47edb6-0cc8-4cb3-ac22-6667e8d03940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_395c6b13-22f9-42aa-b39c-5cd34079b9eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1e47edb6-0cc8-4cb3-ac22-6667e8d03940" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_395c6b13-22f9-42aa-b39c-5cd34079b9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_8fcca1e5-58d4-481e-901e-93614b772ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1e47edb6-0cc8-4cb3-ac22-6667e8d03940" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_8fcca1e5-58d4-481e-901e-93614b772ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_2f0e221e-561d-4031-ab86-fd507d8d032e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1e47edb6-0cc8-4cb3-ac22-6667e8d03940" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_2f0e221e-561d-4031-ab86-fd507d8d032e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8593c9fe-fbd8-41b9-9b18-a29b46dda0c1" xlink:to="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_663bb6d8-0ac7-4d61-98e5-21c099a23b38" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_663bb6d8-0ac7-4d61-98e5-21c099a23b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_6dceb143-0f86-4e14-bf37-9273c2723781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_6dceb143-0f86-4e14-bf37-9273c2723781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_786bf78d-cf27-4f4d-871d-7a494c024ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_786bf78d-cf27-4f4d-871d-7a494c024ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross_92c3563a-c24b-4e5b-bd5e-c4209e35d381" xlink:href="zntl-20210930.xsd#zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross_92c3563a-c24b-4e5b-bd5e-c4209e35d381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_79451d4b-6bc2-49c2-b3c6-367b6a8cf129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_79451d4b-6bc2-49c2-b3c6-367b6a8cf129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_ed85cbb3-f3df-457c-8b1d-71660052140c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_ed85cbb3-f3df-457c-8b1d-71660052140c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_341fca33-de01-4c38-a720-753f3267632f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_341fca33-de01-4c38-a720-753f3267632f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_bde688fd-816e-4491-be78-7ee16d93e2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_bde688fd-816e-4491-be78-7ee16d93e2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ConvertiblePreferredStockDividendsPerShareDeclared_0c8e1333-181b-4379-9367-c40c8c403a12" xlink:href="zntl-20210930.xsd#zntl_ConvertiblePreferredStockDividendsPerShareDeclared"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_zntl_ConvertiblePreferredStockDividendsPerShareDeclared_0c8e1333-181b-4379-9367-c40c8c403a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_793e3f50-7996-4444-8bd2-c12e16da6ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_793e3f50-7996-4444-8bd2-c12e16da6ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering_ed0a8af4-df9b-418c-bc4f-d0970c3d9313" xlink:href="zntl-20210930.xsd#zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering_ed0a8af4-df9b-418c-bc4f-d0970c3d9313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare_0569157d-7142-42f4-8469-9032361b9c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_aa29ab1b-ee57-4343-b7bf-99e4216225aa" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare_0569157d-7142-42f4-8469-9032361b9c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquity" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquity"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/MembersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_af6de149-7e14-43c8-8875-aa0dd205672e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock_75873701-965c-49ce-ac8a-d5160cc743d3" xlink:href="zntl-20210930.xsd#zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_af6de149-7e14-43c8-8875-aa0dd205672e" xlink:to="loc_zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock_75873701-965c-49ce-ac8a-d5160cc743d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquityTables" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquityTables"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/MembersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8ceae0f5-d04d-4032-9a63-857b31fe7e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_f85c3d84-9853-402d-a7e9-d684a31ebe6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8ceae0f5-d04d-4032-9a63-857b31fe7e20" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_f85c3d84-9853-402d-a7e9-d684a31ebe6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_50c564c3-e502-4fcd-98c1-5ea3644837bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8ceae0f5-d04d-4032-9a63-857b31fe7e20" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_50c564c3-e502-4fcd-98c1-5ea3644837bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_b9d04fa0-5f6b-4b2e-a8a8-a09c04e5d9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8ceae0f5-d04d-4032-9a63-857b31fe7e20" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_b9d04fa0-5f6b-4b2e-a8a8-a09c04e5d9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_7594c477-60b6-46ce-b3d6-fce802e1492e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8ceae0f5-d04d-4032-9a63-857b31fe7e20" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_7594c477-60b6-46ce-b3d6-fce802e1492e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquityNarrativeDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/MembersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d804a2a8-a1a4-46e6-8cb0-8d758a92b69e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d804a2a8-a1a4-46e6-8cb0-8d758a92b69e" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_597c288b-7b96-43b2-86f0-faa1bbf6ebbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:to="loc_us-gaap_StatementClassOfStockAxis_597c288b-7b96-43b2-86f0-faa1bbf6ebbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_597c288b-7b96-43b2-86f0-faa1bbf6ebbe" xlink:to="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_81cec943-2046-4cb4-84be-40f71b8d1f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:to="loc_us-gaap_CommonClassAMember_81cec943-2046-4cb4-84be-40f71b8d1f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_75e53ce9-c3fc-4ded-b4ed-6d20bbcfa144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:to="loc_us-gaap_CommonClassBMember_75e53ce9-c3fc-4ded-b4ed-6d20bbcfa144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_63530549-d086-4b39-9b48-4ef68f75273a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:to="loc_us-gaap_CommonStockMember_63530549-d086-4b39-9b48-4ef68f75273a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_deeb3bf8-17c3-45e0-a407-a211d2eacc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:to="loc_us-gaap_RestrictedStockMember_deeb3bf8-17c3-45e0-a407-a211d2eacc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_8f82991a-bc13-4b82-aee0-6434a7c14c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_8f82991a-bc13-4b82-aee0-6434a7c14c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_25c17fed-500f-4572-9176-a818fc3a58a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7f9ef793-5fc1-4e53-8f4c-f0201fa7a936" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_25c17fed-500f-4572-9176-a818fc3a58a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_afc7dc97-f1be-4051-96a2-c3b5a665e455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_afc7dc97-f1be-4051-96a2-c3b5a665e455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a5ef2373-a343-4265-870d-e046c9410ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_afc7dc97-f1be-4051-96a2-c3b5a665e455" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a5ef2373-a343-4265-870d-e046c9410ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_CorporateConversionMember_f5225c91-d49d-42c9-9a9c-611518b5dbe2" xlink:href="zntl-20210930.xsd#zntl_CorporateConversionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a5ef2373-a343-4265-870d-e046c9410ae5" xlink:to="loc_zntl_CorporateConversionMember_f5225c91-d49d-42c9-9a9c-611518b5dbe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_e25e1142-e42c-4243-a0ce-a592763dfc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a5ef2373-a343-4265-870d-e046c9410ae5" xlink:to="loc_us-gaap_IPOMember_e25e1142-e42c-4243-a0ce-a592763dfc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_bea85475-06eb-4b45-a635-8d0fffe93f59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a5ef2373-a343-4265-870d-e046c9410ae5" xlink:to="loc_us-gaap_OverAllotmentOptionMember_bea85475-06eb-4b45-a635-8d0fffe93f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_FollowOnOfferingMember_5d017fe6-07a1-4fc3-9814-d2ae83bde70a" xlink:href="zntl-20210930.xsd#zntl_FollowOnOfferingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a5ef2373-a343-4265-870d-e046c9410ae5" xlink:to="loc_zntl_FollowOnOfferingMember_5d017fe6-07a1-4fc3-9814-d2ae83bde70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_FollowOnPublicOfferingMember_17deef26-9f0b-40c1-9619-1acf2001b237" xlink:href="zntl-20210930.xsd#zntl_FollowOnPublicOfferingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a5ef2373-a343-4265-870d-e046c9410ae5" xlink:to="loc_zntl_FollowOnPublicOfferingMember_17deef26-9f0b-40c1-9619-1acf2001b237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3c59950d-d2d1-4cc5-b8e6-526b45ae9303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:to="loc_us-gaap_PlanNameAxis_3c59950d-d2d1-4cc5-b8e6-526b45ae9303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d5ea6125-0c2c-4725-be52-4bb93612d2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3c59950d-d2d1-4cc5-b8e6-526b45ae9303" xlink:to="loc_us-gaap_PlanNameDomain_d5ea6125-0c2c-4725-be52-4bb93612d2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_A2017ProfitInterestPlanMember_e2381871-1521-49c7-8a8a-ba3bafdafa81" xlink:href="zntl-20210930.xsd#zntl_A2017ProfitInterestPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d5ea6125-0c2c-4725-be52-4bb93612d2d5" xlink:to="loc_zntl_A2017ProfitInterestPlanMember_e2381871-1521-49c7-8a8a-ba3bafdafa81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_A2020IncentiveAwardPlanMember_eb6685d1-eda7-43fc-8e4a-372b373d65c0" xlink:href="zntl-20210930.xsd#zntl_A2020IncentiveAwardPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d5ea6125-0c2c-4725-be52-4bb93612d2d5" xlink:to="loc_zntl_A2020IncentiveAwardPlanMember_eb6685d1-eda7-43fc-8e4a-372b373d65c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ZenteraStockPlanMember_ac8175e4-07b9-4023-b643-f832e9c567af" xlink:href="zntl-20210930.xsd#zntl_ZenteraStockPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d5ea6125-0c2c-4725-be52-4bb93612d2d5" xlink:to="loc_zntl_ZenteraStockPlanMember_ac8175e4-07b9-4023-b643-f832e9c567af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a166519a-c350-4bb8-ba64-b9bbe194623f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:to="loc_srt_RangeAxis_a166519a-c350-4bb8-ba64-b9bbe194623f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b0988e6b-8f5e-4936-8317-3591005c2c0a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a166519a-c350-4bb8-ba64-b9bbe194623f" xlink:to="loc_srt_RangeMember_b0988e6b-8f5e-4936-8317-3591005c2c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9b7e6f9c-b6dc-4faa-9fb4-aafe58dcdbbc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b0988e6b-8f5e-4936-8317-3591005c2c0a" xlink:to="loc_srt_MaximumMember_9b7e6f9c-b6dc-4faa-9fb4-aafe58dcdbbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f1d0ac00-3649-43ee-ab25-5fbb17495a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:to="loc_us-gaap_AwardTypeAxis_f1d0ac00-3649-43ee-ab25-5fbb17495a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8806f8d-17c2-4963-9822-818f2489e84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f1d0ac00-3649-43ee-ab25-5fbb17495a99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8806f8d-17c2-4963-9822-818f2489e84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_733f9bd7-5a8a-4515-a01d-0df3cdae8725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8806f8d-17c2-4963-9822-818f2489e84f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_733f9bd7-5a8a-4515-a01d-0df3cdae8725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_01d1602f-abd3-4508-a0b3-5e7aaa4fe5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8806f8d-17c2-4963-9822-818f2489e84f" xlink:to="loc_us-gaap_RestrictedStockMember_01d1602f-abd3-4508-a0b3-5e7aaa4fe5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b6e2b391-2d27-409c-b0c3-483186ef1884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8806f8d-17c2-4963-9822-818f2489e84f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b6e2b391-2d27-409c-b0c3-483186ef1884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_79806668-4f09-47b5-9bd0-23af2cf02f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8806f8d-17c2-4963-9822-818f2489e84f" xlink:to="loc_us-gaap_EmployeeStockMember_79806668-4f09-47b5-9bd0-23af2cf02f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6b3ee955-9fec-4aa5-ad56-85e926c4ebee" xlink:to="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6de213db-b1e9-4ce0-bfe6-c25935ebae50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_CommonStockSharesIssued_6de213db-b1e9-4ce0-bfe6-c25935ebae50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_38f97f60-0467-40e1-b67e-efe2ab7f4829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_38f97f60-0467-40e1-b67e-efe2ab7f4829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_CommonStockSharesSubjectToFutureVestingProvisions_ef4d723b-d3fb-4af2-9bfa-7d5abad5c346" xlink:href="zntl-20210930.xsd#zntl_CommonStockSharesSubjectToFutureVestingProvisions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_CommonStockSharesSubjectToFutureVestingProvisions_ef4d723b-d3fb-4af2-9bfa-7d5abad5c346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f9a5bd7e-f216-4189-8869-fdf650264194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f9a5bd7e-f216-4189-8869-fdf650264194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions_41d5a36f-9f81-4db4-8f13-0dc1d4319b00" xlink:href="zntl-20210930.xsd#zntl_CommonUnitOutstandingSubjectToFutureVestingConditions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions_41d5a36f-9f81-4db4-8f13-0dc1d4319b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonUnitAuthorized_cc60cb29-515d-4c21-b69d-3dff806ca3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonUnitAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_CommonUnitAuthorized_cc60cb29-515d-4c21-b69d-3dff806ca3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_07df5565-b6ba-4028-933b-4841b80bd62c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_07df5565-b6ba-4028-933b-4841b80bd62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_e38d04a0-731a-4603-9a69-4c49383bd659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_e38d04a0-731a-4603-9a69-4c49383bd659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b18b51c1-d471-488e-9391-f91619cd3380" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b18b51c1-d471-488e-9391-f91619cd3380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_80ca9a3c-f1d0-4be9-9bb4-f27572d6bc88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_80ca9a3c-f1d0-4be9-9bb4-f27572d6bc88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b08969de-07a3-4d2b-92b1-6af0b769c1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b08969de-07a3-4d2b-92b1-6af0b769c1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ee9cd2ea-5e5b-4edb-b1b1-44955bf7ff0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ee9cd2ea-5e5b-4edb-b1b1-44955bf7ff0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8d77de86-a785-4f52-8e03-f513c16012a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8d77de86-a785-4f52-8e03-f513c16012a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_7af8e1e2-8a60-483a-929b-a3f6a48beb13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_7af8e1e2-8a60-483a-929b-a3f6a48beb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5e68e5d3-362b-44f2-8b54-35c269c9b0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5e68e5d3-362b-44f2-8b54-35c269c9b0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_1a228402-e8ff-44a3-86bd-6702ca1f99fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_1a228402-e8ff-44a3-86bd-6702ca1f99fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ProceedsFromIssuanceOfCommonStockGross_86e73f61-a9c7-41c0-b413-7f06f35ea81b" xlink:href="zntl-20210930.xsd#zntl_ProceedsFromIssuanceOfCommonStockGross"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_ProceedsFromIssuanceOfCommonStockGross_86e73f61-a9c7-41c0-b413-7f06f35ea81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock_ab91ecca-6c62-499d-bbcc-4309320a071d" xlink:href="zntl-20210930.xsd#zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock_ab91ecca-6c62-499d-bbcc-4309320a071d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_16b5ecc3-3dd7-47a3-86fd-ccb0cd5afc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_16b5ecc3-3dd7-47a3-86fd-ccb0cd5afc2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7d63be1d-e005-4762-8121-9591aa47116d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7d63be1d-e005-4762-8121-9591aa47116d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease_552c1a72-ae34-4a31-b8e6-7eecd42d85ac" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease_552c1a72-ae34-4a31-b8e6-7eecd42d85ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_01c90785-8983-4192-8e6c-d9228654a46f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_01c90785-8983-4192-8e6c-d9228654a46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_08ecb0ad-b239-471e-bd90-55fbc5a8e997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_08ecb0ad-b239-471e-bd90-55fbc5a8e997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_7340742e-e959-4afe-a81a-e91eb993a559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_7340742e-e959-4afe-a81a-e91eb993a559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm_3caf2415-d78f-4997-b4f5-d38bb0cd311a" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm_3caf2415-d78f-4997-b4f5-d38bb0cd311a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2836179a-bb91-49e8-9efa-3945df7cb240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_2836179a-bb91-49e8-9efa-3945df7cb240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_a9deff57-5421-4687-9b75-74ca280be273" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_a9deff57-5421-4687-9b75-74ca280be273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1d73c226-6214-427c-8be9-16455dbcd06f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1d73c226-6214-427c-8be9-16455dbcd06f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_4d944da1-8eca-48d8-87af-9d2c05e3e2c2" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_4d944da1-8eca-48d8-87af-9d2c05e3e2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3b3c1ab3-e8b4-4841-833a-b43117265c33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3b3c1ab3-e8b4-4841-833a-b43117265c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_76a196b1-f1c5-4479-8d00-eea629009ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_76a196b1-f1c5-4479-8d00-eea629009ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredUnitsAuthorized_239af2f3-8fc5-4180-b223-b964ec278330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredUnitsAuthorized"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_PreferredUnitsAuthorized_239af2f3-8fc5-4180-b223-b964ec278330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9136e7c4-72b7-462e-b2d3-4b804fcfdb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3d94ed00-0e3f-4c7a-ac13-4d4a6d1ab836" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9136e7c4-72b7-462e-b2d3-4b804fcfdb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquitySharebasedCompensationDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquitySharebasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/MembersEquitySharebasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5cd786ae-a12e-47b6-bc33-5c84212c7f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1189fa5e-ec5a-40ad-91be-06698be5ca0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5cd786ae-a12e-47b6-bc33-5c84212c7f77" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1189fa5e-ec5a-40ad-91be-06698be5ca0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_423427ec-f2f1-43be-b0a2-b35077f0446a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1189fa5e-ec5a-40ad-91be-06698be5ca0b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_423427ec-f2f1-43be-b0a2-b35077f0446a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d82136fc-afa7-454d-987d-d689359b3be3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_423427ec-f2f1-43be-b0a2-b35077f0446a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d82136fc-afa7-454d-987d-d689359b3be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a861ff74-fc35-4bde-ba06-fa43ab6a61a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d82136fc-afa7-454d-987d-d689359b3be3" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a861ff74-fc35-4bde-ba06-fa43ab6a61a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3bb4f1c0-2099-4a29-abbb-58366e4f4395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d82136fc-afa7-454d-987d-d689359b3be3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3bb4f1c0-2099-4a29-abbb-58366e4f4395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66c21d0d-4b56-442f-97ab-8f1eb4204c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1189fa5e-ec5a-40ad-91be-06698be5ca0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66c21d0d-4b56-442f-97ab-8f1eb4204c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3388c6a4-66fa-46e6-b826-a10d8e48c3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66c21d0d-4b56-442f-97ab-8f1eb4204c5a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3388c6a4-66fa-46e6-b826-a10d8e48c3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquitySharebasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_302811f9-4dce-45ef-b4f2-33cf8b43c8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1ce9815-3b2e-4804-ac06-3910235fd8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_302811f9-4dce-45ef-b4f2-33cf8b43c8cd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1ce9815-3b2e-4804-ac06-3910235fd8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3c2bc8da-7147-473b-a57b-61c4c860bc59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1ce9815-3b2e-4804-ac06-3910235fd8b1" xlink:to="loc_us-gaap_AwardTypeAxis_3c2bc8da-7147-473b-a57b-61c4c860bc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b215d69-268c-4faf-95c0-16197b7af8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3c2bc8da-7147-473b-a57b-61c4c860bc59" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b215d69-268c-4faf-95c0-16197b7af8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ProfitInterestAwardsMember_ee7001c8-4f39-43be-89d6-a0846586db09" xlink:href="zntl-20210930.xsd#zntl_ProfitInterestAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b215d69-268c-4faf-95c0-16197b7af8df" xlink:to="loc_zntl_ProfitInterestAwardsMember_ee7001c8-4f39-43be-89d6-a0846586db09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0114d6b7-9250-4c1f-b986-d54c7f816489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b215d69-268c-4faf-95c0-16197b7af8df" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0114d6b7-9250-4c1f-b986-d54c7f816489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_8e74cf09-f529-47a4-8f93-42b6da1fca29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b215d69-268c-4faf-95c0-16197b7af8df" xlink:to="loc_us-gaap_EmployeeStockMember_8e74cf09-f529-47a4-8f93-42b6da1fca29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember_b89ceabf-2cc0-412d-b920-42b8a9ed4743" xlink:href="zntl-20210930.xsd#zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b215d69-268c-4faf-95c0-16197b7af8df" xlink:to="loc_zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember_b89ceabf-2cc0-412d-b920-42b8a9ed4743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29de0745-9ba2-4955-b760-d1ea00488bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1ce9815-3b2e-4804-ac06-3910235fd8b1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29de0745-9ba2-4955-b760-d1ea00488bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c0a88b80-ae48-4b14-bf75-2bab9d8e2b96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29de0745-9ba2-4955-b760-d1ea00488bdc" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c0a88b80-ae48-4b14-bf75-2bab9d8e2b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1bafec2b-0965-4803-95bd-7859e519f6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1cfb7312-387b-40e9-9d82-0aa5c9a9736e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1bafec2b-0965-4803-95bd-7859e519f6ff" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1cfb7312-387b-40e9-9d82-0aa5c9a9736e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a4debd26-745d-47d3-9f6f-c02b7c820094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1cfb7312-387b-40e9-9d82-0aa5c9a9736e" xlink:to="loc_us-gaap_AwardTypeAxis_a4debd26-745d-47d3-9f6f-c02b7c820094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1de4f414-65f1-4870-983d-bd1e83bb0391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a4debd26-745d-47d3-9f6f-c02b7c820094" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1de4f414-65f1-4870-983d-bd1e83bb0391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ProfitInterestAwardsMember_51c55d44-f8fd-40ab-975b-ded0535c81b8" xlink:href="zntl-20210930.xsd#zntl_ProfitInterestAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1de4f414-65f1-4870-983d-bd1e83bb0391" xlink:to="loc_zntl_ProfitInterestAwardsMember_51c55d44-f8fd-40ab-975b-ded0535c81b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1cfb7312-387b-40e9-9d82-0aa5c9a9736e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MembersEquity_d8c04e08-23a0-4d5c-85ed-1824ecabec4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MembersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_us-gaap_MembersEquity_d8c04e08-23a0-4d5c-85ed-1824ecabec4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts_ef9ba394-8ad9-427d-a1a2-c4a8401fa31a" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts_ef9ba394-8ad9-427d-a1a2-c4a8401fa31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a8ae5311-8c39-45d6-bc8b-1256c636097d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a8ae5311-8c39-45d6-bc8b-1256c636097d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dec3ebb8-c118-41c5-93d6-465e9c23f979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dec3ebb8-c118-41c5-93d6-465e9c23f979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity_f7191b4b-bb78-4075-bddb-c1fa071b42e4" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity_f7191b4b-bb78-4075-bddb-c1fa071b42e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount_e6718495-40d3-4f8a-be79-5e9d9d1fdc71" xlink:href="zntl-20210930.xsd#zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount_e6718495-40d3-4f8a-be79-5e9d9d1fdc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7d846c4f-469b-4d11-863e-ee60608acbac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4bf1fdd3-db6a-4c59-ab50-fd7ffadabdd7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7d846c4f-469b-4d11-863e-ee60608acbac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquityFairValueAssumptionsforStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6ed0d24e-771d-4cd0-b893-8da647d90868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_eda2aed7-46ed-49c5-9c1f-f8bf1a24d76d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6ed0d24e-771d-4cd0-b893-8da647d90868" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_eda2aed7-46ed-49c5-9c1f-f8bf1a24d76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7b93fe64-4ad0-44c3-9ef3-d4e280bfbde9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_eda2aed7-46ed-49c5-9c1f-f8bf1a24d76d" xlink:to="loc_us-gaap_AwardTypeAxis_7b93fe64-4ad0-44c3-9ef3-d4e280bfbde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c2708cc-1e9c-4e3d-93e4-525eed43d066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7b93fe64-4ad0-44c3-9ef3-d4e280bfbde9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c2708cc-1e9c-4e3d-93e4-525eed43d066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_93149a72-e5a9-4a23-b6d7-0e85f97093c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3c2708cc-1e9c-4e3d-93e4-525eed43d066" xlink:to="loc_us-gaap_EmployeeStockOptionMember_93149a72-e5a9-4a23-b6d7-0e85f97093c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d0575657-26b3-4500-9132-9a303ac6f360" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_eda2aed7-46ed-49c5-9c1f-f8bf1a24d76d" xlink:to="loc_srt_RangeAxis_d0575657-26b3-4500-9132-9a303ac6f360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9b495629-729d-46fa-97b1-59b6e6eeb9a5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d0575657-26b3-4500-9132-9a303ac6f360" xlink:to="loc_srt_RangeMember_9b495629-729d-46fa-97b1-59b6e6eeb9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d1b357f3-3108-4650-b981-8abc44c337b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9b495629-729d-46fa-97b1-59b6e6eeb9a5" xlink:to="loc_srt_MinimumMember_d1b357f3-3108-4650-b981-8abc44c337b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bd1e29d0-077e-412f-82e1-e4ecdb84fb10" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9b495629-729d-46fa-97b1-59b6e6eeb9a5" xlink:to="loc_srt_MaximumMember_bd1e29d0-077e-412f-82e1-e4ecdb84fb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_eda2aed7-46ed-49c5-9c1f-f8bf1a24d76d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_27d00726-ac39-464e-bdc3-2535095cdf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_27d00726-ac39-464e-bdc3-2535095cdf2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_4d0d51ae-67ca-4c3b-8a54-0b42cade3c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_4d0d51ae-67ca-4c3b-8a54-0b42cade3c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0474f25e-5d84-42e4-bcaf-a364d1de04ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0474f25e-5d84-42e4-bcaf-a364d1de04ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_5f62f453-cc0e-4885-80c7-374cc57c50b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_5f62f453-cc0e-4885-80c7-374cc57c50b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_0b0f92c0-5000-4d25-bf88-408aa79e3137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_0b0f92c0-5000-4d25-bf88-408aa79e3137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5d05756e-65c3-44e9-b89c-63a55807637c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3e8dabe9-c412-40b4-89da-9ab72e525de4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5d05756e-65c3-44e9-b89c-63a55807637c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquityFairValueAssumptionsforESPPDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_32a4affa-6619-4cc0-9dd6-95853b031730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8cc5d8dc-c21e-487b-8305-21f86bd9a3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_32a4affa-6619-4cc0-9dd6-95853b031730" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8cc5d8dc-c21e-487b-8305-21f86bd9a3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8fc42a34-e577-4d48-8178-28ba36916faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8cc5d8dc-c21e-487b-8305-21f86bd9a3a0" xlink:to="loc_us-gaap_AwardTypeAxis_8fc42a34-e577-4d48-8178-28ba36916faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba122bb8-4312-4c1c-aa43-2b7b3a1376ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8fc42a34-e577-4d48-8178-28ba36916faf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba122bb8-4312-4c1c-aa43-2b7b3a1376ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_a38f1887-951d-4889-8468-c6f3d18727f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba122bb8-4312-4c1c-aa43-2b7b3a1376ac" xlink:to="loc_us-gaap_EmployeeStockMember_a38f1887-951d-4889-8468-c6f3d18727f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3b0358fd-95aa-49b6-b6c8-832b5def0148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8cc5d8dc-c21e-487b-8305-21f86bd9a3a0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3b0358fd-95aa-49b6-b6c8-832b5def0148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_baefe869-8502-43fa-9fff-d11fe4049445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3b0358fd-95aa-49b6-b6c8-832b5def0148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_baefe869-8502-43fa-9fff-d11fe4049445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3032b195-e585-4aff-94ac-b88e324b4966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3b0358fd-95aa-49b6-b6c8-832b5def0148" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3032b195-e585-4aff-94ac-b88e324b4966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_736ef1f7-b707-4470-b09a-6348ecd704bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3b0358fd-95aa-49b6-b6c8-832b5def0148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_736ef1f7-b707-4470-b09a-6348ecd704bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6fa16640-bca3-42fd-81dc-854f52e84529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_3b0358fd-95aa-49b6-b6c8-832b5def0148" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6fa16640-bca3-42fd-81dc-854f52e84529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#MembersEquityUnrecognizedCompensationCostDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_60918d88-4ecf-4ac6-b22d-dbc79f926ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e2c0e53-b468-451f-addf-b69ffb05b3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_60918d88-4ecf-4ac6-b22d-dbc79f926ba0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e2c0e53-b468-451f-addf-b69ffb05b3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_97d0df9b-6de8-4091-9cb7-ed6526390d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e2c0e53-b468-451f-addf-b69ffb05b3d9" xlink:to="loc_us-gaap_AwardTypeAxis_97d0df9b-6de8-4091-9cb7-ed6526390d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4cc4f5e3-8818-42ed-a8be-8fdbc61c1444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_97d0df9b-6de8-4091-9cb7-ed6526390d3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4cc4f5e3-8818-42ed-a8be-8fdbc61c1444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_44b88d6e-2b48-4d38-a29f-d5e471869f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4cc4f5e3-8818-42ed-a8be-8fdbc61c1444" xlink:to="loc_us-gaap_EmployeeStockOptionMember_44b88d6e-2b48-4d38-a29f-d5e471869f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_7af74760-ebad-4624-b611-31f1cfbefb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4cc4f5e3-8818-42ed-a8be-8fdbc61c1444" xlink:to="loc_us-gaap_RestrictedStockMember_7af74760-ebad-4624-b611-31f1cfbefb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_34c0b702-ad61-4aac-98a0-b0d6fb9d9577" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4cc4f5e3-8818-42ed-a8be-8fdbc61c1444" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_34c0b702-ad61-4aac-98a0-b0d6fb9d9577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_d30baafa-782a-43ef-aba6-3dd17e861f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4cc4f5e3-8818-42ed-a8be-8fdbc61c1444" xlink:to="loc_us-gaap_EmployeeStockMember_d30baafa-782a-43ef-aba6-3dd17e861f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6b3349b-e27d-440e-9aed-18a84fa7beb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e2c0e53-b468-451f-addf-b69ffb05b3d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6b3349b-e27d-440e-9aed-18a84fa7beb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_5c3df8ee-8c7a-4a01-a16a-c4c1b2597dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6b3349b-e27d-440e-9aed-18a84fa7beb3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_5c3df8ee-8c7a-4a01-a16a-c4c1b2597dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_b26ec67d-1ccc-450c-b723-88d8a2769502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6b3349b-e27d-440e-9aed-18a84fa7beb3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_b26ec67d-1ccc-450c-b723-88d8a2769502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f410874f-ec1a-4f16-a03e-b4f119fefc81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6b3349b-e27d-440e-9aed-18a84fa7beb3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f410874f-ec1a-4f16-a03e-b4f119fefc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CommitmentandContingencies" xlink:type="simple" xlink:href="zntl-20210930.xsd#CommitmentandContingencies"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/CommitmentandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8d59d3fd-2dea-4081-8b9e-7491ba15f8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_eaa71c2a-3183-434f-9009-fa5a0c699484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8d59d3fd-2dea-4081-8b9e-7491ba15f8c2" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_eaa71c2a-3183-434f-9009-fa5a0c699484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CommitmentandContingenciesTables" xlink:type="simple" xlink:href="zntl-20210930.xsd#CommitmentandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/CommitmentandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_53b4fbfb-a039-4b46-8354-7c7ac65e7222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_16990ee1-b633-44e9-8de7-ddb675f9980a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_53b4fbfb-a039-4b46-8354-7c7ac65e7222" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_16990ee1-b633-44e9-8de7-ddb675f9980a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#CommitmentandContingenciesFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_55846707-26bd-4c64-8b9b-6baa93c7c642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_dfabffb0-3e64-47a8-bb92-8772368cc0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_55846707-26bd-4c64-8b9b-6baa93c7c642" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_dfabffb0-3e64-47a8-bb92-8772368cc0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_827e40b9-5ea9-41b0-9c9d-f881c28c0e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_55846707-26bd-4c64-8b9b-6baa93c7c642" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_827e40b9-5ea9-41b0-9c9d-f881c28c0e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a8b211f9-4e29-4864-84b5-302a0f3f26ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_55846707-26bd-4c64-8b9b-6baa93c7c642" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a8b211f9-4e29-4864-84b5-302a0f3f26ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_867a6f26-7084-4f8d-85cb-30adf77dc616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_55846707-26bd-4c64-8b9b-6baa93c7c642" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_867a6f26-7084-4f8d-85cb-30adf77dc616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f00ddc23-c956-45bd-9ea1-2c034c85c8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_55846707-26bd-4c64-8b9b-6baa93c7c642" xlink:to="loc_us-gaap_OperatingLeaseLiability_f00ddc23-c956-45bd-9ea1-2c034c85c8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="zntl-20210930.xsd#CommitmentandContingenciesFutureMinimumLeasePaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#CommitmentandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c13171b5-39bf-4211-8271-3dac21269ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_e49e565f-78e3-4f68-9583-4ce27fef80b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c13171b5-39bf-4211-8271-3dac21269ea4" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_e49e565f-78e3-4f68-9583-4ce27fef80b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d4af21de-6b4a-4c1d-bfc0-3712da9c3db3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_e49e565f-78e3-4f68-9583-4ce27fef80b5" xlink:to="loc_srt_RangeAxis_d4af21de-6b4a-4c1d-bfc0-3712da9c3db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5ff9790d-aff0-429f-bb79-0a5bac0adde8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d4af21de-6b4a-4c1d-bfc0-3712da9c3db3" xlink:to="loc_srt_RangeMember_5ff9790d-aff0-429f-bb79-0a5bac0adde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ea484124-7b2f-47ff-b345-508a9b8c4f6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5ff9790d-aff0-429f-bb79-0a5bac0adde8" xlink:to="loc_srt_MinimumMember_ea484124-7b2f-47ff-b345-508a9b8c4f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3acbfa6f-4163-4190-bc04-3b0a69e39e54" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5ff9790d-aff0-429f-bb79-0a5bac0adde8" xlink:to="loc_srt_MaximumMember_3acbfa6f-4163-4190-bc04-3b0a69e39e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_c01b1f98-f7b7-4f4d-8256-2bf79fe176b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_e49e565f-78e3-4f68-9583-4ce27fef80b5" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_c01b1f98-f7b7-4f4d-8256-2bf79fe176b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_37a3a031-6ae7-4f7a-a493-44b7b086b6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c01b1f98-f7b7-4f4d-8256-2bf79fe176b6" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_37a3a031-6ae7-4f7a-a493-44b7b086b6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_4de402a2-85d1-4765-bdb7-14072bef16af" xlink:href="zntl-20210930.xsd#zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c01b1f98-f7b7-4f4d-8256-2bf79fe176b6" xlink:to="loc_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts_4de402a2-85d1-4765-bdb7-14072bef16af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability_35055a95-3df6-48a1-9700-fbcf931bb387" xlink:href="zntl-20210930.xsd#zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c01b1f98-f7b7-4f4d-8256-2bf79fe176b6" xlink:to="loc_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability_35055a95-3df6-48a1-9700-fbcf931bb387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_7b575ac6-3b18-481e-aa5e-add841b64281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c01b1f98-f7b7-4f4d-8256-2bf79fe176b6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_7b575ac6-3b18-481e-aa5e-add841b64281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnit" xlink:type="simple" xlink:href="zntl-20210930.xsd#NetLossPerCommonShareClassACommonUnit"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d5973914-b33b-479a-ba6c-833e11025a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_620629b9-ee58-4705-9a41-55cd0e2f4921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d5973914-b33b-479a-ba6c-833e11025a31" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_620629b9-ee58-4705-9a41-55cd0e2f4921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitTables" xlink:type="simple" xlink:href="zntl-20210930.xsd#NetLossPerCommonShareClassACommonUnitTables"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ed83f80f-c9cf-4f5d-9fde-77e2cd3e9076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9d13db28-f764-4ca3-9198-b7292128f7df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ed83f80f-c9cf-4f5d-9fde-77e2cd3e9076" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9d13db28-f764-4ca3-9198-b7292128f7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_97d81922-5cfa-43d8-bf08-a1491d71329f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ed83f80f-c9cf-4f5d-9fde-77e2cd3e9076" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_97d81922-5cfa-43d8-bf08-a1491d71329f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitCalculationDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#NetLossPerCommonShareClassACommonUnitCalculationDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitCalculationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8f6d8cb4-64a6-498d-b9ba-33b912d66c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_EarningsPerShareNumeratorAbstract_edf1a6a9-d757-4d26-b21d-36e03b3550f2" xlink:href="zntl-20210930.xsd#zntl_EarningsPerShareNumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8f6d8cb4-64a6-498d-b9ba-33b912d66c31" xlink:to="loc_zntl_EarningsPerShareNumeratorAbstract_edf1a6a9-d757-4d26-b21d-36e03b3550f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6e6c8e2c-a55c-447b-bbfd-17fe4177bb65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zntl_EarningsPerShareNumeratorAbstract_edf1a6a9-d757-4d26-b21d-36e03b3550f2" xlink:to="loc_us-gaap_NetIncomeLoss_6e6c8e2c-a55c-447b-bbfd-17fe4177bb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_EarningsPerShareDenominatorAbstract_992e87e0-f728-45b4-8d91-7fa3d585d23f" xlink:href="zntl-20210930.xsd#zntl_EarningsPerShareDenominatorAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8f6d8cb4-64a6-498d-b9ba-33b912d66c31" xlink:to="loc_zntl_EarningsPerShareDenominatorAbstract_992e87e0-f728-45b4-8d91-7fa3d585d23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9d507754-f681-425c-ac09-15f705e8167d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zntl_EarningsPerShareDenominatorAbstract_992e87e0-f728-45b4-8d91-7fa3d585d23f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9d507754-f681-425c-ac09-15f705e8167d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a5abfced-6cdb-4e59-b345-e5caea02b3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zntl_EarningsPerShareDenominatorAbstract_992e87e0-f728-45b4-8d91-7fa3d585d23f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a5abfced-6cdb-4e59-b345-e5caea02b3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8edb717f-fe75-47c2-86cb-ff623d0003f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8f6d8cb4-64a6-498d-b9ba-33b912d66c31" xlink:to="loc_us-gaap_EarningsPerShareBasic_8edb717f-fe75-47c2-86cb-ff623d0003f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3f13ed43-07f3-4d1e-9c6e-f9baff9e16d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8f6d8cb4-64a6-498d-b9ba-33b912d66c31" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3f13ed43-07f3-4d1e-9c6e-f9baff9e16d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7c2f89a1-5a93-4bd1-ba0b-b86ab183ffdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e281de1b-6a4e-4aa3-acde-de77b87cab57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7c2f89a1-5a93-4bd1-ba0b-b86ab183ffdc" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e281de1b-6a4e-4aa3-acde-de77b87cab57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6aa6dd67-9723-4857-9ab6-a8c3678d1a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e281de1b-6a4e-4aa3-acde-de77b87cab57" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6aa6dd67-9723-4857-9ab6-a8c3678d1a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b4f457a1-6504-4e9a-b20f-79f0ef7c1fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6aa6dd67-9723-4857-9ab6-a8c3678d1a59" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b4f457a1-6504-4e9a-b20f-79f0ef7c1fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a9dd1ad0-a8d3-412c-8f0f-c0ccf1453511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b4f457a1-6504-4e9a-b20f-79f0ef7c1fe4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a9dd1ad0-a8d3-412c-8f0f-c0ccf1453511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_99e510f9-3377-4cbf-8fcf-7196cee5d6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b4f457a1-6504-4e9a-b20f-79f0ef7c1fe4" xlink:to="loc_us-gaap_RestrictedStockMember_99e510f9-3377-4cbf-8fcf-7196cee5d6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a86bca33-ef87-44ce-8512-08e8d706733a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b4f457a1-6504-4e9a-b20f-79f0ef7c1fe4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a86bca33-ef87-44ce-8512-08e8d706733a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e09553a1-010c-41b4-abb9-6ac0074109fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e281de1b-6a4e-4aa3-acde-de77b87cab57" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e09553a1-010c-41b4-abb9-6ac0074109fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_76b475a6-9ccc-4b08-9831-ccc44ebe9e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e09553a1-010c-41b4-abb9-6ac0074109fc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_76b475a6-9ccc-4b08-9831-ccc44ebe9e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/RelatedPartyDisclosures" xlink:type="simple" xlink:href="zntl-20210930.xsd#RelatedPartyDisclosures"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/RelatedPartyDisclosures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_2fa9c32e-3dc5-49b6-953d-49b005a556ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_eaf6c3c9-7cad-4aec-a773-c52e47cb5f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_2fa9c32e-3dc5-49b6-953d-49b005a556ac" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_eaf6c3c9-7cad-4aec-a773-c52e47cb5f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.zentalis.com/role/RelatedPartyDisclosuresDetails" xlink:type="simple" xlink:href="zntl-20210930.xsd#RelatedPartyDisclosuresDetails"/>
  <link:presentationLink xlink:role="http://www.zentalis.com/role/RelatedPartyDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_309a4883-2684-461d-bf44-6ccb461bc864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_309a4883-2684-461d-bf44-6ccb461bc864" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_17da879c-db58-4582-ace9-881eef1be834" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:to="loc_srt_ConsolidatedEntitiesAxis_17da879c-db58-4582-ace9-881eef1be834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1d5252d4-4268-405d-85a9-5f9d960d5ebf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_17da879c-db58-4582-ace9-881eef1be834" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1d5252d4-4268-405d-85a9-5f9d960d5ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_a00aafc0-76f7-436f-8d9b-b99457e31b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1d5252d4-4268-405d-85a9-5f9d960d5ebf" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_a00aafc0-76f7-436f-8d9b-b99457e31b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1d0101a2-90cb-4ec3-8157-4b7ec8d6eb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1d0101a2-90cb-4ec3-8157-4b7ec8d6eb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e881aee0-f830-404e-87f7-5e893306b113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1d0101a2-90cb-4ec3-8157-4b7ec8d6eb0f" xlink:to="loc_us-gaap_ClassOfStockDomain_e881aee0-f830-404e-87f7-5e893306b113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_749f361f-968f-4722-a57b-774c562c2c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e881aee0-f830-404e-87f7-5e893306b113" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_749f361f-968f-4722-a57b-774c562c2c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_206556b9-c4b1-4a94-b991-0c8233a8f77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_206556b9-c4b1-4a94-b991-0c8233a8f77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_40d14cda-ce60-4bb7-ab49-68d004f05d34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_206556b9-c4b1-4a94-b991-0c8233a8f77f" xlink:to="loc_us-gaap_RelatedPartyDomain_40d14cda-ce60-4bb7-ab49-68d004f05d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_e7ac6812-caf0-4887-94d3-cd6e44ccec49" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_40d14cda-ce60-4bb7-ab49-68d004f05d34" xlink:to="loc_srt_AffiliatedEntityMember_e7ac6812-caf0-4887-94d3-cd6e44ccec49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_f19b91c7-0e1d-4957-8790-85e5b154ca78" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_40d14cda-ce60-4bb7-ab49-68d004f05d34" xlink:to="loc_srt_DirectorMember_f19b91c7-0e1d-4957-8790-85e5b154ca78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_3928d9ac-aece-404d-b518-af08de173a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_3928d9ac-aece-404d-b518-af08de173a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_52ea5167-6a6b-4ece-8f98-2f5bef872a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_3928d9ac-aece-404d-b518-af08de173a81" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_52ea5167-6a6b-4ece-8f98-2f5bef872a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_LicenseAgreementMember_9943ca11-538c-4c37-896b-9c0c75e68d24" xlink:href="zntl-20210930.xsd#zntl_LicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_52ea5167-6a6b-4ece-8f98-2f5bef872a0c" xlink:to="loc_zntl_LicenseAgreementMember_9943ca11-538c-4c37-896b-9c0c75e68d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_MasterServicesAgreementMember_65dea461-a89a-4ac0-b248-eb76141548a5" xlink:href="zntl-20210930.xsd#zntl_MasterServicesAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_52ea5167-6a6b-4ece-8f98-2f5bef872a0c" xlink:to="loc_zntl_MasterServicesAgreementMember_65dea461-a89a-4ac0-b248-eb76141548a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ea3fd7ee-bddd-43f3-90d0-7bbb3515339e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ea3fd7ee-bddd-43f3-90d0-7bbb3515339e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e86004d-877b-4f74-8a51-0995622ad004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ea3fd7ee-bddd-43f3-90d0-7bbb3515339e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e86004d-877b-4f74-8a51-0995622ad004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_KalyraPharmaceuticalsIncMember_1e160c94-d9ec-4fd9-9261-2b34988c7b48" xlink:href="zntl-20210930.xsd#zntl_KalyraPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e86004d-877b-4f74-8a51-0995622ad004" xlink:to="loc_zntl_KalyraPharmaceuticalsIncMember_1e160c94-d9ec-4fd9-9261-2b34988c7b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_09db6564-298f-4d40-9d89-bf3ac2b5d938" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_09db6564-298f-4d40-9d89-bf3ac2b5d938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e9c50338-ab94-4a19-b6a1-294255096856" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_09db6564-298f-4d40-9d89-bf3ac2b5d938" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e9c50338-ab94-4a19-b6a1-294255096856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ZenteraTherapeuticsLtdMember_caa40696-694a-4d0c-9d8f-5c7e36b50cb4" xlink:href="zntl-20210930.xsd#zntl_ZenteraTherapeuticsLtdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e9c50338-ab94-4a19-b6a1-294255096856" xlink:to="loc_zntl_ZenteraTherapeuticsLtdMember_caa40696-694a-4d0c-9d8f-5c7e36b50cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4d78395d-6160-40e9-8aa8-92288b639e12" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_eae2613b-00a1-4662-ae13-6e2e1b656dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_us-gaap_PreferredStockSharesIssued_eae2613b-00a1-4662-ae13-6e2e1b656dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_4787b89e-7292-4a99-87e3-ec55c2c37457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_4787b89e-7292-4a99-87e3-ec55c2c37457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_d8739bef-a11a-4ddd-8573-82fe69f61f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_d8739bef-a11a-4ddd-8573-82fe69f61f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_RelatedPartyAgreementTerm_88b5f3e4-cb6b-4778-9e3c-4e44d1893b83" xlink:href="zntl-20210930.xsd#zntl_RelatedPartyAgreementTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_zntl_RelatedPartyAgreementTerm_88b5f3e4-cb6b-4778-9e3c-4e44d1893b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_4aa8b2a2-9502-4cd5-8ecb-48671794e441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_4aa8b2a2-9502-4cd5-8ecb-48671794e441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_3bb1e06a-43f5-4ac1-827e-da8bdba067e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_3bb1e06a-43f5-4ac1-827e-da8bdba067e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_zntl_ResearchAndDevelopmentExpenseReimbursements_75c2e6e7-90d0-4728-bc8b-49615905f7ab" xlink:href="zntl-20210930.xsd#zntl_ResearchAndDevelopmentExpenseReimbursements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e6859f89-bc54-483a-a233-f4f336a9853a" xlink:to="loc_zntl_ResearchAndDevelopmentExpenseReimbursements_75c2e6e7-90d0-4728-bc8b-49615905f7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>a15shellcorea.jpg
<TEXT>
begin 644 a15shellcorea.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0 Z17AI9@  34T *@    @  U$0  $
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFI<RV[QLK&XMY!G?U8'_  INGWA-HH,+*K,RMN;<1BOQJ_X./_\ @LO\<O\
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M1<M&N[!DV8()7/3- 'U=!&8854LTA48W'J:=4=M'Y$"KS\H[G)J3=0 44A<
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M **"VWK06Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP=_R*6E_]>D/_H"U_"#\$?\ DL?A7_L-67_H]*_N[\(7"IX8TJ,GYFLXB/\
MOA: -6OPN_X/+/VO=9\*^#/ /P,33K&;1/&V/$LM_N;[7;RVDQC2-!]TJV\D
MYYR*_<TW* M\WW>M?R;_ /!T%^TOXJ^/'_!47Q=X9\0W-HVB_"F4Z3H/V> 1
M20PRI',RN1R[%SPQZ"@"U_P;"_LI^*OC[_P4[\/^--,N[-=/^$,BZOK$=U)M
MN)+:020((U P6W,.#CBOZ6OVW?VIM+_8^_9M\4_$76KW1M-M]%L939#5)C#%
M=W1C8Q0$_P!YV7: .37Y)_\ !G%^R1?^'_A-XT^.,FMVL]CXM=_#4>G" B:U
M>VE60RN^?G5M^ N.#S6+_P 'DO[7GB+P=I'P_P#@KI%[IESX7\61/K6KV[(D
MMREW;3 0_/G=&,.<J>M 'XU_ML?MM^-_V\OCIK/Q \?:C-=ZEJ&5M+.9\P:=
M:;B8X(>^U<D#/.*Z3_@GG_P3%^*W_!4OXJS>&_A]I\:QZ="[WNL7VZ.QM2%W
M+')( <,P'RC'.*\'M/"U]KWB"QT](I+Z\U!UMXX8(R[@D]E&2<>U?V+_ /!'
MS]B"U_83_8=\#^$8KC2;KQ)-9?;+[5+;3_L[7GF?O )1]YF16VY8GI0!^=WP
M<_X,S/!&H_#W1?\ A,OB5XMT_P 1[%CU:"PAMWM3)CYA$S+EEST)K)_:6_X,
MR-'T;X7WEQ\(/B)K>I>,/.B6"WU]88+(Q$_O,M&N[.WI7[J6-KYMVTLC-)*(
M]A8'"_@OK[U EMJENLYFDCNMQ"PK&NS8#U)]<4 ?Q$?M@_L6_$+]A3]H?4O
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M)&,T ?=-46N0]V^Z+RXU^5G?C(]JL#4(C+(F[YH\!N/6OS5_X*\?\'$GA_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT5;N/1O#=C%I]@LTID?RHT"KO;'S' Y)K^3+_@X^G^W_ /!9#XN.%CDCBNX
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MC_P9AP>+/AI%??%SXD:]X?\ %!GD4VFA16]S:B(8V'=(H;)YS7R?_P %/O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?\%+/VV%USX?VMQ/X?\ !.EMI":HTH:+6$60N+F-<!E0[L8;GBOF?_@G_P#
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MRB8DGY@=B]J_A-^"/_)8_"O_ &&K+_T>E?W9^'2J^&='9VVC[)#@#@L=@[T
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M>LI]5N[:5 L.F&W*0A(V'+;AS\W>OZ;I?-MDMUCMV6..0J54@ +CC\*^%?\
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MZIEI4VC8D3?,55FR,5^@_P#PMOP\EFKOKVBV^751OOHFSGMPU '5'D5^$/\
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M_P#P:P?\IF/A_P#]>6H_^B&KQ;_@M\OE?\%=OC[&/NIXON@/_':]I_X-8/\
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MC^PQ^P!XUUP7'VK5M8 \/V<5A>)%=V$US&ZI,><_(1GCF@#^6/\ X*6*M_\
M\% /C,S(+6X3Q5?M&%Z2_OV]:^QO^#1GSO\ A\#ICM(K>;X2U<LH/.0D=?F?
MXH\17WC359+R_NKK4M8O)VGN+J=RTDS-R26/)/7FOTH_X-$,)_P6'TYF/RCP
MGJX.>OW(Z /WI_X.!O\ E#/\?_\ L6?_ &O#7\;=LIDVKM9U/4 =!Z_A7]R/
M[77P)T/]KW]FSQU\-/%UKJ'_  COB337MKU;6?R9YH@0XV/@[3N4=J_B3^*_
M@F3P!\2_$&EPP75K:Z5J<]FL<V5ECC65E7=G!.5 YH ^M/\ @GM_P0B^-O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@GMYV1G#=?F&*_N6^._[/GA']HW2K;2?'/A?P[XOT^W<R6D.I62W"VDI4J9
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MK]=^'-OK7QL^(G@W^R;R\C2/PC=7)D2^M5.Y9G\E@ %=2N&.<CD5]G?LH_\
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M7]*?[<__  ;Y_ 7]OK]HG5/BA\0V\5+XBU2VAM"EAJ7DQ8B38IV[#V]ZY/\
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MSHVN:+<@JR,8Y+:>-N0>X8,.0?2O[RD61,;7A&T8&%Z5\N_M0?\ !&K]GO\
M:N^'NN:#KGP[\/:;)X@E^T76J:-9QVFI>87WLZS;206;J>^30!_,W8?\'"_[
M8T#HK?&S6E6&+8C);V[8 _A^Y7R3\5O'&L?&#QY>:YK5Y=:SXCUZX,]U,SF1
MI9)&SGZEB?E' SQ7],Y_X-%/V5=.O!)*WQ CM95*X_MH91NW_+.OIO\ 9,_X
M(B_L[_LG_#6'PUIOP^T'Q(MK>27L6J:]:QWUZ2Y!"^85!PN!CTH _![_ ((F
M_P#!OQXX_;&^*W]O?$;0]5\(_#7PS<1G5(=2MFM[S5I"%D2%(G +0NN0SJ<C
MBOZ@?A9\/M'^%/@'1?#GA^P32]#T6!+2QM48D00HH5%YYX %:]O9BTA6./[/
M'&H "JF  !@?D*2[B2X,?FRNK0G<OEG:&]J /YV_^#W+_DXSX%_]B[J/_I3'
M7XF^'/\ D<-+_P"OJ'_T,5_8O_P4=_X(L_";_@J3XQ\/ZY\3$\4))X:LY;:U
M73]0%N0KL'(^Z>I%?-UG_P &AG[*]HT-S;W'C^.]#K) )-:W*I!!&1Y?/2@#
M]-O@M_R13P?_ -@6R_\ 1"5U58/A>R3P=X=M=-&5L=-@ALK5FY+*B!!G\JU-
M\W_/2/\ [YH =J=JM[921,V(Y!AQM#!U[J0?7I7\Y7_!S!_P1J\2>'/VBK?X
MJ?"OX>R7OASQ4ODW]CHD,ES=7&H$L[220J"4C*@#<.,\8K^C,M*?^6D?_?-,
MDA:5PS-"S+T)7I0!_"!X&UG5OA5X^AU"RN+C2->T6Y\V B0Q-;2QMG!/]Y67
M[IZD8-?7UQ_P</?MD+<QO%\;=:W,G+/;6Z[?;[E?T3?MG_\ !O5^S7^W%J>F
MWFO>%7\,W6FR33-)X79--:\>4[F:8A3O.><GU->'-_P9Z_LGO]Z3XDG)R?\
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M#\7O^#HW_@D1=_'WP+IOQ;^$/@2SNO%>ES-'XJ-IO^WZA; *D C@4'?ABQ.
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MD/)8KT7/H.*_9#_@WU_X-[+WXLWVE_'+XV:+]A\-:?*MSX=\.3Y5KZ4'/GS
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M/-1BRFOK\22,B*(RJ0D<K]>U66ERZ6ZM^\C )ST- %Q#E1]*6@=** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)A__ (NOS\_X@FOBU_T6CX;_ /@OO?\ XFC_ (@FOBU_T6CX;_\ @OO?_B:
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MH_X@FOBU_P!%H^&__@OO?_B: /OJY_X.W_V1-3>'R]6\=12"=58GPV_W>_\
M%4S?\':O['MSK$:IK/CUL%A*S>&Y%& .,?/7Y_\ _$$U\6O^BT?#?_P7WO\
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M: /T#_XBY?V.?^@Y\0O_  F'_P#BZ/\ B+E_8Y_Z#GQ"_P#"8?\ ^+K\_/\
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MX8?_ .+J"+_@[6_8W&H;K?5/'OF3'YV?PY( ,?\  Z^ ?^()KXM?]%H^&_\
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MP=M_LAV4#A==\>SJL(90WAIQDY_WZ=;_ /!W5^Q_"W[S5/'B2-C.SPW(P_\
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M] &B.E%(IRH[<=*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#X[4M% $7V=O[_ /X[1]G;^_\ ^.U+10!%]G;^_P#^.T?9V_O_ /CM2T4
M1?9V_O\ _CM'V=O[_P#X[4M% $7V=O[_ /X[1]G;^_\ ^.U+10!%]G;^_P#^
M.T?9V_O_ /CM2T4 1?9V_O\ _CM'V=O[_P#X[4M% $7V=O[_ /X[1]G;^_\
M^.U+10!%]G;^_P#^.T?9V_O_ /CM2T4 1?9V_O\ _CM'V=O[_P#X[4M% $7V
M=O[_ /X[1]G;^_\ ^.U+10!%]G;^_P#^.T?9V_O_ /CM2T4 1?9V_O\ _CM'
MV=O[_P#X[4M% $7V=O[_ /X[1]G;^_\ ^.U+10!%]G;^_P#^.T?9V_O_ /CM
M2T4 1?9V_O\ _CM'V=O[_P#X[4M% $7V=O[_ /X[1]G;^_\ ^.U+10!%]G;^
M_P#^.T?9V_O_ /CM2T4 1?9V_O\ _CM'V=O[_P#X[4M% $7V=O[_ /X[1]G;
M^_\ ^.U+10!%]G;^_P#^.T?9V_O_ /CM2T4 1?9V_O\ _CM'V=O[_P#X[4M%
M $7V=O[_ /X[1]G;^_\ ^.U+10!%]G;^_P#^.T?9V_O_ /CM2T4 1?9V_O\
M_CM'V=O[_P#X[4M% $7V=O[_ /X[1]G;^_\ ^.U+10!%]G;^_P#^.T?9V_O_
M /CM2T4 1?9V_O\ _CM'V=O[_P#X[4M% $7V=O[_ /X[1]G;^_\ ^.U+10!%
M]G;^_P#^.T?9V_O_ /CM2T4 1?9V_O\ _CM'V=O[_P#X[4M% $7V=O[_ /X[
M1]G;^_\ ^.U+10!%]G;^_P#^.T?9V_O_ /CM2T4 1?9V_O\ _CM'V=O[_P#X
M[4M% $7V=O[_ /X[1]G;^_\ ^.U+10!%]G;^_P#^.T?9V_O_ /CM2T4 1?9V
M_O\ _CM'V=O[_P#X[4M% $7V=O[_ /X[1]G;^_\ ^.U+10!%]G;^_P#^.T?9
MV_O_ /CM2T4 1?9V_O\ _CM'V=O[_P#X[4M% $7V=O[_ /X[1]G;^_\ ^.U+
M10!%]G;^_P#^.T?9V_O_ /CM2T4 1?9V_O\ _CM'V=O[_P#X[4M% $7V=O[_
M /X[1]G;^_\ ^.U+10!%]G;^_P#^.T?9V_O_ /CM2T4 1?9V_O\ _CM'V=O[
M_P#X[4M% $7V=O[_ /X[1]G;^_\ ^.U+10!%]G;^_P#^.T?9V_O_ /CM2T4
M1?9V_O\ _CM'V=O[_P#X[4M% $7V=O[_ /X[1]G;^_\ ^.U+10!%]G;^_P#^
M.T?9V_O_ /CM2T4 1?9V_O\ _CM'V=O[_P#X[4M% %:2"9+A7C(950@KTW-V
MJ#^SY$O6N51?,9 -N[Y<UH44  Z4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ?\ \%(?BIK7Q\^-GB(:_8Z+JNV?3=1GWW&M7V%?S;@ME9(BIP5/)(K]/O\
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M+(()'RY!S0!_0O\ \%+OVK-/_8M_8H\??$#6--U#7-(T;2V@>WLY%29FE_=
MY;C@N#^%?BA_P: _LG:A\3/VF/'WQTCU;2[;1?#/VC0Y-+FB<W<DMTHF24,/
MEVJ!@@\^E?7/_!UU^V&/@3^P38^%]+L;77].^-DILS??:,)91PB.X62+;E9-
M^<=>G-=E_P &M/[&5O\  [_@G(OCJUUJ>^N/C48];GLWA$:Z88U>WV(V<N"%
MW9..M 'LW_!Q*OG_ /!'3XT^9,&6/1XFVIQNS/'U]J_#G_@VG_X(S:-_P4C^
M).M^//&&J6__  @_PZU*""ZT90PN-1N'3S8LG!0P_*P=3R<U^W7_  <,:&VE
M_P#!'GXV3>:TF_0X("I[;;B/FOB?_@R*_P"3=/CI_P!C+IW_ *2R4 ?H?\?O
M^"(?[-'QQ^"_B'PFGPK\)^&WUFV-NNIZ381V][:-D$/'( =IR,9]":_FLA^!
M?C#_ ()6_P#!:K0_AOH_BZ2'4-'\5Z=ILM_I#O +FTN9HLQ-G!(,;!6!X/-?
MV#M_Q[R?6OY6/^"NO_*S+)_V.N@?^AV] '])W[='[3&D_L8?LB^./B7K>EW6
MK:7X.TM[RXL[-E26=057"EN!RP//I7\T?_!'#]C74O\ @M!_P4LUKQ9X^TOQ
M9XE\!V-Y-J&IZK-<HZVCJ3):6TY;)96"[, $8!'%?OI_P7\/F_\ !'C]H)",
M!?"SL#Z_OHJ_./\ X,IM3=OAQ\;OW&WR]0TY.!]X&.3G\* /U2D_X)-_LXJ?
M);X+?#I8%3< FCQAMWKTK^<[_@JK^RSXC_X(E_\ !4O2O%7@"P\5>&_ 'VZ'
M4-(U5;E5EU*(LDEY;1NI'RC)CP0  0*_JWAF+1.=O^I.!_MU^ '_  >R,USJ
M7P-=F,?F1ZCE,],&.@#]@_A1<_#K_@JS^Q[X!\;>)O ]CJGAOQ=8QZ]8:5KL
M*73V6\$#=C*[P,\BOYM?^"*_P/\ "?Q2_P""\\W@GQ%X=T?6?"RZQK\?]EW=
MN)+4K$\OEC8>,+@8],5_0_\ \$,O^42?[/O_ &)UK_-J_ S_ ((-?\K'UQ_V
M&_$G_H<U ']$/Q&MOA__ ,$QOV5O'WC7POX(TO1?#/AW3Y=;O],T"W2UEO6C
M7'!X7=CC)K^=3_@EG^QJ_P#P7=_;\\>>/OB-XNN6\.>'=174Y[34[DOJ%U:2
M3N;:V63E=L:A5(/&.!7]!_\ P67_ .457QT_[%"\_P#0:_CD^"?A+XA>*I+Q
M? =CXVO&B53>'P]!<RM&"?E\SR1P,]-U ']D$/\ P3&_99T^R9&^$/PQCBC0
M!I#I\'( ZU^"O_!;K_@G%8_\$;?VLO!?QD^$GC&;3_#/BG5C-8V5E<D7VE2I
MB6X < *(75]B*.@X-?"<OP@_:9TJ P_\(Y\:KB.[&4=;34V&.GI63XE_9I_:
M"\<0P2:QX#^+.IPVWRQQWFDZA/M/0E59#^E ']C7[!_[3.C_ +:_[(W@3XI:
M39WVEV?BG3%ND@NI%::+:Q0ARO!R4)X]:_ES^).O^$_C[_P6_P#$D?[17C6\
MM? <?BJ[L;_4[R9Q)9V4,LODQHQ5BJ @+C&,$U_17_P0P\!W_A7_ ()'? _1
M=5M;_1M6TK1LSV=[;M;3H1/*=KHX##KW%?#'_!PU_P &^WQ!_;/^.EO\6_A!
M#HMYJFJ6*6&KZ+/)%8PVD5NC.+A'QF221F((QG@<G- 'W/\  C]B3]C?XY?"
M?1?$W@?X?_"GQ5X3U.W!M;^/3XC]MV_+ORP!Z@YR.M?)W_!4K_@V*\)_M<^)
MM#\7? 6_\+_"G6K=UM]1B,#?V;Y4:DH\,<(^68N?F8GD 5_/?KWP]^-GP"TR
M==7T_P")GA/0M-9[59[B*]L;$29("JS!4Y(.,=:^[/\ @EE_P<I^*/\ @G)^
MSI9_#R3P3#\0(Y=9FU&35=3UF9;A/-V[H]I#?*H7CGF@#^C+_@GW^SSXT_9F
M_95\*^"?B!XK@\<>*-%@,5WK$?F%;H;CM_UGS<+@<^E;'QE_8:^$_P ?_&,>
MO^,?AYX0\2ZQ#"L"7NHZ>LTZ(IRJACV&>E9W[!7[<W@O_@H%^S]I/C[P7J%O
M<6>H1@SVN\"XLI.04DCSN3D'&X#(YKVN@"KI.C6NAV,5O:01V\,,:Q(D:X5%
M48  ] !BK5%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG7PU?Q9X59;?XP>'[0P:;)+/L@U1%R5MG+';$"S$[_:@#U7_ (+4_LS3?\%
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M:/QQI[7">&].FUW3! YS;W<,;>7)A?O $G@\4 ?SC_M$?M-^,/\ @K+^TO\
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M,^(OB#]I:;Q_^RU)':1>(W:ZU*PN-5&GOI\S?,\B3,VYO,9F)48QTH _8O\
M;L^"=_\ M7_L>?$;X;Z3=6VFWGB[0I],AO[G+6]N[C 9]N3@>U?S9?\ !OY^
MVPO_  2^_P""AGB?P/XSUOPYH?@76+RXT7Q'K6HHXAC-F\JHT9'(#..X/!%?
MM1_P;S?L2?'']A+]FCQEH'QP:.Z\0:QKZWEF3K?]IC[.(54G?D[?F!XKB?\
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M+WPS_P"B>^!__!':_P#Q% 'Y+'_@\[^ ?VC?_P *W^)6W^YNMMN?7[U33?\
M!Y[\![Z*,-\/_B/&BN,KOMLM]?FZ5^L?_#+WPS_Z)[X'_P#!':__ !%07?[+
MWPUCEB9/AWX'<[@&SHMJ-H]?N4 ?E5-_P>:_ ;2!Y8^'GQ&N%<9\Q6ML#/\
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M_"M?B1Y:C 3=;;?_ $*A?^#T;X!"5F_X5G\1OF &-UMCC_@5?K)_PR]\,_\
MHGO@?_P1VO\ \11_PR]\,_\ HGO@?_P1VO\ \10!^2TW_!YY\ [B_6>3X;_$
MI_+^ZA>VV@^OWJL'_@],^ IG\P_#;XD-Z M;?+]/FK]8?^&7OAG_ -$]\#_^
M".U_^(H_X9>^&?\ T3WP/_X([7_XB@#\G7_X/3/@+(BJWPV^)#!3GEK;_P"*
MIDG_  >B_ 66"2-OAQ\2F63U>VX_\>K]9?\ AE[X9_\ 1/? _P#X([7_ .(H
M_P"&7OAG_P!$]\#_ /@CM?\ XB@#\F?^(T/X"@_+\.?B7&,@X5[;M_P*G2_\
M'HOP"EC9?^%9_$9<G=D-;<'U^]7ZR?\ #+WPS_Z)[X'_ /!':_\ Q%'_  R]
M\,_^B>^!_P#P1VO_ ,10!^3\/_!ZA\!X5Q_PK?XD-]6MO_BJ?_Q&J_ ?_HFO
MQ'_[ZMO_ (JOU=_X9>^&?_1/? __ (([7_XBC_AE[X9_]$]\#_\ @CM?_B*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@\PM\OTY_*FOJ4,<6]FPI7<..M %BBHUNHVBWAAM(S3$U&*2".0%MLIPO'-
M$]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+0_'7@G6/AEHLEM+*=8N[U;R-9%&5C\N--WS'C/04 ?L917#_"7]H+PY\?\
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MUS]FWX#ZUXP\.^"[SQY?Z/";M])MKQ+61[= 6EDWO\HV("<=37S)_P $@O\
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M_8+6?&]GX'\+ZAKOB"^M=/TW3X6GEFF<1JB*"<G/J.U '145^2'[7G_!W?\
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MM7A\.W7BSQ-XXTV#5[K0;/4$631K::+>C22[2K'<"NT8(KP3X?\ _!ZS\/\
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M*&O:3X9^&.N>,/#^FW306.M0ZG';QZDHQAQ&Z;E!]#Z4 ?M-17P-_P $T/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1CMBNDA_X)A_\%,KBS6UV_%3YOG1CXI8$8[?Z[O0![E_P;>?M;ZQ_P $\?\
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MZZ_X(M_\&UWPTUKX->$?B_\ '#3]2U2\\0:?*LW@;7+416-O*[;8Y,@K+N
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M_'+Q5^T!_P $HO ?B;QMK=[XDUN.>ZL$O;H+YGDQ2^7$GR@#"H .G05\*_\
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M_P"#>?\ 8[T7PY:VMQ\#_"5_<6\2QM<7(G62X90 78"3&21DX]:_F"_X)U?
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MO^"<G[&O[77[0_PYUC4O@!_PFTGA>QOOLUU+H^M&QA^T[0>4\Q<G;BO>K/\
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MC-<;7^I\ROGO_@HU^Q=_P3__ .":WP:OO%GBWX(>"KB^E@8:5HD7GM<7LV"
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M)Y>N:45:0[F&ZXYYKR7_ (,WY%N_^"=GCAIEC#6_BV38^S)7]PG/UH ^>_\
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M/O$2V GO-:UF*2.[DDD <HXC<*-I.T<=!7XW_LK$2?\ !T[IJVJBW:3XH7R
MO\P^[/T':OZD+'5HX)Y+=HYE6W^1I6;.2: /YY_^#ES_ ((D^!OV3/ _AGXM
M? _PS=>&;6WN/L&LZ9H\+-I^F1(C/]L>0DNK%BJG)V]*_0#_ (-E/^"A=U^V
MI^PTOA_Q!K&L^(O&_P /G%KJ]]J,:K')&Y;R!&RXW!8U Z#I7LG_  7J_P"4
M._[02M''M'A64ID?-GS(_FS7YP_\&3'G2>$/CD"#Y1N]/78>OW),XH ]<_X/
M-56?]@_X<NLKJ[>*_P!WL&5)^SOU/I7RC_P;A_\ !"WP_P#MB>"]/^,/QBMK
M7Q+X!WW-KHV@2,9(+R0$I(\X&&0JP!7:>>]?4G_!Z! +;]@[X;JC,H3Q>4&#
MV^S/7OW_  :K0K_PYI\"_P"UJ>I9_P# @T <;_P46_X-G_@G\8?V8M7TWX/^
M#M#^'GCK3Y&O=+N+#=MOIPN%@F:1FVQG.25&>*_*_P#X-G?BYXQ_9Z_X*\V/
MPKM_$5]8Z)J$M_8^(;*-P8-1FMED #9'19 2",9K^I(6,:WJ3?-N^[C/'UQZ
M^]?RP_\ !"K;>?\ !QS<02*K(WB/Q&3D<\23T ?M]_P7D_8R^%/Q=_8I^)7Q
M*\5>"]+U?QQX.\)W::)K$H<W&G@9<;<,%^]SR#7X^?\ !J9^PK\)_P!M3Q_\
M6M/^+G@'2/&EOIFGV=Q8-?"0B%WD?<1M9>P%?NQ_P6( ?_@EU\=-RAO^*2O,
M9'3Y*_'K_@R39K[XH?'6.1W94TK3]O/W?WTG2@#Z)_X.FOA3X=_9N_X(Z>%?
M OA#3[?2?#>B^)[*WTRP@SY5M!B4E!DDXW$GKWKTW_@TT::7_@D3H,UN[LJ^
M+-767(Z@-'Q]!7._\'AMI';_ /!+'2]J\KXLLL,>H^67O6U_P:--(G_!(O1P
MMO-)')XJU<-*'PB_-'VH ^ _^#K#_@H#JW[0W[5^C_ #X=WWBO[-X?D^PZ[H
M<5N!;ZOJ9<-!)%C+2$(^T8P,G&*^^O\ @F3_ ,&X_P !? /[)GA.Z^*'PZL_
M''B[6;1-1U"?7(7BN[,RHK?9BL;*,1G(&1GUK\H_VW[94_X.BKS=,S+;_$K3
M%CCY^[B DBOZF+V[9/WTDVV&#YBR_P 0/ &/6@#^?G_@NS_P;K>"_P!FWX2>
M,OC/\'5\46]Q]M@2'P7IMFK6&FV3(WGS!N9=J;=Q))'S'-<[_P &2[*O[4OQ
MH+=5\)VF6[8^V#BOW%_;TLF;]@CXK))&SR+X/U0^;NRP_P!'D./7FOPX_P"#
M*9F7]J/XV.RB0+X0M%$:C:3_ *8* -K_ (/;W5OB[\#5R"RZ-J.1Z?OXZ_9#
M_@D-_P HO_@A_P!B?8_^BQ7XX_\ ![&]M=?&7X'1<QS?V/?[W/1!YT?7UK]B
MO^"3%K<+_P $T/@LEO<0F%?!UBJ,4ZML'/T]J /4/VP/^35/B;_V*&K?^D<M
M?SU_\&5W_)]'Q*_[$]?_ $I2OZ#/VP+EH?V4?B8\A58_^$3U2,MZDV<HS7\^
M/_!FFDFC_MU?$B.%?.\SPBH$P^ZB_:4Y(_I0!^H'_!U!Y=Q_P1R\9,TCH!J^
MF@&(;N?M K\@_P#@W3_X(TP_\%$/$TGCCQ],M[\+_!^K+'<:2C;VU6[50WE2
MIQB$H>64@Y%?KA_P=5VPM?\ @C1XT"LPV:OI9R#U)N!FO%_^#,F2.S_X)]_$
M2:1F"KXN;<W7C[.E 'Z!?"'_ ()U?"G]BWPMXM;X%>!?#?@#7M?TZ2&2>T+J
MWG>6P@8EV;&UR#Q7Y-_LQ_\ !KY\7OC9^VG<?$K]K#Q1HOBS2KJ<ZE?&UOA=
M/K$^1^[E&U=L;*.2N#Q7[K:YX@M=%T:ZUB^VVNGV-M+<W<K_ #;(HU+%C]%!
M.*_GW_X*(_\ !Q/\6?VS_P!I2_\ @7^RG%')X:\1;] ^WBS\VZU:5VP+FUER
MK6RX./FY!&<T ?JA<?\ ! C]C#PY8275Y\#?!/V6VC:9I)#.%C51EF_UG8#-
M?SU_\%I?A;\)?V-?V^= \5_LM^-+.^@U@G6K>/2)8Y(/"EY')LC@A(W' "[_
M )\G)]*[K4/^"6__  4L6SN+6^L_BO<Q72M$ ?%A*.IX(QYW0CM7RU_P4<_X
M)J^-/^":=M\+[?QQ<I!XF\>: ^MW6FJI$ND.MPT1B=LD.WRAMR\<T ?UI_#/
MX8:+^VE^P)X-T#XJ:7'XUT_Q5X:T^?6;?4@1'?RF&-V9]A4_?YXQS7\S/[47
M[)O@7P?_ ,'"MY\+]#\+:?;_  YL/'=CIXT2'<;=;5A"7CZ[L'<>_>OZA/V%
M[3[9^Q5\*I7DFW2>$-*#8?K_ *+'7\V_[;'G6O\ P=1:@L3-$DGQ*TU?D.,C
M$'6@#^C+]EW_ ()[?!G]CG6=:U;X4?#_ $7P-?:];1VU]-IPD\R>)&W*K!V8
M<$DU^(W_  >X<?M(_ O_ +%?4.O_ %])7]$JEXYU7[.RB/\ C#  _6OYV_\
M@]R_Y.3^!G_8L:A_Z5)0!^LGP*_:1T+]D/\ X(F>#/B/XE2^DT7PK\/;&ZN1
M9Q^9/@Q(B[5R,G<PK^?[_@F;^R+KG_!;S_@IY>>(/B5J/B?7/!D=S/J>I:FD
M"S*?*8/!9S<!461!M.,' .*_8C]L-MO_  :QWYPS?\6OTW@'G[T%?-O_  91
MVDX^#?QQ;]W#Y6M6 ^9,E@8),\T ?H#8_P#!!']CZXAN(?\ AG[P7"URA"21
MBX(VGH3^\Z]Z_G__ &O/A5XJ_P"""W_!6NUO/"&L>,-,\)V>I0S66K&V6/\
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MPV^FW44US!O&]$<MA6*Y )[T ?5G_!,W_@X-^(W_  4^_;DUCP9X!^&?A/\
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M+YLCH/:@#X5_X.&_A1JGQ,_X)._$C3?#VG7NL:A+]FF6RL8C,R[)0TC #G
M)/IBOS-_X-+?V]_A7^S!X;\>^ ?'GB#3/"^O>(-0&LVUUJ3I!:+;)$L31F9B
M,2%NB=QS7] /BO2M/U[1[O0=1D/DZU;3VDJP_+NCD0JV#V;!//K7XG_MI?\
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M%N+@:?.LUIJ.FRK:ZA"@R?+\[:6\LDDE>A- $WA#_@JI^SMXV\&Z/K5K\7/
M>GPZU:QW0CN]7ABN+<.@8*Z%OE<9P0>AK\)_^#G3_@IC:_MK?';PW\%_@[XF
MU;Q1X6TN00ZW:6,*S6FLZKY@-O) ZY,F(W*C:0,Y&*]*\>_\&4OC*Z\6WW_"
M._&3PA8:+->S2:?#>:9<S30VY8F-'8$!G5< D=37WQ_P2H_X-M_A+^P+?^'_
M !AX@C;QE\3='M6AN;Z23=I,LQ;<)X;=U)C=<+@YR#GUH ]C_P""(W[%$?[
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M%S-Z'G)&*_.!O^#*7XAW23>1\;O!*8V[5;2+KY#_ !'[W0T ?0WQ._X.L_\
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M5(P,"O['O&WA6W\7Z3=:9?0Z==Z3J$+0WMI=0"5+I#P593P01Q@U^/'[-_\
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M%U$L4;;(=QF.'V\?B:Q]>\.1ZYIVI:?/*5T[4+4VS+$=K)N!#'/XT ?SR_\
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M^1#8VJ^5''LPL>WA0H[ 8Z4 ?D-_P>C_ /)B/PY_['(_^DSU[[_P:K?\H:?
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MCXB_8M_;RT?X_>"]4\4W$OC2Y&MRZB;!5M/#]_&ZQPQ)( 068)O ?DU^MO\
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MOVC?^"SG[.W[/_PTU#Q5??$CPUKUII*Q[+?P]?17^H2,Q"G;"&Y _E7\UO\
MP7L_X*MV7_!5C]J33]=T725T_P ,>"[.32-&N) RW.H6[2>;YLR'(1]Q(PIQ
M@"ONCP]_P98>.+?5=.6\^-7@V:'SD:_6#2KJ-I(<@E5.[Y6*Y&?4U]9_MX?\
M&J'PU^/7P#\$^'?A;?6?@+Q)X%M5TQ-4OT:XCU.TWM)(TXC :2<LV!(QX48H
M _1/]@W_ ),B^$__ &*.E_\ I+'7\UG[>?CK3?A__P '07B#5-6DL[+3['XC
M:?-<WEQ)LCMHU6 LS$\  <Y-?T=_L-?"+XA?L]_LN^&? GQ*\1^'_%FN:'$-
M/M=2T.Q>PMQ9Q(J0(R.Q)<*N&;/)KY)_X+/_ /!OYX5_X*;&S\1>'+W1_!/Q
M5MSB75)+9FM=3A+9<RQQ@%Y?N@.QX Q0!]N?!_\ :B^&_P"T'JU_;^"?'GAO
MQI-:Q++=6^FW\=PULC'"L0A) )XYK\'_ /@]P_Y.1^!?_8KZA_Z5)7WM_P $
M(O\ @A/X@_X)'_%+QYXHU?QUHGC"#QAH]KIL=K8VDL#VLT4K2.Q+G!!W8 '2
MH/\ @NU_P09\9?\ !7KXJ>!/$6B^//#WA&V\'Z9<6#6VH6,MQ+-YLJR9!0@#
MICGUH ]C^''[+=K^VI_P0I\+_#"\U.\T>W\6_#JPM6O+2-9)H=L:2#:K<$DH
M!SZU^&/_  1 _;VUK_@D7_P4=U3P)\2M2\2>'?AWJLUQ87^ESV03SKW(BL[B
M8-@HBY+%LX .<&OZ6?V5/@[J7[-_[.'@7P3<:A9ZD?"&BVVES211%?M!B0*6
M7/(SC/-?,W_!2;_@A9\%_P#@J#JLGB+6[2ZTCQA:Z=<6VG:EIDWV2,S./D>[
M55W3;6"]Q\H(H ]DNO\ @I%^SRUHUY)\8/AL;KROGC7782K$<X!W5_-__P %
M2_VF]9_X+8_\%6-/\+^#[SQ=XB\$V^I6^EZ)9IIX,NDVK/&EY<(BY.P<R;F)
M& #P*^D-/_X,H_B#<J[+\</!,B6[['4:1=KE@><9;TK]=O\ @G1_P1B^"G_!
M,::XU#P=I][?>*M:MXDN]2U2X%W/&RQ[)/(8J&CC;)RN>1B@#WG]EC]GNQ_9
M/_9B\'_#?3=2NM8L?!>D1:7!>W"*DMTL8P'8+P"?:OYI_P#@O=_RL76__8;\
M-?\ H<%?U*0S,DA14W0QKA5[M[Y]*_(S_@H5_P &WOCS]M'_ (*91_'JU^)'
MA72]*CU'2[P:3)ITS7!6T:,D;U;;SLH _7FX_P"/AO\ KE7YX?\ !T__ ,H8
MOB!_U_Z;_P"E K]#);9KF1&>3/EON&SCCT/K7S!_P5T_85US_@I%^Q+K_P *
M]%\0:;X<DUJYMYOM5[ \RIY4@?HI![4 ?!7_  97_P#)BOQ+_P"QQ3_TF2OV
M>A^^U?"?_!"K_@D_KW_!)3X >)_!NN>*M*\73:]K(U5;C3[:2W10(@F"')/:
MON*S1K=TCCDPI9F=7.YCGT- %ZBBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCR)@*<'C-:%% &;K""Y_T?9([M\P&/D/L3VI\E@9XQ&&:W8J VP9!'IFK]%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %:_N6B(5
M2R\%R0,\#M5"SOKPV<DLWEQMYC,B%@-R=L^E:-W.R-M$+R?*6!'3([?C7AW[
M>'C;XE>"?V1?'.O?##PS'XD^(5GIS?V/HSQ&22^D+*NQ5!&3M+'KVH ^ O\
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MA[@U^,W_  =E_P#!.[X=S?LR7WQZATK^Q?%^@W]II\EQ9HJ+JRW$@3,YZL4
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MG\N[U1$."(@1@DM\O)')KX"T'_@\5^ ,6J11R?#_ ,>6/VR4++(QMQ'&I/\
MK&^;ISG\* /V%MY)+E-\<VY9&!7(Q@#K5RO&/V0OVV/A7^W!X5U+5/A;XTT;
MQ=8:'-%!>2Z;-YGV.21-XBD./O8S^5>ST 1W)81_*VSD9..U4VU&4W;;#"T8
MX4!Q\Q]*Y/\ :/\ VE_ ?[)WPPN/%WQ&\4:3X0\-Q31VC:AJ4GEP":3(C0G!
MY8C K\M?B!_P=\_L^^ OB+?:'9^"_%VN0:5?R11:KI[0&SO<<>;&2P.UNV:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1D_X)'?LW_'[_@E?\%O%GBKX*^!]>\3ZUH:SZCJ=]9;Y[QO.D!<MGDX 'X4
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M_P!OO_@DG)X_T3X?_P#"R-#\$Z5<'4-5\0^&%*:5J/EQ#_2=[#)55RN2.QH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTQK&IW5Y>>+OAU/>7LYN)KAKR;S&<DEC]SN22:CN_P#@S:_:2NMW_%6_#M5
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M]K_\'#O_  1P^(G_  59\%?#?3OA_JOAW39O"-Y=W-X=5E:-7$JJ!LV@]P:
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M.-)\V6;1F59=%2X#9@G0X$F^,A6&>]?KI:Z-##;_ .IA21EVN%^Z: /Y7O\
M@O"^_P#X.+[<\_\ (>\.=?\ KI#7]5"=%^M?BQ_P4L_X-U_C)^V+_P %78?C
MEX?UWP=:^&(]3TF[-O=7$BW.RU:,N,!2,D(<<U^U2PD!?8YH _ [_@]S_P"0
M?\"?]_4?Y1U^FO\ P0<_Y0\_L]?]B=;_ /H3UX+_ ,'%/_!&KXD?\%9+7X:I
M\/\ 5O#FF'P>UV;O^U9GCW^:%V[=H/\ =-?87_!-#]F37/V//V"_A7\,?$5Q
M8W6N>"= BTN]FM&+022*6)*$@$CF@#YK_P"#G?\ Y0Z_%#_?L/\ T>M?+O\
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M&(YM'D-O>W$BW6+0H9. I'.TXYH _9V/_CU3Z#^5?GY_P<\_\H:_BE_O6/\
MZ4)7Z#+"1 J]UQ7R[_P6-_8I\3?\% /V O&?PM\(WFFV.N^(3;&WFOW*0+Y<
MJN=Q )Z"@#\]?^#);_DS7XQ?]CA;_P#I&M?M(O\ K(/]]J_/S_@W<_X)1>/O
M^"3_ , ?'OA?Q]J6@ZE?>*->BU.V?2Y6DC2-8!&0Q8#G(K]!UM6#1]/D8D_C
M0!8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBFR$A#C'XT
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M/ ]*_I3A_P!<_P!17\JW["EG#>_\'.J6MU#'=6.H?$C58IX)8PZ.!YYZ'WH
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MG_!Q9^UQ^TM^W#\-? GB[3_#*>&?$^N0V-]-;^%WMF$#9RP<MQ7[\?\ "N-
M,OD_\(SH'3&_[#%_\33[?X?>&]&:&=-!TE;BR.^.2"RC616'<$#(- '2P',*
M\ACCDCO3ZIZ%I[:;8>6TTD^YC(&<8(!.<?A5R@",W<:]6 Z_I4<>IPRKE9.-
MVWIWKQW]M']JGPQ^Q1\#_$'Q&^(3WT/@OP_Y)GFT^#[3=,SN% \O(X#$=Z\4
M^!/_  7<_9[_ &A/V:/''Q6TO7-1T_P?\/[Q;*_EU:T%G<7$IA\T)!&S_O'*
M] #DF@#[0^VQ_:&BW#S% )'L:>)5)QGWK\_?V7/^#BG]FO\ ;:_:"T+X<^#;
MKQE<>)M>9DLA>:*;>U4A2QWR[SMX!ZCK7V=\0?BWX5^"'A9]4\5>(-(\-:.\
MJPI<ZE=I;Q;FZ*&<@;C@X% '8+?PLR@/]YBH]R*D,RC=\WW>M?F7\1/^#K#]
MDWX>^--2\/-J_C:[U#1;J2V=[;0?,M;AD)4E)!)AE.,AAUKZJ_9%_P""F'P=
M_;V\!:'?>"/%MC<7GB&UDO$TB25(]2ABC8JYE@W%DQUY[$&@#Z(-U&(]VX;1
MWH%W&2WS?=(!_&LN"]$-D4M85(B&T&0[4*]CFH+_ %^+POIUY<:@UI8Z?:H9
MI+B:79&D8&79F/"@#/X4 ;(OHB[+O7<O7VIO]J0?;5M_,'G."P'J!7P!^U5_
MP<:_LL_LI_$A?"NL>)M2UV8VZWC77A^T74;4*Q(P)$DP6XZ5UW[%O_!=+]G/
M]N&'4+/PKXP/AN^TVYAMEB\0QIITEX\OW%A#N3)D\''<@4 ?:\DRQ#+&HY;^
M&$'<X&VJ5K$SRF1I9$^7RBFWY0?[P-?*_P#P4"_X*T?"?_@F%=^%Y/C!-KUE
M=>)UN&TU-(T\WT96+ ;>=R[2<CCF@#ZT.I0A<^8/N[OPIZ74<B[@PQ[U\L^)
M_P#@KE\"?#/[*>D_&+6/%EGI>@ZQH \1V.GSND>LW-L20/+M2VYV)!^4&O%?
MV>_^#EC]E/\ :O\ BG8^"]-\3>(-!U*\CDECN=>TT:=8KL7=\\S284G' [F@
M#]#IM0A@@:1G"HHW$^U.CNHY55E8$,,CZ5XG\;?VUOAG^SU^SK-\5O$_BS37
M\%VMH;J.[M)XYEU(C) ML,!*Y .%4\XKXG\)_P#!V%^Q_<7]G:+K?Q!9]0NA
M#$T_AWRTA9W RQ\SY5&>I[4 ?J,DZR+N5N*2&Y2X3<K!ADC\:X#X;_'?PI\>
MO#MYJW@'Q-X=\5QVI$!FT^_2=('9=P1RA(5L<X/-=59R?9;5(O+6&XP&()PI
M<_>P: -BLOQSJDNA^"M8OH=OG6=E-/'N&1N5"PS^(K4'2L'XI_\ ),?$7_8,
MN?\ T4U 'XL_\$._^"[_ ,?/^"@7_!26\^%?C:\\)+X3M--U2Z5;32?)N2;=
MU"?O-Y[$]J_;JW'DW7WU,;J H(^;/UK^7?\ X-5?^4VNK_\ 8 U__P!&)7]0
MLU_#IEGY]PZQPQQ[F=CA5'J3VH LBYC+LNX94X-$=W'*&*L,*<'/&#7PS^V7
M_P %]/V8?V)M>T_3/%/C"Y\0W6L*]Q$OAJ%-42V:)@I61D<;&R>AZX-9_P"R
MC_P<._LM_MM>*+W0='\8:AH-Q9PK/*WB2T32H)-S;0J.\GS-GL.U 'WLUS&D
M@4L-S=!3C.HDV[EW8SC-8NCBWOHH=4C:-HYHMR- WF)*A'RL#]/2I+F&&[5K
MB1-L*Q<N3AB/I0!J074=R,HV[%/#J>_2OAS]L3_@O;^SC^Q%>:/IOB3QB=>O
M]6>6-$T!$U#[(8V"LL^QQY9YX!ZX-><?"W_@Z"_99^,7Q8T/PAI^L>*M.NM>
MO5TS[;J.D_9=-MF/.]YVDVJHQU/% 'Z2Q7\,^=K9VG!XIUS=QV=N\LC;8XQE
MCZ"LS3]0CU:"&:UN(VL;B%9+>6(AA<*RY#CU&""".M<U\2_B_P"%O@9H=OJ'
MC+Q5I7AO35D%L+O5+F.V2YDZ[ 7(!)'IZ4 =M#?17$ D5P4/.::-4@+LHDR5
M;:<#O7YC>*O^#KG]DGP[XMU33;J^\;21V-Q)9RS0:$729HV*$H1)AE)&01U&
M#7H/[(G_  <6_LL_M<>.)/#?AWQCJ7AF6S@:Z\[Q+9II=K(BD94222$%CGI0
M!][7";)6D4L3(N.3\J^G%?+/_!5+_@I+8_\ !++]F*S^)&O>%]0\66\NJ0Z=
M-;V,\<+YDW'@OD=%KZ5M[ZWUZU@U*SFM;K3[J%)[:>.7<ERC#(8$<%2""".N
M:_";_@ZO_P""I/PK^+_P7UO]G?P_/KC?$#PCXHM;G44FL-EH@B0EMDNX[N)%
M[4 ?I+_P1._;_P#$G_!2/]BJ;XG:_9V>GS:AXKU2PL+>&$1BULXG7R5D .&<
M*V&8=367_P %Y?VXOB5_P3__ &")O'WPPM=.NO%$?B"RT]1=Z>;Z%X9=^\B,
M$'^$<]J_,C_@WW_X+S_L_P#[!O["VD_"GX@ZCXR7Q;<>([RX1+'1?M%NJW+Q
MB/\ >!QZ<\<5^QO[;'[</PK_ &'/V84^('Q0M;V;P3]KMK6$0Z>+V1Y)P6C/
MEL<=CSGB@#R3_@@G^W3\1/\ @H)^Q-_PFWQ0M[6V\4+K5W9/%:6)LE6*/9L;
M82>N37VQI=R;[RYDQ''A@RL,OGZUX=_P3T_;C^%_[>_[/@\=?"F.\LO#,FHS
MZ:B76G+8RM-%M+XC!.1R.>]>F_$/XN^'/A)X8;Q!XH\0:7X=T'>('N=3N$M8
MDD;A5W,0-QP<#/- '7?VA"65=_+,4'UJ0RJ"?F^[U]J_-#XH?\'4G[)_PO\
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M^"*O_!O?JW_!1SX867Q(_:"U;Q%#X#BTQ;+PAIL5VT=P;?(9)HG^95M^6&S
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\&HWQ@\5?M-6>J?M/7=G-X+TE%D2&#7AJ4VJ8;FW8[M\:D$G(/:O0_V8/^"
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M?_9'_P"":'A/2]5U/3-4;QG<-XHC:UA=#9Q7,:,J/N_C&,$CBOR/_P"#F?\
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MP^K3)\WBK60-P/S 2KC%<O\ \'?$OVW_ ()46L<C*';Q?8%6'27Y9>E>J?\
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M?\%;/^")?PU_X*I>%-/DU)F\)^,-+(%MXBL[822I!NW2QM'D*Y; ^9LD8XH
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M@.O!'O7HOQR\'7WC7X%^+]!T586U#6-'N[&V61PL>^6%T&6/ Y8<T ?SF?\
M!FF(T_X*-^-/)6587\(2LF\YX\Y*_INK\2_^#<C_ ((?_'C_ ()I?MC>(_%O
MQ0TWP_:Z-J'AY].MGL-6CO&+F16&0O3@&OVTH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *:D2Q$[5"[CDX[TZB@ *Y7':H8["&)658U4-U
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MQ"C+<GWH$:@D[>6ZTZB@"-+.*-E98U#("%..F:22RAFG61HU:1/NL1R*EHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFO;OV ?^#GWX,?MB:Y8^'?$V[X<>,M:U-=-TW2KN3[3'.6&1(TX 1!G(^8T
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MX/6O#=EJEQ'I_P &]4U&UCD=$F_MB./<H)"M@IW'.* /W4HKX+_X)&_\%W?
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MC\0>*]6(,K;EL[83!HH4/7RU4[5SVK\<?^"V'_!Q);_\%+_V=;'X8S?"G5O
M^H:7K4.IS37MZ)&7RU8>64V C.X'FNC_ ."+_P#P<?Z;_P $Y/V:?#_P7O?A
MGJ'BFZN/$$UT-534EA55O)4VKM*D_)]>: /U+_X.>?VH?''[+/\ P3JMM9^'
M/B[5/!OB9O$=E#]ML)!',T)\S>F2#P<"M+_@V1_:(\=?M6_\$R['Q9\1?$FJ
M>+_$0\4:G:G4-2</-Y2&,(H( X&3^=>5_P#!W/=_V[_P2/TG4EA"_:O$^F2E
M0,NH99#C=7CO_!O5_P %,?A/_P $]?\ @C)I>H?$CQ1:Z2NH>+M96SM%'G7#
MNHB;!1<LH/ #$8H _<JBOPFO_P#@]@T(7EQ'9_!'5KB*.1HXI3K4:^:,X#8*
M=^M?JK_P3I_X*'>"?^"BO[/=CXV\)ZI;S3,-FHZ=N'GZ;. -\;+U(5CC?C![
M4 ?0E%9]I?S/;><&%PLC@*H7:5'>KEO=+=!MN?D;:<CO0!)1110 45@_%/QN
MOPR^&/B3Q(\#72>']+N=2:$-M,PAB:3:#VSMQGWK\O?V /\ @ZH\ ?MA:YXX
M_P"$H\&S?#G0O N@/KUUJ%UJ:7)FC5U0HD:J&9OFS@9/M0!^L%%?BGX&_P"#
MPW1_B5\;;#PAX>^"NO:Y%J>JK86UY;:B&9XFF">=Y80L %.XCTK]:OC3^TSX
M2_9V^%VH>-O&>K6^A^&]-C,LD\Q^9E S\J]2W^R.: /0J*_%[]IW_@\H^&/P
MC^+5QHG@7P)J7Q&T&..-H]8CO18K([#YD\MTS\IXSWKU_P#8)_X.C_@S^UQK
M<&@^+(Y/AKXJU34X]-TO3;J3[4EUO Q(9E4(@#<?,: /U"HJC#J#W^G1W%M)
M#,KJ&4HP99%/1@1QCO56[\4V^DJWVNYABCA@::>X=@D<0'4L3P/QH V**_*?
M]NS_ (.N/@O^RA<QZ;X,M;CXJZW;ZG<:?J=O:N;)+#RN-P=E*R MD?+Z9KQ/
MX>_\'IO@_P 2>--(L=:^$>IZ'I5]<HEUJ)U9)1:0E@'EV!,G:.<#DXH _<2B
MN,^#_P ;=#^//P\TGQ?X3U&UUCP[K<"7%K<0R#[C ,"W]UL$94\BN0_:\_;H
M^&O[#/PMD\6_$OQ/:^'])\^.V1BADF9WR%VQK\S#(Y(&!0![%17X>_$K_@]#
M\(>$O&NK6>B?"G5/$6BV-P\-GJ:ZDL U% <"0(R90$<X-?97_!.'_@X)^#/_
M  4-NM#\,PZE'X,^)&JQ2W,F@7K;UA2,Y(\\@(S,N" .<G% 'WQ15&\U5X)I
M%2/S J;E8-P3Z5\(?\%FO^"X]I_P2%U#P7;ZAX$N_&#^,X9Y8A!>K;_9_**@
MYRIS]Z@#[]HK\J_VG_\ @Z.^'O[.O[-OPO\ %D?AMM=\6?$338=5D\/6U^A?
M3() W+R %=P9<;>#7@/A[_@]:\+ZOJUG;WGP=U;3;>6Y2*XN3JJ2+;H6 9R
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M?QK]'Z^)?^",/_!7.U_X*X_"#QEXHTOP;=>#(_".J1Z48+B[6Z:Z9X1*)-P
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M=9H;D<?,I&00?;-?U+6-RDDC1JNQD4'9C@#M0!9HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML'_!QA'#;K'9L?$?AX22 X)!D@S7]2>E6T-HZ6\*-Y:KYGF8^5S7\:/[=_\
MP4BL?VP/^"G*_'ZS\+7>CV7]HZ;>OI,\ZRRE;4QEEW@8RP0X..,U_0]_P1Y_
MX."/#_\ P5C^-^M>!=%^'.L>$6\.:6-3:YNM2CN%D7S FW"J#WS0!^D5%%%
M!4=Q_#]:DJ.X_A^M 'X0?\'N7_)-_@7_ -A74?\ T5'7Z0?\&_\ _P H:_V?
MO^Q9'_H^:OS?_P"#W+_DF_P+_P"PKJ/_ **CK](/^#?_ /Y0U_L_?]BR/_1\
MU 'V&1D5EW*L\$F9@?LQX+GACUYK48X%9FUV9II(P68$*G8>Q]3[T ?RW?\
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MBJ.WM?L\-I?$%C&$Z?=VGCCFO,?^#FBXBD_X(]?$K#>9YC6B2(HVYVSIT]*
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MO_9_US1_ _PR\+_#OQA=*?L&LZ9$PN+>1#D %V8;6( /'0U^1_QO_P"#9O\
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MX%M)+_P1Z^#\;+;SP+87"-EOF7,\G'XU^=O_  =\_L,_"7]G3X1?#WQOX/\
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MG@W4;5!8ZK:%5\F=LXD*N&W @\[:^Y/VX_\ @VD_9T^/G[/.N:)\.OA[X?\
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MS34\70V_BI0L:Z9K#:19LB?)E+42J$X&>G/6@#[(_P""^/\ P3'_ &.?@?\
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MKYN_X/<W9?VKO@C@D?\ %)7G_I97[I_\$ZU$7["?PA"C:/\ A#],.!Z_9TH
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M^-? _P#P>JM)#^U3\&889HU4>$[H&)3_ -/AXK]!O^#3%EM_^"/>A(C,R_\
M"4:NH4GD$3+D9K\^/^#VI!'^UG\%650K'PC=DD>OVPT ?M?^R?HHM/\ @FAX
M):-5223X>6VZ0_>'^@CBOY3/^">G_!/C6O\ @I1^W-<?#73-4729!?7-Y?RE
M]LD=C'-^^:,8(+X;@'@FOZO_ -E [O\ @F9X(S_T3FU/_D@*_GV_X-2V+_\
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M8X8?BZ)^8]SR,,# /I7]2&G,K,VU&"LH8,3G.><?A0!:HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP7$9GVY5[DQG='$>1N'?%?G?_P &KG[(GB+X^?M6>+OVD/$TWB;05L9[LZ1
M$+:;JIO#()0'?D^43@8_&M7X&?\ !EKJGAOXJ:'J'Q'^+NBZYX)L[E?[7TW3
M;&XL[N]MAG*1REB$)..2#7[C?"KX3>'?@)X L_#/A#3;70=#TF&*"U1(QY15
M5 )VJ!\QQDMW/- '\TME'/I?_!V7-S;W$TGQ7V_O'Q@U_01_P4^_8/T[_@HG
M^Q_XC^%^I:O<:+=ZJ@N;6^@C1Y8Y8CO1!N&-K, ">H%?#.H?\&Y?B+_A\*O[
M5$/Q#T:?1_\ A+_^$I.B"PE%SM_YY^9NVY]\5^L<-G#'#&NYC&IWDNVY@6[
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M9RU:77OC%J__  LSQ%IFIQ:EHYTIGL=/1(U&89X) PEW/SU QQ0!-_P:/_\
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M^7_!+G]B^;_@G=^Q;X8^%E]K5KX@F\-+(K7]M T23;W9^ Q)[]Z\R_X*[?\
M!&GP7_P57^"4NGWDECH?CBQW3Z'K_D_-;R$;56?:-\L0!;Y,@9.: /4/V,_V
MW?A#\9/ G@WPGX4^)'A/7O$R>'[0G3+#4(YKK]U;)Y@V Y^7!SZ5_/O_ ,'$
MO[)OB[_@F[_P4TC^.GP^U3Q5I\GBN]/B2UU_[*BQZ5JCLV88GP5)51GYLGFO
MT!_X)%_\&U_B[_@FK^VIHOQ3UGXD:#XBM]/T^[LCIUCILUO-*98]@<.S$ #J
M1WK],_VQ?V4/ W[;OP1U3X>_$#2X=6T/786MGD0!+BR9AS+#(03&^.-PYYH
M^3_V!?\ @X-_9\_:B\!0V^L^.X?"VO>'M.LXM3E\021V::G<-$ [Q$M\^&#$
MXQC-<S_P42_X.7/@;^Q3H>I:+X0U2W^(/C2ZTIKW2#IC"YTN2?=M6.XE1LH3
MC)P.F*^1_P!I7_@S!C\5?%NZO/A3\3=+\'^"S$BV>G:W:3ZC=Q/MQ(S3*5#
MMR..*VOV0/\ @S6\-^ _B)?S?&CQTOCKP[-8&""VT)9M,N$N=P(<R,6^7;D8
MQ0!]S?\ !&+_ (*)?%K_ (*7_L[7'Q*\6>"?!G@_0]4N&L]&;2;^>:XG>%RD
M_G+)PH'&W'6OB?\ X.]?^"=TWQ-^&/AGXWZ--KVKZQX24:)J%C:6ZR6\5H6>
M5[N5A\RE3@>F*_8SX+?"#PO^SY\-],\*>$-&MM+T;1($@M[6WC6-3M4*7;
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M.^ _[$VBW.D^&-8M_B!XLU+2I;W23I#BZTXS@[5CN94;,9)'89QS7R'^T_\
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MGM7YX?\ !=W_ ((@:Q_P6 U'P+)H?CC2/",W@F.XCD2\LI+@3B5E/&PC&-M
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MX/\ VHO^#,Z;XD?'G6M:^&/Q0TGPKX,U24SVFGZE93W=Q:9Y=3(I4$%LX '
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M:O<2NFU?/*J6E2,@84GID"ORL/\ P9.>.I[YRWQM\)KOC)5DT>X"A\\<;^E
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MP9;X2_LH:'\/;B_AFFTGP_'H)O(XBJ2%(!#OQUP>M?G!_P $FO\ @W1\1?\
M!,W]NW4/BYJ7Q TGQ1IFI6%]8)965E+;S1?:64AB[,1QCTH _6&6X4SQ6Q:+
M<ZC<K-A@/85_-9_P=+_L3>(OV6/VYM)^/WA>?Q)(/$DHU*\U?[*HM=$OX6C6
MV1) ,;FV[@&[BOZ3GB6W>(^3YD?^K\S_ ):)COGJ:XG]HS]GWPO^T9\+M4\'
M^--'A\2>']:B-L]K(%)A5E*F52P($B9)5@,@]* /@7_@E=_P<0?!?]I3X4Z#
MH/C3Q]=:#XV\*^'[:76]0\2^596^JW7"2&-\_.Q8YX XKN/V]_\ @X]_9V_8
MU\.6\=GXBA\?ZYJ^GW,^G#0&6]M8IT&(TN'5@4#,5]\9-?&/[6G_  9HZ-XZ
M\??:O@WX]M_!?A6.T1%T_74FU*\:<$[Y/-4J-A&,+CC%5?V<O^#+O3/"'Q5A
MU#XK?$JU\7>"4MI%?2M&AGT^\>8K\A$S%@ &SD8YH ^U_P#@AI_P5:^+'_!5
M+X?Z]XX\4>"/ OA7P;I;-86\NGZA/)>RWB%2P=).!'M;(8'.:\4_X.K_ -@V
MZ_:H_9*T7XE:)_PE-]XB^'+M%#H^G62S+<6TT@,\TG&Y1&J[LCC'6OT9_99_
M9*\'_LD_!O2/ W@70T\/^&])B6,H^U[BZP,;Y) !O<X&6(R:]+U&UM=;TV:U
MO+-9;2>,P/'( RSHPVLI'<$<$'J* /P1_P"#>W_@X2\#_!CX'>'_ (*_&#Q)
MK@U1]573O#VHW<*+IND6&P!!++D;%#!NH/6OT>_;F_X+>?L^?L^_LT^*/$6D
M_%#0]>UEK)[>P@\/7D5Y>"Y=&6)PF?NJY4D]@*^8/^"D/_!J#\+_ -ICQ3?:
MY\)=1;X?^*O$&H->Z@UVSW&F01L/NPVZ!1& V, 'BN2_80_X-"? 7PRUV\U;
MXR>+E\?_ &:YMY](711+IL4#0MN=9D?=YBL0!C@8SZT ?DC_ ,$P/C)XO^/G
M_!:;X+^-/&6J76N^(/$GC.VO+V]N0-]Q(Q.6. !SCTK^QJV8,6V_=]NF:_(+
M3?\ @VAU;PI_P5PM?VA-#\;^%]-\&VOBI?$-IX8M-+DB-I".D",K>6N/88K]
M=]-*1R211ON5<':>JD^] %RBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@"K+;217!:%4Q)][)QBFV6D+;&9F8O
M]H8L0?X?85<HH HRZ<\TJR-MS&#MC_A]N:DL8[A_+DN"L;[,-$ARH/L:M44
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M67=QU[5<HH H_P!E-<7T-Q*VUHE*[!T;/<U)=V#7"-&I\M6Y)'4FK5% &?\
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MTY2D:JRL68Y/?M34TR2;<LJHL<WSR@'.3Z?2M"B@#/DL9K[3O)DVP%6X*'.
M#Q^=.O4O$N8'MQ&RY"RHQP .[#WJ]10!4;3Y&N(W\YL1,6Q@?/GL?I23V\Y4
MF-4CD9AD@]15RB@#->/4)/+^6)=S%7(;E5[$>YISZ/\ :I&$W,6?NY^_[FM"
MB@#/N;6X=9;>*...W$8\M@WS;L\\58C29$PP5BN &[D=ZL44 4)K.9[J-_+C
M;<VV0EOX.WXYI]]IYNRH9%:-2&"DXY'2KE% %=XY!MD6.,R-PV3T'M4;V+6Z
MJ\*JTB]B<#GK5RB@"C%I;-J NI&^94V[!T^M.N]+,U]'<*WSQ@C;V;-7** *
MMK;R--YDRKN4;5P<Y'K4?]EO:WDT\+;FF ^5NBX_QJ]10!32VD6/=LC\R8YD
MYX7Z4VRL'T^'RXU7:S,6)/(SZ5>HH SI[=H+55D997*E#OX#YK^:G_@K+_P2
M:_:$_P"":G[<Y^.OP)N?$WB2U\0ZA<:C::EIMF)M0T>X</).CQ(C!85#[5=N
M6YK^EW4))/,CC6'S W\?&$-9-M;75S:W5I>-#=YW<*F$=&X*D'KQUH _FU^"
M'_!XW\;O@[\+=-\-^)?ASX6\<:MIL9AN]9U/4;B&ZOFW'+.L:A01TX]*\_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS$\CU_PJ2&%HGD)<MO;(!'W:DHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBC/- !111G% !11FC.: "BBB@ HHHS0 449HS0 4449H ****
M "BBC=0 449HH **"<49H ***,T %%&ZB@ HHHH **"<49H **,T9YH **,T
M9Q0 4444 %%%&Z@ HHS1F@ HHSD49S0 449Q10 449HS0 449H)Q0 449HH
M**** "BC-&: "BBB@ HHS0#F@ HHS1F@ HHS1F@ HHS03B@ HHS10 4449H
M**,T9H **,T9H **,T4 %%&:-U !11FB@ HHHH ***,T %%&:* "BBC<!0 4
M49HH **,T9H **,T4 %%&:,YH **** "BC=1NH **"V*,YH ** <T4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO_!DW9QB3XY8.&8:?M4_>7_64 ?OZC;T!%*PW#'K38D\N,+DMCN>]*_W#]*
M."^.OQSTC]FSX.^*O&_B(SQ:!X.T^74+LP1F:3RHQEB%')/M7\WO[1O_  <A
M_M6?M%_'WQ!<?L]Q^(;'P7!M6WT_2]$;4WC4%AYSGRV93)P=IX!XK]*O^#C#
M_@K[X-_8\^$?B+X&^(/"?BB^UKXI^$[K['?VDD2V\ 9C%F0,=QY';M7X]_\
M! G_ (+&>"_^"0_C?X@:IXJ\+^)/$ECXQLK:VM(]/DB5[=HG9F+;R!@[ATH
M^DO"7_!07_@H1K7["_BSXL-XF\?)XAT7Q3:Z'%X??P65FN8I8#(URH,6\JI&
MWA<9/6OUD_X(+_M#_&#]HG]@*S\2?''^U?\ A8$VM7L,K:AIYL)!:JR>3^[*
MKV)YQS57XR_\%T_!'P+_ .":'@G]I[4O"?B:[\,^/IX4L])ADB%Y;^8TBC<2
M=O!C/0]Q7I7[ G_!2'PW_P %"OV.IOC-X;\-^(=/T2.ZO;9M.OGC:?-J 7/R
MG;@YXH ^7/\ @X%_X+B>)O\ @E=K/A_PKX5\+V.I7WC;1+FYCU>:\*2Z9,LG
MEHR18(D SNY],5]T_L5^.[[XN_LC?#+Q1X@N9+[6O$'A^SU&[G"[?,EDA5F8
M@<#))K^7O_@X:_X*O>$?^"JO[0_@C5?!_AO6M B\!Z9=Z1<IJ;QL;J1KC>&3
M83\HQCFOU,_X) ?\''7P[^-]Y\&_V=--\$^+K'Q1-IUMH3:E-+!]F,D,'+*
M=VWY#^= '[#K=PB58]S;I%)C##;@"F7*17$BPS+(\D8WKC(49XZU\-?\%7/^
M"XO@?_@D=X\\&Z+XR\'^*/%EUXUL)]0MVTV2%5MEAD6,J?,(Y);/%<I^UG_P
M<<_!_P#8L^$?P_U_5+75O$&M_$.QBUM?#5I/%_:6F6<\>^-Y-V%VD@KP3R*
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MYP,"OTF$ZM%O# J!G- "3MM7);:!U-4/LUO<&:0[MLPZ;B"VWT%?-W_!0?\
MX*R?!?\ 8 \':HWC+Q=I@\66NE-JVG^&4FVW^LH#M"Q C;DG(Y(Z5^?VE_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@+\7/@;K5E\(=#N/"'CB-/M%GJ<M]).LKQ@D6Y5VVA9#A2_\/6ORH^#W@O\
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M ^M 'X(?\&[_ ,6?C?\ \$[?VV_$'[/OQ?T?Q?'X;O9SI]FL&ESWVFPZGN4
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MBNIE^%?QRVEF6/4]."_],U,<F:^:?^#PZ)1_P4H\+E5$B_\ "(6Q#^O[Y^:
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M0)<LN,=LYK^EG]EK_@A;^SC^Q/XYM?&/@KP6MOXFM;?R$N[JX>Z7<0,L$DR
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M.'[/TTFC>'?!-N+S6M._M I/IRJ<?:8I2V]F9F5=B]!DU^AW_!NA_P %)O\
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M9=P:;XK3DJWWH^)*_J3,<.FW&%V^7@AL_P )/0?C0!_,K_P79_X(.Q_\$RO
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M%8A0W'(K^?\ \>_\$._VX?\ @FC\6]+O?@U#XG\67FHZ6T;Z[X'5]EK&9/\
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M)<*WF3.7.[YY#\S=> 3Q7L54=*T^*PGF$>[+?,<^]7J "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:3=>#M1NKV\;4V=5=98E48V@\Y4T >H_\&]__*';X"_]B\__ *42U]8?$_\
MY)SK7_8/NO\ T2U>)?\ !+?]F?7/V+OV$OAI\+O$%YI]]K7@O2FT^^FM"QB,
MIE=QMS@XPPZU[=XWM)M7\*7UDLD,;7%K-"78_*N^,JOZF@#^93_@U6_Y3EZE
M_P!@+7O_ $8E?TZ^.O\ D1M9_P"O2?\ ]%FOQ\_X(N?\&_?Q5_X)R?\ !1:X
M^,'C+Q%X5U#0+S3=3LT@L'D,ZO<NI3.Y0.U?K_XJM;S4?"FI6JO;1SWL$D5O
MO)P2RD<T ?S$_P#!KA_RGCU+_L&>(_\ T*OW,_X. /\ E#5^T!_V*[?^CHJ^
M*?\ @CE_P;^?$_\ X)^?\%)[KXR>(_$/AB^T&\LM5MXK.V>0W0:Z/RD@J!@=
M^:_17_@IY^S?KG[87[!?Q(^%NCW6GVNL>,=(-BCS$A$RZ,#QS_#0!^4'_!DT
M\D7PU^.#11^=)_:FG+M+8&#')DUE_P#!XI^PK=7_ (J\'?&_3+F^OV\M=!O-
M.AM&:.SAC#R_:))!PJDG;S@>]?9?_!O5_P $B/'7_!)KPA\2M-\;ZQH>M3>+
MKJUN;4Z6SMY(B1QA]P')W#I7TE^V7^UU^SC\.[#4/AO\>_&O@G3(_%6F#[7H
M>O7&UK^U=L;67NI(_2@#Y=_X("?\%<O#7[5_[%-AI_CSQWH=K\1/!:BQU-;Y
MXM-B:$96V6/<55\1H 2N?>O5/^"MO_!6?P'^Q)^PSXH\3>&_'GAU?B%K%I):
M>'%L+B'5BE^5W()%1FVI@'EN*_.;]L#_ (- H_%$^F>(/@/XXL5TC6#)?7:Z
M^^(H8I3OB%OY:_<"MW[8J?\ X)S?\&C5]\-/VF=-\0_''6/#GB[P5IX6[M-.
MT[=+!J<H;_57 =1F(KG.WG.* /C7_@V4\4S>-O\ @MUX/UR_96U#6(]7O;M\
M;5>66)W8@=!EF/%?JG_P>%>';KQ#^P!X>ALM-U"[6S\1QWEU+!$\B6L0B<%V
MVC  ]^*_,?\ X-\]%M?#G_!P VFV-M:QV>EZGKUM:VH'$,2-*JJ@]%4 ?05_
M4!\4OA7HGQ<\*:QX<\66-KKGA77K5K:^L+Q=T,T;=4(_ND4 ?AU_P:R?\%:O
MAQ\-OAAIW[/'BCRO#]_#<WFH:7K%W<^7;WK2L9)$<MA8MH'!)^;-?IS^W!_P
M5*^%_P"R%^SS-XJ@UC2?%FL>:+;1M'T;4DOKK4;H@E(RL)9@"1C)!K\E?VQ_
M^#/SQSJ7Q\\0:A\(_%7AZU\!WS)/:0ZNSK<6[.2SQ($7;Y:9VKWV@5[1_P $
MO_\ @U(B_9L^*FG>//BIXPD?Q9X+UZ#4]#M]#<&RN8HP&S/YB[L[\CY>U 'Y
MS_\ !![QU-\4?^#@+PWXAOM/ET^Z\0:_JM^]G,#OM6E$SF,Y .5W8Y':OZ3O
M^"GEO':_\$X_CA'&7.WPCJ&[<>_DM7YN_L3?\&]/Q1_9._X*UQ_M :]XE\(7
MGA277M2U1HH'D-U#'<F4H!E<9^<"OU0_;#^$5]^T)^R7X[\":1=6\&H>+]$N
M=+M[F[)\M7E0J"Q'/>@#\(_^#)3_ ).-^.W_ &+.G?\ I5)7]$5['_IGF22"
M.#[@7KN8]#[8K\K_ /@WU_X(E_$#_@D1\:/B1J_C[Q!X;U6S\::1:6%B--=R
MPDBF:1L[@.Q%?JTVFPW3!V7<K$-M/<]C0!_*K_P5I^%OCG_@CY_P62_X6/X<
MU.;S]0U,>)=/U>33-]O')<-(9(!G*NR(3GG//2OWV_8>_P""R_P'_;;^'-W?
M^&_B%IUK>:$MM;ZI_;.W3&^T/%N;RUF9=ZY#<KP*[_\ X*!?\$X/AW_P4>^!
M5QX(\?6;.(W>?2]5B16O-%F; :6 MPK%1MR0>":_$+]H3_@S+^(W_"X=3C^&
MWCSPO)X-9@=._MR63[>ZX&XR;$VYW9Z=J /TZ_X*,?\ !Q!\!_V"-/UC28]<
MC\:>/K?2TO\ 3=*TX^=:7Y9L!&N8]R(<;CSTQ[UZ-_P26_;O\6?\%'/V=V^)
M&N_#F#P/X?OI/^)$T>KB\?45!82%@ "FUAC!ZYK\KOV,?^#,[4CXPU5OC=X\
ML?[%CA3^SAX7D+3/.'&Y9?-7&S;GISFOW3_9[_9S\*_LN_"O1?!?@G3+?0_#
M>AP>3;V-LFR+/\3X_O,<L?<F@#^8[_@MG\'/%G_!+7_@L0OQ:\-ZI=?VIK&I
M?\)AI^JR::3:Z;<2LX-OS\DA5<GKGGI7[G_L-_\ !9+X&?MQ?#$MI/Q%T^UU
MW1+>S&LOJRKIH:=D!?RQ*R[@6#?=Z5[-_P % _\ @GK\.?\ @HW\!-0\"_$#
M38YK>5&-AJ2(&NM'F(QY\!/ ?;D9(/!-?A]^TC_P9K^,$^)5P?A9X^\.MX-V
M@6CZ[*XOG?'S!O+3;][IB@#Z"_X.F/\ @K-HO@W]FN'X1?#?QCI]]KGCB)H=
M:@LU2_@N-)=2"/.4E4DWJ. =V*\P_P"#*_45_P"+VM%"3-_Q+U?(SL^__.O6
M/A;_ ,&F7@[X?_LC>)+.;6H?$'QB\1>&#IMO-J>&TO0]3+!OM%L54.I&" 3G
M@FO:O^#?/_@CYXZ_X)&ZU\28_'NN^'=4_P"$T%I]B&F.YR8MV[=N _O#I0!^
MH$ VQ*!C&.PQ3CTIL>-@P,#TI7^Z?I0!\S?\%?\ _E&5\</^Q,O?_0:_'K_@
MR3_Y*W\=O^P1IO\ Z.DK]L?V\?@SJG[2?[(?Q$\ :3<6=KJ7B[0+C2+2:X)$
M2S2#"YQSBOA7_@WH_P""*GQ'_P""2OCOXCW_ (\UWPUJB^,K"TM[,::\AV-$
M[.V[<!V;M0!1_P"#P;_E%Q;_ /8XV'_H$E=#_P &B#+_ ,.=-.#?=/B[6/\
MT..O6O\ @NU_P3Q\8?\ !3W]CV'X;^#=2T72]9_X2"VU5)-19A&88U8-]T$Y
MRU;/_!#+]@KQ-_P3/_80M?A3XRU+2=2\00Z[?:D9+!F,31SLA7&X Y^4T ?D
MS_P>A6+:C^U+\$&A5?)M_"][A#)L9U^U@GWK]D/^";OQH\"ZC^QC\(=&L?%7
MAN36IO"^GP+81ZO#)<K(L"Y0QAMVX8/;-<7_ ,%??^"17@__ (*E?!&\L+^Q
MAT_X@>'4)T#Q!L'VE,9?R"W/[IW(W #/%?G-_P $N_\ @V(^-'[#7[<WP_\
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M\6?\%9_"^L:]??"NW\'^";.9M/AU-=7%Q+)>#:6B,>T%0%.=W3M7YJ_LT_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:[9?OC^]3!I%L%1?)3$9RO\ LT 53IXEN5?S!^[!W!1MWGM6A$<QK]*3[.@
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M)W9]ZT*3:...G2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ^9';S6BMF5I&(9![?C0!J).LA;:V=O!IU58[>"S3=D*DC C)[]JM4 %%%%
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MH **** $9@@R:8;E 5^;[W3'>DO=QMV55W;OE(]C5*W(LXE@4-##:C!8CC%
M%AM:MU3=O.-VWIWZ5++>1PRA&;YB-W3M6=#=QR7:^1'((^2S!?E>K$D\I*>3
M&K-G#F3@@4 7@=PS14=O(LL>58/S@D=C4E !1110 4444 %%%% !1110 444
M4 %%%% !1110 UYU1]IZXS4+ZE#'=I"S'S).@Q1=7)@E4%3Y>,EAVJ%VF6%G
MCVR=\R<8% %X'-%164\5S:J\+*\;#@J<@U+0 4444 %%%% !1110 4444 %%
M%% !1110 $XJ&3488E5FD'SG:/<TZ9H]ZJQ 9LA:R]1M4M9H%MXK>6Z'S?O6
M*X3/)% &Q14=N28N6W$]?:I* "BBB@ H)P**CN)%BCRS!.<9/K0 D=Y'++L4
M_-C/3M3+;4H;O.QNAQR,5#'/(&D\Z-5;.$*<DBJMW?0P7#?:,JIP(FD&U W8
M9]S0!JRW"P[=Q^]TIZMN%9MI<SHO^EI"+CTC;=\OK5ZU.8?]89.3R: )****
M "HTN5DD*@_,O6G3?ZIOFV<?>]*HSW+%,0K&\V/W9D.W>>] %JYOX[1"SMT]
M.:&OHU6-MQ_>_=XZUEQWJO(J[5-XK 7!B^94/H?PJY//(8SY,:M*#P).* +D
M<@D7<O2G5%:R^8&!92Z_> /W34M !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 C,%')
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M'';-'%N_>*O&>I% $U%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4$X%%174WDIN^4)_$6/04 $=Y'))(H;YHSAL\5*#D5FM=6\\*ED%Q"_W73D8
M[Y-7++B#[JJO\&TYX[4 34444 %%%% !1110 4444 %%%% #6E5<Y8<<TVWN
M4NHE=#E6Z<52E:-+G=)"K7&<?)S@=LU+;7JO,T:/"TRG$B!ON4 7**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBD;[ISTQS0!"FHPR/(JN"8V"-[$U+
MYJ^9MS\W7%4;.&UAA9E6*-';>"#U([U+:(TLGF2[6YS&0>U %NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?M@>._\ @G[_ ,$Y_$GQ.\ W&EP>*M-U.SMT>^M1<Q%)9MIRN1V]Z\A^+?\
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MSTV#2?#6CVEUI7V;0CIY$[S,C\DG=\H%?K1;:S&UH6*LCH0IC/)!/05\4_\
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M&,\FN=^(/Q;\.?"+PH^M>*-7TWP_HMKA;F]OIUAM[<]!EV( R>!FO@/XZ?\
M!TU^RO\  KXHZ_X3O-4\4:S=>'[O['+>:3IBW=K<-M#;H9 ^'7G&1WS0!^CE
MKKD-[>R0Q[F:,9)Q4L=Z&N?)9620C*@]Q7YS?L\?\'0?[+O[07Q:TOPC8:SK
MGA^XU)FS?:W8K96<8VDC?*SX4\?G7Z ?#SQ]H_Q-T&VUWP[K%CK^AZHGFVM[
M9RK-!(O3Y'7@C(- '04444 %1+=HSR+G_5?>J6J,C1O>21.(=KC+?-\QQ[4
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M)\ZV=;G AR^\>HSQQ0!]UM<8;"J6RN[--%RQV_NV&XGOTKY._;9_X+5? /\
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M"\U3PSKUM8Z>^FZ<+-6@>WWNI&X\EN]>E?\ !RU)C_@C=\6TRN)+:W!R>?\
MCXCZ5\&_\&@'Q;\)? 7]COXT:QXP\2:7X=T./Q?8VYN]3N%MX5F:T.U=S$#)
MP?RH _=:QU.-)?L\AVW 4.4V_=!Z<TY=7VW<T4L+1[#\C$Y\P=S^%?FGXF_X
M.O/V5?"_Q$U3P[<7GBZ:XTN]:QDNK?2A);3$/LWQR;\,A/.?3FOO3X)_M/\
M@']HS2GOO WBC1?%%G;JANI-/NDG^R.Z[ECDVD[6(['TH [C^U_->/R8FFC9
MRKN#@1^]207ZW/\ JP67N?0UYW^U5^TIX;_9!_9_\0_$;Q?)?#PQX:M_ME^;
M6'S95CW*O"Y&>6'>O(_^"=7_  50^&/_  4Y\(^)]4^%LFMW%GX1NX;6]&J6
M?V5MTBEUV ,=W"F@#ZF$G(]3V]*IZEJT-JFVX7;D@)D9W'M38[R.[YW-#)(N
MU=XVL3]*^'_VEO\ @X"^ /[,7[7L?P3\5?\ "8+XX:^M=-4VVD^;;B2Y9%CR
M^\<9<9..* /MJZ@D1I+B.95NOL^U4;E0?7%?BK_P2@_X+-_M.?M0_P#!4^X^
M$?Q%T_2?^%=6]QJZAE\.M;RY@+^0?.)]0/K7[47=L-,C698S<R0+N);[P4>@
MKX;_ &//^"ZG[.O[8?[73?"7P/IOB&'Q\CWT9>XT)+>$M;;A+F4,3_"<<<T
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M>>G]HV<(0@[X<EEQQU]17YQ?\&55S;Z=\6OCA.N]G_LBP7&.WGR 9H ^IO\
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M4)&^.0/AE..#W% 'Z=3Z[;V]O'*S860A5XZGIBI9;X1)N93M'WC_ ':^.O\
M@GQ_P6N^"/\ P4WUC6+/X>ZA>1ZEHC!4L=6@%K>W*E=QECBW$LBX^9ATR*^M
M]\T@MWFDVJS<K'\R./<T 3W6MB-8_(B>X>1@ H^7CN>?2I+S6K>PE1)9-K2'
M:O!Y-<S\4/C9X3^"WAS^VO%VO:3X;T-76)[[4;A;>"-V.%4LQ RQZ#O7Y_\
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M]?%O[7__  <"_LV_L,SZ;9ZWXHF\237\DT3Q>&D34GLI8CAQ,%<>6=V>OH:
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M>'[/M]\4/B!)JZ^'["\@L9_[-M?M,LDD[[(\+D<9ZG/%>*?#G_@O)\ ?B/\
MLC>(OCH-3UK3?"'A>9[)X=0LQ;WM]<(H<QV\1;]ZVUL@ ]C0!]LV^I17:;HV
MW#)'I2O?*LXC W-WYZ#UK\J)_P#@[@_95AO_ +4C_$1MN 4&@_N@#[^9U_K7
MWQ^R7^UUX+_;K^!FF^/_ (;ZE;:EI.J*LK1.X6XM2PSY4Z GRY,<E3S0!ZXV
MJ1I.4;*\<'^]2/JRQH24.=VU #]\U66YBL[1HI&#R!>2?N@GMG]*^4/VU_\
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M>^)'Q?\ #/PA\,R:WXHUG3= T.W8+/?7\ZP00$G RS' R>!7P!\<_P#@Z?\
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M$#\*C;Q);^9;JA9VN/N\&OBC]L?_ (.%/V9_V+?$6DZ9K7BR3Q+=:K#-*/\
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M.[2V6695+%5+$9.WM7Y[^*O^#LK]E>UUJ>U:;XA--8S/%NM="$B2E&()SO\
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M+!_P1Q_:";+.R^'/,4L<[";B'IZ5]I3?<KXR_P"#@?\ Y0V_M!?]BQ_[<0T
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M)_X)K>/+#Q#!J%Y:Z+I<GB+3?LDVQIKF"%Y(6(P2RY/*]Z_"C_@Z T^VM/\
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M6,*>F"1P":^3?^#LJQL;_P#X) :I/-9P&^B\3:4D#E,SJAF;=CN!ZXXKF?\
M@S[L_._X)H>((899!!_PE=UEF7#EMD>1CTH ^;/^#TMQ9_$'X$?:(_M?F:?J
M:A!QRSQ@=?2N,_X(R_\ !NM??MW_  UT_P"(G[1VI>)&\$KIJ6OA;38K]HKJ
M.W!#)(LGS*(<%@$P.>:ZO_@]AMY$\>? ^29C'#'8WX1TY;.^/M7ZO?\ !&G3
M_P"V?^"5WP-6:9FAG\'VBL6&&;@\?_7H _&G_@O;_P &ZGPS_8*_95A^*WPK
MO]8T_3-'NX[75].UF\:]GNVFD"1-$X4*@7DD'.:\Z_X)4_L6_&;_ (+=_P#"
M"^&?'FKS6?[/_P &;2+2_(M"T,=^L9SY288A;DJYQ(5QCBOUD_X.JTQ_P1X\
M7VZ^7Y U33!(Y;YTQ.-N!7B'_!FC#Y/[!?CPPJLQ;Q@8Y79L;%^SITH I_MK
M?\&COP1TW]F;Q9J'PQUCQ)X?\3:99/J-K-K6I/>VJ+"IDE0QJH)+*I .>#7S
M7_P9J_M3>*M-_:)\:?!E9+%O!]U82>(7S!_I/VJ,I$,29X3;_#CK7[Y?M%Z:
MTWP,^($OVN8*WAR^$<94;8\6TF<>N:_G&_X,Z/\ E)UXL_[%.Y_]')0!_3O:
M6:0/M^9]I+@N<D$U9J./_7-]!4E 'P;_ ,'+!4_\$=/BP@V^<]M;[ 1U/GQ]
M*_F[_P""4_[ WQ#_ ."GOQ,OO@IX;\;?\(=HM] ^OW[WL<T^G2W%N J;TC('
MF;7X)Z#-?TB?\'+4RQ_\$;OBVK*WS6UOR!]W_2(Z^+?^#*/2M+N?V?/C=>1V
M\<EQ'XFM(X9VC'F+&;3YE!Z@$]J /3?#/_!GI^SA8_#JTAUR[\97_BA-.2*X
MNK;66BMY;L)\TBH4)$9;D+G(%?E1\"/BQ\1/^#>K_@K'>>")/%<;^$X-8CL=
M<FF@E_LZYLY#'NG,;'YI(XV(#\D'.*_JUETM[^Q;S_F>&0M$P;[H]*_G@_X/
M4;:VM?VE/@LMM##:_P!H>';Z:[D$85Y66Y0 D]SCUH _4;_@NCX]T7XO_P#!
M#;XQ>*/#]\NH:'K'A2*_T^YCR$N(GFA*L ><$'O7P]_P9'Q+)\$_CKD?\QS3
MC_Y DKZ'_;355_X-7=6$99D_X5=IVTD8)&Z"OGK_ (,B_P#DBGQT_P"PWIW_
M *(DH _<6\MDDD61E!> [E/H:_E;_P""W,Q7_@Y+5<+\WBOPYDXY'[RWK^JB
MY^[)]*_E3_X+=_\ *R='_P!C7X<_]&6] ']54L(BMY,%CM4D$FOY:_\ @W9.
MW_@XEO!_=N?$I_66OZE[K_43?[AK^6?_ (-VO^5B>]_Z^?$O\Y: /T/_ .#S
MB!5_X)[>!& P9/%ZLV.Y^SO7KW_!JI;K)_P1C\',T;RXUC5 %W?+_P ?!Y_"
MO(_^#SG_ )1Y> ?^QM7_ -)WKUK_ (-5(VOO^",'@^-.L6LZFV.S?Z030!\"
M_P#!U!_P5"U?Q5\6[?X$_#WQEYNDZ7"UIXLTZP25+LWX8@PR,,;XRA7*8(->
M]?L#?\&D_P $_$W[+GA?5/B_K'B37O&7B"TCU62;1=1?3[>."=%EAB,;*3O1
M6VL<X)%?!?Q5MEU;_@[$E6]ACDCN?BO%YD$B!DQ\O!!ZCZU_4E/I2R62JJQJ
MRD"-?N!5'0#'8"@#^8?_ (+._P#!!CQ)_P $D_"/BCXG?#OXAS+\/_$.I#0[
M71(%N&U..RF3+)<SC"R+E3G@ Y%>S_\ !D9;K<_%[X[*_P RG1=.X_[;R5^P
M?_!8.UL=1_X)I?&Y)88F,?A6]E5I8PR[Q&<%<]_<5^/_ /P9"_\ )8?CI_V!
M=/\ _1\E &'_ ,'M<Q3]JOX)GCYO"-X.1_T^5^V?['>E1C_@F'X#;=(WF?#R
MUSENF+$'BOQ*_P"#V_\ Y.I^"/\ V*5Y_P"EAK]OOV//^47_ ( _[)Y;?^D(
MH _DC_8U_9N^*'[8'[;NH>"_A;-=V&M:[>W=M?W-JYC6WL6EVSM( P+1!2"R
MCJ*_?+P/_P &A7[.,?PXTZ#7IO%UUXJAM0FH7D.KF.UGN-N#)'&4RJ%N0I.0
M.*_-7_@U6C63_@MGK/R^9(FA:ZR(?NL1(F,U_4#/9R7PM2T\EOM;?/&@W+)D
M?=)[8ZT ?R#_ +8_[(/Q<_X(+_MGVUS::A-"UJ\DWA[7K M;Q:G;[E)1EW;F
M0':C XW8-?U1_L(?&?6/C5^Q/\,O''B-K634O$OANUU&]\B+RXQ*\>YR!DX7
MVK\0?^#UQ/)^.GP/MY+J9E?0M0P-@P3]HCQ7[$?\$PM/G?\ X):?!Y96\EH_
M!ML5*?-D>10!^!?_  7:_P""A?B;_@J9_P %!;7X+^ ?%$=_\-;/5K;2=/-C
M!(L$L[RHCR3J.9#%(3@D# !Q7Z+?"/\ X,\OV=[;X8:'!XTO/&&I>,(+91J]
MY8ZRT%M=38^9HXRA**3V)-?G3_P;;6%G>_\ !>W4+.ZBAOK%HO$4X6:,,1(A
M8J<'H0>17]/HTYHXKJX@^6XG)"NQQM% '\FG_!9#_@DI\0O^"1]O8Z'/\0D\
M3>"OB-/+<&PTR*>WM[=;=_W N-QVNX##!]0:_5O_ (,QRT'[ /C>&3:LH\6.
M0N.<>2G>O4?^#L'2+!_^"/?B*ZGMXVNK?6]+6.8H"\8-P-VT]1FO,?\ @S,G
M@;]@?QZL <Q_\)?(48KV\A* /V&HHHH *Q[^-;V>:-24D^ZC/RJOV(%;%4Y%
MC%RTF5\Q3LRQQCZ4 ?S>_P#!UE^UU\0O&7[=UG\ 8/$/]G^!X[+2Y1;0;HUE
MGN@ [7&#B1 P# $<8KZV_9F_X-+?V:;CX)^&;?QMK'B/Q1XN^R+_ &SJVA:W
MY%C+<,2P"1;6*#:5X)[&O2/^"^O_  05L_\ @I1))X^^'LD>F_&33X(8(GF<
M0VNLQH J1RRDGR_+7<057)-?C?IVK?M\?\$>[SQQX-T&;QWI-C8W@O-9U'3K
M-]2TQVCB \Q+EXRNP*0,C X- 'WI_P %//\ @TO\-^!_@;;^(OV:FUZX\8Z%
M<M-/I>H7INI=73Y1&D!PJQNARQ9C@@5]M_\ !O\ >&_VE_!/[+?B+PW^TCH6
MI:;=^&+N"W\-_;Y%EO;ZT\IF<R2AVWX<@<XXP*_&K]D/_@ZK_:*^ /B#6+KQ
MU>6WQAM+ZTB6W@U:;[(NEON)+Q^2F6+9"D'H!7[??\$=?^"R/@W_ (*J?":&
M2&YM_"OQ$T<;-<\-E_XSEMUN7.^6,)MW/@8)Q0!^1'_!R?\ \%.O$W[6/[5$
M?P'^&WBI;CX?Z>(;>]L["*19I]28F.XMIB,>8D952%Q@$9!KZ:_8,_X,^OA]
MI/@R^NOCMXHO_&.I:PD%YI4GAZXETU;&$Q9>.4.&W/N(P1C&#7PI^PU FI?\
M'0B17$,=QGXC:F$AE0-'+CS^"#7]2R7GEVT5Q,LD:28A:"-,[2>!] * /YQ?
M^"R'_!O+KW_!-$Z;\:OV==6\0MX;\.,+BYA%S)/JFCR*.;GSAMRK%@@"C/)K
M]*O^"?W_  4!NOV^/^".GCC4_%%]'/\ $'2?!>JVFOPK9R6WV(BTF$60PY+(
MH8D$Y-?HMJEA#>62VMU!!-:YVO%*@DC=?1@>*\C_ &OM!L/"'[)?Q:72M)L[
M*WN/".J>>UM;K&2WV.7;PH&1[]J /Y(?^"5?[$WQ8_;M^/MQ\-?AKJEQINGZ
M_ EOXFOLL;2UTXO_ *RXC5@9(]X VC)R17]''['?_!MC^S;^Q;\2O#_CB#2M
M:\1>)M)M?+=]7OA>:=]H90#(L+)P0PRO.5XK\QO^#+M6L?VT?BBLDGR?\(C$
MY(Y _P!*7@GM7]'-C926FYKB2-()&R(R<JA[8/?- 'Y5?\'/W_!5+6/V._V?
M=/\ AK\.?$]EHWCSQBA6]18V%U%I[*P$D#@CRWWK@-G/M7RY_P $D/\ @UCT
M_P"./P6N?'7[2G_"1PZKXO(O=/TS3[\VMU:(Q+F:=\,LGFA@PQR,\UXO_P '
MCM\S?\%(/!WVBU!6'PM'A5)_>)YS]:\Y\'?\%#_^"EEOX.TNQTAOBR=(@M(H
M[#9X:8QQVZ(!'M;RN1L P>] 'W=_P48_X-'?A_H_[.%YJO[/4?BA?&VDDS-I
MVIZF;S^V(0I_T>(84+(S8PS''%+_ ,&MO_!3/Q-K^L>(/V>OBUXGCDUG099;
M?PQ870=]2EDA9Q<0O-DAEC" *.  .,U\067_  4=_P""FMLS'[5\8!N3.7\+
ME3N_V?W/)K>_X-W_ -F;XP^'/^"QW@_QEXZ\ ^-M)6Z.IW>H:GJ6CS6T)EEC
M=BS,RA069C^)H _3#_@YK_X*>W7[%G[)]EX1\$^(X_#?Q'\:R &TPWVJ#3F#
M(\T3K@(0X !!S[5\?_\ !(__ (-@=._:4^%UQ\0?VDIM<>;Q;&-0TVQT^[:U
MO;=7/F?:IY?F$@F5@P Y!SFN2_X/0+B*Y_;.^%D30+)++X0E9),G]W_I3<?2
MO O O_!17_@I)X?^'6AV'AZX^+']AVEE#;:>L'ADO#]FCC58MC>5\R[ ,'TH
M _0+]O3_ (-+OA:W[-USJG[/_P#PDY\?6A^UV]MJVHF\COXE#;H0NU0'8X 8
MG K!_P"#7S_@HCXLTKXJ^*_V:/B_XHA6XT%O*\/V5TK/??;%D83VXER1LC6,
M +P  <5\:VO_  4N_P""FSA8X;GXO1W$@W #PL>1_P!^:F_X(8?LR?&JU_X+
M._#WQMXX\!^.]/\ MVJ7=_J^K:AHTUO")98I&9W8J%&68_G0!_1/_P %*I8;
MW_@GU\89(Y%*_P#"(:C\S_=_U#=J_E"_X)&?L'?%/_@H7\=-1^'OP^U.XTGP
M_?11'Q?>JS?8X+$N2AN(U8&1"ZX &<,0:_JX_P""G%M!>?\ !.KXR0K(S^3X
M3U!MRCN('K\3_P#@RABC'[2?QGD2=H9(_#-B9HL#8R_:FP<_6@#[#\5?\&BO
M[-1^&>IV^A+XXC\5/9&WMKRXUHR6L-RT>!,8]F3&'Y*@YQQ7XL7&@_'+_@@U
M_P %"K;1[6[73?$UC/%M)C/V'Q!8ERL<CQ;OFC;E@K'((%?V#0S^7,TC;OE.
MP(HRK9[YK^9'_@[1LKC_ (>Z>'E:7/F>'],V=L'S'XH _H,_:)UNX\1_\$[?
M'6H7AC:^O? %[<S;1A0[Z>[' ],GI7X2?\&59W?MF_%]O^I/@/\ Y-K7[E_&
M$AO^"9GBYMS2'_A7%SER/O?\2UJ_#/\ X,J?^3R_C!_V)T'_ *5K0!^CW_!V
M%'(?^"/?BA8%5E&OZ277'W?W_6OQE_X(>_\ !'_QU_P5&O+=O$&KZU:_ ?PQ
MJ?VG5+6.Z=%U.Y "O!;X.(YBC [V4C Q7[*?\'949E_X)!^)D1S&S:_I+$=G
M G_I7G?_  9RB:U_X)S^*IY&,D/_  E<N% [>4G/UH YW]KS_@T1^#5]^S[K
MEO\ !N]\4Z)X]M(UNK%]:U1KZUGV@LT)C55R[XVJ2< G-?FS_P $1?V@?C1^
MP)_P5>\-_!6ZNIO#\?B#Q)'X=\3^'[HF1(7)^<JJMM68  ;^>*_JR@;RYF7S
M.,<._&">F/6OY<]8MXH?^#L6-6DDN)%^+@$SLN&W>@ ZCWH _:3_ (."?^"B
M\G_!/#]AO4K[P[KFDZ;\1/$0%IHMM=V[3&[0D+.R@8 9$;()(P<&OQ__ ."#
M7_!$_2O^"OUWXP^+GQF\1:]J6A07QM;B#[1+%J6H7;(KBX-PP(9-O!'7/>OH
MK_@]0N3#I7P2C52J1RZ@4V_,QRD>=P[5^DG_  0,T>.U_P""/WP#^SV]NB7G
MA6%K@HH1G;>_)Q]XX[F@#X(_;N_X-%/!-IX:L]9^ ?BJ[\&WWAV&XU'4CX@F
MEU+[:J1[XUAV!=CAE/)SU%?CS_P3TU#7M1_X*W?"&;Q1?7FH^()O&UD;^>]+
M-=-() OSLW). .O;%?V827WGVDEQ"DDB*?)6"5,9QP?J*_EI_:,M(;#_ (.K
MY(88XH-GQ2LP8(D"QPG$/"X[4 ?U2Q0)]J:?:/,;Y2<=A4-VTD]Q)";=GM]A
MR21\Q]JLQ=/^!&HB["6XDCAS+&<#).&XH _-W_@Z$_9)\/\ [0__  35U7Q#
MJD.H7'B#X:!M4\.V]K(57SY3'%)YB@'>NS/'&#S7F/\ P:&?M1^+OC9^P_XL
M\!ZY+IJ:9\*]4MM*T4P6WER""6.2:02-GYFWG@\8%?J1\6-+M_%/PM\1PWEJ
ME\+G39H_L;1^9N;8V,#OSBOYU?\ @VC^/GBG]EC_ (*L>+/A'XNUO_A"_"/B
MB/4;K4-'U';;?:=04A;7.\!A)M<A5!YSTH ^MO\ @\9\:>(-'_9E^$_AW0_$
M$VDV'B3Q-/9:G:6]P4-W$;<$&95/SQ[L$ CJ*^7?^#?SX5^(OV!O^"Y%U\&]
M6\9+>Z._A:ZO;K['*]K8ZA,]I%)$6C8_-(GF;03SG.*[[_@IUX=\&_M;?\'.
MGP:\"W]SI_C+P/-!9V&HZ9'?&2W6XCCN&>-]C?*X*KD<'BD_X.+_ (+^"?V6
M?^"KG[-/BS0[6'PW>>*M0M;C6M0CN&C#1VUW;Q+O). HC&#T&!S0!^OG_!4/
M]H[7?V2_^"=GQ8^(GA>.W?7O!N@->V#W<7G1E_,1,.N1NX8U^/'_  :!?LP:
M#\9/C;\3?CIK4.IQ^,M!NS;Z:T4AAM2E\KFXRF,/STP>*]^_X.Q?VV;KPW^Q
MMX+\,^ ?&VCA?B-J#6^M6%E=Q3-JFDO#NB8CDB,R*"&'4CK7V5_P0Q_9(UO]
MD?\ X)P?#OPWXNL]'M/$$,,EW*^FS"=)4G<RQ[G &3M8=>G2@#\N_P#@JK_P
M3K_;4_X*F?\ !0V;0O$.BWFA?"+3]=?3="UG &FV%F-VR\EB60L[X."P 8Y%
M?6?AG_@T6_99C\.6-OJ%O\0FU3[.GVNXCU_;'-*%&]E&S(5FR0#T!K?_ ."S
M/_!QSX7_ .";_C2Q\$^ ])TGXB?$*2<C4[2YN6BLM.BP1AIH]V)@P *$ @'-
M?E"__!3;_@ISXTU2\U736^*=MIMY*UU;P1>'"T*0N2RHC>3EE"D 'N,4 7O^
M#B#_ ((??#W_ ()L^%_#/C;X6^(MOAV]F&CW6BWUW]LU)+G#.92XP NT 8(S
MFOVR_P""!G[4WB[]L/\ X)E^"_&/C"33;R\C,FCP)8VWV=4BM"(4W DY;:HR
M>YK^9C]KWX _M&ZG\,M2^.WQ;LM8TVU\4^)&L9EUJ22"\FNVC\PLMLZ@"/:/
MO#OQ7]#_ /P:N1/#_P $>_!<<C1F-M7U)F(;Y5/V@XP?>@#\S?\ @]3_ .3Y
M/AG_ -B>W_I2]?T(_L??\FH_#'_L4-(_](X:_GN_X/4_^3Y/AG_V)[?^E+U_
M0C^Q]_R:C\,?^Q0TC_TCAH _FB_:'_Y6Q]0_[*S:?^@Q5_5):_ZL_P"\:_E;
M_:'_ .5L?4/^RLVG_H,5?U26O^K/^\: )**** "O#/\ @H+XM^)G@3]CWQY?
M?!O28=5^)-O8EM&LWB619I6=5/RDJ#\I8]1TKW.N1^*/C[1_ G@?5M<\0:I:
M^']#TF$S7E]=2+%'$@[DM@8)P!SR30!_/Q_P3N_X-K?BE^U]^T;XJ\?_ +72
M^(M)L)B^;'[88]3UF61,I-'."X6.(C:5;DY&.E?:NI_\&D?[(^G:1<731>/T
MDC4MOF\1A4A]"Q*8ZU\@?M[?\'._Q<_:A\?>)/AC^R[X7U);>UO4GTGQ+IT$
MDVL3PP?ZY3:[60(S<;@3P >]?*GQ1_;$_P""C_[0WPZU;P7XHC^,&I>'O$$
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M++1X/#FK-'*S3?8Y/F(PI&TU_,;_ ,&SP9O^"]M\\RJSQ6?B,,6^[DDXY]:
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M3>,9_$G[/_Q2\56MQXB\/S-#X:LKU'EU&<0E_M,;S9(81;0H!P !QFOA<_\
M!23_ (*<VEI(//\ C MPS[LIX6+*WX^36_\ \&ZO[,7Q@\+?\%?/"_B7Q=X$
M\:Z-#J%OJEUJ&I:II$UK"\TD;,2690H)8GB@#ZY_X/)?V/?#>I_![P3\9(8=
M8;QA;Z@N@.PF+VL%F5>4YC X.[^+-?=W_!O;^U+XE_;(_P""7W@WQ=XM:S>_
MM9)]$C%O#Y:"&S(AB)&3SM49/<UWW_!9'P-<_$#_ ()A_&G2=-TB77-;NO#=
MS'IUM!;?:)Y)R!C8H!.[Z<U^6?\ P9^_M7ZYX=TGXC_"WQ=XLAL=#\*XNM+T
M2^>.!K>9GD:Z*@X8D%<MG[N.U &;_P '2'@GQ!^U[_P4K^ 7P3T7Q6UCIOB[
M3EAFB,S265K<M=.HFDA4_>"_CBMG_@T2U'7O ?QQ_:"^&.I>)GN].\(3+865
MGYS):K-'=2QRS11$\%]F3@9Z9K _8(\%>!OVN/\ @Y^^.&O:E]E\:V/AZXN=
M<\.SQ7;36MO<1F$1R0NK8*C)Z<9SQ4>K^#? _P"Q%_P=?>';'2&TWP+X4U"P
MCU34(C?&.TDN[NWD=W=G;&YY&S@\9/% 'W-_P<W_ +3WB;]ES_@F#K$OAB.Q
M\SQ1?Q^&;Z6]A$[/97"/YA3D;6X&#VKQ7_@SU_9$\._#7]C35/BQ#::M;^,_
M&^HW.D:C]HE/V=K2VD#0&.,@8)WG+9.:\-_X.K?BQX@_:;_:S^$/[/7P[\5:
M;J<'BHH+[1OM2"&WU0W!2$3L,M$VQ@<'L<XK]K?V1_AF/@_^SSX!\(WUK9VN
MK>&-#L[*Z6SP;<7$<*))M8 !OF4\XYH ]5J.Y_U#5)4=S_J&H _E5_X*7_\
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M@P?Z0;E2D0(?/";?X<=:_?#X^6Z0?!'QQ(JA6F\/WX;CKBVDK^<O_@SC*O\
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MA["RZ/K-YKUIHVN:3=IYEG=0SRI$)O*#;=_EMN1B25W5_1S_ ,%DO^"A-O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0R&YDA0[(&5CL59,*I;&5'-?D!HW_!KY^WAIFC1V<-YH%M8JN(HHO&I41#V
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MOVCO WP7^&.N^,O%?B;2=!\/^&;9KB_O)+@,EO&N,L0N3C)'0&OQI_X*F?\
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M"ZU6P:-FY\L"&3(_&OT%_P""^]\R_P#!(/X^JT4ZHOAB1A*C *?WL?%?*_\
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M;3&...3 ;;B0*<X/4"O(/^"K7_!&;X=_\%5/AK::;KW_ !3WB;2W5M/\0VL
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M/XT:\FG_ !,\1(\>F#3Y4OH=*9'WK,)LC>TH^5@P^7K7T-_P;Q?\$X_VBO\
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MX_'7:IA\SQ/I[(,^EH]6O^#U>XC7]F+X)PR88#Q3>&4@<J/LG45[Y_P;<_\
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M&M=T:S?\)>3T^4_Z.E?87_!<']C/QM^WM_P3W\1?"_X?PV4WB'4;ZSNXS?7
MMHOW<H<_,017F?\ P;P?\$WOBA_P3B_98\6>"_BO:Z/;ZMKFNF_@?3;U;M0A
MB5>64#'(- 'VQ^T3N7X"_$"9H9F9?#E\  PVG_1I.@K^<W_@SREAN/\ @ICX
MFVQM"G_"(W*9)&6/G)7](GQ=\'ZCXP^$/B;1[-U^UZAI%W96ZD@+(\D+H@8]
MADCFOQ[_ .#>G_@AG\;/^"<?[8&N^.?B=I?AVVTZ^TB6TM_[.U87;*6=6&0
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MK_@K-<?&;QAIOA<>"[F?6&+6^KI-< 7)?ROW87/\0SZ4 >@_\'GSM'_P3]\
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M@\\9S7SS=_ 7PW^R[_P<J:7X \(6?V'PSX5^)5C96$(8L(XP(FZDD]23U[T
M?UMQ=/\ @1JR!BJL;;4W'IN/-6J (_LL8;=L7=ZXK^:'_@NC^SM_PQ)_P7@\
M!?%CQ%X@TMO#OQ%\0VGB(D1./[$M[::&*3SC_$>"V5[5_3%7YO\ _!PU_P $
MFM2_X*5_L]V?_"!^'M*N_BOI-]!%I=]?7QMHHK LS7"%CE02=G49XH ^*?\
M@WAM_!/[0'_!9_\ :>\<6NFZ;XDM[0'6O#NH/$'V&6^91/ 6&4+(>O!P:^DO
M^#NSX=>&]8_X):7GBRYT?3[CQ1H_B/2[6UOY(0US9Q2R,7C1^H5L#('7%=O_
M ,&\O_!'[5O^"9GP7U>Y^(NAZ7:?$[Q!<R6EU=Z=?F\CDLU97B4L,*,-N/2O
MJO\ X**?L:Z'^V[^R-XI^'VO:';ZXU[:23Z9%+.T21ZBB/\ 97+#LLA!R>*
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MG_8^U7]I3_@G&NO:3JUGIL7PIN9/$,UK-"\D^IIY?E>5$5X5LMG+<8%?-_\
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M\/\ Q"\0:?I_@RZN%_M>\M_%7VZ:VMSPS+"W$A']T]: /C?]H7]LS6?V[/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 4Y;MI?.C:!VVG 7_GH/45X3_P %"/VY--_X)U_LSZ_\6M<T/4O$NAZ&
M8(FL-.D2.XR[A.KD+P37O$BSAY9%C5G48C4M]_ZGM7G?[3?[)G@_]L#X+ZEX
M"\>:>=6\,ZNT<ES9B1H]S(P8?,I!ZB@#^:G_ (*7_P#!3BZ_X.!?VN_A1\._
MAS'XH\"^']:N(],GT_7+A;BS%Z\IVW+)#GA5./6OZ2OV+?V>-$_9&_9Q\)^
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M-7N"6$8M\YVBW?&-V,8&*_I K%T;P=;^%=(CL-+M;*QM4<L(K>W2&-<G/"*
M/QK:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BH;VX:VBW*NXYQC.*@MM3%[;R.&$?EDH<_PD4 7:*HVF
MI-<P!FW1MZ;<U)]K_P!MO^^* +5%4K75/M%NTO\ "@)8?Q+CVI-*OY-3A63_
M %:L=R@]67^E %ZBBB@ HHJM<WC)<^2J_,4+!CTH LT552^$=PJR2(/,'R#(
M^8CK1]M#<AFQ_N4 6J*JM>[5)W,<=MO6H?MEQ=6<<T2A793^Z;^= &A152WE
MFNA%\ZHT9_>*/FW>V:MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 444C-L7/I0 M%5)M36&9E++\H!(/;/2I+2X:4LL@
M5'[+GM0!/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !115
M=KMH[J164^6B!LCO0!8HK-@OIKQ&D1MN.5C88+4Q[BYN)687 MU6,%DV[@I^
MM &K15.RN[B:XVR1HJ*.2'!S5R@ HHHH **** "BH9;I()=K.HR,@9YJK%J+
MW,9=&5?WF K?+D>E &A10IRHSQ10 4444 %%%% !1156>>1+DC<JJ$) SRWO
MB@"U15.TU1)K==S[78[1N&,FK@Z4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5[L*7&Y<A5+
M9/W1BOG/_@JM'\0O^'=_Q2B^#Z:U_P +(N-*W:)_8@_TS[098^8_]K;NKZ4(
MR*145>B@=N!0!_+&VN?\%;L]?VCDQQA4XI/[<_X*W?\ /3]I#_OG_P"M7]2#
M7F;BX53ODBQA2,8X_6LO6]1L/#NCSZMJ%Y#:VNGH;J22:<10QGU9R0 /KQ0!
M_*K\<_VD?^"EW[,GPZOO&7Q$\2?'KP;H*RQ6\NHWKB*W5W.U%=B.I/ K]K/^
M#9+XF_&KXQ?L)7GBCXW:MXHUS5=8UAI]#U#6VW276GM&I1HCWC+9Q7Y_:9JO
MQH_X.5?^"A\WE7\'A7X,?!O78VFL3(L\+-#,'59$! N!*83@D$(&K^@WPSI%
MGX8TJWTZQM+*QL;51'!#;0K!#$!T5$4  >P% &I1110 57OBI*K^[+MQANXJ
MQ4=PH)4XYSUH _''_@[,_;/^*'[&/@'X/W?PO\8ZQX-NM9U&^BN9]+F\J1PD
M:$#I[FOS4^%WQP_X*E?&[X?Z7XL\'ZY^T)X@\,ZY#]HT_4;0B2&[CR1N5L<C
M((_"OMK_ (/<3M^&WP+_ .PKJ/\ Z*CK]'?^" ++_P .;/V?OF7_ )%D?^CY
MJ /PG&M_\%;L_P"L_:0_[Y_^M571_P#@KO\ MY?\$L?C=INM?&B;QUJT>KZ;
M,MAHGCEF%M,"P7S@JX.588!SWK^J0E2/O+7Q/_P7,_9@^&?[1W[ ?CRX^(5I
M8B3PCI<^HZ3<27"V]P+J*-WB193AB"W\ .&]* .X_P""2W_!0&P_X*7_ +(.
MB?$RQTV;07ENI=/O[4C:LEY$%\XIR?W99OESS7U)7\[?_!F+XVO9OCG\9+&S
MDU&318?#MD\&FRWKO!#,;E@\JH3M5F&,D#)Q7] 4NLV^BW<_G3+:PVT+2/YT
MFU, 9+%SPH'K0!T5%?E/^W]_P=0?!7]E.\_LSP7#<?$;Q/I.IRV&JV$3M:Q6
MWEC&Y92"L@+<97ZUY1^S'_P>-_#'XC?&-=)\?>!]3^'OAV2TEE;6OM;7_ERA
M043R57/S'C/;% '[7T5P?[/WQZ\+_M.?"_1?&'A'6;?6M"UBU2[MKB$@95AD
M;USE6P>5/(KQ7_@J9^WS!_P3*_9%U;XER>'[CQ-:Z3J-K9?8%NO)><W$FW<'
MP<!?2@#ZFHK\P_V4?^#F;X.?%3]EN7XC?$P-\.;6XUU]$MK&.8ZA<R,L8DW%
M4&Y5Q_$1C(ZU\RC_ (//_#UE\1%T>3X0WD>@KJ'V<ZE_; 8F R;1-MV9^[\V
MWKVH _=:BOE7X7_\%@_@/\;/V6_$WQ>TGQHL7@GP?*UOJMU<V[02>8JARD:-
MAI&P0<+DU^97B3_@]<T/3-9U*WLO@S>WEC:W,D%I<?VN%^V1*Q59,;/ERH!Q
MVS0!^[]%?$/_  2__P""W_P@_P""G-AIGA_PO=7FG^/I-(_M/5M!EB=AIH#;
M643D!7QD=/6OLO[3&\:QK))YDA*AMI_AH TZ*^*?^"C7_!:OX0_\$YIWT;7O
M$T=]XTN+&2^T[0K>,RFZ93M$,LJY$+,W]_! YK\Z=+_X/4M/F\26ME-\$;RU
MMVN-ES(-<$FQ2<,P^3G R<#TH _>RBOFS]A3_@I]\'/^"CNAZA<?#'Q3_:7]
MAR)%>VMQ$UM<*Y0.=J/AG4 X+ 8KTS]H_P")?B3X4?!K7?$?A+PS_P )?X@T
MRV,UIHYO%M1>[>6!D;A<+D\^F* /1Z*_.7_@DS_P<!>#?^"FWQ:U;P%>^&[K
MP;\1=)$LEOI7V@W,=U;1?Z^7S  HV,0,'DYK] M4>::WW6+;IH3YFTGA\\8S
M0!L45^>O_!5#_@N!'_P3G^/_ ,.?AOH'@NW^(/B#XAJT210ZS' UE<&5(HXY
M!@[=Q<'G'%?:WPO\8:]XC\ Z7?\ B331X=UF\M$:\L/,$PL+C&7CWCA@/4<&
M@#M**_-W_@I?_P ''7P7_8.NM8\,:7>-XY^(&CW,$4NBVCE(65^687(!3Y0>
M1^%?*OPB_P"#RSPKXE^*NBZ+XR^&-]X:\/7MV([O4X]1^TMI\.#^\V*F9,>@
M]: /W,HKQG]DS]M7X?\ [;OP@@\9?#GQ%#K>CW#M&QV;)XB&*X>,_,F<<$@9
MZUZK',[!8X_W;+UR=WR_6@#1ILK^7&S;6;:,X'4U\I_\%"O^"M_P9_X)WP6M
ME\1O$#6^KZI;S36.GVB---))$FY5?9DQAS@ L,<U^;OPP_X/1_"'C;XE:+I?
MB;X4WWAGP_?7"PZGJJZI]H.GPD_-((U3+X]!0!WW_!VE^VO\4/V.O"GPCNOA
MGXSUSP5<:W=WB7\FG3^4UR%1"@/!SM)-?=7_  1A^)GB3XW?\$S/@GXP\7ZU
M<^)/$VO>&UN-0U2[??<7<AED!9F[\ ?E7XT?\'2W[:WPR_;^_9T^!_BKX:^)
MH=>TRWU/4HV5T\F==JQJ=T;?,O3@D<U^O/\ P0,(C_X)"_L^K"G[A_"B-N+<
M@^=+QB@#[&HHJCJEVD,JKEA(JF3@'!4=: +U%>1_M0?M9>!/V/?A9J7C[XCZ
MQ'H/AO3XE9I_,W2S9(&V.('<[#(R%!.*_)?X\_\ !Y=X)^'7Q;U;0O!/PQU'
MQGX7L90+'66U(VIOEP#N\MD)7!)&#Z4 ?N)17YD_\$\O^#FOX*_MP7NA^&M:
MDD\!>/?$6HR65MH]TQ>%0J[ED:X("+NP>#TQ[U^DDL4.I:2LV]Y5.)E*/C?C
MD8]C^M &E17Y=_\ !63_ (.([7_@F+^U%IOP[NOAS=>+)M2TVVU#[9'J0MEB
M$K%=FW:<D8ZUN?\ !0O_ (.4OA'^P[X=FTJ&SO/$WQ,M(]/GF\- /;JD=S&L
MA;[05*G8K X[T ?I117X:_!S_@\X\(^/OB_H.D^+?A?>^$/"^H78M]2UA=2^
MU&QBP<R>6J9;!QP/6OVE\ >.]#^+/@BRUS0]4M]5TG4(8[JWNK:4,CJ5#+RI
M(R >1U!X- '2T5SMSXIMM,-S>:C?V]C9V*&:2:X80PH@_B9VP /J:_*7]MW_
M (.V?@[^SSXFLM-^'^EWGQ/OH;BYM=2=';3X[!XVVC!92) 2#R..,T ?KY17
MXP_LB?\ !WQ\,?BIXRO],^)GA.^^'>EK9-=)J0N6OOM,V0/+"(H*Y'.?:OUP
M^&WQ3TGXI^$M/\0:#J%OJ6C:K:PW-O+ PD 1U#+DC^+!&1U!ZT ==17QQ_P5
M^_X*FM_P2R_9VA\<R>$9?%"SZQ'I45NEV(22ZLP?.#Z=*^9+[_@Y[^']G_P3
MDTWXR:EX;:/Q3K6IW6GV'A"'4A)<RM ZAG=U&44AMPW+@XQ0!^L5%?@7'_P>
MTV5Q %G^!UXL++M9EUM<Y_[XK]<OV!OV]O!/_!0WX$Z/XS\%ZM:M#<1!+[33
M*#<V4JJ-Z$?>P&. V,-CB@#Z"JC=W1@U.%?W^).!C[E1V+R)<;HE+6L@SN8\
MK4T$#3!O,8'YB<CT[4 >>_M6?%2\^#O[/'C+QGID5NVI^&=#O-1ABN,X8Q1,
M^#C_ ':_+3_@WQ_X*]?$S_@J=^VQ\5;KQI-_9WAO0/!UG)9Z!9NWV(3_ &O:
MUQM;)\QE."<]J]1_X.(_^"N<'_!/SPM'\-9/"+>(?^%N>&=0A6\%X(OL61Y&
M<$'/W\]NE?B%_P $1O\ @K9;?\$EOBEX\\17'@>;Q@GB;2(M,=8[X6WV9$G$
M@;D'=TQQ0!_7?'&]HJ7+0.TDC!62(=<\ GZ5K5\]_P#!-']N:W_X*"_L>^&?
MBE#I+Z'_ ,) )/\ 0&D\PP[)&3[V!GI7B/\ P4J_X+U?!7_@GG/K>AZMJ,GB
M#XA:/I_]HV&A698I=R%MHADF7*QMU)#=,=* /O*BOP;T#_@]BT/4/%%C!>?!
M>\LM-N+F**ZNO[9#FVC9@'D"[,G:"3@=<5^LW[$'_!13X8_\%#O"5WXB^%WB
MB/5M/L9#;3VT\!M[B.08);8^&*\@;L8S0![]14<!+,S;LCTQTJ2@"GJ=G$^)
MC&C3+]UCU4=Z_G8^*G_!2OX[:9_P<DR?"VU^*7BMOAZOQ(ATV/1#=?Z$MN=G
MR!<?=Y-?T3WCSRR.D>V/;@JQYW#OQ7\LWQJFM;#_ (.O-4O)[BVL[.Q^*L,U
MQ/<3+#%"@$>22Q  H _JCCSL7/7'-.K\D_VYO^#MGX.?LWW]O8?#W1KOXFZG
M;:C=:?JT,<C6:6!A;9N#LI$@9@<$<<9K4_X)X?\ !U+\%_VMO$#:+XVLKKX9
M^)M6U2*PTFRG=KN&^#J/WK3 !8E#?+\WUH _5BBLFVU6.XTC[;'=0LLRAXI4
MD$D<B=05(X.1W%<K\5_C9X:_9_\ A1K/CCQ1JD.AZ+8VSWEW/<R#Y BDD(I/
MS-@<*.30!Z!17XI_M0?\'C'PN^&_Q>CTGP!X)U+XB>'Q:12_VS]J;3]TI!WQ
M^2RD_+@<]\UZ9^P9_P '6'P4_:>N9+#QU;W7PW\1:EJ4&GZ592,UW'=^9\NY
MI0 L8#8&6]<T ?K!7X;_ /!VM^WG\8OV./C'\'[7X8^/_$/@J'6M*O9+O^RK
MCRC.5F11NX.>"17[30:Y:Z[/:FWN%NH+J)70P2;DP>0P=>&!]17\_?\ P>FZ
MFS?&GX&^8%MV_L/4@X8;\?OXP* /VF_X)I>,M2^+G["7PD\1>)+^?7-:U3PW
M:7=W?73;YIYV3+,Q]37T !@5\S_\$D;8/_P33^!C?ZM8_"5BX8G[Y\NN>_X*
M'_\ !87X*_\ !/&2/2_B!X@9-?OK*>]L-.LT::266%<I'(4SY>]MHRV.#F@#
MZYHK\#YO^#V_3S(&7X&WA^7Y_P#B>+Q_XY7ZC?\ !/G_ (*W?"/_ (*56#O\
M.O$BMJ>EV\;ZEIEU"894D=,E8R^#(%(()4'I0!]545Y+^VU^TDO[(7[)?C_X
MG3::^N)X)T:74VL$D\IKO9CY0W.,YZXKY3_X(H?\%OH?^"OMUXXBM? LW@M?
M!*V[-YM^+G[5YQ8>@QC;0!^@U%8>JZS:V.GWUQ=7<-C;V*%9KFXD$<42]2Q9
MB  /4U^6_P"R#_P<WZ#^T_\ M[1?!>\\!Q>';*;5+[2E\0S:Y&T#_96=5<+@
M#]YL&.>=PZT ?K)167;7D>JAO+9UVN#N/ >OS/\ ^"E__!QI:?\ !.[]O&W^
M"+?#FX\1236^G7 U$:D(5?[6<;=I4_<^O- 'ZB455T74?[7T>TNMNS[5"DNW
M.=NY0<?K4UR T#;OYXH DHKC_C+\8?#?P!^&6K^+/%NK6VBZ+HEN]S<7,\@4
M;54L0H)^9L X4<FOR!_:=_X/%?AK\-OBG_9/PZ\%WWQ,T&:UC<ZN;HZ;B0YW
M1>6ZD_+@?-WS0!^UU%?B=^RS_P 'C/PQ^)7Q7M=/^(?@?4/AYX<2UF9]7%ZV
MH>7*,;(_*5<G<<_-VQ7ZY_ [XY^%?VDOA?H_C/P3K,&L:#K\"W-O/$^XE6&0
MK+G*-ZJ>10!WU%?G7_P6R_X+AV__  22\4^"-)NO -QXR'C"">[WQ:F+7[.8
M64 '@]=U9_Q\_P"#D+X1_LY_LR^%_%GB.VO(_B'XS\)0>*-&\*('9;@2G"Q&
MX V+T;D^E 'Z245^"7A__@]/T6Z\3:;8ZI\%]0T^SDNXX[FZ&MB3[-$S@.^T
M)EMJDG'?%?M-^SY^T?X2_:G^$^C^.O ^NV^L>&M:M5N;1XR/-4-T$B9W(V/X
M6 - 'H]%<CXV^(&F_";P-?Z]XJU6TT_2=.ADNKF[FD6%(T0%L<D9; P!U)XK
M\D/VO/\ @\*^$/PL\;64/PT\+ZC\2])N+(M<WQG;3?LTNXCRMCJ2>.=P]: /
MV=HK\%M'_P"#U+1I-7LM/U#X)WUC83S1B>Y77!(8(V89?A,G R<>U?K3^P__
M ,%%OA9_P4;\!:MXB^%>N76LZ3X=O%L[V62U>W:&<H'"X;EOE/6@#Z HK/DE
M-E&9VF"V@4L^X8V^I)[#^5?FG_P4:_X.8O@C^PU)KWAWPJUQ\0_'F@ZK'87V
MF6\K1V\65W-(MQ@HX4%> ><^U 'Z>45^"^A?\'K%CJ]_;0W'P1NX8)I%CEF&
MMJ?*&?F?&SMUQ7[$?LD_M8^$_P!M+X-:3XX\%ZE#JVC:K:[XY%E"2(3G*R1_
M>0Y!'S $@9H ]@HKFM<US2O VAZAK.MW\6FV=G;;[B>><1PPQKSRQ(&?YU^2
MW[97_!W?\(?V?_&]C8_#3P_J'Q4AN%E&I3^<VGKI\L;[ @#J=X89.1QQ0!^Q
MU%?CC^R=_P '>/PM^,GB'58OB-HMU\+]-^S(-,N<MJ/VFY+@,A5%!4!><GBO
MUL\(^+]+^*?@_2]:T75K/4M-U"%+B"XMI5=)E(!'*DCZCM0!T5%4)Y&$,ZQ-
MY-P1\NX[OTJW:/YENISNXY/J: )**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH S=6TR34I>)?)92-I0\LO<'ZU^('_!W/\
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MPXORS2-X:T[Y>BC]X]?TB?L]6DB_ /P;%]ED"_V/9D;I=[#]RG?T]J /S/\
M^"R?_!O;\"_$?[$GB;6_@S\+[+PSX^\)VCZKIMIX9M,R>().%%M(&))3DMA<
M'(KYE_X-(/\ @H)J'ASXD>(/V;?%VH>)[B:X\V\\/:?,%^R:,+<.]TGJI9NW
M/(K]^+LQ_9IUD52T:,.!@ 8]*_E\_P"#=:-M)_X.![RXFY5I/$HR&W8R9.U
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M5O'OAVX^(&K^,M%LI;O3_$5LACT.Y\L/*(]F"&W,5.[/W:^9_P#@XW_X(6>
M?@_^SA8?$KX%^!WT"Z\*@66JZ;X?MOW+6Q+R/=SY)(V  9'&*_>"%YCI_"^3
M(IR-QW9%?.__  5F8G_@G'\:V6 ^7)X/ORTH?:,^6>W>@#X?_P"#4[_@H8/V
MN?V8-4^%OBG5/$GB;QE\-Q]IDO-1"M!%8R.([:&)AS\@0C!' Q7Q[_P<P_MC
M:]^VO_P4'\&_LO\ @?6M:TVPT>_CT36K"](CT_4-3DE5H)^,DA4DVYX[\5H?
M\&5&E)<?&?XWR(S1V\F@Z>'(?YI"+B3IW%?%O_!:+P7K_P 2/^"ZWQ.TSPC]
MK_X2#5?%,%OI@BN#%,9FBA"E7R"ASWXQ0!^ZG[%?_!MU^SS^S_\  +0=&\=?
M#_P_\1?&R,;K4-6U:WWNKNJ[H%*D?N4((7(SSS7@/_!<G_@V_P#A;K?[/%YX
MX^!_AWP[\-/$'@FPFOKRRLT,-IJ5N@,DKL?F8RA5 7&!R<U^>DO_  1H_P""
MC-M;E7?XA>3<']RP\<2LR]^?WV:2+_@BA_P4)\2:+=6]\OCRXM[J-H_](\9R
M2QR(1AD9#+@AO>@#])/^#4+_ (*&WG[0GP'U/X1^(M7US6O&_@&$7ZWE^5-N
MFENRQ06T;#GY"#QCH>M?-'_![-=QGXR? U6CB9)=&U AUY;B>/BO<?\ @U^_
MX)-_'/\ X)]?'OXJ:U\5/"Z>';/Q%X=MK+3KDW<=QYLJW(<KA22/EKQ'_@]=
M:6X^+?P/ME,)631K]Q\H5DQ/'GF@#],OV7?VD-/_ &1_^"(?@?XG^(+?4+C0
M?!OP^M+N:UME#2$!57< <=V'>OPC_P""9/[+/BG_ (+A_P#!4;5_$OQ(OO%^
MM>#H[J:]UC7'C638J'?:V<S$8"R(OEXZXSBOUR^/ER\G_!JQJ,-I&TK#X4VB
MO(S?*/FB]:^:_P#@R;MK@>$OC<SP&2.2^L<R%^$(CD_A[T ?I ?^""7['RV^
MU?@#\.VC89\UK1]R^X^:OP"_;]^"/BK_ ((0?\%0M+O/A_>>-O#_ (+74(;O
M2M6,21-=6KNKW=M 0-K*%)CQZ8YK^K>_D"PKE?,BC^60KQM]_>OP/_X/7;F:
M#4/@;M543RM0"EAN)R8Z /V8^%_B;P=_P4@_8QTS6+O2I[GP3\3M$5Y-.U&,
M>8]M)_!*H.,\<@&OP%_X(/Z)\1OV0/\ @O5K7PDN(-8\%^']>NM3EOO#\Z>2
MEY;1^:]F[+UVA<,ISTK]I_\ @BEI"W/_  22^!<)N9<77@ZV#L&.X$[N<]J_
M%;_@X[^&OCK]G7_@LSX=^,5Q+?\ AOPKK#Z3%9:I9WYCFGCM1&+D?(0V-N<@
M]0<<T ?M1_P6_P#BGX=^'7_!,'XO6NO:YIVCR>(O#]SI>G&ZE\MKR[=<K$GJ
MQ /'M7\ONG_LH^'_ (;_ ++'[/\ \;O[:FAU;Q=XWO--U&UE*K;6L-A<Q 2H
M?O9()+9XXK]7/^#H_P#;=\ ?M3_L%_"G0? NN7'B#5O'E_!XHT&V@LI%DN=.
MQ)%OZ9SO!&#S7OG_  6)_9YTNR_X-VK"&Q\(Z6=<T?P]HMS MAHZ1S6DDD<!
MF<*B;@YYWL,$\DT ?I;\(?B!HOQ3^$GA_P 2>&]:A\1Z#KUO')97L#B2&9,;
M=RD=1D'\J_F\_8@^&/B;_@I7_P '".J3?$O1;WXI>'_!?B6_M]7NM0C,T-A9
M0RS)91R$8VHC* ON*^Q_V<O^"F?PQ\%_\&R;:;;>,[JT\1>&O#K>"FEMX)89
M;/6)EDEBB5Q@@[2#O!X]:?\ \&=?[)][X3^ GC3XZ76M-JEQ\1KR719K:4DS
M0O:3EC,TC$[BY?ZT ?ME:VT=E;1PPJL<4*A$4=%4# %1ZHBR6,BL%(([]*L#
MI4=Y'YULR^H]* /Y]?\ @\S^-7C'PMXT^#_P\AU[4I/">M:5<:IJ&DHX^SWT
M\-R%CD<8R656('L:]Z_X(M_\$Q/V'/C9^S#H^FKI'P_^,/CIM/BUS7X[S]]J
M.CM.%!MV5"-J(^5&><YK[Y_X*2_\$V?A_P#\%(_V9]0\&^*M.4WL<1GTC5D^
M2\L+A Q3]X!O,6XY:,$!L#-?@-\=_P#@V6_:T_9$\?3_ /"G-:U3Q)I-QI\<
M]WK&C:JVCR.>6:%E$@=MN,\\9- 'ZX_MH_\ !M9^S?\ M"?L[:MX?\!_#GPW
M\,_%3J;K3M7TNW\NY\V,,5B<L2!$[$!L#.!Q7)?\&^W_  2<_:$_X);:GXPT
M?XA>.=%U3P'K%D)-(T33KIY(;;4#*IDF*LHP6C&,YK\)_P!GK]M[]K?]@WXJ
M_P#"9:5J'Q&NM0T^VN;-H]?AO=4LHU/RR,R3$H<;<ACTK]AO^""__!R7K'[8
M_P 2K7X6_'2;3_\ A.?$-SL\.ZE8626\%_(W(MO*C'RE55FWL<'I0!X+_P '
MK\<:_$'X+;DA2X;3[[SF_B?]['TK0_X(G_\ !$NU_P""A/P@\!?&#]HJ\\8:
ME;>$7CTWPWX:U2&-M.UC1XTW1)R QB)9L8/:J/\ P>I/)?\ C_X'7%Q"MK+;
MZ?J&[)#<^;'MX[YK]=/^".UV]U_P3*^!TTUN%4>$+-_,##:#M[+VH ^>_P!N
M+_@W/_9Q^+'[-7BO2_"/PNT7P7XFM[*2_P!+U3P_:_Z>TL*-(EO\Y(Q(P5",
M9P:_+/\ X-H/VW->_8#_ &\+OX&_$8>*+-?&%T-*B\/;!MT[5F8?/,AY5@BX
M.,U_3,TDR66YE\V3=D[?EXS7\N>G2;_^#LD_=9;CXNG"%/F8?7M0!^P'_!??
M_@FU\>O^"F'PP\-^$/A;XPT?P[X45WFU[3K^Y:*+42"K1%@JG.T@GMUKC?\
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M ,'KD#-\*/@BK2,EG_;&H,I/.6\F/(K] O\ @@7Y;_\ !';X![IMD*>'#(B
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MC<C1G)X+;J )J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)YX'MII%R8R^X#\N* +U0W,F)(UVL<GJ!P*FJK>S*\ODX8MMW@ XS0!^$_\
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M\,Z9;Z;!<W("R3)$@0%@O&2!VKP'_@GK_P $A_A#_P $RM"U#_A6NA7#ZOK
M66]U&_N/M=P6"!#'$[#='&V,E0<$\U]76C,]M&SIY;%02O\ =/I0!\:_\%S?
MV,-*_;(_X)P>/]#UK5K[1+?PW"?$UM-9JK.\EI%(ZQ-NX",3R1S7\PFJ_M7^
M'_'/_!.'X9_ A9-63Q%H'Q!O];O;LK_H_P!DNH8X4V-GE@0>",5_9[K^CVOB
M'1+NQOK6&]L[R)H9K>9 \<R,,%64\$$<8-?CK\)/^#71OA5_P4[TOXW7'B[P
MGJ'@]?$D^KMX3?1"T7E.'VP\GR\*6&/EQ\M 'Z(?\$T/V2M-_8O_ &*OA_\
M#_2]6O=6TW1M.66*XNU59)3/^].X+QP7(&.PKYI_X.4/^"?$G[<'[ =TVG+K
M5UXH\ W,VN:'IVF0+,VJ7#((C$X/.-I8_+SQ7Z!0B%V:..(QK9)Y**AV)C'
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M@?4/&&G:;KFHIKMEXEDMTC_TR=WDN[:!@-K;$;'/.&YK]ZOV8?\ @N+^S?\
M&[X$Z#XCN_BEX:\,ZEJ-BK7-AK%]';ZA#(!M;?'G@D@G\17L_P"V;^Q9\/\
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MJO\ P2O;=_P<]0.1MSX\UIL'J/FN*_JCW26]F_S[)(4($K?=SZXK\D_V6?\
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MK2$@,,$9'/-?JQ?:'#>6,L,NZ2.12CJ_S)(#PRE?0],4 ?Q@^'/VK_#/A_\
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M>L:?\.?&EKX5LX]4U!K1I+:_@"$_-#'MS*6.3(220,4 ?6G_  43_P"#B_X
M_LO>!+S2]$\:'Q7KGB32KN/2[KPH\=Y_9MP(BL32G/R?.RD=>E?FC_P:W? K
M7?VU/^"@/B_XV?%+1=0\776EQ&_M/$U_"6\G61(I\P.N%\W83QCIVKW#]F;_
M (,P=#\.?%NUU7XG_$Z'QCX)6VD$^F:5!/I]Y)(4^1A-N. K<D8Y%?K]^RQ^
MQ_X/_9!^$.B^"_!-DFF^&-#@6&%8QMN)RO DGD !E?'!9N30!^1/_!Z5\.O$
M.M?#OX/^(++0;J^T?P_-=C4+^.(M#9%S&$WMT&XC%>^?\$)O^"OG[/L/_!.7
MX=>%=>\=^&_!/B+P;IL.CZG::Q=):M<2*"Q>($Y9.0,GO7WI^V1^QOX/_;\^
M &H?#7XBQ7MQX<U">*:Y2SN#:SGRW#IB0<CISZU^.?QW_P"#+FW\2_&'6KSP
M#\5]/\+^%;JX9]*TZ_L9[VXM(_X5>4,-Q'/.!0![Q_P5=_X.@/A#\"_!_C/P
M/\-)(_'WBRZTU;:WO+<^9HSI.A23]ZC9WHK'C'45^??_  9\3)>_\%0O$LP^
M>.X\)WCDO[R1\&OOS_@F+_P:M^!_V1O'^I>)/BCK^G_%&\^S2VNEP06CVUO
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5F61O+)R$QP*LT4 5DTQ(#^Y/DKO+L%_C)]:2WT[R8_GE:63! D8?, :M44
M1P6RPQ;>OJ<?>IMAI\6F6_E0KM3)./K4U% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %($ 7':EHH 9]G3>6VC<PP
M:9%8Q0R;E0!O6IJ* $V#=NQ\W3-+110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5&]K&\C,RY9A@_2I** (Q9QAF.T?,03^'2I*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI"X#;>Y[5'+>Q0/M9P
MK>E $M%1K<QN2 P.WK2_:$W8W<XS^% #Z*:\ZQIN9AMZ9HCG65F"L"5."/2@
M!U%%% !113?.42^7N^;&<>U #J*:DRN?E84Z@ HH)P*C%U&8A)N&T]#0!)13
M4D60?*<TZ@ HHHH **** "BBB@ HIDEPD7WF I3.H=5W?,W0>M #J*** "BB
MHY;R.&58V8*S=!ZT 245#-J$-N!OD5=S!1]34V: "BBB@ HHHH **** "BFO
M,L9^9L4R6^B@+!G *+N/L* ):*%;>H8=#R*;-,L$3.QVJHR3Z4 .HJ-+J.1]
MJL-V V/8TY)5D^ZV: '4444 %%%% !1110 4444 %%%% !1110 44C,%'/%,
M:YC6/>6^7.,T 2444V218EW,=J^M #J*C-S&L/F;ALQG/M0+R(M&-XS)]T>M
M $E%0QWT,LDJK("T)PX_NU)'*LR;E.Y?6@!U%%1&\B5"V\;5."?>@"6BH3?0
M@J-X^?I[U-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1144M
M[%"RJSJ"W3WH EHIJ3K(?E;-.H **** "BBB@ HHHH **** "BBFB93*4W?,
M!DCVH =134F63[K9IHN8RK'=]PX;VH DHIL<RR_=;-.H **;+,L";F.U<XS0
MTRHVTM@T .HHS10 4444 %%%% !1110 4444 %%%% !1110 4444 %%-DF6+
M;N;;N.![FF?;8C)MWC<.HH EHID%RERNZ-MP]:?0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 5;L*E['(WF;MI4;5R!FJLZKHN9II%:-B3))(=HC7K5G4[1
MK@QLDKQE&&0#P16-XXA:3PUJ%KM$RS02[P_S;1L- 'Y&_P#!6?\ X.:K']E+
MXNS?"_X)^'HOB!KSV\UG?7AD=5L+QP%A-L4#"<@MDC^\,5^=ES_P5E_X*8R"
M.5+CXDJLIR OA-F"_4^31_P;X?#'2?B-_P %TKK3_%5CIVN6=HFNW<<.H1;D
M@FB<M$P#='! *GUK^I&PT.&RA7RXI&2X?<Z,0=F: /PK_P""9'_!SQXP\.?$
MSPI\'_VE/"6I66I75P;2;Q!-;RIJ,EU,X%LK6VU0JEF4%NPYK]U-,DD?5"US
M&L,^,*ZMN61?Y9K^?/\ X/)O &A_#OX]?!GQ+X8L;72_%&H0W5S=W]FH2ZFD
MA>,Q,S#G<N/E]*_8S_@DCXXUCX@?\$Z/@OJWB:ZO]4UG5O#%K=W%]>OOFFE8
M'.XGDM[T ?3%%%% !49E47 3Y=V,^^*DJ"[A4_,H43,NQ7QTH _);_@Z2_X*
M&_%S]@_PC\);[X2>*I/#%WXBU"^@NW\F-A((XT(^^#W)K[<_X(]?''Q1^TI_
MP3,^#OCKQKJ3:QXJ\2Z$+O4KTJJFXE\V1=V% '11T]*_++_@]F6.V^%7P+C;
MS&D_M74"#GOY4>:_2'_@@,RM_P $</V?_+7:O_",C /;]_+0!]@,<*:\5_;Q
M^)6M?"?]BSXE^+/#-X-/UK0= N[^SN" 3')'$S*<'CJ*]J894UX#_P %+88X
M_P!@'XP1N@:W_P"$/U%F'\1_<M0!^9O_  :P_P#!4CXW?\%!/C[\6-+^+'B^
M;Q):>'] L[VQ1X(X_)>2X9"?E _A%?MA7\YO_!DPR/\ M3?'3R]^W_A%[#&X
M]!]K?%?M-_P5"_X*,Z'_ ,$N_P!F";XH^(O#>L>*-+@U*VTQK33)8XY@\Y8*
MV9"!@;3F@#Z,HKX1_9H_X.$?@3\:OV.K7XT>+M0;X3^']2UJZT*PM_$,RM->
MW,$:R,J&(,.5;/-?)6O?\'JWP;T?6KJUA^$GQ"OH8)7C2XBO;3RYU!(#KDYP
M>O/K0!^T=%>(_L*_M]_#_P#X*"_L]Z7\0_ NI0W%C=H%OK3S T^DSX!:"7 Q
MO7(!QD>]>QIK$3-M^ZV,C/<=S0!;H/(K\^_^"B7_  <@_ +]@1Y+"&]D^)'B
M6QU1]*U31=!N%2ZTN15)8R&4!< \?*3R:Y;]A;_@Z4_9W_;%U+4;'7)KKX3W
M\-Q;VNGV_B*Y1WU>29MJK%Y08<-@?-CJ* /B;4_^"P_[0]O_ ,'$%Q\$[?QU
M-'\.6^(W]@_V8;>+;]F_N;MN[]:_?J"58[B)6YD=1R.<G'-?RXV<MKJ'_!V5
M)(VZ82?%WY55@0#ZGVK^HE;F&#9),R*RE@I' P* -&BO@G_@HA_P<3_ +]@(
M7^F_VI_PL+QIHVH_V?JGAG0[A5OM..W+.YD 3:. <$]17R2W_![/\'5EV_\
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M?%76?#VA^$?%/CO3-+DV0:YI-W;K9Z@-H.Z,28;&3CD#H: /UXHK\A?V??\
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MEJ]UN9W@MMVWS'QR%[UX)_P4JU"&Y_8"^,C*&DCA\*7\<NWJJF!LF@#\1_\
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M^CS]C7]I#P]^V)^S'X2^(WA>\NKS0?%>GB=;BZMS;2R,,HY9#ROS*U?R]_M
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MJ>1_P1L^*B_>P;,Y;KS<)7R=_P &5$2S?L;?&E9<,C>+K?=NZ$?8UZT ;_\
MP7F_X)=_M=_\%)_VF[&S\$WNBK\%K&TM&BLY=8BMV$[#;<N4/+C ! .1QQ7L
MG[/G_!K5^R]\./A1I>E^,O")\3^(+> 1WFK/>RPM>N<DG8K;5ZXX]*G_ ."W
MG_!=KPW_ ,$P?#J^$?"UQ:ZQ\6[Z));;3)&W0Z7"P#)-<)P3&Z[@NTYR*_)'
M4?BA_P %-/\ @H#JEQ\5?!.G_%RW\*>*S]NT]- F\K2U4#;B!2^0,J>O?- '
MT]_P7._X(F_LQ_LW?LQ:UKGP[N="^'WCKP;'_:#Z&^L+/<^(()"J1IY<C[T
M^9\JISC%>Y?\&<_[0WBKXN?L8>/O"VMZG]NT/X=ZU::=H,/EJOV2"6*25UR.
M3E^<FOR4_:(_X):_M<?%OP#X]^,7QZL?%&D:AX#TBWF:X\4YDOM6B\SRUAA=
M21\FXM\V!BOTP_X,D?E_9K^.BXP5\4:<#_X#24 3_P#![A_R:M\%/^QMO/\
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MRG6Y_LZ9[LC=)"&P) I!"M@X-2?\&F]S9_!K]M'X^?#.X\3+(=%F&FZ5%=W
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MH?\ P0@_Y1"?L\_]B=;?S:OH#]HC_DWCQU_V -0_])Y*^>_^"%-VD7_!(GX
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M#/V1/A=)XO\ $GQ"T2;1[>ZALWBT6XBU2X9Y#A?W43%@/5L8%?B'_P $I?\
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MX2?LM_LK^*/&S?$7PY)?6-G)!8#2KV#4;DW<B,L)\F-RS+YFW)Q@#K7YW_\
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M=_&'A'Q]H-KI/VA[$IKMW%I5T9$QN/DS.&V\C#8P:R_^"EG_  21^%?_  5
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M_@O_ /\ !'7Q]_P5K\,_#JQ\)Z_X;T6Z\'W-U/<-?B39()54#&T'^Z:^J?\
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MW]LK3?@I\+_&%A\.?A7HDQGN]:O]3329=1BB<;KHM(R%74,5$(;YMN:_0O\
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M$!P/N]LU^3>D_P#!F7\;KN1Y!\1OAW<0QL4EV?:-P8=<?+0!U7_!Q;_P7O\
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M2F1+B%XD)!7?PK9^M 'P)_P9W7\FK?\ !3WQ;=3+^^F\*73L>G66/M7Z]_\
M!SA_RAJ^*G^Y:?\ I0E>"?\ !#3_ (-\OB)_P3#_ &K]3^(7BKQ5X;U:PU+1
M)M.,&G>;YT<CNK _, -N!7Z:_'_]G/PY^U-\(M;\#^.+&TUCP_KD/DW5K*NY
M HY1P#_$#@_44 ?C#_P9M_&_PC\*?V5?C!#XF\3^'M!DF\4V\T,6H:E#:R3
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6&(M-YLDD/[TLN0'Q[?TK2MYUN$60+ABN[E><58HH CMI_M,*N,C=ZBI***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@!'3S%VFLX6=U]JN/+\N&(] $&9..I-:5% $=M&\:+N;HH&/>I*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH J+:RI>3
M295HW4*L>.A[G/O3'BN59%A_=H5.XGYMIJ]10!0L([P1JLVW/F'<0,97M5B"
MW:&8[<+'Z8ZU/10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !16;=!K?4O,W>;(>$7.U8U[_4T00RQ:@&:9BKGA=O]
M: -+-%9=V+>..1I))#'&<KCL?ZTZ"^^WZ;YVZ1!CDE,,WX4 :5%9/]I+ING>
M=/&P:0[2$)?C.!5VR79M\L'R67.2><T 6:*** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0MU8'?S[8K^G2],.D1QF%E=7DW,1\[*OJ* +^E7T36NW?#NC^^$Z+5I;A&8
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M;&SC(P<4 ?OC<W\-I+$DDBHT[;8P?XSUP*&U"%(]QD7;NVYSWK\N_P#@FO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK/18/+:Y,28+8)P6VC%?SO\ _!#K_E8^E_[&CQ)_Z,N*_H6_X*W?\HOOC?\
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M$_=LN0W]*MT 0VD;PH5;;M4X7'I[U-110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.G_!>?\ 9D^.OPQM?%$OQ4\/>#_[4RPTS7+Q+>]M@I*G<@SC.,_C78_M^?\
M!)3X-_\ !2_1M-A^)6AO>76BW$EQ97VGR_8;I7*% LLJ#?)&,Y"$X!YK\EO$
M_P#P9;Z]J&IB:S^,VDPZ:9V\JW_L>3?%$7X4MO\ F('>@#UO_@H#_P '=_AG
MX7^+8_#OP-\/IXMU73-6>SOK[5<C3KV  A98'C;+ MCKVK]6?V0/&_CSQG\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@""\N'BX1><;LM]T 5\)?\%$O^#@_X-?\
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M)_Y OQ*X_P"H6G_Q=-F_X/$/V8KB)D?1/B4RL,$'2TY_\?K]&/\ AAOX-_\
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MI_\ &Z/^&&_@W_T2OX<_^$Y:?_&Z /SGD_X/#?V89=V[0_B4VX8/_$K3D?\
M?=,M_P#@\&_9>M8U2/0?B4JJ<@#2TX/_ 'W7Z-_\,-_!O_HE?PY_\)RT_P#C
M='_##?P;_P"B5_#G_P )RT_^-T ?G2__  >)?LQNNUM%^)6#U_XE:?\ Q=0G
M_@\%_9=,RR?V#\2=Z#"G^RTX_P#'Z_1S_AAOX-_]$K^'/_A.6G_QNC_AAOX-
M_P#1*_AS_P"$Y:?_ !N@#\YXO^#P_P#9A@3:NA_$I5';^RT_^+IQ_P"#Q/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 48HHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH .M&*** #I1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 44SSE5CN(7'J>M,^V'[9
MY?EMMV[M^>* )J*** "BBB@ HHHH **** "BBB@ HHHH **"VT<\57NK_P"S
ME=J&0-W!QB@"Q14<=RLD8;<,&H9=2\J?;Y9V_P!_/% %JBA6W#(HH **** "
MBBB@ HHHH ***:TBJ>HSZ4 .HJM;ZEYTFUD,?IDYS5F@ HIL\ABB9@NX@<*#
MUJ&"\:0KYD30[E#?,1P?2@"Q14-M=_:7?",$4\-V:IJ "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BF3S>5"S*ID91]T=33$O5>7R_\
MEH "R_W<T 345336%DCN&$;;K=MI7/)-3073328,;(NT,&)ZY[?A0!-113)Y
MUMX]S4 /HJ*"Z6>1U'\)QUZT^&83*2O\)Q0 ZBBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH- !14+WL<3A
M7.UBI;!]*2.\,DB@1G:W\61T]: )Z*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BFM*J=^?2J]OJ0FDVLAC],G.: +5%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44R>=;>/<YVK
M4+7S><RK"S;3U!'- %FBFQ2B5,CZ'VIU !1110 4444 %%%->78P!_/TH =1
M4%Q>^3Y>U3(';:2I^[[U.#N% !1110 4444 %%-EF$(7=_$<4R>Z6"15/\7O
MTH EHID$ZW$>Y:?0 4444 %%%% !110S!>M !151]5R$:&-IHV8J6!P%/XU+
M+=;-RJI=P,A1_%0!-15>VOOM+MA2% X;/4]Q^%3HVY<D;?:@!:*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT5S_ ($^)FB_%#P9IOB+P_J5KJ6BZI;I=6]S"VY)8W4,I'U!!YKXE_X*Z?\
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M;Y=T;-@GID<4 ?//_!M_\:?V@?CI^SGXZU3]H:;Q!)XDM]?2*P&KV/V27R#
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MPR0W<Y("P*(\D,V>"<#BOT[MM7^TG:I5E8;HY <J_L* /PR_:*_;._;6L_\
M@MS>>!]);X@1_!=O&EI8I#;Z&9-..GL(O,_?^7]SELMNXYK]R-#M%A0,T)CD
M5C$N"3A5Z5^<_P 7/^#DGP'\*_\ @I!-^S?<?#KQ1<>)(=?@\/\ ]K)>6XM%
MEEV;7V'Y\#>..O%?H=?^)ET3PMJ&I*WVJ.PAEF= ?F+(I9@,_2@#>HK\Q?V)
M/^#GKX9_ME?M):S\/_\ A"?$7@ZW\/Z9?ZK>ZUJ=[;M:I%:8\PX3YNA)_"O(
M?B)_P><?!WP/X^U;2;/X:>,?$.G6-Y):P:I9W]LL%XJD@2J&^;:W4 C/- '[
M,45^?_\ P2R_X.&/A+_P5!\?ZEX3TRQO?!/BBW4RV.EZM<QR3:A$JY>1"@VX
M7@8)SSQ7WK-/.0OEJOR'+@]7'M0!;HKYO_;,_P""HWPA_P""?VB(OQ.\::/I
M&N7EE<7FG:>Q82ZEY0)\M,*0&)PHW8&37YLG_@]E^%D\_DQ_!?X@+S@R-J5F
M5 ]<4 ?MM17YJ_MG?\'-WPA_9.^#GPS\;:9X>UCXB:+\2K>:2WET:]AC_L]X
M=HDCD$F"2&8C@8^4U]J?LB?M0V?[6W[-/@WXG6.FW6CZ9XTTR/4;6SNG5YD#
MYP"5X[4 >K45634XW?;NQ(!DH>OM5:[U*>UM_.D"PQJ^7W#.U* -*BO!?VMO
M^"DGPG_8>\+V^I?$SQ-8>%VU".=["WNG/F7C1IN"J%!P7X SCK7YCC_@]?\
MA;*TGE_!?X@%8<DO_:5GB0#T^M '[945^7?[#O\ P==?L\_M:^*-2TOQ1'??
M"": 0IIY\07*3C599'V"./R5;!''WL#FOTTDU*:XTB.:TVS-<*"C#[HR,AC[
M8H _ O\ X+]?\%:?V@/V-_\ @K99^!OA_P#$&]TKP==:;I$LFGQ11,K-*S>9
MU4GGZU^[/PQD_MSPEINK-Q)>VL,OF9R7+("V1VYS7\S'_!T"[:9_P70TUYHE
M>)=#T!I2O"YW/DBOUX_:Z_X.%/@'_P $]_A5!I\GB"U\>>.-#^QV=YX4T:7R
M[R /$&+[I%\O"C&<'^*@#]&J*_+']B?_ (.P_@%^U9XXU#2/$EIJ'PG6WAC>
MSFUZYCF74)&?;Y2>2#AAUYP,5^G&@^*[7Q5ID%YIUY;W-O>(LT#H=RO&1G(-
M &M163J6L/I]A-<375K9Q6N99GFX5(QW)K\T_P!N7_@ZL^ ?[*>OZ7IGA..[
M^+4ET9DO9]"N4ACTR6-]IBD$P!+,<X*Y'% 'ZA45^4O[(7_!VG\!?VCO'=YI
M/C"SO_@W:6-LMRM_XBN4GAOV+;?)C$ 8AQ][)XQ7Z@:'XPM/&F@V>H:-=V]U
M::A$ES;3HV])XF 8$8]5(ZT ;5%?"_\ P5=_X+86_P#P2AU/2+KQ)\(O&?BO
MPIK""*/7=-O+:&U2[Y)MB)#NWA1NZ8QWKZ8_98_:S\(_MD?!#1?B#X#U*'6/
M#VLQ!EDB)/ER@#S(B2!\T;$J>V1Q0!ZA16??ZL;2W\YFCACV;F9S@1#^\3TQ
M7PA^P!_P7>L_^"A'[4'BKX;^$_@[XVCM?!=]<66K^(WO;5[&T,<CQHQ4'?B1
MD., ]>: /O\ HKC?BI\;_#_P>\!:KXF\0:K::/H>@(TNIW=R<)9HHRS-W.!Z
M9-?F+^U'_P '?GP%^ _QDN/#'A;P[KWQ0TF&UBF'B+1;R&*R=W7+1A90'W(>
M#QB@#];**_.'_@GW_P ',/P+_;E^TZ9>32?#GQ0VIQ:7IFE:S<+)-K+2*"'B
M,8*A=QV_,1S7Z()>32V]NZO%ND&YE'.X$=C0!>HI$)*#=U[TM !15,ZIY%Q-
MYR^7#'_RU8@**_._]O\ _P"#FCX!_L07/]G:7<2_%+Q)9ZI-INK:/H-PL-QI
M'ECEY&E 4@M\ORD\T ?HY17XM^"_^#TGX3^(?&NFZ;J'PB\=:-9ZA=1027UQ
MJ-J8K&-F"M*X7DJH.XXYP*_7CX6_&GP_\;_ ^D^)O".H6^O:!K<*W%K?6S9B
M>-AD-S@_F,T =916/XM\<:;X$\/ZEJ^L7EOINE:3;O=75U.VV.&-%+,Q^@!/
M'/%?EO\ M8?\';OP$_9Z^)5EHOA6SO\ XL:;<6PNI-7T*Y2&WA))'DD3 -O&
M,YQCF@#]8**_,?\ 8:_X.G_V??VP=9U+2]?:Z^$FI0W$%MIL/B"Y28ZQ)*VT
M+%Y((&#@?-C[PK](K'Q.MW:P[ML<EP/W1R&60^Q'% &M17Q'_P %??\ @MIX
M5_X)!6O@Z7Q)X+\0>,?^$N:9$72[F&$VIC"G+>9USN[5YS\?_P#@Y8^%'P$_
M9$^&?Q.N/#NKZIJWQ0TU-6L?"=O>0C4K.W9G3?(Q_=X#)@X.>10!^D5%?BEH
M_P#P>H?"R?7K6SOOA#XXL8Y)TCFG?4+0I"C, 7..<*#D_2OUV^ O[07A7]I?
MX9:3XQ\%ZS9Z[X<UZW%UI][;L2D\9R,\@$<@CD#I0!Y1_P %6OVP]1_8$_8C
M\7_%S2]'L_$%YX1CCF33;J9H8;O?(J89U!(QG/ KY3_X-V?^"EOQ$_X*?:/\
M:O'OBZTMM.LX_$]K%I.EQS%X=)MVM06BB8J&=2P+9;G)KP/_ (.CO^"QOAGX
M?>"_'?[*<W@W7KKQ-KFD6-_%K27$(L8UE82 -&?G. A''K7P9_P0F_X+X^$?
M^"1OPC\:^'_%G@3Q)XNE\9ZM!J=K)I=U!#'91QP^44(DYY//'% ']4=G(9(V
M)S]XXR*FKYK^/'_!2+1/@5_P3J_X:(NO#NJ76AC1+;6_[*CFC%UY<^S:FX_+
MD;QSTXKYO_9B_P"#F'X0_'S]D;XC_%S6M"U;P#I7P]U"WTHVFJWD,DVJW,\+
MRQ)%Y>0"VPK\W&30!^DE%?E+^Q#_ ,'5_P /_P!N7]J/PC\+]"^%?C;2;OQ1
M?&S.I7-Y;RV]F-C,)'"?-M.W''K7V9^VK_P5/^#?[ VDR?\ "Q/%FG:3KEQ8
M3WVEZ0\A^TZKY2YV1X4A26PHW$<L* /HZBOQ+G_X/8OA?';[_P#A2'Q$VC@M
M_:5G@'\Z^A_V#?\ @Z%^ /[8ES?67B"YE^%6I0WUM8:?;Z[.)FUB2<[5$7DJ
M<88A?FQR: /TMK\;_P#@ZR_X*+?&#]A2_P#A);_"OQA?>%U\1I>-J"V\22?:
M C)C.X'H">E?L,U\SLC0E9(Y. ?[I]37X!_\'MERT>M? S]X/,2'40=O;)CH
M _7#_@E5\3_$7QO_ ."<OPG\6^(=4DUWQ)XA\/P7]U-.!&9)&SG.VOH[2PPL
MUW(L;9Y56W 'ZU\I_P#!#N)?^'2WP"N,?O/^$.M1GU^]7UE&H5.!CO0 ZBBO
MS,_9E_X.9_ /[2?[<%W\$X?AMXMT&\L[W4K276;N]MWM8Q8^9YDI5?GVD1DC
MO0!^F=%?E3^V/_P=K?L^_LQ>-=/TKPK:ZC\8K:]MFGGOO#MRD$6GR*Y7R)!,
MJDN0-V1QBNR_X)F?\'+GPC_X*5?%RY\#VNBZI\.?$+1JVF6^N7<4IUE^=T<7
ME\!E49.XCK0!^D%R%V MG"G/ K^?O_@X)_X*P_'C]EG_ (*QV7@OX=_$.^T'
MP?)I>CN]A!%$ZF65V$I.Y2><#O7[^0Z@;J)<QLFY-W)K^7/_ (.F85M/^"Y6
MFQPJL2'1- <A!@$F1\F@#^GSX<3S7_@O2[N?YIKRR@FD<]9&,:DDCMR:W*Y_
MP#>K9?#307<A573;?))P /*7DFOSY_X*"?\ !SI\ _V&M7CL-+O&^*VLQZA+
MIFIZ/H$ZPW.C21#YGE:50K*6^4;2>: /TFHK\2K3_@]J^$\\K;O@S\0%4@E?
M^)E:<'T_&OT5_8$_X*Y?!W_@HU:V]O\ #[7[>\\11Z3#JNJZ-N+7.C+(=NR4
M[0I8-P2I(S0!]0451DU)A/Y"X:906.!QCTK\Y],_X./_  3??\%*K;]FQ_ ?
MB*'6;CQ"V@/KCWMNME;,N[+LN=V/E_6@#])J@O85E$;;59XVW("<<U^3G[4G
M_!W#\&_V;_CYK7@S3_"/B#QYI^ADQR:]I-Y!'9W$H'S1JLF&!5@5.1C(KJO^
M">'_  = ?";]O7]H&S\ ZAX6USX<7NK!6T>XUF\ADCU"5FPL*^7G#=3DX'%
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M_P"5E[_N<O#_ /Z,MZ_JI'2/ZU_*M_P64_Y67O\ N<O#_P#Z,MZ_JI'2/ZT
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MI(\(X7!XW.>^,U^Y'A[_ (-J/V0]*\.:;8WWPWBU"33[=4GO);N>-KARHRV
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MGC3T\)W/@.S>YUC2C=M'%-$F9&NTE9BWFHH"A%X-?17_  :^_P#!3B;]M/\
M93NO 7C#7-4U[XF?#_=->SW5KY4,6ENPCLPL@X=AM8'OZDU^3/C+]EG_ (*C
M^/M"O=#UK0/CAJ6D7T+6MU975^CPW2,.4=?,P017WI_P:F_\$^?CA^QO\:_B
M]=?%3X<ZYX'AUK1+&&T?543;=,D[L43:QZ @\^M '[@:69381^=@R8^;%3O]
MQOI4=E_QZI\K+QT/:I3TH _*'_@Z!_X*>+^QK^R'8_#OPMXBUK0_B3\0B)+>
M:"QW1OI:NT5VK2=$8AUQW[@BOA7_ ((0?\&[OA?]N?X7:)\:/BUJGB3[(NN3
MQ2>'+ZQ:%-<M50%)/-9A)ARV=RYSMZUM?\'M$QA_:%^!J+&/WGAW4'<C[QQ<
MQU^T7_!+J]5?^"<'P1D:$^8/"=@(T/WF/DCI0!\:_MN_\&OG[/7Q)_9ZUS2/
MAKH#>#O'! N;#4;=WG\R1 2ENX=MJI(=JENPYKY@_P"#;WXC_&C]@7]J?Q%^
MS]\7=#\=P>&[RX-IHS0:1/>:7!J6\;W:ZVA4@\M2 ^=N<>M?N_-#'>73)',L
M+*0\VSA\CD GTJA+K$%S?9=[7,C>1+\XW%1SG&<]: /P:_X.G/V_?$'Q.^,O
MA']F'X=^*M5AOKB\AM_$UI)#]D@N+F>6/[&/.ZE?GP<<8/.:^E_^"<G_  :V
M_!'X5_LYV]I\</#D?C3XA7RBXU.4SO'!IS$ -;Q/&P$B \AL G-?DO\ \'&,
M&MW7_!<3QE'HOGOKKW.E)IB6IVRO<F.,0;#_ 'M^W'O79W?[-?\ P5?N[;YM
M.^/K>8=Q1=37@>G^MH ^]/\ @L!_P:^?#>X_9ZE\7?L\V-KX*USPC;RW]U9&
M\/DZG$@\QF,LC$HR*I*A>IK8_P"#3'_@II=?M!_!C4?@WXN\0ZIX@\6^#H!<
MZ4MS;_):Z:@5 GG=6;>3UR>>M?GCJ_[*/_!4CQ9X<U"PN]+^-\EK-%Y5Q8S:
M@K!T8$,"/,QAAG/UKZN_X-=/^"9OQ^_8X_;*\4^)OB-\,];\$Z/J7AMK>*]U
M&-!"\AE0^6-K$[L GTH T?\ @]2C$FG? IFCBNO](U(LK/M#?)'W]JPO^""W
M_!NEX:_:,^"&E?&;X]*WB/PUXFTX2^&?#R7K20QVK<B4LK!HV#!ALZ<YK0_X
M/6;==*\,_ M6:1E-SJ1X/S9*QY_"OTW_ .""PQ_P1N_9[_[%*'_T.2@#X:_X
M*[?\&OGPQ\3?L^R>(?@!H,/A+Q=X=AENWL9;AOL^JPJN6$DLC'R]BAF&!R>*
M^6?^#0[]HOQQ8_M;^)_A3;ZY<3>"I-$NM3FTJ9]RF[BV(A4GE5 )&%P/:OZ&
M/CHQ;X+>-O;0+PC_ ,!WK^:W_@T1&?\ @J]XD;^+_A%]1.?^VJ4 ?H]_P<S_
M /!//X2>,/V,?B5\==4\+J?BEHND6-M!JHFD_=1I(J*H&=IPK,.G>OB7_@UM
M_P""5OP+_P""A_[/GQ/UGXK>#HO%&H>'?$%M96,DES)#]FB>WWL@VL,Y;G)K
M]3/^#E)MW_!&?XN_]>=M_P"E$=?&_P#P9/C;^RI\:\=_%MCG_P  Z /K;_@O
M'\/=-^$7_!$CXK>']"TZ&RT/1/#UMI]E")BVR&.:)53GG@ <U^%__! W_@D!
MXF_X*<>/[J_U/4'T_P"$'A>_A'B&-9_WE_<8WQ0^22-RL@<&0'*U^^W_  <7
MH/\ AS5\;&Q\R:9&5/I_I$=?#_\ P9,WLUQ^S-\<4DD9EA\3Z<J G[H^RR'B
M@#]&_P!F'_@D]\#?V%];UG7/@_\ #W3=!\0ZM9_89+B69Y2 N63:9"=OS=Q@
MU^2]C_P;C?M+?MJ?\%!?^$P_:2UW39/"E]=RWMY<V6IQW<DD<;CR;81 *$62
M,;6*X(Z]:_?O5IVT^(W5Q(J16VYSC@E0,_H*_"G_ (*G?\'//C'5/CG??"G]
MF73[+6K>;S- N=4\GSI;V[FQ&AM&!4HR,Q7+#[P!Z4 ?>-Y_P;E?L=VEA/+-
M\*;;RX4VNBWMP24'_ _UK\,/^"\W[%_PL_83_:C\'^,/@9XOT6:UU27[<NCZ
M7>Q7J>'KFTD3R\D,S$EAN(?&,&NB?]FO_@JQJ<,T?V/X\+Y</F!3J:[Y5/&W
M_65\B_MZ?\$X/B5^PCX,\!^)/B1'+I.N?$E+RZ?2+I2+_3VBE"N9CDJ2Y;<-
MI/!YH _K<_X)O?%/5/CQ^P%\(?%GC*^_M/Q%XH\/6UW>W( 7[1,ZDL<+@<^U
M?CQ_P>T#_3?@7\RM^ZU$<=ANCK]9?^"-5K'<?\$L_@&TB*QB\(6;H2/NMM/(
MK\G?^#V^)8K_ .!>U0O[K4>G^]'0!^JW_!#O_E$5\ _^Q/M?ZU]8I]P?2OD[
M_@AW_P HBO@'_P!B?:_UKZQ3[@^E "U_%QX;U?X@Z#_P5%\53?#FZOK?Q5JO
MC76-+@DLK?[5<1037DL4S>7@\"-V.<5_:/7\IW_!%VY6/_@X^:>X5%B_X2SQ
M&H..XEN* /U1_9%_X-3/@'\%/#M\WQ(2Z^*6K:E<KJ"7][&;-[)=@!@5(GPP
M+?-D\U^?O_!QM_P1_P##/_!-3QCX*^+GP/M->T71-0N/+N=.LH9&MM#>%587
M#7&2R^:S8PV!Q@5_2D/)U")F:;[HVG:< &OA+_@Y(;[9_P $</BTT;B:%(+5
M0!]YB+A,YH O_P#!OW_P43C_ ."AG["=CJ.H:YJ&O>,_"(CTSQ)/<V@@47+*
MSJ$(X<>7MY&.:_%?_@Z@_P"4Y^F_]@+P_P#^C'K[<_X,H)H_^&7/C@L$<HMV
M\5VA5F/W?]#'!KXC_P"#J#_E.?IO_8"\/_\ HQZ /W._X*D_"/XX_'K_ ()S
M6_@_]GZ_LM.\=:U!8P3R7=TMK&^GM"5N$\Q@=K$%<8Y]*^"_^"4G_!J5H7@S
MPQK>N?M4:1I_BSQ5J4C10Z1;ZD9[>RC# K<>?&0SNXR"K#C%?IW^TW^V9X'_
M &%/V1[/Q]X_UJ'2=&TW2K?R8RQ274+CR08[>,X(W.5(&>,U^ 'QJ_X*^_MH
M_P#!9CQA>:+\ _#_ (FTW3?#=]+?1+X7(MK_ .R/\D:7,F\*^/;O0!^K'QR_
MX-[/V(?!/PHU@ZGX3T/P-9WT36T&M76JO''9W#J5C<-)(%+!N0I/.*_'/_@B
MSXPUK]BC_@NQI?PQ^'OBZ/5_#.M>(W\-WU]&L;)KMC'YCIEER%!90V5/;K45
M]_P3@_X**?M>_8? ?Q$T'XP7'A.^NXOM3:U>K-86DH;Y)G42$X3);@9ZUP__
M  2@^".H?LO?\%_/A9\.]2N+:_U3PGXXDTV:ZME*PW+1Q3*2 W.#CO0!_7+'
M"!"(YVW22*06QCKVK^/']M?]GWQ7^T;_ ,%POB-X%\#F./Q+XB\?76G::TEX
M;;]Z22/WG5> >:_L2=-ZMN ^7'X5_+'\&79_^#M&S1B2O_"W)SCWP] 'ZN_L
ML?\ !KU^SK\*_@WHND_$+PO_ ,+ \231^?JFKW-S)#*9FPVP*CX8*Q(W=P,U
M^3'_  <#_P#!%B^_X):_%.U^)'@'4GB^'.OWQ3342?9<Z-='+"W0 EC&JC.\
MG.3BOZK/*4,#M&5Z>U?C?_P>DGR/V _A^4^4R>+@K$?Q#[.] 'L'_!'WP]:_
M\%8?^"+'AFQ_: V^.HM8O9;6Y6:7R?/CM)@L RF.4"CW/>OQ#\9?L8_#G3?^
M#B.\^#$?A^./X<Q_$==$BTAIGVM:''[LN3NQ[YS7[D?\&K5G%-_P1G\"LT:L
MR:OJ6TD=/](-?D'\0C]I_P"#N:Y63YE'Q=0 'T^6@#^@[]CC_@F7\(?V _$6
MIW'PI\*Q>#W\1QQQZAY,\EP+M8\E0V\G;C)Z=:^E%Z55A0#G'() ^E6@,"@
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M4_\ !M/^QUJGA'5K'3_AK!I]U>V[PPW<-Y/*]I*RE4E +X)5B&P>.*_GI_8
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M_!2G_@Y+^(/[2'QQU?X(_LIV4FN:;J4;Z+::W:KYE[J5RS?+<64@92BD<#<
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M]':9K6_EGQ<&5EPR?PYW<#!K^E>[MFU$K+%'Y<T8V%'_ (E[BORQ_P""FO\
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M\.?\&8'Q:M?$^E-KGQ-\"W&DK>PM>0V<5RLC6P<>:$RN-VW.">,T ?-/Q/\
M%6O?\' G_!92VL8-:U^Z\(ZUK?\ 9>C:G#HQWZ/I6YFB:90/D /&7(Y/6OZL
M/ ?@H^#O!V@Z'#<23Q:#86]BV]=OG^7&J!L_\!SBOGW_ ()F_P#!(_X2?\$O
MM%UBU^']G<76I:U(6GU74=KWS1$@B$.H'[L$9 ]:^K* /SA_X.>/V38?VG/^
M"9GBK7+C5)-+C^%,4OBA(DB#_P!HNB;/).?N@[L[AZ5_/S\2_P!J?3_VD_V.
MOV</@I:^(/$$?B'3=?NK77UG,KPI%=74:V[ L<2;5.0.V,5_7]\4/AUHWQA\
M):EX6\1:5I^M>']:MS;ZA8WD?F0W4)ZHR]P:_&G]AG_@UHUS]FO_ (*&V/Q,
M\=:EX$\8^![>^OKN'0X[:5C;[V9K7 8!08OE^FWB@#]4/V-OV<X_V.OV1/ _
MPS74)M<_X0?3(]/MM0:$127FS.)&1>%)STKY4_X.>#)'_P $:?B1))(LCM/I
MYQ@9'^D+7Z"QV#37DK.9E9DV[L_*/I7S'_P6 _8DUO\ X*$?L3>*/A5X;U#3
M]+U'6GMG^TW2LRIY<@;)V\]J /S]_P"#,&*:Z_8Z^)DRMY"P>*XMQ'.5^RK\
MN.U>$?\ !W7^Q9J'PX_:9\)_M&:3>:Q=#7%M[&>&&P:6WTDV2*8Y7D&0N]C_
M !8''>OTE_X(*_\ !)WQ;_P2;^ 7C3P=XQ\3:'X@N/%>M)J,<^F+(JQ@0B/!
MW@'/%?8WQM^ _AW]HCX7:GX*\9:78ZYX7UB$P75K>1^9OX^5@.F5."/<4 ?G
MS_P1N_X."?A/^UC\(? O@/QIXV%C\7M/T-KCQ#<ZQ;KING%XW((2XD*QLVPI
M@#KS6I_P7;_X+&^!?V2/V*]8M? /Q$TF\^(7BM7L]#&C30ZI&K_*9/.*,PC4
MQE@"PP3Q7QC^V#_P9R6^K>-K:3X,^.K72](AC>346\3L\Q23=D*GE+PNWL:]
M?_X)_P#_  :5^ _@QX?LM>^*VK6WC3QI;279BM[<$Z)<1/&5@WQNNXE<[NO4
M"@#X'_X-*=5O-:_X+"W5SJ"K)/=>%M4FE8J%RQ\HDX_&OH'_ (._?V$=2T+X
MN^%OVB=+O-8OI-1CAT66RM]/,MOIBVB&19Y95SL#%\9; R*^C/\ @C-_P;R_
M$3_@FU^WEJ7Q.\3^,/#>N:+-IM[I\-MIR3+-&)RI3EP!A0N*_5#XO_"#0_CY
M\+]9\)^)K&SUWP_K,!M;FRG3?%,N?X@>N#@_4"@#\V?^")'_  <"_"[]HWX-
M>!_AW\1/'36GQ:L]'GFU2XU.U73].5(#@*+ABL98IMP.IP:^FOVR?^"U_P"S
M]^Q!X!TS7?$_Q T[5X=;NY+2UB\/21ZM,C*F\>8D+$HIZ;CQFOS;_;2_X,T+
M3Q-XPTRZ^"?C>WT?37AG;4X?$+/+(9V?,?E>6N BKD$'GI7GWP%_X,M_&VG_
M !3\/R_$3XC>&+SPC%=%M7BTI)X[J6#:>(BZ[0V['7C% 'WS_P $:?\ @LO\
M1O\ @K%\8?%;VOPST/2?AWX5E,%UK UD_:H9'4M;JL!4%PX&6.?EK],*^=_^
M">__  3?^'__  3:^$1\&?#VS>&!Y!+=:A< &\U,@D@S, -Q4$@<<"OHB@"*
M\,8MV\TX3OSC-?!7_!?#XJ?M!? G]AFY\?? ?4M/\.S>#+J34_$-Q</%N;3%
MCQE5D!W/O(^4<U]X:L5%I\T#7"[A\H[>_P"%<O\ %GX<:-\5?A_JF@^)=+M_
M$WAO5K<PWFE7""1+]#UC93P5/I0!^1__  0)_P"#CNW_ &GXF^%_QVUJPT[Q
MJHEGT_Q%=%+:TU%1EV$K';%$4& O/S5^DFH?&#X!ZMJ<EQ?^+?@IJ4DR%I+R
MXU/3'EED_P!HEB3]2:_)W]M;_@SRTOQIXCL;KX(^,/\ A&[6\EN+C5(O$+-)
M"C2-NCC@$2_*JY(P>P%>$V__  9A_%R2-;-OBM\/TNEDRRF*ZVNOJ/EH ^2?
MVPW^&/Q(_P""Q2Q?LXZ'JFH>"V\16)>UM[.621[M;D&\D11N8Q;]S!A\NWD<
M5^FG_!WK^P_<>+_A=X+^,VC-JEQ+X=A70Y=/MK%IDB@8O*UQ(PR453P21CWK
M[<_X)B?\$&/@]_P3,\70^)-%AU#7?'$EC'&]_J+)(+:7R\2_9S@%58D]>V*^
MR/'/@/3?BAX-U30_%&EV][H.K0-'=6ETFZ"6 \-%*.X/<4 ?DO\ \&_/_!P%
M\//B/\!O WPA^+OC>XC^*D$MS9P3W=B+/3(+&%0+=6N25C!$2XYY)]Z^UOV^
MO^"P?P9_8&_9]U'QE'XN\-^+M0S]ETO2=)U*&^>YN6!**_E.S1QDC!<C K\Z
M_P!L_P#X,[M%^).MQZO\#?&$?A>:_OY[K4K77V:2WCC=MR);K$ORJ,D 'L!7
MDOPV_P"#,/XC:;\1K&;Q1\1O"5UX6AO$-_'9QSK=26W\?E%EVA^N">* #_@V
MS\ >.OV\O^"CWC+XV>(=<\7:)X=\)W\^N6&GNT\NFW\MU+*KVPE8A#Y08' S
MVX%5_P#@]I G_:4^"C*&#+X7O,JJ9 _TON>U?O%^S!^RYX0_8_\ @EHO@7P/
MHZZ7H>FK\L2(%:XDVJ&EDQP7; )/<U\!?\%\/^"$WQ#_ ."N'Q7\ ^(O!_B[
MP[X5LO"NCSZ?>6VJI*TER[S^8&7RP1@#CF@#[E_X)Q''[!GP=_VO!VF8]_\
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MW'KBOV!$#23M<0R9ED&P@_<!'M0!^4W_  >.G/\ P3 T;_L<+/\ ] DKJ/\
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MS@1R74D9-O\ ;2R98 J ,?P@U\#-_P &7/QHMW\L?%+X<EIOE8&"Z^7W'RT
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M#3#X>ZU^P3H7@'P5J%EIWQ2T=S>-XDOE++>7$NSS4D*KN,*D-Y8ZC/-?:?\
MP2._91^*W[%/[)>G_"_XE:]X1UV/P;$-/T2XT>&9!);G<Y,_F?>?>QY':@#\
M$O\ @[&UV?PG_P %I)=4M9O+NK+PKHTL,GEAUWJLA!QTK]@_^"'_ /P6 \"?
MM>_L*:#_ ,)M\0=$TWQ]X0B33O$+:U-!I0>X.YHS")&42*(PN2HP#Q7B7_!8
M'_@W=^('_!2']OR'XN:+XR\':?X8ATS3M/FTZ^BF:9VMRWF8VC;@[L"J/[>G
M_!I7X%^,^AZAK_PDUJ'PCXRU2>W#6FHY_L2",1A9?*CC7<&) (YZDT >B?\
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M &S?^#..S\8>+-/N_@9XRMM LY//EU&'Q.7F4.[;D$'E+\JJ"1@^@H ^WO\
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M^B/[;/\ P5S^"G[%O[/.N>/+CQIX;\136.VWM=-T?48;^YNKF0$0J4B<N$+
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MH&P'NO>OJO\ X)L?LQ:E^QY^Q+\.?A7KEW9WFI>#M%33WN+8,H?:S'(W<]Z
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MI)Q.Q_<^82L;-]XXYS]*_*G_ (*Y?\&TN@_\%$?&FO\ Q+\(>)KC0_BCKUY
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MP<7>)_&GCK2;ZQ\)VOC>WU2]>:P9DO+2-8?,:%6&)EX(^7(SQ7]9#=*^!?\
M@K[_ ,$-? ?_  5E:W\1:QK6LZ7XS\+:/-IVDBWE"VBR.YD4S+M+$;CV[4 >
M^^!?V]_@7XE^%6DZ]I'Q&\"VFCS:>M]!;S:Q:V]Q!"8PZJ8"X(?;QMQD'BOP
MP_X.(?\ @O-\-/V_?@I!\'?A7;ZAK&EO?IJNJ:MJ,$EA)93VSLJPQQMQ(KJQ
M.X'M5>/_ (,NOC.C_+\3OAZK-R#)#==.P'R]1WK[(^'?_!I_\.]'_8 OO!/B
M;4+;4/BYJ4J7Q\36X_=V]U&'6.*,LN\6[94NO4E: .V_X- YE'_!)B-6<?\
M(X:FJ@\$_P"JKXE_X/9?E^.OP*!X/_".ZEU_Z^8Z_2O_ ((5_P#!.'XO?\$S
M?A%K'@'QUKW@77O"*WDNHZ8VE6\Z7T=U*P\PNS_+Y>U1@#G->7?\%\_^"&'C
MC_@KC\4?AYJ7A'Q5HN@P^"=/N;&Z;5EE=IS-*L@*[ >@&.: /LS_ ()6+Y__
M  36^"L>S)/@ZP]L_NA7!_\ !:S]B*3]O#_@G1XU\"MK%_8W>F[?$$<MM:^=
M)<-9J\RPJG??@+QSS7O'[&'P:N/V=?V5_ ?@*\O;?4+SP?HUOI4]Q!GRY'B0
M*2,\X^M>G4 ?RY_\&]7_  60T7_@E[XL\8?#OXS:IX@T#P%-FXM;"+1GFNDU
M%G4/YBX#Q_(.AZ5_0Q>_M\?!W2_AU-XF_P"%G>!YK.'3CJ9B.M6@N&B\KS<"
M/S-QD"\;.N>.M?&W_!5K_@VT^%O[>VL>+O''AIV\)_$S5; QV;Q8339[S?N,
M]PBJ79B"<D'TK\Z6_P"#+KXV20JR_%+X=M'QM#P76Y2.H^[0!]CZ]_P=0:5\
M=OVJO"/PQ_9S^'\/Q%NO%ACLTN->N)-$_P!+8G]UAE(VX&=U?II\=AJ'B7]E
M/Q3]JTYDUR\\*WJRV<),JQRFT??&I ^;#$@<<\5\2_\ !*__ (-T/AA_P3I\
M6:!X]U9I/%?Q*ALHXII[C$EC87H.XW%JI4,GH"><$U^CUY*S74;*6:-5(.S[
MH'?- '\JG_!M3\>? 7[&?_!2*ZM?BW')X?;6K7^QM-_M*QVM87[2*5,WF8\@
M  Y9L8K^BG]I+_@J/\!OV7_A+J7C?7OB)X;OM'TWRTDAT._@U._D+G:-L$3E
MR 3S@<"O@?\ X*K_ /!JYX>_;+^(FO\ Q*^&WBZYTGQYXTUEM1U!M8D,FG*K
MCG8J+N'('4U\C^&O^#,/XO6>NV;7?Q/\!+8QW$?VL1PW(F:+</,"G;C)7.,T
M ?(/_!>S_@I[H?\ P5*_:@M?$WA739+7PKX+M7T;2;V8LESJL)?S!-)"W,9R
M2,<]*_JV_8H?=^QU\*3NW?\ %(:43_X!Q5^6?_!0'_@T_P# OQ,^#_@_3_@K
M>V'A7Q9X9L1875UJ2$PZO#N9FFE\M<M/D@!NF!7Z5?L)_#+XE_"']F#PUX4^
M)VH^%]0U[0+2/3EGT"&2*!K6)%CAR).=^U?F/0F@#U;QO\2/#OPTT9=1\2:]
MHWA_3V<1+=:E>QVL)<]%#R,!D^F:=X+^(GA_XD:*NI>'=<T?7M.9VB6ZTZ\C
MNH2Z_>7>A*Y'<9XKX[_X+@_\$TO$W_!4/]CRS^&7A'Q!I&A7UCK5OJ376I*[
M)B,/Q\@)S\U7O^")/_!/CQ%_P3*_8OL?A=XJU32]9OH=9O=06YLU=5;SBIXW
M#/\ #0!]F[UW8R,]<9I:SI=/\NZMV#7#&-2NY3QU[UHT %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4:R11M-(=LX5\;<]\BJ.AZ1I_@#PUI^EZ9;+8Z;I\2VMK;P#;'#&@"JH'H
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M1W$NF:A")(6>-LI(5_V>N:\9T+_@CC^RO>7!DB^ ?P_6!7\V.5M-&'/]Y>:
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M(,0OY?<MC.:N44 9XT^26\CN)%^>-6&W=P3VJQ#%,]R))-JKL'R==K?6K%%
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M0-&F(\'<&SNSGDBK]% %2X2XDL&6%5AEQA>X6F1:;*MCY<LGG.>2<;>:O44
M48=-:.W7G,V,;O2IHK61H/+F;S.^X#&:L44 5[JW:6#RU7&\89L\BJJ6-Q!:
M^1D3<G$AX*BM*B@"FFE^1:1QQNWRL&))SFKE%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !2.GF(5/>EHH C:#/IG&%)'2JZ:8RVK R;IL<.1D ^N*N44 5UL Q!D(?
M  Z=_6ID4J6],\ #I3J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ J.XA\^)EZ$]\=*DHH A6"3,FY
MPRL,*-O3UJ,:>UO;%+>3RV8YSC('T%6J* *WV27)_> +P0 O3U_.K-%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !55K&4S1MYW"%BPV_>ST_*K5% $,L+NJ8?:5;)./O5-110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#^#A7X _\ !/3XE:?X)\67^O>(-<FM_M%Y%HL*7!T]@<>3/\PV.00<>A%
M'W?<W,=G)'N#F-3PP;/-7P<BOS'_ &9_^#IK]F7]H;XUZ+X.LW\5>&Y/$$OV
M>&^UBUCM[&!\$C>^\XR>/J17Z:6]S'=VT<T;+)'(H=6'1@>0: '3,5B; W>V
M<5#;RK!$JME2>Q.['XUB_%'XH^'/@[X%U#Q'XKUBQT/0=+C$MW?7DHCAMU)
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M- LYD?5+E)3A2D1()]?H* /IJXE$Z#8&;:V< [:_#_\ X+I_\%X?V@/V!/\
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M?LD_\%!]5^&GP9U?PSJV@PZ99W,21:-#J4PE>,M*F1ELJ1@CM7RG-_P<O_\
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MWPA_X)K:1HK>/-6OKG4]8F%M%I=@J2WD8()\YT)&$XQGUK'_ &1/^"BVA_\
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M?6]U:I.+FUN \3L0"<;20><UMF>X@4;MLFYB2P&-B]N*^#O^#<CXF>&_'?\
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M@I8ON.,%AUH ^]'17E5CNVP+@,), \=Z;96\?V)MID59QN;,FXCZ5^4_B_\
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M0:1?,W1?(/WF5.?:B%X4O6C5I&F!WXR<<U^<G['W_!S7^SA^U[\>M(\!Z/\
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M,T+QI\,;G3].UJ]\0II+/J%FE[&\)C9\A&XSD#FO0_\ @A)^VYXV_P""@?\
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M<G_!K# C_P#!&[P:#+G&L:J1_P!-/](-?HW%,WV.U;;Y;,0"OI[4 %K]Q?\
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M>.HUU/3[33KN;2YM*BRR-%,""7<LI;=QP17!?\%>?^#:^']A?P=XL^-GP/\
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M &1?A--'$))9?"&E*\G< 6<6* /P\_X.L_\ @J5KGC'XK6?[/OPU\43)H>G
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M$K&TO(,GRS \AWNVT988XH _%3_@Y2_X)I_"[_@F9^T;X#T#X5VNL6^G^)M
MFU+44U*_:\=IA<,F59@-HV]A7[(_\$M/^"!7[//[/VC_  I^-VAV?BJW\>+H
M-GJIE;6I'MO-N+92_P"ZQC'SGBOSK_X/1[56_:\^$<DDS&%O",^Q4Y4'[6V
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M?_!#O]L#XC?\$C?^"C&H?LX_&3Q$FB^#;R5[:6QO$-X4OF 6R6!@2(5E9P2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /Y6?^"R-Q#'_P '),S.K(T/C'0)&E=PJ(@>W+'G
MVK^GQ?B=X5N+64-XH\/XFZ%=0B5@/^^J_"W_ (+,_P#!N7^T=^W'_P %%/&W
MQ/\  K>"E\.ZT\#6+7NM?9KA-D2J25V''S#UKYM_XA1?VU6#;M:\'LS?Q?\
M"72<?^.T ?TR6GQ4\*VMKM7Q)H+,._\ :$0_]FKY;_X+8W:?$'_@D?\ M KH
M=S::NK>$;B(1V9%P[2Y7@;2>:_$<_P#!J?\ MJ2GR[C6?"#RR#(?_A+9,C';
M[O>OU]_X('_\$^OB%_P3S_90U[P3\8&TO4-:US7'GA6&^-]"T1C4!-S <9![
M4 ?E_P#\&?\ \9OAW\,_CEX\\->,CHMEX\U2.$^'C>PJEPD:*YN-DK#Y/EQD
M9&:_<_\ :;_;_P#@S^QCX,L_$'CSQ]H6@Z/J%X+6.3S?M1:0@G:!'N*\#KC%
M?C%_P4 _X-+_ (B1_$^3Q3\#_&Q\0W>O7US>7_\ ;$\>FBR\R0N(XVC!)4;B
M.<< 5Y+\.O\ @TI_:6\>_$GP_;^/O$WA[3_ \MXG]L7=MKQN[JRB_B>*)UVL
MP[ D4 ?,W_!1C]NSPY_P4,_X*YZ7\2O#>CWFF:"^N:7IL$=Q,LLDP@G2,3[@
M!\KX# 8R <&OZ\M#&[08Y"\4C2PABZ+M#<5^&/\ P4"_X-5]6TKXO>"?$_[,
MRZ$T.B_8GU/2-:O!8VJRVPC/GHX#LS3LI9QT4GBOVF^!5UXPE^!_AZ3QOHNB
MZ#XQDL%&J:=I5VUU9VMQR"D4C ,RXQR1WH _FK_X.:O^4^VF_P#7GX9_]EK^
MGS0?^0+IW_7DG_H(K\4?^"S/_!"'XZ?MW?\ !4^U^,/@>/PG)X/M;;18I6N]
M4\FXW6NWS0$VGI@XYK]L-$MW2PLXQM;R;=8G8'@D #B@#XE_X.2SC_@C'\8/
M^O.V_P#2B.OBO_@RYD2[_9/^-RJY4CQ39.@S@*1:'@^N:_1#_@L/^S/XN_;?
M_P"">'Q"^%O@V+3?^$G\10Q16R7EQY,6%F5LEL'' /:OG;_@W _X)=_$[_@E
MU\$/BAX<^*-KH;77B'6K?4+7^S;TW*E8[?81G:.] 'XW?\%)? WCC_@C7_P6
MM_X3K3]8T75-6NM37Q3:7;Z2YLK>.\>0M$RL<.Z(6S@]<&OZ-_V1O^"F/P=_
M;H^&\FI^!O'NAZY)H;VL&K?O/L@@G>/>5Q)MR.&Z9%5/^"E/_!,+X=_\%1/@
M4?"/C.W73;^-/,T?6H80]YI,IVAG0$@,=HVX;(YK\0?C3_P:-_M"> /BKKMC
M\+O$WA_5O!K2+_9M_J>N?V?>W:[1DR11J54AL@<GB@#ZN_X.MO\ @IQIWPS_
M &=(_@KX!\0:+J&L>,RQ\5V6T73QZ8ZAHG20':I,J <$GVKF?^#)<+_PJ;X[
M.@\N-=9T_P"1_O?ZB2K"?\&E%CX1_8V\;W%UX@;QY\;/$7ABWLM(AU><1V6@
M:DLJ/(\,ZG<PV[U^=2,'I7T/_P &['_!+'XL?\$R_ OQ(T_XI+X?75O$VI65
MU8G3+_[2)(8HV5]WRK@C(H \5_X/4[K;^QW\(_WJK,OB^=U"C!V_9&P*]W_X
M($^ KKXE_P#! +P]X7L;ZWTN\\4:=JVF)<W$9FCB\]I8MQ4<\;\UH_\ !Q__
M ,$Q/B5_P5(_9\^'_A7X81Z"=5\/^(9=2NAJ5[]F3R6MVC!!VGG<>E>U_P#!
M%C]DSQA^PK_P3^\&_#/QPNF?\)!H;7)O([*X\^&(O*S)M; SD'/2@#^?/_@G
M/\=M6_X(<?\ !8B[\&>)/$FE:?X3M]6_X1?Q=K%QIDFRYT]'W-/ #\R98+AA
MDU_4?HOQR\'ZIX9TW5K?Q;H/V&^B2:%WOH\RI( 4.-V>01UZ5\D_\%9/^"$W
MPG_X*GW^@ZOKVH7'@OQ=82"*36M*M8YI[V$ X@<.0NW<=V<9S7XU:[_P:I_M
MD&_NH]+UKPS<:':W,R6 G\3R1RO"'(1BH7@E0#CL: .N_P"#K_\ X*0Q_M&?
M';3?@;X'UK3?$'A?PM(;K48;:U::ZCU=2R&-91]Y=A'"@CWK]DO^"'_[&5W^
MPY_P3X\!^!]3U:/5KP0OK@GMXFACQ>A9_+9&YW)NVDGN*^4_^"2G_!M+X1_9
M$\8^$_B5\4-0D\<?$BUMX[B33+I%EL]$O <^;%*"&DQT^<<YK]8K"T;2SL<D
MJ!A6"\;>P]@!0!_-K_P>E_\ )[WPL_[$Y_\ TJ>OZ#OV1ID@_9)^%;.N?^*0
MTGGT_P!"AK\L_P#@XE_X(D?&3_@JA^U'X)\2_"]O"\FD^'?#K:;>-J.I?9I%
MF,[/@#:?X2*_6+]G7P7>> /@1X)\.ZH(?[2\.:%8Z9<^2^^/S(;>.)\-W&Y3
M0!\4_P#!QG^QEJG[9/\ P3>\20:)K%KI9\(R?\)/.ES:O=/<K C9AC"\JS9X
M/(K\S_\ @UY_X+,^%OV/_"7BKX1_&'Q9H?A/PE9S+<>&UETYUNKB^N)L3J\B
M@DC 7 8#%?T:3Z):W,,T;0QLLRE7#+N5@?4'BOQN_P""KO\ P:B^&?VC/%7B
MKXB?!G5QX7\7:HD4EOX:=4@TJZN=Y,TSS-ET9]Q; &,@ 4 ?J+XT_:'^'_@/
MP1K7BK6O%&C0Z+I</]I2SK?QL5@5-Q;:"21CL!FOY&?^"DW[:^J?M[?\%*-0
M\<:I<66H6JZM;:=HEU90>2CZ?#<D6[,.Y*-U.*^__P!EK_@TD^.'C?XE267Q
M@\=6OA;P6UC*C77A_6O[2N6GXV(8I %VD9R<]JZ7]MO_ (-7/B);?M3Z#>?
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M\RDY() /2OS%G_X-6?VSH8HU;6_"S2LNQXE\3N56,C&,;/3M0!Z9_P '-O\
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M_P &^W[2W[%W[?'@OXC?$+6?#<WA'PZLBW,-KX@:X?YHF10(]H'!(H ^7?\
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M_M/ZM^VA^S7IOQ O/ ^J?#1M;C$ME9:I>17<L]H0K1W&^/ "N#P#R,5^._\
MP=3_ /!0>X^.7C#P;^S#\-]8TWQ!%JE]"_B33HH]UU'J*S)]DC2<D!0P<Y R
M/7%?L]\6O!6I?!?]EC4O#?PA\.Z#=:YI6CKIOAW0]1O'M;%@N%6-I1EE4+DY
M&3P*_*__ ();_P#!LYKW@3]JK4/BY^TK_8^JZA8WK7VBZ%I]]]NMFE8^8L[R
M85PT+@;1R#WH \9^(?\ P;2?$S2O^"3FC:+IZZ#)\2M&U6?Q>^G_ &'_ (F%
M\LL*QC2S-NQNC.7W$[..!FO2_P#@U)_X*1V]CX(\0?LY^.M>T70]<\,W;KX9
MT^:#9+,JL[76Z3.UBKX R1[9K]NKZR:2TN9EA5G:+RU4]Q7X=?\ !0?_ (-H
M?%Z_ML>'?BK^S-_8-GI[:BFKZAHNHZB;"VMIXY4D,:. SLLS!MV>F>* /W,B
M#.@CD=7DC3<6CX5C7\N?_!NQ!O\ ^#A34-[*JM>>)",?>.&EZ&OZ9OA%_P )
M1>?"?1I/%FFZ1H/B>:Q7^U;/3+IKFUL[C^)8I& +J.Q(%?C;_P $HO\ @@O\
M<OV)_P#@K#-\8O&%OX-?PI-/K$N^SU8S7"+<ES&2FT<G<,\\4 >D_P#!Q1_P
M5"_:@_X)F_$/PYKWPQT_P[8_#'5;06EQ?ZCIJ7C2ZCN9M@.\$?( >F/>OJ'_
M ()6_P#!8KX<?\%1?V=9KBZN[#0?%6EVJ0>(='O[F-=I9=IDYPI20AB%&< X
M->K?M[?L ^!_^"E'[/6K>!_&MB/)GW/INH(-\VG3E<"XC4D*6 R,'CFOPL_:
M+_X-$_CQ\-?BYJ$/P7\5:7K7@SRHVM[S5]6&FWT[XS(KQ1J1M4\ YY% '[ _
MM2?LF_L>S?L_>+;KQEX=^&VCZ&VBS#4KW2;>UM[F&W_BDA9%++(.Q4$U^"/_
M  ;PZ3IVG?\ !=+PZOAJWN[SP[9ZAJL=A<-F3_0MLHMV9L<$Q[>3C->P?#;_
M (-4?VHO%_C30+/QUXDT72_!%_.D6J3:?K[75Q8P$_,4C90'('9C7[3?\$M/
M^"+_ ,,/^"7/PUFTWP^\OBCQ)J$K/>^)+^W6*\NX]VZ.(A"554R0",$CK0!^
M.G_!Z:6C_;)^$\:Q^5'_ ,(C/MW#<&_TMNGI7[I_L(>/=#U7]D3X5VMGKVD2
M7K>$=+B$ ND>0,MK'N&S.<BO"?\ @MS_ ,$7O#O_  5,^",DUK)_9?Q)\.VS
M#0=1P/WBC<WV1RQPL3N<E@"1BOSW_P""0G_!O5^TI^QC^WQX!\>_$+4?#=WX
M7\/R2F]M[7Q ]P\<9B98\1[0#R1Q0!YK_P 'L5R)/VIO@@K,LDG_  BEV2P&
M!_Q^5^['_!.S_DP[X/\ _8I:;_Z3)7YN_P#!R7_P1A^,?_!4GX]_#37OAC#X
M;?3O"^A7%A>MJ6H?9721[CS %&TY^6OTU_96\(7WP1_9C\"^#=36)M8\*>'K
M&QO"C;H?,2)4;:W?D&@#^:3_ (*+_P#*TM=?]E%TC_VWK^JI?NM_O&OPN_;"
M_P""!'Q[^,?_  6PN/V@M%B\)R> YO%^GZQ'YFJ;;LPQ>5NS'LZ_(>]?N/!>
MR/=20-'AXXQ(2/NY)Y - 'YI?\'=?_*'36/^QKT?_P!&/7&?\&?MI]O_ ."5
M&M0 [?.\6W\>?3,<8KZ8_P""]/[#'C;_ (*2?L!WWPQ^'9T<^(+K6[#45.H7
M?V>$QP,Q?YL'GGTKF_\ @WP_8(\<?\$T/V*]1^'WQ*;1X_$#>(;K4U73[O[1
M%Y+J@4EL#^Z>U 'X/ZQ>>+O^"&/_  6SOKRSUK1_.M=9\FZU"^TMY;:33[Z1
M6N2BL?O)&Y&X$X(S7]1OPL_:?^'?Q6\!Z9XBT3QEH%[IVJVRW]K,UVB;D;HP
M5B"/IUKXY_X*,?L8_LR_\%L+2U\'R?$#PG#\2-*E,EKJ6@7<%YJMG!$^Z>,1
M;L,K 88L"5Q7Y2_$K_@TY_:FT7XBZM9^ ?$7AO4O"-O=,-&NK_Q(UK=3VO\
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M@O\ @D9^VUXNU3^S_!?B#X5^-,:1<:K<:N4U*ULX9'DBG6!4VF1B5!4G R:
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M -!BK^IJYD:&V#K&TS!SA <;N:_#_P",7_! KX[>*/\ @N3)^T=;_P#"(_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMV$+*LF/E+#(%4[Y$BM&1&6.15WD)QNQS5]EWK@]ZBDL8I9?,9<L%*Y]CUH
MBT:99[".0+M\U=YS5NH8+*.V*[%V[5VCV%34 5[ZU6Y4K*D<D..49<YJK(D,
M3J99?FZ*H^X/3BM(C-1P6<=M'M10%R3ZT 4,-/<?9Y)OWVWS 4RH]*2ZMH90
M&FW13= RG#-BM(PJ<_+][K4;:?"^W*_<SCVS0!7M(-MLA<LK <[FR ?>HS%/
M':[I)(6D#$H^SA0:M1:;##'(JKA93EN>M216R0CY5[8H HS6$-Q;E9E55;EF
M48WGUIL4301?OC#Y0X+A/O+V'U%:1C4MG'M38;:.!"JK\K$L1[T 44M(98U7
M*W$).=LGS8/8BI9S(B>7&T?G=OEXQ5EK.-KA9=OSJ"H/M3C&K,IQRO0T 4KJ
M>WM+5MS1Q[2$8[?7M46G7-F!(D;QM'&-Q7;TSWJ]/80W(.] V6#'ZCI0=/A,
MK2>6NZ10K'U% $,3?9IR&V+"2-@"U<IIB4LIV_=X'M3J "BBB@"KJ(F^5HMA
M7HRD<GZ5 U@L$2R1QR%QRJ$\(?I5^6%9EPPR,YIK6J/NR/O<'F@!MBLJVX\Y
ME:3.?E&!4U(J[% '04M &=%81PSM%Y+$(3(LKD'D]<4LT,CPRR0R*V_[H[@5
M>>%9'5F'*]*:UK&_\/;'X4 5HX L .XJVWJQR,T06KF)?M"Q33+T<+TJ6/3(
M8[9H53]VQW$9[U*ENL:LH'#=: *D,$F&%Q(LCYROE_*0*9';2O-,-VV(]"QS
MS[5<CLHXI&95^9AM)SVID&FPVT>U%PN<XS0!7ECC$2R>4+F2+@8'.?;-6K&U
M6SMEC7=CK\QR>:<ULC,K;>5.X?6I* "J4L$B3KM:**W&=R[>2:NU#-91W!^9
M<\@]?2@"G?VJLJKNF5=WS$/C I8;.,Q;+?A'^])GDX]ZMR:?#-<>:RYD QG/
M:B*PBA555<!3D<T 4[5FGD:..3=';MY;AN33S;(T)60+<-&=VTCKZ5<>W20'
M*_>ZX[TCVT<B[2OI^E &?,%M-,FN#'(KL/.*,V2A]JEL8TDM51V621AO ?DK
MGD59GL8[DMYB[MR[3[BB.QBBE,BKABH7/L.E #K59%MU$S*TF/F*C -24BKL
M7 [4I&X8H R[R4?VQ'&NZ/>AF9@>#CCFK2Q;Y8Y+<Q*K']Y\O+CVIQTN!L?N
M_NH4'/8]:DBMTA155<*G3VH DJ&];,?EYVF3@'TJ:FO$LC*6&=IR* /.?C?\
M-+SXN_ #Q9X+M[ZTL[SQ-H]WID-U)$6BB,T31AF4<D MDBOY9?"GQ)_:*_X-
MO?VKO'.DZ-HVFQZMJ%JMM<ZE?:4;BTU2P6;<DL(W?NPS+D;CD#M7];_D+N)V
M_>KAOCU^S%X#_:;^'NK>%_''AG3->T;6K?[+>13Q#?+'D';O'S#D#H: /QPL
M/^#U+P$/"NGMJ7P.\;7%XT*">=-5M%CDD  =E7&5!;) [5\.?$3Q=\>/^#FW
M]N)=)TNUU/PWX&TZ47%DMS$QL-!L2Q5+F=5($LO.TNG)R.*_<Y?^#<C]CA;1
MX?\ A3>C^5(0Q7[7<=1_P.OK#X+_  !\'?L\^!-+\-^#O#^FZ'I&BVB6-K%;
MP@,D*_=4O]YL>Y- &)^SE\&]/_9[^$?AWP;H.GZ9I5EI%A#;O#9VPA@>18U$
MD@4=-[ MZ\\UWI@D6X&YHTM\8"8Y!J]M&>E1/91O(K%?F5MPY[T 5)X)%N(_
M)W=]VXYXIWV5&$D<A652=P0CMZ58.GPFY:;;^\88)S3OLL?E[=ORXV_A0!1@
M58]TPC:WED^148Y  Z8J172U@+3>6LVW>S;?UJXT*L@4C@=*;/:1W(82+NW+
MM/TH BTJ2*6TW0LK*S$Y QD]ZLTV*)8(U55VJHP!3J ,^VN[7S9HU>-EC^9E
MV_=)-21.;69EDV+#G]V ,5,=/A,SR>6-\@"L?4"GR6Z2CYESQC\* ,PS+_;;
MQ@F-84$K<_*V>*FO;59 K>8L5JW+[1AF/;GTJP^E6[ALQ_?4(>>H'2I)+2.2
M/:R_+C&* *:V2RQB./,4/WLJ<%JCCN5N8/.DE4VK?+@@[@1P*T([2.+;M7[H
MP*<(E ^ZOY4 48[.&01YVW"*<KO&XJWK39@?M2VTDN&F!9=GRXQ5X6D8G,FW
MYRNW/M3O+7.=HSTS0!GW%K"\8^T91E^59%.&/XU+#%]GM\S/&9FX$@7&1VJ=
M]/ADV[ESM;<.>AHFL8IX@C+N53D?6@#.L98S%=+-D_9V,3.QSD59MYX+VU7:
M8Y2V0AV\<5/_ &=#O9MG+/O/N:6WT^&U $:!=I+#ZGK0!5=I7MMK>6UTO()7
MY5/K3+/38(4;:HD:3F3(^4GZ?6K\ELDJ.K+Q)][WIRPJ@7"XV\"@#+$&^5I)
M%^U8/E;$&U54^H-63;+E(XV5-GS%<=CTJV\:NC*1PW6FFVC*[=O;% %%;:'[
M06<^=<]=I^ZOT%$O^BR1AI6$MV=J@G*C'-7#8Q&;S-OS8*Y]J>L"*@7;P.E
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ML-M';QJJJ JC ]J *$8:YF>/SF\ZWP3MX!S23VJ/(&1A;WC?,/[K'W ZUHM
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC-?JEIGB>#6=*MK^SEAO+&^C2:VE@;<LR, 0P]B"#0!J4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%1W,_V:$OM9\=E')H DHK
M/N->57ACBC9IIOX2/]7[MZ5S?QF_:"\'_L]> F\2^-O$VB>%]$25+8WVHW(A
MMQ*^=B;CW.#^5 ':45^0?[6?_!WG\&?A/X?\8:=X#TG4_%7C#17>UTQIH?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M500R$%T(*A=P&,\9Q7]>GCGQ=I?PP^'FI:EK<BV>C^'[)[VXF5/EBMX4+.P
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MSGQQ_9_\'?M&_#/6_"/C3P_I^O:!X@M3:7UK<QY$\9(.TD88<@'@CI7\?O\
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MK=WK5FI92T]G.L;12@J3C<!WYK\8_P#@Z._:/\7_ !:_X*6:UX+UJ2S?P_\
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M75=0B\+>%]0O]0NEBL;&&2[FE8$^4B@NY/L #5F2*ZN8V1K>#Y4W)^\/WO\
M"OA/_@X6_;&U#]EK_@F?XPNO#?BQ/#/C?6/*LM.A9D6XNHV<)<+&C9W#RV.2
M!T- 'Y'_ /!=#_@XOU;]IKXD2> ?@CK&J>'_  'X:N"HUC3;EK:XUJY4G;,D
MB[76':V#&PR2,YK\G]$L]>^*WC2&QM([C6->U:\9@%0R7%W/*WS$GJ26.<GU
MK-4033R.RB:>5\;>P)]*_HD_X-:/^".7AGP;\'+/X_?$#1-67QW>7<\.D:?J
MMAY4>E0JV$N82>7\Z-NK C !% 'Y8VO_  ;I?MC201M;_![5$61EEB/VJWWD
M8ZYWU\D?$WP)JGP@^(-_HNNV-]H?B31+HV]S#-E9+>:-R"WO\P."/2O[K[JW
MCN8O(A5EDA(9"1A6(Z<U^2?_  <K_P#!''PK^TK^SSX@^,WAG0]2MOBGX3MD
MDD@TBQ\YO$$0(01R>@0%GRHSZT ?F]_P15_X.$/&W[&7QK7PY\3_ !#JGCCX
M<^+KF-;N6ZN&DN=(EPL<<B22%BL*KDLBCYJ_IU^&OBS1_BUX/TOQ-HMU-=Z/
MJ4"7=E,KG;/&ZY5L>A!'6OX3;JVFTYX[>[A59B"%4G#P$'!!'KGUK^FK_@U/
M_P""DUQ^T[^RO??"GQ-KFJ:OXV\ [I4FF@4)!II98[>)6&,[=K#D9]Z /D7_
M (/6)U?X\_!/Y4M6G\/ZA*<KRY6YCZU^5_\ P3W_ &KX_P!BS]KWX=_%V^TN
MXUF/P/J;7WV6*54DNOW3H$4MD#!?//'%?J=_P>E7[7/QX^!,DD*LW_".ZBI\
MT[?^7J.OQ/BLHYIK=9O,_?R>7M0;E4=MI[G- 'N7[<O[</Q+_P""DO[1%UXV
M\6W-YJEW>,[V&F6D3M#8PC&$2)20O &['!/->7Z5\+O%.J:IY)\,^(BU]MC5
M8;"6-02><_+S7]('_!LM_P $=?!OP/\ V>-'^,?B_P /WTGQ.\212")-9L/*
M;1K<ED*1J?O+*NUB67/I7ZT+\//#ZG(T/1P?464?^% 'B_\ P3H_9J\)_L6_
ML2>!_!'A>'4;31K#3(]0=+^Y\V6.29%FF+.0. S,<=A7XV_\'%W_  7[\9>'
M_C%K_P '?@KXP\/R>$6T=K+7;JWLBU_9WN\AQ#<A@48*%P5SUK]@/^"M'[6?
MA3]BG]@/X@>+O%K:C#I=UIDVA0&PM_-D6YNXGAAXR,+O89/85_%?!<IJ][!&
M9IWFN2/M-PY+.2>O7K]: -#0O#&O_%WQS::7IMK<:YK6KW*I&D*%IKB:5@.>
MYRS<DU]3?%?_ ((,?M6_!KX;ZQXH\1?"'7+'1_#]LUWJ%Q]HAD$42_>(16+'
MZ $U^O'_  :C_P#!+?X>:'^S=I_[16H1+XB\<:Y<W5G9"\A7R]$CB=HG,9!^
M8NN"=PXQQ7[17WDWU@8W^S7$<PVA9,,D_L1T- '\'_P^\;>(?@WXPCUC1=8U
M;PUK%KNCCN;"X>VN8L_*P#*01Z$5_2/_ ,&OW_!5*[_:D^#MQ\,OB!XXTO4O
M'W@^5;?1TN8V%YJ6EJH+222L3YDGF,1DG/'2O@[_ (.EO^"67P\_8K^.7A;Q
MSX":30[;XF27,E[HD40^S6<\2AWE1B2Q,CN20>!VK\]_^">G[1.A_LP?MH?#
M'Q_K\VI6NE^%=?M[[5/L2%Y9;=&RV%!&X_[/2@#^X0<"BL?X=^.+'XG> -#\
M2:;YO]F^(-/@U*U\U=K^5-&LB;AV.UAD5L4 %>2_MU?$?5O@Y^R)\0O&&@NL
M>M^%M$NM4L"Z[HQ-%&S)O7C<N1R.]>M5X3_P4]/_ !KO^-'_ &*&H_\ HAJ
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MXAAN%=9X)E)6&WV$/#(KH=QR<AL8K]S=-5HK0\^66/[N-NB_[/XU\+?M@?\
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MCS)/F&.,>U?TF? 8_P#%A_!?_8$L?_1"5_-C_P 'F'_*2[PQ_P!B?;_^C9*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO)>]?W*6$PN-"6XCD^T>9&&C)'M7\,O[8D$<'[7/Q.VLS.WBS52PQP/],EH
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MC#"/@C=TSQ0!_'Q%X'UV[GCCET/5TBB?,A%E(/, /3[M?V2_\$8E6T_X)<?
ML0V<UH@\+6P:&4;7AZ\-_M5Y7^R/_P %D/V0?VV['5CX;UKP_P"%VT-XEE/B
M72[72VEW9XC$A^<<8)'2OMCPCJ^B^+/"FGWV@W5C=^'[R$/:2:>5>UGB/1D9
M>"/IQ0!_*=_P=;'/_!9SQK_V"-+_ /2<5X'_ ,$8?^4JOP'_ .QSL_YFO>_^
M#K-0O_!9GQH%^Z-'TH#_ ,!Q7@G_  1A_P"4JOP'_P"QSL_YF@#^T:U^XO\
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MT739+G4+V&SAMXGEE>1PL80 DN2>@ &2: /./VV_VH]-_8T_9A\<?%#4+/\
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MB/X?PZ+:WGBKX>W<TNMFZTQ&C9;F5FAV2L"7X'/3%?J@/A9X4O-1&WPYX?\
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M,.I09PP9<@%PI8*3T)K]GO\ B->^%;7;2'X(_$ ?PJRZC9[@GIG->"_MW?\
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M^8'[8_[5/B[]NKXW>)?BKXLL;7^V_$$T0U*>PM_*MTD"!$"C)VY"]">:\O\
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M^ZJOY;_@9_P:D_M:?#SX[^#=>N]+\"?V5HNO6-_<L/$D1D\J&X21R%V\G"G
M[U_4A0!'<3K;Q;G;:N<9-?QB_P#!=]/-_P""Q7[0BL1&K>,;CYCT'RI7]G&H
M-&MMF1=RY''OVK^<7_@J9_P;2?M1?M8_\%"_BY\2/".E^"Y?#7C+Q!-?Z>UY
MX@CMY3&P7&4*Y!XZ4 ?)/_!L1:++_P %D_AMNC$R"*^(!'#$6[8K^MJVGDM2
MK/:2+)=.)) N!Y?;YJ_!3_@B3_P;U_M,?L'?\%#?!GQ"^(.F^$;7PIHL5TMS
M+8ZW'=3(9(65<(%!/)%?O?ILUU)%Y/\ Q\;6V-)(-C$>H% '\O/_  <S_P#!
M'^Q_8&^-MC\2O!VIR7WA?XG:E<SO8S;Y+JRN_P#73N[X"^6S/\H'(Q7Y\?LP
M_M6>./V._C7H_C[P+JSZ3K^ED-^Y++',@8$Q2@$;D; RN>:_M+_:?_98\"_M
M??"K4?!?CS0;3Q)H6H;1<PW)\MD56!&UA\R\CJ",U^,'_!1S_@T5:]U#5?$_
M[/>KI-=:CJ"?8?"NH,EK8Z7:%<.5N6+,Y##(!'.X^E %;]DS_@] A\-?"I8?
MC'\--6\3>,$N96:_\.R6]G9F X\M0DC%MPYR>AS7Q;_P5U_X.%_B%_P5&T+5
MO MCX?TW2?A==:Q;:EI=C/;+)JMN\0.U))5;:V69CP.A%=)!_P &D'[8$,ZA
MM*\!+!)DLY\2Q;C^&VOT,_X)0?\ !J9X=_9X\0>$/B+\8-4BUSQ9I-L[WOA>
M/9-I]O>;\Q2B=3E]H4'!&#N- '\XLT!L)3Y:LNHR.4>#&UHR.O!K]+O^#17=
M)_P5ZL(69=TOA35]P(^8?)'7Q;_P4NB-O^WU\6EBB@M[>V\5W\,<<  6-5G8
M  #H*^UO^#1^98_^"R^GQQ_ZMO">K'IW\N.@#^IR^\/0WMI)#ED62(PE@?F*
MD8Y-?R=_\'&?_!*6S_X)F_M.6.J^'[Y=2\+_ !#:XU+3X'1WFL"KCS5F<@*Q
M9V)7'05_6I7DO[8/[%?PW_;G^&O_  B'Q.\-V?B+P_YR71BD)217C.Y=KKA@
M,]0#@T ?QF_L6_MQ?$;]@?XW:7X\\!:@--U*RF6YDM6S]EU",?\ +.9 1OCS
MSM/<"OV^T'_@]4^',/AZSCU;X.>/)+\0Q^?-:7]I'%)* -Y4$Y"ELX'I7F?_
M  41_P"#0[68]</B#X"Z[;ZL-8U>01^'M2ECL[32+,J2@6<EF;#<?-7S0O\
MP:3_ +8=K'A='\ Q?O%91_PDT15L'/7;_P#KH ^:_P#@K9_P4WU?_@J9^U9=
M>.K[1QH^BVL)L-*L455N(;4,643,"5:3DY8<5O\ _!)'_@F)XR_X*-?M Z?;
MZ#IT7_",^'[ZUNM;UBZ@,EG!&CAQ"P'S$R!2G (R>:^TOV5?^#0'XT>,_'>M
M+\:M>T7P/H$EH3!?:->PZE,TNX<&/Y0HQDYS7[O?L9?L2^ _V%O@KH_P_P#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_H(6G_AP?_LJ/^(9C_@H1_T$+3_PX/\ ]E0!_4%<ZSI]W$R27%NRMC(\Y?\
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MJ,UU"0BXV^>NT^_6I!XALA_R\6_3'^N7_&OY>_\ B&8_X*$?]!"T_P##@_\
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M#_\ 94 ?U '5=--SYWF6HEQC>)4SC\Z<^N6,C;OM%ON]?.7C]:_E]_XAF/\
M@H1_T$+3_P .#_\ 94?\0S'_  4(_P"@A:?^'!_^RH _J FU>QF'_'Y$GS!O
MEG7_ !IUSK=E<P>6;N%?=9US_.OY??\ B&8_X*$?]!"T_P##@_\ V5'_ !#,
M?\%"/^@A:?\ AP?_ +*@#^H4>(K()M^T6_3'^N7_ !J&35K&1HS]KA7RVW8$
MZ_-]>:_F _XAF/\ @H1_T$+3_P .#_\ 94?\0S'_  4(_P"@A:?^'!_^RH _
MI]M;_3;1E87%NS)D!C,F>?QJS_PDMG_S\6__ '^7_&OY>?\ B&8_X*$?]!"T
M_P##@_\ V5'_ !#,?\%"/^@A:?\ AP?_ +*@#^H;_A);/_GXM_\ O\O^-1PZ
MSIMN[-'+:JTAW,1*G)_.OY??^(9C_@H1_P!!"T_\.#_]E1_Q#,?\%"/^@A:?
M^'!_^RH _J$'B"Q'_+Q;GW,R_P"-+_PD-C_S\6W_ '^7_&OY>O\ B&8_X*$?
M]!"T_P##@_\ V5'_ !#,?\%"/^@A:?\ AP?_ +*@#^H%]8T^63<TULW89F3C
M]:K2S:;)-&PNHD$8P56=0&^O-?S#_P#$,Q_P4(_Z"%I_X<'_ .RH_P"(9C_@
MH1_T$+3_ ,.#_P#94 ?U#+XDLE&!<6V!_P!-E_QH_P"$EL_^?BW_ ._R_P"-
M?R\_\0S'_!0C_H(6G_AP?_LJ/^(9C_@H1_T$+3_PX/\ ]E0!_4-_PDMG_P _
M%O\ ]_E_QI)/$5E(N#<6_P#W^7_&OY>O^(9C_@H1_P!!"T_\.#_]E1_Q#,?\
M%"/^@A:?^'!_^RH _J!&M68@,?VR+DYW>>N1^M,DU*PE'-U#]X-GSUY(_&OY
M@?\ B&8_X*$?]!"T_P##@_\ V5'_ !#,?\%"/^@A:?\ AP?_ +*@#^H.?7-/
MN1^\FM6QTS,O'ZU%%JM@D6UKJ&1<Y&^=#C]:_F!_XAF/^"A'_00M/_#@_P#V
M5'_$,Q_P4(_Z"%I_X<'_ .RH _I\N+_3KM"DMS!)&WWE:=2&'H>:<-2L$E5D
MNXHU52H19U"\_C7\P/\ Q#,?\%"/^@A:?^'!_P#LJ/\ B&8_X*$?]!"T_P##
M@_\ V5 ']/XU+32OS36LC%-A9ID)8>_-$VK64JLHO(T#8QMG4;<>G-?S ?\
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M8\ 4 <9\8OB;J7QR^*7B;QYJ?V)=4\5:G/J%];Q(52%Y&+D@=ER< 9K]P_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M_/K_ ,%,_P#@L]^T5\!O^"Y?_"H_"_CZ;3? 7_"3:/8?V:+2%AY,[PB5=Q7=
MR&;OWK^@02-B/_:/-?RJ_P#!93_E9>_[G+P__P"C+>OZIKBYCL[8332+'''E
MF=C@*/4F@#/DUW["+B[O+B.UL+1&=GD8+\H&6=L_="@$Y]*_"O\ X+0_\'(?
MCO\ X7W%\)?V7-0OKC4-%O3%>ZUIMG]LDU&X&5-M"@#K)'T8.O6N<_X+Q_\
M!?/4?CWXKNOV>_V<;^[U"2ZN18ZEX@TR3,FI2%@IMH&!#!22T;AA@_2OI?\
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MIMY(]?QJSYCM)',TFV/&/+[,3TYK\4Y/^#TCX.ZEO9?A#\1%NE^Z#>6F)?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK<,Q^TY4!F8+\A[U^_-O,L,"B/\ >;O]4AX*>Q]/QK^4KX@> _BG_P &W/\
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M>8%>1[92=DN5(V_>P.M-E^$7_!6*"16ATO\ :&#1\^9]I&Y_K\W2O-?V@/\
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M+JU\>>(?$5[X4OIKC4I]1&GN8([>W.^*V(X6$RQ@+U![\FOZ!?\ @OC-(/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **9/.MNFYCA<XS44.H"<\(W7]/7Z4 ?RK_P#!93_E9>_[
MG+P__P"C+>OZJ1TC^M?C%^W;_P &YWQ2_:Q_X*U#]H#0_%W@^T\+_P!OZ9JO
MV*Y,OVKR[5HBZ\+MR=AQS7[/",X7_9- 'A7[>/[!7@;_ (*#_ O4O!OCC3[.
M:"Z7=:7@4>=8S+DQNK_>P&P2N<'&#7\\7PDN/B%_P;7_ /!6O1/#OC;QA<1_
M"_6KQ'U2:V3[4-2T;>?WHMU)\N4LHX'S "OZBFTL,63RX_(!W*F. W7/YU\-
M_P#!9?\ X(B^$?\ @J;\(;B9?LNB_$_3(F;1]:*X#-@A8)FP6\D$DX'.: -S
M_@J!\!M%_P""IW_!,?Q+IOA/Q-''H^K6":[:WUH@O#*;=#.D.P'[SX"D=03T
MS7X>_P#!NM_P5YT[_@F)\2?&'@GXP:KJWA7P+?0M,;#^R7FNHM4RJ@NF Z#8
M#P<"OU6_X(A_\$M_VH/^"9NM2^%?&GQ!\'^*OA3=!I!I\#W#7&FRC)4VX8!5
M#,<MGK5__@K-_P &U7PM_P""A?B'Q%X^\/R2>#OB5J%I(T<ENJQV6I7I.1/=
M<%F)Z$CL!0!]DVW[=/PIN?AQ'XF7XF^#/[+DT\:B"=7M1<>68_,QY6_=NQ_#
MUSQ7YT_%'_@ZR\)^,OV@?"/PW^ /@QOBGJ7BAULO/U*9]&$=VSD+&-RD$$8.
MZOAW_B"[^/?V?'_"Q/A[OSZW&,?]\U^BG_!++_@V+^&O[!VL>&?'OBB\D\7?
M$O3K,?:!,%?3;"\#9%Q:@@.K+@8)]30!^EG@#4=4U/PCI]WKFGV^FZC-:127
M-K#*)A;3,@,B!A][:Q(SWQ7XE_\ !Y)^Q[9^*?AEX(^.7]N26\GA<+X732A#
MN\\SR/-YI?.5(QC&*_;RXAN8C'';@&!@ 7C^_N[D_4U\P_\ !93X+>&?BM_P
M3=^*\GBCP_INK-X?T6YUJU6YBW(MW%$?+F7_ &AGK0!_,_=?$[QQ_P %D?VZ
MO@_X1T+35L[S3]'TC0K'2YM2_P!$/V&("2;YL*K2(AR,>W-?US?#;P!#X"\$
M:/IL=E::;:Z7:1PI96R*L:,%&<!<#KFOYK_^#1S]E'0?CG^V_P")/'.M3:A9
MZK\-[.'4M'@MR!'<23O)$X8'G 7GBOZ=(+29 WF%9/F!3=V% 'Q+_P '%4WF
M?\$</C49(MDATJ/H>@^T1]:^'?\ @R*_Y-T^.G_8RZ=_Z2R5^GG_  5/_8^U
MS]N7]AGXB?#+P[J-GINM>,=/CM+>:]W?9H665'RVT$]%-?.__!O1_P $A?'/
M_!)#X5_$;0O&VO:!KMQXPU:UO[5]*\S;$D4+(0V\#DD]J /T/;_CWD^M?RL?
M\%=?^5F63_L== _]#MZ_JI,9,3+_ 'CFOQD_;B_X-Q_BK^TW_P %<V^/^D>+
M/"%GX9;Q!IFK?8KGSOM?EVS1%UX7;D[#CGO0!^G/[?\ ^S9_PV)^QY\1/ABV
MI-HL?C#27LC?K%YS6WS*V=G\7W<8]Z_FT_X(*_MXM_P2M_X*.:IX!\?:GJ/A
M?P%X@N[G3-62XTUA+=788PV<C!@&C0LV2W0 YZ5_58\6Z0G;][@G'.*^ _\
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MP5'\26WB+76NO#OBBSMGB.I::%2;42(]L*3L0<HA P!ZF@#V[X&?\%!_@O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\':/Q$CN5/\ PR5X[P>"2MU_+R:_<'RC_?:F2V:3[?,^?8VY<]C0!^'.N_\
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MW/>I* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M 4'K^- &A0#FL5-0G\^4,TN&?Y-HR$'HWI6M:%6@&U@P]1ZT 24444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_@NK\ _V!8+:'7O%D'B35;G4Y--N-,T5DO+S3G52Q\Z,,"@&,9/>O-/V7_\
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MT187"O"3YF_/SYQC /2O-/V4_P!I+PO^U!^SIX1^(_@RWNH_"GC"P%]I\,L
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M<P.!C(&*^TO#GC:Q^(.@:?KGA^_M]3TS44%U97EFXEM[V$]#O'&T^HK^9/\
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M_P"634 ?B]_P0V_X+K_M _\ !0'_ (*47_PL\;:GX8D\)V^FZG=I'::.MO<
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MR1DC'2G?:X]P&[JVWCUKAO@[\<O#?[2GPNTGQ-X)UJUU;2-7A66.ZLY%D0<
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MUGT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM0_\)LVL-K%QI:JVY+/RT0R9QM^]QUS7ZI?MP?'_ ,*_LC?L=^./%GBK7/\
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M.&V@<5_,U_P;<:?9Z_\ \%[=0DO(UNU2V\1.4DC#%'!8J5![@]Z /TP^$_\
MP:1?LRZ'\*-+LO&DGB_7O%5O9I%K-]8:R]O;7,X^^\4;(3&">@R<5^8/_!93
M_@F_)_P0W_:R\%^-_@WX@US3= U;-UID+S3276F/"4W)/.,!TE;^'C*Y!K^H
M^T5%E#1S3E9!\ZA!][U/O7YQ?\'6MO;:C_P2&\63);J+JSUS2E$[Q#>BM/\
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MV_T'X?Z*D-K8V]O':1*J0']VHVC[O:LWXZ64=[\%O%QN+>UNE?2[D&*YQY9
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MOEO_ (,EO^30/C1_V-]K_P"D2U]B?\')7_*&WXS?]>%O_P"E$= '\^O_  1
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MI0!^)W_!GI^TMXL\7?!/XA?"G5GL_P#A$? <T5[I0CM_+N8YKJ5VF61\Y;D
M 8&*]7_X.\?B=J7@7_@F_HEAI.K76CS:OX@B@N[>UN_*:XMS&^Y'12"T9P,@
M\5^?G_!&;XW^*OV,_P#@N1XF\$^*]5D^'OA;Q9KFJRZGIVK*MG'?AI9GLR?,
M (#%@5QC.17N_P#P7;G\'?M1?\%S?V;? .J7EEXET_SH-&\0Z-%<[[>)FN6+
M0R[3E6VD=<'!H ^??^",_P"SSKG_  3D_P""WOPS\":AXYCNK/Q9X8L_$5PU
MH[V=I<I>6)N(X949L.T>[&3QGD5_0A^W5\4]6^!/[&OQ)\=Z \+:YX?\/W6H
M6/G+YD2S(A*DKGD9[9K\<_\ @ZE^ _@GX"?&']FKQMX7T>'P[KUUJL&BWNH0
MRNCFQLE@2"(DG 1$R,^G6OH+_@Y,_;5N/"/_  2[T&Q^&_C_ $*UG\?26]M*
M+._CD;4M-=728)G.Z,L,%AT(ZT ?$G_!J-^S]9?M;?\ !0?XE?%[QQ9ZHWB3
MPOC7M+N+60V]G]LNYI5GRN"'&#PH/%>H_P#!T#_P4H\7_%?]H?PG^S+\&_$/
MVJZOC]A\3:59JT-X-2:4"&U:7*@QO&XRO*G(R:^^/^#<;]D'7?V1?^"8OA;0
M_%":;:Z]K-]<Z[%/92";SK6YV20@O@$G;U7M7X(?\%L-5\4>%?\ @N]\4-<\
M'S7 \3V?BN"?1UM$\RZ6Y6*$Q[4P<MN' YH _4O]A;_@T3^$=M^S[H]Y\>9O
M$FI>/]2S=W,>D:HUC;V"NJE;=H]K NAW L#@UX/_ ,%C/^#9"W_9;^&%O\5O
MV;+[6W7P>ANM7TR[OGGOE"DN;R&4[1&L2+D@9))!%?.C?M]?\%0+_$CW7QI2
M2([XW_X1SKGM_J>PK,\??MD_\%+/B3X8U?0=5/QBU;0]9M)+&ZCG\.[%N(9%
M*NAQ%W!(XH _7S_@V8_X*>W'[>/[)%QX4\;>);'6OB/X++13VRP,LITU2D<$
MTK'(=V;.6SD^E?/G_!X#^W1\1O@/H7PY^&/A;75T7PWX\T^YO-8DMD:.ZF,,
MJHL8D4@A&5R&7!#5PG_!H%^R[\0/V??VG?B]>^-O _BKPK9W?A:T2U?5--DM
M5EE%WEE0L!N('/TK]*/^"S'_  2'\$_\%7/@9-8WC?V+X^\/Q%O#VM!1N1N7
M^S'<=HCE<*&;!( XH _/+_@DA_P;(? #]H3]D+P_XN^)GB35/$OBOQ5;)JL4
M6A:R;*.PM9%!2"6+#$NISEN ?2O3/VR/^#1?X.7WP&\0?\*4N/$&B_$2TC$]
MG)K6I-J%I=HBEG@$05?WC@!58G"DYK\SI/V*_P!NS_@CS\9YM)\(P^+%U34=
M,CDDO?#"/JNGF+<2(FD*%5(*Y( R.*D_9P_X.=_VI/V</C&NL^--<D^)EK:Q
M3VLNB:RXM;<2$;=Q:) VY",X]: /U&_X-QO@7^UU^R9IGB7X??&KP[J'A_X:
M6.G?:=%EU&5+F:WNMZKY:NKL1$$SA   :_//_@Z&_P""8OPQ_P"">/C;X?:U
M\.H=;BNOB#-?ZAJO]H7QNHS+YBOF-2HV ESQS7ZI?\$6_P#@X>\-_P#!2[6;
MSP?XVTO3_A]\0[F3?IUC%,SVFHQ$@*L4DI!>4G/R =!FOB__ (/;GN#KGP/6
M2.-85AOQ&P/S-S'G([4 ?0__  1&_P"""GP#O/@-\ _VD6M?%G_"QFT^U\2L
MW]L'[$;SYN?)V8V?[.:_8.%-B<8'?@5\G_\ !#O_ )1%? /_ +$^U_K7UBGW
M!]* %K^;'_@ZI_:S^(7Q(_X*"67[//\ ;R:?X-M8=-GMK>$&+S);Q5WM<$-B
M5%."H(^6OZ3J_+?_ (+S_P#!!2Q_X*22?\+ ^'\=IIOQ@TU(HA//+Y-OK42@
M(B32'.SRE!*[1DGK0!P_[+7_  :<_LPI\&_#_P#PEFIZYXN\<162KK.H:5KO
MEV-Q.222D6UO+X(X))XKQ7_@I_\ \&H/ACPE\(+?Q%^S';^)%\8:3<M-<:5J
M.I&\DU<97:L#818F0Y;+$Y%? ]E'^WY_P2@U;QQX2\/7'C_1])TO4/MFK:CI
MEHU]I\SI&!YR3O&04"X&1@<5VW[(?_!UQ^T=^S5?ZO=>-)[?XOKJB+!;VFNS
MFU72V1B6D0PH"6;."#QQ0!^U?_!O[I'[27@_]EO4O"O[1VC76CW/A6YBLO#7
MVMEDN[VR\LL[S2AV\QA(2,M@XP*_&O\ X.G,0_\ !=#2U3,<?]A^'R57CK(]
M?MM_P1S_ ."S'@O_ (*I?"%)@]KX?^(VDQ;-8\/[\#=@L7MBQWRQ*I4%\#!.
M*_$C_@Z@_P"4Y^F_]@+P_P#^C'H _?;]N;]LK3/V!OV +[Q_?:O8Z'-:Z%%;
MZ3-=P&:*747M_P#1XBHZ[F7OQ[U_/'_P2._8F\0?\%_?V\?%GB_XQ>)]1DT;
M1$75M?(,J-J$$DK(+6TDR1#L9@0.0!QBOU4_X.J]1>V_X(K:/%M989-9T3=(
MHR5_=OQ3?^#1#1M/M?\ @ED\QB59KCQ7J*23K&-TD8\LJK-UP#SB@#D?VNO^
M#0OX(^)OA1Y/PDUS7O!OBPWD,D&J:Y?RZC:) "?,1HD527;C#9XQ7X-?M7?#
M/Q1\$/VH==\!^-/$&HZY?>"[Q=(T^ZE,JQW$,4NU3&KDD1XS@=*_MEQ<VMAF
M+9</YB@>>=@V]Z_F+_X.U-.6'_@K!H[00VEKN\-Z>TBPX'F-YSYS_M4 ?T@?
M#_Q?8> _V8M!U:\D^SZ?IWA:"\O+H]((H[16=R.IVJ">/2OYK_CV_P 5_P#@
MX^_X*=:OX#\'^)H=5^'_ (;NBEEJ5M$\6G:7I^\JE_- 6!D<YVE@ QR*_H3^
M)\-U!_P3DUQMRI&WPUN#*ZG+H1IC8 %?R2?\$^/C5^T)\%/B=K=Y^S;+XM'B
M;4+ 1:G+HNG_ &F;[/O! ==K87=CG'6@#^@C0?\ @T4_91TOPS:1ZII_Q O+
MU(8DN9(?$;1J\H4!W4&/Y5+9('85^6O_  4=_8%^*W_!O1^V=I?Q8^$NK7'_
M  @LVI>9X?O+B1IHXB,LEE=@L#/@ L> IXIME_P4&_X*C$&X>?XQ75N^8V3_
M (1[KV/_ "QKR3]JO7?VZ/VV_"6G^&/B7H'Q;\3^'].O/ML%I=^'G1+>;:5W
M K&#T)'- ']1O[$/[4NB_MG?LL>$?B!HOB*SUZUUFU1;R[LH6AB^V(JB9%4\
MC;)N![5[?8&0P_O&5GSSM'2O@#_@V]^%'B+X8?\ !)_PEHOB/1-0\)ZM#JE\
MS:;>P-#+$OGD[MKC/S#FOT M+>.%I'C_ .6S;S]: )J_GA_X.LO^"I^L>*/B
M^/@!\//%/GZ/IL3IXIL["&1+R/458@6S.,;HS&P)0 @U_0]7\KO[0%G'JG_!
MUQJT$NV82?%:V5H9%#1O'MBR#G^5 'W9_P $[_\ @U)^!?B7]F#PCKWQ8N/$
MWB+QEX@M4U1KO2]1DL;6*&>-9(X#"RL=\8;:6S@FOF'_ (+]?\$'/"/_  37
M^%OA_P",7P-UGQ%IVEZ3>1V-[8W%W+=:@EX[,T=U',H41HBK@C&<\YK^C^WN
M(6LMMNDMND.8PJ18"XXX'I7SQ_P51TBQU#_@G3\9(KB,7C+X3OI#YL8*K((F
MPQ_NL* /FS_@VP_X*D7O_!0']CVWT'QCXBT_6/B7X+9H=2M(;9HY8M.!6.UF
MD8Y#N^ULMG)(R17R9_P=5_\ !*CX0_#/X&>*OVD+&U\2-\2/$OBBPM;QY-3+
M6165&5ML.W"\1KWKS'_@RBO3:_M#?&RVAW31MH%AO)'"'[3)TK[<_P"#O+_E
M$I=?]CCI?_M6@#XS_P"#=[_@@Y\ O^"@W[#EO\4/'UKXLD\46GB6[LXC8ZP;
M>W"0&,IF/8<GDYYYK^@C0?#+>&M(L;*TF_<V4*6ZA_F^1 %'XX%?F+_P9\?\
MHD_^YPU/_P!I5^J5 %&^TW[5/"TC96-RP7U^M?AW_P '5_\ P2J^%/@#]FWQ
MC^TMIT7B)?B9J&N:78S22:D6L3'(WEL!#MX^51WK]SI^@K\P_P#@[D_Y0V>(
M_P#L:=&_]'-0!\!?\&Y__!"OX#_\%*?V.=6^('Q.M?%5QK]CXAFTZ$Z;JYM(
M1$BHRY3:><D\YK[[_P"#ISPC:^!/^")FM:7IZ?Z+I>JZ)8P!_F8(DH1.?7 &
M37&?\&:?_*,KQ#_V.%S_ .BXZ]'_ .#M ;O^"-7BP'@?\)#I'/I_I% 'XO\
M_!"G_@D)XV_X*?:J5\0ZIJVE_ WPKJ7VO4HTNW6._O  'BA"G]W,48'>5/ Q
M7Z<?M:?\&BWP+N_V?O$,?P?F\5:-\0(X1<VEQJVK/>V[E06,7EA5^9\;0<X!
M/-3?\&;%IY'[!'B]GN-T/_"72;(^.6\E.:_8*^BQ.)&D\E54@8'4GN?I0!_*
M#_P0V^.OQE_X)^_\%4=%^#=U-<:2NO:ZGAWQ3HETWFK:[B-[( VU91@#>,G%
M?N9_P7[_ ."D[?\ !/#]B&\N/#NMV6D_$3Q,/L>A6UY;M.;M"0L[+C #*C9!
M)&#@U^+]_:>3_P '9DG^E--)_P +=52S8'FKQS7UK_P>N:C)<^"O@G"-T<DM
MYJ **N0X"QXYH \>_P""+G_!O+)_P45T;4?C7^TA>>(6\(^*8C=:1$FHO'J.
ML[P,7AG&[*@AEVL-QQ7V+^UG_P &C_P&U?\ 9_US_A5-UXD\/^.H[</IEUJ6
MJ/>6N5YVM$JJ2S ;0<]3FORB_9F_;+_X*$>!_P!GKPGI'PUF^)T/P]T>T6UT
M2.PT7SK8PY)78_E'*Y)YR:[C3?V[_P#@I]:S37#7GQGC7_EH#X<X([8_<T >
MW_\ !N_^WQX^_P""?/[;VM?LP?%[Q!_8GA][DV-KINI*US/9:EA%AMX7!(CC
M8,6V@8).<U_1W$VZ)3G=D=1WK^2O]D7]FG]I#XH_\%2_AK\5/B9\._'4VIZG
MXNLKW7-9N](EC$I#J#-*=H5<*H'88%?UJ1E3&NW&W'&/2@ F3S8F7YOF&.#@
MU\K_ /!7[]HOQ9^QS_P3F^*'Q$\&7&GP>)_#>F"2VFN;;SE :1(^1D9(#'OU
MKZJ8X%>>?M#? KPS^TK\*->\"^-;&/5?#?BBV-K<V39VN =P;@@\$ ]>U '\
MTG_!##_@ESX?_P""Q?QF\=?$+XX^.IM1TC3KP6E]8#46M=6U.[GCWQ2I.Q/[
MM,%2F"3D =*_5+4/^#1W]DMX)(8['XAQF53&C#Q(V%XX+?N^1G'%?EY^W?\
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M/K7]#4=_':K'"RL))!N*Q#<%[\_6@"\UW&A4,P#-QBOA'_@OM_P4U;_@GO\
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MJ_E#_9:_9U_:4^+O_!5'X=_$;XE>!/B%JFK7OB^QN]9U>_T62$!@Z R,0@4
M*HYZ<5_5[\2Y5E^%_B#:Q;;IMTI)'<1-0!_,Q_P:D?\ *;G5?^P#KO\ Z,2O
MT"_X.H?^"I'B/]GSX8Z1\%_ACXJM;/QIXPDV>(+6&)DOK33Y%!@DBE!'ELTB
ME<@DXR,5^?O_  :D?\IN=5_[ .N_^C$JO_P=SPW,/_!7A)K%3]HM_">E2)M/
MS;]TF,#N<XH ^KO^"2W_  :M>#_B5\"+GQ3^T;_PD$OBG67CO+/2-/U!K.72
MXV4L5G;#+*TF5<$8P#@UH?\ !4?_ (--/ _A;]G>X\2?LWQ^(H?&VAE[^[TO
M4]2-Y_:T6 !##PJQN&.[<21A<5\3^'_V]O\ @IM9>'+/[#>_&1=.MX(XH0GA
MP<KM CQ^ZY&W'-2I_P % O\ @J!K:'39I_C(%ER)6_X1WYBA&,']STH ^_\
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MI/VO?AE_PLO]J6^\5:DNL:;;Q>&M+AU1XKRUME ,<K2G>&B>)AL08VXKC?\
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M^/']M/\ 9'^+'[/FF>!_%7Q3L;K29OB-;7&HZ?:7D\C7T21R[)#+$X!C)8Y
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M2I!Y/-7* *>K7$EO!NC9$V]689JK'9K;QW$T,+&XNF!D#'@'&,_2K%WBZO\
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MX5? MFCD\TZKJ &#TQ%'FOT>_P""!$4;?\$<O@ 8RVS_ (1D8R?^F\M?.O\
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M1GO[4 ?A!_P>#?LV>)/ ?Q ^&?[1FC>(ETMM+5/#EI9VH>.^M;@%YA.L@.
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MRY+Q=!7]1FF:?9Z;'#':1QPPQJ%BBB0*L:]E"C@"OP^_X*L?\$$?V@OVN_\
M@K9#\:/"]OX4F\&+?Z1,[3ZNL5T%M6C+_NMI/\)[T ?N-?V^U8]K;2QV@'[O
MXBOSZ_X.=8$_X<V_$:.3:9DN;$C(Z9N%Z5^@6H;G59)/^7>3>%3YB0*^4/\
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MUL_;?OH[B.ZOO"BV;H!(LGC)I(G7/0AEP10!^KGA;_@Y'\"_&O\ ;-T_X/\
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MQ=0B-U0 [P!_=- 'Y%?\'1'[/'BC]D7_ (*4^'_CA'JECJ4?C2:#5].@AM7
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MHQ7Z._\ !([_ ((5_"[_ ()86.IZCH]]>>-/%VI.5&O:K9I;W,$'!$*HK%0
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M ?MI=>!;[XT_L76_A:QO(+$>*/!0TR.Z="5@>:Q$0+ <D MGCL*_FB_X)?\
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M^)6DZS;VMM\*[J1[NP>WDEN+T73(@V%>%"XR<]J\UU;_ ((+?'Z__P""[O\
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MC'CC_@K_ /\ !83PEX&_9_\ B)XR^'_A'4KB+P['?PZC,;&Y,9D8WI2+!".
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MV<'@'3?B.9]5FU&W+V\UD-NYY!@[Q^!K^K@H+V58RL>U>/E;KBOS,_X+E_\
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MW#R:+'"VX20\AW;YB">E7M6D^SVC3?-^Y^;"C);\*BBMT@&5QLD7<RL>1WH
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M&8 X&..*_93_ ()6?\%</A[^W3\ ?#*3?$+PS-\4(]$BU/Q1IL"M;K8RGY7
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M6;@G/ YK]SO^"<O_  3Q\&?\$R_V=--\!>#[8[F=9M3OCD/J=T%VFX<9(4D
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MM?/&4N'"["3NP@Y..*^!;?\ X-<?VVO#EI9IIM_X6MQ"P4+!XQ95B;/ VA<
M4 ?T=?LV_";X8_LG?"'1?!'@EM%T;0]%A6*...\A5YF"A3)(01N=L#+=2:[B
M/QAX=6\:9=5TV29C\N+V-F'LHSGGT%?S)W'_  :T?MY74[22:GX;9Y"68_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMCDU)10!&;.%H6C\M=DGWEQPU.2!(QA55>-O [4ZB@!B6\<1RJJI]A2LBO\
M>&<4ZB@!ODKOW;1NZ9Q1'$L0.U0N3DX]:=10 4U8U0'"@9Y-.HH ;+"LZ;75
M67T(ILMI%-;F%XU:-A@J1P14E% #/L\>W;M7''&/3I2K"J;L*HW')XZTZB@
MQD4WR$ ;Y5^<Y;CK3J* $"*.WM2)"L:X50 >HIU% #3&IQ\H^7I[4NP;MV/F
M]:6B@!H10V[ W'J:1K:-YED9%,BC ;'(%/HH ;+"LPPRJWU%(UO&\7ELBE/[
MN.*?10 V.)8D"JH50, #TIBV4*$8C4;>G'2I:* &F-64J5&UNH]:06\8CV;5
MV@Y Q3Z* $**W4>U->WCDCV,BLO7!%/HH C2SBC<,L:A@, XIRQ*G10*=10
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M9QS3Z* &F%6C*E5VMU&.M--I&2?W:_, #QUQ4E% #6@1X]K*I4C&,=J54"*
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M(^4<=/:B2-9D*LH96Z@]Z=10!'':1PH%6-551@ #I2+90K&4$:[6.2,5+10
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M=2!UJ2B@"/[-'N#;%RO0XZ4Y8E1<*H IU% #?(3S-VU=V,9Q2>0GF*^U=RC
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MV,\<T 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !156\U:.RF6-\^9)]P 9W4&^9950
MQ_-U?T44 6J*J-JR -@-NSA5(P6I8=0==JW$?EM(^Q0IW9^OI0!:HHHH ***
M* "BBB@ HH)P*J"]E&]FCC6,. K>8,,OK0!;HJK/J6R1?+7S%ZNP/ 'MZU)=
MWRVJKEDRQ'!;'% $U%1VUTMSNVG[IZ5)0 4444 %%%% !1110 4444 %%%%
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M26.[E1YH&&RI!_&@#TZBOFG]O3_@JA\'_P#@F_HFEW_Q.\5+I[:U(UO:6=I
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MS)X%\;:1YS6FF><;I;^.$'SW\S ";& &.^:_0LZI-;74 DVL+E]@53]SOG-
M&G17Y[_\%;/^"X;?\$X/CG\/?A_X?\'Z?X_U[Q])]G2!-72W:QF,J1QI(,';
MN+C[V*^SO _Q/OA\&],USQU:6?@S5I+59-3MI;M)(-.EQEE,O"E1_>Z4 =U1
M7X]_MM_\'=_PG^ ?BFRTKX9Z'=?$R:&6XM]5:4OIR6DD;;1M+*1("0>1QQ7A
MT?\ P>S8A>23X(2)Y:Y _MCB3\=E '[ZU%?6_P!KM)(]S1[UQN7J*^7?^">/
M_!7+X3_\%,= OKGX<:E?75]X?M()M:M)K*2(6<DJYV*S#Y\,&&1Z5RW_  6#
M_P""K$W_  2P_9KTGXA-X1;QA;ZUJB:;]C%S]F,&Y&;<6P?[OZT ?G7^Q3_P
M7 ^-'[=W_!9[PS\+M4ATG0?"'@S6];L)8M-WJFJ)%YD<1N 2<D>6",8Y)K]V
M;%YLQK)\S*GSE?NYK^,;]B+_ (*1S?L@_P#!1"3X^2>&UUB.'4]0U+^QUN!%
MO%XTA"F3'.S?UQVK^F3_ ((O?\%@&_X*W?!?Q3XK@\%?\(E_PC.L1Z2UO]L^
MT>:6B$F_.!CKB@#[@HKY?_X*#?\ !6[X/_\ !-K2]-;XA^(([?4=:65;*RM5
M^TS-(D>\"14R8U;( 9A@U^5=Y_P>WPK=2I'\$7,*N56;^V>HSQQL[B@#]]**
M^._^"=?_  6J^#O_  4=LH]/\)ZY]E\56]C#=7VF7<9@>-W^]'%OQYNT@CY1
MT&:^M)=6V>6%W,9_N_+C;VH T**_+O\ X*O_ /!Q3_P[*_:YT_X7-X!C\3R7
MUG:7)NO[1%N(1,2,D;3TQ7+_ /!1S_@ZJ\%?L6_%'1O"?A/PK#\1+Z2P6ZUB
M6#41##I\K*CK&C@,LGRL>0>",4 ?K917RO\ \$G/^"A^I_\ !2_]FY?B-=>"
M[SP3!-?R6<5C<NS-(BA2)E+*-RMNX(XXZU]44 %%>/\ [?/[4?\ PQ3^Q]X^
M^*QTS^V8_ ^EOJ3V7F>7]I"LHV[L''WJ_/G]D'_@Z>\$_'+]GKXG?$'QOX9@
M\"VO@,P0VEE_: NKC5)IE?RU5  VTLH!8 A=V30!^LU%?C7^P-_P=5:G^W!^
MUSX%^&=C\%KVUM_%VHQV=SJ,%\UPNEQOG]\ZA.%&.I('/6OTP_:P_;@^'_[#
MGPTN/%GQ+U^WT72;5U0[<27$I8X79$#N?'? .* /9**_"[XR_P#!YYH/ACXM
M:UIG@WX8R>)_#%C<M%I^J3:@;1M0A&,2F-ERA/\ =-?5?_!,C_@Y1^#O[>NJ
M:/X;URX_X07XA:[/-%#H=UEK6-8S\K?:F"IEUY"]<\4 ?I-15:2["2_?W CC
M:,UE>-/B'I/PU\':CK^NZE::;I.F0M/<7%S(L*1JH)/+$#/' [F@#>HK\9?V
MO?\ @\'^&?PE\<66G_"OPW=?$S3KJ!Y+N[N&?3/L,JOM$0#J=X(&[<*O?L2?
M\'?'PO\ C3XGU33_ (J>'[CX;V\:Q+IUW%(U_P#;)G?:4(51L"\'<>.: /V,
MHKG/"/C*U\:>'++5-)U:SU:QU1%N;6XMV62.2(^C*2#7R!_P6N_X*]R?\$B/
MAEX'U^3PG_PEB^--5GTX*+GR/L?EQ"3=T.[.<8H ^XJ*_,I?^#G3X.^#/V1?
M!_Q \;1_V+XF\;Z+=ZGIOA^SD-\PDA=HUBE=!^Z+L!]X#@YKYF^"G_!YWX?\
M4_$_1=/\<?#.;PGX9O)_],U6&^-XUM$03Q&J98@XX]Z /W.HKX_^+G_!:[X*
M?#/]A2'X_+X@^T>%-4C=-'MWB,=WJ<^61%6(_.%,B[2V"%SDU^9TO_![/"7M
MW7X)LMN6 D;^V>1Z\;* /WQHKYI_X)W_ /!5;X4_\%-?#VH7GPRU2\U"308X
M!J\4]F\'V.65-P0%A\V"&&1Z5]+4 %%17.\_<;:V#CCOVJM;74UK8@W)5FC7
M]XP[?A0!>HK\[_\ @IC_ ,'&/P9_8!OM6\-V-^/&GQ$TM87&B68)MYQ)ZW*[
MD5E&21U!&#7Q]\*?^#T'1_$?Q(TG3?$WPEDT'0IYU&I:DNJ><UA#GYG5 F9"
M/0=: /W1HKQ7]BS]O3X:_M^_"MO&WPS\21ZSHK2R6_DRQ_9[J%XSM8O$WSJI
M/0D8/:O68-4N+HQ@0A2R$L"WW30!HT5^2/P4_P"#HC3?B9_P4'N?@IJO@&U\
M.Z9I^KW^FW/B"ZU=5C46OF9;:P Y\O@9[UY7^T!_P>9>&?AM\8O$&C^$_AG)
MXL\-Z7=_9K35&U VQNU &7V%21SD8]J /W"HK\FO^":'_!U!X%_;A_:&B\!>
M+?#0^'%UJR(FD3W%WYL-U,=Q*NY"K&-HR"3@DXK]7[*X^U0+(K))&P!1U(*N
M#W&* )JSIH9&U%G_ -'6W3EV/WZT:CE&Y]G\+*<^] '\\?\ P<V_M^?&;]EO
M_@HOH.B_#OXF>+O#>BW.AVEY-;V%WY<1+R."<8]A7[]?!;5+C7/@YX3O;J5Y
M[J\T:SGFE<Y:1V@1F8^Y))K^9_\ X.]_W?\ P58\,Q+\J?\ "+6 P/\ KJ]?
MTG? .62/X*>" T@5/[ L0%QU_P!'CH [BBOA7_@I5_P7E^$O_!-FV\0:+K5^
MFO?$"QT\WNFZ':_,MXV[:(I)5R(FZ\-R*^ /#G_!Z[8S:WI=OJ/P<D@L[FYC
M2\N1JN6M8F<!G";,MM4DX'7% '[TT5\\_L2?\%-/A/\ \%"-!U#6/A?XECUG
M3]-F\BXAN(_LMVC8!R(6^<K@CYL8S76?M;_&+QC\"/@!KWB;P=X7A\<:]H\1
MO%TV2\6R66! 7E)D8$ J@)QWH ]:HK\\?^".G_!?SPK_ ,%7-?U[PRWAV;P9
MXTTD-<Q::93<I<6B@!IO,P "&.-O7O7Z!"\DDB<?*K+C!!W9_"@"Y17YW?\
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MJ_F"_P"#/K4YXO\ @IKXNC15DV^%+MAG /\ K4[U_3:FL<R^=Y=O%'%O,KL
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MBBOGS]NG_@I?\*_^"=VB:7JGQ,\0)I-CJER+6)8$^T7.X@G)B7Y@O!^;&,T
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MCC@>M?K+^R#^VUX'_;M^&,7C'X:Z];ZUX?N'91(P$=Q"5.")(2=Z9(X+ 9H
M]HHK,AOIH$D:23SO,D^10F/+'I[_ %KX"_X*-?\ !Q;\&?V%]7U[PG9:FOBS
MXD:.L,BZ-; FV=7Y8?:5R@8#.5Z@\=: /T0HK\ KC_@]MD>YQ'\#V6-7RQ.L
M]5]/N5^H/[ /_!9KX,_\%)+6>Q^'_B3'B73[*VNK_3KR$V[Q22+EXXM^/-V$
M,"5!X&: /KRBLG7O%-GX:L?[0OKV&ST^-"9))2%2,?WF8\*H]3Q7Y0_MY?\
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MCXNW&@P^%['7HYY)K:6Z$@L1$Y7)<@9!"DD]J^._^"A__!TI\&/V3?%LNC^
MK6;XC^+]-U%],U2U1VM[6V5 3YD<V"DGS<?+0!^KE%?B7^R__P 'D7@SXG?%
MFQT?XA> ;CP'X9N(9GDUN*Z:^:-T&501*H)W'C/:OUR_9W_:4\*_M5_"32_&
MG@;5K;6-#UJW6>WF5@)(]W(21,Y1L?PM@T >A45\T?\ !3[_ (* 2?\ !.K]
MCS7/BQ'X=;Q1'HUS;VS6!F^S%C+($SNP>F?2OC;X1_\ !TMX)\5?L&^-/C!X
MG\,P>'=;T'5#I.E^&DU 7%QJ<_E"1<D#<B'D;B, B@#]8**_)?\ X)>_\',6
MI?\ !2G]J+2/AM9_""[T"/4$DEN-5COC=0V05"R[\)A=V,#)%?K- S/"I==K
M8Y&>E "N-R,/;O7X[_\ !RA_P6+^*G_!.[Q?X5^&_P /[3157Q]X:NI9;XAQ
M=:?-YQB5H2#@,!R,YYK]=?&WB+_A$/!FKZMY?G?V7937?EYQYGEHSXS[XQ7\
MA?\ P6Y_X*[?\/8/C_X7UM?!K>#F\&Z;<:(L?VK[0;DM.7\S.!C'2@#^I[]A
MWQ)JGC3]DWX:WVJ7-Y>:A=>&K"[OKB=LR7$SP(7+'N=V37Y"?\':O[=OQ7_9
ME_:(^%%A\,?B-XC\'VEUX?O)-0MM+NO*%Q*+A0K,,<D+Q75_\$:/^#EE?V@O
MBM\(/V=?^%7'36DL8=".M'4]V3;V^/,V;?XMG3/>OG__ (/9[?R/VG_@G)M^
M23PO?$[5VX/VI>I[T ?NI_P3W\3:GX[_ &*_A9KVM74VH:MJWA:PN+N[G;=-
M<2M"I9F/<DG->S5^2\7_  < ?!W_ ()S?\$[/AOHMYJ4?BGXA:?X'TRXLM$L
MSNCN6:)!Y;S)N6-@ Q(/(QBO!?!W_!Z9:^)/%>EV>I?!YM%TNZN8TO+_ /M;
MS6LH2P#R;-F6*KD[>^* /WBHK@_@-^T#X9_:0^%NA>,/!NM6NO:'KEND\,\3
M#< RY =024;D94\BNKNM873T_?S1PQQHTLLSD+'&J\DDG@#'<T :-%?E7_P4
M(_X.J/@_^R5XAN/#O@.SD^)GBK2=5DT_5K,.UG;VBH#^\2?!64;L#Y?7->-?
MLY_\'E7@GQS\9K/2_B-X%G\"^$VMY7N-6@NFOW20+F-?+5<\GC/:@#]N:*\]
M_9Z_:?\ !G[4_P )]!\;>"=:M]8\/^((%GMY(R-Z!AD+(N<QM_LM@BNXMGN)
M9=TFV->?D'.?0YH M445S'Q8^*6B_"/PA>:SKVJ6^C:?8PO<375PP6-%12Q&
M6(&2!@#J3P* .GHK\7_VO?\ @\7^&?PK\9:39_"KPI=?$C2[JW,EY>7$CZ:;
M64,1Y05U.X$<[A6!^SS_ ,'E_A/XB_%BQTKQ[\.;CP#X;DW&ZU5+MKUX< E<
M1! 6R<#CUH _;^BO,OV6_P!K3P3^V1\%])\=>!=:M]3T/6(Q)&V0LL.20%DC
MSNC;C.&P<5U/COXEZ/\ "3PY+J?B34H+"QA2262ZF(CAC55W'<QP![9/)XH
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M(^$>N>.O'VK0:+X?T.W:XD;B2255QGRTZNW^RN30!Z;17XC_ +1W_!Y9X-\
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M_LRR?$[P]\/H?'&C:1*QUP2:DMD^FP?*$D4$$R;F;&!TZT ?5U%?)7_!)/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0!U7_!=__@E3=?\ !&_]H/P?\<O@YKG_  C6@ZYKI?2DL6\N\T.\"-(R0@#
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MN?P_UU 'H'_!P1_P2&A_X):_%;2?V@O@AK$'@_1;[6D:UL+9O)G\/WYRR"U
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MX-M?!K_#?_@N]H/AMY_M']@MK6G-(!M64PI)&6Q[[<X]Z_J^BB6(JJJJJ$P
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M7J,.L"_TYG BOWM%=89)5'5EQD8]:_I[K^6?_@VKY_X.#[[_ +F;^<E?U,4
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M&O\ V)__ +</7[Y^#?\ E&WI_P#V3*'_ --0H _GS_X,^$63_@J+XL#MA?\
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MF)N6",<<\9-?S=?\&N^I+9_\%N]0MY6\R/\ L;7A$53J3(G7_&@#]?OV5?\
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MUH R_P#@WV_X-\O!?Q;_ &?M#^-WQFTO2O'EOX]M!<:1HUU'YUK#;.2#+*,
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MXPVW,UAXGLP6TR,;@GE $$*ZE6Y]J^%_^#MR*2/_ (*M>'Y&B2.&XT#3D!#
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M>TZVN+=/)9L2,CQ\G\^_O7\NG_!"((__  <67TUQ-M:#Q#XB"QXR7S)./TH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 5]1;;"N?[XK/\4SI!X8U0.RKNMY
ML9[_ "&K6J62W<\.Y';8<\/M Q[=ZI^*--^W:'=65M*L<U^KQ+(Z^8(RRD4
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M+#X0_P#!2'0=+TOXIZ'/J$.CRBXM[NQN/LEX& (V&91O,?).S.,\U^1/BO\
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M)OX?_P#!MU=?LO?\%$9OCA\!_B%I?@NRAF,T.D:KIKZEY?G9^UHI+!0'RP0
M83(QTK]6+"%IUC=E,<F-SKNX4^F* /Y0/^"27QB\+_ K_@X(U#Q)XPUW3?#F
M@V/BGQ%]HOKZ410P[I9P-S'ID\5_29K/B_X7?\%1/V6?''A/P5X^TOQ%H&M6
M4NA:E?Z)<+<?9&E3.W/3=M.<&OBC_@KM_P &R7A/_@H7\5K/QYX#U[3?AKXH
MF)76F2Q+VM^H "%88]JH^=Q9N2Q/->Y?\$0?^"5&H?\ !)CX+>-O"NJ>,;#Q
M<VO:U'J:7%M9-:+#MA$>TAB<],T ?@C^PA\=_$W_  0>_P""M-]I/C!O%'AO
MP7_:4MCK&F-$(YM7T_?(MI/(IX,9R) 01QDU_14/^"RG[*>J6<<+?&CX>!0@
ME59-34*AQG'UYJA_P4G_ ."/?P6_X*;:=9S>/-!NI/$6EQNUCJ&GW)LYF9DV
MKYSJ-TJ)P0K' YQUK\JIO^#)?7);V9O^%T:.L+;@@_LB7C/0_?[#CWH ^7?^
M"RO[<VO_ /!:'_@HSI/P_P#A5=>(M>\#V<\.FZ7I,""2-[E"R7-S HSD.@#
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M['_@M9^S%:?#]M8_X7-X,F\K3CJ!LO[13[6Y\KS/)"_\]/X<>M>6?\%+/^"
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ML33P!AYB*=_RLR@C=V)S0!^;/_!:?_@IBW_!57]K*Z\=6.C)HOAS1K<Z5HZ
M$3SVJN662<$D!SDYV\5_7=^S(P_X9J^'O/W?"^FY_P# 2.OS7_X*%?\ !KA\
M,OVI_AWX/TOX<ZG#\.=7\*PIIL%V\+3QWEBH;:LJIMWS;CDRMDD#%??W[)_P
M_P#'WP+_ &?_  SX+\=>*-)\5^(](A6T&L6&F?8[>6VB 6-/*R<,(P%+9Y/-
M '\_O_!Z),LW[=OPV*L&'_"']O\ KX>OWV\'#'_!-G3CV_X5E#_Z:A7Q7_P6
MO_X-_=8_X*Y?'+P_XOTOXA:5X.M]#TG^S3;W&FM</*WF,^0RL,#GI7WYI/PF
MNK3]ENU^'<.H0O=0>&%\.M>F/"@K:"W\S9UP<9Q0!_.;_P &>C?9_P#@J-XI
M=B%5O"EV03T(\Y*_3G_@YV_X)_M^V%^Q/_PD5@NN76N_#"634K#2])B647XG
MVJY<'G"J"W'I5+_@B_\ \&[FM?\ !*S]J'4OB%JGQ(TKQ;%J.CS::MA#IKV[
MH7=6W;F8@XQTK].8K73;U[BQDA^T)@F2.9=Z2!NJG/!'L>* /P,_X-B?^"T_
MA7X#_"K7?@_\:O'=YIEKH\HG\,7.J2I'INDV4:8>T1^"&:1F;;SWYK](OVJ_
M^"Y7[-OPA^ ^M>*M$^+7AO7+O3;61K;2]#ODFOKN:1=J[4/4JQ#?A7@?_!13
M_@UH^$?[8?BK7_%7@F\D^'OC;Q-JZ7]U<JSR:7#%M"O#':IM1-V <KP.?6O
M/@+_ ,&7MEH?Q>TZ^^(7Q.M?$W@VU<F\TK3[26QN+I,$*%E#'8<X.<<XH ^/
M/^"'G[+WC#_@JM_P51N?BE\0=2\77EEX?U!M>O\ Q&L2N9+Z$H]O#.Q&!N0
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M_P!EG_@X-_9?_:<^&[^)&\=Z3\/V^UR6S6/B6X2UO#MQ\X7)^4YX/L:_+_\
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M_'#_ (+G_LQ_"/X3:]XH_P"%I>$_%S:':&Z32M+ODFU"[?('EQID9//KV->
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M]CW2OA3-KEOK[6>HWE[]MC@,(<S/N(Y)(Q]:^E8BP@GA\MEV_P"K9SOWCUH
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M27^S]V) Q!/8_P ZHWENVI8VJ+>XB^Z3R"O<?C0!_*[_ ,$,?^"N-U_P1O\
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M(-VXQ3!U_P!8A!P<4 ?-W_!E 5T[P]\=O.?9_I6FK\_!R5DK]-/^"Y\JR?\
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MKPO>22+I\%\ZQZ?X>O%=VN&<GE'<@*>O(K^D'183I\,B_O8=YX$K^82?7/\
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MH.W=Z\5XC_P4!_9.D_;5_8M^(GPDAU#^P6\::6+!+^8&=;<^8CY*@@G[OZT
M=M\ /VO_ (7_ +5-IJ$_PY\<^'?&4.ER+%=OI=T)Q;LP)4-CH2 37I%? ?\
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MMM64AD>/J3U(.>QJ>"VN(<.S+)([98$\(/05<HH SX-,D@,N[;/O((9SR?\
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M98X]GE.K>9(3\X/;':KL$9AA569G*C!8]33J* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH :9E#[=PW=<=S43ZC%&%W,1O;:..]5[M-EZ+EH3(
MT(*(5'.#3+B\CCVK.&EE;YEB'WEH MOJ,4=TD+-\T@)''''O4L<JRYVG.TX-
M9MQ%#-;_ #32;8/F(]>X%2:3>K-&K+$;:.1OE5AAF- &A1110 4444 %%%%
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M&59P=L1(Y ZT 6I=3$:\+N=ON+_?I\5\LTC*JG<HR1Z5\$:'_P %_/@G=_\
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MQP:C=+";QHUW,D8/WFQV]Q7Y[R?\'@O[,,-W-"VF>.PL>X[AIJ<@'']_J>U
M'ZL/JK0Z@T;PLL)4%),YWGN,>U/EU)4A5U!;)Z>@KQW]EK]OCX4_MD:':77P
M]\7:/KUU)80ZC>6,%PKW>F12C*B9 3L.<K]0:]7CF\NY:XDVK&YVHJ]9,]S[
MT 6AJ:R,NP;@W4YQBC^U5,K*HW*H^9AV->9?M ?M1_#_ /9ETQ=:\>>*/#?A
M73]0#6]G+J5V(&O9HUWM$N>"0O.!7Y[7?_!W?^R[H^NR6)TWQR%M?-4R+IR;
M25./E._D'J/6@#]4(-6FGV_Z*PW.0?FZ+V;_ .M4EWJZV]IYRJ9%WA>/>OD#
M]AW_ (+@? ;_ (*"PZ?'X/\ %UOHNL:I?-86^AZS(EMJ5RRC=F.+)+9YQ]#7
MURMXD2+'&FU61F*_Q\>@H F?6$#+M5F\P[4X^\WI3X-1$DYCD7RY.P)ZU\$>
M%O\ @X+^#?BC]NJ'X!6EGXL/C9=>?PZ5FLE6W,ZYRRMNR>GI7WA;PQ&..2;#
M7&"RE^& H N07*W!?;_ VTU)5;3)A<0LX\KYCDF,Y!JS0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<G(/6@#X]_;)_:TM?^"F'_!8.U^*7AWP[JT&DW'B72+*+"FX'EP7$<8E)1>
MX7<,] >:_=S_ (.;/V)M1_:O_P"";6L7VBZDME)\-9'\420O"]PU^L<97R(P
MO1CNSGD5[/\ \$R_^"-WPP_X)C_".;P_X9A'B+6=0D,FI:]J-HBW5_M),:LH
M)5=N< K@U]4"SABLX;2XMMT,R^6T&SS(C_O9[?6@#^?'_@V(_P""QWAG]E/X
M5:M\(?C!XPT/P?H>GWJR>&HKFR<W%S<W,Q\Y6=<_Q%>"!C-?NU\1_P!J/P'\
M(O &K^+-:\2Z+;:+I,#75U.M[&VV(#)?:I)/T S7Y/\ _!5+_@TVT'XZ:_XD
M\?? _6I/#WB;4IH[BW\+2JD&E&4ONGF,Y+2*S$EL 8SP,5\-ZI_P:D_MI:O;
MR0_VAX1DMYCQ'+XKDVE/0@I^E 'ZI)_P<P_#GXN?M7Z9\(_@UX'USXO:EK'E
M?9;_ $V^BMHG)&9@%F4']TH)//..*^J_^"I]]]F_X)I_&CS(VA8^#K[Y9&#'
M)B/!]?2OES_@D/\ \&W?P^_X)N^-K7XC7FM:AXO^('V&%83>VZ11Z!<E,7'D
M,A_>*Q9ERPY !K[2_;J^ FH?M&?LA_$7P3HJP2>(/%'A^ZTVRDN)/+B\V1"%
MW-V&>^* /PU_X,GC&_QX^.#>5*K+H6GG[WRDFXD[5_0XYFLK:-0L4D;N$VJN
M  >M?DO_ ,&WW_!&OXU?\$OOBE\3M0^*T?AMM-\4:7:6=C_9FH_:FWQ3,[;A
MM7'!%?K9?IF>/_6>6B[\*N<D4 ?S#?\ !TW%YW_!:W3[8S0Q00Z%H<FYDR1F
M1^ :_HA^(/PUF^.G[%&I>#[>1=,NO&'A0Z4ES*"Z6[S6OEJ[ <D#.<"ORK_X
M+A_\$&_CY_P4,_X**6/Q4^'Z>%5\/1Z=IMI,FH:I]FEQ;NS-\NP\\^M?LOX(
M\/WF@^&]$M+J3RVT_3HK:2&+YHW=44$Y]B#B@#^5;_@E5^U!JG_!%#_@JKK7
M@WQ5KEE8>$+O4G\+^,-:N;)]LMC;N[++ #\\>9%7D \'%?TS? ;]KWX8_'GX
M5:7XP\$^-- U;PSJ086<[7"Q,_S%3D.0W4'J*^8/^"LW_! 3X7_\%/\ 6]'\
M23WEYX&\;V+LLNKZ79I-)JD01@D,P<A54,=VX#.:_'V?_@TW_;&T34KBUTO4
MO"+:7#*ZV:_\)2\/[O<<,55,!L8./6@#]6?^"A'_  <R? G]BV^7P_I*WGQ1
M\20ZD^EZGI>AWBVLFFNHY8O(I5EW?+\I[U]L?LL?%#5/VA/@SX?\::IX/U3P
M%-K,'GG1;^YCN+B!#@HV^/Y?F4AN/6OQQ_X)O?\ !I!#X:\3Z=XJ_:*UJ6_U
MC1=1-U-X;T]EO=-U>W POF7'RR!BQR0.FT5^XFEZ''X0T*PL[>-X[&QA2U@C
MB&XQH %08_V0 /PH _F%\ 7,2?\ !V99JL;+Y?Q?D9W9NO#5_4<(XM-C9N!&
MQ&,#N:_$7P7_ ,$!_C=I7_!==OVA-2M_"\O@%?'#Z]$RZGF\DA.<%HMO!YZ9
MK]M8(Y%G$K;EA4!1&!GVH _FQ_X/.6N(_P!NCP+<?8KQ8&\*+$9\'R6_?N=N
M<8W5^VW_  31_:'^$?CW]B_X?R?#G6/"MKH-OI-O;W MVCM%6[2%%N,H=IW>
M8&R<<GGFLS_@K-_P2B\._P#!5_X5Z'X3\1>)-4\,6^DZF+U;JQL8IYFPA782
M^/EYSUK\-]=_X--_VP]$\3ZA;>&M4\)QZ)#=2)9D^)V@:6 .1&[(J85BN"0.
MA- 'Z)_\%XO^"YOP;\ ?LU_%#X0Z#KUKXB\<:I#-X9N]-M6^;3V=,F=GV[61
M>!A3GFOEK_@RPD6U^)OQU\E6;S--TXL ?ODRR9P>U=9_P3P_X-'+]/!WCZ?]
MHC5+5O$>N02:;I*:;<B_CL ZJ1?"1MI,RL" K94@UZU_P0G_ ."0O[1G_!)?
M]I/QC'K6C>!]:^&/BR1K>;5$UIFU2&WA>1K=U@5-I=P5W G R: /O?\ X*T/
M;M_P32^-=FSR)(O@^^?DG/$9ZGO7XW?\&3.HK;?'/XXK)A6DT/3E4@<'$\E?
MMY^W'\,M:_:0_8S^)7@G0+.%M:\6^'KJQTX7;&&-G="H$C8.WFOSV_X-P_\
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M& QP: /!?A3)XY_X+L_\%LK;4KC6M'TV:35OM$6L1:8XM39V$FZ$%5.0TD:
M D]3FOZQ[(10V$<,DLFV ;"23N)^M?*W_!+?_@C_ /#7_@EO\,;K0_#(F\1^
M);MB]]XCO[58;J]&28T(4E0$SCY<9'6OJB.UO&V^9%"TC18<[NA]* /Y:?\
M@BSK.E^'/^#B.\DNIXXT7Q-XA)NI)1%%'F2XZ[J_HZ_:I^&$?[97['_CWX?^
M'?$FC^;XNT2XTF*]4?:([:21<!F"G/'IUK\F/^"PW_!K=XD^)WQH7Q]^S:ND
MZ7=>()WFUK3[N_-C':2M\S31/\S.TCLQ8' ':OKK_@WC_P"">'Q9_P""<O[/
M7C[PQ\6)+.37-;\01W-E/8Z@U\HB$"H3N8#'S#I0!^,W_!%']KZ\_P""2O\
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MW/(YK]X?V7/V2/!O['OP@T;P1X'T.RT?1=&@\F)(01YA(^=V)R2S-D\D]>*
M.P;QWH\NHK#;ZEIK7LC[!;+>1^9N]TSG/MC-:-CK#S^5Y2M/#M<R2#C:1VYK
M\6/ ?_!"7]I#PO\ \%NK?X[WFHZ"WPNM_'<NOM;_ /"0.9C9,& 'D[<;N1\N
M:_:VQF$T7F186'')[C% $VEW)N[?S#&\>\Y 8YJS5?3P#"760R+(=R^PJQ0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJO=ZC':
MQMO<1\A 6X&3TJ*2]DMH9';:_EIDJ#R30!=HIL;;XU;^\,TZ@ HHHH ****
M"BBB@ HHHH **** "BH;^1XH,JRIZLQP%JO'J8BO7CD8[<;@<?*./6@"]15,
MW;221%9(Q&YX.X9?V%-M-64Q/YC;65MN6&,YZ4 7J*1#E!W]Z6@ HHHH ***
M* "BBB@ HHJC<74D9GS(JE5!" @L.>N/>@"]156#4H[A8P&VO(,[6X/Y5:H
M**AO9I(("T:"1E/()QQWK/N-?40M&K2&>3E0$^[0!K45#9S>>I;+=!P5QBIJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BL^YUN.S-Q
MGS7:%2^T(>GMZTRYUOROF'S*R!L*-S+D=QVH TZ*SX=4_P"):UQ(VW:-[H.=
MGM4VGW[7A^9%52H8<]0: +5%%17<WE1?*1O;[H)ZT 2T51_M7#*LA5'#!6 .
M<&KB/O'Z4 .HHHH **** "BHKR5H8-R*"V<<GH/6J]W<S0V#20>7<2*N5&X
M2'TH NT55M;QKBUCD;,>>&!'0T)<3B=UD5%A3HX;)/X4 6J*S]3U"XLX8_)C
M\Z20\ G QZYJ:>=XHO\ 6)N'W02/WE %JBLU;V:58WD98'4G=$I#%QVJ22\D
M@55;YBJ%V8=\=J +U%4[R^DM=.\Y0'; ;:W&,U"FJ2?9_,;9QQ\K;MWN/6@#
M2HJE!=O/9,8FWR=MXVG\J9%J+,6C5F:2/AMR[5_.@#0HK.M);N*1I;AE,;'
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MM[X]: +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 45'=RM#;2,J[F49 ]:JWNI/'Y<:JWF2#)..%H O45FW-Q<0QLHD5HV
M0D3#JI]AWIJSW5HO^N2X;:"0Y$>W- &I14=N6,*[\;\<X-24 %%%% !1110
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M: '453>^\Z640R1GR_D;YA\K5);79EN9(RO^K4'/KF@"Q1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%,N S0MM;RV[-Z5
M]Z6C4*5!;C+';S[4 6J*IZ;.UU/(WFNR1_NRK)M^8=35R@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBFRJSK\K;3ZXH
M =169/JK16DRJ_[V,_>E'EKU]3Q5FYOO(@#<MN(7*C.,T 6J*S9M6$\4T*R/
M#-&H._9TY]*T(&9H5W?>QS0 ZBBB@ HHHH **** "BBB@ HHHH **S[G6#;3
M;7555G$88'/)I]S?207L<<>)-_# G&SCK^- %VBJ9N9)U";Q#(RGD?,H/UJ.
MQU&1H61PLDL)P64Y##U^OM0!H453&JYO&CVG"C(.."?K3KN]>VL&E"!I,95,
M]: +5%57NF-N-W[N3&\@?-P.U36TXN8%D 8!AG!&#0!)10:IZC'-,C+%<_9Y
M&7"\!MI]: +E%9^DZL-02-E9BK97$B^6^5X) /-:% !1110 4444 %%4;G46
MBO(8V+1DL>,95AVY[4V;5EL6W3-(VZ01;43=M)Z=.WO0!H4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1145[<?9;5Y-I;:.@H EHJA#>L$B3S%
MDD;+'G&1WJ1-21K_ ,O=(>/[GRC\: +=%44OC=+OADC:-FPIW#G'6K%G=FZ\
MSY=OEN5^M $U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[ HW?-@'GC.:_:;PKXJTKQIX;M=:T._M]3TO5$6:&[MIA-%("."K*2"/H>M
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MI\8OCE_P7E\"_ KSK'0_!>A_$6XTR9],#QSZK;I%*HAG))#(" V,=17ZA?\
M!7G_ (*(_P##KW]C2^^*O_".KXH^RZI::9]A,YAW>>S+NW 'IBOY3_A?_P %
M)9_ /_!52']I./PW'=>1XHF\1G1#<[5;S X\OS,<8W]<=J /[1M(>9[%3,K+
M)DY#=:M5\#_\$1_^"RLG_!6[0O'ET_@R+P:O@FXMK<(E\;O[49D9LYP,8VU[
M-^WO_P %/?A1_P $V/#MCK'Q0\2R6<.K/]FMK&RMC=W._:6WLB?.J$ C<1C-
M 'TE17X!ZM_P>T&T\074=K\%+>XT^.:1+6=M996FC#$*Q79QN&#CMFOT(_X)
MC_\ !>KX,_\ !1:]TKP[I-]-H'Q"OM.74-1T:\5HX8IRVTP0S/@3'I@+R?2@
M#[THK/6#9YDF_P [S"-P#?=IL\K-.K))NAV;0@[M[F@#2HJBA:6\\E7VK&N9
M$ZYR/6OS1_X+3_\ !?&[_P""0GQD\*^$(/AZOBN'Q#I3ZD)9-0:':%E,>/NG
MTH _3RBOS2_;@_X.2?A%^QW\-]*AU"SU*\^*&K>&M,\1P>'/(E6U=+R%950W
M0&T;5)[=J^0_AS_P>B6/B?QQH]MXF^$RZ'H-Q=Q_;;Z'4WG>S@SAG"!?G('.
M.] '[TT5P?PE^.OASX_?"/3_ !IX-U:WU3P_K-O'<VUW XE(W -L903M< C*
MGD=Z^#_^"V'_  7JD_X)&_$GP7H=K\/X?&B^,--FU&6=]1-K]G:*41A5 4[@
M<YS0!^EE%?D/^VS_ ,'1_@G]E_X=?#_5/#_AFU\7^-O%&DVVLZOH\.I$6VE6
M\\6Y%$Z@JT@;*LG#+CFOHC_@C/\ \%6M:_X*U?#OQ-XAU7P'>?#NQ\.7L-O:
M"21Y8=5#HS>8DK*H(4KC"YZT ?>%%?GW_P %-/\ @X,^#/\ P3JDU[PO>WTG
MBKXG:;9"]T[1;)&>VN69MHBDN(\K&P 8D-R,>]?!_@G_ (/6(]4\3Z?%K?P9
M72M)NKJ..\O(]5>9K:(L SA=GS%5R<=\4 ?OI17SE^PK_P %*_A7_P %%O!>
MH>)OA?XB;5++29VM[BWN8?L]X=N/F\ACO"'(^;&,UT_[97QC\=? G]GS6O%_
M@/P?I_C#6-"B-V^GW>JK8QFV4%YG\Q@1E44D+WZ4 >S45^>O_!&__@O-X;_X
M*LZ[K?AJ;1)?"/C;0@;I],B+74$MID+YOGX !W'&VOOBV>]NEVN%C7)RV>H[
M4 6!NCN)&.UG_A ^\5KY&_X+3Z%\6]7_ & _&$?P%B\3-\4GEM39+H#;;XIY
MHWX.1QMS^%>0_P#!1K_@N%K?['O[<O@'X"^ / FB_$/Q-XVC2.%SKB6_V:Y:
M1D$$N =AXS\V#S7O'_!1']N/5O\ @G;^P9K7QBO?"\.J:II<=G]IT87F%2:9
ME61!* <A68C..<4 >#?\&YWAC]I+PY^SWX^B_:>M?&\/B2^UY'TT>)WW2&V\
MA00G)^7?G\:_1>TV$H553R4RG0 =J^)?^",W_!5UO^"M/P1\4>*I/""^$DT3
M5TTE[1;PW'F[HA)Y@8@$8SCBOK_XB^-="^$_@J]UO7-2M=)TC3;=II[BXF$<
M:JBY^\Q R<8'J: .FKFOBW+-:_#_ %BXMY!#/:Z?<RQRC[\3")B&4]B"*_'_
M /:[_P"#Q#X>_#SQ3IEI\(?"<WQ"LVM)'U2>_D?3#9SJY41H&4^8"HSD5Z+^
MQ;_P<Z_!W]MCX8W'AGQ8K?#OXA:_#J%K;Z9-NEL]JPL4=KIMJ+N&>#WP.] '
MQO\ \&V?_!0#XQ_M&_\ !6'5?"?CKXC>)O%_A^#1]5F6RO[QIHO,CD4(X!_N
M@XK^B6&4RALJR8..>]?RY?\ !J7*MK_P6=U:8A65=!UA04;=O+2(0>.WO7]-
MGC#QSI7@?3M0UC6-4MM,TW2;;[3<SW,BQ00J,\EV(7\,]: .DHK\7?VS_P#@
M\#^&7P=\:Z9I_P +/#=U\2(_)N(M1O;MI--%G,K[555*D2 C)W#TH_8Q_P"#
MO7X<?%3Q+K&E_%CPG<_#NQAM8YK&ZM99-0:_G>0*4*A1L 7YLT ?M%17+^ /
MB-IOQ#\.6NM:/?P:EI.I11S036["1 K*"!E20>O/H:ZB@".Z!:!E"[MPQBN'
M^,GQ.\/?L^_#F\\5>*=8L_#NAZ-$9[R]N6*VEH@ZN_?:*[BYA6>/:W R#UQS
M7P;_ ,%\?V:_CE^UQ^QZ_@/X*QZ?=2:Y=O;^(8KNXCM_-L6C.55G[[L=.: /
MRS_;)_X.#/VB?^"B_P :=?\ @_\ LO\ A_6TT_4Y@VDW.E#_ (GDOV4DS21.
MK;?*;&?7:17C*?"[_@K3+</&UK^T4V/O 7/7_P >K]D?^""/_!)1?^"<7[-L
M<_BS0;"Q^+NM3N=5O%E6\5(5<^6(WY"90X.W&>]?H3-''=M*J?Q+AG!Z4 ?A
MM_P29_X.<_$7C?XY?\*O_:+@T[PK<JJ:-8:M@Q10W4 ,4BW18DF5V4 ;1]XF
MOV]TB.+5-(M+NW/VB.3$B-)\Q ]J_GC_ .#P;]D_P1\&OB3\/?B!X9TV'1?$
M7BYYHM3N;)MB3^0J>61&N C9))8<DG)K]<O^"&VL76O_ /!(?X!7%[/>7U]<
M^%X8[B>>1GD<EY/F+-DL?<T ?CO_ ,%G/^"B?QL_:(_X*VZE\/\ ]E3XD^+O
M$$,=A;6EKI?A&](!O88V%Y&5./G1E(;W%>7W/PY_X*U/>K)!IO[1"QK]T&X'
MS#W^:LS_ ((N-:V/_!QU<--)Y$MMXL\1,'?A2HDN,DD\  <Y-?TLO^UK\.W-
MXLOQ*\!VWV>7"$:]:,6&/3S.N>U '\V4_P +/^"M5RK;]/\ VBB7/S W VX_
M[ZK^@7_@E79_$;2O^"=_PSM/B[:ZU;?$BWTTKK7]K'-XLGFO\SG)Y"[:]S\(
M>--#\::2NM>&M6T[7[*X/E27=C>)<P@KU *$C()Y':JGQ<^*>G?!GX8^)/%W
MB*9K+0_#=G)?7$\,?GN((U+.P0<G&#Q0!^5?_!?'_@X1\0?\$]/C?I?PQ^&6
MCP7GBB.Q2^U34-17S+6:WGC81K#M(82JRDDGCI7YD_"?QM_P4X_:B\!6_C#P
M'>?'#Q%X;UJ5I[:]L+G=;S*7/"Y8?*.1^%=M_P $=/A/JW_!0_\ X+OZ[\2M
M%MXO%_@CPKKMSKVH3:Q(&,6GSO,D&()<[AD@; /EK^FC0-!T_P (6UK:Z;I^
MGZ18JI BMD2"*,YX544 <^U '\TG["G_  <?_'S]B+XM6/P[^,BZAXRTNVUZ
M2S\0PZFQDURT/W3%&S,$7:X'![9K^FOP=X@C\6>$M,U2)6CBU*UBND5OO*KH
M& /N :_%/_@Z]_X)167B_P"%5I\>/ 'A>PM=:\,RM/XNOUNUMM]B%VQD1\!G
M\UP21\QKZ,_X-@OVP-)^/_\ P3AT7PG!K&H:EXH^'Y-KK$ET'D8&1WD0!V)W
M?(,>U 'Z9'I6?;1^9(S>8) S?)OYP.]5Y;V2_A8Q6^^-QM8M)L(K0"[%QC;A
M>@[<4 ?SS_\ !U'_ ,% ?C+^RU^WSX=T#X;_ !/\6>%=)NO#T5S/:Z;>F%#*
M9'!R![ 5^[W[/=_=W?P*\$WE]=3WES>Z'8W%Q=7+;GED>WC9B3ZDDU_.#_P>
M4J$_X*1^#]HVY\(P$X[_ +Z2OZ.OV9Y)#^SQX 29E*R>&M/^3^Z/LL?.: .Z
MNG*7*QJ[98[CGT]!7S/_ ,%7OAU\0OBA^PKXZM?AGXQ7X?\ C.S@%_!KB2/&
MT<4&9)(PR@G+(I7TYKY]_P""QG_!P=X'_P""66NZ9X7TK3;;X@>,;P>9<:7%
M=^7'90<@L\J[L.&&-AP<'->D?\$YOVROB%_P5"_97\4:[XR^%_\ PK#PYXFL
M)M-T:66\,]S=^8CQ.[0LJLJKN#*3PPY% 'PO_P &K/\ P50\3_M&ZIXJ^%/Q
M'U;Q3X_\81R'6K34[^X$ZV-JBK&8QGYA\QS^-?MM#.D96.1E9YBP"]SCM7\P
M/_!+36YO^"/'_!>S7/@[:HOC9=4UH^!OMSG[*P61D;S\#."/[N:_IVM8/[4C
M?>8SM 541P?+(_VA0!\R_P#!7/\ :8L/V4?^"?\ \2/$6I>*+?P3J5QI<^G^
M'+@R&*:2\="8HXR ?WA(.*_F=\,_\%*_VP/#GAWP7XY\1?%3XF1?#KQ)KG]G
M6^JW>H-]BNFMY$-Q$IZ[D4_-QWK]./\ @\N_:V;P]X%\ _ V;2UF3Q$4\4-J
MWG8: PR/#Y0CQSG.<YKS7]NC_@D);?!?_@W7\ ZS!XTFU%_A]<R^,XDDL1&+
MIM66 &$\\"//WN] '[K?LY_'#0?CO\%_#/BSPSKEKXD\->(+*-[;4('+K,<;
M20?]X-^5>@;8[=E0,TC1G)9C]W-?GK_P;1_M#>#/C)_P3"\&^%M!N[B?7OA?
M"FA^(D:%A%!=2,\RJC='&Q@=PZ'BOT \4ZHOAKPSJ5[!MD;3[62Y*$_?VJ6Q
MGWQ0!^!/_!?O_@J!\2/B-_P4Z\)_ ;X)^,O%'PYU71;Q/#^L74%UY4%[=W$D
M;1383)VJKX.>:_=/]FKP;X@^'_P1\):+XLU(Z]XFTO1[:UU/5B2WV^X1 'DR
M>3DY//K7\T/[&%NO_!8W_@X>U+Q;,S^!W;4I/$GV>./[8'^P-$OE[CC&_;U[
M9K^H:QWV+>6R^6TCE5 ;=@?WO;- &K16*^K+9ZZ+?=)(UXC.C*A*Q;>.3TKY
M]_;[_P""K/P?_P"";?A[3KSXFZ]-9W6I2-':VUK ;B=V"%@S1I\RJ<'YB,9H
M ^G**_ +6O\ @]:-OJK+I_P7BNK-II(PSZPZ&1 Q"/\ <XRN#CM7T/\ &W_@
MZ4\(^!/V&?!GQ7\(^&;;Q!K&N:P=%UCP])?F*?2I%A\QG'!9X\X4/@ GO0!^
MNU%?,_\ P2]_;J7_ (*+?L6>'?BM+H?_  CBZ[/<1G3TN#,83%(4SNP"<XST
MKT;]I?\ :?\ "?[*OPBUSQSXWU6/2_#NAV374^[_ %LJ+U\M<Y=_]E<F@#U*
MBOPY_:D_X/&?"O@7XMW6F_#?X?OXT\,6,,+P:S<W;V+RLRY=#$5.-IXSGFO8
MO^"=?_!U5\(/VM?$=MX>\=6<GPS\6:UK"6.FVQ+W5G<HR\227#!4A&[(YX%
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M <J4^4LH!QVS0!^_%T2+=L!B<=%Z_A5.QU#S;1=R3;6+*QD_AQZU^+?[+O\
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M+920%XY[YKOO#/\ P<0?!/\ X*&?L1_$'PO)=2>$?B1KG@W5)9]$N0RVL3K
MZA5N7VJS$%< <DGVH \/_P"#2']NGXN?M9_M,_%+3?B;\2/%'BZUTGP];7-C
M!J=X9E25KG:2 ?\ 9K]X)4\J>-O,\M<X?;QDGI7\Y_\ P9/V9M/VM?CE'(%:
M2'PI:#(YP?MG8U_1PW"M\N[C./6@"Q167=W<J>2J1M^^X4YSM;WKG_B;\6-&
M^!OPXU'Q+XSU:QTG1M'MY;N[N[B=8@ BEPJ[B-S$ @*.2>!0!VE%?B-^UM_P
M>0?#?X?_ ! BA^%?@N[^(6@S60,U_>S2Z7)'-DYC$;*20!@[O>O/O#__  >I
M+-XAT[3]8^"L-AI4US$MU=1:T\S6\3,-S@!/F*J2<=\8H _?JBOG_P#8<_X*
M)?##_@H_\,]2\7?"W5=1U30M$OC8SRW-B]K(LP4-@(W)&".:]GO9$M8[BX>;
M;#!'O8R-Y:1*1\S%CQP.?:@#9HK\H_\ @HI_P= _"G]CG5+_ ,,_#L2?$7Q9
MX5U+[!JMD=T%D4499XKH!DDZ@?*3FOEOP]_P>SS7.M6L-Y\#X;6QFG19YEUE
MG:&-F 9P-G.!DX[XH _H HKYB_80_P""GWP9_P""CWAC6+WX7>))[FXT>X6.
M\M;R%K:Y238&RD3G<Z $?,!C-=G^UY^U_P##W]A;X2S>.OB1KG]CZ%IH#AD_
M>W5T[8!$<(.YR"02%!P* /:J*_!_XX_\'FFG_#[XJ:UIWA3X8CQEX5CGW:3J
MEQ?-8S7,0 ^9X2I*'=G@^E=]^QC_ ,'@GPR^.?BW4M,^+OA&\^&MBD</]G75
MF\NH_;)G?:58*HV*!@[CQS0!^T5%<OX3\<Z+X[\/6>M:'J$.IZ?J<(N[>XMI
M!+%)'CLRDC/M7$_M3?M<> _V-OA)JGQ"^(^K0Z+X;TN 2F02![BX.0"D4.=T
MC#<#A<G'- 'KU%?A7^T%_P 'F7AOP%\7-3T?X>_"^3QEX1MG4V.K7-])9378
MP"28BI*X)(Q[5]"?\$\?^#H_X._MF:OHGA7Q=%+\/O'GB/4VT^TT^7=)9(NW
M<LDETP5(\X(PV,<>M 'ZH452L+^.]MA+ \<RLJE65]R,"."#T.:J>*/$^G^%
M-(N;[5K^STNPM8O-N+FZG6&&!?[S.Q  ^IH V*@OU+QC[OEY^?=T(K\?/VW?
M^#NSX3_ W7;71_ACH-U\1KF&6>'4FF,EBEG)&VU=C8(D5L$Y'&!7DOP3_P"#
MT;3?%?Q)T.U\8_"9/#_ANZN%@U/58-3>ZDLX?XI%A"Y<CT% '[IZE%#<1*MS
M&IA7&"1\I/;%?B1XG\!_MY2_\%V);V"S^+TG[/</CY9XG$H_LG^S!CH,_P"K
MZ]J_9/X;_%_0_BEX T_Q9H>JV>N:#K$,4UM)9NLP4. 0#M)PPR 0>5/6OS6\
M0?\ !Q_=:-_P5U?]F-?AK"!'XQ7PL^M_VF2Q!Q^]\K;COTS0!^J"B&6</MCW
M3+ALCYFQV_"K=N<PKPPXZ'K6--K45C=J?+6.U"N\D[MM$6T9).>@]S7YD?\
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M"D-Q_P %5OV4X_B@WA>/PFW]L76E_9%O3-M$.WY\D#KNZ8KT#]MK]O?X2_\
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M!^O5&:X+XR?$4_#7X#^(O%<-O'>+X?TBYUA(EG^6X\F)I0F_T;;C/O7YA?\
M!/[_ (.HO!7[3&I_$S5OB1X5L_AMI/P]\/+JTEQ'JGVR6_\ WRQ^5%%@%V^;
M.%R<4 ?KU17X8?!;_@[YU#XZ?M&:'X*T'X$7>H1ZMK$=A#<6VH2S3+;R3JGV
MAHEC) 5&WG/ '4U^N_[3_P"UQX%_9*^$.O\ CGQUK2:3X9T"%I+MG'[Z4+C(
M@3(:5^?NIDT >L45^&?[1/\ P>.>%_"GQ/U"S^&?@&3QEX:MUC,&K7=R]C++
MD?./)92>.F:]J_X)T?\ !U#\(/VN?$%GX?\ 'EI-\-_%6L:JMA80L7N+.=&'
M#R7!"I%SD<]* /UBHK'M=42^,=Q#-'<0R1K)$Z.-C(PR&4CA@1SQ4E[KMKH&
MF7.HZC?6NGZ=;H9'GNI5AC@0=69F(  ]30!J45^/O[:?_!VA\+O@1JB:?\,[
M&X^)>H:3J-U9ZVD\;V$5N(V*(8GP1*I8'E>, 'O7 _LP_P#!Y)X ^*7Q+:Q^
M*O@>Z^'/AV*V:>/5+*:34I))@1MC\I5!P>>>V* /W HKA?A-\6?"O[0?PUT/
MQ?X1U>WUC1]6A6ZM+B"8,/G0-M< G:P!&5/*G@U\_?\ !7#_ (*+W7_!+C]D
M^/XH0^%X?%,D.J0:5_9\E]Y"D2[B7WX.2-O3WH ^NZ*_(O1_^#ICX>Z3_P $
MUH_C!J_AN&S\::YK=[I6D^#X-0-S)<20>6Q>1P-T*,KDAF7!*X%?-B_\'IUS
M;S0W$?P+MRL2%$8Z^W0]<C90!_0'=1>?;LO]X5YG^T78ZWJ?[/?CBQ\/_;/^
M$L.AWO\ 8QA/[]KGR7\KR_\ :W[<>]>:_P#!-W_@I%\//^"D7P%TWQEX4OHX
MM1NE$6JZ3YN;C3YP 7!4G=Y88X$F &[5[)^T+\1?^%-?!+Q9XPBM5O9O"^C7
M6IK"7V^:(8FDQGWVXH _+/\ X-P?!W[:/AO]HOXC2?M.1_$Q?#<FA1KHY\2R
M[K<W7VA=WE\GYMF?PK]@J_,W_@B3_P %^[S_ (*Y_&;Q5X1F^'Z>#E\*Z1'J
MGVM;PW'VS=*(]N"HV]<YK6_X+<?\%N[C_@E!KG@726\"P^+!XTM[FY1SJ)MO
M(:%U4= <YW4 ?HY17Y!_M9?\'37@_P#9F_9_^&.O:7X<M?%'Q \8:3#JVIZ#
M!?YM]+MW5N#.H(WAA@J0#@YKPC3/^#TAKOQ%I5IK7P5M;'2[JYB%S=0ZXTK6
M\18;GVA.2JDG'?&* /WSHKS']GK]IWP?^UC\*]!\>^ ]>AU;P[KD*2P^6 9$
M#<A94!)B?_9;!%=PEW]AMKJ:\N%C6W4RR.WRK&@R<D]. * -:BORH_X**_\
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MMKB06=V^LLC7$.X[&9=GRDK@X[$XK[2_X(Z_\'$O@/\ X*A^*M5\+:UI-O\
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M7$'G:?8V\B"6'RPP#"0HX#]LCBOBK_@]+_Y/>^%G_8G/_P"E3U_01^RDC/\
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ML3_M\ZA\.-:T;4-%_L_78GTO^TDVSW-B;G$$XQP0ZKD'O7]KB/(\4S\2;O\
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M;$UQJ$QP9':0_-M+9(4DA0<"O9=>O+#P_#=7>I7,-I80@W$US-.(HX0/4D@
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M:7\=?!6QM=.N/"?B);CQ!>73!OM<,MJJPH@/3!4Y/'6OUU_X+I?$KQ!\%?\
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M22;PMHY9O*#'[J*&PG?[U?TT_MN6TS?L8_%58RK1OX1U0[CQAOLLF,U^#/\
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MS3\.?V1_VJ/ .@_#3P%H?@73=8\-2W=Y%IUOY*W,OVAEWGGGCBOW-_X)T_\
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M;I)&8 $F?H%.<8K]9_V,_P#DTKX7?]B=I'_I%#7G_P#P5G_Y1F?&S_L3[_\
M]%&@#\B_^#+;X[^)M<U7XJ_#V;5-4N/!VAZ?;:C86!?,%E<33MYL@'8OM )]
MJ\B_X.D/VX]?_; _;9TC]GCX>Q^*7M_"<W]FZGH,94V^M:JSJ\$J(.K!)-HS
MCK75_P#!DY]H7XX_&Y[=L[-"T_=&1]\?:)._M7A/[;:1C_@Z8G_>LTC_ !)T
MTMA=NWB#B@#]@/\ @G+_ ,$ ?V?_ (,?L>^%[#Q]\+]%\2^-+ZSCU/5KKQ+9
MK)=VL\R(7MB1C"QMD =LU\9_\%^?^#=/P#\+?@5XH^,'P-\-Z['X@L[^WDN?
M#VD0H--TZQVL;B<+]X*BJ&SGC)K]XHX(896B@W$R,3)O^;^=>+_\%';263]@
MKXL)]FRJ^%]0; FV\BW?DGO]* /PY_X,F?\ D[#XY?-O_P"*3L_F]?\ 3*_H
M\7.[CKCBOYQ?^#)O/_#6/QSR #_PBEGP.W^FU_1UAB&VG:VW@^E %:>26!Y?
M,/EQ",$R=@V:_.3_ (+X_P#!*[XU?\%4/"GA?PY\._'NB^'_  ?9AIM8TW4I
M91%J$RNK0OA%.=F#U]:_1R*$+F1F\R0KY;[N%./:OAC_ (+0?\%H?#__  2C
M^"J0_99M:^(GB2*1="T_R3'#M^XTYDP5_=EE;:?O8Q0!PO\ P3[_ .#<#X!_
MLQ_LUV>D?$;P1X7^)OBZ5!<ZKJ.HVWG>3,0 T<!X(B&,@'GDUQ/_  5U_P""
M</["_P 'OV5]8T?Q#H_P[^"WB+6K&:]\/WD,0M;Z[FMT+B*,G((=MJD?[5?F
M+I?PK_;\_P""VUNOQ<T^;5+K2[./^RU-KJA\/1R(OSY6)642#YO]8 <^M6=+
M_P"#:_\ :P\?ZG>:E\8-4NM&\,>']%U#5&U"\UW^VFMC! TJQK&SDC>5QD=*
M /6/^#-#XJ^)+']JGQKX)76-4_X1-_#1U<Z47_T5[KS43S@O][;QFOU)_P"#
MC#XN>*/@G_P2:^(&N^&=<U7P]J;7%I:+=6DGESB*64)(F?[K*2#[&OR6_P"#
M-VXF?]OSQ]Y,D<EJGA5@7;"LW[].W4#VK^B[X@_#O1_BIX+UCPWX@TZSUK0]
M6A:"6TND60,&!#$;@<$9R#V/(H _G!_X-I?V:_V4_BOJ.NM\<M8\-:QXXOM2
M&D:)X0UY@\-\KHK"XCCQDR;LJ#FOVM\1_P#!%+]E+6-!NDL/@5X!5;J)H!-:
MZ>-\1(*[@<]5SD>XK\GO^"@G_!I3XV^%_C"Z\9?LYZ]-J#W6KB33_#LET;6;
M1[7'47;-EV4CV/-?GK\?_@K^V!^Q7^T$OA_Q%-\46\2:.EM?HFG7M]J-G\V'
M3+1DHW3D'\: /UK_ &7_ /@VJ^,O[$O_  47M?B)\*_B?I.F_#FUUR.26T>:
M1=2N]-RI>WEVKL.[!X''2OD7_@ZY^+.J>-O^"KMCX%UOQ1JC>"=#TS2;J*P,
MO^BZ>\Z[;B9!CABHR3[5T/[$'_!U/\<OA!^TU8Z+^T%-;ZEX63&GZG;)I26-
MSI;DC_2&"KO8JO\ !WS7ZU?\%+/^"6OPV_X+2_LV:+?>9#H_B:>VBU/P_P"(
MXK;;)'%,J,#*!@R Q]%8_*30!PO_  3M_P"":O[!?QJ_9WT^W\%>'_AM\8Y/
M#<<6GZKX@N(1<WDURZ^8!.XP-^#C@= *P_\ @IE_P;<?"']J/X&S:3\*?"/A
MOX6^,M+)GT^_M;?R;6]9MH\NX(RQ10"0!W-?E!^T5_P;Q_M>?L6ZG\0+OP)?
M:GJ'@+0@]V-5TO6C8R:E$D8)D^RQONW]0!R>*\%_91_X*(_M>?\ !/D:]XA\
M.WGCJWL;RVC34;GQ-IES>V\2!B5VFX!5#N/4=: /Z)_^"%_[ 7QB_P"";GP)
M\2^ _BQXRM?%]@UY#/X>%A([6ND6J1L)(1O (W.V[ K\4_\ @O!^U1XM_P""
MK'_!3VW^%GP]L_%^JZ#X9O$T>Q\-KM=?[1C+QW-Q"@/5D'4G.%K]3O\ @@)_
MP7N_X>/>'%^'WQ"C4?%72HS-Y\$6R+6H%&Z2?8HVQ[-RKM[]:_*S]AO38;G_
M (.DK7S)Y(XI/B3J010"/,.)_E]L4 ?M=^R]_P $!OV:/@K^S[X:T/6OAEX;
M\4ZY:V:?:=4UVT62\>:0;B'9<<JQP/I7YO?\',?_  19\*_LZ_"?0_B[\%_
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M$)O^"@7C/X>:-JFBW&NMI.JV$%[I^SQRT2K!)&KIA?,X&TCCM6E:_P#! ?\
MX*)VL*I)=:^ZM(#Y2^/'RP^OF\4 >T?\&PO[;&K?LE_MU>-/V8?%FH:QJEKK
M&I7.F:)9VK@Z7IE[!-(UQ,%;# 2! ,CG@5]M?\'<X:Z_X)-6ZR+##Y?C#3LE
MA^[;_6]/:OCG_@C-_P $$?VEOV1/^"D7@/XE?$;PW8V.B:?>7$VH77]KQ7<Q
MWQN 202Q)9N3U-?97_!X$I7_ ()+P@L&_P"*OT[D=^): /@?_@V?_P""%'A?
M]L.RA^/'Q%;3]<\&Z;J5QI]CX?9=\=[<0_+)YZD8,>'4K@YR*_3_ /;B_P"#
M<[]GS]H[]GK6/#7@GX>^&/AWX@F(NK+5=+M!#.EP@;RXW//[EB1O &<#BN$_
MX-!_^40EA_V..K?SBK]2&_Y:?6@#^3G_ ((83>,_V,/^"YOAWX3V/B*XL_MW
MB27PSXE^P2%;?4XH!*VW!&2F]00#7]-7[<\;3?L=_%AFVJD?@_5$#MWS:25_
M-C^Q+_RM4V/_ &4[4O\ T&>OZ4/V[O\ DR3XL?\ 8H:K_P"DLM 'X._\&5,T
MTG[7WQ='VA9!'X2@3:3_  B[7D5T?_!ZI9RVGQ$^"/F-;R6ZV.H&(#.[_6QY
MS7)?\&37_)X7Q>_[%&#_ -*UKM/^#V/_ )'KX%_]@[4O_1J4 >M?\$ /^#?+
MX;7_ .S9I/Q4^,6AZ-X]NOB%81W6F:=<0^;965H^&4D$ ^;D$'!QBO1O^"R?
M_!MM\*?C!^SOJ/B+X/>&_#/PU\0^"[.;4/+LH/)M-2@C0R3>=@$EPB$)C R>
M:^UO^"-O_*+#X ?]BG9_^@5Z[^U+_P FL_$K_L5M4_\ 226@#^?G_@S4^,7B
M:/\ :A^(W@J#7K^/P:GA]M5CTR23_1ENO-1/.*_WMO&?2OO7_@Z(_P""C=Y^
MQW^Q5:>#]!O/$FA>,OB4YAL-5L'6-888F7ST<]<.C$# [U^<?_!F;']I_;T\
M>!6V.OA!L9&5/^D)UKW_ /X/3Q=0:'\#YY$C;$NH*ZDCTC Q0!1_X-H_^"*O
M@/XX_!R\^,OQH^']UKC:X1!H%IKMLKZ?J=LZAA>1CJ6W J#GUK[/_;P_X-NO
MV:_VA?ATEQX5\*_\(#JGA^"[N+=/"T"0MJLYC.R*3=G< P  &.M>S?\ !!NV
MF3_@D3\#/]%XE\+P$CSMV3E^1_=^E?71C";H6C5ODRJCCDCGG^M '\;_ /P3
MY^%.O_ O_@KU\)_!?C+3=1T76/#/C*T@O-.N5VSV+K(#ME'8X(/'K7]DVE,J
M,T:^7MQO&SOFOY8?C7;7!_X.I9H6@VJGQ1M0JA]Y5<1?>/?\:_J@T]U:1P?]
M8O!P.W:@"U7B/_!0K]J"P_8N_9*\;_$C4K74KRUT'3V9H;';]H+-\BE-W&0S
M _05[=7PG_P<=6HF_P""0GQG<S.K1Z9 4 R,'[1'^= 'X;_\$8?V.->_X+1_
M\% =:\6?%2V\7>)_ >GW4FH:UK+A9(9[Q=KV]M=,>N^,$8'9:_?34/\ @AU^
MR;>:9-&WP+^'=NOED+-#I^'7(P&Z]J_/O_@REN))OV8_C@SA6B_X26Q+[1M(
M_P!%>OVRLGW6Y5E\M9#A ?FX]30!_)O^UY\'_%W_  0?_P""NVG:UX7D\::'
MX-CU!;G2]10K'/K>E[XS=PQMT9#S&1QVK^H?X)_%?3?VD_V<-%\>Z=9S0:3X
MLT4:Q9P70'GP"6,D!L<9 ]*_"#_@]>M+D_M!?!.185A1=$OU5A)G?FXC[=J_
M8G_@F?<R?\.Q/A);W:_9YI/!5JL4BG*G]Q^5 '\M/[%O[ &L?\%-/^"F5[\+
M=,UBSTW[=J^I7]W-.3^[M(+AFF5< _.4SMSQG&:_IN^%G_!!/]F'X6_"_2?#
M<WPC\(^(FT>U6#^TKZR#WMXX&/.D(P#(>YK\1O\ @V?BD@_X. [Z&9HRT-GX
MD V@<YW'K7]15 '\D'_!>'_@DXW_  2$_:4T36_"NM1R>&_%EVVJ^'QDB^TR
M6%U<@X 4!7(VX[**_I'_ ."47Q"U[XY_\$X/@MXN\2:I>:KXBUCPY;7E_?W3
M[IKN1@<LQ[YK\C_^#WK_ )#_ ,"_^O;4?_0HZ_5K_@B1_P HD_@+_P!B?:?R
M- 'U5;6Z6T6V-55>N!ZU)2)]P?2EH _CQ\.>)O#?[9'_  6>UYOVCOB1>:?X
M3C\1ZA:7NMZE<C,5O:SRK!;EB"/+PH3&.G%?T:?!W_@DG^Q7\9OA]HOB?PA\
M'OA9XF\-Z[;BZL=2@L?,CO(LD;T.>02#7@W_  6$_P"#;OP3_P %'?&I\=>$
M-3M?A[XTCAD%^L-H#;ZLRIB)=@*JC%NK=26R:_%C]IC_ ()._MI?L!?"JUU+
MQ WC#3_#<=RMC96^@>()[QU8Y*A8(&)1.#R!@4 ?J5_P5(_X-:]%_:&^*>B^
M-/V>]0\,_#:^BD2&ZTUE:'38/( \N2%44L)2W+$G&0*_4+]A/X3>.O@I^RMX
M3\+_ !%UYO%7CGP_8"TU/6-Y<:I-N8B7<P!.%*KR.U?S ?LW_P#!;K]K3_@G
MM\+M&\)1W^L6>@_VC)=QQ>(]#>6XF9V#2@3W"[FR.P/RYK^C7_@D=_P5$\*_
M\%1O@%%XHTF*>Q\2Z+LL_$.GE6,=C=,N_8KX"OE,'(]<4 ?@7_P3/NC+_P '
M,MJJQ1FZ_P"$[UD;L?*>9\YK]"O^#LG]D#X8^#_V"=0^)>G>!=#TWQU?^*].
M@O-<@M]MW=JX<,"V>00H'X5^>/\ P3 _Y6?;?_L?M;_G<5^KG_!WW_RB(_[G
M#3/_ &K0!XK_ ,&PO_!.7X&?M0?\$X['QCX\^&7A3Q5XDM_%=_;KJ.IVGF7(
MBC\LQH&ST7/%=U_P=8?\%$YOV._V7M"^#_@^\\0>&_%'CY4N[.^TUUCMX-.M
MV,4]L_?#AU& ,8%==_P:%_\ *)>W_P"QQU3^45?$O_!ZA;VY_:7^")DG:(MX
M?U#JI8?\?,= 'T+_ ,$(O^#>+X:Z?^SE;_%+XR:5I?Q"USXA:9%?64-W%YUI
MI\$A61'3(!$QY5CR,&OJ']L/_@W&_9Q_:*_9]UWPSX5^'OA_X>^))@+FPUK2
M+40SK,@)1"QS^[9L!P!G%?B/\#?^"*W[='Q ^$>C^*_",NMOX9U;38KS1A'X
MV:%%A< H?)\SY1M/W<<5TA_X("_\%$'_ 'WVOQ!N;GRO^$^<$?\ D6@#U#_@
MW/\ VI]>_P"";'_!4CQ/^R_XTU;5]=T_7]6;PYI]II\@.FVFJJ^Y[HJV" 40
MKD<U_2=7\VO_  2N_P"#?O\ :F^ 7_!3'X2_%+QYX8LHM(\.>(4U'6KR37HK
MJX*!'#2'DLY)8>]?TE4 5]0RL:R!5/EG=\W:OSG_ .#E_P#8O;]J3_@FUK6H
MZ1X//BSQWX7N(;G3)H(?,NK*W\P-<%#V78OS>PK]&KN3RT5F=54'YMW<5Y_\
M;O"MYK?P9\6:#IS?;-2US1;^UMXB<*\DD#J@W=%Y8<T ?FO_ ,&BOQB\3_$3
M_@GSXDTOQ)KFH:A;>&O$0T?1[>>3<-*MA K"",?PJ"2<>]?.O_!W5X]\(_%/
MXY_L_P#PUBUZUN_$5GK#0:Q8+)FZL(+MH4CD8=MRDE?I7@__  ;F_%B3_@F]
M_P %6?%7PC^*E]?:;XBNHF\-0Z5!*]S:OJID0A2%.S.T']YCVKVSX6_%+PG^
MWY_P=0P^*/#-E)XJ\'Z+I[:?J$]WIA\FUN[:W>-E<.I"[95(#'KC(H XK_@B
MGX%^'_\ P3=_X.!?BU\,9O%D>GZ?8V]QX:T&?4I0L]_,QA9(^!@N<G@>E?JC
M_P ' GQ6\1? O_@DG\3_ !)X0UC4/#NO0PV\*WUH_ES!'E5' /HRDCZ&OSW_
M .#A;7_#_P"SI_P6>_9H^).N:2VF^$-/$.I:WJUAIY*G;=-G>\:_O)-H[DM@
M5SW_  =5?M@^%_VCO%/P8^%/AGQ1JEO=3FUU6\MDBECAGLM1BB-JT@R%;@YP
MV<&@#UG_ (-!/V09O"?[/OBKXH^)O!#Z3X@\0ZK$WASQ'<0;9]3TMX1YOEOG
MF,RJ<^XKXA_X.A;9HO\ @NQ9!7EFQI?AYF8]@7/'TK^A[_@G+^S&W[&W[%7P
M]^%]QJ2ZJOA;2%M4N?+\O<I9G]?]OUK^>/\ X.>?L_\ P_"T]HX6!_L_P^OF
M>=G=ASVH _HT^)/[,'@']I[X*:7X<\?^#])\9:+-;6U[]AU*#S;?SDC 1B/[
MPR<?6OY@/V'OV?/!GBW_ (.&+/X8ZIX;T;4/ MYXTU"QGT.2+=9M GG%(2G]
MU2HP/:OZQ? W_(DZ-_V#X/\ T6M?RT?\$]/^5IBQ_P"RB:K_ .UZ /Z4OV=?
MV)OAK^R#:ZE;_#'P?HO@73]882W]IHT'DQW<JJ521AW902 ?>OY//C#^S+JG
M[:?_  6]\8?"G2[ZWMM0\8>/;ZPAGOB?+B.^1R3CGHIK^R ?=7ZU_*=^QW_R
MM;:=_P!E1U'_ -!GH _<']ES_@WE_9A^!GP6T/P[KGPO\,^--8TN#%SK&JV:
MR75Y(W))88R 3@<= *_%G_@Y$_X(R:/_ ,$V?'.C_$SP//;0^!?'.JO!;Z.X
MQ+IUWL:5E0 8$(4 *,DYK^I"+[J_6OQ?_P"#U[_DS3X0_P#8X3_^DC4 ?7O_
M  ;S?%[Q1\;/^"4_PWUCQ1K5_P"(-:G^T1/J-S)O9HXI2J)GT50%'L*_$_X:
MVGVW_@[.B4S1Q;?BY(X.?F)^;@5^R'_!K]_RAN^&'_72^_\ 2AZ_&KX9_P#*
MVU:_]E>D_P#9J /Z5/VHXOM/[,WQ#F#,/+\+:H/FZ_\ 'I+7\D7_  1B_P""
M:,G_  5$_:JM_![:E:Z3HNBV(U37)T)%VUL'"L(#@CS>1C=Q7]</[3O_ ":U
M\1O^Q7U3_P!)9:_G7_X,S/\ D_?QY_V)K_\ H]* /VB?_@@Q^RHGPXCT=?@Q
MX)>\73A9'4'L!]J=C'L\\G./,S\V?[U?SB_\%;O^"=FM?\$9OVV=+TWPKXL>
MWM[R,ZUX9U..0K=V]NLFQ3*V,>:&!^[QBO[ !U_X!_2OYJ_^#T;_ )/0^%O_
M &)TG_I4] ']#7[)FLWGB+]E[X=:AJ$S7-]?>&=-N+B=CEIY'M8F9R?5B2?Q
MKT*O-_V-_P#DT3X5_P#8H:3_ .D4->D4 <3\7_@=X4^/OP_U3PKXQ\/:;XET
M#5@%O;#48_,AN5#!E##N 1FOY4?VJ?V>/ O@[_@XEU'X9:7X3T>Q\&I\0K"P
MAT:&';9);LL.Z+;_ '3N.1[U_6\W^N?_ '17\J7[:6[_ (BI=2V_>_X69IV/
M^^8* /Z._@7^P]\'?V$[3Q%X@^&_PY\,^#KZ^LBVISZ9:^4UW%'F01DYY .2
M/K7\Z?Q"M/$/_!QW_P %JM0\.:5XEU#2?".EFXN-+LM7E_>:3I\!C^TQP!00
MK,V6';/6OZ<OB+=QVWP\UJ':[RS6-UMW=-WE-G\*_C3_ &8?V4?B]^UI^VMX
MD\&_!V29O&;/?W8:UU;^S6\E)/GQ*&''(^7/- ']1WPQ_P""%7[+?@[P!IFE
MS?"'P/KL^FV<=M/J%]8A[F_D489YB" 6/4X[U^2?_!QK_P $4-+_ &!+>S_:
M2^#UUI_A#1;35+2&ZT6T!B&GWKN!;R6@ P%&PL=QSGI7CD7_  0%_P""AK3K
M;K>>((5ZN/\ A.7.#Z_ZRL?Q?_P;M_M]?$"-M+UVRO\ 6M/E82_9[_QC]HAW
M+T8J[E<CM0!^[?\ P0S_ &X?^&__ /@GYX=\57DFI2Z_I &@ZQJ5TP:>ZN84
M4O*6[Y)[U^ __!P=X)F\:_\ !=SQ=X9L9(8Y_$U[IFE0M+G9')/'%$KMCL"X
M)Q7[B?\ !N/^PW\1OV OV'M2\%_$G2;71]=;Q%<WWDPW:7*S1,J!3E>.<&OQ
M9_X+6,S?\'(L99=A_P"$M\.\9S_RUMZ /V2_X)^?\&W_ ,"_V9_V>=)\/?$;
MP7X=^)7BZX"SZIJ>H6PF5)2H#11'@^2",@'GFOSW_P"#F3_@A+X&_9?^&,WQ
MS^%=GIWA/0;*YMK+4M$MX_+AB>5UCC:%0..<ELFOZ)5^['_O?TK\VO\ @[ _
MY0W>-?\ L-Z3_P"E% '"_P#!HG\6?%7Q9_X)W>(K3Q-XDU#6K?PSX@.E:5Y\
MNY;&V6%"L4?HH))Q[UR?_!8C_@@?\;O^"HW[7MCXD7XB:1I_PRL3!'9:#>RR
M^=8 !5N9(5"E0TF"<YY.*G_X,R7\O_@GEX\8\ >,'/3_ *8)6U_P<!?\' 5_
M^PQK3?"'X1,LWQ<D6&>YNI[/S(]+C?#H%1@5E,BDC Y!H ^E_@M_P0/_ &6O
MA)\)-#\,ZE\)O"'BNZT6V6S&KZO9"2^U#&3OF88!8Y["OS3_ .#DG]D']COX
M#?!"^L?!3>$? /Q>\.^1-!X3TL"&:_CF*@-(F"2NW+#!KYAA_P"";?\ P4(_
M;@A;XP37GB"%_B1$=66-?$#Z:%#\?\>V]?)/R_=P,5QO[37_  0F_:!^ ?[*
MGCSXN?'6]_LN3P]':+;R3ZD-6N-5#R; F_<6CV C\Z /U2_X,\_BCXF\>?L2
M^/K'6]:NM2L_".OPZ9I%D[[HM.@-L'\I!V&XDX]Z\L_X/60]E\&/@7(LB0RK
MK>HM@=>88\UU?_!E-.9_V,_BWDYV^,( /7_CT6N0_P"#W+_DD7P+_P"PUJ/_
M *(CH SO^#<__@WL\$^/?@AI?QX^+5KH_CB'QE:&;P_HUQ'YMI!;ME6DF4@'
MSE=#M*G&#7TY_P %9?\ @VX^$/[27[-UV/A7X6\._#/QCX;2;4K:XL;?R;74
M&VC<D^,L0%5B,=S7T-_P;X?\H:?@'_V+Q_\ 2B:OJSXI_P#),?$G_8+N?_13
M4 ?S/_\ !HG\2_$_A/\ X*8ZS\,?[8NE\)WFD:AJ%_IBO_HMS>6VR.*8KW90
M6P?>OU3_ .#C+]C+X8^*O^">?QB^*>M>#=(U'XB:)H40L-?E@W7EFHG15"/V
MP&8?C7Y+?\&I_P#RF^U?_L!:Y_Z,2OV\_P"#AW_E#C\=O^P%'_Z414 ?EG_P
M:9_L.?"+]LKX*_&"Z^)W@'PWX\NO#^LV,&F2:M;><UI&\#LZ)R, L ?PK^@3
MX?\ @_2?AOX*TWP_H>FPZ3HNCVZVEE8VZ;8K>)1A44=@!7XF_P#!D7_R0OX[
M?]A_3O\ TGDK]QYKA86C#%@SR$+@9YH KW6=.A6..%EASG;$.1ZYK^2_]MKQ
M3I7[5'_!>WQ#X<^-WC"\L_A[9>,Y](NM3N9A_P 2C3$+%44D$*BG';O7]96L
M/)>QS1?- ENZL)1\Q;OTK\Z?^"OO_!O3X(_X*A>(]'\5:3JT/@/QM"V+[4[>
MSW1W]MAL*T2E1OW')<Y)Z4 =W^S?_P $L_V*?C=\'-+\1^#OAS\+_&OA"=!;
MVFK6UIYJSO'\CMNX&XL.?>OF'_@JM_P:[^%_VG=5T;5OV?X?#7PWU:U46M]:
M&,Q:5=P#)W$("QF+$>V!7Y7_ +3'_!'S]M#]A/P!J'B+4%\3P^!],O/L=NF@
M:]+(T@=RD<BVL#9&>"<#C/-<]^SE_P %@/VO_P#@G/X(N=)T?4_$EKHNH71G
M:7Q-HLMPQF( VI)<#/0?=!H _IN_X)9_L[?$?]D?]D30? _Q6\66WC3Q9H[R
M1OJ<,C2#R"W[F/+ '"( H&.U?2M?#O\ P1I_X*_>&_\ @J%\%/M2VLFE^-?#
MD<<?B"Q*EXX7;A) ^ #YA!;:/NYQ7W%0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_*3_P %J]7L
M?#O_  <@:AJFI7UOI^GZ7XHT2\N9YFVI%'&8'8D_0&OZ"G_X+7?LKVXM?-^-
M_@&+S#D[M1'[OZ\5\0_\%.?^#6Z^_P""@_[:GB_XK1_%BQ\.P>)VAD_L]M+:
M:2W\N-4^^&&<XSTKYXD_X,L=5:62$?':Q\B09R^A.V/QWT ?K=_P^P_9-'_-
M??AQ_P"#,?X5PO\ P47^,7AG_@HA_P $C_CQI_P/UBQ^)UWJ?AZXTRUCT*3[
M2TUP=A$8Q_%CM7YF_P#$$UJ$T#26_P <M/$)4YW:&^<C_@=?IW_P1+_X)AS?
M\$J/V:]6\!W'B.#Q7)JVKMJANTM_)"JR*N-I)]* /QH_X-=/V_OAI^P#\;_B
M%X'^*-XOA.\\6&)1J&H,L5GITEJ'WQRL>0Q8X  ZBOUL_:Y_X.+/V7_V6_ D
M>M:?X\L_B%/J%Y]E:S\,7*7%U:Y4GS&#8PHQC/J:^</V\O\ @T<^%?Q[\6_V
MQ\+?$VH?#W5;RZGO=9DU!YM32\DF??E 2 @!+<#UKR#X2?\ !EQI?AWXFZ#>
M>+OBQ'XF\+VURLVIV%K8R6TFH1#[T:R!R4)_O=J /RT_:_\ V]-4_P""CW_!
M3_1OB5JUC:Z?]NU_2K2SM[7.Q;>&X1(F?)/[PI@MCC.:_LGL;4Q::OS,5DC&
M W1..WM7Y;?M\?\ !L_X(_:%^*G@_P >_"_7K#X8>(O#,=M;2N^G?:K6[2U5
M$M_W(VJ'&P%GZN3DU^C7P1\.^+/!?PET72_&6K6_BSQ5' L6K:K:VXLX;V7G
M,B1 D1C&/E![4 ?S4_\ !S*_F?\ !?+3&*LNZV\-* ?;;S^-?T^>'6\W0+-E
M!/E6B*1W)VBORY_X*;_\&Z]]_P %$?V_+?XV0?$:UT6*QCTR+^R7TYG=OLA'
M_+3<.N/2OU+T.%-/TN*S63<MK&L#$C&]@!SF@#XB_P"#D>99?^",_P 8%5OF
M^Q6V1W7_ $B.OC/_ (,K;B./]ECXV>;"L;+XHLV5FZL!:'YC]*_2_P#X*6?L
M97'[?W[(GB_X06NO1^&3XFAC5[V6V-P(PLBOTR/[OK7BW_!&+_@D/??\$COA
M9XT\/_\ "96_C:+Q9J\&I I9FV-NL<7EE?F)W9ZT ?B/_P %OOV8/%7_  2A
M_P""H-I\4_!$WC#2]%\1:F-=L?$LB+&CWTQ>2Y@@<<':AZ'G#5^QG["'_!R!
M^SC^TI\/YFUKQLO@?4M%ABMI&\63I!+?2&/+/'MSE=P(/UK[#_:Y_9)^'?[;
MGP>U;P+\2-%75M!U"!0R*NRXM>0=T,N"T;' !*X..*_(;X\?\&9.D^+_ (M:
MIK/@7XG1^%/"URX-IH]S8O=S6L>T @REAN.03G'>@#@/^#G;_@MAX4^-W@;P
MW\(O@WX^N-2M;H_:O$VH:/<*^EZA:21D+;ENI99%#$$>E>A_\&5TOD?!SX[-
M:^9,LVN:< 7^]CR) 37TOX3_ .#9?X-_"O\ 8^\<>!?"FVT\=>/_  [#HUUX
MGU13J$=M*DJ2F:&&3F(DJ1\I!P<9KO\ _@B?_P $=+O_ ()$>&/'?A^\\:0^
M-&\>7,-\L\%D;5;3R8V3;R3G.[/X4 ?)_P#P>KVT4/[&OPCWY;_BK9PK=_\
MCT:OH+_@W8^'\?Q+_P""&GA'PK<2R6MCX@LM4TZZGA_UFR9Y(R5SQP&/6O0/
M^"U?_!(:]_X*S_!/P3X1A\70^%Y/#&KOJ)N9+<W *M"8\;01Z]:]6_X)@_L9
MW/\ P3Q_8W\,_"UM83Q5-X:>8?;8X#;K()9"WW23TS0!_.+X<UOQ1_P;X_\
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M  29TO\ X*N_!_P[X5AUK3/!^O:/?B\76'TT74S1A67R2XPVW)SC.,]JL?\
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MPM_P98M9^([&XU+XTV>HZ?;W49NK9-&>%IX@XWH&W\$KD9[9S7U5_P %"?\
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MMM)*LE]!&P&UE(9DQZ$5_5EHWA^U\-6L.GZ/96VGV%G"(((X$6.&W4=%6,
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MG_@ZFL3]YO\ A9VI#:.OW9Z_I1_;J#2?L2_%CY67_BD-5//;_19:_//X)?\
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MR.@:OWX?_@M!^RKX>T:ZDF^//@.ZF5&E57U)3(Z]0%X_*N1_X*8_\$//@O\
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M&Y"0=KC)PPY':@#\@_\ @UZ_X*#_  5_9L_X)T6_@OQY\2O"OA;Q/_PE>H7
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M_@D+9_\ !6CX0Z+X;BU?3/">L:3?"[769+ 7$YC"L/)R,-MR<XSBM[_@D/\
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MCC0]6\:1^,#XTU:UOEDALFM_LIBC:,*>3G.[.>U>$?![_@VUU+X3_P#!5/\
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MM+:W6-55%"[FV@ L0 23R3R:[*@ HHHH **** "BBB@ HHHH **** "BBB@
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MIL>FZ?8,/)M+7$,-L@& %10!M']T#% $/@7PHGA#X?Z/X=L9)&CT6TM[-)G
M!D2)%0$XXR0O/O70/H=NS.P7;(S;PXZJ?45!=;=2V+%N\O=EU4[6R#QS6G0!
M"MFJKR2S="QZFJTOA^)[I959HRO!"_Q+Z?2K]% $;6D;.&VC<HP#Z4V"R6!U
M8$_*NWZU-10 4444 5X=,AM2WDJ(BY)8KW)J,:,LD<2S2//Y1SE_XCGJ:N44
M 066G0Z=&ZPHJ+(Q=@.Y/6ECM!&'&X[6/W>PJ:B@"I!HMO &_=J=S%OI4G]G
MQ^1Y>WY2<GWJ>B@"-;54V[1MVC&!Z>E5;C08;Z>1KG-Q&Q!6-_NQD>E7J* *
MTFEQRSQLW*1#Y4_A4^M/FLQ-_$P(Z$=JFHH IW.CK<0,GF,ISNC8=8C[4X:2
MC3>9(S2G:%&[MCO^-6J* *J:/"B;=O&_?^-2164<$3)&NQ6YP/?K4U% %>"P
M6WRJLWEXP(_X5IB:-"I4E=S1L6C8]4)]*MT4 59-(ANHXUN%^T-$P96?J".E
M%OHT%K<R21J$,GWP/XJM44 1O LC#/0=J2&SC@E9E7:6ZU+10 4CH)%VMR#U
M%+10!7BTV.*YFD_Y[ !AZ]J)-/CDMO)^ZF,*!_#5BB@"&2Q61XV/_+,8 ]:>
MD.T_,Q;G(SVI]% %4Z1"U\EPR[GCSL_V,]<?6I!8Q^:S[1N;J:FHH C^RJT6
MUAN7WIC6"LY;)SNW5/10!#>6$.H1[9HUD7K@TU;!?/9V9FW# 4]%'H*L44 0
MK9*L+(I*[NX["B*PCM[588QLC7L*FHH AGT^&Y">9&K>6<KG^&G/;[G4[B%4
M8V]C4E% %>/3XX$98?W6]MS%?XCZTW^RHVN7D8E]^.#VJU10! NG1Q;/+7RU
M5MV!WH2P56R26).3GOZ?E4]% %=M/7<#&S1_/O?;_P M/K4=OHR6B8C=E)8L
M2.]7** ();!9+A9 S*RC''<>E1PZ;)$Y8W4S9.<''%6Z* *T6E0VSS-"ODR7
M#[Y&7JYZ9-3- LD>U_G[<T^B@"F^C1I;)';LUL(^%*=AZ4Z328[JU:&Y)N8W
MQE7[XJU10!%]D7<&!(*\#V'I21V9C=SYCL&Z _PU-10!3&F,LY9;F95[(,;1
M4@TN%;EKA5Q<.@C,O\14=JL44 1"W8;?WK_+G/O0+<]Y&89S@_RJ6B@""QTZ
M'3K;R8458\DX'OUH%EMB90[=<J?[GTJ>B@"N+';.LBR,&QAO]OZTKV*R,C$G
MY#N^IJ>B@"-+;8K+N)5NWI49TU"L?)_=G(-6** (39*;AI?XF 'TIRP+MPWS
M'&"3WJ2B@"G!HT=O<R3+GSI0%+]]HZ#\*D?3EGW>:S2J6#J&_@(]*L44 1W%
MI'=V[12KYD;=0>]0S:>TBLJW$L8+ C;_  @=OH:M44 0-8*P502J[MS ?Q_6
MDO\ 38=2@6.9%=%8. >Q'2K%% $*6*1NVWY5;JO8FFV^E0VUQ),JCS9.';NU
M6** *\U@SW,3K/)&D9YC7[K?6B/3((9%98U5D)*_[.>M6** (9[-;ARQ)Y7;
M3X[=8FW!?F( )]<4^B@ J.:W696!'WAC-244 4;+08[3<Q9I)&.YG;JQ]:5]
M#A8<97<<OC^/ZU=HH A^Q83:K,J@@@#M[5!_85NH)5=DFXN''52:NT4 0BRC
M*_,-S=V/4TV;3HY8=H^4@Y##JI]:L44 0_8@\'ER,TGN>].6U5-NWY=O''IZ
M5)10!";-?/\ ,7Y=WW@/XOK3$TJ%+S[1L'G8VANX7TJS10!";)3<+)_$N?QI
MIT\ 2[7:-I3G<.J_2K%% %*31EE90TCF,=8_X6/K4JZ<L<*1HS*JG)Q_%[&K
M%% %1]&A%VUQ'^YFD 5W7JX'0&GSZ>LZLNYE#GYL=ZL44 0O:;D159D51CCN
M*0Z="2GRC$?W1Z5/10!&ENJ,<=#VIC:?&<8&U54J />IZ* (_LRM;^6PW+C&
M#WICV"LQ//)!^F*GHH :R[B/:HY;023;]Q4[2./>IJ* (%TZ+[*867S%8?-G
M^*D6Q*77F>;)MQ@1_P (JQ10!1M+5H+N7:N59MQ+>OM7YN_\'"7_  22U3_@
MIY\$--U3PM?-9>/?A^L\]A8<"'48W +JW!;=M7Y0.I-?H_<*MQ?M;M(X;'FJ
M1D =J9=VUO<(JW&Z.1N Z-M8_B* /Y3?V8O^"O7[7W_!&;5])\%>-M#\07&B
MV^D_8M!\)>*D>"ULH _#0JN&X.1R3U->L?$#_@YG_:D_X*#>"-3^%/P\^'NE
MZ)XJ\51-;177AEKB35&C4'S$C5B5(*Y#<=":_HS\6? SP%X]O+>X\2^$_"WB
M2\M5\JWN-3TN"\FC7K@/(I.,^E9_A3]FSX<> ];BO?#_ ,/_  CH^IP,SK>6
M&DV]O<0;NI61$##/< T ?E5_P;/_ /!%'Q=^Q;</\;_BA+J&E^,/$VFO;VF@
MR( ;6UD(+_:0PW+.'7@ XP:_92QCD>^DGY6&1%"*>H(JIIYAL[BZ:1)/](DW
M!G;>K<8R!_"/:K.FP-]JEF?<2X !S\N!TP/ZT 7JAO;%+Z)D?[K<'WJ:B@"G
M'H5G%)"ZP1AX%*1G^Z#UQ3CI4<KJTV9GC8O&S?P$^E6J* *\6G+#;^6I.&/)
M]:'TZ-@0/E&T* .U6** !1M ]J*** "H!8*)-V3G?OJ>B@!L,*P)M10JYS@4
MZBB@"O?:<MY;[ S1'^\O4>M1P:+#;6_EJ/EQM_#TJY10!37185D4C.Q?NIV!
M]:F-GN*[G8@+MQZ^]344 0I8QQ1A57;M.1CUITL!<?+(R?*1QV]ZDHH @BL$
MBE\SK-M"L_=@/6DNM+AO;A9)$#,JE1GT-6** *]OIRP+MW,RK]U3T3Z5'?:)
M#?1X;(.<[AUR.A_"KE% $-K9BVA52QD9>2QZL?6IJ** "BBB@"*:T$S,VYE+
M+MXJ*73?-W?O'7=M_#%6J* (;BU\\'YF5BNT$=11-:M+!L$TB\ ;AUX_QJ:B
M@"-+4*K*Q+*W8]J;#80V\/EQQJL9.XJ.A-344 5IM-663=N96W!LCT]*E^S+
MNW?Q=CZ5)10!7^PLVW=-(R[2I!_BSWHCTN%+1H/+4QM]X?WJL44 1&T585CC
M_=JI_A_E2-8QO,LA7YE^[[5-10!&D"ID?PGMZ5&NFJN!N;:K[@O;Z58HH CG
MMEN$VMTID-B(G5BS-L7;S_.IZ* &^7^\W9/TJ*:R$LC-N9=R[>/YU/10 R"!
M;>(*O0?K3Z** *ZZ9&+B24C=)( &)]!TI9]/CN@HE'F*AR ?7UJ>B@"N]DQ9
MMLKQJP  '\/N*9!I$<4MPS9D^T,&8'M@8JW10! -/CC\ORQY:QG=@=Z1-*A$
MOF,H>3!4N>I!JQ10!5BTF.-6'WMPVC/8>E6/)41%!PN,?2G44 5UTZ,+M;YE
M*[2#WJ1K=6V_W5[5)10!7?3HG\SY?]8,-[U(]JCIC'08!]*DHH IG2MTD;-+
M(Q5=K9_C'O4B:<L4+*K,NX\L.OTJQ10!$+*,1E-HV-U7UJ*733)+GSI%CP (
MQ]T8JU10 #@4444 1SVXN$"MV(--6QC 'JK%E/\ =-344 0&Q5WW,S-SG'J:
MDAMTMPVQ0NX[CCN:?10 5!=:=#>S0R2(K- V]"?X34]% $=Q;>?M^8JRGAAU
MJO+I.;I9(YI(1OWNB=)?K5RB@",VRY!7Y2.A':I*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "AEW#!Z444 -DA65-K*&7TIL=
MG%%&56-0K=14E% #4B6-0%7 '2E"A2??K2T4 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(RANHZ4M% $;VT
M;L2R@EA@_2H7T2UD1U:%2LB;&'JOI5JB@"-;.-"N$7]V-J^PI1;QB3?M&[IF
MGT4 -6!$D9@H#-U/K3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** &F-3GC[W6HWT^&0+NC4[<X]L]:FHH KPZ1;6\L;I"JM&NQ3Z#T
MJ1+6.-"JJ I))%244 1BUC$/E[1L(QBGH@10%& !@4M% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%,%PI<KN^9>M #Z*A_
MM"'[68=_[Q0&(]C4AF4'[PXZ\]* '457FU2"WDVL_.,]*>U[&MPD1;YY%+*/
M4"@"6BH;B_AM7C6215:4X7WH-[&(E?=\K' .* )J*%8,..:* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HID\W
MD*#C.2!4&H:FNGZ=<W#*S+;1O(0.K;1G^E %JBOS*_8C_P"#F[X>?MG_ +5F
ML?"^/X=^)_"/]AV.J:E>:UJ%_!+:Q06 9IG*H-V-JDUQG[7'_!WU\ ?V>OB+
M;Z/X.T'6OBYI<UHMP^L:'>1V]O$Y)!B*S*&W# .>G- 'ZT45^>7_  2\_P"#
MCOX/_P#!3+XB7WA*VTV_^'_B2)/-L+#6+R.634T52TC1E!@;>,@G)SQ7Z!?V
MO&0CJ"T,@R).U %NBOB'_@HM_P %\O@7_P $\K+6--O]6C\7^/M': OX3TV<
M1WLB2<[P[+Y>%7DC.:^(F_X/<OA:K*/^%'^/\L/^@M:<?I0!^W=%?#G_  33
M_P""_7P-_P""DJ:/H^E:BWA/X@ZU)<+#X2U"7SKX)%D^9O1?+PRC<.<XK[;3
M4HY;EHUY\L[6/HWI0!8K/U0&)-K9D6>0+C^Z#7YW?M__ /!Q_P""_P#@G[^V
M\GP0UWX:^*-:U9XK";^TK6_MXK<+=8VG:PW?+G)K _X*/_\ !T9\'/V#_BY;
M^"['P_JWQ*U2&'?JCZ-?10IH\_&()/,'S,5(;*DC!H ]^_X+G_'+Q=^S'_P3
M1^(7C3P'KDGA_P 2:!;0O:W407?'F5%_B![$U\N_\&LG[<?Q5_;Q^ OQ8U7X
MK>+-0\77^A^(K6QM7NT1&CC>V+L/E4=ZS/\ @H-_P4$TG_@I=_P;C_%/XI:7
MX;U3PA;W\QL$L=499)LPW,0WY4 ;6W<5Y]_P91HQ_96^,TFUE>3Q/9EF=LB0
M_93R* /VIFMUTY!)E_+C4*(U7=3)VS;)'@J1\S,1\H7OS7&_M"?M%>%?V4_A
M)K7CKQ]KECH_AW18#-/<2G:!C@ #DDDD#@'K7YU_L?\ _!SMI?[>7[0EI\/?
MA_\  'XA:NUS.T-S>1ZC:F&U@# -<-G'R*IW8ZD4 >-_\%VOVJ?VP_A5_P %
M =,T7X$K\0)/A_<:18F<Z7I)N+/S2[>9^\V-S@#/-?LIX#U:>;X=>'[S4%N&
MOGT^W^U1^7\_FM&N[<.WS9K\_?\ @J)_P<2^"_\ @F)^TE9_"'5OAWXF\2:E
M?:?;7D=]8WT$,,2S,5"E7&<C;7Z%^#]8;Q7H6CZS;CR+?5+&.Z,3\L#(BLO/
MMF@#9LFC:-C&,#/(]#4U?F;X0_X.7?A_X@_X*2+^S;)\._$FGZNWB:;PW+KT
MVH6ZV,;QAB9BOWMIV].O->?_ +4W_!WS\&?V>/CEK7A'1_ OB;Q]INDR&%==
MTO4((K6ZD7AU59!N!5LKSW% 'ZY45^87_!.W_@Z4^#O[>WQUB\ W7AC6OAOJ
MVHHJZ2^LW\,R:I<%L"!/+'RMC)RQ P*_3.+4O.MDD6-FW8. PZ'O0!:HKR3]
MJK]NCX5_L2>$[77/BEXQTOPCI=[<_98)KIF;S9,$X"J">@/.*_++Q#_P>J_"
M71O$E_96_P (/&^H6MK=2P07D6JVJQWB*Q59%!&0K  @'G!H _:BBOS5^)'_
M  <V_"'P7^P5H/QQTOP[JWB0ZEJ,6E:EX9M+Z%-0T.X=&?9*S#:V% R5R/F%
M?4'_  2]_P""BV@_\%0?V6++XI>'] U+PS9WE_<V/]GW\R331F!]A8LGRX/:
M@#Z*HHJ.6;RSPN[N<'I0!)17E7[4O[;'PQ_8K\ P^)_B=XLTWPGHD]PEJEQ=
MECN=\X 506['G%?ES\0/^#S[X2>$/&VJ:3IWPG\:>(+:RNI(+:^M=4MDBOXE
M8A9D##(5P,@'GF@#]FZ*_)/]E/\ X._?@+\?/B:NB>+O#>N?"G2?LTDSZWK5
M[%<6R2+C;"5B4MN?)P>G%?J9\./B;H_Q:\*:9KWA^[CU+0]:LX[^QO8\^7<P
MR#*L,X/(YYH Z"BOG/\ X*A?\%&=#_X)?_LJWGQ4USP[J?BJPLM3M-,>PL)T
MAFW3L0'W/\N!CD5\R^#?^#FSX.Z]_P $_P#5?CQJNB:IX?CM]2GTC2O#5S?1
M/J&MW,2HQCB91M7*L3EL#Y3S0!^DU%?FC_P3#_X.5O!G_!3S]IVW^&OA_P"%
MOC#PW)-87-\^K7M[!/:P^2F_8P09W-T%?8_[5G[?WPK_ &(O"FFZU\4O%>G^
M#].U:Y-K;2W99O,?:6Z*">@]* /9Z*_%+6/^#UKX4V/B#4+.S^#/CK4K:SGD
MBCNXM5M1'<HK$"101D!@,C/K7WY_P3[_ ."S'P3_ ."BVA:/'X.\16MOXMOM
M/2^O?#<\NZ\TMB<&)VP$9@<?=)ZT ?6-%1+=*TC+_=_6OES]OS_@L)\&/^"=
MVE:C;^-/$-K)XQATU]1T[PU%+MO-5"G:$1L%%8MQ\Q% 'U117XES?\'L?PO3
M<4^"/CZ18\;RNK6GRG\J^H/^">O_  <N? +]NO5(=&OIY_AMXJU+4X],T?1=
M7G%Q<:NS@$/&8EV@;OEPQ'- 'Z*45!97PO(&DVLFUBN#WQWJ6*59HPRG*MT-
M #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** (-0_U*_[XJAXD_P"17U7_ *]IO_0#5_4/]2O^^*H>)/\ D5]5_P"O:;_T
M T ?Q@_LDVOCSQ%_P46U+P_\/[S7+#5?%6JZEH-Y<:79?:IX=/NIVAN6V8/R
MB-B23T'<5_0A^R%_P:V_LV?!'X6W6D^-M%N/B;K33LZZMJ436DJ1G&(PD;[2
M!R<]>:_*[_@V881?\%Z;QH5>:4V?B0, ?N?,:_J&DFDG2'9-%\KXFR#S["@#
M^8S_ (.%_P#@E?HW_!*/X[>#_B9\%;+7-)T'6)%N&CM(7^R^&KB%T$8\[)R9
M&^;:_4C'-?K-^PO^VYX[_P""E/\ P1CUK4OA'X@N)?CIINBG1FU75(5LU_MQ
M55C)D@KMP?O;<>U8_P#P=;7EJ/\ @C]XIC5P9FU_2>#U8_:.*\)_X-3?BIH/
M[.W_  2B^)?C#QQJ4?A[P_HGBB>[U#4KHG991"&/,C[03@>PH \]_P"";O\
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M!/\ Y([X0_[ UG_Z(2OYGO\ @[311_P6(\.LA79_PCNE!=HQC]X]?TP_!/\
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M%V_^"4_C3_@K5\ /"OA'PSXF\/\ AJ?P_K)U.2;4XI7CFS$R878">_>O0?\
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M>J>&M7\5>&;=-/271()(;<V4:K';Y63G?M7YCT)KQS_@N!_P3F\3_P#!4_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<W3Z4W[6F\KSN STJ/41,(-UOM\Q>0&Z-]:I_P!HMGS5,GS#:JD?)N__ %T
M7)-4AB1F9F547>3CH*=%?QSRLBM\R $\52OK>2XTAH;AMLMP-N%['T%2VTZ0
MVJLZK%,1M7=QD]!0!.-1B:1EW?,J[B,=J>+E"H^;[W0'J:SX;M&E\N11;W;_
M "Y[.?:G,INITE: ^9;_ "Y8=0>#B@"\;E C-GY4ZFH_[3@$LB>8H:-0Q!]#
M4+*(9=K^6MLXV@9ZFJ^I0V(G5YHH&\S"JQ/)Q0!H6M_'>(C1MN$B[EXZBI(Y
MEE'RGIQ5,I':0*D?E1S*NQ!G@>U6+.'RURP7S#][% $U,-PJR%><CGI3ZK7%
MVT,S!@5C &''K0 JZE$UZ;?YO,49/R\?G5C-4+B22VM?,+*8EYD:0XPO>KEO
M(DT"M&P:-@"I'0B@!9'$:,QZ*,FJ[ZO F[+'Y$#D8Z U:/(K+\H'6FE4-(LR
MB)^/E7'- %][R../>S?+C.<417L<VW:3\XR.*J7EVH "1I-;+Q(%Y93V_"B.
M^41B2'=-#]TJO.R@"]'*LOW6#>XIU5=*MOL<)B6,)&IRN/?FK5 !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% ".-R'Y=WL>]?)7_!5?_@J?X#_ ."6WP1L_%WBI;C4M5O+B2#1=&@)C;5)
M5"ET#X*KM5L\^E?6DK[(V;C@=Z_F-_X.+_C7XC_;D_X*W:#\*O".KW7Q \(Z
M.+ :=H.DXNH+>_)9;X *-WF;5PXSQCM0!6^)'_!U-^UE\4_B5XDU?X3Z58Z;
MX4GNE>TTN?PT-4FLTVCY6F48/()Z#K79?LF_\':7QF^%WQ%UI?V@_"L7B[3+
MRR@2UMK#3DT2337\SYI7# EU*\8 [5^Y?[(/[!'PQ_9&\#?8_A_X&T/P?%K
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M_2DK]N?^"8W_ "CG^"__ &)^G?\ HE: /=8FW>:IZ1]/;BOYA?\ @[SG8?\
M!6+PQ\Q^7POIY'U\UZ_IYA_UEQ^'\J_F$_X.]/\ E+%X9_[%;3O_ $:] ']*
MOP!B6/X'^#=O\6A6)Q_V[I77UR7P$_Y(=X-_[ 5C_P"DZ5UM !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M #9'6-"S<*HR:_F7_P"#E3]GWQ%^QY_P5G\-?%_POI4W@+P7X@33TL-<TMA:
MK<7T>7O3^[(;?M8%B1SGO7]-+KYB%3T-?*W_  4__P""67@O_@J;\%U\(^-I
M[G29M)D:?1=5M(A-/I4K[5>1$8A6+*H4AN,4 :W[&7_!2#X/?MB^ ?MGP]\;
MZ9XF@T/[/::I<"X^S_9IS$&VD2A2<X)XS7RM_P ' 7_!5/X;_!K]CKXJ?#'3
M?B9::7\6K[1(KC2+;3IG$\BR2KC9)'P"55\_-TK\U?C=_P &DW[2WPS^*VL:
M;\)?$.CZYX&\X?8;W4=<_LVZNAM'S211J0I!R.IXKLOV/_\ @SU^)_Q!\;ZE
M-^T)XS3PWI\,,3Z?+H5XFL37L@?YXI?,"E$V]"">30!] _\ !H#^RMJ7A;]G
M;QU\2/%'A&VM[SQ??Q3>%]<N(4>[N[3RW6Y\N7EE!D !!QDUT/\ P<"_\%;_
M -I[_@F1\;?#=[X%T_08?A+JUK#;07NHZ<MS-/J"AGGA#[P>$ /3%?J#^S;^
MS[X:_98^$/A_P3X-L9-'\*Z#;?9+*RC0D#)^9SDD@ELGKWKS3_@IU_P3*\#?
M\%-?@.W@OQM%)"+',^DZM GF7.CW+ *TT<9(5F*Y7#<8)H YS_@EK_P5X^'7
M_!3/]GR/Q-I^I6>AZY8)'!K6D7ERB3:=.0<9/"L'P6&W. <&MK_@HQ_P4Z^'
M?_!.?]GR]\;:]K>GZI,8GM]*T:RN4-SJ]P!GR8V&51MN3EN.*_$GXZ?\&C_[
M1_@;XH:O:_"KQ+I.J>"XRC65_?:T-.O+WY03YL,:D*0<@<GBNA_9-_X-&_C/
M\5/%UW;_ +07C<^'?#-O LVEMHNHKJ\DUQN *2))MV+LS\PYSQ0!P7_!N;\%
MO&'[=?\ P5@U;XU>+?#U_P"+_!^FM?2WMYK>+M;6>4,UF-TGWFC( !7."O:O
MLC_@Y?\ %,/[9W[4'P+_ &.].ADTGQ%XPUN'51X@E</9P^:DD6QHE^<D$9SF
MOU4_97_9'\'_ +(?P;T+P'X%T>WTCP[I46&")M>:4<F1NI)9LGDX&:_._P -
M_P#!%[XW?&?_ (+:S?M!?%?Q19MX+\"ZS]O\%PVMQ'--+;(Y,=M*FT&-<,QR
M"3F@#]./@_X-O/A]\*?#/AO4KJWOIM'TJWT]IH$*(YBB6/.#G^[730PO:PPV
M_,D>W8P)^8>Y-0V=BJP/;QHUMY;;LKR#WX)J:YL/M,N]6:%G7;O'44 1V3?8
MH&W;HXU))\P[F;Z5_+?\6;G[3_P=:ZC/'Y?ES_%N!<LGS<K'R#VK^HZZL&\Y
M)IMTGV<811SN)XYK\2_'G_!!3]H+Q1_P70NOVA(X?":^ 9/',?B*-?[5'VKR
M5"\>7LSG@\9H _;I9)FN9(8]JK&BD.PSN]:^!O\ @Y!_8WU#]L;_ ()J:]IV
MGZ]:Z--X5NE\22O-;R3"[6W1\PHJ<AFSP>E?>MJYGNHY<2(TGR.NWC(_I46J
M:.-0ANA?*)[0@[82@<$?3O\ 2@#\-?\ @U'_ ."GOP[\&_!Z?]G'Q0TWAWQC
M:ZE<W^G7MU,(X-6\U\^3&A&49%0EBQ .:_;=_&_ARY>!I_$NCED&["W\:JQ_
M[ZK\C_\ @JE_P:QZ5^T;XT\4_%#X)^(KOPOXZOK:)['P\52TTV:X+$RRO<9+
MH6#$D 8R,5\&C_@U>_;>N;+;_:WAMKBW.S:WB^15&>>#MYH ] _X.F/^"C?P
M_P#V[?BMX#^"_P .I+C6M2\$Z_*]]JD3&:U,TJ>0\*QA=VZ-ER2,@CI7["_L
M0_":;_@E5_P2A\/:9KEQ#XPE^&_A>XU.Z>P0VYNE >X*)OSM.#MY[U\Z?\$J
MO^#:GP3^P/X^TGXC^+=1G^(GQ#:RA?R=1A3[+H-Y@F5X9%/[W.YERXZ<]:^G
MO^"NO[/GQB_:%_8BU[P7\"=2L=%\4ZY<107+W=PMO')8%76X@W,K##J0.!GT
MH ^&?^#8KX*W7Q9^,7QX_:JANH[+0?C!J=SIUMH,@WWFG[+D7&]Y!\K A@O
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
>%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>exhga.jpg
<TEXT>
begin 644 exhga.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1"H17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0?.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %9I;F-E;G0@
M5G5L=&%G9VEO   !ZAP !P  " P   AN     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MCFE\$:QJGB+P_:SR^*_$)OY]+-Q.+C2(8(4<JOS0NULH?#'C!D7'7J#72)X
MCM[.SBL?$&KV<]K:BS:[A^S^9<0C[B2!H2AVY(!"@C)YY-)IG@.72M)@TRV\
M6Z\;.VM_L]O$PM (EV[0<B %B!TW;AW()Q5SL^:WR_'_ #7W?,4+I*_];?\
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M88; Y.,\ GH#5^2\CCL[.X/Q!\5-]N0R6\$>DV[W#H#@MY(LC(%Y')4#D>M
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M? P&9HY&#/&P,6QE) /W<C'6IX/#EQ:ZCJEM%-.EAJ3I=?:(I5\R&955&!#
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MVEQJVHRRWC9NKI_)9[CY0N&0Q^7C:N  @QR1SS52MJU_6NGX;_@/2_E_P/\
M,K1?$WP_+XSC\,B5UOI'\H;GBXEV;_+*;_,!Q_$4VYXW9XJ]J'C&ST_4VMGL
M[V:"&=+>YOH40PVTK[=BO\P?G>O*J0-PR12Z7X0M]%U*2XTW4=0AM92'EL/,
M1H7D"A=Y)0R D*,@. >XY-)=>#K.YUB:]^V7L4-U+'-=6,;IY%Q(F-KME2P(
MVKPK ':,@TM-/Z_KK^'F+7^OZ_K4@T;Q[I^MZG;VEK8ZE$EQ)<0QW%Q;B-#)
M"<.A!;>#U/*XX/.1BN=\3>*]7M_$VK1M+J^DZ7H\$$CS6=I:W G$A8$D,6=3
MP-K8"KM8N,8K:TSX>1:7J5I=Q^(=8F^RW<]VL,OV;8[S$F0-MA!P23T(QGZ4
M[5_A_'K%WK$TOB+6($U>%()X8?LVQ$0_*$W0EAU89)/WC[8%9682O=V_I&;?
M?$!/"VN:\OB6]26UBN+>+3X5$4!^>)G*EY'5,_*3EF4<8 SP>PT+6[+Q'H=K
MJVE2>;:72;XV_'!''H017/2_#JVFU2?4Y->U?[?))%-'<@VX:WDC0QAD BQR
MK,"&# Y/%=7:0-;6L<+W$MRRCYIIB-[GN3@ ?@ !Z 4EL&NASVN_\C_X4_[?
M/_10KIZYC7?^1_\ "G_;Y_Z*%=/0,**** "BBB@ HHHH **** "O+/$[3GPY
MX]MF@OKC4+F\2*&.TM9+B3RS#&8R%16PO#\D8SFO4ZKFPM3J0O\ R5%T(_*\
MT$@E,YVGU&>1GIDXZFCK_7E_D&Z/)+G^TGD\3W42>(=;M+C07M4N]1TF2&X2
M8Y"PQ0K%&74[LEO+XP,L>U^WOI8_!&K6C7'BO5Y9='\E8+W0)8O(?85VIMMX
M]^2X' 8@+DG%>J44UI_7K_F-.S3[?\#_ "/-H-+O=!\0:7<:7:W$OA:9Y;_R
M1;2>=I\I@DW((=N_:Y;(7&0V1CY@*H_#V_FT?1M.CO[CQ9*T5G(LNF7&@2I#
M;G[V5<6ZEB I !9R=V!S7J]%)ZB6BL>3:!8W]I\$[Y[J;7IY)-+FM$TJXTUE
M>"0[@!'&D2R,"6'S-NXYR #5_1;B;1/$@U^^TW5)=.U'1[6VC>+39Y)K62$O
MNC>$*9%!W9!VXXY[9]*HIWUO_77_ #&W=6?];?Y' ZMJ8M_'GAZ\DT?5(X8[
M>\>4V^F3S!/,V;"YC0@,VPG;G(XSUK#N#K%IKFC>.6@N)8)[V6.:PM]!NOML
M<$J[#YG))"^5&?\ 5KTX)R,^M44EIJA/56/&5MKC5/$.O:M+9:[<:*NL07DN
ME2Z7-!]HC6&(+/&&C61V22/)CR<A?NYQGH_%7DW/B[PMJ-G:ZN8[YC!J BTV
M<H]KM9D6<>7\F)0G#8(#-G@FO0Z*I.UO+_*W]?Y;#UOYF?K4$+Z1?/)IXOV-
MK(A@4#=,I7F,'_:Z5RW@V*_LO$$UA#)J5YHMO;%8Y=7M&CGM9-P_<I*R@S)C
MG=\V-H^9L\=S14K1W_K^OZ[@]58\TO--N]0U[Q!K/ANUNH-=T^\!@^U6DL$5
M_!Y$:/#O90'4LC8*YVL%;H>676FZAXGT/3/#"QMI_P!ET=6NWU'2+B:)G>$1
ME$8-&N]0S?Q$@GID''IU%'3E_K1?TQWUNOZV_K^D>1?:IO&'A/0=$U33]:M]
M8A4J;J;1+I(X;B-"(I][1A0"X5N3QGG%3C4+V#QCX?U[Q%H^J1W<EE<"Z6TT
MNXN5M5946.,M&C<EE=L=1NY[5ZM13D[MON2E96/+_AC-<65GI%G=W7BAI?L[
MQ/IU[HKP6UL2=V?-,"#@*1\SN3NXKJ_ O_($N_+W?9?[2N_LN[_GGYS8Q_LY
MSCVQ70W$$=U;203 F.52C ,5)!Z\CD46]O#:6T=O:Q)##$H2.-%PJJ!@ #L*
M+C>I)1112 **** "BBB@ HHHH **** "BBB@ KE;S_DL&C_]@*__ /2BSKJJ
MY6\_Y+!H_P#V K__ -*+.@#IKAIEMI&MHTDF"$QH[E%9L< L <#/?!^AK@[;
MXDW]S<6]NFBVBW%Q8?:(XFU!^)Q,(F@8^1@$,3SR>#\N.:] K$C\&Z!%=QW,
M>G(LT5Z]^C!WXG<$,^,]\GCIGG&:%OK_ %_7Z!T_K^O^'.6N_%NK->PVNEZ;
M]EENM?;3;G[5?EBH6#?OC^5U4$+D #'J 6.)?AWXFU*YM=,TK5X9)VN+.>YC
MU"6Y#R3>7/L8.NT!?OJ1@GC/"XQ6X? /AYOM&^UN7-S=_;9&>_N&(FVE=RDO
ME<J2I"X!'&, 4FD> ?#^AWUI>:9!>1S643PP>9J5S*J(YRR['D*D$\\CJ!Z"
MG&W7^M/\Q/7;^M?\M"CKGC>^T?5M7LTT:"X33K:VNED^W%#+'+(R-D>6=K*5
M)QD@C'(K4T?Q)+J>NWNG3V2VAMV?8'F/FNJL%#F-E'#<D%2PQC)!. [6/!N@
MZ_=O<ZO8_:7E@%M*#-(J2QAMP5T#!6P22,@XR<=:GT[PSI.E7YO+"V:*7RS$
MH,SLD:$[B$0L50$@$[0,X&>@H7F.6^GE_P $XSQ#JNJ1_$"]^V/+#IFE6MI<
M6XL]2>-Y)))70*\?E['#L A#$A0 P.3Q?G\?:I9ZM;:->>&P-3GNUMOW-^KV
MZ[XV='\PHK$$(X/R9&T]>,[ESX+T.\U:]U*[MII[B_@%O<K)>3-%)&.B^47V
M#&21A1@DD<DU$/ >@!K)_(O&DL;C[3#*^HW#2>9C:&9S)N?"_* Q( )'0D4*
MVB8W9MO^MO\ /4C\7ZUK&D6NC_V3;6DD][J,-M,)KAD50W) (1LYP1G ]<5R
M>B^/+WPYI5TWB".XU"SBNM3Q?R7 :9OL\C$)Y84#!48!!'(^[CFO1-5T>QUN
MVC@U*$S1Q2K,@$C(5=3D'*D'\.XR#P:PHOAIX6A=&%G=NL<DLHCEU.YDC+2_
MZS*-(5(;)R""#D^M)=?G^G_!#M\OUO\ FBQX0\477B:WNFO=&NM+DMW4#SH9
MT256&04,T4;''0_+@'N>M4T\;71L;C5)-& TC+):W*WBF2602B(*\94;-S'@
MAFX'.T\5O:/H=CH5J;?3A<>6<?\ 'Q=2W! '10TC,0H[*#@>E4D\%: GVY18
ML8;\N9[9KB5H"6Y9EB+;$8DDDJ 233=KZ$J_4Q[CQWJ5C=1Z??>'0-2:]AM6
M2WOE>!1*"4D\QE5B/E8$;,@CTP31_P"%HWD6GK>77AL[/+O04@OE=O-M6(D4
M;E4%"%)#$@\?=Z9Z&3P%X?EM+>WD@O&%O<+=1R'4KGS3*HPK-)YF]L#@!B0!
MTK'UGX7:0WAVYM]"MYQ?".X^R&ZUB[\M))U(D9LL^<Y)(*G//J34RTB[?UI_
MG<J.LE?^M7_P!9OB#?VZ2QW&AV\-VT%O<VJ/J.(Y(Y21\S>7N#J01L17)R,9
MYQ1'Q7NI=*%];>&G9$TK^TYC+>",!!)L=%^0L6&&QN5<X[=MO2/A_I,&B6L.
MHV1%Z@ADEEBU"=V22,$*(Y20ZH,MA1M7#$;>337^%WA-XY(S9WJQRVYMGC35
M;I5,1;<4P)<!=Q)Q[U;LI>5_T_S_ *Z$*[7W?I?]1\?BO5'UF;2WTFR2[6\C
MBB0Z@_[RW9&?S_\ 4\$!2-O(R"-PX)7QUXSE\&Z>EU#IT5\/+DFD5[KRF"(
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MZFM>RLK?3K..ULHA%#&,*H)/?)))Y)))))Y).:2^'7?3\M0Z_><_KO\ R/\
MX4_[?/\ T4*Z>N8UW_D?_"G_ &^?^BA73T#"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *Y6\_Y+!H__8"O_P#THLZZJN5O/^2P:/\ ]@*_
M_P#2BSH Z*_NOL.G7-UY;2>1$TFQ>K;03@?E7FUCXV\<7WAY]5_LJPMXG6&Y
MM!*B,UY&Q^:&-8[ER9 "NUSM#$X*+UKU&LF+PGX=A<M#H&EQL;@71*6<8/G#
M.).GWQD_-UYH6_\ 7]?UYAT_K^OZ\CA)OB!XIFCTVWT"RL=8O[NWEO&6"$1*
M%1POD$2W"%74G#-\Q4_\LZVE\2^(-3EU2?2IM'M;;3W:W>"Z1Y)5D\H.K[E<
M*02P 3 R.0_:MT>#/"ZVZP+X;T@0K-]H6,6$6T2]/, VXW<#GK5MM#TEM6&J
MMI=D=1">6+PVZ><$_N[\9Q[9H>UE_7];?CN'7^OZ\_PV/+=2^(FOW>E6\5OJ
M6D6=W>Z?I=[$J0.9%\^98Y1CS<E02#D8(#8SG#5TF@>,_$.M>+)($TB-]#BN
MI;.2[!B0HZ X<9G+L&(X3RA@$'<PKJ(?"^@6]I):P:'IL5O*NQX4M(PCKN+8
M*@8(W$G'J<U.FAZ3'JYU6/2[)=1*>6;Q;=!,4_N[\9Q[9JKJ][=_^!]W_!![
M6]/R_P ]?P/,?&UWJUSJFO03ZC"UO8W^E?8K95>(AFF3.Y@^&7#D$%><J>,"
MMN#Q1JDNMZ?:ZI::1<O#J5[;&Z560HT<)=&16+;"5)#'<>_&#QUNH^&=!UB1
MWU?1-.OWD"AVNK2.4L%SMSN!SC<<>F3ZU5B\"^$8+Q;N#PMHL5RK[Q,FG1!P
MWKN"YS[U*T5OZZ?Y ]5I_7D1^$]<O]7M;A-46%+Z (7A2)HMF]=P!^9U8=@R
ML0<$\=!Q$7COQ%!IQ&GZ=H-CMTR_U*0*)'0RP7!5U"C;PV<[\Y))..,'TVST
MC3=.BFBT_3[6UCN',DR00J@D8]68 <D]R:R4^'G@N/=L\(:"NX;6QID(R/3[
MM.^M_P"MO\P6F_\ 7](Q-7\7:S";Y8'LK2-K5FLI'@:7=(+<RGYE?&[_ &&5
M?E4MELX&(/&GBZUT.\2&?199-*\/PZHUU+!+(;@E7RC()!L.8R-VYNF<<X7T
M:W\-Z'9S1RVFC:?!)%#Y$;Q6J*4C_N @<+P..E,MO"OAZRG::ST+3+>5X/LS
M216<:LT6 /+) ^[@ ;>G%&FO]=_\T.-E:_\ 6W^3^\XNY\?ZS%XB_LJW?19G
MDO+.)0Q=9(8YXR22@8[R&'7*C!%5C\2M=T_2TU#4K73[F-4U*-X;6-T=Y;1F
M&\$N<*VW[N"1UW'I7</X-\,200PR>'-):* @Q1M8Q%8R.A4;>,>U-M_!/A6S
MEADM/#.CP20,7A>*PB4QL>I4A>"<#D>E'<E75OZ[_P# ^XY"V\:>-#-I5K?Z
M1I]HVI7JP174S+RC0O('$,4TN<&-ADR#/& ,G$VA>)M>UCQ=X>%U>V,-K<:7
M=275O% VV65)DCRK&3CD@C(; W#G.1U/_"$>%/)CB_X1C1O+BD,L:?V?%M1S
MC+ ;>"<#GKP*EA\)^'+:U6VM] TN*!%D58H[*-542##@ #&&  /KWIII._\
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YC7?^1_\
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M<#L:*YO_ (5SX(_Z$WP__P""N#_XFC_A7/@C_H3?#_\ X*X/_B: .DHKF_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "N5O/^2P:/_P!@*_\ _2BSKJJY6\_Y+!H__8"O_P#THLZ .ENF
MN$M)6LHHY;@(3%'+(8T9NP+!6('N ?H:P/MWC?\ Z%[P_P#^#Z?_ .0ZZ2B@
M#F_MWC?_ *%[P_\ ^#Z?_P"0Z/MWC?\ Z%[P_P#^#Z?_ .0ZZ2B@#F_MWC?_
M *%[P_\ ^#Z?_P"0Z/MWC?\ Z%[P_P#^#Z?_ .0ZZ2B@#F_MWC?_ *%[P_\
M^#Z?_P"0Z/MWC?\ Z%[P_P#^#Z?_ .0ZZ2B@#F_MWC?_ *%[P_\ ^#Z?_P"0
MZ/MWC?\ Z%[P_P#^#Z?_ .0ZZ2B@#F_MWC?_ *%[P_\ ^#Z?_P"0Z/MWC?\
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M#M6=_,5\?58T)_/O744K6 YO[=XW_P"A>\/_ /@^G_\ D.C[=XW_ .A>\/\
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M[)=.L(K2.6:5(1M1IGW-M[ GJ<#C)YXY)/-6:**-P**Z6/[8;4)KNXG(7;#
M^P1P9 #%0J@DG'5BV.<8!(JS#;16YD,2D&5R[DL26/U/L /;%2T4 %%%% !4
M4-M%;F0Q*097+N2Q)8_4^P ]L5+10 4444 %%%% !1110!3T_2[?3?M#0EWE
MNI3+--*VYI&Q@9/H   !P *N444 %%%% !1110 4444 %%%% !1110 4444
M%%%% ',:[_R/_A3_ +?/_10KIZYC7?\ D?\ PI_V^?\ HH5T] !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %<K>?\ )8-'_P"P%?\ _I19
MUU5<K>?\E@T?_L!7_P#Z46= '2W5NEW:2V\K2*DJ%&,4K1. ?1U(93[@@BL#
M_A ](_Y_/$'_ (4>H?\ Q^NDHH YO_A ](_Y_/$'_A1ZA_\ 'Z/^$#TC_G\\
M0?\ A1ZA_P#'ZZ2B@#F_^$#TC_G\\0?^%'J'_P ?H_X0/2/^?SQ!_P"%'J'_
M ,?KI** .;_X0/2/^?SQ!_X4>H?_ !^C_A ](_Y_/$'_ (4>H?\ Q^NDHH Y
MO_A ](_Y_/$'_A1ZA_\ 'Z/^$#TC_G\\0?\ A1ZA_P#'ZZ2B@#F_^$#TC_G\
M\0?^%'J'_P ?JE>^&-!L;JTM7NO$DMQ=OMBBB\0Z@6P/O.?W_"KD9)]0.20#
MV-<KJ#MI_P 1(+R:)IEN-+D@M54J"TRN',8+$#<ZX(R1]P^E'5?UTN'3^OZ\
MS,CTSPO)XRD\,K>>)?MT=K]I+'Q#J'ED9 *AO/Y8!E)'8,I[UL-X%T=5+->Z
M^ !DD^)-0X_\CUR=SH'B6*ZT;Q5#::O=ZFM_))=:*SV*I##*"L@#Y!;Y0F,R
M-G:.!_#5T[P-J4%W;6R^%K2*VM[O4E,LLL03[+<;F145=Q(&X J0HR/3FAW4
M?/\ 7^OU'I?[OZ_#\4;NEZ;X6UG6)M.T^]\32/%:Q7?FG7M16.2.7.PHQF^;
MH>G';K6U_P ('I'_ #^>(/\ PH]0_P#C]>70>!];M=,%N/ LWFVVC65M;-!<
M6BJMU%*TDD@_>C#$L3NQD_-Z\]1>>&=3O=7N+FX\/S_;S<M<)J\-S$DCVI4_
MZ)N$@<-@[,?ZO/S[@:<DD]//\Q=?N_+_ #.DE\$Z7'+"B2>))5D8JSIXDOL1
M#!.6S< XR,< G)'&,D2_\('I'_/YX@_\*/4/_C]<)8>%]5TO0_"3/X.U&[O+
M6">/58DOK?,FZ%H_G+3@.22,-DE5R./NU3@\":G+X;N([7PA)HES<W<=SJ4%
MLM@JW40# 6\*;GB*ID']Z &.2<$\#5G;^M_Z8':>(M!\/>&?#UYK.H7'B>2V
MLXS)(MOKVHR/CV G_4X ')(%4?$MKX<\*VMG>ZG_ ,)6=/N'5)+R+Q%>&.VW
M8P9 ;D-COE5; !)Q7/:SX!UF7PY-I<&B76KPS:2UOIQU*ZMA+IDY>0L6V$(,
MJZJ#$&P$"_=YKO\ 6HM1ETW0X7T22^83QF]BMYHF2%=A#9,C)O&6[#) /':A
MJVW?\ Z?)_D9D&@Z1/XEDTA(?%>V.W6X%]_PDMV8'5C@ 8NM^<@]5QQUZ9UO
M^$#TC_G\\0?^%'J'_P ?KE+GP5K>EVNN:?:6D6LZ.\%M%IUJ[@.D(F9I(3N=
M0X4'Y0Q"D85LC.>>M_ VMVQ@L[SPG?:A90VVI0"/[5:B$B67=;@1>:J# ST4
M8RN.G"Z?U_7D5;7?L>F?\('I'_/YX@_\*/4/_C]'_"!Z1_S^>(/_  H]0_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5RMY_R6#1_^P%?_P#I19UU
M5<K>?\E@T?\ [ 5__P"E%G0!U5%174SV]I+-%;R73HA98(BH>0C^$%B%R?<@
M>]8'_"4:O_T(GB#_ +_Z?_\ )5 '245S?_"4:O\ ]")X@_[_ .G_ /R51_PE
M&K_]")X@_P"_^G__ "50!TE%<W_PE&K_ /0B>(/^_P#I_P#\E4?\)1J__0B>
M(/\ O_I__P E4 =)17-_\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_ +_Z
M?_\ )5 '245S?_"4:O\ ]")X@_[_ .G_ /R51_PE&K_]")X@_P"_^G__ "50
M!TE%<W_PE&K_ /0B>(/^_P#I_P#\E4?\)1J__0B>(/\ O_I__P E4 =)17-_
M\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_ +_Z?_\ )5 '245S?_"4:O\
M]")X@_[_ .G_ /R51_PE&K_]")X@_P"_^G__ "50!TE%<W_PE&K_ /0B>(/^
M_P#I_P#\E4?\)1J__0B>(/\ O_I__P E4 =)17-_\)1J_P#T(GB#_O\ Z?\
M_)5'_"4:O_T(GB#_ +_Z?_\ )5 '245S?_"4:O\ ]")X@_[_ .G_ /R51_PE
M&K_]")X@_P"_^G__ "50!TE%<W_PE&K_ /0B>(/^_P#I_P#\E4?\)1J__0B>
M(/\ O_I__P E4 =)17-_\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_ +_Z
M?_\ )5 '245S?_"4:O\ ]")X@_[_ .G_ /R51_PE&K_]")X@_P"_^G__ "50
M!TE%<W_PE&K_ /0B>(/^_P#I_P#\E4?\)1J__0B>(/\ O_I__P E4 =)17-_
M\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_ +_Z?_\ )5 '245S?_"4:O\
M]")X@_[_ .G_ /R51_PE&K_]")X@_P"_^G__ "50!TE%<W_PE&K_ /0B>(/^
M_P#I_P#\E4?\)1J__0B>(/\ O_I__P E4 =)17-_\)1J_P#T(GB#_O\ Z?\
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MEK>/Q?=QE[3Q1X;G16*%H]$F8!@<$9%YU!XQ4ALO&X&3XB\/@?\ 8!F_^3*
M.EHKEK>+QA=P+-:^)_#<\39VR1Z),RG!P>1>>HQ4OV'QO_T,/A__ ,$,_P#\
MF4 =)17-_8?&_P#T,/A__P $,_\ \F4?8?&__0P^'_\ P0S_ /R90!TE%<W]
MA\;_ /0P^'__  0S_P#R91]A\;_]##X?_P#!#/\ _)E '245RPB\8FZ-L/$_
MALSA-YB_L2;<%SC./MF<9[U+]A\;_P#0P^'_ /P0S_\ R90!TE%<N+?QDT[0
MKXF\.&55#-&-#FW '."1]LZ<'\JD^P^-_P#H8?#_ /X(9_\ Y,H Z2BN;^P^
M-_\ H8?#_P#X(9__ ),H^P^-_P#H8?#_ /X(9_\ Y,H Z2BN;^P^-_\ H8?#
M_P#X(9__ ),H^P^-_P#H8?#_ /X(9_\ Y,H Z2BN;^P^-_\ H8?#_P#X(9__
M ),H^P^-_P#H8?#_ /X(9_\ Y,H Z2BN;^P^-_\ H8?#_P#X(9__ ),H^P^-
M_P#H8?#_ /X(9_\ Y,H Z2BN;^P^-_\ H8?#_P#X(9__ ),H^P^-_P#H8?#_
M /X(9_\ Y,H Z2BN;^P^-_\ H8?#_P#X(9__ ),H^P^-_P#H8?#_ /X(9_\
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M13W^J:C/$EG+:/;2&(I*LA!9F)CWALJI&U@!M& !D&JO@6\2]CNQXW\1>?'
M;=9"EB3Y9()!S;<G*CD\^]>?Z-9:>=12Q?0[2--4L!X=NF2W"[[FW;#]ON^7
MN;/?RQZ"K/V3P1:_$G4%6Z\&V:VM[;A;1K.,WID5%XA=7!4[P 5"$D@C(SP^
MJM_6OZW_ !$[V=^G]?FOP/3-*\-_V5JEW?+JVH7374,4)CN3$RH(QA6!"!BW
M))+,<D_2L=/AGI4,UI>V]W<0:Q;W+W#ZQ%;6JW=R6W961_)PRX8C  Z#TKAO
M#D'@$^(KV2:\\$O;F^NU2TBLXOM6P[@2T@<[HMN[(V!0O4X%:.AV]K<_\(/$
M\-OK.G&X,^G7P1)A;$02%X=W.W#A2N/[N."@R1]ZS] :M==K_@=O#X+LQ:V$
M=_>7FH3:?>F]@NI_+60.6+%3Y:*I4DGC'IZ#$FG>$H=)U"273]4U&"QDF:<Z
M8LB>0)&8LS [/,&6).T/MYZ5R_Q&UI);MK2QMI=0GT.(:G,+:Z@C^R2*P:-I
M?,E0A2JR9P&X/3IG)\21Z+XY\::=_P (]_PCM[>W^C.\=Y/< 7%L/,79-%L5
MF9T^? RO0_,.:(ZM?UT_X'X7%*RW\OS_ .#^)Z-#H'D^*[G7?[3O7:XMTMS9
ML(O)55)*XQ&'SEF/+'[Q]L5=:\*2ZOK46I0^(=5TR6*W>V5+);?;M<@L?WD+
MG)VKSGC;QCG/ Z5HFDW_ (\\1W%M'X=2TT[4?,U&_65/M+)]F42Q2($V^6S;
MRQ9L9#_+GD&CZ[X&_P"%+3Z,FH:"P_L^>26S22)E5LDAG4<+\VW!..2N.<5,
MG:-_*_WHT2;G;O\ U_D=BG@!+26T;1O$6L:5'9V?V.**W^S.HCR"23+"[$D@
M$G/TQ6E)X8#ZYI6I_P!KZB'TR!H$A+1,LP;&XR%D+DG:O(8=/<Y\_P##\_A1
M=65/$[:8+3['9_\ "/BXV?9RGE?-]GS\OF^86!V_-]WVJUXM\06=OJL-SI]K
M-<VOA7R));B*YA5++<<2+*KRK)GR>!A6.6(Z\5;5I6\_Z_,S3NK^7]?UV.NU
MKP-I>N7]Y>74MU%-=VJ6Q,,@7RRC[UE4$'$@.,,<]!Q3M2\)&]O-/N+'7M3T
MDZ? 8(4LUMRNTX!)\V%R3A0/3CI7)7UQH]SXAUZ_\.3V&JPR:=$^J:9:-'*+
MR)Q)F4H/O2 %""?O*<<Y7&:?"O@6#4?!-M?Z5H<<^I6Y,D<\,0>8_9U5< C)
M^;&,?Q>YJ4NG]=0<DG_7E_7_  YVS^"+G[=]KA\8:_!,;=;=V7[(Q=02<DM
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M1F[A.5Y[@YY)I;:]OUU_._\ 3#?1]?\ AOR9/;>#6M/MS0^(M866\NS=F4-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M."VYCG()VJ>MFX\.^(;R'7H(?#-S:)=:!9VD&^>V"O-"6+)A93CAP 3Q\IY
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M*** "BBB@ HHHH H3Z'I-SJ\.JW.EV4NHVZ[8;R2W1IHQSPKD;@.3T/<TO\
M8FD_VU_:_P#9EG_:>S9]M^SIYVW&-N_&['MFKU% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 9VH^'M%U>Z@N=6TBPOI[<YAEN;9)&B.<Y4L"1
MR.U:(&!@<"BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "N?USQC9:#=213VMY<I;Q+/>36R*
MR6<3$@/)E@<?*WW0QP"<8YKH*\^\6:'?WWB'4;?P_<W$4NLV"6E^LNGN\"Q_
M.!*LQ945P'8%1O)^7@=:.H].IZ K!U#(0589!'<4M16T"6MI#;Q9V0HJ+GT
MP*EINU]"5>VH4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
8 !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image1a.jpg
<TEXT>
begin 644 image1a.jpg
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MS$V81V#__I2KY,>YV\E\/F,JI?WK\FNFL:3.\>@LS9JTH/OHF4:_6CYH>2K
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M82VJ5F_"F#&3&#%V#,/'?,K!HR? <9M.'3LQ8,P<SIW<1X6JOGS8^SU*5ZW
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M?N3[%<NH6KX\;W4+(L^23_2$X;SL694%JU>Q>?,FEGZU$'=/#\9^OL3PFBE
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M) )9VBIOE'C8E*=1!*+T)S4#Q8,E18N-Z_Z5RE_M-_>8!$P")@&3@$G@[T[
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M\!T5;DL_TM'_X25MG6KX_]KV_]"-><@D8!(P"9@$3 )_&P(N6'/4@S<]/8/
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M"2MSL3O;B^VJCI]=5CP:JPJ-G$Y&8DNUK;*+&^D)G%B>^G+>B*?VF)LF 9.
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M\?,/W^&CWL-0Y2K'KIT[47;D- 9'=L+:70?-D*,AR9E>I?FRM,"ZS'P<.W0
MA:>S,'SP1,Q)-N"IJA1K5JW"B;/%9K8]H1'!$>=54<D*I1@BD$F$4@!%B'7]
MH3)KC'5]?1KOO5<#7@UX->#5@%<#7@W\9S7@(SOURE@14':A$(,&#4#+=]_&
MFV_^$Y_V&X7<(IWWM'?'5O3[?*"4OF?E:GS:HQ_*G4Y4EQ2@8_@G.'OX',8,
M&HA/!XV'RU&,V _[8/'N?)U!),-DY\7S],7T[XP$! 67L'7%/$1^]A7R#IQ
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MB>AUXYFT"*>,'C1(PKT_7@UX->#5@%<#7@UX-?#[TH /O4OJ=3' 1( !0\R
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M%L6LU*%+\315*G@B07YQAPHPENE%3N.=H[8H/UQE7,O 8%.52L6F#/P:T+C
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MBK%LUE0\_%(3["JX*/$*<BN0,O03O/C8B\@M5CX8:2_.A=\3CV/ ],7(R]J
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M146S?J\-LSI"-CC^&6-N$HN\0MLJ@VE4-C6,%E4MB]):.I(+62C7+CFB]I(
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MSO8I@$3Y$?X(5VN)1$-/8$,0;1V,E_KC=D[7/1-6&NLIDO;ER>J)%L^8JH^
MXOJ#@.Q?'>1!WZ>8][?KDC38CJ7IR+"NO@C]6KV1"D47T%FKWDF#(HC'DOW.
M;QP$4PKPM>W+,UNKKBTZ!'B_=E!B]_/X*PFDS5,6 M=:!ZG10T9]2'7^@CP#
M?A%8B\+_V:4/'RINK,N"N<X%U7?YRA7DGSHCTQ?ES<_]T.I8K/ AO/"'RN1\
M ;X)&QZ))+F_&70'>XF0H5ZNQZV3#;4V^1!6BL2EYR]@PYKU**G@WFK<?-:)
ML\7G<2 S&U4R0=&4#1>.']B-8T?RU1"P3&EGI*PNSHPM&Y"8G( 9LU.Q<-X"
M)"7/P,19"W#LY$D<S\G$K)FI2$R9(>'3$I.Q<=L.>5O8MW,GCAP](9JLELZZ
M#)D']B+[U#G3>)PX7I"'%1NW"(\ZH%V.$_G9V+(K4X9:A!E7#<Z?S$7NT5RD
MI>] 2E(B9LV>C6\6+D%*2BJ24F<A]\193W4Z73BT8P_.%5V$L_P2?OYQ,=;N
MRS9K#Y&=*I1>.HVERU?B;,D%G#]W&@OGS$-R2@I2DE*P=/'W*"UEIP_D'3^"
MV7-F(4GBDC'_FP4X<^&JU)(^PRZ473B/A=\L0DI""K*S=#VLRIHKV+EE$RY=
M*A=UBBZ=0.7E"]B]?S_.EI1BY>HU2$E-14IR*E(2DS!CUBR</G<>YXK/8_'B
MQ<@O."MME,-&?"O-R\G"IJU;8:^^C.UI&Y X8S:24V8A-3D122FIR,S-!>P7
MD;%F"\X7EVC[8:==?0';L_8CZT@!ELR>@^3D5,R9OQ!S9GV#E.E)6+9JHQH2
MEQ-EETJP*V,ORJHX'X(ML!09&];C<%Z!R,PWD3,Y^<@\G _.UN%QIO",T$I.
M3L&1 IU+QS;GJ*C$ZF4_(BDU&<DITY&4F(BT';J$@\M>B>V[]Z/PJJZ#Q>?D
M>.$I_+1^,Z[4\"U<+ ,.[#N 0_GZ[% 99X[E8=.&S?*U*HV&O:H2.W=GX%)U
M!3*/YN)442$J*JMD\<TKE1P846/"S?S.Y9U&UKYLF<Q/B,#Z$]# CHW#"XX:
M'#J0B=DS9R(U*05)R<E8NWZ;]HM.)X[FYN";;V8A.2D1B<G)F+-P,4Y=NBI:
M<,H"KRX<SL_'].0DS)TY ^>+=!(_=QC8MGDK+I662GW:7?2:E**\Y RV[#J
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M/8J?%L##V0&!4=&H'J)C^T<H*<I"?&H^?.Q"L#;3 2NG&\BJ>(G)R4F\GIC
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ME!>4ETKT3X E\0[#?SW1_*3!1T8UM)R.@6;U"8U,M=!D?VO%8E"Q!8>C(?^
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M6*OPC)*4WA^T,4?0J ]07%2 8!\/N+BXP,/+%YEI98QR^R>&X1T9!)5)F<*
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M*F(9GA[6>"4E!Z:[#6TO^3215DN3^V1H<GV#$!5-Z0*,"+*QPLMN*0:1J2@
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M1AB8X/SHV8\S"IQ1X(P"9Q3X,Z? GQ0\D=X1EAP=CE0*J%0:',H6VT$  "
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MD@AS/&\HM0JHE ?8U^DEWRP#C%HM%!KI?",U@BV)>B@U&FA4@N8'[ -&=#-
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M]*(F)9":T_3(,S,OD%>,JEU->&NKZTK0E':D:DV1\H*.223W!1MBR+NQIFE
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MB:*\H3SEO:4DBIXB*4JB#"E2HNB]29+)-$R2F?PMXIR;(JO&[,.^?ICI1B5
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M[@Y.#W;A%1!,DP%SXG:#-MXX34AX >/W!PC_PH/6&3D9N,#.S!QB@]/YPB^
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M@^&P,S4YJ>@U,3[.X-@0D]-3BG=M=@=CIDE&Q\8P&<E,9=8)6:3/4H=#H'4
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M3*J &9UVQ=@R"658O_%2PEBK(#*#5)9S$;3J1F-623DR^$H*2QE:V(A%2J:
MO!1]U"02:X"V $C,E&)TMT!4=RIU KL(O'^%A$M."Z[%Y5@3W681"%*C%*@:
MI7;I(K[5(J!O4@#)HCP)H*?19.,7>9-))BPM@EDL-X+#);AW(O!7-E29[Y2
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M:BDOOZEXRF_]E_SPQS\E("*1Q*0DVCON$>F;0GUY"TM+4WSXJU\2E^%.V[/
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M1%--'<GA\;0UW<8S)(4I32Z.Y2?RU9=?T_STN3I,(W4)[>6$HW:5B^-_C,3
M6"Z=T-G:M<'"PK[-&]E<?)9%RR ?KP^E9626!PTW^,WK;U%14<6\3 +C)5Z
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MF4S.V%7JD&LGBLA*WTI0[$F6IH<)"EW'V4=/F9MS,&>S8[$ZU($7NWV8*,]
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M7OL?V51:K6+RLO*RV+AC.Y-C(YBG9ZFMO</GGZ_C7)D1"ZADR32W+YPD)/:
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MR&;<(3&4$LXAD\5$46X6_KE:9L8$QE%:(G&8\IN+(_F)O/;:?T?R :T\Z6Q
M=LHO'B,F.D[%-3YI[67/UD/TM+>PY_@I3/."P+! 4G0P%RZ>5;FESI\\P;D;
M]=16/*'R5IV:OP//ZOC#;U]GZ]:#S,S-,3$[S=S" K<NE9$6G\S8U 2WSEX@
M.CZ#D:E1HM9]A5] #",F,^-6J[+\][<TDA@22D?/2QZVM[,F*(DGZN2T$6<J
M"M6F; X</:#2#L2M_9S5JX)4_9=/GV"==Q&+LP-X^G[-F08]SR9F3(Q,SZJX
MU@7[*"%?K^-N>:WF#9.)4=,,XW9)]"$O)T\;C[,V,(@.B\P!69$&"?@RG.J;
M;5@737P5[,?])V*-6\(U/TGPEY_R'_[#]VAY-L;TV""QOF&</7M.K:/FZ6DN
M7CC$E^N]>?92!ZE+SB>5)W')SK[-^?S@[]^A?4AOEN;M$R2N^I0UZT-5WCRI
M__;54M[R33!BGE0CB0Q-8N=1]V9G@;:6B[P=',4CN[O-T':NAF3/=*4\B>KT
M*E1 %_%G]?\U<95I]<E)3T<+:=GIRG]Y[/A)9BU6E5GW\,%C=/<:B]0?M?LN
MGCVLXZ-/5K/!PQ,OCPT$^/NR;_\V=IV\PKCB71%.,@FMG"X]S,5S550>.\O'
M'W_(!B_!I?,@+3F1%T-C2@BK1(2R\*E)O4A+0PW)">D*[RPU,YM[[7K']+RN
MG+T%.YE:=-O:'-Q[^)AC!TLI+=G!W6?M6BRJHWM+3/6TD9&SA;MM0Z1E%3 R
M/6,H-/-4W3G/)QY1*L^-M'6@NY6]N[>IG;!_0!#[3USBY9@^(;,Y>Q-??O&U
MPH+S]I"8&$\R\W>HMH\/OV3/MCR\/;SP\PCE_+D[3-@$S$1*U:-TY?P%*FYJ
M_#7M<'#BLDRP)2?S_V7O/>"CJKKU_[RO75\$L8""("A2% %!!104Q%Y 1>D@
M!$+H'>F]2%&47D2:-.E%>F^A!TA(0D(G(=1 (&WJ\_^LM<^9"<5[[^=S[W]T
M_#VCF7+.+FM_]V'6,VOOLS>.G#B!F$-',:Q/?]VOKU?WOM@2<<CW:]O,N3$S
MG#*S,K#QC]5HUZJ-IATS<382['WL/"Y<N9",GR>/U_WI.K3O@+6;S-PIG:\B
M!F6X,';0$$0<L:-H:9@W<R1J?/,U0D.;([1)&-IVZ:UK/$V>^SNV1>Q$2NHE
M#!LS!HD7[)OC@8B-"W3N6,K-%.S8O B??R9LFJ-9DV8(;1*.%BT[X=+EJUBY
M;A%JU/Q,[9$]$(<-^A'1468NAG213,NSINTA]?(Y+)T]&4V:?HOP%FWQ^ZQE
M2+&V5SF\-P(_#/G%^%#K6EXT=3@:M>^#R[9"E?;IPX,3IZ(P;/3/N.F+%+@Q
M;\)/6+QNL_6KT0399\R9A2-']^%PY&[4K/Z%SG62O?VD?UNV[H"C\2>M/C37
M\^;?9V'F[+G6W #YL2D+"DH_N^%RI&++BG5HV[J]7K>3Q_V*Y-.&65Q,#+ZN
M^8W^>Y']!!LU:XH=N]=CZ[)I^.++.F@B[$-#T:)U9QP_9R:*'X^)Q+!AP[2?
M>_?O@:T']IAK5]N9A>'C1N*GF29JH C2+V!0U_;XP[K-78;8YLV;@BD+S/#O
ME%%3L'F]^=4JK7=</XW01LTQ:_5>I9:1<0DK5\Y#UT[&_I$__8P]D5%Z%ZS^
M"-4+UX&#.[=@W)05UO4M;L0HVN,']V#"Y%^LH7S18P)&;/@58Q:9NWV2XT]@
M^K@Q" UMC-9MV^&W6?-PWIHPOG'^'-2H7AU-FH;KOGLRGS&\0U><NR W;<B0
MD?SFS\28T5,Q9^E.9-Y,PD^C?L1EF5VK#[$C$YO7;\"D"3-U;;!%<Q>A6;/6
M^N]VPM09.'$U5>.JLO"FO3;3N!$_X)N:7RMGV2]SY-A).)YL!&#JM9/H.OA'
M'$M.A=OAP-8_UJ%KAX[:5X-'CD5TG+D^A$'*N3,8^_,H+:=CNTY8OG(=,LTM
MQ!HY6?C['#1OUAC-6K3";[.7X:8Z7.#R^43,'#<*+9HV1>.FK3!ST3)<U&4?
MS(_CJ5.FHG'CY@AO&HZY<^?@BE[3Z?AQ9&_4K%,'H6'A")4Y?*&A^'G\9,"1
MA@&=.Z)>'?-]%=JT):9,7XA+J29J)M,Y=$H',K!HWAR,F[M:K_&)XZ9@TRI9
M&D0N, _<J:?1,K0)IBS?9AV1ODZ#,RL-"V?.0:/&H1CRPV2DW\Q"8L(1;(K8
MJ;>Z2U=<3(Q![VY=T*Q).-:LV8(TKQ?K-D7@@E[;7JR>-A9OO_4V6H1W0%AH
M$WP;VAAK=NR&P^G Q#'#T*AQ(W1LTP?'SYQ'S-%=^*3"&ZA?/PQ-F[=$H]!0
M3),)T!X75BV9C=H-:Z-!6%.LWFJ):/U2,:V8,7\VEJ\U0Y5K9D_"8NN'Y*Y-
MFS'BIP4Z1Z]/[_:H7;\!0ILV0>.PQFC4I!E^F3$77H]P[(SZ=>LAK&DHPF1>
M6>,FF#C]-^N*]^!$[%8,&ST&29ER[<F_PNOX>? 8'-F?@ QW&@:/'8/XDS(R
M9+X_3AW<@3JU6^*@-0Q\^<Q9S)S^"QHW;8:6S5MBZB]3=)TQ_:>F662^HT19
M'=BX>@VZ]QFC-SR8Z]V%V3\-Q-C9YFY=:?'^W9O1<]2O5B1;OQ4P:?RO6+EA
MG?:AI#E]?!?ZC!Z/L]92"'+LY*XH_/+C#&O:@^G_?VC@"=GVMO-YC%L7Q-1A
M/?\Y _O_ZME?K@QGR()T3@DOZAI/Y@X*N05=MT>P8BVF&T4;N^&058"SK=[J
M<<OR\;)4OCA3\P4HELKWI5/3F1A3IMV;DLXE@SJBD?WSI<0AZ-( DMSZHM<;
MP_7N&M-VD3*R=8O\9S_,I#S_9[D3QTR.]:6PWRACW6)$MDRPHG_V23UN*P'K
M*\@^=^>KGV'V<U*&/4R7_;B\-S+,'+US 53I<)NRS-/QO[^EG&S5FK?^=+H:
MO"[2:(3:+?EN^>#/(U;9#YN+_6H?E]>['<M^/OO[.]/ZZ_"G\Q_+;HTY?^<1
M\^5ESOIS^DNSW]EUVZ^WIO5_NK,&_[D[^\8NW<]!66?KK^SL_269?&+++0]-
MX$_UY^]NRW=G(;<<L3_(M7]'G?;);/UMZI5GOP62[-8CQH9;4YAY9']VG6=G
M(>\UK]SU:,T[BX\_CB%#1N#Z=?,+W&>:IKRSS;?WA['%MM)OF=WGMY;G/^\_
M?K=_7_YZ_YR=F6KQ9^?E>T?:ZW_XZY;OJ%OS^=/9O/15OR/]^>YLDY1NG_>7
MD?V[Y?8>S)XC^[\C^5%W^^/V([?:;*?.GDHBM_(#Q'R?^E+<PL&?WFS[Y-]%
MPJ3WG[?SRZO=2G/,_^G.MIJTQ@[3!Z9M_CPV1WWU?>_+>9/&6.#_G-T.?_U^
M._TEF[-V^;?D\R62-_Z\OC39^/OK]]?F2V>],<7)LWGG+]%\EF3^=[?G_N=\
MSB:>_HI&2=C7+S9NM<#($G-6GHWPD=^&]M"'IA<!) MK6H)(+ESS\.>QRY5M
M'XSLLCI7\\JHK @&4[[DTAUZ=.L!_Y8B>F>3==.A_V*1?8]DZP5CGBPY8-_M
M9]?)5Q(@@;\7 ?FNL+\OUJQ>A2-'LL^+_'O92FM(@ 3^G@3^6O'DS80C/047
MDB\CZ=)Y7+IP"M=DFQ-9 T,V2W5F(?GJ521?2L:E"XDXEWP1%]+2="/&+(GJ
M"%/=HD<6'\R P^U$ALN%E.1D7#J?C!LI5W'MRB4D7[R(2U=2Y>8@W8#2ZTE'
M9H;L\"-35V6#5%F<VVS@*ILFZG8+.H?& ;?+ 6>61+^D,MFG)PO)R1=P]N)E
MZTX)V1;0#8_N-R3BR8BPOV=WTRH2^'^;@"V<[%>A(;_6;3'U_S8=MIX$2.!_
M2N O%D\N1.[9BF:A;=!0YH8T;XPZ7WV!ZO6:(^5&,@;U_0Z??U4+3<+"T#0T
M5,>)EZ]>@ZM)Q_#^)U]@Q18S[T)TS:5S1]!OZ"!L.1R#7IV[(K3QMWBO<A5\
M^N'GN@[/H/[CD&INK,&2N5-0MU9CG+ITR=H!&U@_8S%&#?M9QZ!5)UESIGZ;
M/@T3?C0392]=3,2L<:/0.JPIZK5HA5$39^'2Y13<2$W%LMFSD7Q1MDW0W/]3
M_DQ' B000 (BDF1S6GMX@\(I@/!9%0G\@PC\Q>))UJG)R#9 ZL9W7;JA]^A9
M<#C.XKOVH9BWTZSW(<R-+'$C^=0>%'RA%*K4ZHBKNC$B</'$!C1IU1R[K,TC
M98Y2KPX],&NJM46 -9J7EI:.X7T&H''C1A@W=XY/ZJSX80)Z=>EKUC:2RG2L
M/ MC1_V$(3VG:)</[-<?RW\W"P5*<:-'CL/P'\Q"FFL7+\3,>=D75OL'725L
M"@G\@PB(@+)%4_8(U#^HB6P*"9# _\\$_EKQ))/7=!5E,XMH\?PY:-QA *[*
M=O=9\>C1.0P+HLQ>>WX.7B3%[\>7C5OAH\;?8<"("7KJRO$-:-Z^%;8DV_M=
MW43?3M_CUQD[];P]*5%VW^[7;0@V+IV#CCWZXIIU%\OZ,>/1O\< WUT><@>&
M"+#)H\=C>%]90\.+%@V_Q:^CI_K6!Y&"+U^6!>LR<.5:(GKT^Q$7[#T=_ ;S
M'0F0  F0  F0P#^(P%\LGF2BMMRVZL:)R'VH6ZL!=MKK]J0?0Z=6=?#!-Z%H
MT[XK6K=M@Y:MVN'0_D.X<OP0OF[5 YN/QN'K+S_'MCVQ2$^*1'B;,&P\?]6*
M)J6A;^?!F#'-6L]&UY;)Q*2QPS!MGFPRZD'G]OVPY^A%[<XUHW]"WYX#_.M:
M6'?K_?+S) SK;8;M]N_<C _?KHJOOOH:G;OTQ)9==E3,";?W!GKV&8)M.\RN
MV_^@:X1-(0$2( $2( $2R$;@+Q5/]B1L9]IYM&W6&O.6KE?A(W$H3WH\.G9H
M@A]_6X##T4=Q^$BD[@4DBUTF'=N#C[_MB MN-U8N^!4-0SLA.68'VG1MARW)
MMGB2A1[[8LY4LS:'M#GSXBG4^;(*N@\9@MFS9N&]=S[#H.&_*8[5HT?IHGFR
M;K@.#^KMS ZH>.II+Q8(7+MV&:M7+4;'CIWP1JG*F#CI-VNQ C=&CQN-A4OM
MC1.S4>9;$B !$B !$B"!?PR!OU0\&9GBQH0A ]"]G[6/E"H7%Y >BX[?M<><
M_=&WP7;A[+'MJ/YM!YQ(=>MZ3D-Z=L"P[DT0WJ,7(GQSGAP8V'$ 9O_J%T_;
M5Z]&K=J?8^S$<1@_9BR&#NB/>@U:0-;X6C-A(GKU'*R[U1OQ)!+.B:D_3<2P
M/K/@=CEQ(]V:<6[%MHZL6(L&7S7&R73=% WCQX_'PL5F3M1M1O,C"9  "9
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M"PY=*!.Z*:)L+>!VN73;EK2T-&1EFJ$VA\.)] S9)\Z26[K*L!L>1P;2;J3
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M!()0/)DA-)]@40'SOQ%/?FET>[?:9\RK/(MP,V-UUB=+^/F']>0X'R1  B1
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M @R<U9$ "9  "9  "00W 8JGX.X_6D\")$ ")$ ")!!@ A1/ 0;.ZDB !$B
M!$B !(*; ,53</<?K2<!$B !$B !$@@P 8JG  -G=21  B1  B1  L%-@.(I
MN/N/UI, "9  "9  "028 ,53@(&S.A(@ 1(@ 1(@@> F0/$4W/U'ZTF !$B
M!$B ! ),@.(IP,!9'0F0  F0  F00' 3H'@*[OZC]21  B1  B1  @$F0/$4
M8."LC@1(@ 1(@ 1((+@)4#P%=__1>A(@ 1(@ 1(@@0 3H'@*,'!61P(D0 (D
M0 (D$-P$*)Z"N_]H/0F0  F0  F00( )4#P%&#BK(P$2( $2( $2"&X"%$_!
MW7^TG@1(@ 1(@ 1((, $*)X"#)S5D0 )D  )D  )!#<!BJ?@[C]:3P(D0 (D
M0 (D$& "%$\!!L[J2( $2( $2( $@IL Q5-P]Q^M)P$2( $2( $2"# !BJ<
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M  D$F #%4X"!LSH2( $2( $2(('@)D#Q%-S]1^M)@ 1(@ 1(@ 0"3(#B*<#
M61T)D  )D  )D$!P$Z!X"N[^H_4D0 (D0 (D0 (!)D#Q%&#@K(X$2( $2( $
M2""X"5 \!7?_T7H2( $2( $2(($ $Z!X"C!P5D<")$ ")$ ")!#<!"B>@KO_
M:#T)D  )D  )D$" "5 \!1@XJR,!$B !$B !$@AN A1/P=U_M)X$2( $2( $
M2"# !"B> @R<U9$ "9  "9  "00W 8JGX.X_6D\")$ ")$ ")!!@ A1/ 0;.
MZDB !$B !$B !(*; ,53</<?K2<!$B !$B !$@@P 8JG  -G=21  B1  B1
M L%-@.(IN/N/UI, "9  "9  "028 ,53@(&S.A(@ 1(@ 1(@@> F0/$4W/U'
MZTF !$B !$B ! ),@.(IP,!9'0F0  F0  F00' 3H'@*[OZC]21  B1  B1
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M$B !$B !$B"!X"9 \13<_4?K28 $2( $2( $ DR XBG P%D="9  "9  "9!
M<!.@> KN_J/U)$ ")$ ")$ " 29 \11@X*R.!$B !$B !$@@N E0/ 5W_]%Z
M$B !$B !$B"! !.@> HP<%9' B1  B1  B00W 0HGH*[_V@]"9  "9  "9!
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M A1/ 0;.ZDB !$B !$B !(*; ,53</<?K2<!$B !$B !$@@P 8JG  -G=21
M B1  B1  L%-@.(IN/N/UI, "9  "9  "028 ,53@(&S.A(@ 1(@ 1(@@> F
M0/$4W/U'ZTF !$B !$B ! ),@.(IP,!9'0F0  F0  F00' 3H'@*[OZC]21
M B1  B1  @$F0/$48."LC@1(@ 1(@ 1((+@)4#P%=__1>A(@ 1(@ 1(@@0 3
MH'@*,'!61P(D0 (D0 (D$-P$*)Z"N_]H/0F0  F0  F00( )4#P%&#BK(P$2
M( $2( $2"&X"%$_!W7^TG@1(@ 1(@ 1((, $*)X"#)S5D0 )D  )D  )!#<!
MBJ?@[C]:3P(D0 (D0 (D$& "%$\!!L[J2( $2( $2( $@IL Q5-P]Q^M)P$2
M( $2( $2"# !BJ<  V=U)$ ")$ ")$ "P4V XBFX^X_6DP )D  )D  )!)@
MQ5. @;,Z$B !$B !$B"!X"9 \13<_4?K28 $2( $2( $ DR XBG P%D="9
M"9  "9! <!.@> KN_J/U)$ ")$ ")$ " 29 \11@X*R.!$B !$B !$@@N E0
M/ 5W_]%Z$B !$B !$B"! !.@> HP<%9' B1  B1  B00W 0HGH*[_V@]"9
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MY:1U\X-3+USI#SY(@ 1(@ 2"E4"(J"++_9@V6,Y!'+#\>=WBY$V41AR+Q^.
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M)]W_4$YZI2=$R(LXE+BB7*\>U<""/TOV9E3Q96EBZ5ZW7KVZPOK?]VN!EI$
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MAA:FIB2Y&%3H66(R0^_ZDPVUY;BTW0P52]GZPT$A_%?_+'F.!$B !$C@[TQ
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MV,ESR+QX$I]5?AUY\CZC93Z:XS'T'CI1Y[UH5$3&X&0HSL0]S$6GEO&)!$B
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M1*2E#L&2-]?!*X&'HRC8OQW#4@9AYM2Y.'VF'.>\GV/=YESX:+=@(,8 ,SL
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M/H)#!=P/HZR<,9I,#(A0)()0) P**<9U,!F:VP8P'8424 )*0 DH 27P_YN
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ML6:5]!,,!Q$*A1 (,^P!$ Z'$>!4'2U.888IB"(4UM5V"8#U0@DH 26@!)2
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M\J)^XD24.6Y"V=>_B="!?=**!$-@!7%*M^64Z8!7:GEJ)6RMK@24@!)0 DI
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%1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_10a.jpg
<TEXT>
begin 644 image_10a.jpg
MB5!.1PT*&@H    -24A$4@   \@    $" (   #=\H$'    ,DE$051X7NW6
ML0T , @$,?9?^E':= A*N[P)K@H  -A)\B<  &#*6 , P($WU@$  -8:\@E6
11>SJ+LL     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_11a.jpg
<TEXT>
begin 644 image_11a.jpg
MB5!.1PT*&@H    -24A$4@  !$(    $" (    %[@U,    -$E$051X7NW7
ML0T , S#L/S_M(.NO2 &R%$?: 8  *!'DC\!  !<9F,  ( R;V,"  !090&(
3%,+F.M!?;P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_123a.jpg
<TEXT>
begin 644 image_123a.jpg
MB5!.1PT*&@H    -24A$4@   ZX    $" (    !"_4P    -$E$051X7NW6
MP0D , P#L>R_=/IJ QTAEEX&+W!5  "0I*__  " W2:%WP( @"A2& " 4 ?I
3KQ$EUD,=P0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_124a.jpg
<TEXT>
begin 644 image_124a.jpg
MB5!.1PT*&@H    -24A$4@   ZX    $" (    !"_4P    ,DE$051X7NW6
ML1$ , @#,?9?FK3 "+'4^;S 5P$ 0(P>[@<  !];*3P'  #DD,(  (1Z-((7
1'TPR$FD     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_125a.jpg
<TEXT>
begin 644 image_125a.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0 Z17AI9@  34T *@    @  U$0  $
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M?@#_ ,1SG_5KO_F2/_O75K2?^#Y:QFNE6^_9ENK>'/S/!\0%F8#V5M.0'\Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_B<_\)M_:7V/[+I]S>_ZC[!%OW?9]G^L7&_=SC:?U^H **_ '_B.<_ZM=_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%O(XF_>+I-DT<LO3D>9<-:H.S*)ASR*_7ROYVR?^'Y__  =4?]!3X5? .?\
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MC?9?^/WR_(_X^/W/W_\ 6?)][BOV^HHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _B#_P""
M3O\ RE-_9I_[*KX7_P#3O:U_;Y7\0?\ P2=_Y2F_LT_]E5\+_P#IWM:_M\H
M\:_:U_X)\_!G]N3X?W_AWXG?#WPUXFMKZ)HDO);)$U"Q8@@26]TH$L,@SPR,
M/0Y!(/\ '-^VI\ ?$?\ P2]_X*)>-/ ^BZ]J-KKGPK\2[]$UJ!_(NQ&I2XLK
MH%<;)#$\+G' 8G&17]OU?QC_ /!?[XYZ+^T9_P %B?CMXH\.W4%[I#:W#I,-
MQ"P:*X-A9V]@[HPX96>V8AAP0002#F@#^K[_ ()??M;3?MU_\$_/A1\5[M(8
M]3\7Z#%+J:Q+MC%]$S6]WL'9/M$4N!V&!7O5?'?_  0!^!FL?LY?\$=O@1X7
MUZWFL]4&ARZO-;RJ5D@&H7EQ?HC \JP2Y4$'D$$<8Q7V)0!^ /\ P?.?\VN_
M]S7_ .X6OH#_ (,J?^467C[_ +*KJ/\ Z:-'KY__ .#YS_FUW_N:_P#W"U]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\@?\ @]6_Y19> ?\
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M>U\1?!WQA)8:]91'YIX8I7M;^W4G&1)"9D!Z?.#7ZY?\1SG_ %:[_P"9(_\
MO77Y%_\ !5']N+0_^"CG[9_B+XP:+\/?^%:2^+(+9M3TI=9&JI+=Q1")KA9!
M;P;?,1(R5V'YP[;B7P #^V+PEXKT[QWX5TS7-'O(=0TG6;2*^LKJ$[H[F"5
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!_"'^R=X_\ %7PH_:G^&GBGP+HO_"2>
M-O#?BO2]5\/:1]CFO/[5U&"[BEMK;R(2LLOF3*B>7&0[;L*02#7[>3?\%^O^
M"I5O$TDG[%JQQJ,LS?"+Q: H]S]KK\@_^"3O_*4W]FG_ +*KX7_].]K7]OE
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M1A5)^O\ _@^<_P";7?\ N:__ '"U] ?\&5/_ "BR\??]E5U'_P!-&CT ?/\
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MLUY!>1^6\T4L8S);H#NC;*E@,'! !\P?\&N/_*"CX&?]Q_\ ]2#4Z^_Z\?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_('_@]6
M_P"467@'_LJNG?\ IHUBOT^_:Q_X3O\ X98^)?\ PJW_ )*;_P (KJG_  B/
M_'O_ ,AC[)+]B_X^/W'_ !\>5_KOW?\ ?^7-?SP_MJ_L%?\ !7__ (*)?"S3
M_!/QB\*?\)AX9TO58];M;/\ M/P5I_E7D<,T*2^9:RQ2'$=Q,NTL5._)&0"
M#V#_ (,8_P#FZ+_N5/\ W-5^_P!7\P/[#'_!+C_@K%_P37_X2C_A2O@7_A"_
M^$T^R?VS_P 3KP=J7VS[+Y_D?\?<\NS;]HF^YMSOYSA<>[ZEX"_X+D?$"W:Q
MU#4[G2[>;Y6FAU#P79L@]=]J1(/PYH _;_\ :J_:\^&_[$OPAU#QU\4/%FD^
M$?#FGJ?WUY+^]NW R(8(AEYI6QQ'&K,?3 )K^27_ (*O_P#!0SQU_P %T?\
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M (16X_LS_D5O^0Q]KL_*_P"07^__ ./?[7][]WZ_-LH _3ZBBOR!_P""H_\
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MW"R7,L)YA:8SHNQP'Q; D %<@'ZX4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAA1^GU?S@^"_^"7'_!2;]J#_ (*F_L__ !K_ &C/ O\ ;G_"N_%?AW[=K/\
M;7A:U_L_1[+5Q>R?N+&=/,V>;</\L;2-NVC=A5']'U 'P!_P='?\H*/CG_W
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M#-/U[XQ>/M)\$Z?JTS06*W$<US=7SJ 7\FW@22:0+N7<50A=RY(R,]!^R_\
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MX]/W?^J_VOO_ #5^O_\ P0Q_X;L_XNC_ ,-K?]0G_A#?^1?_ .GW[=_R"?\
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M&^*'[9OCVXU:[U"Y%]?^'['5Y-1U76)./EOM1)PB\!2L#2,5X62,@4 >)_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "OA#_@J!\ OV_/BI\?='U#]E?XW?"_X:_#V'P_#;ZAIGB2PAGNI]4%S<
MM+.K/I5V?+,#6J@>8HS&WR#.YON^B@#\@?\ AC;_ (+)?]'8_L__ /@HMO\
MYGJ/^&-O^"R7_1V/[/\ _P""BV_^9ZOU^HH _('_ (8V_P""R7_1V/[/_P#X
M*+;_ .9ZC_AC;_@LE_T=C^S_ /\ @HMO_F>K]?J* /R!_P"&-O\ @LE_T=C^
MS_\ ^"BV_P#F>H_X8V_X+)?]'8_L_P#_ (*+;_YGJ_7ZB@#\@?\ AC;_ (+)
M?]'8_L__ /@HMO\ YGJ/^&-O^"R7_1V/[/\ _P""BV_^9ZOU^HH _('_ (8V
M_P""R7_1V/[/_P#X*+;_ .9ZC_AC;_@LE_T=C^S_ /\ @HMO_F>K]?J* /R!
M_P"&-O\ @LE_T=C^S_\ ^"BV_P#F>H_X8V_X+)?]'8_L_P#_ (*+;_YGJ_7Z
MB@#\@?\ AC;_ (+)?]'8_L__ /@HMO\ YGJ/^&-O^"R7_1V/[/\ _P""BV_^
M9ZOU^HH _('_ (8V_P""R7_1V/[/_P#X*+;_ .9ZC_AC;_@LE_T=C^S_ /\
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MV/[/_P#X*+;_ .9ZC_AC;_@LE_T=C^S_ /\ @HMO_F>K]?J* /R!_P"&-O\
M@LE_T=C^S_\ ^"BV_P#F>H_X8V_X+)?]'8_L_P#_ (*+;_YGJ_7ZB@#\@?\
MAC;_ (+)?]'8_L__ /@HMO\ YGJ/^&-O^"R7_1V/[/\ _P""BV_^9ZOU^HH
M_('_ (8V_P""R7_1V/[/_P#X*+;_ .9ZC_AC;_@LE_T=C^S_ /\ @HMO_F>K
M]?J* /R!_P"&-O\ @LE_T=C^S_\ ^"BV_P#F>H_X8V_X+)?]'8_L_P#_ (*+
M;_YGJ_7ZB@#\@?\ AC;_ (+)?]'8_L__ /@HMO\ YGJ_1[]@KP;\9/A_^R=X
M4TC]H'Q9X?\ ''Q=L_MG]O:WHD*PV%[NO)WMO+5;>V V6K0(<0I\R,?F^\WL
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %?EC^T+^R?_P %8/$?Q]\<:A\.?VF_@?H/P]O_ !!?W'AC
M3+_2[=[K3M+>YD:T@E8Z%*3)' 8U8F20DJ?G;[Q_4ZB@#\@?^&-O^"R7_1V/
M[/\ _P""BV_^9ZC_ (8V_P""R7_1V/[/_P#X*+;_ .9ZOU^HH _('_AC;_@L
ME_T=C^S_ /\ @HMO_F>H_P"&-O\ @LE_T=C^S_\ ^"BV_P#F>K]?J* /R!_X
M8V_X+)?]'8_L_P#_ (*+;_YGJ/\ AC;_ (+)?]'8_L__ /@HMO\ YGJ_7ZB@
M#\@?^&-O^"R7_1V/[/\ _P""BV_^9ZC_ (8V_P""R7_1V/[/_P#X*+;_ .9Z
MOU^HH _('_AC;_@LE_T=C^S_ /\ @HMO_F>H_P"&-O\ @LE_T=C^S_\ ^"BV
M_P#F>K]?J* /R!_X8V_X+)?]'8_L_P#_ (*+;_YGJ/\ AC;_ (+)?]'8_L__
M /@HMO\ YGJ_7ZB@#\@?^&-O^"R7_1V/[/\ _P""BV_^9ZC_ (8V_P""R7_1
MV/[/_P#X*+;_ .9ZOU^HH _('_AC;_@LE_T=C^S_ /\ @HMO_F>H_P"&-O\
M@LE_T=C^S_\ ^"BV_P#F>K]?J* /R!_X8V_X+)?]'8_L_P#_ (*+;_YGJ/\
MAC;_ (+)?]'8_L__ /@HMO\ YGJ_7ZB@#\@?^&-O^"R7_1V/[/\ _P""BV_^
M9ZC_ (8V_P""R7_1V/[/_P#X*+;_ .9ZOU^HH _('_AC;_@LE_T=C^S_ /\
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M .9ZOU^HH _('_AC;_@LE_T=C^S_ /\ @HMO_F>H_P"&-O\ @LE_T=C^S_\
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MJ* /R!_X8V_X+)?]'8_L_P#_ (*+;_YGJ/\ AC;_ (+)?]'8_L__ /@HMO\
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M;_YGJ/\ AC;_ (+)?]'8_L__ /@HMO\ YGJ_7ZB@#\@?^&-O^"R7_1V/[/\
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M@-EJT"'$*?,C'YOO-[!110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117F/[7?[9?PT_8.^#
M-Q\0/BQXHA\(^$;:ZALGOGM+B[9IY6VQQI%;QR2NQP3A4. K,< $@ ].HKX#
MM?\ @Z%_85N[F.%?CI&K2L$!?P?K\:@DXY9K$ #W) %??-O<1W=O'-#(DL4J
MAT=#N5U/((/<'UH ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?&OB[3?",]]J-@-*UO2'NKR*T+EH%6-S$9"S))#O8I@R*230!_23117Y@_\
M!:O_ ()C?MH?MH_M3Z!XI_9S_:$_X5-X)L/"MOI5]I'_  G>NZ#]IU%+N\ED
MN?(L8)(FW0S6Z>8Q#GRL$8520#]/J*_BS_:%_;W_ &O/V:_C[XX^'.N_M/?'
M"[UOP!X@O_#>H3V'Q&UJ2UFN+.YDMY7B9Y4=HR\;%2R*2",J#P/W._X)<?\
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M>+M$UR[CO[K44U'2K6]N8[W,=RWG,9LR/M>196W#YF%?F!^P5_P3@_X*2?\
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MK6UTKQ;J.CZ5_:-]KNHV:7-PEJ__ %Q#R"-GV1@ -M H _?ZBOP!_P"'!?\
MP5._Z/4_\R]XN_\ D2O'_P!O7_@G!_P4D_X)V_LG>*_C%XV_;$\0:IX9\'_8
M_MEKHGQ7\43W\OVF\@LX_+2:&*,XDN$)W2+A0Q&3@$ _I>HK^1+_ ()?^(OV
MY?\ @K+\?=8^'/PY_:M^*&BZWHOA^;Q)//XD^)OB"VM7MXKFVMV16@,SF0O=
M1D H!@-\P( /W?\ \."_^"IW_1ZG_F7O%W_R)0!^_P!17\H7_!5OX;?M]?\
M!'S_ (0+_A9G[6OQ US_ (6)_:']F_\ ",?%'Q%=>1]B^R^;YWVA8-N?M<>W
M;NSM?.W S^WW_!<[]@7]J;]N/_A5W_#-'QJ_X4__ ,(O_:W_  D?_%7ZOX?_
M +6^T?8OLO\ R#X9/.\KR;G_ %F-GF_+G<V #[_HK^.+]O7]HS]M#_@G;^UC
MXK^#OC;]J;XP:IXF\'_8_MEUHGQ*UV>PE^TV<%Y'Y;S/%(<1W" [HUPP8#(P
M3^E__!,K_@EI_P %#_'OBK]GSXW:[^UEJ&M?"W6KOPYXXU#0;_XG^);FZO\
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M")/[>7_!(;P!J'Q!^"/Q\\2^-O"_AF%KS4+'P_J=Y97<,$8W-*^F2O)!<1J
M255I& !.P@$@ _I"HK\%/^#?[_@Y6^.G[97[:G@7X"_%K3O"WBR/Q@FH"+Q1
M;VO]FZE:M:Z?<WF98X1]GE#?9MF$CB(W[LMC:?WKH **** "BBOP1_X*:_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA+XDVJEQJ%I!)J^A3-T+*T0-S%D\[&B<*#S(V,T ?L77\]/_  4<_P""7'Q
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M444 %?/_ /P5B_Y19?M+?]DJ\4?^FBZKZ KY_P#^"L7_ "BR_:6_[)5XH_\
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M-/\ A"_^$A_MG_B2ZAIWV/[5_9?D?\?<$6_=]GF^YNQLYQE<_P!/U 'Y@_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\0N/["?_ $0W_P O/Q!_\G5]_P!% '\P/_!UK_P2X^!/_!-?_A0O_"E/ O\
MPA?_  FG_"0_VS_Q.M0U+[9]E_LOR/\ C[GEV;?M$WW-N=_.<+C] /\ @RI_
MY19>/O\ LJNH_P#IHT>OG_\ X/G/^;7?^YK_ /<+7T!_P94_\HLO'W_95=1_
M]-&CT ?K]1110 5_$'_P5B_Y2F_M+?\ 95?%'_IWNJ_M\K^(/_@K%_RE-_:6
M_P"RJ^*/_3O=4 ?V^4444 %%%% !7B/_  4PT"X\6?\ !.']H'2[16:ZU+X;
M>(K2%5ZEY-+N54#\2*]NJOK&D6WB#2+JPO88[FSOH7MYX7&5EC<%64^Q!(H
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M_P#ZD&IT ??]? '_  ='?\H*/CG_ -P#_P!2#3*^_P"O@#_@Z._Y04?'/_N
M?^I!IE 'Y ?\&5/_ "E-\??]DJU'_P!.^CU_3]7\P/\ P94_\I3?'W_9*M1_
M].^CU_3]0 5\7_\ !2;_ ((+?L\_\%/+B;6O&7ANX\.>/)(PB^+/#DBV>I28
M&%$X*M%<@849E1G"C"LHKW#]O3]M7PK_ ,$[OV3_ !7\8O&UAX@U3PSX/^Q_
M;;;1((9[Z3[3>06<?EI++$AQ)<(3ND7"AB,G ,/[ /[<W@__ (*/?LK^'OB]
MX%L]>T_PWXDENX8+76H(H+^!K>YEMW$B12RH,M$6&UVRK*3@D@ 'X$_M7?\
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M7_!C9JUGH=Q)H?[2NG:AJ2H3!!?>!'LX)&[!I4OY64>XC;Z&ORX\2?!C4_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO"<,$^JI_8FHZ=]E28NL1S=V\0;<8WX0DC'.,C/T17QG_P $J_\ @AQ\)O\
M@D)XA\9ZE\-?$/Q$URX\<V]K;7Z^)K^SN4A6W:5D,0M[6 @DRMG<6S@8QSG[
M,H AU'4(=*T^>ZN&\NWMHVED;!.U5&2<#GH.U?S9_P#!T-_P4$_9)_X*8?!O
MP!XF^$7Q0A\1?%#P-J,ED]B?#6KV#7^E7*[I/WMQ:QQ[H9HXV568<2S8R3@_
MTDZSI<>N:/=64S.L5Y"\#E#A@K*5.,YYYK\BO^(*G]EG_H?OV@/_  >:1_\
M*R@#^8&OT8_X-I?^"JWAO_@F'^VKK$GQ&UJ;0_A7\0-&>PUR[6TGNUL+FWW3
M6=R88$>5\-YL.$1L"Z)/ )'ZS?\ $%3^RS_T/W[0'_@\TC_Y64?\05/[+/\
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MW^Q!\,?A/'/%=3>"=!@L;RXB!$=S>$&2ZE4'D*\[RL >0&%:WQK_ &W?@O\
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M [HL@22-BA.0)%.,,,_JA_P;A_\ !0GX!? [_@C'\&_"WC;XX?!_P?XFTO\
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MZUHFM?$KQ'?Z?J%A<)<VM_;RZI<O%-%*A*21NC*RNI(8$$$@U_4[_P %0/\
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MOXPUK1-:\03>))Y_$EU;7-TEQ+;6UNR*T$$*",):QD H3DM\Q!  !](5Y_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 <W\3/AW-\1K31XH?$GB3PRVD:Q9ZNTFC7$<+Z@M
MO(':SG\R-PUM, 4D4!6*D[71L,.DHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#>H3V#I'=0V]Y?0V\KQ,ZNBR!)&*ED8 @94C@@']EG_#V+]EG_HY;]G_ /\
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M;C4+31/'_A^_\-ZA/8.D=U#;WEM);RO$SJZ+($D8J61@"!E2.#_.#_P<+?\
M!O3\%_\ @DU^Q?X8^(WPY\3_ !0UK6]:\:VOAN>#Q)J-C<VJ6\MC?W#.JP6<
M+B0/:Q@$N1@M\I)! !^]W_#V+]EG_HY;]G__ ,.'I'_R17L'PM^+/A7XX^!+
M'Q3X)\3>'_&'AG5/,^QZOHFHPZA87?ER-%)Y<\+-&^V1'0[2<,C \@BOY8O^
M#;W_ ((J?"S_ (+!_P#"YO\ A9FO_$#0_P#A7?\ 8G]F_P#",7UI:^?]M_M#
MS?.^T6T^['V2/;MVXW/G=D8_I=_8*_8J\*_\$[?V3O"GP=\$ZAX@U3PSX/\
MMGV.ZUN>&>_E^TWD]Y)YCPQ11G$EPX&V-<*%!R<D@!\4O^"A/P"^!WCN^\+>
M-OCA\'_!_B;2_+^V:1K?C+3M/O[3S(UEC\R":99$W1NCC<!E74C@@US_ /P]
MB_99_P"CEOV?_P#PX>D?_)%?,'[>O_!K_P# +_@HE^UCXK^,7C;Q=\8-+\3>
M,/L?VRUT35=.@L(OLUG!9Q^6DUC+(,QVZ$[I&RQ8C P!_+E^Q%\%-+_:4_;0
M^$/PYUVXU"TT3Q_XUT;PWJ$]@Z1W4-O>7T-O*\3.KHL@21BI9& (&5(X(!_9
M9_P]B_99_P"CEOV?_P#PX>D?_)%'_#V+]EG_ *.6_9__ /#AZ1_\D5\ _P#$
M%3^RS_T/W[0'_@\TC_Y64?\ $%3^RS_T/W[0'_@\TC_Y64 ??W_#V+]EG_HY
M;]G_ /\ #AZ1_P#)%>P?"WXL^%?CCX$L?%/@GQ-X?\8>&=4\S['J^B:C#J%A
M=^7(T4GESPLT;[9$=#M)PR,#R"*_ '_@LQ_P:_\ P"_X)V_\$V?B1\8O!/B[
MXP:IXF\'_P!F?8[76]5TZ>PE^TZI9V<GF)#8Q2'$=PY&V1<,%)R,@_H__P &
MN/\ R@H^!G_<?_\ 4@U.@#[_ **** "BBB@ KRG]I3]NGX-_L=623?%'XG>"
M? K3)YD-OJVK1075ROK%!GS9.A^XIK\B?^#AW_@YEU3]GWQKK7P(_9UU.WA\
M6:8S67BKQE&%F.CS<A[*R!!7[0O228@^6<HH\P%H_*?^"8O_  :A>)OVP] M
MOC!^UEXT\9:;=>+@NIQ^'H+GS-?O$<!EFU"[N!(8G<8)B"M( PW/&X*  _3&
MZ_X.;?V&[/4S:/\ ':Q:4';N3PSK4D7_ '\6S*?CFO?/V9_^"G/[/G[8U_'9
M?#3XP> _%FJ2C*:9;ZHD6I,/46LFV?'OLQ7S%8_\&JG[#MIH@M9/A-J5U<;=
MOVR7QAK G)]<+="//_ ,>U?%?_!1W_@SBT?1O!U]XP_9=\5:_:^)M)4WD7A/
M7[Q)8[UD^8)9WH"/#+Q\HFWAF(S)&.: /WFHK^;[_@B!_P ',?CS]F;XM6?P
M/_:HU35=4\*I>G18/$NMAQK'A"Z5_*\F^=_GEMU<%7:3,L)R2S(NU?Z/K>XC
MNX(Y8G22*10Z.AW*X/((/<&@#DOC7^T+X!_9K\*V^N_$;QQX/\ :)=W:V$&H
M>)-9MM*M9KAD=UA66=T1I"D<C! <D1L<84X\O_X>Q?LL_P#1RW[/_P#X</2/
M_DBL_P#X*@?\$O\ P#_P5E^ 6C_#GXC:OXPT71-%\00^)()_#=U;6UT]Q%;7
M-NJ,T\$R&,I=2$@(#D+\P (/\P7_  <+?\$O_ /_  2:_;0\,?#GX<ZOXPUK
M1-:\%6OB2>?Q)=6US=)<2WU_;LBM!!"@C"6L9 *$Y+?,00  ?U&_\/8OV6?^
MCEOV?_\ PX>D?_)%26W_  58_9=O9UCA_:2^ <TC'"HGQ!TEF/T N*_%W_@C
M/_P:_P#P"_X*)?\ !-GX;_&+QMXN^,&E^)O&']I_;+71-5TZ"PB^S:I>6<?E
MI-8RR#,=NA.Z1LL6(P, ?17C'_@R=_9UO=&FC\/_ !0^-6F:@RXBFU"[TR^A
M1O5HTLX2P]@X^M 'ZY_#CXN>%/C'HG]I^$?$_A[Q5IO ^UZ/J,-]!ST^>)F7
M]:Z&OX[?^"A'[ ?QX_X-X_VM]"N-%\>:G9QZQ&]YX6\9^'9I=/&J1Q.OFPS1
M;CMD0M'YD#&1"LB<N&(K^@3_ (-V/^"R5U_P5C_9BU:#QE'96WQ8^',L%GXA
M^RQB&'5H)E<V]^D8X0OY<BR(ORJ\9("JZJ #]#J\/\6?\%-OV;? 7BK4M"UW
M]H/X'Z+K>BW<MAJ&GW_CK2[:ZL+B)RDL,L3SAXY$=65D8 J000"*]PK\8?\
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MV6?^CEOV?_\ PX>D?_)%'_#V+]EG_HY;]G__ ,.'I'_R17XP_P#!9C_@U_\
M@%_P3M_X)L_$CXQ>"?%WQ@U3Q-X/_LS[':ZWJNG3V$OVG5+.SD\Q(;&*0XCN
M'(VR+A@I.1D'X0_X-Z?^"7_@'_@K+^VAXG^'/Q&U?QAHNB:+X*NO$D$_ANZM
MK:Z>XBOK"W5&:>"9#&4NI"0$!R%^8 $$ _J-_P"'L7[+/_1RW[/_ /X</2/_
M )(H_P"'L7[+/_1RW[/_ /X</2/_ )(KX!_X@J?V6?\ H?OV@/\ P>:1_P#*
MRC_B"I_99_Z'[]H#_P 'FD?_ "LH ^_O^'L7[+/_ $<M^S__ .'#TC_Y(KZ
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MNIX>_P""1WPKM='T.WL?$WQF\66S2Z'HT[$V^FP9*?;[P*0WE!@52,$-*RL
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMT!W1ME2P&#@@ Y__A[%^RS_ -'+?L__ /AP](_^2*/^'L7[+/\ T<M^S_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT?%'X0VDMR8X(]TVN:,,R7%K@<M)%\T\0Y/^N0 M**_5:@C(H _DU_X-D/\
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MHS_9XX[:.5=LT*JF^5\(2#N.&'U_10 5^ /_  ?.?\VN_P#<U_\ N%K]_J_
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M )DC_P"]= '[_5^0/_!ZM_RBR\ _]E5T[_TT:Q7S_P#\1SG_ %:[_P"9(_\
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M_P#IWM:_M\K^&/\ X)[?%+0?@=^WU\#_ !MXIOO[+\,^#_B!H.MZO>>3)/\
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M'+G_  M'_BUW_"RO^%E?V3_S,G]C_P!G?8?MO_3K<>9O^V?[.WR_XMW'W_\
M\1SG_5KO_F2/_O70!^SW[:O[>OPG_P""=WPLT_QM\8O%?_"'^&=4U6/1+6\_
MLR\U#S;R2&:9(O+M8I9!F.WF;<5"C9@G) /G_P"T?^P5^S9_P6:^%GPQ\;?$
M+PI_PLCPS'I1UOP?>?VGJFCXL]3AMIC+Y<$L$G[V.*W;;,NY-N,*2P/\\7_!
M:O\ X.0O^'P?[+&@?#/_ (4S_P *[_L/Q7;^)_[2_P"$M_M?S_*M+RV\CROL
M4&W/VO=OWG'EXVG=D?T>_P#!)W_E%E^S3_V2KPO_ .FBUH ^@**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _ '_@^<_P";7?\
MN:__ '"U] ?\&5/_ "BR\??]E5U'_P!-&CU\_P#_  ?.?\VN_P#<U_\ N%KZ
M _X,J?\ E%EX^_[*KJ/_ *:-'H _7ZBBB@#Y_P#^"L7_ "BR_:6_[)5XH_\
M31=5\ _\&5/_ "BR\??]E5U'_P!-&CU]_?\ !6+_ )19?M+?]DJ\4?\ IHNJ
M^ ?^#*G_ )19>/O^RJZC_P"FC1Z /U^K^1?_ (.K[/4+7_@N!\59+SS/L]Q8
MZ')8;@<>3_9%HIV^WFK+T[YK^NBOQQ_X.FO^"'_BO]NO2M$^-WPBTF37?B!X
M/TTZ5KF@VX'VK7=.1WEBDMQ_RTN(6DD'E_>D1P%RT:HX!]M?\$)_B]X=^,W_
M  2(_9_O_#=S;W%OH_@W3] O4B8;K>]L85M;E''56\V)FP>H=6Z,"?K2OXG_
M -A#_@J3^T!_P2;^(>I1_#OQ%?:!&]V1K?A76;0S:;=S)\K">UDP8Y1M"EXS
M'* NW<!Q7[$_LF_\'L_A'6XK6Q^-WPCUG0+K 2;5_"%VE_;.QZL;6X,<D:CT
M$TK8]>E 'ZQ_\%,_V1Y?V[_V"/BI\);5]+AU/QIH4MKIDNHLZVD%^A6:TDE9
M%=U1;B.)B55B ,A2>#X)_P &]/\ P2_\??\ !)K]B_Q/\.?B-J_@_6M;UKQK
M=>)()_#=U<W-JEO+8V%NJ,T\$+B0/:R$@(1@K\Q)('KO[%__  5X_9S_ ."@
M#0VOPO\ BGX=UK7)D+_V%=.VGZN,#+8M+@)*X7NR*R_[6,5])4 %?S%_\'7/
M_!7GQ=\<OVL-?_9W\)ZU>:3\,_AW)'9ZY!:3&,>)-4VK)+YY4_/# Q6-8CQY
MD<CG<=FS^G2OXK_^"Y'PPUKX2_\ !7?]H;3=<AFANM0\;ZCK4'F*1YEK?3->
M6[#U4PSQXH _1+]M3_@W%^&O_!/7_@@GXT^+7BK^V/$/QYL[#0KV2[>^DAL-
M FN]5L()K:"WC*K(%AGDB+S;]S9=0GRA>Z_X)1_\&VWP!_X*6?\ !&?X9_$#
M56\4>#OBGXFBUCS_ !'I>H/-'+)!K%];0&6SF+0LBQ0Q*5B\HL%SN#$M73?\
M%!_^"W/PG_X*>?\ !N%\3+&W\3:7H_Q@AT_P[%KOA&]G6"^>ZBUS3#/-:HQ'
MVB [6D#1[BBD!PI!%?;_ /P:X_\ *"CX&?\ <?\ _4@U.@#^??\ 9D_9H^)G
M_!+G_@OW\)?A/K6L7^D:YI?Q1\-Z7=W>D7<MO;Z[IMSJ5J58%2"]O/!(-T;9
M&&9&&0PK^P>OGGXY_P#!*?X!?M)_M6^$_CAXT\ IK'Q1\#R6$VBZVNLZA:FT
M>QN3<VK&"&=()#',Q;]Y&VX85MR@*/H:@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY_P#^"L7_ "BR
M_:6_[)5XH_\ 31=5] 5\_P#_  5B_P"467[2W_9*O%'_ *:+J@#^(.OH#_@D
M[_RE-_9I_P"RJ^%__3O:U\_U] ?\$G?^4IO[-/\ V57PO_Z=[6@#^WRBBB@
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M_!ZM_P HLO /_95=._\ 31K%?K]7Y _\'JW_ "BR\ _]E5T[_P!-&L4 ?/\
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M_P#!6+_E%E^TM_V2KQ1_Z:+J@#^8+_@UQ_Y3K_ S_N/_ /J/ZG7]?M?R!?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\ O^#YQ"4_9=;'R@^*
MP3_X)?\ "O??^#*B13_P2V^("9^9?BIJ!(]CI&CX_D:XG_@]O^#UUXA_9*^#
M/CJ&%I+?PKXJN](N&49\H7]J)%)]!NL0,],E1W%<[_P9#?'6SOO@W\</AG)<
M)'J&EZU9>)[>!F^::*X@-M*RCN$:UA#'MYJ>M '[L4444 ?/O_!6>58?^"6'
M[2S,<#_A5?B=?Q.DW0'ZFO@/_@RK1E_X)8^/"1][XJ:B1[_\2G1Q_2OJ3_@X
ML^.UG\ O^"-GQNO;JX2*X\2:,/#%E&3AKF6_E2V95]2(GE<C^[&Q[5Y#_P &
MC?PANOAC_P $;O#^J74+0_\ "=^)M6U^(,,,T8D2R5L>_P!BR/4$'H10!^G%
M%%?E/_P6!_X+S?$3_@FY_P %6O@W\&M+T7X>W'PW\;:;HFJ>(M2U>SNY-2LH
MKK6+NSNFADCN8XE"6]N&7?$^'W$[AA0 ?9W[:'_!)O\ 9Y_X*!H\OQ4^%WAW
MQ!J[1B-=:A1K#5XP!A1]K@*3,J]D=F3_ &2,U^7/[6'_  9->"?$$=U??!3X
MMZ]X;NN7BTGQ9:)J5J['^ 7, BDB4>K1RM]>M?NA10!_%-_P4!_X))_M ?\
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MZDS_ 'FN;BP@EE)]][M0!ZI1110 4444 %%%% !1110 4444 %%%% !1110
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M<+?!?_@DU^Q?XG^'/Q&\,?%#6M;UKQK=>)()_#>G6-S:I;RV-A;JC-/>0N)
M]K(2 A&"OS$D@?T??L]?&O2_VE/@%X'^(VA6^H6FB>/O#]AXDT^"_C2.ZAM[
MRVCN(DE5&=%D"2*&"NP!!PQ')\O_ .'3O[+/_1M/[/\ _P"&\TC_ .1Z]P\)
M^$]+\!>%=-T+0M,T_1=$T6TBL-/T^PMTMK6PMXD"10Q1( D<:(JJJ* %
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M,5] ?LR?\$SOV?\ ]C:\2\^&7PA\"^$=3C4JNIVNF))J(4\$?:I-T^.>F_%
M'XB_\$-_^#9SQM\=_BW9_'C]J[2]2L=%:].M6?A36RS:MXHNV<R?:-25_GCA
M+G<8I/WDS9WA4_UG]%:(L2*JJ%51@ #  I:* /F__@J!_P %0/ /_!)KX!:/
M\1OB-H_C#6M$UKQ!#X;@@\-VMM<W27$MM<W"NRSSPH(PEK("0Y.2ORD$D?S!
M?\'"W_!4#P#_ ,%9?VT/#'Q&^'.C^,-%T31?!5KX;G@\26MM;73W$5]?W#.J
MP3S(8REU& 2X.0WR@ $_UN_&O]GOP#^TIX5M]"^(W@?P?X_T2TNUOX-/\2:-
M;:K:PW"HZ+,L4Z.BR!))%#@9 D89PQSY?_PZ=_99_P"C:?V?_P#PWFD?_(]
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MKJ /,_V0OV0_ /["_P  ="^&OPUT.'0_"^@QXC0'?/=RMS)<3R=9)I#RSGV
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MVEC&9+>9=I8,-F2,$$^0?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\
MT7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS
M/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\
M@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11
MO["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\
MT7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\
M0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\
M@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5
M\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$
M4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\
MT7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS
M/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\
M@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11
MO["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\
MT7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\
M0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\
M@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5
M\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$
M4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\
MT7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS
M/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\
M@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11
MO["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\
MT7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\
M0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\
M@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5
M\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$
M4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\
MT7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS
M/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\
M@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11
MO["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\
MT7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\
M0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\
M@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5
M\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$
M4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\
MT7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS
M/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\
M@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11
MO["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\
MT7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\
M0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\
M@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5
M\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$
M4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\
MT7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS
M/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\
M@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11
MO["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\
MT7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\
M0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\
M@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5
M\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$
M4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\
MT7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS
M/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\
M@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11
MO["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\
MT7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\
M0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\
M@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5
M\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$
M4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\
MT7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS
M/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\
M@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11
MO["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\
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M /X+#?\ !QA^S7_P4:_X(X_$WP%X3U;Q-H7Q'\4IHYL_#>LZ),LK/!K%C<S
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M /O^BO@#_B*-_83_ .BY?^69X@_^0:/^(HW]A/\ Z+E_Y9GB#_Y!H ^_Z*^
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M?^69X@_^0: /O^BO@#_B*-_83_Z+E_Y9GB#_ .0:/^(HW]A/_HN7_EF>(/\
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MLL_]&T_L_P#_ (;S2/\ Y'H_X=._LL_]&T_L_P#_ (;S2/\ Y'KZ HH ^?\
M_AT[^RS_ -&T_L__ /AO-(_^1Z/^'3O[+/\ T;3^S_\ ^&\TC_Y'KZ HH ^?
M_P#AT[^RS_T;3^S_ /\ AO-(_P#D>C_AT[^RS_T;3^S_ /\ AO-(_P#D>OH"
MB@#Y_P#^'3O[+/\ T;3^S_\ ^&\TC_Y'H_X=._LL_P#1M/[/_P#X;S2/_D>O
MH"B@#Y__ .'3O[+/_1M/[/\ _P"&\TC_ .1Z/^'3O[+/_1M/[/\ _P"&\TC_
M .1Z^@** /G_ /X=._LL_P#1M/[/_P#X;S2/_D>C_AT[^RS_ -&T_L__ /AO
M-(_^1Z^@** /G_\ X=._LL_]&T_L_P#_ (;S2/\ Y'H_X=._LL_]&T_L_P#_
M (;S2/\ Y'KZ HH ^?\ _AT[^RS_ -&T_L__ /AO-(_^1Z/^'3O[+/\ T;3^
MS_\ ^&\TC_Y'KZ HH ^?_P#AT[^RS_T;3^S_ /\ AO-(_P#D>C_AT[^RS_T;
M3^S_ /\ AO-(_P#D>OH"B@#Y_P#^'3O[+/\ T;3^S_\ ^&\TC_Y'H_X=._LL
M_P#1M/[/_P#X;S2/_D>OH"B@#Y__ .'3O[+/_1M/[/\ _P"&\TC_ .1Z/^'3
MO[+/_1M/[/\ _P"&\TC_ .1Z^@** /G_ /X=._LL_P#1M/[/_P#X;S2/_D>C
M_AT[^RS_ -&T_L__ /AO-(_^1Z^@** /G_\ X=._LL_]&T_L_P#_ (;S2/\
MY'H_X=._LL_]&T_L_P#_ (;S2/\ Y'KZ HH ^?\ _AT[^RS_ -&T_L__ /AO
M-(_^1Z/^'3O[+/\ T;3^S_\ ^&\TC_Y'KZ HH ^?_P#AT[^RS_T;3^S_ /\
MAO-(_P#D>C_AT[^RS_T;3^S_ /\ AO-(_P#D>OH"B@#Y_P#^'3O[+/\ T;3^
MS_\ ^&\TC_Y'H_X=._LL_P#1M/[/_P#X;S2/_D>OH"B@#Y__ .'3O[+/_1M/
M[/\ _P"&\TC_ .1Z/^'3O[+/_1M/[/\ _P"&\TC_ .1Z^@** /G_ /X=._LL
M_P#1M/[/_P#X;S2/_D>C_AT[^RS_ -&T_L__ /AO-(_^1Z^@** /G_\ X=._
MLL_]&T_L_P#_ (;S2/\ Y'H_X=._LL_]&T_L_P#_ (;S2/\ Y'KZ HH ^?\
M_AT[^RS_ -&T_L__ /AO-(_^1Z/^'3O[+/\ T;3^S_\ ^&\TC_Y'KZ HH ^?
M_P#AT[^RS_T;3^S_ /\ AO-(_P#D>C_AT[^RS_T;3^S_ /\ AO-(_P#D>OH"
MB@#Y_P#^'3O[+/\ T;3^S_\ ^&\TC_Y'H_X=._LL_P#1M/[/_P#X;S2/_D>O
MH"B@#Y__ .'3O[+/_1M/[/\ _P"&\TC_ .1Z/^'3O[+/_1M/[/\ _P"&\TC_
M .1Z^@** /G_ /X=._LL_P#1M/[/_P#X;S2/_D>C_AT[^RS_ -&T_L__ /AO
M-(_^1Z^@** /G_\ X=._LL_]&T_L_P#_ (;S2/\ Y'H_X=._LL_]&T_L_P#_
M (;S2/\ Y'KZ HH ^?\ _AT[^RS_ -&T_L__ /AO-(_^1Z/^'3O[+/\ T;3^
MS_\ ^&\TC_Y'KZ HH ^?_P#AT[^RS_T;3^S_ /\ AO-(_P#D>C_AT[^RS_T;
M3^S_ /\ AO-(_P#D>OH"B@#Y_P#^'3O[+/\ T;3^S_\ ^&\TC_Y'H_X=._LL
M_P#1M/[/_P#X;S2/_D>OH"B@#Y__ .'3O[+/_1M/[/\ _P"&\TC_ .1Z/^'3
MO[+/_1M/[/\ _P"&\TC_ .1Z^@** /G_ /X=._LL_P#1M/[/_P#X;S2/_D>C
M_AT[^RS_ -&T_L__ /AO-(_^1Z^@** /G_\ X=._LL_]&T_L_P#_ (;S2/\
MY'H_X=._LL_]&T_L_P#_ (;S2/\ Y'KZ HH ^?\ _AT[^RS_ -&T_L__ /AO
M-(_^1Z/^'3O[+/\ T;3^S_\ ^&\TC_Y'KZ HH ^?_P#AT[^RS_T;3^S_ /\
MAO-(_P#D>C_AT[^RS_T;3^S_ /\ AO-(_P#D>OH"B@#Y_P#^'3O[+/\ T;3^
MS_\ ^&\TC_Y'H_X=._LL_P#1M/[/_P#X;S2/_D>OH"B@#Y__ .'3O[+/_1M/
M[/\ _P"&\TC_ .1Z/^'3O[+/_1M/[/\ _P"&\TC_ .1Z^@** /G_ /X=._LL
M_P#1M/[/_P#X;S2/_D>C_AT[^RS_ -&T_L__ /AO-(_^1Z^@** /G_\ X=._
MLL_]&T_L_P#_ (;S2/\ Y'H_X=._LL_]&T_L_P#_ (;S2/\ Y'KZ HH ^?\
M_AT[^RS_ -&T_L__ /AO-(_^1Z/^'3O[+/\ T;3^S_\ ^&\TC_Y'KZ HH ^?
M_P#AT[^RS_T;3^S_ /\ AO-(_P#D>C_AT[^RS_T;3^S_ /\ AO-(_P#D>OH"
MB@#Y_P#^'3O[+/\ T;3^S_\ ^&\TC_Y'H_X=._LL_P#1M/[/_P#X;S2/_D>O
MH"B@#Y__ .'3O[+/_1M/[/\ _P"&\TC_ .1Z/^'3O[+/_1M/[/\ _P"&\TC_
M .1Z^@** /G_ /X=._LL_P#1M/[/_P#X;S2/_D>C_AT[^RS_ -&T_L__ /AO
M-(_^1Z^@** /G_\ X=._LL_]&T_L_P#_ (;S2/\ Y'H_X=._LL_]&T_L_P#_
M (;S2/\ Y'KZ HH ^?\ _AT[^RS_ -&T_L__ /AO-(_^1Z/^'3O[+/\ T;3^
MS_\ ^&\TC_Y'KZ HH ^?_P#AT[^RS_T;3^S_ /\ AO-(_P#D>C_AT[^RS_T;
M3^S_ /\ AO-(_P#D>OH"B@#Y_P#^'3O[+/\ T;3^S_\ ^&\TC_Y'H_X=._LL
M_P#1M/[/_P#X;S2/_D>OH"B@#Y__ .'3O[+/_1M/[/\ _P"&\TC_ .1Z/^'3
MO[+/_1M/[/\ _P"&\TC_ .1Z^@** /G_ /X=._LL_P#1M/[/_P#X;S2/_D>C
M_AT[^RS_ -&T_L__ /AO-(_^1Z^@** /G_\ X=._LL_]&T_L_P#_ (;S2/\
MY'H_X=._LL_]&T_L_P#_ (;S2/\ Y'KZ HH ^?\ _AT[^RS_ -&T_L__ /AO
M-(_^1Z/^'3O[+/\ T;3^S_\ ^&\TC_Y'KZ HH ^?_P#AT[^RS_T;3^S_ /\
MAO-(_P#D>C_AT[^RS_T;3^S_ /\ AO-(_P#D>OH"B@#Y_P#^'3O[+/\ T;3^
MS_\ ^&\TC_Y'H_X=._LL_P#1M/[/_P#X;S2/_D>OH"B@#Y__ .'3O[+/_1M/
M[/\ _P"&\TC_ .1Z/^'3O[+/_1M/[/\ _P"&\TC_ .1Z^@** /G_ /X=._LL
M_P#1M/[/_P#X;S2/_D>C_AT[^RS_ -&T_L__ /AO-(_^1Z^@** /G_\ X=._
MLL_]&T_L_P#_ (;S2/\ Y'H_X=._LL_]&T_L_P#_ (;S2/\ Y'KZ HH ^?\
M_AT[^RS_ -&T_L__ /AO-(_^1Z/^'3O[+/\ T;3^S_\ ^&\TC_Y'KZ HH ^?
M_P#AT[^RS_T;3^S_ /\ AO-(_P#D>C_AT[^RS_T;3^S_ /\ AO-(_P#D>OH"
MB@#Y_P#^'3O[+/\ T;3^S_\ ^&\TC_Y'H_X=._LL_P#1M/[/_P#X;S2/_D>O
MH"B@#Y__ .'3O[+/_1M/[/\ _P"&\TC_ .1Z/^'3O[+/_1M/[/\ _P"&\TC_
M .1Z^@** /G_ /X=._LL_P#1M/[/_P#X;S2/_D>C_AT[^RS_ -&T_L__ /AO
M-(_^1Z^@** /G_\ X=._LL_]&T_L_P#_ (;S2/\ Y'H_X=._LL_]&T_L_P#_
M (;S2/\ Y'KZ HH ^?\ _AT[^RS_ -&T_L__ /AO-(_^1Z/^'3O[+/\ T;3^
MS_\ ^&\TC_Y'KZ HH ^?_P#AT[^RS_T;3^S_ /\ AO-(_P#D>C_AT[^RS_T;
M3^S_ /\ AO-(_P#D>OH"B@#Y_P#^'3O[+/\ T;3^S_\ ^&\TC_Y'H_X=._LL
M_P#1M/[/_P#X;S2/_D>OH"B@#Y__ .'3O[+/_1M/[/\ _P"&\TC_ .1Z/^'3
MO[+/_1M/[/\ _P"&\TC_ .1Z^@** /G_ /X=._LL_P#1M/[/_P#X;S2/_D>C
M_AT[^RS_ -&T_L__ /AO-(_^1Z^@** /G_\ X=._LL_]&T_L_P#_ (;S2/\
MY'H_X=._LL_]&T_L_P#_ (;S2/\ Y'KZ HH ^?\ _AT[^RS_ -&T_L__ /AO
M-(_^1Z/^'3O[+/\ T;3^S_\ ^&\TC_Y'KZ HH ^?_P#AT[^RS_T;3^S_ /\
MAO-(_P#D>C_AT[^RS_T;3^S_ /\ AO-(_P#D>OH"B@#Y_P#^'3O[+/\ T;3^
MS_\ ^&\TC_Y'H_X=._LL_P#1M/[/_P#X;S2/_D>OH"B@#Y__ .'3O[+/_1M/
M[/\ _P"&\TC_ .1Z/^'3O[+/_1M/[/\ _P"&\TC_ .1Z^@** /G_ /X=._LL
M_P#1M/[/_P#X;S2/_D>C_AT[^RS_ -&T_L__ /AO-(_^1Z^@** /G_\ X=._
MLL_]&T_L_P#_ (;S2/\ Y'H_X=._LL_]&T_L_P#_ (;S2/\ Y'KZ HH ^?\
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M_P#\.G?V6?\ HVG]G_\ \-YI'_R/1_PZ=_99_P"C:?V?_P#PWFD?_(]?0%%
M'S__ ,.G?V6?^C:?V?\ _P -YI'_ ,CT?\.G?V6?^C:?V?\ _P -YI'_ ,CU
M] 44 ?/_ /PZ=_99_P"C:?V?_P#PWFD?_(]'_#IW]EG_ *-I_9__ /#>:1_\
MCU] 44 ?/_\ PZ=_99_Z-I_9_P#_  WFD?\ R/1_PZ=_99_Z-I_9_P#_  WF
MD?\ R/7T!10!\_\ _#IW]EG_ *-I_9__ /#>:1_\CT?\.G?V6?\ HVG]G_\
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M_P#(]'_#IW]EG_HVG]G_ /\ #>:1_P#(]?0%% 'S_P#\.G?V6?\ HVG]G_\
M\-YI'_R/1_PZ=_99_P"C:?V?_P#PWFD?_(]?0%% 'S__ ,.G?V6?^C:?V?\
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M_P#\.G?V6?\ HVG]G_\ \-YI'_R/1_PZ=_99_P"C:?V?_P#PWFD?_(]?0%%
M'S__ ,.G?V6?^C:?V?\ _P -YI'_ ,CT?\.G?V6?^C:?V?\ _P -YI'_ ,CU
M] 44 ?/_ /PZ=_99_P"C:?V?_P#PWFD?_(]'_#IW]EG_ *-I_9__ /#>:1_\
MCU] 44 ?/_\ PZ=_99_Z-I_9_P#_  WFD?\ R/1_PZ=_99_Z-I_9_P#_  WF
MD?\ R/7T!10!\_\ _#IW]EG_ *-I_9__ /#>:1_\CT?\.G?V6?\ HVG]G_\
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M_P#(]'_#IW]EG_HVG]G_ /\ #>:1_P#(]?0%% 'S_P#\.G?V6?\ HVG]G_\
M\-YI'_R/1_PZ=_99_P"C:?V?_P#PWFD?_(]?0%% 'S__ ,.G?V6?^C:?V?\
M_P -YI'_ ,CT?\.G?V6?^C:?V?\ _P -YI'_ ,CU] 44 ?/_ /PZ=_99_P"C
M:?V?_P#PWFD?_(]'_#IW]EG_ *-I_9__ /#>:1_\CU] 44 ?/_\ PZ=_99_Z
M-I_9_P#_  WFD?\ R/7N'A/PGI?@+PKINA:%IFGZ+HFBVD5AI^GV%NEM:V%O
M$@2*&*) $CC1%5510 H    K0HH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMXN^,&E^)O&'V/[9:Z)JNG06$7V:S@LX_+2:QED&8[="=TC98L1@8  /I_\
MX>Q?LL_]'+?L_P#_ (</2/\ Y(KV#X6_%GPK\<? ECXI\$^)O#_C#PSJGF?8
M]7T348=0L+ORY&BD\N>%FC?;(CH=I.&1@>017\L7_!M[_P $5/A9_P %@_\
MA<W_  LS7_B!H?\ PKO^Q/[-_P"$8OK2U\_[;_:'F^=]HMI]V/LD>W;MQN?.
M[(Q_2[^P5^Q5X5_X)V_LG>%/@[X)U#Q!JGAGP?\ ;/L=UK<\,]_+]IO)[R3S
M'ABBC.)+AP-L:X4*#DY) /8*\<_:=_X*$_ _]C$(OQ2^*G@GP3=21^;%8ZCJ
M<:WTR?WDME)F<>ZH17Q)_P './\ P6+U[_@F9^S?H/A+X<WD=C\4OBD;B.SU
M':'?0-/A"B>Z13D><S2)'&6&!^\;K& ?RI_X(2?\$"=0_P""R,OB+XV?&KQE
MXHM_ HU>2U,L-SYNM>+;]0KSNUS,'V1*74-(5=G8NH*E"U '[21_\'-/[#DF
MJ+9CX[Z?YS' 8^&M:$7_ '\-GL'YU](?LX_\% O@?^UYM7X9_%?P'XTNBN]K
M+3-9AEOHQUR]ON$R?\"05\EV_P#P:H?L/PZ"+-OA3JLUP$V_;G\7ZO\ :"<?
M>P+D1Y[_ ',>U?F#_P %S?\ @U]L_P!@WX,:A\;O@'K_ (DU+PMX6=+K7M!U
M.59K_1H2P'VRVN(U0O%&Q7<K+O1<OO8*VT _I2HK\3_^#-K]M'XK_M0^"/CI
MX=^(WC[Q+XXTOP'_ ,(\-!76KLWDVG+<C5!,JS/F5E86T("LQ50GRA<G/[84
M ?/_ /P]B_99_P"CEOV?_P#PX>D?_)%'_#V+]EG_ *.6_9__ /#AZ1_\D5^,
M/_!9C_@U_P#@%_P3M_X)L_$CXQ>"?%WQ@U3Q-X/_ +,^QVNMZKIT]A+]IU2S
MLY/,2&QBD.([AR-LBX8*3D9!^$/^#>G_ ()?^ ?^"LO[:'B?X<_$;5_&&BZ)
MHO@JZ\203^&[JVMKI[B*^L+=49IX)D,92ZD) 0'(7Y@ 00#^I.R_X*I?LP:G
M.(K;]H_X"W$C' 2/X@:2['\!/7K'P\^+OA/XNZ8U[X3\3^'?%%FO6?2=1AO8
MA_P*-F%?DOK/_!E'^S//9,NG_$?XZ6MQCY7N-3TJ= ?=5L$)_P"^A7R5^UC_
M ,&AOQP_9*2;QU^S;\5;CQGJ&CJUQ%IZ%_#WB&(#G%M/'*8IGXS@M"3C"AC@
M$ _H_HK^97_@F=_P=4_&K]C3XFQ_#O\ :<M]<\?>%-/NSINHWFH6WD^*_#4B
M,4?>6"FYV,#OCG_>Y'$@V[#_ $C?!_XP>&?C_P#"_0_&G@S6K'Q%X6\2VB7V
MFZE9R;X;J%NA'<$<@J0&5@5(!!  .DHHKY+_ ."P7_!6[P1_P2._9M/BSQ!&
MNN>+M=:2T\*^&XYO+FUBY4 LS-@F.WBW*TDF#C<JC+.H(!]/>.?'VA?##PO=
MZYXEUK2?#NBV"[[G4-3O([2UMU]7ED(51[DBOC_XD?\ !Q=^Q3\*]5DL]4^/
MWA>ZFB8JS:/97^LQ'Z26<$J-]02*_"G]F7]G+]JS_@ZC_:4U3Q)X\\<W6D?#
M?PS=@7VI20O_ &'X?9QE;/3;$,%DN/+());<$VM+*2R!_P!<O@I_P:-?L<?#
M/P[!:^(_#?C#XC7ZJ/.O=9\2W5H9&[E4L6MU5<] <D#J3UH ]U^$O_!P+^QK
M\;-6BL=$_: \$V]Q,VU!K0N=#1CV&^]BA7]:^NM"U^Q\4Z-;:CIE[::EI]Y&
M);>ZM9EFAG0]&1U)# ^H.*_+/]I'_@SZ_91^+'ABYB\"Q^,OA3K6P_9;JPUB
M;5;5'QP98+QI&D3U5)8R?[PK\EK_ .(G[6W_  :M?MB6_A636FUKP+JCF^M=
M/EDEF\,>,K,-AWB1N;:Y7(#E-LL;%<^9&R^8 ?U@45X-_P $X/\ @H?X!_X*
M<_LO:/\ $[P#<2);W3&TU72KA@;S0KY IEM9@.XW*RL.'1D8<-@>\T ?/_\
MP]B_99_Z.6_9_P#_  X>D?\ R11_P]B_99_Z.6_9_P#_  X>D?\ R17XP_\
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MP/\ #G0KC4+O1/ 'A^P\-Z?/?NDEU-;V=M';Q/*R*B-(4C4L51023A0.!V%
M!1110 5S_P 4OBWX5^!O@:]\4>-O$WA_P?X9TW8+O5M;U&'3[&UWNL:>9-,R
MHNYW51DC+, .2!705^$7_!YW^V7>7NC_  K_ &:/"[7-]J_B:Z7Q3K5E9J9)
MYT#O;:?;A%R7\R8W#[,9W0Q$ Y% '[._ S]K/X5_M/MJ:_#3XF?#_P"(C:*(
MCJ(\,^(K/5OL'F[_ "_-^SR/Y>_RWV[L;MC8S@UZ!7\C'_!KW^W+_P ,9_\
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M C^BJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0*_K&K^"OX'_ !"N?A'\:O!_BNSD:&\\,:W9:M ZG#))!.DJD?0H*_O4H ^
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M,AZ$5^:?_!Y_^PU_PLG]F'P1\>M(L]^J?#>^_L+79$7YFTR\<>3(Y_NQ76U
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M\.M'\(:UK6M>-;7PW/!XCM;BXM5MY;&_N&95@GA82![6, EB,%OE)((^A/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.<0^)];AC_[X2\"_I7L'[.O_  1\_9A_90UNWU3P'\$/ .CZQ9L'MM2GT_\
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M6MA8V<8AM[:WB6*&! ,!550 J@<  8% 'C?_  3W_8$\ _\ !-?]F+1/A?\
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M^C:?V?\ _P -YI'_ ,CT ? /_$:M^RS_ -"#^T!_X(](_P#EG1_Q&K?LL_\
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M,J[ \$BN?_X=._LL_P#1M/[/_P#X;S2/_D>@#\_?^#>G_@M=^SKXD\&_!?\
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MAI%O]INX[*/3M2A>5(5^>3$EQ$-L89OGSC )'Y0_\$,?^#B76O\ @D=H]_\
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M!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\
M17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?
M\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 1
M1O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_
M $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<
MO_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P L
MSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_
M "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?
M\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 1
M1O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_
M $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<
MO_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P L
MSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_
M "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T
M??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T
M5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!
M_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O
M["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["
M?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+
M_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,
M\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_
M\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1
M_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O
M["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["
M?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+
M_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,
M\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_
M\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0
M!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\
M17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?
M\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 1
M1O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_
M $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<
MO_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P L
MSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_
M "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?
M\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 1
M1O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_
M $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<
MO_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P L
MSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_
M "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T
M??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T
M5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!
M_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O
M["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["
M?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+
M_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,
M\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_
M\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1
M_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O
M["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["
M?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+
M_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,
M\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_
M\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0
M!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\
M17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?
M\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 1
M1O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_
M $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<
MO_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P L
MSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_
M "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?
M\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 1
M1O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_
M $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<
MO_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P L
MSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_
M "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T
M??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T
M5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!
M_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O
M["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["
M?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+
M_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,
M\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_
M\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1
M_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O
M["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["
M?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+
M_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,
M\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_
M\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0
M!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\
M17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?
M\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 1
M1O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_
M $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<
MO_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P L
MSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_
M "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?
M\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 1
M1O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_
M $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<
MO_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P L
MSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_
M "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T
M??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T
M5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!
M_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O
M["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["
M?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+
M_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,
M\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_
M\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1
M_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O
M["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["
M?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+
M_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,
M\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_
M\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0
M!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\
M17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?
M\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 1
M1O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_
M $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<
MO_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P L
MSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_
M "#1_P 11O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?
M\11O["?_ $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 1
M1O["?_1<O_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_
M $7+_P LSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<
MO_+,\0?_ "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P L
MSQ!_\@T ??\ 17P!_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_
M "#0!]_T5\ ?\11O["?_ $7+_P LSQ!_\@T?\11O["?_ $7+_P LSQ!_\@T
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MOER*LB;HW5MKJK#." <B@#H**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** .?\ BE\)_"OQQ\"7WA;QMX9\/^,/#.J>7]LTC6].AU"PN_+D66/S
M()E:-]LB(XW X9%(Y ->/_\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#P
MZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\
M#IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/
M_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_
M /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 4
M4 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%%
M 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P C
MU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]
M?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'
M_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD
M?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\
M-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\
MPWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G
M_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V
M?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_H
MVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^
MC:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]
MEG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?
MV6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\
M#IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?
M\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P C
MT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_
M\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'
M_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##
M>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\
M-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9_
M_P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G
M_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-
MI_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_H
MVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_9
M9_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]
MEG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#P
MZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\
M#IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/
M_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_
M /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 4
M4 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%%
M 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P C
MU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]
M?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'
M_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD
M?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\
M-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\
MPWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G
M_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V
M?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_H
MVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^
MC:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]
MEG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?
MV6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\
M#IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?
M\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P C
MT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_
M\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'
M_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##
M>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\
M-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9_
M_P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G
M_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-
MI_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_H
MVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_9
M9_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]
MEG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#P
MZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\
M#IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/
M_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_
M /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 4
M4 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%%
M 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P C
MU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]
M?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'
M_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD
M?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\
M-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\
MPWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G
M_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V
M?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_H
MVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^
MC:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]
MEG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?
MV6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\
M#IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?
M\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P C
MT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_
M\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'
M_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##
M>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\
M-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9_
M_P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G
M_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-
MI_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_H
MVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_9
M9_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]
MEG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#P
MZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\
M#IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/
M_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_
M /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 4
M4 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%%
M 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P C
MU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]
M?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'
M_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD
M?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\
M-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\
MPWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G
M_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V
M?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_H
MVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^
MC:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]
MEG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?
MV6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\
M#IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?
M\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P C
MT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_
M\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'
M_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##
M>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\
M-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9_
M_P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G
M_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-
MI_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_H
MVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_9
M9_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]
MEG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#P
MZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\
M#IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/
M_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_
M /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 4
M4 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%%
M 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P C
MU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]
M?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'
M_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD
M?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\
M-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V?_\
MPWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_HVG]G
M_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V
M?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]EG_H
MVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^
MC:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\ #IW]
MEG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?\.G?
MV6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P CT?\
M#IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_\CT?
M\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'_P C
MT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##>:1_
M\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\-YI'
M_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9__P##
M>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G_P#\
M-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CU] 44 ?/_P#PZ=_99_Z-I_9_
M_P##>:1_\CT?\.G?V6?^C:?V?_\ PWFD?_(]?0%% 'S_ /\ #IW]EG_HVG]G
M_P#\-YI'_P CU[AX3\)Z7X"\*Z;H6A:9I^BZ)HMI%8:?I]A;I;6MA;Q($BAB
MB0!(XT15544 *    *T** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BORQ_:%_X
M(&?M)?&/X^^./%VA?\%$?CAX)T3Q5X@O]8T_P[81:H;70+>XN9)HK*+9K,:>
M7"CK&NV-!A!A5' X_P#XAQ/VIO\ I)Q^T!_WYU?_ .7E 'Z_45^0/_$.)^U-
M_P!)./V@/^_.K_\ R\H_XAQ/VIO^DG'[0'_?G5__ )>4 ?K]17Y _P#$.)^U
M-_TDX_: _P"_.K__ "\H_P"(<3]J;_I)Q^T!_P!^=7_^7E 'Z_45^0/_ !#B
M?M3?])./V@/^_.K_ /R\H_XAQ/VIO^DG'[0'_?G5_P#Y>4 ?K]17Y _\0XG[
M4W_23C]H#_OSJ_\ \O*/^(<3]J;_ *2<?M ?]^=7_P#EY0!^OU%?D#_Q#B?M
M3?\ 23C]H#_OSJ__ ,O*/^(<3]J;_I)Q^T!_WYU?_P"7E 'Z_45^0/\ Q#B?
MM3?])./V@/\ OSJ__P O*/\ B'$_:F_Z2<?M ?\ ?G5__EY0!^OU%?D#_P 0
MXG[4W_23C]H#_OSJ_P#\O*/^(<3]J;_I)Q^T!_WYU?\ ^7E 'Z_45^0/_$.)
M^U-_TDX_: _[\ZO_ /+RC_B'$_:F_P"DG'[0'_?G5_\ Y>4 ?K]17Y _\0XG
M[4W_ $DX_: _[\ZO_P#+RC_B'$_:F_Z2<?M ?]^=7_\ EY0!^OU%?D#_ ,0X
MG[4W_23C]H#_ +\ZO_\ +RC_ (AQ/VIO^DG'[0'_ 'YU?_Y>4 ?K]17Y _\
M$.)^U-_TDX_: _[\ZO\ _+RC_B'$_:F_Z2<?M ?]^=7_ /EY0!^OU%?D#_Q#
MB?M3?])./V@/^_.K_P#R\H_XAQ/VIO\ I)Q^T!_WYU?_ .7E 'Z_45^0/_$.
M)^U-_P!)./V@/^_.K_\ R\H_XAQ/VIO^DG'[0'_?G5__ )>4 ?K]17Y _P#$
M.)^U-_TDX_: _P"_.K__ "\H_P"(<3]J;_I)Q^T!_P!^=7_^7E 'Z_45^0/_
M !#B?M3?])./V@/^_.K_ /R\H_XAQ/VIO^DG'[0'_?G5_P#Y>4 ?K]17Y _\
M0XG[4W_23C]H#_OSJ_\ \O*/^(<3]J;_ *2<?M ?]^=7_P#EY0!^OU%?D#_Q
M#B?M3?\ 23C]H#_OSJ__ ,O*/^(<3]J;_I)Q^T!_WYU?_P"7E 'Z_45^0/\
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M/_$.)^U-_P!)./V@/^_.K_\ R\H_XAQ/VIO^DG'[0'_?G5__ )>4 ?K]17Y
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M!^OU%?D#_P 0XG[4W_23C]H#_OSJ_P#\O*/^(<3]J;_I)Q^T!_WYU?\ ^7E
M'Z_45^0/_$.)^U-_TDX_: _[\ZO_ /+RC_B'$_:F_P"DG'[0'_?G5_\ Y>4
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M_EY0!^OU%?D#_P 0XG[4W_23C]H#_OSJ_P#\O*/^(<3]J;_I)Q^T!_WYU?\
M^7E 'Z_45^0/_$.)^U-_TDX_: _[\ZO_ /+RC_B'$_:F_P"DG'[0'_?G5_\
MY>4 ?K]17Y _\0XG[4W_ $DX_: _[\ZO_P#+RC_B'$_:F_Z2<?M ?]^=7_\
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M_P"7E 'Z_45^0/\ Q#B?M3?])./V@/\ OSJ__P O*/\ B'$_:F_Z2<?M ?\
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M'_?G5_\ Y>4 ?K]17Y _\0XG[4W_ $DX_: _[\ZO_P#+RC_B'$_:F_Z2<?M
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MZ2<?M ?]^=7_ /EY0!^OU%?D#_Q#B?M3?])./V@/^_.K_P#R\H_XAQ/VIO\
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M3]J;_I)Q^T!_WYU?_P"7E 'Z_45^0/\ Q#B?M3?])./V@/\ OSJ__P O*/\
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MRC_B'$_:F_Z2<?M ?]^=7_\ EY0!^OU%?D#_ ,0XG[4W_23C]H#_ +\ZO_\
M+RC_ (AQ/VIO^DG'[0'_ 'YU?_Y>4 ?K]17Y _\ $.)^U-_TDX_: _[\ZO\
M_+RC_B'$_:F_Z2<?M ?]^=7_ /EY0!^OU%?D#_Q#B?M3?])./V@/^_.K_P#R
M\H_XAQ/VIO\ I)Q^T!_WYU?_ .7E 'Z_45^0/_$.)^U-_P!)./V@/^_.K_\
MR\H_XAQ/VIO^DG'[0'_?G5__ )>4 ?K]17Y _P#$.)^U-_TDX_: _P"_.K__
M "\H_P"(<3]J;_I)Q^T!_P!^=7_^7E 'Z_45^0/_ !#B?M3?])./V@/^_.K_
M /R\H_XAQ/VIO^DG'[0'_?G5_P#Y>4 ?K]17Y _\0XG[4W_23C]H#_OSJ_\
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MSJ__ ,O*/^(<3]J;_I)Q^T!_WYU?_P"7E 'Z_45^0/\ Q#B?M3?])./V@/\
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M/^_.K_\ R\H_XAQ/VIO^DG'[0'_?G5__ )>4 ?K]17Y _P#$.)^U-_TDX_:
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M3C]H#_OSJ_\ \O*/^(<3]J;_ *2<?M ?]^=7_P#EY0!^OU%?D#_Q#B?M3?\
M23C]H#_OSJ__ ,O*/^(<3]J;_I)Q^T!_WYU?_P"7E 'Z_45^0/\ Q#B?M3?]
M)./V@/\ OSJ__P O*/\ B'$_:F_Z2<?M ?\ ?G5__EY0!^OU%?D#_P 0XG[4
MW_23C]H#_OSJ_P#\O*/^(<3]J;_I)Q^T!_WYU?\ ^7E 'Z_4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M5\@?\%6_^"U?PL_X(^?\(%_PLS0/B!KG_"Q/[0_LW_A&+&TNO(^Q?9?-\[[1
M<P;<_:X]NW=G:^=N!GY _P"(U;]EG_H0?V@/_!'I'_RSH _7ZBOR!_XC5OV6
M?^A!_: _\$>D?_+.NE\"_P#!XW^R)XNOXX=0M?BUX7C8@&?4_#D$D:>Y%K<S
M-^2F@#]6:*\!_9#_ ."I?[/?[>!6'X4_%;PIXJU)D\S^RA.UGJ@4#)8V=PL=
MQM'=MF!ZU[]0 445\(?\%0/^#A;X+_\ !)KX^Z/\.?B-X8^*&M:WK7A^'Q)!
M/X;TZQN;5+>6YN;=49I[R%Q('M9"0$(P5^8DD  ^[Z*_('_B-6_99_Z$']H#
M_P $>D?_ "SH_P"(U;]EG_H0?V@/_!'I'_RSH _7ZBOR-T/_ (/0OV4=6O5B
MN/"?QSTR-B 9KG0=.9%]R(]0=N/85]M?L,_\%@?V=O\ @HQ.UC\*_B1I>K^(
M(XFFET&]CDT_5D1>686\ZJ\BKQEXMZ#(R: /IBBBB@ HHHH **_+9O\ @[N_
M997]HK_A7?\ 9/Q4X\1_\([_ ,)'_9>G?V'_ ,?/V?[;YOV[S?LO_+3?Y6_R
M^=F?EK]2: "BBOF__@J!_P %0/ /_!)KX!:/\1OB-H_C#6M$UKQ!#X;@@\-V
MMM<W27$MM<W"NRSSPH(PEK("0Y.2ORD$D 'TA17Y _\ $:M^RS_T(/[0'_@C
MTC_Y9UVW[-/_  =M_LX_M3_M"^"?AKX?\%?&VSUWQYK=IH.GSZCH^EQVD,]S
M*L2-*R:@[J@9@251B!G /2@#]2***\S_ &QOVKO"W[#G[,GC#XL>-1J#>&?!
M-E]MO8["-)+J?+K&D42R.B-(\CHBAG4$L,D=: /3**^'_P#@EO\ \%^O@K_P
M5M^*OB/P9\.M&^(6@Z]X;TH:U-%XFL+.V6ZMO.2%FB-O=3DE'DC#;@O^L7&>
M<?<% !17QC_P52_X+F?"7_@D+XG\':3\2O#OQ%URX\;VMS=V+>&;"SN4B2!X
MT<2FXNH""3(N-H;H<D=_D_\ XC5OV6?^A!_: _\ !'I'_P LZ /U^HKYO_X)
M?_\ !4#P#_P5E^ 6L?$;X<Z/XPT71-%\03>&YX/$EK;6UT]Q%;6UPSJL$\R&
M,I=1@$N#D-\H !/PC_Q&K?LL_P#0@_M ?^"/2/\ Y9T ?K]17YW?\$^_^#G#
M]G/_ (*+?M'Z?\+?#-C\1/!_B;6H)9-+?Q7I]E:6NI3(-QMHG@NYSYS+N959
M5#!" =Q56_1&@ HHKY _X*M_\%J_A9_P1\_X0+_A9F@?$#7/^%B?VA_9O_",
M6-I=>1]B^R^;YWVBY@VY^UQ[=N[.U\[<#(!]?T5^0/\ Q&K?LL_]"#^T!_X(
M](_^6=?7_P#P2D_X+5_"S_@L'_PGO_"L] ^(&A_\*[_L_P#M+_A)[&TM?/\
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M]KJ6DWT5[:7 ]4EC9D;\#0!N45Q_[0OQKTO]FOX!>./B-KMOJ%WHG@'P_?\
MB34(+"-)+J:WL[:2XE2)79$:0I&P4,Z@DC+ <C\L?^(U;]EG_H0?V@/_  1Z
M1_\ +.@#]?J*_('_ (C5OV6?^A!_: _\$>D?_+.OT>_8*_;6\*_\%$OV3O"G
MQB\$Z?X@TOPSXP^V?8[76X(8+^+[->3V<GF)#++&,R6[D;9&RI4G!R  >P45
M^<'[>O\ P= ? +_@G;^UCXK^#OC;PC\8-4\3>#_L?VRZT32M.GL)?M-G!>1^
M6\U]%(<1W" [HUPP8#(P3Y!_Q&K?LL_]"#^T!_X(](_^6= 'Z_45\(?\$O\
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M_!\KIIU$JW[,]\+3/$@\>J9"/]S^S\?^/5[-\$O^#TK]G?QM<P6WC;P'\3O
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M5Z]X=^+7B+7/!-]_9NHWV@:7IT^GFX5%,L:/-?12$QNQC?,8P\;@9 !/Z/>
MO'&E_$[P-HOB30KR+4=$\0V$&IZ?=Q'*7-O-&LD4B^S(RD?6@#6HHHH **_.
M#]O7_@Z ^ 7_  3M_:Q\5_!WQMX1^,&J>)O!_P!C^V76B:5IT]A+]ILX+R/R
MWFOHI#B.X0'=&N&# 9&"?(/^(U;]EG_H0?V@/_!'I'_RSH _7ZBOA#_@E_\
M\'"WP7_X*R_'W6/AS\.?#'Q0T76]%\/S>))Y_$FG6-M:O;Q7-M;LBM!>3.9"
M]U&0"@& WS @ _=] !1110 45^0/_$:M^RS_ -"#^T!_X(](_P#EG1_Q&K?L
ML_\ 0@_M ?\ @CTC_P"6= 'Z_45\W_\ !+__ (*@> ?^"LOP"UCXC?#G1_&&
MBZ)HOB";PW/!XDM;:VNGN(K:VN&=5@GF0QE+J, EP<AOE  )^D* "BBO'_V]
M?VUO"O\ P3M_9.\5_&+QMI_B#5/#/@_[']LM=$@AGOY?M-Y!9Q^6DTL49Q)<
M(3ND7"AB,G (![!17Y _\1JW[+/_ $(/[0'_ ((](_\ EG1_Q&K?LL_]"#^T
M!_X(](_^6= 'Z_45^0/_ !&K?LL_]"#^T!_X(](_^6='_$:M^RS_ -"#^T!_
MX(](_P#EG0!^OU%?G!^P5_P= ? +_@HE^UCX4^#O@GPC\8-+\3>,/MGV.ZUO
M2M.@L(OLUG/>2>8\-]+(,QV[@;8VRQ4' R1V'_!4#_@X6^"__!)KX^Z/\.?B
M-X8^*&M:WK7A^'Q)!/X;TZQN;5+>6YN;=49I[R%Q('M9"0$(P5^8DD  ^[Z*
M_('_ (C5OV6?^A!_: _\$>D?_+.OI#_@E]_P<)_!?_@K-\>M8^'?PY\,_%#1
M=:T30)O$<\_B33K&VM7MX[BVMV56@O)F,A>ZC(!4# ;Y@0 0#[NHHK\_O^"D
MG_!Q]\#_ /@ES^T@WPO^('A7XK:QX@72[?5OM'A_3+"XL_*G+A%W3WL+[AL.
M1LQTY- 'Z T5^0/_ !&K?LL_]"#^T!_X(](_^6=?H]^P5^VMX5_X*)?LG>%/
MC%X)T_Q!I?AGQA]L^QVNMP0P7\7V:\GLY/,2&66,9DMW(VR-E2I.#D  ]@HH
MHH **^;_ /@J!_P5 \ _\$FO@%H_Q&^(VC^,-:T36O$$/AN"#PW:VUS=)<2V
MUS<*[+//"@C"6L@)#DY*_*021\(_\1JW[+/_ $(/[0'_ ((](_\ EG0!^OU%
M?D#_ ,1JW[+/_0@_M ?^"/2/_EG4EI_P>G_LK7$ZH_@?X^6ZMU>30]**C_OG
M4B?TH _7JBOA?]CO_@XY_9+_ &T_%ECX=T+XB-X7\3:DZQ6FE>*[)])DN9&X
M6-)FS;LY. $$I9B0 #7W10 4444 %%%?F7^V'_P=;?LV_L7?M->,/A7KWAWX
MM>(M<\$WW]FZC?:!I>G3Z>;A44RQH\U]%(3&[&-\QC#QN!D $@'Z:45D^ O'
M&E_$[P-HOB30KR+4=$\0V$&IZ?=Q'*7-O-&LD4B^S(RD?6M:@ HHK\X/V]?^
M#H#X!?\ !.W]K'Q7\'?&WA'XP:IXF\'_ &/[9=:)I6G3V$OVFS@O(_+>:^BD
M.([A =T:X8,!D8) /T?HK\E? O\ P>8_LI>,_&NDZ1<>&?C5X>M]4O(K635-
M3T735LM.5W"F:8Q7\D@C3.YBB.V <*3Q7ZQZ7JEKKFF6][97$%Y9WD2SP3P2
M"2*>-@&5U8<,I!!!'!!H GHHKQ_]O7]M;PK_ ,$[?V3O%?QB\;:?X@U3PSX/
M^Q_;+71((9[^7[3>06<?EI-+%&<27"$[I%PH8C)P" >P45^0/_$:M^RS_P!"
M#^T!_P""/2/_ )9UZ_\ L%?\'0'P"_X*)?M8^%/@[X)\(_&#2_$WC#[9]CNM
M;TK3H+"+[-9SWDGF/#?2R#,=NX&V-LL5!P,D 'Z/T5X_^WK^VMX5_P""=O[)
MWBOXQ>-M/\0:IX9\'_8_MEKHD$,]_+]IO(+./RTFEBC.)+A"=TBX4,1DX!_.
M'_B-6_99_P"A!_: _P#!'I'_ ,LZ /U^HK\@?^(U;]EG_H0?V@/_  1Z1_\
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M%OAFQ^(G@_Q-K4$LFEOXKT^RM+74ID&XVT3P7<Y\YEW,JLJA@A .XJK?HC0
M445\@?\ !5O_ (+5_"S_ ((^?\(%_P +,T#X@:Y_PL3^T/[-_P"$8L;2Z\C[
M%]E\WSOM%S!MS]KCV[=V=KYVX&0#Z_HK\@?^(U;]EG_H0?V@/_!'I'_RSKZ_
M_P""4G_!:OX6?\%@_P#A/?\ A6>@?$#0_P#A7?\ 9_\ :7_"3V-I:^?]M^U>
M5Y/V>YGW8^R2;MVW&Y,;LG !]?T5^6/[0O\ P=U_LV_LU_'WQQ\.==\$_'"[
MUOP#X@O_  WJ$]AH^ER6LUQ9W,EO*\3/J*.T9>-BI9%)!&5!X''_ /$:M^RS
M_P!"#^T!_P""/2/_ )9T ?K]17Y _P#$:M^RS_T(/[0'_@CTC_Y9T?\ $:M^
MRS_T(/[0'_@CTC_Y9T ?K]17Y _\1JW[+/\ T(/[0'_@CTC_ .6=>O\ [!7_
M  = ? +_ (*)?M8^%/@[X)\(_&#2_$WC#[9]CNM;TK3H+"+[-9SWDGF/#?2R
M#,=NX&V-LL5!P,D 'Z/T444 %%?%?_!4_P#X+P_!?_@D7XV\)^'/B-IOCKQ!
MK?BZQFU*"T\,65I=265O'((UDG^T7,&T2/Y@3;NR89,[<#/K_P#P3I_X*&^
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M^&?!&G/J-ZMJBO<W&"%2&%795:661DC0,R@NZ@L!R/C_ /X)P_\ !R;\ O\
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MVBY@VY^UQ[=N[.U\[<#/R!_Q&K?LL_\ 0@_M ?\ @CTC_P"6= 'Z_45^0/\
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MZQ\.?ASX8^*&BZWHOA^;Q)//XDTZQMK5[>*YMK=D5H+R9S(7NHR 4 P&^8$
M'U__ (*@?\%0/ /_  2:^ 6C_$;XC:/XPUK1-:\00^&X(/#=K;7-TEQ+;7-P
MKLL\\*",):R D.3DK\I!) !](45^0/\ Q&K?LL_]"#^T!_X(](_^6='_ !&K
M?LL_]"#^T!_X(](_^6= 'Z_4444 %%%?F7^V'_P=;?LV_L7?M->,/A7KWAWX
MM>(M<\$WW]FZC?:!I>G3Z>;A44RQH\U]%(3&[&-\QC#QN!D $@'Z:45D^ O'
M&E_$[P-HOB30KR+4=$\0V$&IZ?=Q'*7-O-&LD4B^S(RD?6M:@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#S_ ..G[)WPL_:@_LO_ (69\-/A_P#$3^P_
M-_LW_A)_#UIJ_P#9_F[/-\G[1&_E[_*CW;<;O+3.=HQ_)%_P<>?"?PK\#O\
M@LY\9/"W@GPSX?\ !_AG2_[$^QZ1HFG0Z?86GF:'I\LGEP0JL:;I'=SM RSL
M3R2:_L=K^0+_ (.CO^4Z_P <_P#N ?\ J/Z90!_0=_P3*_X)D_LV^/O^";?[
M/FN:[^SY\#]:UO6OAKX<O]0U"_\  NEW%U?W$NEVSRS2RO 7DD=V9F=B68DD
MDDUUGQH_X(!_L=?'71IK/5/@%X#TCS5(6?PY:'09HCV96LVBY'7!!![@CBO0
M_P#@D[_RBR_9I_[)5X7_ /31:U] 4 ?S#_\ !:'_ (-CO%7_  3?\.W7QH^
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M\-0WEMIVBZ=%I^GVM]:L;>Y2*")5C3,8MI&V@9:=B>22?U/_ .#7KX3? ?\
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M^$7P_P!8^SZ=XFL?^$AU'PIKCQ[GT;45U[4PI)')AD'[N5!G*G(&]$(_$/\
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M(?\ A#=._M7^T?[.M9_MGVGR?-^T>=^\\W=OW_-G/-?SP_\ !T=_RG7^.?\
MW /_ %'],K^GW_@D[_RBR_9I_P"R5>%__31:T ?0%9_BSPGI?CWPKJ6A:[IF
MGZUHFM6DMAJ&GW]NES:W]O*A26&6)P4DC=&961@0P)!!!K0HH _#'_@[K_8B
M^"_[-?\ P3;\$Z[\.?A#\+_ &MW?Q*L+"?4/#?A6QTJZFMVTO57:%I8(D=HR
M\<;%"<$QJ<948^[_ /@D[_P3V^ 7_# O[-/CK_A1_P '_P#A-O\ A7_A?7?^
M$A_X0W3O[5_M'^SK6?[9]I\GS?M'G?O/-W;]_P V<\U\P?\ !ZM_RBR\ _\
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MZAX;\*V.E74UNVEZJ[0M+!$CM&7CC8H3@F-3C*C'[G5^0/\ P>K?\HLO /\
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MNC=T.TC*NP/!(K\K_P#@T4_9[\ _M*?\%)/&VA?$;P/X/\?Z):?#6_OX-/\
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MY&_]2Z^K]_J "BBB@ KY8_;"_P"".W[/W[5WPE^)&F3?![X4Z5XS\?6%^/\
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ME !7C_[?W[6>F?L+?L8_$CXM:KY+P^"=$FO;:&4X6\NSB.UM\_\ 36X>*/\
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M'QW?>*?&WP/^#_C#Q-JGE_;-7UOP;IVH7]WY<:Q1^9/-"TC[8T1!N)PJ*!P
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M6/S()E:-]LB(XW X9%(Y -=!10!_.#_P>4_LG?"S]E__ (9Q_P"%9_#3X?\
MP[_MS_A)O[2_X1CP]::1_:'E?V1Y7G?9XT\S9YLFW=G;YCXQN.?</^#13]B+
MX+_M*?\ !-OQMKOQ&^$/PO\ '^MVGQ*O["#4/$GA6QU6ZAMUTO2G6%99XG=8
MP\DC! < R,<98YX__@^<_P";7?\ N:__ '"U] ?\&5/_ "BR\??]E5U'_P!-
M&CT ??W_  Z=_99_Z-I_9_\ _#>:1_\ (]'_  Z=_99_Z-I_9_\ _#>:1_\
M(]?0%? '[?7_  7._P"&'/\ @J;\%?V:/^%7?\)1_P +@_L/_BH_^$D^Q?V3
M_:6KSZ;_ ,>OV63SO*\GS/\ 6IOW;?EQN(!^<'PM^$_A7X'?\'N=CX6\$^&?
M#_@_PSI?F?8](T33H=/L+3S/ 32R>7!"JQIND=W.T#+.Q/))K]S?C?\ L/\
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MT_PWHUMI5K-<-JFJHTS10(B-(4CC4N1DB-1G"C']5U?S _\ !ZM_RE-\ _\
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M#[636?AY\(+:"..X1BT=MHL-W%I]L\8YR9I))+HKV5IVSA<5]>?\&8/[<O\
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MZO>>7H_Q6T[^T='1V^5-5L49RJCH/-M3,6/4FVC% '],%%%% 'Q!_P %8O\
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MC:?V?_\ PWFD?_(]'_!)W_E%E^S3_P!DJ\+_ /IHM:^@* /G_P#X=._LL_\
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M!>CZ9H@TVVTG3;?30NP6D5JB0!?38!MQ[8K2HH ^$_\ @I5_P;U?L\_\%#_
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MS0M(^V-$0;B<*B@< "OS?_X/5O\ E*;X!_[)5IW_ *=]8K]?_P#@UQ_Y04?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ^3_ /P9H_M2?\*G_P""C/B;X:W=QY>G_%CPU(+>+=CS=0T\FYB_*V:^]^:
M/LC_ (/3_P!I2XTK]GGX0_!/1VDFU3Q[X@EUV\MH/FDD@LT$,$17N))[O<H[
MM;>W/ZO?L%_LUV_['?[%WPO^%\"QJW@GPW9:9=-']V:Z2)3<2\?WYC(_U:OQ
M'_:9_P"-I?\ P=Z>#_!Z_P#$P\(_!&XM(+C^*%4TB-M1N%=>F&U"0VY]<J#Q
MT_H2H *^ /\ @Z._Y04?'/\ [@'_ *D&F5]_U\ ?\'1W_*"CXY_]P#_U(-,H
M /\ @UQ_Y04? S_N/_\ J0:G7@G_  =)_P#!$W_AM+X.2_'7X:Z3YOQ6\ V)
M_MBQM8LR^*=*C!8@*.7N;<99/XGCWQ_,1$H][_X-<?\ E!1\#/\ N/\ _J0:
MG7W_ $ ?R6_\&WO_  6CF_X)D?M)_P#"'>-=1E_X4K\1KN.+6!(Q:/P]>G"1
M:F@[*!M28#EHPK?,8E4_UFV-]#J=E#<VTT5Q;W"++%+$X=)$89#*1P00001U
MK^8C_@Z7_P"")O\ PQI\7YOCS\-=)\KX6>/;X_VW8VL7[KPOJLA).%'W+:X;
M+)_"DFY/E#1*?JK_ (--_P#@MA_PLCPS8_LM_$[5MVOZ';L? &I74GS:A9QJ
M6?2V8\F2%06B]8E9./*0, <G_P [UW^?^B?5^_U?@#_SO7?Y_P"B?5^_U !1
M110 4444 ?R!?\'1W_*=?XY_]P#_ -1_3*_I]_X)._\ *++]FG_LE7A?_P!-
M%K7\P_\ P=+64EK_ ,%T?C9(ZE5N8]!D0XZ@:#IR_P U/Y5_3C_P2,U&/5/^
M"57[-<D3!E7X7^&X21_>32[=&_(J10!]#T444 ?D#_P>K?\ *++P#_V573O_
M $T:Q7W]_P $G?\ E%E^S3_V2KPO_P"FBUK\^?\ @]:U*.+_ ()C_#NS+#SI
M_BA93*.Y5-*U4']77\Z_0S_@E;92:;_P3 _9OMY5*R6_PN\,QN".A&DVH/\
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MM/$'@/Q5 3#+=VZ2AH95=<!;F!PJR 8*NH8#:Z$_TL_\$&?^"OVD_P#!6/\
M9+AOM2FL[/XK>"TBL/&&F1X022$$1W\*=H9PK' ^XZR)R%5F /SG_P"#&/\
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M-\-:=H64^Z?LMK'!Q[?)7F__  5B_P"467[2W_9*O%'_ *:+J@#X!_X,J?\
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MGX;21NCKY=O?1+GN5^RR!1_<F;U-?T$4 %?Q!_\ !)W_ )2F_LT_]E5\+_\
MIWM:_M\K^(/_ ()._P#*4W]FG_LJOA?_ -.]K0!_;Y1110 4444 ? '_  ='
M?\H*/CG_ -P#_P!2#3*_(#_@RI_Y2F^/O^R5:C_Z=]'K]?\ _@Z._P"4%'QS
M_P"X!_ZD&F5^0'_!E3_RE-\??]DJU'_T[Z/0!_3]1110 4444 ?@#_P?.?\
M-KO_ '-?_N%KY _X(J?\/)O^&6-?_P"&.O\ DF7_  E=Q_:?_(K?\AC[)9^;
M_P A3]__ ,>_V3[O[OT^;?7U_P#\'SG_ #:[_P!S7_[A:^@/^#*G_E%EX^_[
M*KJ/_IHT>@#Y_P#^-Z_^?^%?5\@?$G_AK#_A_I^R5_PV+_R4W_A*_!_]F?\
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MOA+JUYY/A_XT:;Y-JKMA(]6LU>:W// WPFZCXY9VB'. * /ZB**** /X@_\
M@K%_RE-_:6_[*KXH_P#3O=5_;Y7\0?\ P5B_Y2F_M+?]E5\4?^G>ZK^WR@ H
MHHH *^?_ /@K%_RBR_:6_P"R5>*/_31=5] 5\_\ _!6+_E%E^TM_V2KQ1_Z:
M+J@#^8+_ (-<?^4Z_P #/^X__P"H_J=?U^U_(%_P:X_\IU_@9_W'_P#U']3K
M^OV@ K^0+_@Z._Y3K_'/_N ?^H_IE?U^U_(%_P '1W_*=?XY_P#< _\ 4?TR
M@#Z__9._X?.?\,L?#3_A5O\ R3+_ (172_\ A$?^1&_Y _V2+[%_Q\?O_P#C
MW\K_ %W[S^_\V:] _P"-Z_\ G_A7U?K]_P $G?\ E%E^S3_V2KPO_P"FBUKZ
M H _F!_X)<?\+V_XBP_ O_#2_P#R6W_3_P#A(_\ D'_]"=<_9?\ D'_Z+_QZ
M?9O]7_P+Y]U?T_5\ ?\ #C'_ (WK_P##:W_"T?\ N3?^$;_ZE_\ L;_C^^U?
M]MO^/?\ V/\ ;K[_ * /P3_X/DO$%Q;>$/V:]*5F^RWEYXCNY%[%XDTQ4/Y3
M/^9K!_X,:M(AF\0_M,7[*OVBVM_#5NA[A9&U5F_6)?RKUK_@]I^"MUXH_8^^
M#_CZWA:6'P?XJN=)N65<^2E_;!PY]%WV*KGU=1WKYW_X,@_BA;Z1^TK\=/!;
M2*MUX@\-:=K,49/+K974D+'\#?K^= ']'%%%% !7XY_\'KND0S?\$U?AO?LJ
M_:+;XF6MNA[A9-+U-F_6)?RK]C*_$;_@]U^*%OI7[)?P4\%M(HNM>\776MI'
MGDI96;0L<>QOU'XT ?)O_!D_X@N+;_@H[\3-+5F^RWGPVN+J0=B\6J:<J?I,
M_P"9K^FNOYTO^#(;X)W6I?'OXX?$=H66QT;0++PW%*5^662[N#<.JGOM%E&2
M.V]?6OZ+: /Y@?\ @]6_Y2F^ ?\ LE6G?^G?6*/^"7'_  =:_P##M?\ 83\"
M_!7_ (4+_P )I_PA?V__ (G/_";?V;]L^U:A<WO^H^P2[-OVC9_K&SLW<9V@
M_P"#U;_E*;X!_P"R5:=_Z=]8K]?_ /@UQ_Y04? S_N/_ /J0:G0!^=7C#_@^
M0UR]T::/P_\ LVZ3IFH,I$4VH>-Y+Z%&]6C2QA+#V#CZU\[> /V)_P!J[_@Z
M-^-I^*GBCQY\+]+T+3E2R\N/7()4\+VA=F\F'2[:26YB9CO8?:O+:4C)D( (
M_HE_;X_X)P?"G_@HW\$=9\&?$7PQI=Y)J%L\=AK:6D?]J:'.0=EQ;3XWHRM@
M[<[7 *L&4D'^1_PYXR^,'_!";_@IAJ,>GWDNE^.?A7K;6%]"K.EGX@LMRMY<
MB]7M;J HXSR%D1AM=5( /ZQO^"6W_!,#X?\ _!*3]FFW^'O@?[1J5U=S?;]>
MUZ\15O-=O"H4RN%X2-0-L<0)"+W9B[M])5Y[^R?^TOX:_;'_ &;?!?Q0\'W'
MVCP[XVTN+4[7)!> L,2028X$D4@>-QV>-AVKT*@#Y_\ ^"L7_*++]I;_ +)5
MXH_]-%U7P#_P94_\HLO'W_95=1_]-&CU]_?\%8O^467[2W_9*O%'_IHNJ^ ?
M^#*G_E%EX^_[*KJ/_IHT>@#WC_@X3_X(UV/_  54_9:;4/#=I:V_QD\ 0RW?
MAB[.(SJD?WI=,E<\;)<9C+'"2A3E5:3/\Z__  1M_P""H7B[_@C?^VU_:U_:
M:K_PB.HW T/Q[X;D0QS20)(59Q$V-MU;.79 V#_K(R5$C&O[+J_ +_@[-_X(
MF[A?_M5?"_2?[H^(FEVD7T5-71!^"3X_V)2/]:] '[O_  M^)_A_XU_#C0_%
MWA35K/7/#?B6QBU'3-0M7W0W=O*H='4^X(X."#P0""*_!_\ X+Z?\K37[%?_
M '(W_J77U>6?\&I'_!;#_AGCXAVG[-?Q,U;R_ OB^]/_  ANH74GR:%J<K<V
M;$_=@N7/R]DG;IB9F7U/_@OI_P K37[%?_<C?^I=?4 ?O]1110!_,#_P>K?\
MI3? /_9*M._].^L5^O\ _P &N/\ R@H^!G_<?_\ 4@U.OR _X/5O^4IO@'_L
ME6G?^G?6*_7_ /X-<?\ E!1\#/\ N/\ _J0:G0!]_P!1WM[#IUG-<7$L<%O;
MH9)99&"I&H&2Q)X  Y)-25^?/_!S3^W+_P ,4_\ !*GQE#IUY]E\5_%$CP7H
M^QL2(MRC&[E&.1MM%G 8?=>2/G)% 'YR_P#!)BSF_P""U/\ P<@?$G]HW4HI
M+WX?_"F=M2T02J3$H3-EHT>W^!S'')=X'_+2%CSDY_H@9=RX(R#P0>]?S/?\
M$"_^"^7[,_\ P20_8WOO"/BCP?\ %_6/B!XHUJ?5]?U#1M'TV:S8 "*V@BDE
MOHI&1(4#?-&N))I0,C!/W'_Q&K?LL_\ 0@_M ?\ @CTC_P"6= 'X>_\ !:G]
MC.[_ .";/_!4?X@>$=%2;2=&CU1?$WA*: F/R;"Y;S[<1,.?W#[X-W]ZW-?U
MA?\ !+?]LZU_X* _L"_#+XK0R0MJ'B31XUUB./ %OJ4),%Y'CL!/'(5SC*%3
MT(K^;W_@XL_X*Y? #_@KK<?#GQ+\-?#'Q,\/^.?!ZW.F:A/XBTRQM[>_TZ3$
MD:!X+R=M\4P<JI4 BXD.[( /UQ_P94?MR_9=6^)?[/&L7GR72CQGX;21NCKY
M=O?1+GN5^RR!1_<F;U- ']!%%%% !1110 4444 %%%% !1110 4444 %%%%
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M&"AG8@ 98GD_N=_P2X_X*[_M]?M0?MV>!? OQJ_9@_X5W\,M<^W_ -L^(?\
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M.X<C;(N&"DY&0?T?_P"'^G_!4[_HRO\ \Q#XN_\ DN@#]_J^?_\ @J/^W/\
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M\*?;PP=*'AP?\(AJ_A_^UO/^V?:O^0A+)YWE^3;_ .KQM\WYL[EP ??M%%%
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MEKI%TVH:?H\.HK:>(O#Y.=T<,LA$=Y!M++M9A(R-L9)LLS ']%%%?SR^#?\
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M6!(FH>7CE1;B.XF#=I+Q.?3]@/\ @U-_8<_X9)_X)<:-XIU.S^S^*?C-<_\
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MX@L/$FGP7_PYUJ2UFN+.YCN(DE5(D=HR\:A@KJ2"<,#R #^TRBOP!_X?Z?\
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MV<]G)YB0I%(<1W#D;9%PP4G(R#_0]_P0Q_;Z_:F_;C_X6C_PTO\ !7_A3_\
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M^(GC'XA?$!+M=1OO%7PO\172PM=W*W-Q)"L!A*O)(H!8EOER!@$Y /Z2X_\
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M[3XTUZV;3_#7[,-G:Z\PVI]J\6SZ@H?W@CLHG/TW@^] 'W!_P=G^.]!\)_\
M!%GQQINK2VZ:EXHUK1M/T5)"-\ETE_#=/L'7(M[>XSCMFOS3_P"#)3X::EJG
M[<WQ<\8QQ2'1]#\"#1KF0#Y%GO-0MIH@?<K8S$?0UY-\5O@3_P %!O\ @XU^
M-VC:MXJ\"ZUH_ABQ9DTQ]2TV;P[X3\/12$>9)#Y^9)V.%W,GGS$!1]U0!_0+
M_P $@O\ @E;X3_X)*_LI6_@'0KO^W?$&J3_VGXFUYX?*?5[TJ%^5<DI#&H"1
MIDX&6.6=B0#Z>\0^(+'PEX?OM5U.ZAL=-TRWDN[NYF;;';Q1J6=V/954$D^@
MK^=O_@C!\&]-_P""ZG_!;KXX_M'?$OPSIOBKX;>&FEELM(UZPCOK&=K@-::7
M:S02JT<@ALH9'((.)8XVP"0:]P_X+Z?MV_MTZQ\7?C9^SQ\+/V>_$7B+X-:Y
MIEII%MXOT+X?Z[J&H7EM=:=:RWJ1WD,C6K?O);BW;;"=JAE/S@M7Q_\ \$KO
MVJOV_O\ @E=\(9/AS\/?V-O$5UH^N:ZVK:EJ>O?"KQ--J$\DBQ1'=)%+%&$2
M.-0HV #YB<DDD _H _X=._LL_P#1M/[/_P#X;S2/_D>C_AT[^RS_ -&T_L__
M /AO-(_^1Z^@** /R6_X.+?^"+?PE\2?\$O_ !CXI^$?PA^'7@7QG\,W3Q4)
M_"_ABSTJXU"Q@#+>02-;QH7C6W=Y]IS\UNN,9-?F9_P:%_MR_P##-O\ P49N
MOAGJMYY'AOXV:?\ V:BNVV./5;4/-9N?=D-S"!U+3Q^E?K5_P75_X*#?M:_L
MG?$[PSX3^ '[/</QH\&^*/#LTFOSS>!M:\0QP3-+)$;9GL9HXU5HL$HX+$-G
M.#7\ZOP]_P""=?[7GPG^*FB>,O#?[-_Q^T?7/#>JP:SI<D'P]UDBRN()5FB*
M[H"V%95QDD\<DT ?VN5\ ?\ !T=_R@H^.?\ W /_ %(-,K@/^"*G_!3G]M#]
MM']J?7_"W[1G[/?_  J?P38>%;C5;'5_^$$UW0?M.HI=V<4=MY]]/)$VZ&:X
M?RU <^5D'"L#^;_[>O\ P4?_ ."DG_!1+]D[Q7\'?&W['?B#2_#/C#[']LNM
M$^$_BB"_B^S7D%Y'Y;S32QC,EN@.Z-LJ6 P<$ 'ZO_\ !KC_ ,H*/@9_W'__
M %(-3K[_ *_FA_8*_P""C_\ P4D_X)V_LG>%/@[X)_8[\0:IX9\'_;/L=UK?
MPG\43W\OVF\GO)/,>&:*,XDN' VQKA0H.3DG^EZ@#E/CE\$O"_[27P@\1> _
M&ND6VN^%?%=C)IVI6,X^6>)Q@X/564X967#*RJP((!K^.K_@J3_P3Q\?_P#!
M%C]O'^P[;4M5AL[.[3Q!X#\5VY,,EY;)*&AE5UP%N8'"K(HQM=0P&QT)_M K
MY2_X+$_\$M?#/_!5_P#9!U3P+JGV73?%FE[]1\):XZ9;2=0"X 8@9,$H CE4
M9RI# ;T0@ _!3_@CE^V?KG_!0?\ X.@_A7\7/$UE:V/B+Q18W,.II;<0RW-G
MX+N+&295Q\HE:V,NS^#S-N3C)_J8K^2O_@W>^"_B?]G3_@XR^%W@7QGI%UH/
MBKPK?>(].U.QN!A[>9- U,'GHRGAE92592&!((-?UJ4 %%%?/_\ P5'^/OQ4
M_9?_ &$_'7CKX*^"O^%B?$W0_L']C>'O['N]7_M#S=0MH)_]&M'2>39;RS2?
M(PV^7N.55@0#\@?^#YS_ )M=_P"YK_\ <+7T!_P94_\ *++Q]_V574?_ $T:
M/7Y@?\%6_B3^WU_P6#_X0+_A9G[)7Q T/_A7?]H?V;_PC'PN\16OG_;?LOF^
M=]H:?=C[)'MV[<;GSNR,=?\ \$O_ -K3_@H?_P $FO@%K'PY^'/[(7C#6M$U
MKQ!-XDGG\2?"OQ+<W27$MM;6[(K020H(PEK&0"A.2WS$$  ']1U%>?\ [)WC
M_P 5?%?]ECX:>*?'6B_\(WXV\2>%=+U7Q#I'V.:S_LK49[2*6YMO(F+2Q>7,
MSIY<A+KMPQ)!->?_ /!4?X^_%3]E_P#83\=>.O@KX*_X6)\3=#^P?V-X>_L>
M[U?^T/-U"V@G_P!&M'2>39;RS2?(PV^7N.55@0#\[/\ @\A_;8F^&/[(/@_X
M$Z!-))X@^+^J+=ZE;P9:4Z99NCK&5'.9KMH-O]X6\@P:^J_^"=?_  0S^ W[
M//[$7PU\)^/_ ((_"/QEXZT[18I?$6K:[X1T[4[VXU";,UPK3S1,[I')(T:9
M/"1H!@#%?@W^TUXJ_;T_:[_X*#>$?VC?'/[)OQ$U3Q1X(DT]M*T'_A5_B(>'
MX5LI#-#&823,R&9GE9?.^9G;HIVU^Z__  0V_;Q_:@_;@T;XE3?M*_!G_A4%
MQX;GTY/#\?\ PB6K>'_[429;DW!Q?RR&7RS%#S'C;YGS9W+@ ]U_X=._LL_]
M&T_L_P#_ (;S2/\ Y'H_X=._LL_]&T_L_P#_ (;S2/\ Y'KZ KE_C?XGUKP3
M\%O%^M>&]/\ [7\1:1HE[>Z78^1)<?;;J.!WAB\N,AWWR*J[4(8YP""10!_(
M%_P7_P#V$H_^"=__  5&\=>&]#T]-'\(>(I4\6>%8[:/R8;:RNV9C#$JX")!
M<+/"H'185K^H7_@C3^V^G_!0G_@F_P##/XD7%TMQX@N--&E^(AGYDU2U_<7+
M,/X?,9/.4?W)DK^=S_@JEXT_;L_X*\ZAX-OOB3^QWXUT+4O!,=S!97OACX6^
M)+6>XAG,;-%,9WG#HK1[E "E2[\_,:Z+_@EK^TA_P42_X)(_#;Q-X1^'?[*O
MQ#\0:#XHU)-6EM?$_P +O$5TME<B(1.\'V=H-OF(L0?=NSY*8QSD _JAHKS_
M /9.\?\ BKXK_LL?#3Q3XZT7_A&_&WB3PKI>J^(=(^QS6?\ 96HSVD4MS;>1
M,6EB\N9G3RY"77;AB2":] H *\3_ ."C'[%NC?\ !0O]BSQ_\(M:DCM8_%NG
M&.RO63=_9U]&PEM;C'4B.=(V(&"RAE[U[910!_&K_P $[_C]XL_X(:_\%=]&
MOOB%I&H://X)U:;PYXUTS:6D;3YQY4[H!_K0JLES$5.V3RXR#M;-?V*^!O'.
MC_$WP9I/B+P[J=EK6@ZY:17^GW]G*);>\@D4/'(CCAE92"".QKX<_P""U/\
MP00^'O\ P5Q\*PZU'=1^"?B[HEMY&E^)H;?S([R(9*VM[&,&6').UP=\9)(W
M+NC;\D?@EXI_X*2?\&ZT]SX7'P_U'XB?"6VG>5+9;&?Q%X=0%B6FMKBV(GL=
MQW-LD\M2Q+-$2<D _IFIL\Z6T+R2.L<<:EF9CA5 Y))]!7\_]O\ \'M?BJWM
M_P"SKK]EN-M>4;7V>,IHU#?]<#IY<<]M_P"->9_'/]N3_@I'_P %W-$F\ ^
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M858F(!FE*JJEEP ?HE_P5B_Y19?M+?\ 9*O%'_IHNJ_F"_X-<?\ E.O\#/\
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M[9:)>?#G6I+6Y#(T<D,RI$C-%)&[QL%=25<X8'! !_9A7G_QT_:Q^%G[+_\
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M\$Z1J'A_P9I%AJVK3:]JMC90V]YJ<L$<$FHS(BK).T<:K&C2,"Q5%"@M@
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M8V/&<T*[_P#K@VGL_7MOS[T ?T 33);0M)(RQQQ@LS,<*H'4DU_)#_P<;?\
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M!WP[GCL=;>!SMBDD5;W5Y@PX#1VD44(STEB9<Y;%?HW_ ,%SOV^OVIOV'/\
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MW*-5U:>0ZCXCUUXA'+K>H.H#R8YV1*%5(TR=J*,DL69OIJBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X/]I_XJZ]
M\#OV>O&'B_POX+U;XB>(/#NES7UAX;TV5([K5Y47(B1FXSW(4,Y (1'<JC?S
MR_\ !-K_ ((_?&7_ (+J?MO:E^TY^TUIU_H/PWU;5%U.>VNH)+27Q.L6%AT^
MSB;YX["-$2-IB<E%VHS.7D3^E:B@"'3M.M]'T^WM+2WAM;6UC6&&&% D<**,
M*JJ. H   '  J:BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[/\ VEJ7V*XO/LWGW$5M%^ZMXY)6W331K\J'&[)P 2/D#_B*-_83_P"BY?\
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M\5O^$:\;>&_L_P#:6F_\(SK%Y]F\^WBN8OWMO:21-NAFC;Y7.-V#@@@>?_\
M$4;^PG_T7+_RS/$'_P @T ??]%? '_$4;^PG_P!%R_\ +,\0?_(-'_$4;^PG
M_P!%R_\ +,\0?_(- 'W_ $5\ ?\ $4;^PG_T7+_RS/$'_P @U]/_ +%7[>OP
MG_X*(_"S4/&WP=\5_P#"8>&=+U631+J\_LR\T_RKR.&&9XO+NHHI#B.XA;<%
M*G?@'(( ![!1110 4444 %%>7_M1?MJ?"?\ 8I\&KKWQ6^('AGP+ILV?(.IW
MBQS7A'58(1F69A_=C5C[5^?WQ+_X/#OV0/ FJ26^EGXI>-(8V(%SHWAM(HI/
M<"\GMWQ]5!H _5&BORJ\!?\ !XI^R%XPOXX=0C^*WA6-^L^J>'(I(X_J+6XG
M;\E-?7O[,O\ P60_9>_; NK>U\ _&SP/JFIW9"P:9>WATK49B>R6UVL4S'_=
M0T ?3%%%?/\ ^W/_ ,%1_@3_ ,$U_P#A%_\ A=?CK_A"_P#A-/M?]C?\274-
M1^V?9?(\_P#X]()=FW[1#]_;G?QG#8 /H"BO@#_B*-_83_Z+E_Y9GB#_ .0:
M/^(HW]A/_HN7_EF>(/\ Y!H ^_Z*^!]/_P"#GW]A?4[E8H_CI K-WE\):["O
M_?3V0'ZU].?LQ?M[?!?]L^RFF^%?Q.\&>.'MT$D]MIFI1R7ELIZ-);DB6,<]
M704 >N4444 %%? '_$4;^PG_ -%R_P#+,\0?_(-'_$4;^PG_ -%R_P#+,\0?
M_(- 'W_17P!_Q%&_L)_]%R_\LSQ!_P#(-'_$4;^PG_T7+_RS/$'_ ,@T ??]
M%? '_$4;^PG_ -%R_P#+,\0?_(-??] !17R!^U'_ ,%ZOV3_ -B[X[:Y\,_B
M9\5O^$:\;>&_L_\ :6F_\(SK%Y]F\^WBN8OWMO:21-NAFC;Y7.-V#@@@>?\
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M\(UXV\-_9_[2TW_A&=8O/LWGV\5S%^]M[22)MT,T;?*YQNP<$$  ^OZ*^%?
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M-_9_[2U+[%<7GV;S[B*VB_=6\<DK;IIHU^5#C=DX )'R!_Q%&_L)_P#1<O\
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MS/$'_P @T ??]%? '_$4;^PG_P!%R_\ +,\0?_(-*/\ @Z,_838X_P"%Y_\
MEF>(/_D&@#[^HKY/^!'_  7._9'_ &DM?M]*\)_'CP--J5TXC@MM3FET:6X<
M]%1;Q(2S'L%R37U>CB1 RD,K#((Z$4 +117R!^U'_P %ZOV3_P!B[X[:Y\,_
MB9\5O^$:\;>&_L_]I:;_ ,(SK%Y]F\^WBN8OWMO:21-NAFC;Y7.-V#@@@ 'U
M_17P!_Q%&_L)_P#1<O\ RS/$'_R#1_Q%&_L)_P#1<O\ RS/$'_R#0!]_T5\
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M,_AC]G7X2>(O'7C35H=!\)^$]/EU35;^5'D6UMXE+.VQ%9W.!@(BLS$@*"2
M?G_]C;_@M=^S%_P4 ^+<G@3X2?%"'Q5XLCL)=3^P/H6IZ:SV\3(KLKW=M$CD
M&13L5BV,G&%8@ ^J**** "BOG_\ ;G_X*C_ G_@FO_PB_P#PNOQU_P (7_PF
MGVO^QO\ B2ZAJ/VS[+Y'G_\ 'I!+LV_:(?O[<[^,X;'@'_$4;^PG_P!%R_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+7XF+X3G\ WV@:C>>'1X9^V?VW+I=]]I!-U]JC\KS(UCAYB?9Y>[YL[1^BE
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MDDD_'_\ P>K?\I3? /\ V2K3O_3OK%?K_P#\&N/_ "@H^!G_ ''_ /U(-3H
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M38_VIX9\8:5=:)J]GYTD'VNSN87AGB\R-ED3=&[+N1E89R"#@UX__P $G?\
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M_P""I?[$?B3X;W_V6T\1PK_:GA75)5_Y!>J1*WE,3@D1R M%)@']W*Q W!2
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MSX9_$S0_^$D\$^)?L_\ :6F_;;BS^T^1<17,7[VWDCE7;-#&WRN,[<'()!\
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M-M1549P !@5^,'_!T=_RG7^.?_< _P#4?TROZ??^"3O_ "BR_9I_[)5X7_\
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MXP^(&@Z)J]GYTD'VNSN=1MX9XO,C99$W1NR[D96&<@@X-?W.5_$'_P $G?\
ME*;^S3_V57PO_P"G>UH _IZG_P"#6W]A66)E7X(-&Q_B7QGK^1^=\1^E>!_M
M1?\ !FC^SI\3M NI/ACXD\<?"_7MI^S>9=C6M+#=O,AFQ.?JLXQD\&OU^HH
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MW3?MMQ>?9O/\#2W,O[VXDDE;=--(WS.<;L#   _H^KY__P"'7'P)_P"&[/\
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MJ:7<Z'J=Q97EO-:7EG*T$\$R%)(9%)5D93R&!!!!Y!%?V:_LN?\ !!7]D_\
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M /!J5_P2X^!/_!2C_A?7_"Z_ O\ PFG_  A?_"/?V-_Q.M0TW[']J_M3S_\
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M>P_\,=?V!\0/^%F_]!/[#:?V#_R!_P"U_P#6_:?/_P"/?Y?]1_K./N_/7O\
MX _9.^%GPH^*>M>.O"WPT^'_ (:\;>)?/_M?Q#I7AZTL]5U7SYEGG^T7,<:R
MR^9,JR/O8[G4,<D T =!\6/A;H/QQ^%GB;P3XIL?[4\,^,-*NM$U>S\Z2#[7
M9W,+PSQ>9&RR)NC=EW(RL,Y!!P:_ '_@Z _X(S?LV?\ !.W]@7PCXV^#OPW_
M .$/\3:I\0+/1+J\_P"$@U34/-LY-.U*9XO+NKF6,9DMX6W!0PV8!P2#_0]7
MY _\'JW_ "BR\ _]E5T[_P!-&L4 ?G__ ,&I7_!+CX$_\%*/^%]?\+K\"_\
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MR5:=_P"G?6*_7_\ X-<?^4%'P,_[C_\ ZD&IU^0'_!ZM_P I3? /_9*M._\
M3OK%?K__ ,&N/_*"CX&?]Q__ -2#4Z /O^BBB@ K^=W_ (*<3R?\%MO^#EGP
M#\ ;)VU#X<?!^==-UH1G,.RWQ>:RY/\  SE$LL_WX4]>?V^_X*%?M<:;^PC^
MQ3\2/BUJ?DLO@O19KNTAE.%N[UL16D!_ZZ7#Q)[;\U_/G_P;,_\ !0[]FO\
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M7J_X*G76@S*/V2[OPWE2/MMO\(?$N^'W'VB>2/\ -2*^F/\ @RI_Y19>/O\
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M 4444 ?@#_P?.?\ -KO_ '-?_N%KY _X(J?\%.?VT/V+OV6-?\+?LY_L]_\
M"V/!-_XKN-5OM7_X037=>^S:B]I9Q26WGV,\<2[88;=_+8%QYN2<,H'U_P#\
M'SG_ #:[_P!S7_[A:^@/^#*G_E%EX^_[*KJ/_IHT>@#Y_P#^'^G_  5._P"C
M*_\ S$/B[_Y+KY ^)/[7GQ]_;1_X+Z?LE>*?VC/A?_PJ?QM8>*_!^E6.D?\
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M/U?S _\ !E3_ ,I3?'W_ &2K4?\ T[Z/7]/U !1110!_(%_P='?\IU_CG_W
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MO_#^_P#!/Q9_X2/^R+'2KZ[EU6V_M'7;;48/M$<EM'$NV&%E?9*^'( W#+
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MGK-/9F022:9=H3'<VKGC+13*Z9P-P 8<,*]BH **** "OXGO^"T7C*X\=?\
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M<?#O_@GS\=O$%F[1W>A?#SQ!J$#J<%7ATVXD4CZ%17\:?_!-3PW#XS_X*-?
M#1[E5DM]6^)'AVSE4C(9)-3MT(_(FO[2/VQOA;<?'+]D3XJ>";5/,NO&'@_5
MM$A0?Q/<V4T*C\2XK^*+]A7Q[#\(/VX_@YXHO6^SV_A?QUHNJ3L_R^6MOJ$$
MK$YZ8"&@#^Z6BBB@ HHHH **** /Y O^#H[_ )3K_'/_ +@'_J/Z97Z7_L1?
M\'=?[-O[-?[%_P (?ASKO@GXX7>M^ ?!6C>&]0GL-'TN2UFN+.QAMY7B9]11
MVC+QL5+(I((RH/ _-#_@Z._Y3K_'/_N ?^H_IE?T'?\ !,K_ ()E?LV^/?\
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M#"(B)D[8XT4EB"Q^AJBLKZ'4[*&XMYHKBWN$62*6-@R2(1D,I'!!!R".M2T
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M[FO_ -PM?0'_  94_P#*++Q]_P!E5U'_ --&CT ?K]1110 4444 %%%% 'X
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MQW=M-KNJ1RQM[,C,/QK:_P"#H[_E!1\<_P#N ?\ J0:91_P:X_\ *"CX&?\
M<?\ _4@U.@#^9K]M;]G#QM_P1X_X*6:UX8T^_O+'7OACXAAUCPOK&W#75LKK
M<6%V/X2639O R XD0]#7]?7_  3N_;2T+_@H1^QGX#^+>@>5%#XLTY9+ZS1]
MQTV^0F.ZMCW_ '<RNH)^\H5NC"OS,_X/$/\ @FW_ ,+R_9AT3]H+PWI_F^)O
MA5C3_$'E)F2[T2:3Y7/<_9KA]V!P$N9F)PM?*/\ P9Q?\%)/^%2?M ^(/V<_
M$M_Y>@_$C?K/AGS7PEMJ\,7[Z%<\#[1;QY_W[5% R] 'ZA_\'*__  4?_P"'
M?/\ P3@URVT6_P#LGQ ^*GF>%O#WEOMFMDD3_3+Q>X\J!BJL.5EFA-<K_P &
MLW_!.#_AA[_@G;8^,->L/LOCWXT^3XBU#S$VS6FG[3_9]L>XQ$[3$'!#73*?
MNBOSZ^+UQ)_P<>_\'&UCX3M7?4_@/\$V>&X=#NM;K3;*8&ZD!'!^W7A6%6')
MA,;?\LS7]&MO!':0)%%&L<<:A$1!M5 .  .P% '\0O\ P5B_Y2F_M+?]E5\4
M?^G>ZK^WROX@_P#@K%_RE-_:6_[*KXH_].]U7]OE !7Y _\ !ZM_RBR\ _\
M95=._P#31K%?K]7Y _\ !ZM_RBR\ _\ 95=._P#31K% 'Y ?\$,?V^OVIOV'
M/^%H_P##-'P5_P"%P?\ "4?V3_PD?_%(:OX@_LG[/]M^R_\ (/FC\GS?.N?]
M9G?Y7RXVMG[SUW_@O=_P5.GTR51^QW-I?RG_ $F+X0>*=T7N/,N67CW!%7/^
M#&/_ )NB_P"Y4_\ <U7[_4 ?QL_M0?M0_$3_ (*!_M1Z='^VU\2OB-\.8]+R
MEE;_ /""F6'1(7;]YY6G^;;&/.U09 LCOL&XMM K^B[_ (( _ +]DKX(_LQ7
MK?LN^,-/^(1U1XG\3^(;B?.N74P#>6EW R1R6J+E_+A,:  LWSL6=OI3]NK]
MA#X<_P#!0_\ 9^UGX>_$?0;+5+'4+>1;&^:!6O=#N2I"75K(1F.5#@\'# %6
M#*Q4_P >/[-7[3'Q*_X(^_M^SZWX9U*6U\2?#?Q!<Z)K=DDI6UUN&WN&ANK.
M9>C12>6PY!*G:ZX95( /[<J*P?A5\1]-^,7PO\-^+M&D:71_%6EVNL6+L.7@
MN(EEC)^JN*WJ /X0_P!D[Q_XJ^%'[4_PT\4^!=%_X23QMX;\5Z7JOA[2/L<U
MY_:NHP7<4MM;>1"5EE\R943RXR';=A2"0:_;[_A_I_P5._Z,K_\ ,0^+O_DN
MOR!_X)._\I3?V:?^RJ^%_P#T[VM?V^4 ?S@_M8_\%MO^"DGQ7_98^)?A;QU^
MR+_PC?@GQ)X5U32O$.K_ /"K/%%G_96G3VDL5S<^?-=-%%Y<+._F2 HNW+ @
M$5]@?\&5/_*++Q]_V574?_31H]?I=^V[\%-5_:4_8O\ B]\.="N-/M-;\?\
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M#5%97T.IV4-Q;S17%O<(LD4L;!DD0C(92.""#D$=:EH **** "OR!_X/5O\
ME%EX!_[*KIW_ *:-8K]?J_('_@]6_P"467@'_LJNG?\ IHUB@#[^_P""3O\
MRBR_9I_[)5X7_P#31:U^$O\ P=8_\$3?^&:OB1=?M(?#+2/+^'_C*]'_  EV
MGVL7[OP_JDK<72@?=M[ESSV28XSB5%7]VO\ @D[_ ,HLOV:?^R5>%_\ TT6M
M>P?%;X6>'OCA\--=\'^+-)L]=\,^)K&73M3T^Z7=%=P2J5=#WY!X(P0<$$$
MT ?A/_P:8_\ !;#[3%8_LJ_%#5OWD88_#O5+N3[RC+/I#L?3EX,]M\0/$25^
M_%?QG_\ !8G_ ()A>,/^"-?[;G]DV-YJW_"*WUS_ &[X"\2QN8YI8(Y RJ95
MQMN[9]BOMP<^7( HD6OZ,/\ @WT_X+'V'_!5?]E9+;Q%=6MO\8O ,,5GXILU
MQ'_:*8VQ:E$@X\N;!#A1B.4,,!6CW 'P#_P0+_Y6FOVU/^YY_P#4NL:_?ZOP
M!_X(%_\ *TU^VI_W//\ ZEUC7[_4 ?S._P#![+XRN+[_ (*#?"OP^SL;32_A
MY'J$:9X5[C4KV-S^(M4_(5]H?\&3WAN&U_X)R_$[6%5?M%]\2)[-VQR4ATS3
MG4?@9W_.ODW_ (/=/A3=:3^UQ\%O'#1M]CU_PA<Z$DF.#)97KSL/RU!3^-?3
MG_!DE\0+?4OV'OB]X5613=:-XY359$SRJ7=A;Q(?Q-D__?)H _:BBBB@ K^>
MW_@^1\-PVOC7]FW6%5?M%]9>(K-VQR4ADTUU'X&=_P Z_H2K^=?_ (/A?B!;
MZE\;_P!G[PJLBFZT;0]7U61,\JEW<6T2'\39/_WR: /1O^#'+QC<7OPW_:,\
M/L[&UTS4M!U"-,\*]Q%?QN?Q%JGY"OWBK\//^#(7X476B_LT?'/QO)&RVGB3
MQ+I^BPN>CM8VLDSX^G]H+7[AT %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 ?@#_P?.?\ -KO_ '-?_N%KZ _X,J?^467C[_LJNH_^FC1Z^?\ _@^<_P";
M7?\ N:__ '"U] ?\&5/_ "BR\??]E5U'_P!-&CT ?K]1110!^,O_  >R^#;:
M^_X)\_"OQ R*;S2_B''IT3X^98[C3;V1Q^)M8_R%?''_  9,^-+FQ_X*!_%3
MPZKL+/5/AZ^HRIGAI+;4K*-#^ NI/S-?4O\ P>Z_%RUTK]E+X*^ S*OV[7O%
MEUKZQ@_,([*S: L1Z9OP!Z\^E?/?_!D5\)+K5?VK/C5X\$3?8M!\)VN@-(1\
MIDO;Q9PH]3BP)/IQZT ?T@5\?_\ !=W]N3_AW]_P3"^)'C2RO/L?BC5K3_A&
MO#3*VV0:C>AHDD3_ &H8_.N/I;FOL"OYQ_\ @[R_;*TCXZ?MW?"S]G>X\31^
M'_!O@-K?4?%NI>5)<1Z==Z@R#S9(HE:23[-8[90J*6(NG4 G H ^U/\ @T&_
M8;_X9Q_X)U7GQ/U6S\GQ)\:]1_M"-G7$D>E6I>&T4]_G<W,P/1DFC/:O9O\
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M%=P#_KG<1RI[A0: /:**** /G_\ X*Q?\HLOVEO^R5>*/_31=5_,%_P:X_\
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M=X7U#P?_ ,$1/@+::FDD=Q-IVH7J!Q@F&XU6]N(3]#%+&1[$5^#7[#7_  2
M_:4_X+P_M=W7Q6^*5OXAT'P9XIU)=3\2^-M7LS9_;X?E'D:;$RCS3Y:B*,HI
MAB51D_*$;^K#X;?#O1OA#\.]!\)^';&'2_#_ (9TZWTK3+.+_5VEM!&L44:^
MRHJC\* -JBBOD#_@M7_P5;_X<^?LL:!\3/\ A O^%B?VYXKM_#']F_VW_9'D
M>;:7ESY_F_9Y]V/LFW9L&?,SN&W! /Q _P"#U;_E*;X!_P"R5:=_Z=]8K]?_
M /@UQ_Y04? S_N/_ /J0:G7\X7_!:O\ X*M_\/@_VI] ^)G_  @7_"N_[#\*
MV_AC^S?[;_M?S_*N[RY\_P W[/!MS]KV[-AQY>=QW8'U]_P2X_X.M?\ AVO^
MPGX%^"O_  H7_A-/^$+^W_\ $Y_X3;^S?MGVK4+F]_U'V"79M^T;/]8V=F[C
M.T ']/U%%?('_!:O_@JW_P .?/V6- ^)G_"!?\+$_MSQ7;^&/[-_MO\ LCR/
M-M+RY\_S?L\^['V3;LV#/F9W#;@@'YX?\'B?[5&K>.[OX-?LH^"?,O\ Q)X\
MU2#7M2L8&_>7!:4V>F6WN)9VG8J>A@B-?5WPD_X-4_V,?"WPK\-Z9XJ^%+>)
M_$VGZ7;6^KZP?%>N6_\ :EVD2K-<>7%>)&GF2!FVHJJ-V  !7X'Q?\%K/^$L
M_P""S[?M?>.OAI_PEQL;TW>C>#_^$A^RPZ7Y5K]FLE^U&V??Y "RY$*;Y1OP
MN2#_ $M?\$8_^"I/_#W7]D[4OBA_P@O_  KW^S_$ESX>_LS^VO[6\SR8+:;S
MO-\B#&[[1C;L.-F<G.  >;?\0N/["?\ T0W_ ,O/Q!_\G5%>?\&M7["UU9RQ
MQ_!.2W>1"JRQ^,M?+Q$C 8;KTKD=1D$>H-?H)7B__!0_]KS_ (8*_8M^('Q?
M_P"$>_X2O_A!=/6^_LG[?]A^W9FCBV^=Y<FS_69SL;IC'.: /X\->T[QK_P2
M'_X*9S0QLR^+O@;XU#PNV8TU%;6<,C'_ *8W$.TX[QS>]?VG? _XPZ'^T)\&
MO"GCSPU<?;/#_C+2;76M.F[O!<1+*F1V;:P!'8@CM7\:_P#P6&_X*/:'_P %
M4OVMO^%M:9\,_P#A6.IWVD6VG:O:#7AJZZG/!N2.Y+_9H"K>3Y417#<0J<CD
M5]C?\$J/^#K37/\ @F[^QAH'P?UGX/\ _"S(?"US<_V7JI\7'2G@M)I#,MLT
M9LI]VR1Y<-O'RLJ[0$R0#^HNOP!_X(%_\K37[:G_ '//_J76-?8'_!:O_@Y"
M_P"'/G[4^@?#/_A3/_"Q/[<\*V_B?^TO^$M_LCR/-N[RV\CROL4^['V3=OWC
M/F8VC;D_B!^P+_P7._X8<_X*F_&K]I?_ (5=_P )1_PN#^W/^*<_X23[%_9/
M]I:O!J7_ !]?99/.\KR?+_U2;]V[Y<;2 ?U^T5\@?\$5/^"K?_#X/]EC7_B9
M_P (%_PKO^P_%=QX8_LW^V_[7\_RK2SN?/\ -^SP;<_:]NS8<>7G<=V!]?T
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M'T?_  J[_BUW_"M?^%:_VM_S,G]L?VC]N^Q?].MOY>S['_M;O,_AV\_T^_\
M!4?]N?\ X=K_ +"?CKXU?\(O_P )I_PA?V#_ (DW]I?V;]L^U:A;67^O\J79
MM^T;_P#5MG9MXSN !^0/_!\Y_P VN_\ <U_^X6OH#_@RI_Y19>/O^RJZC_Z:
M-'K\@/\ @N=_P7._X?1_\*N_XM=_PK7_ (5K_:W_ #,G]L?VC]N^Q?\ 3K;^
M7L^Q_P"UN\S^';SZ!_P14_X.0O\ ASY^RQK_ ,,_^%,_\+$_MSQ7<>)_[2_X
M2W^R/(\VTL[;R/*^Q3[L?9-V_>,^9C:-N2 ?U>T5^ /_ !'.?]6N_P#F2/\
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MV3;LV#/F9W#;@@']GE%?@#_Q'.?]6N_^9(_^]='_ !'.?]6N_P#F2/\ [UT
M?K=_P5 _X*@> ?\ @DU\ M'^(WQ&T?QAK6B:UX@A\-P0>&[6VN;I+B6VN;A7
M99YX4$82UD!(<G)7Y2"2/8/V>OC7I?[2GP"\#_$;0K?4+31/'WA^P\2:?!?Q
MI'=0V]Y;1W$22JC.BR!)%#!78 @X8CD_RY?\%J_^#D+_ (?!_LL:!\,_^%,_
M\*[_ +#\5V_B?^TO^$M_M?S_ "K2\MO(\K[%!MS]KW;]YQY>-IW9']'O_!)W
M_E%E^S3_ -DJ\+_^FBUH ^@*_B#_ ."3O_*4W]FG_LJOA?\ ].]K7[_?\%1_
M^#K7_AVO^W9XZ^"O_"A?^$T_X0O[!_Q.?^$V_LW[9]JT^VO?]1]@EV;?M&S_
M %C9V;N,[1_.#^R=\=/^&7_VI_AI\3/[+_MS_A7?BO2_$_\ 9OVG[+_:'V*[
MBN?(\W8_E[_*V[]C;=V=K8P0#^[RBOP ?_@^8EF7;#^RZ/,;A<_$8MS]!I8S
M7#?$K_@YM_;A_;:T^30?@'\![CPNVH#RUOM"\.WWB75(<\925X_LZCKEF@..
MN1B@#[^_X.:/^"O6A?L&?L=ZY\,_#FKP3?&#XJ:;+I=E:6\H,VB:=,#'<7\H
M',>4+QPYP3(VY<B)\?BQ_P &T7_!+G5/^"@'[?&A^*M6TV1OA?\ "2]@U[7;
MN1/W%[=QMYEI8*>C-)(JNZ]!%&^<%DS[[^QQ_P &K'[2?[=OQ=D^(7[3WB34
M/ >G:U<B]U:;4=075O%FLYZX&YTA) V[IW+)Q^Z8#%?T-?LD_LB_#_\ 8<^!
M6C_#GX9^'K7PYX6T53Y<,>7ENI6QOGGD/S2S.1EG8DG '    /2J^?\ _@K%
M_P HLOVEO^R5>*/_ $T75?0%?@#_ ,%8O^#K7_DY;]FC_A0O_0T?#+_A(_\
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M^#VOX%Z7H<LG@_X1_%G7-2"GRX-9;3])@9NP,L4]RP'N$/TKY6TSX"?M;?\
M!T_^U#X5\4_$SP_??"G]GCPW-YELPMY+6RM[9RIE^Q"8;[Z\F50IGQY28_@
M$; 'Z7?\&I'P,N_@O_P1H\$WE] ]M=>/-6U+Q-Y;C#".2;[/"Q]GAMHW'^RZ
MU^D%8OPV^'>B_"'X=Z#X3\-Z?#I7A_PSI\&E:990C]W:6T$:QQ1KWPJ*HY]*
MVJ /@#_@Z._Y04?'/_N ?^I!IE'_  :X_P#*"CX&?]Q__P!2#4Z_(#_@J/\
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M?]1]@EV;?M&S_6-G9NXSM !^ /\ P2=_Y2F_LT_]E5\+_P#IWM:_M\K^$/\
M9.^.G_#+_P"U/\-/B9_9?]N?\*[\5Z7XG_LW[3]E_M#[%=Q7/D>;L?R]_E;=
M^QMN[.UL8/[??\1SG_5KO_F2/_O70!^_U<?^T+\:]+_9K^ 7CCXC:[;ZA=Z)
MX!\/W_B34(+"-)+J:WL[:2XE2)79$:0I&P4,Z@DC+ <C\,?^(YS_ *M=_P#,
MD?\ WKKS_P#:Q_X/*?\ AJ#]ECXE_#/_ (9Q_L/_ (6)X5U3PQ_:7_"?_:O[
M/^VVDMMY_E?V:GF;/-W;-Z[MN-RYR #]KO\ @E__ ,%0/ /_  5E^ 6L?$;X
M<Z/XPT71-%\03>&YX/$EK;6UT]Q%;6UPSJL$\R&,I=1@$N#D-\H !/TA7Y _
M\&5/_*++Q]_V574?_31H]>__ /!<[_@N=_PY<_X5=_Q:[_A97_"RO[6_YF3^
MQ_[.^P_8O^G6X\S?]L_V=OE_Q;N #\ ?^#H[_E.O\<_^X!_ZC^F5_3[_ ,$G
M?^467[-/_9*O"_\ Z:+6OY _^"H_[<__  \H_;L\=?&K_A%_^$+_ .$T^P?\
M2;^TO[2^Q_9=/MK+_7^5%OW?9]_^K7&_;SC<?U^_X)._\'6O_)M/[-'_  H7
M_H5_AE_PD?\ PFW_ %ZZ;]M^R_8/^VGE>;_L^9_%0!^_U?RQ_P#!V?\ \$T/
M^&1?VXH_BUX;T_R/ OQL>6_G$28BL-;3!O(SCIYVY;@9^\TDX PE?U.5\S_\
M%>/^"?>F_P#!3+]@KQM\+[A;>/7;B#^T_#-Y+P+#5H S6S[OX5<EH7/7RYI,
M<T ?(O\ P:@_\%+_ /ALG]A$?#'Q)J'VCQY\$UATK,KYEO\ 1F!%E-SU\H*U
MNV,X$,1)S)7ZI5_%!_P37_;U\;_\$=?V[K;QW;:%<7FH>'7N] \3>&+JY-B=
M2@)*3V<K[',;I-&C@[&VR0KE2 0?Z(O^"*?_  <?_P##X3]J+Q!\-?\ A37_
M  KO^P?"T_B7^T?^$M_M?S_*N[2V\GROL4&W/VK=OWG'EXVG=D 'Z>T444 %
M?D#_ ,'JW_*++P#_ -E5T[_TT:Q7Z??M8_'3_AE_]ECXE_$S^R_[<_X5WX5U
M3Q/_ &;]I^R_VA]BM);GR/-V/Y>_RMN_8VW=G:V,'^8+_@M7_P '(7_#X/\
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MXL<L"\>&+1[0#XS_ .#8#XU:?^TG_P '#'[3/Q&TBWNK/2?'WA[Q3XCLH+H
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M6\101QR27D\]YK=U).%-M<!B3+'(24='RI4D$8K^WJ@ HHHH **** "BBB@
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M\'KWCWQ[;-:> _V8;&/59!B(W/BBXUA=W_7*&S@9OH&%?/\ \;M(_P""FO\
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M,ULK@\J\S2-,R]=A@! 92!^L5%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM3?](Q_V@/\ O[J__P HZ_7ZB@#\@?\ B([_ &IO^D8_[0'_ ']U?_Y1T?\
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M1T?\1'?[4W_2,?\ : _[^ZO_ /*.OU^HH _('_B([_:F_P"D8_[0'_?W5_\
MY1T?\1'?[4W_ $C'_: _[^ZO_P#*.OU^HH _('_B([_:F_Z1C_M ?]_=7_\
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MY _\1'?[4W_2,?\ : _[^ZO_ /*.C_B([_:F_P"D8_[0'_?W5_\ Y1U^OU%
M'Y _\1'?[4W_ $C'_: _[^ZO_P#*.C_B([_:F_Z1C_M ?]_=7_\ E'7Z_44
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M'_?W5_\ Y1U^OU% 'Y _\1'?[4W_ $C'_: _[^ZO_P#*.C_B([_:F_Z1C_M
M?]_=7_\ E'7Z_44 ?D#_ ,1'?[4W_2,?]H#_ +^ZO_\ *.C_ (B._P!J;_I&
M/^T!_P!_=7_^4=?K]10!^0/_ !$=_M3?](Q_V@/^_NK_ /RCH_XB._VIO^D8
M_P"T!_W]U?\ ^4=?K]10!^0/_$1W^U-_TC'_ &@/^_NK_P#RCH_XB._VIO\
MI&/^T!_W]U?_ .4=?K]10!^0/_$1W^U-_P!(Q_V@/^_NK_\ RCH_XB._VIO^
MD8_[0'_?W5__ )1U^OU% 'Y _P#$1W^U-_TC'_: _P"_NK__ "CH_P"(CO\
M:F_Z1C_M ?\ ?W5__E'7Z_44 ?D#_P 1'?[4W_2,?]H#_O[J_P#\HZ/^(CO]
MJ;_I&/\ M ?]_=7_ /E'7Z_44 ?D#_Q$=_M3?](Q_P!H#_O[J_\ \HZ/^(CO
M]J;_ *1C_M ?]_=7_P#E'7Z_44 ?D#_Q$=_M3?\ 2,?]H#_O[J__ ,HZ/^(C
MO]J;_I&/^T!_W]U?_P"4=?K]10!^0/\ Q$=_M3?](Q_V@/\ O[J__P HZ/\
MB([_ &IO^D8_[0'_ ']U?_Y1U^OU% 'Y _\ $1W^U-_TC'_: _[^ZO\ _*.C
M_B([_:F_Z1C_ +0'_?W5_P#Y1U^OU% 'Y _\1'?[4W_2,?\ : _[^ZO_ /*.
MC_B([_:F_P"D8_[0'_?W5_\ Y1U^OU% 'Y _\1'?[4W_ $C'_: _[^ZO_P#*
M.C_B([_:F_Z1C_M ?]_=7_\ E'7Z_44 ?D#_ ,1'?[4W_2,?]H#_ +^ZO_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA/0X_,N]0OI-J+GA451EI)&/"QH&=B0%!)Q0!VU%?@;^TY_P> >/_C;\5/\
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M4/#?PZ\2ZK:PW"HCM"TL%\Z+($DC8H3D"13C##(!_1=17G_[)WC_ ,5?%?\
M98^&GBGQUHO_  C?C;Q)X5TO5?$.D?8YK/\ LK49[2*6YMO(F+2Q>7,SIY<A
M+KMPQ)!->@4 %%%? '_!<[]OK]J;]AS_ (5=_P ,T?!7_A<'_"4?VM_PD?\
MQ2&K^(/[)^S_ &+[+_R#YH_)\WSKG_69W^5\N-K9 /O^BOYFOB#_ ,'B/[8_
MPE\9ZAX;\5?"3X,>&?$6DR^1?:7JWA;6[*]LI, [)89-15T;!!PP!P17V/\
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M-!MY+S7M8\/F[TRUC&7O+JSFCO885']Z22W5![L.E '\X_\ P:G_ +)_A?\
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M+_E*;^TM_P!E5\4?^G>ZK^WROX@_^"L7_*4W]I;_ +*KXH_].]U7]OE !7X
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MX:)_X)VW_P +]4O/.\1?!74C8Q*[;I'TF[+SVK$GD[)!=1 =%2*,=P*^GO\
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MZ?J_F!_X/5O^4IO@'_LE6G?^G?6* /U__P"#7'_E!1\#/^X__P"I!J=??]?
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M<?\ E!1\#/\ N/\ _J0:G7\@5?U^_P#!KC_R@H^!G_<?_P#4@U.@#[_HHHH
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MLE_P3=N/^"5?[=GB#X7QZI<:UH)MH-:\.ZC<*$N+K3Y]P3S0H"^8DD<L3%0
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MHGVC_AV=^T3]EW?:O^%8^)?)QUW_ -E7.W'XXJG_ ,$G?^467[-/_9*O"_\
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M9_W'_P#U(-3K[_H **** "OX@_\ @K%_RE-_:6_[*KXH_P#3O=5_;Y7\0?\
MP5B_Y2F_M+?]E5\4?^G>ZH _M\HHHH **** /G__ (*Q?\HLOVEO^R5>*/\
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MCG_W /\ U'],K^GW_@D[_P HLOV:?^R5>%__ $T6M 'T!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5_(%_P='?\IU_CG_W /_4?TROT?_X+,?\ !K_\??\
M@HE_P4F^)'QB\$^+O@_I?AGQA_9GV.UUO5=1@OXOLVEV=G)YB0V,L8S);N1M
MD;*E2<'('R__ ,05/[4W_0_?L_\ _@\U?_Y64 ?D#7]?O_!KC_R@H^!G_<?_
M /4@U.OR _X@J?VIO^A^_9__ /!YJ_\ \K*/^(*G]J;_ *'[]G__ ,'FK_\
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M/(U+Q?K*H^H3(<%HH%4;;:$D9V)RV%WO(5! !H?\$5/^"86F_P#!*;]A_1?
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MS[XHU2UTB^\:7\/B+PH;B01IJ%XL0ANK52?^6K1QV[HO5A')CD '^B2OP/\
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M7?\ R)0!^_U?B#_PUC\5/^(SG_A5O_"R_B!_PK+_ *%'_A(;O^P?^1&^U?\
M'EYGD?\ 'Q^^^Y_K/G^]S7G_ /PX+_X*G?\ 1ZG_ )E[Q=_\B5Z!_P $N/\
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M;[2[Z&./X@V%I'NDL98U$<>J!1UB9 B38'R,BR'(=V7WG_@U?_X+8^&?C?\
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M +#7_"!?M!^ ?C]I%GMT_P >V?\ PC>OR(ORKJ-HFZVD<_WI;7*#VL:^O/\
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MR?!_P?XFTOS/L>KZ)XLUW3[^T\R-HI/+GATY9$W1NZ':1E78'@D4 ?TO45^
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M8,!D8) /J"BBO@#_ (+G?L"_M3?MQ_\ "KO^&:/C5_PI_P#X1?\ M;_A(_\
MBK]7\/\ ]K?:/L7V7_D'PR>=Y7DW/^LQL\WY<[FP ?@#_P '1W_*=?XY_P#<
M _\ 4?TROZ??^"3O_*++]FG_ +)5X7_]-%K7X0_%+_@T"_;0^./CN^\4^-OC
M)\'_ !AXFU3R_MFKZWXLUW4+^[\N-8H_,GFTYI'VQHB#<3A44#@ 5](?L1?\
M$'?^"A_[-?Q]^$-YKO[4^GW?PM\ >(-&FU#PQ8?$KQ+):S:-9W,)EL(K1[1+
M=HS;QM$L+;8R"%.%Z '[G4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%>?\ [4?[4?@3]B[X$ZY\3/B9KG_"->"?
M#?V?^TM2^Q7%Y]F\^XBMHOW5O')*VZ::-?E0XW9. "1\@?\ $4;^PG_T7+_R
MS/$'_P @T ??]%? '_$4;^PG_P!%R_\ +,\0?_(-.B_X.B?V%9I%5?CHN6.!
MN\'>(%'YFQQ0!]^T5\V_LT_\%@OV8_VOM?M]'^'OQJ\#ZYK5XVVVTR:\.GW]
MTW3$=O<K'*Y]E4FOI*@ HHHH ***^6/VR?\ @M;^S'_P3^^+<?@7XM_%"'PK
MXLET^+5!8)H6IZDR6\C.J,SVEM*B$F-CL9@V,'&&4D ^IZ*Y?X*?&CPQ^T7\
M)/#OCOP7JT.O>$_%EA%J>E7\4;QK=6\JAD;8ZJZ'!P4=592"& (('44 %%%?
M+_[:O_!9C]FS_@G=\4]/\$_&+XD?\(?XFU32H];M;/\ X1_5-0\VSDFFA27S
M+6VEC&9+>9=I8,-F2,$$@'U!17P%%_P=$_L*S2JJ_'-<L0!N\&^(%'XDV.!]
M37WCX<\1:?XO\/6.K:3>VNI:7JEO'=V=W;2B6&ZAD4.DB.N0RLI!!!P00: +
ME%%<_P#%CXI:#\#OA9XF\;>*;[^R_#/@_2KK6]7O/)DG^R6=M"\T\OEQJTC[
M8T9MJ*S'& "<"@#H**^ /^(HW]A/_HN7_EF>(/\ Y!KH/A/_ ,''G[&/QQ^*
M?AGP3X6^,G]J>)O&&JVNB:19_P#"):Y!]KO+F9(8(O,DLEC3=(ZKN=E49R2!
MDT ?;]%<_P#%CXI:#\#OA9XF\;>*;[^R_#/@_2KK6]7O/)DG^R6=M"\T\OEQ
MJTC[8T9MJ*S'& "<"OB#_B*-_83_ .BY?^69X@_^0: /O^BO@#_B*-_83_Z+
ME_Y9GB#_ .0:^O\ ]ES]J/P)^VC\"=#^)GPSUS_A)?!/B3[1_9NI?8KBS^T^
M1<2VTO[JXCCE7;-#(OS(,[<C(() /0**\._;?_X*1?!?_@G#X9T'6/C/XS_X
M0W3?$UU)9Z;-_9%]J/VF6- [KMM(967"D'+  ]C7SC_Q%&_L)_\ 1<O_ "S/
M$'_R#0!]_P!%?*W[''_!;']F/]O[XO-X#^$?Q,_X2SQ6EA+J9L?^$=U6PQ;Q
M,BN_F75K%'P9$XW9.> <&OJF@ HHHH **JZUK=GX;TBYU#4;NUT^PLXVFN+F
MYE6*&!%&69W8@*H')).!7PK^T[_P<N?L=?LOZE/I]U\4H/&VK6Y(>T\'6<FL
M+QZ7*8M2<\8\[/M0!]Z45^26D_\ !YU^R?J.I_9YO#/QNT^+=M^TSZ!8-%C^
M]B.^9\?\!S[5]I_L/?\ !8K]G/\ X*)7@T_X6_$O2=5\0B-I7T&^CDT[5@J\
ML5MYU1I54<EHMZC/)H ^FJ*** "BH[JZCL;62::2.&&%2\DCL%5% R22>  .
M<FOSM_:J_P"#IO\ 9!_9;\676AIXNUSXD:I82&*Y3P7IJZA;Q.#@@7,LD-O)
M]8I''OF@#]%J*_,;X _\'<'['_QN\3V^EZEJWCKX</=.(X[GQ5H:QVNX\#=)
M:2W"QC_:?:HZD@<U^D_@_P 9:1\0_"VGZYH&J:=KFBZM MS97]A<I<VMY$PR
MLD<B$JZD<@J2#0!I4444 %%>*_MI_P#!1+X,?\$]/!$.O?%[Q[H_A&WO-WV*
MUEWW%_J)7J(+6(--)@D LJE5R-Q&:^ =1_X/,_V3;+Q";*/P_P#&J\MM^W[?
M#X?LA;D?WL/>K+C_ (!GVH _6BBOFS]@W_@KG^S_ /\ !26UFC^%'Q T_5M:
MM(O.NM!O8GL-6MD[L;>4*SH,@&2+>@) W9-?2= !117CW[5?_!0/X)_L/Z.+
MSXL?$WPCX)\R,S0VE_?*;^Z0=6AM4W3RCC_EFC4 >PT5^4_Q&_X/&?V0_!&L
M/:Z9;_%GQA"K8%WI'AR&*%QZ@7ES ^/J@/M73_ W_@[5_8Y^,FNP:?J'B+QE
M\/Y+EQ''+XFT!D@W'INDM7N%0?[3D*.Y YH _3&BL3X<_$KP[\8/!&F^)O">
MN:3XE\.ZQ")['4],NTNK2[C/1HY$)5AVX/45MT %%%% !17G_P"U'^U'X$_8
MN^!.N?$SXF:Y_P (UX)\-_9_[2U+[%<7GV;S[B*VB_=6\<DK;IIHU^5#C=DX
M )'R!_Q%&_L)_P#1<O\ RS/$'_R#0!]_T5\ ?\11O["?_1<O_+,\0?\ R#1_
MQ%&_L)_]%R_\LSQ!_P#(- 'W_17P!_Q%&_L)_P#1<O\ RS/$'_R#1_Q%&_L)
M_P#1<O\ RS/$'_R#0!]_T5X_^Q5^WK\)_P#@HC\+-0\;?!WQ7_PF'AG2]5DT
M2ZO/[,O-/\J\CAAF>+R[J**0XCN(6W!2IWX!R"![!0 445\8'_@X5_8['Q]_
MX5C_ ,+FL_\ A-/[?_X1C[)_PC^K?9_[0^T?9O+^U?9?LVSS>/-\SRL?-OV_
M-0!]GT444 %%%% !17Q=^V9_P<$?LI?L->)[SP]XL^)MIJ_BK3W:*YT7PW;2
M:O=6TB\-'*T0,,,@/!2616![=:^88_\ @\^_90?5%MSX7^."PL<&Y.@:?Y2_
M@+_?_P".T ?K?17Q+^S)_P '$_['W[5-Y#8Z/\8M$\-ZM,0!8>*XI-"?<>BB
M6X58'8] $E8Y_"OM33]1M]7L(;JUGANK6Y02PS1.'CE0C(96'!!'((ZT 344
M5\ ?\11O["?_ $7+_P LSQ!_\@T ??\ 17R!^R__ ,%[/V2_VS/C;H_PY^''
MQ<M]>\9>(/-&G:?+X>U;3_M1CB:5U66ZM8XMP1&(4ODXP 3Q7U_0 4444 %%
M!;:,G@#J:^"]=_X.=/V&_#FN7FGW7QTMS<V$[VTOD>$]=N(MZ,5;;)'9,CKD
M'#(Q4CD$@@T ?>E%?('[+G_!>K]D_P#;1^.VA_#/X9_%;_A)?&WB3[1_9NF_
M\(SK%G]I\BWEN9?WMQ:1Q+MAAD;YG&=N!DD _7] !1110 45\8'_ (.%?V.Q
M\??^%8_\+FL_^$T_M_\ X1C[)_PC^K?9_P"T/M'V;R_M7V7[-L\WCS?,\K'S
M;]OS5]GT %%%% !17Q!\6/\ @X\_8Q^!WQ3\3>"?%/QD_LOQ-X/U6ZT35[/_
M (1+7)_LEY;3/#/%YD=DT;[9$9=R,RG&02,&M7]G;_@X(_9 _:L^,V@_#[P+
M\9+/5?%WB:<VNEV5SX?U;35NYMI81B:ZM8X@[8(52X+L0J@L0" ?95%%% !1
M7C_[:O[>OPG_ ."=WPLT_P ;?&+Q7_PA_AG5-5CT2UO/[,O-0\V\DAFF2+R[
M6*609CMYFW%0HV8)R0#\P?\ $4;^PG_T7+_RS/$'_P @T ??]%?+_P"Q5_P6
M8_9L_P""B/Q3U#P3\'?B1_PF'B;2]*DUNZL_^$?U33_*LXYH87E\RZMHHSB2
MXA7:&+'?D# )'U!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >?_M1_LN>!
M/VTO@3KGPS^)FA_\))X)\2_9_P"TM-^VW%G]I\BXBN8OWMO)'*NV:&-OE<9V
MX.02#_.#_P '6O\ P2X^!/\ P37_ .%"_P#"E/ O_"%_\)I_PD/]L_\ $ZU#
M4OMGV7^R_(_X^YY=FW[1-]S;G?SG"X_I^K\ ?^#YS_FUW_N:_P#W"T <_P#\
M&O\ _P $9OV;/^"B7[ OB[QM\8OAO_PF'B;2_B!>:):WG_"0:II_E6<>G:;,
MD7EVMS%&<27$S;BI8[\$X  _0[Q1_P &JW[#NOZ5);VOPEU+0YI%PMU9>,-9
M>6,^H$UU(F?JI%>(_P#!E3_RBR\??]E5U'_TT:/7Z_4 ?R._\' ?_!"]O^"/
MOQ&\+ZYX/U_5/$GPO\<230Z9<:B$_M'1[R$*S6T[QJJ2;D8/'(JH3MD!4% S
M_JO_ ,&DO_!6#Q=^V5\'/%WP=^).M7?B+Q5\,8+>^T75KV8RWE_I,C&,Q3.<
MM(UO($ D8DE)T4_<R>?_ .#VOXH:)IW[$_PC\%RW$/\ PD>L>-SK=M!N'F?9
M+6PN89FQUV^9>0#/<_2OEO\ X,D_A9K6I?MI_%WQM'#-_P ([HW@E=#N9MI\
MLW5W?6TT*YZ%O+LISCL#[T ?TGT444 4_$?B&Q\(^'K[5M4NH;'3=+MY+N[N
M9FVQV\,:EW=CV55!)/H*_B?_ ."C?QR\7_\ !0O]IGXO?M&S:7J4G@_5O%D6
MEPWLB?NM.CDBG&FV;'_GI]CL6SCC,;$XW#/]('_!U7^W+_PR+_P2VUSPSIEY
M]G\5?&:X_P"$3LU1L2)9,N_4),=U, \@^ANUKQW]C'_@B!%XH_X-E-4^%=YI
M<<?Q'^+&E/\ $.-I$"RP:NRI<:9$2>4Q!#;0N/X?-GX^8B@"E_P9G_MR_P#"
MW/V.O%GP/U>\\S6/A3J/]HZ0CM\SZ5?.SE5'4^5="8L>@%S&*_9NOXU?^"!G
M[;<G_!/?_@JA\/O$6J7$FF^'->NSX1\3K+F-8K.\=8R\F>BP3B"9N_[@BO[*
MJ "OE_\ ;5_X(S?LV?\ !1+XIZ?XV^,7PW_X3#Q-I>E1Z):WG_"0:II_E6<<
MTTR1>7:W,49Q)<3-N*ECOP3@ #Z@HH _AU_;K_9\M_AM^W1^T3X5\"Z!>0^#
M_A=XSUVTC@A:6Z71=+M]8:PMS))(6<HK26T6^1B2TB9)+9/["_\ !IC_ ,%L
M/LDUC^RK\4-6_=2LQ^'>J7<GW&.6?2'8]CR\&>^^('F)*R/^"+OPO\/_ !L_
MX.4_V\/"'BO2;/7/#7B6Q\?:=J>GW2;H;NWE\662.C#W!/(P0>000#7YV_\
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M9G/>OB__ (,Q_@5;> ?^":GBSQLT"KJ?Q \97 ,^,%[2S@BAA0^NV9KL_P#
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MXNTU)KNT5]QTV]0F.ZMF/7,4R2)D_> #="*_G!_:(_X)M_\ "ZO^#93]F_\
M:&\-Z?YGB3X7_P!NZ7XB\I,R76BS>)=3V2'')^SW#YP.B7,K$X2O8/\ @S=_
MX*2_\*L^.WB+]F_Q-J'EZ'\0M^M^%O-?Y;?5H8O](@7/3S[>,-_O6H &9* /
MZ1***,T ?G9_P<T_\%'_ /A@+_@G#K.EZ'?_ &7X@?%OS?"^A>6^V:U@=/\
M3KM>X\N!M@8'*R7$)[5_(]JFEW.AZG<65Y;S6EY9RM!/!,A22&1259&4\A@0
M00>017[>>-I&_P"#D'_@XYM]%A9M4^ GP39DE93NM;O3+&8><WHWV^\8(",,
M8&4_\LJ_+G_@J[$L/_!4G]I1$541/BIXH5548"@:O=<"@#^K_P#9<_X(*_LG
M_L6_';0_B9\,_A3_ ,(WXV\-?:/[-U+_ (2;6+S[-Y]O+;2_NKB[DB;=#-(O
MS(<;LC! (^OZ** "OF/_ (+'?MNQ_P#!/;_@G'\3?B5#<K;Z_9Z8VF^'03\S
MZI=?N+8@?Q>6[^:P_N0O7TY7X%?\'7GQKUS]M#]M_P" _P"QKX#N/M&H7>HV
MNI:K&I+1IJ-^_P!GLQ*!]WR+=IIF/0)= Y&#0!^#GC3X>>*/AY9^&]:US3]2
MTV/QC8'7M&NI\JVH6PN9[?[0ASG'GVTRY/)*9Z$$_P!G7_!&W]MY/^"A/_!.
M'X9?$F>Y6X\076FC3/$0!^9-4M?W%R6'\/F,GG*/[DR5^;O_  =5?\$K]#\)
M?\$NOA3XJ\!Z9Y<7[-\-KX9EV(/,?0YEBM@\A'+,ERENV3_S\3,3R<^(_P#!
MEC^W+_PB'QC^(?[/NL7FVQ\7VW_"5^'HW;"B^MU6.[C4=VEM_*?V6S:@#^BZ
MBBB@#\P?^"L7_!!7]D__ (98_:6^-?\ PJG_ (N;_P (KXH\;?VS_P )-K'_
M "&/LEU>_:?(^U^1_P ?'S^7Y?E_P[-ORU_*[I^C>(?"&C:/XQM(=4TVR;4I
M;?3-7AWQ*+VU6":18I1C$L0N+=S@Y7S4/<5_;!_P5B_Y19?M+?\ 9*O%'_IH
MNJ_'#_@W^_X)L^$?^"IG_!OM\6OAKXF6*RU+_A:FHWWAS6O*WRZ%J2:-I BG
M'<H<E)$_BC=@"&VL #] /^#=_P#X++V?_!4[]EX:/XIO+>+XS?#VWBMO$EOP
MC:Q!]V+4XE'&V3&V4+PDN>%62,']#Z_B9^$WQ,^,G_!#_P#X*+_;OLLOA_XB
M?"_56L=5TR9F^RZK;G'F6[D?ZRVN(B&5QU5XY%((5A_8/^PC^VSX*_X*%_LN
M^%_BKX#N_.T?Q%!F>UD8&XTF[7 GM)P/NRQOD'LPVLN5920!/VU?V"OA/_P4
M2^%FG^"?C%X4_P"$P\,Z7JL>MVMG_:=YI_E7D<,T*2^9:RQ2'$=Q,NTL5._)
M&0"/YX?^"N__  2X^!/[+_\ P7T_9@^"G@7P+_8?PR^(G_"*?\)#HW]M:A=?
MVA]M\17=E<_OYIWGCWV\2)^[D7;MW+M8EC_3]7X _P#!?3_E::_8K_[D;_U+
MKZ@#]7OV*O\ @C-^S9_P3M^*>H>-O@[\-_\ A#_$VJ:5)HEU>?\ "0:IJ'FV
M<DT,SQ>7=7,L8S);PMN"AALP#@D'Z@HHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "OP!_X/G/^;7?^YK_ /<+7[_5^ /_  ?.?\VN_P#<U_\ N%H ^0/^
M"*G_  4Y_;0_8N_98U_PM^SG^SW_ ,+8\$W_ (KN-5OM7_X037=>^S:B]I9Q
M26WGV,\<2[88;=_+8%QYN2<,H'U/XW_X+U?\%3KK09E'[)=WX;RI'VVW^$/B
M7?#[C[1/)'^:D5],?\&5/_*++Q]_V574?_31H]?K]0!_&=>_$O3_ -O[]L.;
M6OVX/C?\3/ NN*Z6MW._@DWILK8'<+>.&.2,V: LQ"QVKJ"Q;:Q8U_4C_P $
MAO@]^SG\$_V,]&TK]F/5M$\1?#^25I[C6+.^6]N]4O2J^9+>R !A<[0@:-E0
MQ@*H1% 4<_\ \%I?^"8'@G_@I7^QEXNTG5-!T^3Q]H6DW-]X1UU8%%]I][%&
MTD<0E^]Y$K*$DC)*D-NQN56'\Q?_  0X_P""EWBC_@FM^W=X1UJSU2YC\"^*
M=1MM&\8Z6TA^RWMC+($,Y3IYT&_S488;Y67.UW! /[-***\;_P""A7[7&F_L
M(_L4_$CXM:GY++X+T6:[M(93A;N];$5I ?\ KI</$GMOS0!^(/\ P4XGD_X+
M;?\ !RSX!^ -D[:A\./@_.NFZT(SF'9;XO-9<G^!G*)99_OPIZ\_T0001VL"
M11(L<<:A411M50.  .P%?S(_\&S/_!0[]FO]B/QK\8/B]^T)\5/[&^*GCNZ&
MG6:3>']4U&X-H[_:KNY:6UM98\W%P8AM+!@;4DC# G]<?^(HW]A/_HN7_EF>
M(/\ Y!H _ +_ (.7OV&O^&)/^"JWC7^SK/[+X4^)N/&FC;%Q&GVIW^U1#' V
M7:SX4?=1H^ "*_HX_P""#7[<O_#P#_@F!\-_&-]>?;/%&BVG_",^)69MTAU"
MR"Q-(Y_O31>3<'_KX%?D?_P<[?\ !2/]D+_@IQ^RWX/U#X6_%2'Q!\4OA]K)
M:RLV\,ZQ9-?:==*$NHA+<6D<0*O';RC>XXCD RS 'G?^#,?]N7_A5O[6/C+X
M%:O>;-)^)UA_:^B1NWRIJEDC-(B#UEM#(S'_ *=$% ']*U%%% 'X _\ ! O_
M )6FOVU/^YY_]2ZQK];/^"K'_!-;PC_P5-_9#USX:^)!#8ZI@WWAO6O*WRZ%
MJ2*1%,.YC.2DB?Q1NP&&VL/R3_X(%_\ *TU^VI_W//\ ZEUC7[_4 ?Q-_!SX
MJ?&/_@AY_P %&/MWV2;0/B%\,=5>PUC2IW/V75K8X\VWD(_UEM<1%65QU#1R
M(00K#^PC]A?]M/P5_P %!?V8/"_Q4\!WGVC1/$=ONEMI&'VC2[I>)K2<#[LL
M3Y4]B,,N592?S]_X.>?^")X_;[^!;?%[X<Z3YOQB^'=BQFM;:/,OBK2TR[VV
M!RUQ#EGBQRP+QX)9-OXZ_P#!NW_P67O/^"67[4/]A^++RX?X,_$*YCMO$=N<
MNNBW'"1:G&G7,?"RA>7B[,T<8 !^M7_!ZM_RBR\ _P#95=._]-&L5]_?\$G?
M^467[-/_ &2KPO\ ^FBUK\^/^#S_ %>U\0?\$G/AO?V%U;WUC??$_3+BWN()
M!)%<1OH^L,KHRY#*RD$$'!!S7Z#_ /!)W_E%E^S3_P!DJ\+_ /IHM: /H"OR
M!_X/5O\ E%EX!_[*KIW_ *:-8K]?J_('_@]6_P"467@'_LJNG?\ IHUB@#\,
M_P#@GC_P5V^(7_!,KX!_&GPS\,8[?3?%/Q@_LBW'B1FW3:!;V8OQ(;>,C'GR
M?;%"R,2(PC$*6*LGZ3?\&A_[/_[._P =OB?XF^(7C37)O&7[2NAWLFHV>D>(
M &2PMV8$ZI:[V8W=P9&.^9OGA8KA5++*_C7_  ;,_P#!,?X;_P#!4_\ 9S_:
ML\!^/K/R+RW_ .$7N- U^VC4W_AZ[*ZT!-$3]Y&PHDB)VR* #@A67XL_:K_9
M3^.?_!#[]N"SL;^ZU#PIXR\+W0U3PQXGTIF6UU: ,0ES;.1AXV&5>)P<9:.1
M>2" ?VN45^=__!"'_@O-X5_X*O\ PS3PWXB;3_#/QO\ #MJ'U?15;9#K,2X!
MOK(,<F,G&^+):(GNI5C^B% !1110 4444 %>#_\ !3?X[_$_]F?]AOQWXX^#
M/@W_ (6!\2M"CLVT7P__ &3=ZM_:#27MO#*/LUJZ3R;89)7^1AC9N.5!%>\4
M4 ?S+_M?_P#!?'_@II#X O?^$@^%NN? _2VC*W&J67PRU'3VA0CDB;4/.$9Q
MGYE*L.H(/-8__!$#X!_L+_M*?M#6/BGX^_'#Q)XY^+&K7XOH_#GCS3CI&EZG
M?,VXFXNVFN$OG:3HDD\7FEMIBD!(K^G]E#J58!E88(/>OY^O^#M__@CIX%^%
M7PQT_P#:3^&?A_3_  O=-JT6E>,]-TV 06=W]HW>3J C4!8Y?- CD*X$AF1B
M-P9F /Z [:VCLK>.&&-(885"(B+M5% P  .  .U>)_\ !337Y?"O_!-W]H+5
M(&*S:;\-?$=U&PZADTNY8'\Q7YO?\&B'_!4;Q+^UC\!?%7P5\?:M<ZUXB^%,
M-O=:%J%W*9+FZT>4M'Y#L26<VTBJH8_P3Q+_  5^FG_!0'P5-\2?V#?C;X=M
MT:2XU_P#KNFQ*.K--IT\8'YM0!_*G_P;&Z3'K7_!<OX$PR*&5+C6)QG^]'HF
MH2+^JBO["*_CI_X-K/$\?A'_ (+>? 6ZF8*LVHZC9 G^]<:3>P*/Q:0#\:_L
M6H *_EU_X/0M)CT[_@JWX2F10&O_ (9:;.YQU(U'5(_Y1BOZBJ_EG_X/+?$\
M>O\ _!6G1;6-@S:'\.],LI /X6:\OY\?]\SJ?QH _:K_ (-FM?E\2?\ !#KX
M#W$S%GCM-5M03_=AUF_A4?@J 5^0'_!Z_K\MQ_P4B^&FELQ\FS^&MM=(O8-+
MJFI*Q_*%?RK]D?\ @W%\%3> ?^")WP#L9T9'N-'N]2 /=;K4;NZ4_BLP/XU^
M0/\ P>T^"IK#]O+X2^(F1A;ZKX!_LU&[%K;4;J1A^ NE_.@#]4/^#5_28]._
MX(:?!V9% :_N-=GD]V&MW\?\HQ7Z%5^<_P#P:E>)X]>_X(A_"^UC8,VB:CKE
ME(!_"S:M=3X_[YG4_C7Z,4 ?.?\ P5_TF/6O^"4G[24,BAE3X9>(9P".\>G3
MR#]5%?S/_P#!JMK\NC_\%Q?A);QL535;37;64#^)1HU[-C_OJ)3^%?TI?\%G
M_$\?A'_@DM^T==3,%6;X=ZU9 G^]<6<D"C\6D _&OYO_ /@TZ\%3>*O^"V/P
M]OHT9D\-Z/K>I2D?P*VG3VN3_P "N5'XT ?UM4444 ?CW_P5N_X*V?M[?LN_
MMI>-/ _P1_9SE\9_#/1X;%M+\41_#K7=7-RTMC!+/_I-O,+9_+GDD3Y4^79M
M;)!S^07[2G[??Q4_X*%_'73_  G^VW\5OB9\+_".GW"7,>C:=X& MK)LE2[V
M'FV[;@-P69UG==S #'RG^P&O(OVT_P!A?X8?\% ?@MJ/@7XH^%]/\0:5>1.M
MM<M$HOM(E88%Q:S8+0RJ<$%>#C#!E)4@'SY_P0H_9Z_9-^"7[+DEQ^RQKVE>
M-=/U1X_[?\227 FUR_G4'8EZK(DEOM!8I 8XU4,6"99F;[@K^-GX4?&[XE?\
M&]W_  5I\16&D:I=79^'OB*31=>LD8QVWBS2!(#MDC)Q^]@9)8RV3&[(PY7G
M^Q+P-XST[XC>"M'\0Z/<+=:3KUC#J-E.O2:":-9(V'U5@?QH U**** "BBB@
M K^(/_@K%_RE-_:6_P"RJ^*/_3O=5_;Y7\0?_!6+_E*;^TM_V57Q1_Z=[J@#
M^WRBBB@ K'^(/CS2?A9X"USQ/KUY'I^A^'-/GU34;J3[EM;01M++(?945B?I
M6Q7Y6_\ !W'^W+_PS%_P36_X5YI=Y]G\3?&R_P#[%54;;(FEP;)KYQ[-F" C
MNMTWI0!\B_\ !MOX#U;_ (*=_P#!8?XX?MC>,+.0V>@75P=%2?YA;7M^&AMX
M4;HPM=.1HO4>;$<U^[7[1'P-T/\ ::^ WC'X=^)8?/T'QMH]UHM\H ++%/$T
M99<]'7=N4]0R@]17XW_\$)?^"PG[#_\ P34_X)N^"_ .O?&2&Q\<:DTOB#Q8
MD?A'79MFI7)!:(O'9,CF&%((-R,RMY&02"#7V'_Q%&_L)_\ 1<O_ "S/$'_R
M#0!_,3\*/&?C+_@D3_P4TTW4KJ&2/Q9\$/&CV^H6\9V"^2WG:&YB4G_EG/!Y
MB ]TER#SFO[7/AUX_P!)^*_P^T+Q3H%Y'J&A>)-/M]5TZZC^Y<VT\:RQ2#V9
M&4_C7\DG_!R1\?\ ]GW]KS]N^W^+'P!\;P^+;7QEHT*^)XET74--:UU&V A6
M7%U!#N$MN(1\F[#0N6QN&?V>_P"#1?\ ;E_X::_X)MO\.=4O/M'B;X)W_P#9
M&UVW2/I=QOFLG/LI%Q !V6V7UH _5:OB+_@NS_P2 T__ (*[_LJV^@V-]9Z'
M\1O!L\FI>$]4N@?LXD=0LUI.5!80SA$RR@E'CC;#!2C?;M% '\0GQ1^!_P"T
M5_P2&_:,MVUK3_'7P>\=:5(_V#5;.:2U6[0'#-;741\NXA;H=C,A&0PZBOOO
M]D;_ (/)_P!H;X,V]II_Q0\,^$?B]IL "O=LG]AZO(!QS- K6YX];?)/4FOZ
M8?B7\*O"_P :/"%SX?\ &/AO0?%F@W@Q<:;K&GQ7UI-_O12JR-U[BOST_:M_
MX-1?V1?VD%NKK0_#.N?"G6KC+"Z\)ZBT=OO[9M+@2PA?58ECR.X/- &=^Q?_
M ,'9/[+/[4FH6>D>*M1UOX-^(+IA&$\40J=+>0]EOH2T:*/[\XA''TS^F.A:
M[8^*-%M-2TR\M=1TZ_A6XM;JUE6:&YC8!E='4E64@@@@D$&OY2?^"KO_  :Z
M_&#_ ()S^ =6^(7AC6;'XL?#/14-QJ-[96K6>JZ- .LUQ:%G!B7/S212/@ L
MRHH)'H'_  :C?\%:/%W[/_[8'A_]GWQ)K-WJ7PP^)4TEGI=I=2F1?#^JE&DB
M>#/*1SLIB>,?*7D1^"&W ']0%? '_!T=_P H*/CG_P!P#_U(-,K[_KX _P"#
MH[_E!1\<_P#N ?\ J0:90!B_\&W/P\T7XN?\&\WPI\*^(]/@U7P_XET_Q-I>
MI64PS'=VTVNZI'+&WLR,P_&OYM/VUOV</&W_  1X_P""EFM>&-/O[RQU[X8^
M(8=8\+ZQMPUU;*ZW%A=C^$EDV;P,@.)$/0U_3+_P:X_\H*/@9_W'_P#U(-3K
MYA_X/$/^";?_  O+]F'1/V@O#>G^;XF^%6-/\0>4F9+O1)I/E<]S]FN'W8'
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M_P!E5T[_ --&L5^GW[6/QT_X9?\ V6/B7\3/[+_MS_A7?A75/$_]F_:?LO\
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M_A8GBO5/$_\ 9OVG[5_9_P!MNY;GR/-V)YFSS=N_8N[;G:N<  _N\HK\@?\
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MRYFE=7=BPR8DXX)(!^__ /Q"X_L)_P#1#?\ R\_$'_R=1_Q"X_L)_P#1#?\
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MA\FPUJ/-_P"&=;,>Z30]252(Y?4Q-DI(@^\C-C#!67^4_P#8F_9]\6?LJ?\
M!;SX'_#OQUI,VA^+/"/QC\-6&HVDG\+KJ]J0Z-T>-U*NCCAT=6&00: /[2**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@#B?C=^S1\./VF='LM/\ B1\/_!/Q!T_39C<6
MEMXET*UU:&UE*[3)&EPCA&*\9 !QQ73>$_">E^ O"NFZ%H6F:?HNB:+:16&G
MZ?86Z6UK86\2!(H8HD 2.-$555% "@   "M"B@ HHHH **** "BBB@ HHHH
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MOO$%A;^)]3L-4MWNM.TM[F-;N>)1KLI,D<!D90(Y"2H^1ONG]3J** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **\_P#VH_VH_ G[%WP)
MUSXF?$S7/^$:\$^&_L_]I:E]BN+S[-Y]Q%;1?NK>.25MTTT:_*AQNR< $CY
M_P"(HW]A/_HN7_EF>(/_ )!H ^_Z*^ /^(HW]A/_ *+E_P"69X@_^0:T?#__
M  <S?L.^)KM8;?X\:?&[' -WX;UFT3\6ELU4?B: /NZBO*_V>/VY?@U^UI$3
M\,_BEX#\<RJF^2VT?6K>ZNH1U^>%6\Q/^!**]4H ***\?_;5_;U^$_\ P3N^
M%FG^-OC%XK_X0_PSJFJQZ):WG]F7FH>;>20S3)%Y=K%+(,QV\S;BH4;,$Y(!
M /8**^ /^(HW]A/_ *+E_P"69X@_^0:/^(HW]A/_ *+E_P"69X@_^0: /O\
MHKX#MO\ @Z%_85NYUC7XZ1JS' +^#]?1?Q+6( _&OH3]ES_@J!^SW^VGJ"V/
MPO\ B]X)\6:JZ&1=+@OQ!J3*.K"UFV3X'<[,#O0![Q1110 45\0?%C_@X\_8
MQ^!WQ3\3>"?%/QD_LOQ-X/U6ZT35[/\ X1+7)_LEY;3/#/%YD=DT;[9$9=R,
MRG&02,&N?_XBC?V$_P#HN7_EF>(/_D&@#[_HKY?_ &</^"S'[-G[6_PL^)WC
M;X>_$C_A(/#/P;TH:WXPO/\ A']4M/[(LS#<S"7RY[9))OW=G<-MA5V_=XQE
ME!\@_P"(HW]A/_HN7_EF>(/_ )!H ^_Z*^ /^(HW]A/_ *+E_P"69X@_^0:^
MU_@K\9?#?[1'PD\-^.O!VI?VQX5\7:?#JNDWWV>6W^UVTJAXY/+E59$RI!VN
MJL.X% '4445XA^V]_P %'?@S_P $X_"FAZY\9O&7_"&Z7XDNWL=.F_LF^U'[
M1,B;V7;:0RLN%YRP ]\T >WT5\ ?\11O["?_ $7+_P LSQ!_\@UZ_P"#?^"S
M'[-GQ _8V\6?M Z1\2/MGPB\#ZK'HFMZ]_PC^J1_8KQVM$6+[,UL+E\M?6HW
M)$R_O>ORMM /J"BO@#_B*-_83_Z+E_Y9GB#_ .0:/^(HW]A/_HN7_EF>(/\
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M (BC?V$_^BY?^69X@_\ D&@#[_HKX _XBC?V$_\ HN7_ )9GB#_Y!KH/A/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#_P1Z1_\LZ /U^HK\@?^(U;]EG_H0?V@/_!'I'_RSH_XC5OV6?\ H0?V@/\
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MYX4$82UD!(<G)7Y2"2 #Z0HK\@?^(U;]EG_H0?V@/_!'I'_RSKZ/_P""7_\
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M;@9^0/\ B-6_99_Z$']H#_P1Z1_\LZ /U^HK\X?V"/\ @Y^^ ?\ P44_:O\
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MTM_%>GV5I:ZE,@W&VB>"[G/G,NYE5E4,$(!W%58 _1&BBB@ HKY _P""K?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >?_ +4?
M[+G@3]M+X$ZY\,_B9H?_  DG@GQ+]G_M+3?MMQ9_:?(N(KF+][;R1RKMFAC;
MY7&=N#D$@_S@_P#!UK_P2X^!/_!-?_A0O_"E/ O_  A?_":?\)#_ &S_ ,3K
M4-2^V?9?[+\C_C[GEV;?M$WW-N=_.<+C^GZOP!_X/G/^;7?^YK_]PM '/_\
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M_@E3XNLM-O/LWBKXK./!FE;&Q(D5PC&]E ZX6U69-P^Z\T?J* /QY_X(B_\
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M9I_@GXQ>%/\ A,/#.EZK'K=K9_VG>:?Y5Y'#-"DOF6LL4AQ'<3+M+%3OR1D
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M>VW[B&=()-EQ*[_O(VW;MK;E 4 'T!117F?[97[36C_L9_LJ_$#XIZ\5;3?
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M7[+WC;X#:O>;]4^&]]_;FA1NWS-IEZY,T:#TBN]SD^MZHH _:^BBB@#\0?\
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MJYC\0:CIEE\\EYJ%R6MM.M\<894-PY#<;;B-C@#-?G%_P;N_MPM^P7_P54\
MZMJ5TUCX7\:3'P;XBWML1+>\=%CD?/"K%=+;RL3T6-QWK]!O^#>CPCJ7_!5S
M_@MU\:OVOO%5G,VC>$[B:;1([@;OL]U>*]K8PC/#?9M.BD4X^ZQB;C(KX!_X
M.-OV'#^PI_P55\>6&G6AL_"OCR0>,] V+MC2&\=VFB7'"B*Z6X15'1%3ID4
M?V(45\G_ /!$3]N,?\%!_P#@FA\-/'UW=_:O$T%@-"\2DMND&IV>(9G?T,H"
M3@?W9UKZPH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<[1C]OO^'3O[+/\ T;3^S_\ ^&\TC_Y'K\@?^#&/_FZ+_N5/_<U7[_4 ?/\
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M7(R1&HSA1C^JZOY@?^#U;_E*;X!_[)5IW_IWUB@#](/^#</_ ()[? +XX_\
M!&/X-^*?&WP/^#_C#Q-JG]M_;-7UOP;IVH7]WY>N:A%'YD\T+2/MC1$&XG"H
MH'  K[>_X=._LL_]&T_L_P#_ (;S2/\ Y'KP#_@UQ_Y04? S_N/_ /J0:G7W
M_0!\_P#_  Z=_99_Z-I_9_\ _#>:1_\ (]?CC_P;O^$]+\!?\'./[86A:%IF
MGZ+HFBVGC2PT_3["W2VM;"WB\5V"10Q1( D<:(JJJ* %    %?H?_P /SO\
MC>O_ ,,4_P#"KO\ N<O^$D_ZE_\ MG_CQ^R_]L?^/C_;_P!BOO\ H *^(/\
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M^)-&MM5M8;A=4TI%F6*='19 DDBAP,@2,,X8Y_I^^"G[/?@']FOPK<:%\.?
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M ()M_MAV/[?'[#/PT^+-DT(E\7:-%+J,,7W;74(\PWD(]DN(Y5&>H />O<*
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M\":+#IOP@^*DTD]A;6< CM?#VI@;KBP55&V.-A^]A4  (9$48AS7]7M>(_\
M!1+]AGPK_P %&_V0O%_PG\6(L=KX@MMUA?B,/+H]_'\UO=Q_[4<F,@$;T+H3
MAS0!^6/_  :+_M _ _\ :&^%H\)ZA\+?A3HO[07P?A=[+Q-:>%K"UUO6M(E#
M0_:A=)$)FFC$IMYFW9=)(BQ8R/7[>5_$I\+OB!\5O^"*/_!2**_:U;2?B%\(
M=>>TU+3W=A;ZG"/EF@8X^>WN8&^5P.4E1UP=I']D?[(G[5'A+]MC]FSPA\4O
M!%Y]L\-^,-/2]M]Q'F6K\K+;R@<++%(KQN.S(W4<T >(_P#!8KQ7^SS^SU^R
MAKWQC^.WPO\ AO\ $=O!EF]KH%KXE\/66IW-Y>3']S96[7$;E/-D"EMOW41W
M((0U^2O_  ;&_P#!(+1?VV?'WC+]J;XU?#_P=J'@W5KZ\M?"?A270+9=!O+B
M1V%S<I8E/(%M;Y,$*!2@?S" &A4UD?\ !1?XO>(_^#E/_@LCX9_9V^&>J7"_
M!'X7W<QU'6+4[[=TB94U'5O[K]K:VSE6+*P($S8_H2^#7P@\._L__"CP[X(\
M(Z7;Z+X9\*Z?#IFF64(^6W@B0(HSU)P,ECDL22222: *GP4_9[\ _LU^%;C0
MOASX'\'^ -$N[MK^?3_#>C6VE6LUPR(C3-% B(TA2.-2Y&2(U&<*,?S8_P#!
MZM_RE-\ _P#9*M._].^L5_3]7\P/_!ZM_P I3? /_9*M._\ 3OK% ']/U?EA
M_P '9O\ P4*\0_L8?L!:5X/\&ZE<:/XH^,NHS:,]];N8Y[72X8@][Y;#E7?S
M((B1T2:3!!P:_4^OPK_X/A/A=J6L?!/]G_QI##(VE>'M:UC1[J0 [8Y;V"TE
MB![<K838SZ4 ?.?_  :>_P#!'#X>_MOZAXR^,WQ9T.U\6^&?!&IQ:'H>@WJ^
M987FH>4L\TUS'TE6*.2 +&V48RL6!V@5_2+X6^&GAOP-X>CTC1/#^B:/I,2"
M-+*QL8K>W1?01HH4#VQ7X%?\&:W_  4>\"?"SPWXZ_9[\7ZYI_AW7/$NOKXF
M\,27TZPQ:O-+;PVUQ:H[$+YP%M R)G+AGQRN#_0A0!\!?\%?/^"!?P?_ ."B
M?P'\13^'_!OAOP=\8+2TDN= \1:59QV,EW=*I9+>\\L*LT,A 0M(&:/=N4C!
M#?D+_P &7>FW&C?\%7OB-9W<,EO=6OPNU.&:*1=KQ.NL:.&5AV((((K^G>OC
M7]B7_@AS\(_V"/VW?B%\>O!.M>/KGQ5\2(-2MM0TW5+ZTETFSCOK^&^E%O''
M;1RKMD@14WROA"0=QPP /LJBBB@ HHHH _*'_@X\_P"">WP"^!W_  1C^,GB
MGP3\#_@_X/\ $VE_V)]CU?1/!NG:??VGF:YI\4GESPPK(FZ-W0[2,J[ \$BO
MYG=2^&GCS]GW0OAO\1OL^J>'[3Q?%+KOA'6[:0QF5K*_EM7DBD4Y26&YMFR,
MAES&W =2?ZP?^#H[_E!1\<_^X!_ZD&F5\M?\$[/^"7WA;_@JW_P:U?"+X?ZQ
M]GT[Q-8_\)#J/A37'CW/HVHKKVIA22.3#(/W<J#.5.0-Z(0 ?6'_  0$_P""
MQ&F_\%7?V48SK=Q:6OQ>\"QQ6/BVP3$?VS(Q%J,2#_EE/M.X 8CD#K@+L+?>
ME?Q/_LR?M!_%W_@B'_P41&KKI]UH?C?X=ZE)I'B/0;IRD.JVNX">TE(R&BE0
M*Z2#(SY4J9PIK^Q#]C3]KSP7^W9^S9X6^*7@'4/M_ASQ3:B=%; GL9A\LMM,
MH)VS12!D89(RN02I!(!H?'3]D[X6?M0?V7_PLSX:?#_XB?V'YO\ 9O\ PD_A
MZTU?^S_-V>;Y/VB-_+W^5'NVXW>6F<[1C\ ?^&3OA9_Q&<_\*M_X5I\/_P#A
M67_0H_\ "/6G]@_\B-]J_P"/+R_(_P"/C]]]S_6?/][FOZ/J_ '_ )WKO\_]
M$^H _;[X%_LG?"S]E_\ M3_A6?PT^'_P[_MSRO[2_P"$8\/6FD?VAY6_RO.^
MSQIYFSS9-N[.WS'QC<<^@444 %?SV_\ !U5\7/%/[?O_  48^#?['GPS5=2U
M;2WCO+VU\W9$=6OU!B\X\[5M[(>:6QPEU(><5^]WQB^*VB_ GX2^)O&WB2Z%
MCX?\(Z5<ZSJ5P?\ EC;V\32R-[D*AP.YK\(_^#7#X4ZU^W__ ,%*?CM^V9XX
MM6DFM[ZYM='\SYT@U#4"6D6)O2UL=L ']RZ7TH _+W_@BY^V7>?\$U_^"H_P
M_P#%VM//I.CPZHWAKQ;#.#'Y-A<M]GN/-4\_N'VS;?[UN*_M"5@ZAE.5/(([
MU_)#_P '2?[#7_#'7_!5#Q)K6FV?V?PK\7X?^$PT\HN(TNI6*W\6>F[[2KRX
M'1;F.OW\_P"#=K]N7_AN_P#X)7_#_6+^\^U^*O!,1\'>(2S;I&N;)$6*5SU+
M2VS6\K'NTC>E 'W%7/\ Q2^$_A7XX^!+[PMXV\,^'_&'AG5/+^V:1K>G0ZA8
M7?ER++'YD$RM&^V1$<;@<,BD<@&N@HH _G!_X/*?V3OA9^R__P ,X_\ "L_A
MI\/_ (=_VY_PDW]I?\(QX>M-(_M#RO[(\KSOL\:>9L\V3;NSM\Q\8W'/YR_\
M$V_VO?%7_!(7_@I5X?\ %VJ6.H:?<>"]9F\/^,M&(Q-+9F0P7ULR]#(FTNH/
M EAC/:OU:_X/G/\ FUW_ +FO_P!PM>-?\'AO_!-O_A1'[4FB_M >&[#RO"_Q
M8Q8Z]Y28CM-;ACX<]A]IMT# #DO;SL3EJ /Z4O"'BW3?'_A/2]>T6^M]2T?6
MK2*_L+R!MT5W;RH'CD0]U96# ]P:T:_'K_@T#_X*2_\ #1O[(&I? OQ)J'G>
M+O@Z!)I'FOF2\T*9SY8&>3]FF)B/98Y+=17["T %?SB?\'=/[<VK?M2?M1Z+
M^S1X!^T:MI?PJL+KQ5XHBM&W+-?QV,MU)N[%;/3TED)'0SR@C*5^Y_\ P46_
M;3T/_@GM^Q?X^^+>N>3-'X4TUI+"T=MO]I7\A$=K;#O^\F>-21RJEFZ*:_![
M_@C[^Q;KGQ4_X)M_MQ?ME_$KSM4\4>//AWXTTS0+RZ7Y[AI-.NY=3OU[?/-B
M!67&/+N%Z-0!\7_\&X?PG\*_''_@LY\&_"WC;PSX?\8>&=4_MO[9I&MZ=#J%
MA=^7H>H2Q^9!,K1OMD1'&X'#(I'(!K^MWX%_LG?"S]E_^U/^%9_#3X?_  [_
M +<\K^TO^$8\/6FD?VAY6_RO.^SQIYFSS9-N[.WS'QC<<_RA?\&N/_*=?X&?
M]Q__ -1_4Z_K]H X_P"-?[/?@']I3PK;Z%\1O _@_P ?Z):7:W\&G^)-&MM5
MM8;A4=%F6*='19 DDBAP,@2,,X8Y_F!_X.Z_V>_ /[-?_!23P3H7PY\#^#_
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M$[X:V27&G:E=2;KCQ%HX98P\C'EY[=V2-W/+K)$QW-YC']=*_CE_9Q^(L_\
MP1X_X+U1FWN)+/1?AI\2[WPUJ!9SB?17NY+.8MG[V;5S(N[^((>" 1_8U0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?@#
M_P 'SG_-KO\ W-?_ +A:_?ZOP!_X/G/^;7?^YK_]PM 'T!_P94_\HLO'W_95
M=1_]-&CU^OU?D#_P94_\HLO'W_95=1_]-&CU^OU !7XR_P#![+X-MK[_ ()\
M_"OQ R*;S2_B''IT3X^98[C3;V1Q^)M8_P A7[-5^(?_  >Z_%RUTK]E+X*^
M S*OV[7O%EUKZQ@_,([*S: L1Z9OP!Z\^E 'RU_P9,^-+FQ_X*!_%3PZKL+/
M5/AZ^HRIGAI+;4K*-#^ NI/S-?TPU_-__P &17PDNM5_:L^-7CP1-]BT'PG:
MZ TA'RF2]O%G"CU.+ D^G'K7](% '\P/_!ZM_P I3? /_9*M._\ 3OK%>P?\
M$9_^#H#X!?\ !.W_ ()L_#?X.^-O"/Q@U3Q-X/\ [3^V76B:5IT]A+]IU2\O
M(_+>:^BD.([A =T:X8,!D8)\?_X/5O\ E*;X!_[)5IW_ *=]8K](/^#</_@G
MM\ OCC_P1C^#?BGQM\#_ (/^,/$VJ?VW]LU?6_!NG:A?W?EZYJ$4?F3S0M(^
MV-$0;B<*B@< "@#B?&'_  >Q?LZV6C32>'_AA\:M3U!5)B@U"TTRQA=O1I$O
M)BH]PA^E?GI^U)X?_;2_X.@/CEX>\9:'\(=0\/\ PSTI)+/PS]IE-IH&DPR.
MOGSM>SA/M4K%$$CPH21$BK&-N#^T_P"WQ_P;E_LR_MB_!'6=%\._#+P7\*_&
M1MG;1/$'A728M*^PW0!,9FAMPD<\); ='4G:3M*-AA_.%^P[^W/\9_\ @A'^
MWEJ5D7U*S'AG7'T?QSX/DN#]AUN*&0QRJ5^YY@7<T,X&1E2"R,RL ?TQ_P#!
M$3_@CQH'_!(']FJ\\/KJ4'B3Q_XNFBOO%6N11&.&XDC5A%;0*WS"WA#R;2V&
M=I)'(7<$7[2KFO@U\7?#_P ?OA+X;\<>%=0CU3PWXMTVWU;3+M.D]O-&)$)'
M8X894\@Y!Y%=+0!\_P#_  5B_P"467[2W_9*O%'_ *:+JOY@O^#7'_E.O\#/
M^X__ .H_J=?T^_\ !6+_ )19?M+?]DJ\4?\ IHNJ_F"_X-<?^4Z_P,_[C_\
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MKNO?9M1>TLXI+;S[&>.)=L,-N_EL"X\W).&4#Z__ .#YS_FUW_N:_P#W"U]
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MKXGB71=0TUK74;8"%9<74$.X2VXA'R;L-"Y;&X9_9[_@T7_;E_X::_X)MO\
M#G5+S[1XF^"=_P#V1M=MTCZ7<;YK)S[*1<0 =EME]: /U6KY_P#^"L7_ "BR
M_:6_[)5XH_\ 31=5] 5\_P#_  5B_P"467[2W_9*O%'_ *:+J@#X!_X,J?\
ME%EX^_[*KJ/_ *:-'KH_^#G;_@B>/V__ (%-\7/AUI(E^,7P[L6,MK;1YE\5
M:6F7>UP.6N(LL\..6R\>"73;SG_!E3_RBR\??]E5U'_TT:/7Z_4 ?R(_\&\?
M_!96]_X)7?M2?V/XJN[J3X-?$"XCM?$ML=SC1Y_N1:G&G7='G;*%&7BSPS)&
M!_7)HNM6?B31[34-/NK>^T^_A2YMKFWD$D-Q$ZAD=&7(964@@@X((-?S6_\
M!U?_ ,$3?^&9OB5=?M'?#/2?+^'OC*]_XJS3[6+]WX>U25N+D ?=M[ESSV28
MD9 E11[5_P &F/\ P6P_M.UL?V5?BAJW^D6Z,?AWJEW+_K$ +/I#,>ZC+P9_
MAWQ C;$I *?_  7T_P"5IK]BO_N1O_4NOJ_?ZOP!_P""^G_*TU^Q7_W(W_J7
M7U?O]0 4444 ?D#_ ,'JW_*++P#_ -E5T[_TT:Q7S_\ \&,?_-T7_<J?^YJO
MH#_@]6_Y19> ?^RJZ=_Z:-8KY_\ ^#&/_FZ+_N5/_<U0!^_U%%% !7XF_P#!
MY-^V'?6/P>^&?[-?A5IKOQ%\4-4CUK5;*V^:::T@E$5G 5[B>\.Y?]JR_/\
M;%W6-"S$*JC))/ %?RV:)_P4?^"W[4G_  <G:G\?_CAXVB\/?"/X>ZC++X4D
M?3+W4DO1IV(-,6..UAE=-\Q-\2RA0P<9!900#^B+_@FO^QY8_L#?L+_#/X36
M:P^=X2T:*+4IHONW6H29FO)A[/<22L,]%(':OQS_ .#U?]AK(^&G[1&CV?KX
M+\2/&O\ UTN+"5L?]O4;,?\ IBN>@K[_ /\ B*-_83_Z+E_Y9GB#_P"0:\)_
MX*9_\%QOV!_V_?V$/B9\)[KXX0_:O%6C2+I<LO@SQ!MM=1B(FLY2?L' 6XCB
M)QC*[AWH \R_X,M?VY?^$Y^ OQ _9_U>\WZAX&N_^$F\/QNWS'3[IPEU&@[+
M%=;7/^U>U^X5?Q5_\$5OVX6_X)[_ /!2CX9_$.ZNFM?#?]H#1O$F6PC:7=_N
M9W8=Q%N6<#^] M?VI1R++&K*RLK#((.010 ZBBB@ K^9W_@]E\8W%]_P4&^%
M?A]G8VFE_#R/4(TSPKW&I7L;G\1:I^0K^F*OYN_^#W3X4W6D_M;_  6\<-&W
MV/7_  A<Z$DF.#)97KSL/RU!3^- 'UE_P9/>&X;7_@G+\3M855^T7WQ(GLW;
M')2'3-/=1^!G?\Z_9*OQ7_X,DOB#;ZE^P_\ %_PJLBFZT7QRFK2)GE4N["WB
M0_B;)_\ ODU^U% !1110 4444 ? '_!T=_R@H^.?_< _]2#3*_(#_@RI_P"4
MIOC[_LE6H_\ IWT>OU__ .#H[_E!1\<_^X!_ZD&F5^0'_!E3_P I3?'W_9*M
M1_\ 3OH] ']/U%%% !1110!Y/^W3^U5I/[$/['WQ$^+&L^6UIX'T2?4(X9&V
MB\N<;+:WSZRSM%&/>05^1?\ P9U?LJZMXXF^,G[5GC;S+_Q)X\U2;0=-OKA?
MWEQNE%WJ5S[B6X:!=PZ-!**A_P"#T_\ ;D_X1;X3?#G]GO2+S9>>*[C_ (2S
MQ$B-AELH&:*SC8=UDN/.D]FLTKW#_@GQ_P %U_V ?V$OV*_AO\)=+^.4+1^"
M]%AM+N:+P7XA"W=ZV9;N<?Z!_P M;AY9/;?0!]N?\%6?V+;?_@H+_P $_/B=
M\*VBA?5-?TEYM$DDP!!J<!$]FV[^$>=&BL1_ SCH37\I?_!$#]M&Y_X)Q?\
M!4KX>^*]8DFTK0YM1;PMXKBGS&(;&Z803&4'D""3RYR.N;<#VK^CO_B*-_83
M_P"BY?\ EF>(/_D&OYJ_^"TWB[X-?$W_ (*._$/QI\!_%$/BKX?>.KI?$,<L
M>F7FG_8KVX&Z\@,=U#$__'QYD@*KMVS* 25. #^U,'-%?%'_  ;X?MR_\-Z_
M\$L_AWXBOKS[9XJ\)P?\(CXC9FW2->62HBRN>[36[6\Q/K,?2OM>@#X _P"#
MH[_E!1\<_P#N ?\ J0:97\^/_!O3_P %0/ /_!)K]M#Q/\1OB-H_C#6M$UKP
M5=>&X(/#=K;7-TEQ+?6%PKLL\\*",):R D.3DK\I!)']!W_!T=_R@H^.?_<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!K=YG\.WG[_H *^?\ _@K%_P HLOVEO^R5>*/_ $T75?0%?/\ _P %8O\
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M"_\ #2__ "6W_3_^$C_Y!_\ T)US]E_Y!_\ HO\ QZ?9O]7_ ,"^?=7]/U?
M'_#C'_C>O_PVM_PM'_N3?^$;_P"I?_L;_C^^U?\ ;;_CW_V/]NOO^@ KY_\
M^"L7_*++]I;_ +)5XH_]-%U7T!7S_P#\%8O^467[2W_9*O%'_IHNJ /Y _\
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ML&:))XE?RVQT="2C#LRD=J[B@#\ ?^#YS_FUW_N:_P#W"U^PG_!3;]AO1_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OP!_X/
MG/\ FUW_ +FO_P!PM?K]_P %1_VY_P#AVO\ L)^.OC5_PB__  FG_"%_8/\
MB3?VE_9OVS[5J%M9?Z_RI=FW[1O_ -6V=FWC.X?S!?\ !<[_ (+G?\/H_P#A
M5W_%KO\ A6O_  K7^UO^9D_MC^T?MWV+_IUM_+V?8_\ :W>9_#MY /U__P"#
M*G_E%EX^_P"RJZC_ .FC1Z_7ZOY0O^"*G_!R%_PY\_98U_X9_P#"F?\ A8G]
MN>*[CQ/_ &E_PEO]D>1YMI9VWD>5]BGW8^R;M^\9\S&T;<GZQUO_ (/7O'OC
MVV:T\!_LPV,>JR#$1N?%%QK"[O\ KE#9P,WT#"@#]]_'/CG1OAEX.U3Q%XBU
M33]#T'1;:2]U#4+Z=8+:S@C4L\DCL0JJH!))-?Q\?\%WO^"ETW_!6G_@H1>:
M]X5AU"Y\$^'XT\,>"[,0MY][ LC$W'E8W>9<S.S!<;@GE(1E:^D/C=I'_!37
M_@OWJ-OI&O>!?%7A_P"'TTZSIIDFFOX4\+PX((E<W)$EWM/(W-.RG[H!S7Z?
M?\$6?^#8WP+_ ,$WO$.G?$CXD:E8_$KXOV8$EC)'"1HWAJ3'WK5' >:8<XGD
M"E>-D:$%B >R?\&\W_!,V[_X)D_\$]='T+Q):K;_ !$\;W!\2^*4X+64\J*L
M-F2/^>$*HK $CS6E()!!K[JHKY _X+5_\%6_^'/G[+&@?$S_ (0+_A8G]N>*
M[?PQ_9O]M_V1Y'FVEY<^?YOV>?=C[)MV;!GS,[AMP0#\0/\ @]6_Y2F^ ?\
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M*O#OQS^&>O>#?%NDVFN^&?$UC+IVIZ?=+NBNH)%*NA[C@\$8(.""" :_CO\
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MTO+;R/*^Q0;<_:]V_><>7C:=V1Y__P $,?\ @N=_PY<_X6C_ ,6N_P"%E?\
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MU#4_$+>,!IK2)L2&" 0?89?DB'F,,R'+3.>,X']7E 'P!_Q"X_L)_P#1#?\
MR\_$'_R=7Q)_P<"_\&Y7P'_9U_X)R^(/B9\ ?A[-X3\4> +VWU35@FNZGJ7V
M_2B3%<+LNKB55,9DCG+* 0D+CG-?NU7Y?_\ !?W_ (+L:3_P3'\4:5\)]?\
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M ,I3?'W_ &2K4?\ T[Z/1_P5'_X.M?\ AY1^PGXZ^"O_  H7_A"_^$T^P?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7\N'_  >5?!6;P!_P
M5(T/Q8L+?8?'W@NRN/.Q@-<VTLUM(GN5C2W/_;05_4?7Y1?\'<W[ -Y^U9_P
M3XL?B1X?L7O?$WP/NY=6FCC3=)+H\ZHE]@#_ )YF.WG)/ 2"7N: /IO_ ((
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M_/*=TDF!C<J@ _H^KY__ ."L7_*++]I;_LE7BC_TT75?0%?@C_P4U_X*E_\
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M?P=XI6_0P?V%=K,/(N)U;!3R9U:.0MC8DTK'[N*_K@K\M?\ @N-_P;4^$_\
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M"OQ0+OP]XGT+P7J.H:;JR0RB2WG62&)HWCECV[XPQQN>-N0PH _L1HK\@_\
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M^K7GA7X5^(]>\)ZI(KZMI]EI[^)_#FK!.%G?[&QDMWQP),PR8P&R,+7TV/\
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M7_LG_A'/^*0U?P__ &M]H^V_:O\ D(32>=Y7DVW^KQL\WYL[EP ??]?S _\
M!ZM_RE-\ _\ 9*M._P#3OK%?M_\ \%J_VO/C[^Q=^RQH'BG]G/X7_P#"V/&U
M_P"*[?2K[2/^$<U'7OLVG/:7DLESY%C)'*NV:&W3S&)0>;@C+*1_.C_P5 \/
M?MR_\%9?C[H_Q&^(W[*/Q0T76]%\/P^&X(/#?PR\06UJ]O%<W-PKLLXF<R%[
MJ0$AP,!?E!!) /WN_P"#7'_E!1\#/^X__P"I!J=??]?S0_L%?\%'_P#@I)_P
M3M_9.\*?!WP3^QWX@U3PSX/^V?8[K6_A/XHGOY?M-Y/>2>8\,T49Q)<.!MC7
M"A0<G)/L'_#_ $_X*G?]&5_^8A\7?_)= '[_ %? '_#\[_C>O_PQ3_PJ[_N<
MO^$D_P"I?_MG_CQ^R_\ ;'_CX_V_]BO@#_A_I_P5._Z,K_\ ,0^+O_DNO/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGC?HROD'/8X(_KO_ ."Q?_!);PG_ ,%=_P!F.+P5K6J2^&?$F@79U/PWK\4
MN#IMR4*.DD>5\R"1<!T#*<JC Y0 _D=^RY_P90>.K?XVV-Q\9/BAX)D^']C<
MK-<6OA4W<VI:M$ISY):>&)+;>."ZF4KS@$X( /WL_9<^,_\ PT?^S-\.OB&+
M(Z:/'GAC3?$0M"<FU^V6D5QY>?\ 9\S'X5^9/_!W'_P4A^(7[$O[+?@#P3\.
M-8U#POJGQ=O=0BU#7+"4PWEK8V26YD@AE7#1/*]U%EU(8+&X!&XFOUB\+^&=
M/\%>&M.T;2;.#3]+TFUCLK.UA7;';0QJ$CC4=E55  ]!7RQ_P6+_ ."2WA/_
M (*[_LQQ>"M:U27PSXDT"[.I^&]?B@%P=-N2A1TDCROF02+@.@93E48'* $
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M&3XH>"9/A_8W*S7%KX5-W-J6K1*<^26GAB2VWC@NIE*\X!." #][/V7/C/\
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MB\%:UJDOAGQ)H%V=3\-Z_% +@Z;<E"CI)'E?,@D7 = RG*HP.4 /Y'?LN?\
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M0^'O^$G\17>FSM;W&KI+<SVT-H95(81+]FE9T!P_F)NR%P?WJK\__P#@NO\
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MR(,JEHU1MX^7<H)S^]5 'X*_\'B__!3#XD?!?QQX&^ 7@G7M5\)Z'XA\/?\
M"3^(KO39VM[C5TEN9[:&T,JD,(E^S2LZ X?S$W9"X/Y"_P#!,7_@IW\3?^";
M/[3/AWQ=X1\1:P=#.H1#Q!X>-R[V.O6C.!-%)"3M,A0MLDQN1L$'J#_3)_P7
M7_X(4Z#_ ,%A? ?A_4-/\00^"_B=X+CE@TG5I[<SVE[;2$,UI<JI#[-XW)(N
M3&6?Y6#$5\*_\$S_ /@SHUSX+?M(Z#XW^/OCGP;XAT/PG?1ZE:>'?#'VFXCU
M>:)@\0N9KB*'9$&52T:HV\?+N4$Y /WJK^9?_@[>_P""FGQ*\4?MU:Q^S[H_
MB#5O#OP[\!6%@U]I]C</;IK]Y=VL5V9;@J098TCGB18VRJLCMC+<?TT5^6/_
M  7D_P"#;VU_X*J^/K'XG?#_ ,4:7X)^*-K9)INH+JL,C:7KT$>?):5X@TD,
MT8)7>$D#(%4J-H- 'XS_ /!N-_P4V^)G[)/_  4/^&?@*R\0:OJ7PY^)WB"T
M\+ZMX<N+AYK-'O)5@BNH8V)$4L4KHQ= "R*RG(/']<U?C'_P13_X-5+G]@[]
MH_2?B]\9_&'AOQ=XG\*.TWA[1?#R3R:;:714JMW+-/'&\CH&)1!$H5\/N)4
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M'IUW=!0K7<,T$<CQLX4%T,3!GW/N!8BO4?\ @@W_ ,&WUI_P2I\>7_Q-\?\
MBC2_&WQ2NK)]-L%TN&1=+T&"3'G&)Y0LDTT@ 7S"D>U"RA3N)H _4ROY%_\
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MA9)II  OF%(]J%E"G<37ZF4 ?Q,_\%./^"G7Q-_X*2_M,^(?%WB[Q%K T/\
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MWB7X@7$FI^+O!^NW7A*_U5U"R:QY$-O/%</C@R&*YC1V_B>-F/+&ORZ\9_\
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M9_M3_$OXA_&*3XA:UX^\8:AXYDN/M?\ ;TNK3_VA')G(*2A@T>#T"$!0
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MMPF>!((K:1$;^%Y%8<J*^C?^"=7[!/@[_@FK^R;X;^$_@EKFZT_10\]YJ-T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M455UK6K/PWH]WJ.HW5M8:?80O<W-S<2B*&WB12SR.[$!550222  ": +5%?E
M]XS_ .#O#]C_ ,'_ !BD\*QZA\0M9TZ&X^SR>)].T!9-'7!P7&Z9;ET'/S)
MV1RNX$9_1_X2_%KPS\>/AIHGC+P;K6G^(_"_B.T2]TW4K*7S(+N%NC*?S!!P
M5(((!!% '1455UK6K/PWH]WJ.HW5M8:?80O<W-S<2B*&WB12SR.[$!550222
M  ":_,CQG_P=X?L?^#_C%)X5CU#XA:SIT-Q]GD\3Z=H"R:.N#@N-TRW+H.?F
M2!LCE=P(R ?J#17._"7XM>&?CQ\--$\9>#=:T_Q'X7\1VB7NFZE92^9!=PMT
M93^8(."I!! ((K8UK6K/PWH]WJ.HW5M8:?80O<W-S<2B*&WB12SR.[$!5502
M22  ": +5%?E]XS_ .#O#]C_ ,'_ !BD\*QZA\0M9TZ&X^SR>)].T!9-'7!P
M7&Z9;ET'/S) V1RNX$9_1_X2_%KPS\>/AIHGC+P;K6G^(_"_B.T2]TW4K*7S
M(+N%NC*?S!!P5(((!!% '1455UK6K/PWH]WJ.HW5M8:?80O<W-S<2B*&WB12
MSR.[$!550222  ":_,CQG_P=X?L?^#_C%)X5CU#XA:SIT-Q]GD\3Z=H"R:.N
M#@N-TRW+H.?F2!LCE=P(R ?J#17._"7XM>&?CQ\--$\9>#=:T_Q'X7\1VB7N
MFZE92^9!=PMT93^8(."I!! ((K8UK6K/PWH]WJ.HW5M8:?80O<W-S<2B*&WB
M12SR.[$!550222  ": +5%?E]XS_ .#O#]C_ ,'_ !BD\*QZA\0M9TZ&X^SR
M>)].T!9-'7!P7&Z9;ET'/S) V1RNX$9_1_X2_%KPS\>/AIHGC+P;K6G^(_"_
MB.T2]TW4K*7S(+N%NC*?S!!P5(((!!% '1455UK6K/PWH]WJ.HW5M8:?80O<
MW-S<2B*&WB12SR.[$!550222  ":_,CQG_P=X?L?^#_C%)X5CU#XA:SIT-Q]
MGD\3Z=H"R:.N#@N-TRW+H.?F2!LCE=P(R ?J#17._"7XM>&?CQ\--$\9>#=:
MT_Q'X7\1VB7NFZE92^9!=PMT93^8(."I!! ((H^+GQ<\,_ 7X9ZWXR\9:WI_
MASPOX<M7O=2U*]E\N"TB7JS'\@ ,EB0 "2!0!T5%?E]X*_X.\/V/_&/QBC\*
MR:A\0M%T^:X%O'XFU+0%CT=LG <[9FN40\?,\"[1RVT D?IQHVLV?B/1[74-
M/NK:^T^^A2XMKFWE$L-Q$ZAD='4D,K*0002""#0!9HKG?BY\7/#/P%^&>M^,
MO&6MZ?X<\+^'+5[W4M2O9?+@M(EZLQ_( #)8D  D@5^<'@K_ (.\/V/_ !C\
M8H_"LFH?$+1=/FN!;Q^)M2T!8]';)P'.V9KE$/'S/ NT<MM ) !^H-%5M&UF
MS\1Z/:ZAI]U;7VGWT*7%M<V\HEAN(G4,CHZDAE92"""000:QOBY\7/#/P%^&
M>M^,O&6MZ?X<\+^'+5[W4M2O9?+@M(EZLQ_( #)8D  D@4 =%17Y?>"O^#O#
M]C_QC\8H_"LFH?$+1=/FN!;Q^)M2T!8]';)P'.V9KE$/'S/ NT<MM )'Z<:-
MK-GXCT>UU#3[JVOM/OH4N+:YMY1+#<1.H9'1U)#*RD$$$@@@T 6:*YWXN?%S
MPS\!?AGK?C+QEK>G^'/"_ARU>]U+4KV7RX+2)>K,?R  R6)  )(%?G!X*_X.
M\/V/_&/QBC\*R:A\0M%T^:X%O'XFU+0%CT=LG <[9FN40\?,\"[1RVT D 'Z
M@T56T;6;/Q'H]KJ&GW5M?:??0I<6US;RB6&XB=0R.CJ2&5E((()!!!K&^+GQ
M<\,_ 7X9ZWXR\9:WI_ASPOX<M7O=2U*]E\N"TB7JS'\@ ,EB0 "2!0!T5%?E
M]X*_X.\/V/\ QC\8H_"LFH?$+1=/FN!;Q^)M2T!8]';)P'.V9KE$/'S/ NT<
MMM )'Z<:-K-GXCT>UU#3[JVOM/OH4N+:YMY1+#<1.H9'1U)#*RD$$$@@@T 6
M:*YWXN?%SPS\!?AGK?C+QEK>G^'/"_ARU>]U+4KV7RX+2)>K,?R  R6)  )(
M%?G!X*_X.\/V/_&/QBC\*R:A\0M%T^:X%O'XFU+0%CT=LG <[9FN40\?,\"[
M1RVT D 'Z@T56T;6;/Q'H]KJ&GW5M?:??0I<6US;RB6&XB=0R.CJ2&5E((()
M!!!K@OVK?VL_A]^Q)\$=6^(GQ.\26?A?PIHX4374X9WFD;A(8HU!>65SPJ("
M3@G& 2 #T:BOS9_9;_X.L?V3_P!J3XW6/@6'4?&W@>^U:Y6ST[4?%6E0VFFW
MLS':B":*>7RMQX!F6-<D D$@5^DU !17G/[5O[6?P^_8D^".K?$3XG>)+/PO
MX4T<*)KJ<,[S2-PD,4:@O+*YX5$!)P3C )'P_P#LM_\ !UC^R?\ M2?&ZQ\"
MPZCXV\#WVK7*V>G:CXJTJ&TTV]F8[40313R^5N/ ,RQKD@$@D"@#])J**\Y_
M:M_:S^'W[$GP1U;XB?$[Q)9^%_"FCA1-=3AG>:1N$ABC4%Y97/"H@)."<8!(
M /1J*_-G]EO_ (.L?V3_ -J3XW6/@6'4?&W@>^U:Y6ST[4?%6E0VFFWLS':B
M":*>7RMQX!F6-<D D$@5^DU !17G/[5O[6?P^_8D^".K?$3XG>)+/POX4T<*
M)KJ<,[S2-PD,4:@O+*YX5$!)P3C )'P_^RW_ ,'6/[)_[4GQNL? L.H^-O ]
M]JURMGIVH^*M*AM--O9F.U$$T4\OE;CP#,L:Y(!() H _2:BBO.?VK?VL_A]
M^Q)\$=6^(GQ.\26?A?PIHX4374X9WFD;A(8HU!>65SPJ("3@G& 2 #T:BOS9
M_9;_ .#K']D_]J3XW6/@6'4?&W@>^U:Y6ST[4?%6E0VFFWLS':B":*>7RMQX
M!F6-<D D$@5^DU !17G/[5O[6?P^_8D^".K?$3XG>)+/POX4T<*)KJ<,[S2-
MPD,4:@O+*YX5$!)P3C )'P_^RW_P=8_LG_M2?&ZQ\"PZCXV\#WVK7*V>G:CX
MJTJ&TTV]F8[40313R^5N/ ,RQKD@$@D"@#])J*** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*^N-%T6S\-Z/::=IUI:V&GV$*6]M;6T2Q0V\2 *B(B@!550      !5HC(H
M_@#K^KO_ (-#_!?C'P=_P1^T^3Q5'>0Z?K7BS4]1\,1W *[=+98$R@/1&NDN
MW'8[]PR&R??_ !G_ ,$ OV.?B!\89/'>J_ 7PA-XAGN/M<PBENK?3YY2=Q9[
M&.5;1\GDAHB&).<Y-?7&BZ+9^&]'M-.TZTM;#3["%+>VMK:)8H;>) %1$10
MJJH       H ^1_^"_O@SQA\0?\ @CG\>M*\"1WDWB&;0$E,-H"9I[**Z@EO
MHU Y;=9I<+M'+ D<YQ7\8M?W^$9%?'OC/_@@%^QS\0/C#)X[U7X"^$)O$,]Q
M]KF$4MU;Z?/*3N+/8QRK:/D\D-$0Q)SG)H \ _X-#_!?C'P=_P $?M/D\51W
MD.GZUXLU/4?#$=P"NW2V6!,H#T1KI+MQV._<,ALGW_\ X+^^#/&'Q!_X(Y_'
MK2O D=Y-XAFT!)3#: F:>RBNH);Z-0.6W6:7"[1RP)'.<5]<:+HMGX;T>TT[
M3K2UL-/L(4M[:VMHEBAMXD 5$1% "JJ@      "K1&10!_ '7]7?_!H?X+\8
M^#O^"/VGR>*H[R'3]:\6:GJ/AB.X!7;I;+ F4!Z(UTEVX['?N&0V3[_XS_X(
M!?L<_$#XPR>.]5^ OA";Q#/<?:YA%+=6^GSRD[BSV,<JVCY/)#1$,2<YR:^N
M-%T6S\-Z/::=IUI:V&GV$*6]M;6T2Q0V\2 *B(B@!550      !0!\C_ /!?
MWP9XP^(/_!'/X]:5X$CO)O$,V@)*8;0$S3V45U!+?1J!RVZS2X7:.6!(YSBO
MXQ:_O\(R*^/?&?\ P0"_8Y^('QAD\=ZK\!?"$WB&>X^US"*6ZM]/GE)W%GL8
MY5M'R>2&B(8DYSDT > ?\&A_@OQCX._X(_:?)XJCO(=/UKQ9J>H^&([@%=NE
MLL"90'HC727;CL=^X9#9*?\ !WEX,\8>,/\ @C_?2>%8[R;3M%\6Z9J/B>.W
M!;=IBK<)EP.J+=26CGL-FXX"Y'Z<:+HMGX;T>TT[3K2UL-/L(4M[:VMHEBAM
MXD 5$1% "JJ@      "C6]$L_$NC7>G:E9VNH:??PO;W5K<Q++#<Q."KHZ,"
M&5E)!!!!!(- '\!M?V=?\$!?!?C'X>_\$=?@+I/CR.\@\10^'WE\F[!$T%G)
M=3RV,; \KMLWMUVGE0 ,#&*/!7_! /\ 8Y^'OQAC\=Z3\!?"$/B&"X^UP^;+
M=7&GP2@[@R6,DK6B;3R L0"D#&,"OL(<4 ?E[_P=Y>#/&'C#_@C_ 'TGA6.\
MFT[1?%NF:CXGCMP6W:8JW"9<#JBW4EHY[#9N. N1_*+7]^6MZ)9^)=&N].U*
MSM=0T^_A>WNK6YB66&YB<%71T8$,K*2"""""0:^1_!7_  0#_8Y^'OQAC\=Z
M3\!?"$/B&"X^UP^;+=7&GP2@[@R6,DK6B;3R L0"D#&,"@ _X("^"_&/P]_X
M(Z_ 72?'D=Y!XBA\/O+Y-V")H+.2ZGEL8V!Y7;9O;KM/*@ 8&,5\_P#_  =Y
M>#/&'C#_ ((_WTGA6.\FT[1?%NF:CXGCMP6W:8JW"9<#JBW4EHY[#9N. N1^
MH0XJKK>B6?B71KO3M2L[74-/OX7M[JUN8EEAN8G!5T=&!#*RD@@@@@D&@#^
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M?A[\88_'>D_ 7PA#XA@N/M</FRW5QI\$H.X,EC)*UHFT\@+$ I QC K["'%
M'Y>_\'>7@SQAXP_X(_WTGA6.\FT[1?%NF:CXGCMP6W:8JW"9<#JBW4EHY[#9
MN. N1_*+7]^6MZ)9^)=&N].U*SM=0T^_A>WNK6YB66&YB<%71T8$,K*2""""
M"0:^1_!7_! /]CGX>_&&/QWI/P%\(0^(8+C[7#YLMU<:?!*#N#)8R2M:)M/(
M"Q *0,8P* #_ (("^"_&/P]_X(Z_ 72?'D=Y!XBA\/O+Y-V")H+.2ZGEL8V!
MY7;9O;KM/*@ 8&,5^?\ _P 'NG@SQAK'[-?P0UK38[R7P-HNOZC%KOE M#%>
MS00"QDD X'R1WJACP#)CJP!_<(<5@_$[X7^&_C3X!U3PKXNT+2?$WAO7(#;7
M^F:G:I<VMY&>=KQN"K#(!&1P0".0* /X*-,TRYUK4K>SL[>>[O+N588((8S)
M)-(Q 5%4<LQ)  '))K^ZS]C3P]XH\(_L@?"G2?'$DTOC32_!VD6FOO*^^1]0
MCLH4N2S=R90^3W->-?LW_P#!#C]E#]DGXMP^._ /P7\.:/XLM9?/M+^XN;O4
MFL).TENEU-*D#CLT2J1V(KZNH _#W_@]T\&>,-8_9K^"&M:;'>2^!M%U_48M
M=\H%H8KV:" 6,D@' ^2.]4,> 9,=6 /\YFF:9<ZUJ5O9V=O/=WEW*L,$$,9D
MDFD8@*BJ.68D@ #DDU_>O\3OA?X;^-/@'5/"OB[0M)\3>&]<@-M?Z9J=JES:
MWD9YVO&X*L,@$9'! (Y KYO_ &;_ /@AQ^RA^R3\6X?'?@'X+^'-'\66LOGV
ME_<7-WJ36$G:2W2ZFE2!QV:)5([$4 >R_L:>'O%'A']D#X4Z3XXDFE\::7X.
MTBTU]Y7WR/J$=E"ER6;N3*'R>YK\AO\ @]T\&>,-8_9K^"&M:;'>2^!M%U_4
M8M=\H%H8KV:" 6,D@' ^2.]4,> 9,=6 /[A5@_$[X7^&_C3X!U3PKXNT+2?$
MWAO7(#;7^F:G:I<VMY&>=KQN"K#(!&1P0".0* /X*-,TRYUK4K>SL[>>[O+N
M588((8S))-(Q 5%4<LQ)  '))K^ZS]C3P]XH\(_L@?"G2?'$DTOC32_!VD6F
MOO*^^1]0CLH4N2S=R90^3W->-?LW_P#!#C]E#]DGXMP^._ /P7\.:/XLM9?/
MM+^XN;O4FL).TENEU-*D#CLT2J1V(KZNH _#W_@]T\&>,-8_9K^"&M:;'>2^
M!M%U_48M=\H%H8KV:" 6,D@' ^2.]4,> 9,=6 /\YFF:9<ZUJ5O9V=O/=WEW
M*L,$$,9DDFD8@*BJ.68D@ #DDU_>O\3OA?X;^-/@'5/"OB[0M)\3>&]<@-M?
MZ9J=JES:WD9YVO&X*L,@$9'! (Y KYO_ &;_ /@AQ^RA^R3\6X?'?@'X+^'-
M'\66LOGVE_<7-WJ36$G:2W2ZFE2!QV:)5([$4 >R_L:>'O%'A']D#X4Z3XXD
MFE\::7X.TBTU]Y7WR/J$=E"ER6;N3*'R>YK\AO\ @]T\&>,-8_9K^"&M:;'>
M2^!M%U_48M=\H%H8KV:" 6,D@' ^2.]4,> 9,=6 /[A5@_$[X7^&_C3X!U3P
MKXNT+2?$WAO7(#;7^F:G:I<VMY&>=KQN"K#(!&1P0".0* /X*-,TRYUK4K>S
ML[>>[O+N588((8S))-(Q 5%4<LQ)  '))K^ZS]C3P]XH\(_L@?"G2?'$DTOC
M32_!VD6FOO*^^1]0CLH4N2S=R90^3W->-?LW_P#!#C]E#]DGXMP^._ /P7\.
M:/XLM9?/M+^XN;O4FL).TENEU-*D#CLT2J1V(KZNH _#W_@]T\&>,-8_9K^"
M&M:;'>2^!M%U_48M=\H%H8KV:" 6,D@' ^2.]4,> 9,=6 /\YFF:9<ZUJ5O9
MV=O/=WEW*L,$$,9DDFD8@*BJ.68D@ #DDU_>O\3OA?X;^-/@'5/"OB[0M)\3
M>&]<@-M?Z9J=JES:WD9YVO&X*L,@$9'! (Y KYO_ &;_ /@AQ^RA^R3\6X?'
M?@'X+^'-'\66LOGVE_<7-WJ36$G:2W2ZFE2!QV:)5([$4 >R_L:>'O%'A']D
M#X4Z3XXDFE\::7X.TBTU]Y7WR/J$=E"ER6;N3*'R>YKTFBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
,H **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_128.jpg
<TEXT>
begin 644 image_128.jpg
MB5!.1PT*&@H    -24A$4@  "N     $" (   #Z-?RF    2DE$051X7NW:
MH0T , P#P>R_=(K:2,4QNT.6O,)7 0        !D]/4?          !;)E!X
I"P         @1*           ,0=0W$4?C,M>GL     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_14a.jpg
<TEXT>
begin 644 image_14a.jpg
MB5!.1PT*&@H    -24A$4@  !-X   /)" (   !"YW+<  "  $E$051X7NS=
MV7,<UWW^?T(4)<N.RUFK<IO[_!^)),NI+!>)Z4JY4KEPQ?8OO\3)C9UR);8B
M4A3V(?:%(+A))$51$L4-)$$ !$5LW+19EDC&HC9*)$$2NP#,?#\ZC^;HL&>P
M$-O,]+Q?%UUG>GIF>KI[NL\SYW3WNI___.>SL[-W[MQ)I5+3SA=??#$#
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MT10     D&-$4P    ! CA%- 0     Y1C0%     .08T10     D&,+1%,
M     %;; M$T2:LI     &"5$4T!     #E&- 4     Y!C1%     "08T13
M     $".$4T!     #FV0#0%     &"U+1!-D[2: @    !6&=$4     )!C
M1%,     0(X130$     .48T!0    #D&-$4     )!C"T13      !6VP+1
M-$FK*0    !@E1%- 0     Y1C0%     .08T10     D&-$4P    ! CA%-
M 0     YMD T!0    !@M2T039.TF@(     5AG1%     "08T13     $".
M$4T!     #E&- 4     Y!C1%     "08PM$4P      5ML"T31)JRD
M8)4130$     .48T!0    #D&-$4     )!C1%,     0(X130$     .;9
M- 4     8+4M$$V3M)H"     %89T10     D&-$4P    ! CA%- 0     Y
M1C0%     .08T10     D&,+1%,      %;; M$T2:LI     &"5$4T!
M #E&- 4     Y!C1%     "08T13     $".$4T!     #FV0#0%     &"U
M*93.SLYFCZ9)6DT!     *O,1U,+I$13     $ .*)=:P89$4P    ! #OC>
MO-/3TT13     $ .*(I:#B6: @    #6FE*GVDO-U-04T10     L*9\-+40
M.CL[:\,LT10     @-663.,*O0    " W"": @    !RS$=3;AX#     ,@-
MHBD     (,>(I@    " '//1E'-- 0    "YX:-I]E93      !6VP+1-$FK
M*0    !@E1%- 0     Y1C0%     .08T10     D&-$4P    ! CA%- 0
M   YMD T!0    !@M2T039.TF@(     5AG1%     "08T13     $".$4T!
M     #E&- 4     Y!C1%     "08PM$4P      5ML"T31)JRD     8)41
M30$     .48T!0    #D&-$4     )!C1%,     0(X130$     .;9 - 4
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M@3^2^?W?5:..KCH;?2,XX68VX_Y>46/IVC>9UKAH6EI:VM;65EY>;JN,GP
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M_4[ 4SKU-\#DSC$QT.?T]O9:.JVOKZ^LK+0U6^]80*VHJ+"-01=MUK81FZ.
M#GE6>_%?39N]E7MZ>GP"CUD4!X X62":L@<O7%J/*2Z#!!2]2#3UC:5$TUA2
MGU[+I?W]_;IY3%5557EY^:9-FRR:6D"==&;<I9NGIJ9B<Z!7;49?38VE7U5P
MDLGN[FY-$'T- ""?^/TVT31N,J.IKX\238&B$D;3<%= -(T?A5*UF@X,#-AJ
MM2QJZ=1"Z>;-F]6Y]_KUZZ.CHRG7P&CIU&\G\3CBJ]74']V4P#L[.U-Q^8(
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MP($#-34UMG*UEM6Y=__^_;95W+ES)SS6Q^"(K[-G[:OI"D\V9LSIZ.B(3@H
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ME&.]-F.KGU@$M2RZ8\>.YN9FRZB60B><67?985WZ2*VF>MC;VZN7IPHDA -
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M&I1+%5"-1=-//OED?'P\_X_XOKYBT=3?GO3MM]\>&QO3S/NOH,),6F%=[0D
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M!@<'H\<B  !0](BF6"*MUS":AF@U!8I'UG--?2ZU875U=4-#0[^["QR700(
M %D13;%$6J^^ AI!- 6*QX+1-)%(U-?7ZTH2T:,0  " 0S3%$FF]^@JH+Z@7
M']$4*!X+=NBU:%I75Z?CC2YX&#T6 0" HD<TQ1)IO4:BJ;=QXT9-0#0%8B\S
MFOI=@:)I=76U1=-S[M8.KW./<@  D$V.HRD*E]:KCZ;JMN?Y5E-6-!![63OT
MBK^OJ453W0CN7/K.A    *$<1U.E%Q0BK=>2A<XU)9H"L9<UFH9_6BF:1H\_
M     :(IEDCKU5= 5?#EC1LWVBI/$4V!(D T!0  RT<TQ1+-$TW7N7--B:9
MD<@\UY1H"@  'A31%$LT3S0MH=44*":TF@( @.4CFF*),J-IB'--@>)!- 4
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M?_NW?XNF4K=S()H" (#%()IBB;1>2^:(IEP&"2@&^IG/.#_YR4^B.P*': H
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MKIKZ2K-MV[;Z^GKHV:)%BP)OW=J^E2DK\%N&C8867+Y\>6UM[;Y]^ZP9;]*
M X@=!0>E>5)-\YR=YCDIY13?UU8^<3SZZ*,L9 Z?(R$$\=64=FH!7TUYR>E\
M#1)"""&$>)VAJZ:$=SENW;JUL;$12E9:6GKZ]&EFQWM0HSOD"G[+L*9H@9*2
MDHJ*"FR;FIJ:FYO9.+=LPP'!CD(=I9IRL)1V:@.GY"M?^0K/<F:*)X081")J
M:E!-<2U9N7(EI51J*H000HCN&&0U[0[.U^46K%^_/I%(T,00;FAHX"ABIWUR
MA;C+T</KZNI>??75\^?/'SUZ%((*.[46B.^2#G@46BA7Z(W#&TW1)?W"%[Z
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M,[9\H'F3)T]N<S.T&6-9#2[=3>@%*//!@P>C%Q,AA!!"B/Z1W6K*K"%C'*
MZ-_##:S7F]M8[Y9A5!]:CCXTNO4<V$EW(TA-_62TK\V;-T?4R +TU91;H?>A
MAQY"1__C'_\X=OGO__YO?GH3X<JN*U>NA"+^PS_\@[][BYNJ^J=_^J=H=GQI
MZ6-V;Z3E_\E/?A(&!7- :<>.'?M/__1/O"N5-[B"?JII$-ZM"L]$ 7[THQ\%
MX8)#'>':N1Q:O.^^^_#!X)\FW_WN=R%R4,&@\ZH_/%"SX]Y[[V4A\1G&)QF%
MA)HRF?_K8\V.;'D6D DROWCQ(ASO_>]_OWW]F?+:M6OCQX]_RUO>\O6O?]T^
MF4PP;]X\'.5[W_L>C1I%S7.SCBF*J 5//0K,.<QL\, 5^ ,?^ #:ZI577K'<
M#+Y$V5 13A*&>,/2D^$*2?P,M+MQ6B1 X7GK:;-;QKG%^?:@(S450@@A1(;)
M,C6-D I7:MFQ8P=7&0G<2 B[X-:%S6$X6L4 .LU+EBQ!&&K*15RBJ0<:J:E?
MNR]_^<MX=^O6K7R+N]B[@>=4B/_H1S]Z]]UW(V?.984^M8>SB)$,:IKG1DWM
M)/)$EY240&/^Z(_^*'"FBC3O>,<[?-/#OI_^]*<1?_CP883?]*8W(4P=@B95
M554AD_ZK:=*-6,+KD#G4MSU<+ J':'-WP_+;]^YWOQL?#'[?O_G-;R+QHD6+
MK#'];RAR.WKTZ._\SN\TNR67^"<+O/HK7_D*I9$'#3H7K-5-%F D,D<;?N$+
M7\!>BQ<O#KSE>7GK+P)0??MD\BU6 7;-?/ -0O,B/?TSZ4PRX9X)%+A2,4\&
MJ*8X*#.,P%TZPJ?(OO&-;\2!(*(\RXCA?0>!^W31L6MK:_F#9LTRN$A-A1!"
M")%ALE5-N2-[<H'K1:&4O/6NM+34B4/NKX3$"G(P+7!]<72UT0*G3IVBFO+,
MI:\=_'M-[88T8FG2=_2,T2LUW;!A ]7"OC!,8Y$IMSK1_???CQ9#SKR=]9WO
M?">LS):67;5J%;*R45,>"!_U1QYY!.KU\8]_O,7=2,RE=&!QJ?#[B<#'/O8Q
M* 2GN,^:-2O/W2M(P>-'HI]JZHSRM96<.!N6HZ86SP!<"Q8]=>I4+O6$ES_X
MP0_RW(1>5B22(0K_V&./W7///2PG$MB$7FL]9D[XP>:H)BN%8J/UH*8([-RY
M,_"J@#+@T-@=JI_764U9!=AUTC4.,OS7?_U7Y/#6M[[UN]_]+O\IZ'#*W>Z&
M-#O"1^,@_7O?^UZ4\.+%BTEW=GQX",9C1^P^;=HTG#B4A(.Q[<[>$VX&/E-V
MN)5^.3?;/CF#B]14""&$$!DFF]34[_99(.D>\[!]^_:4Z_*R:VLC+3F/WV5'
MX,*%"]>N73MQX@2ZO!PKZYQ\@.F)FN8 -U%3/]FCCSXZ?OSXV;-G7[ER!<;R
MZJNO7G%<NG3IZM6K."_U]?7,!]^H][___6BE#O>X%-@=&A#VPEF=.-S:M6OQ
M[K>^]2VJ%S_8V'>L(W#_1T!L\!5%>7[ZTY^R $SV\,,/8U_^08-D4-\\-W!*
MF^V_FO)KB'Q>?/%%Y/S][W^_W8WHMKE5F@+77#4U-?GY^7CW:U_[6M)9W_>^
M]STT#M34&H$>#AE#R_SD)S^!]K#N_")S0B]V1S.B =&>UZ]??^655RY?OHR7
M9\Z<"<*;-@D_<MB7BR%Q8C!^&=A$3S[Y)&*@^I%[33FA%VK:YD9]T42'#Q_F
MIQI[W7'''7_S-W^#XIT]>Y;_]2!/E!]EQJ$_]*$/(1E^.E$DG%^>:X*7B.0<
M8!X(^4^>/'G*E"G('-O?^[W?.W7J%&K4ZJ8*-[HG[O#YS)$[AP<16P:)WVBI
MJ1!"""'233:I:>"EMP Z<^@F0LE*2DIXF,#U6:U3V-M#9!U^!=$A1D_Z^/'C
MZ/6R)^TE''@B*_3Z6)H<:/\>JND7O_A%=MRYN.OH\$$I?/G  P^TNWL+F=N#
M#SZ(2&KJH4.'\L+GFG#ZZ,J5*Z$!CSWV&+PEY88' ;Z0(]PJJ50R.,QSSSV'
MHSSTT$,)M\01$B/S/_JC/\)!\77@WQ;X,*  [>X1K!3=_JMIX-H$GHE\[K__
M?OC;(X\\\O\<"* =WO:VM[$I\)O"19A@L"C&[__^[W_E*U^!PZ-J7_[REYD>
M1^2"PVS5-K="[[IUZR9.G(C:C7(/[T$ [3/&@< HMYQOJX,G KM3!4<XB:)J
MHIQHM#>\X0V0?\3\_=__/?;UJS9W[ERDIUT';C 6[-NW[U__]5^Y<#&/B,.A
MG"@P'Q7+]O_ !S[@YF*_!O^7X>EFF%\!WFB:=(.B:(H9,V:@IOC6<!%CE!-G
M :W'E#S1O-W42CB(:-14""&$$!DFR]0T K.&CZ&(LV?/9B3ZM1R%L#2_WB'G
M2,96?"DM+:VNKIXS9XZY4_I:0/>:^LE@7.B[0]7>^][W?OC#'W[( QKS^<]_
M'DH#\<#G$VT"-45#<9P07+ER!=;TCG>\@R-I^?GY,)QO?.,;%)L6-V<;+['+
MUJU;V:04&'C72#=?%R\O7+B E!_[V,=02'P,4F[XL=4MJS-Y\F1\31)NF:5^
MJBE!R>?/GT]=&>&>:(KRTUNF3IUZSSWWH,KGSY^'RP5NH=KO?.<[%!N4),]Y
M._;BLV<0?O_[W_\'?_ 'K>XY*_Q(<T+O'7?<\<$/?A!9(0&:$=OWO>]]:&$H
M+JN<"G]/D!NV^/S#R;'CPP\_#%-%:U,4D;BJJ@H-R+6(K!904R2 N/K?(^S(
M$6:<QW,1%^X  (  241!5-_]W=^%FHYV#XG!OF]^\YMY.E)NXC3B[[WWW@]]
MZ$-VEE%:!%!([)MTP\6!>["J_4]T^O1IO,NGVN+<L<6N7KW*SP;JPG-D)1Q$
MI*9"""&$R##9JJ:6;^ &')#;_OW[.3Z#E^@*^R,/?3[*$"=>+VC/TJ5+<<+6
MK%E#G^DRV4#1$S7- =K<_' TYN<^][D\IZ8TC8B:\KFF4,<@_*>@U2UI8V;+
MESPI#SSP *2(7PR.K2&>0W#X&"];MNSVVV__N[_[NQ9W.R5D";+*<3PV,L(<
ME:7=P0Q?>>45CKAR&22[XYKD.0,\<.  1TUQE+_\R[]DL?E]Y(<DZ=3TEA^8
M#C?8RX?'<,B1=V,FW'(^+6[A'U2*DQ?P943D#W[P Q1[\>+%;F#RM=9#O=[Y
MSG=R7+3#*1D?_I1R1KU^_?H\=[<M6Y)MR-9C:7G39BI<E&BT6U:7*^*B!>"3
MAPX=>MO;WH;VH>SAK:]^]:NCNIK0^\,?_I#Y'SY\>-6J59<N74JY'RAX-7]&
MFL/%F3[YR4_"/UE3!%!").9I9=DZPCN06>O /7;XW+ES>_;L.7+D"*O 5F(;
MHE38G6<PZ98FQKL4VD$GHJ8C]%Q3(8000J29N)K"12FH,V;,0'C6K%E44\+N
M5M!CW[$=DP.BII'T>-D0/@VRO+S\[-FS+-_JU:MMY*&WA\@BV&LGK":ZN8L6
M+4+XQHT;^_;M"]*\I$I/)O3F %2I#C=JBJI%U)0MC^W?__W?H^.^9<L6*I/M
M&[@S!>]*ABN^!J&:)L/5=U+NV9XP-PY:<JXLE(EV!#6BB!87%T-R2DI*BHJ*
M\*7%-Q8*RM%4?%';W VE?*XI+,N^96#OWKV0G]_YG=_!41"&8_SU7_^U*9#[
MAKY68-2Q)VK:[FXN7;!@ 8<<@W (EZW$-*UNJJT5  :+4J&";#>4$PE0'8YJ
MHO TS, 5!CO"\$>XA\?8A]Q*:X=(NCL_&4;F;"M$?N8SGT%SH9IO><M;1KC[
M3@-7GJ]__>N13Z:I*:O\V&./H3SX]6 ^V-$F5*><;4)$'WSP0?[F?.0C'T$S
MXBS8[R.K9JW'UD +//[XX_?<<\^33S[9X<2597Y-T)V:IMR0[UO?^M961T?H
M]H..W6O*<S1":BJ$$$*(-!-74TCI<\\]!RF=.7,F397]-.MDDEMV7PG[;.RV
M#;R:!N$3'5!$R-B.'3M.GSY=65FY8L4*WKO%7BQ+$-DQ!V"OW9HX<(-+Z.RB
M3XF7A86%3):^ND?4E-U6!J))LY:4^ZSRL]3EJ"F;%]LO?_G+: HX5:M;CJC5
M33<-0FUC)M05;!]ZZ*$1;ADDCI<B0[@KSMWG/__Y__B/_UB_?OU(]US3I)M?
M"NE"XC_X@S_@7--&!P\!YLR9 ^U\]-%':;F?^,0G4$CH*[V(X"T^=A5ZAO(C
M-]2%Q?9K86IZD\\,*]X>CIK"ZVBJS(=;/S$#7*%W_OSY;$]6'/7B0V+0;FO6
MK*FJJJ*W(\W:M6L1_\@CCU@)+3?^@+2Z)\=TN.64DNY>4^:,'*"">/EO__9O
M^'S>=]]]'2%\>(Q?-:KI/_W3/S';_/Q\WN :A&K-$]WL%E5"Y*E3I^"];/;W
MOO>]>6[4E.5A.9/A:KWFJQ#1=>O6Y;G9L!UNU2M^25'])O>L'62+-I\R90I7
M6F)N5L)!)+(,T@BIJ1!"""'23%Q-7WCAA1DS9F#+";T(L*?$#G;@]69[ KMG
MW&4 U-3@CNP(!JYPZ#[""DZ>/'GMVK65*U=&TO>\Q%D-VJ&NKF[;MFUHY"U;
MMG1T?GJD3Y];WB<^H=>P- -RH$$DZ30LY63CYFKZV&./W7WWW1LV;+#)G$$X
MQ,>//6R$8Z<(O__][\]S"_]PNBD'RK C/KV(7[UZ-=KSJU_]:A ^O?,-;WC#
M[-FSV]V]J?P[A@5K=V.)'-?BUXHK].(K;85'MK"^RLK*VV^_';ZW;]^^M[SE
M+?9D&B:STD(_W!?V9F>-SD8U-:_C-]H26 YL 21#XH4+%S(>A>&?1Q!+KF\T
M>?+DI)O1RFGY7*/X"U_X C.QW*RH:);KUZ\C)=*GW'--6:H.!S^9:)9O?O.;
M+ !2?NUK7\OK2DVY2%+@)M].FC0)^^*X/",\RRPGRG;OO?<^]-!#B,=!<091
M;,[^M0R-E/O)XYE*N7%1\'N_]WOFI?:'!?Q\G*/=_3W!)V!%LQL,NKO75&HJ
MA!!"B#015U,8*7044CIMVC0**J>SL;]D/>UH/Z8;V,OE[@.IIL1V1V\/V6[>
MO!G]W=+2TF7+EIT_?YY]2I8XA_';D%W>G3MWHM8'#QZDR739R%U&]I;AH*9!
M^*'O""?T\HY-&F;@5? K7_D**HX/(5_BH^@+9"H<Z(-^X%T^US3I9B-P](S?
M"&S9^T>3?NM;W[+;IZ%,^(KR[LUV-TT 'L67<!L(&':!:"&KCW_\XWGAJ&EK
M^-09?@/+RLJX7A$<XZ_^ZJ^8%4M+.IR:\HOCQT>@ ;[TTDNHP@]^\ -6D-_K
MH/,9MR;Z_O>_CQ(N6+"@P]'FAGQY=&@JG V:%WA3@M>L68,8M$#"+3Z<=.OQ
M\N/-8G.TF5OD-M)-A&YQM^9BE\]][G.3'/@I",);53EJ:F4+O%'3I ,Q:&0Z
M&.H%2^1D8&R???;9/_[C/\9;+ .V<%0DP^\,&SE"N[L?E2>("7A7,%H@Z905
M9Q;Y0^^AP1_YR$=2;L(PMC9".^A(38400@B18>)JREM,N0P2!U'9Y[3^*K?\
MT_^6I$*2_5=39A2-=:3<K7J<R-KF^OK0,__=(=+;&UC8&K9EW6$L9\^>A?\<
M/GR8TR,#;WAY8.E231F()LUF:)AHVS__\S]'[?;OW\\82I3QM:]]#>].GCS9
M'G,R;MPX!@"<<,*$"=>O7^?G_X$''J $FE\%;M0.WZO/?O:S>>X&/V38V-A(
M-WO3F]Z4<O82.-^CGG%WWA*)4P#!0\PG/O$)A/&5YKO4I*1;?0>!3W_ZTSQ!
M?&8)L<]&1ZBF-_F^V"?M1?=<4W@=OU^,MV0FO8S\WO>^AQHM6K2(U0^<[U55
M53'EO_W;OZ%4-MD56QA^GGL,#]IPXL2)*-5XQYAPO=RI4Z<6%!1 \%XSW8Z.
M$6YV=! ^\96WJN:YI\CP$"@A3Y"5, C5%!;*^K)LT%J>01P46WS([:!O?>M;
M4>P;-VX@0Y@JXG%>QKCGV43@J0_<.<59*R\O_^$/?\@BX6, 9W[#&]Z >M'W
M>*;XDWJ3EL\P6@9)""&$$!DFKJ8<*9T^?3H">#E[]NPF]Q!X]O&"L&/<J1/3
M/>ROLN_:7S7UL1W;W7@4^W;'',7%Q; R^ .Z]4'XC-,^'V@H$Z\4V^'4J5.7
M+ETZ??HT'\/(R'0T0G?WFD8$(*M)N55P6MWC<_GPF-V[=[>YNR7I0L:7O_QE
M6S!FI'L4)WOSC(2NH+GX'!'L^,$/?M"<) C'(3F0V.%N^,0NCS[Z:-*-L.&@
M^"KRCX:$6]^57ZK F4_@_BCZT(<^!-59MFS9PP\_C)P+"PN1C"J;='=+\FL,
MEX,:09S^XB_^(OYYZ.B9FG+0<LZ<.2@8O8Y#Q$S0Y;Y(A@_)K%FSDF[-WJ0;
M2PQ<^5F7?__W?W_C&]_(U9N0U<LOOPQ_&^F@HS),Z$AGSISI<)-X<3J0@(^,
M:G;K=9\[=^Z>>^[Y\8]_G'0.GW"SIK_][6]'/IE4TW_^YW]&L[#\W)X_?_[)
M)Y\<Z4XB?'B$>\[-SW[V,T[51IXXUA_^X1^B#/P*\(Q'0)'\,X4PSCZ,%(7'
M=K1[4NN4*5,>?_SQ5#BY@Q. (Y^KP4++( DAA! BP\35U!;IY=CITT\_75!0
M@#0'#APX>/#@KEV[RLK*D'@01DV[@[D'KF.W<.%"#CW!43F/KM6M1M-E=SEG
M8 63;F0,7?/JZFJ<6O1QITV;1G7WS8%M/B MW^6H*8DFS5I2SI0HA!0\?JXZ
M'&Q&?KK:NX+N1.6PT=$V-T<WZ;RTO?.46D[3Y5!G6PC]R@X7(>6F"C>[)]!P
MG21^&%A(_Y//STG"P626(7?A DO='8@PDW8WJ;C9X4]([@[6U(B\FW)+;=>Y
M9SYQ.2B6G[4FW-%:OL.--K>Y^>H(H!C\^R#II)?AFIH:[L):LX[^<3M<^_#L
MV%M6=QZ"AT:I+ >6C1\)5CQ>3N;\ZR,Y4FYR!_=EL?VCIT+B.PX*&S9LH)':
M5]O4%%>%Z)5$""&$$*+?=*>FG-#[W'//+5BP@!VMP#TZGATS>)\]M>'F^-VM
MM*@I2Q:$0T.%A87LO!85%:&SV^QN%6MS@MIIMUR!C>N_#%R;+%FR!*=M\>+%
M,(U6=U^BF0/3]+_E@Z[4U'JQEF9 #C2(\!-+Y:!(!&Z4LM$]5Y,)F/)U:W&$
MGO(:22=+*2>0.!'\H":=!R;"&==&JQLXY5>NW3U<I+JZFM^?2$K_N+[>M#N1
MYKZ,]'=AYK0IBR?<RPK?W8ECP5@D5(0IXQE&=F]W9IYT4M<6N_^9XZA(PYD.
M_,)2H2/BQV,Q@7VP;>D@O%M968DMZX[T'"OFR\#]>V6'YIEE##V3D=9B5E.V
M6^#.3JM;N9<? +[EGS*#+R/59,$"UQK\!XTIXR=W<.$':?WZ]?9UYO"IU%0(
M(800:26NIER5=\:,&=.F38.=0DV#L,/,CA;Z?ENW;HWV9KJ!G;=4^M24,!\4
M\>3)D^7EY2@N I<N74JX^_0"=V-;=)]<P6_#5K=(3%55U8LOOH@6/GKT*-JA
MW0UP6=]]H-H\Z$9-&8@FS68X:;;-+8UKNA*$MR8&X2Q0*E,$2B-%I=4-"::<
MY]@'TC\==HYH2AWA'T(M#DM&;$?Z'H=S$V[8G".H0?AYL,1,R9<194VY+R:-
MZY9?%K9 A_,Z'H@5C*9S,'/D7%]?;Q;GUSH(?U]H[&Q,5I^TAP/(K0Y&LBX,
M!*%7LPQMSF9;PE5PF]P::1UNA+.FIL:*Q*,@IL,;@+4B)=T?"CPTL^*H*7-H
M=LL+LPQ\ER5D[4A'3$U95,HP ZQO,@V3[?O/FC5KJ*.CW7VV4E,AA!!"I)NX
MFO)&TWP'['3.G#EM;D(<>U_L1Q44%+#7=TO8"60O+HUJRBXIMA<N7+AX\2*Z
MU]")'3MVM+M.<*-["&1TGQS"6ID/TJ"9%!86HM%Q=MD()+IG__#O-;4;TD@T
M:=:2"C^Q_ +@<T7)H0OUO$FI+CA!'&D,0F]D#GX^_([1;2P9WXK;#F&DZ1".
MTA(N7>OGGPJ_=TDW-&I9,6!'";S)"%U"&:.7<@*PY18O'F,ZW -(61X[4,IA
M89I>1[@@D/W<1/),A@3AG;<4RPXWX]J:R]*P'9AA9+('VXI'B;<M=T^Y#P#+
M1B-E)@@S$*\R(^/Q^/"TNS%MYA:XD\O,F=Z([)AYDNY7?MRX<312_M\D-15"
M""%$6NE239]W\.$Q4%-VPIO=[8KH7"U<N)"KJ_0$ZVLETZ>F[$$R<.K4*<[H
M:P_OM&1_O>.F7>TLQ2INV  1PC!S=-D/'#@0A-UK:X0!:?:@>S7-L5%3O]W8
M=-: #,1/A,&6-TUB3.!ICX5),EP8R3]'D9AXP,(16XX7+%(,P_^"Q L0(?Y6
M=]GZ,?'O8,K!@!]OC6 P9:JKB<TDDD,D6WL9WSW967TCY\+"!@OFU[=+.NT3
M8F]9@BX/,11(N;9ZX($'^+WFP*G45 @AA!!II4LUG3%CQB_<TTV?>NJIZ=.G
ML_.6<+?%)9W]V6#,+;&N6C)]:AJX8B7=2B>0L14K5B3=H$114='5JU>Y,$QT
MAYS [^:RE1-N>97 -<B&#1N2;M24 TH4)-MQ0%H^/J'7B";-6JRA?%E*N?\^
M_/;O"9&4=J88[C*?2&0R-MKI%\_"EB=?=DF7F1BW5";N8I[FYQ9)$\_<\ ^=
MZCR:&GDW@L6WQQ;WLGRLK>*9=!E)NJLX=_$;.6[:/8&[^W[KEX1'Z:YLF81E
MN_?>>_/<\LA :BJ$$$*(=!-74S[7%%[*L=.%"Q<&[I$3*;>$!_I4UZY=LT<M
MW!+K:R73IZ:6"05LT:)%+"L.B1IR6N" '&B(P[;EG6P(E)24( P_#SI[BR7V
M7_:-X:"F!C_'0>=!5&Z[\YG 2Q/$AMJZ3./'^.K20Q'RL[(,X_EW"0^1"I?\
MN0F1\OOX!_7#K(L=(DS^.I&8^$N?> (_322>1$Y9TL% E]G&8_Q3[/NP)>@5
M=MSH&T,#,^?[[KMOI'N"CI9!$D(((40&B*LI)_1.GSX=@9DS9\Z;-Z_-K;&2
M<EW6;=NVM;IG1D1[,]W #E@J?6K*')C;C1LW^))]1X@9ZL8 5[+)85AQZX*C
M00X=.M3DX+UM/ V=]ND?R&W2I$GLL/)N-!\_F;>3$")K>,][WL-14TJIK8?T
MS#//'#QX,'HQ$4(((83H'UVJ*5?H16#V[-FPTZ2;*EM04 #-:?$6E8SV8[J"
M0I1*GYH&WH!&NUN*MB-<TA.9[]^_GV6]Y4!0EA)IP':W,&G@VN3LV;-\_BQ;
M@*?!4O:_Y5/=JZD_:MK_ PDA!H6(FMIZ2%!37"UPY8A>3X000@@A^D%<36FG
M(#\__[GGGGOZZ:?Q[MZ]>P\<.$#+@.9P$#7:C^D*"E$JK6H:A/GPX1.!&R9M
M<X^:*"PLY.%[/LZ;740:D'+>XAY8@I?_\S__$[@3QMM-_<3];WGD,''B1(ZE
MV'"*X2?S=A)"9 W=J2FN"E)3(8000@PX<35]_OGGN9T^??H++[PP:]:LDI*2
M()PD:X\>[*%Q4 Q3Z5;3#D?@'L^ (]DC(E"W9/A\PDX[Y J1!N18<8=[6@9J
M/7_^_+JZNO/GSW.197^7 6GYVVZ[C3U7KI+B8VD&Y$!"B,P3G]!K:GK0$;V>
M""&$$$+T@[B: A@I[?07O_C%,\\\<_GRY9:6EJ:FIL"Y3T?X'+YH/Z8KTJZF
M?@[PTI1;I;:QL3'IUN>LJ*A8LV8-#^_ME(.PE>UILSQ#U=75QXX=PZGEDW\L
MY:]WZP?(Q]24HZ::T"M$+A$?->77'&J*RX;45 @AA! #2UQ-8:0S9LR G4YW
M+%Z\&'9:Y^#H(^FAZ]&8Z(9I4=,@7&^30X4L7'EYN4UJ11UR=<C4ARW)ZN,\
M44W1"#C'I:6E7 G)3SD@3)X\&?U4=%A'.DQ-1V@9)"&R'U]-\:7F.KVC1X_&
M):&PL%!J*H000HB!):ZF(#\_G\L@<5HOI*^LK P)BHJ*X#@=[@$ET4Y,-Z1=
M32T'YDEI7K9L&0(W;MRX=.G2IDV;4%P;3LPEV+)^#"W=7C8U-:$'>>3($53?
M;RA+T$]NO_UVN_TLLA*2I1G PPDA,HFOIOP'"B_'CQ^/JX+45 @AA! #3EQ-
M;=046[[DC9Q0GK5KUW+XK:ZNKH?&07M*I4]-?>BE8,^>/>?.G7OYY9?;W5*]
MQ<7%/9?IH0E'0;N,L3%A:V@+(X#NXXX=.]#FG)!MXLI;<V\"=_=%UV#F#0T-
M7 :) RG8LN=*HOL((;*-+M447_9O?>M;N&S@@A&]G@@AA!!"](.XFD)*N4+O
M].G39\Z<"37ED%O*W<D(T;MZ]:H9T"WACDR?%C5EUMPFW0)-7 $(Y4:@HJ*B
MN;GYS)DSN3JG-]Z ?DQ5555145%M;>V*%2LZW#-U>"[95FU=P2G!G!W-79)N
M'2G"!/RO N&[[[[;5D9AMY5A7TWC)11"9 6^FG*I,P1NO_UV!'#QD)H*(800
M8F")JZF-FL)..;F76D=5:6EIN7SY<GU]_5!14X,%XO N=/3 @0-<# DEWK)E
M2S1U5N&WDHDE7S)@K<Q(GC T!5K@W+ES34U-:]>NW;1IT\Z=.S=NW+C%L7GS
MYJU=L6W;-FZ1!@'LA< V#TNY:]>N29,F<0VD\>/'TTXYFU>CID+D +Z:3I@P
M@?\]X6N.&%XYHM<3(8000HA^$%?3YYY[#CH*+YTV;1H$%:8*N>,X&95GW;IU
MG!S:$TR:,J2F'.6[<.$"*M/0T)!()! ))>/AL@MK'(Y;LFIL0(YM(A)ANXT6
M=;2GYG#B-1?FM:8F3' 3_#1L5<JP#XZ+S.^YYYYQX\9Q+,5&32/WF@HALI3(
M"KW^_(C"PD*-F@HAA!!B8(FKZ<R9,V<X^.28.7/F!*'Q!6YA'>C/GCU[J*FW
MQ(0HF28U38:W7-*7..D4,GWPX$'>7UI75W?@P &6/BNP-K$ 9\^RW=B '6YP
MN,U-748U88DX,3Q)%%2\/'SX\*%#ATZ=.H43O&/'#IRSO7OWHBEV[]Z]=>M6
MA'=W!9)QR_2[=NW:MV\?8_ 2X?W[]Q<XD-7X\>/MR3&T4XV:"I$S^&K*;[=M
M\0.K45,AA!!"#"QQ-073IDU[_OGG.:=WR9(E$!\;J*,9056&BIKZT,U(65D9
M!TLYYKMHT:)HZJ&*M8D%3$JM=GZ[T50[PF6-UJQ9@Y.'^B*FNKJ:3Z3%*:2H
M<Q@YV7D:L _CF08@/=K0/RYA#KSK;.+$B1Q4\0E+)X3(5B(/C\GS;B;7D*D0
M0@@A!IRXFL)K9LZ<R960'G_\<6RA(8V-C?21RLI**,^1(T=Z.*?7=YETJ2D/
M@(!-;86C'C]^O+:V=M^^?8&3MRQ24\,:A_\*M#E,4SF;%S$X<SR+?)P#3E7@
M%!1GJ,/='$QC[P@G9+.53&CCM(<+'?$T\5AMW@)(U%3$W'7776/'CK4.JU;H
M%2*7B$SHM7^@\'W'KTWT8B*$$$((T3_B:@H7G3%C!@25:R!!4_?LV5-:6GH@
M!.E7KUY- [HEU*A4^M34<F#.U+# #?I!1^OKZZ%5*#&<C?$T.N["F)[3P]):
MMI;>8EK#YXO2#^EX+ _=CT.4EBQP7HIP75U=04'!YLV;]^_?7U)2<OCP89AG
MTJU(S-PZW&1F2JSM!9@GP\SPYD124D21"3R_K*P,9<!GY<B1(T>/'L5VW+AQ
MZ*V.=EB?E?@96E@(D45$1DT-1.JAID(((808<.)JRN5Y <-04\Z*#<*1ML ;
MGKPE-)U4^M0T#O-,)!+SY\_'46[<N(&8%2M6,)X5Z*V4$N; ^D3?ZPK6E&$>
MD4=G]>FB4#[$0/0IDTR&<$U-#4I>7EZ.+4X#I+2AH8%9M;L%D)+AM%X[!+7<
M+QNMDFIJD3V$U6QV!"[SBHJ**U>N(#?&H(6G3)G"/BMO1>OR7M,^'%H(,13H
M<D(O ]$KB1!"""%$OXFKZ?///S]]^G1L?_&+7_".4_H4[938N.,MH>#0N=*H
MII%\^!+NA%HA7%U=7555Q1A.<^UY!>*P/M%8CW@"UC\(%S3BPD4=X0S;%@=B
MVMQ#8]>N7;MERQ9LSYPY<^+$B5.G3C&3CG!<U/PVZ+P*% _A'YV1O:ILI/!M
M;J4EEA->>OSX<2Z\Q#MX.9L7W58&?/P,+2R$R"(B$WKSI*9"""&$2"=Q-:6=
M<F8O'QY#_;&QMUZY!DTGE6$U90PL%+6B5G%8DF_YMZ1:^K[!ND5B_/@.-R&6
M;YDB<GB3TEA?7W_Y\N7KCI4K5_+F6/HSTT "*8=<RBBBFA'MY+&X9:/'T]P2
MJT(0WN9J:KI@P8+ N31SONVVVSB;U^;[24V%R!FDID(((83()#=14UND-V*1
MO7(-.AHM*8UJ&H>#O,7%Q2EWOV5M;2W]"N5H:&@P>8OL=7/BZ>,Q)-Y8-M1)
M,4;U%RU:-&_>O#U[]ER\>!%V^LHKKS!Q,AP(A;5VN,>'4F5M]-)4TS]Z/,Q&
M#]RQ[*V>PV*TN@60@O"@>_?NA4+S7PJ\Q8>:0DW1>;5N*WNNED]W322$&.)H
M0J\00@@A,DE<3:&C?'@,@9I2IJA%OJ?TA%1(1M64V282B6W;MG$JKQVWL;&1
MUMJ'0S,'JT\0SICUX5M)=Y,G#\'&0B-"04^>/(E67K%BQ9HU:Y*A-YHS<Y8L
MUT!BHS.FW=U<RF2,9,ZVM2(QQF!,W]34/X25#5EMVK0)):FNKL9;4Z9,R7,+
M\W)M7G^ME$@^0HBL0\L@"2&$$"*3Q-64=LKQ4BZ#!#'APC<IYW=4JA[B>U/F
MU#1P,WAQ"%2)0Z90NU6K5E545/"6SJ#WAV:9.8!)\TRZ!ZBTN;LQ"1/P/E(V
M$\)HY=FS9V_8L.'RY<M<V8@9FKM:_O;2 OY_ /%W@\[K.3$^DB>+:C$]A_DP
M?\NSOKX>@DU-1>2;WO0F]E,G3)C $53KO$;R$4)D'=VI*9":"B&$$&+ B:LI
MGV@Z??IT;//S\Y][[KG%BQ=OW+AQ[MRYRY<OAV'-FS=OS9HUE-5;0N&B(F5.
M36ETB40"5O;BBR_BV COW;OWVK5K@;N3D\G:W)-:;"\6QHK$<OLQ07CO95BI
MU^*19UU='?(I+"Q$&VW>O!GF!C$V?0W"H5$^[L7&/_U#IXFD&S7MFYKZF-]6
M5U=C6U!0P+K_YF_^)F]"&^$$U6Y(R]-S387(?FXRH5=J*H000H@!)ZZFG,=+
M1WW\\<>Q#9S-<9XI5\#!CCWT'9.XC*IIX')N:&C L6#2$*JS9\]NW;JU)5P:
M-Y+2!CE95M;-+QLC.1,X<-*+]+MV[2HI*4'S0=5V[]Y=65G)*:]X%REK:VL1
MP.'JZ^O;PR>X0%EY]+;P$2QI9:#4E+!Q\#FX=.D2JKQFS9HI4Z:,'3O6O-0;
M4_GUJ*D0(DO1J*D00@@A,DE<33EJRK5YL5VZ="EGJE),.-"X??OV:">F&[A7
M*O-JRDFG"+SXXHM'CAPY=^[<Y<N7+UZ\2,,.8H.6C(R4A^4.O,30W<V;-S_E
M2#E/2[IIO8&;N\N8(%R$J<U[(&P0WJW;X;"7:66@U)2G,'#53[KIW4U-38BY
M^^Z[QXT;-R(<3K%!E1%24R&R'ZFI$$(((3))7$UYERD=]9EGGIDS9PZMI"-\
MK.:Z=>MLINHMH=10\3*JINWNGD^4&)4\=NP87L)+.;!IPL89MBWATUE84.Q;
M5U?'$K.09\^>+2@H0.N@C0X=.H1,\"['/&T UC?8I(,!2Q"I:63D-DT,H)H&
M876X1:,E$HD[[KB#:_-R&20;0?4G]*;O% LATHHF] HAA! BD\35=/KTZ;!3
MKH<$-86@4N),1XN+BVU(\I90]RAZ&573P.E?8V,CM+.HJ*C-+5:T8<,&'!%.
MQ65[ S<,R)1)=Q<H*H:WZNOKL>..'3MFS9KUQ!-/P&SIHJQ_X";TLOR!-Z!J
M_L:7!NMOX4@@K0R4F@9AO?AX6#14;6WME2M7QH\?#RF%D5)0;>Q4:BI$#G 3
M-8U>28000@@A^DU<3?/S\V&GSS__/ +3IDV;/W]^X,8@.36UIJ:FLK*RY[)#
M+TME6$WIS1S?0UGAEI#)ZNKJ9<N6\6991%)*4VX*+I)55%1LW;IU\^;-\-BR
MLK*C1X_"OI)N\BI,-0CGZ%)B_?J;HYNL^I$^K"R;PUZFE0%44\(F/7GR)*3]
MXL6+;WWK6ZVW.LI!+_755 B1I4A-A1!"")%)XFHZ8\8,3N@%<^;,@9K"1^KJ
MZ@(G7X<.'8+IT/BB_9BN>%U,,ZRF07A79+M;?VCOWKV!T\55JU;QW:2;QWO]
M^O7R\O(5*U:@PKMW[Z:U<D08ILI"MCJX>!(<%9%-34V\K33HQC;]+8]K"8ST
M5=QGH-240Z8=#K0&/BZ,N>NNNZBCX\>/M_%2J:D0N<%-U%03>H400@@QX,35
ME*L?\5[39Y]]]KGGGDLD$H&;Q(IDER]?3H;W8/8$2EDJ\VK*Y8YXE%V[=K6&
M2SG-G3L7.LHR!=Y0IXUS4KI\F-)V&?I8.5GF[M2TN^J@!6IJ:EH<D/!V!QH*
M3827"Q<NY(VF"$^8,(']U-MNNPV=UY$C1[+G.D+/-14B^^EN&22IJ1!"""'2
M05Q-9\R8,7/F3 CJ].G3X:5///'$E2M7EB]?OGKUZ@XWFY6#D3TT#LI1*O-J
M:DJ& Y\X<:*TM#0(U]?ENQQ1M,1^^/4LLA_6JSLU[0XZ?*M;?)C_0Z3<DWBP
MQ4?DXL6+@3-_J.G4J5.AHZ-'CQX[=FR>6PS)>JZ66RZUIQ##BIN,FD:O)$((
M(800_2:NIGQR#+P4 6@JPOOW[^]P#^QD=X43>GLX<$HY2F5837F4JJHJWB *
M7GKI)4[*19TO7+A@*6E?MI?OJQ'\>*N5]_Y0Q-PR^D:(5<1@>L(S;3?9-C8V
MXJ.0<N>.C?;&-[Z14HK>*A?I-?Q#6%@(D47X:LKOM=14""&$$.DCKJ8V<#I[
M]NS\_'R$JZNK6UM;Z^KJS%-Z/@[G*T_FU-2@FS4U-;WXXHOEY>6(.7?N7$U-
M#=^-.%NZ"Y,Q_$9/=EZTZ298]:]<N1(X%VUH:.!LWE;WL%;$GSIU"JV'EYS0
M"R^=-&G2Z-&C)TR8X'MIGM14B.Q':BJ$$$*(3-*=FH+GGW\>V[ESYS[]]-/H
MI7"=VG:W5"_G>$;[,5WA6U)&U;3-W1O9X>X@1;BDI"1PJ^R>/GWZQHT;07AS
MJ5\ "[/$?CA]Y4PK23<(S!'.(#9&RAA+S# 'Q.?-FS=[]NSITZ?C$X# G#ES
M\"' !^+QQQ_'!^)_W=-O\=;==]^=Y]9 8I_5[[E&LA5"9!V:T"N$$$*(3!)7
MTQ<<G,T+&9DY<R9L9<.&#<7%Q<>.'>MP2[2VA\\XO27F09E64QXR"/6LJJJ*
MQT4=+EVZU.'NF@W</9-Q<_/SB> GN'G*H4"'6TF9E8W#A8[X[)RD&UQ-AFUU
MWWWW<9"$TW2YM5XI&3UZ- ,<41GI8)H16@9)B.Q'RR )(800(I/$U91&B@"D
M%(**,"=UPB47+U[,U7IK:VLYZ'A+3/>2F5=3_R5*S(>^-#8VKENW#D=G37(/
MJSCE,^'H[*2OP[<HYSQ)W!V-\^"##XX;-\Z\U-24\NGKJ#_3CUL2+X\0(KOH
M3DV!U%0((800 TY<3;D2$A]M:FH:.--I:&@H*BJJKJZ&XD4[,=WPNIB:FG[J
M4Y]*=;;3M.(+]-JU:X\?/W[FS!DX*FJR<^=.5(-WT'I[Y C)<"@8=9P]>S9=
MU$X&$_ 4H/HX_7XC\ 3==]]][(.B5SIZ]&A[-HQM+<8W4L#15&QYE)QL7B&&
M"6:GV(X;-XY?;?XMA6M&]'K22^"WN/S@HH) 86$A MA&$V46E 3U*G3@BHCB
M15,((800(IW03@\<.&!VRH?'_*][QBG(S\_GK,_ W;;9TM*R<>/&1"+10[4T
M(<JHFE*]@E"T\/+2I4O%Q<50T_7KUQ\^?'C3IDVH RJ3P^[$=I\_?WZ[>]I/
M*EP8*>F6X>6S7O'6H4.'VMS=PS1)!M E91^4\LF!4SJJ=57IHF[0]#7L)7=D
M^P>=_R 00F01OIH2FT;QF<]\YE/]X^&''_[D)S_Y)W_R)Y_][&=_]*,?+5Z\
M>-E@LV3)DGGSYFW;MJVTM'37KETTU>@U4P@AA!!I(ZZF8-JT:7RTZ;///OOB
MBR^:EW*8[=RY<[APFWK<'#I1*L-J&@&':VYN1L^CHJ)BZ]:M4%,^!Z6JJJJ'
M"]AF$::"M- %"Q8DO?MI+6"^ZH^:,@8OW_6N=[$#:D.CIJ.<ZQM?E=>@O@:N
M)/)2(;(74],1;J[$Z-&C_7^CJ*E]YK;;;D-N$R=.1%93IDSA(2SS00$%N/_^
M^W&EP#6"8[FX*$:OF4(((81(&W$U?>&%%^"EG-8+7GKI)8XO!LXUH'B0RHT;
M-YKFW!S*3BK#:DHKXX$9P$'S\_-/G#B!RERZ=&GQXL5-34UXBT]&,;B+'Y/M
MS)T[ETT=J1?5%"T0F=!+[KWW7G83_5%3]AW'CQ^/WB2ZE8R)8)V\2(9"B*S#
M'S6U;S=_#09$(_DWUJ1)D_(Z+[<V6*  =]YY9T%! 2Z-NW;MBEXMA1!"")%F
MXFK*Y7FG3Y\.0?WYSW\.4PW<D"F<SHRRN+BXAPL)T?52&5;3.!#1EU]^^>K5
MJXV-C0T-#65E9965E7!4.K>1 UYJ8Z2V>A7-TZ\:PEP ">!<1M0TZ2;TQKN>
MHT>/AI':DR1&NE$4=%NY90#B.L[1$2Z#'/=>(4168&K*7P.;Y!__<>@#8\>.
MS0N'7OD,JI'N)O9!!#]<;WSC&[=LV;)OW[["PL+_T[VF0@@A1&:)JRFD=-:L
M6?GY^7#4V;-G+UBPX/CQXY"XBQ<OGC]__LR9,]CNV;.GKJXNVH_IBL%44\I8
MRHT-PL1>??55U ''A9T>.W8,+_$6A3NZ9Y9C-4JY>TV['#7E_:4I-Z'71ICY
M%EYR&23V&CF>P,[HQ(D3#QTZ5%)2<N3($>P(PS_L..) H+2T% %L_6,)(;(1
M?]0T[J4VV-@WF#-^4D:XY=9(-%%F09&@IILW;\:O7'%Q\: ORR2$$$(,-^)J
M.G/F3-@I9_-"39]^^FE$+EJTZ+GGGILV;1JV$%>\U<-U>JD\J4%14Y_V]O;K
MUZ]#3?G$%,3PF:V18OB&E@- ,E]ZZ26[G]:O&BI.(XV/FB+RWGOO94?-WS*0
M=*LH14:;#3O?T3>$$%D"O[_8OO.=[QP_?OSH$$Z.,,;V#TZOB$2.=^2YN;Z\
MH=W^'>LSO<KA]MMOW[9M&Z04%\7HU5(((800:2:NIL\__SP7Z7WAA1>>>NJI
M-6O6<.XGE[.%YG >:$-# V+XDI,W&QL;@]C:-S8@-_AJBN.N7+F2)4:53IPX
M@7C4P?>H''.J@5)3 R]Y[B+WZ HA<@S\++SO?>_CMYX3*")T=KI>TV4.>6YX
MEB.T'$3U?W\RP-2I4W?LV(%+(RZ*FM KA!!"9)BXFG+(E&KZ[+//3ILVK:"@
M@ FX17K$;-^^'5=PO-RS9\^V;=M@*UPAB0YHW1MZ;*;5-&Z8-.;5JU>SB"AK
MRDWTI9I:^OB.6<T JJF]3+G5?:6F0N0P_.%^SWO><\<==PR@CMX2FS9L8Z=<
MPC=C1-3TX,&#T6NF$$(((=)&7$WAI9S3B_"L6;-FSYX-#8'*M3MH=HE$HK&Q
MD<J##@PTE9'0EOKZ>KS%.QD#;VK8(*LI;>KHT:,G3YYL:FI*N<?)!,[0NDR?
M&PR(FAI\237M;D*O$"*KX4\T Q_XP >@HV/'CNW22WUE'2CRPE'3D6YMI-MN
MNRV:8H"(U,6 FN)ZQHNB1DV%$$*(#!-7T^>??W[&C!D,O.#8OW\_$G#-0HZ@
M8A=$VA*&!P\>Y) IK=/OYU!_,JVF<<R5ERU;1LE&R=H[C_"27-+4/JOI>][S
MGA&=U=0Z<U)3(7(>?LWKZ^M;6UL3B432W;81@3^D TB'MZQWNWNZU9UWWGG'
M'7=,30/VR^:#7[FI4E,AA!!B\(BKZ2]^\8O\_/S_=3SQQ!/SYLVSW@(#UG4)
MPFE?G![;X923?0QGHZ\G8.+!5]-V-W"Z:M4J"S<U-77$K,Q_F>WT64TCHZ8,
M<,(;S['45(B<)#*1A,;8*46:L</YUYL!QS=2'ZFI$$((,8ATJ::  2Z)1)<,
M8GT&^J?U'ZPSPP"WU)]4AM74BF+0F%$:U+.^OIZWF+;%EO.)[YC5#(B:TD@M
MD)*:"I'3\"<[&IM!XA>5@>6U"U(W3 WO->6R"M$+IA!"""'225Q-H:/T4KOO
ME)-A*3C4&5[<[2IOIFHQK_< /$W-J)H:5A0H*"<<O_+**]>O7Z=9K5V[ENL.
M=]JG-\2ECFUAS<1(2^"WE*4Q]>=;#%MS6_H^,"!JZCOJ"$WH%4)D.?@1"T=)
M?_W7&]&HJ1!""#&(Q-64HZ;D>0<GZ-)?>FM)5*W48*FI8?>:GCY]^O+ERP@W
M-#3,F#&#[_JUZFT-@W *G&$MQ:PB.AJ$VFF1\7@_,H@)<,_ILYI&[C65F@HA
M<H:4IZ81I*9"""'$(#)<U!1U@(M2TN;.G=OA;IS]C__X#Z[3Z]>J5S6T=D$^
MR!_AQL;&I%LR!/*&0%-34^".;H^%K:^O1PQ7%D& "<K+R[E7:VLKUSAN=TL>
MHY6N7+G2Z9"]H<]JJE%3(42NDG)JRO%2C9H*(8000X?AHJ8\*)DU:Q8,L*ZN
M;M6J5<>/'[?!R:#WU2/,' $HI46VNR?M0.',?E/A(E$\(N<8\RU&TA4I?C=N
MW+"L^E:J8(#4U+IN#*3<N9.:"B&RE%3L7E.IJ1!""#$4&"YJ2O'K<$#&KERY
M0KE"Y5DE7U![#O>%9**-+ERX4%96AGHE$HDC1XZ4E)3\ZE>_XDAILP/B>O+D
M2:2OJJI"@L.'#^/EL6/'\!;.!%[BK?/GSS<T- 1.=\^>/8NW6.;.A^TI4E,A
MA(CPV@4IAM14""&$&'2&D9HV.0)G?1LW;ERV;!G"!P\>M 1^^AYB>U545"#/
MK5NW0CO+R\MW[MR)8]77U[.]X*ZOOOHJ1#0_/__,F3,HP#/// -3K:NKNW[]
M.EYNVK0)0GONW+D3)TY F_$6E+*RLI)-;V[96]*DIAS7]7<10HAL(17>:VI>
MRI\XJ:D00@@QN P7-;7CPL=0GWGSYL$A&QH:"@H*3"][6S?"\5C(YY8M6Y #
M!!4'VK%C!V(XOQ?^B7@HZ/GSYR]>O'CITB44X-BQ8S@ZVP',GCT;Z2&E2(:3
M ;E%P2"WS<W-B,_\J*F601)"Y"JISLL@V0_="*FI$$((,:@,%S4-O*(C4%96
M5E%145-3@SK7UM:V.VBMG7>Z-=PED4ALWKP9E=JP80/R1^>FS3VK)@@E$,>Z
M<.$"='3Y\N7PTI*2$NP(^613+%JTJ-TMU!2X%94*"PNM)&PN[X"]H,]JJE%3
M(42NDM*HJ1!""#$D&49J&KC2<(P4<@B9A"[" S=NW$C1:G,/F.EM#0ERV+9M
MV\Z=.V&\K:VM"-37U]^X<8-'J:NK>_755WGO*/H]SS[[+-04+QL=$%0()'*X
M?/DRFP66RVS[/%Y*I*9""!$AU96:YKE?.:FI$$((,8@,(S6UB;N@J*@(%88H
MMKO)O2Q,0T.#GZ:'L$7:W3)(ITZ=0E904S3EF3-G(,!X>?[\>>@?7E955>&(
M$%'H*\*G3Y\^<>+$D2-'$'GQXD4<'9'(#0FN7KWJMT\?2D6DID(($2$E-15"
M""&&),-.34W#_NN__JO=3>)=M&A1X)XORH5V_5UN"?/$-I%(8'>ZKE\['L("
M2 .IXU%2SD(9C]UM<B]B_+9.A2.]?6! U-1WU!&ZUU0(D>6D.JLIPT1J*H00
M0@PBPTA-":L!#T15VQUGSYX]=>I4'[S4!ZK&IK$&8FX63P]L<S>@,L8DELK*
M9@J\1[#22"W#/M!G-=4R2$*(7"7EJ>GK2AHB-15"""$&D6&DIBEO^!%E>.&%
M%[9MVU9>7EY75W?LV#'$\%DOO:JA96A[^2.<YI:6K26S@&EATI$*&YK[]JW1
MC3ZKJ49-A1"Y2BHVH?=U,96:"B&$$(/*,%)3P@JTMK96554A4%965EM;>_CP
M8;[+-7)[19?BYTNI'^,G\]-'Y)!Y4AU]U^TM Z*FUG5C("4U%4)D,ZF8FA*I
MJ1!""#&X#",U93DL;,)665FY;]\^E JJ!N.*>%I6$U%3GYZKJ>^H(S1J*H3(
M<E(Q->7+$5)3(8008E 97FH:A..3V/*I+:@;2K)KURZX5JLCNELVTV<UU;VF
M0HA<Q=0TCM14""&$&$2&D9H2FE7@W"QPC@J:FYO7K%F#0'NX.FYNT*6:\A3>
M7$TU:BJ$R%524E,AA!!B2#*,U)3E8)@W<-;7U[>YQY#BY?+ERVMK:WM;O2'.
M@*BI37AC("4U%4)D,Z]=D+H"OW*WWWZ[U%0((808+(:7FMHVD4B@ $N7+J6V
M(7+1HD50M5P:,@UNJJ;M[GFJ*:FI$&*8\=H%J2NDID(((<3@,HS4E-#' K=(
M[W__]W_3LLZ<.;-GSY[R\O(^K- [E)&:"B%$A)2601)"""&&),-(36V U,(+
M%RY$8:Y?OW[TZ-&JJJK3IT]SFFMDQ^PEHJ:LN[7 3=14RR )(7*5E.XU%4((
M(88DPTA-"6?M8IM()+#=LV</2M+<W(S(%2M61 88LQU3TV2(K4+,Q^3@1!PZ
M="AR:O$6U'2T SK*[0B-F@HA<@)34QLUM9^XVV^_?>?.G;@6XHI86%B(G\?H
M-;.7(!->90\>/(AM04%!-(400@@A0H:7FMKP(%R46S[1%.&:FIH-&S;XB7,
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M5,3ERY<'X<-%4VZ$=M6J53AB>[A0<. DUC]H?T@Z$)@W;QZ.%81>VN&>#<.
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M=W<7%Q>7E95U=G9"U$'T<G&:Z%T )\<6WQ*)1)J;FXN*BN)!]".:9;_]H?V
M,H\__GBB--6HJ1!BQ,$W4#BW__PAP9.0G_[TIZ.<0R^;2M.H^/C!#WZ0@9?>
MEP5I["O&C!FS<.'"ZNIJ3CW%6YSJE$BC"B&$&'%(FKXS[RCNW'JW;=M&5]O7
M7W_]Y9=?]MUNA_2W_<*Q(.C1G#ESJJJJCAX]BC.?.''B].G3QXX=.W%W..G
M^>OKZV?.G!GS O9Z/[-?8KVE*8TA2\0D3840(Q.VA-:P&VPD@[?5>Q,ZECD_
M^]G/&%$I+8AMGN9% $[SUJ?AQV'C-\M;MFS!FQNZE--039IJNJD00HB12*I+
MTUA@D4!K[=RYL[.SDXITZ]:M+&!CI\,&TK2CHV/5JE7;MV^/1"+\"F0FFD?O
M%W:3\..+BHIXP4,%0CD^,<^A-]$8BDF:"B%&%(D-(+<#-(-#@J?ZUW_]U[1
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MEJU?OQZ)5:M6E924,,V/V.(C,IFS=NU:B,!UZ]9ABX](,!-V W)0'CDLO#8
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M_W=.-PT?*8008G D2E-K:=,TUU0((41R,51I.E0D39.66X[.SLZK5Z]F9&3
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MA$AN)$W%\+$YHCTN#!+E*.,A=75U06KRWN/C=[_[W=&C1U.4IKEYIZ/<,J>
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MFMHP*;:0D965E;6UM4BL7[^^L+!PIH.V"\4G%2EG*)EQ8Q$U"#W$D"@K*U,
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M)DS@^.>4*5/0,J,=9E@X%%CHX$D8%QWU$-OERY?C*'PO&FH.=5+CL?;ZZ<'
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MI%PUU/X+M2C35A[;.@<$*C0Y-"J%Z"]_^4M<#4C'>2X*D;_6*+0E9X3.<+
M!2KEZ-P@B!$3S"D(%GR>ZUQVH6F7+EV*[RHK*[MTZ1),4X:1B[LQ4H:1X_BV
M+7;(L5/3.U9>W'=X7V*2IB(1/KIXC!]^^&$N(4-=RNFFHT>/AC2-1")QS><6
M0HA!(&DJ1-) @Z>UM95F,U03Q-N$"1,@31F/)]^%A%VY<F5M;:UIOP<0#G[6
M.+7I*](:Y[O+84^_/!6IG\_R!PX<V+IUZ^K5J_&7&:\XWRT*BJL!Z<CH1+/<
MZLW<4F=B%S[207>6"UED6I3S3GF@+U#IT\O)I?C&-]]\\]RY<QP"]0=%8<%:
M]#@3-5R#E'J5DC4>Q)GK=7?%_8-/5DS25(1@M>"S"A6:Y:!%Q4FGV=G92.,A
M;VMK\Q_IF PL(83HBP$<>L-%A1 C 7J-$4@UAN&AJZJ)J&W;MOG2[L$$\I+S
M0JDYJZNKZ9H+7;UOWSZD]^_?CTP4JZJJ6KIT*5<$A3Z<,F4*5V/FG^4?)_2\
M9;Y)4^8C45)2 @'/-6 H1//=K-'BXF(H?)P?RA/'KE^_OKZ^_MJU:RTM+=>O
M7X\';GU4F*%;X.<;U)_<Q8]6H$=Q4AX\)$W%0%"=0HARNJEO47$<]>C1HV@L
M^-BS)H5/(800PC& -%7C*<2(@X^MF4 '#AR 2"LJ*J*3ZESGT O=!0T6%H(/
M&#;L"6G*0=$C1XXPFM&.'3OV[MT+=<UIH@Q6Q"BXU).+'*'9H05NB1>3Z*94
MZ8[+::*3)DW">6S1'2L)#;QGSQZ(85[;'K=,"P<VJ22Q[>SL]&]!?^VG;Y=2
MW?BBM$]E*^X[O&LQ25,1@@_S;>>OGYZ>/LIY\)HY!7)R<K!]Z:674%6LC?"/
M31VL0R[5_OC@"37]NE B-9$T'09L/>R5%-ZM]D3<;V*!BQF$W/GSYR&Z(% A
M3:=/G\[QP"5+EE#^U7A^L(>=WVQOA1C&"A\*UFNQDS!A;K?^M$^FL>4:+?:1
MQ7@J.\]!%Y*7CKO0HO7U]75U=<C<O7OWVK5K%R]>O'#A0NI&*%+.I(7VAK9$
M&GOQ9^F%R_FB#*C+85(>13E*0<NK@>W$B1-QB2P>+Q)E965GSIR!,=G>W@ZS
M$PDZXO8$3KFDJZL+N[BNH1[\9.5=82II*OH$#4$T&D53FYF9"6G*D5(.F=*_
M][GGGD-ML>GC?=H-R<' C2![]>+O52PUL6O"E[<0*8O6-1T>_77_T6*)JVT1
M]PE62.M[?>NMMZ#WY@8CAYQ1"=U56%AXR$6L-2EH(7 'B2E)7Z!R"BO5)L\6
M"E;$! 1J2(@R71-,)>6!^_;MV[1I$U1TOO.JQ7;!@@4<^:2\S'=39PM<C*)%
MBQ;A(V0J!X?-:]?&16UE5XI/'FA[ERY=BE^%;ZRLK(0BI?,=[2BH#\I1TR.\
MSL1V29HF,7:[)4U%&+[L(Y'(U:M7393:ZJ9DXL2)K#"T#]C=Q88C%6#4>/SE
MF->C'RZ4\L1=[+O;SB'G[;??ON6Z0GM5-2%2@Y T]0D7%;WQW?#,?HT%[GEJ
M4L3]@G7/HKQ.FC0)NHYJ#<QW0(\U-C::"*RNKC9WV7>E9P*VBTK2CTY$>0FA
M6U55!2&*712]ID@!_7(/NV5%3YPX@6]'8O_^_9""'#NMJ*C Q]+24HC,:0Z.
M:E),<L#3$@4NE-'"A0LI+^>[A5LA2J%CN5++'+=>SBP791<%ID^?3CF*CU,=
M*U>NG#QY,BY.?7T]K8(0ID)]?'^KT-[$PB)I,.M1TE3TPM[W$!*4IE"DZ8Y1
MSKF7#KVCG!\:%%HT&N66[855K&2EQQ%W*VYW='18./)4^.]#I<?%>>:U0L.B
M\0V1LDB:#@_?0N4RVE2G;6UM<1FIXK["ZL<M*BHTF$VVM(%$J#YJQ8:&!JA$
M#F/:B.5@P.$U7KQ<P*!$X("#!:A[>5J;.(H<*EA05E:V>?/F#1LV\+=Q;!-2
MDXN"4F3ZHI1B=?'BQ5";C*";[\:!J6"AO7$@/D)\4H%#OB*!')1'X14K5D"!
M_^8WOVEJ:N+U85Q<?P##KE[B);5\O[!(>NQV2YJ*,*P,/6ZZ^?>^]SVN'&,>
M:%SL=.S8L<W-S2C3TM+"D;%+ERXEY:BI71-":8K$C1LW(,C]Y^6WQPA'W(W
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M$#-Y"(MA%SXRDS#_?8>GM>^"8,9OQI;#':'_R'_'-!/<(A^Z]",?^4CX["D
MKALGW_(ZI 41>@%NXK9MV_RJ)402X)MQG**/!O,+7_@">]G8]?9.M]:H47A
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MYN+N<A4&[.(98.TPPO!M1103]P]6[)BDJ1@8:P''C1M'0XHB;51?PZ0^-F*
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MLK)CQX[A*V[<N/'::Z]!@K)A9<_?K6 0=>O6K?%[Z%72$_1'?O_[W^?_LBO
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MN(;==+WP[)GU5:C9##P/9:J=T$\,;/SP94K#*>Z.NAG$GK0<^SW\^.Z10CP
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M!TB:"B&$$$O%_[4E3840W07N)V^]]=:0(4,&#Q[,&20(5"YQY$NGT D(XS+
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M7_[B@>FH1+-SL2F?%V]YG_;P6UX>#T!'G'M,.2QYK1J T9-0>)^*Y%G&S<,
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MTO^%BZH6YTB?.(P?F6--F"MFF>GC;<4PE.MQW$Q2Q,6V]QV39<IU!E.NLT<
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MP3"<(!29EX\'^$/N0IH.M$]W\I$;LV-(U)>K3 <,&'#???<5;9J]T=Y,]LW
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M%Y:H ;;99ALTRX]^]"//A>'1\FA_*"7J$&3!F54WY3TPCU7K2_^E^F1@@ ]
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M#[DS,'[29G"C*&UKEG<5+&?2:Z4IQ"%36'WUU0\ZZ* ?_. '.!Y0C?WWW__
M P_\U:]^18.LSC:5VF.//=!G[%?/CBE[&= '.^RP VQE&-QGG'%&T?:YHGC8
M9IMMCCSR2-CTR'?_ -PP8??==]\?__C'?%S1TO:=8";>?=(T/D7/FK"@U\/3
M$=<Z)FDK3;--::":!Q]\,"N.%F!EB[:6'7V!MGWDD4>X3)="B,:QI\\+!L?A
MPX<C%[1DV4 4*EN^T<>^8,LTV5NL-+ZA>WDEG'KJJ8OL=<2H^$N(ZT4W4\N<
MS5<_#]/O5FF:6BY%VYFVSE[!Q0#;;[_]?#S#P3$,.,P.,O 36C%N7H?E ?R
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M=^^&-,T2LV0FA+'H>/KIIQ/AY2B-&S?FREY:ZN"H5Z]>\^;-N0%5LZLJV'V
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;1DT":?K_ .,23'8Z$P=F     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_15a.jpg
<TEXT>
begin 644 image_15a.jpg
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M @     ZC&@*     .@PHBD     H,.(I@    " #B.: @     ZC&@*
M .@PHBD     H,.(I@    " #B.: @     ZC&@*     .@PHBD     H,.(
MI@    " #B.: @     ZC&@*     .@PHBD     H,.(I@    " #B.: @
M   ZC&@*     .@PHBD     H,.(I@    " #B.: @     ZC&@*     .@P
MHBD     H,.(I@    " #B.: @     ZC&@*     .@PHBD     H,.(I@
M  " #B.: @     ZC&@*     .@PHBD     H,.(I@    " #B.: @     Z
MC&@*     .@PHBD     H,.(I@    " #B.: @     ZC&@*     .@PHBD
M    H,.(I@    " #B.: @     ZC&@*     .@PHBD     H,.(I@    "
M#B.: @     ZC&@*     .@PHBD     H,.(I@    " #B.: @     ZC&@*
M     .@PHBD     H,.(I@    " #B.: @     ZC&@*     .@PHBD
MH,.(I@    " #B.: @     ZC&@*     .@PHBD     H,.(I@    " #B.:
M @     ZC&@*     .@PHBD     H,.(I@    " #B.: @     ZC&@*
M .@PHBD     H,.(I@    " #B.: @     ZC&@*     .@PHBD     H,.(
MI@    " #B.: @     ZC&@*     .@PHBD     H,.(I@    " #B.: @
M   ZC&@*     .@PHBD     H,.(I@    " #B.: @     ZC&@*     .@P
MHBD     H,.(I@    " #B.: @     ZC&@*     .@PHBD     H,.(I@
M  " #B.: @     ZC&@*     .@PHBD     H,.(I@    " #B.: @     Z
MC&@*     .@PHBD     H,.(I@    " #B.: @     ZC&@*     .@PHBD
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M1-,$T10 T M4R")W0:^5-M4XQ5'=;JJ/]]UWGY[3J_Y5/R,  /.$:)H@F@(
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M\;S5:K5Q20  M S1-$$T!0#TCK#66VFK5"IO><M;<NXZ7KW:-"R"X9.3_%P
M +06T31!- 4 ](*PD-4=&QD9&3GCC#/ZG5QPHZFZ4B^__/)BL5BKU7@2$@!@
M_A!-$T13 $#/LA, BZ:J>HJCGA7!E2M7ZH+>[&P  +0.T31!- 4 ]*Q:K5:M
M5OW5O&'YL^&J5:NL")9*)3W.%P" ^4 T31!- 0 ]:V1DQ,J<+WG^U:::8F+W
M4-_=NW=GYP0 H$6(I@FB*0"@9Q4*A5JM=O;99ZO7U-]KJA&K@^5RN3=/#P
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M+P"@)8BF":(I   J<WJ^D1Y]%#ZA=V!@P#X>=-!!M]YZ:]@> ("Y(YHFB*8
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M +00T31!- 4 0.Q\P )JN5RN5JN92WG[^OI6KERI>U#5F,H( &@)HFF": H
M0.R>;#3FV%E!H5 X[;335 T'!P?#LFA#-<[.#P# ?B&:)HBF (!>Y@N<G0;H
MFMYRN9S/YS_SF<_T]_>K[U37].H2W[Z^/EW02V4$ +0$T31!- 4 ('8=H<J<
MQ6+1AN>??W[.7<>;<^^/\5VF-J[3!BHC * EB*8)HBD  +[,^9%\/J\ZZ-.I
M+Y0?_. 'U<5:*I6JU2HE$@ P%T33!-$4 -#CFFN<32F7R^>>>V[.15.E4UW6
M:R,?^<A'BL6BY5)KHVN ,[,# #!S1-,$T10 T,M\@?/%3D,[-Q@9&?&=I3Z7
MFH&! 7U;=ZB2 ("YB(BFHH)*- 4 (*3K=54*?67TW:?Y?-Y.&ZJ.3BFHE0"
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M030% "##3@QTN^FXLVW;MN.//SYS*>^2]-F\NN]TV;)EW&@* -@/1-,$T10
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M.^^\<]NV;997+7E>?_WU%EG5.VIG+ \]])#%U+ONNLNF[-NWSV)M2RHUT11
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MJ)G>8JH1S:O3-05(#6TA^7S>IBN=ZMO]KMI$4P!MH$-91#1-141348TAF@(
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M7-"K FJG&0J*>NC1?%=5+=Q^*Y_/^[[3;*-)$$T!M$%$-&T4$4U%-89H"@!
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M@9E$TU#=7<&KGLE.7<H;!TDX'/$K8[E4]YWJ8S.B*8 VB(BFC72@)IH230$
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M !":(IJ.N5M,PT07+_C^TKAQ#</5M@VI5JNZFI=H"J -(J)IHXAH*JHQ1%,
M $+-T=2/V&F#W@Z:G6=QJKLG#.N^69T.^A"^=.E2OQ-R1%, +:)#331Y-(UY
M>0S15(BF  !,&$W[^OILJ!37-:=-]?3Z9-LNE?MPDT-$4P M$4T73=4@.UOW
MBHBFHAI#- 4 ()1Y0J_Z#\/*F)UA,5.A-R,C(T^<'@7"$T>B*8"6B(BFC2*B
MJ:C&$$T!  AEHJDOCI91U: K*Z/>A=/?WY_9:B&: F@))<^(:)J*B*:B&D,T
M!0 @U'Q![Q+'1NZZZZY[NM2O?_UK&VJK+: 230',!R7/B&B:BHBFHAI#- 4
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MTP31%    $#;$$TSB*8)HBD   " MB&:9A!-$T13     &U#-,T@FB:(I@
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M@F@*    H&V(IAE$TP31%    $#;$$TSB*8)HBD   " MB&:9A!-$T13
M &TS;32->7D,T52(I@    #FR;315 VRLW4OHFF": H   "@;8BF&433!-$4
M    0-L033.(I@FB*0   ("V(9IF$$T31%,     ;4,TS2":)HBF     -J&
M:)I!-$T030$   "TS;31-.;E,413(9H"    F"?31E,UR,[6O8BF":(I
M@+8AFF8031-$4P    !M0S3-()HFB*8     VH9HFD$T31!- 0   +0-T32#
M:)H@F@(   !H&Z)I!M$T030%    T#;31M.8E\<0385H"@   &">3!M-U2 [
M6_<BFB:(I@    #:AFB:031-$$T!    M W1-(-HFB": @   &@;HFD&T31!
M- 4   #0-D33#*)I@F@*    H&V(IAE$TP31%    $#;3!M-8UX>0S05HBD
M  " >3)M-%6#[&S=BVB:()H"    :!NB:0;1-$$T!0   - V1-,,HFF": H
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M[ZE#4K\8N=#H-WQ"VD:%?$VQW:N=H]7SK(W6P7Y:"7\\[0BU5;(1VQ5^_=5
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M):X'6#.&)Q@ZV;+EZ,]=<1<MZ^95S:N_@F+PG7?>:1'7\OE55UVEYV.%"P&
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MQ#;L^0B]#XPUQDTS/!X??ELI98_<,&H1]5>.<!=M1C#-15#3V=G9^?EYA(G
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MT&NMHM82RCF]T)-8<>.*%#X%T:HPU7@\/#P\/"SBU%05 CMB347DVFNO?9N
M1B/NMN.GL"5S@W[3U-1$[<?^RP&<\5(6,MC0K.RE]&YL; 0=W;Y]>WEY>9T
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MU*-!NC8T-.@"76H;8;07*)0!P=+2TKR\O'7KUI65E<&^JJIJ@P T=<^>/3!
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M8@A/[@6Z\<8;(?[JZ^NM1]_R/3P\/,*VJ:G5X1*>FAJP3__^][^/[N8#'_B
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M(**L7:QO=JFM'>]32^=5S=I3*+326GEBGYR,!3'^_>]_CR>Z+9)G]'<'#AS
M*_LR=G\<6F5GQ_K?+*MS]7Q@-[4>'AZ]"4]->PR4]4E9G5A04! * <C.SN;Z
MEC!&WD@,QHX=&Q_[AXJ YV.//59;6^OT"OT-3!UD?5&$[8,#*5G;(]KO._.*
M:N@#L$;AN7/GSFW;MB$^G<KY+5NVP!<K6_M,)JXWJ):@PRB.FSC:<M"6?3OH
ME)<AK>%^/A3HY8033DA$%P;8<-X--Q..$%BUS(9I0XC;.Y\.B7;"4;1EK_-F
M)/!<ZNDZ:AM:!YA&)<G\RHCIJ^:#XZPWX*FI(I"^@^HU\X3%S1+7'&-)_?WO
M?T?'I!.G'@,2K!)AU'VKF=5#6PWG%>DX'6VO"*4NT1<<%,DM=R-'CE2N2/ZI
M8D3KF"X@9]VC)<W#AP_75QKHR[HD*'#BHH.6IYUVVNFGG_[QCW\<E'+?OGV(
M;5U='9>M:;^IJ4C+L&PRMIV$-O32$JUW8X9X>'CT#0)/37L02DWS\O(HSA8L
M6* ;+<+68Y#<'P_)3JE*::LR%Q+YR2>?9%EH5]'?P(@A46^^^>81T6'N@P37
M7GOM=:T1M^D]W'###?C=U[_^]82A!YV%\I".L],A9HY.7[OP=_72!;]]"1L]
M1TDZ))BKFK=L'=K2VT<'G25,K(;*5%@'?3E@(2*&1Q]]=->2J08;!QL9%0Y=
MJS"=A:>F<2B=>.211S2CAIA33U%V+[WT$C*-O-1K H<UVB%47*?:+"?ZU-;6
M)F4YC"H;,!\4J"$I^[KQB9LL[KGG'K2O*Z^\\MO?_C:)J [#*;2;4'O:V-E.
M*VHH/30T.E!!<81,@?)5IU[I??+DR>/'CW_]]==1=7EEBR9<AU?4A@259L*1
M$G1 RW8RT,/#HU<1>&K:?:@(2T<CBUNW;DW):3'EY>6Z>T'=\,D^(#<WUPI?
M-0/77'--_Q>.''%<OGPYNQ/V'X,0+#C7MM=@?T<RT*F<IW<-)-$N[XI[&1J=
MH:*^' ?M8ZC M>W'4/;5<5CMJOW$:M:]4S:QW#XDG%_P;-YX(#9\A>.F_:C&
M <(Y>O1H&$:.')EH[5W#MT]E09W]46?AJ:G"R0?T4$N6+$%QV-65MC(TR9$V
MG"_R&$@(HD6\Z>AF49KQK*FI">4, KX&<JT Z"B>JP2+%R]>L6*%BC54GK::
M\)!,$L\25PU$7^D^X]#VD=%!1T-EZ.W44T_]Q"<^\<E/?O+11Q\]<.  ]"ON
M3&%:F(HP-JKBZ%'DG^TH5_S4C@,/#X]>1>"I:?>A(BP=71=15U>W8<,&'@!3
M5%3$$<?02$Q\:FQLQ!/4U%$05:S#P%6C#/F=G_4_(%&@IC8)@P=.V1TN&&IN
M'F\_"7&R834/M5$W74#W0^A5.(I4Q]&.-N:8K6770.]#H^&)H8+63C+\CM!X
MDF0ZLQ_M0QGIG7?>N4  %7;1HD4+%R[$<W&$>?/F77OMM?32J?"[#$]-'6@'
MA,ZHL+#PW'//M=G%ZD%NP./*O!HP4$%VJBNY6J*3\%#H5%2@L:#TUZQ9\V\"
MK1X.*&>&1$?L6KV%3U0GFNDRD6F#J([ZV5_0DK61O_CJ5[\*D3)KUJRM6[<B
M;M"OK"K%%+U]U%YT?CN3V>7F;ZFI)Z@>'GT/3TU[#)2)S$.(^ D3)L"\=^_>
M7;MV<2HU-%.FU=758;0 ^*:;;E*YK'./?*6;?JYCH6] /W?999?9F#O(V+<-
M +Q7Z5*RT5:&=P1." S3@?.)KX["T378 /LSXI'L2,SIP&ZOLKG7EG>ZA*_-
MG41^?OZ&#1OR\O(*"@JX9(.@Z""2F4"!GY)C/SB1DN[,ENFD=!90:IODK@@&
ME8H&U.@F%"%V]]UW:QKUV1M@R%_YRE<8D]:R:C#"Z3O2LEKGHHLNLMF5B*HE
MGA_[V,<:&AI8<!X#!D&T3C641=TH8CRA>_RS0(6272%B&ZG:P^6($2,2K<_(
M=5;M$JQ.&>T3K4?KA@A'A?BB$*NIJ2DO+W]+P$7%E#.,N2:$TH8G&,%9964E
MV[M6>/45MF:8*I<<LP/:M_75P\.C]Q!X:MI3L"(,NEI)24F]W X':<OC!!2.
MR+O^^NOC8X<4ZV/&C&F*;NFP(?0?L,+4UM9>?OGE[1"5(1'<#X<Y;*+Z,G5'
M1.!/V\GYC'!\M>/=)FJH'/2?E97%RIG1C0.;.0ZL&_N:$7%??0#\#FKZ;;?=
M=OOMM]]\\\VWML8MM]SR[6]_^UO?^I9C3T#G0Z.@4I6;F[MZ]>HM6[9 >>)!
MD4DY(9G<J46.XF ;3\I))&X;.Q2ZX$5!*<00.JN*!>8>OY1<M*"IX%==+5)8
M6/B-;WPCT6Y-ZRFPDEQYY95"O7U?]C9$_7YGC"",]'N;:78,9>S8L9IO':\,
M'OT-MNQ(Y%#N?_[SGS_]Z4\/:3U=&1?F*FSYU5K23"_\JMYUGC,*K%4X1\A^
M5+TJYJM?_2KDY#>_^4TH2V%TY))&>]VZ=;3GDR-?-D5:I=5 ..S42K:,"(P0
M<X+R\/!XKQ!X:MJS2,L9$LC&AH8&+HS!LWW=$2XIOJU8I^&XXXZ#@AO*S"1/
M] V-G.U5,>K\A4\R9+6A ?''$VKZ.]U1!$V4=DZ)UGOPC-M! 9L/W<P!]:Z!
M6!L;LKY:C4$5BX1HI2@4#H3K)W5L_:J.XB"C)8%/I+(TJS[40?"_&=<>,UWM
M_#HA]S2.'#GRM--.R\_/!RU$4\*SJJH*S^KJZKU[]Y:7E^_;MP]F6.)USYX]
M>,57D,EITZ:5EI:"29)?I60&DFQ'$41SC/Q$5I:*9B#3,CVE[066"'S1HD6S
M9\_.R\L[*/?FU=75!4+AR!;HC(=YA"),'-'19UH4TQ6V%C).9#BA05T0YL;&
M1CK@<CMZ1-XN6;($^N5]]]W7UHV%'0$KCZV-;8'.;K_]=BJ[C-Y@AI8@2X=5
M%+"9QBP]\<03F</,M%ZM8!Y]"10EA\E8W%9X9CPUP-%#,H+=P1##;"'J;1_A
M&/ ) K!" !F+^#3+0= J.;6^P;!MVS:(:WYE=6V=( \/CX&,P%/3'D1@[H_!
MZZY=NZ"N4>]TG49(B2*K:V.L[@Y1#L6:<Q%!=(XY$=<:>Q :>$>8,./6).?[
M6=JIW9)";3C=U_KC0(;-"N5:;=&\CD ]VM"L?<:053]0&^MQJ* MQVH8/GRX
M#3SCCS*"@^4WW'##@P\^^,,.X_[[[\?SH8<> K%ID9W;RA([ A!+-,!03L-F
M765SL\0RC#99-30T%!<7;]BP8>/&C24E)?3(%AU&"GTZ(J+I*!HZ6*,V] )[
ML+)FV;;'35",!J4!-+/"PL+-FS=OV;)%3Y4DS>/OK"H6;W?Z-1"H/:,1=]]9
M.&'&?Z%NV%FH99,<G8+H(0,+"@IX1Q%H/RQY[:&ZU/SL(.@>X4!A!?6% 86E
M:BN1EB*@P$Q+Z:>C O(@D!N\EQBX[KKK$E';9R,=&EWCP>H:>F(_@,!&<<\]
M]]C>F1TQ*X#MDFRM4!L^:="CO-EQ<'R38T^ZQ?3,,\]\X($'(+HAQD,9L:*L
MH^P-1?#:I196SJ"!+UZ\F-%N1WWR\/ 8D @\->U!!(::(C,W;=J$)^2OH]XY
M@.2U/81V T08*=;4$AA..Z%U'^DVYG@9 ?83-@*TKZBHT"38SL_B2$'&3P,;
MMING!M!6%AT2UN,0,P]I%0L+ZUB?2DII/B(Z(]$YEY_NAXB: C=46[_TI2\I
M$V#%UM<X*$](&+0"=QQ:P3@S7U961@5+ R>LV8+> QG6"<S"K5"T(I(6:$LP
M3YTZ=<&"!0?E3@4V6(9),LQ &!/]-0TJ+9T_\@D'H+C,'QK4&4+F6K7ITZ=/
MFS9MSIPY020]](02_DC#9 ;2G@:UZ7'P=QH!3;5^M2XU0^ E/S\?R4%BD< ]
M>_8PR>J2G"<IZY:9%1T$O0.<^H;W-6O6.(&HFS#*&2XY\5 DY0YJ9 ZJ_6NO
MO:;BVFGRMF)[# QP^!C45$O</K7HK8V]\$G=*-!Q''/,,33KQ:2P/.644T)I
M>FS[;(D<F6),4C)RUR)#C0?DP*T6&31DRU5 )')=!C=!V$\>'AX#&X&GICV+
M(-)98=ZV;5LH2C M7:<"ZE*+%BW2/1@4\<HT#@C"V&):)YQ> M5-_1U["%J&
MT9P)E6DHHXPVXZ\@J_G,9S[SG>]\YY9;;KGMMMMNOOGFVV^__3\'#9!8[C^\
M^^Z[K[ONNKONNNOBBR\FY7/RZI!07U %GG[ZZ0<??!"A/?[XX\\^^^PO?_G+
M__F?__G%+W[Q/ZWQU%-/P1+/1Q]]]*<"6,(+^GL4*X>Q=^S8@;I:6%AHEY+R
MR:J;DIN0."&F8-4-6[.R.."]61:I:KOH.!@LH]$L2U[):FAC04L'Y+&LI>EH
MLDY#KJFI*2HJVKIU*Q+>+*MV==B%#(I^^63:&:P:@HB6IX12)J-)/"I;:!$D
MF78"ED&%TI2:Y#S))ME,CC:.F&S?OAW4+C<W5R<*@M9LD*E0 Q/^;BZT70I=
M1CQD?445TCD-L-"-&S=NV;*%;! ))P6B<&"VT'UH2H'9V!$$,KX  \+'OQ#"
MBA4K6F2RQ>9\2JHEEQ:GHP75Z4[6N@$&+3OF [,+.3-UZE1($F>=#@WL<5*>
M#QSF8-&SP7)^$D_V(_&>6C%4P(Y&G>GH.:&.+[SP0O0OSSSS3$Y.#AMI&,V+
M4CBP5:+NH0M(RLA(6B1S75U=6D2N.K!"!O5SUZY=C+.?-?7P&&P(/#7M)JP\
M53 /H>[/F#$#AMV[=[LN(M#[RI4K;0>@*V,3,FM*Q4L76:FOC+_N$:@NR TA
M+3+I=$"N$=-/[#,0*ZJ#4/216(VV&H;*V3F3)DW2D/4Y2*!)5M70==$NG+(.
MA.% +P\$"Q8L0!_?C@K.W_&Y:M6J,-(X]6G#![5 52PM+25?2LD22FH5U"?H
MGG$(6J_MI+T#C488C:UT#8PM W2";0N!:&.- GJABH,G<FS:M&F@4KP'CT7C
M!$N;C'^D/7UUL#3IA>%0#W.^.G5CV;)EBQ8MVKQYL]VW"3=LCSK;@*#( ,.(
MZZKC[H!I9["A1 \50'F[ED4@K1Z5*CL[&W31AF"AD:=9LUISN"/0<.KKZ_?N
MW0OS^O7K:>- \Y;Q=+)Z,(-907G>(BM[3SOM-*>[X6MU=34=^]P[K&$;"#MQ
M- H=WQR2Z3 DVWT/E0M@$A%!'3Y\^*A1HS[XP0^>>.*)\^?/#XU8UD:J8,VA
MS-=:9"M5VNR R.A=G?&3X\##PV, (_#4M >ATC.(-%<.[9>5E:F>YR"0Z2 8
M+KOLLG'CQNEXI!JJJJI8*%QM2"^]*J89>-J,:*9D]J.AH4%G@(%UZ]8M7;KT
MZU__NG9O=@">T,%7]&K.7]CQ#!(P2]D3JTT<K?Q$H+U^#:0RD(0 K[WV&@<^
MTM%4MH7Z2@NQ!.W4"+"9!]&Z3=0NAMDLNRZYAAQ $5=45"@U98!J8 CM1#XT
M!=T%UD2_0<3<E-RV'P[=,T/ 2Q'YVMK:Q8L7KUV[%DFC/;>A<MUI:#0AA16#
M_!I/:;K=K8P:H):+>K<U@5^=<-*R$>" [,6B?$ JD(3"PL+R\G(21;)3NH_'
MK3M@W!A);?XIH<&@RB4E)6C[N;FYM%>5EQ%P*J$3I:#M]2,=!%@3*B0" 355
M2YMV&C0)ZF;0PF9.*IJK#V5F&SD9)R2@'U_\XA?#+C58CWX%%A\K  >1(3K0
M9;.LN5!+P>[[R"./_,A'/G+VV6>?>^ZYO& F*2M'("H/1'OR\=R[=V\8:8QM
M59+ -/:XQ&O'8QC%7-MO-X6&AX?'X87 4]-> E6Z[.QLY.?JU:O=SP9D&I=>
M>FE"KK!W=(7;;[^=:V"L=&Y'IO<46 WPY-DM7)J8EAM9O_SE+W_A"U\PG=K;
M8#^G,Z4<D<W*RJ(];"HK*QE"V"?Q[S]@_VJUY"YHS#;'Z)TELG'C1M"5]G.5
M[1H4XLTWW[1NG# YG:)F];5OWSZP7]#:O+P\4A0RU7@@<3@:1A>@X7<PJ$#
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MHR)"B%T(+T-:4T6'+L,720Q&I9H:!<W96D<^E.KFF5_FNMZ%$(,,25,AA!C
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MM*VMK;V]?=.F355559.,ZNKJO$WT+1I7""&$$$61-!5"B,&/*](H6  IY?;
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MZ>$PP1!6%.\&.$=(4^;>;B.W.'K!!1>P?<\___QV^V8!%<()%(S.+7PV;-B
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M6^FZT?[XPM)NTX3>R"3][D;&7IUF@L[ :HR2EZ^IB*&#=P8JZDY[O>J=P2_
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MHAR.(XXX@E8!X4(2L/SS-K&+!A6L$80\Z*"#0NOK_///I[7&!#.!H;[//OM
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MHXU= E&B_. '/V"R-#3CP"B,"I2;P]V=(TVIRK"%-.U,UM7D(;8@>JWK2<(
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M0 . 5LIN1L;&,(\XXH@I4Z; ;FFW:6Y9FPQ56EKJT]-H/]!]WGGGN6$<FZD
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MEH3Z>0!];@">HU6VHH0UX;D9@59\SI3J=R#OLV*5$>^ZO38BIUP@$ @$ H'
MNH"[1OQW;IA[-FC0(#%)HJ8=GEU2PNHLZ*TDE7!D)C][]>K5NW=OUV%M.@G9
M&J*FF;E*RVV7'8$%,KU[GH 8O&Q?9<@3CQGO,R^X(ND.D15+VK+BJ&7\K=QJ
MHSM4ZTIZVIU1O+2\X$4NEL*+X/BZD\==2C$#J TG%=2;//LL69#IF=[]U X$
MZZH)O\T+5YO%SYB(5ER@0V3FDKH[6[YM\*91C^%K,\ZSO A$YQT%WTJ@_FJQ
M<A6+M1G#][N=(2OV(OH3M2: #IB7(6/RH#"961&YPOX^%NUK>A64HJ>4RHR9
MT.5:L33:67=GH^!M\5QT*),75B(41D/IW4:Q^)-TGO!/!+SU1A$"A4WE15R=
M>85P\W#3*7]R.T3:%M=Z<<0<UF@S0NXK E*#9 4/;%C,>87MU/5;#$376&ZA
MX&7V=="NS4@4ET<I+]XK^33($QZ.&(;%MOX4+[=SU_)B23"U^:"#9AVJ!2.M
M)Q]DHB&LT5R$[GO--=NRZT-6$LZ+1A%._])B$YIVR>;F H% (! (K&7X?V3]
MCW[XX8<W,, A_;C*;J&F?(B!@S ]AYI]L57JR:QI9&N(FN9-W>C,XZ%1[GJ1
M4H*[7=102H!FE3Q=JBIMO;-60-I$<T\9OU)^LQI9>Z>_0V\R+^13:E'2C<P.
M;=4,ST_=T-=NMT?#D+<W5ZIG%V6[Z'YS/1TB*S9;^L_V][L'C4Z88:IPWG[$
M5__Y+%5"CTHYA>QK:+9Y6C!%AYIWD9\WJ9UJ2+K#Z>0R::;-CE?@ EVCUCYB
MF24,JC-M4[C92QJ"U:GA=65*UDB;Z+";;C32I5O-F<V5=%A#<Z($+]7\$'D3
MC282[C]+,N0WZQ8(! *!0&#=@O_._+N_X((+.%.7P*8?S/L:O^P()6K:H7PI
MDY6]_?OWYTK!SGR2-82LNZAI(! (! *!0" 0" 3>(OP-<F:K+ <.'.B!4PAD
M\Z?^2EC-J&FEV''J45GXJGZNSCK';D=0TT @$ @$ H% (!#XIT#SVBBQQ&]^
M\YL58Z0;V%&ZSB$[P^I0T^;H*SFJ_^<__[DO6%N;"&H:" 0"@4 @$ @$ O\L
M@!-FMLFH:N>V"'Z4KD<XN\#JG-!;,2Y:.E1)/P</'ERW;\BGRJP=!#4-! *!
M0" 0" 0"@7\BI*>NU.S4V"E3IA#5%'7L.F1:63UJZERW1X\>I'OW[JWK]==?
MWV9?"FAT_H' -82@IH% (! (! *!0"#P3X'2]L[TTP!GG746')*#D1*:6<;J
M+.BMM%\5S#F]!QUTD!18M&@1!6.O:2 0" 0"@4 @$ BLIRBMH14[XY-XPD]^
M\I-NW&M:L?VK P8,(.<K7_F*FG[YY9=S^]CAVF>%04T#@4 @$ @$ H% X)\"
M\-+T2WO+EBW3]:677A)-6[ER9=^^??F03#NBV1ZK3TT=G_O<Y]C46K7=K6K4
M%2"Q%K &J:EW@X0=\M3Q)EK?Z8LDB9*PR_"SV49I\=*M%#[,=+;]S=<'15;G
M^Y9I7_RG)TK=61,H637-)-\SURB\H=7O<LE6:1=>U_*I>=.<SM \K[S1/)DM
MI79M+I<+DFB&WZ)(%TOV2Y(INJ@_A2N?)DK5EHSC?[.Z:$(ZE^ZF/[NXE2>F
M<Y7(+\U/OY+HPDJ!0" 0" 0"ZQMPV'1M:VN[\LHKT\!IAU]_$345IY,PGI7G
M^WK@5%C7KWWM:_A[RY<O?]FP3IRQK-NIJ3N7I9^E_!19$Q'%%HR!;OEW=: $
M2I2,A2FIO]FM=[AKWH5,%W#]U5QCM;<%:TZDS;VYIM\HG&_D28N8R.WI^G<V
M+JL)1B1/V 7Y7O^++[ZH-&L#<C-(AZ9#/31L,Y"O"4D72ORP0S23J"[@-3<7
M\1P)^!/AF2B9MU>I,\724GF7I*M9#4=:JC,Q\ET9BF3VL&#8/)D8S $-2M;E
M(Y].==ZBZ>=+!OWT_,Y4RMM;TC,[-()KWK 9U46=@4 @$ @$ NLG5JU:)1])
M5[G*[WG/>WKTZ ')!'Z@D4=-<:A2$MNW;]^WO>UM(K=(WG???=1<XBQYX9RG
M.6L:6;=0TU3I-.W=>]V.I>U2BB(K5JQ J[HA-]]:7K77UEQS<TX):=DT,X7G
ME^#NOO_LL(AGN@N.)+=6QZ%_BRC5K*E&<VJ:M&R8TM<WA[3CWN4\&7<]-B^\
M\$)NHR;H)^WR4#D#\8+ M=7HIU_[A291&V6]"#)I3E:PQY)8"N="GN.5--?6
M+(,!2Y*=875D\F1ZN%8E]4I_,IJ16L9G7</ 0Z0<7A/HVBB(MQ?Q[GB.MYC9
M1Y\IR\*2S-:6E!Z*9OC H09V2ZO-V@=O_:D)! *!0" 0" #\*!+REQ8N7"B/
M^LX[[QPS9DQ+\0V87KUZ#1X\6)SS8Q_[&.<G(<^Q2:63DXXXX@@JE.LEUXX0
M:Q<>W5I UBW4M!GT*FL?7%J=KN+%4NKIIY]NF#\-L:D:*15=\7I6I\(4U);F
MO-$:<.Y)E.]U! :8[N3),=!K%#1'6UB/S*JM ?"?=,$I0=>@(\WPN^W%7X&>
MA]SJ7[Y\.8R40&C7IG,+4ZIFT*#G212]5"1%LU8=ZN9@SI/V1-J$IY$LU985
MG"KK\L'Q*>TR5-4ATH+^T_7LHOOI]"YU@5M"S0X?SXN:NQ@+!%(%Q$(SH[6N
MI\:(6S#5I/2;0=:>>'>A6R 0" 0"@<!ZA=31\M6VQ$[EW7WWN]\M,4^H*5Y?
M;@MZG;O:!VA:9L^>+0?;F0)>.C&A=8BL>ZEIZLAZSNKXK,BGCBF1O:NOOOJ4
M4TXY^>23O_G-;YYVVFE//_UTS7;ERHAUB_^X.\Y/RG;6(ODN3TZ'&I9R2C)I
M#26@$L)=&(%;'=;PIO%J3]I3#M&)4PQCQHPY]=13O_&-;UQZZ:6^&C/5*GL+
MT:IFX^3&)+_^]:]KU$:/'BT%3CKII#__^<^U8FMUJ?44\&>-?FMKJTI)<XV^
MYH J*=DM[;(#F:XI=W,12I%/.GT04LLPOC[*H+.^I/!*TGE> HV6*B]Q\M=M
MR_N"I*X:!1E0HZ\Y(&,>>^RQBQ<OKEKXNM'TO@9X<ZBD2O0G3,-Q^NFG:UB5
MN.JJJW@872 M#E)[8C3/]Y[F21-<.]0G$ @$ H% 8'V&NU70T:K!G2MERL.?
M.'&B:.HNN^PB:@K;Q"$4%^W=N_>$"1,>>. !+YL;RY48P086JWH1;]33:P'9
M&J*FZBV47?2]42SAZZ)C:4$YIN(D\IZIH71XE!B_& ZV?N&%%VJV\I.?'_S@
M!Y$O%7&DNX39/7S%%5<P-G6+UF+]DIZ9^<IXX9)Y\<47SSOO/)6E4ZF82VK@
MO=%4']]SG,9^WSJ\:4!:W..99YYQ'4CP-N7XXX_7+<[=H@AFO.FFFSHS78=0
M$7^YXJM#U341'M$8JN( ,<>L6;.DF"19K LP/FH07Y5N-)$NH,=ZG_[TIY][
M[CDUQW/59F $I<_UUU]?L?Z*T#+Q6)S0H;FHL%X0(5K?88<=T)P9XK.%S/WV
MV^_AAQ_6_)2&ZB9J9%T^-0U#)?FN<6DU10KU]['''D-#_CJ<<,()ROS !SZ0
MVV QU3M$PW81+UFRA+G*&[4Y<^;0!0:"5D@L7;JT9OOCJ\91:_:^P,%?/?VI
M4H5_^,,?O!3*]^O7KV)F.>NLLQ8M6I19])@:L#;Z?_O;W_8BI5ZWV,H3H4^?
M/@L7+L2 FAN4U5-6&K5 (! (! *!]1GN&M6+K5)DNNO5_#-U4-/B)+B;>ESK
MW/O*UA UE5^+ZRD?M+G;'0(3B['(QU59'%F8":S&W5E==]YY9Q9YMMF&W38[
M66>GG79RK_<U%[@H3B8?DW5<=MEEN-3TO:R3(3.W&P]>/\>.'4N=\MI+1;">
M()*,[UXQ;N/Z.#7UXYB[!9G1@%KQ"@2V)AV\7;>>JR'<<LLMT#8I4S=:>..-
M-Y9,US5HD=<MJH$/+LV8,>/HHX].F_8SQ'KW[BW[?^$+7WCAA1=HNFZK"."E
MHE5H(IKTX0]_6!/ "_JH^2!>??757AP2Q?Q1%Y#<99==X/^,K(\4:3*I,"\V
MK^;VK(H$ID-62=AI__[]6VQF;K?==I___.<S.\2L]'AW"%5.A;XWO3.HK<<?
M?QP-J?G$$T]4_HX[[NBU>5]*:!@5;Q1?HY*83$USWAWQ0'[2*0DP6QC*5RAI
M\9J YT)CH<Y*<M"@02I+/<R?BK%-)32L&O3E!LG7B^4,*BYJZD50@"?:?^JN
M<OKV[7O444>QYD17'K1 (! (! *! ,#]PU\%GBYYN7ZKN4@*%R;MUW6+K%NH
M:7-/Y%_B>E:2J%2*YB+@^NNOEQ,LSU5.\\]__G/<99@/ZHE[R$7N87C_^]^?
M)VL@:\61H2G^]K>_X0$[MTSANQEA2I[OH]4PD'GRR2<3F,6_KQN=0QB!-N/)
MRL<%%X.ZV7#333=);75MVK1I2NAGLR9O#CY8=!]SG7?>>=(0'I@5(64WH/B#
M!] ..^PP%JFWV?$VT@WNI+(42=O*$UX'$&!1:&ZO%41CX!Z?_.0G<U,/$LX:
M;(DY,;OLLLOJQF:7+%FB6RK+ (E2HMLO?O$+K,1!2JOL"*7ITZ>/'CWZU8E5
MJ5Q[[;5UV[>]TD[&$E3*[PJR.:\P7/^:!3GI1<4F!FDR595(H)0\_?33O10%
MZ:/X_ TWW.#U+UZ\N-;^F%_J27]RMU+$+1]ZZ"%FCI="!F,2ZJS:<6KD?/WK
M7U=9HJ9>>6>0/L0P/_>YSU4*!OCDDT_*/@QTW9A_;@\:W1>...((W2)\C6)\
M9%G6>,][WB.Q=[_[W>JU!!JV:D UP$)ON^VV3WSB$Q!4\?:J+</.[;'*;.*-
M&S=.M][^]K?31[KLDY;QO>:::T:.'"FQ33;9Y.&''^:UQ6M="@0"@4 @$ @4
M)).K>^FEG^YEE9 ZD!0I9>;) 9]I9C,=6*/(UCDU)>$VPEW^Z$<_6C.>B1LM
M?QWV@F>LJT@IDO 6=O$V+%[D9J7.1QYY!+)$[V@%X=S&#T8'J^0NQ1'CI^IG
M$:^'F^2.<]>O7F3FS)D;&FB4(TQ= ,4R@S?W5D!5&$?FFC-GCM._??;99^'"
MA>1C3XC9Q(D3Z8@8[+QY\UP9\3IH88O%$CV_I&I6T Q5J.'(BP'Z[G>_^^J0
M6T!5[(5Q@:Y0\$M?^I(OCLWM'!U>"D"-/O2A#U6,U8O,-(J5]#5[<2! KI1_
MR"&'H"25>-@V-\;E<3E&JFK(D]%D4C4ZHJ9*$'L_Z:23\O8;5M6$)AL<;]JT
M:;P<$4_VW@&W56JZNKVM0"NQKSR)T[HPHU,M8OB-XNS<U:>F=9O5LKEH?Z58
M0"OB!^?DVK#(:FMKJRS_DY_\!*UDA*NNNJI>1+#9;[!DR9)!@P:ICV*G/&7U
MXGG,BL.?5EF,E!!WQ0:]GBPYKEG45+>&#1N66Y?]EH^%:J:SU'#AA1?2A:Y[
M&@@$ H% (+ ^ R\Q_5ERG#K[B?_ICA9.G3NE>&AX=.O$$\O6,C7M4)(617*.
M//)(/-2\L'A:UB'7^=EGGY67+[_YU[_^-4>&<@O+>A>4_^233T)1O+CSC<SX
M &/3W) /DK#++KL,'#B0>BK%HL2\_1)MUV&CC39"[(033A O;10!,2IT#IS6
M_U: #KH2<*L7+*A7KUY,4Q2K6D2K:N$XT5$GV"(#RY8M@XU 39WR@51/:BN!
M0Y54.72W;]^^UUUW74K(F5>9&;EAA% &E+ HC;&25YBS%!.E[]V[=XNMF-6H
M83HG,UDQ,T69U!;+7-7<QS_^<020+$5-51L"7@_5Y@4UK=B.6==0^=MMMYT4
M./GDDY'W?)Y2,I6^XXX[8+\K[=1HNN!*4I!6F&\HH^N##SZ8)]24^K,D<%HS
M@HJ,\E>?FF))V8<7-\(]]]PC[I?9QZ_R8L)[0ID2X$W!N]_];I8!0R"E@SCM
MQAMOS%CX..;%WSZW&!T\\, #U=Q7OO(5U* >29Y]]MG*WV*++1!F%$@C0\V2
MK!2;>]LL>.X/:2 0" 0"@<!Z"WRMAD4L\+?EM+NWZ7YF9F&JW!Q='"U\+0=%
M5A3?972?%O<O+_@1^:6X"Z[=VD&VEJEI,PB%Z?K,,\\,'3I4Q*9BIP1A(&P!
MR6%@**46#SKH($D><\PQ_'0=2LH\\<034*:46N2%Z9LU!^1[M71DWWWWG31I
MTK!APRI&,U#&??3,IHY:42\@(1,G3JS: 3/P$*YM=@I6]XZQDYDVBT!6BH@9
M6FEZ$=NLV=;!-HM/'G+((9_ZU*=DP]_^]K>Y64/Y+%7ULEY_%]K2(U7[T8]^
M5,12!=_QCG<\;5_]\1H\07CS(Q_YB,34M'3PITLU?.M;W\)N(T:,\%6=I><'
M8J\B8K^HVJ]?O[K%&ZGGEEMNH9*Q8\<.&C2(M"B3ZE^Z=&F>!-@;'5%35;+C
MCCLJ4X20%CL$Y.U][WN?)-_VMK>U6<R65P,KBZ7%]-H3E8*:/O;88[5B-6\)
M64$=T8<>K3XU!3???'/%R/][W_M>3ISBO0.@^'+;)JU;&JEMMMFF8L<:W7KK
MK9AEE:W0_O*7OXQ]>*,!N?5*J,?'Y9)++I&D6/V\>?/R0G_=/>><<XB:,C-=
M : .<MS1LF7+6FS3J=3@9"F7"00"@4 @$%AO@<.&WXC_Z;?<F5Q6?"Z!#5G.
MF]SIRHKU;K5DK2C.<]5B5_C2K,&L%OOLO+:BP;6!;%U14R^"[=1_N=0>EL00
M6-PE^4EM-5LO"N=DM2&2C?:?=A3$> G$I7$8^LBU6?D4R%2,+\$JM]ABBXJ1
M(KB3HUX$OC?::"/.R_G>][[GKR+H#A9F!J1EWS0R0UYT5GU\_OGGX992X-_^
M[=\R^Q#EW+ES>4V"C'J!-5;:5ENTRFTU+/1)5G6SI'8#-.H"JD&L;Z^]]J+1
M(X\\LF$#ZOU%K%[L&5ZX<*$&);>:B3>R?9&A5PW_^,<_O!42?H75JQX]A,R6
M%EN1Z\3)N]#:VKKYYIO3ESY]^G!B+407K1H=+>@5MM]^>V5^XQO?H&O>-$/6
ML$E(<^/&C5,-0X<.S>T=%9(IA7-YU8.VO7KU>NBAA_)BMGC3:9&\>,60FXE6
MGYIFQ@8AS&KNN...RZVJTF3C9]V@(J-'C][ OL(L3K[*4+<_3PQ'SYX]X:4"
M3=,CTJZ,Y#>T':>S9LW*BSFCICFA5]2T9K%6U\2[K[1&2O*L1%!SN?V%10#A
M0" 0" 0"@?46N$SX17(X\;']+L%2^4YRI\6)H*DP*7>E,J,#>1&FJMJR-:XK
M[>,.;1:X@HLZ<?5H0=K<FD:VSJEIP\CDHD6+CCGFF(I%>\1M(%$NW*%%Y-&R
M%O&G/_TI.24QVO5CD/#%\_9,PT>ZU 5^>H6//OHH+KMR-MML,\@/8EG"AY6X
M_/++B?]4+'!WT447$22$[?SPAS^</W^^KT#NL%]O G4[3ZAA\2[-)[6")76=
M,F5*9F08/=/!Y8U(S:@IG^%)HZ9)]67C.-R&HIJBP2HEXUQVV66KBH.1@%O8
MYSW<TFM0SK1IT]!9]<R>/5M/%P\5SUM>S!.>JX9A@^(<71'C%<5AO)S0JWH(
M%2J]\<8;5XQ _O6O?X4W^F/&N%#0AQ)J*D)(YJM],/A,UBTU>M---VD&#A@P
MX(]__"-_!3!U6L0KJ12'$K&@MY[L/2[)<Z6_^1N)FDK^\<<?Y]6)</755V,]
MWJ%X'W/[^P5EU4,D:MIBIRAOO?76&$U_]31ME".%=]]]=Y_;>3*4>6%&VM6U
M?__^DH?2(UPK3NB52HB1#TBW&3(+];^R/-K>-*%P(! (! *!0 #_#2<?[ZO:
M_F@2]V_QM;B+7YK6PSHXBN!]N:-8M[ $K)6&LD[")VL:K_B$:Y.:-DL2.FL8
M3Y!C*H=XX<*%>;'T.76%'2BI:H\]]EB1D%UWW16=4S'WI)]ZZBG4<+>X68=2
M9MHHI3BL!6KTMK>]S?N5FHO$978"3<4X3^_>O:%YD*B6XN0A^NO-O45DACS9
MN:<$GZZ!N0T<./ __N,_:K8\W9N&RC*MZ_;B1)G777<=1:2G:]BUJLP9OGL)
M]<J+5;A4GB<:LHY4-ERT:!%BF<U[I??==U^*'WKHH54#BKD X&EASHB^8NI:
M\N%@L6NGUJK_F&..H4>:5V*_:-(H@(G(X9; ,4BGG'(*+:;$+"_B@5Z$&JZ\
M\LK,^B7=6*&:ZDRU2$JWAQYZ*"LV.;L,8EX*;L9U]:FIBHLM8Q/ZY0NY72 O
M'A^:DQDUM[V(>O>"8<LMM^2]C[AEW>"CV2%TZX$''O!V45*U$35]QSO>D3ZA
MW@7LP"LZ1O^G/_TIK3 W7FL@$ @$ H% 8/T##AN^^IPY<S;>>&-1"?GV P8,
MD+??OW]_W2+")$+W[G>_F\5H-4/J2LDG7+QX\6FGG7;!!1=08=UXK&C7>]_[
MWKESYR(F;Y:[=]QQ!X$?=/!ZUC2RM4Q-\_:.:5[$4E[1H_BZQH(%"QJ&M%0*
MK_#XXX^O%%Y[GO"'5)\GGWRR0S7>$)@6Z.E1J>9>*X?ORN!GGW_^^7G!T!A[
M=F,*?.&#Z*)WMF%3@9E$.)YVJ1Q#.>OS'&^=-"-8MSBJ-U<I:"H0GY>1:0OU
M:D9<V:8(A09>) 55C1T[UK_:\OO?_YZQJQ3A5E>FI">CX/WR?,U *C_DD$/(
M29&:.BW;8@'JK#C>-C=JBMI850^5=),=R(39YJ9&S>B04]-&P4Y9$,LQ2-XN
M"01HFI^$IHG;5^W5@/>H5)#>I9_5]1%I,51L7.ZYYQ[J85SR-T)-U3514Z_-
MFW:5Z"9IKZ=>G)N%*>K&F8<-&\;D.>><<ZK)EVRHQ(NG%3[RR",5>X2Y2[OC
MQHWS+G/*D:[I5VK=",K,[>7%*OLR#74& H% (! (!')SV$0[Y6BY:T>\!%=*
M[M/HT:,WWWQS)+.."-V2)4OZ]NTK>7;2U>U$3(F]_>UOE]?'>D9<."7NO?=>
M?..29[NFD:U#:@HP7R/YXJ4H7+,.E/(K=1YWW'&2_^ '/YAWOD*R6ZAI"J*F
M+78,$FTQ,Z 3%UYX8?_^_24P:=(DSL7Q5Q>". QE*W;4D[O@J;M/A3 3KYE\
M5@*G'<1TJ0QW44:)B1,G[K;;;O+[:93KAH833CBA;OL_,PNT2MX_'N-(V2E$
MSG^><<89V%P@8H9,7FS%K"7G Z?P'!)T<__]]V<"'';8863ZE8YD"3ORLC2*
M)&+^T5$(%6:\Y99;*M;W0P\]5#D<*:PKDO5DIWC6"34M@7YEQ?N4*Z^\$MT:
MAI)D;EVHV.=PV9!9,G**.^^\DT'/;1JHMM6GIL(O?_G+2A&>I5../'D1X#^Y
MY8^>RVRYY9;DB%LB5C>XH=+:<NO@@P\^Z)70!5TYH5> Z/K["](]#17CY \_
M_#!O#;RL5QX(! *!0""PGB.S76,5BSVP.8ZUD),G3X:5C!DS9M---T6X9F<:
M>=FJ+=.5F-SL?__W?Y=76;-3>ZIV)-+0H4,ON>22#WWH0X@U+%3&Z2$EMW8M
M(%O[U-1!*;];*5SJ!0L6M),S>!.I>IS@(FKJ537KOQ:HJ:-6(#>%B8.WMK:B
ME>2G39L&#6BQ#X<V[/345#%R:D6\5&9\V3X9ROQ#!D+KW:0XFN#<*[UTZ=*J
M!=^H\\477]2M=QHVVVPSYPF;;+*)ZI>&$%0V:@J\=*&5M(^I;=D/G!FM_=.?
M_D3!2A&LZW 6^?PN$0_I.7+DR(HQVT]_^M-DI@^#IQN&/*&F*L*XDT,79%Z8
MOZZ+%R_6+8Y$$EBQ4"N^=L,XTA'03$W3*XFL>"- G5.G3LUMSKMZCJQ@U% R
M7?_XQS_FR9L41\/^$#1LT$E0\ U14TTP?YN0MW\P?5KRDZE"CM-%[]H[WO$.
M'D9Q2UXTI$BK=5,\^NBC\$RW0-4^=4OX_>UO?_N..^XX;-BPK;;:2E<GPX,&
M#=INN^TR6P[=L$4!?(F7$?%6 H% (! (!-9SR+VO&*/QPT'D+/WH1S_:P(XO
M%3658Y\7A,Y) 667+%DB[VOBQ(EBISOMM).H 2LQ=963)I]-99][[CF*ZWK_
M_?<[CWBU^;6"[)^$FLI\/7KTP*L64\(U3\52<$LR+.C=>>>=O0ENI46ZBYIZ
MG;[7-#-@+M<6/YYXJ>\8)%PN8<VD;;?=%@^^VM%G,'.C$"IRZ*&'BJ2-&C7J
MLY_][/_\S_\H?9CAD$,.65%\D@@%T@2@Q3;;T[QLV3(H4UNQ<_JIIYYB&^$&
MMK/WP@LOS&V^2LQW*FHL.N1.N;55LS.[,N,D-<-]]]VG(O"-1OM#DM'-<YSG
MN,[<VF>??2K&W-1?FN9N*I\F:!U.E1<!1FGB)_3F9@=8O?(UJ;;??GMI*-+%
MYUO4RFHNZ/6F78&LZ%'%N/&4*5.X124E89<D2%CZKFDJAL+P]EKQ0:#5IZ:Z
MQ0@2G&R^ZPG2S,E&\:59Q@ZMH*85BYHBR63F+L5+%;*@E[ Y8AJ[L6/'PDMY
M]]%F9UP__OCC/_G)3Z1DGSY]],?QBU_\(OOR_84%DJ0#@4 @$ @$ IE%GG!Q
MZP7DH7WXPQ_&A3OQQ!.'#AV*:U<KMA-25I)RR08,&/"WO_WM=[_[G7RP6VZY
MI6Y+.^6MB=J(7#SPP ,2N/766VEKYLR9^5KGI;DUO;:I:>K1Y@4SD6G>]:YW
M(3]]^G1LW2S/,#2*S;OB;')\60*:%^8K&;&[J&E>:))24_)1%9WE4G/4,JM&
M6;?=9C%/L,TVVX@&].[=6_D+%RXD*$I5F0$G'OI::;^DEB@?'2FUSA3$.%D1
MR/)3<#(+X<*0Q0TNO_QR7UHI9:A'^,4O?B'%G-HYLF)6T"@*I]J*[ T>/!@-
M9\^>W2@^XEJJ!,V53^0P+V)WRA\]>C3,=N^]]R;:[#7XE>).5E4)W-)E\F2O
M:6X=)P1-$QP!K;O3IDVK&;!JPT#7LHZH*: )3$'ZV6>?K1@/U&/LIDB+()^;
M)AXM%X5CGJ03LI%\7:IA@5,OOOK45,5GS)C1OW]_VM) D,FLR-O/&;?JG#ES
ML(,*NI@'L;_ZU:^F\\WMS'"XW92X]MIKU;OWO.<]/)N(C1\_OF+'(/$(^'#K
M*G;*3!/T)PC6RBL5Q!BX0" 0" 0"@?49F3GV<I\X ?3^^^^_YYY[[KSS3B6V
MWGKK(4.&+%FR9.7*E:><<LJ@08,H N?$3\-YDS^YZZZ[9G:<S0X[['#111>]
M\,(++('<:JNM<O/E=MQQ1[EDN'90T[7OC&7KD)H";">;7G_]]1YYJQN/3R6S
M]EL-5436]#!=GC ']YY!-U)34**F]22ZV#!*5C>.JMGC*N5%-Z7SMMMN6S&*
M4K6 7IM].R@S>"62[->O'T24MCPMRBH7G^.+79X$P?W/?.8S8G>[[[[[CW[T
MHV;+NS)WW'%'Q6A5KUZ]VBQ8IWI$36E.^<UE\Z0M:(GGJ%^:0F(R8K:?_>QG
MZ5I)WCNH]( ! T:,&+'GGGM.G3JU81%=%:%IX>FGG\96&"=/-%>.'J2Z[=LF
MT*=&J[91%H6]"UZ0KO%>P.TY:=(DY9>BI@T;B&9J2C[$GG$D >_BNZ8NW"%J
M!0U6<P\^^&!6G#:4RO"3*\_@"EO"O?K4-+>"VV^_/6V)[7MF7BRB)EVW".U+
M+[VDB?2UKWVM8F9\__O?C]'HH-M*F8L6+2JM/%]>?&"65S!9<00QQR#3G/+'
MC1M'I)I1P)(HH.OTZ=-I0K.Z8:MY5]EB9M3SM@*!0" 0" 366S0L@%$W:DKL
M2FY;W[Y]6;AWWWWW$>@:,V8,._)PY^1&UHNXJ+PO"<^=.Y=Z9LV:A8/'J:NL
M;EMF\'Q14P)L>9<N;K?C%9=R+5/3%)EY_ C<>^^]6%F^+)EIM8WB;8$2K:VM
M4O+22R^5*RR7G2 ;M7FU7O"M4]-2[TH+>M-;:D+4Z-9;;WWTT4=+=ZM&635U
MMMQR2ZG->:19TV<P)8.OSXZ[Q8L7XZEG!7T2AV> TOHS^TQ(FZU<?><[WXEZ
M9]@Q12[@Z9I]MD@_/7!*:!'E*T8PZ!T%_<I$]Y\.-:VY>\HII["%=?_]]Q=[
MS OZD0JS#'CBQ(FPRD&#!EU]]=6RS,OV.9G==ML-S<57903O=:F2NO&6IY]^
M&CW[].F#86GN^NNOYX5%GA \>)0:4HLTT6*GDY&N)T'%K"-J"MHLSEDOXOFJ
M\XM?_*+JT1557;($.&&E^&#L(X\\DO:KPX*UY$LMJT]-L<#11Q\-Y3[XX(/K
MQ6>!2@;D9]W6>X\:-0I+?NE+7])/R?-\;;?==MA'8Y$7+SX<_CJC;C/V3W_Z
M4__^_;?88HO''GL,)3-[*0![UYQL-E%F<_+44T_%+%===55N*D'(5S5M< T$
M H% (!!8?^".$TZL$O/GS]]HHXTX7S<OR(6N8@T2EBN^V6:;4<2"7Z\L6,ML
M.^%O?O,;.8<#!@S Y2.8).:5%2>,R ^7$ZCT^>>?+Z;SQ!-/Z"Y-OZK-VD+6
M7=0T]3LS6SZ*7ZO.8SZ8%3UTOYP<)?APJ(Q8L1#*A1=>R!C@;9/ 7R=_Q(@1
M&)=;WGHIH5M___O?*[9L]:T;MV;1(8T?74,WKS:S)9T;V@ZZ#>U\5,]'3!@]
M>C3*'';888WDFT*N-F*K[(NW-0/Y7A7Y:69>./3X] W;.BB2KZN(W]*E2ZG3
MA6%Q%U]\,?QPUUUWI53-3NBE:[K%=/=2G4$R8LNY/1[#AP^'%&VRR2:\:$G;
MA0^KB0T,:H7X*IUE[?'..^_,NXD]]MB#,!V3Q"N!0O_L9S^C!ET9%+HI 3^,
M-R]:)_X&*U9#LDF+'?!#3RL)-85K[;333A(X_OCCO5'N8@V(K@C8QAMO++%S
MSST7!5P8E.8A@T+7Q.)\W$M%2CFT>,())Z@4QU"[0".9,XA1H931<$R9,H4.
M2L.''WXX3YY06FG8L_;@@P]JH'F.KKSR2C)Y?R:VJ9]\">F((XY0Y>D[E(9-
M7;BZY'_P@Q_TZM5+?^.HG%'+;;#&C1NG^H<.'4J^3UU77J.OO[,M!M'OS!XB
MM46G H% (! (!-9S9/8V7]Z1Z!(!//QA?+,VVQ*EQ$DGG;3YYIOCC&7%<C_E
M3YHT25[6M==>Z\ZGBIQSSCG*?."!!U1VV+!A9.+3/O?<<R([W_K6M^2<N_>8
MZK-&D74+-06N?68< %^\DIS8F4IZ)YWQ$Q']W__]7PB#N!/NJ1>7[0C0;;/-
M-LAH>)S >,TD*%@W:NI'O/BMMX(MMMBBQ<X0RA-6X.U*)377KU\_/R.+?%F5
MDWY0>]&B12(Y]!VSYP5MJ!O/='::6E7Y?%0W]=V]N"Q3MS.[)DR80"N5)'A(
M59G%:65;A@8[$Z)4_@TWW."A5"JG?GI!<1+>:&[L0C]%#N?-F_>^][T/XK?I
MIINNL".M4WE->K6;+L1MV)H!KV?!@@78%O-*,0_6N?(___G/J4$X_?33E2DR
MYDI>?_WU="TO-"<FG%E@>:4=MZ/G=D/[B$O%WH-PU^U)M/"TTTY+>51FQJ_9
MYF$U)UY*\84+%WI!-PX_/9.^H[#PZ*./>IVI<)IF8B# 65\R;-Z>ZN=%Y7FR
M$V#QXL6Y\?"--MH(,_;OW]__-N7%C%475'; @ &HI"FM>=56+)^6H>H&D49,
MO<LNN\#PT\Y2IPQ%0RWV.D#V0>V&\60^'O/.=[XS+YY'UUD)3I;3M/G<YSZG
MXAJ+F3-G4K.+!0*!0" 0"*QOP)M*<QKVQ0VY57!(MHFZCR=W5]34HZ9X4W6+
M"DR>/%FE:K89#;^:37-04\G(3Y,?N,*^:K'<OBCSJ4]]"K^N87&+1(LUCJP;
MJ2G CBN++W,(8IL3)T[\WO>^Y]?SSS]?U^]___LB4:6"NIYYYIEXS'*=Q>EE
MH!5V)NT33SQQWGGGX0?W[MU;3O-MM]V6=Q(U=3SSS#.5@H&4;KU1X"NSH%<5
M^II#]Z$U>#-FS.C5JU>E./+T?PWGGGLNOKLH:\76+GIGL7G1PJL3L929PKE!
MAS]SJ^'NN^^&(<M*W_G.=V1J7JC4[%@@3E*M6&15!)+92<3_FFNNJ11?/=5(
M26T97 F-U/<2J,)S#1I'YFNM6(#*QT)4B8R@CD-XJK9D]_GGGU<1YX1BF+1;
MM8VI3'V95,H/'CP87CUITB01.1&8-H.$1:(@SWWZ]/$UMW >:*>H::7XHDQN
MY-;-PK5N[P*@WX#Y0[10$ E4\=UWWQT+T'?FZ@477$ 1U-MMM]T:1GW3Z5<:
MS:J%A95FWJK4G__\YS0"F<IC0_Z.U.R#5"I^XHDGJKDMM]Q2UI8FYQF^;^#G
MM[_];25D*+KF5:D+/0R''GKHQ1=?C %7V>>(?OSC'_L["(FI"X2=J\49N=0C
M'6Z^^6;5P)36<.AI8D %*> VE,SX\>-E0W_ALL)V.+#7=.C0H?PIY!G,DE.U
M:G8BE+3".#YPKDD@$ @$ H' >@B\RLQ\5]C0,ML+6F(TNBLO3IEL <.A DJS
M>E0"SC#Q//'QY JNLA-Z&Q91D-L,?56FF X;]-8RLFZAIB5W/+>P##L/Y;.J
M;[ =MU2E.->GI?C$1:W@-OCE;E#L*Q+%RL,6"ZEQ5U9[R>#NN(.!)%]4!Q>\
M6>Q-0 .F\?,*F2Y^%Y(CU[_41WZ2<__]]V.B-ZH/G4I_IC6@"2KE%C>K%!\1
MH6GLGUZ%!0L69!:*E#'GS9NG.9H*EU#J2\7.=.4X8E=#F#QY,K2<P6+H-RP8
M:<6FQ/SY\]4BWU-%>;JS>/'B579&J^9,C^)C0E12:GKTZ-'>6:YUPW7774?K
MA/[(IW[G/()H'NI5BH79V&'APH4[[K@CC99:%(TGQ_-5A"@E"I2&@Q95)W>]
M'A;T^H0OP77.K1+]&>*8HK3=](^.]^*::Z[A+XA7J[*8$4E_8\*C1,B4G;K+
M[ M#E&4T?59GMF\>29HNM:['7#ECQXZE8,UV,E-6M8DV2VS8L&'.15$/FTAA
MS1^92$^QQ#CZ:^3(D6VV5!B90" 0" 0"@?43^$(U"U>LLIUQ! !2@<R6)=:*
MSU*DWJ_'GU;8TC^*-"RB0T@&-Y6C;6H&O&NU L.J%@>+>(MK&MD:HJ;J#VPD
M=63=2_9$2_NO+[K%)TR8,'SX<&0VV603$HZSSS[[UEMO19* 6UI)GNBC!,<@
MJ:$5MA7SK0-JND'R_<:\\+EKMA"1H?W6M[ZUQQY[5 J2L\TVVWSWN]]%!M\]
M-5H)S#.'YY?F(@F/+Y&3&2.2TR].+F( GR%:V],^9]K#HJECQHS)3%7643?L
M?-1KK[TVI62,G8]@BR%-#!HTR-_!H%O50J#GG7?>IS[U*0FPK)3#Q)@/IYYZ
MZK1IT]IL/Z%;@U*K;&'P*L,?_O"'E)KV[=M7+8H)*W/777<=/WY\M8A&TN6L
MX#RBIF@KSD-\SS7,B_%JLW-E-]ML,[1ZV8X[YL'34[W##CO01^\I:@P<.%!7
MW955;[SQQFJRW+J$=-1XFE;::=+4.7/FS(;%6E/%2H _,[=%36&5NJ9#4"F>
M(S*G3)E"%Z@ALST&RI&M9'\OZX^>.L6:!5XN, $HGDXD96J\SCCC#$K1"Q]3
MC<C>>^]][KGG8MC6UM;<9H(3W;/..DMB6VZY)6_@,#6HV5]/6*A:.>200^B+
M)N?11Q_-]'#A0" 0" 0"@?4$[D;B"]5M,1I^.X>GN*N6FY/)E;6XC6(1'$ZU
M\MELA8^'7PI5\02W<+VJML4RZW()YQI%UBW4%*1FPCW-"AZ?6^78-VV"GJ<M
M+K?#5.MV&*]^'GOLL>(_@P</WLSPCW_\PVM8LF0)IJQWLJ"7[D A%BY<^*;[
MY:"YACGQ_H+!.X4,;S56VD[EI4N74HJ"\^;-8\:TV0<PTU)O"-26)O+BL!^4
MX4H\ZMEGGQ6GDNDVW713F5$\7PDI7QJL-H-/T\S@597TS(JE!:6QRXMQK]J[
MEK///EO-J5&UN/'&&V^^^>;3IT]7*QI9GIFJ?1^(&E;:<EP?2DX)4R74L+%!
MZ7IQZA([5%,]LV+U+*;@YXL&2%<JK&G&JPJ"JXP4A) QI4(ZY5:MV5LK\FF+
M6^E Y(E6W,KLE";97(I)^57VTHN%KVDI0+N2?[$X<IG^YC8NOBS66Z0O61$S
MSZU%$H+JX19#+QMNM-%&0X8,82N"-%EA^X$S.[TM+>@)4#,\\, #&L1APX:I
M$M5PYIEG:H[!0F7A!0L6\,<1_JE\=4%I-:%)F-L4U<_4MFVVSKQNJ-E;DMQ&
MA#\=J0*!0" 0" 0"ZPG<"W+'M6KK;&M&35FREQ<\$Y\0%]&!KR5AG"OHE=_"
M[Z(XUZP(L2)6M?7#[JY[M6L!67=14_/&7W/E,UN+B.^.ZXF,7]T]=2 CNW"J
M#62IS0)?-=NY"Y=H*P)NF?G3SB6H.:V3=*WX5DIW6=9G@!LJ2Y8I,JC$Q,B$
M+,$!JLG+C-6W<]HO6O?IQ=WFM!N-R0==9#A@SO $KA2I%2%?S OE2.OTQ"H+
M?Z7O8'P>4X^/",2#GU4CHES5!&]]VBQHMJK8PUVWN"4$AE&K&[7#;JQ&2&^A
M%8HQ5:35RW8$,0W1.HHQ9^A@F]%7GCIF$=P8W<CWFKG2(J.) B3@8VX$0)&&
MO<6@K=PT=%51QN5+8+RP)#HS6 V#BR&PRDA@WGXF4+__E:DG[]LP"!U49IN]
M+*!F5SNM!&'L0X6K##R/V*%:+"\AG5G,UL>+6[QN< VI'Y."W&@M-=16^^D(
M! *!0" 0^%<%[B@N'#_S)I^36ZGOA%C5V%.;K1;,DDV(7@3OKF[++;G5*#X4
MHH1SA)+_MD:1=1<U71U@)K^F!B(S%<L+&N9BZ=VLRP,\T]HZ0ZG1#O&Z B64
M=.-GO?WG80*!0" 0" 0"@4"@,Q   &VVC*ZM".<XK6AM;6U8%*1F"^L0<Q I
MS2Q:0)B$: 259/;IBH8%?J J*VV-8<V6YND6E7B (2\8#2&*-1=%R+J=FJ8<
MS-,I56LF:<TY)6"4S. _R?'\#MLM(66S=+99TNOTG&8.G,HTT\[F.@.!0" 0
M" 0"@4#@=2$J\9>__&7Z].FLW64]8]W.YOC=[WZWPCY<LM).,-+UF6>>F3%C
MQMUWWSUKUJRZ8<Z<.?#5F3-GWF7X[6]_>^>==ZJLKJJ*+VB(V:J)VV^_77=_
M]:M?W6U051++C?=":%/6HSKGSIW+@L%2[+"[D'4+-7U#9 RF1W^ZZ%4SY0.N
M7GJW0\FW@LR0)[S4F\C:!T731"F-JIUU)! (! *!0" 0" 1*&#Y\^(8;;GC_
M_?>SKRJW..I++[W4TM+2L%URJVP_U\$''[SMMMOV-.C61S_ZT1MOO+'-(!G.
ML/1C+/FJP@TWW-"PO8<BI=SE<,U*<?3I=MMM!P<F0)HGO%37*ZZX@HUOS:&[
M;D'6+=04.)W+.^*<W')>UPS>!Z0YS=S/*\E-OE05E:=DT@LZG"B6KAT2R+3^
MK+UE"&K[3W+2WI7*>CH0" 0"@4 @$ @$.L.>>^[)-Q$XWXB#/)Y[[KE>O7JQ
M!73ITJ6GGWZZ..>!!Q[XP@LOB'=,G3I5Z7[]^MUVVVT0VL,//[QA>T<;MA#W
M13MZ5W6*E++*M\T.I,SM&X<-(V)MQ<DFLV;-RHW=I/1'I29/GIQWQ-JZ"]D:
MHJ:P^9J=:.I&\3Z0(^I/#DN9:[:*.F5QC>+$(%8_(PS]DZ2& 0MFMFTUL_-:
ML#*\,66/7JU7XNNG2=?:?PBDS99K$[!>:>?BU.SPF(9]>Y,MQ?HI'=A 7+4#
M>);;%S*J=EH,\P9]6-+ME0<"@4 @$ @$ H% AQ@Y<N1'/O*1;;?=%A+1L+V@
MXAUP2&'4J%$#!@RX\<8;\^0H4W&0_?;;KV?/GK_YS6_$2C[QB4\L6;+$B5)N
MH=<##CA@M]UVRPNZFQLM$@W.;'DPK2LQ<^9,!&!,;;:X5_6( (OR>-EN1]:-
MU#0%3+)>4&W60\/9W$ 86IEB<<XJO9^9;<^M%Q\IX>C.E;;8NLT.O*T6)^[6
MBC-XJ0&N2-K[0K504-0C0HT"2/KP((GR5%LMCKIE-E #DO7BE*,V>\U _4P.
MFEAI0(U (! (! *!0" 0Z +[[KOO\.'#ERY=.F_>/")\8A;BF:*FNCMW[MSW
MOO>]HJ_U)'0)'Q%CVG###4>/'MW:VOJ9SWP&;O+22R^I^,*%"W4]ZJBC/O"!
M#W@IZ,P&&VS@+(;F9LV:U59\8\);$:/Y\8]_[)RHJ*,[D74+-74^F>;4BY.(
M94=91.:8/W_^HD6+Q"H7+%B@G^KYXL6+U9SL3K#1V69NRB@?6RB=QB1SBV*3
MST=</"J+61MVWA0<-26<*J5Z:O8I#BJOVJG*2-*NRT,I"9%+D@]IJE3#0KZI
MH:IV2A5D%3J=VV<P!*+D:V[\ H% (! (! *!P+\2]MY[[X]__..B& ,'#A3O
M>/[YYY4I&B5J*DHR<^9,)40^4VHJS)DS1V3D_OOO[]&CA\1&C1I5M:\DYL96
MQ&)TU2VBIBE@O' 9B-5]]]U'< X!#\A-F3)%:GB(KMO1_=34BXND/?'$$^IJ
MW[Y]6UI:]MIK+VYEQ8Y0$;\O?>E+HND#!@RXZZZ[4N/6#9(4W=]NN^T@G*+I
M$I9!-]ML,^G\Y)-/(@PSS(T-JDX)B/<Z%_4ZE;/]]ML?<\PQN2DY;]Z\(4.&
M2%@:7G7559F=K9P7>T2KMEB7/<'"JN+#F^+8\&2&ENW"5U]]]4I;])O;ESPU
MD&+C4J9?OWZZV[-G3X*Z=-R5\6L@$ @$ H% (! ( %&S/??<$Y8H&O7((X_
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-A     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_16a.jpg
<TEXT>
begin 644 image_16a.jpg
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M  #HF6@*  ! ST13    >B:: @  T#/1%   @)Z)I@   /1,- 4  *!GHBD
M   ]$TT!  #HF6@*  ! ST13    >B:: @  T#/1%   @)Z)I@   /1,- 4
M *!GHBD    ]$TT!  #HF6@*  ! ST13    >B:: @  T#/1%   @)Z)I@
M /1,- 4  *!GHBD    ]$TT!  #HF6@*  ! ST13    >B:: @  T#/1%
M@)Z)I@   /1,- 4  *!GHBD    ]$TT!  #HF6@*  ! ST13    >B:: @
MT#/1%   @)Z)I@   /1,- 4  *!GHBD    ]$TT!  #HF6@*  ! ST13
M>B:: @  T#/1%   @)Z)I@   /1,- 4  *!GHBD    ]$TT!  #HF6@*  !
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M  #HF6@*  ! ST13    >B:: @  T#/1%   @)Z)I@   /1,- 4  *!GHBD
M   ]$TT!  #HF6@*  ! ST13    >B:: @  T#/1%   @)Z)I@   /1,- 4
M *!GHBD    ]$TT!  #HF6@*  ! ST13    >B:: @  T#/1%   @)Z)I@
M /1,- 4  *!GHBD    ]$TT!  #HF6@*  ! ST13    >B:: @  T#/1%
M@)Z)I@   /1,- 4  *!GHBD    ]$TT!  #HF6@*  ! ST13    >B:: @
MT#/1%   @)Z)I@   /1,- 4  *!GHBD    ]$TT!  #HF6@*  ! ST13
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MU[*S<=^^?=D!F++/LY;C-;M5(\'>>..-$;<B@T42BQAVZ:67[BVV;=LV.^G
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MT"::0M=$4P &3C0%VD13Z-K(PV, &#;1%&@33:%K>DT!&#C1%&@33:%KHBD
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MQJ(I=$\T!6#@])H";:(I=&WD#KT #)MH"K2)IM UT12 @1--@3;1%+KF@EX
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MID";: I=$TUY%,4>>WK0X3%?3 ]=B@Z]IH<8U:6Z&'5I'^&"/<)J<+C-BZ9
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M"W"(#54;S\+4\C0J/BS_E>#XSB(Q+YH"+:(I=&U4B*8 #)9H"K2)IM UT12
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M:_V* L#2(YH"E6@*W<GO6WRY\FK>M&O7KE-//759D4?BVG%ZPPTW-*>::@T
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MGCU1K7E@%DT!6 )$4Z 236%1B(/N3#DPUY^;+B]FRI6]<W-SNW?OSOY5H12
M)6,JFDX%U*PCFL) B*;0L_BNQ1%W[]Z]3W_ZTU>L6%&/Q\T[(?W-W_S-IDV;
M?!\!6&+TF@*5: K]R^_AQHT;ZZV/ZIV0XE =Z?0O__(OY\N=D'29 K"4B*9
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MK@$6SIH" .H%T12 (YH"M47;I&?48K&X_OKKZX+>RFA:"K?SU?E2']RW:@
M:AS1%( CF@(U2G\?M=?QX\?K@.WG3G6)[P8;;-#>WIYFQW4-Q2E3 $ =R473
M7$!5&:(I,$P038$:I9!IT72]]=;36=/FYF8_6JO/X8<?[G?HC>^$! ! 7>"L
M*0!'- 5JD7*I;Y\Z0H\>/3H^8#<U-1UWW''VJ1VP/9<24 $ =81H"L 138&:
MUM/3T]7592FTM;55Q^GXXMYCCCFFN[N[&*B\;](  -0^HBD 1S0%:I1M@/YW
M4[\!4DM+2Y(=ORVL'GC@@?;IDB5+M"7'&14 @-I'- 7@B*9 [;*<V=W=;9MA
M4U-30V#'Z1$C1L2'[5FS9BF.<KX4 %!WB*8 '-$4J&G:,O_E7_ZE,4BB^_3:
M:W-S\W///6?Q-26: @#J$-$4@".: C5*=T+J[>VUUXLOOCA_N,Z\\,(+?I->
M'PH @+J0BZ8\/ 88SHBF0$VS:&K)\Y)++O';(.5,G#BQ6"P6"@7_ERGI% !0
M+SAK"L 138%:5 ZT 79W=]LA.7ZH::RQL=%"J1^SN0T2 *".$$T!.*(I4-/:
MV]L53?TFO3EV++=B.FM:"GRK!@"@QA%- 3BB*5"+?,NTS*D+=,>-&Y<_8@=-
M34UZM.F X0$ J =$4P".: K4M 4+%FAC7-X%O4;G2].P&?-'4P! '2&: G!$
M4Z 6Q5NFT8V.\D?L8.3(D=I._5)>'Q8 @!I'- 7@B*9 +?(M<UE0#))P^6Y#
MX(?M$2-&Z+BN;99<"@"H([EHRL-C@.&,: K4*&V<.E^Z=.G2GIZ>"1,FZ%#M
M1V[=&ZFSLS-.I&RV (!ZP5E3 (YH"M0NG06U=-K>WFX!==JT:4D61V/=W=W:
M@%,>:@H J"M$4P".: K4--L2;3/4?7I//_WTYN9FOZ"WI:5%1^[.SDY/I-RJ
M%P!01XBF !S1%*A%OF7:P5C/+.WIZ?GB%[^8/V@'"Q<N5#354#XL   UCF@*
MP!%-@1JEK:^KJ\LV1HNF=E0^ZZRS=.36-;V-07-S<U-3DWU*(@4 U!VB*0!'
M- 5JFH52'9*[N[OM;1+ETB2ZGZ$_VA0 @#I"- 7@B*9 +?(M4U?SVB'9-L:.
MC@X=JIN:FI+H**YHZH.4@W@D  #4IEPTS054E2&: L,$T12H:<J<>JZI'[S]
MR.T9]9)++K'"O;V]N@U2_-=3  !J5BZ:YJ@,T108)HBF0$WS\Y_JF#-GCN)H
MS [G%UYX84]/CW*IK@'V8>,.  !J"M$4@".: O7D'__X1Y+= "G.J!=<<,&2
M)4MLL^WN[K;7W"&<: H J$U$4P".: K4NCA8OOCBBZ-&C4HJ#N$77711&B[H
M33F$ P#J!]$4@".: K5(6Z9>]<=1^=O?_N8'[-;65N_><<<=__&/?_B1NU H
M^"   -0LHBD 1S0%:I2.UKF>75U=?AND^'Y(C8V-^J-I1T='RFV0  !U@F@*
MP!%-@;I1#CR7Q@=O>[LL:&]OCY]QJD'4,6!<  #4@%PTS1W=5(9H"@P31%.@
MGECLM,-V8V.CCMG>T=S<O,LNN_3U]<V=.U>Y-'[2J=Z^.18  &I#+IKFJ S1
M%!@FB*9 /;%-,@F/,_5#N"?5<>/&*8YV=G;&0910"@"H6413 (YH"M0-';];
M6EJ2[(^FHN/WZ-&C;8/MZ^O3/9#*@3KR(P( H#8030$XHBE03U[?2@,]VE3=
M.IRWMK;:!ELL%BV:=G5UJ; /6'E')0  JHYH"L 138&Z40JVWGIK.UJ/&#$B
MB0[D>OOM;W\[#5?P+EBP0(-P[A0 4,N(I@ <T12H)XL6+?K=[WZ79%DT/G%J
MOOG-;]J6:\?OMK8V'\33*0  M89H"L 138&ZH<WUD4<>\6.V_]>TJ:G)8NKU
MUU]O!;J[N_WR74(I *"6Y:)I+J"J#-$4&":(ID ]L6/STT\_;4?K,6/&Z+#M
M)T[572@4EBY=2C0% -0%SIH"<$13H&YH<YT_?_ZNN^Z:A*.X+NMM:FI*LALC
M]?3T%(-X$   :A/1%( CF@)UP[;*KJXNBYT?^]C'DNQ\:7PLM^ZVMC:B*0"@
M7A!- 3BB*5!/"H6";9463?7GTB0$5)TUM=>6EI;>WM[^\ @9E2>: @!J&=$4
M@".: G7#MDH]MG2???;)';S]?D@[[+"#I5.B*0"@+A!- 3BB*5!/%$W[^OI:
M6UMSQV^=.WWWN]^]:-$BWW)]"R>C @!J$-$4@".: G7#-LE"8!VC1HU*HMOS
M^IV0MMIJJS1LO_%0;XX" (!:DHNF/#P&&,Z(ID ]*1:+'1T=UA$?O_U^2-8Q
M8<*$9YYYIJ^OSP<AF@( :A9G30$XHBE0-VR3M&BJUY_][&<Z4^H434>.''GG
MG7=V=76IO&_A!%0 0 TBF@)P1%.@GO3U]?7V]MJV^>"##R99'%6'CN*65^^Z
MZRXKDQN0: H J$%$4P".: K4DZZNKE)XNNEO?O,;/XK[_W,LES8W-]]VVVU^
MA]Z44 H J&%$4P".: K4&3L\VX9YUUUWZ;!=>2S?8X\]=-VORA-- 0 UBV@*
MP!%-@7IBQV:+G=I<=]YYY_A WM+2HHM[)TR8T-/3DQN0@ H J$%$4P".: K4
MC7+0U]>GY/F^][TO?PP/=^NUH[N?-8V?(@, 0*W)1=-<0%49HBDP3!!-@;KA
MFVLY/.!TK[WVB@_AZE8T/>&$$]*P%7=U=2G0^K   -2.7#3-41FB*3!,$$V!
M>M7>WCYRY$C_F5E7\ZI[]]UW[^OKTX'<0BSG3@$ M8EH"L 138%ZXJ= 35=7
ME\Z1)@.CJ=EIIYW2\*09BZ\63=.PA>?'!0! M1%- 3BB*5 WM+GJP3#E<$VO
M'[P;PI-CO'O*E"F=G9T:JO(9IP  U BB*0!'- 7JCV^W\?%;9TW]]*G.E_;U
M]7$U+P"@9A%- 3BB*5!GM-'J];;;;FL,<L=RZV,%.CHZEBY=VM/3X]LY   U
MA6@*P!%-@;JAS55G0<OA@MX[[KA#T51']!$C1OCAO!BDX1^GN?$  % C<M$T
M%U!5AF@*#!-$4Z">>"[5V^]___OQ(3S)+NBUU][>WN[N;A561@4 H-9PUA2
M(YH"=<FV4#M.__WO?]]XXXW]<!X_/\8V7DNG/3T]',X! #6+: K $4V!>E(*
MM&&J>]*D2?'?3?V:7G^HJ1X>PXE3 $ -(IH"<$13H)[H@E[/F1T='5MMM55+
M2XN.Z JH>K4R/3T]5F;)DB7Q&   J!U$4P".: K4$PN<VC;3\,!2\YO?_,8.
MWOY04^O0WTWWWW__OKX^*\GS8P  -8MH"L 138&ZX9MKFITX+10*MI$FV1$]
MOD/O)S[Q"=N*.SL[X_(  -04HBD 1S0%ZH8V5W_5];JVJ<:'<[_Y_D$''=3;
MV]O1T6&OG#6M.JV"<I!F9[_SA0!@F-%>T?:'?NU/[L9^*D8T!88)HBE0Q_H"
M'<)U%/<3IUMMM=4KK[S2W=VM\Z6^J6,M4ZO+NWMZ>OH#6R^L% ##F>=2XS?S
M\XPJ*DDT!88)HBE09W0L5T=75U=[>[O%T<KKH*S/[W__>\L_VHI)056D5:95
M8+M62Z?=W=WVJE\6 & XTWT3XIOYZ1"F/MJ+$DV!88)H"M09_]>HQ1L]&":^
M#DIG3:V/=?SQCW^T K8A<T2O!5IQ+[[X8F7;"P"@XY?O%8FFP#!$- 7JALZ\
M^=6AO;V]:=AT+>K$(4?)Q][.G#G3K^;U31UKF5:!K[7Y\^<31P%@"/$M_;3G
M))H"PP31%*@_MFT6@YZ>GHZ.CI:6%AW"X^>:)N'<J=^AEYON5)%5O@*JK:_7
M7GNMM;756UT  -'/=@WA^6?>4WM1HBDP3!!-@7KB";,4'@RCMZ-&C4HJ<JD.
M\!:$>&Q,C;"5M2SXR$<^PHE3 (AY+O57T?Z3: H,$T13H%[91JHM5-$TR6YL
M&%_9JXM^AZ:]@#;Y7,\T/#K5>\;]E8IS5ZO&'>HN1U<@#T]>#^[88X\=(IKJ
M(ZW*^(<& !B&_ C5U]>7W[T"6.=X.Y-H"M0915/C%_3F H_%FXLOOCB7'M^2
M2L;9TGNJV_<:N7&JO]\3. V[E;C ,*?ZZ>[NGCIU:KR:8EJ#S<W-^0\ 8/AI
M;&S4_K-0*'#6%!@.B*9 O5(TM2AXS#''Z!#^^JV0LJNA&L+?=8X]]E@[H@^1
M2^/@6LK^$JD-7Z_:%7@9#:+@J@)Z:]W>IS]<>>5)-1YV>%*+2C5I3CCA!&]X
M^2KSM^I0.LW]U@  PTI34Y-NK&![T8Z.COR^%< ZAV@*U*5RN%"V$-A;/Y#'
M#R:QU^.//UYQR#?U2OZ1'?XUMIZ>GJZN+NT$E#P7+UYL>P/KJ;=61C=8LC[6
MO[V]?>G2I=:QV6:;;;+))IHK*V8]H^D,4ZHN1?1R>)#/Z:>?[IDS%S[U@P+7
M\0* Z*C4W=UM!YJ^OC[M2P&LJXBF0+U2-%56U"$\OC=O<W.SY9RCCSYZQ<]8
M*IKJA*=&;DT!>UL,MP*V/KV]O87PH%3+I6UM;==<<\W55U\]=NS8.&C9=*V,
MGKFJW4A^,L.,[T65\ZTF/_O9S^H4MRK-G7WVV6>>>>:T:=,LNYYUUEE?^M*7
MK/M+ #!<V3ZPHZ-#QQUR*3 <$$V!NJ2<8P=L2XE+EBS9;[_]XE-M_N]3RZ@+
M%BQ8P7RHBZ8406VT]GK>>>=]+;".9. I/C^_-V+$"/77JT73"RZXH*NKRT:H
MNU9HYY*?V+"AGP94 Z5P)X^E2Y=6YE*SWGKK6;WU!OK%04TQ !B>]"NG?B=5
M.AW.1Q-@."": G7)HZEU6)*Q])ADMW6-602:-V]>NOQ_>VH\ZEZT:-'LV;,M
MRMYSSSTV8#PV2TWJB -PY<6HZMANN^V*(>6FRY]NG2H/*5\ZH@+:KUK-Q/7F
M6EM;T^Q*Z72=JSH 6 5*I[X+S7\,8-WBK2FB*5"7M U?<,$%28BF#8&Z%7CF
MSY_?$_3U]5DHTB_0Q7 ?W5*X<=&)F<I3>3XVB?\&65G839X\.=YUK,W&Q!#Y
MT#]21_PJ\96WWC\^YUD.,;ZWMU<MI+:V-JO/_G G*IUG[@M4U2IL/97\-4@I
M/-K4"@]Z0>_(D2,[.CIT!;7/B3H   #6>=[R(9H"]<J2S->^]K41(T8HX5CF
ML9"C#&D=TZ=/UW6AEGE>>^VU%UYXX9EGGKG]]MM5WB_'3;)[_&9!:8!<1O7<
M.VA2W7[[[4OA8M0E2Y;DYW6MR 7+M.(Q-KG(IQB91C<E]E=]JK>Z%U0YG/;4
M A;"_3E>#[+ELG5;G^[N;BMC'5V!%?MC\$1@J\/7CJK4ZTW]E5W]Q"D  ,#P
M030%U@5_^<M?-MA@ \N9N7C9W-QL@<<VY*E3IQYZZ*'O?O>[E8+\_*="IL=:
M?:H"\7B\?&MKJ_=,!CMW:GW&C1N7AIV+LEE^7M]^VJ_%KU+,;B_LQ;2CTT?>
M/XZFGDO;V]N]IPJ7PK-V2H%"N.52ZYXW;]X11QQQ]-%''QBHBJQ.XBJ*>?]1
MHT9I/.ODM=    !#(YH"ZP+;5#WA. NEZF@*+'_J:9GQJ4Y/1WI54HWS4MP=
M\Y'DJ+S.*'KP6PM\0CJ3Z?LN#WC>43E+0_3Q#J50"ZB]O;U:NE=>>67&C!F/
M/OKHPP\__-!##_F32./_Z"KS>]VJTI9W=MH*WW+++99.*^<'  !@G4<T!>J;
MMF';5!4R]7=3"S\*2(,&2/MH@PTV6'_]]>,3IV/&C%%>4D^-Q!-4'*5\G#Z)
MRJ"59J<6X[.1;ZMR)AWL?*/WL?GQ&HO[IUE-QO_SU*>E<'94'6;*E"E[[[WW
MGGONN<TVV]BRZR$]HMI(HK/0JL:6EI9<W<85&[^]_OKKT_!<64U:,1L  & X
M()H"ZP++,#-GSK2$,V'"!(4<3SX>A^(SHGJZC">B^$2?YU6E7!6+(ZZ/9_3H
MT?Z4&A^52K:WM^OY,>E@YR3?#N7LEL4ZO=D7GENC>2B&>S[I'H]IV+E9_U=?
M?=5Z=G9V]H?;02U<N- ^NO322RUP3IHT:?+DR5H6+8[.B,9]DI _%4'CRE$]
MJ/:\CQ>(4^B@?;[UK6]YP%X[]08  % CB*9 ?=/I-=M:%RQ8H'CC\<D3D3H\
M9ZIG'$?C_LG  ;U[UUUW/>FDDXX[[KA''WW4PIZ%SR>??'+\^/&Y030>W:MV
M+82K>!*ZU9.BJ;U:_K0XVM'140QZ>WN51:VD=7_O>]^[\<8;__W?_UWU$(?/
M)(ONUC.NNK@CM[QQL?@BWLH!74/VCU__R"9W[;776L5J=_SF0@(   P#1%.@
MOBF:*BLJX7C:J<Q1E9JR/T"J.^[0ZY___.?77GMMZ=*EBG9*?3H#:3%OXL2)
M&B0W$MT3V&<OS?8UOL?Q1)T.O'UNW+^\G*?8Q65R_37(LL"ZN[N[O=@YYYPS
M8<*$R9,GV^OZZZ^ON:WD<;&R#@?-F;F$+_%MI9**WPA<95Z][KKKTHI+BP$
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MG__YGW?====--]TT8\:,7&&_AM;W+3I?^F:)0#LFWSWY:4GOJ'H.U SH9DL
M  !8?413 *NN'.Z%JV>$IF$_HGL4Z:1HH5#(I<HX<\;QLAQ=%JO=3G^XB:Z_
MC4OF.JJB<NJ5?0   +#BB*8 5EVQ6"P$/3T]'1T=]M:?=^K_!8VOO-594^_C
M<=15]DG#[BD>6YQRJR67D,O!@!(   !8&413 *O+=A2*HWIM;V]7SS3+;+GD
MYO$RQR_W3:.,&H]'?<JU<>>AW$(!  !@=7C+BF@*8-79[B(.EN)]M*/)%?!H
MIPYU^PE5]8_+Y_I4?KHV^0P#  !@C?#&%=$4     % =1%,     0)4130$
M    548T!0    !4&=$4     %!E1%,     0)4130$     548T!0    !4
M&=$4     %!E1%,     0)4130$     548T!0    !4&=$4     %!E1%,
M    0)4130$     548T!0    !4&=$4     %!E1%,     0)4130$
M548T!0    !4&=$4     %!E1%,     0)4130$     548T!0    !4&=$4
M     %!E1%,     0)4130$     548T!0    !4&=$4     %!E1%,
M0)4130$     548T!0    !4&=$4     %!E1%,     0)4130$     548T
M!0    !4&=$4     %!E1%,     0)4130$     548T!0    !4&=$4
M %!E1%,     0)4130$     548T!0    !4&=$4     %!E1%,     0)41
M30$     548T!0    !4&=$4     %!E1%,     0)4130$     548T!0
M  !4&=$4     %!E1%,     0)4130$     548T!0    !4&=$4     %!E
M1%,     0)4130$     548T!0    !4&=$4     %!E1%,     0)4130$
M    548T!0    !4&=$4     %!E1%,     0)4130$     548T!0    !4
M&=$4     %!E1%,     0)4130$     548T!0    !4&=$4     %!E1%,
M    0)4130$     548T!0    !4&=$4     %!E1%,     0)4130$
M548T!0    !4&=$4     %!E1%,     0)4130$     548T!0    !4&=$4
M     %!E1%,     0)4130$     548T!0    !4&=$4     %!E1%,
M0)4130$     548T!0    !4&=$4     %!E1%,     0)4130$     548T
M!0    !4&=$4     %!E1%,     0)4130$     548T!0    !4&=$4
M %!E1%,     0)4130$     548T!0    !4&=$4     %!E1%,     0)41
M30$     548T!0    !4&=$4     %!E1%,     0)4130$     548T!0
M  !4&=$4     %!E1%,     0)4130$     548T!0    !4&=$4     %!E
M1%,     0)4130$     548T!0    !4&=$4     %!E1%,     0)4130$
M    548T!0    !4&=$4     %!E1%,     0)4130$     548T!0    !4
M&=$4     %!E1%,     0)4130$     548T!0    !4&=$4     %!E1%,
M    0)4130$     548T!0    !4&=$4     %!E1%,     0)4130$
M548T!0    !4&=$4     %!E1%,     &!8\_N6Z!Y4K+)4?K2E$4P     8
M+BSHY7L-)I="5W"HU4$T!0   (#A904#IQ53F;<LN?J(I@     P+.02YM#7
MY586%G\;?[KZB*8     ,"PL6[;,@EY/3T\I*!:+RSL=:A_U!%U=7?9:*!14
M6#DQ)9H"     %:-XE]?7Y_%/4N;ZJG F6.)M+>WMY2EPN[N;NMC;ZW;,NJ
MD:XA1%,     &!9*(9%:YK2HN7CQ8@N9EO@&9M(WV$?*BE;8HJR5]T#KF;8<
M#)C :JBY:+H&E^TMK<UI5<MP6$:L<?K:K-E]S9KBL[2:\S;TX)6?EL*U+NJO
M[C6K<KFT$WZS!   P%OQ5EP:KLCU;N]0OM-EO3-GSIPX<>*VVVX[:=*DK;?>
M>O+DR?9VN^VVLS[;;+.-=5C_*5.FM+6U66$;Q ;L[.S4&"J;+JO/1U4KT;1>
MQ.M@#:X/H):5(_G/,D-\5'5O.?-#T%"K-FREW'A\KOKZ^NPHHEW_VQ&  0#
MNDTM"OTIU-H5A4*AHZ-#F:ZWMU=_']UHHXU&C1J5! T-#?ZJCJ:FILTWW]RZ
M&QL;U=,Z5&#"A D77GBA1J5SISKCFIN'5>8-I-J*IF^T']=0*W!0E2/W/I4?
M 6_3%_+M&.<*>IN6Z"UINJLY]36R$QQT!H;N.?29S-5<KN[ CB+Y#P   %:,
MVB$*C6G(J-:];-FRKJZNF3-G?OWK7V]N;E8$C5GX'#ERI(72SW_^\XV!0JE1
M>5%AZ_C][W_OS9XUTBH3;T354#3UY93\QVM(KHE97J/5NJ8L;_%S<QY]DA?7
MX="MZM64K:X!\H7J4.6"Q&]7=AGCRG'Y0FO+T%-_.^8P'N>JC=D'69T_W_M(
MXGD8>I8&':12Y4C>LG#<QXX9MEQ;;+'%TJ5+T[!3]IW2$.,!  !P:F#HE&9?
M7Y^:$_:ZS3;;Z$RI@JC"YXA W7JU,9QWWGG6'2=2E;17&XEWZZSLHD6+UF K
MQ4=50]%T[:BLQ,H^55>#LS1\5":'-665Q[QJ0ZT;M.Q> RL;3>,Z7\OUO[RA
M*G\+LY+M[>V#[G57>9X! ,"PHC:#HJGT]/0<=MAA8\:,4?[T,Z(M+2W*F0WA
M(MZ1(T=><<45-NRR9<LNO_QR]4RB:WV52#42>[7,V-W=G8:+>_,SL:J\M?/V
M1E/5T8HTK2K+5#;@5L3R)E<Y)Z4@*O*&RC%4]AFZ_Q &'>0MSVIJ*)6QU_@Q
M1/Z1/JWD)365N-@00ZV(51Y\B*'B<:I[B,)KA\]#;L8&%*J0F_G*59PK4,D+
MO&7)=,BO0=QGZ&*#?D/B[OCMH-M.+)O. /E"F2$^57__5/_&7"G+&[.+9O"-
MDG%W*?OWO_JK8U"5X\G)]?<ZU/ZV$!X:IGOBY4H./5H9HH /[O(E  ! G=/Q
MO1 NZ#6=07-SLR5,O7HZ5325]=9;[[333BN%\ZMJ\'SE*U_Q3_TZWOALJO79
M88<=;.2Y/!+/S,KRP==2-'W+.=9)9Y4IA_2U"O^\6MZ$U#-$T=>5PP(N"W(E
MTXH4L;QQIJ'DRI[#T<ASXU?4''02:2B0FW.K&;]=BGW_XD]]*(U3BZDQZ#XK
M7E(=0\__&TL^V(RIO\90*5\ZXR.4_,<#O]GE+"P-+++VE,.JL0JTJE.W9J^8
MW6L[/T"@,EXSJN?>WE[_LI7"6M,XE[=T^B@G7RBC3S7%7#$?5I_:;.M7M,IO
M?BE\6Y2.-(C*:RDTB-'^3GV&K@&G_6-<&^7!MJ^X9R5-JQ0>M+52>R?-N>^F
MM?B:#=6)%M-G4K,7SXRMJ?;V]G)6A]&XW^2?QJ/*E5&!4JCG4O@.Z/^EFI9]
M9+MXC:H0;LL>SX.&75X59?7WAJ$_C>5* @" >J=&B+4\[4#_P0]^4%G4SW\V
M-37%?>SUDDLNT1-BU-924_"JJZ[R,Z5>,LGNBF09U<+M?OOMIU:3-X'T-C]#
M*\8'[%]3T32>%6_W:$8]'>GUS6$R_5F;6)]:^25+EBP+MS9.HS$/L;0J:4/Y
MG&MR+@U3Z>CHF#]_OG7T]/2DH?;C,:@NXA2Q>/%B;T?&LU$(I\C3@;=FUJ0K
M%U!]-!Y[U;EO-?33,*R'<!_6Y[F<U9A-R!JR6O>:;2V@6M[%3#P&%5-YK0*-
MS29G[7L5T_POC]9=&BI*#?HTFTE;_%)0##\BV)@7+%A@9:S&-&Q<,_Y6??2'
M.E]JE2F&K4C+8J\V?HW6[RVVFGQ.XFXMB[^-YU:+IH[^P);.PH-7LE=U)5\B
M6V5:<"VLAK7%[ ][C7*(?[FAG VK2BZ'[5&?YF:U'%9H6UN;JBBN*!709F7C
MT9>A/_RN86\U8%S2M@NM4)NN)M<?-A.-P2:APO'7/AX\GGE]NG#A0EO2UUY[
MS5XUQ6+8&^2N_5!5J+;3,!Z-*JY>S9A];=1AW]YX<K%<_:2A&GUSMFGIFZ^;
MR^D>Z,5L@TK#:O*M3'VTFGRBWK^4[7Q]/DMA+Z$:TXI3?Q]*X[&4JP. ;UGQ
MDEH9FZM""-(:O\V/:BR>JTJJ0]]GQM\$Y6J-LQ0V?VU92L(  *"NY=I.UF)1
M&W+???>-0ZF?,K4^K:VMZCCQQ!.][>UC4,<99YQA$73]]=>/<ZF/2E?\[K[[
M[A:^RMEYB&BF5IJWW-0$6L/15*Q>M# V][[,E8U:]50Q*__44T^I"67EO_"%
M+WB%NM?/*U=(PKEI;X1I)7G]VNJQF=E^^^TUA@,..,#>J@7I^5"SH4;JJ%&C
M].?@>?/F:0R>Y:0_-/'M]=EGGXWG38L0O\8TG\;&KP#@97[RDY^D652.&[6:
MELW800<=I)(?_>A']4.(&J,Z09^$Q??Q)V%:6VZYI7UU1H\>_:M?_4I7A&NU
MJGFJP@,J<2#_^IH;;KA!,^-??:NWWJ OG%.Z[;;;-%U;?7%3V_FZWGOOO:W8
MR2>?K+6<1G-E*=1JP%+0Q1=?;(NSWGKK;;WUUOTA$\:C6AV:C3ONN,.WKB3;
MTAJBVO/U$J_$*5.FV%*___WOU]M33STU/_9 "V6OUUQSC4J.&S=.,4"+[/?L
M3J*-7/6<#)RB]3G[[+/3+"#E)J3O0#ELK5:?2;B16FXIM.LQ]]UWW\,//VPE
M[9N@;42A2-NCOF-IR)-)F"O],S[^)KSK7>^Z__[[;4&T"]-B^ES%*UTK]'>_
M^YUFQM:C0J!^$_%IN?/..T\33:*UX+_5B>T9'WSPP<<??]RF& <_&;3JO&YM
MM_O00P_-GCW;OJZ: 7UO-1LV(9M#*Z:?;]*PL?M73OL$JSV_B,4G6@J_6?A;
M&_:'/_RA)FVO\?K2.M*O+5HN*_.'/_Q!L=FSNN;'PZJF:/M ?>0_<U0JAWV=
MUIJ-^9Y[[LE]6U3SMG+WW'-/V[+T/=ECCSUT.(E+ @" NJ,60GQ,5RO(VX%J
M>ZB)H@;#M&G3"N'T@S6_-:P:EAJ;MW#B/YTV!CY"-6EL$@<>>& Q"WJKS&>^
M?XU'4^^P]J@:B#;K6M1<@])+VJ=>:\\__[S::O;ZE:]\177A#<VX1F(JIDKQ
MF5<5ET-#O)BE7S6X7W[Y93_#H(:==]C@/DY?TYY@5=)_6K#5J4DG V.&.G*L
MOS=,-5=>\O;;;_?:2+.UHDD8J\E##SU4:6'JU*G=X3K 0C@7JB6*JR5NH&MA
M+9U.GSY=D6#1HD5:Q1ID>;.:#*SJ6V^]U>=--5 (^=]FP^8M_@W"DK.*Q8OC
MZ]UFP!K$(T>./.&$$W*?*C+93!YYY)&:J#6@7WWU5:W->&RKQM>=O7J0CF]!
MIII4=ZY*U92?/'FRC>0#'_B :C5>A$JV.-_YSG>TNBWY^+D[F[I64%S_\;22
M: W:="VVZ3S>\FJ@')QTTDGQ&!11_*W&/W;LV!UWW%&SH9SCZT5;7'M[^PX[
M[*"I>S(<,V9,0Z"WMG;2$'5T6[;<6H[?3IHT29.V86UR;6UMFK0G,:UNZ[C@
M@@LTB8:*S5PY2MV-X2>Z77?=5;\3^>2T:?M,^K#J8Y6O>=A\\\T_^<E/VM1M
MFRUE?Q^UUS/..&/##3=,PMZC%++ZTJ5+BX&F8GQF;%0^4>_0XAB?^O>___V^
MZ/\(Y>P?"D8%;$$./OC@4G81=3RJ8O8#F1;A]--/5T^?XJ#L(\VDN?_^^[UD
M_!O$>][S'B^S]]Y[ZTSX$.,$  !UP8_FI7!UWD477>2)(\D:8W$SZ8HKKK V
M26]XV&DQ7+>H;F\9EK,;-%Y]]=4:T&G,<60]Y)!#TJA%M&I-"Q_J;8FFZN[I
MZ?'%B.-BY2#%$$U567_\XQ]5V.;D[+//]E;U9S_[V4]_^M/V>M1@/AWH?$X<
M9KRU9Q]9]6V\\<;CQHU3M>J!#;X:]*KK%7T=Z-+394$\S\O""1:=C+7&^F<^
M\YDC W78_%CZTAC>][[WV3Q;3YN]?_[G?[;7PP\__+CCCM-T]5VQ8G?<<8=F
M(*YY=6L1_*SI@0<>6,["MNI--/(CCCA"M6%O;4+6[<MBZ5>!Q!9<K6U]JP96
MY!L^$V@\G_K4IW[WN]_%LZ157 A_F#2GG')*$N[6I0G]^<]_]EK20L7K8J^]
M]K)9^MSG/J=&OPH40[/;RG_I2U_R:+'UUEOWA5/3<2M_=?CV]MACC_US8(MV
M]-%':TFMZGS3M?RO K;N_/6LL\ZRF=Q]]]T;0@@?(IIJ(])94YV42T,E](7K
M^)-H2[;16FUK_.K6MTA?).MSYYUWJK95AY7T33CYY),UYQ,F3-" MD0V$NLX
MYIAC;-&: YOHAS_\8=6G*K^<_7QC7W5;-9KA#WWH0S;SQ>SZ6ULOVV^_?4.X
M_,-&<NJII_H6&L^8.O3ZTY_^5"OQT$,/M5K]QC>^H5V>;3+Z&OBZ,+;S2<*W
MT>966XK14MAWV,9@W?XUM@Y;A+0B$YH]]]Q3@ZL"_0NL3[4G_<(7OJ#O;3E\
M@6V+L'E+PF]^M@O6V+032$,"MZG8'DD%#CC@ )OZ*Z^\4LC^<)L.W$@;LFC]
MR"./:#?/6U4  &Z0241!5/-\8_Y"M=C;XX\_/@D7/FB6GGON.9N$(J(75E*U
MU\;@M--.TZCZE__WYC3,1F/X$3 )T;04_3=5KS;")$O7MGYU??(J[.<! $!-
MT8'>VU=SY\Y5:T3GM.+3,&I-6?]EX6&G:6BKJX&1:Q+H;7^@QGE\"B<>FT;X
M]:]_?>'"A3XSJ\ '[%^ST?3UAFJ0AH:=YMMX@<I!TBR::@F??_YYSX'GG'..
MEGF''790^;BU5TFM[71@*SD-;4UC<?&3G_RD3ATT9&=$Q<M;3X58S4PYNCPX
MGG_O,^CDS/CQXY-PUNO**Z_T !!/46U'7VJ+IO'@7L:[+<:H*@X^^. TU)A]
MVI==EYN$\)\;@Z;XTDLOJ<%JK5)+F%9&9_"2[$>4>)"8KX4T.HN;9G.EE-79
MV6D=9YQQADWB\<<?U[?6VN7^C:]<*.4?BU)I&*WE 8W*&NB6T/2EUXQ96-*E
MFW$]K#+?8KV/KSOOJ9JT23_UU%,JH(^\PPKOL\\^*G;222?YJ"I9R>]^][LJ
M.6;,&/74&M$D;!GGS9OGDZ[\"@W=/T>_#IC==MLM'7A6OQQ8.E4!^QK8TJEB
M=76KYN&=[WRG?6K;R*Q9LW1J4=\Q6\4V^)(E2^S+DV3GF?7+0AK]])-F>['P
M8T7?K;?>:E\&^U:\]MIK5O[::Z^U3_5#3USA&DIG39/L(EA?6.TN[8MA(_S3
MG_[TJ4]]*@D)5KM4'SS-3E?^Z$<_TN :0RD[K?KRRR__]:]_U9PWANL.EH5;
M6VDDEUUV61+.;*<AOVFB:79VU]Y><LDE^A''1F*OO_K5KY:%7Z;ZPS^Q?5?I
MO\39[%E=^<:NE9Z&/Z[;-]P*_/=__[=*OO#""S:>18L6><DTVPOU9]=NG'[Z
MZ9I$KMYRRME94ZM)BZ:V^FP![>"D$[ VG^]ZU[M4R3OMM)/UUZCB;1P  -2C
M<G;*RIHN=GS?>NNMDX'WX+4FT.C1H]7&ML; A1=>6 [G2]0PTT_S_8'UMW:7
MMS?4 +8QJ[%D)DR8\/H/Y]$U;IY$O.6S:KSYI]E8D]'4^RC_B$;HC<5XD#2T
MR3R(/_/,,TJ#UO_LL\]63XNF;[G /HFXI]ISUE#3V1M+"Y=>>JFF==YYYZEE
M%L^YIJ):MO:H-PI]5LO134W2BLEY>453<_755Z?1+7_TJ0_K&?C'/_ZQ]R^'
M>1:-TWBTL'2M8=]8<T%#N$(X7G=:-#6+528)IXSZLK_8>4^?L9CFI++.?7GU
MD9KX-A+[QEO#??/--]?,^'DG+ZG9LX[==]_=RAQ__/'EL"&E(0/8>/SB[20\
MU?=O?_M;(:B<AU7F:R>-%J0<75BO2)R$WT=4F2KL)6T,^J^IE1PBFFK ZZZ[
M+@G?(LM[ZJFTXU-YY957XO&[>.T/6L!IYJVDK5G-U90I4W)E^K*[7AUUU%':
MFYQQQAGZ2'?<L<J?-FV:OHJVQ^D(M%+TO=6I3BO\G>]\1^O77O_PAS_DMHYB
M."F:AJN%&T+VWG[[[2UWZ>YP&H^^MQK*UZQ%4ZWW-%LOO@=089L?6P2;)4W:
M]K9>4L44'6^[[3;O[Q_94FB?>_/--^L_I;:#UB6[W>$/V%:@,?P6>----]ET
MM5O7LI3"53'[[[^_=NASYLRQ8E9[\<SK&A@;R><__WGM6';;;3>??V?SH/_Q
M6C"V\&_U;$MA(59;=_PEUT:1AKV03>[,,\_LR^[BNSSEL'&I$FP>+)IJA-K8
M[=./?>QCJKI]]]U7WP=;NM[PE_7\N   0%TIAP9J,4337__ZUZVMK6H2Z-=\
MG: 2:P)]Z4M?LO:/M026A;M=*"]86EFR9(FN!K6W/__YSW_P@Q^H3"G<Y='&
M;[E)[1RI[$ZS-IBWQ%:*MTG>"#BK'TW%QUL.<3S)KAHM!P/+OEFXE%WE:"SA
M^")]]:M?U0)OM]UV*E8Y$HG[5T[KI9=>LI'H=BR:EKVM;."6LTRH.?%:]H:C
M%XO?YN9*;W4.RGSSF]],0RVKQ1DO<CGZ>]CMM]\>?QI33VO1ZISD00<=I#2R
M+)RZ\3'$WP,-8BUI:]/;E\R"EH8=,V:,M[R3;-7X4#F^=/XJZM95P=;@'C=N
MG'*(]?S(1SZ2A/5XXHDGZG1HFJ4+M^>>>UJ9XXX[+@T99MZ\>85P7:7F, DG
MG2PYZ'2?[O<[:+6L&E^07'65PZI73=IL//WTT^J?*YEF\V\LBL3]G<_MM[_]
M;9746=/^<&5R*5S%K?ZV[)INY;"#OAV4!E<T-9:<T^@4<5M;FXU$.Y<GGGA"
M9PY'A*O9[:-B^%NC?27\IS5+DAJVG 7I^,I/ZWCTT4>U==A(?.K.=FJVB>V]
M]][Z:IURRBDVR$47763=%E-MKV=EXE_CQ'=VFHH^+6<_ 7K,LS$_^>23^IZH
MCZ\@;:VWWGIK[NNJW70I_#AEK[II64-VI<#K:SW4OZ9^RRVW](<+F'4KX/YP
M4M2^@:JQ:ZZYQOKHNOI2V/JT"6@':F^/.>:8)'QY;!7$-::93$/4M/J_]]Y[
M;?Q[[+&'*MQV<7[W8]_/E+(MU-@A1*-2R%2!2J7H$GU=T*O;E=O\^[WUWOWN
M=VO,JEC][=SK"@  U*E"^+.2M2B^_.4OJ_W@6:8Q_-_'\JJ]6MQ3NZ@<FGEJ
M#^RVVV[6?I@]>W8I>R+)L<<>:P/><\\]7=&-(:W_Q1=?7#ER;W[X56"KQALY
M;U<T3</Y!,UW4W;Z<7G-(+6KY)EGGO$F6GS6-!WL))[3='.O/C.ZT^\##SR@
M/I89U$:W=F$\>!I='RCE[%1DO%Q#4\D)$R8D8<TIFA:#7$E?:BNF$SXNGIP&
MM#:Q5O^!!QZHGN)?CN+ /\WVA7]IZCMGW[9XB32X]_$)Y?C*\D9VW%\G9'[[
MV]]JZI,F3=(7.@F+,WGR9)UY\P%]WG1!K.6Z8M9$MF):0<;&\^<__UDSKV1;
MREK_FOH:YZLX_A+ZWV7CZ6H1=-8W&?*"7I6\]MIK53FZ6-07Q*?RCW_\(S<5
MS4DTIOQ7.OY(-,BIIYZJ<>JLJ7X#2\.*+H4<91VV96G?T1!.:Y="<+55X"<M
M/_&)3Q2S.\%J0-]_:<=DXYDU:Y:M(WT5TXK9LQ&^^.*+FVVVF4:H'5Q[>[OM
M#4>-&F6!OY@]KSA>EO///U_E<R,LACL2Z6NL&?C3G_YD^]:&@7\0Z,_N=/VC
M'_VH'/B8O9B^;);3=MQQ1RNY__[[E\+U\.IONUH;YZ&''EH(=PRRI?"3BI=?
M?KD6]LHKK[0)Z9^K-]UT4W^XXZY^<;21V#+NM--.6MTWWGAC&GYV\:G;.*=/
MGQ[7B>WK-<^[[KJKS96^,,7L['TY^C8JFJK $(K1OP-^_O.?E\+&:&'^XQ__
M>)(=.;1T?JH\#2LT5UT  *#NJ$ECK0N/3J)+M-3QM:]]36V;[O!H&;4Z]%<C
MXW\"LD]///%$G0E0DZ8<[DBB!H/.-R19T\+RE-\$V-LS:=3L]SE\R_9&W*XK
MKY%H6CE)JR#-=!*=TZLLIIYJ5!FU7\N!ZM<6WJ).?_:,S4&I-M625GM+*\EZ
M6CM2U=<=[G2J9KKNR6ET0LD;A9I/?92LK6AJ7QK_KVG<2/6)6LP[_/##*Z.I
MU4E#=N>5W#6TQ5"':F'_Y2]_43']24_-5DU:K?Q*OK[T>XE^68D_+82?9S[P
M@0^HA6WMW9[P; QK@FM^CCWV6!_$QV9]=$'L<<<=IZW".G29I>69YY]_7CW[
MPA6,*U[GJ\-7L:^.9#G15"M%T=26<7EG3<7J^?KKKU=56"I+PZ@4N57M23AK
MZN4U ^J(^ZB>M94.6B&:>3]K:FLDC<Y4:]VI5H\^^FC-S[GGGJLOCQ6X]]Y[
M-3/VC7WNN>=T68&///<]+(>,:FM0*[TK_%55_3643<@"7D,X/?CLL\_VAY.0
MUO/U7QT:&BPF^:[01VA;I65CC; OW'>Z%,[L::OLSYX[JN^2;056,A=-B]E-
MU :-IN+][[OO/AO#%EMLH7MT:PYU+_$DVTW9YJ:MR<9LFTQ+T!V>+ZHMS@:W
M[ZI&J,6QW;'J-@F[YC34O#XJAFN#+;@FX9N@9;&>=]UU5V.XM-L. )WAD3RE
M0%6JA4I6.)KJ(NHD_ ZH)U$IE-J<VS%CZM2I_<NY<&/0Z@(  /7"C^9VH%>#
M*@E-336PC>5):V84PG6Y:J48_570[\1A[2*UN-+L#B;VD;6"KKONNF*09A>!
M%K(0,6;,F*9 8[ IEK+?_9<%T3R^-6^0J-&[!J*IJ'8T]H4+%ZJYUABN]DRC
MEJZ7\:&TD$GV'S:UTLXYYQR-0<_M\,12*0T_&/BU@KK3S[)P3N.PPP[;>..-
M;3S]X42'+I_;99==K ;77W_]WO"$0_M(E_R50^/;9Z:\5J)I$B[H]=:GQI!K
MC,9WZ$W#"/L#'T,A9)@T^J^:?<GZPW,LQXX=JV_>@P\^V!&>'9IFCZ9(LFNM
M<](P _J.JH^WF#5C5F]//_VTOHZ;;+)).:NHG_[TI]H2K,+__O>_QX%9]MY[
M;S7'R]E/#YH3C5F_%"Q8L,"K*YZEMX//>;PZ*J.I=^RYYYZJMY-//MGG+4<E
MO_6M;ZD>1H\>K?Z]X9I^GTH<3=-L$CZX%=:9M_[L2F#_**;^'DUWW757%5-_
M!2KKML28A'JV=/3$$T]8%K(:MFWARBNOU(";;KII9WCXJJTRC4&K7E/QY=(W
M>41X.$UN_MO"XV$TE7>\XQTS9\[4;-M'5@/ZJL0W.4O#:.T+>?[YY^M3K?12
MD(8%[PZ/_]7MRRWK^O\E5"S-=BG:2PP1346[U"3L;?_ZU[^F(5+J%T3[*HX<
M.7+BQ(G:::39A<>:G/71U<C](9HFX4;BA?!@Y$((_RIF2V'??UOJCG 3J?[L
M_L;V==I@@PVLP$8;;50*E]I:S_OOO[\I_ G$1K@L_)I6"COT<K:M:9PK$DTU
M+<U $IYA.V?.G"3[1=->Y\^?K_'W1Q<@#%%1  "@CEAK1)<K*B(F62._I:7E
M\Y__?']VXT:U-ZR8I0DU,[RDM;V]I:>+&=6HL-:1[F&A8=6P]T>HQ&.P/K/#
M5<%J"%GC+6[,QW,[*"^CMLH:BZ9I&'4QG+*SV=+L6D/0DM4AAQQB*?'@@P^V
MUT.#PS*Z1Y$*6YM/@]NHOOSE+ZM>QHT;=_CAA]L8-& E^^BAAQY2VTN#+UJT
MR'*.M0+5^&L(45XW1.D*CXW1%#O"<V:M!:PFIBK1:UGMN7(P<"F72R57*IHV
MAO^G:2FTC'I5S:C2+#FH\-2I4S5";V<WA#.B6O9EX=8U:N!J*K90RJ56S-K-
M^F*]OLHS ROR#9J3(XXXPJK]^../5Q,\C;XW-KDQ8\9H#/H;7AK^#6CCWVFG
MG;36OO*5KZ@"]:F:U_J7W:FGGGKTT4=;,?TD8WGIC#/.T%;A=:Y!--3;QR?G
MJR,9+)KZ;$R9,D7UN<466^1K+;#U9>O(.KP>=$%O&GX]T2K3CN/C'_^X%=/S
M4;0AJ,Y5^>;((X\L9/^WU!C$YRJMB*;CQX^W\=CF9J.U#AO;)S_Y2:OJ))RR
MLZI^\,$'=2%'7[@=SF677::9V7###;7MQ!4>3TAO%2PM:MH@MK[2+!QJ*.O6
M(NMF7<IX-MIITZ8EX1MH=5((YT6UHM.PZ>FLJ7VJ#5"CTG=8@?#66V^U*E6]
MV:2WWWY[GR5-6EOKH-$T_@J5PE>Q.3RE]D]_^M.R0#-YYIEG)N$.1MH5:/O2
M^5XK[Z=,K8_V&Q_YR$>TN:7A#+G^K&N5?\\]]RCK]@2VP_'9L\K_WO>^IS]1
ME\*.>\LMM]38TE /.@NM1=#W)%FQ:)IFSX;1A.Z\\\Y]]ME'<Z[+;*QF=#Y<
ME1._ @" NJ9&BTX^)>%W:D4#Z[#V23%<C;@LG#7U5I;:5'&\U+_,U. \^>23
M5< ?#O^=[WQ'#94TNS3OZJNOUK1TVD"C.O?<<_O#"95BB+*:M\JVV:"\C-I"
M:R":5D[56F9JI[JX"G+4J#+69-1BV!ATUU8?2K7\YC 1^^C7O_ZU3C250[M0
MYW#NN^\^%;#F6AHUH*W)^V__]F_6_XDGGK!UV1_.SZ19KO;1EM=*-$VRKY$&
M\=>8WZA&T;04+O5<ECT#Q@9_^.&'9\R8\?O?__ZQQQZSUT<??73Z].G64S5F
M@W_N<Y_3=T6GT?P$U/+X/&RRR28]X?8V\2+,F3/'&KZ6=BR@ZENH<T$:OP8\
MYIACWES:P"I'9TUSD] J?N"!![K#1==:37&=K\(7<@7Y*HY71V4T=1_\X =5
M9GD5V!!N$=00J,^X<>,TJKZ!%_2JF'^]<]72$'ZO4H5H*\W-B6CF/9IJ1Q-_
MBS2?BM-WWWVW%=:J5#"[XHHK] W9;+/-=,<C5;ZO!;VF445UAWM6641\[;77
MU-_G1+]&61S2V4ZC_\1KF[(OX;;;;CMW[ER5%YN'\\\_7]7E5Y5H6?PG%=&B
MV1@T7<V,1J)/!XVFXCTM*VI;>^:99_JR?[WJASWKO^..._:'Q]6DV:UW;1[.
M.>><4O:KEA6SU*<YM W0>NHDLY9NXL2)*J-IZ3Y)LV;-TN*\\YWOU.R5PL:K
M_;L^TC&C(SSQ1;/J>Z$5B:;E\)/!B, &T7V/-)->J^7P!]?* 7-]  ! W>D+
MUZE9ZTN-AZ9@Y,B1IYQRBIIGRJ[]X5?UPPX[S&.%6)O!HFF:77KI#QVP5VOJ
M6V%K2U@K72V<WG!%F(U6/^N+&I/GG7>>&E=IUL98\9:&EUQCT53B.5BZ=&G<
M1%Y!E@HT3\:BJ7K&B7QY?OG+7Y:SVXIJ3DK172M_\I.?**PN"S\;E,,-3JP-
M;;FK$.X7HJ2W+$3\))MGC40SX\LU-)5<V6B:6S1_FXOB-L)!HZE>O3&:1,%)
M;ZWU7PAZLW^-^D>#\H]L/-:D3J/KA,7O\;/++KOTA[-)^KIKV_#!EV7_XRT%
MUO&!#WR@,60G+9IU/_[XXYK0Y,F3%9YU[U!-:&4KW^4_6X[RBD53C=/*[+77
M7FKK#R&N6%M,^YJEH094&U'!U\7;2,/ 'V*2\ U4H%W>0FGF/9HFV?[(QZD
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M\)2%^B%""UDH_O2G/]'*E>3FS,9>D=F!3,K+?^S2;/P,F36M%-N>_8^/TI$
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?( B"( C>2B1-_S^/]XX'R7$XZ0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image_17a.jpg
<TEXT>
begin 644 image_17a.jpg
MB5!.1PT*&@H    -24A$4@  !-X   /)" (   !"YW+<  "  $E$051X7NS=
MVV\<]WW_?](B+<GQH4U1H"U^OU\1)STD09&X.?W2% %ZVS_EA]X4:/$%DJ(%
M>KAI>U&@Z%7;H$T3NTDL6Y)UH"1;LBW;LD2)(BE1EB59E$CJ9%.BQ-/NDKL[
MO[<^+\\['\Z2J]&2XUTNGX^+Q>SL9PX[NS.?SVL_,[,]/_C!#VJUVOW[]Y,D
M60Z6EI:J       4PX*G'BN5BD71N;FYGA_^\(<VRIY8.K6Q]IH-UP$
MV&A)H %[M#0Z.SM;J]4>1M.EI:5RN6PYU5ZS8?6= @    "PL=19Z@,61>?G
MYQ<7%WM^\(,?J-?4<FJI5%*$!0    "@4.HUM2AJPP^CJ0W9*/67)N&*T^P4
M      !L$)W0:U%4\;-2J3R,IHJJ2J?9*0      V#A^Q6D2+BE5(%TEFL;E
M      #80$13     $";$4T!     &U&- 4     M!G1%     #09D13
M $";Y8VF       4)&\TI=<4     % 0HBD     H,V(I@    " -B.: @
M  #:C&@*     &@SHBD     H,WR1E,       J2-YK2:PH     * C1%
M  #09D13     $";$4T!     &U&- 4     M!G1%     #09GFC*0
M!<D;3>DU!0     4A&@*     &@SHBD     H,V(I@    " -B.: @    #:
MC&@*     &BSO-$4     (""Y(VF])H"      I"- 4     M!G1%     #0
M9D13     $";$4T!     &U&- 4     M%G>: H     0$'R1E-Z30$
M!2&: @    #:C&@*     &@SHBD     H,V(I@    " -B.: @    #:+&\T
M!0    "@('FC*;VF     (""$$T!     &U&- 4     M!G1%     #09D13
M     $";$4T!     &V6-YH"     %"0O-&47E,     0$&(I@    " -B.:
M @    #:C&@*     &@SHBD     H,V(I@    " -LL;30$     *$C>:$JO
M*0    "@($13     $";$4T!     &U&- 4     M!G1%     #09D13
M $";Y8VF       4)&\TI=<4     % 0HBD     H,V(I@    " -B.: @
M  #:C&@*     &@SHBD     H,WR1E,       J2-YK2:PH     * C1%
M  #09D13     $";$4T!     &U&- 4     M!G1%     #09GFC*0
M!<D;3>DU!0     4A&@*     &@SHBD     H,V(I@    " -B.: @    #:
MC&@*     &BSO-$4     (""Y(VF])H"      I"- 4     M!G1%     #0
M9D13     $";$4T!     &U&- 4     M%G>: H     0$'R1E-Z30$
M!2&: @    #:C&@*     &@SHBD     H,V(I@    " -B.: @    #:+&\T
M!0    "@('FC*;VF     (""$$T!     &U&- 4     M!G1%     #09D13
M     $";$4T!     &V6-YH"     %"0O-&47E,     0$&(I@    " -B.:
M @    #:C&@*     &@SHBD     H,V(I@    " -LL;30$     *$C>:$JO
M*0    "@($13     $";$4T!     &U&- 4     M!G1%     #09D13
M $";Y8VF       4)&\TI=<4     % 0HBD     H,V(I@    " -B.: @
M  #:C&@*     &@SHBD     H,WR1E,       J2-YK2:PH     * C1%
M  #09D13     $";$4T!     &U&- 4     M!G1%     #09GFC*0
M!<D;3>DU!0     4A&@*     &@SHBD     H,V(I@    " -B.: @    #:
MC&@*     &BSO-$4     (""Y(VF])H"      I"- 4     M!G1%     #0
M9D13     $";$4T!     &U&- 4     M%G>: H     0$'R1E-Z30$
M!2&: @    #:C&@*     &@SHBD     H,V(I@    " -B.: @    #:+&\T
M!0    "@('FC*;VF     (""$$T!     &U&- 4     M!G1%     #09D13
M     $";$4T!     &V6-YH"     %"0O-&47E,     0$&(I@    " -B.:
M @    #:C&@*     &@SHBD     H,V(I@    " -LL;30$     *$C>:$JO
M*0    "@($13     $";$4T!     &U&- 4     M!G1%     #09D13
M $";Y8VF       4)&\TI=<4     % 0HBD     H,V(I@    " -B.: @
M  #:C&@*     &@SHBD     H,WR1E,       J2-YK2:PH     * C1%
M  #09D13     $";$4T!     &U&- 4     M!G1%     #09GFC*0
M!<D;3>DU!0     4A&@*     &@SHBD     H,V(I@    " -B.: @    #:
MC&@*     &BSO-$4     (""Y(VF])H"      I"- 4     M!G1%     #0
M9D13     $";$4T!     &U&- 4     M%G>: H     0$'R1E-Z30$
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MNK)H6BJ5=N_>'9J^RY7T;^@!Y*0\8[O/O7OW;%>R!H;NE.,[E'8Z-3FTWRG
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MSEIZ0QJOQI(H%FK16KIO;5]S2<+&T4 U[:NII9_O<G0/4M\X*JFYZ=$VOJ^
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MF9Z>OGGSIKUJ;1=KGSWUU%/>+/-VC.;IS8*8:FY\!G;NW*F/PQKQ-AR?T$A
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MFIS1E%Y3 -B",M'TR2>?U+"\\,(+V0E2<5V@88NF2<BERJN90"N*IG7^/ 9
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M0$?*&TUI#0.MV:AHJOV1: H W42']$PT=7FN-16K'1X\>)"$VN21T;1&KRF
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M% "PEE6CJ1__FU]KJIRI <N6T]/3&FA2W6@2HBF SA2W<HFFP,9;3S3E#KT
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M8U>S:+K6,0Y <WFBJ<Z_4C2]<>.&LJA'4UUH:FS 6BTVQH:7PY^JE\OE[+P
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MU^;GYZ]?OV[#<32-&R)$4P#8.CR:QA6!6'7@T;12J93+Y;&Q,76?^K0K9P8
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MG+5+IJ>G:]$=>HFF -#=EE-6!3SSS#.]:0K5!:7VV!?LV+%#_:7;MV^GUQ1
M5R*: L7*&4V=KCCR:TV)I@#0E70 UZ/BI3WNW+E3AWJE4!=?8NK#1%, 789H
M"A0K9S2-=S&+IIEK3=4<45N$: H 7:"67E J.J?WV6>?5195?ZFJ -T 2;4
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M 6!3(9H"Q7JL:#H_/S\Y.6E/,R?TQLT4HBD =),XFC;VFO;W]^NF ^^\\\[
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MKFAJ-<OT]'02K@111:!T"@";&M$4*%;.:*JFB4[KM9W.3^@EF@) =VN,IG[
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M2C3[5BGG/Y7,BM14"!$4I*9"Y)9,U)2Q@NU9[>KJ0C@"*2U)X?:=2DV%$*+
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MA!!"B.# DT+2@ 1. 2M6K'#5M#AU6T<D$G%'RLQ_-O$A-15"! 6IJ1"Y A$
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M(800><+\:HKVO[V]G3G5:RJ$*&#<>%5J*L1))ET($5Z,CH[6U=5A:3,P5N#
MK9Z>'JY'!3QF:&EIF3&C?.FQ9YQQ1F5E)7M*.55&34U-5575???=9_?"6Y*2
M!KM2""%$?C*KFA:GID'"J:&UM94Y%]"P2TV%$$'!;=^DID*<9'P!!%X.# S
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MM;6?_>QG8;,P6VS(^Y&X5;:!BQ!"B$5D?C7%LJFIR5MHVRXU%4($!:FI$(L
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MJS3[3I,&=T,AA!!Y2(9J.NMEQQ,B-15"! 6IJ1"+#Z,-1 Q;MV[M[^^?F)B
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MRJS:<ZFI$"(HN(V;U%2(Q<$79$!'5Z]>C94;-VY\_OGGW3Q<(CJ!Q[IJ6FQ
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M*4VYY'S4X@)28B^VIIE 0B';V-XSX([!*W9:_"9EU&[BO/';]0S[G2F$**J
MMW%>YRQ_+WQL@C3MZ.C C85_NN:S('TV.CL[T_:";->N7?[L2-ZPA!"B  CO
M3I*F0A0$Z;C+ H'V]O:JJJK%BQ=G;-*+=/"JFSZ'?;IXQH.D*T,/AN[..]_Y
M3GXP1LL7#R N)@F?CQXAZN@G/_G)]'B>*O=*A1.Z[ 2..%3]&]_XQKESY])?
MEZ2_&/A-@T1Q=QPN7=Q5_*+U@+A03+.+O"3^%N/ZZZ_WBO#X*Z^\TM\YEMBW
MIGP64)%RF8JG"N.M/AN?H7?__OTF9L\0WJ:$$*) ".].DJ9"% 2AYP%I6E%1
ML7SY\I1-QNL_*673A0$BAX:&Z.6X^^+NYL&#!V'3W=V=/(:X^*3CUP&HK,'!
M0=1"6$<B)V$1P2-'&=YQQQWLS6.D!-)%9=:L67P%QD<_2AN%GS02%PA>U=/B
MWYF^YC6O&;:IOWIZ>KB55W[X2NNSG_TLG@)=75VXGW1T=&"),';I&A<\1SCI
MP LOO, W9:-N54((43!(F@I1<%"4<NPN7 JX'4N6+#ERY AC'+X.'[%I,SD-
M$KV9T+G?L6/'B/T0(M(T2)-%>%>-K)K@$:+PX4266.<V'<U?]5B)7/#JA5_^
MO>]][]9;;X5>XJ  =A\EK<7Y41(+?H8C&_S/VP5CJ* XZ%=<0/QB9@ 7/$4C
MQ"2N>6[R6SK?$=Q___UX%E175]?4U!P[=JS.J#T;)TZ<J*^O/W7JU)8M6_R5
MF1!"%""2ID(4%M2E*?NC(P)P*?BJ>]&B19"F=%S8;KGD4*[0L_2W[%AR7E^)
MTDGF3*=V<&_MZ>EI;FZ.S-&?/7NVCTH-51;\SKESYYX19%. \')%@93810M?
M/!P[RJTY\:(KB2TG'\_)]!B/X=91UC$Y<YLP]F2YRL#T>+Z<\X19Y1]*7//X
MUA*KB#ESYEQE()!X%Q#FK22NNPG"7<9:S<E9;<8R\'C/=LBO3B;>%(;/R@3-
M<D*%?\455Z!LPZ/[Q8/2GC=O'@N?D=R%M<_ZNN>>>U:N7+E@P8(-&S8L6;+D
M.6/IV5BV;-G"A0M7K5IU].A13D"0>(,FA! %@J2I$ 4'U2G;X/;MV_O[^]>O
M7__LL\]BE?V?43!8E,.TX++XQ+P.U YVY \)F>"+QQ"3A=]%47<N/NEWHM80
M@S![2!@_%2BQWF/VPDVWWY;@6J5H9['0C.Y[3F;$DWYQ=^XUF21RZ&&/YVEZ
MQACV*G;+Q*I;<B_&^]:2>,H<-Z:]&T^0&39\E#LR6<;[H?THB<SX1X\^Q)HO
M%,:'1V&"3"?<E%CU,&%./#\AW#>QB:N)(S),>Y(H--_=$TG$9-LXB:,'6T9Q
MF3'-FOP,&ZE;$M\'IH_.'E=9S@S0K,2TZV<_^UG<4MK:VOA2TF\RB4 V>!#T
M]O;R9]?);4((43!(F@I1B+#I8?G,,\]@%4N(3/X_)@IT:4-# Z=!<L^&?@P#
M\&-NN.$&>"0='1V>LIAD,O'\50B\[&4O"VO*76>$7_[REW.RGZG #!.6'N:U
M&OXS8WQ@=OWUUV-'_@J2LG;69 %1A^5L(Q'/30D;AS&A?<XP<<LP!1XB/)"G
M/$%0SO/GS\=RMG6<E@2RAY=EH@JR8TKLM4*)51GW]:J<"*RO<#5Q,7@\S1C#
MEI)S:T["I!SNE3AZN)J3[+U"+K<W+#-,:C+,?&8??4;<1TVE6C)&V3*>2[\Y
MD!G64AY^^&&?.V!@8& HB\%<]/7UA7<D>G<>(X00A8.DJ1 %"@?T4IJ6E955
M5%0\^^RSOI5OOGMZ>N!VH)WZMZ;NRLR(.SWHOJC7-%_P7MK<W R!.C.>4>:R
MN*-OINDQ:(;''W_\T4<?_=[4X/L& CCK'_S@!PA<??75[KO[99S3<2=05O/F
MS>.%7<B]0)G1)#?'C+4U$3D1F[/"WK;>WMYDF>8B40742PC\Z$<_0@VB[AY[
M[+%D[0:PHKVZ<Y*]*1'C*3SQQ!.,"0.^-807%0. D4^,QG>/C_,K?&LBS!1>
MM#.8 @Z! "YFQ/SPAS\,#3Q+-$:YH<2NN>8:?R,0$HI5#W/IK>-SG_M<9/^C
MPLT_N]=T'/H-/%:D2X40A4QX@Y(T%:)0R-AOZ^!YKUNW#DL(FQT[=BQ:M,A=
M6&^Z*?LJE6_K2X+A@O1O;KGE%DK34:F+283W4G:<=G1T0%-Y7Y/[G> 3G_A$
M9-//3 7X6!FRV:%X<89%0:?<7?-LV&L',O'0]T297VR\&3),L7?6;&0;,)U$
M?!@YSJ8P)ESU<$Y8YFF;@+<D&"_*FP8+/"Q_CZ&-WUMP(+YMX:N!$*_E['@&
MN$O"('N7M$$IY62LQA'IQHD=P]6,#5C *?,U'QF)AS P[#LRDKAQF*#;,Y[I
MT\ 3";<F8&9807X3\%(-RY:ES:IA'3&>D9___.<A2B.[\S-99M@S/Q;,6";7
M=26$$(5#>(.2-!6B4& #[.OK>_[YY[=LV3(X./C+7_YR\>+%_JVI.QG]_?W=
MW=W77GLM_1AZD_1[X,'/G#GSHQ_]:#B:2TP^]*197ZPC5A8[46?:!$@///
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MBPH*QE555?[1>!070CKXYZ2'PQ-T0LGJ"BHL%B<[,C-:3WJ&)XZGPT"V5O1
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M,#?YW3MMDUUE=)$4#*S-LK*RQ-L*(8008BH3^BJ2ID(4.M08[&J#GFEO;^=
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M9$<???1_Y5:!(BZ__/*"O0[4WU(KG2:C=TF"*%-HTC!O&S'ASR1;"0 U54-
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MXW-3KD<N*>A+^=@ -'&Y?=3TF]_\)F-3:I&\R0RR&!UUN^VVHW68T)O8T);
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MA?V95#MZH#]QU3T\(B(B(B(BXBN'BM%.G"L&0N7=X;"5;442?_=\\<<QP\?
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MF7;V-Q^^;E&'B(B(B(B(B(B(%00YAXVP>^">($Q3SF;PN;N8<[9;\QA#4:'
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M+@U(O^<]\, #E7*???8)XTGI65##;Z7!I$UEV7KKK?OV[<OP%RV-H^\4""9
M^M577UU,3&DNN^PR$8]&&RBC"O7U]>NMMQY"Z K5;5EMS"7%55==A:JB&8DA
MGR( ;(<T5*TU:JKX29,F>4:WL_/,&3-F,&6W6[=NIYQRBL1^\,$'XIFOO_ZZ
M(EDY3+.RA)+^!@5B,2>&G3)E2JX1"2B2HX$E3?*)]Y2DH1VKJTQQHJ8=;#[P
M<<<=QZ<!SYB:$!K=.T.C#3,F[::F:::2*JBG6JT@4YQVVFG8Q^V99A+8=_H_
M__D/S'_555=]^NFGT^Q,9-10#Y?.?_O;WWB#\!0@Q!\0+'G;;;=U[MQ9=:0L
MBE :^IN406 Y QF1P$M'!4F"NLU[[[VGIXRG,B(B(B(B(B(B8L4'CJ)\PF'#
MAFVSS39___O?__K7O_[I3W^2>RE7<\B0(;B"\H0??_SQ4O-%<*5L(% 4M%>O
M7C?<<(.\V=2<4MA*Q>97_N$/?ZAD(S?XGP,&#' A;7C(K<']\/3+I::.DJUU
M;+!AST<??92%<)7@Z$N\9SQ^SU6TD:)--]U4I4R<.)'A(]@IZ2O&*+CNO__^
MA8R:MH'J6KCF\M<E0<U\Y957KK766C4V Y/6]62$U9#P*R60AEZ1#S_\D/3'
M'GOLR)$C]]MOOY*-?:/AIT4N5:/F</755\N,4F#EE5=V)5M$KFAOLFIJ"IY_
M_GE2.J5)K<LJ9=D^&7S]ZU^'%?_L9S\KV8P"W16OXYN-S-AD(X&2"3.'@ EJ
M.S63+'/@@0?.G#G3U:9/>ECRL>V8,6.JZU4=DP:L5<VTU59;41&V>FXQ?1C/
M$YLL"37EUJNOOLI*:5E#SS"$W+L3*O'X??SQQR*H>EF0^.*++Z9+\':XXXX[
MZ$YSY\XM9]N)>8TJMBK5BY:22MR]>W>]B8AOLK'?.H.$8$EJY+FP/W,3U$"H
M_=9;;_%J\V01$1$1$1$1$1$K,A)C<W+V]MY[[YUWWCDU1I;8C+G?__[W\F,O
MN>02^>$*B)KBLN);0JQ2FR@JLB-_4L[D,\\\@[]:S):>RID4D<$1=2+#,"$*
MM.$AMX;0V_PRJ:EG<6];I6^XX89. %A?6EU#MXZRG'3227+$=]AAA\2V]B6^
M&L.'#^=3@1>*33WL*0E7W^W:M>N>>^[)-,O>O7O7V;9,F(MDA%676V^]M6 S
M5WW&;SD['40V<;+JH^&+;:TL;"34Y/- U!0J*.,04VU&X/5-K0I,NVV1FM;8
M]&GU47IAF@W95>SSC"@H7U;$_;H9SCCC#(I0@E=>>86-H HV:@JX2Z[Z^GI,
MA-A0JQPVVVPSJC9Z].CV/P:N\#;;;-.I4R=)./[XXVD:+R6T/V$>N26EIJD5
MI*>:@=!>O7KQW82R<I7R[B$J6["YT.II#7;>:=D6!K"7E?J;$N=F7+BH<O8X
MI-91)>>PPPY+LZ\SZEUUML61XM$$Y<E%(+$%[E)#*=EB:NK4J;P=2!,1$1$1
M$1$1$;&"(\DF .ZWWW[B1Q4;PUAL:\04$"_XU:]^E9AC_^BCCZ;&UW"\<>_G
MS9N7V!D9X\:-DW,^;-@P>"DN>MEVUCS@@ .&#AT*?\%17&^]]7#CE\YO#'-]
M"=344WJ@,5N#]^:;;ZINXC#B=23 $&[EG.JZBF#(FU]GG75$?K"ISTU-,Q=<
MUY$C1TH9V=&S.Q)#/M80^NYB#LSME*K]^O5C)2<E L]UY)%'BKN*3C!9MVAK
M*=4/?OWK7XLQ,G::&"--;94F=00HTYH^[<<55US!J&GGSIV+&9-O UYBH?4)
MO1!+'S4-,Y9LW%O7M]]^>_WUUV> [I133BG9..'<N7.5AH%KZ2/*^L033RA&
M]E$N&4<)BO;85(SEAB8-C8/=&#4MV ZZ.5M5,GH?1CI*]IG 1TVAIF'#50-]
M>-+:3TW+-@)YR"&'%&P.K0IJL+W+V,^9!*0D?K$=,_.O?_U+/5GV66655?@H
MH[XQ:=(D_50[JH<WV 1=ZD@ .>&CH; D*/WVVV_/T'395J6BN4"R\'DD.WU5
M->6;B]*_\<8;']EN;)XR(B(B(B(B(B)BA4+.54NR37KWW7??G7?>.;%M=7UL
M3&[>55==I03R%1]YY)$D(WWN3(KF//300YTZ=?K#'_Z@GYMOOCGG/I!,&>4E
MWG[[[:)"TZ9-<Z=TP( !>.R?R3A:1%B%XA=/31V>!;XN6]Q]]]V,VC%&Q&AJ
M=?K0*9?[WJU;-V5Y^.&'%<^)+)X8_J#P\.'#I<:0(4-"::'.N9^ [%Q%GV!-
M:B&U!SP-AD!BLNO:LV?/@HV:<NNMM][JTZ</=$A0N&O7KI7LS,_&[ 3+3TM=
M%KCFFFO@AS(.,6T4X;92@'JU2$T1&%)3NGX:;!TT?OQX"EU]]=6G3Y]>ME6L
MJ?6SA0L7,EQ9L,V99(333CM-V>?,F4/190-&=JT\X';60U)K./'$$\,$;8/L
MDK_--MO4VF%"K4WH=6G<*AF[3I:$FJ;-EW>FMN(\#0BA%U',EADKO?K5WGOO
M+<7T"*3&%6?/GGWVV6=WZ=)%YMIPPPV99=%B;PE-A)+"S)DS,6S)3E3R)Q%3
MDXN,)2/M\&3U7NEPP $'P%3C^3$1$1$1$1$1$2LLJMU"_-M]]MEGIYUV<J]/
MUXLNNDA>XF677;8XF-"+HYN:4\HHT;'''KO99IOAV\M=?^.--]P95K(:.Z91
MM':555:![@IR4RL9.UL*A%7X<JAI+C$E*OV$"1-L3=PG%*@ZF<?@@B.S;"/+
M8O"R;QH<RQ/F3;*UIG+]/7))D63+5@514R@6[4$"OA8((J6%[*@5>?F=.W>^
M_?;;4^,G.^ZXHY@&\36VGK9LIT=Z7DKA)Z?@>#/3-$V&,#'A'&ZXX88:.Q34
M)^CZM6![([F1<\@H3 O4M-:.(46@R">S59625;AJ G8Y$K[__>\K>]E 0R39
M@U&T$3R.WF%0E[P$9(I/)CK;K .J*7Z+8BYGBRVVH)233S[9U?Y,8"AEWW;;
M;95WU55797"X&@5CSO/FS7-2#0-?(FI*MRS8!%V/"1-0'>"MKY<(N4B@(LX[
M[SQFV/;OWY^4*.-YJ^$?=\1L:3ML7FM'RW2P+:#4?.S$"TNOLU."R:C(EU]^
MN6QSC.?/G]]V61$1$1$1$1$1$2L(\+=QH8<.'2HW3QZO7#NYD2(O#;8O#(?*
MR"'T";U0JL261LI[E$,X<^9,#BR]YIIK:FUOG5)VZ(8\1OF'*D+<:O#@P8PP
MK;?>>GC^;;O'K2'T-K\<:IH#7KNNC+D5C+FEP?S,7&)B_!9N]X,//HC^U;Y[
MLBRH:0@U,-0NI*9 -86_*8&\_V'#AE5L#C 3L@715#A K6V2U&B;]T).0K69
MO=EH)]NF ;%99$=6>MU;ZP'J235V>@T#C'6VU)"V($:![MV[.Y-WD*:F%6I*
M@[)3#C%$4D3!2-WHT:.E),>9YAJB9/-^__"'/XAQ]>K5B[%3J8$$_5Q[[;7)
MSD-5LH%E.CJBDJ6EIJG9L&RCIE)5Y3(E&WBM"]G@<#$;SRS;A-AD2:@IK>F2
MPY1T&.I"FX8FXB6B7/YLRU (49=#;&-V"FZ8T<.)+0^HL5:>-FU:DGU/*=A4
M:N\/3-FMM4\#M +3@-5C?__[W[.<%<M[QXN(B(B(B(B(B%B14<EF90I[[;67
MZ(]B6+2ENYP3"960'_B$+:]CV -_3[F..^XX>8:L"BS82)O"=]UU%]14O$ Q
MC7;PH5QZN>(''GB@N.Y&&VT4ZN#A=B+T:;],:HK?G&9V%!YXX $\YD(VH)<8
M<F',YS+A $\]]11R<LXTN3X/-:VN6DA-*<[9@@*,EXIQ*8U_BD QG/Z==MJ)
M(;NR$>FY<^>R+!#A)9M%Z:Q O83C9YIL.2X%,<T2_M8BKKWV6LS8LV=/5S+-
MZE+*3MHM!2LY@9.T:FI:8VQ6['%=P_KKK[_))INHCHP#*ZPF0$C9AH)#:EHQ
M<*O)UDDS)JSPAAMN.&C0(.S)S&?U<@Z#A;0CQ*]+34UI'95%]C%CQE U5Y(T
MV*1B'Q32[/2G9$FH:6K5A!\*86383SS>%1@R9$C!^G^:=>\++K@ ;==<<TTB
MO<ER:GNXUKX[*,N''WY8R2;T\FU"UPTVV$#D7(VXSCKK;+[YYFH[/@WH-:0B
M>)?11NH ?!YSR1$1$1$1$1$1$2LL\/F+MM?NT*%#!P\>K+"HHVZ]^^Z[:39\
M4K9S31]__'&8"(ZN\LZ8,4,L1B3"R8OD;+;99B-&C"C:TKS4:%=B.^;HY]__
M_O>^??O^YS__66NMM5B\MG0(O<TODYHZ,(>N]]UW7\'F0$( B,Q)1E1XJV S
M0A]ZZ"$TQ^EWUY]DGX>:5J/M4=."C5!)I9MNNDDMBHDAAT7;$TA^/Y:IV,I5
M:N'5H19JX.]][WLC1XZ4YJ)JAQQRR$$''73PP0<KK"O#K:1O$5===166[-&C
MAY,9 B@#Y7/*ZLB8:0O4E)'2O_[UKZ5L3%\5N?+**[_[W>\6;!+O"R^\4#*P
MZ2X5H:407K0C@)FOFV9'SA##?K:RFPRK@EYZZ25H/!V2*S*7CIJBC (#!PYD
M4NOHT:/+AIP9^0K @YUF'#5I-S7U>$9EX9FY(DA#O3R][,;AR(5@-OO/?_YS
M/C&(-Z(MEF^C]#J;M:M<>K^0DOXFJRJ2!L7F"JB+%NR3F/K)$4<<P4P/;M%#
M/L^+)B(B(B(B(B(BXHN$^WYB/;OLL@O.OSQSIMWA!XI'R$U]Y)%'THP*IN:(
MCAT[MENW;J^__CJ.>J-M!C1AP@3YBF*VL ;YF2*EB4$Q$R=.7'?==7OW[NVN
M:<[I;0_"+"L$-<58<H*?>NHIAN#D0Q=M7]F<"XY1*O9) -=YVK1I!5OZR*$F
M7H4P5[*LJ6F+:TW3C/O)T6=";YI5K6S;-14-"BB^4Z=.HF&,'):RC7]24[5D
M8XFIM3V3,WT>IA,,:NKE5N/ZZZ]GBJ:N&(IX-U&:#>0VR]8F-46!IY]^FI0<
M@YE:'5G *=W>>.,-ZKO(SN2D7MXBU Y^)8I>R?;C36UAK;ABC:UXY"KYL@,$
M%1T(+!TU3;,!V^VVVZY@WS*./_[XINP$8;</ 7\@J0MLL)W4-,V$B$PR4"G&
M[O&)O2]"LWOKZ#G_UK>^18OSO.AZPPTW%&Q^>Z]>O>ALN4<)@0!1*-FG3Q]1
MT]3T+&5[,DD?)<#R7F65N_KJJZ/JEEMNF5K+PDX9,0Z+BXB(B(B(B(B(6&&!
M9RAW<<B0(;OOOGN:S;6$7S3:1BJI#>R-&S?NN>>>$X&2;__\\\_+7SWJJ*/V
MV&./1IORB9,O5U!<8..--W[BB2<@,G)*Y1QRX @#;!MNN*'\=G?[EP+NE*9?
M.C4U7SV1R=RQWF"##1AN8M.G,*5^LF.0PO*>&PT__O&/Y54/&C0H-2^\1:,D
MRYJ:]N_?OT5JFAK_$9,4P1;Y\3FKM&[)AL4A/.P8E-I&K&XZ#U3L:X?82$WS
M[8L(K+SRRI)3O4PTQ%577<6XKG@R1D;/G$F]1 ?M5=,2-063)DT*<R%9R0HV
M*72UU583.RW:X+"N\^?/+QEVVVVW[W[WNSOOO/.++[X(VU2?1@+&*=I \<47
M7UQC5!QBSRUTIM#D<U#3BO&Q@0,'JH@Z.].EV-*Q.FX6KC1?TFYJ2BY)5A-0
MD-J185A&7SU9DBU5ERG4L5]YY15V)"K86E/N%FT0GDC%S)X]FQ9!)0*\/C"@
M8AC</N*((YQXEXR:LK[4R^6*)F^]]19[=ZUD)_$J5X,=K)K8LQG6+B(B(B(B
M(B(B8H4"WAT!O$?1C:%#A\K]#AU=?%K=DC_)CJ1XU(R+,"0V??ITR*%GU,]+
M+[VT;]^^C;;43LP"MU:B]+.^OOZ>>^X1+6)<!S66%&&N+YF: MA::L/-HT>/
M[MZ]NWQT"61Z81H()R5L)['Q:'%.V7'LV+&>)F0R(%G.U-253(PJW'CCC1T-
M^@GS5$78VD?Z,QA89]NNZB[\ 6VYTM**5V,G=K9*V4#%4SON,I>E&N)%,'SU
M/.];89:<81T9,VV!FA+_W'//56<7"6?!M#BYNJS:D9FZ/!X*Z*ZHD93YQS_^
M 95%K$N09<2%'GGD$<:3Q9$6&SR-7Y>.FB89.=]NN^UJ;35F]>$Q85FN&,0O
M:3<U!;K[QS_^L4>/'K6VK?'DR9-Y!%P-4,H&KM4KKK_^>D:,=]IIIX\,4Z9,
M4>*]]MJKUO;1G3ES9FJF#M\R,$GLK#XFEEMC:UROO?9:;R,%(+>ZQ8O#=2"@
M!/_YSW_J;#WJ[KOOCE;,1?>O:Q$1$1$1$1$1$2LR$F,BC-[E1A?*V8)2?#_Y
MZDYAB@;\\XH-!'H6]Q@_^. #%GG!:)!3L5$?N(SG<A>Z_0BS+$MJ&LI-C(]!
M(<1)<(A#N-]<L4%G)6"1KJ[777<=,U&9"8ED3Y\8WU,6W67V[ZVWWHJ-2-"L
M&(,:Z8 ##E#*8<.&Y>\M.21MC376H&I.$B@7,J8VZ]>O7\'&H"9-FH1)<??%
M'-Y___VO?>UK-38V"!];;(<(N1Q:NM$&T\OV3<*+II1&F_G=1GV%*Z^\$FK:
MK5LW6M.+: UT+Y8I*J.($,RD8AVW8--!H:;5A6*''7?<$?XC"OKFFV]2KHBT
MVNOMM]]FCR_5NF+'SV*6-*L"C\3IIY_>V7#000<I%]0T[(VJN*AIC7WF.?74
M4UV3ZD .G_0;PS>^\0VR'W_\\9C:TW@XM#FMH.M;;[U%[9#C6KEDSY*:*'%(
M70LV<"W<>>>=Q(<IB]GXY.#!@QFW5" U!=15E)+IWR><<()N;;CAAN^\\PY-
MCQ#TYUV@Z\,//\S0Z(LOOLB+J6PHV39(M&!B;Y T,Q0U36SNKC11[21!B7G[
M2(>V!^<C(B(B(B(B(B*^1(0^89J-J3# (%\T3(:[SKQ47$3/Z\P"GDDD69#L
MV?$,D5PT&AGZBDDV!H-P0+RGJ49X%YG+@)JFF8_N/XLV%Q%OGLJ$"!/#Z/#1
MB[8:LU>O7GWZ]!&M"@66;8,6747T9\^>W;MW;Q;(,<O7DZ7-:YB8C4:.'"E-
M]MEGGR#54D(*B)I"X5(CBEX< 268-6N6,\,//OA +C[]0#553"&;75DVSN.#
MPX#NPI3=QFQ+'N]#BF2N++3-<^5P]=570\!$>.@B;2 <&:.]!%DXS::GIS::
M"F5]]MEGT^9?%E+KH-)S^O3I'>TD5=6N?__^BVT'X(I]@Q$8WY:$]]Y[#W:-
M9#J;R.KWOO<]&E1E39DRA;V44(#JDYX9N9)SXHDGEIOSVS:06-]6H2R+E011
M4]HNUWQ<*]FJ3CB> B+;]&>ONPL/@4'FS)E#!4\YY92"?:189955PA<$H!'7
M7GMM:B2HY_"I(K$!<]33$\$TW;Y]^_+*<"6IE\)//_VTBM"#L_ONNQ>S3U\D
M:[)MD+S+I1DC=9/R4\4]^>23*DB->-111WWR'LH&ZB,B(B(B(B(B(E9 N$>*
M"UJT,95RMIVG.XH$\*A#$N$NI3Q__';&)T)\]-%'(B9**6<XS=BICZ)!@YW<
MILT]:B^H#81IEB4U=5" ](9F=._>_:*++KKTTDLOO/#"BR^^^))++M'U\LLO
M5^"RRR[[Y2]_22YW@A,;%RW8VD5=#SGDD)MOOMF-=>.--XX8,8*Q'=UEM:X[
MV3FX)OOMMU_GSIV5L3T&^DRLN>::!3L>1HU!#"0AS6HQ;=JTW7;;3;00GG;H
MH8>>?_[Y5UUUU08;;%"P76VZ=.GR@Q_\@/66$ D7CB@7F .$H<5;(:Z]]MJ"
M;10LI%EG;1'<0J#"G'FCO"(J<.:*D1S)45-*<[:;(J_GHL.( MUSSSVLLY6$
MG_SD)TVV$RP+@Z^YYAK%2XYNT?1\B2C:F+DH'$-VRG[000=Y9Z@$I)3.N=UV
MVW4PC!DSAEZ1&$C3!I"SU59;U=B0]0DGG #O1:Q+P/B>BV\!*NCUUU^'/5YW
MW77JM-+_$L.E!GJU\/O?_]ZI(R6.'CV:*<H#!@PX]]QS%QK*MC/6<\\]5S">
M+'W$*B=-FH3%FH)5J4!<O8/-B"[83.8)$R:4;!Q>5Y6^TTX[\;RH[236;9[:
MVR2U[8(%%83-P_I^\O:REU31)F,4;'!5VKYKFXRW]F1%1$1$1$1$1$2L")"S
MRO8N.'6+[.32-%L(R4@,3%+)<+R5I6C#JDXOTVPQ*EYHD@WJ+#9P=[&-$5(0
M\DF?-N=Q?BUE)V+^5]%6$#J]RXR:5I,?\2Y&",5VY.G*;_:A(0\P2I8&.L'3
M=.W=NW=G.X)%>?OV[;N2[4PK]QUNPZ:U\K;EB).^18KR"8TSQ4:.'"E1>^ZY
M9W6:)0+2UE]_??1/LY8@GG!BW$;4CH'3@BTO9LBQD(U)CAHU"H%N<\)9.9\"
MA5UM"B+L&:LQ;MPXS+O**JNDK4@&+EG2ID^?CIW5< S985@82YU!](G(G"9%
M^UZBWCEPX$"&^&JRE8U)]L'FMMMND_ >/7HP$YN1YX)->56)WBM8H.M%(-\5
MWFRSS6ILSK"HJ2=PM%;3A;;/M90<-&@0!\^>>.*)]'.RY#*B@%M8%1$GQSAH
M[MI24Z"[>^VU%VS0!:J4'_WH1Z1D5)EO+K#]GCU[ZLIN57I-L..9YZ6"7&4T
MR>>)J#6@"6%)T(/&%KNN/ .PJ>T(7;"GQEO$Y5>"G<3?>>>=@CVPTDT"F5--
MRHB(B(B(B(B(B!40/L<0+HH3*!:J*_O7E&W?S8HM-Q-U2FR?2R7 (:S8+#D8
M*1*4?L:,&7/GSN7N[-FSDVQ%&!XUXRB46#9FB\,97BDWM4F"Q+2&T E?9M0T
M%$J8K7%PW-V#)X!+3: V./@1O9G_*5QPP06=[004G/X.-E(JP$X9;E6RD(XC
M)S%DZGQBFF'#ADD91DW#6TN'_OW[0Z4P5R@0/H!*:O(''WSPG'/.06>Q*07^
M]W__5_1##<DG#0;!7>U/RV@%[4F3VH1>-%QWW7691]K.C$ZGWW___<1Z89-M
M(0N=*]@.O:0,Z:+JRQ"KNKNNXDZ,OO[E+W_13WIVT?#;W_ZVS@[>I _PK8$&
M5?QO?O,;'@_7-M>59;=O?.,;L++CCS\>^X<)6D,IV\E6Y(VR?OSC'Z?!?.P6
M.P;*L'/5\\\_7Y.-Z]9F$X_ITO1/ZK7[[KM7F@^A%^WKE+HK_)#-F5===54L
M(,/JUHLOOL@4[HK-^EYD1^^$FDC(M&G3+K[XXCH;T^YL!\#*R)A"DB7VO//.
MJ]AG&K;.2K('66I(0ZFM]'JY%+.U!_[ZJ-BKJFPCY(\]]A@-K?0[[K@C;1<1
M$1$1$1$1$;$"0O[;__S/_XC*+;(-BG!WY5+><LLMUU]_/503%OK$$T_\XA>_
M.//,,W_ZTY\F1B\7VU8C\$P)4?R8,6-..^TT23OCC#-^]K.?2;B<?/G 9Y]]
MMNZ>?/+)9QC&CAVKN]=<<TV#[7MZT447E0VNE0J=/'ERH^W&U#8O39<3-07N
MY:=F*4@\+B_"N>OA-. >%$H\D:($#3:;>9555MEHHXW66&.-WKU[K[_^^HSD
MX,0WV.:W.5)!$:2I&*$7N5* K67"E$L!E%?1,V;,\&%2;E7L,T/)9IEZW1,C
M>(VV:K28;6!%2FH'(0GE *]%&$, >Z;--^P)P<</&7#Z].G$M%%Q:I2:6$;V
M_4S1^OIZ%!8O2C/BW11L:D7>1MM..LF&.I4=(LKS4+)Q?_$E:JWKS3??O,$&
M&_3MVU?45%=1)DKG*$Z^Q^1ZB.LOE<H&YB2T:+IJD$"*\:V(Y<J)G4+D>4/S
MIE99Z<QNP]!+$NCJ)]_PDXK3]%0P%()523!\^'#U855977JUU593@%P8.;4/
M2Y[7;/FI*$IOLD]0RKCQQAO+;@,&#%A[[;6Q RPZS9894+62[:BTT#!UZE0D
MJ$9ASRG;YRYO5M^T[8,//O T$1$1$1$1$1$1*R 8J&#H,K%Y< VVF''777?%
M/Y0CVJU;MY566LF]4*7_PQ_^,&O6K"8;_)3K*(;5IT\?>>9R4-=99YTUUUQ3
MR>292]IMM]VF>.553.?.G?OW[X^<_???'Q]2>7%6TXS[Z/KLL\\R7.<.;6L(
MW?AE24WQT0E@F@;;R*>2S7).FSO9I"%O.6"MC;9&+C&O6OP!3@_1*MO$43QO
MX&'7@4 NS'!S*1B.^YS@@T1H*-<!?L+@=9.-@$$G@'[.G3LWL6\5)4/UYP0W
M8QCC1FN[=1TE&R=L#WE#<^Q3,EY=M,V98,Z)]0=,)]+"(D:(C6O"3Y\S0"-"
M=4A<R>:7"HT&RB*C9"ZTO:P6V\>;<L;NO,J40J"4'9="2FXY6JLF6:@(] ^3
M4D<O(I<=CHT%4BL:_=/LP2,9#:TJ++"CAUT:ZF%/+%.QV;-NY$HV]:)H^UI!
M[_F$\5\-,E3L86FTP7:%_</88IOTWV!?O*@@%)KO'23 VLBL9#R9<)I5N62[
M/:E](<FT$4W63(^(B(B(B(B(B(@5!G+D:FREVZFGGHH[C5\Z9,B0G7?>N6B'
M"XJCBHM>?_WU..<3)TX\[[SS.G3H<.FEE^+H-MF(%&P+GUF14Z=.77?==3DV
MALF>NC5FS)@F6Y**_REW45=14[Q<]X&%9YYY!MY;^BS^%=Y%GV5#34-X&02X
MXEY[/'#_N,4L[MS[-4Q#@A8SMH9<XG8"]5K,DHOD)VT3EM5BWHB(B(B(B(B(
MB(B(B*6#*$9M;>WTZ=///??<<C9Y4]<]]MCCV]_^]I-//MFM6[>CCSZ:P9@T
M8%5E.QM2:1 R?_Y\B"LT=;$->(KTLBNOPW<AA>DP%K7QQAL[37/6\\033SBG
M#254(V1)RX6:ADS, Y!,X'348\)P[B>)P^QA&) ^+#0GT%&=YC-3IJV/JO$S
M9*%A//"\$1$1$1$1$1$1$1$1RQ!=NG1Y^^VWQ3A...&$!0L6,!]SWWWWW6FG
MG6Z[[;;>O7NG1OE\WR,@_OGPPP^+G3)13E>FX#$B*B$S9\Y4WG?MR :G,SEJ
M6C$:O,$&&[ <#'(+G7SNN><($-D&0JV6"S7-H9H!^EAH:[2M.DL(ST6@M62?
M'\X\\S>J;K7&1:EI8O#(B(B(B(B(B(B(B(B(SX\>/7K,GCU[SIPYM;6U[(?2
MT-"P]]Y[[[+++O???[_()ZN]PBQPT0D3)A3LT'O='3QX\+>__>WMMMMN^^VW
M%Z?=88<=!@P8\-IKKX6YTBIJFMHJL'7777?GG7?^UK>^)2'*J, W#:P^8X9P
M3DZ(4+?E2$U=B1RUR_W,D3H4".[_%SEI# U7D\:D]1-!';EA91*W5G1U0WID
M.5L2Z:!H5S5,'!$1$1$1$1$1$1$1L0SQ"9$K%#[XX /QCK%CQZZUUEH+%BQH
MLM-)1$UOO/'&CAT[^NK0D%+J^M!##_7JU6O^_/ESY\[=9Y]]A@P9<OCAAX\<
M.9*3($0/(4<A1<I14RBN2.R($2.&&_;==U]=)4U$MYR=F/IE4E.7WI1M!,JP
M,IO6."TDYJ.//J*L)MLDIFB;N(1\KV+#Q*GMVNIALBQ>O)A=9_@2P*VF#.4,
M+LV;@>P5XZ*H1'8,G97\W\-.V$Z&J=)H6+$S2Q?;SDS"O'GSV&FFR69FLRD6
M&=DNE4UH&FVW&Q<>$1$1$1$1$1$1$1'Q.2$:R5Z[NG;HT.'>>^\5Z=AOO_U$
M#N^^^^Z:FIK4R*'O;0D)$F=Y^.&'N0M/*=IVH;KUZ*./UM;6DLRS$*B>T*M<
MHJ9--FLW))G//?=<R4X,^4P&] 514^H&Y4N"+4-A;B2@5J7LZ,@F.V3%*Z!;
MG),)U6174ID5:7!%K%:R_7++ME440KA""T/%H)>IU1R52K;?5).-.#M]13U0
MMN\!C38/&TT\ :J2IF(3K*DCD8A-L_U.42,B(B(B(B(B(B(B(F*9H% H<$:C
MPI,G3^[:M:LXSIY[[BEJ.FG2I.[=NQ]YY)&0EX;L\)2B'?&X\LHKCQ@Q@IB%
M"Q="1)52X<,..TR$,W?V1%I%35/C5AMMM)&31X3HKJAI8O"4K2&\N\RH:761
MB7%.<4N%92^1SYF&^OIZF6#Z].F*E(%T5:%*!CELS(Z9X<I=?G+,*<G2[/3%
MU 94(:6N>=D@[LK89BB0XT]*=L*/"J5M&@Q>:T\O"8UVH@8,]J.//E+\W+ES
M(:MI,#>XF'UFH @"4DP2&#MU'AL1$1$1$1$1$1$1$?'Y(=+1L6/'V;-G,QZF
MZ^&''_Z-;WQ#G'.77781^UAGG77Z].G#'D@,W7%2X+[[[EM34_/BBR\JC3@.
M!!4F* +UX8<?BO'FR%%:14W)XCOT<B7Q\\\_WTY2&;+(949-TX#1<4UL&^*W
MWGI+]NK9LZ<8_&Z[[>;\#>OHYU%''=6I4R>9[,DGGZ1TET;U#CGD$%4X-79W
MXXTWRDQ*O^ZZZYYVVFD2[H9HL#V1&5E5 A%@Y(A)$@ #!@PX^>23RS9VJC1J
MK<Z=.]?6UMYQQQV?C) &2U@55JO4U=5)_Y566JG!)B<G]B%!V<5L)4%YU:C=
MNG6[_?;;8<*I;7BE9"I7,:J7%%;=H;4AL(.3VXB(B(B(B(B(B(B(B"6"N(9X
M!SRE:'L.O?[ZZR(IN^ZZ*\SKXX\_7FVUU;IW[RY>(]8C7J; Q(D3(9:S9LU*
MC4.%/ CRJ62^$Q(<#6J:VIS0--MY9Y---B$2 DCXN>>>2UO?'BB$L[]TF5-3
M,E9L4%CA@0,']NK52T2QSB ;W7KKK0Q:-F:[0LE '3ITT%V%3SKI)%;Q0MN$
MV;-G;[KIIG?>>:>8X0LOO+#RRBLKO8BBC"O&*,KWV&./N<["O'GS'GWT40EL
MS!9_4MM&FX[[TDLOB2NJ7-U2QE57756%2IJN$MB_?__)DR<G-EM8&NZXXXZB
MG1(EYJFRI/RX<>,@P,*?_O0GW5)\P2#]UUACC????[]HBU%5_1UVV$'98;9*
M("'77GNMN"L$F \;$1$1$1$1$1$1$1$12P<QE\LOOYR!4""6,6/&C"NOO/+>
M>^_U2#&429,FB8PH\66775:Q>:.PI(J-?R;9$"@RH::77'+)_/GSTV L[6]_
M^YLG)D:!FVZZR7]R5P$Q7L+\; -A@F5&31$JPIW8/%B%Q21%R<3W[KGG'NHC
M6CABQ(C4IKR*W(OLK;WVVDH J]Q___U%.Q]__''Q-PB>TKSWWGMB@!*HGV*/
MQQQSC.0S9GW!!1? *L5UV4Y)F#Y]N@@GU)2ZI-F\:NDP?OQX4<0%"Q94[#.
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MBX?S_)[S[SZS^LSO/.>L6:.!'G[X834O5[>Z$DN6+%'DQ(D3Z=WZ:?7E 0
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MIJZN+M\4(:QYDA        #@;N'UJB[XZOSH'PMZB^K24Y^&PG)3
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81&KZ+]\#1*'$&E5@     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image_18a.jpg
<TEXT>
begin 644 image_18a.jpg
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M 0  :)DT!0  H&72%   @)9)4P   %HF30$  &C9K&D*    <S)KFMIJ"@
MP)Q(4P   %HF30$  &B9- 4  *!ETA0  ("625,   !:-FN: @  P)S,FJ:V
MF@(  # GTA0  ("625,   !:)DT!  !HF30%  "@9=(4  " ELV:I@   # G
MLZ:IK:8   #,B30%  "@9=(4  " EDE3    6B9- 0  :)DT!0  H&6SIBD
M  #,R:QI:JLI    <R)- 0  :)DT!0  H&72%   @)9)4P   %HF30$  &C9
MK&D*    <S)KFMIJ"@  P)Q(4P   %HF30$  &B9- 4  *!ETA0  ("625,
M  !:-FN: @  P)S,FJ:VF@(  # GTA0  ("625,   !:)DT!  !HF30%  "@
M9=(4  " ELV:I@   # GLZ:IK:8   #,B30%  "@9=(4  " EDE3    6B9-
M 0  :)DT!0  H&6SIBD   #,R:QI:JLI    <R)- 0  :)DT!0  H&72%
M@)9)4P   %HF30$  &C9K&D*    <S)KFMIJ"@  P)Q(4P   %HF30$  &B9
M- 4  *!ETA0  ("625,   !:-FN: @  P)S,FJ:VF@(  # GTA0  ("625,
M  !:)DT!  !HF30%  "@9=(4  " ELV:I@   # GLZ:IK:8   #,B30%  "@
M9=(4  " EDE3    6B9- 0  :)DT!0  H&6SIBD   #,R:QI:JLI    <R)-
M 0  :)DT!0  H&72%   @)9)4P   %HF30$  &C9K&D*    <S)KFMIJ"@
MP)Q(4P   %HF30$  &B9- 4  *!ETA0  ("625,   !:-FN: @  P)S,FJ:V
MF@(  # GTA0  ("625,   !:)DT!  !HF30%  "@9=(4  " ELV:I@   # G
MLZ:IK:8   #,B30%  "@9=(4  " EDE3    6B9- 0  :)DT!0  H&6SIBD
M  #,R:QI:JLI    <R)- 0  :)DT!0  H&72%   @)9)4P   %HF30$  &C9
MK&D*    <S)KFMIJ"@  P)Q(4P   %HF30$  &B9- 4  *!ETA0  ("625,
M  !:-FN: @  P)S,FJ:VF@(  # GTA0  ("625,   !:)DT!  !HF30%  "@
M9=(4  " ELV:I@   # GLZ:IK:8   #,B30%  "@9=(4  " EDE3    6B9-
M 0  :)DT!0  H&6SIBD   #,R:QI:JLI    <R)- 0  :)DT!0  H&72%
M@)9)4P   %HF30$  &C9K&D*    <S)KFMIJ"@  P)Q(4P   %HF30$  &B9
M- 4  *!ETA0  ("625,   !:-FN: @  P)S,FJ:VF@(  # GTA0  ("625,
M  !:)DT!  !HF30%  "@9=(4  " ELV:I@   # GLZ:IK:8   #,B30%  "@
M9=(4  " EDE3    6B9- 0  :)DT!0  H&6SIBD   #,R:QI:JLI    <R)-
M 0  :)DT!0  H&72%   @)9)4P   %HF30$  &C9K&D*    <S)KFMIJ"@
MP)Q(4P   %HF30$  &B9- 4  *!ETA0  ("625,   !:-FN: @  P)S,FJ:V
MF@(  # GTA0  ("625,   !:)DT!  !HF30%  "@9=(4  " ELV:I@   # G
MLZ:IK:8   #,B30%  "@9=(4  " EDE3    6B9- 0  :)DT!0  H&6SIBD
M  #,R:QI:JLI    <R)- 0  :)DT!0  H&72%   @)9)4P   %HF30$  &C9
MK&D* - I927&/]"+?"G6UM;J/P(LA%G3U$<; -!Q U]=F>C2,@"P$*0I +"0
MUBN3UPZ;%P187-(4 %A(TK0IMY3&9;XR]0VG7BN@XZ0I +!@8K6D-)C=5B=D
ML:?\L5Q91JB/#] 1]4\G:0H =%VNHJQ68BWET*%#N<9B727D2Q&O2:Z_Q8^Y
M>C>R+@=TGC0% !9)K)-DE,9E--C*RDH.Y^7 K:VMK=3$NMS!@P?C,E\WJW-
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MD*;0%1-IFBLE2^,S]-ID"C $4],T.=84Z+=9TQ28M[*Q=*G:H3<WF6::6O\
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M%8YMV[;%Y8X=.YP&"6"8FFFZ['M-@6&8-4U]_,'\Q/OKA2]\85GMR"\XE:8
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M- 5@-$.:.M84Z"MI"IU@AUX 1M/2M"P.I"G0;](4.F'/GCW2%("-TG39L:9
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MJ:=!LM44Z*59T]2:,<S5GCU[LD6E*0!%I.FF39O*0J%N<E2 !2=-H1,<:PK
MJ/&!GUM-8Z&0"XC"5E.@?Z0I=((=>@$8-3[P[= +#(<TA?;%^\MID !HDJ;
M<$A3Z 1;30%H:GYYC#0%^DJ:0B<XUA2 IG(:I)*FQ>2H  M.FD(G//_YS\]5
MC5SYR+60<-QQQZVNKL8(:Y7)NP'0:[:: L,A3:$3)M+TN,K6K5MW[MPYJMZ
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MV0]'^:4?Y:99-"?^?YS@8FD^_?^%__L4YFKJ[.43GWH3W3'Q"W(:)& XZA^
MTA1:$VE:CU)IRGKU=4'Y>Y_(B?)C#OSOE*D5DV-4)D>JS#+.T?T?[]Y4GV Q
M.5)EXM:CCUD?SA\G1IYZY?]4\^Y3'^5_Y.@S7Z[QE50=-/'K=JPI,!SU#T!I
M"JV1IK 0>O9.[-G3Z25I"@R'-(5.J*=I"51I.BCK8\TKZ\/U3:GU,?\7<FH;
M?2]1>>@<*#_61Y@8LZY^90Z,I_'?8]:OJ5_?U+SO4:Z?>F6YOCZ0PQ/7U*^?
MN*D,Y.N6PT6..3&=HRMWJ=]KZD36:[_ZB>O+9?V:,EQ&2/6)-*=&!SD-$C <
M]063-(76. T260ZKE?SXS<_A\B&<PX<.'<H18B NHS2._,_E(\9]\^&RLC*W
M4ADS9R.OS.%RWQPA[AYSLK*R,GX>5RGWRLLC5Y_/B8>H7SFA/K4B;ZK?-U^0
M,ES41OGOF\I]<SHY6@Y//$K>Y7#E2/52Q#/-YYY/.9>:.9-Q97W,B:D5^4!%
MSDG<JS[;^:#KU6\\YRVF?Z3V&Y^80IE./D1>DP,YM1S(1SEX\&!,9[V:[2/C
MOP2ZK)P&J:1I,3DJP(++Q5.2IG",E#=4#L3E"U[P@LS14';<DJ:]MUZU2@Z7
MZL@/WDR1<-EEE\7EOGW[HH4RC2Z__/*LH,B,N,PRR8&\/D:XXHHK8OS,DA@M
M;LHFB6MB@C%<<B4?I431_OW[LW,.'#@0<_*C'_UH5"T>8@K9GZ5G<B!&B'O%
M3?6_ZA!WC^N_\YWOY#S$CS%.SG \1)E@SGPN<?()7GGEE3'_.7Y.*B<;/\8=
M8VIQ:\YY/H5\@NM5-UYZZ:4YG'?/>LQ7,A\E7I:<VL'*J'IJ.<)J5:WE9<P9
M6ZW".U[\?([Y2L9$XC4<5;^(4>UPS;@^IYGW/53E:US&U&(*,9!S%0/Y"L2/
M,6:^SCFK^;O(WT[<%"]%SFI.?[WZS\45E?P;R&OB,G]K<7W<:^_>O?%CC)\/
MO5K]QG.R,1MQ?3QB#,3$RVM+ETWLT%LW.2K @JLOF'(Q=T2:PEQ5*]O3TW3;
MMFWUU0YIVGNE:C+S8NUSRY8M2]6_)^*W7S:D7^M:U]JU:U<,G'ONN3GF?_S'
M?VS>O'GKUJUQ90QLJN3=<^",,\XH?UVYO>6'/_QA1DZY7*M$/<9=XB%B.)(F
MZRA3*L3U\2CQE_G=[W[W4!7&Y0\X+M_SGO?$8\6\??.;WRS/HHC<NNYUKQNS
ME$D9?^0QJ7Q&<;ESY\[EZKRCR^/=!.+6R*I<Z.2CUQ_N+__R+V.<4TXY)>Z2
M3S.?:?SXU:]^-2MN?;QA\PE/>$*.'-/,U?KR0,]][G._]*4O51G^7UNG7_&*
M5^3+'N/$F-NW;\^!S95,@D<^\I&9D7&O&/G44T^-1W_5JUZ5SS2G,ZJJ+T:X
MZ**+XB[Q!-_[WO>6=V[<ZX033LCA[,EXD;_XQ2]^_>M?O\E-;I*_[OQ5?N,;
MW\AHC\NHS6SOI6J+V<DGGUSF,^<PKX]YCC^)G'C\IN*^%U;B0>,5B%MCM$]\
MXA.77'))=F]YH<KLT5E3CS5-DZ,"++CZ4DF:PK$P\6ZJ5KS7G__\Y^<*1UG7
M7)*F@U&*+E<W8QTT8R/3*+LB.B<NX\/Y2.7+7_YRW!17EA76;)LLEOCQ%K>X
MQ6JU]V;T3\1)7!DKN!F?47%9IX>J[7CE<=?&&VPS6J*++K_\\IQ:%,X/?O"#
MW.28?XJY@'C?^]X7(^S>O?O.=[YSAFX9(;=&+E?B$6/X3__T3Y>JO_"8[7A2
M,<V<>!9F_LW'[&62':FV6)8_^_CQO//.RW='!GG*T(V[W_WN=\_HBKB-^7_,
M8QY3,KC(1XG'C62]X((+<JML/,J;W_SF2+Z,__K$<Y;RFL<__O$Y&_%<<K:/
MJR)VO;;=.YHPEYCGG'-.=N:[WO6NM6J?X;@^IA-//.8MMVW&W,:+?^UK7SNG
M%H\>+V/<:\>.'3'9^]___H>J+;UQF2]LW'2M:UTK+D\\\<0R ^6#(BXC3=>J
M[;WQO%[[VM=N&N\"FM6];=NV>/2;W>QF9Y]]=FX3SGDN W3'Q*?]U#3-R_IH
M #U0_P"4IG#L7-6CXU7\N-RS9T^F15GGR#5.:=IO^4D[JCY_RY5YS:<^]:GX
M [CG/>\9K76DVMEU5&UMRQ&^\I6O1(Q%5^2>I7EE3B1C8[7: 76MJLWCJLUK
MD4:13*-JR]Y*M:]O[E :PUDO&5&1HX>J'4%CRE<M#Y:6(H./J[;BYL2+^/%#
M'_I0W#>RI]R:67NHVB\W!G*5.F<O_^9C(&HYIG_FF6?&K9_XQ">RW'*$G)]1
M%<9Y33Z[\,I7OC)F)I=*Y?HC5<'^S,_\3*3=TY_^]'Q]8B)/>M*3WOK6M^8$
M1]7KG/>*RQO>\(;Y_LH'BE",-(WY?]SC'A<C'!SO([TZ/@2WS$GNVQQ7UO\I
M<.&%%^9LI!C^X0]_^.A'/WI3Y;WO?>_A:L?=F$@^Z)%J3]V<STLOO?2DDTZZ
MXQWO^+6O?>U )9]43OD+7_A"C)"/&,4>4[OXXHMS3]U\+OE2E_G,X7AM8YR8
MPJFGGGK;V]YVO=JW.6YZYSO?&0^4'S(77731D:JQ<^)Y7[JC_F<_<AHD8$CJ
M'X#2%(Z%?#>M5HY4R1&7YYY[[L26D"5IVG?U'$WUE/K\YS\?"?2KO_JKF1"C
M<8:M5Z(N[G"'.^2&M8D[CJHI9_SD0$3I Q_XP.M>][HWOO&-L[MR>VF9@5S3
M71N?NS4WZ,6/7_SB%^.F?_W7?\T1SC___-6J>'/B44$?_. '8R9O?_O;Q\2_
M]:UOQ94QM_F'G3.6=\SA4D$YV_>][WWC+_QC'_M87CFJ_9&7.4G98"]^\8OC
MW9';>[,JURHQ\,8WOC$>Y?333S]8'6@:S^LQCWG,W__]WS<G%2(FXP79L6/'
M(Q[QB"-5S\?=8SZ?_.0GEQ<M[U+/MG)-1F:4\.M>][J8_SO=Z4[YH)F($?;Q
MLL1K<J][W2M&>_>[WYV_FI!Y7W^1G_.<Y\23.C0^HU)YV=_SGO?$TXGZC6[/
M!?&1:OOSWKU[1]5S/S0^CU'.< Z4IQDE$S/PJ4]]:FU\N&Q)W"<^\8G;MV__
MJ9_ZJ?5QLM)]TA08COHB6YK"L9#KNX<JJ]4NE^%%+WI1=NFFVBZ(TG0@\I>[
M7BD_?O:SGXT_@'O<XQXE/LOX\6?SU:]^];:WO6W>E)I_(6OC$_#F)L$'/_C!
M)YYX8@1/?JKGIM$<,__>UL=]E7^9D4 77'!!_ 5&V+SRE:^,VOG=W_W=W "8
M(X1WOO.=6[9L^:W?^JW'/O:Q)YQP0DPA1BXANE;MAKH\/H]HEE(.QWTC3>-!
M/_K1C^9-Y;*\#F7,O.GE+W]Y)&6\6;)+4]XE)GO:::?%T[SDDDO6JIU:'_WH
M1[_M;6\K#[<V#L+HQK7J\-IXZ%O>\I8_^M&/8N3<:OJD)SUII78RIYQR3KQ^
M38R?FZ ___G/'U?M)IV'@^8+,JJ:,_+O80][6-SZC__XCSD_5RU9*[E@C9<Q
M&OY!#WK01S[RD;A[WC&/R,U3%CWJ48^*NT>CCL8;P&,.<POYP>H@X?(JU5_5
M%/,6<Y@]'Q//WW(\7#[9W$*^6GWRC*;]V= U$SOTUDV."K#@ZDLE:0K'0KZ;
M#E>;L_(M]NUO?_O44T^MKW#D?\2E:;_E[[1^6;_IG__YGV-E]%[WNE=D3+WH
M<LQ(T]O?_O:Y]2ROR4_L\N-HW&-1-5%*SWSF,^,O[8E/?.+NW;O//__\[*4T
MJM(T-^AE?94:O-&-;O2-;WPC?OSQCW]\@QO<X/333R_+B;PRPC)F\NRSS\YM
MB2]^\8O7QV?!S5E=JHYUK,]53CENO?>][QWW+5M-ZR/D..OC3<%Y^;*7O2S>
M%V5[:7WD<)WK7&?;MFVK55K'Y6__]F_G5M.Z?(*77W[Y11==%,_WYC>_>5X?
M:1KS&6EZI)(/??6[_O=K$@/Y<L7OY2YWN4LD<=XEW]$QSDUN<I-X7I&F,=J[
MWO6N?+G6JJVF2^,T'55G]XW^O."""[(2CU2'E1ZN(O;[W__^=[_[W2]]Z4NE
M6O.5W+MW;_Y8$KK,9P[DRW+RR2?'"Q7WC0G&[VAU?(;D?/H77GCAYS[WN:C<
M&*'Y-.D@:0H,1WW!)$WAV,EUZ /5^3QSO3.W+V64)FDZ3/F[CC2-/X!?^[5?
MJV_*RX'X<)ZZU72MM@$MQRQ_78]][&-'U::S:)Z8;$RSG-)V5-MJFIO:<I?=
M!SS@ 3'F>A6W\>,/?O"#W!P7(T3PY .][WWOV[5KU_WN=[]O?_O;<66,$*F6
MT\S*RC_C3*;R+'(^[W.?^\1-N=7T*-8K,?#RE[\\'CUF.Z=66C$N([;C@9[V
MM*?E76*&'_.8Q[SM;6_+<<IT<N YSWG.4A7,>3!M9&'N#QS=GH69HV5/EKNG
M]6K#<KY;X\T;4X@>CM$B)M>J:HV9C)N>\8QG/.(1CXC1WO.>]^3U<<=-U0X1
M^;KEX\;EYNJ4O*>>>NHIIYP221ESOF_?OB/C+\4954\SE\UQWTLOO32O7ZF.
M(IZ8MQPY+N,W==)))RU5)W"*7\?IIY]^]MEGQ\.M5EM?RX;E_%V7EX7.:N[0
M6Y84DZ,"++CZ4DF:PK&3:X=9';G>6=8V"FDZ3/F[/GJ:?N4K7\G461I_$>YR
M]4TS>64T2;;'>K7O:%QSSCGG[-^_/_ODUK>^]9O>]*:KMJ!5U117YJE<1^/#
M7^,1?_2C']WL9C>+?ENKOB<S3UR4AVA^YC.?6:M.,!O7?/"#'XQ'?^ #'QC3
MB='N>,<[1@B]^,4OSC,&Y0E^PT1'K<V<IOE\\SWRTI>^-&;RO//.._?<<__X
MC__X><][WI]6XL>8L9C5=[SC'>7DPX]__.,?]:A'G5N),?_HC_XHQOS#/_S#
M[=NW[]Z]^_CCCX\7]D@E9N9O__9O8TYR3]<H[7PUZC&P5)TC*D]!-*K.[92]
M'7>/A\XO"#U8?6UL/$K<ZR4O>4EN-6VF:0;AH>HK6./NO_=[OU<>*V8@I_S\
MYS\_7N1#U=>?YN/&+S'GJIQ&.+]HJGQB/. !#XC9*'MBO_[UKW_L8Q^;YQ9>
MKL[V',/1Y'_V9W]VL#JB=7V\<)^:N'1*,TW+KWYR5( %5U_=E:9P+)1WTTIU
MS%Y>4U_G**3I,.7O>FJ:ILB/2-.=.W?FMX:6'(W+B)"(ENM<YSKY1:,9J#'.
M$Y_XQ+A7.?(PQCQ<G8,W*B5&*/6U/MZ'-K^<YG[WN]^AZLM+XOHHGPB;&.U/
M_N1/\D\WKK_@@@OBT3--,]66JN^Y*0^=452?_WR(_U&:CJH:?\UK7E/6SK=4
M7]>9FQRW5M]<^KWO?>](M9DQCR9]]*,?O;GZ^M,8_\033\QVS3,)Q\BGG')*
M3CFW2;[YS6^.7BU%FN,<-_[6T+@\X803<F/F)9=<$O?*%SSGZB,?^4B\2?-E
M/%*=K.BDDTZ*:3[\X0]?FI:F^:#KU=;7<G;E4756WI-//CGF,.8V9^-0]34S
MAZO]A'_XPQ_&-3>]Z4WCM8TZ+1\4&;3Q[,X\\\R8YO>___U1M4U[5+UT<=]/
M?_K3,<UX"O&4EZJ/E/@Q?GWYT+JTFR;>[Q,[]-87$_71 'J@_@$H3>%8*.^F
ME>JTG.N57.&0IHQF3M.[W.4N,5"V$^8?4F[9N_SRRW-[X)'J",98J7WRDY^<
MI^2-N\0XT2JWN]WM\OP]*^,OCSE2&57;]"+MHBHC?9_QC&<\\YG/?-K3GO;T
MIS_]5W[E5TX]]=0[W_G.&:(QM4C3Z*('/. !N3WV2/7MHS';U[O>]6(B,1O_
M]S0M^?3B%[\X9O*E+WWIN>>>^Z(7O2@Z^465/7OVY!./)W*P$G=Y_.,?_]"'
M/O0%+WC!__M__^^%+WSA<Y_[W*4JY)[UK&>-JI,#K8[%R&]YRUOBUB<\X0D9
MX:/Q4:GYT#E.OLCYK./5BTD=KLYU_/&/?SR>_I%J!]V8@>C&>#%CX"$/><C2
MM#3-R>;4XC>2 S'SN<"-7WH\KZSN>*D_\YG/C,;[5\?=O_G-;QX:?Q7MJ KC
MPY75*K#+'.83S#G/!(TIQ$L1KU5\PAQ__/%WNM.=XE>S6NW]F[]Q.F7B_2Y-
M@>&H?P!*4S@6JH*XZ@V5:YSY8ZYP2%-&,Z1I?"Q'FM[^]K?/.LHK5ZIO(3I2
M'::8.W9&M1ZN=AJ/6(I4RXFL5P>4/O"!#XPK_^(O_N)@]<4G2[63%:U51T[F
MGV+9D)BGZ3KAA!/R+_- ):;V_O>_/V8R,BRW_^?C_L[O_$Z,\YK7O"8FOJ62
M,UF>Q=K,:9KRCA&E,0/16IEV6659I/&X/_SA#[/-\N5ZY",?^=:WOK4$<\[>
MB2>>&$\D$SVFD^^^&(XTC1I\ZE.?FF-F9*Z/S_:4+^QHO+?S:'QH;EX9X\?P
MYS__^9BK4TXY)9YL)E^$\=*T-,U;LXTOOOCB3,HCU3\(P@]^\(/\)>9K>-))
M)WWO>]\;50&Y>_?NKW[UJSD/JY6\/E^???OVY4"\#GF6H\/55NO5:H?M0]77
MS.:1[=>[WO5B)D\__?0CXQ,RT7%VZ 6&H[Y@DJ9PC.0;:FJ:UNM4F@Y3_JXW
M2M/\6/[RE[]\N]O=+C^HCU1;S_+6U6H37P1;Q$]NH,MV>O*3GWRDZJZ,M LN
MN"#6='?NW!G%$B.7K:89/(][W.-V[=IUSCGGO/&-;WS]ZU__5W_U5^>??WYT
M;%R^X0UOR V&&3QYAM[[WO>^69M9C!_[V,>V;=MV7/4=I+G':9GS')@]34MX
MQWU?\((79-KEE5FDN9Q:K_:/S5C-UR12_._^[N^RGR/;LC#CN<3[ZQWO>,>H
MVE"9KV1XTYO>%&D:SSJ?0CY<>=RX,K=JYD/'^!D)^;@Q?CR+"R^\,&8FTG13
M=0QJC!-MO#0M3?.7$E/[VM>^%C-3TOKRRR^/JLSY&56_QWP-\YIXE/B-_.A'
M/UJM=N[-/XF<G_7Q]Z;&I Y7IYZ* M^S9\\5E4/55M8#U5?^K%7G78N)Q^_]
M^M>_?OZNZ;YFFI8EQ>2H  NN+']'TA2.@?HJKS1EJOQ=3Z1I_2\G>B/2](PS
MSBAUD7&R5C7;)9=<D@62?V"'J],7E:VF.848X3.?^4Q,_PYWN,-EEUVVJ3H)
M4$XY8O5A#WM8U,L__=,_Y03SCD>J#71QZVFGG?;C'_\XT[=^K&D9)UQ4?3O+
MK6YUJUB?CD<OCYL#V6:SI&G*I__RE[\\IG:@.H5/SMAH_,1SH%P3,_/8QS[V
M[6]_^WJU(*O?FF^K?__W?S]0?;-H;A'-WG[2DYZT5FV/S6EFBX[&I^I=K;:^
M9@UNWKPYWJ<YSI'J++N1H"]\X0MW[-AQZJFG1D#&E1L=:YK3C!#]UK>^=>UK
M7_N#'_Q@UF/^IO(A]N[=&U=&FBY71YSF?P&V;]^>4X[?;^ZONS;NTO5J2;U6
MU6D^4)[L]_#X-+QY(J6#E;CRA!-.N/&-;YQ_)'2?- 6&HZPJC*0I'$OYYCHT
M_EY*:4I=9$:F8Z1I;ALL-V4.?>4K7_GE7_[E&"T/)LR_I<R>&,XOALE3MJY5
MWZCYE*<\I71:3B0S+(HT@BI/H10!$W=YQSO>L7OW[K/..BM":*W6>^6^+WG)
M2W[_]W\_'^C#'_YP3"'2=*7ZNM&<; [$P\7CQE.(ILH[YO6CZH\Y1ON-W_B-
MN/5C'_M8QE49IR[?'3G-E[[TI3&?65_-\>NS&C,6:?K6M[ZUC%9NC2?ULS_[
MLU%]SWK6LZ(/1]5)@_(,O>><<TYIT2/C?8!SD^:H.BZTO,BYD;F,?,899\0U
MN0ONJU[UJNS,/-;T'_[A'\I+EV_JS-2<3DPP[GCK6]\Z7L9\ 3,78\[CE[)K
MUZZ\>XX?8UY\\<4Y;ZM7ETV;<QM/\-)++\U7_GG/>]ZG/_WIP]5&UQCM?>][
MW^,>][CHX9_^Z9_.DT6-:GLITUD3QYK638X*L.#JRW=I"L=.OKFD*1/*+_JS
MG_UL_ '<XQ[W*/&0^3&J0BO2-!HCUEG/J$3>W/:VM[W-;6YSJUO=ZO:WO_TO
M_N(OQDT?_. 'UZLSZ\9TGOC$)^9]TWJUX32F\XI7O&*I.J]O5%]&5/[M':EV
M$HYX*U&7,GISY! /L51]<\GJU?<.C9NNN.**O_F;OXF@.N&$$\I$\BED7]WG
M/O?9O'GS1S[RD?H=-[)>?7E,/)'REID8H3Z?,?%'/_K1[WSG._/*<KE65>LS
MGO&,Y>HTO-_YSG>.5"W]QC>^<>?.G?%Z_L(O_$*\@/%BQDL:KV?\F*]JB%?U
M"U_X0OXN\LS HVJWVWA!7OO:U^;.MW&9FT!CFH]ZU*.6JJVFZU58Q@/E5M/U
MJK2S>".S-U5G XX)WOG.=X[?VL___,_'98P6:?JI3WUJM=I(&V-&<,;T[WG/
M>][N=K>+68K9R[GZQ4H,W/*6M[SC'>^8>R.'^(WD<<*[=^_^I5_ZI9CY[.?(
MW9CR11==E(?LEK\HNLQID(#AJ"_?I2D<._GFDJ8TK54;RB)-XX_A7O>Z5]9@
ML5Z=C?;?_NW?<MM=_IV4\Q5%8N4U<?G^][]_M3K&,JZ/-,TVRS2*:1ZICJN,
MO\#(H:7J"S,OO?32YSSG.3$<_7.P^O;+C+K\$\W[QH][]^Z-<7[NYWXNIA /
M$;-QYIEGYIZQ9>9'U1(ECS6-8,OK<_YSF1+CW__^]X_I?.A#'_JO)S9-/G1.
M.2HZGF;NWCPY7J4\NWC6CWG,8W*'WKPIIS.J9CY&B"J.N;KQC6_\]:]_/2+M
M#6]X0VXWSFV\6ZKO%\UW8NF!N/(___,_<R)Y33YB/%;\IJYSG>LL58D>,9_S
M\)"'/"3N&VF:'1XCEVVMN6P]5!U?&@/QZI4OC-E:?6%IO#+O?>][X[<<(^0_
M"%:K,_3F;(0\17!N&DTY__&X,7+NR/V-;WSCK+/.RC,&YU,[KOH&VMS\FW\,
MHZJNRPM(1TS\A4]-T[RLCP;0 _4/0&D*QTZ^N3)-1]7*[G^%J30=MK(A*Q+B
MXHLOSAQ*>7T.1%%<=-%%<6M<1H1\^]O?CLKZ5B4&+J[LK[Y()L:/T7[P@Q_4
MIY\[J8ZJN+KDDDN^^<UOQCBKU7>-Q/"/?_SC?)2LEUP6E/%C.![EN]_][GIU
M$J 8/R;>W&J:#Q'S%G,R<6O^^)U*[LAZ%#D/\5A1E?$T2^).54:.6<JC82?'
MJ,1LQ_.-><N7:-^^??&,8CYS;N,9Q4"\L#$<EW%3/&Y<D\O(F&:^7.5ER1>D
M?LVHVD\X[E+R/BYS(O7?8TXMAK_WO>_E#,1$8N+E^KQC#L<(,3/?O+IO5/)7
M'[<>J38"E_O&=.KCQ/1'XR7]1J\,75#^2%+S6%-I"O15_0-0FL*QDV\N:4I3
M*8>2J77YR9PWE<O\\\A[K5?*K>7ZE#?5QZ_+#_Q1;2+U/[QZ83:GN3;>7EH>
M=V*NCE3J]RI=6G^4IOKTF_.<RO43(^1=UL8[KY8'*C_6EW'EON6Y;S1C4V^:
MF,_Z1-;'B]2\LAGDY;4M+U>93@[D'3=2?_KUW_M1[I53GKR6[I&FP'#4%UO2
M%(Z=?'/9H9>FB=]UR<62H*D^7&ID(L#JP3.U0^IW;&[YS+;).]:#L_G0]8GG
M-?6I33RC>J >77FLJ3,_H3Q*&7E]W/#E6>2M.5R?9OW6G,[$/*^.OZFE7-\<
MR(E,?<V/,O\3\U.?U?H+5>:J/@^IS'/**6PT>_ECSN3LOPA:Y#1(P'#4%V?2
M%(Z=?'--I.G$:H<T':#\13=_W?5K)F*C7%,?IUZ2Y<K\8YMZ?1EN=LYH@PVP
M4W.K.2?U[JHK3=M\LA,FGN9&ZNE55]I^0GDU\O(H<]*\OODT1[7Y7&MLI%V_
M>B[FXK5^E^;XY2&FOO@3Z@\]JCVC,D)]RO6!HTR3CI"FP'#4%ZS2%(Z=?'/9
M:@K 431WZ"U+BLE1 1:<-(5V2%, KE$S37- F@+](TVA'=(4@*:)3_NI7QZ3
MZJ,!]( TA79(4P":I"DP6-(4VB%- ;A&=N@%AD.:0CND*0#7J)FF94DQ.2K
M@I.FT YI"L UDJ; <$A3:(<T!:#IR/B;;%=75^/RSG>^<RP.MFS9DHN)7#3D
M,N)J=P-8?-(4VE%/T_A1F@(P&G_:Y^7:VMK=[W[W3962IN642)/W!%APTA3:
M(4T!:(H<S>VE.7R/>]PC6K2^@)"F0%])4VA'/4W7[= +0-6BL?:ULK(2P[&
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MFL9J1[2H- 48,FD*#)8TA78TT[2L@DA3@,%JIFE9.DA3H-^D*;1C:II.D*8
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M^DV:0CND*0!-4],T!Z0IT&_2%-HA30%HVBA-@V--@7Z3IM".C=*TK((L25.
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M[9B:IG;H!1BXJ6EJAUY@"*0IM*.9IK':$2TJ30&&K'FL:2%-@7Z3IM .:0I
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M>GM[N[JZ6EM;M1N'V;AQH_Z@>V]>&2[''7?<KEV[="[&"@! E5(J31VF00*
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MI-4^=>N5C_?.38)8S87Y>+U#KS"K9=JT:7;4S!JKMO&DO@  4"V42E,':0H
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M+3Q"X?'XKK9VEG?]K0VKJN[8L4.W()O^H"%IX;AGLGO7XOYT&F%1V'TY5KT
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M/JCI6'>="S)CXL2)TJ4F4(?(3%>G,7%(SQ-)_:]\Y2L2*MFD#W?T'='/ N6
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M?-O:N3T]/7I0=74Y,J+7_6-'K$*U&RO8&VZXX1O?^,;55U]MVZ]\Y2NZJ#\
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MNG7K,\\\8]NVMC:)5>\R4 C]"#2MKNJ%I*PBD8_)6C63:LHB25/%X]=R-P
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M*U>:>_7JU6O7KC6]FJ1O6 T?[>CH2-*^N(70I*E(XNMZD>E5+'<LAN,P&3<
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MN\8BUG?CD     !PX(B-+J0I0%4B$54(S7U6;5>N7"G)EPU7;I3")+QW8L=
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MDYW+EBV3C[G5.[>GIT>!^\. TJ>??MKD:'M[>W.@$+KF6F#-\;M;[
M!QZD*4#5X]58"M.V"Q<N7+-FS8H5*S9MVF0.4ZKF7K=NW<Z=.Y-0U0NAVZVF
M39*F+8;VU4R$       '!Z0IP#"A&#K92IJ:%GWLL<>2M*^OFE([.CJTV]/3
MT];6YH=4Q[W*[Q8I     ,!! 6D*,$SH[N[6<-/.SDZKN;V]O29!S:WQG&H1
M+084S,*WM[?WASF*%,- F*QHMT@!      X*2%. JD>",Z,J!]V-/57YXU>
M,Z@G     ,"! VD*,!S(Z$Q56[6"QHVB:?#=W'Z6)&[L P    !P<$": @P?
M2IM&8_^D1'-JE9=2?Z0I     !QDD*8       !09I"F        4&:0I@
M     %!FD*8       !09I"F        4&:0I@       %!FD*8       !0
M9I"F        4&:0I@       %!FD*8       !09I"F        4&:0I@
M     %!FD*8       !09I"F        4&:0I@       %!FD*8       !0
M9I"F        4&:0I@       %!FD*8       !09I"F        4&:0I@
M     %!FD*8       !09I"F        4&:0I@       %!FD*8       !0
M9I"F        4&:0I@       %!FD*8       !09I"F        4&:0I@
M     %!FD*8       !09I"F        4&:0I@       %!FD*8       !0
M9I"F        4&:0I@       %!FD*8       !09I"F        4&:0I@
M     %!FD*8       !09I"F        4&:0I@       %!FD*8       !0
M9I"F        4&:0I@       %!FD*8       !09I"F        4&:0I@
M     %!FD*8       !09I"F        4&:0I@       %!FD*8       !0
M9I"F        4&:0I@       %!FD*8       !09I"F        4&:0I@
M     %!FD*8       !09I"F        4&:0I@       %!FD*8       !0
M9I"F        4&:0I@       %!FD*8       !09I"F        4&:0I@
M     %!FD*8       !09I"F        4&:0I@       %!FD*8       !0
M9I"F        (X58 18*A>C((,2!#S1(4P      @!&$A)[O[DE_NK\<I3IV
M3R?N&TA3      " $4JIX,Q@DE!A2D,B30$      &!?R.C)4L$9DPFLW4QK
MZOX":0H      #!2Z.WM-:'7U=4U$#"Y)]U7BOEW=W=;R,[.3G/D\WF%+ 2R
M\;YHBDA3      " $84)U%CK2:9FD"*5$+60IE$[.CK,OS^P>WS[ :0I
M  # 2,%47CZ?5UMH8V.CR3W;E=K,8"%-E)HD[.GI,2EKX=7BVA=0;+&>?)%4
MM#0MIF0/[#_B^/=TH3WY.\\; \"PI%P/_/ZJ<?M\^GYY+PU]%^HD,^@A
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M!;&7,90&*_4Y<.A:?L47^A*,:VOL'IJ]#[D/Z!T;^]C'H+FYV15I?/3 )0,
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MYN9FSR,_);;5,BA,8V/CH(%E*5IL;6UM]?7U V%J*?/75B%EKNF0,L6P"+V
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M&,9LD0:Z!WB[E^W<CMP^L6RZZ:;<4A=__?77R\9"6VTZ9<EZ]J.//LK0$WV
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M/\YLV;J4]';GV2P\% 5- $_E^^^_3Q8U36[M6[./'7Q!B-.[$-)CF7JQ7BE
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MRC/B&Q/^\,,/F54'HT%.S9Q2'$+/U8F;VA'B+/B6LX>:QG(SXV-P /F=,&E
M);F2BYKC0)=MK>9\\\UWP0478()8+)1,1A&?X4Q+N<ZUCL^9H)2WWGJK%&W/
M\S6A)E]LL<6HFOO92(8Z2KT^??J4;+A); 235FQ^YD<???3..^\LN^RR#39-
M5VK/-'C#9Z'3M-A@.OS$BZX:R\)W]S8B;]4V]6$'9UGR_///EV5$_V0ES(AP
M C '!;;==MN24<%##SUT\N3)2G#++;<X-45S+R*V'GW1?ZI_\R1LOOGFC;8U
MD2@*JZY)G >&IO ==]SA \+#A@WS&G$<Z+KKKENR(T8VVVPS:4[/<0DU&U]]
MY957U/0]>_94RM_][G>Y5?]3V^<I#Z.FT@&;Y]%9._ E\5Z^+#B\IJ1G&R%1
M4S<R\?[<JHE?>NDE,3&9[JRSSG(+YQT\D)GM2O7XXX\WV93LAC B[>WNH+[8
MBJM^'GC@@2IHS377S"-J%^=UY2L&IA7(R#+"_///O\LNNW@%8_54$3:O:K"O
M&%=>>27-6K99#+#$W ZP4E_5$^<3?1$B5>&KDR9-.N^\\]0<O7KUHKM6;(B5
M !(D7Q(R@VM.@#3#AP^7)FK6T:-'U[]/$Q(2$A(2$A(2ZH%75C/DP==E?A^N
MM2?#AV1Z7=7@>2MA=:%3#'S":IA4Z-GQ_9!<-AI)C)>"'(0#XCU-/>*[R)P-
MU#0WN071^/V0G"CAYX@3EVV:;HL-U^CG&6><P4X\%U]\<5P?]VCE!^-S*\V)
M)Y[(UK)?R&T/K[_^>LE&JSM/UD6H+J*FKO5'6@  (55)1$%4W>S\U3QL9L,M
M DHP<>)$AJ'D:G_XX8=BI/0#55,QI7!,2-4&T^#;+I_NHO2*A[/1+;C28RIA
M/-E+1)-J6)TH7N&'Q##]%>MY0%ABB274-!"\JAUSI$@_%+34=JUIW+*.+"SO
M;#$B+8(Z8<*$M=9:2\12DA=::*'6Z$1-TJN4QG LC5M &:L&R1DW;ARW2C:8
MZ;W"U5:,FAX)ZB?,FOXT;'B;V>$Q\9BV[JK06EARR>.ZY))+J@G4%FRGC%A4
ME9PUUEBCT?80<K51@#0J4>95[6#7"M>BD7.RQ!ES8U\"VR!1M=P*\EQQ1L)E
M^S"!_J*F*DO4E/1</67AI_0AH$Y8"B?],*'7"\K":+PL27/((,I(Y\G"VX?1
M>Y6N!.I.K*>E+"].*4\XX035BP'SW-Y6-*5W-@S%'KR%*C K6%#/4;?14[/
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M%_W.M,V?I:<J2]^F4GPC0"; SE7[I%>VTV):;- 56^5U]D](2$A(2$A(2"B
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C"B&$$$(((8005Q&HZ;\ COD'VI!T$^P     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>image_19a.jpg
<TEXT>
begin 644 image_19a.jpg
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M:6QLO&S9LJE3IPX;-DQ#0V/:M&F+%BW:OGV[KJZNO[]_;FYN146%JDF[:QW
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M\:AD@X=Y%#?#,$RKA#6581B&::&(WCQR$II:MJ"@(#0T].S9L]NW;Q\S9LS
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MD2/SYLWS\/ @6PX.#D;@08,&+5Z\F'IW*3#7/89AF-8!:RK#, SSOR'\!$I
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MS\^OJJJB7>0]HC=NW$A.3@X("+A\^;*)B0GT#(*J>(?MPT!Q%JH&&6[:/YM
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MP?K""R\\\\PS__[WOS_ZZ*.#!P]>NW8-;=^:FAK%,WMM',HZZ 'TR=#0T,#
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MAT;.(\_5#T2G!C$+" A ?99O$D6 VHY3ADF*3?*B0;#P\/#KUZ]3%['(*Y$
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MKB&(T,+"8N[<N=A$128O^KN!J!"SEY=7MV[=<'-'?: $/)H<8QB&80C6U <
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MK&."0"(D3FWL^R>(S 0'0L3LV;,1I56J5'%S<\N=.S>AHWGSYEV[=ITW;UY
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M-:A2OE9*UN<0A(&G^B(1QV)I4A_M^ZX7$J.^J,E5'S]^'%FX9,D2J E- 3-
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M7H<.'7*=3L9"(H2D3'GD*._1:1MS-:T8]803>SY]^C2,>>O6K>L4X.480T!
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M5?DT\4\__80<[=6K%_7_^NNO<=N.'3N.'CT:D4E&(,H=.'" :[QRY4K<4N.
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M^/'CZ$P, R,A"*!.D3JLP9W/G3N'L2%ED7-R2P6]A^/_I(#7PQDB(R,)"[B
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M-=<KQA81$2&C8Q!C'3IT^."##U"&+5JT&#5J%+)6;%6W@)/A46$R#B<*" C
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M?4RF3)GHT?%MSWD_$9:PQ+XH]!")B+FI4Z>>.7-FZ"2<L#SP0M=(ATT/*GO
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M+%FRG#ESVI<%]Q"B!&; C9I;>\=,IM5WQ9S49Z*??/(),=^^EK)R#QO[;45
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MLD',/1E_Y*>??J(=@?M//?54R9(E00+N[$2;3"6_;2;E(E1VT*!!@'YNA+T
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MH%BM\ EN'CAP($@Z>_;LD"LPT^;-F\49('4N,^$6<,;!@P>!M@ @&@AL%$K
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MIY\J'YLMW?G>O7LUXGHS9"U*"Q$ P?J$3(.0D4:\&-#G[RI]^_:%BO?ITP<
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M<!)EAJT\@R9!MT!2/*A%BQ9P#] JD*Y$B1+:*1&L"30DC?L""*V"FR&B #O
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M^_?' @DX!PX<( H1E+1XC/)7,6Z9R<#^ -97/G@?>!U:!0'&2N&W^!V/@S^
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M(,[E :>I0)#BQ8M7K%@1U:LQO) /OL,2EO@C0A+^&/;1#LL#+-!4.EK/Z9:
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MV#P%PR RP'S<JQ*?8:3D3P-1 $U^\9D7:FBR;=NV\J#0&U'=_OW[\4=HJG*
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M>CXSH]4?& -1SO?NNOY]49>L7R$,=?_TJ4 HT .("AA-[^@W^\3 ID#>L"!
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MNG[]>H@^'1^KRJQ@+LU?+D<D0177JE6K;-FR)4J40"=TZ]9MNOKV#,YP48&
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M=W38>*36(C:;PJDZ)I'9(J3%DNSD+.EENOQB:HPFZE?G9LZ9OB]K_$HSZ02
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MHT:-VK=OGS7U/UBF2F5I1X(/72 T-'3^_/ET6U]?WQT[=NAV\=A -MQ=A5Y
MY(D?/_["A0OU3H]C8FQ&U 4.5[.FD:GR5KD93K5\SX4+%QCH'0KZD$.]0BR+
M)F@%&_6%GA?BGDPU7+Y(-&0 >/OMM^G,U]6'?:WI;-B(@W"ZGHD17$J4*)$N
M73K8K<<W<&S$:4@KP^G1:<@APT4^[MV[AP3JW+DS9$5F4=+ZF]1#/YF8AQ)@
MT%VQ8H6\:HBLXA!2BI (EW5_FN$>&V4/GL80!6U]I+Y[.7SX\&;-FD%D+UVZ
MI-.X*T^G>M[%L%>Q8L4<.7)PHB;$WI GBTP%5*1 @0)3ITZ=/7OVK%FS9LZ<
M6:-&C<&#!Q<M6A2R;JAL]82"*$ "Z/N8,6,D6_>2NP.%!K=>N7(E,N#''W]$
M?"Y:M(@!Y=BQ8Q<O7L0X^C:!0#]T109P+E*6<Z&/4&WJA8KX0RU$82@IRP8M
M"'O8M6L7*8.#@RW?9H@9A+@[5.N0,V*I??OV<E%WEF:XWA-#/]"X"!CHKWSI
MA"IS.C6E_'*C0?*,+J1I$&Q]^_:-%R]>R9(ER9.2'#IT"(%:JE2I+EVZ+%BP
M0*L7=R>)4(_^,)TT!\+[DT\^R98M&]$/K] O0SYW8!\:%(4_8," _OW[]^C1
M8\*$"?)\6&/=NG4HL8"  (["3W+GSHT>TX_%#)<4EVWW]N+0GCU[?'Q\,F?.
M3#<4+])S>@U7GT7!R@,0"\@<?_/S\SMSYHSUF#J7=J]9LR8YR^1 ,Z2_4+4Y
M<^9XS-Q0WW.F=Q!DK ?4Z?0"&II.Y%$A$R@8T<:-&X?11HX<.67*%'J$QY3_
M<#C5JC8X& &V8,&"I4N7KERY,GT<%W*J>SKAGA8JLV&&]!=ZTZU;MU#XB1,G
M)HR(]=SC3UR!A'WW\LO8IR=>B6^(!=B6E0Y%P9K/=:JOU, MY43I_MX,FL\>
M<5*F&LJ:\+.<.7.F2)$"EN;Q8;<-&W$1PKD-=4NU3)DRJ5*E@E ^]0TT&W$.
M,B0@7> ?2 7#-8HP;,R?/Q^9"AT4F<IP@HZ5!6/AP6O6K('MP?,0=;)^#Z<3
M#V'Y#,:($"0!7%:OM>!Q8).-RY<OHPK"U>.1O7OWRA-+O09I9.#TL+"P+%FR
ME"M73OYZ3YO<)_VN7;L6/8,4%S5"84:/'CUDR) *%2J@5(W(WWVR@"J,'3L6
M82-_G\J 28^@@I1C;<CWM&G30D)"-FS8@"5%ZD=$^183S22K 4/-L=BR9<O,
M$ZL$F)3VXNCRY<MI&M/9,8=30:@J%(320F1I<2FM>X$E)1("@]>O7W_FS)F<
MA5Q!;N$VJ"S$ZI^1J0*L@89)EBP9"I/*GC]_?N+$B6A4&A']#TFB$?7-?OT*
MJQ OV:8*(T:,*%^^/)D0]!!X_.)@F/>Y3W'4[.T/-46?/M*S9T^$Q,"! ^E]
MYN(%!06E3IVZ5:M6.7+D2),F3;5JU?#)"->+H!KNS23 &FA(&C1[]NR:U4AB
MK4\( O27ZZ[O55B $W)%CX\H 805"8W/1';Z; 6/3T0--:EXQHP94']W5V$/
MD8>X1#^R'#+CYY]_)AEZU?W)CPT!ECQZ]&CKUJWQ@;1IT^)IX\>/GS1IDKQT
MX/ T9<:&&=H^=$S&*6)(PH0)\3ISFCAGQJA+ZW M,27;YE\"P@7UG57CR4S8
MIC.>/7M6;L5*@'*G"K$!<56F$LJ)MIDR96K4J)&7),:&C3@!'4#OW;M7N7)E
M:-_&C1OM&S$O'AA7G&IQ$:2"T$H96A@\("7(5'2FD+F+%R^B*_3M4GTZ*E06
MD$ 5,-X</'@0X8&(17?-G3LW.#A8ORAH@;RW8RAM($\L&=&Y^J-'CWKTZ-&T
M:5,$&,7PJ/2DD*A-]"WEC.+1D$>X/TU%Z?GY^4FV%(R2P+,'#1H$O2A4J)"D
M<:?%'N'O[X\Z$C9O/>8)B'EYTP^C84"JKV\J2[UTI;2@<BA(,L9^N./"A0O1
MNH@Q2: %":=LW;HU-#1TZ=*EV[9M@S#)3& Y&F/(5;1TX2]#(=YRXL0)C[66
M*Z(,4?X0WP8-&E"2+5NVX!ZHCL.'#T/@Y$70F-T+$Y$FYD*YT61%BQ;%-TJ6
M++EBQ0J];H>4+4+-GG6H9P*ZM#AA2$A(O7KU4J1(D35K5CQP\>+%#/&X<;9L
MV8H5*Z87]7E><"I(=\"2N/W0H4.[=^_>K5LW')5.)_$94[#GE5=>29 @08T:
M-5#=&%9.U]W$S"8]MA=AOWW[]K24K"'L3AQ),&'"!/J1^[P)0TWCQVZS9LUR
M[X].]7@?8U*P_?OW6XX:JO?A#^A,=*SUF ("E2;VJ($=ZGUI-!7]VMW)I1;R
M*S%-3&I)9L-P/5&O4J4*K2SO(YPZ=4H^!>1P<0.;]'H)N@D#7)(D2>@L#E?<
M-O?'N (=+CP.RN(5XA[FOL8O09X J]\:DY1.-9R=/GT:$2LW#66/.<_8@S@I
M4VFGD2-'5JA0H6/'CGOW[K4>MF'C14&+%BTR9,@P>?)DCXS$Q@L D:F,IGK@
M1'G2XKUZ]8*/"AV!K&S?OETO>BD,SPSS?AG/.!'5\50V@Q;]]MMOS>,3-!<B
MVZI5*\0JK-3R($M?:\F2)67+EI6'P-&"^]-4)'&[=NTT \,.\+/APX=7KERY
M8,&"T1H[.>N''WYP>LU"R'S]^O6+%BUBP':X7I@T3-6, DXU:8IV017P:]%X
M,M66/"$!L 0$&VK<?:W%OP10C4Z=.K5IT\;I]D4!<W50RZ@^FGO#A@U;%62Z
M[\Z=.P\>/+AQXT:THMF7S/EX"70[]O_PPP^3)T\^;-@P\49]5"PL)0Q7[U-=
MOWX=>=^Z=>N\>?,B4'OW[KULV3+<7K_C@& K4Z9,8&"@OO40LX+]M;A]^S92
M;?#@P8A2Q"H;"Q<NA(J,'S\^E4*#!@WHQ3&8XRTF0NS11^;,F:/WFVN-<?"E
M&3-FR*-[,PSU$@$:5:8A.$TKB^J&N'/G3L:,&>73D19CDNS^_?LHHN#@8.>3
MG4A?HE^_?KB*Y?5X2<PE.)&R1:O/VC!#FHR>2!L1?B/4-U<(4'Y^?MZ\@F[#
M@C5KUN3(D:- @0+6 _\,1*C/->O>ZC1-&XY0JP P=C@4K&?&)L0QF2KV)3I7
MJU8M9\Z<A%IBKB74VK#QPF#0H$'PE;Y]^T;VLI"-N Y:%H)[_/AQ/50@9B9.
MG @=U.^DA8:&(H3TTU1-&35T;F9X,_:(3#7O$2'!U0L5*K1Z]6KS&"8CG$/I
M2=0(,M7C,YFH$=MD*C)IP8(%APX=,M2EA=9[>=&PL+#%BQ<C02]<N&"X'@7+
MU?536:=:3@F).'/F3,1P9(WU9\" B) K5:H4LMG\SJ&NA5P4+Z+)2I8L&104
MM&G3)L0&>Y"I#*,T-#9')4;M44\%U=^]>W?FS)G??_]]VE3NDNB6-4,::,N6
M+0,'#D37??;99XT:-3I\^+ (5(>ZSQ*N5DELUJP9BA>FY?Z,[GG!H>8=X&GH
MR1X]>O3ITP=IY^_O7Z5*E==>>PW)C5"49-8SGP;Q%@1JPX8-R=EZ6,&AYLGW
M[]_?/'=:+*PZJP-/2Y,FC:%NZ$L9(DS3U]E.FC3ID"%#+'U$_OZA5C->MFQ9
M9#UH]NS9:-&K5Z]::O=8@39Z\."!QP<^-KR!A [Z9J9,F62UO%V[=A&-:]:L
M^>NOO\; H_Y1L,0NM@/5]\]:MFQI2O6"PVP!"0BRQ^D:F,2+<">&;UE:R3T^
MQRK$,9EJ*%9'E$R=.G7%BA5A"8;IG0UK4ALVXC@@E T:-*A0H<+%BQ>MQVR\
M$&"<V+!A@[E]V0X("(#[ZCUKUJS9N7.G93D?,V0T$D0H2#QT1K+H@H;E::H>
MSV[=NH5FJ%2I$@)&EH$U7$16-NK6K=NM6S?Y8GBT$'MDJJ2Y?OVZ/$[4I-_P
M6F"@3N?/GX_6"E-?PCQY\N31HT=I4+0B)( -1"P"E>9;MVX=P]:5*U>,)VG$
M7P(J(FJS:=.F6[=N-9X4J+I-:2S(;O;LV=%4FS=O_E%A[]Z]_*5X;=JTH5UD
M0J9^!/?_U_ .Z!/L2599LF3)EBT;+8M5=<M* D.I68PV>O3HSS__/&W:M&7*
ME$&LRKQ9\5Y#S:U%U=>N73MGSIQ3IDQ!OIJGR_[E-HP!3IPX,7+D2"2$]%:*
M6JQ8,21WT:)%D9&4-B+*=YNC %XT<>)$&(ZY.<P^B;OV[MW;?>%H22-'=^S8
MH>=?B$F=ZF$[OY1VT:)%<NM3"FEN:\@K2E4?U=E*#O+X'5=W;X7_1A]U?\&\
MTT:T(&V$_=.E2]>\>7.&_CP*C1LW]C(H_<.A.QWF(B:/'S^^=.G2DR=/MJ9[
M<2$Q/XK((YU:WAB*(EGL0=R3J7 X?W__C!DSMF[=.@:3:FS8B$. VK9MV[9(
MD2)_U?HK-F(;$#.06L*:'C#.GCT[9,@0J*3>@]K9M6N7<%9OR(HW:00B4S5)
M%9(D#[( X@'E@Z*P4$_2(QY@Y_+J7;00>V2JR![DD"QA9?ZTC#<7Y2K(U+ES
MYRY?OGS3IDU8:<.&#>@]M%]H:"@9LD'#<8ADERY=(G_$?]0$(L: D!T[=BQW
M[MQCQHPQ/\LR/T]#>-2M6Q=9B+(*5:#,^_;M0[&$A(1T[][=U]=7C""Z* 9Z
M@\O)-Q[+ER^?/'ER-BB5.4&XFNN+A[=JU:IPX<(4AB9>L&"!K&)J3HE8@F+Z
M^/@4*E0([?V'ZVUJXV_0^3$ 98!^3)TZE3[2OGW[H4.'=NG2Y>NOOZ8)"-=K
MUJR19-[XH3NN7+FR8L6*2I4J84RG:^*N_ KP*!IZ\^;-'AT5#4DO6+9L65A8
MF*&*JHLAZ2GV_/GSW3-WJF>Y9\Z<(<'5JU<]7AHOHGCXF_NEY6F![L@V8@;B
M_*A1HU*G3EVR9,F&#1O2%H0U1@1K.AN>H&5JN/H.,(-4U:I5B</6="\ZHNB#
MTIW_\Y__F._,QF;$,9G** @M@%<U;]Y\_?KUYD/N0=.&C;B.W;MW#QHT"#Z'
M2HDB[MB(BQ#%\N]__QN=!C745/+$B1.]>O4:,&" T#[V(-MP )D/Z9'X2E;Z
MKPZ&3Z6,[N^FBI#00H5+DP ]H[]"(2KHL\\^6[UZ=0Q6]HI5,M6IGC;_]--/
MLV;-HAB69T=10(IZ[MRY*5.FS)DS!Z%%O>2E2O05PI6_4'DNH6>Q&C$2?M[C
MT:-'L%M&1M0+%[580/YV[=HU8\:,T-^#!P_2IHRA*$ V4-2H&HS MK9>S*9N
MXL]0:LS2HT>/CS[Z"(Y(P<1<_-ZX<0.IC)S#?W+DR(&<.W_^O,7@2/J%"Q>2
MYE__^M>P8<,HJEDF/=6EGP%D/1)*0HM3?BKURR^_8/Q77GFE8L6*]!<,^UC!
M>J87(&?\A%IGSY[]T*%#\CC:,#V(IOJX%B;"R)97Q\50]^_?W[MW;\N6+3E=
M/%R,)LW*+]%FTJ1)ITZ="G<M%2:9RR_.4[MV;:(0Q9 ]XK>2N>1F\2XIX7-O
ME[@.;>&@H*"F39L>.W:, 'OMVK5]^_:97U26-.:_-C2T3*5K;-NVK46+%LV:
M-=N^?;LUW8N._Q("5]0U[W2XYCM(3#"'UEB+6"U3=2C4HSM!LU&C1NG2I6-
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M(\6G3)G2MV]?"H,\)EP7+UZ<*B=*E"A+EBR^OKY88,6*%20CEF(?F9P/O4<
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M=-NV;9&=29(DH<<]>/! @CS# ?*84V3)=X8#9"0U0KA"B=&HB,"//OH('4[
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MXI4K5]@V.YZ-.(KG+%/U:.%P!2Q\EZZ+N^/Z3@5)8.XP-FS8L!'7\>#! P3
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MMFTK4:)$PX8-1X\>W;U[]]:M6U-8IZG.;J$[H.TMDJF&^L(39T(]R[8?V$9
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M"74\;Y7&_6_^7BM>FTS5=4']]N_?GU&!45 _+PF-=$TY"Q8L6'C3P0 )L6,
M9LP0KPAW1Q6L7KT:TL: Q*#+59&=H6K1PM]^^^TGM:<Y/$#6NF"L8AQ"\G$O
M8Q(G7VF(C;I,9=2$N->M6W?<N'$)$R;T\?&!N6;-FM5)IIJ?>4NT\C27 VZ)
M'S\^; -),&+$B+\]Z=?"/PF[[=F+9_N"#@SW'C[;?^;&C1NG3Y\.]9%&7+=N
MW=2I4[%#QFBH_R^__&)34^;@H/ D>=[?NW=O>*>\<96-); '-$FH>H%CEJEB
M!A@J*A=AD#MW;M0F5-ZN%C@A*N1NQHP9(:FRZ<73IT\E&XA,N#[\-4F2)!]\
M\ %R8NW:M9S?MV\?7+92I4K-FS=?OGQY2$C(2QKKP-6K5[%5[OK#]!+>IJ"U
MF<P()?Y&C1JA6- D:!OT&*+"U]>W6+%BU("$=(7KPW02[=&C1ZR2J3:'D'#*
MC/RIWS2:(9=P1!3$S\^/:J1^Z->;-FU"A%,S;C_9I;F1)9LW;Y;/CUU!8V$)
M9\^>=96I- =MC1B6Y>)<ZPW#PSSDJBLSE#/X,8RJ=.G2B,P2)4J4*U>._*,#
M8?DVTYMV,H!](F9H:-P12A6!A!/C-W'BQ!A IDR9<N3(@:7Q9]RX<0GFX>$1
M+KTHX[G:4(?J0@*A$&2Z 1V$WC%AP@3Z%-:K9:IKN6(Y=$=S-2UYCR>CE7R[
MSCB%CF*\Z]6K5[MV[>CFU'S*E"EI,NI9ON9-DR8-M9TG3Y[2"@PN^ UT 7V0
M>V7W(//$;Z=TL4#<5_'BQ;W5EI:ZQ37,9\0/<.;)DR>7+U]&R.'0?OWUUXC>
M]D<WJ"4,-4S!4"]7Z7<P! 9TQO=#APZA.?GSL5KD7P@ YD2UX(0O* @3P ,?
M#@^1K.@L+E%,@E%2BOQOM;BZ^2F5*V*X$B+"ZY&IVKSHH@P)L)\Y<^8P,NE*
MB26U8\&"!0O1!(:6Q8L7X_=>J(^%0&!@(,0:.H@ZE>>@#,SF1[P:.A(&*NZ"
MED'.;MRX87<A#9$CZC(5)9PW;]X&#1I,F3(E08($NW;M@CCFRY?/2:82\N[=
MN_)-%Y>$,0@H&K2/%%>N7#EJU*A76NK)0C0A+.P%2O7,R9/>PSV]1G@N7;J4
ML1C9"4^"84.O$1XPQ1T[=G )2_M#3<DS%"G$;J$^R->Z=>O"N;%;3G(CDG7!
M@@5BBDYO4U$C\,B.'3NB3J%9W;IUPZ(P+;@79  ),6;,&.1BR9(EH5,8OV$B
M VB5(4.&(&7?4?N"T'<,]:W@MFW;2#U[]NQ06^Y"4QGJPV\TP-RY<XE9'O0X
M=1S)C_QR%_P8A0DIE,Y(WIHU:]:R9<M(:)Q$*\^81)/S)Q0\]LA4+8'T2Q+#
M49^<H5EGS9HE7_;J6PP'0ZM9LR:M@'0T5*N%JAF>HT>/[MJU*QW<'%Z#4A-A
M0$" \P6'6\!CH-!TKLS 3K Q#,/Y@H),XJ4YC C((?%CMQ4J5"A5JI2OKR_:
M T)/L[9MVQ9OHX-Q[X8-&PB6,&%"Y%"! @7*E"F#$RM?OGR-&C72I4LG$U-E
MC5^9]%NK5BU9(L[)?G2$-O4@0 L,5]C5RU[I+V:3L)D>E\B?^CB6PVU51 64
MEWKP\?%A($B5*E7%BA7KUZ_?I$F35JU:T=T**.3(D2-Y\N1)DR:52=&(V/3I
MTQ-26HI@.FFG&B/R^?/G5ZM6C1:71C%?-4P#J--YLO3]]]_C,1"*B&%9#<[U
M]FB"9)4,R,[ 4BB1J;=NW:)0.&'(@+@U,^A'G(< 2(>UJTD3FDL8JKR$@4O@
M;*]=NT8!$:M(UJ"@( 9?.B._'!,)EPB#O^5V>J(N>RRQR=<@4^T.(L7O@P</
M"A<NC$QEH-(V)%5LP8(%"V\QH/BP.@9%&6, I!!N#>UFS& 48=R";+D=*OYT
M+&WJX>$!T6?(3Y$BA;^__S.UCD+XL)$AZC)U_?KUA.S4J1-" @EZY,C+-6.A
M%$XR-4RM$@G#0#G$CQ\?7ANF5@F&TWMY><6)$^?V[=M0U:%#A[[24D\6H@EA
MME#;LV>G@@Z/\?(:.F00DG+[]NW=NW?'_*!'F-/%BQ<G39JT1ZVQ/&W:M,N7
M+XM,%5,A&/(5N\62%RU:1"O3^NB?Q6K[$)N+3 59LF1ITZ8-K.NWWWXCSF7+
MEF$_,$MD#%+DRR^_A \D2Y8,1<JQ)!3FV/(1J\.B9/U5V.WAPX>_5X _-&K4
M"(Z+<>[?OY\^-7;L6&SLP($#D@>)1U,+#K1"L"F% UU>N' A[)"^<//F3<I;
MITX=(M%=PQ5<'3!@P.#!@Z%Z\GD;4<6VMZD",[.27%$N6I.6A<6::T8'Z-.G
M3]VZ=<W+C%-CM&R+%BVD=$[@ZJ-'CV2C(^=K"M*X-*LLD^D$\K-OWSXB=_NJ
M5EY+HAA=W\0*2!U;JEZ]>HD2)4C"KDCF]>O7.3-RY$@=C%1P/A@8P6@F6>"W
M6+%B2-;<N7/+ZU-\*2)6OJ($K5NWYA8CO,VX0E)T.BE=0->M#F!VT6YO?+,@
MQ=0E%4&N.XX4,-0T0=+3TY.*9< J7;ITI4J5"A4JE#]_?EJ!)N"W?/GR=.1,
MF3(5+%BP??OV,V;,D,=>'!<O7ER^%9>&"#4]?#'48Z/)DR?3D;&$2 9!\RV&
MPRU@5W2$LV?/,BASX/1 (5H1IF;;XL1D$77).;W@SIT[:$N<L&1,LJTS9E-K
M5N,/]<P7M[ KI?I,;;>.9V:XAUJ$A(30-8*#@RDLPA7WA7;E3Q'&Y$2SBTAB
MCDG$M$R5-I"*IBYFSIP)R^G<N3,.SEPU;T'7M6#!@H5( "V#Z<JQ.#W9!00R
MQT""6KAQX\8?:EE4MUQ9?"F$_AVUI632I$EQI]J+1A%1E*FD1<;0J' ^6&#*
ME"DO7;J$-H!8N'Z;^L,//T ^3I\^_?'''R,;&"9__?57/S\_F ?Y[-6K5\^>
M/4>-&H7"B2@Y"S&&Y[872-7;%RY/&S=^T, !\^?/I_E@2+U[]\8"Y1.[]>O7
M;]RX$7,=-VX<#6J^_2<%3%1V7)0SV"':U5#FY"13&>BQ&0\/#TV L+U#APXM
M6;*$%#G \M&9<-/4J5.7*U<N("#@EOKH5 +3'1 Y??OVK5&C1O;LV=$;F!.J
M"5V*G-ZR90O&N6O7KFW;MGEY>6W8L,%F6M=41_+<]$$FQ[=OW\Z0(0-JF0+Z
M^OJ2#=*%0'?HT,%IW5H-F!R9Y"YY[4;@_OW[P_R(-E:]344\TT_)F.%XD64X
M_ :_NW?O1G;*XE)2169R3_=$A$^9,L4\,_#\^?-H16YTZV<(A@*A<66M(S,D
M/#RX7[]^-+'350%$>=BP85!SJM?IDMPN:RSI+6TUI)YAX5VZ=,$--FO6C&;%
M)'!!.#<DJ)[;3 []_?V3)$F2+U^^LF7+5JY<&4-"K#9HT "%S,E$B1*AA3)F
MS)@@00(:]\,//\13(1+"I6="6/B)WR+&PM1R-0)3V/_ K578PC\I>+-@5W3=
MM5RZ1/J =J'_TH[OJ!UHJ?/FS9LW;MRX3ITZ39LVK5JU*GV')BM9LJ3L.KMI
MTR:[6CD/)X#SZ=Z]NTS\=@L,@)CI@%BI\S43S.WBE&>RA_?#DT1DHM$!4?4X
M3Y&I.DN<I_.>.7/FRI4K%RY<<'U$0FX/JC66W%:^$\QAPM1+5YFA(/(5[4HJ
MLE;3\>/']4.W<%&\/L2T3-6@"K[YYILR9<I@HVO6K G]JX7(+%BP(#0"#B2K
M<3I?MO!& 5(^:=(D/63^_OOOC,K0908>QHS%BQ<S?@@_<V4PPH0X0 K"I=Y[
M[[W,F3,SS" JW&K:B!!%F?I,K8P*;9T^?7KGSIW3I4MW__Y]] !,PJU,A?]!
M\<D;O-^F'J5/F##AW7??C1LW+F)@T:)%LB&-^2X+KP5/:/#G3V\=VS_%V]/;
M>Y3L+423K5BQ@N;&U3Q7BQZU;]\>3LE(C0X\<N2(K,=K5C4:N"8B6;Y\>:CZ
MFAH@4^']AN)5V#Q2!-UK5^^F;(YYCQ CQ  L<^C0H1#9WW[[C;M@G&A:B"R&
M+0Q![)-^@>!!/^3(D2-5JE1%BA3IV+$C5L=5Z"QLCTCX=7HOISN16+O\GCIU
M"N&4.''B$B5*H%@X1H=CO?GSYS]\^+#T)M?>APW7K5N7[ 4%!<&)$3QY\^;=
MNG4K%8)L=I6I+]2FB.&B<$ ZLF@;YVNF%U.2#5>J:KAS#AJTQ>C1HUT_^)04
M;]RX@9+'X<A5<SPD1Q//G3MWX,"!N"/M'^CU7;MV#0@(N*'V%G**D]^U:]<B
M?:%V<DD*I84!^2$S\KFO3DX.^(4KBP.4V8_ZJF[W[=NWKUZ]^N;-F^8;!21T
M]^Y=O$KJU*D_^>23ZM6KRPLZ_BQ4J!"V(8'EA5OZ].F1I@T;-B08C8X#S)(E
M2X8,&9(G3QX_?GS$$AH)C2H+\\J\:+'55W*M%@1.S80*PI-0O2E3IJ37Y,J5
MBP/:B%Y,0U2I4J51HT85*U:DYA,D2("]R8WGSIV;.7.FGY_?EU]^*=:K(Y0#
M6H?^SKUT0-<'&69H:]3'&G+RVK5K&+#K)-MH@DU]RGO[]FVL5)]DW!>7*%^?
M<F#N4/)+ %PQ.E;?];=A=[QTI=2/'S]VZXM>(UZ/3+6I:3P8'$YDZM2IL@JY
MV>59L&#!%703*./8L6,W;]X<VUR)A5>%R%3Q>[0L@ROT'0IXXL2)X.#@:=.F
M/7WZ5%K9E1Z)"V6@2I@PH6S*5Z!  7F)X9;+1H0HRE2(VF>??>;EY05S;=JT
M:=*D21G/=NS8X2I3&>H8<2'ZC*RRTI(4 8M-EBQ9O'CQ#AX\.&/&#&R8 WV7
MA=>%WYZ_,)[_=O/P[BG#!_EXOVS?Y^K3073@A D3]N_?3VO2IL.'#V_6K-GN
MW;L1-IZ>GACJ;PHOU94)&!(6A>DN6;+$4+HT5"VB"Q/%PK%/M"5)(#N?JP4M
M#1/1# D)F3-G#BIQX\:-<%F(*9H$(9HO7SY(@E,7(+:]>_=VZ-"A>/'BV)4L
M;X&P)'62)@G9W'+/GCVG3Y^6CTC_='QS)7Q43#TP,+!\^?+(%=37X,&#*=W*
ME2OKU*G#&3/9U136KB@R$KI<N7*D*"<K5:J4+ETZ[N68++G*5*0L?427U PS
M^W0++=+<@F+24C___+/;,#00(A_M'1I^34JA6URE5\H<W3#'S@L2P*8>'U"3
M[=NW7[5JE78I]/K>O7MC&#20F=G++?QR?L6*%=3Y"_42VZG5,"3:U-_?7ZS%
M?#M_8A[</F+$",BWY$>"Z4@N7;J$R+Q^_;J^D:O(Z8L7+]*.1-NV;5O49K9L
MV>K5JU>[=NT>/7H@LSFO]WJEHH8.'8HU8C85*E3 ]=6O7Q]=BD;"S+A7]M'%
MO[WWWGMXMKAQXZ*KL1RI 5<_;.&50'OMW+FS5JU:[ZC%"V2UJOCQXU/Y=&%:
MA,JO6;-FZ=*EWW__?:2LKG!9F&WV[-DRP<%M?\%^RI8M.V[<.*>)F6+M.I@^
M*>?-$)O$XV%C\F%\#,"N7A??O'GSX<.'DBM.D@?4,LKHRI4K_%Y3NP$;X=T%
M.:2_0!5,D?T=V-R]R=<YB0V(:9FJ2\YP@@<I4Z;,K5NW:"2K_UNP$!4P)*=(
MD0*I\&^UWZ:%-Q$R(@8%!2'8],##0 5%WKIU*R/3R9,GS8L/N04LDP$L29(D
M#/GOOOMNR9(EG4-$ 5&4J>0->@?[7[1H4<&"!6%O>/+MV[?GR9/'=:5?AEL<
M.Z7X^../Y<,P> -"MU>O7I /%"STD?-(B-@S$/X/(]3X\XGQX[U-2Q>,'^-%
MN^S:M<M0@@1NA$J!&CY^_/C[[[_?MFT;#0V!\_/S&SMVK(^/CZ^O[Y#P&#9L
M&#*F<^?.W*4-&Z*/ ,!^T$O=NW='LR$;[(Z-$+4-V-6JF\0_9<H4%"-B]<:-
M&R1*0FA"M/&6+5OLX9DE 39MVH0LS)T[-V9),-1FITZ=9/H<8JE5JU:R"C$T
MU]78X'D>'A[(U&/'C@D)05ZBL3%4=+@.)@61K))G,MFP84,\,+0X3#TJ0A1A
MU3([P'7?5&ZA-M!%$HF.5O#TZ=,3)T[LV+$CHJOW[]\_=.C0#S_\X/;Q$PG1
MFR*AJCU[]NS;MZ_K-%H!25.Q"'*I6*<,X*!0<<V:-3.[!61DX\:-<07F:I%+
MH6IW9=P"7D(>=@@D0*@"+@XU(F>TV)"BV=1>)I]\\HF>,2[G=?Q2\\AFV#GM
M3DMA@0,&#,!*$:B???;9F#%C:)<.'3K0H-0,&EYN#%.S' WE[K# S)DSITV;
M-EZ\>,F3)^<8:8H?PWY031DS9L2*\&^R?E*J5*GDW:];763AE6!3KZ,G3IS(
M4(4TC1,GSD<??90R94J9 $R[\YLF31J:@.Z,:D6[&HY' PL7+L22ERQ9PN B
M49ECEO:]=.E2EBQ9\!CFX4P;CVOG<H5$RV GJPH[7XX>D'F<K:SB*QF6^>H4
MAS^Q^0L7+CC-HI<P2">"R;R&?PHVQ[,A^3,JE18#B&F9JLN_=^_>VK5KXS(@
M6Z'6C%\+%J* ,#53"\\.48AHN44+L1]AZA4!U'G^_/F:[=V^?7OUZM500UKV
MS)DSX\>/=[[-!+MZ^PHCA&DQS*,5X<%_PXM&4:8R4J) EB]?#H/,GS\_9,*N
M9&K>O'E=92IC:JE2I0(# U.D2.'EY64X% CL'SD-'83*<W[?OGW_3<#":X+-
M"#.>/S/"7AS8M6/"!#\8O\S[-91X@!IZ>WO?N7,'5H1-HAYW[MQYZM0I#+56
MK5J8W"<N@-G7J%$#":&-"G*)E<(@RY8MB_T\4ZM\R55]8"A))@=H)[00]K]U
MZU99/J1.G3IP5NR'/\WZ1W21O$9#:21.G!C501$@<%S%5:*9"Q0H4*A0(?0,
M A@C)$7YWMM0V[$V:M0(%<=YV3P#"=2N73M$^ VU:+; G"+*!PU,05#=\GH6
MWDQ5H.5D(C02W4FF4JZU:]=B\SH2,TB:.J&P;AGA@P</B K=?O'B15U19E#\
MUJU;4V/.%Q1HP04+%J#2S6\@S0?7KEU#<,I0XI0!BD9)J5@*^\RQ<!$E6K9L
M&>T[:- @K2W-8H#"'CAP +EHGG%M5Z^@I1JIX<*%"PLCU]Y&+LD9M K&8S82
MN9TS5$7ERI5Q';0F]5RF3)DB18H4*U:L=.G2HT:-PIW2:I,G3Z:\R/)0-5_:
M,&E40[5XITZ=BB@D2)#@PP\_1"^A5_72ODF2),F:-2O'LD4*1D5Q)!*[->/O
M_P=IB/[]^S-JX!#2I4N'KTB6+!D-(8M7T1R,)@D3)LR>/7NU:M48F Q')Z)]
MZ5;SYLT3+R$G[8[7]78U'SXX.)@;#QTZ1,?4!FE3^UK1Y67Z1N0M&*HF'<A7
MFFZ7\HH./%=K-\@T8W$X>#E\+'V3@C#*XP#-GPQ(T5#15Z]>/7?N7+3R0+<^
M)^81TS+54(]I,1H& P8>J(RAG*F6KQ8L6(@$4$8&<EQV1-O368C]$ IU_/AQ
M2)OA>'@'E5R\>/'ITZ<9I>22'E.=&*0 F5>R9$EA5_S*ZYK(AV%71$6FDKUC
MQXYUZ]9M\^;-$&X(A.QWCXIPG?1K*&Y=6BWAR"]Z1MP[$C=.G#C0$8K)L9^?
M'X+<[0LB"S$)2-]S&V+5.'SBS.19<V#_<$$AY8::>X9-+EJTZ+$"#=>\>7.D
M6B0<#MDV=>I4;C$<*G3.G#G(5XE02[X7:N<#.=;)">\4@\%R/#P\5JQ8\=57
M7]$ING3I(OLA(>H0(?H;;)OZL@NNAD6A%>&XD-TF39KLV;,'YB=3?T>/'MVR
M94NL$=6-)0MA174O7+B0DZ@:=!%Z#/7U\<<?0TOD?;(3Y%NU+5NV( OI C+K
ME9.[=^]&*;5ITT:*PX&33*7>Z"GSY\\/']]_P%6$'YDW(GAE]^C1HWKUZNW?
MO_\/T^ZO&O!7F3^O5PER D1VR9(EHK4$9F="5T7'TA/U&3-H2A\?'U0E"ESF
MS5+GB &Z/S4I[RJ=7!,!H->S9\^^>?/F"\?B569<N' !\T!7.[W@U09 8^'Z
M\!*XP9"0$,0GM<<MWM[>=>O6I:H;-FS8JE6K?OWZX8Y.GCSYU+&YKE0.7A$K
MY2[]U$-'3GYH_6S9LJ%%2Y4JA?-$Z,I&G?@EE*J\1$V4*!&_R%><*@V-8G'K
M%2U$'5+_TK4K5ZZ<)DT:6J%$B1)T9SI+_?KU^:5%BA0IDC5K5NH?[=JB10ML
MS'"LGL6?.7+D6+ERI=T!0[6X- V_]^[=V[9M&S%@G[J;A*F-7C!O>BM=$B_!
M>/?33S_1:_!@=-X7X4$GPEV</W]>'G/H_$<?R#G90(O>4,LERLG+ER^39_K(
MX<.'9:$*V;!:"BL9(X=X17H3_L$<X3\"/&2LLOF8EJEB"MA*\N3):]>N'1*#
M"VI9L/ 6 %^&3,4=.^U:_C\%O;R!?LS_1D"/UH9J1P8A6*_AH+,,I7!9FI5!
M"PX-00]3T+=(#+K%(>+0+%0B! L%6+9L63G_2HB*3#74RBCMVK4[=.@0!T6+
M%H73<W+'CAUN5_JE:)?5ANGH!'2.H1[]0C3EJ3D$=./&C6/&C/GRRR]=:;>%
M&(;,HC5>ZH?+:]=L&#APX*9-F\QF@$!"Q?WPPP\T*W*H?__^-)Q\MZEUIJ$L
M1\@-(6?,F($TDI-_AE_I5\=L=_EPT7!<E:C02! UK,[3TQ/-@W0D;^G2I2M>
MO#BZ1>;^:<C4V;ESYV970&TB,-!OLA/@U:M7R3,BIURY<NAPT5>(PYHU:Q(A
M]+>T6M<7Y0.!AA!3.NUA[*J"1%U#729,F(!2\O?WQ[;%>M%4J.(1(T9(X!X]
M>J#B()VZ<B"4&+SLWFE^,2L@3@2YW.X*J25ZV?;MV]VZ>M3CXL6+4:&(.K>]
M"7:.DUFW;IW;KDTQ\3-P8CT_U@P8\/CQXU%QJ#YYGT/^X?JH"R0$M:I#VAT+
M8AGJ)38M[G979()1;]0819;;PQP[/4H XE^S9LV\>?/0DY2+%JQ2I0J#'8X.
M5=FQ8T=:C>+@6Q##%)EL.Y4:ST-A=^_>_<+T""S4L0X6/A;WA2YJW+AQ]>K5
M:?>"!0OFS)GS';43;_KTZ3$&F88J[U>1Q)<N7=)RR,+?0*B"X1C^Z)MQX\:E
MGG/ERI4T:5+JO'SY\K(MJCP +5RX,"U";Y7/7N0N.C5F@/\)%[6I0V%7='\:
M%%^A38)6H_<QSJ+T&(F0H'0'QE8$'N%1']]]]]V#!P_H@YBZ+,S&U5NW;NF/
MF:,/>B@G=2R9@9A:DN*@DQ';Y 05>DJ!G.L^(EV&XE"NBQ<O1O+$\*U!3,M4
M0WU<-W+D2/B*CX^/^#ZW_M>"!0NNP$G!&PH5*B2;"OX/ OX'"X'KW#+M5/%&
M0!R=C-D01(89)(&^!!.=,V<.(R7<"SH%+S]Z].C2I4O'C1LW:=*D@(  ).+F
MS9NAI)R7@99?M&+KUJUA5*5*E=))1!U1E*D(CZI5JR*,UZ]?#\F35T/D,$N6
M+$XR]47XJ3$2(5Q!-B$ F"XJ5V2J*VNW$/.0]J(WH4@9FK=MVQ;FF&\I#81,
M165!Z5"#-&7SYLWI?<+D--D21"Y3S=9%_!"L??OV'51[*F#8:)+)DR<3,Y11
MJ"WA42/3IT^'L^[<N1.NB4@680FCQ?C-24LI$!6RP6\B!=G[5-8+Y1<#ALL^
M>_;LIY]^0FLA2'Q]?2DOY8+=#AHTJ&G3I@L6+*#4$K/=M*:HH68C5ZA0(6W:
MM.A8J9][]^YU[=JU;]^^=%XI'5*J5JU:9,/NF",*,UZX<"$]VBR<-$2F^OGY
MN>VY=B53(?1DTFW?),Z]>_=2>Q%MPF%7NS'W[MU;]W$-R0^:$/?B]DL\;J'M
M$(IDS_P)'+6*9L!:#-7$.F-AZJTX)4)JHF_-51?J6,,)OT>%M&_?WOS*&DN
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MHT:-8'[P^P$#!LB&'SMW[I0)<JYO4T,5)#\Z3DF%%.?/GT\\V[9M,]]BX?7
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MB%#\IV0O,#"08E*9&3-FC!<O'GHU08($(HT0J!A#]NS9Z]2I\XY:.!W55*!
M >I-)Q>1;[00.5S-WJ:>O=(T='-18MC Z=.G:43Z)O5/ZW3MVE5FNM+UEB]?
M7J5*%;R-VSXB#Q&Z=.G"7?[^_N81$QO P\@[6-=L".SJ3;MD29R&G'<[\OZ#
M$,=BJ/UOZ"EFVT8<G5<XI_#<L:"1%($<_OSSS[A'^LZK3IYZ0Q%S,I7:Q!GA
MW7!YPX8-,QR^PX(%"U&$,)6#!P_"$6%F%RY<^-\<._'=!PX<>./>I@JDR1X^
M?'CHT"$]UXZ6A<GY^/A  1E<:6*&9QF!9/@TQR" (Q8K5DPV3H![81*&P],Z
M!XT8D<M480!<_>BCCQHW;KQ@P8(A0X9 ($110/O@^K"]5JU:K5V[-B @8/WZ
M]2B<M0K+EBTC_+5KUR0&B9D(*=WBQ8M'C1IE3?J-;< F42,C1HQ CAKAIVMB
M5] F1"QM)^]71RHX;8=@BU2FFD?\B1,G5JA0 0\FF]=?N7)%WIH*-[4K?0B!
M(Y[1HT?/GCU[\^;-&(Q,):!WH$S&C!G3IDV;1HT:8?SHST6+%LF^+-)97J@5
M?5!6Z$#RT[9M6X2HF&M2!<1)T:)%Z353ITY%IJ)"]^S9(SQ8&*162D1%/HL7
M+X[^P7KE/+^P251NKUZ]9"N:%PJ)$R>FBNB\8O!TY]V[=V_=NO5/TR899M"5
M$-+RC;K; ,39L&'#-6O6N)6I\CJH08,&M(4KH9*L(N=0X"AA'4 GQ %U3G/C
M!)PT@.ZPE*5,F3+(3OW"ARI=N7(E54?+&J:O^)ZKF13<>.3($>*<-&D2=4MM
M].[=FV:B\M&'-6K42)X\.?)OV[9MM]2[($G("?JDN=0VM:HSV@:#80@@!@0,
MMC%V[-CNW;NCU8F\4J5*&(:ARG[__OUY\^9A& 2F!6?.G$E-(CZQ%M0LEO#!
M!Q^\IY!*(6W:M+ESYT:@BE+%NK ZG;J%Z(,8I*>G)R,:E1\_?OQFS9K)PU",
M#2> Y3!D8,G:,$12RI^/'S_&&E.D2*$_$1=\^^VW1X\>O7W[MAZ #&5%<J.K
MX84IN.V&T03,&R^'?3J=#PX.AAO0C[CDM&FJH98D),"Q8\?DFPBGJV\?HEVF
MBDT8JCT8;_"&'AX>,MWWE>B4!0L6!+CO_OW[XY?Q8OID3/K6UP[8#WH)YN%\
MX4V M!1L'EH,L=8--V'"! @6@]8WWWP#<W7[Y-B,H* @J+-,D6((/W7JE.%@
MY\Y!(T;D,M6NGGDC#*"8_?KU(WO036Q/.#?\.V_>O''BQ)$\N )QBQJ1Q](Z
MB5]__55DZH$#!UXIJQ:B&S3-BA4K:%]TA3YIYH7(K4Z=.J'*.'GCQHU5JU;1
ME$A!4942.!*9JN,D_+!APY K\ETH6I<#;OQ6 7K +YD1#48 N)J7EQ=*#*6!
MPB%IB)I-O0!Y\N0)0J5ERY9HSLJ5*R-+H'=.JU_^J;8?E"7*R#\6&R]>O.S9
MLU>O7ITS%!G1<NC0(?2/=$:QU3#'(K30W+Y]^\*;*916>C:UO%/.G#D18R2G
MSZ-X-VS8\+UCMQ5\%&H*KAQ1QR3R=>O6D3?G"PJB#/W\_/;OWQ_)DIX4'Y$6
MR?N?I4N74E)92DH@F1$12'LA\!"-9I^C.^S3IT^[=>M6L6+%TZ=/4_.!@8&$
M[].G3[Y\^;A+PM!VERY=HD>/&S?.Q\>'J^7*E9-U<:@ZY,>($2.0B+5KU^8J
M7NOPX<,Z,V;-[#J*4;%DX/KUZU]]]145.VO6+)IXV;)E_&(,_';NW)ELX)TF
M3Y[<6@%%/6C0H $#!@P=.A39\^FGG\H$ 8J %B7;F$J5*E5RY<J5,&%"E"K&
M@#3E(''BQ$F2)!'?A4S%WO3K8@O1"K%&!A?YBN3==]^M4*&"S#.G![5MVS9_
M_OS3IT]WOLT!S*]QX\;ITJ73[24>"5= QY&OS=WV/IN"\]D8!#J3$=^\-!19
M??3HT=FS9R]>O$AQSIPYX[KL, 'H#LC4UYOY&$.TRU3#P9P8=7#T#%<X%P8>
MMX\&+5BP$ ED((<F,O!WZ-#!/&WR?\1A"1BZWL1O4\U 'V[>O/G(D2,B^8"O
MK^_HT:/AOE>O7G6[<Z,9A"<,?$M(U=BQ8V&9\I#XE1[_12Y3#452&4<AG?!+
ML@?71,;8U"NFG3MW<CYITJ0)$B3X6 %=*NLTIE$@8RA;38@9DN$3M!HLDZCD
MNUP+L0<((?GL4-[,"T2 B85 ^Y!#Z#J$I7POBN%Q+/9@1$&F:@-#IJ9.G5J.
MY84M7.W\^?/P,\C9Y<N7B1_MBDZ3N: R=[1%BQ9('?P>W40;+:3MX,&#5:M6
MS9(E2^'"A5$I6+6\V9, -L>G^\2&U$F9,F5JA63)DA4L6!"33ILV+5Q62TVG
M)T24&A(\8<($J.%SM4J3G*?X.7+DF#]_/O6F%S)!19-_>0%"HKBI]>O7XZ_,
M[W/,H"!KUJPA_\X73*#K47;Y:-;YF@*N \'F^OFKGO(*HZ7@U*K-]$Y;YP=/
M@B0CD^;E6/1[3DZ2@;QY\]*.JU>O;M.F3:%"A3)ERH2B*%&B!-T9&HV"Q1M@
M.8A_VII60/L1DFY.+=V[=X\60:_21JC' @4*+%Z\6._H(SD1WZ53%Y.@(1X\
M>"!-'Q 0@ 2E(;IV[;IERQ;H.Q6"A?3JU8N\5:]>O4&#!ADR9/B7PGOOO1<W
M;EQT:<^>/5&VY)P4D::9,V<F3-:L69&O9!4#P PX@U[%:U$BV0CZ';6<C[^_
M/]I;9\E"=*-DR9)(S7?4^E6=.G7"%1BJ]V$V+5NVE"D)?YAV#]8'&%C=NG6Y
M5[>7]!1ZW]&C1\59V=2V4B)&;&J4=!THPQ1D.':Z%$W AD-"0LS?C5/&V[=O
MRTQXE*K;Q8T?/GQ(CXYHV;.W#]$N4_43OAT[=N!-2I4JI=?$"Q?.@@4+4<.O
MO_[JY^=7OGQYF)/A8!NN/O=MA7F <<O\8C_(-D,1(XU,%S04%X1KPN^A7^?.
MG9/WY#*@&A%X2Y0 A$]DZO+ERPW'MV&O9 E_*5,AW R9A($'=^S8L73ITDY?
MP:%C]? O9X0]<!+)ZNWMK<G$^/'CDR1)@O]'YR!?_U**6X@!2*O)+TV&X8T8
M,4(6.)4 9G.BK=%">![Y3@Q],G7JU)4K5VJ!9/LKF2JPJ[>IR ,$'I;#[X\_
M_B@K_2!L<&YKUZXEB<Z=.V,_Q+9GSQZBQ>_!ZI WDR=/[M"A [_0T)LW;TJ<
M6#+R%06%YD1\+EVZ%)I+A@U5!.E!4A:8;G!P,)JJ3ITZ*);TZ=,C6E!Q]$>2
MT"\M)</8?].F35$X*#&G;D(MP9Z19W)2A)98N^ZYBQ8MFC1ITOW[]T,CD*GT
M=[UFE2LDGHD3)R+VW$ZOD#CG*>A7N*ZXH?8RE762= X-1X50I1LW;J17ZKG*
M&E)OE!'-B11$?]:J56O4J%%4_LR9,ST]/3F9,V?.FC5KEBE3!JFP8,&"39LV
M$:'=L?R;3H6F)# ^I%FS9O7JU=N]>[=V:S8E(:A\,L"]M YTD1*14(L6+=JW
M;X]_.WCP($VL_9O4#/9030$?A9&0240F"AG9B2*E91&K,JTC08($\LH4@9TC
M1XX*%2HT5,!4\N?/GS)E2JR1@RQ9LKRC]E E!JSK?V&WC]@ NYJV0\^EI5*G
M3DV#B@D92FIB !X>'IC65U]]=?CPX5MJ%5SS[:C33S_]-&/&C-B/'FX /9I;
MSBA<N' !O8J@1>,]>O0(8R,2.KN,7]I6-=SVUG\</__\,S)5[P(-#9 5E2@(
MWO6F0O@[7H)24#21\?\+B':9*D\T?_GE%T@87J!MV[88AUA S-B!!0MO&:!9
MLGV"K'LA?OF5Q,F;#EW82.:YQ6;09 Q.1X\>U?.1&*Y&CAPIGU&=/W_^Y,F3
M=K6+FN9DSE$8QJQ9L_+FS2LR=8F:CBC/C-T&C@AN9:H,V/+[X,&#_?OWERU;
M=N[<N6@#9.H7ZH,T(_SS @W)MAQ#]= \^D_D!ZP1K@#I9#B0+2XLO%Y(*TN[
MTU+P.82BEY<7S$ETD1-[H\6'#Q^.K6(YV!O*$*5JWE<I*C*58Q0(M!)C@)#=
MOGT;5GKJU"F2)F9B"PH*NGSY\I=??HEZ)'XDY=:M6V&<\H:-O@-;'3MV[( !
M _S]_>5UKDTM=#1GSIQ>O7H5+5I4%I*E*\$WG"0B3H.04-M]^_;UZ=.G1HT:
M>?+DJ5V[-FP8/7;QXD7S]%HX<;ERY6#)9%*J(DQM*LLQ(@<S)E?B@<T597/H
M53*)EJ-WFY_CF$$.91E>MU<EGBE3INS=N]>M3)5$:04DJ-L7+X(??_R1FAD_
M?KRA;K$KL2>_AGHY0X7[^/B8.;&\5I)2P)OI_F2#+MRM6S><0/'BQ?$;!0H4
M0.JW:M6*J^O7KT=)0K+Q&%!_9(!3B0B#YD2C4B$(19R !)#Z)#RV1]-C +U[
M]QXX<.#JU:LI%RJ%<M$*N$KQ]MIB >7*ER\?#4& TZ=/#QX\.&G2I"E2I"!O
MV#!9Q0SP.2@?)%#BQ(GC*Z!CDR1)DBY=.G0L1HAQ\@L[I5"Y<^?&G<:)$R=1
MHD18B-LZM_#/PJ8^.:8I:2-:Y_WWWV>XD5G]@$Y*Q\3G;-RXD6&1/Z]>O:IG
MC(L),9)6JE0I5ZY<M)><D5\Z%X:!*"5R;N$8U\'MM*PL4,2?6"QI_:EV5941
M39XW.?F]: *.B%SI>6$<D#WT)ST1A\,Q5\/=H, EJD+O!>!\^:U##,G4I4N7
MRFRQ0X<..8>P8,%"U*!5@7P6R)@JG,.(0,E8B%60YF-$9""$>R'_:#L96:':
M</3 P$"&'_CZA0L7GCQY N.'00JA=(H*+OC11Q_)Q@DB4UT58U00B4R5H9IA
M<O/FS9"VF3-GUJQ9$P& #P]3V]YH%NN*,/5=7ZI4J2"+^B0L&18"W60X@(P>
M.'# M5P67B^0BT.'#O7V]D86TE+Z$8,&$@XN-6W:- 0D5DH+HB@:-6HDTUQ%
M :)G5JY<*2S35::*+-F^??N0(4.P]N/'CV/GV#_DC)-X-I0)&E44@DS]13JB
MLE O" \.N$0>H)Z$7+AP(>*G;=NV(K&(^????R<J9&>6+%F0(F7*E$'\()Q"
MU99..@]BO3!4XI$U@2AXP8(%D2Y-FC1!_=ZY<X=4,&!4&9+)+-L,]4(#"00_
MEC<AVI*=3+IITZ94CAR[[2QHLQ4K5KA]9R(@0K0NBCTBR43%$@DR55:0TI"<
MZ$0'#1J$JA1G(B?- \?UZ]>K5Z^.SI2N+3=2?#HI>I+*S)8M&_7 B$,DM#BM
M@+*%[M/<\I9;3QAVJ@$=&]F;,&%"\^;-J6I\SL2)$]$):]>N'3=N'%Z%:,DA
M38SLQQ-.G3H5&\!)D@%,<<2($6B53)DR84AY\N3A*KJ=I#&,$B5*()[1.=@2
M42%3<3*X&L[0N$@467))WEK/GCT;%HI41KL25?;LV1,D2,"QO&CE5UZZBE.5
MQQ_FLEB(#MC5PO6TD6A4:A[-*28JWJ--FS9SY\[%PM&H1XX<N:(0JJ:%V]3T
MW3U[]G!+UZY=#<?S"T#3$YAH)8E0]:Q*PF.3SQ3HO(R .#W]N<'ITZ<1M.;9
M[]$'N]H^&D\BR=G5E_8W;MP@,^3\V+%C#+5H42>_05VAKN5#<;E+SMMB2EK'
M/*)=IAIJ&2Z&BE*E2NW:M4N_K+?ZOP4+?QMXL6+%BN7(D0/6*!KC;?50;Q-D
MO'FA]J"'8(G>$R7 2 D5@WNA42'N#%2PNE6K5D$'X78^/CZ,T\N6+8/505@A
MB A:^0I+&%5 0 "CLJNH^$NXE:D"L2B8**(%F3I__OS*E2L7*E1(YAKIL5/3
M DT"= P(:>[5?UHR-?8# H3('#!@ -*(AA9*!^.'LF.9,,6K5Z_"'6%R'AX>
MZ$P(%G1J_?KU&.1O:N]0VG?Z].D8I*%LPU6FR@'FU+AQ8T@8J;Q02R5A]D0E
M^XBXM60BAT(,'SX<L21Z1E;^1.,A;ENW;MVY<V?)'K=S"?7;HT>/XL6+ITJ5
M"O&).H*SBLFY^DPR0#$A?P1#^6#P>%>L/77JU!3MWVKC!QU>EN=-D2(%J;Q0
MRRR9XY$_A8-2C6@GPS3QV G(IR5+EOQ;+9WM"JDK E#S3A,=!2(";]VZA9:3
M)6<B N4:,V;,M]]^^Z?Z&-YP\%HYID')ZH8-&Q#>V[=O[]NW+Z5#Q67,F)':
MHVZ1CI!XW%1$<M3<]YV(M:P!0^5C%?# CAT[BM>J4*$"TA21N7'C1GP=V6O5
MJA4I4O.T%]J8YD-8RCM5*@K9B23&P#9OWCQX\&#T/[<W;=J4HI$K;&/4J%%8
M6N;,F5>O7FW.@(;.(6V-RD6<4V3L$]_;I$F3-&G29,V:%>LJ6+ @E!6/ZK;)
M+/SC>/#@ 6WZX8<?)DF2I$"! CU[]I3SV"K]O6K5JMB_O#^4O8ZQ)?WX@P,L
MQ,O+B_'1<)@E)Y%_!P\>E.6"C8BGF]G54YL7"G@P>ID\@=7^*EI!SZ7K:3.C
M7+B@PX</XPFQ><9ZS-X<GEP1GD+!'^13"W-?>UO--7IEJEW-.(?H)$V:M&;-
MFN8/,,+"?S%OP8*%OX3F.OCK*E6J,*;BW\5?6XC]$(\GKRF"@X-E;5YI/L9@
M.!;"E2&*WQ#UO0H.DV#P>(8N2/E)A1,*A&G7KEWSYLWEXRM/3T_"."47%40B
M4P5$"Q<L6K0H9 X?7JY<.7D^'17@]B=-FJ3_M&1J[ ?V(&^<D*!00Q0:[=Y'
M <W0K%DS"#W:#!O^_///?7U]<430IKU[]R(;.(#J$</,F3-15H:+3!7R)Q*4
M>S$J9(^LED0PNL.5*U>@B?*2Y$^U7 I:@HX@?214;3&"\2.D$3S\RN=JD,O;
MMV^C<Z9-FX9=S9HUBS]%^L)3"8D>1H'4JE4+^HL,TRMGNEH[18,X<A>EZ]*E
M"SH*M;9X\6+R)@\$M:B;-V\>BLMPD61*][V$H3@HF>%V(V*6C":<,&$"972*
M1R Y7+MV+:5#H3E?5F^;#;6(U/+ER_4FGSH#YC_W[]^/G*,[Z_%"PE#A%RY<
MV+ES)WJO08,&-'W[]NVK5Z_.GY]]]MG4J5-IS3U[]E #M(5\ZVNNMU %U\Q+
M_0.*1AN1=._>O2M7KHP.8=C*DR=/L6+%!@X<2.2+%BVB@+**+Y(^2Y8L*,;)
MDR>O6;-F_?KU_*(YD;(T!_JV6[=N;=NVW;1I$\H695*W;EW4+']2*#@]D@91
M3?R(]C#UTMYP/$?3%2)9M:FO82G[=]]]AU@]HS;IQ?*Q5>R*C&'_V(FY&BU$
M'^[<N4-?%IF*D="RTDR8=X<.'?+GST^#8KH,A8R/=&&&16[1SH06/'[\.+^Z
MO;A1.K*6J:XFZA;:5%R=PS\.N]J/^L<??]1GR#.=\1N%\^?/TV?Y->>$XUMJ
M?CNN4B:P1.18WB9$ETP5SRAF)%LJ3Y\^'1\G+D,"Q( =6+#P]H&^<_?NW7KU
MZF7(D.'2I4N1K !I(78";L1(<_'B1<,Q?*('QHP9P^C+R+1[]VZG18R%"[Y0
M'^;1W#!FF<S&P+QY\V8H)B22/_5[DJCC+V4J[*UDR9)=NW9=L6)%M6K5X/JR
M4HMF@>+JS9!(( K(U*%#A^JH+)D:^X%I(7B@^S0<RK- @0(5*U:$M<LN()TZ
M=4)%0!-_^.$'[ T)@33"5B%;2!I_?W\L$%F"]A!M9@LO4[5U8<D3)TY$8W O
M-HP3@X!B:3 V;1)!04'H-^2QIZ=GBQ8MX \P-J%TW,X!V2#%8<.&C1T[%CWS
MD\*^??OH$6@M6.^Q8\<0ND0(5<78* 66G#MW;HE-OJT-4R\_M?U+9Y37*120
MC.W8L0.)17@D.D(=+81.)A6$G+PFU08OQF^.!PU//:#APQP/Y5VY,MT*160X
MU)3354/U_0T*KOM2&(YM%$B7!J(J=$ZD1)*<7;TO0KKC*"C+M]]^&Q(2@C!#
M%O;JU:MAPX9X@$*%"M&U6[=NO63)$K*$L+RE/@?]^>>?<3C$IN<EFE/7?TK9
MI9B8$"U%:U(_K5JUPI!&CQ[=LV=/XD=ASIT[%U$J6\6";=NV;520 UQ?OGSY
MT,F84_?NW;% ,DR#HE3)%;Z1YL#J?'Q\N.3M[>WAX5&\>''9W93VPA*0J67*
ME('$1U2? J>"A*H'$'8UZQ*:2L'-[[@L1#<PF+Y]^[[__ON)$R?&2/ J\C#E
M\>/'V;-GQSBQ7MJ7#G7NW#E,]^3)D^A5+/.YVL-9]P+=9!CAM6O7,&.9&6MS
M[-TMD) ZL/XS3$&?CV[0I\B>]&M)G6,$*B7%,9)_?*,\G)(LR2\D@7+)K!/#
M4;28S';,(QIEJA@$O1V'WJY=.]R6?NKV%E>H!0O1#3H1CDPV"CNCMM6R.M2;
M FFIFS=O,M+(:TEQB5 WD:G0-5B7S'N4 =4IAC"E#[FT7@$"=_SX<:T8G0+_
M)?Y2ID(H,V?.7*-&#6A$J5*ERI4KAUR![V[=NI5\;M^^?6MX0#TYC[?G($F2
M)#!4'94E4V,_T'4T'ZTS0B%;MFSUZ]</# S$5N_=NX<6^O333[D*1T1_0BXG
M39IT\>)%E ^-BY[D=@C6C!DSD&?" 5PG_1IJS1YN1+I@Y[@RN@,1DJ[F9)Q$
MQZ+?$!Y3IDR!N?KZ^J*?L;?3IT^3A%TI,>0B\9"N+.-TX<(%]#.B=/+DR4A<
M<GODR!$B?ZZ PD38H&HP2^P9'8L9$UYZDZ0;JJ#%I$U]X4;_HJ.AN+ITZ8*4
M(I]$7JQ8,50KI)GDZ$3D7$2:F+3$@*Q:MVX=&;8KZ&C-H..;O]]V!3>B44G7
MZ=&50'HNZ9(K2BVR7,Z8PW O%)]2(.#GS)E#3=)>+5NVK%*E2L6*%>O5JT<K
MHRH# @)H2EF?1OL$#2'Q^D]S82D^%77KUBUT)DX )X;<Q7X:-6K4H$$#JAW9
M2?9(EX)@&XL6+:(.^27;(E.YB^SQ6[Y\^4Z=.@T8,&#X\.%DDA8_>O0HNAJ3
M,!R3=6E9U&_7KEU[]^Y=MFQ96M90RH04/_[XX\J5*]^]>U?\I&1/9UAG7I^1
M4C@UG,#R3C$&^BE\YMUWWTV1(D6?/GT8.Z2Q:.N<.7-B0LA4S!)7@\\Y=>J4
M+.$KR[R]4+/NG>:4B4QE/)6U]+4Q&"91:FY?MR>C%21$)C%L9+8D:E??Z-Y4
MP-I1L'IU !W 4)\)X)%NJ>6."<\OE?#<L7W46XEHD:EACGVQ,2PX3<*$"2]=
MNL0@YQS.@@4+KP+Q4W@E'!S4#9FJG[*[L@H+L1;R :I\D";$".(%)V,,7KER
MY:I5J]PR6H'8 ,.8?-\%8'6RTI+A[G5-Y' K4V5HE*$= 9 J52JX(_HD;=JT
M6;-F[1\I!@T:) <0330JA,-P3&SFS^3)DY/BBA4K?'Q\T!CF)54MQ ;04D%!
M00A19"%"#H(X>/#@'W_\40@]_ E"F3%C1@0D#!*1B;FB/;#;-6O6U*E3!X.A
M?9&ILD.2H73%_/GS,V?.'*I>6,D; )) 7G*+X7@;@!+>JB9J&FJG1+J#GY\?
MP81^$>";;[XA::P1^8KN1?.</'D2DH<)7;UZ%97+&>)$ J&1R">J#-N;I$#,
M\%I91>G$B1.H)KI,R9(E<^7*A=2D@ 2 [<GN(_;PKR+-[):TT)Q[]^Y%T4&F
MFS1I@M)KW;HU&FS,F#$R?_70H4-H)-%4V#D*2F\ZI7FD3L)0GXP.&S9,CMV"
M;,C;5&KR3\?:RYI,RQG"()B7+EU*NAS_J?8*HEJ@\LC@A0L73I\^O6?/GK)Q
M:)DR95!W??OVI3*I+FZD*<T[K]C=S733*4H+TBXH!]GTE8*C;_%:D#VQG%4*
MM!27D*.$.7#@ $V,=AT[=JQLS#MPX$#.(#SD73HFQ,&%"Q=H=S)V_?IUPU%C
M.FD-'!1%Z]RY,QZ)YN/&Y^KCLN[=N^,/,5J9H?VJSM#":P$M13>A/R9(D."#
M#S[ >]!EQ+"1:K5KUZ9_82%X #P#_9?1DV[(K]MI\&(M&,"WWWZ+%9G?BDO'
M,7<?#=?SKF'^<?SRRR^45,^2L*M%\G%3LM@O?4'<B.Z,<L"E_?OW4S1<EBQ@
M1@P<RY?;''- S/3H/QWK'IOA5$;YTVYZ0J>K0ASO?^]\?8@6F2HEIY 8F8>'
M1Z)$B="H0GTL6+#PMR$]BR$9!P33PJU#!\W?-EB(S; [YL7)(GYZ(PTNP>=@
M=;*""\S2^4X%\P##\*9E*N3L)\=^<:_*S-S*5/GE).JW18L618H4@>G"-6$,
MD$OS[9$#8BT'DO-1HT9]]-%'L WHNY>7E[P#L1#; /]#AHT?/QZ96J%"!20-
M;,GF>-V$210K5NS33S^]J1:G12NB VE0'!$2B*L__/##M&G3$&R&,B14#<:3
M*5,FB1P:0&P(*L2,;*!B4[M?HI=V[-B!P>#<T#QH*MB8+!HDS$%Z"@PL.#@8
MB06I)6/T(PF#K=(C9"&ECAT[;MZ\F:@X>>;,&7]_?W*+B"6 /'EY].@1D:,S
M"Q4JE#!A0FRR0X<.Z"4=E615RU1A;$+@R PE@@O>N7,'&8S<:MBP8;9LV2A@
M^O3I"Q0HT*5+%[(A']G.G3N7FM'^62I0LR,Y(!+7MZE"$_6?"._UZ]>;&92^
M*IGD3ZJ%.J?R;6J;EI"0$"IAP( !Y<N7SYT[=[Y\^5*F3$EA^1-==_3H4;HA
M561^5R-9TDE+A>M\&JH[2W@T 'Z#_DN*1)@A0X;&C1N/4I_6"U'F@/;%L2#C
M#QX\2'@: E59KUZ]G3MWFA_/24)R(,=[]NSA=OFR0)(V5X4&F:$%X\:-BZ:]
M=>L69_;MVT<229,F;=.FC82QFQX'6(BU"%7K?A<O7CQ>O'COO__^[-FSZ>9R
MZ?SY\TV;-ATY<B0=]O+ER[),P[5KU^A?'(B4=0OLD&!T>49&_<;5.5"D,)ME
M- %'A!LQ/R$RE-'2-_%L=!F]'[5 LB1SGD5^RY0K^CM.E:A"%.A?W"A*59="
M^G68@AR[=G"!!#"?>>WXYV6J5(2A1I<Q8\84+ES8S\\/SRY5XQS:@@4+48;V
M-1Q#;N"%/CX^J!WG<!9B,1@8#APX !LS?VSV^>>?0_09>J&M,#E3\/_"3+D@
M?Z)1WWWWW2%#AKB=[!<5N)6I D["$F"W:=*D*5&B1(X<.;)GS]ZK5R\=P"W$
M1)T>2C)>0H[);8($"2#-[=NWQV[W[MW[JKFU$-V@16CT*5.F>'IZP@X_^>23
M1HT:Z05RY;D#) DSZ-^_/\*2\].G3^_:M2O*$]T(W3QQX@1GD&>A:C(MEH!,
M39<NG:$H >P*/H!\0N1HJ[M^_?H77WS!&;M:4T04LJ',YNG3ITA? J"*90J<
MO,T#)-2V;5L4)AT'6X*KP<P(<._>/8SML\\^@^_*%%9^CQPY A7!\/;OWT\
MA!->%"5)HA,G3D1GIDZ=.D^>/#"6P,! V<T5P:S)C(9-O6$PDQD.2)=4B&K.
MG#GMVK6#<)<N79H(X\>/CWZC6B@1TAW=2#:H/>J38I+*[=NW*?CHT:._5;BI
M-DN467\4F6 7+ER D1-FQHP9T'38)V045<8E=#57\22(.AH"M=:L63,$.0)>
MOBBF./Q)1YL_?_[QX\>E]FC!,/6DS&VAS"?M:J\LFH!;N)?LK5V[=LV:->26
MZLJ;-R_-BB!'.<AW@V08.3ULV#"R@8#T]_='#'_]]=?KUJUKTJ1)SYX]R;/P
MP%#UF;W91<CR"G+&K"@DGZY>0N8339X\F3:%T$/WJ<]*E2HE2Y8L9\Z<-+U3
M> NQ&;3FO'GS\N7+]^&''Z)499*%7?&<Q8L7UZ]?GQZ*D=-WCBI<NG2)+N#V
M5:H&W>3<N7/!P<&R12K2CL["282K;//&[71_K$C>.H:J%XGR*S$X=8?H #FA
M(.:.P'!,1R/G%)-LRR))&G8U*_C4J5-<Q=V)=](9-FM.#@B)7R()NB<%IPM3
M:L[().$_U3QAZ89F5R9]4T<8 Y40%?SS,E5 W3$8X#)@-F?5!@9V=S-)+%BP
M\$K07BD@((#AOTJ5*CBU\$$LQ%[@!ADVQHT;!Q&7QZ@VM;DY_!@"C:M$?T)D
MW;I*\W@&11.9^J]__<O;V]MM^*@@$IEJJ(4'.W;L6+-F388W6>0SZC!S389;
M- \DLDB1(DV;-NW;MZ^7EQ="/?P=%EX_:#4:?<.&#:A0Z'[5JE7KU*F#"I)+
MAGIX\>3)$]11YLR9JU6K!JFB<5&)*$#8)"(-/88QZU5G,5I45L:,&;%MN.;0
MH4.AGGK[]!=*=N[;MV_]^O6RYPW:DJX!EX)4'3Y\>-FR95A+F3)ERI<OCR+=
MN7,G:O#TZ=,04'ES2# X+N8T=NQ8I#+<#DY&)@DS=^Y<^6P5\4SJV/#5JU=;
MM&@Q:-"@6;-FB;X2RX>QK5Z]>OCPX:B[HD6+DASR$O5+<L3F]KLO,T$,52L,
MZ4XD[! )AXNFIT^8,*%;MVYUZ]:E)ILW;X[L)WYT+,?TA;)ERU*3.7+DX#>+
M G7%<8H4*1RS)=Y![G*>NNW>O3OYKUZ]>J%"A;@18890[]RY<]>N75NU:@6A
M'S)D"%*9HM$NU*'.DA&>@-G4RV$Y%C4NEP@O,PF1E+MV[4)V;MJT"=E C;5I
MTV;@P('4\ZA1H\@#Q[0.];-ERY;//_]\Q(@1)(V6QE20Q)C'QHT;*3CJE/J7
M;6Q$>$CJDIQ3K88Y=()DVUS#KB"?M#A5@1+&-7WUU5<,A:E2I:*>Y4V^H8KC
MVG 68AM0C/3Q3S[YY..//T8RX$ST)5P*PQ-V=>+$"9H8OX&+N'__/JWO5D')
M27[Q WH%-4-9V@LUCX-[Z?4W;MR0&>;8.<;)GS@]>=JB8W8;_S^+VPJ&2HNL
MHCR1T[(?"E8M?LP(WTW((?V+JV8RX 2[@M-)J0%2D0=_@A\59)+P$P69+!W;
MECOYYV6J>!:L 5<E.V[I22^1U*P%"Q:B LVK @,#82V0%;V"CH58#A%L:(!2
MI4I!+J75&#88D%"#\&_9.A(*[G:0,/M/2*%9IAI_=UB-7*;>NW>O3Y\^!0L6
M9#2%3&@N&PED+#3"RU3*".E'U9!5-,F2)4M0K68Z8B&6@.$;N4C3T.YH##Q,
MPX8-Y4-3T3:ARE1@-I]^^JGLA<X9>)ZOKR^"I'+ERN@9[D6:Z@B1#6G3IIT^
M?3IJC7:'&NI%>F!%1(7:0=1]]]UW'*!O93_AH* @621VU:I5:$[TCRPS1L<A
M'I) ?(JER?M2B1\1)9]#DULH'2**6S \3 [I" >%[Y(?%/C@P8-)Z_OOOR>2
MWW__G0.Z(7'Z^/CDSY\?NHPPINRDSGDHG39^<S=T^C-,;;[*+P8O,_'H7]1G
M2$@(M/CBQ8ND3HV1&7]_?Q+JU:N7K&"$R.RFX.'AP6_+EBTK5*CPP0<?T,'?
M?__]U*E3DR79&):"4RTH0S)/06!9\HH)OR'4EN3D7;'NR](312CJ?.H\FT$8
M,BE?#J.E&S1H@.BE#D4DT$ <D%4\1J=.G1"KY HC0<12YP2@F#033=^^?7NJ
M#GM8L6+%Y<N7Y:6-89H/(GG3V;!'L+Y41"#\S9LWT<88(47F#!9+KM*E2X?X
M7[ERI79!EDR-_6!,;-NV+4:.E\"ET/VUH=(=.+-@P0(,3[Z4P>"Q*"S-:<TD
M@=R(+9T\>?+(D2/2$0R'[Q)(GWVN\.C1([JV?&5]Y<H5)")#GK;2: 5911OK
M%9ZP6'R%K,=FJ"\ON*J+HRN$J]0#G314/= 1\6E3D**Y9EY*+6%>ZE>UW-1S
M]>&80-8_PP%2=GH3GLH\SRLVX)^7J89CKGF=.G4R9<JDETDP_BZ1LF#!@H8>
M>L^>/3MKUJQRY<K1UZS!^(T CI$A ;:=,6/&9LV:&6H(87CP\O)*F# A8B P
M,!"V)\N'R-50QV2\,+4NG43"+^P0@?K>>^]!9,>/'R_#S]]PL!')5'G'@@"
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M1_J3WH ! Q\''7H(V0$! 25+EER^?+DQ3^%K 8/KE"E3RI4K)^NF,"1 $V'
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M G>0)=.Y!"%*(Q"EN:-$"1N_UN5\_>8?55\0T2]3J3-!I&S9LOW[][>?N&;
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M3%F4V&PE2O^RVD31K#I"=S260/KNW;M/G#AQ]NS9-!HBF8:59J<PDNQ]9*I
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MPRUS5CG 5F6)E#_^^&/5JE7/U3XN:%2"WH8-&Y!_LK+NG3MWS"HJ1JA'?XA
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MDB2I4J5:N'!AM#_;-Q ML([M8O^#!P].D"!!GCQY1HX<B2-'J+="GCY]6J!
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M!'O XIRD 20!A,/#PT.'=>?2%H(/DGY(/'"U,PJ0O+U[]_[RRR^P-((>VPF
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MUGT6GGM"+]H-F]W7W_ S7COJ]W=LX-_;=]Z7[FZ=7CMO9M?J0]K-Q8#/)P
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M*-F&[5ET\F]??X?:4Z^T"3W@C!DS9L2<2I<NC3T8RLS(AENV;,%S&5GG'0*
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M3,\PUM]]]QT1@Q-A.!A]QH7M1#\Z4(\FS::3*</N-V_>E-5B,!CD2K1HT>1
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MFS:5J]!:.*1LI,'MW#5W[ER8*H^&0^IPG ,LB!LS9LPX<.! 3$F>176@])*
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MD\P'!JMY>GK*/HV:*@SW<O)9\CJBFAIVP&16K5H5$1$A:(^KF+D^5@/IQ49
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M-W^1@H4+E/PH7[&\Q3[I/VJL]@>-_!I%M!$ZBBUDS)@Q7[Y\LV?/EFF]G">
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M7T*P#EF+B'K!OG "<$M.&A7FQ@#)C4O0R%]__14R)BL)01&#@X-]?7WAPQ1
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M!%8"'"%=\%7 Z^>??]Z_?W_KVY18^K$_"ETP7F Q8(X\JU6K]O///P.[993
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MS9H[=^[*E2LW;]Z<&\^?/T],Y:&AH:$ S8T;-W)OK5JU*E6J!+63F<;<"V>
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M@!BAL >XI_IT8O_^_:5AM<<3!T@%H:FR%#"78)@08'H'_X8^2%8VM9Z\;DP
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MQ01:M6J%;I,_Z>4+6'E6X\:-A9(-&3*$@E$,V._UZ]>YRHWUZM6C^O(XN_I
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M+!LH^1/,ID^?7KIT:7FBQ+"7A&HR 0> _#PO1!.R!1<"IJ]<N5*D2!$Y"<B
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MUJTK5JRX9LT:HFF! @7"U&X<8(NA0X>F39OV[;??AH$8:FW2ZTHHH<RHI.*
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M)A+/F3.G>?/F6*),*" ]EZZJ54]X(E;3KU^_I$F3OJ4VW<&@\N3)4ZU:-4P
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M 8P (,*!@>:-&C4";7 C((.3^A&'#AV:-FV:\ V;$IAPT:)%MV[=*C4%>M*
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M?V?YJ]!44!TX$C<D8QW_:L#PBE>\\G(13 .D  X"1V C>@#M?UM , 1(^)B
M0FN5]?M^0[7/IDV;<N?.#7JK5Z\>H%.CS!AQ<XQ"2A!\ZM2IY5L[IT*B6G@$
M2#I?OGP$[^O7K^N0;"T2"/[6K5OP1D+^Q(D3P87ZTLN%N X8A5B^W'F^__[[
MP'=2 CT-=1<TM4:-&L!<EYI2*'H"I2]7KARP'@X# "6.PBTUD8"TRT+!AGL;
M7NZ*WKR&:A!N;-NVK:&F>O;NW5N^AT0/);TUL5?^!+'J/$1KP8(%O7KU@KW
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MI UY*,9%AG)))_"\[=5$(?G?<4JZ>!Z86$3XITV)QR41N=WZ%,S3H5Z3P?H
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MU6H%E/:6+5M.GCQI7D'N!;%DR1*RY5S7 T_BSIT['WSP0??NW>4)-U4$JZ#
ML$\JAZO+6U:I-'ZW;=LF)\J(/G.'*D."98QQ<' P9 69.F[<.,/TC1SI3YTZ
M)8.KN?2<.7/0J#U[]N3W@5I^X 4UP#] 9'C$(VZ(+:LEPF*W&5;CH=5P%#K<
ME1R@# SV<?<6*T6W8&4&YX2KG8;#K-BPDH8M*SDXNB[^LQH15A)9[<:?KYZX
M"#D],BQACO,DN<NE#$=%4BS+X\>1CAJ,L#M21MJLZ@R;^K$:MD@'G>,H-6H/
M)ULQ<->\_C'$F] /2-/F+5H6*E*D5NTZ?OZK3X6<%G_17B/.):VF.VBK:8D4
M@<WTP:0+M'O*\Q3K7WDNXP),KGGSYO(MJ#:Y5P%=/)<@:=Y/"$(XQ8\?GZ"D
MDPF](1E,W3P&Q.I<B-AP5J.+<T%>T9!GSIS9NW<OFFWTZ-%3ITX=-&A0NW;M
MRI0I4Z-&C0D3)K!GP8(%+5NVI-66+5M&\\GJ.WCQ@0,'<,;0T%!4*$$)9Q=M
MX+!-$ZV*4,N$V-5H"%T\D0%VYQ,!F44)\P@)"4$-<G6T*/>(!L;9O;R\B&-]
M^O3Q]O:>.7,F?S9HT "YCGZ6TZ6)9<-0\0?-3(%U&00<)?\"!0KT[=N74$8<
MDX()7!(#>2%,_$2FIDV;5K]-?6IB-UXZM'G03)@<C9XF39K"A0MC&/*\ '/"
M3DJ4*-&I4Z?[]^]CBF+P3VT@O5,)/1O="AT*-B +&E^Z=(G?TZ=/LP<%>_CP
M8:R+/]E/ HQ3N]M3,W\->):5:E!"BKU__W["E!;MY]1*-C)LWAP<W(B*-RQ3
MM:T;ZLLN0EZ*%"F@;G;G0#(WW'#CY0*GH]N@%TF>/+D><O,L6AD38%6O1 QG
M/V17M ^2BMA#;)NGK1?H/D-($DILQ(@1$*Q7/8B1+G/CQHVH/D]/3RA=7H4\
M>?+DRI4K4Z9,GWWV6=FR9>O6K5NO7KW:"I!L^%:O7KW@>? SU"-,%/:Y?OUZ
M,YM\$2Q=NA29>O;L6>,9O;70/BHM:=*D7$Y4HLTD4_5(/[$$]F_>O-E0W_4)
M:SQ__KR\ )&V("M)B0DM7KR8;IADL-4K5ZY )JAJ2+:^NE4-[H+%MF_?'C:/
M4J6N7KU&!6KECS_%G^'X07JB:MB,8N_*MM0&&C72\C@RPB$R]3&K^G56[6/)
MP"DJ55]E:C(TJT.K_KGM4*HN0)<BAI6XC706SVIWZ&G'/\>U[ [!C'96A7;D
M1X)(B\WZ\BM-5 ITLW___F@,?A<M6B3?&VL**!".)78B9F!.8'&N1B/&)D<M
M"F+/]K_[=O&IP-)PZGGSYKD4\I]#;L%UKZG\48DIM2%3*,F 52F2PY">C*MV
MTSR?X0HH-UF9]NQ9QV*,.W;L6*> V@P,#*11<*XJ5:ITZ- !QE^_?GTD&=H,
MX<J-^_KZXLM<EQ.A["Y!TG!ZO>GZ?\92T:+F_5%A4RMRH1Y1!?@RA:E6K5KC
MQHV#@H(" @(0DS(L8NC0H9T[=QX[=BS[_?W]>_3H@8]3;%GR2AX?2-P R.99
MLV9-F3)%7T6*1R6@QG_XX0?,C\S-7S-&K6I##3^>-&D24;U\^?+$U8(%"[IE
MZNN$W>D(_!+S,8R,&3-6KEQYV[9M(E/I7VA*^CLZ: P;$T)5ZB]-7&!N-;;I
M/NA&\0B,!PN4E690JN1SZM0I[(H$9(C,NWCQHKQKE<_+7_JS*K$]N5D=QV2/
MCG*Z\.;$VKFL"I0-\W8A*JAQ;L<\',F-9^$-RU2!-*I-34":)$D2HMYS8Z@;
M;KCQ]T DA8/Z^/@@4T5[N*:(89!7=@1TZ0"@67 FR#3:3*;P,9R/N@Q3,#'4
M)Y0P.8@4FGS__OW13R_TSP'=A*BA^M*F3;MJU2J9(('N%M9UX, !.BHH;*#"
M@@4+ID^?/F/&C&EJO)R\8FVD4*-&#>C77RWJY,F388>BPW7'Z0+V0P%3I4HU
M?OQX/26OR-2B18O"AF6)2WF7BT8=/GPX=$%F4:(\%!LV()G382.V)0?9(_TQ
MU0X'+5&BA Q!E'<XD6I=.S)IUZX=-8 @AW-+]_S*;<^A!I%Y$:(('5K/81@6
M*T(P2B4]MCG49B2*D',,E<#N^ FWV13]OX\EVAS[5+;(1;M#BEHC.,/Q0E7E
M[H0ZEXO9E8"U/.6)J[J\E,'Q^C5"+A)F<5P;DF=1TC?"46B[0Q [7O3"BFR.
M-[TO&R)O=N[<B16-&#YL_KRY7M.FSIHY(R@P8-^^?;MV[4*E0!.Q9YD'"[>*
M5//9B*]9E19]EM4)GMJAB\%$?V+TP%FP-_U=XLN%,$YAJ%'++X=DFZ,/'SZ$
MM^!*J#6K>AN)\>./J$?"P@6%/7OVH#_GSIV+Q(+JR/O/18L6$0UFSIPY=>I4
MQ&>#!@UJUJP)N2<RD  WI/Y;MV[-4;2<^<F.54VLO77KUE:M6B$)B#QXKE2F
M.)U$2S-<'@SI\D?=P^F$5H@U)9P_?_["A0L)31,G3B2<RGO=WW__G1+BXS(%
M#B%E\.#!E!-U3:256:,Q&[-*CU33ZA $$-4NESMRY,CRY<O;M&F#L$%^T*!2
MA\^R#<R22FO8L"'I/_SPPR)%BLA'!,]*[\;+A38S?C&_K%FS9LZ<N5*E2JA'
M KM=?7C)_MJU:V,;&/#V[=L/'SZ,_3_KT:2YX3 23B$&VJ,\Y1&(><MGV/2P
MF-G)DR?E.T_7I"\#J%^LZ^S9LR*,Z3&)@5R=/I&;#5,KKD=U)3%@V>9T"  ]
MJ>R1>(N;<*=BY-8HX<4-,V*$3-7-28PK4Z9,SIPYH[:Z&VZX\;)P__Y]5!,R
M==NV;4)N8GB@I(3()'@2P9T_45,P&WDE:(;$#7E=P'U!!^%/RY8M>Z#6]C2<
MBO<5 28*GXL5*]8WWWSSU,^KI-,U=\G22_TOQ=\".< )BA4K)DK>];""3>D!
MJB)=NG14HR;9=+H4^(<??F GC!FZ#$<DGT.'#B$ D &&J<#A:G5U0_7!4,.U
M:]?*ET@"Z7UAD%Y>7NAA^F^H27!P,(VU9,D2I&FS9LT@KU#J7KUZN7#N5P0K
M I!F?WQJP:BA4WJ,719XZMC5,,?K3S68U@61ULCPL'OVB'NW+QX+6#1ERIAQ
M73IUZ]J]SXC)L]=L.W3MQNT'$?9[#I'[,/+Z\?F3QPWNU;57KVZ=NW7NW;MO
M]ZX]NO?HVJ-'#\>0YIZ]^3?']_"Q2P_#1;M&:6&']+3>WKA\P93QTWQW7#MS
MY5:$0XH:MLC'ACW<<F[;X-Z=NH(>?;IUZ?)[SY[]>@\>/L7_\@,EE%\VI'VO
M7KV*B.K?Y[?R94KEROYMFI0IVK5IB:::-6O6O'GSL WDRNS9L[V]O6?,F#%P
MX$!'Z7KT&#=N',),AJSCDO#4D) 0LH*9R0Q;+E=YB<# EBK(^HHO$=9GO$UU
M 6E0H;*X*\2Z29,FR%2J9>S8L9C!B!$C\""J#D5*(1<O7LSV].G3J3I4'&D0
MEALV;-BY<R<52!JJ%^_CET"'1"1G'1Q6K5J%>SYU  +>BC?AC @V6D'+T6?5
MMFA7_2=U2*1"#W.)X<.']^[=NYM"]^[=*0P:%<^EV+1[U:I5$1LHC?7KUQ-7
M^_7K1^*V;=OBSD2)OGW[BK3&)+@U[HL;82>W)F'!4%/C4,+^_?OK!<-T,3 S
M\ADS9@R:,^H]1L6]>_>(M-SUSS__3$ K4*" ^VWJZX34L_R6+ETZ18H4R9(E
MRY8M&^)-FGO3IDTX H:$&=!E\R>=X]Z]>Y_Z1$G;N55]>L  H+,  (  241!
M5'U0(6H:Z;.D(]/[M8YU,>R7 KD0EWBLYO GK"&&9?@QOVR?/>M8TID-&9Q,
M;XB3<@LNZAHMC>/HIS-X-^F)&#++H!O/18R0J1JT'\;]SCOOO/*G[&ZX\?\8
M#Q\^/'KT*+V+GY\?H=:(V5]'A*M90YHW;YXG3QY(LQY-ZD(EI;>3[HI^A6X
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MY09=,W7#A)@E4VDM(AHV[7K #3?<>!G0T9S FC%CQOKUZV_=NE6&WCV9\ U
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M]71@E\&#NHW8=.;4'8OM[.%+^[9=N!UZY.J)(<V[K3[TX,0CP[A]Z4K(UN#
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M;6=AR,:/'X]')1(9"TWEE[MVIEM^=Y&AY(!X\?[[[S,N9<J4,9["G#AQ L5
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M]Q./>AY-FC5OT+1]ZVX^OO/W9MBT['O0EO^8B.K*?'YTR67Y-#$$0!ZX;>#
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M*U*DR!-//.'IZ0G.HT,&#QX,\9LZ=>JT:=-FS)@!- <9KURY$@Q*7T%E">U
MO:%#A]+A5:I4D4@FN=U+5]"9Q#^&!F3@>DV)D0F]7;UZ==RI_$FX126HS_CQ
MX^^GMZEZSUDM$$J3_KVF25-?D=H4/M?L^EXR.O^TZBL.J>:F:CKYM&2:'1:'
M]%6.Q:HO7,3_S5H.Y-&1D^VPYV9HV29KKL629K=8R49?14G+)>\L&[G;-(M>
M["T]0Y,5>LR!7;\S2Z^!E6/]BI[I#4[:()4.D_ZLPJ$OXDLQ.OZRJ!5]]5I;
M]=LM>@Y6M5X3A5@UDU((,C)IL&2[Y*^F^ZK# B6BO2!44-KHT:/A:2C\L\\^
M"]5$YX%Q)("E@'0QEE*E2H'ST$#P*'SI[;??QBG%Y6VV"2-JW+CQ1Q]]5+9L
M691\W[Y]BQ8MZM*ERXH5*^[Z$,?99$"39(X-4@?(7J-&C7KW[MVR9<M)DR9]
M_/''Y-9/"=4 'T.Z )3)R<F027F4YHPF#Q\^#$,#-SL4X@P*"NK6K9M1D)',
MF:8*JIX[=R[-3U5KV$)6R0>*ZW*7\X$(38/?!@8&4A#\$'9'>VD+3!7&2#5P
M)E]^^:7QCM3'QX<$>%3QNLX@GE$8,V8,3L98'ED>DY& ]%R%:L(J"0I$ 6(!
MMD^'PPQGS9I% EP$W0*Q[-6K%PVAU<'!P32$2Q!+:#]^X]"A0US:O'GS+;7<
M*_TS<N1(^@$71XAAO"B=(:8"\%Y:A-/#:P'KV[9MR_ANW;I5]MB4ZKD(.5,T
MS(>05+QX\<*%"\OJLAQ#OXT7]2X=Z)8_2.SJT3-#C$H0L"I4J#!GSARL55-#
M@)DW:]:L5JU:1#1@ &HO.H;"P.MD.D!,3,Q++[V$VLAJV,93#"@?^HSAP%1/
MGCR)ET!#R#D^/IZ4Y" [D*-C0A%ESJU+]7Y'L>>)ZX4\<2AV3;RF@=0M7KUE
MA5U3?R*R- %[EQW@J397,]3Z2?<>W-WB+ 6+IHKRR2@RHOA0/#)^6?SLS^B-
M6]QR?XB+"W-VQW;U;,_9"@SJ:,M;,5+^%':*9]^U:Q>8C* .T@(I @WA*H"V
M\N7+@WL(-B" #S_\T,/#@S\)(809< ;@!G(%0"Q:M"C0Y,B1(\ %>2U@48MM
M2"D$'GPT*<>-&P<J-9;0<*ZA77V4!3S"4X-=PL/#M;SX=-^(#!F0[I___"=
MBMX  <MT.%"UO)VN7[\^$)#.KU2I$D"9;G_KK;>(].7*E7M R3???-._?W_
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M("'2K%FS!IP!R  K@(?@KB V*8AL06R??/()6 3, 8(!L1E%B\,EA\&#!Y/
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MY96L".X:?X6!@(-A4[ O2!W$M7+ERC!#_!B,E)->7EZ#!@W"N>$Y(7APK8"
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M *I5JU:S9DUP"#8%W@"'@$\P<_3PR)$C%]6^J0X5 44G#>N6!T:HNG%&U$9
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MI$&!&W,A%F.'<&5Z-P@EH(;SA[K?WM3/3VR19WPQ'_4,)CE<+H=?J89."(*
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MW-OLL1:C$#Q*/A9EO@TLA4/$1XX<2080F4HYT$IRBV>@><UK3VYVI7;P*T*
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M7W]-:L*]04_^+%FR)+C)4?RY=.E2@BX@(,#?WQ]4(G7# G4&\T2?Y[<3)T[
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MY]7'CE")9&KHV@-E]R(;7B)0:K@9H;B+7O#T'DLLL4R(4A0\#P% ]!*0:#S
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M/T%K>93D4$9VHV7,#Y/%%'@Y278(+1E])*VGN3Y_TA'3U4<FS0>*<2P(*I-
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M#W &@A1* ,#I4:DW;MR [S5MVA17@0<>5@:L! 0$@"/RK@J1F#!APA$C1H@
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M&./QX\?/GCU+?E$FPN4??_QQ?-;KD(4H3_:,:@A,1"DZ%M9!H.#29\Z<.6:
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MFCL@4P.(-61I5J9NVK1I[-BQ(2$AL9.I>-8__O&/J 9QT*D\IB]N:&BHE:E
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MM!P$&(Z0*U>N>?/FR;5M:]I]7(@PO"O<\;)!:_2]WKESYYSGCQ?(S,X;G#;
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M%UXH7+APD2)%"A8L"%M%V5*3C1LW;M6J%4$FFD^^?OOM-XP3 >S>$&UP!A@
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M)%!29]Z\>=.G3S]FS!A8 1*=6T:U)DB0P']ZK3O*5$(6*3Y?OGROO/**_]8
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M;[HWWPI=!4.E-;D0[)F4B7ZFO=0Q@;,1&88/'\X)Y\Z=J[(A4]]XXXW V]0
M+*P9LW#9]S:5:(#I:I0UC=9K]XR+3&W2I GG)W<,&## [GD;V ,M7$X71^AL
MNI#'#,$BUXXPS\>=H&:F3)G"+6MB*M?639LVJ0:.'3O6H$$#]K&%C]\"WQ,0
MOC &B)GFV]"MB:*X]O2_Z]=>>RUQXL3D%^=ZCY% =F>%)A<@+5 7JC1ERI3N
M;0'$"E I-&KJU*DAC3BXZO_SSS\?,F0(2>'HT:-8+R[_P0<?0*@\!MH'@@TM
M?/?==]5P.MN__O4O31#@;P:1(L+WZB72[!D76"_FIN#\]L$Q)=30OK;#W1TO
MJATXC_WH1C4 )R0"./M#L1XRK#-#1+F*?8@3J3T'<'L\2#*5-L8@]*9.IAQN
M>ADU;-@P39HT6(,UE-#04,CTQ(D3<3DD*](48HVHP'-.GS[]Y9=?8FKV,4^8
M0W'=T5+C$1[#(Z]?OW[X\.$M6[:@J?KV[=NZ=>N*%2OB^56K5B7MH7]JU*A!
M=' I,1O$B1H(!M%<6WB[E4W4P&>.P>*=40#7@O+JXP'_K$\5H2>S9<N&C(2.
MH#E18JA0%DA(Q"\R$^=G*WR7PB/A.G;LF#%C1D1ISYX]D3<$.'0IFX*"@CB6
M0E+Y1(IKUZ[=O'GS9S,5LB9'55^I"/-]@M.-63-SYLP#!PZH.[>S=11K4)+H
MWDAE*C%HUJQ95)U>#CNAF^W2I0OQUSGGL@4FP6EA2U9D<@DLBD,H*N>DI6B=
MJ5.G4C8$;?KTZ1'G5(@-@O[MI1!L_SJW_I7P^)[OJ# >\VDT5;1KURXLK67+
MEI]\\@GM?O+D27Y1JMSCF#%C<!GN:^/&C6G3IH5I[=RY$Y]:OW[])3/ XU_I
M-?<G_&M CN9:Z36F14T2Q/;NW5NE2I6F39LN7+@P.A_PR&:(8)AEI%]<._&G
M&5V3IB3HK5RY<MVZ=2M6K*"]-.,%%DL+MFO7#H?=MFT;,E5%E4S5?%0!!.!U
M&#8+Y N$Y="A0PD7]>O7)_40NE$+SMWB(E-;M&CQUEMO]>K5"\:L<]X>]D +
M13;WVKB!8 [=)(=JX!^-_7/\5N!9I(;RY<N__?;;I#G75M*0:N#4J5.E2Y=&
MU]FT<@\30=RAPI,0R1IPF._--/6J?VWR. 2GJUW(_A"VUU]_/5FR9/;;5-NF
MKL;U;U-:!-9!E3[YY).N30'$#ATZ=$B2)$GRY,EAC/:-!1R =(,!X^R:1W3?
MOGU0.-K.:UP#Y,V;MT"! OO-_/9BX)@W_)"=X9#Z5B7,?-=V&VM76-"RL_4C
M=?-8@")19ISQZZ^_UGC"D-B?S&@U]IO2VQ1/\)@(IJ$Q53 =\N&''UXV'>NT
MC]=8+'%/[RVX(@N2Z_((YSD#B X>))GJ->$)%J7W8S(1W("LEB5+%DQ0@I-?
M=OCJJZ\P1TQ0KP[<)[I'L"5!GJU9LP;Q5J]>/71IM6K5"!,HNL6+%^_9LP<A
M!'-%U(6$A%2J5 D%J/F7O#Y7L>>Y>/'BM&G3$.'V$DYP*M@ ->/U>X/'\C??
M?+-Z]6I2K+;:30)71(00MFK5JE6T:-'NW;OW[]^?3/S_V#L+.*NJM8T?AJ&[
M0^D:1!H)I5/Z L,$0TIW-UP%!:1!.J1;I:6DQ$8!)?V4T O275/GG/W]SWH]
MRSW[#--Z+SJO_(Y[=JR]UKO>>)Z]UUZ+/?7JU9-/%F%NY)B9,V>2>JD#(4Q&
M6</QN%:F4P,0=^S848;7FFMNJ-AQ\^9-\CI<5(Z*DYMC$R![]^[=GE13A/H#
MP1^JI:AECQ@ : D;D-5!-0>00[JE '>XEB17.6HH<Z+AV!@,/"@H"-@!EJ)1
MC1HU*E.F#*2]8,&"E2I5HE-:MFR)0F!N!P\>I!\A;S1?BC*+9YQUJ@?SGD\9
MP]UC9N(LH@2+M9O_1"U$6)G=#JU"D$!7+5JTZ-^__]"A0V%-Q8H5PUH^__QS
MTA+!%UR% C=LV"!SUI%[,F?.7*)$B:-'CV)U$R=._,2]5/T_7,2T#/?+<PU#
MM9B[QJ'>QN"YV R!"Q^7K!^M<!>,#1K@.4# <,]/;BA#^NFGG^B:K5NWPDA7
MK5JU;MVZLV?/DDI_45/JRP:D%)C(F7BK6&GB3+^)8A$=OIR*IF(PX\:-NW;M
M&J8+,UFV;!FLU9P[XDE3ITZ=VJ=/'XS0$L1B(E*-L!BON1I#H4":0$@DT>!0
MY)2//(1(2#H@)\Z>/9M\:CF*HR5-FM3;VQL%$CQEB35SP[5F/).%B)Q@V:-C
M3IS%KD972;!RF 8QB>A:R;8G0A Y?/@PR1W]$,2D_KJV9&<0 MCF]==?!^2@
MGSIUZ@ A^*VEI'#APE"C 0,&6 OU$&FO_I,@MF3)DJQ9LZ9+E^Y92DN4*,1B
M.?07W>'EY44^DG0@V83$T:%#AS5KUAP_?AQ_!P^0+WY0(O8 ?'KYY9>K5*DB
M\RE*L9<O7^9D$A!7<>://_[(5:05X@;\4 ;NF6]MN!-H@G>E-D@$FR$)_OSS
MSU #_:&?MGEMM/I\78C9+V@OE^O'Q)P&8D0M[)$"]86TG9.YED0?A\^CG/8P
M;AGN-%SEA3PQPHS@D"=A3L-5C]\'%_\A.##WYE"PPW@0YK [@0?!1EBXX?K/
M>&@X0XQPCCH=_"_4:=QQG?[DIIU-^O!)\--P(TSIR7"$&8X0UQNAQU?O&@;'
M@QV_SW:F=6(7"!/^P'4+U]]WN7VHP1T,9WB(87_L*I-_87>D_B'!=O6GZ]9V
M(X[X]CFCJ9@7 ,L\O 2+GS5KUDLOO;1OW[YG15+#9#U_C5B2BHA3K;"$/\-(
M(7ZPG4Z=.LV=.Y<L>$'-9ZW',^M+H&?3IDW+GCV[#'PU%RN-Q0& #@L7+K2K
M839: U((;KEKURZ2JR=N-M041"02&";ZA/_OW[^?>P$[_/W]:]:LF2=/GERY
M<@$ON'N3)DW6*O'U]<V7+Q^9Z:H2F2%&YKF5,F&5D%CSRN]X*9=SE?RI6^=4
MF0^!J:(0O5.WT:XF9X,LH:)?U-+2#E,J#553J!$*03:H3HJ5,N5RE$FLW+%C
MAP10PZ-3]NS9 PM%.= P\!;)$NP%%\66R*/ERY?/EBT;R14*"FR:HH2&H&HB
M'75^I$1>G*Y<N=+/SX]H_JQ^EW:)F/M7]IM;'4^1<N@1XJ:\%Z5N8\>.)=F4
M*E6*=F$MLB *FD$_/RG!K?AMW[Y]BA0ISIT[!RF%IG(Y='3;MFWP>:P(Q=+=
M:=*DR9(E"]TQ>O3H5JU:+5JT*%+3^N<(JKZA%LI"\ @9Z&$H\[NLY(Y[P30M
MDL]0,M8%[2=PR>SV48M<!1RDF_14F681,\-E\'I,<=.F33@LO7_FS!G.MQ@8
M?RY8L #?P?=Q9ZES(DU-%(OH8,7&I4N7X&-CQHPA7.#[Q%4,+ %I*I%VPH0)
M\C8U#E%%6[@C(=ZIFALN;D6TQZGY?:+6@30+J7/HT*&PM6/'CGD>)<5 4]$
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M7KSXO??>(U\,&S8,^%&E2A5/FHI <3D*(Q7*O4T)V8=\>DX)68GNEO%<L1)
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M2L/59/@@"LR& NE0[ V(^*S/N^(IM)'Z8Y#"C1%AR^8U,G30"%,S.\@<2YQ
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M4Y_>OG+BVH:>MM1I;26Z+/CZMJ?SA[@&!QOAEP_V;5&N1.:DMN294V;*G:5
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MJ3IT<)2,.6W:M+Y]^W(+3XN-H40;_V,BNCE2#4]WLPA!<O#@P61)G%U2N5F
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MD>:F!!2I+?9#Y;$KF83L@OJ(G;Q,H\P.&&U-Q XI09]Y_?IU[-^"X@!.P%3
M !9[_/AQ]& ^&F.)#4UUV)W7?WCK=9]4MD(O-Y[PW86;KE:%J[=6_-]%.AU/
M3JS=\>_6:6T%DJ4.V'L^^)<GH8HO4E@T;U/U!H6$!S]Y>NG<MU>OND+_Z4^^
M7=S%0E-=5#3,"#="PHQ;USY;L+ISI4PVFW?:VK6[+/KRRM/[5Y]R0K@43GDQ
M1K_/&4W%[# U;$5POT/A/&@5UI J5:HOOOA"7JC^V=;O*>)RU 3W'C9L&-F(
M=(YC: LF@1T\>!#$#[@GGS5IT@1*5K=N7?R<@ LEZ]FSY^C1H_%\LAI._J42
M2L K(*N00W[-2=VN"#EQ@7,(+O '?<AI@JIW[]ZE3&%6GN]M@*1[]^Y=MFP9
MQ PJ2YU)HE#*UJU;R^JI% O@H-IL4#TP!(P1VKQX\6)P,YGIDIK@&S+V\.%#
MFD^5B%E<" 6EY$V;-I&H*.VEEUXJ4*! _?KU 3'$Q,:-&]-P--"]>W<:#OI9
MOGPY;!8 1-M!^93\JUJZ"F^G9-V;TBZM51TT+2=8Q*%H8;A:Y(HP2MBE?-2R
M<N5*HC#*;]NV;=^^?2&95(S*-VW:%+;6I4L7:!A1F"[KU*F3CX\/6 05D2/-
M)<L&+(7>)$#K0U*E4/?XX5 E0DW%6O29YO/_ A'SD)J'JO$PLE"8K))7O'AQ
M_ MSE9>!&,:.'3OHEX4+%QKJF4CUZM6S9<L&&X?&HZXX+%W]MQ$QO!"UR!.9
MZ:1:7 Y-RL2_,LVO#.T^=^[<G3MWV)"!#WBBY6%*I+TO/87!X!H05.*;C!/V
M-'+I4(M=F?W"(E*R;./:<EHB34T4BVC[88-0__;;;[_YYIO$=A(!:$^;D [(
M4=-4PQVQ26JR(*?91 ,# XDJ0X8,X1:>J2I:"54#CR-]1AE;D7;IN$WB)@"2
M+%:O7@UV7[5JU<J(0IH@91 8IT^?CLM+[M8R;]X\;V]O:,"3)T_(?>A'?ZOV
M+/=\7L2A'EX#9N;/GZ]IJK8*D,#$B1/EY<$?UT0IF,?V[=M1J2YMUZY=P /B
MJCGT[=FSAV0M-%5&5\K)S[L^_S(118DR 7) H,R9,P/M -)R G@&F%J[=NV-
M&S=BMS N2R=2PK1ITTJ7+OW!!Q^ J60G") H@;_@!? W;(,H 4^30;"R$JGX
MJ=TT@NQ9B"C^(G4F'5.9^TK(PL%J#60XIWZ5(GK0=OLL >I<O'B1"_69-$H^
M1W>J1\F&*@0-D.CM:IUYCL85(,6&IG+;VR?>_5>IS%XE7VHP?.^Y>W<=AC/<
M-;,2%7W@(J1A-[Z;_^%;33,E*VU+TW[_+\;%)W9%%CGG3HQHJNLFKG]/PT+9
M$V*$.OYO\]'WK8-^0UTDU*6>$,,>?./BM2_V[U@]N4O]"I7+56LP9,GT3:?O
MA86'J))<-XAQCS]G-!6EP8C.JI6=0MQ+/A*_L QH*@&.#>LU?YIX^A4.3_0D
M0^/ 5$_<3P[!TTJ4*)%7"54EPI*Z@/MLERU;%AY(*_ B,Q'5 B?,E"D3K,D9
M<:BP"*&!]#EERA3S3IW^*1.B6*M6+:<:DF$Y!T?]Z:>?X-4C1XXD)+5KUV[
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MHQ-'J'NX8K=NW<J7+X_]RU%#?9D"P  YP$ME_EMN ;K#\D&26 MH$U?")$"
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MZQI\?&7=Q"9-R^9.6Z!;PV%[+SVD4SC1#N\WK<D:C3Q_-!7+QH"(U.:8A2G
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M0YFT9\F?N!7 HT.'#J0SSYK+V]1DR9+A8F/&C"E8L& \WK$DI AY(" 0<,B
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MG#]_'HKEB/BB,LZFHR5<S8M+6@79PW:>1)QY..*YKCV8;/?NW0E Z=.G)P3
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MQ8>F<M7RY<L)K7Y^?KX!08%MVP<&M27X!/K[\\O.UFYQO43U"VS?OGV0OV]
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M"HOX7=6?2E.A3*".#!DRH$/SH%_# PS\=T4JAF9P'WAUJE2IP!LQ)$A1B#8
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MZ'N( ::C9YTU5%^2Y*I7K[YITR88BX!FW*9QX\9DQ 3I:;'(,/6Q."0S("
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M+6*HE(:?PA8L^2!2ZTJDJ8D2K>CHP<8EM2 -87#BQ(GXNPR<,U26 9-A2Z0
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MJ8EB$7/T((QC(6/&C"%M_>M?_YHZ=>JL6;,(R//GSR?RPU)JUZ[-QK1IT^
MOKZ^PMQ.GSZM::J&O!2U;=LV_7Q$A,Q"NB'X3)HT*0Y1.CSBG 41#\9+I&37
M<V*5*'7$UF(YV7(4_X*?0*(H9//FS0$! >A$UH&S7.LIGGJ0O.^Y/\ZB2[,K
M&J8C@RL;1111@IRID^S#AP\!Y1DS9I1/<YVJ*/E]\.#!H4.'2.NZ7Q)0X G8
MB;^_/];X\LLOLY$M6[8"!0JD2I4J@Q),#J#%GP*NP%WPL11*.)0]>W9R'->"
MQ!HU:M2E2Y<^??K(*##Z")9%2 <(Z:D]+.*(C*R&JA7[S-TJ>C!4F.W:M2OW
M;=JTZ=-GS.?O-,WIJB_4VV8PX#3Q6'[)030\29(DZ.&##SZ@&I9JFTO30H%@
M,\ 5"GG]]=<!SUR(5D>.'/G_[)UWG!15OL75QP*"@BXHP@*BY"A!0"1+EAR5
MG!1$D,R294F"1$FBDH><!Q D2I*,( *"((.LB NN:0VK,-W]OM[S^FY-]82>
M!./;/G_TI[KJUJT;?O?W.Z?JUBT]V@FL8$S &"Y>O'C@P $L06]%$42N7+GR
MN0$YTYA0S4MFKCOT0PW+('46+,ZQ$ R<YD<[?_+))Y2'PE ,YU,?%S3 G5:J
MOE [W[AQ@P'K'"::R^D:AO;27 YY'*T9A) P_"%EJL=H,RP>@W!: ]L,/"00
M7,UC7N= 2V@F4I1<$@J-6\@]"@TVKTD^P9B@3=.W;]]RY<H]\<03-6K40/OE
MR)$#?YHS9TY-^L6%V?<*(LVB9*X;-N@Z]-[)DR>1#:BF%2M6=._>O6;-FFW:
MM$%LS#-8NW;M3H-=9GHJWN$+LS #KD'M@$]!3>'1*,FGGWX*74;9$DL6+UX<
M%A:&2D2!H%B( 3 2F/2($2-0(^A)1B8NK'7KU@A=U)H>H@(NNGW[=AR!%N#E
M*KH/Y_([[*%W)&O)'W*#$.(O^>MY*4&";3+4_#$JB![&!4/!]:DK+D$+R,?I
MU1WE'&<7W#*06XDS<4R@)' RRD83K5FSAM@VTK'4!R4DO&$2JU:MHI=I?%FI
M(X,8(6^H0FI/DKALG[$BK4I%F6E>K*5]^_8#!P[4AUZI!7:R;=LV)"B:'Y^.
M/7S[[;=4H63)DGIT?.S8,8P-F^?H*Z^\4J%"A1WF,YN<5:! @;QY\Y*8?JQ3
MITY2E3DEP^.XFX ]VTYWC=-8H!QHM D3)H2'A]LOAB> 6(M3,A88(%NW;J6/
M%&B#H1>VM)R">>AO2*:&X(*U$S8NF^^FXA::-V^.0%6HLDX87T&8P'M@?D2W
M!@T:^/P1^2[S.7A<1+5JU:I6K8KG1!L4+UZ\8<.&3K:-3$7BZIO>.C=>4#$T
M*((<C+'#Z=""\>36,[A X)!0)T/<!1J F*M;Y]&F=T)Y.N%.D0C8"E*8$R=.
M'##0,S%]1M4%NAXY5]- 78R\H3?I1W1@SYX]O5'E$S%::QDFDTS%7S5ITJ14
MJ5)0*>):_OSYL4!T:=:L6=D)K6K4J%&N7+DH;>K4J?]B@)RK7+DROYC?_???
MCW;E4/KTZ?_TIS^Q_8CY0"#Y$/[(D]K5K5NW8\>.T!((#R%2R[<Z%:-@^T7F
M%^E_**>PCF^'/NE[PIDS9V8(//_\\X,&#9HY<R94BE@ ^Z+9CQX]&A$105^@
M@N!1ZF[;1\ZNUTX]_0,$=\97NG3I('4;-FQ0,:29[2F2898%*1.B/TU$<W7K
MUDT&242#A5)WYTRQ.*V.DD /X GZ"HO/?\M#/.V''WZ $R+4J1=L!/F*)SE_
M_CRGG#5P$KE$L@A;5 K 1>DO15@U2)2D#E#F<^?.,2JUM@N$6:^D42_*3PX4
MV.?/G*RH1> ,38\!+4SB#S_\T'DHS@8,(7;\(66JUSQH8B1C\;]&?4WY9[/2
MK-?_*F:M6K5P!%\FT0?K=0DT7KMV[? L^MA#\"9(P29/GHSCPYGB 9]YYAG<
MRL,//XP_S98M&RZR7KUZ<,1;YG8LA<=3W+AQ@VI^]MEGV#T^!0FZ<>-&Q"02
M#LE$Y.C2I0N.YJ677D*RXJ%@JP0&/(Y&OMRES]]N\E#DC,,ENM XU *MHMOA
M!"%8R-_,NKC(473CV+%CD32C1HW"L:(8J3A[-"E+\V^1LIPR?_Y\BJ=B"Y'F
M"8]M&>WQF/>4. 5].\3@5?,Q&/*<-6L6E2(T+C/0PUB\-EX&=V!GC'C\KC\R
M*A&7/=@$SD-)",JS:-$B"DQ<H;5IDZY=N_K\JH"JT9(XW^7+EQ,RZ2E?U#N@
M@4B\4XX3Y(__I6U1DNC_SIT[8S!T-(U,UW_PP0?8&P9F/;@LA/8O7;ITGSY]
M%B]>+(V*$+IX\6+UZM7A6'0-]2*L$LLA 1@A^:.!?8Y'?/]?X37PF89B;"+O
M"<Q0\^"MCB8B*-)<=(>^0:>([DX7'/!^= W%8 !^:;YQ[QH:L4 I$1O0:)4_
M)%-#<,$:-AN7S;NI>(\.'3HPY"&=]@&CUWSXMT*%"J+71!8MH00(7A)I>H=0
M[[E(N&;*E$GYZ[=%BQ:$H;Y]^Z(*8O><R0UGN&2;,4+L(_*BN+9LV4*<M=-_
MA,T&)&!;]WR=H-'2IDV+$**M^$O+Z'T_]U6C@]K6O3>)8*,/P8ON@U00VE:O
M7DT(FS-GSLP $/'16G4,GC5@0U__1J:^\LHKBOX^?X<2N&$C*//DZ,U+ERX1
MBYLV;0J;@DIA/$6+%D5DHM;RYLV+BB8\<;1 @0+ERI7#V H5*I0G3Q[2M&K5
M"MY5OGQYRJQE^?/ERT<@@X#ER)$#/H9\394JE:P49,^>'<-NV;(E_8A]HE=I
M(I0\? ")13&^-Y_']$3]P(DZSN[!*F@ERH94IMW:MFT+"YHV;1JM"GV"^82'
MA],%6-&V;=MV[]X-P> OEL:>4Z=.H9U.GS[-M:Y>O7K-0 O/WC0?7*"S$-O8
M&)6%%D+_&(8W_5-\9<.V8#X'B^:BM ,59T23/W;.U:M5JX:2CU=(TBLGT E^
M8WDFY#$?2J7DN(Z(B A]-Y@ JA5TE<!5U/C"#A:US"6S:&74)-&  E >F!*$
MDZ:&V..UV$-K\\O?"//Q+>'?__ZW)CSJK[VBUS_Y'S^I2<(A)!7^D#)5&]C?
MYY]_CH_0SD!7R)!@!.(@[#!()$3L<.6X9IR4%G *9ES9-$0"I(+FJ.!#*U:L
MJ,]I$K ??/!!O R*$3_X]MMOP_Z7+%F"MX(0H!;TW7,T'B$DS'QV^9P!8T;C
M)-IBV$#K\0L\GQE.> <$<[]^_;00+LX7H<A5<%OOFJ"[??MV+G'HT*$)$R;H
M^>=(LP 2Q6!#7S1%LY%>DI(XY[ZV'QJ]MPQP82L,$+V<BT^$9!.SZ4><EUU-
MSA,@1&."LU*"ZY N;5O@/V?&![H$K4W$A<K3._0^FHWH9?/$;1%OKERY0H/@
MZ&DW7ZSWX+WF?@$R Y>-O\99$YQV[MS)7YFKJSH)@&JMV>"XSNN.KQ.I1CZ_
MD_4ZIGQC442L[MV[0Z>HT3X#W"[5)XHC=^DU2HYJK5FS9OKTZ1$V\#/VVRX+
M'(G_ST#KT4T'#AQ@@,3+MWC,^_.TZKQY\[3,FSM%?/#%%U] "Y8M6P:'UL/8
MFT&_#T,OWS0O"F(2=*A*$I*I(;A@392-R^:#-%@(O!^NC[5HAJ'/&)[>V&=$
M$)=Q@,V;-Y>3P>?W[]^_5Z]>FG4)X.N$GI=??IF(YO-'57[;M6M'5!HX<"!Z
MX#\E"!KR\SY'F1,,#2)%3T8*SIG(2YE[]^Y-1?CM&8 ^??J@TW";_+H.T1IH
M5/LT59-^B1<2$NYK1X>;YL&471;XEU]^"7*8!P.R(OB>-, [\8M7(9#](P#V
M*P >?X!FX\<??^24_/GS]^C10Q''YP]>E/G(D2-4.<AH'B^@0,:,&8.9P:8:
M-&A .(9-9<V:E2!5IDR9VK5KT^P2L>Q$PI4H42)GSIRY<^=^^NFGZ0YT+/N?
M>NHI?=6/T['J4J5*9<F2!>&*T.5$9"VGD&&V;-D@:6G2I"$?:5>2H7AKU:K%
M)3 )>!',#<*&L$2M06D($'H@><N\]PC%JE2I4K%BQ30#"Z/ZS<P'1'!2$6(K
M;4Y$@$I!P.!7B&I*116H&FH6KD7(X)<1MV;-FI5^(&71J%B=OAF!QJY2I0J*
M&B.$VJ&!.67KUJU0"TU&LXN/B!=Q+E5#DR/IT?E#A@QIW[Y]G3IU])IQ\, F
M#QI0D< IS=+PT?Z-=-RB#7(LQ Z;R:_FK6E:F"I'&D1-^!]X#5&4TU!YJ Y]
MQW!#CGYJOF?#<+#I]44,J\:=WB;23(:GG6EMNS.$Q"-%R%0Y-9\_8FDC)JM5
M&@8YAO+99Y_I9HDS/MD$>,G''W^<\:]5-*/D$G_\9MZTP8)Q27A&S-=9VJAI
MH\%O9@[&^^^_3\S&!^&S-"]%LTWNOOMNO(P>J.(]\1WX60(YC!8Y1Q48;[$0
MXF@+X(WZ:$6-K-"(-T%\$D&)OH@N!"I4E:MHMHF*JE-(-M)\* ^O1V)]:)3
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M+5NVI#JT!L5&HU(IVH1?/<^_]]Y[(9R86>/&C>&Q4NG4<>;,F9K6C@ ^<."
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M]>G3Y]"A0XC/K5NW4F5^AP\?7K!@0087M2 R852M6K5BS$(N"?E4_X_8L[%
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M$B5*0.%(6:-&#51?_OSY[[OO/E+>93XW"&U X;@*Z837+%]"\Z(;$=49,F1
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MA):H97B^\<8;_.),H!QO&A!0#A\^'*TONE/PQB!3(\U,:4B1YHC&"3D]U\[
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M;W"%]%?]^O7Q[^HI_/*J5:MV[-@!U2M<N'"?/GUD)-$J'"'20.8D*XHE\6V
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ME@FIA?(>/7K49]:N?.FEE[!>/'[[]NU[]^X-@W%EE?)!R(1Y0[P4AX(/-MC
MO'GSIDV;QNG.]$%&7V<R/>/"1?S\\\^N !\M1TD,J."''WY(F;___GLK4T>/
M'HW8CDFHA)!"$&A:$$2&YYDS9QB>^_;MV[!A QQWQHP9K[WVVL"! ^E6?NE9
MZ#*_LV?/1GB@G?;OWX\3D*E;6 ?E-6_-*%MR8[RC::5A"&%D0K9:T9HA0#[.
MEZBK5JW:HD4+CT'P,E52IU*E2A0RF*'G@L<AVV*7?PF#[D*Z:J%QBOR@Y+A]
M[5$QS&.DW]O6^4$:V/G?_O8W.H(PX<S!(C! )#>\IJ.1A>I33.755U\=-&@0
MOVR/&3,&_R:-JL\9;#% D>) /O[X8]@Y&PCO=NW:45-7SOP6+5H4ND\<Q%J(
MFUJF.##<J,>CK7M@XI0,ZZMQXWW[]JU5J];<N7.+%"F"M=/UKO4(7?"8>TRG
M3IU*ERX=]+5GSYZ[=^]6FT3;,MI)V$INF4JDH"[8+1Y&;(%+$*KX>_CP8=W=
MUE=Y+OO?0=6R2;B%'\PRR#8K]C *2*P9$XZ+) %^,,OSBID$8S:,4"2#M.NU
M:]<H.=X,]B7-217LD"<-^UV+@=FN(1,JA:O4_F N'4+P2'$RE0[6T_; M4/B
MA,>LT@DP/D)=VK1I(=F-&C5B\$0[R&\#/.8A2:1Y^8U?##TL+ QO1137%YDS
M9<H$Q=>[Z3ESYJQ2I0I<GQ .D] 2%.X<0[A#$(WPF=E?,#:HVY$C1X@Z9<J4
MV;5KUQ=??*%DQ!CB.B8'I>O0H0-^W-X2%@L1$?'ZI\3(Z4>:57-QA>?/G]>2
M"?%Z(A<M5%J7";D&@BS3N5-L[-]FE4[H;[=NW6!@$%^*I#7]J.S;;[\]<N1(
MR1M" IR&L$J5!PP8 !'Y8SU-%0@P,#!GR>5,'$FB :VT>/%BF-S.G3O1_#<=
MC\V#&;DR!FW_\Y__1*.N6[<NVG>0DMQ]451L>,*$"12;;A63H"*AIZDI'W(C
M]."OYGT_ +7:N'$C;D<OEP(BB-8]&C=N'&+CY9=?GCIU:MNV;>G?P#5F%:1N
MF=<0;OEGZ.F! P,?DEVO7KVGGGJJ:=.F;[[Y)C(5<8(/_,5\O]%FXK3\9YYY
M)@'?36W2I$F#!@VJ5:N&'3H2)@1)2Q/5+/9OX&!$H94O7W[!@@4^<VG7'78$
MGI6IFO3[XHLOT@M>\[$?9TJ?/\IX_/,[Q&><T/S;)*S@3>/E;IKOE-@[XS9_
ME8$K:BT95]UE #0.FA:E2FC0?B6+- _6*E6JA";!K2U<N!!3I#7T$(*<G>O-
MJ(65H<>H-:=U_8%@;Y'@5#$,!L+6K5OSYLT+S=,DK$#[<8*C< #B*?Q0TW-L
M([N3&K ?*I+<,I7@B-'V[]]?;_1X#7NAG$3,$R=.G#U[%G5*:4\8Z#UV9![*
M#>$GN[II[N-3G62=](N58FR2J1I$%K8!57A9=923#51(- B4 /NT):3 U,6N
M_*].U%&O^2 M+6#?T8VILT)(&%*<3*7+L6GZVWD#)GC8@?K&&V^D3Y\>U5>_
M?OU39O7\J D3 IDF]HW/U=04;%=+BC$@&9:?^*$7^1B-APX=(J@?/WX</</@
M6;]^_>C1HPE4$(C2I4L7+5H4)XY K5&C1K%BQ7+DR%&X<.'FS9OC])<M6Q;3
MRM<AW%E<OWY]_OSY&-C*E2L_^N@C^JY/GS[V$>+ITZ<Y2C F(+5LV1)6AV?'
MNV$J^&ML!CO!E6,5,!58X*)%B\:.'4O\AI]A ["WR9,G$Q5$2J)>.5D@\F$M
MS>-7T3?-6VUMVK3!1 D\6#B_F#'J%&W6HD4+:#'#C>!$'6&<'$*^[MV[ESW*
M)\IE4A*<E044& I%=P1*Q%A W=]]]UU],,"2B6#@=3PST<TXPB%4 R]QV^Y,
M4?@9,V9@PX3JUUY[#<,;,&# ^/'C\3QZ_J\O-P(XI;ZS%PMP@%]\\06).8L
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MMXB >HKE++F3]R<,:B54O?12(G.+!8H7"Q8L6+UZ-36ENQE9"!Y]3)A0J%<
M2 8M9$P1+O&K1$EJC7&6+U^^<.'"Q$<B#CFL6K5JW;IU:]:LT9!D#]L,:GT1
M2@_5\53\D@.!AFOM-F#CHX\^(N;JN0A$%V^F[T0$^H$D 7$J3YX\R%3[-1VO
M6:2:L(4#M-,>K0'K7I7'B-5 DY95!!Y*$BA;:V/V$EXSCQ>NCIU 8&B]"W[
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M-FT*RX%%)=B/AY!\P#[Q66A4HC+A<->N73 \^LN^54(P>_;99PDJ\%K"&&+
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MT6U":U-R3E:I4@5W+R7G+AD9NWKU:KO:HHFG$*M?5AO\$C\<.W9LY\Z=ORM
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MJ\4OSIJ3PF Q@/+F$:E ZH2&N)65(V(7(?1]$ G(!%'T:Y-3$43<7335 B0
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MS>HQ<?\*Q,CH/QUJ&*"AY TK2G!"]]$+OG&(&40+".T>!5SG6;5XN,P(W:=
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M5JSX^../0RKD $.7KZ&\.P#BA,5]Z:67)DR8(*-J5O,FSH?\%C])O'G$%59
M;KGBTT#1"8'N#ADR!.> ?I&DCE-Z\<47\5H" P.__/)+E+[,V=.)2YKBXHB%
M2U/;#B6K?8-L"@[WC!TB\!:*?U+M@^T!;0X%F>J,"OH+3:!')K,/_4;ZZ:1)
MD^#&9$G;L]M#&F7RY,D\Y3VH(D!.(!N:]ECA4B,2>ALD#Y XU8LOF*6F$'O>
M5F)&!*ZZX> 8FS9M\J<TD%6J5 _M>H!L0$)\?E$64#GI[O-^K7"JN<T4$T_.
MIY]W_OQY9)ZW^[P+1H\>O6C1(L]0!8<Z7@7"AK!!4^D^,N]NJ_\S)+=OWXZ4
MVMW[B%J!!T/]R#)R[^8PU 8!>+KBHUN=,$)H*=DF2@*MCSO42!$O];?+E*&$
MEHPA"71YZ^/2(^CF])WM[L.3: 5*C9M+B*:I5F*IF:K\Z0W8@IRB(<SV-I!T
MA-#"'ZA;WHM%HZUI+W'OZ*=0Z(GNT51=*)]U^#N E!&)A6^\_OKKD-(GGWP2
MC??::Z_5J5.G?OWZCRA4KERY39LV5%IH:"B5H^91F1.ID/;-FS<CHMNV;=NJ
M3D:AT\G\2?&;90!9.]" 'U?5<5,R(L25R#0]KWCOO?>^__Y[?RSW#J"=[Z5+
MET+>9LZ<2=^W?O3QQWF<"OI/V>)>RX-8"DQ;L6+%/+[%"'@6&\<;Z<N>]Q26
M+U^.0$H']+A%]LADJU:M,)0>MPPEAPL7+B1EY-/[6<DA=Z'!/C4MB6.C/3[!
M:)#F%U]\8;5$^A6DC$+ WC5HT$"3'!IZV+!A%2I4D#V0[RF\"WL;0*0QT_@A
M,M=)GG6HS?-H-4@^UD'JRJ4V_D1T96:$S")$AF5"/EH40<7H([>D(YI6=)I(
MB(=^L^8AIR!J4PQ?ECHC1SX&H;C05*AB\5C(+0P3 X2"Q:Q3\$RUB0Q^@GRL
ME-30MSA=XGU9(55$3)+U*=*YN$?(I:EW"*N.%J?3"AW-I1B%-?#,F3/8-HP9
M+!=-@:=")^$J6_]#=60A1[(Z*^_^^^\?.' @+DN'#AW@$O0Q#U__+N$R;&CB
MS-0K<2M&=)FV+#$]Z=J*D4&3P_IMOY 9N_3"]!_+3MPVYVC<Q3UGQ@T+GAV^
MQ?PJFAZ[8L749@,W7#0RSJQ:-*SKQ*6'MA].NG3YF/.RRT@]O6GGC'Z#MAXV
MD@W3D&:>3SQ_Y,BEI!3>E7;T<L+*6K5"+B5=6S=W:.^YZV<=O6Z8>PA?.A.S
M8=;:+2>N'.S_6N/Q Y<L[M<FO$>;52>SKJ$D[39GNN%R9MY8TKS7V)"9N\_>
M/+EY9K=O*Y9I^>%;HW?&K0GOUZW#[)WS3J:YL(PWSNR-B8[><C(N=DJ;3T.B
MPR]FFHM1S8U_<=4=ZF5J$^.<A#36JE6K\.UH,K0VC0BQU!'0AIC;Q8L7T\2X
MB;'N\[@,-\5"@6+\EBU;II?)$1-#>^#  70NFG34J%&0R<Z=.^/N&'<Z<\P;
MO(M7UZU;]\TWW^S8L:/^$.ZR?(YUJOWZT?*(*/E!>K%2Z/$,M1\8C@A_8A6P
MW+-GS\:ED._3N&MX<A06IX>JL/JRXN]BV*R& >O.*Z!5$"VRQ%M(61,/3#Z4
M0#;GL'8N@0Z1/.--XA<.'SX<I_"6>/YA+:^AJC<F)D:.@-)+*,7<ZC@^(<7$
MS&_<N-&?&:-E9=L>SQOJ<7T2B><]=9=D\74PP-;Z%+C4\>LDC@75'!@_#U?#
M7TYX"R0-I]GSA@+-BDPBS)XWW,4,#P_GC=Y4TZ%(FBRR]4D=T6]4$7Z OP_2
MD]0F']86T7"I.6DK5ZZ4"?.XN>2!U.@7_E*3V:?R*<3C%C*V=NU:1-&G/PKH
MU-(K=97*E;Q1==SU^5+N4@F(J[^#9P4T#6TM_<5:6)%&O&1Z$W%H].G3IR.-
ME *_<.K4J>/&C<,6\&/:M&E<ITR9PI5*@QW!BPB<<"N@FC-FS""<N\3TN.L!
M$H&,C5/@3QXA?7E6V!>9(80K;BM5YY%S_?OW!&E0L?CQ:K'#DB5+$$)J ^O<
MJ5.G?_[SG_GRY6O:M&GW[MT_4/A0@1]%BQ8M6[9L[=JUZ]6K5ZM6+3@MUK]J
MU:J??/+)"R^\4*! @4*%"A4L6!#U+EM2-6S8\(<??N#ZHP*,M&;-FM]]]]VG
MGWY:IDP9_D3P9/VGX6N"\:^"Q]<9A*UERY;//_\\]$^6WMG5AW6YZ[,_:MC5
M*:;!P<'RIZ@%R  )5JI4R5\^T>K5JE6;J&:(> />V[Y]^]6K5WO+%9E!5;9M
MVQ;J[M,:(J*OO/(*-LOSAAMY\^;%$/O4PW3)PH4+BV+T?C5=B=:4J2*B"77-
MV-3)NN7*E</\Z0'DZ.AH:J!7KU[ZJU-.P3MOV0=9I0B8YH\^^DA,FY2"'[0C
M3!LA1-1U?"@]JA*IT"]UJ*6ALJU&0D+",?=!J>"$.M8;YQ8!H#*E[^BD<A8>
ME2"=5$IDO>52/);,)*EMZBG:X<.'\6?P.G"_D26K@: 199F#?MP*S %TUZ?D
MY.(>(9>FY@"\]85\U_$(%)Q61Z3VZ]>/OLUOO!EZ.RX=:A%7 RIR26WU27>B
M___/__S/D"%# @("4/=PE5/N\S!R"D)3TY,O0E-[SUES/34U:?/4T6-#^J[8
M<V[?DJW#F]:8M7[!ON43>XQ;&KYA\]%3&0[#F7QRT>+)];NMO&"D)L=$#VDR
M8O6NK7.6AJ\<%[,_V9:9L.]@Z/#)!\X:=G,P]>KQ^1$S!@;-V'0DT965%GO^
M].K:=4//)=W<N69<G<Y3NH=MSDRVI]H2Y@7U&S%_^8$+^X>]VS)LQ*I50[M%
M=.^P/L&IEMG9#6R<*S-E1;M^$R;,/Y9D),=M"F[P09%Z3[TS>=_-C9MG]*O7
M<T;0\KUHSN1+":$C@B:&;TY*6MSVLY#5D9<S#1LJ"SN6[E0GU[ARGJ8:REW
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MW1O+A$5'L^OI@CCT,V?.A+W (C#GI]7F> [W.)M-S>\*#0U]\\TWK<,^<E=
MN[_TTDO///,,]$ 'WB4TG\&^(HJ%"A5ZXHDG2%_HH@ CAW!BYU#-T"?9(X%
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M6NLZN6#L_./;=D\9%Q XI,^@?D.']>G79_"X+@,F'#MX8LZ0KF,']1_2?^"
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M1EW"=1$5B8;(=>_>/5^^?+)*),?M0:K:X^[IIY]NV+ A%D@")9.(.A87,X!
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MRE:1DH*A1(X(,J=70JP@<<H( ?8(S\6]QG\6316]+]+FW=,,=V?S&<%;JCQ
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M3S\ET*ZF7*+@5JQ8@=E&$K!S<*VY<^?"T^19PRV$<#/LA#[,@RN<E@=ER O
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M[5N[0MFJ]5H,#HV\EIQT;&50WQ95WBGV5IEO.BX_?N5D6E*F,\7(NKYYU;S
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ME)047!>8_(D3)TAARY8M.#\D3G? R9']I;0RE-2<"O)#&M&J+25<_YD+XW=
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MU_L]SR][,F>MO8^H("7G^6-_UE[39Y[VFYDU0^;TI]R,/#\A)9WP,#5AVTY
MGE@+_0V^RRF$2Q8M6G3111?!,>X3ZN]+,9MJNNNNN_+GSX^.&#-FS*!!@Y!S
M\ FN>9><Q,MJU:H!:+%G18L6??311Q]XX $LNM0$8H"H(R%4#!'"?J-H@*.Z
M&),(,/%UUUUWXXTW-FK4"&6$TX]_+Y%((9G9RF'OGB^W;%PTMGVMJH\_T'3
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M[8K4 U\U6#HQB&%%!:534%&24+B_#D\>*0+%H>NH+4X"S_'D^4\^N3KHP:^
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M1H%L7?+ 5)+BH#$7+5H$G\ 5+I6T53*#[,AH\Q$C1K1HT0*V6;ERI?SI(*>
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MHA$DQ1 IPY^8,6.&.[W,%ZB$?5ZNF:.0&P&AM_%O0@YED&P(E<<]2HD/41W
M5'?P)CG34:M7KT:![+,;^?C5#GQ5$O=QX<*%']LUO^&\K($@!R!?D/3YG*F"
MZ.3ERY>[LD+$*+A9-E$N,+5GSYXXM7YD19"'I]&ADF@_2J0Y;[_]MCO(Q"_=
M/3-DJ+4N7;H4+ERX;-FR8.8LHV.^*4,53@E3#]B9+NJ6778!&!TX:]:L'CUZ
MM&S9LGCQXC1DQ(@1V@\5S98AGCU[-OY,2D .$\+)FJ&.,C/%"3%&@Z+DV#C*
MM^G(Q<]*SM0@>OW[]Z?MOFP.&3+DU[_^M?M[I%RL_W"2M*)M4(G\:J>)F#"7
MX1,G, 2,4;ERY:I7K[[=SG4+D?@Y2"(],!6RB5!OW9I]+2J_O-ENE)&1\;X1
MN!$>AN7VV#EP6=_S.\S#)V6+*D!+"X"Y]J9K>,(,#?)%A4.?#!PT4I[B?*0)
M$/Z-W8SJTNHA2%ZUI8]=W<LHA81(:C:PE8D,<ZB0:YI 9:B2.E,7J"+1V(AO
M[<1@)5'I<9M2=/EH@/PBB( N%1!P,)7AH(OP#UVTDX!.'IBJ@^SE7N<B+8X%
M)TV:=//--T^<.#$<X^@3F.2::ZX13$W)]+#FE"E3*E>NO'[]>NWGA+DQ<J"1
M=]YYITZ=.CS,G3L7X4F9/(^.(<%[N!$,UN#!@U% N(#MV[?7D9B!#3=JJU"A
M0NY-8"8$7=.]>W>TE=.>BLP;_( ^??K()@7VM6?CQHU!O_I+*'[/)9=<4KY\
M>3 J(!9/SI_L#)(*-&ZD]TX*T&A@VF[=NN%JD!66*3IEF,CU>J[O)))?>>65
M)4N6W&GWO^?1B4@A&^P30>X>>=]5#9*6]3TC%]GQ=F![PO4YC9]*<S<\;+>+
M5?@5,E&HBL#/@%<!2P  /#98"Y )#/._I(HGUXAX^,<__H$NQ5T(DD4[()&P
MV2)D%HO@$JKFKCFT#IA'*Y1637"$,T0UT,;NO:*1+6*.$DCGIB.M +:H<)$/
M+B#RZ*X2)0Z:?\V:-0[8)'+NP<,!>O'%%TF5;HM-[]Z]::/[ZU<5GP;_3Y^@
MQW(2H0P0Y>I920X3IM)I=#C^'R-%$=2?T9%'BY)AZ/&VR<K-2@3)D\/%3JZX
MP+Z4&S!@0/WZ]6O4J $$.GH.\>&3."0E3(W9 5%;MFQA].O5JU>M6C7@ ?J9
MRH\:-0J >NJIIX)4TWWUARVH6[=N@P8-P@%&\&'5JE53+H@%-LKMVK7+M,V?
M&A>?D!18+G2LD=^37Z>Z]"@7HK' ;Q"UO^6!MB-*=(B+%N7P//K!!-NL6+%B
M^/#A> 6//_[XL\\^"YLA^ZA*Q-_7&.Y!# FC5JQ8L67+ENF6-S2"BBR91>Z$
MG="WB"2ZY2N[G85?@L!(.C(7[0J.Q?WF(9== #^&X%)*W[!A ^HERMA!4AY]
MM18W2$_UW)ZRP#- >M8OB@BXZ&MIY29"KM'23J#42[GK'R4,K-_0@3J&2F\"
M&Q'>[[%O6>FQUU]_'=1*OR'4=#M6!F=OMYU@G"/3)+FB&1JJ39_L39[A&IBJ
M?--NRM5?]_Z$II,'ILK)E@K.A8<2R9.[D>T;;[QQX,"!X1@_@I3YWN0Q7^F(
MHO/GS^_#U(0=K/I-\EHDZC]]^G0L&;X7WH-$"V, .D5*JU2ITK!APZE3I[HK
M"O+HN")\/F JP ^-@P[JTJ4+@Q4DQYKQ+5*D"-;=C1T/J)M^_?HQH&).,7#,
M#B#%_'3NW%EZ)V%S[8\\\@@>H>;L\10?>."!G__\YT#?\>/'AUR0$+D2J8.V
M,N(VM6C1 H0\>_9L?P75MP2Y2--A4K%BQ8H6+;K-CMG(HQ..XC:_GM(Y" R,
M@=#D^H3BF+%.K%RY<OGRY?[+(!D3_P!X [QT:M %\0Q_OF8'\<OM5G(]X#I@
MGE>M6D4.>H]S/V_>/*R^_BJFDR9XCU*$,U5*W%:$ BN($O'SP ]*Z"KC8V,L
M!<##I=5[$9)(YC1$H2X"J4 %B+:;^@D1]:>!!R.KJ0G;8;%DR1)]M)\PEXM\
M]+6JFB"2:8C;M#IJ!P7BYK,<Q6QM#8V$B53?RF=2)>-VU3-I?6?.$=&H(?@V
M[LU3' Y,C=NY(V0[<^;,08,&H0S1,-3?GZL2VE0UE(0Z,-RTE&'5&I&+0^=/
MGCRY3)DR%2I4P-"G0^,_&:G_4\)4^D>U!5??>NNM!0L6!*;J:W\:B +_[6]_
MRQN<U^C\!6_HI:9-F]*]H2 1G5RZ=.ETF_H>>NBA.^ZX(QV,IU88(\3*#660
MY':8$)9S'R&G3"[:MV\?#=QO)V/SBR&;,6.&/QP\PQYMV[9U;_)@ZA&A++OI
M!-R%1ATV;%BK5JU*EBS9H$&#OGW[8OKGSY^/MK%3;]=J@RX"J&VN*"@2HFWN
MO/-.S'TZ=21.$(AZS0B6EG8*\4/,OL,4< 6UHOQA;&UJ=?>Z'UF*V_&-5 E%
M[:.R7(@XGWSR"75S.D=*SZ750]R.^<VPC<$NK2-:2B9H2,E[X*4*1TU%!PVF
MAI9S75:!33HP4K0(O4T'OFF$#B2)5JI1%XC;/CN&QA6M!SJ$WEZW;ITS9(&9
M5$;?*?/#K.=Q3B</3,5-03Z1F:CJ#U'<W!<L*&BA=^_>T8TWATGP%H8?!()[
M!/+$#&.'4!9@RR6Y$JCCRBNOO.&&&\1#$G6L^_KUZS?;37JP'9E<<\TU&/B_
MV_EC"9NV;-FR)<55JE2I<>/&F*O07JP\.AZ(D4)Q].G3AP$2]N/9'?@IYJQ9
MLR:&W/?I4863)DW2]15!TO.364+CX"+KV --;;9KUZY3ITYPPLB1(WD@MY_]
M[&?5JU<G$R57-.>2^JI*I@5=#^OB4XX;-PX/.]-V[+@X1X1<Z\BY29,F^?+E
M U>H8B>'ZCS.R><N_17O.0/I$V/TY9=?!C8T4=0$ 50PF5E&H2 R7+QXL99W
M4HXLC J;I0S2@ANL&"2Q4^!EXB:;HU7"I8:'$;0]R3.K,?83)DR F5URYU50
M9WA>"Y[B0)'LO3J*T.[=NV=Y!SLIK3*AZR9.G$AR5=*O*H0%(8BBU3E^!5ZS
MTS*CBU3*!)V_8L6*E!OLM9J*H^DZ',<%R*?VAH@2O[5ORW4U<3C8J%NW;OK$
M-/2>M%1RS9HUN^S.P%!H8)-N,C0N-!>8BFG3I ,]1K9XTD6+%OV?__F?,\XX
MX_[[[Z<.($R7LU-0^DLO47]])$PF_F>HJC9-&S%BQ*.//@H80R5&N>(G(S50
MPL(@7G[YY<!4.#FP+WJ>?/+)^^Z[KVK5J@\^^" 5QC-Q.['56& J08H?)3R$
M-FW:8#)2#L>0(4/ ZC"__B:\%218A<X!%?MOW(@C,L 8(C@@X7H^87B;G'$M
MG$ IR"?B(^:C1HT:.W8LO].,FC=OSBCCG*Q:M0H/&S: #S%,M6O7#KR3KE06
M!;FND#K2>Q7GXO@)4Y+/QI)B]^PW65+F8IY\1.MP'6$D^AS!85SP&/$',+@#
M!@S '45"%RY<"$^B@7OUZG7UU5?#G%$E(%)/QNVT?T0>P1>^#<?S%.-/0!)S
MC2,,-G?N7#C9K33ZU="SXP<XX;WWWD/A  51I)I8"37GD!V)_/[[[Q,ARG+R
MB[9OS][G' KZ3E*%&1UJZ^92?<JR2\NV;MWJ?PPE!J:J8%10*ZI#)Q53!UI!
M/ABR_48QNP"6,=*) X&52%JB_=WNQ9&@R7QHO%Q?Q9+.P(E")SQ,=5W_UEMO
MK5Z]>N?.G>D&P,5,F.."8)<O7QYA3K>VGCO!(JA[C,VEEUYZUEEGG7_^^>>=
M=UZ! @4J5*C0OGW[CKE2PX8-SSWWW*NNNBIA2@'QP ##6^\:P;54#UMUW777
MM6C18N7*E8'5&?ELT* !MJ1RY<I-FS;MV[>OLU5Y=/P0 PIK#1X\N'?OWKBV
M6'UX[.FGGX;-I#CPQNK7KP^"14F) 0+[>(S(3SWUE+@TYBUWH$"'#Q^.6R#%
M!WOC^N C%BY<^/KKK\<RS9DS!T>P6+%B;B>8<VU];T.EXV(2C8)JU*@!*D:-
M1K7S$2'G'U 9_!@,))9/4T(I?: \^EYT^'T(PS#TLG^!)8RZ;A@_#%NF+9E&
M0V'=,6/&Z 37*,&HN+^"<"EK-6/&##C-\:1/Y P>PY$*//?"94*MX%40B\^B
MBO/QQQ]OV+ !S\RM#&#7<9K]+6&*F3!7%?DB,CI6H:X@)V6$XL8=S'FHM3,9
M] P^'QZ/G&")IW*(FU<'G"8'F1Y7?^+@5X'PM2CJDS*A2U]XX864"X,"%?[)
M-+G U(2MX.4.4_OTZ8, 1@<H89M^,24ZJ3@4&G@PU5$N,+5GSYY4(V8?HP)]
ML8^__O6OSSSS3(P=2/7QQQ^GA@Y(J#C70&JNXW])2+]1B@.BBLDO#N74J5-O
MN.&&N^^^&S?.53AES8\JN<I35>P^N)2ZP9:@T_SY\]/>"1,F8+MQ2##H"2,E
MA.=_][O?5:E2)2/GJJ8CF@],]6\N\.G99Y\M7KSX*Z^\XM+Z#Z#0FV^^.1H$
MT5V,6KUZ];;;QARQK@N%A\F96DF@4E9L\^;-7;IT^=.?_G2;T9U&IY]^^CGG
MG'/KK;=6K%@1=-2Y<V>,'?4O4:*$EEL#3Q+CYNT$GA:*YP29?F2]U(.KJOY&
M95Q__9<G/3E5EFEWDR3L(WFD!KY"&R-H\^?/QZG ':U;MRYNZL477URH4*'N
MW;M'-;PH8>2$%TED^)S5\"F<\FB2/^>..< QSF5_2N#Q!JH2V<1,\"O9Q-NA
MB[*\O099-B^)]D8)1[LE9L /K!M:#CT<4A%:I]44<(CB=KD@%:-*?I?&S5(S
MH*@.[0$&>=)DK<.]]MIKR*_65TFHUAVRC2<Q.ZR$4"P.*AW#NFO7KA"ZB7M;
MET\@,3GA8:H;8.PZ6EB7X^6,\B_R64$C!&N*9:,,^IV4R+D/7@]Z\R]13D\X
M7D6+%L6<[+%CQ_!OX#_I!;B0E]1GRY8M:'Q +[I&=AUGKG3ITG7JU*E5JU;K
MUJV[=>N&'Y.NL7ETK(BQ@PEQX#ITZ-"W;U\T$3XZ@P5_HESPI/'5<.90)8?L
M^WCI%VCTZ-&777:9-JCHI3+$V,^:-0M4><@NW8)5<-% ?67*E'GRR2?WVM%*
M6* ++[P0#1YX-[Z(+>4Z)^P\4@K%8CWTT$/X3UIZC7F?3!PE@N$![3?==!/B
MF7)K:![]&(JE 8=ZF66'S;@XZ=3%UJU;%R]>S.BD7-D+;$44SU@K2*$@^ <D
M@UU,";<@<IX^?;I"XSF_<>4O?(A0!)[A=!$$_]!R;N.92,R,TXPK=L"NX@QL
MZ155237<-*6J&C?UKE4OC+HDRQ6D#'D&,8X<.9)L_34ZUUB2D#G*60Z!2ZX<
M>(ET SCE4;GZQVVS\8(%"U+.IDO)H]6C():$8+9%BQ;YAV,?#DS%E+@M%8XT
MZ&/'CGTQS7&^5!*M @^X]OI$MHRO'Y0+3$71":829]6J54V;-BU6K-C/C$XY
MY110*UPD!:54&H[ FDQC&2 = BS?RQ7JH@76'/1GV;)E.W7JY.8O7"_]9)2P
M%4CZDQ8!FXL4*0(V*URX\"VWW#)GSAQ\XBS;/.GBJRTXES #IA_CKK.C0I1I
MFS-;M6J5[G.D=NW:77/--;"'+\NN^5I-C?8&;W#QL41X#COMO.N0$H8)R?F)
M)Y[00HT?Y(C,P3D@U7?L[B+$8=FR994J56*4GWGFF18M6H"![[WW7JK'</_R
ME[^D(+&K&VL)+\]3IDSQ1=61&G70NP;<9SR]]'_]T+A)>KK*GZRD5CMF<%U*
M_]"-[OWV[=L9OJI5JZ)L4XIYD.Q2&  XAQBB$]S A:/^A*3:ZA>1 ;"A'%)N
MF'=$JQ% ,![ZA%;H'AI2V:'%KY+6F;FX84)"TUE&E!6:+27./!PB+3@S'4]^
M_?77F #-#H<ZF3?(.*,F$.L:BT"AX?_O__Y/AP+2.EJ$\-(B7$$BT[J,C QR
MQG2JR:AWS)/6DY6):^RQ'=G#IQ,>IHH82 9FV+!AC%\ZA@L-B1P._?KOOQ<Y
MM2LZS*R J<6+%P>I?O311[ 4G(3LX2=I14+H!6[#;3KSS#,U^T5!RY<O!Y_<
M<<<=O7OW!@)AI#&'/WC'<AX=/<(1P;%[ZJFG\$50E[CXC1HUZF*D^VG\=51'
MJ)6A0X=^;=<#)HSTGFAXNO?<<\^($2, JVW;ML4QPL:39Y4J55#<, QX%3\)
M-"BCI;0'[3@[U!,:#0<7]P5#12EN)M)Y4;Z=.QJ$BW_;;;?A>+UIA^6D,Y-Y
M]+UHGYUE'S<*A]F88I]6KEP)/@$E H?T@4W*^' I'B<V%=,856)D!?^@IGSW
MT1%O_FX7BZ?\N#&P*T!A8,V_^$4K*QB8S+-R?J8HBMM67IC'05P7Q!L*U7Q_
MIFW-PD)/FC0)U>I\ N6O+N(9KP6I#&%I)RQHX'GSYJ%U)1W*Q'<O*(OD^[VC
M?92MJHT? V;SIZX51.LF3)B@TXE"%+,+ZV?-FN7?X"=R&?I+H[G U,"@HV!J
M]'P4M6+&C!GX-,Y3\8DD '[_LUZ? "2,H!;D]287F-JC1P\=-P*K;-Z\N67+
MEABLL\XZZ]QSSP7 8,O@R:S(SNK W"]*6;%B!?U,0AJ[UXYX,$7XKW$,DFXE
M;O2X<>,NN. "?S_M3TQ9-L/(+Q4N4*  J.SZZZ^7@E5'2:.ZZNDE+:(_;[_]
M]KY]^Z;S?6$8E/RB18M2.N*@P3_\X0\Q(\>*>F!<J ":5D6+/UU74S$@2K-F
MS6#R9&;_YG#L#CD#CV4U7 2?+KKHHC)ERNBF7S6?!XS:"R^\X#B?#!&E!QYX
MX)133I'_K?>^?>'YBBNNZ-^_?W1-3-*T>/%B<:,;?4E38!V(FQZR5JX?0N0W
M_Z2GN)E^=:#?(7I&*BM6K(B#D4[,':%(T5<H$Y)(ZJ-S6VY<?F**F7N,5L15
M1K6&IDTUW&AXZH]"PQ;@*<&N.AB9E_Q%6E$:[L"7O7;7:+KO:2E+>.\'*)F$
M*0?ZT!<WGXB __^!G1X?'2]^24@$7XC\:!D&') %XKQCA ;&Q%/B^^^_ORMY
M02M-R+"3F0G2F.*#D80^_ &-.E9TDL#4A)T"C^)[RR[J" >GIY26X/!)>B&P
M?%1N(CEEF LA)V7+E@6IPJ-X*HC3&T;:Q91E7R0B6J!0#!+.O90%J>Z[[[YK
MK[UVS)@QVCP\>_;L="L8>70,"?\#E=&A0X=V[=JM6K5JY,B1N!T\X]@!7'D
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M.?J?YD==3U4,F*H!BI)\M1\&4[.\K1/1+G7DNC1F5P=ID43;"^/>=XDA(C+
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M;ETV&NOFC9Y$F=QZZZW///.,'5\G_Z@7&GJB;#TF\@.]T:-'#\>438N@U0
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M0V8!#Z3:[;??7K]^?0ZQYS\&NW;MTM.?M]]^^_/@'-W*S7I+6P])B"3/T(V
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MLB C7W[Y97B UD&5:L*6X!]UZM0AA,ANV;]FS1KLA) F=Y,Y<^8N7;I FXA
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M3Y^F8,\__WRV;-EP@Q3O+S-K,4[;/;R6JOCAAQ_P.90<CV>+IZ*J*FSBBT'
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M4BUV['UB.F,BX3=$&8(U8\8,5#TWOG[]>@KYYIMONF4J&U0@9?O3X*QKWMV
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M>-.F34>-&O7\\\][$T5PI<)O9NA]_?77H8Q3IDPA0@1,(/SRRR]A$A4J5(!
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M16Y=47]"$8X>/8KK@PO""&'5T%]ZA+X"A7/K6FXED$A0!FCZ_/GSL4.T*+$
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MFTR]26W]I_F<&'["MNQ!K\3=3T.0Q%[S.GE2SRR /D ]9-[A8)"R4@BQ'G
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M!G/+W*]]T.@/?N\W>?+DM&G3DBVNUF?F>*#W$5FI'WX5[2 9N/+_5G32@=A
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MRBNO+%FR!*>'=M]HT?-3;'X[XLWE1GSV4F/287-GU1PJH:_@:1H]E):2[#R
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MM!#.&3-F(,E(" Z-SK+;:D$^]UID47EX^HI3<:&T4RZZ+\=:-]TCVE1.)WX
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M6"VYU;6>NFN12^Q_2]<94,QD[D/ND;XN<H]2O"E9]TA-KQPTLD:GIK(PG^Y
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M5BM'Z9Q93JEV_WL'(OLC1Z* 9#2E1 [M^W[)P(NRY#K]@D8O??OSV@2@:)(
M+$(1OWC !90P2XU1R[9_M#]5^TO]!;/Q*&Q#%P@-L(1FBT0-/,<D,"T>)^#!
MOP0Q;9(@(:/XUF D+H+/C*2;%& #:?O-#(^>R&WBQ(G-FC4#;DV9,N5[6S\9
M\=1QVK1_*@GG2&5'E^2PQ1!*L@F$P"-1DJW>V6SK$Z@CIA33^-Y[[ZVR5334
M%%@("E5@1FW1@<"B0X<.!;H_\<03(#$=V W!G!X]>BB08].F33$&E2M7[MRY
M\[OOOBOG&-0Z9LR87KUZ\2)MM&#! AH+"RW0R^LE2Y8$,G7ITH4\>_;LR1V2
MR> EVW F:(<2.HSJ*I)@.U7('UPZSH@/ 8.7+EV*O4<I^!.K/[H__93>_8@M
M[,&@OOSRR^1,\1 &:I?=#"U:  "  $E$050U:]:SSSX;''C666?1P;7%!0;N
M]>*S:QPGF%=:4GG\5C:#5UP)PZ;C$$4Y3[LL3'_TZZ0!X!4J5 AGB$Z'M<89
M@O.M6[<&HPX;-HRFO/+**QLV;+C;5BME_&DG;/[[(5,1[F;8&SN@[N2/$X"H
M3)HTJ7W[]C?>>&.K5JT0 (#EM==>2ZGP"72B>N_>O3MUZ@1709X@VV+%BO$+
MVH>EW&S7KEV'#AW JX E/+DO;4LGWLQ!.U_47Q@50#*3GM92V31LO\^V6LGC
MW&0K!K_W%A:ZY6I;+)2NS<>DXJX#=GRENI6XH18,D/]SZI[^E $>JH<&;OHS
M\9/&XW1]V%M@^8OM";3UDMLU";G&%CHJ+.V''WZH3:&OV7GTW.$:5(^[S)WE
MRY?K/G_27SZV $Z?6Z0<36-JNFE;+/K>(\TGBXV:H>("[CFN;K7]>[N\?8/[
M[&01S7:J1HXYCD4!"B1(RY5,RJ2CHH 4!84LBB1I(2\>FX.X^VRIOY8N:] '
M0MHW&B'Y;K1EDU&\+5!47_C>!G]UK5&;]1:L2,,T;B:6;NL@ZPI;5 RXI:LJ
M\+)VRM"7<=9)^1\+T:QK@-DZ(W+^V4B+.S0%'>W19=R;W--H=@5>U$W_G4@4
MP_5*V#=YJWE7--@.V\D/X-]@H>-@(TR@RBU;MMQJRRA@ H8,KP P3TW!\)KL
MHFK^&JD,RM\55;Y0BLVXHLGA#!P#H#9NW!@[A7MS^^VWMVW;MGGSYL#4BA4K
M7G;991@OG/"B18OJ3%?<#Y)A,7&-<'=I%(SO5CMDF*<DGC9MFK_6[CIR%-N(
M,B:76]CL/HR"1?O^W$@\^A;:&W^# @0J>"(HC=!XLD<CRFIOL['C>!O-A!OJ
M@+(O=#?@I2:TA OT&[%%7F*=_T,1^Q:=D4=[?)M@D2L N8.[_L1DB' BM&%/
MGO4HV4:Z<5$<N%6Q(]Z &D*[R[=B_&]"<8E&IYQRBI G=-II)\>=?&K<2>=4
MO__E$2M_B"2%(@F[7IMV?[<F)<[[O[C3XDXY/2[NC%/Y.2WN_\Z).SU'T:OO
M[#OJU9]2CZ$YA)RDYFH"$SFT9EB-[,4O/O>TJ^[^^$ADGRTI3M.P490:93AA
M_[9E W.>DC/+^8WFK=GV[:&(G8V3.C1"KJMGWG7J2:?%7=A@T@=[O['<5(T,
M^@.*#[Y/G3H5\8U82O>6GZ1'] @UFC-GSCY]^N"CJ&#!U%&$1.)%C1\_7F X
MFA)M41"..."'_-/#9K^#4#' -ESYOGW[ H'H&+KOY.]/IO38E>Q1DI$_F:[5
M3\+FIM.'=]C>]#<LUB[:7\@3D*G(1OWZ]7OPP0?!!H *;2+E#AB5-(!VU#1*
M><2($??<<P_JF_N #7#%&6><<>JIITK.FS1I,GGR9-G%(W:X/"I [8*:0"G,
MGCT;(R% 4J5*%5!?K5JU9LR8H5U 3QFIV$(C@%Y,]4[?VG*J(ZM&86ZZZ2:@
MU^#!@ZD+.D(0,1JK!.3-+Z[BCWO+W[@X[L\]]US-FC6S9<MV&AW81IVR9,ER
M_OGGERA1 IAZ^NFG \"F3Y\><XG(45+&XA1H=_J.MC]!=+V81HL[W;IU _]3
M>.VGHA,-&3+DAAMN>."!!X#<M'6E2I5@'5)]E/+LBA&=/IP6@(T<.9(V'6/G
M-]:H4:-:M6K=NW?OTJ4+KD#^_/EYE#IF9X-WJ4-R=LUO[MRYX3-RQ>M+ER[%
MF9#Q2+:A"DV3!BB]DH0\O*I^H4>)%O,<::3*<@UQ!.$,;L=7%L<2#PGAQ (E
M^**U*;=06K#TW^]%V53=<67PIXSX9G'#OG!-_F^IV"+W5MA;!>#^W&\'@?Y@
M(5(1!H',N7/GNNA$=$Q<*_K1K%FSM+1AL1VS](7%3MQI6S$UP)'B.7"[;/Y3
M3H#6-&J>DX: 2_C-*RT2K'\KJ=Q*2!GNL4@V:)CDM!O:Y2:Z/U4%_Y^9E$DG
MFB1RCH*/,R37^\(>RM)UBJ=AG)))LO4+>XQVV4DP#L1^8T&AA2K?LW.25MD>
M5^@K6P.OM<0;;#\GBDBSIMMM-X$0,AF"CM;:4N3W[10W^CMV$X6)^7[\\<<Q
MY3.-,)=D^^Z[[Y(;Z@Z\RNNJM?OU,\%=1ZL[E^98R>607E9AWS2I=*!4!UH:
M=W_%BA4X'MH4@.7*DR</!A?[U;-GST&#!N'LP0$82^(4V[D0]A93J#F<4O63
M5"ZOY,J5Z^&''U:1#MHBJ2_LS'8^I/-4,5*R2LZ!YSIOWKQX+#A"F*?//_\<
M?Z-9LV8%"Q;$GXEX0A)0=')@_-6/6;#?)-4. ="BUM^7R1\AN5M'O&"3)Y3$
M+D?^^VI96+'?-@?!#:T4HSD0%7H0_4OSO0$6:=0U>G0;VF!#2P?LT%3>DC4D
M9\U:^RG))GAXM-_;(>R*QT>Y20'<BDYUHHC) &]]94>V>CG]72A.F"%?OGPZ
MYQII+I'O\CSY"N<I5*S]R$73/MIY*)*\/W0P$CH4V;?MXR43)P_M6K-X_OR7
MYLU;L&S'^\<\,_>C+W<D[#P2"2>'4Y?@PI-PZIQH*DP]O'YLBZIUJE]5J?F
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M%0\)_M-,5UUUU5UWW04.;-6J%27GZ:VWWHJQ]W\EFI2S,G?%@V,41F/A&GH
M+U$8"5O;MFUSY,@!T_@%TH/PM2^(.["K5*E2M'Z[=NW&CAU+_T)[(#G.B]*W
M9$X"FD>/(FF+&C;[G6@Q;+3 ]:#M5</2:,Q50$Y3A70'_M3R8-)(-05XGN*1
M^YR?Q.KT>!6)8F-Z*57'D 6J/6*DDN_WG9A*UY!32W-K3SB.T5@C^N:<.7,6
M+5JT;-DR7%YX^(6=:;[)5H4A$NI*!VU-]8^VZ?1;VTJWSH+?8M2U<>XC.P)4
MR_"TOR[>)G]X"P9J5>$ABUTGAJ17'7_;Q7SD)Y=/.&J61H\"%'@]DS+I1%!
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MDR['4M[]Q<)1;MKT:V1\8.>J5:N0F==??UTGN-!Y\8%6V!0W=_@3U:'Y"ES
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M]EO\GG>-T%KT'?[49BVZTF[O6%%5P9&_))F429F42?]."BC&L#DAFJKZWG;
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M9LVNOOIJ,$_7KETG3)@P>_9L//C__.<_: <M671E<%]4.86'_15Q%'TGF@*
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MLF?A$50+LJ2)]QS>@H"B&3 JA]8<#+\X^MHE1%,)= "T[_7KU_-G>U^1S1I
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MF50IKP%[E#$D8 0+%BQT!AUW'Q)1M4VT6FQTZ:B<PR'W%U!>V01YXIM-[4$
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M[G?NDO?5\+LY?([11-.J@" 7D21(2K)X5TX+O7'>Z\*%LR?][H04DG-9 Y2
MD,'&74OPOA3@=?[2^7,!?OX^7CX^%[W\O'W\O2X$>H7X>H5=C7MX*[^DD">?
M*I$EGF2,8R6UK"V2'[*W N*/GO:)S/'/A-1$481<2)4SKB/_984\O'KR\+7<
M\S$EA4\*+D,I94FB9^B-1GU!5N+MY$!_[S,GO?TNG/6_=#8X_F:&F&/0<;P
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M V<>BRK,KA)EA-Z\(.L?7)X_J+%[G48?+%V[Y]^?J9B:+CWGG+PC9)8;Y:A
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M\*XV#>WL/7HOG[@SX+')*+$ET.K@"0_+PG35DNO?C%G6W\-IR/C66R)(51E
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MV$?6!,-AR4U1,F4"/>)D8V;@SG??;^54L\FX*1NO%9GH+D&HJ<_25-*XY;0
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9)A!%_3](O9!RZ4MWB@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>image_20.jpg
<TEXT>
begin 644 image_20.jpg
MB5!.1PT*&@H    -24A$4@  !U,   !&" (    6\"K\   ".4E$051X7NW8
M,0T , S L/(GW?YCL,@^ R&S      "TS!L      /B<\PL     4./\ @
M  #4.+\      #7.+P    ! C?,+     %#C_ (     U#B_       USB\
M    0(WS"P    !0X_P"     -0XOP      -<XO     $"-\PL     4./\
M @    #4.+\      #7.+P    ! C?,+     %#C_ (     U#B_       U
MSB\     0(WS"P    !0X_P"     -0XOP      -<XO     $"-\PL
M4./\ @    #4.+\      #7.+P    ! C?,+     %#C_ (     U#B_
M   USB\     0(WS"P    !0X_P"     -0XOP      -<XO     $"-\PL
M    4./\ @    #4.+\      #7.+P    ! C?,+     %#C_ (     U#B_
M       USB\     0(WS"P    !0X_P"     -0XOP      -<XO     $"-
M\PL     4./\ @    #4.+\      #7.+P    ! C?,+     %#C_ (
MU#B_       USB\     0(WS"P    !0X_P"     -0XOP      -<XO
M $"-\PL     4./\ @    #4.+\      #7.+P    ! C?,+     %#C_ (
I    U#B_       USB\     0,T!MCQMK^#:'!(     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>image_21a.jpg
<TEXT>
begin 644 image_21a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" )8 X@# 2(  A$! Q$!_\0
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MC1F/106(YXH UJ*Y-?BSX(;IXRT#_P &D'_Q5+_PM?P/_P!#EX?_ /!I!_\
M%4 =716!HWCCPYXENS:Z1K^F:M<JGFM#8WD<S*H(&XA6)QDBM^@ HHHH ***
M* "BBL;7?%FA^%S#_;.LV&D^?GRC?720>9MQG;O(SC(S0!LT5RG_  M?P/\
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M&%'C<'!5@6R"#3?^%K^!_P#H<O#_ /X-(/\ XJ@#JZ*Y&/XN>!I5R/&.@?\
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M<J&&V6&Q>-^#SM;@\=:];HH \3_X>C_%/_HT?QA_X&W?_P KJ/\ AZ/\4_\
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MS;40!1EBQ/O7V?0!D?\ #9?Q4_Z(=I__ (5-W_\ *JC_ (;+^*G_ $0[3_\
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MB@#(_P"&R_BI_P!$.T__ ,*F[_\ E51_PV7\5/\ HAVG_P#A4W?_ ,JJUZ*
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M["4_BPP\[:QW?. U 'T?\0/'/AV]M;72;?Q!I<^JC7-,C-@E[&9]ZZC;[EV
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M?0- !1110 4444 %%%% !1110 4444 %%%% !1110 5\_P#[??\ R9M\6?\
ML#/_ .AI7T!7S_\ M]_\F;?%G_L#/_Z&E '!>$?^15T7_KR@_P#1:UJUE>$?
M^15T7_KR@_\ 1:UJT %%%% !1110!Y]\3/\ D=/A-_V,T_\ Z9M3KY_\#_\
M) ?VM?\ L9O%O_I(*]R^.D/BJ"+P9K?@_P +'QCJFB:Z;V32AJ,-CYD36%Y;
MEO-E^4;6N$XPQKYOT/0_CMHW@#XM>&?^%*><?'NJ:OJ/VK_A*[$?8?ML0CV;
M<GS?+QG.4S_LT ?;]>&?M6?#ZZ^*5C\-O#MCJR:#>3^+([B'4)+);Q(G@T^]
MG7,#D+("8L8;C_>^[7N=>??$S_D=/A-_V,T__IFU.@#Y+_9+^'$GPD_;A^(O
MA:?48=8EL_#SS/>6]A'8Q.9I;&<[;>,E(U'F8"KQQQCI7WK7PA)X9\6>*O\
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MXZU'_A-?[+^(O]D^1XFO8+D?V'!/]IN!LWS_ #'Y-W]P<"@#VSX:?\B[>?\
M89U;_P!.-Q75UP_P=M[JS\$>1?7GV^]CU34TGN_*$7GR"_N S[!PNX\X'2NI
MU>WNKS2[V"QNSI][)"Z07?EB3R)""%?8>&VGG!ZT ><?\VL?]R9_[8UU?Q+_
M .1=L_\ L,Z3_P"G&WKQ/_A#O'7_  H/[?\ \+%/]C?\(SY_]D_V';_ZC[)N
M\CS<[ON_+OZ]ZW_&_@3XB6NC6[W?Q1-_$VIZ<@C_ .$>MH\2->0*CY!_@<J^
M.^W% 'O%<I\5_P#DEGC+_L#7G_HAZZNN;^(>F76M^ O$NG647G7MYIES;PQ;
M@N^1XF51DG R3WH @^%'_)+/!O\ V!K/_P!$)75UYKX!\2OX7\-^&/#GB+2-
M0T&]BL[;3XYKH126\\RQJFU9(G=5)*_*'V$]J]*H **** /G?XD:-XCU3]I[
M1+KPLVEKJVF^'/M8&K^;Y#(9IX6'[L%L_ON*[_X4^,O$?B2_UBR\1#3/M-F@
M;_B60RHBN+N\MG7,CL6&;3<#A/O=*I?\W3_]R9_[?4?"3_D</%O_  /_ -/&
MKT >K4444 %%%% !1110 4444 %%%% !1110 4444 %?/_[??_)FWQ9_[ S_
M /H:5] 5\_\ [??_ "9M\6?^P,__ *&E 'A&A_&#1M+T73[.6UO6E@MHXF*Q
MQXRJ@'&6J]_PNS0_^?74/^_<?_Q==9X1_P"15T7_ *\H/_1:UJT >??\+LT/
M_GUU#_OW'_\ %URO_#8GPK_Z&C3_ /P/M/\ X]7M=>:Z/XB@^%5Y=:'XFN5L
M=(FO);C2-9NF"6S1S2[_ +-(^ D4J/)L0-]]/+P2V]5 .O\ !?C+2O'WAFSU
M[1+J.\TNZW^3/'(L@;9(4;YD)7[RMWK;K.T'Q%I7BK2;?5-$U*TUC2Y\^3>Z
M?.L\,FUBK;70E3A@P/O6C0 4444 %?*_[3O[5/AKX0_%;P/H^O:+KIDT>_\
M[<>>UBMY([FUDL;VU!BS.&W"67!#A/\ 5,?[N[ZHHH ^$?V6?B?I/QF_;I^(
M?C'1(+NVTO4O#*^5#J"JDR^6;")MP1F7[R-CYNE?=U%% !1110 4444 %%%%
M !7GWP._Y$O4O^QF\0_^GF\KT&O/O@=_R)>I?]C-XA_]/-Y0 ?''_D2]-_[&
M;P]_Z>;.O /C?_R.FG?]ES\/?^F:SKW_ ../_(EZ;_V,WA[_ -/-G7S5^T!H
MEY>?$.WN(?$.HZ?%-\9-!M$M;>.V,<$IT>S(NE,D+-YR] &8Q\<QF@#U;X*]
M/@#_ -DRNO\ W"U] 5\__!7I\ ?^R977_N%KZ H \<\#^%9?$'@"XNM.F6Q\
M0:;XK\17&G7;]%?^U[T-$^.L3CY7'XCE5-<U^SE)<_%#2[C4=2M?L.C:+XDU
MF:'3_/CF\^^DU&XG\US&2"L2S*J>K[GQ\L35<\"7EQXOT/4O!&FR3PQ2^(/$
M,NM:E;R[#:6S:S> 0HP(832_-@C[B;GRIV;H_AIHZ_#SPO>>*-"LV73K?7M<
MM-6TNSBXDM$UB\"31H/XX5[#EX]R<E4H [_X'?\ (EZE_P!C-XA_]/-Y1\<?
M^1+TW_L9O#W_ *>;.F? 2[AOO -Y=6LJSV\WB37Y8IHVRDB-K%X001U!%/\
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MC7F5O)KLO[9?@;3/#VM_\([>ZEX3U:W:^^R)=;8UGM9B-C\<F):N?VU\4_\
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M6@"M\9/"NI:=\-]8N)_!&CZ1"GE9O;7P_9VLD>9HQQ)'J$KKGIQ&?3CK7/\
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M3_Z<;>@#JZRO$6MP^&O#^I:O<I));Z?;27<J1 %V1%+$+D@9P/6M6N4^*_\
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M07?EB3R)""%?8>&VGG!ZURWP>U6VUSP3_:5E)Y]E>:IJ=Q!)M(WQO?7#*<$
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M^\9_\GD^!/\ L#2?^@WE?0-?/WC/_D\GP)_V!I/_ $&\KZ!H **** "BBB@
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MZ]\8_ /A75KC2]:\<>&]'U2WQYUEJ&K0031[E5EW([!AE2I'M6=_PT+\*_\
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M  M?P/\ ]#EX?_\ !I!_\51_PM?P/_T.7A__ ,&D'_Q5 '5T5RG_  M?P/\
M]#EX?_\ !I!_\51_PM?P/_T.7A__ ,&D'_Q5 '5T5RG_  M?P/\ ]#EX?_\
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ML26L,D4;;YI)>%DEE<??[R'_ (#]VNUH **** "BBB@ HHHH **** "BBB@
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MX_O5]X:5I%EH5E'9:;9V^GV46=EM:QK'&F22<*H &2<U\*?LK?"H?"W]L2&
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M"^C:KXDU;SM/U*Q@NWTC3X/L\#;T#[9&+.[KSC&X ]Q7HD<:0QJB*JHHP O
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M_P DL\9?]@:\_P#1#T 'PH_Y)9X-_P"P-9_^B$KJZY3X4?\ )+/!O_8&L_\
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MT?WT^7<J[ESZ=XF_YJ/_ -E-\+_^Z_7G_P"R]_R7[QQ_V,WC?_TKT.@#W_\
M9Z_Y(#\-/^Q9TS_TDCH^./\ R)>F_P#8S>'O_3S9T?L]?\D!^&G_ &+.F?\
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M%OV>M&^"&H>(;_3M=\0^(;_75M5N[GQ#>QW4F+=76,*RHAX5\<YX5<5ZE10
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M9=Z(V#W53_#7;?\ #/7PK_Z)IX0_\$%I_P#$4 '_  T+\*_^BE^$/_!_:?\
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M;LJ,#I-WM9).4<$#/RL2,X;!XKOOAI_R+MY_V&=6_P#3C<4 =71110 4444
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M2VLCQ7$:."T+G5-5<*X'W6V.C8/9E- 'L5%%% !1110 4444 %%%% !1110
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M(GB77FTVSUCQ58P6,6G:?<R7%M;1PQ2(I,SQ1LQ8R9/[L8_VJ4F_9MKXE_\
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M:OTWOH);:F5XE_Y!L/\ U^VG_I1'7G_[,/\ R2&W_P"PSKG_ *=KNO0/$O\
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M-^SUH_B^_8ZOXA\1:EH;W\>I-X?O+M)[+SD.5VF2-IDCR,^6DJ+[4:1\!O\
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M;J588+>"PMI))G8[5556Y)+$G  KZ5\6?#WPMX\^R_\ "3>&=&\1?9=_V?\
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M!(G7^]6I_P ++TG_ )\_$'_A.:C_ /&* #X:?\B[>?\ 89U;_P!.-Q1\5_\
MDEGC+_L#7G_HAZC^&8D/AB622WN+4SZGJ-PD5U \,@CDO9W0E' 9=RLIY'>I
MOB=:37OPV\5VMM#)<7$^DW<44,2EGD=H7 50.22: /!_C'^T,G@[QAJ;>$;C
M3M7GU'1K.)-2M[N.:.T>.>YS\HR';$O3/'4@BN@^%_C6T\3:5\/(I]2TZ3Q!
M)XBU.]O-.L[F-WB+Q:BQ.T,3LRZX/^TO->K?\++TG_GS\0?^$YJ/_P 8K&U/
MQ+!XF\4^#HK&QU@"TU22XGENM'N[:../[%=)DO+$J_>=!U_BH ]$KRGXC_\
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M&T;_ (55]J_LZS@L_._X2.U3?Y<:INQ@XSCIFMC_ (6'\3_^B1C_ ,*6V_\
MB:]5HH \J_X6'\3_ /HD8_\ "EMO_B:/^%A_$_\ Z)&/_"EMO_B:]5HH ^7M
M%M_C=X:US5]0T_P-IC_;[F>:);^]AF>VBDF>8PJZW"#;OD8GY>3^&V]\ ?AI
MXX\/_%WQ%XI\5:+%I::K;7#LT-Q&Z>=+/')M55=V X;K7TG10!Q_Q'LM1ETJ
MSU'1M,_MC6-+O([NWL_/6 S=8W7S&^5?W<C]:YK_ (6'\3_^B1C_ ,*6V_\
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MU]_:%C%I<UNTGD21[9!%=L1AU!Z,M?45 !1110 4444 %%%% !1110 4444
M%%%% !1110 5\.>+_BMX8\/_ +)7Q=\/ZEX@CEUG4/"ETMK%';NRMOT.&)(]
MT:E 593&<GJO-?<=?/\ ^WW_ ,F;?%G_ + S_P#H:4 >>>";J*]\(Z.\#;D6
MVCB)Y'S(-K#GT(K;KS+P#X^T#0_"-C97M]Y-U'YFY/(D.W,CD<A2.AKHO^%J
M>%_^@H/_  &E_P#B: .KHKE/^%J>%_\ H*#_ ,!I?_B::OQ4\*M]W5/_ "!+
M_P#$T >6?L%?\FF^!O\ M^_]+[BOH"O"_P!A[2;W0_V7O!=CJ5I<V%[%]N\R
MVNHC')'F]N",JP!&0<U[I0 4444 %%%% !1110 4444 %%%% !1110!E>)?^
M0;#_ -?MI_Z41UY_^S#_ ,DAM_\ L,ZY_P"G:[KT#Q+_ ,@V'_K]M/\ THCK
MY)_81\1?$SQ_\&M2NK3Q7H5M;6FO7<2Q:IX>DNI-\@CN9"'BNH%VM)<.<%21
MZXVJH!]ET5S_ (4L?%-G]I_X2;6=&U;.S[/_ &3I,MCLQG=O\RYGW9^7&-F/
M]K^&QXHM?$%UI\:>'=2TW2;U90SS:IILE[&T>#E0D<\)#9V\[OP_N@&Q17D'
MQ!U+XI> _ 7B;Q,?%'A&^&C:9<ZC]E_X1:[B\WR8GDV;O[2.W=MQG!KRW]D;
MXB?$SX\_#[Q'XTNO&"1:K'K=Q:6^C36$!TM8Q%#*J?(HN!CS&4-YQXZAS]X
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M)^URI:M<?VB8_-:-6"EMAVY(KWO3=+L]&L8;+3K6"QLH%V16UO&(XXP.P48
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M_P"$/@7Q-X:OK#6?#^KZY;:K8'4)DV0FR$$C.T:$;C).L<F. /F*K]3^&O\
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M?:#J,^?(M]01<3X&3Y<D;.C''\.[=[5U% !7+_$N![GP)K4$2[I98-BKZDD
M5OW=W#96TMQ<2K#;QJ7DED8!54#)))[5Y_XG\8:EXF\,77_"+>%M1UQ)EC:W
MN)I(;*"4;@<KYK"3&.0=F#V- '):?\:?%MI86ULWPYOF:&)$)1KUP<#'#)9,
MA^JL1Z&JGAGXK^+/#FG36W_"O;^X\V]N[O=Y5^FWSKB2;;C["?N^9C/?%>U^
M&1=#P[I8OK;[%>_98O/MO,$GE2;1N7<.#@\9%:U 'AUW\?\ Q)I]K-=7/P\N
M[>VB1I))IOMR)&JC+,Q-C@ "J6K?M*:OH">9J?@B338]AEWWDU["-@9%+?-8
MC@-(@^K+_>KU/XK_ /)+/&7_ &!KS_T0]7+O1KBX\;:7JX,?V:UT^\M'5L[R
MTLELRD<8QB!\\_W: /)X_P!HC7I?)V> IV\ZX>VBVO>_O)4W[XQ_H/++Y;Y'
M;:W]VKG_  O;Q9_T374/^^=0_P#D"NB;19]!O?!EK<-&\C^*=2NQY>2-LT.H
MS*.1U"R+GW%>DT >$7'[16O69NC<^ IX?LMNMS<>8]ZODQ'=B1\V/RK\C\G^
MZWI4(_:3U=]6DTY?!$C:A&Z126@FO?.5WC,BJ4^PYR41V'LC&NU\3:-/XEU[
MQ_I%JT:7.H^%[2TB:;(56D?4%!; )QD^E=3X@T:XU/5?#EU"8PFFZ@]W,'SE
MD-K<0X7CKNF7\ : /++7X_>)+Q'DM_AY=SHKO&7C^W$;U8JR\6/56# ^]+=_
M'_Q)I]K-=7/P\N[>VB1I))IOMR)&JC+,Q-C@ "O1OAI_R+MY_P!AG5O_ $XW
M%'Q7_P"26>,O^P->?^B'H \LU']I35]'CN'U#P1)8Q6R1RSO<S7L8A1V949M
MUB,!F5@,]34]O^T1KUU,L4'@*XEE?S=J1O>EF\IPDF +'^!R%;T/!KUBTT:X
MM_&VJ:N3']FNM/L[1%7.\-%)<LQ/&,8G3'/]ZO+/%-[J?PTUS0!#:/J%[J$F
MN0V\EO;37$<3W-[%=(76-2YVQ*Y*J.=C=N: *D_[2FKVNIQZ=-X(DBU"4#R[
M222]$TF<XPAL=QSM;_OFKA^/WB5;N.V/P\O%N9(WDCA;[=O9%90S ?8<X!=,
M_P"^M;&G/X4M]#O-/O;/Q'JEQ?,)KV^N/#FH">>8=)-RP#:5Q\FW[F.*J^"O
M$MWK/Q3M-.NH]0NETK2+M5U2[TZ>T:5)IK8Q>8LB)B3_ $:7) VMMR/XE4 K
M_P#"]O%G_1-=0_[YU#_Y I^B_M#W=Y;S-=_#OQ9(Z3O$'TBPDNH6VG:WS2+$
MP97#JR[>"M>T5RGPT_Y%V\_[#.K?^G&XH J_#>2;6+;5/$%S87VFSZK=ETMM
M4@\FYBAC C163^'[KN!_TTS_ !5X=\?[2=/VF_AI=-#(MO))811SLIV,RWK%
ME!Z9 =,_[RU]35\_?M'_ /)4_@O_ -AD_P#H^TH Z'X003^-O"?@^ZN(S'H6
MC:=:I:PR)C[5=+"BM,1_=C.Y4_V]S?PI7:_"C_DEG@W_ + UG_Z(2N.^#5_=
M>&/"?A'2K^9YM/U73+:;3;J3JDI@#O;,?^^FC_V=R_P<]C\*/^26>#?^P-9_
M^B$H ZNBBB@#RKX_=/AS_P!CGIO_ +4KU6O*OC]T^'/_ &.>F_\ M2O5: .*
MUK2]7T#Q')KVA6JZG%=(J:EI8=8WEV A)H6; \P#Y2&(##;\R[:\EUC4'UO]
MJ_P%J:Z?J-C;OI<\ _M"TDMRTB17+,HW@!MHD3.W/WJ^CZ\J^(?_ "7;X1_3
M5_\ TF2@#U6BBB@ HHHH *\J_9;_ .2$^&/^WG_TJEKU6O*OV6_^2$^&/^WG
M_P!*I: /5:*** "O*O@#T^(W_8YZE_[3KU6O*O@#T^(W_8YZE_[3H ]5KYMN
M?&G@OPC\:_'5MXXO//@A>QDTJ/4HYKY8"83)+Y0(?R_F=3CCV^[7TE7E.CZ-
MXA\&?$?QOXDN-%.J:?KAM/*32KA9)HE@0QY=)/+R6!W87=CH-U "_P##4?PP
M_P"AG_\ )"Z_^-4?\-1_##_H9_\ R0NO_C5>@:#XAL?$M@+S3I3+#N*,'C:-
MT93AE=& 96'H16K0!Y5_PU'\,/\ H9__ "0NO_C5'_#4?PP_Z&?_ ,D+K_XU
M7JM>4?'/X&'XT'1/^)W_ &.--\_G[)Y_F>9Y?^VN,;/UH =_PU'\,/\ H9__
M "0NO_C5'_#4?PP_Z&?_ ,D+K_XU7JM% 'E7_#4?PP_Z&?\ \D+K_P"-4?\
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M$^[D[$R>OR+5C7=1U35]"^)-UK.D?V%J4G@V/S=/^T+<>3AM2 _>+A3E0IH
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M<IIW_)4_$/\ V!M,_P#1]_75URFG?\E3\0_]@;3/_1]_0!U=<I\-/^1=O/\
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MAOED0_*3][UKW"@#D_&7_(Q> _\ L,R?^F^\J/5?#VBNFNZ)=ZE]GG\7><#
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M!Y3\+->\5:KK][;^,-+L=(UB*V\YX+&3>/G95&?F8#Y8TX#-]>R^K5PND_\
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M\-N&/B.W/SRR)&@X4]7=10![%7(^+/A];>+=>T'63J6H:;J&B_:/LDUBT?\
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M))PI8=!\P].:]CK@-$L/&/AJ&\L[72=$O;9]0O+N*>?6)H799KF28!D%JX!
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MHHH XK3+&:+XHZS>-'BVFLXXD?</F9,%ACKP'6NUK!M?^1HN/^VO_H%M6]0
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MZU:W;*K#*S9'E$<#=_J^A^3:R 'VC=74%A:S7%Q-';V\,9>6:1@$C0#)))Z
M5Y99^%-5_:M\02>'[6V>V\#P,#=33Q$"89XED'!SQ^[BZY^<[=OR<C\(M(\0
M_M%^-+[PIX>DN6^%^CSHT.JWF<\'F-L\RJA7]T"<_P![E"4_0SP5X*TGP!X?
MMM&T:V^SVL/))Y>5C]YW;NQ_SQ0!GZ1\+/#.C^ Y?!JZ7#<^'YHFAN;:Z42"
MYW??,F>I;U_+'%?(OBKPKJG[)&O0V%_-/JGP@OYO*TW5ILO)H4C'Y;>X;O"?
MX).W0U]V5A>,]!@\4>%-7TFXL[._BO;62$VVHJ7MI,J<"4#G;GKB@#XS^)_C
MZ^TC1[BP\*?8KSQ-);":*2\8_9+*)CM%Q<%<G;_<4?/(>!PKE<?X0?!JV\,W
M$=U'J-[KVLZJT>HS:K) )+K4;@D#[;L!*S)&V^)[7CRH]V/XS6A\%OV7K^'0
M[R\T.-FT^VE$IC^VL%U*:,[0MO<')_=KN$<QR@.U!N16->YZ)K^C>"])$D.=
M5\97K22RVD4(AND=,I-*L#9070C93)&I'F[,C/6@#11=-^$&E_+]D7Q4EEPD
MC&>#2[:1NA/RRFT$\?7YS'O]*\UT^QN_B+XDU#3?+O9%=&MM0NI&6213D_Z)
M(Q4I<-&P62*X7E$VY]%;'I_B#X@ZU9MINH172O<O-)JUK+YGENRC<;4[MT0G
M1OWL$B[$*M]*]FTC1SH-G'IV@*OVI%'F30QC;M7&43H HQC/<T ;WA3X7Z1X
M;\/#2UM8PA3! YV]^"><YZGO7&Z#8ZC\&/$[:>TJR>!+OS)096V_V?)U)3_I
MFW=.QY'^UZ1X;\31:W$\3_N[V'Y98^G3N,UIZII=MK-E+:7<2S02+@JU #[2
M[@U&UAN+>6.XMYE#QS1,&1U(R""."#7BO[3O[*_A;]I/PC>VNH0M9>(1:2PV
M.JVS^7)&S*1M<C[R'.UAZ,U8.B>,;O\ 9X\:7_A[Q##-#X+O9#-I$\69HK89
M^;' ;'.73^ ]-P;->W7?C/28KNPL(=1@>]U*![FSQF1&C5=WFL5X">Y(ST%
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M/H]JMM9P^WSNW=F/=CZT 4/AO\-] ^$W@_3O#7AJP73]+LHQ''&H&6P -S$
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MH]O;704O+I$<2)*!G;DQCG&3BKGBGQ$GA?1VOY+6XO?W\%NEO:[/,DDEF2)
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M?-:ZA,PX X#2-CVH [^N U&#4+KQGXT@TBXCMM5E\.6*6D\GW8YC+J 1CP>
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M%>6?LQ?\+$_X0"__ .$1_P"$7_LW^U)/,_MK[1YWF^5%G'E_+MV[?_'J /H
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MII$V?L-ZMRLQMDWE0Q"DL(6/3< 1_+ZAM[>*T@C@@C6&&)0B1QJ J@#   Z
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MJUYKX[\666O_  \\=6=K#=QO#X<GNR+NUDMVVR)<QJ"D@$@.8'ZJ."N*]*H
MY/QE_P C%X#_ .PS)_Z;[RO'K'48KKXP_#JTC6Y66UUGQ5YC26TB1MOFG(V.
MRA7]]I..]>P^,O\ D8O ?_89D_\ 3?>5X]I^KV=[\8OAU8P7EM+>V>L^*OM-
MO%(K20;YIBF]0<KN'(SUH ^C:*** .4^)?\ R+MG_P!AG2?_ $XV]>4^,_\
MD\GP)_V!I/\ T&\KU;XE_P#(NV?_ &&=)_\ 3C;UY3XS_P"3R? G_8&D_P#0
M;R@#Z!KFO%'A7PIJ;?VGXCT?1[QH8]GVO5+:%_+09.-[C@<D_G72UXWJ>CV&
MM?M0I#J%E;WT4?@\2(EU$L@5A>D!@&!YYH U/ WAS0;WQD-?\.Z#I^EZ+9VL
MEK!>6=FD'VZ5W!=EV@$H@CPIZ'S6Q]VO4*** "BBB@#!M?\ D:+C_MK_ .@6
MU;U><7WC2U\.?$*\AU*\TS3=.2-&:ZU"Z%OS(G12WRL?W*?+QQN.?EVUN?\
M"U_ _P#T.7A__P &D'_Q5 '5T5RG_"U_ _\ T.7A_P#\&D'_ ,51_P +7\#_
M /0Y>'__  :0?_%4 <I_S=/_ -R9_P"WU>K5XOHGB'2O$O[3;W6D:E::K;)X
M0\IIK*=)D5Q>@[25)&<$5[10!RGQ7_Y)9XR_[ UY_P"B'JYKKZ7JVIVWAO4]
M/BU"*^MIKOR;F%9(&6%X00P;/.Z:,CC^'VJG\5_^26>,O^P->?\ HAZQ?'>G
M:KJWC;1[71M7_L+4I-&U#RM1^SK<>5BYT\G]VWRME0PH FU76X?$&K>";F!'
MC1/$=Y:E9,!M\-KJ$+'@G@M&V/:N_KRG1NOA#_L<]:_]RM>K4 <!J.MQ>&O&
M?C/5[F.22WL/#EC=RI%@NR)+J#$+D@9P/6MZZETKP]KMK(MA''J&O7(M)+F"
M)0\KQP2R*96X)"I%(!UKBOB/_P U3_[$V#_W(UH^(=.U2U^(/ANZNM7^V:;<
MZR/L6G_9U3['MTR]$G[P?-)O;GG[M &U\-/^1=O/^PSJW_IQN*/BO_R2SQE_
MV!KS_P!$/1\-/^1=O/\ L,ZM_P"G&XH^*_\ R2SQE_V!KS_T0] %N]DTOQ)J
M.H^&]1T^._CAMK>[GANX5D@D6224(,-G)#0,>1_=K U76X?$&K>";F!'C1/$
M=Y:E9,!M\-KJ$+'@G@M&V/:HM9T[5-6\:^*[31M8_L+4I-&TORM0^SK<>5BY
MO2?W;_*V5#"LW1NOA#_L<]:_]RM 'JU%%% !1110 5PWC7Q[?>'/%OA?P]IV
MEV^H7FO_ &ORY;J[,$<'D1ASG;&Y.0:[FOFS]K?18/$&K>$;:X:2-$T_6[H-
M&0#NAM4F4<@\%HUS[4 >R:;X4O;S5[35O$5W'>WMKDVUI:*4M+5B""X#$L[X
M.-[?@%YKKZ^8O _[(O@_Q-X,T#5[G4=;CN-0T^WNY4AGA"*SQ*Q"YA)QD^M;
MG_#%7@?_ *"?B#_P)@_^,T ?0-%?/W_#%7@?_H)^(/\ P)@_^,T?\,5>!_\
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M $3?XH_^$)JG_P 8IFA^"?&7[1FO6]E<>&]=\&^#8I-[GQ!I<ME).$;&]HY
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MH]3N;6VM(%BFT^/'EW9DNK;:7SG[FQL8Y^?KC(;VZO*OVI/^2$^)_P#MV_\
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M>7-XD^Q9V5W B*C?A2%&[9CJ,\U]MUY5^RW_ ,D)\,?]O/\ Z52T 4/^&5?
M?_0$L_\ O[>?_)-9NI_LA>#;Z57A5M/0+CRK=I64GU_>2,<_C7NU% 'S]_PQ
MIX2_Y_+O]?\ XJNU^'/P5LOAKJUO<:=?R36T%M<6X@EC^;,SPN3NSV\CIC^*
MO3** //?BEX9U2_>RU_2_%Z^#FTBVN?M%VUA'=JT+^6S9#D8 \K->'> /B-X
MV\7I"=6^)L_AB.]E=--GOO#ML8+U0VWB7A0^X,#&?]GD[J]S^,W@;4_B+X(F
MT73M1_L\RS1RSH>!<Q+R8=^#LR=IW8/W>F*\PUCPIH?B/Q3'IMUI\/@.QT:P
M%R;34EC:&^F0;0Q3=LGBAA5LR!@_[WJNV@#NO^%>?$__ **X/_":MO\ XJO,
M?!VFKXBT\W&J>,?B/:W"P61":+)?74)\S3[:9V++%+AC),YQNX^7C%:O[*7C
M!-9N_$-J=:CALUD1-,\.R3L[P1*"2Z>82VT^@8X[_P -<[X"U#PIHVH>-;6Z
M^&-_XK1/$M[]GNM+\/17<-O""@6$,<;=N,[!T#4 =SX=T+P]X7\06^M-K7Q$
MUNY@D1U35]'O+@,5CGC7+-:!P%6YF. P'S5D_#'XL:-;^-+W[(ESJD&LD^7<
M6BH%@!US4(090[*R_/=1#:%+#N*Y_P ?Q^'O%FFVMKI/P=UO29X7GN&>7PV]
MJDNVTG$49:W_ 'G,S0\=/4UWWA;]F^S\.:W9WMM=V%A%%/%)<IIUE<))<K'*
MLR1EI[J957S8HF.U=WRXR-QH ]OHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "O(?@\O]G?$KXJZ2R[6CU2&^^;TN(R]>O5Y':LGA_\ :;O81\L6
MOZ#'<'_:GAD*?I&M 'KE%%% !1110 50UK2K;7M)OM-O(_-L[R![>=-Q7<CJ
M589'(X-7Z* /DBWG\0?LC^,OL\_GZU\/=3EW!]OS1D_DJS*!R.D@_N_P?46@
M:_8>)M(M=4TNZCO+&Y3S(IHCPP_H1T(/2F>)/#6G>+=$NM)U6U6\L+I-DD3]
M^X((Y!!Y!'2OE6]_X2K]DKQE EO<7.J^ ;VY\WRF5<2?*05)(.R91S\N!)M7
M_=4 ^PJ\QU'3KKX3ZA<:SHUO)=>%+AS+J6D0KN>R8\M<0*/X>[QCZBL/7/VG
MM T>]TF6WM)=3T&\LA>RZI#*J-"#*8MHB;#.RM]X Y YYJIX^^.-OJUM?67A
MR^DM='@9(K[Q';X<[F&1;62_\M;A^F?X.O\ M* <3\8OB9I'Q174]-DM+1/"
M.DS1M)XEW&2=G(W>5:KP#(^&4#)&/G.!T\Y\9Z>_]JV>D:QIL_AFPMXTN=%T
M:.Y$MK-$T>6"RI%)OG=]IW,IS\R<?)78_$3X,:\GP[75KG2UAL[.W=K70;%B
M9-)3AA(QSMG9L?OB1GN.$VU>^'6G:'\0_A1<:!J5O=ZTOVEKFQBT>.2>31(V
M 'EF27;CYED/EY.1_>W+0!+X6_8Y_M;PY8W6M:E)HFJRS+)/:6L?F(L.2?*.
MX_ZS[OS9(&WHW6O>_P#A6=C89.@7M_X5R<M#I,D8@/&.(94>-?JJ UD?!GQI
M+XCT:?2+F"Y34- \JSN)I8Y4$WR?*W[SYP^T?.K<@^NX&O2: /./%OP8T?Q3
MX5UK2Q-.E_J42Q/J]TYN;D;)$D5=SGA-R#,:X'T/->:>!M9\3_LY'3O#WCJ6
M"\\*WC;+35[5FDCL923^Z<LJG:>O3Z?Q;?>_$GB33O!^BW6JZK=+9V%LN^22
M3] !W)Z "O'_  [X;U'X]ZU:^*?%=JUIX-MG\W1M F_Y>?2XG'<'LO?_ '/]
M: >Z(X=596W*>01TQ3Z:J[>!TIU ' ?%FS?Q!I.F^%E984\1736,UP\(D\J)
M89)FV@Y7<1%A<_7^&O$? OCS6OV;_%"^#?&;-<>%YW)LK]<D0 G[R=_+_O+U
M4_\ CWL7QL\26?@C2=%\3W4ZA]'U(3+:,V&NP\4D+H@[N$E9A_N>E<CX-^&]
M[\6[_P#X37XBVJR0W43)I7AYF/E6D#C[[=/G8<^O?KM" 'N%M<Q7L$<\$BS0
MRJ'22-@592,@@CJ#5FOGK3M1U+]F?6X=)U::?4OAM>R[;+4&R\FF2,<^6^/X
M/_UCG<M>^6US%>P1SP2+-#*H=)(V!5E(R"".H- %FO!($C\$?M+:[X@\1O9:
M)I.KZ=(EEJ-Y>Q1K<&,62F/!88*E6//7/^S7O=5;VR@U&TFM;J&.XMID,<L,
MJAD=2,%6!X((H \U^)OQ-\'WWPV\5VMKXKT2YN)])NXHH8=1A=W=H7 50&R2
M36C\!?"^J>"OA3HFC:S:_9-2MO/\V'S%?;NGD<<H2OW67O72:-X'\.>&KLW6
MD:!IFDW+)Y336-G'"S*2#M)50<9 K?H \J_:D_Y(3XG_ .W;_P!*HJ]5KRK]
MJ3_DA/B?_MV_]*HJ]5H *\[\-:GK?AFTOK&7P=K-\#J=_<1W-K-9>7(DMW+*
MA&^Y5ONNO517HE<[X[\96GP_\*W_ (@OX9[BTLU0R1VJAI&W,$& 2!U;UH Y
MGQQK&O>)O!GB#1[7P/K<=QJ&GW%I$\UQ8!%9XF4%L71.,GTKTBLWP_K,/B/0
M]/U6VCDCM[V!+B-)EV.%=0PR/7FM*@#&\1>%M/\ %$=K'?K<_P"BS?:(9+:Z
MFMI(WV,F0\3*WW7<=?XJ\J\3>&;3PY\=OA5]EFU";SO[6W?;M1N;O;MM1C;Y
MTC[>O..M>W5Y5\0_^2[?"/Z:O_Z3)0!ZK1110 5Y5\0_^2[?"/Z:O_Z3)7JM
M>->-]9T_4OV@/A9:VE];7=Q:?VMY\,4RN\6ZV &X Y&=K=: /9:^>/BA\,-*
M^+'[0UOI&KW%W;V\/A9;M'LG5'W+=NN#N5AC#GM7T/7@W[3/@XZ=X?U/X@Z=
MK>L:1K^GV<%C'_9]WY$<D37*Y#[1N/\ K/[W\*T 5_\ ABKP/_T$_$'_ ($P
M?_&:/^&*O __ $$_$'_@3!_\9KW/3M6LM8M_.L+RWOH<X\VVD61,]>JDU>H
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M4O\ 19M=B;>M]>6%_</G;LR?,U%LX7@9Z4 =Y\-/^1=O/^PSJW_IQN*/BO\
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M;08;VP^(/C>:5_M>1<:T2O[JQN;A?NJ/XX$!]MU 'T;17E7_  H(?]%&\?\
M_@\_^PH_X4$/^BC>/_\ P>?_ &% 'JM%>5?\*"'_ $4;Q_\ ^#S_ .PKA]+^
M'%]>_$G4/#S_ !!\;K90?:=LBZV?,_=PZ<ZY.W'6\ESQ_"O^UN /HVBO*O\
MA00_Z*-X_P#_  >?_84?\*"'_11O'_\ X//_ +"@#U6BO*O^%!#_ **-X_\
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MNTKS!;#Q;X8.LZ-I>BVFIVVHW5S=VFIO<)&EN9Y"["XC8;FVL[XV!]RA0=M
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M .SKL? /C:S^(?A2Q\0Z=#<0V-YYGEI=*%D&V1D.0I(ZJ>] '24444 %%%%
M!7E/[1?_ "*%K_W$?_3/J%>K5Y3^T7_R*%K_ -Q'_P!,^H4 >K4444 %%%<?
MJ/B;5=4U6XTOPU;6\C6C!+S4[_=]GA?@^4JK@RO@\X("]SGY: .:^'G_ "7;
MXN?32/\ TF>O5:^1?@!\3O%?CWXI>+;FUBT>&_U2R@N[E)HI1$?L^R%50AR5
MW"3))WU]+^&?$S:\]U;7-JVFZK8D)=V,C;]F[E'5QPR,!P?Y$$4 ='1110!Y
M5^U)_P D)\3_ /;M_P"E45>JUY5^U)_R0GQ/_P!NW_I5%4OA_P =^([/PIHW
MB/Q#!87NAWUE!>7-UIL3PR6"R('+/&S/O1<_,ZL".NS'0 ]0HIBL'4,IW*>0
M13Z "L'2?^1I\0?]N_\ Z :WJP=)_P"1I\0?]N__ * : -ZBBB@ IC,$4LQV
MJ.234=S<1VMO--*=L42EV/L!DUX]XN\.#Q5\*?$GB?Q%&UY>SZ-<WEE8W',&
MGJ8':,+']WS0-NZ0\YZ;1Q0!I_LM_P#)"?#'_;S_ .E4M>JUY5^RW_R0GPQ_
MV\_^E4M>JT %>3?M%R)_PB5LFY=^-1.WOC^R-0KJ_%UQ>ZCJNG>';"ZDT]KY
M)KBZO8O]9%;Q[%81G^%V:1 #V&X]<5XI\>_">C^%=>\-#2]/AM'FT;Q$9YE7
M,TY&G'!DD.6<\]6)H ^EDD65=R,&![J<T^O'_ ?@.*#X9^%M8\-)%H_B+^R+
M2;?"-D-[)Y"$I<HN%D#?WC\PZ@UZ9X<UR'Q+H&FZO;!EM[^VCNHU;J%=0P!]
M^: -2O*/#_\ R7;6OK??^DNAUZO7E'A__DNVM?6^_P#270Z /5Z**P/&NNS>
M&_#-W>VL(N;W]W!;0L<"2>5UBB#>Q=US0!N/(D>W<0N3@9]:\I_9:D1_@9X;
M0,"Z_:<CNN;J6I/%?@6RTK1=/U.__P")SX@76=+9M4NTW2*6U&WW+$#GRDY(
M"KV]:\-_9 \'Z9XJA\7_ &V%ENK?[)]FOK>0Q7-L6\[)CD7#+T&?7O0!]CT5
MRW@;4KR6VU#2]2F^U:EI-R;6:Y*!?M"E5DCEP. 2CKN_V@U=30!Y5\?NGPY_
M['/3?_:E>JUY5\?NGPY_['/3?_:E>JT %>9?$CQ[H7P[\?\ AG4O$-]_9]E)
MI>I6ZR>3))N<RV3 812>BM7IM<IJ/_)4_#W_ &!M3_\ 1]A0!R7P^^*'A?Q]
M\5->.@ZI]NWZ-9X'D2Q_ZJ>Y\S[ZCIY\7_?7UK?^->JVVC?"3Q?/=R>3%)ID
M]N&VEOWDJ&-!P#U=U'XU>T[_ )*GXA_[ VF?^C[^CXK_ /)+/&7_ &!KS_T0
M] 'B?Q[^/?@7QI\*-<T;1M<^V:E<^1Y4/V.=-VV>-SRZ!?NJW>N@\;?M'_#O
M6-%MX;/Q%YLJ:II]P5-E<#Y(KR&1SS&.B(QKHOVI/^2$^)_^W;_TJBKJOB7_
M ,B[9_\ 89TG_P!.-O0!U=>(Z?\ 'GP+X3\7>-[;5=<^RW#:SD)]DG?[EI;0
MORL9Z212#_@/I7MU<GX-_P"1B\>?]AF/_P!-]G0!XI\(OCWX%\+_ /":_P!J
M:Y]E_M#Q+?:A;?Z)._F02;-C_+&<9QT/->I_!/Q5I?BWPE>W>E77VJW&M:CE
MQ&R??NY)DX8#K'+&?^!>M9WP!Z?$;_L<]2_]IUU7PT_Y%V\_[#.K?^G&XH Z
MNBBB@ HHHH **** "BBB@ HHJM>7D&G6DMU<RK!;P(9)9';"HH&223V H XG
MXR>.KOP'X*ENM-A:XUB]G33[!0HVK/)D*S9XP,$\]^*O_"GP,OPW\!:3H'VA
M[I[9"TDC-D>8Y+OM]%W,V*RO!_Q5\)?%VQN+"V8LUQ$ZMINI1".2>$Y4LJDD
M.IPW0_6M?X;33_\ "--9W$DDS:=>W5A'-(V6DBBF=(R3W.P*"?7- '74444
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M"/<3LC50JC)))P!WKSG_ (9<^&'_ $+'_D_=?_':]5HH \J_X9<^&'_0L?\
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M>*/SI54E(]V-Q X&3ZT >?\ Q@^(%UX5L++1]!B-YXOUJ1K73;9>=A_BF;/
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M!KKXT6TE[XWLKG3=((*Z=X?$A22#(Q]HG*GF;^ZO1!ZEC0!ZU17@]IKGBGX
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M_1.?'_\ X(__ +.NCTG2-3U[Q';^(-<M$T\6<;)I^FB02O$7 #S2,OR[ROR
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M^7Z5Z!7R5^R;IGBKP_H6MZCIWAXWD.M>0+.]GN8X[5/*,ZN9,$R<,W14.?\
M9ZT >V^(OC/%H/B#4-*B\'^+-;:RD2*6[TC3!/!N9%? ;>.0'7/%4O\ A?H_
MZ)SX_P#_  1__9UV_A+P]'X8TG[+YQN[J:62YNKID"-/-(Q9V('3DX [ *.U
M;U 'E7_"_1_T3GQ__P""/_[.C_A?H_Z)SX__ /!'_P#9UZK10!Y5_P +]'_1
M.?'_ /X(_P#[.C_A?H_Z)SX__P#!'_\ 9UZK10!Y5_POT?\ 1.?'_P#X(_\
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MVV2VU.%H'C/H21M_6@#T^BLO1_$VC^(8]^EZK9:DG]ZSN4D'_CI-:E 'E/\
MS=/_ -R9_P"WU>K5Y3_S=/\ ]R9_[?5ZM0 4444 %%%% !1110 4444 >.:I
M)?1>-I7TRWMKJ^'C(;(;J=H(V_XI\9RZHY''^R:O?LM_\D)\,?\ ;S_Z52U1
MU2.^E\;2IIEQ;6M\?&0V374#3QK_ ,4^,Y170GC_ &A5[]EO_DA/AC_MY_\
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M^U:W:PO^9X_[AW_M6@#=HHHH **** "O*?\ FZ?_ +DS_P!OJ]6KRG_FZ?\
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M !QOB4=>GOS7NGQ6O(-/\)0W5U-';VT.K:7++-,P1(U6_MR68G@ "OG[QO\
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MI.BOG[_A,_VAO^A$\/\ _?\ 7_Y*H_X3/]H;_H1/#_\ W_7_ .2J /5OBO\
M\DL\9?\ 8&O/_1#T?"C_ ))9X-_[ UG_ .B$KQ?Q%J_Q_P#$N@:EI%UX(T2.
MWU"VDM)7AN8PZHZE25S=$9P?2JMGXK^.GP^\%PPR>"]$CTK0]/"-/-.CNL,,
M6-S;;GD[5["@#Z=HKQ?0]:^,_B"SEN;9? <:1W-Q:E9!>@[X9GA8\$\%HVQ[
M5I?\7O\ ^J?_ /D]0!ZM6%_S/'_<._\ :M>$_$#Q%\6M-\2>&=(O=,\+:Q>Z
MJ+O[)::6TR;S'&';>\S#:!\I^4@G:PRNZDT[4?CMI%P9K3X=^'X96783]K#<
M=>]V?2@#Z4HKY^_X3/\ :&_Z$3P__P!_U_\ DJC_ (3/]H;_ *$3P_\ ]_U_
M^2J /H&BOG[_ (3/]H;_ *$3P_\ ]_U_^2J/^$S_ &AO^A$\/_\ ?]?_ )*H
M ^@:\I_YNG_[DS_V^KE/^$S_ &AO^A$\/_\ ?]?_ )*KC=:\0?&#PUXU'C;6
M?#>AZ5<'29],7S)/,@:.)9;UOECG9]Y$+X/3^= 'UG17E/\ Q>__ *I__P"3
MU'_%[_\ JG__ )/4 >K45\[7WQ'^-,'B*XT2RT3PGJ^H0R2H\=GYR !(K:1G
MS+,@QB\B'KG=5C_A,_VAO^A$\/\ _?\ 7_Y*H ^@:\J^'G_)=OBY]-(_])GK
MD_\ A,_VAO\ H1/#_P#W_7_Y*KGM%B^/&B>+/$/B&'P5H[7NN?9_M227,1C3
MR(RB; +D$9!YR30!]145\_?\)G^T-_T(GA__ +_K_P#)5'_"9_M#?]")X?\
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MO/'-!?*)-R0RN5&6X+8W=LB@#H/^%!#_ **-X_\ _!Y_]A1_PH(?]%&\?_\
M@\_^PKU6B@#R63]G:SN_^/OQQXVOE_NW&L!Q_P"BZ;#^RU\/]ZO>6-[JDB]'
MO-0F)_\ '6%>N44 <=HWPA\%>'UC^P>%]+C>/E9I+99)0?\ ?<%OUKKU4(H5
M1@#H*=10 5DZ_H5EXFTFXTW4(3-:3J R[BIR"&5@1R"" 01T-:U% '(Z#\/;
M;1]574[K5-4UV_BB,$%QJLZR>0AV[@BJJJ"VU<MC<?6NNHHH **** "BBB@
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M*W_@;:3WUY;6?R[&4[M1ZM<M_P#P%7:^>C^\^A:***R+"BBB@ HHHH ****
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MZ=JF"_=*3WTO\U?TZ.S3>EKV>]S]VIR^OX/[[ZZWZ['6T444AA1110 4444
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MME"NX$8QGBM^;7K*VT.36))@NGI;FZ:;:?\ 5A=V[&,]/:A_N[MZ6_"W]/\
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M_AI;PE_T!_'_ /X;GQ#_ /(%>K44 >4_\-+>$O\ H#^/_P#PW/B'_P"0*/\
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M0_\ R!7JU% 'E/\ PTMX2_Z _C__ ,-SXA_^0*/^&EO"7_0'\?\ _AN?$/\
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MC_\ \-SXA_\ D"C_ (:6\)?] ?Q__P"&Y\0__(%>K44 >4_\-+>$O^@/X_\
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ME_T!_'__ (;GQ#_\@5ZM10!Y3_PTMX2_Z _C_P#\-SXA_P#D"C_AI;PE_P!
M?Q__ .&Y\0__ "!7JU% 'E/_  TMX2_Z _C_ /\ #<^(?_D"C_AI;PE_T!_'
M_P#X;GQ#_P#(%>K44 >4_P##2WA+_H#^/_\ PW/B'_Y H_X:6\)?] ?Q_P#^
M&Y\0_P#R!7JU% 'E/_#2WA+_ * _C_\ \-SXA_\ D"C_ (:6\)?] ?Q__P"&
MY\0__(%>K44 >4_\-+>$O^@/X_\ _#<^(?\ Y H_X:6\)?\ 0'\?_P#AN?$/
M_P @5ZM10!Y3_P -+>$O^@/X_P#_  W/B'_Y H_X:6\)?] ?Q_\ ^&Y\0_\
MR!7JU% 'E/\ PTMX2_Z _C__ ,-SXA_^0*/^&EO"7_0'\?\ _AN?$/\ \@5Z
MM10!Y3_PTMX2_P"@/X__ /#<^(?_ ) H_P"&EO"7_0'\?_\ AN?$/_R!7JU%
M 'E/_#2WA+_H#^/_ /PW/B'_ .0*/^&EO"7_ $!_'_\ X;GQ#_\ (%>K44 8
MOA;Q):^+M"M=7L(K^"UN"_EQ:IIMQI]PNUF4[[>X1)4Y7C<HR,$<$45M44 <
M1\8- T'Q;\,_$NA>)-371]$U:R>PN;XS+"81*/+!#MP&W,,9[XKQW5K_ .)W
MPNO/#$/Q B\*_$[P=)K%E8)J]MI\ECJMC<2S"*WN&MR989")'CRT9B*\L!_=
M^AM;T/3_ !-I%WI>K64&H:;>1-!<6ES&)(Y8V&&5E.0017'>&O@AX4\+:I'?
MVL.J7<L+^;!%JNN7U_;VC\@&W@N)WC@P&('EJN!Q2CI)-[76GSO\GYK;3>Q,
MO>A;U_%?U=;'-_LP;AX+\3?;#G7?^$LUK^U"?O\ F_;9/*W?]N_V?;_L;:XO
MXU:QHS^#M \"_#S1)-?@U_Q!*U]IOA9[5&-M;7/VC4<&::*+YI?W+YD',[=^
M*];\4_!7PIXPU=]3OK6_M;Z0*MQ-H^L7NF_:U48"W MIHQ. .,2!ACBM/0_A
MOX:\,ZCIUYI>DP:?)IVG?V39QV^4BMK4LKF-(P=JY95R0,G:.::=W%O2UMO+
M]+I*W\O70;^UYMO[[_BKWOWZ:Z?*]_XBU#3/A!^TIX,U;PMJ?@]5T?4O$>CZ
M?JDEJ\WV2\@F,P!MIYH_ENDG/#YQ*O KZ:UW_DB6H?\ 8NR?^DQJ7QE\)?"_
MQ N)Y]?TPWDLVEW6C2NES+"7L[C;Y\)\MER&V+SU&.,5BZ-^SYX3T&8&WN?%
M=Q#Y#VQM=2\9ZQ>VS1.AC93#-=O&?E/&5XZCD5G47M*,J?5I+[DTOPM?YFT9
MI3A+M)O[^6_XI_*QQ/[/NB_%8_"KX<S-XS\''0_[&T]S9#PC=?:O(\E#Y?G_
M -J;=^WC?Y6,\[.U>Y6NC0V>I7EZCW+2W6W>LEW+)&NT8&R-F*1^^P#/?->;
M:7^S'X)T*UM+?3[[QO96MHJQP6T7C[7A%&BX"J(_MNW:  ,8Q7I=MI,%IJ5W
M=QR7+376W>);N62-=HP-D;,4C]]@&>]=52:J3<EU;?WG'2@Z<(P?1)?<:=<9
M\2/#ECKOAJ[EOH6N/L$$UQ#&TK",2B)PK,H.&VYR-V<'!Z@&NSJG?646HVD]
MK<+YD$Z&-UY&5(P1D5R58N<'%;M,ZH249ION?/GPF(U;X%?L]^'@ RW>DZ9J
M%RA_YX6MI'+G'_7?[,/^!4WX[6-D/A_8:_X?N=$N?A[H>LP:SJ.AZ-:!9;^Y
MBOP[&.YCD**RSAI'C\HM)(FTNF37LOAKX?:#X0AT:#2;'[+#HVFKI%@OG2/Y
M%J-F(_F8Y_U<?)Y^7K63_P *.\&?\)"VL?V7/YK7'VHV']HW/]FF??YGGFQ\
MS[/YWF?/YOE[]W.<UV5:BG6=6.BYG+YWNOP2]']YRP@XTE![VM^&OYM>GW'#
M_&2/3O%VDZ]\'_"$%K'KOB:"0ZS)9PJ(]*M;C(FO+G QYKKN$:GYI'Y^ZKLO
MIFG_  X\/Z9?PWT.GJ+Y+@78N69BWG"V%KO/.,^2H3Z5Q8_9=\!)K>MZO:_\
M)3I=_K=XVH:B^E>,]9LDN9V !=DANU7H% P. H X%>KVUJEG;)!&S,D:A09'
M+O@#'+,22?<FL4[127]>7HOZ[&SNWOI_G^K_ $1Y?\;M8_LDZ.?^$O\ 'WA8
MOYO/@CPK_;7GXV?Z_P#XEMYY6/X?N9RWWMORWO@GJG]JZ-J#_P#"3>-?$^R<
M#[1XV\._V-/'\OW8X_L-GO3_ &MC\]^U>FT5*TN-ZV/!OV@/#]C;>(?A[K$<
M+-J-UXSTF%YWD9ML:^;A5!.%&>2%ZGK7>Z]J?AKX3#4M=FT[56?6KY);QM$T
M:]U6::<0I$KM%;12NH$<"+G:%X]6YW/$GA+2?%9TS^U;;[2=,OXM1M?WC)Y=
MQ'G8_P I&<9/!XKH*4-(N/>3?R:CI]\1/6?-_=2^Z4G^J/"_A=JD.M_$WXOZ
MA<)/'9W2:7/"E];2VLRVC6.1OBE57C^?S_E900=V>:@_9G\"Z'K/P&^&VJWF
MGK/>/H&D[9IF;>4MLRVO?^ R$CZUW7C7X(^$?B!K*ZIK%A=G4/LXM)IM/U6[
ML/M< 8L(;@6\J"XB!9OW<H=?F;CYCGM;"PM]+LX+2UACM[6!!''#$H5$4# 4
M = !51=D[;OE_P#);_CK^8V[KE[WO_E_7D7**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNCP1^U1J&K:+IUEJ/A?Q;I:E[G0-955F:-3M9XRI.X*Q"L"%(/:@#Z3HHHH
M**\V^('QL\-_#;Q?X1\/:O<-'?>([E[> _PQ #AG/8%RB#_>]J])K.-2$Y2C
M%W:W\CJJX2O0ITZU6#4:B;BWM))M-KT::"BBBM#E"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\.@_V>_^?/Q%_P"#8_\ Q- 'UTWCOPTBDMXBTL <DF]B_P :_,7X3O!\4/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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?518C-:F)4%%U%&;4=N:2NVKM[O7?=A1117H'R)__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>image_28a.jpg
<TEXT>
begin 644 image_28a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1/!90# 2(  A$! Q$!_\0
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M/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V\(?^".U_^-T?\,]_"_\
MZ)MX0_\ !':__&Z]"HH \]_X9[^%_P#T3;PA_P"".U_^-T?\,]_"_P#Z)MX0
M_P#!':__ !NO0J* //?^&>_A?_T3;PA_X([7_P"-T?\ #/?PO_Z)MX0_\$=K
M_P#&Z]"HH \]_P"&>_A?_P!$V\(?^".U_P#C='_#/?PO_P"B;>$/_!':_P#Q
MNO0J* //?^&>_A?_ -$V\(?^".U_^-T?\,]_"_\ Z)MX0_\ !':__&Z]"HH
M\]_X9[^%_P#T3;PA_P"".U_^-T?\,]_"_P#Z)MX0_P#!':__ !NO0J* //?^
M&>_A?_T3;PA_X([7_P"-T?\ #/?PO_Z)MX0_\$=K_P#&Z]"HH \]_P"&>_A?
M_P!$V\(?^".U_P#C='_#/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V
M\(?^".U_^-T?\,]_"_\ Z)MX0_\ !':__&Z]"HH \]_X9[^%_P#T3;PA_P""
M.U_^-T?\,]_"_P#Z)MX0_P#!':__ !NO0J* //?^&>_A?_T3;PA_X([7_P"-
MT?\ #/?PO_Z)MX0_\$=K_P#&Z]"HH \]_P"&>_A?_P!$V\(?^".U_P#C='_#
M/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V\(?^".U_^-T?\,]_"_\
MZ)MX0_\ !':__&Z]"HH \]_X9[^%_P#T3;PA_P"".U_^-T?\,]_"_P#Z)MX0
M_P#!':__ !NO0J* //?^&>_A?_T3;PA_X([7_P"-T?\ #/?PO_Z)MX0_\$=K
M_P#&Z]"HH \]_P"&>_A?_P!$V\(?^".U_P#C='_#/?PO_P"B;>$/_!':_P#Q
MNO0J* //?^&>_A?_ -$V\(?^".U_^-T?\,]_"_\ Z)MX0_\ !':__&Z]"HH
M\]_X9[^%_P#T3;PA_P"".U_^-T?\,]_"_P#Z)MX0_P#!':__ !NO0J* //?^
M&>_A?_T3;PA_X([7_P"-T?\ #/?PO_Z)MX0_\$=K_P#&Z]"HH \]_P"&>_A?
M_P!$V\(?^".U_P#C='_#/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V
M\(?^".U_^-T?\,]_"_\ Z)MX0_\ !':__&Z]"HH \]_X9[^%_P#T3;PA_P""
M.U_^-T?\,]_"_P#Z)MX0_P#!':__ !NO0J* //?^&>_A?_T3;PA_X([7_P"-
MT?\ #/?PO_Z)MX0_\$=K_P#&Z]"HH \]_P"&>_A?_P!$V\(?^".U_P#C='_#
M/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V\(?^".U_^-T?\,]_"_\
MZ)MX0_\ !':__&Z]"HH \]_X9[^%_P#T3;PA_P"".U_^-T?\,]_"_P#Z)MX0
M_P#!':__ !NO0J* //?^&>_A?_T3;PA_X([7_P"-T?\ #/?PO_Z)MX0_\$=K
M_P#&Z]"HH \]_P"&>_A?_P!$V\(?^".U_P#C='_#/?PO_P"B;>$/_!':_P#Q
MNO0J* //?^&>_A?_ -$V\(?^".U_^-T?\,]_"_\ Z)MX0_\ !':__&Z]"HH
M\]_X9[^%_P#T3;PA_P"".U_^-T?\,]_"_P#Z)MX0_P#!':__ !NO0J* //?^
M&>_A?_T3;PA_X([7_P"-T?\ #/?PO_Z)MX0_\$=K_P#&Z]"HH \]_P"&>_A?
M_P!$V\(?^".U_P#C='_#/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V
M\(?^".U_^-T?\,]_"_\ Z)MX0_\ !':__&Z]"HH \]_X9[^%_P#T3;PA_P""
M.U_^-T?\,]_"_P#Z)MX0_P#!':__ !NO0J* //?^&>_A?_T3;PA_X([7_P"-
MT?\ #/?PO_Z)MX0_\$=K_P#&Z]"HH \]_P"&>_A?_P!$V\(?^".U_P#C='_#
M/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V\(?^".U_^-T?\,]_"_\
MZ)MX0_\ !':__&Z]"HH \]_X9[^%_P#T3;PA_P"".U_^-T?\,]_"_P#Z)MX0
M_P#!':__ !NO0J* //?^&>_A?_T3;PA_X([7_P"-T?\ #/?PO_Z)MX0_\$=K
M_P#&Z]"HH \]_P"&>_A?_P!$V\(?^".U_P#C='_#/?PO_P"B;>$/_!':_P#Q
MNO0J* //?^&>_A?_ -$V\(?^".U_^-T?\,]_"_\ Z)MX0_\ !':__&Z]"HH
M\]_X9[^%_P#T3;PA_P"".U_^-T?\,]_"_P#Z)MX0_P#!':__ !NO0J* //?^
M&>_A?_T3;PA_X([7_P"-T?\ #/?PO_Z)MX0_\$=K_P#&Z]"HH \]_P"&>_A?
M_P!$V\(?^".U_P#C='_#/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V
M\(?^".U_^-T?\,]_"_\ Z)MX0_\ !':__&Z]"HH \]_X9[^%_P#T3;PA_P""
M.U_^-T?\,]_"_P#Z)MX0_P#!':__ !NO0J* //?^&>_A?_T3;PA_X([7_P"-
MT?\ #/?PO_Z)MX0_\$=K_P#&Z]"HH \]_P"&>_A?_P!$V\(?^".U_P#C='_#
M/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V\(?^".U_^-T?\,]_"_\
MZ)MX0_\ !':__&Z]"HH \]_X9[^%_P#T3;PA_P"".U_^-T?\,]_"_P#Z)MX0
M_P#!':__ !NO0J* //?^&>_A?_T3;PA_X([7_P"-T?\ #/?PO_Z)MX0_\$=K
M_P#&Z]"HH \]_P"&>_A?_P!$V\(?^".U_P#C='_#/?PO_P"B;>$/_!':_P#Q
MNO0J* //?^&>_A?_ -$V\(?^".U_^-T?\,]_"_\ Z)MX0_\ !':__&Z]"HH
M\]_X9[^%_P#T3;PA_P"".U_^-T?\,]_"_P#Z)MX0_P#!':__ !NO0J* //?^
M&>_A?_T3;PA_X([7_P"-T?\ #/?PO_Z)MX0_\$=K_P#&Z]"HH \]_P"&>_A?
M_P!$V\(?^".U_P#C='_#/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V
M\(?^".U_^-T?\,]_"_\ Z)MX0_\ !':__&Z]"HH \]_X9[^%_P#T3;PA_P""
M.U_^-T?\,]_"_P#Z)MX0_P#!':__ !NO0J* //?^&>_A?_T3;PA_X([7_P"-
MT?\ #/?PO_Z)MX0_\$=K_P#&Z]"HH \]_P"&>_A?_P!$V\(?^".U_P#C='_#
M/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V\(?^".U_^-T?\,]_"_\
MZ)MX0_\ !':__&Z]"HH \]_X9[^%_P#T3;PA_P"".U_^-T?\,]_"_P#Z)MX0
M_P#!':__ !NO0J* //?^&>_A?_T3;PA_X([7_P"-T?\ #/?PO_Z)MX0_\$=K
M_P#&Z]"HH \]_P"&>_A?_P!$V\(?^".U_P#C='_#/?PO_P"B;>$/_!':_P#Q
MNO0J* //?^&>_A?_ -$V\(?^".U_^-T?\,]_"_\ Z)MX0_\ !':__&Z]"HH
M\]_X9[^%_P#T3;PA_P"".U_^-T?\,]_"_P#Z)MX0_P#!':__ !NO0J* //?^
M&>_A?_T3;PA_X([7_P"-T?\ #/?PO_Z)MX0_\$=K_P#&Z]"HH \]_P"&>_A?
M_P!$V\(?^".U_P#C='_#/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V
M\(?^".U_^-T?\,]_"_\ Z)MX0_\ !':__&Z]"HH \]_X9[^%_P#T3;PA_P""
M.U_^-T?\,]_"_P#Z)MX0_P#!':__ !NO0J* //?^&>_A?_T3;PA_X([7_P"-
MT?\ #/?PO_Z)MX0_\$=K_P#&Z]"HH \]_P"&>_A?_P!$V\(?^".U_P#C='_#
M/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V\(?^".U_^-T?\,]_"_\
MZ)MX0_\ !':__&Z]"HH \]_X9[^%_P#T3;PA_P"".U_^-T?\,]_"_P#Z)MX0
M_P#!':__ !NO0J* //?^&>_A?_T3;PA_X([7_P"-T?\ #/?PO_Z)MX0_\$=K
M_P#&Z]"HH \]_P"&>_A?_P!$V\(?^".U_P#C='_#/?PO_P"B;>$/_!':_P#Q
MNO0J* //?^&>_A?_ -$V\(?^".U_^-T?\,]_"_\ Z)MX0_\ !':__&Z]"HH
M\]_X9[^%_P#T3;PA_P"".U_^-T?\,]_"_P#Z)MX0_P#!':__ !NO0J* //?^
M&>_A?_T3;PA_X([7_P"-T?\ #/?PO_Z)MX0_\$=K_P#&Z]"HH \]_P"&>_A?
M_P!$V\(?^".U_P#C='_#/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V
M\(?^".U_^-T?\,]_"_\ Z)MX0_\ !':__&Z]"HH \]_X9[^%_P#T3;PA_P""
M.U_^-T?\,]_"_P#Z)MX0_P#!':__ !NO0J* //?^&>_A?_T3;PA_X([7_P"-
MT?\ #/?PO_Z)MX0_\$=K_P#&Z]"HH \]_P"&>_A?_P!$V\(?^".U_P#C='_#
M/?PO_P"B;>$/_!':_P#QNO0J* //?^&>_A?_ -$V\(?^".U_^-TA_9[^&&./
MAOX1!_[ =K_\;KT.B@#Y9^(W@O0/"'BRZL="T:QT*R*I(;72X!:Q%BH!8I'M
M7)  SC)P**V?C5_R/EQ_UQC_ )44 >F?L^_\D)^&W_8LZ;_Z2Q5Z#7GW[/O_
M "0GX;?]BSIO_I+%7H- !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!\Y?&K_ )'RX_ZXQ_RHH^-7_(^7'_7&/^5% 'IG[/O_ "0GX;?]
MBSIO_I+%7H->??L^_P#)"?AM_P!BSIO_ *2Q5Z#0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 ?.7QJ_Y'RX_P"N,?\ *BCXU?\ (^7'
M_7&/^5% 'IG[/O\ R0GX;?\ 8LZ;_P"DL5>@UY]^S[_R0GX;?]BSIO\ Z2Q5
MZ#0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?.7QJ_Y
M'RX_ZXQ_RHH^-7_(^7'_ %QC_E10!Z9^S[_R0GX;?]BSIO\ Z2Q5Z#7GW[/O
M_)"?AM_V+.F_^DL5>@T %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'SE\:O^1\N/^N,?\J*/C5_R/EQ_UQC_ )44 >F?L^_\D)^&W_8L
MZ;_Z2Q5Z#7GW[/O_ "0GX;?]BSIO_I+%7H- !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!\Y?&K_ )'RX_ZXQ_RHH^-7_(^7'_7&/^5%
M 'IG[/O_ "0GX;?]BSIO_I+%7H->??L^_P#)"?AM_P!BSIO_ *2Q5Z#0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?.7QJ_Y'RX_P"N
M,?\ *BCXU?\ (^7'_7&/^5% 'IG[/O\ R0GX;?\ 8LZ;_P"DL5>@UY]^S[_R
M0GX;?]BSIO\ Z2Q5Z#0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 ?.7QJ_Y'RX_ZXQ_RHH^-7_(^7'_ %QC_E10!Z9^S[_R0GX;?]BS
MIO\ Z2Q5Z#7GW[/O_)"?AM_V+.F_^DL5>@T %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<F&64^(K1#8)]FFG$DRE\J"T2Q8;'S2J"0< ]!_PUC\$?^BR?#__ ,*BQ_\
MCM 'JU%>4_\ #6/P1_Z+)\/_ /PJ+'_X[1_PUC\$?^BR?#__ ,*BQ_\ CM '
MJU%8?A3QGH/CO1K?6/#6M:=X@T>X+K#J&E7<=U;R%6*MMDC8J2&4@X/!!!Z5
MN4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>1G.TCK[A_P3/18/V1?#L2LY6+4]6C7S'+$*M_. "22>@%>,>(+#XP_!C6?
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MP?#NB7?V^Y%R(KK0K1TML0QQ>7$-GRI^[WD<_/)(?XL#0_X8!^$G_0G^&/\
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M">.G?$+P=%;1_'OQYK-I=Z=-%ILE_?6VH66R="=ZIY8\R-L*Q"LI.T88$ @
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)EY'/ < 'J"*?J-A>^&=1GUC1X6N;>8[[_3$Y:X(4#S8@6 60!1D?QCKR!D
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M !1110 4444 %%%% !1110 4444 ?.7QJ_Y'RX_ZXQ_RHH^-7_(^7'_7&/\
ME10!Z9^S[_R0GX;?]BSIO_I+%7H->??L^_\ )"?AM_V+.F_^DL5>@T %%%%
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MI8F1<$F6%?\ GL<\C^/UW8SI:KING>/M&MI(Y'7:WVBRU"%0)K28*RB6/<I
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M3]^!#.OS^3A75')"B3W;]IBWF\;_  .US41:O8^+_ 5W:^+8K"-3*QGL)/M
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M )(3\-O^Q9TW_P!)8J]!KS[]GW_DA/PV_P"Q9TW_ -)8J]!H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /FC]M34[C1K/X07EKI
M5WK<\7CH%+"Q>%)I?^)1J@(4S21QC )/S.. >IXKW[P<^[PGHW;%E#Q_VS6O
M$?VMP#=?!?(_YGP?^F?5*]O\'J%\)Z*%&!]BAX_[9K0!L4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(_\%#;
M^XL?C_\ LF012-'#>>-XHIT61E69!>Z<P#@$ @,B-@YY13VKZH6W_P"%6EE0
MJ/!2J JH%1=!5515C154?Z+PQY),!/'[DCR/D?\ X*66+:I\<_V3+-;F:S>X
M\:");BW8"6,M<V #(2.&&<CWQ7V7X?\ $D_VPZ1X@,%KXA@C\P%<1PW\("![
MFW4NS",.ZJRL2T;,%)96CDD )]>\/MJ4UO?6,BV6KVBE8+G864(2-R,N0)%;
M8H*YXP"I5L&G:1K%MXIL[NQOK58+N)##J&E7#++Y8<$#=V=' .UNC D'!! P
MI98_A7")) 8O!4>6DDD9530552Q=V9A_HN%QQGR=R_\ +'_4;?B#0I;\17^F
MS_8]7M03;S'=Y3D@_NY5!^:,\9&>#@@@C- %*PU"?P->Q6&HR2W.AS,(K/49
M9&EDMW8L?)N)&/*]%24\GA&RY5I=+5M(N[/43KFBIF\;:E[82,0EY&",E06"
MK.JC"N>& "L<;6C33]1MO%-C>6-[9A9%1K>^TV[3<,$,I^\,21, X#8VMSW#
M 9VG7ESX*NK?3KZYDN]"N95AL;Z3,CP2,X"V\IV_=^8!)68YX1COVF4 UW32
MOB)X=4-']HLY65VBF5DE@E0AE!'#131NJD=&1E!&"!C'T;5[[0=5@\.Z]*UU
M<L&&G:PPP=0144L9 L:QQW W.61<*RJ9(P!YD<&CK.CW-AJ$FN:!&DE\X!O+
M#>L<>H !0&+8XF55 5N 1A6.-K)/)!HWC[PV[20M=V%R<E9$>*1)(GR#@A7C
MDCD3((PR.@(PPS0!F:GI=SH>IRZWHL!G>9MU]I8( NSA5\Q68@)*J*V&)"N/
ME;'R,G.?"2UTWQK\!/ GE7$AMO[&L6BN;5O*FMI4A125/WD=&#*5(R#N5A@L
M*W=(UR\\/ZE#H7B.Z#7-QE=-U2<I$NI$*[M'@'Y9TCC+.H 5E5G0861(?.?!
M.O+X&\"^&KRSTW73?V^C6<.K:,-%O"TS16X0M%^[V+.""N0<. %)&%9 "[^R
MKK[K\ ?A9I&I1?9;]/">EM;X(V7<7V5-I0]V50OF+@;6P?N%2>Y97^']TTUO
M&T_AJ1BTL,9+-8,2/G4EL"#!R5Q\G4?(#LX?]G33]/\ &/[+WPJC\]F6+POI
M:1W5LZ^9;3I9QH65N=CHQ=<$==RL,9%>B^'M>NVOVT?5U5=4C1I(Y8E81740
M8 2*<8# E0T>3M)'52I(!9U[0$\4)9:A872V6HVP#V6IQ*'^1BK,C#_EI!(%
M4.F1G"D%'5'2#PSX@DUN&>TU*S^P:Y9;(K^R.YD5F7(:)V5?-A<YVR*HSL96
M"NCHN<ZS?#II+B'=)X7<EI8(T+'3CP T:@?ZGC++D;.2/EX36\2^%H->AM;R
MPG2PUFT#"QU..(2F)6QOC9<C?%($4.F1G:I!5D1E ,, ?#$$EU3P8JC#Y1%T
M6-54*@Z9MC@D9_U.?^>7^IT/$.@7+7O]NZ(4BUV&(!XI/EAU&- ^VWF;#%0'
M8LLB@M&<GYE9T>SX;\3_ -M7,]C>VXT[7;(*;S3WE#F)6+".1&P-\4FQBC[1
MG8P(5U=%Q_,/PT W[QX2&[,CMD:0 "Q+L6_X]\+@'/[K(R/*_P!4 ;%I>Z;X
MZT*_@6+?&2UI>V,V%EMY<99'P3M8;E;(/(*NA(*DTM/U.?PY>QZ;J\QE@N#B
MQU&3&91G"P2$DDRC/!P-X)(^;-6->\/W$][!K>CRI%K,$8B82E_(O(0VXQ.!
MP#D$I)M+1DG&59T=UAJ.F^-])N(GMV01L(;W3;DJ)K27:KF.158[& *.""<@
MJRL0P) *VI:?/X:U"76M'MWN8IW\S4-,BRS38 _>QY8!9%P<CH_(^\0:TK^U
MT_X@:%#+:W+",GSK74+.3;-;RC<H>-^0&7+JP(((+*P*EE.;I>I77A[48-$U
M262YMG/EV.HN&9I%"C]W,V !)UP1]_'KP7ZC87GAO4;G6=*1IX)3OO\ 38P6
M\P#=F2$#I-DCC@/@?Q8) )="UVZ.H3:/K<20:Q #*DD"%8+N'<0)82V>0-N]
M,LT98#+*R.^==:5/X(OIM2TBW,VASNTE_I-JBC[,[-))->6ZJNYG=VS)%GYS
MF1!YF]9]G4-,TOQUX?MYXYBC$_:;*_@5?/M)\,HECW [9%W,""#G+*P(9E-7
M0]>N/MXT/6HDAUF%&DB*9$5Y I"FXC.!CEE#Q98QLZC+*5=P"IXH\*Z7\2=&
M@F@NHP]Q:M';ZE JRI+;2A3)$QY#PRH%#*&&1AD9'577Q']BGP+)-\)]&L?%
MFKWFO>+OA]J]_P"'S'+>2-;:8]NTEO#'&$2))@+22,B5T+_OF&4QL3VZ\L;G
MP9>W.I:7;3W>DW$QEO\ 2H%W.CLV7NH!G/)):2)1\WS.@,FY9O./AOJ]GX9_
M:-\8Z5I4D<_A_P =:1:>--)N;4J]K<SJ!:WK1."%8%!I\N$W$F5W9OG44 ?0
M(&!2T@Y -+0 4444 %%%% !1110 4444 %<+HW_);?%G_8OZ/_Z4ZG7=5PNC
M?\EM\6?]B_H__I3J= $_@+_D9OB'_P!AV+_TV6-=G7&> O\ D9OB'_V'8O\
MTV6-=G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAJ>FRHS(>JRQ2#<I!!((Y5E+*P=6(/R;^W=X=76?C?\ LT7DL\L3Z-XH@OD
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M*9_#LC+!8ZC*PS:'*HEO.Y.7+,<)(>O"O\^UI-'6-&NM/OI=?T*$/?.H-[8
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M$0R8  <*!@XP_;G.9->T*Y^T_P!N:$(8==BC\MXG.V'4(U#%;>5L,54,QVN
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /G+XU?\CY<?]<8_Y44?&K_D?+C_ *XQ_P J* /3
M/V??^2$_#;_L6=-_])8J]!KS[]GW_DA/PV_[%G3?_26*O0: "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YX_:W&ZY^"X]?'G?\
M[ ^JU[=X-0)X3T;WLH,Y/_3-:\1_:W8+=?!<DX'_  GG_N'U6O;_  >P;PGH
MN/\ GRA_]%K0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/,\L,6"2*^!OB<*Y5\#.&!"LC*N0J2?#>1$^?_A$6&$.69M);YF8NS,<V_(
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M+>5VBWC)P^W<,D X)KEOAI_R23X%?]>6G_\ IJEKV1/NCZ"@#B?AW;0VFO\
MQ B@B2*)==B"I&H51_Q+;$\ <=:[BN,\!?\ (S?$/_L.Q?\ ILL:[.@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7M_A#_D4]%_Z\H/_ $6M &O1110 4444 %%%% !1110 4444 %%%% !1110
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MU'4;W2=)U[2!K=[;01Z/OMKZ"SBG>%-T<SM'-(IC+.PDBRI.U"RA'K?\->_
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MXTWPKHZZ9;:?9Z!;VX$TDA6.6VDDD!+LQ)9T4DL2>#SUS]?T %%%% !1110
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MH **** "BBB@ HHKS/XWZG-IGAJ&2UU*^TVY\TB,V .YVVDX;##"\9[\XXH
M],HKB/A%<-=^#(96O;R^<RR!I;Y6$F0<$?,S'&02#GH:[>@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ^$?^"F\8!\ $$YVR=_^HSH?^-?6,44?PE@V
MQ*L/@5%SL 5$T) O10 /]$X[G]QGC]S_ *CXZ_X*#7>H?\(GXGN46&;Q%9:Q
M8Q^'H+I4E#P^9IDGRH^1\]R&##&"(HL@\%OL_P  >)X[W2;;3[HR1ZI!;QNT
M<C%VEB/$<P<@;PX7). 0<A@"#0!-XF\*R27D6MZ/(EKX@B18MTF!'?1+O9;>
M9@K$+EV*N 6C8DC<&D21^F:II_C;1[^VEMLJ0UIJ.F72C=$S1KOAD7.#E77!
M!*LKJREE8$T,-\+W+<MX+8DMDY.C$EV=V=F_X].0 H'^C_\ 7'_CWO\ B+PU
M<WM]'KFBS0VVMQ1B)7FW&"Z@W!C#*H..Q*28+1EB0&5G20 R[*]N/!-];Z7J
M<\EQHL[B"PU69R?LYRB1VEQ(SEGD9B1'*1\_"-^\*M->UC2;NTO3K&CE$OT4
M">TE8K!<)E<AR!_K JD*^.,@'*GB72-8L/&>C7$,]J%D7]QJ&DZ@L;26K%06
M@G0%AG:P;J58,K*2C G/L)[KPA?0:7J,LM[I,T@CT_4Y79VC9L!8+ENA)9B(
MY"3O^57/F;6E +NS3O'6A;3Y\,>[:P!,5Q9R#]8W4]#GOP2#RNB>(+RWU)=$
MU<(+W+&"[1-L=X@+8QT E &YT^I4$$[8M8T:YM;TZUHL:G4=F)[7(B34%Q\J
MNV"0RY.UQTZ'CI7U"^T+Q-X8N[V[N%M[& O++<3L(9+*:+.Y\M_JV0@D'MP0
M2#2;26I23DU%;LFU"QN/!=_/JFDP-<:3<2&74=+A3F-BQ:2Z@14)9V))>(??
MY9?WF1-'XQU#PQJ/A2/6K_6K73K&+R[ZSUHW:1"UD8;8ID=CMR1)MPP*N'*,
M&5BI^<-/\=?$C]J&*XT3P1J?_",>"[.1[2Z\9,K+=ZAM/#6\8QL/R@L<@?,<
M8(*UV^G?L)?"B.V"ZII5[KUT[>9-J&H:C.9YF(RS,491EFRQP.23^'$J\ZFM
M*.G=Z?YGTDLKPN"M',JSC/K"*YFO\5W%)^5VUU2-+]D[QK;W?P+^'&C7;1:?
MJMOX6TX1123HWVJ&.VB1I8R,'",ZHZ$!HY.""K1N_:$K\*8<@B/P1&,'[J)H
M2!69F=BW_'K]T< ^1G/^J'[CS;4_V$?AH@2;PU%JWA#4(P=E_I&J3K*.0?XV
M8= 1T[G&#7,0?%;Q[^S'K-EHOQ.N/^$K\$W4ZVMEXRB3;+;-@_+<QC)/(QNZ
MX!)+$D 6(G3UK1T[IW7Y(?\ 9>&QB?\ 9M7FDOL27+)_X=6GZ7N^B/H[7]!F
MU$Q7NG7 L]8M59K68JS1MD'*RKD;XVR,J3P0"N"H-+I>J6GBJPO;&^LE2XVF
M.]TRY <,K93)!XDBD (5CP0"" P91B1N?A_MEC/F^#9?W@*$YT@G<S,23C[+
MPH '^IYZPG]QMZ]H)U"2#4+&1;/5[8YBN54 .O>%S@DQ-P" >N&7# $=Q\PT
MXZ,IV5_=^"+N/3[Z=[O1+B01V5_,S/);R.V$MY3@G820$E8GLK'=M,FAK6B7
M>GZ@^MZ$BF^; N[%G$<5^ORC)..)55<(W<85N-I2/2M6M?%&FWMGJ-FL=S"/
M(U+3)AYBJ67D LH$D;#(#8 8;@0"&49]G?/X O8;&_D:7P_(5BL]0D8$VC$H
MB6\K'E@22%E/))VO\Q#2 &T]MHWQ#\._OX&N["X()BG5X9(Y(WR#@X>.6.10
M01AD90000",;1]<N]#U.#1?$-R))Y=PT[590D*:AA6=D95P%G5%9F4##A3)&
M %=(='6='NK"]FU[0X0U^Z@WNG_*@U!54A1N/"2KD;7SA@ K<!63YA^"WBOQ
M-\7;7PH?$5Y>7,6K1 :U#8W4L45O*;9F?R#'GRRD_EA65D9?]8DBLJ@@'TEJ
M^G7N@WT^O:-"]TTBAM0TQ&YO%5<*\6Y@JS   $D!P K$81DM7%GIGCC0H9(+
MES;DD175M\DMK,A9"5)&8Y$8,I!&0=RN,9%4]*UR^T35(]#U^03W$C,;'54C
M6*.]3)(C90V!<(BY<  . 9(P%\R.%^K:5=:%?SZWH<7FEF!U#2PP"7*]Y4^7
M(G"\+D@. %;'RL@!)H>NW*W[:1JP2+4D5WCN(E/EW<2D@,I( #C@O'SC/&0P
M-57$_P /YGN( TGAASNFM44NVG$87=$JC_4C^)!]SDK\I(6_-!IOC70K>XB8
MO$S)<6]Q$FR:VE0X#*&&4=3N&UAP=RL#EA4.AZW-;W7]AZV5CU787AF0_+?(
MH4-*F/ND%L,@/R\8^7!H L>)?#$'B.WM-3M;M;+5[92UCJD:"7RU<H7C(/WX
M9-B!DR,@*P*NJ.J>&_$O]L2W%E=0#3==M OVNP+[]FXL$D1\#S(WV.5< =&4
MA75U7-D0?#F8SV\6_P ,DF2:")0/[-X8LZ*!S&Q(RI^YU *Y"ZWB/P\/$\5K
M?Z==+9:K:*SZ=J.TR(A=<$.@=1-"XV[HR0#A6!5U1T , )_PK+8HS_PAP.%)
M8XT889F:1V?_ (]B0H&!^YS_ ,\O]3P/[27[,EE\?+%W36[O0=0862M+:;5:
M5+:[^T1J'(/EN69E67:QC\QL JTB/ZOX?\1#6Q=Z=>VW]GZS:_+<Z=,ZL0I+
M*LJ$'+0R;&V/@9VE2%=75<LJ_P /Y2?FF\)R'<I0_-I9.3C  'V4 #G/[K)S
M^Z/[H ^5O"?_  35^#6M:.GV/4_%EK+:8MKO3[B6P>YL9@B-Y4V+=AO560\,
MP8,K*2K FG=?\$S/A7#J<NE:QJ?B5K*]EQ97L$MF@Q\C"%V%J-DF3A2" PQ_
M$"&^QO$&A73WPUK0W2#7($\LI.S+;7D>[/E384D <E'4$QEC]Y6='?8W6G>.
M-#G2:S/EOFWN].OH@DL$@^;9(F2 PRK J2&!5U)4J2 ?(OB+_@F)\.K!(;W3
M]0\27EO S&ZL@;$S31[<YB(M<;QCA3UR>AQ5ZU_X)?\ P8\0Z1%<Q:WXGGM7
M(D1XY;-""KYY'V0$$,N"IY!!!'6OJ'2]2N?#E[%I6L3R3P7+".QU*1MS2M\Q
M\F7 PKA0,'^/)_BZK?Z7/X:OGU?18#-#.X:^TU#CSN?FG3C/G  \$@..#S@T
M ?(VA?\ !-KX7&^.C:SJ?B*+68T:16A:R$-Y""%$T9-G@<LNZ/)*%ADE61W\
MI_:[_81\&?!'P;X9\6>']5U><6_B/3;>:WNVB63]Y<*HDC>"%&X!8;<]75@0
M4PWZ0WMIIGQ!T2RN(9':'>MW9WD.4E@E'W74GHPRP*L,'+*RE2P/RI^WCKUT
MGP7TK0M=,<6LP^+-$9'C 2+4(Q=1[IX5+$@ L%9"248C[RLC, <]\#? >J_%
M?QG\7&T+XJ>*+/0]$U^.WT.W@URZNM/:"2&WNPY99TEE$A>0%A+RLS%2&"L/
M<_ .CZ!XHU76?#NKIXJ\.^,-("R7.C-XYU6<O;L2([J%Q<+YD$A5@K[5(*LK
M*KJRCS;]F.ZU'3OB;^T)K.G64U[X>/CA[:ZM(;5EG\U+6W62: X4R%&+^8F"
M6!5D^8;)O4/VB;>._P#!.C^,='\67.@7>F7$36>IZ=<@P7$%SMADCE7>J3Q,
M'20*&5MT2%7!'(!9U'X:Z9X7U&2:^U3Q5<Z#<$$73>+=6#6#88L92+H?N?E'
MS$90D[B5.4A^+?P8TY/ US=:?JWBJ.[@EAD6";QAJ?DS_O%'ER%IGVKDYW*,
M@J",C(;!^$OQ;@@TV_@\4_\ "37VIMLCN+!-'N]3BC4E@'C>".3,<@/!(7.Q
M@1N5E637?B78:982:-9Z=XGGT:ZEB6W>Y\,ZG;KI["96",\ELD:0;00&9ALP
M!]S&P \L_P"">_PN\/:W\,O'MP]UK=O>KX\UF*Z33O$^H0 2*Z >8L-PH+[-
MF68;B-I).17MY^&VF>%M;^S:SJ_BN71[ZZVV6J/XNU2-8)9'"QVDO^E#EG8+
M%(!AN(VQ)L:?RS]A'P[)=_#7QEJ^E216FMP^.M=B$KC*7,/VO<8)>IVDY*L
M2A8D9!97^HM-U6S\9:1=VLUJL<ZC[-J&EW85V@9D!:.0 D,"K @\JP(()!H
M\NUSX!:/8ZT_BO0I_$UUJKVBV][:1>+=2#ZI;QEVBC65KH%7C:60IN81GSI
MP&X21[FD_#;PMXETQ+S3]8\4S6TI>-7'B[6 RNK,CHRM<@HZLI#*PRK*RL 0
M:U[&>Y^'UW!I&HS37NBS,L>G:I/(TLL!"JJV]U+(Y:21CD),Q^?A7/F[6GGU
MS2;[2[Z37M"B6ZNV .HZ4N!_:42J=GEEG5([@?(%D8[75?+? $<D(!\TV/[-
M-NOQ;\7>&]2^(?CS0+37[>WU*$:5KTT<6J2O'+;SB0SK)NF$%I;[EWL2 Q4*
M@"IT4G[(,_@?1-'MO#GQ6^*D>@Z3 EF=*M/$*ATM8T C$"B#JBK@1@9(/'(
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M-E&=H]+X-_ 71K/X2Z7IWA[4_$NER:)JVI:>L/\ PE.HQPZ@UK?75O(95CE
MB\YD:7,2C8S#[ZAD?Z#T7Q"VH27&G7\(LM9MEWS6J/N!C+,%EC8CYD;:>V1T
M(!%>4> XC\)=>\=6L5LL'@,:WY\$$1PND&:UAN)Y]SO@6KSR2L551Y3EF(\I
MV,(!LZ!\/_#OB&S>6.[\76US!((+NRF\7ZN);68!6:-Q]KQT8$,N5*LK*65E
M)^)/V,_@Y\//%FG^';'X@^$](\3::/!.C-I-WJ5DK16,ESJVN%H7=Y68R3S%
MMK*JJ=J)][9YGZ$:UH=Q?7$&L:--;VVNQJJ++*I,5U;APS02@'./O;7 )C9M
MP# NC_!__!*?XBQ?%G3O'&F7>C0V\/AKP[H7AMHY'$Z7JK<ZQ,964J  ?M)7
M:<\+DGG  /K>]_9P\'Z/X<32?#/ANQL=(2.6";P\'>+3[N&4@2QO$K;<D;L$
MCNX((=J]#@_L[Q]X><,)X@S893F&ZM)@!QZI(I(Y'J",@BLG2[N;P9=66D:C
M-/=Z1(RV^FZM-(\T@8\""Y<C[Q.%25B?,.U7/FE3-9UO1)[2ZDUK1(T75 NV
M>UD8(E^H! 5VP2"N0488QP#\O0 NZ1J]U%>_V+K9'VT@M;WD2E(KQ,D@#L)0
MJY9/3)7(R%S-5TVX\&7T^HZ/;R3Z5.S3:CI=NF2K,27N8$5"S.Q.7B7[_++\
M^1+Y_P#&O5;/Q7X>M)-,U35;?48Y6\JVMBT9CD4G<Q &5E0@X.>^1D'GM_A?
MXB5-.@T:[OKS49LRM9:E>[BU_$K?,V2J@.I)!0=AE<KD* 3^-/!'AGXQ>#TT
M_6+>SUK1[D1W4$DL23H#MS'*JN&4\-T8$,K$,"&(KC?#VJ>//"^J1>&MFD^(
M98%C,5OJ5\]C.]K'(JR7-LX6<W" 2QH8YBDD3H!)+,)HY3VFH:1<^#+Z;5M+
M@:[TZYD:2_TJ!07\QRNZXAR>H 8O&!\^69?WFX2WKNSTWQWHMG/#>OY3,EU9
M:CI\Z[XI!RDB,,J<@G((*LK,KAE8J0#YF_8O\;:7XC^.WQRL++P-K/@[4;1M
M(%Y:7][;3P6< M,6EN@BD?!/^DL A*(@C0;=H%?8E?GY^QA<:9H_[9O[0M]X
MIU73;7Q0;31;2UVS^0EW%]F#7$D44C%L I:EAE_+\U5+MD,WW4OC+0&&?[:T
M_P#&[C_QH V:*QO^$QT'_H-Z=_X%1_XT?\)CH/\ T&]._P# J/\ QH L:[J1
MT?2+V]""0VT$DPC+;=^U2<9YQG'7]*\?^'O[0FM^(? ?AKQGXG\%?V!X:U[2
M(M:CU/2M1;4XK*&2WAF1;I?)BD0GS) 61'11"2[*&%=_XS\8:$?".MA=:T\G
M[#.0!=1\_NS[UPG[+'BG18/V7?A!#+J]A%*G@[1T=)+E 5(LH001G@YH ]A:
MY*Q[B0 !R<<9]?I_B*\[N?BUJ^L:+?:IX1\+MJFG6J-(FH:U<MIEK=JN[>T!
M\J25E&TX<Q!'#(8V=6+#@+NTT6'QX? 8UN.'P=J$T?B1TDU3S(6BB"I+IL'[
MS,-NLR6DK1C*,LTD>THS!?8/%GC#0CX4U@#6=/)-E, !=1Y_U9]Z %^$GCH_
M%'X6>#_&1LAIA\0Z/9ZM]B$OF_9_/@27R]^%W;=^-VT9QG Z5UU>)_LJ>*]%
MM_V7_A!%+J]A%+'X.T='1[E 5(LH0003P:]3_P"$QT'_ *#>G?\ @5'_ (T
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M?AMXS^!\6G^$OB-X4\0:TOB+1[J.TTG6[2ZF"QWD<COL20DJBJ6)Q@ $GC-
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M&=F.Z5\L-LF"6"MO^92\H!#I'COXK:S;M)%\3[6.2-VBF@D^#&L^9!(OWHV
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M]NK#;(.!YL7))B).,GH<@X(-9;[OAJ^0&E\&R$ J SMI#$JJA5 _X].22?\
MEA_UQ_U%W4=.M_%NFZ?J&GWRY $]AJMG(&&UMK*589#QN ORY(88Y! -2^&O
M$3W'FZ=?VXM-9M<?:((\^4^>3+$Q W1G)YZ@Y!^;J 1>*?#=Q<31ZQHCQP:_
M;IL19W9;>]3DK!<$ G;N)*R ,T;$D!@71TL;[2_'FBW]M=:<98)/,LM0TW4H
M &!P0T4D9R""I!SDJRNK*65@:H!$^%"94*G@=!]Q0JKH:JHQM4+_ ,>O'?\
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M-@!P2/52K8(71M:A\2VUS9WMND5]#&(M0TN5A+Y193P3C#QL-V&/!P> 0P7
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MN?#E_+K6D0/<Q2'?J&EH<M* &S)$,X$P)Y!.'Q@\X- '$?L^_"SPK\ =&N_
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M @@$,H /%=1_9*\'0Z;<O9?#'X/75\L3&&&7P-#%&[@?*KR*S%03C)5&(R<
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M<D X9><,C'&,YQMX;H'B*[TS44T+7F$E[*6^PZD$$46HJ-S; N>)U1"64##
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M%E>.20 XOX]_#'PI\4O"6DZM>:9IFKWEI>6<FFZA/:Q7:K'+=0;U&\$-'(H
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MDW-#=P;@Q@E"GO@[),,8R6(#*TB2>!_M,+<:QH7AKXFZ%%<6_B+X?ZC]IO\
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M;+4;<Z?K-F56^LV)= 2H(:)BH\V%LD*ZCG:RL%D5T7)<GX;RDR.LG@[(.]\
MZ/DHJH%"Y^S'+L6)_<Y[Q?ZD \J^('[9_P )/"L":7XS&LZ9<3226MUI%YH%
MU)+%)&L3NCQQHVT 2Q,'!*L&5HRX(:N?\&?\%"/@V9KC3[_QC>_8H5!M=3U'
M1KZ)Y59@HC<&W \P$J 1]X'/7.?H37_#,YOF\0Z#%;Q>)8H/*82D1IJ$2[F2
MVGD"LRH&=BC@,8RQ(!5G1[-G>Z9XYT:[@DMW9#YEI>V5PFR6%QPT;CU_B5ER
M&!5D)4JQ /GS4/VV/@SX:U*?6=&\9BXBG8-?Z5%I=XHFR1F=/W'^M SGD!P
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M4XAM[-25)0J8R,[MS '2ZSI=UIVHW/B#08'NKMT3[=ID;@+J,: @&/<ZI'<
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MB"&5N,*RMT) ,VZTVY\)WEQJND0M>:==3-+?Z7"N7\QB-UQ#G/( RT8X;EE
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4-QDEMDF"T9<D*RLZ/-X>\2KK#7%A?0#3]:M>+O3GD5V522J3)@G?%(%;:Y
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MT&YTC4)_$'AZV$]_.0^HZ7&4B&IE0J+(&886X14 5B0K ".3@1O%SOQBM?\
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M9+(N P!=!MWK& >'^$/ .D>(?A+\*?B.FK:Y>>,C9Z,T6M2^)+^X4&]ELQ=
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M(96/HND:U?:7J$>B^(IEDN9'<Z?JGE+#%>J"Q$3+N.+A4 W*,"0*7C  D2(
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MQM:^-8_&<D;.^FZ3+I'V.:"]OKB11_I,LBR+<7<@ZHT9A /S X /$?C#>/\
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MF."R'...0<@\]>;N(Q\+1((U'_"&J-Q7 ']C * NQ47/V4X.2?\ 48./W/\
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MKN91PP!= !O6-=8TNY\,WTVL:6DES:3$R:AI:@G>,$M+"O3S23\R]'Y/# 9
M)M#UYKR233;^-;;6(%_?6ZD;9H\X6:,$G*,2 ,]#D'D<Y;AOARP9"\_A!Y "
MGSN^E,SJ!@=K89R1@>1_UR'[G3O[*R\5Z=;7]K=F)XSY]MJ$)VF$@@L".,J2
MI#(W7YL\@8=X?UZZOY;BPU"$6FLV\8,\"*1'-G'[V)F^\AX'JIR&YP2 -\0^
M&4U=[?4+"5;#6K4YMM2AB5V",RM)$X(^:*0(H9,C.%*E71'6'2M3M?&6D7^E
M:YIT$5]'&L.JZ3=#SHMLBYX+JHE@<;@KE><,K!75T7/98_A>H$*J/!A7B.-0
M!HP VJ$15S]FSC/_ #P_ZY?ZG8\2>&6UB:VN[.Z73M;LPPL;\QF7:#C>CH&7
M?&V%W(6YPI4JZHR@&?8:C=>"M2MM(UFYGO='N7$>GZK<L7D61BV+6XPN, !1
M'*3E^$<^9AI]#7=#N$U!];T-5&J(H2>$MM2]C4,1$V<!6!?*R<D<]02#!I6M
M6?C"SU#2-6L(X+U(O+U'1[ITF/E2ED5L 8>"54?8Q W ,K!75T6K8ZQ=^!KZ
M#2]8N?/T6XE6'3]7NI!F)W9$BM)V+%F=F;;'*1\_".?,VF8 S_&U_8^,_A]+
M&GFQQR:C9V]S"DC0SVSB[AW(6C8-'(N5P58$9!4D$$^!?MEWU_H^F?"C1]7,
MDR#Q_IQLM2CB/ES1""X41R'.%G&X \ . 67'S)'[[\7?#LL6EQZUIMPT&H)>
M6$<L3 M%=QB[B(1UR/F_NR=5R>&!*GP_]KW5?^$@\ ?"5II-T_\ PGVGP74,
M<+6S1,;:ZS&R;V*,$91PQSD$':10!VG[((1+SXTA%49\<D\#'_,'TO/\S^=?
M1%?-W[&5E/8_\+@CN+V74)H?&IC:YF1%>4?V/I9#,$55W>NT*/8# 'TC0 44
M44 ?.7QJ_P"1\N/^N,?\J*/C5_R/EQ_UQC_E10!Z9^S[_P D)^&W_8LZ;_Z2
MQ5Z#7GW[/O\ R0GX;?\ 8LZ;_P"DL5>@T %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% 'SQ^UMS=_!?\ ['S_ -P^JU[AX0X\)Z)_
MUXP?^BUKQ#]K;_C[^"__ &/G_N'U6O;_  A_R*>B_P#7E!_Z+6@#7HHHH **
M** "BBB@ HHHH **** "BBB@ KSS4(F\:?$:ST]OM0TKPT4U"Y_>[(;B]=2(
M(F4',HB1FF97 57>T=2S*=G1>.?%)\'>&[W5%@CNYXE$=K:R3>2+FX=EC@AW
MX.TR2.B#@\L, GBHO WA@^%])\F>X%_J5S(UUJ%_M(-S=/@R/\S,P485$0LP
M2-$0':@P =#%'M0 CG^52;1Z"EHH ;M!QD#CI2D ]:6B@#G+#P-H6E:G/?6.
MAZ;9W<URUX]Q#:1H[7#!PTI(4$N1++ELY/FOD_,:IVGPT\+6&E:/I]MX7TNW
MT_1Y_MNFV,-I$L5E<?/^]A3 6.3]Y)\ZX/SMSR:Z^B@#-MM(MH=7GU-;2%+^
M:&.WEN@@\V2.-G9%+8R55I)" >!O;CYC6E110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?('[;D22_%;X&
M121K)$VLVRM&P!# Z_H (([@U[QJNMVOPBL+F_U2X9/!-O$]PUT%9O[+4<D;
M47_CW"XP>3'G'W#\GRA_P5.\67_@+2?!WB;2Y3!JFC6UQJ-K,%5MDT.KZ'(C
M ,K*<,H.&4CU!KQ#QA\7?VN=0T7QAI=WIFK^(] L-/C_ +2DTD:/=1W%E=*R
M))$L-D7FC8"12T2MM\N3<1L? !^B'A?P?JO]E6_BB2>XM_&NHA+J]6[:-TC5
MU5CI[! %$,8 12H+@Y<LY>3S.DM9].\>:+=Z??VA5U*QWVFW+9EMIN'"E@>J
MY#(R'^XRD#!K\3/A/X#U3XE_$+5/"EAJ>@Z9)86UO=R7VIZ];B%7G D*>9':
MR$LAD1&14_=%'WD!6V_7/PL_8U_:3^$&KZS?>#?$_AOPQ=W*I;/(VJK-%=JJ
M;DD\LZ4^45Y77Y@K95\85@S 'WUI6N7.@ZK%H^NRO.T[$6.IN /M3$NWDNJ@
M!950=N' )4##*L?B'1;[2-7N/$7AZW:XNY O]HZ9NPNHQQHVSR]SJD5P#M D
M; D55CD( CDA^$/ACJG[5/[0NC^-+.T\<Z/:)X>U^[\,:I::E-9QRK=P%-[Q
MM#I+_+EQMD#*<JQ&, UNM)^UIX-N/"UOXR^)6D>&]/UNZLK&%GFT^>Z269T1
MK8#^S@LUR@9Y"BR ,J.5=@C$ 'V\!I/Q"\/94F[LK@,-R%HY8)5)4X/#0S1N
M&'\+HR_PLO&?8Z_<Z#>2:3XAF5IF#26NHLI6.\A7M(0H2.X Y9%&& +H  RQ
M_%VF^&_VO[W1(/&?A/QOH&OQZZ+>22+2+ZP)E4@*96$FF1Q;T& [!BV(PH#[
M$49/@ZU^,7[0GQ/3X;^.?'\.N>&K>*#4];AL;581&G#K ^;&UD64Y56C9?DY
MS\R%5YZU7V44UN]CU<MP/UZJXSERPBG*3[)?KT2ZNR/:;C]H/6-:\3:KI_P0
M\+7/C*U/G+<7%RPM]*M;T8 :%SM#YRS21@@,2KJ06<MH7/P^_:+\1/%JUYXE
M\&:3JMG.9;2WL["62)00-R^8V' DQM;@\<@YQCZ#\)>"-%\"Z#:Z-H&G6^E:
M;; B*VM8PBC)RQX[DDDGJ22>M,\;^.-(^'GAN^US7;R+3]-LTWR3RMV[  9+
M,> % R20*Q=*4ES59_=HE_7F>DLPI0J*EE^&CV3DN:3_ $^Y+YGRI\7OC!\7
M?!7PT\8:3\2? EG=Z=?Z7=V:>(/"\Y:WB>6W*1AHY#N \QL%F*]<!3C+>*_&
M#]H'Q#:_LJ_&#6K"[U?5O!>J:OJGA71-,T_2U^S:=:3_ "++<RO&72!DN2L:
M[TV2>6B*48+%^BOA?7=/\?>%M.UJT'GZ9JEI'<P>8N"T4B!E)'/.TU\$_ME_
MLW0?#[2KJ72+V2V^'>MRW<<^C/)(EEIFI36,]M;W9$:LWE(T^]E5<Y0##?*H
M4I3P]I.7-!_>O/T-X4L+FJE0C35+$+9*_+*VZL[VEVUL]K(J?"3Q3?W?[1'C
MS1M%UC6_#NHZ!8V>O,^E6/FVFI>;H>F(L-Y(8Y(XUC2UN?+,H/[VX5E#%&23
MZ%_8M\6R_%GP/XV\0:W!'<7>OWVDWNH03VNQ)7F\,Z,7Q&P V,V_'!4CIQ7.
M_L\?#^Q\'KXJUB2?&@3ZA9Q2OHU].+G2]VCZ4H2Y4$@0@KG  $$9C;'E,YA[
M3X.?#BV\)Z_\4[7P=MT^?0/$-CI=A#<32-!/:1>'-'6.WG;DL !\LA#,C$D9
M#2(_>?)--.S/4],N+OP3?0:3J$L][HTY6#3=2F:2:2/  \F[D;)9B<A)V/SY
M"N3)M::UK.BSVEZ=9T15&HJI$]IN")?J%P%E;&0R[<*_8Y!R"15JQOM+\=Z1
M>6=U8>;;R>99W^DZC I*\;7CFC.5*E2,')5U8,I96!.98ZC<>#KVTTS5+F>\
MTJYF$%AJ<Y+21N2VVVN&QT 7;'*WW_E1B9"K3 C07^R_'.C.=I(#LF7C\NXM
M+B/()&1E)$(R"/8@D$5XI^RS97O@[QS\7-*\11W%I>ZEX@CO+)[M !>01Z?:
M0&0,H"[B8F)4 <9(&T9KV76M%N;6[;6M("+J**JW%LWW+V-0=L))P 022K\D
M9QR"17/Z ^E^.M:\5HP+1I<VGG1^8%GM+A(E8*2&^212!G!].H() .BN]-N/
M"5]-JVCVSW6EW,IFO])@0;Q(Y7==0CKN #%XA]_)9?WFX2W=5T[3?B!H-E-:
MWC2VSM'>66HZ=/M9&'S)+&XZ@C@J<JZNZ.K([*:N@^(+G3]0BT#69(WOSD6U
MZ J#4 %RS! 3MD'.Y?8LHQD*FI6=UX.O+G6-,AFO-,G9I]1TN%6EE#8.9K9,
MXW$\O&H^?EE_>9$H!Y-\?-=N!\/M.T/7A'#KT/BKPM(7@0I;WJ?\)!IP:> ,
MS'8"P#1DDQ$@$LK1/)Z&L4GPTF^7>_@YR2%)9WTAV9F9F9F/^A_,H"@?Z/C
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MPVS)G FC&23&Q]>0>#SUYZY23X<3E8P\OA!V 9 K2MI;NP''7%J 2<=(,?\
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M(A((V21LRE7,&BZK>Z+J%OH&NRO<7+@G3M4"9%]&H7(EP J7 &24  <!GC
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M$?W%_P 1>'[N.Z/B#13%;Z_!'S#(1'!J,8W%;>=]C,$#.65U!:-B2 RF2.0
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M?M ZGI)6TUB#XO>(U4N^V*Y0>3B"<@$^6"S$, 60\C(+JW??M%>!(_C1X?\
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M);9-'@&KWQ620$@_9F4)R5W1%B6S&28?:=<\/7$U^FN:-Y=IKT*B!_,R8[R
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MZ:XN5UC2#%;^((DV%I!LBOXTWXMIWVLP0,S,KC)1CD JSH^EH>MMJLTNGZE
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MC2;GXM^$%TF2,6L6JWOA]YDBE#+'%!+))-YFZ3<JH[%M[*P9@[)Y@!Z'\6-
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MI#KC(D^"KZFWPN\+1ZY=O?Z[;:=#9ZE=R,6,UU$@BGD#'!(:2-R&(&<@X&:
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M$1))4A3<P.&9< GB@#[*L;JZ\'7L>F:K<2WND7,PCL-4N7#2))(S;;6XPH&
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M.  1\NZ/)*$CJI5C5N;.Y\$W\VHZ;#)-HL[M+J&F1*6:!F)9[JW4#+9))DA
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M.(P<HN^1!N)PK?6>A6+:9H]G9._F&VA2'?C&[:H&<=LXSCF@#0HHHH ****
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M/1KU%?RB4#&-QR#U4JRD@_*R]C5=&;X>.B2L#X1R DI(']E_=58SW,!+=?\
MEG@9_=_ZO0\0:!)+-%J6ERK;:S;CRXI)"S0SQ$@M%(BD94\X(&4)W+_$K 'B
M?Q9^'WA'PO\ "GQOIVI^%- DF?0;]M-UH:5;(URXMI6V';&!'*BJ#D<-PRX(
M95\2_:,^$E[I?PP\=:Q9>&Q'>/;^)HM6MY=&LH--@T>*SU=K&>*1;8LLJDV3
M!XW#N2JR'"_)]3?%_5K3Q7\ ?B1'<6H\U-!U 76FWH1V@86TA574$@@D!E;.
M""&!QMKF?VF=4N?#W[-WQ<TG6KDRB7PAK(T_4Y %$Y%E-MB<[O\ 7\$\##@$
MKSD* >%?"#P?H_Q5OO%T]WIS:IX:GOA:WM]IND6UU=QW4>A^'A!$7EADDA,9
M-X<+M9)$.2&45V/[)W@K3)&\9Z7\1/!VB2>,FU/3VG=]#MHX?M!T#29)H% 7
MRUE5F=V1=H8M(T8P&V;W[,FG:G;3?$;6-':>[FCUW38;G2I)B(+F+_A'M&):
M,'Y8[A=S%3PKYVN0 CQ=C\'1H_Q$USXT3O$;FPN/&%K(HFC:*:"1-"T<@E6"
MO%-&Z]PKHX.<,* .LL?!&F?"*]O]7\+:%:VVC7S^=JNG:39 3*R@!9;>.-,M
M@[B\('.XNF)-ZS=)J^DV_BK3[.]M+M(YXP9=/U6#8YC+  ,C<@HPZKR&&._(
MI:+J]UHVI1Z'KDHDNY1LL=2;:O\ :2HH+EPH58YU^8E!PP!=  '6.*^M)_ D
M\^I:;;M/X>D8SZAIMNFYK4X9Y+FW15)<L<;XA][<73Y]RR@'E'[1OACPO\1/
M"&C6GC'PKHFHZ]IGB;0(4CU*R2[$=O<:W8Q3&!Y$_P!5,@*N!C(^5QZ_+7_!
M1+X ^#?@OX:T.^\'^%M!T.UU)M:4KIFDQ0W:.^DWS.AE1=SPEF5E1O\ 5;#M
M)0HL?U9^V!XCTO2?A3X=UB-+W4)3XJT*;3;K2+4WTJNM_!./+B0YF,B1%%10
MVYY(\X&77YM^/GQE\.?M:^(/ACX"O]+\4>$[J;4[VTNY=5T:>Q25+G3KFVWV
M[2H1N4R,=D@4_NW +<$@'WCK_A^:^NH=:T>:&TUN)%B\R4$17=OOW&"7';(.
MR0!C&68C(9T?X-_X*<?'8KX4\!>'(+_3-*D77;/4=5T?5=/N+J[@DAD5@CF'
M,2HF]69 Y,RNIB8*!YG0W'P@^)FB:!X?N/\ A>7CV+PO-HZ:Z%L7M5FTZ42I
M*J.5MQNM?WH0@ )$L8#(T1;R8OC!^RAXL\9:)JM_K?QH\7:Q+X=TJS\1I#/'
M:!)2DDLRIM2!1N7[,XCD<-L,SD*075P#ZA^$_BG4+3P3X5_X2&[CU73-5L+>
M73]:@:?&)(T\N.X,[>8I<L/+>4ELL(Y&,H$D_P ]_P#!4O3H])^"VA^(+<)%
M<)XAC-THCQ]I1;&\8!@",NH4A6)XWMQS@3W_ ,"O''CW7M-\+ZC\>_'4D<]K
M?7MW9W,5A"T+VTEO"T%S$MOME1Q=EL,6C955AO5E:N,\9?L^>)OB'H.@:9X^
M^+GBG5/"^JZ-'K&F&8VY>VO/(*>5*ZVP*MMF(29GPSR%"BML\P ]6^&?BJ"S
M^#7PJUF73EU/0[[1?#_A?4)+:[*7NDWS3):V]Q!&5V31F>XXF20855DC$RN:
M^1/A'\4M;^)O_!1/Q?>:_JEUJ1T\66E6#:AI0TRXCM8_$&GM'');E48. S$[
MU#9)X   S/CK^PMH/PW\7> ;>7Q5XQ\3ZQX]N5:2XFU>&*19C>6%NK.[0,9&
MW7X?<3P8C_?W##O/ASX>_8R_:/NUMAXR\467_".P7]Q>65M'=7UO=PZA'=R*
MR++"56.+3Y=[K(=H)8Y2@#]>;O3;CPA>S:GI%L]SIMS*9;_2H$&[S&9=US".
MN[ 8O$/O\LO[S(EMZCIFF_$#1;*YM[YFMF,=[8ZCI\V'C<?,DL;C@@@D%2"K
MJS*ZNC,I^#;#_@JI%8:0)+_P9XVFCBW6XO6\'JHFDB0^<7']H!48-'-N52=H
MC.<8(&9J'_!1'QEI.LRZAX.^'E]/I5] TUWI_B'1=3LITO Y!,20)<Q*&49;
M$GS,P8JA5S( ?2_C?5]1GT3XBZ!J%A'>>*8[+3EBL[7RHX=64. 'MQ.7159F
M5&24MY3, Y="DDGA-W\-_%7@*2_UN+0='TMX=7N-+M+QH(6E\-&ZET^2WGNI
M/.VM%%;L6DBM\1PNLZQL('3R?*/&'[;GC_QU!J3/\/;.VNKB>VGM;^TMM8::
MPF@<X>$MIS ,061@P((+*RLK,ING]OOXE27%^ES\.=,^TWNI6^K,BVFM*',$
M-M&P1/L1.PF)023D;\'/!(!Z1-^SKXFGU*VL)-)L=0>P\075M9:M;K%"E]C3
MO$,_[J.62=X(EN+V"$*S,5\L.A7"E?4?!0B\8?%CPO::GX%F233=6\2_;=:2
M>V:(/)<Z@AM9%9A+/;E)&((C9"[+D*T<FSY#B_;T^*/@.:#[%\)4U'1[/4Y]
M9MK>W@U"&+3U:&1&@5Y;:/$0$A91@[<,H(38B6= _;+^/6K6WAWQ)H?[-/B"
M\2.[OM2L]6L-,O9EN+>\N3<21+(+<AH6#A<@\[588(4@ ^YO 6H3>$-<^'1U
M&Z2;1IO#-Y#:2B,(;8M+IBI P5=FT$;5D)'WE4@D;F]=U;1;JPNWUW1(E?4"
MH^UV.5C74%5<*&8CY9%XVMWP%8XP5_-72?VU?V@[2_TJT3]E[Q#?/H6BRZ9-
M:MI=^S/%.T!#NGD'&?LN ,$'+=<5[W\.?VY-3\/:+8VOBOX'_&31[9+>W5[B
MX\)7$L-G*5"R0B8N9)8Q)\L;L@<[E#*""Q /K6:/2?B-X=FA9GGL9BT,J O#
M+%(C<C((>*5'4$,"&5@""" :R=*UJZT/5H=!U^433RR-_9VK;4A2^R7;RMF<
MBX1%+.  KJ#)& !)'#X?J7[5MJNKQZOHWPO^+EO=R;8[Q)? 6H&&YB7@9 3Y
M9%!RKX.0-I&,%?%?CQ^UYXO\>:_I^F>']-\8> / 31*VJ7MQ\/KR?7$NXS(K
M)&7!@4)+)8892)%DR0ZD(K@'N'@[X::AHWPF^''CSP&L\7B2P\.:=+=Z E[+
M!8ZW#]G#RHT"R+%]K<NWESR _,5W[EZ>W6MWH?Q0\'Z;JFG7D6HZ1>*MW8ZA
M;KM\L@$K(A(S&RY(.1G[RL.HK\]?AA\:OB3I7A72- 'CSXJQ1Z?;V^G6D6F?
M"9+M6"6XS'NDB5RR^7,!D'*1AB02RKZ_X+_:$/PC\,+<OX+^+GB*_26YO=<N
MKOX=7-@FI&29I6N"JH$CFCC.P-E5<(JN1\KQ@'U?HVMW-K=C1-8P-55"\,R#
M"WZ*!F13@!6R1N3.1P<[<&JKJWP]E:YMX_,\,8+7%M$O_(.^4DR1J%R8V."R
MY^7.1QD#*^'7CGPY^T/\,].\5:5!?0:/?3SBV>X98;B.2VN9(?,!C=@/GB9@
M<]",CD@61X\E\/7%OHVL127VOR "RALE2-M3^4LSQJS@(556+JS*!@X)!% &
MUXMTF#7+>WO[:]BT[4[17DL=4(WK"&7YA(NY?-A< ;HRP!PI!5D5TX[0O'>L
M?%1TMM'EM?"\$#"2\EO(_/N[F'?(J2VD3[5%O*4W173APRHZ^2#RF?:>#-3T
MJ2'6/%MO;7.C>9]I?PYID[S6.DR;F=IMT@C-TH?YBKQA8RB.D:,K,WH^OZ':
M^)K:ROM.NQ;ZC ?.L=1MCYB@,.5<!AYD+X 9,@' 8%6574 X_P .>&;'X'6A
MM-/@/_"&2/YLT[LTMS8W#'YIIY"2TD#!8\NY+0\9/D_ZCI]<\/W5W<V^M:/+
M';Z[;PB(I*[I;746\,8I54D?PGRY &:(LV-RM(DDN@>(#K2W-CJ%K]AU:U"B
M\LG)*G*@[XV(^>%LD*^.S*0KJRC%V?\ "L)$P/\ BC0<!@ #HO*(D:(J?\>A
M^8[B?W'?,/\ J #:L-0T_P =:+=126C&//D7FF7T2B6"08)CD3)P?NL",@JR
MLA92I-+3-0N/"][;Z3JT[W%I<,([#4Y&+M+P2(9F"@!P.%8_?Z??^]-X@T&\
M-PNN: ((?$$,10Q2/Y5OJ,8#%+>=PC,%#,2LBJ6C+$@,K2(\UE=Z7XZT6[BE
MMI7@)DLK[3[R/RY(G4D.CIP>P((RK*5="596(!7OM.NO#]\=8T>V,RR,&U#2
MTVJ)ADYF0 ']^,D'+8<+@G.TK?NK33OB!H=G<Q.3&"MU9WB+MEMYAD*ZY&5=
M?F4JPY!96!!93F6&J7'AR^ATW5;@W%E<2;++4Y" 79BP2WD.<EPH&U_X^ 2&
M^_)?Z5>>']2GUG18S.+AM^H:5$547385?-1F("RJH[X#A0&.0& !)H6NW4%[
M_8FN&*/6(D+0RJ L5_$H7=/&N3MP6 9#DH3U*E&;SWP-J=WH>M>-UTU;_4[;
M1_$5Q;ZUI[%[F5))X[>\BN+++D[$M[N(2P!1O=9'C4R9^T]1XI\7^'==L--L
M[5[S6-4OBMQ80:(";R%AO(F)R! JF-T+S,B;OW3$L^QL?X0V&MZ#KWB3_A+K
M?3=)\2^()HM2N;;2WDDM+F6.!+;SX9)<,Q\BWME=-BB-D'RL&$D@!U^K:3#X
MVTS3M4TC4H(M1A5[C2]6MB9;=O,0CYU211<0.K#<A;!PK*4D1'3$UKXFR064
M&DQ:.)/%]Y=II@T:>5"J[]Q:Z+$@R6PBBFE##!<1,FU9,HMW4[*X\#W4^KZ5
M;27>B22-/J.EP(TC6_#N]U:1(A>61F93)"OW_F>,>;N6?QK]IKQS>^%?$?@O
MQ'X=\:?#3P]=/9W(LKOQMXJ;2EG1Y()&\M4BD6XB<(@D!QC*E"KE74 W-<_9
MW\%Q^(++5OB'IJ_$O2H(9;*QF\41)=PZ(LLB.R1V:Q+;QPED'[XH98P%1G,(
M B]FU70'O;B+5M,9+/6;<>6)'4;;B$-N,$IP?D;J& W(6R,Y96^5_"G[3/Q.
M^)5KKY\-S?!#6_[)G:VN8[3QI<N'<IO0HXM"C*Z,,-NVY+*VUTD5>V_9J^.&
MK^+?A_/K>M>$;CP)X?M]0DLAIE[<&8Z0BI#Y>7,49-NQDX.T^5@\^6,Q 'NN
MG:G:>,]*NK2YMA'*H^SZCIER YB9D^:)Q]UE*MP>58$$9R*YZUNKCX?746E:
MG/)=:'*ZQZ=JT\F6MF 1([:YDD=FD=V)$4Q'SY"2'S=KS]#X@T*6]N(M2TJ:
M.TUNV0I'))DQ31E@6BE4$94]CR4)R,_,&73=0T_QAIMU;W5D@EVFVOM+OE1W
MBSD%)%R058$D<D,I!&0: ,;7]&O=)U2;Q!H$+7-V0#J&DJP_XF21HP01%W5(
MKE3M D8A7 6.0A5C>&TW]D_$+PY*%D%W9S%XV>!C%+#*C%2%8'=#-&ZD'[KH
MZ?PLM4+.[O/!-]!INJRW-WHUTX@T_4YFDGFBD.XBWN3@]@%CF)/F$B-SYI1I
MY]8T>[T_49-;T&+S[Q]@O=-\P1QWR J#(I.%6Y5%PK$@-A4D( 1X@"31];O+
M'5!H>M8>[DWO9W\496&\C&2$8XVI<*H!9!]Y070!0Z1MNM.N/#&HOJ>D0?:+
M6:3S+_385 WDL,W$8P3Y@&=RY^?'&&QNF"Z/\0?#T4C*;FRGVN@DC:&6&56W
M#<K /#-'(HQG#HZ\@,IJMH6MW6EW\'A_7IS/>R!A8ZD5"_VBJ(I<L%4+'..<
MH,!@I=  '2( U+NSLO'&DV6HV%UY,X03V&IP*K21%@,XR",'HRGJ.#VQ)HFN
MRZF\^F7\*V.M6RAYH$9F1D+$++&W&Y&V].H/RGWRK_3[OPSJ$^L:1%)<6\[>
M;J&EPC+3-@#S8LD 2 #D8 ? _B'.A=VUAXVTFSOM.OT^T1YFL-2MSN,4FT@G
M&>1SAD/7D'GH 85Q OPOW'@^#&'S@D*-& \QF=F)YM>1P!^Y_P"N/^HT==T"
M34+JWUK2)HK36DB1/-E&Z&[@W!V@EQV)W%' +1DDC(9T?1T+73?74FGZG%':
M:W;*2T.X8ECR )HN23&Q'?D'@\XSS\D,WP\G9P)6\(N^&&6=M*+' (&2!:<D
MG'^H]HA^Y -/1]8L_&.EW4%Q;*DJC[+J.E781WMF9 S0S*"RY*N#D$JRN"I*
MD-6;I=[<^"+JTT;4I9[C1Y62WT[5)G>66$X55M[N5V):1FR(YF/[PX1B9-K3
M7M<T:34)H]6T:2.+6H82(VD9EM[M"#B&X YV@L=K8+(2Q4$,Z.^ROM-\:Z3=
MVMY:;HSOM;_3-2B1GCSE6AG3)4JP.>I5@0REE8$@":WHES;79UC14C&JJO[V
MV8A([]!@;)&VDY4#"N/ND_W2PJW'+IOQ"T1U,<@C#LAWKLGM)T)&1GE)$/(8
M>Q!(P:P]/U&Z\%:C!I&KW$UYI=W,L&FZM=,99DE;>PMKDA0 J@!8YV;]YD(Y
M\W:T^CK6AW4%^=<T5EBU94"36['"7\2!BL3GHK GY9,':21R"10!YG\5=0UB
MVUSPQI-]"+BX6\&W4&+)'<V_G0 ME4VK..,IP#AF0XR%]%O])N?!MW-JFE6[
M7>GW#M)?Z5 @!\QV7?<Q#'7 )>(??Y9?WF1+POQ:GTGQQ:^&R\8D,5]MDAF5
M1-:7"7$&,]0LB'!##H<,I(()Z71OB[X:LY[C2]>\6:'+<6$DL(U0WUND<[0_
M+.' ?$4T;!E=#CHQ& &5 #?O+'3?'N@V4L5VSVS217MAJ.G3%'B9>8Y$D4\Y
M(P5(*NK-&ZLC,&C\.>(+DW@T+6?*@\001[M\2F."_C &Z>!2Q.P,RJZ$EHV9
M02RLDDE74K.X\/74VMZ-%)?Z/<_Z1>Z?:YE+Y )GMEW;=QZN@'S\LHWY$E_5
M-/T[QKI$;VUZ"=WGV.J6,BF6"3&!+&^",X)!R"K*2K!D9@0#,N+6;P//+J-G
M"\NAR,TEW81*7:T8XS-;Q(I)!R2\:GG)9/FW"31U?1TUZ&WU32[I(-3A7S+*
M_3#)*I4D(^/]9"^<E1CH&4A@K"+0/$%S=7\VB:S MIK]LGGYMU?[->P%V6.:
M*1E )^52\09FA9E#%D>.22G<VLG@>XFO-.A:30)"TEY8PJ"UH3O>6XB'5LG!
M>(?>/S("Q*R &SHVM0^+-/O-.OM/6WNXA]FO]-N%WH-R]MRCS(G&X!]H! ((
M#!E7+BEG\"7$=E?3&?P[*PCM+V1N;1B56.WE.,E22 LA)_NMSM9K6K:-'XD6
MPUG2;Z&UU*.,-9:G;@3*\3E69">CPN I(!_NLI5@I%K0-=MO$]O=V6HVT=MJ
MMNJQZAI<KB7R]ZY&#C$D;<[7P,\@A65U4 I^)?#MS>7MOK&BSQ6NN0((=UR6
M:WO(-X9H)54]>&V2@%H69B RM)'(RUO=-^)'AV^L+VVE@)VP7VFS2"*\L)L*
M_ER/#(3'*NY'5XV[I)&Y4JQ@MY9? #QV=U)))X<=@EK>3/S9#&!#,[-DJ3PC
M_16YP6M>)/#]Q-<?VOHK11:_!"RJLK[+:]0 E;>X(5B$!8E7"LT9+%<AI$D
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M3@G:3DA@,H3D?Q!OBWX8R)XC_P""JGQ(2^T\V_G_  VCBNK*\CW*#YU@'0Y
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M3?;9EC7( 8[B7X);8N!N'/T[XTM=.\;>"[G4K6Z<8L99K._M%430Y0[L%P0
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MZ=ID&H>-1;7+Z3#]AFDB_LK4FV>;!L<*2B$@,,[1GBOJ/P8"/">CY '^AP$
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MQ026P&)D@7M+ELD#[^#T;&Z<MH_Q \/N(W%W9S%E+1,8I89D8JV",-%-'(K
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MQ/(K2+$?"EV&95*AB!MY +*">VX>M=;X@_92^&%A<G6])^$O@N]"QA;K2O[
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M962W!\LL%9HX\D%59>RM_P#@JE\*HM*\[4M&\16T\<(DN4B^QS)$VW+!6^T
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MOM,;PEK*17R#C>N;3:+A5 56. X4(Y V/%REQ_P4X^#NO6#VE[H7B4H"HEC
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M _=DBDCD7(SM=67LP-5=$URZTO4(-!U^<27LG%EJ;(D4>HX#OL"AN)T12SJ
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MB9?Z-=Z%JDNN:%"DL\SH=1TJ-D1+TL47S@Y'^O1%"JQ*AU 23 "/%-!)I7Q
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MY""Q.5&W>F3M+)R596:+7=$NK;4VUS0E1[R0*+JQ+B..^7Y06SCB943"L>&
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MKT&O/OV??^2$_#;_ +%G3?\ TEBKT&@ KRGXU7WB3P_J/A/6?#%O:33OJ/\
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MJU%2@YOH=F#PM3'8B&'I;R=O^'\NY!\9/VE?"?FV'AS0+*Y\;^-))R]EIFC
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MC2^"59E_$$_A7TE0 4444 ?.7QJ_Y'RX_P"N,?\ *BCXU?\ (^7'_7&/^5%
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MO(I$0H&21 ZG:>1PP.#S67\7M!NM>^''B&"P>*+5(;8WVFSRYVPWT&)K65@
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MZ^7YP^5+B'.XPRM@G8>2&&64G(^\0P!%I&JWWAZ]@T/69FN(I3Y5AJ;Y)G
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MW$R1(88^Q@^&O]BA-3T*^9M>+&2YO[^0S-JBL^^2.=NRG)$908@&!&OE@Q,
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M9B=_".3)M:?B-<_:0^"E[=0ZKIOQF^'MGK,"A%E?Q-8A;B(,6,$I\PG83G!
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MRK ,"'BFCD4@\AT=/X66H-(UFZLM3CT;6F+W;JQL=15"(KY!DD-@!5G"@ED
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M>Q#RKG:4)0KYR28*G:1@C(Q4/Q=M--2?P1K.J >5H_B2VEB=@6"37"2V$9P
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX6T_7-&DM[FQ>X\- M>V\%B]@EP'CU)6F 2YDW^9\T<DA VQ/'OVOB;^R_\
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M?#.:?P%9SI;Q:SXPN(-/TK0U0 -"D<!DF>'"CY H^S;U8L("BQ]WJOP!^/\
M\5\ZGXP^,UIX$NTLYH;72OA]I $4,CD%9)+R=O.E4X4/$NU3Y<9!!&: /:-5
M\<Z1\$4MK?Q/K^GZ5X6G)2SU#5;V.$6FT#,<LDKC<N2-LA.1D*Q)*LW@'C+]
MOGP&_B/5C\)--\3?%CQ;8$07^G^#M%GO;2[53(JAYPNT*&4[;B-9 5/ D7&W
MIOA?^QA\%+?4+S4-=\)2>,/':%1JM_X\O&UJ]FY98Y6\TF-D9051UC7(C&0'
M1@/9/#&GVGP?M;/P_:6<5IX.C(@T]K:/:MB2['R9 !M$>2 KCOPW)4L ?/TG
MBC]I;]H;2+BQLO!_A+X0Z-.WEW6I:MJ;:SJEDR'I#% $19T=0Z[V4K\I^5A6
M?XA_9+\0^-$O=$^+/Q<\:^-M0N;>>31[>RN4T?1KN4PH566*! ?.CG+R(KR$
M&,94,%F"?66KZ/=P7QUK1@!?X"W-E(Y6*[0%0<CH)0JX5_3 ;Y<%7.FE?$3P
M\$FMQ/:.Z,]O=1E)8)D977(SNCEC=592,,K*K Y - 'P#\%_A[X=^%G[27AB
M7P-I6GCPEXR\/6FK>&]+^PP?:9K)(%N&#W=PGFB[9Y;Z0)N;S8HU4RPK;C;]
M87>I^&?$OCWPUJIF%O)XFMGT;]VS"Y^UVWFWMDA !:%XXDU-\.J=71_FVI7S
M1\?M0UOX7^+= UJ9K^TO? ?B>6[.I/;%H_$&GR WLUU))"J+"8+275H=FP"5
MO.6+<<QCZA^-'A[_ (1_2'\9Z39-=3Z5J-MK%_86EH;BXNEC9(YGME&66Z-J
M98@5'[Y':%N&5D .UT37;F"^31=;>/\ M-5)@N5PJWZJ.610Q(9?XUY'< J>
M*[1R^ )9KJU0MX=D8RW-JB@FR9MS/,ASS'R-R ''4<9%7%N=(^)'A6*\L+U;
M_3+AO,@O;&;:T3J2&9''S*Z,&4C ((96&,BFZ/K%S9WYTC6 HU/!DBN(4*QW
MR\@%<]) JC>F>, CY>@!9U[0;?Q-86=]8WR6^H0#S[#4(29(_F X=591+"XQ
MN0D C!!5E1EC\/\ B'^VC<6-_:_8=9M $N[1SE<8_P!9&W!DB8AMK@#HRL%9
M644)$E\!W3W5G%)=>'I6+SVL.9'LV) #QC./*[L@'&=R\9%:NN:%%XKBL]1L
M+I;2_@7?8ZI"JN0C%&9/1X9 J!DR,@*059590#X.TSXA>%_V<OV\OB+J>M1W
M^G>$(;2?3EN;#3;B]BLV;3M F5'$*L8X]D#A %VKM  "CBG^S-\=O!_PP\.^
M/;ZXN=9TCQ7=^,]8U:SMY_#.JFWU6SED#0)</%9RLB')96 \R(D_*5:2.3Z,
M^-GPT\ >-OAS\2=;\2?#CPL_CRST"ZDOKR[TB&>Y61;1Q!+'<R1!Y4Q'\D@Q
MCR]I"LC*O Z/^S7X<\+^'O[8G\*?"R7PQ<75U=3WVL^ [>X;2(=Q*F63[3&6
MAR'9I#_JRZ_*D2GR@#N;C]MGX*^)M'FM;Z^UQXI8Q'<V4OA+5F:,N@)C?;;,
MNX!AD ^N":IZ9^W-\+=!EDL-2U[7[G3E*BUU27PGJZM\\FU87!M02X+( X^_
MW^8?/B^(_P!C72K-CJ=MX8^$UH-)@NKI'D\!@6UP71B4E5KQP%5PK!@I*! J
MX0E&FA_9T\/ZIHZ/:^ ?A1/<M<II]]IZ?#2%;FQF?;N$VR^(5D5@Y*L058,C
M,&4D J?$+]I;X(>*-,UBREEUS6=#UM?(UOP^_A'68UOT;:"ZN+52LJJO]X!P
M &P<,OF.I#X=?&3XJZ-H?PTOO&M]X?.CWJZH$O=9L2+V/4-/$"QSWI CDPEU
M&6C.0ID!ZXKTV\_9GTGP5=Z+I^H>#?@[<Z=<3);IJUS\.E=W9Y/+BB<_:\^8
M6DC4,S'?ALMO(5N:U+X1VWP9_:O\!7NCZ%X6B>]\.ZB]Q8^$/#ATLW217NF@
M#9]J=-^7!!(7.UE.2X90#S77/AKIW@OQA<:!<^,/%-YK=K\5=!T*./\ X2O4
MQ#<:7<V]E)+"%:X.23-+N(+,@=?F(Q7U5XA_9H\&^$7DU:SL=?N="1'?4-.L
M_$&J-/",R2/=6Z1S%YI6=COB.6<8,?SIY<WCGQ,NW\5-K<L<RV1O/CMX;B6>
MP?YX0=/TE1@LI D7 )5EX<$$<5]A:+K5Y_:$ND:U&$U6(&6*:!66&[AW8\R,
MGHP!4.F25)X)4JQ /FW2OV?_  ;XHT#P=<KJ^M:7J.H^%H;F+6!XCOG?SY6M
M2N T^"LC%04&-V1@AMI'RQ^R1I]I\1_V:M<O?$WB_7]0\5CXEZ9HD%P/%%['
M=+I\U]ID4B*B3@C<DUT,[<C<Q!X&/LCP)9IX9T_P/JFA:;_:NA77AB*[N](M
M JA)A+!+)>6RA<N[2?/)&#^\VF1,REQ-\=?L1^&[34?V3M7U95AM==M?C)I4
M%I>/'E\/J&B[HGP59XLA9#%N +1(>"BD 'U;X>_9R\$?#/Q#K>F3GQ%-X/MQ
M:K;O<^+-2(T8&)$6,*LX/V8[22V3Y9)SB,YCZ'Q7^S7X+D\<:5::?+JUG>M8
M7-Q#%/XFU-EG*20!D8?:=Q4JS#Y3P=IYV@5Z+\._$+ZMXS\86UU;I8:[9BS-
M_IL<N\KF-@CH^%WQML;8^!G:RL$='5,FY:+X9^/=/CFN&B\,#2;E8G(^71P'
MARTCL^3!]W:-N(L\GR@/+ /@'Q=H.F^#M#^!UY+XG\::G;^*-/@OO&5C=ZY?
MW[?9_MFC&=8X$;>(S!<79&Q-[1R'KT'TK\+_ -I+X'?!K4]?MK"[\0+I6KW0
MU%M4N/#NNW-P9\+%Y4[S6Y9MJB-(G7^! K ,H>7P_P#:-T*35O!?['T%K8V.
MJWMSH%A;FTU*V26UOQ]LT!4@N1MRT)9R2H(ZD9P3GZ>T#]F'P_K,;O'X+^#M
MC?VLNR>VE^&*+) X/_7YR#C*L.",$4 4M?\ VQ_A3IVIR:]H6KZ^]Q($6^TU
MO"FLJMZB\;T!M0$N%10%<D!P CD*$>+S+]KG]J?PG\4?A9I^C_#[6/$XUT^)
M--GE^S:'JNG-%#%<*\K&=H$5 N,D[QC /6NPU3]D[2O!ODZ1>>$/A3?:/>_Z
M+;:L_P /8Q-#+([!;=V6Y!3 :-(I69F<@*[>:5:;QSP+\$]'A_;I\<>'+WP5
MX+\4V.FZ+)<+H*Z'#:::<Q:,"UO;.TL<,X\UR&/WV+*Q17+( >I^%?C?!K7P
MP^#-GK>IV^LZW<:+875QJ$%^DW[ORK-YY;IY9"8Y$8MO#,SN 74'$@B]QNOB
MEX.^'\\^J:9XKT.XT*8O<:CIL5_ 7MC\SO<VT48W.[,P,D(Y?ET'F;EG^?\
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MIX<\=_LX^(=*\%77B%/B%,NGR)H]IHNLVKF,7\/GH;E(866*2**X7(>-G3<
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M&W_8LZ;_ .DL5>@T %%%% '(?%?0Y/$GPX\2Z9"K/<W.FSK;F.+?(D^PF*1
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M+\4[#Q/X)T_4+'PKXBU?2TUZRTB>.\TZ72?M OI4TZ1%%V(9#\E_N61%,;,
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MTKK%:WCG<;5F952!\#[A+';(S'LK'(!?2UG1[BTO7UO041]1*C[59AEC34%
M 4,V#AU&-K?\!;@@K'HFL0^);*YLKRQ6VO[?$%]I\Q\U8RZ9^4X EC8,<,
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MNH!Y'J'A3XN> =(CM9_&7@:Z\+M-+)-)<^"KR:/3%/SKE7UC*VZL&P=S"+*
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M,7Q7L_&?QM3X8P^&(-(3QU?7&J)>Q22ZC/*=+TME2R3?% LC9E/F3.5+NFX
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MZS7%_%)](L_#QU#5[B^L$LG66"]TN-I+R*7.$$"*K/)(Y.P1*C>9NVE6#$$
MCO\ X/\ A75WMS?6M]>O;R&:$W&JW<AB<QO$S*3+P3')(A(YVNPZ$@]C:6D5
MA;1V]N@BAC4*B+T ' %>0?#"Y^+R^(';Q(FAWO@]T=;(W<;V6O1JC[4>Y2)Y
MK:8R+\Q,9@QE3Y<99HH_8T?<,XH ?1110 4444 %%%% !1110 4444 %%%%
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M9[\.?&WX=:QXHU+PWX?O-5TR_M+3^S[3PQHL"74!T>RN65-UF4CE:>[D?>0
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MTF7X::9J'B-+1+6\N-?#:C]M"A0;F!9RR(&9CN,2IACC &VO1_A+=W/P_P#
MFGP7Y\_P]I+RZ1<2",!M/:VD^S).D2+A+698Q-LSBW$H )B&8O0=5TJR\5V-
ME<VMZF]566QU.U9'>,/@AE;!#*P7!'(8'FN3^'5Q?6/Q&\8Z;?V\T$]T+75G
M&':(3,IMY?(<J%,+):V\FP;F61YMQY2@#K_$WAN66Z36=%V6^O01E06RL5[&
MH.VWN"%)V98E6 W(QR,AG1VV=YI_CC1+ZSO;'= Q>PU'3-0BW8)7#Q2*1AE*
ML#QE65E()4@G/21/AGYAC"KX,09=1M5=%&'9F)_Y]LXX_P"6/_7+_4Z7B'PW
M+=7*:WI,T5OK<:",2, $O(-^[[/*<$[3SM<9*%B1D%T< Q[:^E\#WT6FZO<&
MYT.XD2&PU6[D!,<CN%BL[@GDL2RK%*>7X1SYNUIM#6M&N4OEUG2)!'J "QSQ
M3',5W"&/[IES@.,D+)@[3ZJ6%6-&UJR\6Z;/!- %F4?9M0TRY"O)!(R9:&11
ME>58'()5E(()4@G(TZXF\!3V^DZA<R76BNZ6NFZG<2-+- 2%1+>ZED8M([-Q
M',Q!?*(Y,FUYP#2@?3/'FANCI,B,RB:W,AAN;.<;756VME)%^4Y!_NE2002G
MA_7KVTU&/1M>E!O&4_9;WRQ%%?#!8@#/$J*I+(, C+*,;@C=:T2YBO3J^B^5
M%JBJ%>"5ML5XF?NRD*3P.$8#*D_W2RE[-IOCOP^08YHXF<@I*IBGM)AD$^J.
MA.58>Q4D$&@#YJ_X*)?"_4;[X":UXI\*74%GJ/A6]@\60).RB*VN;61I'N(@
M48;V#2;HSA7;#$@[Q)]":7+I?QA^'WAS7[(O;B^M(=7TN^B$37.GR2PG9+&Q
M#*'5)74\,C*SHP9'92R\MH-<L=3\$^*[<WMOJ5K/:";YD2_M70HR%E">7-L)
MW*A&>73 W"/YQ_X)ZMK'@OX'7GAMEGU2Y\#>(=2\+:U:;RS-)%<;Q<097<"D
M,J*8 Q#*BE</E' /I[0_$-P+V31=<6.VUR)6F1$),5[;J54SQ9R0N64.A):)
MG )96CDDR!!'\*5VQJB>!HE*E %5-"C55 14"C-H=K$Y/[@^L/$'2ZCI.E^/
M]$M+F*[=[=_+O+*_L9=KQN.4EC<#G@D%6RK*61U9693F^&O$=[+?'1-=$$'B
M&&+S \">5#J,:B,/<6Z&1VV;G"LC,6B8A265HY) "SXBT!M46*_L;@:?K-FC
MBUO60ND8;:71XPP\R-]JY4D=B"K*I5='UNV\3P7MA>6:6^H0KY5]IERRNR(Y
M90WH\,@1BK8^;D$*P95QWV_#-I93*/\ A#@?-=I6^;16+.[R,[-_QZ<] /W'
MS=8?]1K^(= ?5O(OK"<6.LVJL;2Z(RI)7_5R*"-\)ZM&2.0"I5E5@ >>>)K7
M_A7'Q-\%:[JEP[Z&6N_#\.I75QD6:WIBD"7#,<D-/96D,3AB<R[&!+*U>*?'
M'Q)>?L^?MC>#O%>GZ#:1V7C>W71KR[3RT?5;@@ 6Q D!$T7V:T\EW4J?M,R;
MN@7Z+\91MX_^'/B/3&T-+W7;./?_ &)<D".:ZB/FP[7D 5HWD0,DQ& <$A71
ME7P3]J[3?$&K?!/1_%'@36+Z72;0VVN:5=6E@MU=R1;HKFTM4@>/+$7,5C,A
M8@GR3$Y/F#< >O\ CMO#_C*U\#>,;R.6"TAU*'3[B.>.5)D6\:.*.!TX:*1;
MS[!('"[D>"-@5P2.STC5KK1M2CT/7+E[FX<&/3=6DC!:^ 3<ZR!458YP 69
M KJID0 "2.+CM3@;XO\ PID\2^&;:WAG\0Z+'=V\+W 6*^22W1[>4R;,I+&6
M4QR8R-JYQD;>M\(:OHGQJ^'-GJ)M[A++4(OW^G7:&"[L9T8"2"7:VZ&XAE1E
M.UMR2(<'*@T 3:SI5[I5_/KN@0F:>;YM0TI67_3P%"JT99@D<RJ%PYP'"A'(
MPC17)5TCQQH0FM[AI;23<T=S;RF&6WE0[20>&21&!5@PRI!5AU%4-*UV[T/6
M;?0=>G2669S'IVJN$B6_P)'$)4'B=(TRR!0' ,B #>D,FKZ1>Z'J,FO:%$\L
MDF!J.E[CMNT57PT0+!4N 2N'(PZJ$<X$;Q #_#GB.1KV30]7:--=@$DT)&U%
MOK8. +B(!CP-Z)(.JN>@5XV>&:*?P)/)<VPFG\/2N7N+2-6=[-F9?WD8S_JA
MAF9 ..2!U%6[RUTWQYHMG<0W,J!9!<P7,#-!<VTR-@D*0"C [D>-QR-\<BE2
MRTWPSKUY-))I6MPQIKMK&&D:WC9+:^7Y09[<,Q(7)"E&8M&< DJT<D@!9US0
M;3Q1!9:AIUVMMJ, WV6JVH60JC$,R'^_#)M4.N0" "I5E1EJZ1J47BNSO](U
MK38K?4(HUBU+39E\Z%E<'!4LH$L3_, V/X75@K*RBM+'+\/KB2ZM87F\-ME[
MFUC7)L3WDA15R4."63MPR_Q"M3Q!X>3Q+;0:C97D=CJMLKM8:G&BRB'<N&!&
M0)(GPNY,C( (*LJLH!DVEU<^#]0@L]2EGO-'GD"V-_,S33V\KL0L$Q /&#M2
M4GYN$<E]K2VM?T">6[36M#,5OK\,:Q.)/EBOX5W,+>4C) W,Q1P"T;,Q 96=
M'73-8MO$]M>Z+K%C%;ZA&A2_TF=EF5HG+(K@8Q)%(%;:V!GE6 9644H;Z;P'
M=0:=J$K3:#*ZQV6HW#C=;,[(D=M*W5LL2$E8$MPK'?M:4 T]-O\ 3O&FCW,4
MD+-C-GJ.G3D++;R[ 6BD"G&=K _*2K*RLA*LI-#3=1N?#=[!IFJ3/<Z?,^VP
MU-N=Q)"I!.[')D)(VO\ QX /S8WV?$?AR[DOX=<T.5;;7[<")EF9S;7EOYBL
M\,J!@,D*PCF(9H6=B R-+')-8:GI_C31IDFM>K>5?:5?JGG6\J@,8Y$R5W="
M,$JP*NI92I(!6U;3[W0=0N-<T=)+OS<-J.E1MDW6U  \6Y@%F V]<!P &Z*R
MW;NUTCQ[H$<MO<M(I):VOK-ML]M*/E+H2/DD4Y4JP_O*P(+"LW3[VX\*7=OI
M&IRRWEA,52PU&5F9G..8KAL ;LYV.3\XP&^< R3:IIMWX>U)]:T2!IQ*0U_I
MH(5+A1G]Y&,<3C('8.%VL0=C* 2Z+KEVM^^BZQ&+?5%5I(IH580W<0;:'C)Z
M,  60G*EA]X%2<J\T>3P1>2:EHMIY^B7$QN+_2;:,?Z/([L\MY;H%R[LS9EB
M'W^70"7<LW03VFF^/M&M[A)&\H,L]K<H@6>UF7.'4,,I(I)4JP]58$$BJ.B:
M[/#<G1=9,<6K(A:&<'Y+Z)  9T'0<L-T9)*9')4J2 )J.F6GC&QT_6M&O8K?
M4$03:;K5JJ3 Q2E'9>N)()0J;T!&<*RE71'6?P[XA;6UFM;VV_L[7;,*+[3E
ME+"/>3M>.3:OF1-AML@ SA@P5U=4SM0T^Y\(:G<ZKID4U[I5V[3ZCI**TDR2
M$H/M-L">.%+20*O[P_.F)=ZW%C6-,@\9:99ZSH.I0Q:C'$;G2-9@/VF B1#@
MNB.HG@<%28]P#?(RLKJCJ 4H[D_#C$>_;X-4X63/&D!1E@[LQ/V8D;1@?N>1
M_J_]3T.OZ)+>3)J&DSI;:W;*1&SLPBG7YL13@=4R20>JGD?Q!J>B>($\0&ZL
M;VW_ +-UBW'EW>FS2J[!&9E25".'B?:VQ\<X96".KJF;;RR?#F==X>?PO,3M
M(W,^F.2Q(;M]E V@$G]SC_GE_J0#=M+K3_&FCZAI]_8(ZN'M-0TK4(@XP059
M'0Y#HRDX/*LI]#6'97=YX'O8K#5;B>YT:ZD$=CJMPYDFBE=_DM)R%Z#(6*5B
M2^0CDR%7GW-:T%[^>'5].=+/68%"K*0 MQ&"28)3M)V$DG(Y4\C/(9=/OK/Q
MGI=U:7=JJ2H#;:CIMRH?RV9 6B<$892K#D<,#D<&@#&UC1;W2]1GUWP]$)K^
M;:=0TM9%@34L!$\TL5XN$CC 0DA7 6.0A1&\5W&C_$#P^"0;S3YG# $/;NLL
M<F>1\KQ2QRIGG:Z,.S+65#?3?#^]@TK4[AI_#\KI!I^J74GS6[,T:1VMQ(SE
MF=F8B.4Y,F0CGS-K3V]:T6[TW4WUO1E$MZZA;_32P5-01$(7820L<RY #GAE
M&Q^!&\(!'HNNW6EZA#H'B"X6>_ERMAJCJD*ZF5#,T>T'Y;A$3+* %8 O&  Z
M1,N[.[\#WDU]I%O-<:'<R&:^TRV3<\$CNS2W<()YR26DB )?)= 9-RS7RVD?
M$+PU(B3&ZL9RT3/%(T4T,D;%6&Y</#-$ZD9!#I(A^ZRU!H>KWUAJ@T;7&$MX
M=\EEJ4<>R*\B!8B-^RW"(,LHPK<R(  Z1 &I>6UAXST?3[ZPU"-BRI>:?J=A
M,)%^90RNC XD1E/(Z,II= UR2]F?3]4A2TUNV7]X@&(YUPN982228R2!SRIP
M&[$X$UG=^![Z;5=/AGO='N)2]_I<2/)/%(VT>?;@'D??:2)1\Y)=!YH99M^]
MT^R\9:;:7MI="-P!/8:I9LCL@8 [D;!!5A@$<AE//6@#GVAE^&[EU5AX.!P8
MUS_Q* %"J(T53_HQY)S_ *G_ *Y9\F_XAT"2\F&J:2T<&N0QE5\W,45]& VV
M"X^4G8"Y(8 LA)(R&='T-#UR74I)M+U*);+6K90TT463%(A.%EB9A\R''(ZJ
M>#V)YZYC'PL!,07_ (0X R.GRJ-' 5F9@<@_9R=O'_+'G_EG_J0#4MKO3O'&
MBW]EJ%F'A8266I:;J$*D+N0!X95.0RLK#GE6!!!*LI.=9ZI/X*OX]-UNZ>XT
MFZF$-AJMTX+12.^([2X;.68[@L4Q/S\(Y\S:TVCK>A2W-Q:ZKIEPEOK,*B-)
M#_JKN$MO,$APQ"DC*N 61N1N#.COTO5;'Q;IEY:SVZ[TS:7^G7(#F%RN6AD7
M!!4JX.02"K*02""0!FMZ->+?IK>CR"+5$58IH)6;RKN%6+>6_. PRVU\?*2<
MY4D&S:W>E>/_  ])#()D4LJ7%L[F&ZLYE(<*Q0Y21"%(*GLK*2""<72;F[\%
M7MOHVI2RWFB2E8-+U29WDEM\*BK;7<LCEY)'?=LF.-^ DA\W:T^CK6BW,5VF
MM:(BQ:JJA9+>1@D%W&"/DE(4\@+\C@$J3T*E@0"71]9N;+4(]$U]T>_.397^
MP1QWX 8D*N3MF5 2R]",LO&Y4I:OI=YX:O;G5-,MY;K3)6+W^EIEN"69YK>,
M9RY+?.F/GP2/GSYFE'+IWQ"T&2.2*:(9*/&^8KFSF'&1T:.13RK#V92002W2
M=7N[/4/[#UEMUVX9K.^5<)>1#/#':%6=1RR 8(&Y1C<L8!!JNFZ;XVT>WEBG
M_>*?M>FZG;A1-:3;"JS1%AC<%9E^8%65V1P49E,>@:]<37DFC:TD=MKT*-,O
MDY$-] I"B>(GH"2N^/):)F )961Y(]0TF?P=>R:GI,!N;&Z?=?:8@  8L"US
M'@$E\9W1C[_4?/D26KRPTWQWH5A<Q7#M$_EWEC?V4Q5XW'S(Z,/4<%3E65F1
MPR$J0#-O+>?P=?SWFFQ2W.C3R%KZQA4RS6TKMN>XBRQXYW21 '=]]07W++>U
M?2HO%5M8:OH^HQ6VHQ1&33M3A/G1&.0*6!"L!+"X"$C/9&!5@C"/PWXBO&F7
M1O$!AM_$5O$&,J+Y-OJ48"[[BW0N[*FY@&C9F:)B 2RM&\E6XLY_ ]S+J%A%
M-<Z)+(3>Z= K/+ QV@2VZ*"3GYF>,=<ET^?*R@&OH6OVGBB"]L-0M5MM3@&R
M^TJY99"BL2%;T>)]I*/C! ((5E95S89I_ DT5M=--/X?D8);WDC,\EHS;CY<
MS$G]WPJHYZ<!CT)LZSI">(+.SU;1[I;;5(4,EC?1?/$X9?NR $"6%L@E<]@5
M*N%9;>CZU#XJM;O3K^Q%K>Q#R;[3K@>8I!R R[@!+"^#MD P<$$*RNJ@%#Q+
MX8EFNO[:T;R8/$,4?E,'Q%#J,2AREK</L9E0-(S(Z@M&22 RM)')S?B;XK_#
MNWTNVL/&>N:5X>GO+A+-=.UJ\CM+E+I&C*J@+!MR.\3+)&2.4D1MK(Q^<OVC
M5\0Z-^T=X ^'&M>/]7T'X4^,(Q':_9+V*Q>*:);A9;030O%<E7\RS16D9XP9
M I5R05]A3]D7P+I;RZK8:9:ZIKTT@-RVMPJUE?\ [Y9722UB1+:.1G7<)XX1
M(K@,?,&Z-P#TS1-4O=)U"+P_KTK2W$HVZ=JI4'[>BIN<2[45(YU^;* X=5+I
MCYTB35M,O="U&?6_#]LUQ<S 2:EI$;+G4"%549&=E5)U50 [$*ZJ(W(VH\4M
MM<Z1\1-$N[&[@8%&^S7]@\NVXL9\*X5BC91U#(ZNC=&CD1B"K5'I6MWND7T.
MB^(IU>XE=O[.U5D6..^^^PB90<"=$7Y@,"0*70 ;TB /"_VI?VS_  -\$[;P
ME8ZOI>M>(T\3K=&RN=#FAA>WEMG19-S2O&8I49MI'565U8 @BO/?!7_!4WP1
MJ]U!I?B+0]5T>X99I!?W3VQ@>-&  80RRL'8.O1<9W8P!7U/XS\%6UQ]KU"/
M2K?7;:<I)JFA7J+/#J"("5:-7PBW"DJ%=L!U4(Y "219K?!CX6>-O#["#P+X
M=^R7 ($D.CP1312*WH8\I(DB_=8 JRX(!&* /A]_VY?&7A+PSXG\2V?C'PG<
M:7821WESI?A_PGJ.IBU25X8@X>:ZMDC5I96RK%%!QMW,Y%2Z]^U9\4+KQ%X)
MO/%WA+Q!;>;>JVD&T\!0V%UJ#':1;P2S:Q*LB2-Y0=%1BPV[2CA'7UKQAH_A
M^U^%/[1.M:7I6EZ9#=>!M4T*PN=,LHX8M46PAOQ<W"M&JA6,TYB:,@?\>N]<
MHR$>/_MC^$=)L)_V.;:^2*Z\)WFOZ?\ ;-%N;436XC/V$3*J8QL=2VZ(JP8L
M<8R0P![_ &'[;WB.YCCM+O\ 9P^*T6K);Q37-M;Z;#(L98'[K&125)5P"5&<
M'@9KBO#/[?&G^ _&-QX3U'X4^./"NA6,=N!!K5A% NAB1"8HUV.Q,#I%*ZH!
MF/R9%4,@"P_2NL? 3X=ZWI$3:=X3\-Z?<0D36MTFD6\B(VT@;UV[9%(<@J2.
M#E64[6#=#^&_PYU.XN-/O/AWX5L=7M &NK$:7;OM1B0DJ-Y0\R-]K;6P/NL"
M RLH //#\?H/$!A\5>#O"FO7&H*#;/=P:)J$EMJ$,+RJ;::1+1OE20R;64%H
M7+G#!I8Y!_VT/#6N6VHZ9>^"O&9GC/V/4M-;POJDKVLC1JS02&*T==P213\K
M$$,I4E2">I?X*^!/ -^[S>!O#UWX4N)BY=]*AEFTJ5F=W=Y'!)M"64  ?N,_
M\\/]1J>(OV>?!5W<P:GH_@[PS:ZO:_(J76E1-:W<)=6DBE15QN(4A)L%XF)(
M#H9(I #Q*7_@H)X5\%:[H?AB\TW7=>;4M8;1+*>"UE::WG1HE-O<K*HDDF5Y
M%'[M7?[N\!CE]3XT?&VTA\ >+]7N/ OB<:9+H]W'KEA>:%?I:7MH8=LK.6M@
MBRK$I"NS*" %<@8*>(_L?^'-)'[6GC#18/#R:%HRZGXOB30F@B1+5,Z!^YV1
MDI\O3Y"5_NDC!/WQ8SS^%[RWT;4YY[O3YV$5AJ<SEY"V!^YN&  #'G8Y/S]&
M^?F0 ^$?V-HOV4-3T/XB7.H6OPS?3)/%DK:2?%4-HMP+4V%D2(UO!YHB\XW&
M!C:#N"\5]+>&]+_903Q!I;Z!:?!M=<6[B;3VTV+21<_:-X\HQ;!N\S?C;MYW
M8QS5#X&?#?PGXH\=?'B\USPQI&N7,?C^6!9]1L(KF14_LK32%#.I. 6)QG^(
M^M=3KGPP\#ZAXWT#1M#\'Z%82VEY#J^H:A8Z*B-;QP.)88TG6,(DDDRP94DL
M8O-P!N#J >WT444 ?.7QJ_Y'RX_ZXQ_RHH^-7_(^7'_7&/\ E10!Z9^S[_R0
MGX;?]BSIO_I+%7H->??L^_\ )"?AM_V+.F_^DL5>@T %%%% !7GOQBM+^+0]
M.US32B7VB:M97P=P"$MO/6*](!ZL;22Y4#U((^8*1Z%6)XU\-0^-/!VN^'[B
M62"WU6PGL9)8L;T66-D++D$9 ;/2@#SKPK\-?!W_  M?QY?W^B:1J'B*>\MM
M06>[M8Y;FWADM([==A8%EC9K:?D8!;S1R0U>L06T%O!'##%'' BA$CC4!54
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MV[=S J#0!U&D^&/$/@"XBTO1?$%U=:H^9(8?%-]<:C::TB+&S!99)7ELYP$
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M4,S%9 "8V)(#*TD;@'A?_!-K7/[!^&'B&RO?,-G=Z]9):W\LBD&=M#TLBW8
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M,GF1$L[89DPV(YO0-9T>'Q7:6&HZ=>I!J$*_:+'4;<[T*. =K $>;"X"[ER
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ML 7A09?<73,FY9MNYM-.^(&AI+#=MY+,7MKVT;;-;2J2A9"1\DBG>C C^\K
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M95/=E8-&X(5TDC;/W)(V*E6JK')-X#N4M+R>2Y\/R,%MKR9F>2S<AB4F8_\
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M*"0.0""  >%>%K.V\._M;:1JFB/I&C:[J!\:"1[H1VZ:O*-6M(XH)Y=ID.0
MJLN64HORNH:-OM'2M3TKQWX<N8;FV=XG>2RO=/U*$I)'(#AHI$/KD$,,JZLC
MHS(RL?SE\&6%_P##?X#?"Z#5'EATIKWPQ=ZA_:LHADTB<:QI\MP96E()B+"1
MB#EXW8C!C.(/T%\8Z;%HZ3^+[2YM=(U&QMM]Y=WCK#;W5I$)'\FZD(.R--TC
MK(.8F+$ JTD<@!\Y?#'P/\2=3\2?'"T\(^-H--TZV\>7#20W-H/MUY,-)T_9
M$UZPD6*$AD4L+9Y?DW;R20WT-\*FTK3M/O-!T_2M4T2XTVXW75IK,S7%T[S
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MZW2>0F!$ZR *!@G[9D@?P+,9[9#+X<D):XM0JK]BR69[A<X)C)^^@''WAW!
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M='9HNKV7B_2+F&XM=LJYM-1TNY =H'* M#( 2#D,O.2K*05)4@U597^'$Q9
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M]E+X&?"_Q'^RIX,\3^+?!>J:WJ>I/J0N[ZVUZ^MX4,=]/''&T<,RQH=B( %
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M0S20H/GR73]Z76?3!TGQ_P"'XW*?:[2;;(JR*4F@E4A@2IPT4T;J#@@.C+R
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M&-?FTRVMM03P_9P6Q$]PZ1R-;6FJ(S+,;I0Y,9RJ0MPT:O7V)<?'KXKKX_\
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M[''PI_ZD&GUZI7E?[2?_ "3O2?\ L<?"G_J0:?0!ZB?]6?QKE_!G_(Q>.?\
ML,1?^F^SKJ"?D/T-<OX,_P"1B\<_]AB+_P!-]G0!\_?M\_>_9S_[++X<_P#;
MBO7OV7O^39_A)_V*.D?^D<5>0_M\'+?LY_\ 99O#G_MS7KW[+W_)L_PD_P"Q
M1TC_ -(XJ /3J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO)%X3\0ZI?VMRMVD9E>))K":.W9V7.$EC@*LK!V^ZQ/5NH^(]EXBT7QQXO\
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M$&+/!'<JHED=54'$BA@N3^\&_'U/K>BW,=Y_;6B^7%J\:!'AF8I!=QY7Y)R
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MJZ*R]-XB^-6J^(?!VLZ=;R:U%XB^Q21W&F/X"U5FMQ(KJLC$)DH^QC&<#<0
MPC(;9Z?X?M=5^$&F^7J][#JOA83S/]JBMEM$T.,RS2+OS*W^BI'Y49(YB*E\
M>2VVVZKQ7X=N-<LQ=Z1>)I?B"WBD%AJ+1^9&KLA"B5 1YL))4M'N!X!#*RJP
M /D']@.?6/#?@/6='U>"_L-/%SHMO>ZC=VLMK>6TZ>'=)!M)(Y%!2)<>6)>.
MVW E5QS_ .V'\-[WQS^U#I/ACPQ!96VN:YX4DTBV:Y=H8"9M(\31#?L!'"X
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MM7@L%WZA;'<\[PQ0O"P"G8TJJ[+'M(<1LH![/;O_ ,*R=!,[#P8HPLTC #2
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M-#J-^MSIV@Z7J$C/>:1X=B-_-ISLSM-?6TTZJLLCEA*T1ML9#,%ED++-H/\
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M]D:7]U]JE@>Q*J?]D=OI*OGG]D%U>Z^,[*P8'QQD$'((_L;2\8KZ&H ****
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MR;8RY 0#!XS@@?9FL>'KS0M2EU[0XEFEF<-?Z4FR-;T<*9@2/^/E$&%)(5U
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MB*Z$DQLP!RK1O)#+'<>"KZ2YA66XT*9]]S;)OD>TD8C]Y&,G]UR2R*.,[@
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M"Z<!TBANM.E\%7T^J:7 ]WHMU*\M_ID2?-"[.SR7<(/+%C@R1 _/RZ#?N68
MU_#OB02SRZ5J*+;:Q "[0H=RS19PL\9SG:V.03E2<'J"U$H_PXE+KND\)2-E
MD&6;2F9B2Y9F_P"/7GH!^Y_ZY?ZFS>6=CXRTC3]1L;\2HR)>Z?J=C-YJ<J2C
MJRG$B,I&1DA@3ZU-X8\2SZC/+IVJ)';:Q;(#+&G$<PP,RPY))3+ <\J>#V+
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M:^(VF_M#:5%X9TB3QI=BQ,SSV^M7FGR)%"8\QR*;@J8U:]\Q&W[O,Z%5#+*
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M^%B:=_SX:[_X)+O_ .-5Y?\  O1KG3/@5\,=?T2/S+QO">D"^T]6PM^BVD0
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M%+RBGJWT[+KH=5^QIX,O[7PIK/CG7&=M<\:W[ZNR.S$PVS9,,>"Q& "S# &
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M0M%-93Z2=)8!3="WL="D96D8$(K?;$92N"&B&X[20?M&2;1O'VA/:SQF>RN
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M;BWGM',)9[6]T^_@*212@X>-UZ9/W@5)5E99%9D9&;A?BEX9N-;^'7B/P5K
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M':7<KR%I)'=B(YS]_A)#YNUI]76="N8[_P#MC1_*CU55\N6.<^5!=1[E.R7
M/S*H;8X!*DMP064SZ;JEAXQTR\M;JT (W6U]I6H*C/$3UBE3+*00<C!(92I!
M8$$Y-E>7/@N^MM,U*6:[T:Y98=/U6Y9II8I26Q!=-C 'W1',[?.?D<^:4:<
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M:>#_ (HZ+?\ PHT74;*YAD\=:-JD.H7(*8QNECM_)LW$>7DG= H"NR+& 6A
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M0(L3><SB"\@WAFAE"D<_>V2X+1%F(#J\L<@!\6>-K?2_A+%\2CXHU*[U/5/
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M^,]*U,3?9T=+Y#;RF-TFMK2UN(7##^[+%&V.0=N"""17ZR5^52?#'XC>*_\
M@IK\8?%?P[M[&\D\-S6,>HV]UJITV26"XM(PT<<PAE*%UB=2ZKN4,2A5MK*
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M415%D$B(D<:M[=^R9\0;K]H_]ESP=XCUZX>37Y8I+>YU*TQ#*;NWD>W:ZC(
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MMB 6>XMHHU9G=CDR0J,N270>9N6;4UG1K7Q5865S;W:1S(HFT_5+<K*T3,N
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MOVFWOM*O51WB)R&BE0%EPP.<@D,I!!*D$T71OATV]%:7P@Q^:( L=*^XJA%
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M)Q@<J'C))B9@"6#1R2 $FO>'?[7DM]0LIET_6;0'[/?A%=MA*EH6_O0OM&]
M0> RE757#O#^MQ^);2[L[^S6TU2W58M0TZ0^:D99<Y5B%$L398JX SA@0KJZ
M+CB-OAGY0BA(\'!0FR($MHQX551%4YM>N>0(-HX,)/D:WB+PW_;#6U]8S)I^
MMV8<6E\4,@C#LADC=-R[XY-B[ESSA2I5U5E *EK>2_#^5+6Z??X9<K';7<S
M'3^ %AE8G)0G&USR,X;L3IZSHMS;7;:[HR*-4V#[3:$@+?HH.V-F/"N"WROV
MZ'(/$6BZ_;^)(;ZQO+<6.I6Z[+W2YVCE:)&+!9!@X:*0*Q5B.=K!E5E=%HVM
MT_@&X@M;N:6?P[*VVVNI&9VLSS\DS,23']T*W;A6Y(+ &OC2OB#H<\4A>2V<
MM!/"KF*:"52"5+(0T<J-@AE8%2 RG.#7RE^US^W)!^R=X=N/#:&U\6?$BZC,
M>B6T&U@J$[4FOHU?>C+_ '54"9L%-H+B+W;]H&+Q!HWPX\6>(_ VMV_A[Q9;
MZ5,(;J\MI+JW=@IV$P(K%Y0<"/:CDDA=D@.T_F%^P1^Q7XW^(/[3.K>,?BOI
MVL:4?"U\VH7IU2.2.XU'4W=V1DG# DK(#,TJ,>1'C_6!@ ?HG\!_AUXZ^'/P
M_L]?\1:S=>)_'VMNNI^*+"XE6."2>5$!CMTY2%X8T2--NU)-AWA2RO'ZA<VF
MG?$7P_87UG<RPA\W%I?1(8;NRE&5WHDJ;HY!EE>.1>[QR(P++4>D:K>^'[Z#
M0==FDN9W4C3]49"3?(J@N)=BA(YQ\Q*J '4%T  D2(U?1KK0=3N_$&@6XGN)
MF$NHZ4NR/^T2$1%=69@%G5%55=CAE 1R,(\0!/X:\0W5W=S:1K4$=OKEM'YK
M"V5S;7<.\JLT+,,9.%#QDEHB0"2K1R259(I_ ,\EY90F;PVY:2ZLXU -B<L\
MD\0QED8Y+1CV*_Q S7=CI'Q'T&UO;.X.8YGGL-2MQ^_L+I0\1E02+\DB;I$9
M'7N\;JREEJ70/$<L^H2:+JXCM-=AB:58UP(KV)2JM<P+N)V@NJLA):,LH.5:
M-W +6N:)%XKL;74+&_2UO8%,]AJ4!\Q$W*>H# 21,-I9,@' (*L%9:VDZQ'K
M\5SI6JVJ6^IQ*4O=.E*NLJ$8WH,G?"_9CC)!4@,&44Y8Y?!%P][:":[\/W,A
M>YM4RSVSLP+3QC/W.69XU7U9>X.KK6C6WBJWL;_3;M8+R$">RU*V(8;3M;:>
MTD3[5W*",X4@AE5E ,6WNI? <\.G7LS2Z [".SU"=RS6C' 6&>5V).XG"2$<
MY"-\VTR7_$6@737O]N:,R6^OP)L\N5BMO?1CGR9\ G )8I)AFC+,0&5G21VB
MZNOB*"_TK6;*.#48(Q#?V$@,L+!UZHS*!)$_.&(_O*0&5A5"UGN?!%Y%9:C-
M-=:-<2!+._D9YI8)69CY4YQ]T\!)2<GA6.XAI #1M+[3?'>@W4<UH7MVDDM;
M[3=2AVO$Z</&\9Z],@@E74JZ,RLI:C8ZE<^$KR#2M5N'N["=ECT_4YW&6=RV
MVWF..H PDASOR WSX,D^N^')#J7_  D.B^3:>(4A2*1I%")J,$>]EMIWVEMJ
MM)(R, 3$SL0&5Y$DL:7J.G>-]'NXY+4["9++4=.N5^>!RH$D4@SC[KYRI*LK
M!E+*RD@%74M+O- U.36M MO.\Y@U_I8Q$MT25'FJ2.)U4 #H' VL00C)HO%I
M?Q#T"WN8IVDM79)[>XBS'+#(IX89&Y)%((*L,@[E8=0<G3M2N?"E_%INKS/+
MILS^58:G.PP&+ );RL6)9R3A7)^?&&^?!DDU;3+SP_>W&O:)&]V\IW:AID9P
M;W"A5:,E@J2J%4 GAPH5NB,@!-H6MW-M=+HVMO$-55<PW(PD=_&!DR1KN)RN
M?G0GY<C!P5-4=3LKGP7>7FL:;%/<Z3<,UQJ6F1*\TL1"Y,]I& 268@%X5'SG
M+J/,W+-LW,>D^/O#\36MTTD,C%H+RT?RYH95RI*MC*.IW*5(X^96'45Q'C3X
MSQ?"I+&U\3Z9>7NL7EU]EL4TE$VWX\N64M'YLBJI6.!BR%L@[>2&!H \]5[N
MW^"WPFU'2)8X;^T\.VEQ'=;D*J/)MH\.F/WL+-(N] 1T5@5=$9>\\$:I)KGQ
MF\:V]_8R6&H0>'=&M[JVD4F-F^T:H=\3$ 2QL&!#X]58(ZLB^,^ /$!\/>!/
M#ELWPPU[4-,TC1(Y-8T]'TPQVDB1$W%W:A;K<TDDJ8DBXW$EQMD\P3>D>%O^
M+D?%SQ#X@@TV^\*ZM!X<T4Z9J%P;2>5X)+K4)&Y@FE1[>;:BLF]2=@8;&6.1
M0#O[>?\ X5FRY&[PA)GRRHQ_9.2JK&JJN/LO/!)_<\_\LC^Y\[\9Z7H=[\1O
M$/B&]N]7BUW09[2XM_+O+MK%8$BA<1RVR2")T,C,V63.[:X)*#'K/AKQ&=?6
MXM[RT6PURR9#>V(<RJK,"4>.0JHEC8#Y9% ^Z0P5T=%^8/B)I4?@7Q;\1(X+
M1Y/"\-G;@O\ ;%A318EBA*Y0L"]OE0,$'RB5Z(%\H [N'XB:'\0O[3G-IJUY
M%=V:Q2:>+-)_L[E65HW68$ $-D!0.^5!Z\!^R+J!\(?%WXZVM]9ZE%I&H>*X
M#8ZIJ+.7.ZUC,:3EQO 8;525RV]@5=@Y3S(/V/O"ND^,_@EIVN:8MCJ.H#Q3
MKRV=_=I]JBNK8WEXR)*3DO$>&!))!P1R3GZ4\%+I.MVWBS2'T>&T@^V&WNM%
MN($"A&MHE92F-K1O\V" 58$^] %_6-$N[#53K>C_ #WL@1+ZPE<B*]B7/S("
MP6.< D*Y^\H".0-CQ<O\7+O2_&?P%\9W"K'=VQT2\D5;B,;X9D@<C>C F.6-
MUZ$!E="#@BMVSFNO NH0:?JLLUYH]U*(]/U*0M++#,[L1;SD+P,%5CF8Y?(1
MSYA5I^:^.VCW5G\,O'6M:*D8NYM&NS?63R%(KU/LY4R#CBX1$ 5CC<$5'(78
M\0!Q?[*VM%OV8OASH6LB&P%[X4M18WZ%V@FA%JFX2$X$<J DE"QW(A=3A9%B
ML26K^!/CQJ.J:?8SSZ.URDE]8VL1D:)FLI6,\$:#<SMAV>, E\%D4R9$GEGP
M'\2:SJ_[,GP_T">SL]1TB^\/V(M1*V]PT21*/**.KK)'-&67 +!URI  (]0^
M'.K:A8?$8>'_ !C=?:/$L^H*5O#''%%?PQV-R!A4P!(% + !0P 9!@.L8!Z-
MKEA9^(K:\UNWN5BDM+I;BTU.W9&,4;VL0:12?E9=I#$$X8 CGD5\YZOXBN;S
M73IM\L$%_91E3&MP+@3IO8^:L@X<$L>@!3..N&;Z&ATV7P=K/B"\TNT:X\.W
M5\TFI:5;H-T$CQH\MW"H7+,Q):2/.7)+(/,W+-\[^-M-@UK4);BWU=-01KB2
M>RU.WG64D!V5),K\I#  XY!1U]10!C6\4WA32M<\F,OH3QVS2'S406)^W6S,
MQ+NJB(8 V@$J6&,H?W?TCHW@8ZQISZS9:Y>S:['<2P17,M],L$T22,%B98V
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M3\-O^Q9TW_TEBKT&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 ><U](08.&XV?VDQ##D^4,@;N.4^&'PFB\.?#'0]834VE-E\+=2'E& #?\
MVG.MZWS9/^K,6P8^]G/! % 'SM_P\-_:VO+.&X7X1>$V@F\/_P#"4QR+970W
M:5P3=C_3?N89??GI7KGPY_:'_;"^(/ABRU.W^$NBP"XB2Y4C3(TA>*0%HVC:
M;682^5VD_*,;A[$]OXW^#L?@/PWXTB&IO?'P?\$/^$8C(A6(7*LMSF8@'Y.;
M$?(,C]X>?EKZJ\#^&4\&>"_#_A])S=)I.GV]@MPR[3((HU0-CG&0N<9- 'Y\
M_M(^%/VL/VC/A3J7@G7OAK86EA<RQW*M80V$#F2-@R+YCZW*%!. 2$8\G )%
M>])+^VH%3:OP#*\?=;6CQ[<>GO7U31C- 'R-\<M'_::UCX*_$&QGN_AOJ\%Q
MX>U""2PT71-2:]N@UM(K16X-TV9FR50%3\Q7ANA=\#_VW?@_H?P<\!:?XE\<
MZ=I'B"R\/V%MJ6GR03AK6Z6W198V&PX*L&&.HP<YKZV*@]0/RII=0><#'O0!
MY5\.OVI?A=\7/$HT#P=XRL-=U?R7N/LL$<H;RU(W-\R@=QW[]#7K-><Z;(OC
M?X@1^([:>=]%TNPDM-.96 M[J::3]_,5Y),8@C2-P%XFGY=9!CT:@#S']H#P
M?KWC[X>:GHOAEM-369X9X[=M6EDCMU>2WFB!<QH[8!DW8"\A6Y'%?%L'[>GQ
M5:XC6?XE_LYQ1;PLK1Q>(791G#87RQDCT)'/<5^CS< GVKSSX>S3^&-?USPM
MJ; NUW<:MIMRS ?:K>YF>:1,84;X)7=&5-P$;6[,Y:4A0#Y3\+?MJ?$'Q%\1
M_!/A_0]?\!_$J+5]7M;;4[?P5X7U9Y].L7FC2>[F>6YVPQHKG]X5<*<;ABOO
M&HO.0%0/XC@8'?'_ -:I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[3=-T':U[J>DW%TB/;+AF>ZMH@-SECN:2(9W8WH/,W+, =SX9\27%_,VF:E
MEKJ]N@:5(MQBF0\"6)B/F4]QU4G!SD$YS ?#%6= !X. +.B@*NC !F9E &3;
MDXXS^YS_ ,\O]5=UG1[7Q+86US:7 CN5(FL-5M KO$63AU8_*RD,00<JP.#4
MGAWQ&TDT^FZJBV>MPJ9G@5MRS1;BJRQ#D[3MY7JIX.<J6 (?%'A_S'77=,GB
MM-8@C">;(P6.[A#%OL\K[20A+-M<9,;,6 (+*_":9^T#X)\>^$=2NM'CN/&$
M$<9LKK3]&M?ML$MPR@FR%P/]%9VWJF3+L.\98*<UY_X7\*Z/H&J^(]9\6:&F
MHZ;HFM7-K=2ZA&M[<:80_F6TD+.Q\JR>VD@?[/"H\MYF^5E+^7O?$KXQ>#_"
M\EGXBEUV*;Q TR6NG6.BV,VKB1V)\NVG%JDA667<50L1M8GR]X$@D ,']G_5
M9]#^('Q0?Q#IVI:19S>*+>"T?5]1BN7L9VT72%C@N9%9@9GC>)$EW2Y99$,I
M>13/Y=^WU\.;KXE?M _ [PQH TR#7O$NB^--*2YU%6\H,^D+&K2% 6&W>V"
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M#&Q ]/T+7_"WQA\*/>Z3>6FL6'G/!YUM*C/;74+E64.I(62-T&"K<$ @XP:
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ME9271HW7NZ.I7<IK:5JMWX?U*/0]<E\V61F.GZFJ"..Z0#B)_FXG4#+* !(
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M4 8XY;#)U4J>JE20#M=2T^S\<Z7IFKZ+JMH-0%N9M)UJ#%Q&RR*#GY6 F@D
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M5?@BNH_##PY/'_:WBK4]>$MG;.)M,9[D:>9!_P M%7[39!8\%DRN0NP[?/\
MX>?LQ^#X#\/VU?P9HL6HQ?#CQ%XI*&PMITO'&H6QLY)U9660"WN!@,-RAL#:
MPX /%]._;]\%6?A[3;!M!U\R6OP=/PZ<B.#:;XK&OG@^;GR?D)SC=S]WK7T1
M\.?^"Q7PJ\&_#SPOH%WX1\8S7>E:7:V,TL,%H4=XHD1BN;@'!*G&0*SOV>/A
MCX*U^^^"FGO\*?!'Q#^W^"?M&J:AI>F6]NMM(XTHLU[YKR>==6ZLS2,"K/\
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M<[J].\2?'#P/X0TO0M3U?7XK/3]<MYKK3KDQ2,D\,-H]W+("JG:JP1.^6QT
M'+*#S.G?M5^!=9L;6^TVR\;ZEI]U$D\%Y9> -=G@FC<;D='2R(=6&"&4D$$8
M- '6?#K7-&O_  [;:;I5I#HCZ5!%9S^'$6*-]'98P%MGCB8I&%7;M"$H5VM&
MS(5)[:O%?#GQ,L_&/QBLWT*P\46]E>:3+!J/]M^$M4TR)7B</;.DMW;Q1Y'F
MW*L@)9MT9 Q&:]JH 1N :\K^*ZV'B\Q^%+31[+Q'XACEM=4BAN9W@33%$Y5+
MYIHQOC92LGE!"KRF-U4JHD=/39[N.W!\Q@@'&YB .>E?/'PY_:"\&^';/6);
MW2O&\>I:CJ][>74P^'VNL]R//9+=G=;+YBMM';QC/(6-%/W> #O?AS\.O&?A
M+7Y+W7_B=JOB_3GB,4.C76G6<$%L200R2)%Y[E0"H\R5B026+-S7J5>.6?[6
M?PVN/$&D:)<W^N:+J.KW,=E8)KWA?5-,2ZG=U1(DDN;:-"Y9U^7.><]J]CH
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M?QWJIGN&,<7]C[/%%V7F=B5W0-M&2<M&QR=T9/D@'M'P6UNU\0_"_P /:?-
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M:016]W(Q9K61VPENV%'[OD!9">. W8FUKFBW<&H'5=%1!J(0">U:0117RC
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M<WVF!R%N$4',D8Q@3C(&20'X5B-J,ENZL]+\<:);.KR-"Q+VUT%V36LJY7<
MZY25?F4JRY!#HPP66@#-O]*E\!:E-J>D0R7&BSNTVHZ3!'DP,SR/)=6R(A9W
M9WS)"#\_WT_>;EGN:KH]GXML[#6M*O4M]0A02Z?K%NBS'RI"C-&>H>"4(@9
M1GY2K(Z(ZS^'/$$Z7C:+JZ!-50,\4L:MLO8EV@RJ< !LL-T>25/JK*S95[87
M?@V^EU/1K62^TNYE,NHZ1;+NECD=UWW4 +=!\[R0J"7PS1CS=RS@&GX7\12:
MND]IJ%N+#7+,HM]9%S( S*2LD<A11+&V&VR*HSM8,%='1<@,GPOC$4@">"4
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M!#(=,NVLFNHS'L)67=M29",AE*G)!^X]+U>Z\/:E!H.NS!YYG*Z=JK!(TO\
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M'((;<RL-O# $7[%VCV>@P_%^PTZW2TL;7QKY-O;1 +'$@T?2]J(O154<!1P
M    !7TE7S9^Q?%?QK\8!J4D$EZOC4I-):HR12,-'TOYU0DE W7:6;&<;FQN
M/TG0 4444 ?.7QJ_Y'RX_P"N,?\ *BCXU?\ (^7'_7&/^5% 'IG[/O\ R0GX
M;?\ 8LZ;_P"DL5>@UY]^S[_R0GX;?]BSIO\ Z2Q5Z#0 4444 %%%% !1110
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M$#.555W$*"<*!DG '2@#::,,P)SD>A-2444 >(?M<Z!I^O\ P@U&WU"SMKZ
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MKB/A5XGO_%6CZC<Z@P,L5_)"BB,(40!2$89ZKNP:[>@ HHHH **** "BBB@
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M/!"A\2;37SW^WW>:OX;\?_!&^\+O%9^(+_6[FW-R&EA,ZI9SK&CO"ROA!<W
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M2#7NGPC^+EAXKUGQ_J?AFSU"?3K'4HWUO2!:2B6":2TAD\VWC8))Y@'S2PE
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YU\5/C'9_"X6, \/\
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M!K_32S%;B-0V'B'03CY>3]\*$;HCI9T[4].\;Z+<Q3V+&#>T%YIU_"/,B?\
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M)8I,)'?1KTBE;!(*Y8JX!VDOP0S*7YTSQ[H)B>!_(64J\-PI2>SN(F_$HZ,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*4 '*$MG 'R_>&#Q0!6TW5;CPS?0Z1K=R\]K*=ECJ<O ?  $,S$_ZWKAL8<
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MFOMNB@#X>_X=+_#O_HIOQ8_\*"V_^1:/^'2_P[_Z*;\6/_"@MO\ Y%K[AHH
M^)]._P""5/PVLI4:7QQ\1M4"7$-PJZEK-M,JM&X<87[,.I !]AQCK7VQ110
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M0PXQM'N4\*6GAS0-=^S^;9,;RUU:*-8QJAAAQ,S(BC%PJF1F11\ZJ70<21Q
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M0GX;?]BSIO\ Z2Q5Z#7GW[/O_)"?AM_V+.F_^DL5>@T %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^U%^R)\8KKX37VHIJ$\MVT\L/B>WGOK+R<$R:@LRCSQ;".-Y7=3\JI(S*'#
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M6OMNB@#X5TG]F_\ ;,T0WPLOVB_#UNE[<M=S)_PC=LR>:X <HIMBJ!BNXA
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M(]%UN997FW+I^ILBHEV.2(F^;_7JH.0  X5G3 #I$NL:1>:5J,FN:#"LUQ(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:\BMO#ZZ]HOQ/^'MU;I81W!N6AE=5F6>TU"-V-PT>0 //:[C*%LL8"Y"B04
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7<%M+X9U#3[1II6"R)&5N8H(2JK^Z^4J2=K<D, .U_8-_P"32OAW_P!>L_\
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M>_ADM;U_-:-8H2'+B?(7= REE) !D&UV /1_&O@FT\<:1+&DQL[QK>6**[@
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M_#;_ +%G3?\ TEBKT&O/OV??^2$_#;_L6=-_])8J]!H **** "BBB@ HHHH
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M?$_4](U"TU?3;CQ' \-Y93+/#*IT;3>5=201SV->H;%_NC\J /F_^Q?VC?\
MGOI?_A96W_S,50U[PW^TY>Z'J%OI.J:+IFJ2V\D=I>W'BJWN([>8H0DC1?\
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MC\J-B_W1^5 'R5\2(?VF]!\%:GJVFR6L]QIJ"^>UL?$=O?7-U#$PDFMX8?\
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M44 %%%% !1110 4444 %%%% 'SE\:O\ D?+C_KC'_*BCXU?\CY<?]<8_Y44
M>F?L^_\ )"?AM_V+.F_^DL5>@UY]^S[_ ,D)^&W_ &+.F_\ I+%7H- !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 55DL4>0R;5\PG.XCGTZ\&K5% $<<0C&%Z= /2F20;SG=@YX/4CZ5/10
M!!;VR6RL(U5 3G"KBIZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ,3S_P!1.V_P- '/_"X8@^'PR3_Q1\7\K:O5J\J^&'^H^'Q_ZE"(?I;5ZK0
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M "HH ],_9]_Y(3\-O^Q9TW_TEBKT&O/OV??^2$_#;_L6=-_])8J]!H ****
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M&H89["?3I@QW0W$XF<GINW GAL9 SW-=528Q2T %%%% !1110 4444 %%%%
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M]%? _A7]HWQW?_L3PW6LZ[=V_P 3=,;PQ<7.I+&%-W8:E?V;V\Z,% 8/!-)
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MAK5M?>-;;XD>$$N$?P[XI%Q%->W4+!FEBN6AQ&S1/\H=0N1C*@CD ]GHHHH
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M_BL_^%6>/K/=QYUQXF\,K&N 3R18'&<8Z=QZT ?:]%?)7_"0?M)?]"/XI_\
M"M\-_P#RNK+O/$_[4_VIA;?"B>>W!4++=^.M-61L#DL([0*"3U"X'L.E 'V3
M17S;'HW[2&W_ (\_"*^Q\9W'_P IJXKXB?"[]J+QBU@=/G\#67V?S0XO/'/B
M"/=NVXV_V=#99Z'_ %OF=MNS+;@#['HKXF\.?LU_M%W83_A(/%WA+2SF3/\
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M*I?^%9>&O^@8/^_TG_Q5=110!R__  K+PU_T#!_W^D_^*H_X5EX:_P"@8/\
MO])_\57444 <O_PK+PU_T#!_W^D_^*H_X5EX:_Z!@_[_ $G_ ,57444 <O\
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MZ'A^73]7U+[7#IFEW$!B=X$(41+')%:,V,_NXF &=M=U/^TZMIX _P"$LO\
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M.\9!V)<1(&*JJIYM\"]?T_X9>!_!UM'^R]XOM_&NBZ'!;S:U;^'--A\VZCM
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M_5;?X<QRZEI/B;X;W&CV$%_);S1AXKNWA\\1%5E5T:/<?,6ZD)0D!EUOV3_
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MH 1E!ZTP1 -NR3Z GI4E% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !370.I!XIU% $(@4%<
M<;1@8QP/3^7Y5-110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^JK3]E'X<6JW*^3XCO(+JTN;*X@O_&.L7<,L$\+PRHT<MVR\I(P!*Y!P5(8
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5%'QJ_Y'RX_ZXQ_RHH ],_9]_P"2$_#;_L6=-_\ 26*O0:\^_9]_Y(3\-O\
ML6=-_P#26*O0: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 ?.7QJ_Y'RX_ZXQ_RHH^-7_(^7'_7&/\ E10!Z9^S[_R0GX;?]BSI
MO_I+%7H->??L^_\ )"?AM_V+.F_^DL5>@T %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !32BD<@'\*=10 @&*6BB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH ^<OC5_P CY<?]<8_Y44?&K_D?
M+C_KC'_*B@#TS]GW_DA/PV_[%G3?_26*O0:\^_9]_P"2$_#;_L6=-_\ 26*O
M0: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YR^-7_(
M^7'_ %QC_E11\:O^1\N/^N,?\J* /3/V??\ DA/PV_[%G3?_ $EBKT&O/OV?
M?^2$_#;_ +%G3?\ TEBKT&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 444A('>@!:*^?OCO^W)\(?V=-3?2O%WBI#KGEB5='TR![
MNY W;?FV#9'W.)&4D#C/?Y^3_@M-\%0 #X6\?,<=1867Z_Z70!^@5%?%WPZ_
MX*R? 7Q]JMM876JZKX-DN76*)_$5AY<6]I%0!Y(7E2,?-NW.P4 ,69>_V'I.
MIV^KZ9;7]M<07-I<QI-!<6\HDBE1@"K(PX92""".",&@"]1110 4444 %%%%
M 'SE\:O^1\N/^N,?\J*/C5_R/EQ_UQC_ )44 >F?L^_\D)^&W_8LZ;_Z2Q5Z
M#7GW[/O_ "0GX;?]BSIO_I+%7H- !4<I(B;!P0IP:DJ*XR()"O7:<<9_2@#Y
M"_X)?_'?QS^T-\ _$'B/X@:X=?UFV\33Z?%<_9(+;; MK:2*FV&-%.&E<Y(S
M\W7@5]@/RI^E?CG_ ,$YOVJ_%_P-^"6N:%X?^!?C3XG6=QXAGOGU?PY:S2V\
M,C6ULA@8I"XW@1JYYZ2+QW/U2?\ @HE\3"/^31/BI_X+[G_Y%H U?^"7_P >
M_'O[17P7\3Z[\0=>_P"$@U6S\0/8V]P;."V\N$6T#!0L,:#[TCG)!//L*\!_
M9\^)_P"US^U1XM^)5MX3^-6E>'K+PIJOV3RM3T"Q<LDDDP0*5M"3M$)SN/<5
MWW_!%'/_  SOXT]/^$JD[?\ 3I;5\\?L1?M&>*/@+X[^-D?AWX/^+/BDNIZZ
MCSOX:MY919;);H*)-D3X+[SC./N-UH ^MO\ A1_[<O\ T<;X5_\ "<M?_D*O
MJ+X(^'?'/AKX;:-8?$CQ':>+/&D)G.H:Q96ZV\-QNF<Q;8U1 -L1C7A1RI/-
M?+/_  \2^)G_ $:)\5/_  7W/_R+7UO\.O%VI>./ &A^(;_0;WPQ?ZE9QW4N
MBZDC+<6;.N3#(&"D.IX.5'TH ^?O^"@?[1'B3X+>"/"OASX?7D=O\2_&VLP:
M3HX,*3-$A<>;,L<D;H_S-%%A@/\ 7@C.TT[_ ()]_M#^)/C=\//$>B^/Y(_^
M%D^"M9GT76T")#)( Q,<SQ(B)$<I+%M7/-NQXW8'B'@SQ'IG[2W_  4N\0>-
MI/$%G'X0^%%B-*TYI9F1+J[994;RS\JX$K71+Y;<L4> 5.59XDU[2_V:?^"G
M.D^*X]?M9?"/Q:L3IUVT4I:.UO0(T7=C<IW3) =Q*[!<R9 498 ]D_X*;?'+
MQQ^SY\ -+\3> =<_L'6IO$-M8R7/V2"YS"T%P[+MF1U^]&ASC/'7KGZ4^&^I
M76M^ O#.I7TWVB^O-+MKB>;:%,DCQ*S'   R6/  'IBOBS_@LL[/^R;HA/?Q
M;:=O^G6[K[,^$G_)+?!G_8%LO_1"4 6OB!IGB#5O!7B"T\*ZI#H?B:XL)XM+
MU*>)9$MKHQL(9&1E8,JN02"IR >.:^'_ (B> OVW/AQ\/_$_BR\_:$\-7=IH
M.EW6JS00>';022)!$TK*N;/&2$(&>Y%?H)7E_P"U+_R;+\7/^Q0UC_TBFH ^
M%/V9M7_;._:?^%=KXZT7X\:%I%A<74UJMK?^'K(R@QL%))6S(P3[UZ'^T=XV
M_:#_ &6_V,]:U_Q/\2]/U_XACQ';I::YINDVJ1PV+JB^28FMU0D.LC;BA/S#
MGCCI?^"1W_)FNC?]A>__ /1HIG_!7?\ Y,YU'T_MFQ_]#- 'TW\"O$FI>,O@
MC\/?$&LW/VS5M5\.Z=?7ESL5/-FEMHWD;:H"C+,3A0 ,\ 5Y;_P4 ^*?BGX*
M?LM>*_&7@O53HOB/3Y;)+>]^SQ3[!)=Q1N-DJ,ARK,.5..U?.WP8_;R^(?A7
MX/>!-%LOV6OB5KMGIN@V%G#JEE8W#07B1VZ(LT9%L04<*&&"1AASWKSC]N']
ML?QO\7/V:O%'A?6OV>/'O@#3KR2S:37M<LYTM;<I=1.H=F@11N*[1\W5A0!]
M.?&_X]>.O!__  33T[XJZ1KOV3Q[+X9\/:@^K_9('S/<R68G?RF0Q?,)I!C9
M@;N ,#'EOP>\-_ML?&3X7^&?&^G_ +0/ARPLM=L8[Z&VN?#MF98U89"MMLR,
MCV-:G[2O_*&[2.__ !1GA/\ ]':=65^RO_P4?^!'PO\ V=OA_P"%/$/BF[M-
M:TC2(;2[@32;J01R*.0&6,@_4$T 1^+?VA_VB/V)/$7A:_\ CAK.A?$_X=:[
M?265QK6AV*V][92! 57"QQ1\$.P!4E@D@++A<>F?\%,/C]XV^ ?[/OASQ;\.
M/$']AZI?^([:Q>[%I!<B2V>TNI2NV>-U&6CC.0,\=?7YZ_:S^-UK_P %&[OP
M3\'?@GI&J:[8Q:RNKZKXAN[&2UM+-(XFB!WMDJJK<2%MT8R3$$W%L'T7_@LC
M8IIG[)'@VTCW>7;^+K.)2_)(%A?#)/'/'I0!U?\ PH_]N7_HXWPK_P"$Y:__
M "%75?"?X1_M:Z'\1M#U#Q[\;_#WB7PC!/NU+2K31+>"6YCVD!5=;52OS%3P
MPZ5R/_#Q+XF?]&B?%3_P7W/_ ,BUW'P3_;)\=?%CXEZ5X8U?]G;Q_P" ]/O5
MF,FO:W9S1VEL4B>0!V>W4#>5"#+#EAB@#ZFN#M3.<$9(Y]C7Y>>.OV_OB19_
M'G5?&VE:YITG[/?AOQA9>%KM+6RCN8KR.1)3/<K<K$TAV^2T@\ML'=" '&2W
MV+^WC\=$^ '[,?BWQ!#+$-9O(QI&EQO+Y9:YN 4#+P23''YDVWN(B,C.1X;\
M'_V7] 7_ ()TR_".]U72M/\ $OBK36U6^-]>-$L&IR%)X!*N[<AA,=M&P48S
M"Q*MDA@#[KT[4K75[."[LIXKJTN(UEAGA</'(C#*LK#(((Y!'M7QA;?M$?$"
M7_@J#??">3Q!GX?PZ.+I-(^QVXQ)]A24GSO+\W[Y)QOQVQQ6Y_P3#^-K?%7]
MFS3=&U:[@_X2GP8_]@7]DQ"7$<4?%L\D?#+F,>6"1\S0R<Y# ?'?[4GQ_'[-
M'_!3CQ?XZ327UV\M]#AM;.Q5]JO<2Z?$B;SU" G)V@DXP,9R #[P_;-_;-\,
M_LH^ A>3[-5\7ZC&PT;1%<$RO@XFEP<K"IQDC[QPJG.2*'[$]C\?-9\.3>+_
M (X^)S]IU=#)IO@Y-+M;7^S8]^1),Z1B4R$8 C9CL4_/N=B(_A?]D2?^T_VZ
MVU#]I[2=2M?B=J]I!J/AK_A)%6WM(I9%)C7R'&-^TA8ER!')&Z[?-"[?V"AV
M;%^8%NIZC)QZ?TH L44A8#J<4FX8SD8]: '5Y)^T5X0^+'BWP796GP@\;:?X
M$\2IJ"2W&H:C91W4<MJ(Y \6UXI &+M$P('1#SS@^M @TM 'Y??M2>(OVS?V
M5OA@/&VN?'?0]9LOMT-C]FT_P]9"3=(&(;+V@&!L/?O7H?@OX;?MN^./!VA>
M(;;]H7PS!;ZO86^H10S>';0NBRQK(JMBSQD;L<>E;7_!8G_DT-?^QBLO_0)J
M^I/@!_R0OX;_ /8M:;_Z2Q4 ?(W[<?QV^+O[-^@_L_:?I?C**/Q#K,XL/$VH
M0:=;21ZE-&EJLCJLD1$89WE8! N-_3CC[YK\T_\ @LM>OILWP)O(K:2\EM]9
MO)DMH1\\Q4VI"+@$Y.,#CTXKT?\ X>)?$S_HT3XJ?^"^Y_\ D6@"U_P5$_:'
M^(/[.OP_\$ZI\/?$'_"/WNHZP]K<R_8K>Y\R,0E@,31N!R.J@&M7_@IW\=O'
M/[.WP$T#Q%\/]<_L'6KCQ-;Z?-=_9(+C= UK=NR[)D=1EHD.0,\=<$U\1?\
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MPUX] \1:#,K,8_/W/+]G7)(R$>X3?NY^S)G+'"@'K7_!4#X[^.OV>/@%X?\
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M54F_;GU2X_:3T[4(OB]?VT6I>&V\0,4A2X=2P18R2OF"-P(4/RQF)U 614
M/N?]BS2/CQ=>%I/%'QT\737.JZHF^R\*#3+.U&G1$@AYFBB5S*1@>66^0?>R
MQ(3Z:J)0@/&,]3BI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2^5;6-LI>69L%F.>@50"S,Q  !)( )'[+?!?_@E'\./#_P "-2\+^.X(]?\
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M ,+>*/BKX:EU_P :Z_"VJW5T=5O87$<[%X5<),H+B-D+':#N9@<XS3?VOO\
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M_DFO5_@Q^S%\,/@"'/@/P9I^@7$D1@DO55IKIXRY<HUQ*6E9<D<%R,*G& *
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MR=X6\)Z/XM_X+0?$'^V=-M=4&GZ-;:A:+=1B18;A=.T]4E4'C<N]L''!P1R
M1[M^WQ^R//\ '?P=I_BKP;))IGQ8\*$7>B:A8B.&YNS&V]8&G)4H5<%XVW@(
MY8_Q&O;=*_9Y\!:1\;-5^+-IH)B\?ZI;+:7FK&[N#YD0CCC"^49/*'R0Q#*H
M#\O7DY]+=%<$, P/4&@#Y9_8 _:P@_:=^%,2:M-Y?C_P]'':>(+5E*M+)@K'
M<XVJH$OEN2JC"L&&,;<_5%>/Z'^RQ\-/"_Q?O_BEH_AQ]*\=:@TAO-3L]0NH
MEN#( )-]NLHA;<0&8&,@N-Q^;FO7(]VWYNN: )**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /@/\ X*X>$_$GQ%^'
M?PR\%>$]/GU;5M;\5B.WTV +F>5;:7!)8@*%#.2S$* &)( )KJ?V7OV7_A]_
MP3]^#>J>./&VHV7_  DPLO.UWQ),#MM8RJDV5J/O%-X  5=\S[<C[B+]7^/?
M%7A_X>^%-5\7>)+J/3=)T:UENKK4&B,C6\0&7*A0S'.T?*H)) &"<5^"_P"V
MY^VSXB_:W\9(D8FT3P!IDI;2-"+@L6P5-S<$?>F8$X&2L:MM4GYV< 7]MS]M
MSQ#^UKXT:& SZ+\/=,F8Z3H>\KYI&X+=7*ABK3LIP ,B-254G+L_Z._\$;_^
M33+G_L9KW_T3;U^(M?MU_P $;_\ DTRY_P"QFO?_ $3;T ?C%X*\:Z[\.?%6
MF^)?#.IW.C:YILRW%K>VK[7C<?H0<D%3P02""":_:/\ 9X_:*^''_!2+X*ZG
M\/OB#I]I!XM2W!U+1@X3>P)"7UB2Q<!>">\9;:VY6!;\/P2*WO!/C?7?AQXJ
MTSQ+X9U6YT77--E$]K>VC[9(FQ@^Q!!((.002"""10!^A'[/O[(OBG]DC_@I
M%\.=-U+S=0\*W[:H^DZ]'&1%=1C3KLB.3LDJ84LA/'##@@U^OL!S&.F>AP<U
M\L?L*_M::9^V/X#:\U72(;3QOX4DA&I0^1NACFE21([JW<@[1(JSKM!W+\ZG
M*D%OJL#'2@!:*** "BBB@#YR^-7_ "/EQ_UQC_E11\:O^1\N/^N,?\J* /3/
MV??^2$_#;_L6=-_])8J]!KS[]GW_ )(3\-O^Q9TW_P!)8J]!H ***0G:"3VH
M 6BO/?@K\>_ G[1'A:Z\1_#[7/\ A(-&M;U]/FN?L<]MMG5(W9-LT:,<+*AR
M!CGKD''H5 !16;KWB#3/"NCWFK:SJ%KI6EV<33W-[>S+##!&HRSN[$!0.Y-?
M(GB#_@K!^SYHFK7-C%K^JZN(F*FZT[3)F@;!P=K.$)Z=0,'L2.: /LVBO-_@
MO^T#\/\ X_\ AV36O 7B>T\06<3!)TB+)/;$E@HEA<+)'G8V-ZC<!E<C!//_
M !K_ &Q?A!^SOXALM"^(7B[_ (1_5;VU%[!;_P!FWESOA+LF[=#"ZCYD88)!
MXZ8Q0![117RK_P /1OV8O^BF?^4#5/\ Y&JYHG_!2O\ 9O\ $6M:?I.G_$;[
M1J%_<1VMM#_8>I+OD=@J+EK< 9)')('K0!]/44U6##(/%*S!1D\4 +17#7'Q
MJ\%6WQ3L_AL_B"W/C>[LWOX]'C1WE6!<$N[!2L?48#L"W. <5V[,%&30 ZBO
MES4?^"FW[-.EZA<V=Q\2T6XMI&BD":)J4B[E.#AEMR&''4$@]B:],^!G[4GP
MP_:3;6A\./$__"1G1A ;X?8+JU\D2^9Y?^OB3=N\I_NYQMYQD9 /5Z*** "B
MBD+ $#UH 6BOE3_AZ/\ LQ?]%,_\H.J?_(U'_#T?]F+_ **9_P"4'5/_ )&H
M ^JZ*X+XR?''P1^S]X2C\3^/M:.@:&]TEFMU]EGN<RNK%5VPH[<A&.<8XZ]*
MM^*?B[X3\%_#&;XA:SJWV/P?%9Q7[ZE]FE?$$FW8_EJADYWKQMR,\@<T =E1
M7RK_ ,/1OV8O^BF?^4#4_P#Y&KI/ /\ P4!_9\^)>LG2M#^)^EB]";PNJPW&
MFJ_(4*KW4<:LQ+#"J2>IQ@&@#Z&HJ,3IZ]\=*^;OC;_P4%^"7P(\22Z!KWBL
MW^O0.%N=.T6![M[4Y8,)63Y$8%"#&S;QE25 ;- 'TK17S?\  S]O[X*?'WQ
MN@^'?%?V/7Y<F#3-9@>TEN,8R(F?Y'//"*V_Y6.W S7<_'+]J3X8?LV_V)_P
ML;Q/_P ([_;7G_8/] NKKSO)\OS/]1&^W'FQ_>QG=QG!P >KT5\J_P##T?\
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M&\BFL)[AV#$+"EPD9F.$;(C#;>,XW#/N"2*Y(4YVG!]J 'T5YE\;/VDOAO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% %#6=*LM=TB]T[4K2WU#3;R%[>YM+N)989XG4JZ.C
M9#*5)!!!!!(-?S\_MM_L?Z[^RO\ $R^46LDW@75+F630-34[U\K.1;RGJ)8U
M.TYQNV[@.2!_0K7)?$SX8^&?BYX3N_#/BW1;;7="N]IFL[D':2IRK @@@@@8
M((/O0!_,)7[=?\$;_P#DTRY_[&:]_P#1-O7SY\;?^"+?B.UUK[1\*/%%A?:*
M86=['Q1<-%=I("2$22*$HX(QRP3!')YR/L;_ ()R_ ;QE^SI\"+[PEXWTZ'3
MM5&OW=W&L%U'<))"\<*HZLA/!*-PV#QR!F@#\ JU?#/AG5/&6OZ?H>B6$^J:
MOJ$ZVUK96J;Y9I&. JJ._P#GBOM3X=_\$>_CGXHGM'\1'P]X,LWD47*W]_\
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M?>5I^SK\*K"[@NK7X9>#[6Z@=98IX= M4>-P<JRL(\@@X((Y! KXX_X*-?\
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M/OQ ^.^N_!NX\#>'CKL?A[5I[O4V6[@@\B)FMBI'FR)OXC?A 3\O3IG[?HH
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M9M[C_B8:@RXV)/DB16.7^9TCV@G";B&K[]E\(:-/X<?P]+IEI)X>>T-@^DM
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MW?LG_M%>-_BS\#]"MO'?@[Q4)-2U[PFTPCN!/B61V12=TF)"SH(CN)E:,1$
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^5% 'IG[/O\ R0GX;?\ 8LZ;_P"DL5>@UY]^S[_R0GX;?]BSIO\ Z2Q5Z#0
M5Y3^T_\ $W4/@_\  'X@>+M*"-JVDZ/<7%GO 8)-MVQN5/55=E8@]=N.]>K5
MYG^T9\+;KXT_ _QUX)M+B.UO=:TF>ULY9F*QK<%,Q&1@K$)O"[MJD[2V.<4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% 'R5\-?A<_Q'\&?&K3_ #/[(URV^)VJ:MH6K30Y-C>PM"]O.N>=FY2C
MA2-\;R)D!S7'>%H/&GQR^%GQDUG1=#73_'FF?$FQU.+1M24I;W%_I-IHYE@5
MMW,4DUC(D<A89!3)3)V_<U% 'SC_ ,-P>![K3H[.RTGQ5<>.)8"8_ Q\/7::
MLMQL+?9Y$,>Q"-IW.7V!?GW;?F'AOPU_9>3Q%\<=!T+XK6$]SJJ^!;G6K]=$
MU&\T^WM[^]UVZNY8$>"92RQFY9 "[ [=W?-?H!10!\M_ KX<Z-^S;\;-7\&/
MH[7$?B82W_AOQ9?3RW^H30*JM<:7/<.I:-864RQ@N%='Z-*DKMU>J6TI_;G\
M.7'E/Y(^'.J1F7:=H8ZGIY STS@'CZU[S10!\LZW\ O"/QE_:N^(DOB[3M3N
MHK#PSX>6TDLM8OM/&7FU3S 3;31^9]R/[V=O;&3E_P '?@]X>^#W[7WB_3?"
M]A?VFD7'@;2KEC>ZC=WY:<ZA?JP$MQ)(P 5$^0, .N 6.?J.B@ HHHH ****
M /G+XU?\CY<?]<8_Y44?&K_D?+C_ *XQ_P J* /3/V??^2$_#;_L6=-_])8J
M]!KY-^"G[:WP:T'X.^ M-O\ QAY%[9Z!8VT\?]F7K;)$MT5AD0D'!4C()'%>
M^_#7XP>$_B_HEQJ_A#5/[6T^"Y:TDF-O+!B545RN)$4\*ZG(&.?:@#M:2EHH
M B$*@YQS]<_Y'M1]G3;MQQQQGTJ6B@",PHRD$9!&.3GBG!0%V@<#C%.HH 8B
M+&,*,#TI#"C')!S_ +QJ2B@"$V\;=5!^OZ4JV\:9P@&3D_D!_05+10!$(4!)
M"X)X)%!MHS_ .N?ZU+10 PQ*<<=.G-'E+Z8^G%/HH C$*#HH%.50HXIU% !1
M110 4444 %%%% !1110 4444 %%%% !117C_ (Z_:S^%?PU\5WWAOQ'XH_L_
M6+(HMQ;?V?=2^7OC61?F2)E.5=3P3U]J /8**\#_ .&[?@=_T.Q_\%-]_P#&
M*/\ ANWX'?\ 0['_ ,%-]_\ &* /?**\#_X;M^!W_0['_P %-]_\8H_X;M^!
MW_0['_P4WW_QB@#WRBO _P#ANWX'?]#L?_!3??\ QBC_ (;M^!W_ $.Q_P#!
M3??_ !B@#WRBO _^&[?@=_T.Q_\ !3??_&*/^&[?@=_T.Q_\%-]_\8H ]\HK
MP/\ X;M^!W_0['_P4WW_ ,8H_P"&[?@=_P!#L?\ P4WW_P 8H ]\HKP/_ANW
MX'?]#L?_  4WW_QBC_ANWX'?]#L?_!3??_&* /?**\#_ .&[?@=_T.Q_\%-]
M_P#&*/\ ANWX'?\ 0['_ ,%-]_\ &* /?**\#_X;M^!W_0['_P %-]_\8H_X
M;M^!W_0['_P4WW_QB@#WRBO _P#ANWX'?]#L?_!3??\ QBC_ (;M^!W_ $.Q
M_P#!3??_ !B@#WRBO _^&[?@=_T.Q_\ !3??_&*/^&[?@=_T.Q_\%-]_\8H
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M_0['_P %-]_\8H_X;M^!W_0['_P4WW_QB@#WRBO _P#ANWX'?]#L?_!3??\
MQBC_ (;M^!W_ $.Q_P#!3??_ !B@#WRBO _^&[?@=_T.Q_\ !3??_&*/^&[?
M@=_T.Q_\%-]_\8H ]\HKP/\ X;M^!W_0['_P4WW_ ,8H_P"&[?@=_P!#L?\
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M?]#L?_!3??\ QBC_ (;M^!W_ $.Q_P#!3??_ !B@#WRBO _^&[?@=_T.Q_\
M!3??_&*/^&[?@=_T.Q_\%-]_\8H ]\HKP/\ X;M^!W_0['_P4WW_ ,8H_P"&
M[?@=_P!#L?\ P4WW_P 8H ]\HKP/_ANWX'?]#L?_  4WW_QBC_ANWX'?]#L?
M_!3??_&* /?**\#_ .&[?@=_T.Q_\%-]_P#&*/\ ANWX'?\ 0['_ ,%-]_\
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M]_\ &* /?**\#_X;M^!W_0['_P %-]_\8H_X;M^!W_0['_P4WW_QB@#WRBO
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2*J*67;*$/ 9>0,<]>M% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>image_29a.jpg
<TEXT>
begin 644 image_29a.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0 Z17AI9@  34T *@    @  U$0  $
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M/^'4/[+7_1M?P#_\-SI/_P C5]#44 ?//_#J']EK_HVOX!_^&YTG_P"1J/\
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MM?P#_P##<Z3_ /(U?0U% 'SS_P .H?V6O^C:_@'_ .&YTG_Y&H_X=0_LM?\
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M_P -SI/_ ,C5]#44 ?//_#J']EK_ *-K^ ?_ (;G2?\ Y&H_X=0_LM?]&U_
M/_PW.D__ "-7T-10!\\_\.H?V6O^C:_@'_X;G2?_ )&H_P"'4/[+7_1M?P#_
M /#<Z3_\C5]#44 ?//\ PZA_9:_Z-K^ ?_AN=)_^1J/^'4/[+7_1M?P#_P##
M<Z3_ /(U?0U% 'SS_P .H?V6O^C:_@'_ .&YTG_Y&H_X=0_LM?\ 1M?P#_\
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M/_R-7T-10!\\_P##J']EK_HVOX!_^&YTG_Y&H_X=0_LM?]&U_ /_ ,-SI/\
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M0!\\_P##J']EK_HVOX!_^&YTG_Y&H_X=0_LM?]&U_ /_ ,-SI/\ \C5]#44
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M ,.H?V6O^C:_@'_X;G2?_D:C_AU#^RU_T;7\ _\ PW.D_P#R-7T-10!\\_\
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MVOX!_P#AN=)_^1J/^'4/[+7_ $;7\ __  W.D_\ R-7T-10!\\_\.H?V6O\
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M'_X;G2?_ )&H_P"'4/[+7_1M?P#_ /#<Z3_\C5]#44 ?//\ PZA_9:_Z-K^
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MN=)_^1J/^'4/[+7_ $;7\ __  W.D_\ R-7T-10!\\_\.H?V6O\ HVOX!_\
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MP#_\-SI/_P C5]#44 ?//_#J']EK_HVOX!_^&YTG_P"1J/\ AU#^RU_T;7\
M_P#PW.D__(U?0U% 'SS_ ,.H?V6O^C:_@'_X;G2?_D:C_AU#^RU_T;7\ _\
MPW.D_P#R-7T-10!\\_\ #J']EK_HVOX!_P#AN=)_^1J/^'4/[+7_ $;7\ __
M  W.D_\ R-7T-10!\\_\.H?V6O\ HVOX!_\ AN=)_P#D:C_AU#^RU_T;7\ _
M_#<Z3_\ (U?0U% 'SS_PZA_9:_Z-K^ ?_AN=)_\ D:C_ (=0_LM?]&U_ /\
M\-SI/_R-7T-10!\\_P##J']EK_HVOX!_^&YTG_Y&H_X=0_LM?]&U_ /_ ,-S
MI/\ \C5]#44 ?//_  ZA_9:_Z-K^ ?\ X;G2?_D:C_AU#^RU_P!&U_ /_P -
MSI/_ ,C5]#44 ?//_#J']EK_ *-K^ ?_ (;G2?\ Y&H_X=0_LM?]&U_ /_PW
M.D__ "-7T-10!\\_\.H?V6O^C:_@'_X;G2?_ )&H_P"'4/[+7_1M?P#_ /#<
MZ3_\C5]#44 ?//\ PZA_9:_Z-K^ ?_AN=)_^1J/^'4/[+7_1M?P#_P##<Z3_
M /(U?0U% 'SS_P .H?V6O^C:_@'_ .&YTG_Y&H_X=0_LM?\ 1M?P#_\ #<Z3
M_P#(U?0U% 'SS_PZA_9:_P"C:_@'_P"&YTG_ .1J/^'4/[+7_1M?P#_\-SI/
M_P C5]#44 ?//_#J']EK_HVOX!_^&YTG_P"1J/\ AU#^RU_T;7\ _P#PW.D_
M_(U?0U% 'SS_ ,.H?V6O^C:_@'_X;G2?_D:C_AU#^RU_T;7\ _\ PW.D_P#R
M-7T-10!\\_\ #J']EK_HVOX!_P#AN=)_^1J/^'4/[+7_ $;7\ __  W.D_\
MR-7T-10!\\_\.H?V6O\ HVOX!_\ AN=)_P#D:C_AU#^RU_T;7\ __#<Z3_\
M(U?0U% 'SS_PZA_9:_Z-K^ ?_AN=)_\ D:C_ (=0_LM?]&U_ /\ \-SI/_R-
M7T-10!\\_P##J']EK_HVOX!_^&YTG_Y&H_X=0_LM?]&U_ /_ ,-SI/\ \C5]
M#44 ?//_  ZA_9:_Z-K^ ?\ X;G2?_D:C_AU#^RU_P!&U_ /_P -SI/_ ,C5
M]#44 ?//_#J']EK_ *-K^ ?_ (;G2?\ Y&H_X=0_LM?]&U_ /_PW.D__ "-7
MT-10!\\_\.H?V6O^C:_@'_X;G2?_ )&H_P"'4/[+7_1M?P#_ /#<Z3_\C5]#
M44 ?//\ PZA_9:_Z-K^ ?_AN=)_^1J/^'4/[+7_1M?P#_P##<Z3_ /(U?0U%
M 'SS_P .H?V6O^C:_@'_ .&YTG_Y&H_X=0_LM?\ 1M?P#_\ #<Z3_P#(U?0U
M% 'SS_PZA_9:_P"C:_@'_P"&YTG_ .1J/^'4/[+7_1M?P#_\-SI/_P C5]#4
M4 ?//_#J']EK_HVOX!_^&YTG_P"1J/\ AU#^RU_T;7\ _P#PW.D__(U?0U%
M'PO^VO\ \$__ (#? [X6^$?$O@OX*_!_P7XHL_BC\/DL=9T#P;IFGW]KYOC/
M1H9/)FBA#J3$[*<=F/T!7LW_  4L_P"3>_#G_95/AO\ ^IOHE% #/^"4_P#R
MBS_9G_[)7X6_]-5G7T+7SU_P2G_Y19_LS_\ 9*_"W_IJLZ^A: "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!\^_P#!2S_DWOPY_P!E4^&__J;Z)11_P4L_Y-[\.?\ 95/AO_ZF^B44 ,_X
M)3_\HL_V9_\ LE?A;_TU6=?0M?/7_!*?_E%G^S/_ -DK\+?^FJSKZ%H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M /GW_@I9_P F]^'/^RJ?#?\ ]3?1**/^"EG_ ";WX<_[*I\-_P#U-]$HH 9_
MP2G_ .46?[,__9*_"W_IJLZ^A:^>O^"4_P#RBS_9G_[)7X6_]-5G7T+0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 ?/O_!2S_DWOPY_V53X;_\ J;Z)11_P4L_Y-[\.?]E4^&__ *F^B44 ,_X)
M3_\ *+/]F?\ [)7X6_\ 359U]"U\]?\ !*?_ )19_LS_ /9*_"W_ *:K.OH6
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH ^??\ @I9_R;WX<_[*I\-__4WT2BC_ (*6?\F]^'/^RJ?#?_U-]$HH
M 9_P2G_Y19_LS_\ 9*_"W_IJLZ^A:^>O^"4__*+/]F?_ +)7X6_]-5G7T+0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!\^_\ !2S_ )-[\.?]E4^&_P#ZF^B44?\ !2S_ )-[\.?]E4^&
M_P#ZF^B44 ,_X)3_ /*+/]F?_LE?A;_TU6=?0M?/7_!*?_E%G^S/_P!DK\+?
M^FJSKZ%H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% 'S[_ ,%+/^3>_#G_ &53X;_^IOHE%'_!2S_DWOPY
M_P!E4^&__J;Z)10 S_@E/_RBS_9G_P"R5^%O_359U]"U\]?\$I_^46?[,_\
MV2OPM_Z:K.OH6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ^??^"EG_ ";WX<_[*I\-_P#U-]$HH_X*6?\ )O?A
MS_LJGPW_ /4WT2B@!G_!*?\ Y19_LS_]DK\+?^FJSKZ%KYZ_X)3_ /*+/]F?
M_LE?A;_TU6=?0M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!\^_\%+/^3>_#G_95/AO_P"IOHE%'_!2S_DWOPY_
MV53X;_\ J;Z)10 S_@E/_P HL_V9_P#LE?A;_P!-5G7T+7SU_P $I_\ E%G^
MS/\ ]DK\+?\ IJLZ^A: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMK'Q%HEY;6EQL'FQPSR>-X3-$">)3%&6 R8X^5 !^BG_  \1_;K_ .D=H_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M% 'OW_#US]EG_HY3X!_^'&TG_P"2:/\ AZY^RS_T<I\ _P#PXVD__)-> _\
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M!_\ $)OB;_\ +"@#W[_AZY^RS_T<I\ __#C:3_\ )-'_  ]<_99_Z.4^ ?\
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M/_R37@/_  W-\8/^BD'_ ,0F^)O_ ,L*/^&YOC!_T4@_^(3?$W_Y84 >_?\
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M&@#Z_P#^'KG[+/\ T<I\ _\ PXVD_P#R31_P]<_99_Z.4^ ?_AQM)_\ DFO
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MI!_\0F^)O_RPH ]^_P"'KG[+/_1RGP#_ /#C:3_\DT?\/7/V6?\ HY3X!_\
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M)CYT!EN_]#COQ+9?99@(?WI/FY#I@"@#Z_\ ^'KG[+/_ $<I\ __  XVD_\
MR31_P]<_99_Z.4^ ?_AQM)_^2:\!_P"&YOC!_P!%(/\ XA-\3?\ Y84?\-S?
M&#_HI!_\0F^)O_RPH ]^_P"'KG[+/_1RGP#_ /#C:3_\DT?\/7/V6?\ HY3X
M!_\ AQM)_P#DFO ?^&YOC!_T4@_^(3?$W_Y85Y[\(_\ @I'^TUXR\8:_8^+
MW@K1]/W?V1J'_#(GQ$U'^W"-3U* 9ACO]T)-E9Z?><DX&K&+_66TAH ^P/\
MAZY^RS_T<I\ _P#PXVD__)-'_#US]EG_ *.4^ ?_ (<;2?\ Y)KP'_AN;XP?
M]%(/_B$WQ-_^6%'_  W-\8/^BD'_ ,0F^)O_ ,L* /?O^'KG[+/_ $<I\ __
M  XVD_\ R31_P]<_99_Z.4^ ?_AQM)_^2:\!_P"&YOC!_P!%(/\ XA-\3?\
MY85YW\!O^"DW[3'Q#;QG_P )LG_"NO[#\57NC:(1^R+\1-5'B+2HO+^R:L/)
MO_\ 1S/D_P"C2_O(L<DY% 'V%_P]<_99_P"CE/@'_P"'&TG_ .2:/^'KG[+/
M_1RGP#_\.-I/_P DUX#_ ,-S?&#_ **0?_$)OB;_ /+"C_AN;XP?]%(/_B$W
MQ-_^6% 'OW_#US]EG_HY3X!_^'&TG_Y)H_X>N?LL_P#1RGP#_P##C:3_ /)-
M> _\-S?&#_HI!_\ $)OB;_\ +"O//V>/^"D/[3'Q&\(MJ'CZ)OAEK2BSVV/_
M  R)\1-9#^;IEE/<#SH;\#,-[/=6?3]X;#S1^[EC% 'V#_P]<_99_P"CE/@'
M_P"'&TG_ .2:/^'KG[+/_1RGP#_\.-I/_P DUX#_ ,-S?&#_ **0?_$)OB;_
M /+"C_AN;XP?]%(/_B$WQ-_^6% 'OW_#US]EG_HY3X!_^'&TG_Y)H_X>N?LL
M_P#1RGP#_P##C:3_ /)-> _\-S?&#_HI!_\ $)OB;_\ +"O//V8/^"DG[3/Q
M9^!VAZ_\3O\ BTOC:_$[7WA7_AD;XB:ZVEE)Y8H@+V&_$4WF1"*7Y1QY^P\@
MY /L'_AZY^RS_P!'*? /_P .-I/_ ,DT?\/7/V6?^CE/@'_X<;2?_DFO ?\
MAN;XP?\ 12#_ .(3?$W_ .6%'_#<WQ@_Z*0?_$)OB;_\L* /?O\ AZY^RS_T
M<I\ _P#PXVD__)-'_#US]EG_ *.4^ ?_ (<;2?\ Y)KP'_AN;XP?]%(/_B$W
MQ-_^6%>>?LP?\%)/VF?BS\#M#U_XG?\ %I?&U^)VOO"O_#(WQ$UUM+*3RQ1
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M ?\ X<;2?_DFO ?^&YOC!_T4@_\ B$WQ-_\ EA1_PW-\8/\ HI!_\0F^)O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:UE4MS^]D]OS!KU&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBODGX1?MO7O_"(^+;GQ9JFFKJ\<;W>BQ_9)2K$F4B(
M^6"3$,0<Y_B.9#D$ 'UM17CO['/Q4UCXO?#.2\UR1;[4-/U*6S:Y6/R>/)AE
M'R_]M<?A7L5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%<!^TGX\N_A?\&M>UO3/^0A:_9]@]Y)XHOY&O"O$G[;>H1_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!\^_\ !2S_ )-[\.?]E4^&_P#ZF^B44?\
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M]9ZAXRU/Q)9LL2VBWBG-@L8Y )D?KQGZ5Z=110 4444 %%%% !1110 4444
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M10 S_@E/_P HL_V9_P#LE?A;_P!-5G7T+7SU_P $I_\ E%G^S/\ ]DK\+?\
MIJLZ^A: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^>_B!_RE
M)^#?_9*O'?\ Z=O!E?0E?/?Q _Y2D_!O_LE7CO\ ].W@R@#\@_\ @UT_Y/%^
M!7_9JVO_ /JSM3K^@"OY_P#_ (-=/^3Q?@5_V:MK_P#ZL[4Z_H H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB&XBDCF+ I:3))L260Q ']!%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'S[_ ,%+/^3>
M_#G_ &53X;_^IOHE%'_!2S_DWOPY_P!E4^&__J;Z)10 S_@E/_RBS_9G_P"R
M5^%O_359U]"U\]?\$I_^46?[,_\ V2OPM_Z:K.OH6@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "OGOX@?\I2?@W_V2KQW_P"G;P97T)7SW\0/
M^4I/P;_[)5X[_P#3MX,H _(/_@UT_P"3Q?@5_P!FK:__ .K.U.OZ *_G7_X-
M5-3UB\_;5^']OK&GG[+:?LVZW'HBBVAMVO[3_A/IY6PPNI#-_I#7*[I4M3\F
MSR2B+<W']%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*0_?E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M10 S_@E/_P HL_V9_P#LE?A;_P!-5G7T+7SU_P $I_\ E%G^S/\ ]DK\+?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y]_X*6?\
M)O?AS_LJGPW_ /4WT2BC_@I9_P F]^'/^RJ?#?\ ]3?1** &?\$I_P#E%G^S
M/_V2OPM_Z:K.OH6OGK_@E/\ \HL_V9_^R5^%O_359U]"T %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5\]_$#_ )2D_!O_ +)5X[_].W@ROH2O
MGOX@?\I2?@W_ -DJ\=_^G;P90!^0?_!KI_R>+\"O^S5M?_\ 5G:G7] %?S__
M /!KI_R>+\"O^S5M?_\ 5G:G7] % !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ?F-_P74_93N_B_HWQ MEO/%DUC\:OA'J7A5=&T:T@N'U
MOQ7X;F;Q3X:M+>,0R70EEA7Q"LF#Y<L<2Q_NYVMR_B'["_[4 ^)7[,/_  37
M^/.DWGB2/1OA;JMQ\ ?&?AWPQNU'9_:=E#I%G<ZG*LD:PP?;;#1KLP31G']H
MVQ0R211>=^C/_!1@CPE\%-)^)ENPCNO@KXHTGQM=7S-N&A:7#<"#7[GRL9FQ
MX?O-9'E^7))ALP)]H$)'Y%_L6?LZ:W\'?V??^"CG[$]EJ'B32=<^$NJCXD_#
M.+0=3BD\;:G/#MU#3+B+[,3Y^?[+\/D^1#'+%+J!C_=22QB( _H#HKS']DSX
MXM^T]^R]\._B8^E_\(_)\1/"VF>*1IZ77VG^SUO+.*X$'G>6GG>6)<;C& 2.
M@Z#TZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKEIHUZM]#=-KUJWCZXF:\\OC[.5N)KFU\J3)/V7S/N2@#^BB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M** /GW_@I9_R;WX<_P"RJ?#?_P!3?1**/^"EG_)O?AS_ +*I\-__ %-]$HH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH _ KXA^#=<_8Z_X*H_L%_$%M.U+Q#IO@
M77]4_9D>Q^RM:MH%M:WU]IF@WE_. X%[=Z+JUMJ0A,4(N(H/,BQ%,#%^C/\
MP2@.D_!7XK?M+?L\Z?XATV_7X0?$F?6=$T:R\.C2[7PSH7B*T@UNSL8?*'E&
M**[GU*,#>7Q;\I%&8HQ^7'_!T[X4^(UQ^TA+\%?!7@GX@>.M/^/6K:-\4M/C
MLM+-RT6N:5I>I:-J=G8106IFN =-ATB>0&63[.(2^ EUD>^_L$_MS_M$^(_^
M"]/A/4?VC/A-XG^#%A^T!\+[[0_!&A6C.]C);V%Y/K%K+J1EF.;^UMY-0BDS
M'%-$;R'-K;QSDD _::BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% 'S[_P4L_Y-[\.?]E4^&_\ ZF^B44?\%+/^3>_#G_95/AO_ .IOHE% #/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %?&/_  6:\;?\*)^"WPQ^,UUXT7P;HWP-^*GA
MSQ-K%VVBG4OMNE7=P=#U*$##%?\ 0=9N),QQ22?N"(P)"'C^SJ\Q_:S^!S?M
M/?LO?$3X9IJG_"/R?$3PMJ?A8Z@]K]I_L];RSEMS/Y/F)YWEB7.T2 $CJ.H
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M65Q"LUK:W DE$\X''[LA20_3(!_2E17Y _\ $-Q\.O\ HRC]G_\ \27\;_\
MRFH_XAN/AU_T91^S_P#^)+^-_P#Y34 ?K]17Y _\0W'PZ_Z,H_9__P#$E_&_
M_P IJ/\ B&X^'7_1E'[/_P#XDOXW_P#E-0!^OU%?D#_Q#<?#K_HRC]G_ /\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"4GRO_@WX^%7Q:_:,_9IN]:T?XC^*?B_X7L[>QT'3]$\0_''QI\-O^$!N;&
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MQ)T_^WKN*,":\$$5@8H/.E#2^4IQ'NP,CFNH_P"&&?C!_P!$W/\ XFS\3?\
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M;4 ??O\ PL+]J3_HB_[/_P#X>+5O_F8H_P"%A?M2?]$7_9__ /#Q:M_\S%?
M7_$)?\._^@;\ O\ PC_&W_S;4?\ $)?\._\ H&_ +_PC_&W_ ,VU 'W[_P +
M"_:D_P"B+_L__P#AXM6_^9BC_A87[4G_ $1?]G__ ,/%JW_S,5^;NA?\&A_@
M;P[XZ\2:Q>>(O@[JECJ[6WV71KSP1XI73_#QABQ)]F:+Q:DY\[/F2?:IIL$?
MN_*3*UTO_$)?\._^@;\ O_"/\;?_ #;4 ??O_"POVI/^B+_L_P#_ (>+5O\
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M_P#AXM6_^9BC_A87[4G_ $1?]G__ ,/%JW_S,5^<7_$'[X+_ .%F_P#"0_\
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M:?XA,T6(_M+2^+7G'DX\R/[+-#DG]YYJ86NE_P"(2_X=_P#0-^ 7_A'^-O\
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MJW_S,4?\+"_:D_Z(O^S_ /\ AXM6_P#F8KX"_P"(2_X=_P#0-^ 7_A'^-O\
MYMJ/^(2_X=_] WX!?^$?XV_^;:@#[]_X6%^U)_T1?]G_ /\ #Q:M_P#,Q1_P
ML+]J3_HB_P"S_P#^'BU;_P"9BOS?\??\&@G@OQIHB6^F^(/@]X0D'V@&]TKP
M3XHFF8R6TT"@BZ\63Q?N99DG3"\RVT0?S(C+%)T?_$)?\._^@;\ O_"/\;?_
M #;4 ??O_"POVI/^B+_L_P#_ (>+5O\ YF*/^%A?M2?]$7_9_P#_  \6K?\
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M%\%>)Y;^Q(FR?*%[XLN(#NYB/F0OQG&' 8=+_P 0E_P[_P"@;\ O_"/\;?\
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M_P#_ (>+5O\ YF*/^%A?M2?]$7_9_P#_  \6K?\ S,5\!?\ $)?\._\ H&_
M+_PC_&W_ ,VU'_$)?\._^@;\ O\ PC_&W_S;4 ??O_"POVI/^B+_ +/_ /X>
M+5O_ )F*/^%A?M2?]$7_ &?_ /P\6K?_ #,5\!?\0E_P[_Z!OP"_\(_QM_\
M-M7.?#+_ (-"O W@GP3IVCZEXD^#OC:^LS,&UC6O!7B>*_OR9L_O19>++>#]
MWD1#RX4  &[+DL0#](/^%A?M2?\ 1%_V?_\ P\6K?_,Q1_PL+]J3_HB_[/\
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M_P#J;Z)11_P4L_Y-[\.?]E4^&_\ ZF^B44 ,_P""4_\ RBS_ &9_^R5^%O\
MTU6=?0M?/7_!*?\ Y19_LS_]DK\+?^FJSKZ%H **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KY[^('_ "E)^#?_ &2KQW_Z=O!E?0E?/?Q _P"4
MI/P;_P"R5>.__3MX,H _(/\ X-=/^3Q?@5_V:MK_ /ZL[4Z_H K^=W_@U*\>
M'Q1^V]\.[ :-XDTO_A%OV;-<TXW&H68@M];#>/I[OS[%L_OH!]J,)D_Y[V]P
MF/W>3^QO[0'Q+\2?#;]JKP__ &7'J6N6CZ3ODT6TNY?].;%YSY6'!(P.<=AZ
M4 ?2M%?//['7C[5O'OC'Q]-JQU*/9=0[;&ZO);C^SA)+/^X&>./\\5]#4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !117SS_P]<_99_P"CE/@'_P"'
M&TG_ .2: /H:BOGG_AZY^RS_ -'*? /_ ,.-I/\ \DT?\/7/V6?^CE/@'_X<
M;2?_ ))H ^AJ*^>?^'KG[+/_ $<I\ __  XVD_\ R31_P]<_99_Z.4^ ?_AQ
MM)_^2: /H:BOGG_AZY^RS_T<I\ __#C:3_\ )-'_  ]<_99_Z.4^ ?\ X<;2
M?_DF@#Z&HKYY_P"'KG[+/_1RGP#_ /#C:3_\DUX!X]^'W@W4O%_A[4_#_P 1
MM)\::'XVN_MRZW:7D-Q]@MI1!Y,_G12_ON9S-YP,8Q@Y.: /T%HKS3]F_P !
M6OPW^&%II>F:XWB"SCN962]#YMV!Z^3RXX(Y&2#)YO/.!Z70 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !16'XUT2ZUWPA
MJ5C:WQTZ\O+6:V2\7&;0NI'F@>HX(]Z^'?[=\9?\+,_X1;_A:G?_ )#/_"13
M?V;_ *CS?]=]/_(E 'W]161X<L[K3-!L8+S4$U*\CMU%S=;!#]I. #+@=/P]
M:UZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **\;_ &K?A1IGQ1\):;'JWC!/".GV=W\SW#XM[QCR 1YD?[S@\YR,R#!S
MD?.?['7P^M?%OQ*_M!/$'_"/7VCW<%Y9V9.+B^SYXF@_UB?\L80).#0!]X44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 45\W?MN7GB+1I+'5]'\:+X?M;.U;=HXN3;7%_^^7,L/EY,QQMX/^K _P"F
MIQ%^Q#!XC\42:AK>L>-!KUFUK]CCT@ZK+=7%BYF.9IP?]4Q$)\O'8GF@#Z6H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HKXE_:XUWQ=X-^)E^UM\0=1:QNKP%;/2]5F@N-/XAQ%-%%Q",$\C_ %N3
M)ZBOHS]F;1M6T'X:M_:WB)?&&H7UU-=_;K>Z^T6[ 8B$*R]P/+_ YH ].HHH
MH **** /SU_X.8_V6O\ AIC_ ((W_%".TT/_ (2#7OAS]F\<:0QO#:_V>+.;
M_3;C)D6.7R],EU']VV[.?DC,GE5^;_\ P9P_$'6--\>?%+X9ZDWBW1[SQ9H%
MM\0_!MY=6QDT7[-:7LNF:E,L<CKY@N9VM8)/*'[S^S6!ECDM8B/WY^,/PIT/
MXW_"CQ)X*\3Z?_:'AWQEI<^BZO9B[EM_MMM<PF&>+S8B)1F$L,@@X/4=1^%W
M@ ZA\+OVB/\ @FO\=KKPPMQXD^'.KR_LF_$+18?%=E=P>&=4LS=Z-:9\I/,\
M^6.XU"^,8\R-HDMHQ(OFI-* ?NUX5\3CQ++):744FFZYI\@^V6F[@#H)E/ E
MAD ^23V((CDCDC3J*Y7Q#X?NY-:_M;2SY6K6N5VGY8=0AZ^1.!USSY<O6(^H
M,L<MWPQXJM/%NE+=6I5BS31D9SMFAF:*:(_]<Y5*GW% &[1110 4444 %%%%
M !1110 5QM[?WGBO5UTW26DL]'MFVWE] <%\?\N]OQCM^\E_Y9_<3,F3$7M_
M>>*]773=):2ST>V;;>7T!P7Q_P N]OQCM^\E_P"6?W$S)DQ=-96%KHNEK;VZ
MK:6ML, #@** /@'_ (+PV%KHFE_L3V]M&MO:V_[4_@8*H& H_P!.KZ%_8X_Y
M.)_:M_[*I8?^H3X3KY)_X.:OC-I/[/'[/_[-'Q&UN/4KK1O /[0OA;7[^"U&
M;A[>S@U.>40[]F92L1 RPYQR!S7J?_!$G]M/PQ_P4$\/_M"?&#P3IOB/3?#/
MC+XI*UE9:U:0V^H(;7PKX=LY?-$4LD0S) 2N)#P1G!R  ?=%%%% !1163XCT
MHZ]HM]8B2\L?M5OM^U6S;9E/L<=1_C0!K45^?FI_ WPWIWQFT_P\WQ#TO4-%
MO+7[<-:+0?9;#_7?N ?-SC]SWES_ *1TK[3^#OA2W\'_  PT/3K?4)-9M[:S
M""\9@RW@.>0>GE\_)C(" #)') .PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBO O^"A-_<6OP4T\1_\ +QJT*?3]S,30
M![[17P9\9OC5XH\7>$/ ,%[I_B;P[)H]KFRO;BZF7_A(+CR8<3G]U&3WY_Z>
M.@K[SH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHKY+_ &M_&NL>#?VF_!]Q9KJNH-8V\-[:65K]YC)-,)8C_P!=@!%]
M,4 ?6E%?'WPX^(.M_$']N#3[S5['5O#37EK-9_V1<W,N?(%F&\K!"#.1YW0_
MGS7V#0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !117Q?X2^,/BGX??M,^/[BQTW5/&7VR[O;+[#;7,W2&?]U-CRI,>4,P
M>U 'VA7Y+_L2_$K6OBM^U5K.L>(]0;4KZS_;D\9Z)&_D10@6EC\.]3T^RB(C
M '[JW@@A!/)QERSL37V/_P $[=:O-6_X3#[9J.I:C_I4%Z3=]3<3>=YTH^N!
M7Q!_P35_Y.,\1?\ 9_\ \1__ %"-<H ^_O\ @FG_ ,F]^(_^RJ?$C_U-];KZ
M"KY]_P"":?\ R;WXC_[*I\2/_4WUNOH*@ HHHH **** "BBB@ HHHH ****
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M_6CX,_LK>'?@AJM]J&DS:I=7MY;BT=[JY7[HYQ^[C3'UKU2B@ HHHH ****
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MQ]_V574/_33H]'_!ZG_RBT\ _P#95=/_ /33K%'_  96?\HM/'W_ &574/\
MTTZ/0!^P5%%&: "LSQ'I-GXFT>_TV\PUK>0-:W"^JR#&/U_6M.B@#P'_ (=S
M^"/^@EXJ_P# N'_XU7K_ ,.?A_8_##P;8:'I:[;*Q7:N?2M^B@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N/^+_PCT?X
MR>"CI.K_ &[['YZW1^S/LFW#/0X/K7844 >9_$#]F_PS\1=+T6PO[7439^&<
M"R2VNBH6 8'D^ISY2@G_ %G ^<<UZ9110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6WMU6TM;88 ' 44 %E86NBZ6MO;JMI:VPP . HJY110 4444 ?C[_P 'J?\
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M4Z_H K^?_P#X-=/^3Q?@5_V:MK__ *L[4Z_H H **** "BBB@ HHHH ****
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MHH **** "BBB@ HHHH **** "BBB@#Y]_P""EG_)O?AS_LJGPW_]3?1**/\
M@I9_R;WX<_[*I\-__4WT2B@!G_!*?_E%G^S/_P!DK\+?^FJSKZ%KYZ_X)3_\
MHL_V9_\ LE?A;_TU6=?0M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %?/?Q _Y2D_!O\ [)5X[_\ 3MX,KZ$KY[^('_*4GX-_]DJ\=_\ IV\&
M4 ?D'_P:Z?\ )XOP*_[-6U__ -6=J=?T 5_.Q_P:H?$_1O'/[:_@'2])O3>7
MG@G]FS7=&UE!:S*UC=OX]FOQ#SQ-_H][;29BX_?;<[U8#^B>@ HHHH ****
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M\M;CX>:,NH:)<X7SK*YA$1\F:+(!7)##;(AECECD?VC_ (=0_LM?]&U_ /\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:O\ R<9XB_[/_P#B/_ZA&N4 ??W_  33_P"3>_$?_95/B1_ZF^MU]!5\^_\
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MG]Q,R9,7365A:Z+I:V]NJVEK;#  X"B@ LK"UT72UM[=5M+6V& !P%%7***
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5^+/_!-[XI>%S^V_XA\#CQ1X=/C;_ANCXBZ[_8!O
MH6U3^S_^$/UN'[;]ESYOD>;^[\['EB3C)(Q7[35^+/\ P3>^%OA<?MO^(?'
M\+^'1XV_X;H^(NA?V^;&%=4_L_\ X0_6YOL7VK'F^1YO[SR<^69.< G- 'Z2
M?\$T_P#DWOQ'_P!E4^)'_J;ZW7T%7S[_ ,$T_P#DWOQ'_P!E4^)'_J;ZW7T%
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'S[_ ,%+/^3>_#G_
M &53X;_^IOHE%'_!2S_DWOPY_P!E4^&__J;Z)10 S_@E/_RBS_9G_P"R5^%O
M_359U]"U\]?\$I_^46?[,_\ V2OPM_Z:K.OH6@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "OGOX@?\I2?@W_V2KQW_P"G;P97T)7SW\0/^4I/
MP;_[)5X[_P#3MX,H _(/_@UT_P"3Q?@5_P!FK:__ .K.U.OZ *_G8_X-4/B?
MHWCG]M?P#I>DWIO+SP3^S9KNC:R@M9E:QNW\>S7XAYXF_P!'O;:3,7'[[;G>
MK ?T3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ H/2BB@"JYS!)\NWY37\Z?_!P'\36\
M(7'[0WAL:!XBU'_A*_#_ (;4ZG96OFZ?HGD>)=4<B\D_Y8B7'[L?QR5_1=<;
MDMY"3_":_GS_ ."[0#> OVL"W?P]X2_3Q3JA%>_DO\*M;^5_^D3/R+Q*JT:>
M/RSV\>?]]32Z:O$4$G\G9^=K']"@Z44"BO /UT*XV]O[SQ7JZZ;I+26>CVS;
M;R^@."^/^7>WXQV_>2_\L_N)F3)B+V_O/%>KKINDM)9Z/;-MO+Z X+X_Y=[?
MC';]Y+_RS^XF9,F+IK*PM=%TM;>W5;2UMA@ <!10 65A:Z+I:V]NJVEK;#
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M><8VBOL*C'_R5DU%%%>>?;!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7X_\ _!-7
M_DXSQ%_V?_\ $?\ ]0C7*_8"OQ__ .":O_)QGB+_ +/_ /B/_P"H1KE 'W]_
MP33_ .3>_$?_ &53XD?^IOK=?05?/O\ P33_ .3>_$?_ &53XD?^IOK=?05
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?/O\ P4L_Y-[\.?\
M95/AO_ZF^B44?\%+/^3>_#G_ &53X;_^IOHE% #/^"4__*+/]F?_ +)7X6_]
M-5G7T+7SU_P2G_Y19_LS_P#9*_"W_IJLZ^A: "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *^>_B!_RE)^#?_9*O'?_ *=O!E?0E?/?Q _Y2D_!
MO_LE7CO_ -.W@R@#\@_^#73_ )/%^!7_ &:MK_\ ZL[4Z_H K^?_ /X-=/\
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M#OASIFO:AIO@?6-?M==L/$WPQ\&RP6O@5]%\%ZSH,QU!M9FUB.*6ZLY?#UG
M99)(Y18W9$<-P#-<_;/[4GA'5O$?QP_9IN[&PU*^M?#_ ,1[[4-0NK:V>X6P
M@;PCXFMQ-.0,0Q&:>"(%N/,GBCZLN??** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ()^C?[E?SZ
M_P#!=\_\4%^UA_V /"?_ *E.IU_05,>&_P!ROY]O^"[XSX#_ &L/^P!X3_\
M4IU.OH\@^"M_@E_Z;F?BOBM_O>5_]A-#_P!2<.?T(5QM[?WGBO5UTW26DL]'
MMFVWE] <%\?\N]OQCM^\E_Y9_<3,F3$7M_>>*]773=):2ST>V;;>7T!P7Q_R
M[V_&.W[R7_EG]Q,R9,7365A:Z+I:V]NJVEK;#  X"BOG#]J"RL+71=+6WMU6
MTM;88 ' 45<HHH **** "BBB@ HHHH **** "BBB@ JAKWAZS\1Z.UE=)NM7
M R <=*OT4 <CX2\07B:E>Z/JRR?:]/<&UNBH7^T+;KYW0C*DB*3'.5$FR..6
M//75SGB?PQ#XBT[R<;9(6!M;R _Z187 R/,4]B.!CH1E6!0FJ_@WQ#?:A]LL
M=0EC@UG3VVW2>7A2"3Y4RCC]W(JDC&<<IO\ ,BDH _E@_P"#5,_\;'=1_P"Q
M<'_ISL*_K%MO]5']/Z5_)U_P:J?\I'=1_P"Q<'_ISL*_K%MO]3']/Z5W8C_=
MJ/K+]#Y#*O\ D?8_TH_^DLEHHHKA/KPHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?#?_ -3?1** &?\ !*?_ )19_LS_ /9*_"W_ *:K.OH6OGK_ ()3_P#*+/\
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M?_-%7IW_  Y/^&O_ $,WQE_\.?K_ /\ )='_  Y/^&O_ $,WQE_\.?K_ /\
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M,\Q_XB5_@O\ ]";XP_\ "U\"?_-%1_Q$K_!?_H3?&'_A:^!/_FBKT[_AR?\
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M<_7_ /Y+H^K83_G[^##^VN*/^@1?>O\ Y,\Q_P"(E?X+_P#0F^,/_"U\"?\
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M HHHH **** "BBB@ HHHH **** "BBB@ K\?_P#@FK_R<9XB_P"S_P#XC_\
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M$&)SY<,:=% ']#%?S_\ _!KI_P GB_ K_LU;7_\ U9VIU_0!0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?.O_ "<?^W7_ !2>
M%/V>3]#=^+M0L?\ MG*!8:+>_P#36VN?^$C[3Z?Q^,G_  =&?\%@?BA\!?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX?X#_HRG]OW_ ,-!_P#=='_#_ ?]&4_M^_\ AH/_ +KKWO\ X=0_LM?]&U_
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M,G_"ROAG\/\ X@G0?A9\%1I__"4^';/5?L'G>"(1+Y)FC?R_,\F#.,9V#N*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5^ '_!C-]S]J3Z>%/_ '-5^_\ 7X ?\&,WW/VI/IX4_P#<U0!^P/CCPUK7
M[,?Q%\0_$CPKINJ>(?#/C*Y@U+Q[HEK:FZU$W,5I#9C6=.B&99I8[2SMHKC3
MU!,L5O%):+]JCEMM2]:\%>--(^(OA'3=;\/ZCIVJ:+K%K#J%A?V-TMQ;7UO*
M!+#/#+'D2Q2 Y!!PP/<'GI*^;=,S^Q#XU\.^'K-MWP;\::LNB:+$T6U?AYJ4
MD<AM['S2/+_L>ZDA%I;1$B2UN[BSL[<2V]U;0V !])4444 %>(_'_P"+&M7_
M (TT'X6> ;[^S?%GB,?:M9UF*VCN)_ NAF*?_B:>3*#"9YIX/L=K'/UE:>X^
MSW4&GW<-=#\;?C0?AF=.T?2--;Q1X^\4&5/#OAU;C[.;TQ&+S+VYE,;_ &2Q
MMO-B-Q=&-_+\V*.-)KF:VM9H?V:O@E)\ /AKI^F7FH3^)/%5[B_\5>)C9BVF
M\6ZJT,,<]]/%YDAB\SRE6*$'R[:&"&VB\N"&**@#?^&?PUT?X*>#K7PWX;M%
MT_1[%9?+C-S)<7#SRR&::>XFE+RW%Q/-*TTDTQ>2266621Y'D)/Y9_\ !LC_
M ,G&?'W_ +)7\#?_ %!UK]@*_'__ (-D?^3C/C[_ -DK^!O_ *@ZT ?L!7X_
M_P#!-7_DXSQ%_P!G_P#Q'_\ 4(UROV K\?\ _@FK_P G&>(O^S__ (C_ /J$
M:Y0!]_?\$T_^3>_$?_95/B1_ZF^MU]!5\^_\$T_^3>_$?_95/B1_ZF^MU]!4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\^_\%+/^3>_#G_95
M/AO_ .IOHE%'_!2S_DWOPY_V53X;_P#J;Z)10 S_ ()3_P#*+/\ 9G_[)7X6
M_P#359U]"U\]?\$I_P#E%G^S/_V2OPM_Z:K.OH6@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "OGOX@?\ *4GX-_\ 9*O'?_IV\&5]"5\]_$#_
M )2D_!O_ +)5X[_].W@R@#\:_P#@U>\)Z5H/[9WPMNK+3M-L+S7_ -F77+Z^
MN;:U$3WUP/B)>6XEG( ,THA@@B#$Y\N&-.B@#^ABOY__ /@UT_Y/%^!7_9JV
MO_\ JSM3K^@"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O@#
M_@BO_P R;_V:K\&__=HK[_KX _X(K_\ ,F_]FJ_!O_W:* /;D_9]US]DJ;[;
M\#]'\-Q^"[(?:[_X76UE#:V[\+YO]@3^;%!IDTH8RR02QFTNIH8O^/"6YN[^
M3?\ AVGPG_:X\:>'/BM8Z8VL>+/AF=3T32;K7M(O=,U;PE/>QVC7D4UC=QQ3
M6<\T,5L09H8Y#;3KY?[BZS+[E7C?QB_9GT?XE^.%\=^'QIO@[XJZ';+9Z1XV
MMK$7%PUL,R_8+]?W9O=+D,A,EH90,MYL4EM<Q0W,(![)17AWPU_:)N]%\=:?
M\/OB=9MX>^(-TTR6%]9Z5<0^&_& CB,_G6%W('BAGDAAN)7TV:8W4(MKPC[3
M;Q1WTTGQ/_:ACL/&U]\/_AG9^&_B%\4K#RFUC1'UG^S=/\*0&%95FUBZBBN)
M+'SHBOV:'R99KDD&.+R(KJYMP#K?C5\??!O[.'AB'6O&_B2P\.V=Y=#3;%9P
M6NM5NY$=HK&Q@C!EN[R40L8[6".2:4C"(QP*\NNO@OXH_:V$EW\8M)?P[X)A
MXLOA[I?B*:X.J+)R3X@FMO+BG_<L8)-(C:YT_FX,LNI>;;?9>M^"O[-=K\-O
M&O\ PFGB75M4\:_$76[7['?:Y=O.MO9B1A-+;Z=8R2R1:99$PVP\F#]Y-]FM
MY+N6[N(OM)]DH _'W_@]3_Y1:> ?^RJZ?_Z:=8K[]_X)3_\ *+/]F?\ [)7X
M6_\ 359U\!?\'J?_ "BT\ _]E5T__P!-.L5]^_\ !*?_ )19_LS_ /9*_"W_
M *:K.@#Z%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OP _X,9O
MN?M2?3PI_P"YJOW_ *_"O_@R\^$.M?#;P9\7M9OFT]K/X@>'O#>O:;]G;<XM
M8]4\4Z<1.,#;)]HT^YQCS,QM$<CE0 ?NI7-^-?!>D?$7PCJ6B>(-.T[5-%UB
MUFT^_L+ZU6XMKZWE!BF@FBDR)8I <$$88'N#STE?&7_!1#P9H?Q,_:)^#GA/
M5-*^#_Q)U;6M,\0_V1\+_B5>RVNB^(9XVTN:;5;>7[#J$37UA"&BCA:V$IMM
M3OI$ECCAF$@!Z9\'?%NL? ;XG2_"GQMJ>J:E8ZA>LWPRUK4KAKJYUS3X[19I
MM+NKN0YFU2U:.Z(,O[VYL%AE\VZN(=2EB[SXQ_&;2?@QX4AO+J/4M2O]6NQ8
MZ%H.G(L^IZ_J,BF6*TMXI/+'F_NYI"9)(XH889IYY(H(998OR>A^)=[XN_9&
M\?:FO_)O^O?%/X/ZGK/Q"\8_$2YTKQOIEI+I?PZE-S<FVM?*\_R?(DFO5U"W
M,<CSR)@Q1^9+_P $XOVG/$7Q'_;D^#_Q:^)FE_&*\7XM:2+33]1\=Z+HNB:'
M':BPBTW3/$5EY5S)=+/=7=G<1_8Q$+:UD\?B*"4?VA'+K0!^G?P!^"NL>&?&
M>O>//&4VFZA\1/&UM8V.H#2F+:9H6G6IN9;32;<D1M-# U]=$W4L:S7,L\LA
M2&+[-:VWLU? 7_!'/]C3X?>(_P#@E/\ #JQ\6? OX,Z;9_$+P5X<N]9MM+L(
M-37QM;16%M/:7^K"6QM\W?GRSS>4WVGRY/G2XD)./3_^",OPE\,?"G_@EY\!
MV\(^&O#GAQO$W@#P]KFKG2;"&T;4M2ETFR\Z\N/+ \Z:3 WRMF0X&2>H /JZ
MOQ__ .#9'_DXSX^_]DK^!O\ Z@ZU^P%?AQ_P:"?'!OVB?BC^T5X@_LO^R8K#
MPG\,_"[6QNOM&_\ LG1+O21/G8G^M^Q&7;_RS\W9F3&^@#]QZ_#O_@FW^T1H
MX_X*7>(OA*T2C7?^&T_B-XL\TZMI@!MCX5UNT"_8_M?]H_ZS_EM]D^R\[//\
MS]W7[B5^/_\ P35_Y.,\1?\ 9_\ \1__ %"-<H ^_O\ @FG_ ,F]^(_^RJ?$
MC_U-];KZ"KY]_P"":?\ R;WXC_[*I\2/_4WUNOH*@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /GW_ (*6?\F]^'/^RJ?#?_U-]$HH_P""EG_)
MO?AS_LJGPW_]3?1** &?\$I_^46?[,__ &2OPM_Z:K.OH6OGK_@E/_RBS_9G
M_P"R5^%O_359U]"T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM_Z:K.O /^#B;_DT'0_^YY_]5EXTKW__ ()3_P#*+/\ 9G_[)7X6_P#359T
M?0M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^/_P#P:7?\F[Z;
M_P!DKT+_ -3?XC5^P%?C_P#\&EW_ ";OIO\ V2O0O_4W^(U '[ 5Y_\ '']G
MCX>?M&>$X='^(G@GPGXWT6UNA>6VGZ_HT&J6J7&&C$XBFC=?,Q*PSC//UKT"
MOFWXA2?\-P>-_P#A#M->.\^$OA?5KB/QW>O\VG^,;B*&:%O#D.#^_@BN2DE]
M*#Y)-K_9TB77G:E%:@%/X0>$=*_:J^*6J>.%TG3%^%=MX@@U?PT+2VVVWQ!U
M."SLQ%XJNFP#=PQ- (+$2CRS_9\-_')="73);3L/CU^QSX3^+7PT\%:#I=CX
M=\.WGPOU:QU_P!NT>"YTSPWJ5A#+%:8T_"12P1P2M#Y0,4D<;%X);:XBAN8O
M;J* /'?V9?B3H^M>$U\$+X7TWX=^)O -K;6-_P"#;0!K;0[;:8[.6PVQQB;3
M)1#_ *-/'%$/W$L4D=O<VUS:P]]X*\%Z1\.O".FZ)X?T[3M+T71[6'3["PL;
M5;>VL;>("*&"&*/ BBC P !A0.P''"_&7X,:MK/BM?'7@%M/TGXB:-;+8*+Q
MV@TSQ;IT;>:-+O\ R]Y\K=+-]GNO+DEL99Y9(XY8Y;FVNM[X!_&O2OVBO@OX
M;\9:/#J>GVFO0$FRU5$AU/2KH$Q7%C=0AG$-Y:S+-!/%DF*:WE0CY30!Z!7X
M ?\ !C-]S]J3Z>%/_<U7[_U^ '_!C-]S]J3Z>%/_ '-4 ?O_ %^/_P#P35_Y
M.,\1?]G_ /Q'_P#4(UROV K\?_\ @FK_ ,G&>(O^S_\ XC_^H1KE 'W]_P $
MT_\ DWOQ'_V53XD?^IOK=?05?/O_  33_P"3>_$?_95/B1_ZF^MU]!4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!\^_\ !2S_ )-[\.?]E4^&
M_P#ZF^B44?\ !2S_ )-[\.?]E4^&_P#ZF^B44 ,_X)3_ /*+/]F?_LE?A;_T
MU6=?0M?/7_!*?_E%G^S/_P!DK\+?^FJSKZ%H **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KY[^('_*4GX-_P#9*O'?_IV\&5]"5\]_$#_E*3\&
M_P#LE7CO_P!.W@R@#\:_^#5[PGI6@_MG?"VZLM.TVPO-?_9EUR^OKFVM1$]]
M<#XB7EN)9R #-*(8((@Q.?+AC3HH _H F\8:/!XC&DG5--75+A<BS-TOGGCK
MY6<U^"__  :Z?\GB_ K_ +-6U_\ ]6=J=?JE^U5_PDG_  UIX>_X1//_  DW
M]A#[!N\GKF\\[_7?NO\ 5>M 'TEH?C+1_$&I7D%EJ6GWEY8_\?:6]T)C:''0
M^GY"MROFC]A;^T/^$V^)_P#:G_(6^V0?;\;?^/GS[WS?]7[U]+T %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7\OO\ P:J?M]^$_P!B^3X[:5JFJ^ =
M/\5^-AX>?1D\:^+8?">B&VM#J9O)9]1ECDV[?M%O&D,44TTDD\9\H01W-Q;_
M -05?,/@_P#X)6?"7X?^%-.T70-1^-6EZ+H]M#86&GZ?\:?&EI:V%O"!%%!#
M%'J@6**,#  &% ]!P >>_!3]L/\ 93^'?C+_ (37Q'^U9\%_&WQ"UBS-G?:Y
M=?$>Q6WLED(DE@T^QDOI(M,LB8;9?)@_>3?9;9[N6[N(OM->M?\ #US]EG_H
MY3X!_P#AQM)_^2:?_P .U/A[_P!#)\?O_#\>-_\ Y:T?\.U/A[_T,GQ^_P##
M\>-__EK0 S_AZY^RS_T<I\ __#C:3_\ )-'_  ]<_99_Z.4^ ?\ X<;2?_DF
ML?QA_P $K/A+\0/"FHZ+K^H_&K5-%UBVFL+_ $_4/C3XTN[6_MY@8I8)HI-4
M*RQ2 X((PP/H>?&_^(7#]A?_ *(>G_A8^(?_ )/H ]\_X>N?LL_]'*? /_PX
MVD__ "37DOQE_;!_9'^(WCN/QQH'[1W[./@WXK:/;BRTCQG;^+]%GNC I,G]
MGWZ_:8VO=+D:0^9:&0#+>;%);7,4-S#SO_$+A^PO_P!$/3_PL?$/_P GT?\
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M#_XNKWC/[#_PANI?VM_R!_LLWVW.?^/;RCYGW/;/3W]J_/G/@S_A9W_,T?\
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MX8\_O_S\>7Y?.<[^,4?\$_O^$1_M[4/L7]K?\)I]E_TW[1_Q[_9?..?([_\
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M_#>J?\(5]C_TVQS_ *1]J_??]-?^O?\ Y:U]E?!:X\,WGPPTR;PJJV6@MO\
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M#]H#_P ''@C_ .:*C_AL3XC?]&H?M ?^#CP1_P#-%4?_  ZA_9:_Z-K^ ?\
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M+/"<3V4V#%+(",'/->H5\^_\$T_^3>_$?_95/B1_ZF^MU]!4 %%%% !1110
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M7S[_ ,$T_P#DWOQ'_P!E4^)'_J;ZW7T%0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'S[_ ,%+/^3>_#G_ &53X;_^IOHE%'_!2S_DWOPY_P!E
M4^&__J;Z)10 S_@E/_RBS_9G_P"R5^%O_359U]"U\]?\$I_^46?[,_\ V2OP
MM_Z:K.OH6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OGOX@?
M\I2?@W_V2KQW_P"G;P97T)7SW\0/^4I/P;_[)5X[_P#3MX,H _(/_@UT_P"3
MQ?@5_P!FK:__ .K.U.OWV^PVW]J>?M7[3MQGOBOY\?\ @U>\6:5KW[9WPMM;
M+4=-O[S0/V9=<L;ZVMKH2O8W!^(EY<"*< DPRF&>"4*1GRYHWZ,"?Z&* *T5
MI;V[-M51]I//^U5FBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "N3_X4;X)_Z$SPK_X*8/\ XBNLHH R/#'A'2/"&E^1
MI>G:?IEKC[EK;"W7\A6O110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7)_\ "C?!/_0F>%?_  4P?_$5UE% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &1XG
M\(Z1XOTOR-4T[3]3M<?<NK87"_D:RK3X.^#[;4O.M_#/AB.[@&-R:9"&3\AQ
M7644 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 8GB+P7HWC!1_:FEZ7J7V?\ Y_+2.XQ^8XH\.^"]&\'J?[+TO2]-
M^T?\^=I';Y_(<UMT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 <MK'PJ\+^*=;&H:EX=\.ZA?*,"ZN["&><_B5S^
MM:VC>&K'PKH*V.F:?I]C:Q@A;:WC$$(SUP%']*TZ* "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J:G96NK:4UO<*K6UP,
M$'N#S5NB@#D_^%&^"?\ H3/"O_@I@_\ B*V=&\-6/A705L=,T_3[&UC!"VUO
M&((1GK@*/Z5IT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7YJ?$GX:Z?\6/VRM0\.ZPWB+3["]_:DB+G0]<O=%U"/R_@L)0L=
MW8RQ3Q'*@?NI1N7,9RA(/Z5U^?W_ #D2_P"[J_\ WB- 'OW_  [4^'O_ $,G
MQ^_\/QXW_P#EK45[_P $S?AG?6#1S>(OCV\$PQA_CIXV96S['5L?G7T110!\
M<^.?^"&7[-GQ-T"ZT?Q'X;^(/B31[H_Z39:I\4_%5W:DY$@+12:F1G.#S_C7
MV-110 5\W:K_ ,%+_A+::UIMA9ZCX[\3->Z3#KBCPQ\-_$7B.WET^>XO;2WO
M1-8V,L?D7,UC<FWE'R7,2^;%YD4D<E=?^W%X;\;>-?V,_BYI'P[EU*/XAZQX
M+U6S\-&RO/[/N4U.2QF6U\B<R1B&43%2)#(/+(!R *^-_$OB?1E_:?M_&7P_
M\8?'GX:_"/QE\&/!(\&W_P *OA'-KVFZE:17OB&>&W,3:!J(L_L]M=VA2'%L
M1'= %&POE 'WI\/OB3HWQ)775TO4&U%O#&JSZ-J]L;::"YL+J'[T4T,H$@)B
M:&:,XQ-#<03Q^9%-%(_#_LW?MT?#?]KC[&/ ^J>(2NI:6NO:<VN>%=5\/C7M
M-/E$WUA_:%M;_;8!Y]MOEM_,CC^TP;\":+S.=^ HDU3_ (*!?M!:IH^T>&;?
M2O"VC:MY!^SVY\2Q0WUU>$Q<&6X_L>]\. W6TB2(01"0_9?*A^-?V=_V&?B5
MKW[%FE_#SQ-?^+M6UCQQ^R=/X1\'W7BG28M-M?AGJ-S86D&KZ1?FTLX#%',?
M[!-N+L75T!H^I$N-I$P!^A/P0_:@\"_M)1ZDO@_Q)_:G]DM"^&M+BU-[;2^:
M8+ZV\Z./[98W(BG^SWL'FVMS]GE\J23RI,8.C?MZ_"?Q!\,_&GC*S\3LOACX
M>Z5+X@UJ]?2[Q NF)!-,NJ6T9B$E[8316]P;>\M!+;7/V>8022F(@>!_M(?"
M7Q9_P48'C#_A'?#?B3P2R_!CQO\ "^7_ (3:PFTH)KNOG2_*A7B3SX+0:6WV
MB\M?-M9?M,)M);O$WE<]^W1HOBC]M#X5_%CQ1X=^'?C_ $]?#/P#^(/@B32=
M:T2:WU/4M=U>+2Y8;"P@&_[=Y/\ 9;"2ZM3):S27-N+2XN_WWE 'V=\&_C;H
M7QP\&G6M!T_Q9I]K;7'V,IK_ (1U7P[<%@@/$%_;03&+]YQ((S'][G@X[ZN+
M^&/A/4/!G@.QT?5/&'B/QMJ-L)EDUG65L8-0O\RLW[T6-O;P*8@PB'EQ)P!G
M=)EJ[2@ HHHH *^??^"EG_)O?AS_ +*I\-__ %-]$KZ"KY]_X*6?\F]^'/\
MLJGPW_\ 4WT2@ _X)I_\F]^(_P#LJGQ(_P#4WUNOH*OGW_@FG_R;WXC_ .RJ
M?$C_ -3?6Z^@J "BBB@ HHHH **** "BBB@ K$\1>"]&\8*/[4TO2]2^S_\
M/Y:1W&/S'%;=% '+:/\ "KPOX6ULZAIOAWP[I]\PP;JTL(8)Q^(7/ZUU-%%
M!1110 4444 %%%% !1110 5_.[_P5Q_X)E:+_P %"?\ @MW8>"[?6/\ A!_$
MWQ0\>Z[H5]XF:UDU(?9=(^'_ (1U*SA-H98H_P#63W0RI0_Z2<EQ$BC^B*OP
M=O?B9K6H_P#!Z3IW@R>^4^%]&U2^UJPL3;PXAN[WX>645W-Y@ D_>16-J.20
M/)& -TA(!A_\0,?_ %=%_P"8W_\ OI1_Q Q_]71?^8W_ /OI7[_44 ?@#_Q
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MI\2/_4WUNOH*OGW_ ()I_P#)O?B/_LJGQ(_]3?6Z^@J "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ^??\ @I9_R;WX<_[*I\-__4WT2BC_ (*6
M?\F]^'/^RJ?#?_U-]$HH 9_P2G_Y19_LS_\ 9*_"W_IJLZ^A:^>O^"4__*+/
M]F?_ +)7X6_]-5G7T+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7SW\0/^4I/P;_ .R5>.__ $[>#*^A*^>_B!_RE)^#?_9*O'?_ *=O!E '
MXX?\&LWAV'1_VS/A5/:G46;5OV8-=NY_M5]-<1B3_A8EY#BWCD<B&+$*9BB$
M<?F&63!DEDDD_H3K^?\ _P"#73_D\7X%?]FK:_\ ^K.U.OZ * "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\J"/,41FEQ&);FWBW^;-%'( =I17SA\*O^"FOPE^-;^')M(O_B!'HWC$6_\
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MY2D_!O\ [)5X[_\ 3MX,KZ$KY[^('_*4GX-_]DJ\=_\ IV\&4 ?D'_P:Z?\
M)XOP*_[-6U__ -6=J=?T 5_/_P#\&NG_ ">+\"O^S5M?_P#5G:G7] % !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'+/_ %)O[ /_ (BO_P#?^@#] **_/_\ X<L_]2;^P#_XBO\ _?\ H_X<L_\
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MKO41/%"L#B./RHR#<,?,Y((!^JU%?C[_ ,05_P"RU_T/G[0'_@[TG_Y5T?\
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MVOPEO/"NMW-W]FLM,\2>+];T^:^RT,47D2#4GAE,LDJA(Q)YIS_JQW^NHO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K\_O\ G(E_W=7_ .\1K] :_/;Q)HWBUOVN?''BCPGX(\1?$23X?_M(
MP:WJ^DZ%=Z;:WPM)?A%9:;Y\1O[JVA.)[^W^4R@X)(!(H _0FBOGW_AL3XC?
M]&H?M ?^#CP1_P#-%1_PV)\1O^C4/V@/_!QX(_\ FBH ^@J*^??^&Q/B-_T:
MA^T!_P"#CP1_\T5'_#8GQ&_Z-0_: _\ !QX(_P#FBH ^@J*^??\ AL3XC?\
M1J'[0'_@X\$?_-%1_P -B?$;_HU#]H#_ ,''@C_YHJ /H*OD_P#;0_99_:2^
M-'Q.L-6^#?[57_"C_#-KID-I=Z(/AKIGB3[?=>?*S7OVFZD$@)B:&+RN1_H^
M1_K#77?\-B?$;_HU#]H#_P ''@C_ .:*C_AL3XC?]&H?M ?^#CP1_P#-%0!\
M_P#_  [N_;K_ .DB0_\ #!^'O_CU?9_PI\/ZYX2^%WAW1_%GB >+_$^F:7;6
MFL:VUA#IQUV[BBQ/>""(F*'S9<R")3B,-@=*\P_X;$^(W_1J'[0'_@X\$?\
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ME@U,^;%#;740MS/Y%S=^7-$ #XV^#4FJ:%_P2)/@/4_&G[2#?$.V^$>D>&-
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M?_E%G^S/_P!DK\+?^FJSKZ%KYZ_X)3_\HL_V9_\ LE?A;_TU6=?0M !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %?/?Q _Y2D_!O\ [)5X[_\
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M_P"RJ?#?_P!3?1*/^":?_)O?B/\ [*I\2/\ U-];H ^@J*** "BBB@ HHHH
M**** "OP _87_P"4ZOP]_P"SJ?V@O_4>TFOW_K\ /V%_^4ZOP]_[.I_:"_\
M4>TF@#]_Z^8_CSXEM/V4_P!L_P -_$K5#J;>%?BY::7\+M:O(+*:[;0]3COK
MN70)CY4>V"SFFU/4K2XFE+C[3<:.H$:&XDKZ<KF_&O@O2/B+X1U+1/$&G:=J
MFBZQ:S:??V%]:K<6U];R@Q303129$L4@."",,#W!Y .DKYZ_;'_Y.)_92_[*
MI?\ _J$^+*Q=#\-?&S]DW5-06S;4OV@/ATUT&TG1YKR#3_&WA*U6&"&.R@N[
MIX[36XC+^\,VH75K=11+,7N-2E8"OC;]O?\ X*=?%KP-_P %/_V._#&K?LV^
M//!OP];QY9)<:[XENK-_M>J:M::EH,-O!=Z?<7EF/(@OKFZ,,LIN9MJ_);QC
MS90#]9,<+M[=LU5O)/*MI)/E$:#(+' ^IJ:4?,BL6W,>#[U^>?\ P7<_:?U*
MS^&?A_X#^!I%F^('Q;O(+62SM[OR;H:>9@H7=YD?E?:9ML7[W]W+&+M,Y%<F
M/QD,'AY5WT/HN$>&Z^?YM1RF@^3VCUF]H02O.;\H)-O7H>7_ +<'_!1+Q_\
MM\?'O3_@)^S%?:@MFMVO]L>+],N#;^<8F#2&&ZC.8+.(@;Y>MR?W<?R'_2/H
M']E/_@B)\%?V:= 5=<T.P^(NO74(6\N_$%I#/;EF\GS!!:8,4*^9$&3B24>:
M4\PBO1?^"=G[!WAO]@CX V.CV=A8MXLU"""Y\1ZL!YS:C<@=!+Y:?N8B6$<>
M!@<D;Y'9_I.T?"YPJ%LDC.:\?+\HYW];Q[]I4Z=H>2_S/O.+/$"E@Z7^KG"/
M-0P=/1SVJ8B:_P"7E22Z?R0V2_!+>V6UC4+&L<87H!BEFMUN =T:NN.XS7R=
M^VA_P5_^$_[$WB[_ (1O6+[5/$GBJ/R6O=)T.U%S-IT$O(FG:62.*+^$>7YA
MEQ-$_EE#FC]B_P#X*_?"?]MGQ>/#>CWVJ>&_%4AF:RTG7+46TVHP1<F:!HI)
M(I?XAY?F"7$,K^6$&:]'^UL'[?ZM[1<_X_\ #GQ_^HG$G]F_VU]3J?5]^?D=
MK?S^GGL)^V1_P23^$7[6_A'4&F\/Z;X6\:73SW5IXDTRR\B;[3(_F>=<11&,
M763]\2_-\\NQXW?S*^./@9^U#\3_ /@B[^T:/A?\:M1U3Q=\*-<(.@:^WG7'
MV"VCQ%Y]O]\^7$OD">T_Y99\Q,]+G]>GC65"-WW^I'M7E?[4/[+'@W]L[X+Z
MCX-\96+:CHMP2\;Q@QW5E<KD1SP2\F.1"3VP02C90NAX\=E/O_6\#^[J?@_\
M??\ -'U'"/B4Z='^PN)KXC+ZGV'_ !*3?_+RC-ZQ:WY/@>J:UN=QX/\ %MCX
MYT.SU71=0LM0TO4+9;NSN+9_.ANH9.8Y!(.#D<\$YSZ5T$<N5QM[GBORU_X(
MB_M&^)/@)\8/%7[*_P 0SI6GZIX3NKAO#I%N;87++,TUW$OFF.27S1,;J#$7
M,1FDSY8CS^ID;DLR^G>N[+<?];P_M7O_ %^I\OQQPC4X<S:>7\_M*>DZ<_\
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MOW]-=9Z>Y4IKJX6Y-+QMJOTN'%%-1PZ!@<@]#3J^B/R,**** "BBB@ HHHH
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MD_\ R-1_PZA_9:_Z-K^ ?_AN=)_^1J^AJ* /GG_AU#^RU_T;7\ __#<Z3_\
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M[R-H+N+1XYHI)!K-U+(?L&&DVI@?/,_]"%?D!\2/^5F'X-_]E5\>?^JG\&4
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MM?\ AM'XC:S_ ,)X/$4&/[4_X176XCI7]F@>=_J/W_VO/E?\L\9K]QJ_'_\
MX)J_\G&>(O\ L_\ ^(__ *A&N4 ??W_!-/\ Y-[\1_\ 95/B1_ZF^MU]!5\^
M_P#!-/\ Y-[\1_\ 95/B1_ZF^MU]!4 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!\^_P#!2S_DWOPY_P!E4^&__J;Z)11_P4L_Y-[\.?\ 95/A
MO_ZF^B44 ,_X)3_\HL_V9_\ LE?A;_TU6=?0M?/7_!*?_E%G^S/_ -DK\+?^
MFJSKZ%H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY[^('_*4
MGX-_]DJ\=_\ IV\&5]"5\]_$#_E*3\&_^R5>._\ T[>#* /R#_X-=/\ D\7X
M%?\ 9JVO_P#JSM3K^@"OY_\ _@UT_P"3Q?@5_P!FK:__ .K.U.OZ * "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#X _X+4?\SE_V:K\9/\ W5Z^_P"O@#_@M1_S.7_9JOQD_P#=7K[_
M * "BBB@ HHHH **** "BBB@ HHHH *^>OVQ_P#DXG]E+_LJE_\ ^H3XLKZ%
MKYZ_;'_Y.)_92_[*I?\ _J$^+* #_@E/_P HL_V9_P#LE?A;_P!-5G7T+7SU
M_P $I_\ E%G^S/\ ]DK\+?\ IJLZ^A: /GW_ (*6?\F]^'/^RJ?#?_U-]$H_
MX)I_\F]^(_\ LJGQ(_\ 4WUNC_@I9_R;WX<_[*I\-_\ U-]$H_X)I_\ )O?B
M/_LJGQ(_]3?6Z /H*BBB@ HHHH **** "BBB@ K\ /V%_P#E.K\/?^SJ?V@O
M_4>TFOW_ *_G._8!^+VD:U_P<DZ!\/;==377O"W[0WQIU^\FDQ]F>VU#21!"
M%[^;NTRXW_*.#%R>B ']&-%%% !7Y^_\%\^O[%__ &=7X&_E?5^@5?G[_P %
M\^O[%_\ V=7X&_E?4 >ZC_@JQ^RVOW?VE/@+C&!_Q<32>?\ R9KXA_8[\1Z7
M^W)_P7@\=?$S2=0U/7/"/@2P<Z-=VUS]HT^+$$6GA1*@>'R;CS;^ZB$4@\P#
M?C_6"OMW_@E4F/\ @EE^S:?^J5>%O_33:5\Q?\$3E5?VW_VT-WWU\;*.>O\
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M@%X@^(/B#3=3U71]!$'VNVTT1RS_ +V:.'@2/&#S*."1Q^1]2LY 8\?*N#C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *_/[_ )R)?]W5_P#O$:_0&OS^_P"<B7_=
MU?\ [Q&@#] :*** "BBB@ HHHH **** "BBB@ HHHH **** "OGW_@I9_P F
M]^'/^RJ?#?\ ]3?1*^@J^??^"EG_ ";WX<_[*I\-_P#U-]$H /\ @FG_ ,F]
M^(_^RJ?$C_U-];KZ"KY]_P"":?\ R;WXC_[*I\2/_4WUNOH*@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_(#XD?\ *S#\&_\
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MOY__ /@UT_Y/%^!7_9JVO_\ JSM3K^@"@ HHHH **** "BBB@ HHHH ****
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M-/U2\D$37IM;4Y7(DU"&0_NH[F:$ ^@J*^4_%/\ P5T^$/@?]D[XQ?&2_O\
MQ'#X6^!7BC4_!7B:V_LTOJ":K8WD5G]F@49CF^TR3VQCE\T1@7,7FO"5E$76
M_!#]L:]^._CB^TO1_A+\4K/PW8:_K>@R>,[V\T/^QS<Z9>WEG<-Y2ZF^H^4;
MRSFBC_T3^[PL9+  ]_HKY23_ (*P?#]OAAKWBB[\/?$#2].TWX?ZI\5]%^T:
M4/\ BL/#%A#!,=4T^993 1(MQ;@6EW-;7T?GQ>?;0I(&KVO0OC'I.L_M">(_
MA] FH-KOAC0-)UV]N2=MO]FOY]3@@ Y_U@;2[G?P.L/7G8 >A4444 %?/7[8
M_P#R<3^RE_V52_\ _4)\65]"U\]?MC_\G$_LI?\ 95+_ /\ 4)\64 '_  2G
M_P"46?[,_P#V2OPM_P"FJSKZ%KYZ_P""4_\ RBS_ &9_^R5^%O\ TU6=?0M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M +1TW;<"SM+2ZDCVQ><OG&-5'F["X,@! /Z7_P#ACOXC?]'7_M ?^"?P1_\
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M /JSM3K^@"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]'\/^![7Q+\3_A1JGAU[A=4U.74FU>RN=7O(I8?L=Y"+8J"1< EP,1N?6O\
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MP2F%I A,1,1(. 2,9 P:^A/R%MMW9^57[9G[&W[=7[=OPQ\6> _B%XN^-#>
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MF9XQY<WE2DQ>:H D(R.HK]I*_'__ ()J_P#)QGB+_L__ .(__J$:Y0!]_?\
M!-/_ )-[\1_]E4^)'_J;ZW7T%7S[_P $T_\ DWOQ'_V53XD?^IOK=?05 !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 ?/O_  4L_P"3>_#G_95/
MAO\ ^IOHE%'_  4L_P"3>_#G_95/AO\ ^IOHE% #/^"4_P#RBS_9G_[)7X6_
M]-5G7T+7SU_P2G_Y19_LS_\ 9*_"W_IJLZ^A: "BBB@ HHHH **** "BBB@
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M^G<T %?SU_\ !(_6I/V;/^#A#]K#XG^*-#\67O@WQ-K_ ,1/#&GW?AWPS?\
MB6YDU"S\1Z1<W0:RTZ&XNH8HXKRV)FDB$69T3>7R*_H4K^6WXDVUOXD_X*A>
M%_"_B_P7X3\9?#WQI^V)\3?"=_9ZM<7%Q]O75IO#VF7W[B-8S!+;P7,,UK=1
M3&07!#[(_(0R@']!_P#P\K^'O_0M_'[_ ,,/XW_^55'_  \K^'O_ $+?Q^_\
M,/XW_P#E57\\7_!1G_@FQ:_L\?'GQ?\ #?P_X#\0_$+X7_#_ ,5Z=:"VTM_#
MVE^./$A;P_X;LXXK6[M-!DF'V6^US3%N(F\W[=)J\$B6\D\-]?#ZZ_X(6_\
M!*RQ_;9_9M\8>./C#;^'_#OBJ\\5P.MEH?PN^'\]B=.N/#>B:A8SQ1S:%<^1
MYMO>P2F&$QQ[F8O$)Y)2X!^L?_#ROX>_]"W\?O\ PP_C?_Y54?\ #ROX>_\
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MHZEIEX<"/,7]G1ZQ;SRR-++F#2(XXTCCE-?3E?GOI?\ P3+_ &K?%?C/P?\
M\+._;@;XC>!]!\4:+XGO_#:_"'1]).N'2]3M]1A@%W#-YL.9K2$EAQV((R#^
MA% !1110 4444 %%%% !1110 4444 %%%% !1110 4'I10: *\++*AW%F ]5
MKP']H'_@G+\$OVIII[KQA\/="O-2U&[BNKV_M2=/U"^:*-HHC+=6^R67$1QL
M+D8P.@%>_P"YL=/^^C2Q\INW+^ Q6-?#TJT>2JKH[LKS?&Y=5^LX"K.E4_F@
MW!_>M3\]_'7_  ;C? /Q-XIO-2T_4O'7AVUN!S8V&J0M;6OOFXBDE_\ (F/:
MM_X;?\&^/[.?@C1/L^K:/XD\8W@F+_;=3U>:WG;TCVVI@BV_]LQ7W2BEHR"O
M?^]FB1#Y04+GGH&KSO[ RU/^#'[D?<5/%[C6=+V/]J5[>51I_P#@2U_$Y?X;
M_#/P_P#"OPO9:7X<TG2] TFT!%I9Z=:1V]LH;Y_ECC  [GC'4FNKSM7ZT@"C
MUIQQMKV#\]K5JE6;J5G=ON.Z4444C,**** "BBB@ HHKX)_X+=?\%NO!W_!(
MGX/_ &6S&F>)?B_XHM&;PWX8:0LL0)\O[??[.8K2,]%R'N74QQE0LTT(!X__
M ,'!7_!P7I?_  3>\)WGPK^%M]I^M?'K7K0EW!$]KX!MI!G[1<9.V2\=<&"V
M(PH*RRCR_*BN?F__ ((Z?\&OFG?%OP9J/QA_;2TWQ%XF\6?$3.H6GA;4M8OK
M6^L3-)YTM_JT\4B7!OICD^2TO[H.WG@SR>7;'_!L;_P1<'CZ7_AL#]H#2_$.
MN^,M=U=M9\$6GB ^<TID"S_\))/YKO-//-+(QMS, 1M^T@2F:WFC_>:@#\_?
M^(7#]A?_ *(>G_A8^(?_ )/KN?V9_P#@A%^RG^QC\;?#_P 3OAG\*SX;\;>&
M3.=/OSXGUFZ^R^=!+!,/*FNI(CF&:88,9^]Q@X-?9-% 'S#^T]^TYXR^$_[2
M?@GP[IFH>%+'P7=7NDCQ1?7-@-9U&S;5-4.GZ?;S01:A9S6$5U< 6MM=QVVI
MH\S3&>.VBM&EN/+]<_;1^/VLR^)-!\,^&O "^+O!>J#P3>Y:WN;KQ#KI,]YG
M2-/N=3LHCC1(+'4WLY=0_=PZV1]IDGT:YMKWZZUSX4^%?%_CKP_XHU3PYX>U
M;Q5X-%S_ &+J]U8Q7&HZ%]JB\J?[/,?WD'FQ +((R/,'!XQ6%\8?A/\ "_6O
MAMXRA\=>'OA_>^$]=D76O%(\0Z9:3:=J7V6* ?:;\3#RYFBBL[<"67_5K;0<
MXB&#;<*=-U':)\;WG[=7QXT+X>_%7Q[8>.O@OXX\%> _@?:?&+1;NU^&VLZ,
M?$(U"RUZ6RA_?:S(8(HCI<$LF8C+)'<&+$+@2UG?$S_@J9^T%^R=X@\ Z?\
M$7X2KXDO/&>E>,]0_LZUTB'0[Q9=+L]+DT>%?LFL:["?M^I7O]FQYE$LES?V
M21Q;PD=U[1\=/^"D7[(W@Y=6C\4>+OA[XF;QGIG]AZT+*Q'B+^T=.C,I%E?&
MVCGS #>W.R&?]V?M$^P',E<+\ OVMOV!RR:+X+M_@WX(2SSK$*GP?!X=M8I_
M.L9_-BFGMH(?.$]AI\W!\PR:="_6U!C\W^U,%[3V3JPOVNCZR/ ?$;PWUM8"
MM[+^?V<[??:Q],?L3?&75OVE?V,_A'X^\0_V?9:]\0/!>D^(;ZVLUVP"XNK*
M&>40JY<B(&4@#)(&,D\U[$<;:X#X*^(_ ^M_#C08?AW=>&&\'V=HMCHR^'W@
M_LR&VA/E"&W$/[H11^5Y8$?";<8&*[_;N6O3/EZM&K2G[.LK-=QU%&:,TC,*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *_/[_ )R)?]W5_P#O$:_0&OS^
M_P"<B7_=U?\ [Q&@#] :*** "BBB@ HHHH XZ^^%7AG4[C4_M'AGPZW]M:M;
M:[>"2PA*W^HVGV?[+>S''[VXB^Q6ICE/SQ_9H,8\I".0^,?[%'P7_:4\9KKG
MQ ^$_P ,?'FN6=L+.VO_ !%X9L=2N!;KF01"2:)R(@93P.FX^M>P44 >'W/_
M  3[^ M]\0=2\22_!/X0R>*->^W?VMK!\(Z9]OU+[=%+%>&XF$/F2_:8IIUD
MW$^:LTH?()!Z+X(?LE?"_P#9A?5&^&/PY\!_#F37/)74!X6T"STI=0\H2B'S
MQ#&@E\LRS$9Y&X^IKTZB@ HHHH **** "OGW_@I9_P F]^'/^RJ?#?\ ]3?1
M*^@J^??^"EG_ ";WX<_[*I\-_P#U-]$H /\ @FG_ ,F]^(_^RJ?$C_U-];KZ
M"KY]_P"":?\ R;WXC_[*I\2/_4WUNOH*@ HHHH **** "BBB@ HHHH ****
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M]IVI_$/Q)>0:A>V5BL(&@6]MHVF:19:698OW4TD%GI=LKS+@&3(WS8,TO7_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "OS^_YR)?]W5_^\1K] :_/[_G(E_W=7_[Q
M&@#] :*** "BBB@ HHHH **** "BBB@ HHHH **** "OGW_@I9_R;WX<_P"R
MJ?#?_P!3?1*^@J^??^"EG_)O?AS_ +*I\-__ %-]$H /^":?_)O?B/\ [*I\
M2/\ U-];KZ"KY]_X)I_\F]^(_P#LJGQ(_P#4WUNOH*@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^<_B?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P!_P %
MJ/\ F<O^S5?C)_[J]??]? ?_  5V\(:MXZ\9:]HFAZ;J>K:UKO[,GQ<T^QL+
M2T-S<ZA<S-X7CBA@CB&Z2:1L *,DY'':O>?^'E?P]_Z%OX_?^&'\;_\ RJH
M^@Z*^?/^'E?P]_Z%OX_?^&'\;_\ RJH_X>5_#W_H6_C]_P"&'\;_ /RJH ^@
MZ*^?/^'E?P]_Z%OX_?\ AA_&_P#\JJ/^'E?P]_Z%OX_?^&'\;_\ RJH ^@Z*
M^?/^'E?P]_Z%OX_?^&'\;_\ RJH_X>5_#W_H6_C]_P"&'\;_ /RJH ^@Z*^?
M/^'E?P]_Z%OX_?\ AA_&_P#\JJ/^'E?P]_Z%OX_?^&'\;_\ RJH ^@Z*^?/^
M'E?P]_Z%OX_?^&'\;_\ RJH_X>5_#W_H6_C]_P"&'\;_ /RJH ^@Z^>OVQ_^
M3B?V4O\ LJE__P"H3XLIW_#ROX>_]"W\?O\ PP_C?_Y55YI\2?VDM'_:5_:?
M_9KMO"7AOXQ1KX7\=WVMZS=Z[\+/$>@Z?I]I_P (EX@LQ-/=7]A!",SW=M$!
MYF29AP>H /2?^"4__*+/]F?_ +)7X6_]-5G7T+7SU_P2G_Y19_LS_P#9*_"W
M_IJLZ^A: (73(/X5R_Q*^(>D_"WX=ZYXFUB[CM-'T&UFO[NY*F0+!''YDC?+
MR, $^O'TKJ\X:OB?_@NU\5#\._\ @G7XKM1J%]IVI>*+VST.S%N91]O#S"6:
M#,8! DM(K@/T&"5SR*X\=BUA\-.O_(KGO\*9)_:^=83*O^?]2$/2[M?Y;GR]
M_P $N?AMKG_!37]MWQ)^TG\0#>SZ+X4U$0:#I-YY-Q!:W7,L$'08%E#+!(A$
M2;Y9Q)OWQR&3]=B-BM\N?I7SO_P3%^#*_ #]@OX9>'([?4--O8]$BO;^TU$!
MKFTNKG-S/"Q 3_5RRRCIVKZ&:0=-Q5N>:XLCP'U:@G+^)4]^?JSZ?Q4XF6<9
M]46&2AAJ'[FC!;0IT]%\W\;\VSRG]J+]J7P7^QA\(=0\:>-=2DT_1;5MD<:
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M_P#5N/[?W_B1W_X;UY[^TM\!?%7B?]G+X@:;X%^ O[<>D^-[[POJ=MH=W?\
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M%57[J@ 42G;&QQR 32@X%,N9?(MI'_N*6_(5]H?SENS\C_V=_P!F;PG^W_\
M\%.OVBXOV@6U;7=:\'W8M/#FBWFH2:=G3OM<PAEACB\N7R8H3;?=_=?Z=YDG
MFR2B6KGQL^ '@S_@G7_P4O\ V<+?X!V.I6=]XNNI;+Q-X9M]6O-0 L9988?M
MDT1E,H7ROM,N928A]@,FS,,AK)^"'[-TW_!>GXF^-?BYX\\17GA7P+X;U&?P
MWX2LM#M[.#5Q;XBE_P!)G\J0X,4HS&9)?WEQ-L\M/]:?'#]FZ;_@@M\3?!7Q
M<\!^(KSQ5X%\2ZC#X;\6V6N6]G/JYM\2R_Z-/Y49P(HCB,21?O+>'?YB?ZK\
MY5%>Q^M>S_=\_/[;3GMS_P"6F^W3H?V-+'2>8_V)]?E]8]A['ZA:?U?VGL.3
MDY[\G-_R\_A_Q/=]I]L_7R([HU)]!3B-PJ.VE\^VC?\ OJ&_,5(3Q7Z,?QR]
MS\G?VHO"<W[!_P#P6]^&/CG0=,U!=%^+UV+2[L[6XAMK:^N+J7['>_NXQDB(
MRV-W(91^]DZ/U\O]7(SL@#<]*_,;_@YD\&:;?_L[?#SQ']EWZMIGB8V%K<_\
M\X+BTFFF^N39P_D*_373G6>PA;^_&IKYK*:?L<=BJ'FI_P#@?_#'Z[X@8C^T
M>&LBSBL_WOLZM"?_ ' FG#KK[E1+Y?=:!S1117TI^0A1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %?G/XWUW_A _P!K_P 1>*IO#_B[5="\'_M.0WFM#PYX9O\
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M444 %%%% !1110 4444 %%%% !1110 4444 ? 7_  <&_P#!3GXA_P#!)_\
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MXL[HV5U-8W"B75/#P)@N872:"3G EAD62/@HP(% 'BO_  _T_P""IW_1E?\
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MQ&_Z.O\ V@/_  3^"/\ YG:^@J* /GW_ (8[^(W_ $=?^T!_X)_!'_S.T?\
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MQ*"%A?;'/=?NX81$9)(Y(Y"(7\V)Y9(Z/$WA3XX_\%H/B)X)L?'?PKU/X/\
MP5\'ZHNJZQ!J_FQWNM7$0 :%-T<%U^\AF,0DCCCCC)F?S97BCCK]4%B1#M^7
M;U^M!B5VV_+CKCTKP_[#][V/M7[+^32W^9^G?\16J<W]H?4J?U^UOK-ZG/\
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M*#_ 3XU^,['PYX+^-7P@\9>*;P2?8='T#Q=IVI7]YY<32R>3##,9"1&CDD<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?C[_P 'J?\
MRBT\ _\ 95=/_P#33K%?L%7X^_\ !ZG_ ,HM/ /_ &573_\ TTZQ0!]^_P#!
M*?\ Y19_LS_]DK\+?^FJSKZ%K\*_V)/^#MC]FW]FC]CWX0_#O7_!?QJU+7/
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MA?X<FXLVN_#/AQ(M0N%$>3++-(X@-Q+YF<1F2*(!8OW>\&4\F(X@PZ_<X?\
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MK%SI]U:WNLSW;#[5XC=88I%O[4 Q'+F$[P!&F>L_86_X+$_"+]D7X!S>"_\
MA'?#.G6-IXL\27^E66@_%/X:0Z?9:;?Z_J6HV<4,7_"1Q^5Y4%W#$8A^[C*G
M860$D _6JBOQ(_9[_P""O<GC3X"^"]:\7?M%?&I?%6K^'[&[UI+/QE\";&UC
MO)((VG$,%]+'=P1>;G$5S&LJ#B10X-;OPX_X.XOA)\$O@)\+K'XL>'_B=XF^
M(.H>"]+U#7-3\.CPSJ5M?7<D*K/,?LFI 6DIF6=OLDT4,T090\,60* /V:HK
M\??^(U#]EK_H0_V@/_!)I/\ \M*/^(U#]EK_ *$/]H#_ ,$FD_\ RTH _8*O
MGK_@JQ_RBS_:8_[)7XI_]-5Y7P9X6_X/'?V:/&WBK3M)L_!'QHBNM4NX+*VD
MOK70M/M5>1@H\^>;58X88@2<RRR".,99R ,UT/[;?_!:_P"&'[2_['GQ<^'>
MAZ=INFZY\0O!FK^'K*\O?B[\-DMTN+JQG@C,QC\3.PB!EY(5L#M0!RG_  96
M?\HM/'W_ &574/\ TTZ/7[!5^/O_  96?\HM/'W_ &574/\ TTZ/7[!4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% $,I_=R?[M?!K.Q_:8ZG_D:?7_IZK[RE.(I/]VO@S&?VE_^YH_]NJ^\
MX'M_M-_^?;/Y/^D_*:>1*#?^]QV]3UBR_P"":/@#X2>,+KQ1\![/3?@%XTO+
M*"SO&\*Z1;PZ'XAAMFEFA@U'2,+:W$1FF^>:'[+?^7F..]A24Y[W]F7XP:S\
M2?!__"/>-4TW2?BMX6M;6/QIH]FK"V:XE!VWUAYI<RZ7=F&X-O+DY"S12>5<
MVMS#%[#;_P#'O'_NBOF;]LNXUCX!?%+X>?&7P_8Z;J$EYX@T?X<>+].N;QK1
M=1T;6M5M+*SG_=Q2>?>Z?J-S#- )<11VU]JZ+B2Y$@^#>Y_5U/X4?32"L+Q9
MX3LO&FC7VEZOI]EJ&GW]L;.[MKE//@NX7&)8S&>""O'(.<UO]!3=]&ZLS2G4
M=-J479GX_P#QQ_9=^)?_  1<_:6_X6E\%M)U?Q?\)=7.==T!#-<?8+:,&4V]
MQC>1'$OGFWN\?NL^7)GDW/V[^QO_ ,%4_A'^VF%L_#6O2:3XF8$GP]KJ"UU!
MB3,1LP3%/^Z@,I\F20HF-XCKZ=V^8BJRKM;C:3G-?"7[5W_!"7X+?M#_ &S4
MM LK_P"'.L26LS;=#:*/3S.8A%%YUGQ%B/9TA,7F9DWN20]?+RR[%8!WR]WI
M]8/_ -L[?D?LZXOX?XJHTZ'&2G2Q=."A#%4TI.:6B]O3TY[+13@U/17O:Y]W
M&9#%NW*5]:!*BQ[MRJOK7YC?\.]/VU?V?_$%Q'\.?VDK/Q%8ZA;1&[N?%$EQ
M<3&=#+_J8+J._$0P03Y4D8?/,?[L9BU+_@GE^W-\>?%>GV_CO]I"R\.Z'9BX
MS=>';R:WN<R# _<6UO9B7_MI+^[/*<UU?VKB$K?59\W_ &Y^=SS%X<Y0W[;^
MW<+['O:OS_\ @'LK_*_^1]B_M9_M_P#PS_8CT&XD\;>)-/AU;R#=VFBV1^T:
ME?#][Y6(QRHD\DQB64I%OX,F>GYUZAX<^*G_  7T^/UC=WMAKGP]_9Y\/W'V
MNTDNHN+P;IHO.@X\N:\D'G1$@R16P_OOQ<?17[/'_! ?X8?#[QBWB7XBZQX@
M^*7B9[N2[NO[2;[/IMY<M,)Q,T0+S3$YPXEFDCES)O0YP/N?PCX5T_P1HMII
M>BZ=8Z?IMA;BTM+>V7R8+2%!B*,1]  ,#@#%<DL%CLQ]['?NZ?\ (NO^-_HC
MUJ/%'#/"5)RX5Y\3CGI]9J0Y*=._6C3>M^TZFJ[*Y@_!CX-^'?V>?AMI?ACP
MWINGZ)HND6HL[*SM$*H@!';J23\SR')<DNQZFN]5E5/84U.,,,^XIPBX-?3T
MZ:@K(_%\1B:N(JRK5G>;U;>MR2B@<451F%%%% !1110 4444 %%%% !1110
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@/\ P\8\$?\
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M/C0]>\-V=SHUC<1_$F\O;8V-N1)%%%%9ZI%$/W<93]\F/+(+8'BW]NW_ (*
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M9>:C$&M)=,MF_>BRG4$>FX\>6)/A?]EW]LOX??!#7?VN/!?C+Q1\*_#MW?\
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MQ'YZ 1B(>8 ?=5%?//\ P]<_99_Z.4^ ?_AQM)_^2:/^'KG[+/\ T<I\ _\
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MU%?WW@W0;'XQQVU]\>)_%^BWQT[7[06MC?6=UH5EG,T:3DQN<;8L$2?ZJU\
M_P#@H9\(+C]BGX%^'=6^)/P6\.ZAX7\!:'87^/$ME_:6Z/3+.'_2,RY^T1&
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MXMDW3CS91$,#ZL*ZJN+^-FN7GAOX7^(+C3=#;Q!?+; KIZVWV@WQ?]WM\O\
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M_P#9U6N_^JQU.@#^@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@/P;I_P_T?5FS;:3:ZC=7ZV4&!B#S[F229^/ODG$DF3Y<8V1Q_:?[9__  2
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M]+TO2_&?Q"T?XOV'PL?PQXKM%U#PEJ6C7WPUM&F^TVB^7++*?M$J_P"O$9&
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M^UMXU\(^-!J%U_P@5]KGA>^ELXC?:+<6%GJD\(FC97AF\OS+?]X>)#YN8D&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%7VG]S_EW_FSZ_%>*&$R=K"\%86&'4/^7\U"IB*GFYS5J=]^6"5GU9^<K_\
M!LO\%]O_ "-/Q+W?]?\ 9'_VTKSZ7_@D/^U%^R%;:==_!;X^:CXBL='M[N2/
M0;UYM/MF;!Q!#:223VLGF>9/_KO+"2;7SD^9%^K[1F1?O*Q]*=%%L'3:?K6M
M;AS M7HP]F^\-/R.##^-O%J?L\?76(I]85J<*D'T^TG;?HT?F;^RE_P6:\4?
M"GXC6?PQ_:G\.ZOX'\8-<165KXB:P^SV%Z!F(RW #F(K)-$?]*@'V?\ ?=(T
MC,A_2P3I/"NW;)YG(P>"/6O$?VP/V$_AY^VYX131_'VC_;+BS29M.U*S/V;4
M--GDB$9FAD'!&-I,4HDB<Q1;T?8!7PS_ ,$Q/CEXD_X)S_M3ZE^RO\3O[4_L
M?4M3FF\)ZU=,;>V3S,^25\R5XE@NC$"D4).RYFDC?S)))/+PHXS$X"K##XU\
M\)Z0GU])_HST,=DF3\68"MFN04OJ^,H0YZV&7\.<.M2A=W7)]NF[VO[KLK'Z
MP#I10&W"C.*^D/Q@KM&OF_Q;L]<U^(O_  <5>*YO#/[96C_V'K&FZ9XN\.WG
MPU\5Z-&\D37!BTV;Q^\DZPM]Z.*>:UC.1LWSPJQ'F"OV\G;8F>JBOPI_X+4V
MWA7X[_\ !:7X=^&;C4K[S]4A\,_#S6'M7^S7%H+S5I9#'%YD>,^7J4,O'F#I
MT,9KQ<\Q<\/AFJ/\2?N1]7_5S]$\*^'</FV?P>._W?#IUZVE_P!W3U?WNT->
MKL?;W_!!W]CYOV=OV31XRU2*0>*/B<(M7G0Y 73U!^QQ']X\?,4IFR DG[\(
MX_=\??,3;V]!C(]ZK0+'%;*J$JJJIX'0=*FCD E*C/R\FN[ 8&G@\-#"TME_
M3/F^+N)L3Q!F^(S?&?'5G?T6R@O*"22\D6,48HS1FNP^?"BBB@ K^0+_ (.C
MO^4Z_P <_P#N ?\ J/Z97]?M?S]_\%D/^",3?\% OVY/B)XI\%^)&T_XN^,?
MC-I?PYM$UV\$'AM=-M/AO9Z[)/,(K62<3EK<J",I@@>7U< '[_?9P%^]VQ4<
M;;69 I\M>_K7P+C_ (*EJN/^, SM_P"QNKR7]J_]MK_@H!^PG\.K7Q9\2&_8
MN;1;G48;%+7P];>);G4+MI,G; )7CBW"..:3,DG13W !QQ6+IX>DZM9V2/1R
M7)L5FN.I9=@*?/5J-0BO-G9?\%NO^"J=U^SS8M\*_ASJUI'XTU*#=KM[;SG[
M3X>MV53$BD<1S2YSUWQ)\^S]Y%)7T1_P2H_;%?\ ;7_9)T;Q'J!=_%&F.='\
M2<'+WT('[_B&./\ >Q&&;$0,:&<Q_P#+*OY\?B=\3_$?QK^(>H^)/$VJ:AKF
MLZQ<F[N[RZ8;F)[#G@#@)$.(P B#I7T'_P $S?VPOCA\#?B"WPX^#&H?".+4
M/B+?PJI^(T^I#1+6ZBCEQY7V64%9KC]U%D(3(1"F#Q7Y?D_%U3$9ORU7^[J:
M)?D?W3XA?1SP64^&R6!I\^.PW[RI/K--?O%_@2UBM_<[MW^K?^#U+_E%IX!_
M[*KI_P#Z:=8KZ _X-<O^4%OP-^FO?^I#J=?G[_P<9_"O]O'XL?L&Z:WQB\-_
M +Q%X+\-^*X==N_^%36?B*[U+3A#IE^3>W7VM3%#81PM.))>,2-"#QFO4/\
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M06TR)3+,]S=WQU#4;:7RO/$EW9ZC;>7&L9C\F2(S2?GU_P '-7V[]C7]K_\
M95_:P\/IXF\,R>&M4O/!/BSQ3H(LKK5++3IQYD-M:V5_YEJTYLIO$'ERF$H)
M"OF.,1 ?37PKL?V5],3PS=>!?"OB;]L;XB>&6MVT[QMC_A8VJ)<VH$O/BJ_D
M&E:9<1;3=_8S?V@CDGWP6XDNHA* <'X2\1? 'X.?\%%_!_C;X2?#[Q)\;K[Q
MQX7OM%T_Q?:V4_B.YU'7=/9I;>+2/%VK2I9W$TNEWGB 732:I*?)T"WM!Y3V
MRVTOUI!J7[2_Q3;SM/L/@_\ !O369I+2WU^TO/&^J7\$G(6ZAM;G38+&:(8$
MJPW6I1223G9,$B$LWC/_  4!\9?';Q#\!V^+MKX(\*_";3/@7=#XD6%UXGU4
M>(_$P@L(9XM4@;2+&2/31+-ID^IK$W]JW(DC:)/]"N)A=6&C^TAIW@OX::]I
MEA\;OVC/B!J?C36_-.BZ+I_B6\\%6HNCY)N8-(L]!EMM0U-B9K81:=-<:E??
MO;1(Y 9I990#Y:_X.+?V(/!WC+_@GQXP7Q9^T!XI\5_%/X?W&D^);(^+/%UC
MIUO8:?-??8AY^CZ?;6]I)$(9=2DCGCLS?RRPF*.29 +:OO?_ ()[_'_2?^"@
M'[(_P]^,%S>:3KUOXDTV&\L_+T:6SM=/OHI&ANOW$QD*SK>V\PR)9?+X2.60
M?Z3<>0^"?"?@_4_V?_&7PP^"W[+^I-X4^)UK=:=XGN]4\/?\*E\,W336_DWD
M%Q#)#'K$/^AXBBGL]+N8S))$AN/,%S+%X9_P:H_$;7/!7P3^-W[+_BS4!J/B
MC]F/Q]?:&;NTMHAI:6EU/<#RK:;"3S?Z=9:G,3/$#LGA&<#RX@#]:**** "B
MBB@!H_AK^6W_ ()"_!O2?V<?^"Q'[1G@#0?[4O=%^'J>(-!L[J[R;EK>SUNV
MAB:4Q^7^\/DC.,#<> .W]22_PU_,S_P3_P#^5AK]L3_L/^+_ /U)HJ]KAG_D
M94/4_,?&;_DA\S_Z],_IBTW_ )!UO_US7^0J:H=-_P"0=;_]<U_D*FKQY;L_
M2,/_  H^B_(****DV"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH _/O_B';^#_ /T&S_X:'X9?_,M1_P 0[?P?_P"@V?\ PT/PR_\ F6K]!**
M/S[_ .(=OX/_ /0;/_AH?AE_\RU?DC\=O@5\;OVT_A1XD_9/\ ?"[PI_PA^F
M?M7ZUX<T/Q]!_P ([X5MOM&FZ5>1_8[[3=+LK?S)8].AGO)+U(B9 ODI&[B*
M.OZ<J_'_ /X)J_\ )QGB+_L__P"(_P#ZA&N4 ?HY^R%\?-9_:1^":^)/$'AW
M3?#.MVVO:]X=O;"PU0ZG;K=:5K-YIDIAN)(;=IHI#8^:"88CANF>GLE?/O\
MP33_ .3>_$?_ &53XD?^IOK=?05 !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#Y)_X+#_M.WG[+7[!GB[6-+U#^S?%&O20Z#I.UID837)Q*898P
M#'-'!]HFCD/ DA'7[E<G_P $/_V2[/\ 9F_8ST77&BLWUKXE6L/B&[NHU#.8
M)85-G!YOEI)B.$C]VV_$LTVS@UY;_P '"E_=_$6T^!OPFTV&P:Z^(GBTFTO;
MVZV6]I<1F&TCR!&_7^T2?;RON29(K](M&A%I9PJ.GDA<>F!7SE.FJV;SK/\
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M)#E?,D\O'UU_P2K^._P]^._[(V@W'PS\/KX-T7P\3HU_H>-S:-=(!++$9O\
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MW[B:>J]I4UZ74->A^5__  K?_@I<=W_%Y/C]_P"&<^$__P T]> C_A^KC_\
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MAA\90Q"OAYJ2\CYG-^'\RRFK['-,-.A/M.#A]US\A_\ A7/_  4P_P"BR_M
M?^&<^$__ ,T]'_"N?^"F'_19?V@/_#.?"?\ ^:>OV S1FMSR3\ ?^-Z_^?\
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M#5?WU#]W4_GAO_P5ZGUG#/BMFN @L!FR^NX-_'1K:KUA/5TY[V<=F[V9X_\
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M7 /Z4J^</VN=OP[^.OP*^(RXL;'1?%4O@CQ-J3#>4TO7K<P0P>7U/G^((?#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]E4^)'_J;ZW7T%7S[_P33_Y-[\1_]E4^)'_J;ZW7T%0 4444 %%%% !1110
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M>&(O^"BW[-D+Z-9Z?X)^,FG6]M"MG?7%W;N;$1>;'Y'G22VEQ++C:9))O-R
M/WA<R5Y-+'8_#?N<;3YU_/#_ "W/M,3P?PYGK>,X;QU/#M[T,3/V;@]/@J/]
MW-7O:[A.VZ/TZ(<HJKM;)SD\5)*5C&YRO'&:_*S2_P#@JY^UWXD\+Z#I.B_L
MPZG9>-+ZX,5YJFI:-J4&CDMGCR9?+\D?-#^]ENMF5E]]D?C3P1_P44_:VU2_
MTF^_L'X0Z#):[7:PU.WL8KV=) 05FM9+J_CE.1G;(D>R+'J)-)<14YK]Q2J3
M_P"W&OSL33\',92J7S7'X7#P[SQ%.3MWC"FYR=^FGK8^B_\ @I9_P5B\'?L+
M>$;[3=)OM)\1?$R])MK/2([H2+II\L2">_\ +YBB D!6//F2Y^3 $DD?F7_!
M)O\ X)W>--*^)U]^T7\;K[4M4^)'C"W+6%AJEK']JTF&7),\_'[F8QXB2*,1
M_9XBT9'[PQQ]M^PA_P $2/AI^QUX@_X2;7I/^%B>,[<@QW>I:?&MIIQBG,L4
M]G:9D\N; @_>M))(# #'Y7F2)7W#@XX4G QUQ6>%P.)Q&)^N8_\ [<AV\WW?
MY#SGBK)LCRNIP]PE>I[72MB9PY)U(=(4X;TZ;W=WSSZV2L3*NUZ^'/\ @O1\
M7O\ A47_  3W\0VT=QJ5K>>,M0M=%M[NV&X+O)FF6;TADAAFA/KYP3 4DU]Q
M%\G\<5^;_P#P<R)Y?[%'@K_L>K3_ -(M0KNSZHX9;7?]QGB^$N%I8GC++:=9
M77MH/[G<^D_^":_[+2_LB?LA>$/"LFGQ:?K$UM'J&LHSQF9]0F'F7(,L8_>^
M7D11GD^7!$-YQD?1*L48*/3-,T]E.G0'JK(OX<5*&4RMQRHKT,+3A0I0I+HC
MXS.LSQ&98^OF&)=ZE2;G)^;=V>2?MA^/_'7PU_9Z\1:M\.]!/B_QN&M++1M*
M PIGGN(8?-EQ_P LHO-,LG*#RXS\\?\ K!^7'[-O[/\ \0O@/_P7'^%?_"T/
M%-IXJ\<>,+/4=:UBZA&8\/9ZE#%$2^PG]U!D 11A /+1/+BS7[/2Q;.5Y.,8
M/>OS=_:&;;_P<B_ U>@7P3(H&>H\C7J^?XBPZ<Z%7M4I_P#I?_!/UOPCSRI1
MPN9Y51I0_>87%2G.UYM*BVH7>T$U?2S;W;25OTL Q1CBB@\BOIC\4/F'_@J5
M^SM:_M1_L6>/M#N--OM1U#2=-EUO1C;6OG72W]M&TD7V?]W(<R &$B(>88YY
M4'^LQ7G_ /P0Q^/G_"_/V"=#LYGOVOO =Y/X9NUN+6&V!$/ES6WE"/C;':2V
M\?8Y4]<;S]FW<JQVDD<KJ=P(/&!CJ?TK\/O^"3?Q4_:H\#_ O7K7X%?#OP3X
MP\,_VY(]]=ZA-!%<I=^3:B2+F]M\?N?)P?*Q_*OE\RJK"9G3G_/"?3M9G[IP
M5E=7B#@?'Y8ZM.G]6KT*D)5*BIP3J*I":YYM;J"=KZV\C]SO-]FI?-]FK\UO
M^&C_ /@I)_T0KX;_ /?^V_\ EO1_PT?_ ,%)/^B%?#?_ +_VW_RWKL_MRE_S
M[J?^ ,^?_P"(3XS_ *&&"_\ "NC_ /)'Z4^;[-3)YL0/P?NFOS9_X:/_ ."D
MG_1"OAO_ -_[;_Y;TV3]HW_@I')&RGX%_#C##!Q/;?\ RWH>>4K?PZG_ ( Q
MQ\)\9?7,,%_X5T?_ )(I_P#!&_2[?4?^"@W[76K266G?VA8>*6LK:^:,&=89
MM3U(RQ^9U^?R8. ?^6,6>@-?IFAP"?E++Z5\"?\ !$3]B?Q]^RMX2^(GB3XF
MZ3J6F^._'6MJ;M+S5(=0:[MH8FFBN3)%)+F62>ZN _FR9)&?>3[XM)=RE6;,
MJXW&KX>I5:>!A[;?MZMG%XN8["XKBBLL#556G3A2IJ<-8/V=*G!M>3:;7WEH
M=****]D_-PHHHH .M&,444 %%%% $%T,6\G^ZW\J_F@_X.<_^1L\>?\ 80\*
M_P#H[Q;7],%U_P >\G^ZW\J_F?\ ^#G/_D;/'G_80\*_^CO%M>I@_P#=JOR/
MSOBS_D<9=_B?_I=,_IFHHHKRS]$"BBB@ HHHH Y'_A5?AO\ X6I_PG/_  C7
MAO\ X37^S/[$_MW[%#_:G]F^?YWV'[7M\[[/YW[WR<^7YG/7FK7A;P7H_@^R
M%MI.GZ?I=JUY=7YM;6V%JK7-U<2W$\Q48!EEFEFED8Y,DC%R<DYZ2N:\4>,+
M/PW MI++(-0N?^/&SMOFN+TYS^Y!(SCC.?DC!RY"<T >8>#_ -@[]GWX)W5Y
MK7AGX,_!OP9+&(?M=[IOA#3=/.+>XAO8BTD<0($5Q;P3@D_)+;12#!B!KIM)
M\#KXKU74+V'26\+Z7KUQ]MU![3.GZGKURL,,$4]P8@DT1$,%N!^\,IB@AC?R
MQ&8JV=.\"WNN:J-0\5-I>IW5NV;&TBM2;:P'7K)_KIL\>=^[&!A(XLR^9VM
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M)T\S2:;/XK\GX:>'98#*S7 MK&*VN-6AG^T2D[9]*MHI,32B;!B^T 'YE_\
M!1WQSJ/[+O\ P6F_8L_:,TKX;^(OA5\)=/>R^%<=YXOT>RT?PWIND/-<0BX0
M6]\9M-']FZI<R1VFHV]E);_8 7BDV7$4/[R5^2__  <*?L.?&#]JO_@E3\0-
M>\:>)] U*^^%[1>.]%\'>#=+&GV.GM$S?V@=0U"^DDFU+[)ILUZ8I((]-\U@
MSO;2/+###]L_\$L?VI?^&S?^"<GP:^)5UKC>(=:\2>%[/^W+[[&;7[;JL*^1
MJ7[GRXP,7D-R/W:"/C]WF/!(!]'T444 -7^&OY3O^"&_P?U3]FS_ (*=?&WX
M>ZXVFWVM?#_2-7T*^N+1@UL;FSU>TAF:(R>7F/=$V"0#@YP,U_5B/X:_F9_X
M)_\ _*PU^V)_V'_%_P#ZDT5>UPS_ ,C*AZGYCXS?\D/F?_7I_H?TQ:;_ ,@Z
MW_ZYK_(5-4.F_P#(.M_^N:_R%35X\MV?I&'_ (4?1?D%%%%2;!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7X_\ _!-7_DXSQ%_V?_\ $?\
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M?\*/$G@KQ/I_]H>'?&6ESZ+J]F+N6W^VVUS"89XO-B(E&82PR"#@]1U'8T4
M?"?P#^*NN>+Y/V(OB7XNO?[6\;^,/"NJ?"WQ1;_9H[6XT_6[O28=8U*>:*,
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M01Q3W\T7E2>4'\E%BA#>7;0P0VT7EP0QQ@ _17X/?"G0_@A\*/#?@KPQI_\
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M?BR>VT]="\(Z;93WLVE3/ MQ,NES&3$5M'))%,\=O#'MBC /VQ^*?B7^R_\
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M22)****V/+"BBB@ HHHH **** "BBB@ HHHH **** (;H_Z/)_NM_*OYG_\
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M[48O$D-Q//<2ZQ#X6ABG_LNQ)MKHW)MXK>Y$EN 7?VW/AY\=/AU\*;[1KO\
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M-_Y!UO\ ]<U_D*FJ'3?^0=;_ /7-?Y"IJ\>6[/TC#_PH^B_(****DV"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *_'_P#X)J_\G&>(O^S_ /XC_P#J$:Y7[ 5^/_\
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MC_V%_P#HN"?^$=XA_P#D"C_B%P_87_Z(>G_A8^(?_D^O&_\ @H%_P;H?L<_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]'*? 7_PXND__)-'_#UK]EO_ *.4^ O_ (<72?\ Y)H ^AJ*^>?^'K7[+?\
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M]&'_  ]?_9K^&D<:V_[1WP;U[18VY+?$;2KF^LNN3F2Y\R>'@G_EI+R-@D#
M1_SG_P#!M-_R>5XW_P"Q%NO_ $NL:]OAE?\ "C0]4?F'C-_R1&9_]>I?H?UP
M:;_R#K?_ *YK_(5-4.F_\@ZW_P"N:_R%35XTMV?I.'_A1]%^04445)L%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7R3^W3X%UCQ;\2[&XTCP_XEU"ZCTJ'_ $VT7S[4 3S9
MA\GRO]=WSYO0C]V>I^MJ* /)?V4?#U_X<^#6GVMWINJ:7=;9<VNJY+*2?X1_
MRQB_Z98X_P!KF23\V?\ @FK_ ,G&>(O^S_\ XC_^H1KE?L!7X=_\$V_VB-''
M_!2[Q%\)6B4:[_PVG\1O%GFG5M, -L?"NMV@7[']K_M'_6?\MOLGV7G9Y_F?
MNZ /U"_X)I_\F]^(_P#LJGQ(_P#4WUNOH*OGW_@FG_R;WXC_ .RJ?$C_ -3?
M6Z^@J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^??^"EG_)O?
MAS_LJGPW_P#4WT2BC_@I9_R;WX<_[*I\-_\ U-]$HH 9_P $I_\ E%G^S/\
M]DK\+?\ IJLZ^A:^>O\ @E/_ ,HL_P!F?_LE?A;_ --5G7T+0 4444 %%%%
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MHD_LXZC8#3]>GN+M;6(-.;R"V+AB?-\X2@"22Y  /TLKYZ_X*L?\HL_VF/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#_VE7[ *&'H*7+'NM=7]O+_GQ#_R?_Y,\2IX2NI4]K_:N*_\H?\ R@_'QO\
M@A'\0G?=_P +<_:G7V_X65",_P#D*N/^/7_!N3X_^./PYO\ P_-\6OCE>?VB
MT)8>(?%46K::?+G\[]_9XC$N.V)/];^\]J_;"9%8\Y-/!VC;FBIGBG_RXA_Y
M/_\ )FF'\*:E&K&K3S?%<T?^O'_R@_'Y?^"$GQ#50/\ A;7[4YQW/Q)AY_\
M(5+_ ,.)OB'_ -%9_:F_\.3#_P#&J_8#+>HHRWJ*O_6!?] \/_)__DSF_P"(
M0R>O]K8K_P H?_*#\?\ _AQ-\0_^BL_M3?\ AR8?_C5'_#B;XA_]%9_:F_\
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MCF\46(B@O8OL]CJV_-I:2_;3YD/V>3?Y'W^17[8+&-W>GY"UC_;BZ4(??/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[/\ R:#KG_<C?^JR\%T ?H)1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?V@/@G)HNF_#CQGI]]??\)UIGV2SN)]3\)S0PF7SMHDD6WN"@)!(MY2,^4P
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **,T4 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 44;J* "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K\._P#@FW^S[O\ ^"F7B+XJ?\)EX\5E_;2^(WA3_A%1K./#&?\
MA%=;N_[0^Q;/^/XX\GSO,YA^3;WK]Q*_'_\ X)J_\G&>(O\ L_\ ^(__ *A&
MN4 ??W_!-/\ Y-[\1_\ 95/B1_ZF^MU]!5\^_P#!-/\ Y-[\1_\ 95/B1_ZF
M^MU]!4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\^_P#!2S_D
MWOPY_P!E4^&__J;Z)11_P4L_Y-[\.?\ 95/AO_ZF^B44 ,_X)3_\HL_V9_\
MLE?A;_TU6=?0M?/7_!*?_E%G^S/_ -DK\+?^FJSKZ%H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _//PW,OPM^&/@=;G=_:7[._[24VA
M_P#"-$8M[#3=?U&\T?1K*"5<Q0P6NB>+](NXH8M\<<=M#9X@?/D_H97PK^T5
M\+]<\3Z[^VM\-?!=C_:7B;QIX"T3XC>'=]Q#;W5CXNNK/4M(L3;3R-''!Y,O
MA;1Y[>4XEANC++YP'E"+ZY^#WQ6T/XW_  H\-^-?#&H?VAX=\9:7!K6D7AM)
M;?[;;7,(F@E\J4"49A*G! .#T'0 '8UX#_P4D_9YNOVI_P!@3XR^ ;#P[I?B
M;6/%'@W4[/2-.O5@83:G]DE:R.9<112QW8MY(Y2?W<BAP5QFO?J* /Y7?@K^
MQCH/_!QK^V1X1FT37O'OPWO;/X,::GC;QMXIT6;7/^$P\5Z(-,T[4&MF-\!+
M_HU[II+&02'Y7DB#S^8WHO[1?_!HB?@%KMC8_P#"_+S5%O8B_P!K;P ;>W0^
MFX:@]>[_ +">IV/[ ?Q/^%?A/5_%?CY?^%$?M4^(_@?HGAC?##J+^$_%>FM/
MID^HP".WEF@GU*S@O8YCB.0+.\<<IBACC_8#]HW]EB3X]ZY87W_"0WVFBQA*
M_9/L_P!HMW/T\R/G\: /PR^!/_!F>GQQ\&C7(OVC-1TH><Z;+CX;Y$FT_>1_
M[4PP]^*[7_B!C_ZNB_\ ,;__ 'TK]OO@/\*8_@AX*_L5-3U#40)Y6#71VX')
MQ#'R OM7H% 'Y_\ _#EG_J3?V ?_ !%?_P"_]'_#EG_J3?V ?_$5_P#[_P!?
MH!10!^?_ /PY9_ZDW]@'_P 17_\ O_1_PY9_ZDW]@'_Q%?\ ^_\ 7Z 44 ?F
MK\6/^"$2_%7X9>(O"O\ 9?[$'AU?$^EW&F#5?#_[,_V35-,,T3Q&XM9_[=/D
MS1YW1R8.) #C(Y^*_P#B!C_ZNB_\QO\ _?2OW^HH _ '_B!C_P"KHO\ S&__
M -]*/^(&/_JZ+_S&_P#]]*_?ZB@#\ ?^(&/_ *NB_P#,;_\ WTH_X@8_^KHO
M_,;_ /WTK]_J* /S_P#^'+/_ %)O[ /_ (BO_P#?^C_ARS_U)O[ /_B*_P#]
M_P"OT HH _/_ /X<L_\ 4F_L _\ B*__ -_Z]^_8;_92UO\ 93\/^-(-<UCP
MKJU[XUUZ'6EL_"_A4^&M'T*WMM%TS1[>QMK0W=WMBCATR'&)?XL! !7T%10
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M_<>"_ACH.DS[6NM*TV"R8CH6CA"_TKHZ "BBB@ HHHH **** "BBB@ HHHH
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M&QU'S,-K7Q/US1M1;RY6B/G6=]KT<T/(R/-B&1AQF,BM[_AAW_@I1_T;L?\
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M2/\ U-];KZ"KY]_X)I_\F]^(_P#LJGQ(_P#4WUNOH*@ HHHH **** "BBB@
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MRE.\?_\ 9*]1_P#3MH];S=Z,/5_^VGCX7_D8UO\ ##\ZA_3]1116![ 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M45ROA[XD:?XCU8V6)K'6 "QL;Q/(N"!C) _Y:QY./,B\R/(.'.*ZJ@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\?_\ @FK_ ,G&>(O^S_\
MXC_^H1KE?L!7X_\ _!-7_DXSQ%_V?_\ $?\ ]0C7* /O[_@FG_R;WXC_ .RJ
M?$C_ -3?6Z^@J^??^":?_)O?B/\ [*I\2/\ U-];KZ"H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#Y]_X*6?\F]^'/^RJ?#?_ -3?1**/^"EG
M_)O?AS_LJGPW_P#4WT2B@!G_  2G_P"46?[,_P#V2OPM_P"FJSKZ%KYZ_P""
M4_\ RBS_ &9_^R5^%O\ TU6=?0M !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\1/[<\+:7?CQ0='.E?\ "1&6SAE^W_8\#[.9\^=Y/6+?L[4 >F4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ,F]^(_^RJ?$C_U-];KZ"H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#Y]_P""EG_)O?AS_LJGPW_]3?1**/\ @I9_R;WX<_[*I\-__4WT2B@!
MG_!*?_E%G^S/_P!DK\+?^FJSKZ%KYZ_X)3_\HL_V9_\ LE?A;_TU6=?0M !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\W_ML-_P
M@7CCX(?$[884\)^/+'0=;-KA=2O=-UZ*71(K($?ZRW_MB^T>ZFA:3RR-.$H$
MDL$*$_8MMO\ A"OBK^T%X#VK8V.A^/?[>T6PG_X^&T_6--L=2N+T @22P7.M
MS:_B4DQB6"XMXR([7RHNK_;)^#.K?M"_LX>,/"WAV2QL?&S6JZCX6O=0<I::
M;KMC*E[H]Y,H#DQPZE;VTQ7RY$D6WV/'(A,;>3?!3XUZ-\5_VQ?A=\0O"JWK
M:/\ M'_ W^W7M]2"K=6D&CWUA-IJKY3$0RD>+=0%QS*,V\&PQ^7(90#Z^HHH
MH _*S_@K#\&]6\0_\%6?!VC>'[C3;S7OVM?V>?'WP2TY;YFM;7P_<6D!U:._
MGEC$AFBE,XA,0C4Q#,N93^ZK[A_8!_::?]L/]BSX6_$UKSP_?7OC3PII^I:F
M-$?=I]EJ4D(%Y!"=[D>3<>?$8C(98S$4?YP<?(W_  <CZ;KGP]_9Y^#GQH\*
M:@/#NL?!;XI:1J6K>,K2[BL]0\.:)=^=IUZPG%K<R^1---8Q30Q6EV)%QYEK
M<)$4K>_X-Q?#WB;X'?L!:]\$?&WA_P#L#Q1^SKX_UOP->72>>T&O#SQJT=]
M)(8I1!+'J:^5D'S(A%*.)M@ /T-HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"-X]PV^M?SF_\ !VC^
M]^+GQ$'?S/ Q_P#(7BBOZ,L[LGZ5_*__ ,'4W[5EUXD_X*7_ !)^&]KIL=A9
M:';^&/M5[]H^T3:A<V]A=WD,\7">1'Y>MM$8OWF3 LF\9V5OA9QCS+^Z>'G6
M7U<5[!T_L5(R?R9_31^SXWG?!KPO_LV$ _\ (0KM@H9^#UXK\I?V*/\ @K]^
MU9^TK^RSX2\9?#']AE_&7@O4[5K:RUG_ (7/HVFF_-M,UK,WD36T<L>)H)0
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MH>E>*+>+78(,CB;%[>:M'N,K2GR<D1(T48^SJ "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7QM^TQ_P0A_93_;-^-OB#XG?$
MSX5_\))XV\3& ZA?CQ/K-K]J\F"*"$>5#=1Q#$,,(P(Q]WG)R:^R:* /E/X7
M_P#!'SX)_!GP39^%_!/_  N#P;X=T\2_9-)T'XP>+M-L;'S)&ED,4,.IB)29
M79B .2Q)R>:_F_\ ^#:WQGJOQ"_X+[_![6]<U+4-6US5[KQ'?WVH7=PUQ=ZA
M<RZ'JDDLTTDA)DDD9CN8G))R3G)K^NROYO\ ]B[]I?PO^QU\!?\ @D_\2/&]
M_P#V;X7\*V_QAN;VZQG EGGA  ZD[I%X'+$@+DD4 ?T:7M_:Z+I;7%PRVEK;
M#))X"BN035]8\<2!-!S8:3R?[:NAY_VU2<XMHA)[<32_N^!LCECDR/CKQK_P
M4C\3:+H?A'Q5XV\$^"_A#'KT"ZAH]C\=?BE8_#U;U"L4F+:TM/[5ENIX3,IN
M%O(K4VQ:TV1B3S?+^=I/^"O4G[6Z?V?\,/B3\?/VE->NO^)=?:'\"?AC_P (
M3X8L3-@6<.LZGK,=SJ&F?:Y#<1_VA9W\1ABMC(D<,L1EE /U)\4>*? _[+WP
MRU#Q!XE\0Z+X.\+Z?LDOM;\1:L+:!&D:*&(W%W=2#)8^3$#+)R?+0'H*\?TC
M_@J1\,OB)J>J6?PG3QC\>M2TF\6Q/_" Z+/J&BM/Y$,[PC7I?*T,21V\XE<2
MZA&>?+YE,<1^*?!W[&W[97QG\6Z;XH\'_"GX*_LO:Q9W,-B/&/Q)\6WGQB^*
M'A^W+_Z5/I.IW8N8([.2WFFA&GRR(-[7C9B-SYM=9^S[_P &T^B:5I>O:?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML:%9:O\ 'SXEV'B;0[*U$WGB%Y9M8UV>#YM_E&#3Y3YLY0F*.664 &?\:_\
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M %%%% 'S[_P4L_Y-[\.?]E4^&_\ ZF^B44?\%+/^3>_#G_95/AO_ .IOHE%
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M?:/M'_/'RNN?;K0!U5%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC_NM/_MW0!^_U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOY=S"=A!!(![A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT+7SU_P2G_Y19_LS_P#9*_"W_IJLZ^A: "BBB@ HHHH **** "BBB@ HHHH
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M-OP^TO1;599HEFGN9[36;^Z6*&)GDQ#:3N=FP)SP ?H[17Y__P##Z;_J<OV
M?_$J/_O!7G/[/7_!Q ?VA?"$FL-_PR+X'\HV0^Q>+/VCO[-NV^U:98ZCQ'_8
M3Y\G[9]DE.?W=U:W<7_++<0#]1J*_+7XX_\ !QKHG[/$VG?\)%XE_8_U&/6/
M.^S#PO\ &C7/$Q3R_+SYQTOPM<>3_K./-$?F<[,^6^/)? /_  <PZ+XIBU^Z
M\4?M/?LP^"?M&J7#:1I&F?!_QWXL5-../)$][)+INZXX*OMM8XR%$@QYACC
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MP!_X)!=/^"/'_=:?_;N@#]_J*** "BBB@ HHHH **** "BBB@ HHHH ****
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M];F\M?%'@/X57\^C,RSRPSV_FWAMS))&8F#^5&8\G'F;Q($ /OZBOS3^./\
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M,F&$N997,LJB1\N,U[E110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/PD1-]J@T>WG/E'4?+!:'0M(& @Q]EXP99?,]%_X6E\1/^DU?P _\(?P1_\
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MB?\ 2:OX ?\ A#^"/_DZ@#[Y_P"'KG[+/_1RGP#_ /#C:3_\DT?\/7/V6?\
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M_P"+^J>(M"#&<P#3VET_PW/-]L_=F7!A\L1;<R;B ?O#_AU#^RU_T;7\ _\
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MA+I5I;QW?GROCS88;6:.("/S9"(Y(_WDHH _'S^P?VIO^C$OV@/_ !/'5?\
MY84?V#^U-_T8E^T!_P")XZK_ /+"OV#HH _&?PE_P3T_X*%>)/"FGZC>7GP5
M\-WM[:P7=U87_P =OBXUU8%U!,$QAUN2(RQG*L8I)(R0=CL,$\_X8_X(O?MH
M1?&?QAXR\8>'_P!AKXS7WB>RT_3[2S^*%]XM\<)X2MK3SSY.G3ZJ)[N&.:6>
M:60-/+F3[GEC@?MQ7C?QH_;-^&O[/7BR/P[XD\9::OC:\MUU"S\+Z8LNL>)=
M3MBQ!EM]'LTEU">,&*8DPPRB.."61SLCD*@'YO\ _#IO]JC_ *-M_P""0O\
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MI_\ E%G^S/\ ]DK\+?\ IJLZ^A: "BBB@ HHHH **** "BBB@ HHHH ****
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M=V!$.GPP136T<:V<=G-/$3*99B8("7)\UY/T<H **** "BBB@ HHHH ****
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M6ZNA9VVH:_K,&EVKW&&D$(EFD1?,Q$QQG/'UK^?[]GKP!^T1_P %"?A)\/\
MX^?$K]N#XP?#GQM\7-*U"PT32/A=\,M:UF_U#0]!U*6W::^C\.BW"^3?:C<
M&6*3 NXSYI,ICC]Y^"__  ;H? C24U6WT?\ 9@^/WQ+_ +=6$Z'KOQ<\?:;X
M3T.PMX_-;[0PTF7^U[<S1,N(;K2I)HY%ACEBM?WQ0 ^S/CW_ ,'*/[&G[/NL
M^(K*Z^,FF^)-<T2U^T"Q\+:;>:W'J;>0LZ06U[#$;"25]PCR;H1QR$AWC(D
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M^'/#GA#P[8><;32M#LXM/L;,RRF64Q01 1@F9BQP!RQ]3D _!W]H/X(?$O\
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M3X2:6NG>$]'UCXM>'H;?2_(#"R -Q+=[8+7S9I8(H5C\N;R9$=?+(D_I=HH
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M>_B!_P I2?@W_P!DJ\=_^G;P97T)7SW\0/\ E*3\&_\ LE7CO_T[>#* '?\
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M::KY6L7DLOEGY?+UB^U>",&.,B&V@R)#^^E]PH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^??\ @I9_
MR;WX<_[*I\-__4WT2BC_ (*6?\F]^'/^RJ?#?_U-]$HH 9_P2G_Y19_LS_\
M9*_"W_IJLZ^A:^>O^"4__*+/]F?_ +)7X6_]-5G7T+0 4444 %%%% !1110
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MW?RI?LZ']G* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_?\ AA_&_P#\JJ3_ (6%^U)_T1?]G_\ \/%JW_S,4?\ "POVI/\ HB_[/_\
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M.3Y?JO\ P[4^'O\ T,GQ^_\ #\>-_P#Y:T?\.U/A[_T,GQ^_\/QXW_\ EK0
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M(_2%% 'S[_PQW\1O^CK_ -H#_P $_@C_ .9VC_ACOXC?]'7_ +0'_@G\$?\
MS.U]!44 ?/O_  QW\1O^CK_V@/\ P3^"/_F=K/B_X)ZV?B(&X\<_%CX\>.-<
MR%2_'CN^\)^5;YXA-KX<.FVC');]]+#),0<&0QQQQQ_25% 'SY_P[4^'O_0R
M?'[_ ,/QXW_^6M'_  [4^'O_ $,GQ^_\/QXW_P#EK7T'10!\^?\ #M3X>_\
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M6?[,_P#V2OPM_P"FJSKZ%H **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ?I=JUY=7YM;6V%JK7-U<2W$\Q48!EEFEFED8Y,DC%R<DYZ2@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M??L[>';/P1IOAJXENYGAAM]3BMA=3V7DSS,\,T()EE5WDD>$R2?IU10!\/\
MP:_X(!_LI?!_Q1)XENOA7IWQ$\;:M:M'K6N?$*YF\677B&XE(EFO;B*]EDM?
MMLTJ^;)-%%&<F8+Y:2%:^X*** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBOFW_AXW\//&
M$C0_#!O$GQZO).(Q\-K7^V-+:?YO-@EUGS(]'M)XXL2F&[OXI/+,6Q"\L(E
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MT+7SU_P2G_Y19_LS_P#9*_"W_IJLZ^A: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KPW]L3XC:]\%-!^'OBC1[K_B7V/CW0-%UFQ>WA=M?M=9O8M"$
M1F()@\BYU.VOLQKF3^SO(S&DQ<>Y5Y[^T-\%=)_:,_9^\:?#G7)M1LM&\>^'
M[[0;^XM& N4M[RWEAE,.\.!*%E.,J>O?&* /0J*\:_8V^,VK?M"_LX>#_%/B
M*.QL?&S6K:=XILM/0I::;KMC*]EK%G"Q+DQPZE;W,(;S)$D6WWI)(A$C>RT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /'?V=?@IK7P-UKXA6)FL9/"NM^-[W7/#5C;R,S:?:ZA#!=Z
MAYYD /G2:S+JUT!F4".YB1#'&!%%[%110 4444 %%%% !1110 4444 %%%%
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MVC_#OP3X3\$:+=71O+G3] T:#2[5[C"QF<Q0QHOF8B49QGCZ5Z!0 5\_R?\
M!.SX3ZW\?M/^)/B+PQJ7C/QGH]W/?:/=^*_$&I^)+7P]<2W$-U)/IMI?7,MI
MILIF@MRAM(HC&(0B8C&!] 44 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5]HM^GERF$F:TOHHYXN02#+$,C:X^0@G#_:5^"5]^T+\,;WPK8_$CX@?#/\
MM%G6[U?P8]G:ZH\$D4T1A$UU:W/DY$F[S8?+FCD@B,<D?(/J5% 'B/PS_8+^
M%/PI^(=GXJL_#/\ ;WC32Q*MAXI\5:G>>+/$FG6\D+1M!;ZEJDMQ>06Y$LW[
MF*419GF.S,TA/MU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?Q.U;QW\:KRZ_P"/ZU\:>);BYT/7,8$7VC0(?L^A$Q8A";=/4>9!%.<W&92
M>B_\-9?"_P#X7G_PJO\ X61\/_\ A97W_P#A%/\ A(['^W,^1]J_X\O,\_\
MX]_WW^K_ -5\^<5Z57&_"7X0^$_@?X%TWPUX'\.>'/"'AVP\XVFE:'9Q:?8V
M9EE,LIB@B C!,S%C@#ECZG/94 ?./C;]G#XP_%SXJ-_PD7QX?PS\.C]N1?#7
M@/PJNBZIJ%O+/%Y4-]J]S=7DP\NW$T7FZ<EA+YEP98Y(C'&%Z#X9_L%_"GX4
M_$.S\56?AG^WO&FEB5;#Q3XJU.\\6>)-.MY(6C:"WU+5);B\@MR)9OW,4HBS
M/,=F9I"?;J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^??\
M@I9_R;WX<_[*I\-__4WT2BC_ (*6?\F]^'/^RJ?#?_U-]$HH 9_P2G_Y19_L
MS_\ 9*_"W_IJLZ^A:^>O^"4__*+/]F?_ +)7X6_]-5G7T+0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 ?/O_  4L_P"3>_#G_95/
MAO\ ^IOHE%'_  4L_P"3>_#G_95/AO\ ^IOHE% #/^"4_P#RBS_9G_[)7X6_
M]-5G7T+7SU_P2G_Y19_LS_\ 9*_"W_IJLZ^A: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/EE\J,B-,1@ >G44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^??^"EG_ ";WX<_[*I\-
M_P#U-]$HH_X*6?\ )O?AS_LJGPW_ /4WT2B@!G_!*?\ Y19_LS_]DK\+?^FJ
MSKZ%KYZ_X)3_ /*+/]F?_LE?A;_TU6=?0M !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !117.^+]'O/$7A34+"QUC4O#M]?6DUK;WUC'
M;JQ:0$+/")HI8O-B)#*)8Y(\J-Z$$B@#HJ*\._X)_?%77OC/^Q7\,/$7BS4%
MOO'6H>$]/'B?,,5M<)KL=N(M3@G@C"""XAO8KF&6'$?E2P2QF.,QD#W&@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKS'XW_M:_"_\
M9A?2U^)WQ&\!_#F37/.;3SXIU^STI=0\H1&;R#-(@E\HRP@XY&X9ZBO.T_;:
MU[QS-CX9_!+XP>,HY,V:ZSKVDQ>"M+L;L_PW,6L/;:K]G3="TL]KI]T-F1'Y
MTT<D- 'TE17A_P ,[#X^:MXZM=;\::I\'=#\*R;VNO"FA:-J.L:B@\HB+R==
MENK:.7,N)CG2H\ &(9/^DGW"@#YPU_\ X*7_  G'Q.USP'X1U#Q%\4/''AMU
M2_T;P)H%YX@.G74L\\,=C?7D$;:?IL\DUM<1$:A<VPBVEY6BC!D ?B-^T?\
M%9=OAOX>_#[X6:+>A6L]2\:^(FUS7-,V8W"YT;2P+2;S&!5/)UO CFBE?YQ)
M:U]'T4 >8_ _X?\ CKPC/J5]XZ^(A\;:SK1@#6MCH$&C:'H0C$H_T&#,]V#*
M"#+]KOKH>8I,?DHWDUZ=110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ%S;7L$^CE5QCR[47FO^85,6\ZA%O$OEQ^5[%0 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M\^_\%+/^3>_#G_95/AO_ .IOHE%'_!2S_DWOPY_V53X;_P#J;Z)10 S_ ()3
M_P#*+/\ 9G_[)7X6_P#359U]"U\]?\$I_P#E%G^S/_V2OPM_Z:K.OH6@ HHH
MH **** "BORY_9L_X..)/VBO^"R6H?LG_P#"G!I']G^*_$?A?_A)QXM^T"0:
M3%?2&?[']C3_ %OV'&WSOW?FGE\?-^HU !117Y<_M)_\''$G[.O_  62T_\
M9/\ ^%.#5_[0\5^'/"__  DY\6_9Q&-6BL9!/]C^QO\ ZK[=C;YW[SRARF?E
M /U&HKS']K/XXM^S#^R]\1/B8FE_\)!)\._"VI^*3I[W7V;^T%L[.6X,'G>6
M_D^8(L;A&0">AZ'\3_\ B.<_ZM=_\R1_]ZZ /W^HK\ ?^(YS_JUW_P R1_\
M>NC_ (CG/^K7?_,D?_>N@#]_J*^<O^"7_P"W.W_!2?\ 84\'_&L>&U\&_P#"
M:/?_ /$G_M7^TOL'V6^GL_\ 7&*($G[/YO\ JQC=WZU]&T %%?GG_P %M?\
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M31=8M8=0L+^QNEN+:^MY0)89X98\B6*0'((.&![@\@'245^6W_!9[_@X[?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI:>$_P!FW08-0U%=%U*\\1W]U9"Y=;6]NK=-,BAF:$':9(UN+@(V/E$\N/\
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MLM&\>^'[[0;^XM& N4M[RWEAE,.\.!*%E.,J>O?&* /G7_@AK_P44;_@I?\
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M(U+]SY<8&+R&Y'[M!'Q^[S'@GQ7_ (.0?VOK']DG_@DI\4'F_L_^W/B):?\
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M6J />75R"EAHMHI7SKVZFVGR8(NI(!9B5C02221QO_7+_P $JO\ @E+\//\
M@D_^SU#X-\#PMJ6N:L8KSQ/XHO+0+J/B&Y"G!(_Y9019;RH 2(@3GS)9)99
M _X)5?\ !*7X>?\ !)_]GJ'P;X'A;4M<U8Q7GB?Q1>6@74?$-R%."1_RR@BR
MWE0 D1 G/F2R2RR?5]?EO^V[_P '$.A?!W_@I'\'_P!F;X3VOAGQIK^N>/=*
M\,?$'6;DRW&F^'HKJ\BM9=/MO+D3S;^/S<R2$F*W*>48Y)#+';_<W[;/QFUC
M]FC]C+XN^/O#W]GWVO?#[P7JWB&QMKM=\!N+6QFGB$RQE"8B8@",@D9P1@4
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M6OUZ_P""4_\ RBS_ &9_^R5^%O\ TU6=?D+_ ,'S/W/V6_IXK_\ <+7Z]?\
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M_LE?A;_TU6= 'X"_\$U_^5R/Q'_V5;XC?^DVN5_3_7\D/@3]L[PK_P $^?\
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MQ796XM;BW@NI8O(TR(R#,\4\4#WTC0L$4Q7]M)^\RGE@'R1_P1:_X(Z?M/\
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MEK9JB/<B)8H[.WD\L3-9VPW>69\DR37$NR+SO*3[>H _G+_X-/O%>K_L5_\
M!5K]H3]FGQ)J?A%;NZM;NPNKI;EE;4-9\/W\D BL3*8S-&T-QJ$Q4Q>:8[<2
M8C6.0'I/^"(^DW/_  4W_P"#D'X\?M.?VMJGB/P?\.KS4[CP_K=HEO8+=)=>
M;I.C03VLD:3&)M&BN3D1QR"2VC,K[V(D^??^"[TNJ_\ !+3_ (+W^-?B9X;L
M]/T^3XB>"K[6]!_X1Z];3;K2KG5M$O="FOS+'%^ZO(]16ZO28CF0[3YL;R$I
M^E'_  :%?LU2?"/_ ()2-XZN+/PY_:7Q;\5WVHVM_:1G^T#IUJ1IT<%S(8NL
M5Q;ZC+'%F2,"YR"KRR  'ZU5_/;X6TF__P""5O\ P=^3V]YJFH>&_ _[1%Y<
MW NKJ.'43K8U]9)8H<11&2"(^(81"F1%(D< WR&(R2R?T)5^%O\ P>9?![5O
M"7@_]GOX_>%/[-\-ZYX+U^?07UNR+6VO+<2J-0TWR9HADQ6S6-]("9!Y4EP#
M&#YDA !X?_P4 9?^"H'_  =N> _AK'_P@/B3PO\ #_5](T-ENA]IL=0T[2HF
MUO5K.Z \V.6<2'4K3RB@CRJQR!2))*_I"K^=[_@UK\/_ /#:W_!8']I7]IJ]
M\/\ A_3[-?M^HVNFW4GV[4-!U'Q!J<T\)MI3"!^[M[:^@DG BD*S@!"DLH7]
MT?VI_P!I/PW^QY^SYXQ^*GC:^%CX7\$:1/J-^%DB2XO#%S%! 998XS/-+B&*
M(N/,DGB3()Q0!_/[_P '1WQFUC_@H!_P5[^%G[+/AN.QT^\\&7EEH-M?ZNOV
M=#K/B$V$AS-$9";..$Z?_P LA*)/M7$H\JN_\+?\&]G_  4O\!^%M.T/P]^U
M[INCZ)HMK!86%CIWQ3\4VUK8V\(\J*&&*.S"QQ1@8"@!0!TXKS[_ (-+OA+K
M'[8W_!4#XK?M&^.'T_Q%K7@^VGO[F[;-K=#7=>FN,WJPPA(/*^SQ:G&ZD;(S
M<Q;(CC=%_2I0!_._\2_^#;[_ (*._&3PA>>&/''[57ACQGX;U$Q->:/K_P 2
M/$^I:?>>7,LL8DBFLFC;$J*PR,@@$<UO?\&4W[;NUOBI^SO>::>_Q$TB\M;7
MD_\ 'GI][#/)YO\ V#S$!%_S\EY/]6M?T!5_+_\ \%6I%_X(S_\ !S)H/QDT
MG_B4^&?$NIV/Q(N;32O^)CJ#:?J#36>O0E;O]V+BZECU;8JR>7&MU$8Y(< 1
M 'T#_P 'S/W/V6_IXK_]PM?KU_P2G_Y19_LS_P#9*_"W_IJLZ_&W_@]5\;:/
M\0O"/[)FN:!J&FZMHNL6GB6_L;VQNEN;6_MIET62*>*5"1)&ZG(8<$<CKFO0
M_P!B3_@[8_9M_9H_8]^$/P[U_P %_&K4M<\ >"M(\/WMY8Z/IDENUQ:V4-O+
MY)DOXV\LM$<$JI(QQ0!^ZE%?C[_Q&H?LM?\ 0A_M ?\ @DTG_P"6E?<W_!,C
M_@IKX _X*P_ #4_B+\.=+\5:3I.C:Y/H%U:^(;6"WNI+J.""=N(9IU\G;=I@
M[LYSP,<@'\[_ /P73^!8_:A_X.=_$OPSDU-O#Z_$3Q1X-\,#41:?:CIQO-)T
MBW$QBWH)=GF@E=ZY QN'!K^BO]F[_@F;\'_V6/V,[_\ 9Z\.^&\?#?6=*N[#
M6X[FX*WWB$W4'V>\N+F>+RY6GFB/,L93RQA(Q%'%%''^"/\ P4H_Y7(_#G_9
M5OAS_P"DVAU_3_0!_*+\;OAI\0/^#6/_ (+':9XJ\)Z?XC\3?#EQ*^@W.K7!
ML[?QSHLT,0N[">:V/EF:VED7[T?$T%I<FV\N2)#_ $U?LL?M)^&_VP_V?/!W
MQ4\$WPOO"_C?2(-1L TD3W%F9>98)S%+)&)X9<PRQ!SY<D$J9)&*\?\ ^"OW
M_!-W1_\ @J=^Q3XA^&NJ/]EUNU#:SX-O/MDMO!8:W%#-':33F..3,!\UHI08
MI/W4\I0"01R1_A]_P00_X*4>,O\ @B]^V=KG[+OQ]L=.\"^!=>UZ7^VCX@ M
M7\'ZZ;:(0WIGB$@EL[D0VD1D8_9Q&T%RDL<0F,P!_3C1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX\URSMA9VU_XB\,V.I7 MUS((A)-$Y$0,IX'3<?6N9_X=0_LM?\ 1M?P#_\
M#<Z3_P#(U?0U% 'SS_PZA_9:_P"C:_@'_P"&YTG_ .1JF\)?\$S/V<?!'C/3
M]:\/_ /X+:'K6CW<-[9WUCX%TRVNK&ZB82PS0RQP@Q2QL P88.0#[U] 44 >
M/^(_V'O@OXV^-4?Q$U;X5?##5/B)'=P7P\2W7AJRN-:2YM?)$%P+IHS*)8A#
M!L((,>P8["O8*** "BBB@#Q_X.?L4?!?]FOQFVN?#_X3_#'P'KEY;&SN;_P[
MX9L=-N#;MB0Q&2&)"8B8AP>NT>E'AS]A[X+^"?C5)\1-)^%7PPTOXB27<]\?
M$MKX:LK?6GN;KSA/<&Z6,2F6433[R23)O.>XKV"B@ HHHH ^?_%O_!,S]G'Q
MOXSU#6O$'P#^"VN:UK%W->WE]?>!=,N;J^NI6,LTTTLD),LLC$L6.3DD^]?0
M%%% !1110 4444 %%%% 'F/QO_9*^%_[3SZ6WQ.^'/@/XC2:'YRZ>/%.@6>J
MKI_FB(3>0)HW$7F&*$G')VCT%=5X*\%Z1\.O".FZ)X?T[3M+T71[6'3["PL;
M5;>VL;>("*&"&*/ BBC P !A0.P''244 %>/_&/]BCX+_M*>,UUSX@?"?X8^
M/-<L[86=M?\ B+PS8ZE<"W7,@B$DT3D1 RG@=-Q]:]@HH **** /,?C?^R5\
M+_VGGTMOB=\.? ?Q&DT/SET\>*= L]573_-$0F\@31N(O,,4)..3M'H*ZKP5
MX+TCX=>$=-T3P_IVG:7HNCVL.GV%A8VJV]M8V\0$4,$,4>!%%&!@ #"@=@..
MDHH ^?\ Q;_P3,_9Q\;^,]0UKQ!\ _@MKFM:Q=S7MY?7W@73+FZOKJ5C+---
M+)"3++(Q+%CDY)/O4/\ PZA_9:_Z-K^ ?_AN=)_^1J^AJ* /GG_AU#^RU_T;
M7\ __#<Z3_\ (U=-\'/V*/@O^S7XS;7/A_\ "?X8^ ]<O+8V=S?^'?#-CIMP
M;=L2&(R0Q(3$3$.#UVCTKV"B@ HHHH \2^)'_!/CX"?&OQG?>(_&GP5^$'C+
MQ3>"/[=K&O\ A'3M2O[SRXEBC\Z::$R$B-$ !X 4 <#%8W_#J']EK_HVOX!_
M^&YTG_Y&KZ&HH \2^&__  3X^ GP4\9V/B/P7\%?A!X-\4V8D^PZQH'A'3M-
MO[/S(FBD\F:&$2 F-W! X(8@\'%>VT44 %<;\6OA#X3^.'@74O#7CCPYX<\7
M^';_ ,DW>E:Y9Q:A8WABE$L1E@E!C)$RAAD'E1Z#'944 ? OBK_@VJ_8E\<>
M+-2U:Z^ ND0W6I7=Q>7$=CXCUK3[57E8M^Y@ANHX88@3Q%%&(XP0J   5[Y^
MR'_P38^!'["VGI#\*/A9X7\&7L<,^G?VO:VGVC6+RVEF^T2P3ZC+ONYH?-Q@
M2R''DQ  "./'OU% !7C_ (C_ &'O@OXV^-4?Q$U;X5?##5/B)'=P7P\2W7AJ
MRN-:2YM?)$%P+IHS*)8A#!L((,>P8["O8** "BBB@ KQ_P"#G[%'P7_9K\9M
MKGP_^$_PQ\!ZY>6QL[F_\.^&;'3;@V[8D,1DAB0F(F(<'KM'I7L%% 'C_AS]
MA[X+^"?C5)\1-)^%7PPTOXB27<]\?$MKX:LK?6GN;KSA/<&Z6,2F6433[R23
M)O.>XKV"BB@ KQ_XQ_L4?!?]I3QFNN?$#X3_  Q\>:Y9VPL[:_\ $7AFQU*X
M%NN9!$))HG(B!E/ Z;CZU[!10!Y_X8_9S^'_ (1^$;?#W1O!OA72_A[):W%B
M_ABSTB"WT9K:X,WGPFS">3Y4WGS&0;<2;FSG<:\Y_P"'4/[+7_1M?P#_ /#<
MZ3_\C5]#44 ?//\ PZA_9:_Z-K^ ?_AN=)_^1J]4^$OPA\)_ _P+IOAKP/X<
M\.>$/#MAYQM-*T.SBT^QLS+*993%!$!&"9F+' '+'U.>RHH **** /'_ (Q_
ML4?!?]I3QFNN?$#X3_#'QYKEG;"SMK_Q%X9L=2N!;KF01"2:)R(@93P.FX^M
M=YX*\%Z1\.O".FZ)X?T[3M+T71[6'3["PL;5;>VL;>("*&"&*/ BBC P !A0
M.P''244 %<;\6OA#X3^.'@74O#7CCPYX<\7^';_R3=Z5KEG%J%C>&*42Q&6"
M4&,D3*&&0>5'H,=E10!YC\$/V2OA?^S"^J-\,?ASX#^',FN>2NH#PMH%GI2Z
MAY0E$/GB&-!+Y9EF(SR-Q]36Y\6OA#X3^.'@74O#7CCPYX<\7^';_P DW>E:
MY9Q:A8WABE$L1E@E!C)$RAAD'E1Z#'944 >?_ []GCX>?LY^$YM'^'?@GPGX
M(T6ZNC>7.GZ!HT&EVKW&%C,YBAC1?,Q$HSC/'TKT"BB@ KS'XW_LE?"_]IY]
M+;XG?#GP'\1I-#\Y=/'BG0+/55T_S1$)O($T;B+S#%"3CD[1Z"O3J* /'_B/
M^Q1\&OB[X1\,:#XL^$_PQ\3:#X+LSIWAJPU?PU9:A:Z);;88O)MH98B((L0P
M+MBVC$,78"N9_P"'4/[+7_1M?P#_ /#<Z3_\C5]#44 ?//\ PZA_9:_Z-K^
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M$JG&<\_2O0* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8#/)VG'0T >G4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9DL[?5KN&\T.\N_._<6,%\ACD:>:+:8Q+;1 R9B0R2&(2_J50 4444 %%%%
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M8W#@U]??\0,?_5T7_F-__OI7S]_P4H_Y7(_#G_95OAS_ .DVAU_3_0!^ /\
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MV:_VJO\ @U+_ &C+'Q=\.?&2>)/AMXT-E:/KC:-C1?$$\/[]M,U&SD>3[/<
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M]-N-2T^^^+NOM=W[BUA:UO-,TH0SRV[229DBE^VSZ=,AB'(MY09!GRY/IO\
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M?\HL_P!IC_LE?BG_ --5Y7Y8?\&DG_!8&]^*/AE_V6OB'JVI:AX@\,VTVH>
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M_-J7QL\*^?K<5];Z/#9V^N:'YMO'YC>2!#]HAGF6%@(H@8FMR@DD%S(/9?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7OA'X!ZSXH:U^+7CC2SK>BZ#_8UZW]H6L:W3--YPB,,6!97!Q+*#B'W&>_\
MC#\5M#^"'PH\2>-?$^H?V?X=\&Z7/K6KW@M);C[%;6T)FGE\J(&4XA#' !.!
MT/0@'8T5Y?\ LO?M0^!?VQ_@9H/Q*^&>O_\ "1>"?$?VC[!?_89K3[=Y,\L$
MO[J:..4$30S#F,9P2!BCX@_M0^!_A3\:OA_\,O$'B)M/\;_%K^U/^$7L?L=S
M-_:1T^ 7%Y^^BC,47E0L"?-DCST3)XH ]0HHHH **** "BBB@ HHHH ^??\
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M%>(+;QM)<BU-M)'!IGDPZ%92D"XA^US?9+:2:(RCS([>_,3@QK@ _ISHHHH
M_F _X)K_ /*Y'XC_ .RK?$;_ -)M<K^G^OY@/^":_P#RN1^(_P#LJWQ&_P#2
M;7*_I_H **** "BBB@#^8'_@RL_Y2E_$#_LE.H_^G?1Z_I^K^8'_ (,K/^4I
M?Q _[)3J/_IWT>OZ?J /RV_X*G_\&S_A7_@IY^U_IWQ7UOXS>/O#K,;:RUS1
M&M8=3M5TZ$0*MOI+,T?]F@_Z5*YD6Z7SKII/+ZB3]!?V>OV>?!?[+?P:\,^
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M9SSQ]??\0,?_ %=%_P"8W_\ OI7OG_!E9_RBT\??]E5U#_TTZ/7[!4 ?GO\
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M@9  #22&..*22, _GR_X*4?\KD?AS_LJWPY_])M#K]??^#HW_E!;\<OIH/\
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M?P:\,^ ? /AK2_#/@_PM:?8K#3[3Y=F.=S=3++(29)))"7DD8NY+DFOYP_\
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ME;Z'X*O/^$&^TM<M-:V,\,LUUK^J+:3FW02P!98G57+70TJ(I+)YD0'[V?\
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M_P#\$U_VU?#G[6/PG\S2] \5>)K?6IKVXO(;NZT3QJ+B?43,MO+&0T$WD_:
M#YT8E6X0B*(V\5?IIX=_X*1:+_P5-_X-V_CI\2=)C:U\06OPK\2:-XQM!9S6
MUO8:U%H<LMW# )))-T)\Y98F$LG[J>(.1()(T^W/VI_V;?#?[8?[/GC'X5^-
MK'[=X7\;Z1/IU^5CB>XLS+Q%/ )8I(Q/#+B:*4H?+D@B?!(S7\H/QATKXM?\
M&^O[7GQR^"%UJVH:_P"$_B%X,U3PK?B".73M-\8Z;J6F7,&GZD(YHY!YEK-<
M%B8MVV6WO+9+@H\KL ?H?_P8S?<_:D^GA3_W-5^_]?@!_P &,WW/VI/IX4_]
MS5?O_0 5YW^T+^SSX+_:D^#7B;P#X^\-:7XF\'^*;3[%?Z?=_-OSSN7H8I8R
M!)')&0\<BAT(< UZ)7\W?[3/[>?Q:_X)+?\ !R??1?%#XL?&#Q!\#;GQ4VMG
M2M4UG5+?15T36H929K>SS/%<6^ES7<JHL,9$DNF%4$3\1@'T9^TQ_P &6GPC
M^(GBD:A\*OBSXL^&]E=74]Q=:?JNEIXEM81(P:&"T/FVTL440W+F>6YDD5H\
MN&!:3\^_V@/^""W[;W_!'[P)J?Q>\+^(ICI]AI$__"1ZQ\+/%M];ZAH>G1RV
M[-]J79;3RP$A93Y(E2-;5I9?+2,$_P!3'@KQII'Q%\(Z;K?A_4=.U31=8M8=
M0L+^QNEN+:^MY0)89X98\B6*0'((.&![@\GC7QII'PZ\(ZEK?B#4=.TO1='M
M9M0O[^^NEM[:QMX@99IYI9,"**,#)).% [ < 'Y-_P#!O!_P<0:U_P %'?&M
MY\&?C19^%].^)5CH_P#:&AZ]9"*PM_%D-M%$MQ#-;M)Q?CY[HBU41/$LY$5N
MMM^]F_X/4_\ E%IX!_[*KI__ *:=8K\]/^"%?@[1_CI_P<X:KXL^$.GZ7+\,
M_#OB#QCXGM?L=FNFVVG^'YH[^SLS!:OY;+$3?6$8B$8DC$P_=A8Y"/T+_P"#
MU/\ Y1:> ?\ LJNG_P#IIUB@#\__ /@E]_P:J?\ #R/]A/P3\;!\>1X-7Q@;
MX?V,/!7]I?8OLM_<69S/]OBW;O(+_P"K& P'.,GZ$_X@8_\ JZ+_ ,QO_P#?
M2OOS_@UR_P"4%OP-^FO?^I#J=?H%0!_+[_P5!_X-5/\ AVY^PGXV^-A^/(\9
M+X/-B/[&/@K^S?MOVJ_M[,8G^WR[=OGA_P#5G(4CC.1^@'_!E9_RBT\??]E5
MU#_TTZ/7T!_P=&_\H+?CE]-!_P#4ATROG_\ X,K/^46GC[_LJNH?^FG1Z /@
M/_@]3_Y2E_#_ /[)3IW_ *=]8KZ _P"(&/\ ZNB_\QO_ /?2OG__ (/4_P#E
M*7\/_P#LE.G?^G?6*_I^H _ '_B!C_ZNB_\ ,;__ 'TKZU_X(P_\&XC_ /!(
M#]I_7OB9#\9E^(G]N>%KGPP=._X1$Z48?-O+2X$PE^UW&<&TV[3'CY\YXK]2
M:* /S]_X.C?^4%OQR^F@_P#J0Z97S_\ \&5G_*+3Q]_V574/_33H]?0'_!T;
M_P H+?CE]-!_]2'3*^?_ /@RL_Y1:>/O^RJZA_Z:='H _8*BBB@#^8'_ (/4
M_P#E*7\/_P#LE.G?^G?6*_I^K^8'_@]3_P"4I?P__P"R4Z=_Z=]8K^GZ@ HH
MHH ***^8_P#@K;\._B#\5/\ @FI\8M-^&/BCQ=X0^(5KX=.KZ'>^%?/.M2W5
MC(+S[#;?9I4E\V[^SFTS'S_I)^63_5D YW_@I?\ \$8O@3_P57T[3KCXG^'=
M2T_Q9H]K]@T[Q/H5W]FUNPM1,)C!G#PS1DYPL\4PC%Q,8Q&\A>OR:_:6_P"#
M)?Q/IL]Y<_!_XV>'=5^T:J_V/2?&>ESZ;]CT\F4KOO;7SS//'^X4D6L*29DD
M_=[1&?7/^#2__@K=>_'72?&WP5^+GQ&\2>)_B4VJ_P#"3^%;OQ/XFN=2U#Q!
M:M;".[L;<W.1_HOD"?RO-)<7,TB1 02R5^X] '\F5O\ '']N'_@V;^/.A^'=
M>U+4'\+BVU2UT/0-5U.?6? /B"U\]O-GM8HYD\F43LEQA?L]T@FB,J!+AHY/
MZ/?^"9W_  4#\,_\%-OV//#7Q<\(6']D+K7G66L:.U[#=W/A_486(GMYS$<X
MSB6,D1R217$$ABC\W ^1/^#M/XH_#_P[_P $E/$7AKQ=J'AK_A,O%FIV)\#Z
M?=P+/J+7EK?6\EU/:\$P^59&YBEF&!BZ$1?,R1R87_!GG\-M:\ ?\$BM4UC5
M+&6UL_&'CO5-=T9_M$3?;;6.WL[ S+CF/_2+*YBVRX)\DM]Q@2 ?E3_P78_X
M3C_B)Z\3?\*PW?\ "R/^$I\&?\(GG[/G^UO[*T?[%G[5^X_X^/*_U_[O^_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:?8FM988)?(BAM;J>:**XD:&266**,2*/+,J2B2O5_\ @DW_ ,%X?!G_  5
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MG_!1?_@GY-I?B?Q9\0O'_P 2_B_!?^-_%?B.^,UUKUY%J?AXDK%TBC,T]U,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO;^TG_P7U_X)_P#PA\/JUGXF\$ZK/\0[VYO@5L)--CNX+ORH6C#R&?R_#]Z
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MR\._M[>/?!_BKXGZK/K7BB]\,^$Y]$&MW4LLTWG31V>JQ1DB2XN"H VQF8A
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M3_[/\.^#=+@T72+,W<MQ]BMK:$0P1>;*3*<0A1DDG ZGJ>QH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^??^"EG_)O?AS_L
MJGPW_P#4WT2BC_@I9_R;WX<_[*I\-_\ U-]$HH 9_P $I_\ E%G^S/\ ]DK\
M+?\ IJLZ^A:^>O\ @E/_ ,HL_P!F?_LE?A;_ --5G7T+0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?/O\ P4L_
MY-[\.?\ 95/AO_ZF^B44?\%+/^3>_#G_ &53X;_^IOHE% '\ZOP"_P"#LW]H
M[]F7]G3P+\/]#\'?!>^T7P-HMEX<T^74-(U-KF2VL[:"&%I6BU"-6DVQKE@J
M@G/ KK/^(U+]J;_H0_@#_P""35__ )9T44 '_$:E^U-_T(?P!_\ !)J__P L
MZ/\ B-2_:F_Z$/X _P#@DU?_ .6=%% '[G_\$8OVT?%'_!1'_@F]X#^,?C;3
M_#VE^)O%CZFEW;:';2V]C&+;4KJTC\M9)))5/E1+G,AY)(QT'UC110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'XX_P#!
MPC_P<!?&;_@D[^UWX5\#_#GPW\,]8TC7O"D.MW$GB+3;VXN%G>ZN(B%>"[A
M3;"G!!Y)YZ ?!O\ Q&I?M3?]"'\ ?_!)J_\ \LZ** #_ (C4OVIO^A#^ /\
MX)-7_P#EG1_Q&I?M3?\ 0A_ '_P2:O\ _+.BB@ _XC4OVIO^A#^ /_@DU?\
M^6='_$:E^U-_T(?P!_\ !)J__P LZ** #_B-2_:F_P"A#^ /_@DU?_Y9T?\
M$:E^U-_T(?P!_P#!)J__ ,LZ** #_B-2_:F_Z$/X _\ @DU?_P"6='_$:E^U
M-_T(?P!_\$FK_P#RSHHH /\ B-2_:F_Z$/X _P#@DU?_ .6='_$:E^U-_P!"
M'\ ?_!)J_P#\LZ** #_B-2_:F_Z$/X _^"35_P#Y9T?\1J7[4W_0A_ '_P $
MFK__ "SHHH /^(U+]J;_ *$/X _^"35__EG1_P 1J7[4W_0A_ '_ ,$FK_\
MRSHHH /^(U+]J;_H0_@#_P""35__ )9T?\1J7[4W_0A_ '_P2:O_ /+.BB@
M_P"(U+]J;_H0_@#_ ."35_\ Y9T?\1J7[4W_ $(?P!_\$FK_ /RSHHH /^(U
M+]J;_H0_@#_X)-7_ /EG1_Q&I?M3?]"'\ ?_  2:O_\ +.BB@ _XC4OVIO\
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M-7_^6='_ !&I?M3?]"'\ ?\ P2:O_P#+.BB@ _XC4OVIO^A#^ /_ ()-7_\
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MM3?]"'\ ?_!)J_\ \LZ** #_ (C4OVIO^A#^ /\ X)-7_P#EG1_Q&I?M3?\
M0A_ '_P2:O\ _+.BB@ _XC4OVIO^A#^ /_@DU?\ ^6='_$:E^U-_T(?P!_\
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M"'\ ?_!)J_\ \LZ** #_ (C4OVIO^A#^ /\ X)-7_P#EG1_Q&I?M3?\ 0A_
M'_P2:O\ _+.BB@ _XC4OVIO^A#^ /_@DU?\ ^6='_$:E^U-_T(?P!_\ !)J_
M_P LZ** #_B-2_:F_P"A#^ /_@DU?_Y9T?\ $:E^U-_T(?P!_P#!)J__ ,LZ
M** #_B-2_:F_Z$/X _\ @DU?_P"6='_$:E^U-_T(?P!_\$FK_P#RSHHH /\
MB-2_:F_Z$/X _P#@DU?_ .6='_$:E^U-_P!"'\ ?_!)J_P#\LZ** #_B-2_:
MF_Z$/X _^"35_P#Y9T?\1J7[4W_0A_ '_P $FK__ "SHHH /^(U+]J;_ *$/
MX _^"35__EG1_P 1J7[4W_0A_ '_ ,$FK_\ RSHHH /^(U+]J;_H0_@#_P""
M35__ )9T?\1J7[4W_0A_ '_P2:O_ /+.BB@ _P"(U+]J;_H0_@#_ ."35_\
MY9T?\1J7[4W_ $(?P!_\$FK_ /RSHHH /^(U+]J;_H0_@#_X)-7_ /EG1_Q&
MI?M3?]"'\ ?_  2:O_\ +.BB@ _XC4OVIO\ H0_@#_X)-7_^6='_ !&I?M3?
M]"'\ ?\ P2:O_P#+.BB@ _XC4OVIO^A#^ /_ ()-7_\ EG1_Q&I?M3?]"'\
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MJ_\ \LZ** #_ (C4OVIO^A#^ /\ X)-7_P#EG1_Q&I?M3?\ 0A_ '_P2:O\
M_+.BB@ _XC4OVIO^A#^ /_@DU?\ ^6='_$:E^U-_T(?P!_\ !)J__P LZ**
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M\ ?_  2:O_\ +.BB@ _XC4OVIO\ H0_@#_X)-7_^6='_ !&I?M3?]"'\ ?\
MP2:O_P#+.BB@ _XC4OVIO^A#^ /_ ()-7_\ EG1_Q&I?M3?]"'\ ?_!)J_\
M\LZ** #_ (C4OVIO^A#^ /\ X)-7_P#EG1_Q&I?M3?\ 0A_ '_P2:O\ _+.B
MB@ _XC4OVIO^A#^ /_@DU?\ ^6='_$:E^U-_T(?P!_\ !)J__P LZ** #_B-
M2_:F_P"A#^ /_@DU?_Y9T?\ $:E^U-_T(?P!_P#!)J__ ,LZ** #_B-2_:F_
MZ$/X _\ @DU?_P"6='_$:E^U-_T(?P!_\$FK_P#RSHHH /\ B-2_:F_Z$/X
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/O[R%,YC(()'?(*** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>image_30a.jpg
<TEXT>
begin 644 image_30a.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0 Z17AI9@  34T *@    @  U$0  $
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M1T__ .,U['10!XY_P[V^ _\ T1'X1?\ A(Z?_P#&:/\ AWM\!_\ HB/PB_\
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MO@/_ -$1^$7_ (2.G_\ QFC_ (=[? ?_ *(C\(O_  D=/_\ C->QT4 >.?\
M#O;X#_\ 1$?A%_X2.G__ !FC_AWM\!_^B(_"+_PD=/\ _C->QT4 >.?\.]O@
M/_T1'X1?^$CI_P#\9H_X=[? ?_HB/PB_\)'3_P#XS7L=% 'CG_#O;X#_ /1$
M?A%_X2.G_P#QFC_AWM\!_P#HB/PB_P#"1T__ .,U['10!XY_P[V^ _\ T1'X
M1?\ A(Z?_P#&:/\ AWM\!_\ HB/PB_\ "1T__P",U['10!XY_P .]O@/_P!$
M1^$7_A(Z?_\ &:/^'>WP'_Z(C\(O_"1T_P#^,U['10!XY_P[V^ __1$?A%_X
M2.G_ /QFC_AWM\!_^B(_"+_PD=/_ /C->QT4 >.?\.]O@/\ ]$1^$7_A(Z?_
M /&:/^'>WP'_ .B(_"+_ ,)'3_\ XS7L=% 'CG_#O;X#_P#1$?A%_P"$CI__
M ,9H_P"'>WP'_P"B(_"+_P )'3__ (S7L=% 'CG_  [V^ __ $1'X1?^$CI_
M_P 9H_X=[? ?_HB/PB_\)'3_ /XS7L=% 'CG_#O;X#_]$1^$7_A(Z?\ _&:/
M^'>WP'_Z(C\(O_"1T_\ ^,U['10!XY_P[V^ _P#T1'X1?^$CI_\ \9H_X=[?
M ?\ Z(C\(O\ PD=/_P#C->QT4 >.?\.]O@/_ -$1^$7_ (2.G_\ QFC_ (=[
M? ?_ *(C\(O_  D=/_\ C->QT4 >.?\ #O;X#_\ 1$?A%_X2.G__ !FC_AWM
M\!_^B(_"+_PD=/\ _C->QT4 >.?\.]O@/_T1'X1?^$CI_P#\9H_X=[? ?_HB
M/PB_\)'3_P#XS7L=% 'CG_#O;X#_ /1$?A%_X2.G_P#QFC_AWM\!_P#HB/PB
M_P#"1T__ .,U['10!XY_P[V^ _\ T1'X1?\ A(Z?_P#&:/\ AWM\!_\ HB/P
MB_\ "1T__P",U['10!XY_P .]O@/_P!$1^$7_A(Z?_\ &:/^'>WP'_Z(C\(O
M_"1T_P#^,U['10!XY_P[V^ __1$?A%_X2.G_ /QFC_AWM\!_^B(_"+_PD=/_
M /C->QT4 >.?\.]O@/\ ]$1^$7_A(Z?_ /&:/^'>WP'_ .B(_"+_ ,)'3_\
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M /1$?A%_X2.G_P#QFC_AWM\!_P#HB/PB_P#"1T__ .,U['10!XY_P[V^ _\
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M$CI__P 9H_X=[? ?_HB/PB_\)'3_ /XS7L=% 'CG_#O;X#_]$1^$7_A(Z?\
M_&:/^'>WP'_Z(C\(O_"1T_\ ^,U['10!XY_P[V^ _P#T1'X1?^$CI_\ \9H_
MX=[? ?\ Z(C\(O\ PD=/_P#C->QT4 >.?\.]O@/_ -$1^$7_ (2.G_\ QFC_
M (=[? ?_ *(C\(O_  D=/_\ C->QT4 >.?\ #O;X#_\ 1$?A%_X2.G__ !FC
M_AWM\!_^B(_"+_PD=/\ _C->QT4 >.?\.]O@/_T1'X1?^$CI_P#\9H_X=[?
M?_HB/PB_\)'3_P#XS7L=% 'CG_#O;X#_ /1$?A%_X2.G_P#QFC_AWM\!_P#H
MB/PB_P#"1T__ .,U['10!XY_P[V^ _\ T1'X1?\ A(Z?_P#&:/\ AWM\!_\
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MT4 >.?\ #O;X#_\ 1$?A%_X2.G__ !FC_AWM\!_^B(_"+_PD=/\ _C->QT4
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MZ?\ _&:/^'>WP'_Z(C\(O_"1T_\ ^,U['10!XY_P[V^ _P#T1'X1?^$CI_\
M\9H_X=[? ?\ Z(C\(O\ PD=/_P#C->QT4 >.?\.]O@/_ -$1^$7_ (2.G_\
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M)'3_ /XS7L=% 'CG_#O;X#_]$1^$7_A(Z?\ _&:/^'>WP'_Z(C\(O_"1T_\
M^,U['10!XY_P[V^ _P#T1'X1?^$CI_\ \9H_X=[? ?\ Z(C\(O\ PD=/_P#C
M->QT4 >.?\.]O@/_ -$1^$7_ (2.G_\ QFC_ (=[? ?_ *(C\(O_  D=/_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "FS?ZMO]TTZFS?ZMO]TT ?AW_P<M?\GU^$
M_P#L0[3_ -.&HT4?\'+7_)]?A/\ [$.T_P#3AJ-% 'ZR_P#!/O\ Y,2^"/\
MV(&A?^FZWKV&O'O^"??_ "8E\$?^Q T+_P!-UO7L- !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "FS?ZMO]TTZFS?ZMO\ =- 'X=_\'+7_ "?7X3_[
M$.T_].&HT4?\'+7_ "?7X3_[$.T_].&HT4 ?K+_P3[_Y,2^"/_8@:%_Z;K>O
M8:\>_P""??\ R8E\$?\ L0-"_P#3=;U[#0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4V;_5M_NFG4V;_5M_NF@#\._^#EK_ )/K\)_]B':?
M^G#4:*/^#EK_ )/K\)_]B':?^G#4:* /UE_X)]_\F)?!'_L0-"_]-UO7L->/
M?\$^_P#DQ+X(_P#8@:%_Z;K>O8: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %-F_U;?[IIU-F_P!6W^Z: /P[_P"#EK_D^OPG_P!B':?^G#4:*/\ @Y:_
MY/K\)_\ 8AVG_IPU&B@#]9?^"??_ "8E\$?^Q T+_P!-UO7L->/?\$^_^3$O
M@C_V(&A?^FZWKV&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M ILW^K;_ '33J;-_JV_W30!^'?\ P<M?\GU^$_\ L0[3_P!.&HT4?\'+7_)]
M?A/_ +$.T_\ 3AJ-% 'ZR_\ !/O_ ),2^"/_ &(&A?\ INMZ]AKQ[_@GW_R8
ME\$?^Q T+_TW6]>PT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %-F_U;?[IIU-F_U;?[IH _#O\ X.6O^3Z_"?\ V(=I_P"G#4:*/^#EK_D^
MOPG_ -B':?\ IPU&B@#]9?\ @GW_ ,F)?!'_ +$#0O\ TW6]>PUX]_P3[_Y,
M2^"/_8@:%_Z;K>O8: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%!8 T
M%%%,FF6!-SLJJO4DX H ?131,I/WES]:%<,/7Z4 .HHHH **** "BN:?XEZ-
M:_$G3_"<^J6L/B/5--NM7M-.9OWUQ:6TMO%-.O'*QO=6RMSP9E'.<UTN: "B
MBB@ HHHH **:TRJV-R@XSC/:D\Y<_>7KC\<9_E0 ^B@-FC- !10#FB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC9\3/VJ8]M_>*?*M?AMAF%S+ECNL#\Q[XPN>@ Q0!ZA_P[=^'O\ T,'QX_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !4<OWU_P ]Q4E1R_?7_/<4 ?QY?LK?\I5/@#_V<ZW_ *=]%K^O
M#X;_ /("NO\ L)WW_I5)7\@W[)^M)/\ \%<?@7IJQS"2U_:32Y:0QXC82:UI
M2@!NY'E$D=MR^HK^OGX;_P#("NO^PG??^E4E '0T444 %%%% !1110 4444
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MT ??]%?G_P#\11W["G_1<O\ RS/$/_R!3C_P=%?L*JH)^.7#=/\ BC/$'/\
MY(4 ??U%? (_X.B?V%65F'QRX7K_ ,49X@X_\D:3_B*-_83/_-<O_+,\0?\
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M_B*-_83'_-<O_+,\0?\ R#2_\117["N,_P#"\O;_ )$SQ!_\@T ??U%? /\
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MPK^&_C[5M.^)5]86E[XD\,V>K7%K;C3-*D$"//&S+'YCNVT$+N=CC+&OF?\
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M]T2NF]@ZIN92*\)MO^"KW_!(RT"AK7X*^9'_ !?\*6O"00?4:5C\17I_B?\
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M%XUQDL_A3P?A!ZG_ $O/'?O4&N?LA?"JYT2X_L/]BWX9R:PT1%HFLZ!X:L;
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ME+F[T>., [LE@UK)N&!@%>3DA?[1$^[0 M%%% !1110 4444 %%%% !1110
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M%+8.?FV@G&2!D@?ES_P5^_X)8>)/VJ?VJ[7Q/KWQS\&>,/C5-X?B\/:9X/\
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MXBATVWUJ>T\.> ->\1_9;6YEN(H'E?3[.>.,R26ERH1V5SY+G;C!(!_-L?\
M@VH_;$Q_R;'\+U]QXVY_].U-@_X-IOVQ(8]K?LS_  RF.2=S>-AGDYQQJH''
M3IV[GFOZ-/\ AXW\/_\ H7?CQ_X9#QG_ /*NNK^"7[7'@_\ :"\1ZUI'A^/Q
ME9ZKX>M[6[OK3Q%X-UCPW.D-TUPD$B)J-K TJ.UK<#=&&"F)MV.,@'\STO\
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M()9EC D=$N- 9$+8R54R.54D@%V(^\<_V8I]V@!:*** "BBB@ HHHH ****
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MSNL2R31NRH&DD;:"!N=CC+&OE/\ X+W?\B[^R;_V<QX'_P#1US7WI;_\M/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _*__ (/"?^40DW_8YZ5_*>OCS_@T
ME_Y29?M _P#8FV/_ */MZ^P_^#P7_E$-)G('_"::5DCM\L]?&?\ P:':1:Z!
M_P %(/CY9V5O':VL/@VRV11C:J9N("<#ZDF@#[>_:]_Y2>>$_P#KX@_]3CX9
M5^G-M]Z;_?\ Z"OS&_:]_P"4GGA/_KX@_P#4X^&5?IS;?>F_W_Z"@"6BBB@
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M +'_ -)TKYK_ .#@?_E#-^T%_P!BR?\ THAKZ4_9W_Y(%X'_ .P!8_\ I.E
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M<%C;P2QN$0-;*50.TKN ?LW1110 4444 %%%% !1110 4444 %%%% !1110
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M<M?\GU^$_P#L0[3_ -.&HT4?\'+7_)]?A/\ [$.T_P#3AJ-% 'ZR_P#!/O\
MY,2^"/\ V(&A?^FZWKV&O'O^"??_ "8E\$?^Q T+_P!-UO7L- !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-E^Y0!^?O_!!3[O[:'_9UGC?^=C7Z"5^??\ P04^[^VA_P!G6>-_YV-?H)0
M4444 ? __!>[_D7?V3?^SF/ _P#Z.N:^]+?_ ):?[YKX+_X+W?\ (N_LF_\
M9S'@?_T=<U]Z6_\ RT_WS0!)1110 R=5>-@P!7N#T-?BM_P35<-_P=W_ +7!
M7;M_X02XQCI_K_#U?M/=Q>;;NN=IQP?0^M?@G_P02\?ZI\6_^#C/XS>*M<FC
MNM:\3?!6PU;4)4B6)9;BXB\,2R,$4!5!=V.T  =  * /WQHHHH **** "BBB
M@ HHHH **** "BBJOV[!;<N.>.>H)Z_Y_#- $EW>0Z?:R332QPPQ@N\CL%5
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOKZ80-9 NV6!VH&8*&8KM5F7:\-?M6>'(OVI?%UPND_$QHW\+:%%L'P]U\R
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M27;/"\5]:6<WF^9]S[V>#G\^.#Q0!9HHHH ;,<1-]*_ _P#X-Y/AOXB\.?\
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MGW_R8E\$?^Q T+_TW6]>PUX]_P $^_\ DQ+X(_\ 8@:%_P"FZWKV&@ HHHH
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MGW:_C$_X)2^)K&Y_;5_9$T6.X634M/\ C=:7T\0C?]W%/<:&D;;B IRUO*,
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M'>6LJR(HB+"':"59FY.<*3R : /UP_MCXE?] /P+_P"%%=__ "'1_;'Q*_Z
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MMO4XQTQ_];I^%3444 %%%% !1110 4444 %%%% !1110 45'<S>1$6K/\/\
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MA?\ INMZ]AH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGL1HXM9KV2.>-(K:;[66^WR;HW>WQY" .?,8I['10!Q7[.WP9L_V=/@/X+\
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MWH _H1A_U:_[HIU-A_U:_P"Z*=0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5X_^V%^PM\+/V\_AZ/"OQ6\$Z#XR
MT=0XMVO82+S36?;NDM;A");=SL4%HV4LHP21D'V"B@#^9/\ X*C_ /!I)\3/
M@!=7_BK]GZXO_BMX1C2ZO)]"F6*#7-)AC"ND48,G^GN4+@+$B2LT858F9E!^
M_/\ @S2T:\\._P#!,/Q]I^H6MQ8WUC\5=4M[FVN(S%-;RIINE*Z.C ,K*P*E
M2 000:_6BXT^&Z7$B^8H8,%;)&000<>Q QZ55T;PMIOAV]U*XL-/L;&XUJY6
M\U"6W@6.2^G6&.!996 !D<0PPQAFR0D2+G:J@ &E1110 5GOH%L^N+J'V>'[
M8L?E"<*!*$SG9NQDKGG:3C.#C(!&A10 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!#><0==O(R?09Y-?#<6O^#O@]_P %)O!OB37]6T'P
MRVL>&/B+83:AJ-Y':)=,FO>&'BCS(P5I%4R,J\M@' VKQ]T28V\\?CBOS_\
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M_P"Q T+_ --UO7L->/?\$^_^3$O@C_V(&A?^FZWKV&@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** /RO_X/!@6_X)#2#J?^$TTG ]?EGKXO
M_P"#06[N[[_@HK\>);ZS6QO&\&6?FP).)E3_ $J ## #.5P?;-?:'_!X.?\
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M-FW.RHJJ69E )'35\K_LH:=K7A/XC11_$.WNK.ZNA=Z=\,DO1]HDL="B8/\
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M,OCK_P *"?\ ^*KF?C3\#88?@[XL?_A)?''RZ->-\VO3E>('Z@MR* /Y-?\
M@E3_ ,G4_L;_ /9>U_\ 1WAVO[+4^[7\:'_!*RXC/[6O['=N'C\Z/X\1R/&'
M^9%:?P\%)7J 2C8SUVGT-?V7I]V@!:*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF.Z66-1@'EQG R:[<."Q'<4 +1110 4444 %%%% !7R'X.G\G_@H]X%^7/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *;-_JV_W33J;-_JV_P!TT ?AW_P<M?\ )]?A/_L0[3_T
MX:C11_P<M?\ )]?A/_L0[3_TX:C10!^LO_!/O_DQ+X(_]B!H7_INMZ]AKQ[_
M ()]_P#)B7P1_P"Q T+_ --UO7L- !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[-/_ &2KPO\ ^FBUH ^@**** "OYL/V]O^"37Q8_X*B_MY?'AOAGH^EZM8^
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M _/W_@Z._P"4%?QR_P"X#_ZD&FU]_)_Q\R?1?ZU\ _\ !T=_R@K^.7_<!_\
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M7^N1:EX@V681A=I:HT;+"5+0>4\)W']YO'%?I#_PZW_9E_Z-S^!/_A Z3_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=JML8/\ A'_VE?'.G/)YH;S\WD=SNQM&T8N-NW+<J3D9P #[JHHHH *^!O\
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MBBB@ HHHH **** "BBB@ ILW^K;_ '33J;-_JV_W30!^'?\ P<M?\GU^$_\
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M=_A7\#O#6G^*(?&&B:6GBFWN+ZSLI8K2WO+*ZA:*2YEC4,;F"+(4DLHY '(
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M /IHM:;_ ,%9/^46/[2O_9*_%'_IINJ=_P $G?\ E%G^S3_V2KPO_P"FBUH
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M_9;_ .A^^/W_ (.](_\ E90!X!_Q'-G_ *->_P#,D?\ WKH_XCFS_P!&O?\
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M?\5Z?I[:N^AVM_?V<<<-Y>0SW%K=PA5D:2-K>ZM9H'$J(69-\0EB(D/S9<_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
MV;_5M_NFG4V;_5M_NF@#\._^#EK_ )/K\)_]B':?^G#4:*/^#EK_ )/K\)_]
MB':?^G#4:* /UE_X)]_\F)?!'_L0-"_]-UO7L->/?\$^_P#DQ+X(_P#8@:%_
MZ;K>O8: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _*_\
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M(R^W=M!;;G )XH ^C@<U^?\ _P '1W_*"GXY?]P'_P!2'3*^]M.7; >>,_\
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M_ L'Q%T/X#Z;=6MC?0?\+/FN'M[S3(-2AF6/PMXBD(-O-/!'(0%++F52&56
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M?]D/\/?^FGQ)7TC\?_\ D>_VB/\ LCVF?^C/$M?-WQ]_Y+Q_P4P_[(?X>_\
M33XDKZ2^/_\ R/G[1'_9'M,_]&>): /I*+[[?Y[FI*CB^^W^>YJ2@ HHHH *
M*** "BBO'_VZ;;Q1/^S'KTW@_P 3Z_X,UG3[FPOI-;T73H=2U#3;*&]@DOI8
M;66*9;AA:+<?N1%(\@)5$=V52 >OYW+7Y)?L6#'_  =[?M??]DUTG_TC\-U]
M<:7^QA\=-6TZ&XM?VU/BE-;W"B2*2/P9X0=)%(R&5O[+Y!'((X(Z5B_LV_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,^FZ=<RVMLMY<QP/)% 9A%YSA253<00H8C&X\#KSS0!>E^[^7\Z_AM_X*/\
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MO_DBC^S?B9_T%O G_@INO_DB@#D5_P""D7[.J#CX^?!7_P +?3/_ (]7P_\
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M6^&WC#Q-JG]B?8](T3Q-9:A?W?EZYI\LGEP12L[[(T=VVJ<*K,< $U]O1?\
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ML0R6;X(,<RG;(^0BL=I;:MY_VL_VND4D_L@^&>/^JQ6G_P @4 >(_P#!4/\
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MO^"FO[.K?,RK\3O#1X&21_:MMV'?VK^WVTD\S?C!4G((.<@T 3T444 ?(O\
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M>.VGW$&V9=I51\X.3C!]*HH \U7Q-\7L?\B3\.S_ -SM>?\ RIH_X2;XO?\
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M)\+?_#>ZA_\ +JN:^,G@_P"-4?PA\5-+\0/A?)"NCW9D1? %^K,ODOD G62
M2.Y!QZ'I0!_*!_P2CUQKG]M7]D73?LE\JVGQOM+D7+0%;:4R7.B*41^C2)Y6
M77JJR1D_>%?V=I]VOXT_^"5Q!_:L_8YV\+_POI, \D?O_#O?O^5?V6)]V@!:
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ ILW^K;_=-.ILW^K;_=- 'X=_\ !RU_R?7X3_[$.T_].&HT4?\ !RU_R?7X
M3_[$.T_].&HT4 ?K+_P3[_Y,2^"/_8@:%_Z;K>O8:\>_X)]_\F)?!'_L0-"_
M]-UO7L- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?EC_P
M>!.T?_!(EV5BK+XTTD@@XP<3\U\7_P#!H3HEIX<_X*,_'JQLK=+>WM_!MD$1
M,X&;F!CU)[FOL[_@\)_Y1"3?]CGI7\IZ^//^#27_ )29?M _]B;8_P#H^WH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ ILW^K;_=-.ILW^K;_=- 'X=_\ !RU_R?7X3_[$
M.T_].&HT4?\ !RU_R?7X3_[$.T_].&HT4 ?K+_P3[_Y,2^"/_8@:%_Z;K>O8
M:^0?^"$?_**SX4_]Q;_T[WU?7U !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 ?E?_P>$_\ *(2;_L<]*_E/7QG_ ,&AVKPZ]_P4>^/=Y;&1
MK>;P99%"\31L<7%NI^5@&'(/45^I7_!P[_RAB^/W_8OQ_P#I7!7X?_\ !LP/
M^-S_ ,)O]KX;WI/_ ("2T ?U(0_ZM?\ =%.ID/W?Q/\ .GT %%%% ",@<<C-
M>4>*OV,OAWXL_:R\._&Z\\+:?=?$OPKHTV@Z;K4NYI;2TF9F=8U+;%DP\BB4
M*'"3RIN*2,M>L44 ,6-4'RJJ]N!3Z** ([CK'_O?T-?''_!&@J?"7[0R[?F7
M]H'QZ<X]=7D[_G_DU]CW7^I_$?S%? __  3]U&YNO^"X7_!0NRDN;AK.UE^'
M,T4)E/EQ/)X>D#LJ] S".,$C!(11V% 'WY10.!10 5\#?\$K_P#E);^WG_V/
MFC?^FB.OOFO@;X4_\K(7Q<_[(MH7_IQGH ^^:*** "OS_P#^#H[_ )04_'+_
M +@/_J0Z97Z 5\__ /!6+_E%E^TM_P!DJ\4?^FBZH ]\A^X/\]JDKY\_X)-?
M\HL_V:_^R5^%_P#TTVM?0= !1110!^>/P/\ ^5B?XE?]BEKO_I%\.Z_0ZOSQ
M_:G_ .4__P"S[_UZ6/\ Z8OB%7Z'4 %%%% 'Y_\ _!T=_P H*?CE_P!P'_U(
M=,K[^A^Y7@/_  5B_P"467[2W_9*O%'_ *:+JF_\$F?^46?[-?\ V2OPO_Z:
M+6@#Z"HHHH ^.?\ @X'_ .4,W[07_8LG_P!*(:^E/V=_^2!>!_\ L 6/_I.E
M9?[8G_)H_P 4_P#L4-6_](IJ\3_X(5_\H@?V>?\ L2['_P! H ^LJ*** ([C
MK'_O"O@'_@@E]W]M;_LZ?QS_ .V5??UW_J#7P'_P3S_Y3L?\%$_^Z;?^H_/0
M!S_A7]FIOVF?^"O7[6.EZEXDU[3?"=G8^")=7T73DM?)\1DV%YY4-TTT4C?9
MT*R,R1A&=BFYMBLC_=7A3P!X,_9W^&G]EZ#IGA[PCX;T6!IY([>*.TMK:-0&
MDE<@  [1N9V.2?F8GDU\3_M+_%/Q1\+O^"ZOA;_A#?!.H>./$>O? ZZTNUMX
MIA;65AG6XIC<WL^US#;@0E P1MTTL"'8KM(GMW@?]B/5OBCXKTWQ?^T%KUG\
M1?$EJ(Y;?PO:1R1^"]'E49WQ6,S,+F99&9DN+@%T"P[55XS(X!\[_MZ_M>Z9
M^TGJ7[/UOX$TN\\0> ;/XW^$B_C6VN(/[.N[Y-6\J."V4MOG1HTN)&FPJE#9
MR0B>"Z2=/TG0;5%?%7_!?#7M"\"_\$E_BEILU]IFE2:I8VMAIMH\\<!O)%NH
M&$,*$C<0BD[4&<*3C K[3A<NF3ZF@!]% HH *^!_^"<7_*9K_@H-_P!A+P%_
MZC[5]\5\#Z)_RLY:Y_V;3;?^I1+0!]\4444 %%%% !1110 4444 (S!!S2+.
MCYPR\''6E8;E(KY@_; _X)'_  D_;A^)EKXL\<3?$)-6L[!--C71_&6HZ;;"
M)'=UQ#%*(PV9&R0HSQG.* /I[S%_O+^='F+_ 'E_.O@P?\&X/[./_/Q\8?\
MPX^K_P#QZC_B'!_9Q_Y^/C#_ .''U?\ ^/4 ?>?F+_>7\Z/,7^\OYU\&?\0X
M/[./_/Q\8?\ PX^K_P#QZC_B'!_9Q_Y^/C#_ .''U?\ ^/4 ?>?F+_>7\Z/,
M7^\OYU\&?\0X/[./_/Q\8?\ PX^K_P#QZC_B'!_9Q_Y^/C#_ .''U?\ ^/4
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M C*SO%+X)\>_M/:GX=ANM8TC0M)OK@M(UF/!,%PULA8^6KLOB?;Y@CV;PA=
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;-_JV_W33J#
MUH _#G_@Y:_Y/K\)_P#8AVG_ *<-1HK]P(ON#Z"B@#Y'_P""$?\ RBL^%/\
MW%O_ $[WU?7U?(/_  0C_P"45GPI_P"XM_Z=[ZOKZ@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** /B[_@X=_P"4,7Q^_P"Q?3_TJ@K\/O\
M@V6_Y30?"7_LFUY_Z225^X/_  <.\_\ !&/X_?\ 8OI_Z505^''_  ;$B<?\
M%F_A4MQL/_%O;XQ[3G"?9) ,\#^OU/8 _J5A^[^)_G3Z9#]W\3_.GT %%%%
M!1110 4444 1W7^I_$?S%?!O[ .@7FG_ /!;#_@H-K$D.W3[^X^'MK!,)$.Z
M2'PZS2C;G<-HGB.2,'=QG! ^\KK_ %/XC^8KXW_8853_ ,%3/VX2?O#Q'X0
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ME;X8)YJ2?:TESX)_9Z^%#7,TWAGP-X-\+V9=I'D@TO2](MD!.>JPPQ@9.>%
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M,@^-$40Q(P4@S:\>5S@D;0 2,@9 QDY_M83I^-?Q5?M8<?%#]H__ ++?;_\
MHWQ#7]JJ]_K0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"U5\;OB=\>?CC>?$;P[^THNA_L\^)O&-W?206>J>(=+F\*+HF@7UQ?Z?\
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M?E:O_P!&7_MR_P#AMH/_ ),H ^^**^!_^'Y6K_\ 1E_[<O\ X;:#_P"3*/\
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0>M%!ZT
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M_"S_ (-PO"6C^-_^"PWPGT_7--TW6-/D^'5V6MKZW2XB9A:2$91P1D<D<<4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@^X/Q_G7S;^UE_R<C\,?^P%?_P#J2^$J^DH/N#\?YT 24444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4&BB@#^*G]J__DJ/[1__ &6^W_\
M1WB&O[55[_6OXJOVKO\ DJ'[1W_9;K<_^1?$-?VJKW^M "T444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?6TV6>H6VG*ES!JB1/8S3I>ZG:H;7Y62 2RLZB(Y /YD_BO_ ,&\?[77P7^
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MX<_])=:K^ZU>_P!: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M (7#_P#R!0!_0I03BOYZ_P#B..US_HV_3?\ PN'_ /D"C_B.-ULC_DV_3?\
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M]_BM9?$+0?!N@WWPYOM>\3>)[:UA$.@7NH3Z=IEQIGB>[5#''?10W+>=X?\
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M(_\ P0C_ .45GPI_[BW_ *=[ZOKZOD'_ ((1_P#**SX4_P#<6_\ 3O?5]?4
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M&MO'W_1K_P <_P#P;>#?_E]1_P -;>/O^C7_ (Y_^#;P;_\ +Z@#W6BO"O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!:__ !%'_#*OPP_Z)SX#_P#!!:__ !%=]10!P/\ PRK\,/\ HG/@/_P06O\
M\11_PRK\,#_S3CP'_P"""U_^-UWU% '!V/[+WPVTK48;NU^'_@VUNK>1)89H
M=&MXY(74Y5D8("K \Y&#P*[M1M'%+10 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 49HH- '\5/[61W?%/]H[I\OQMMQQ_P!=?$%?VJIT
M_&OXJOVK_P#DJ/[1_P#V6ZW_ /1WB&O[55[_ %H 6BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXQ(,,JLH8 XXR,]J^,_^#C7_ )0J_'__ +!%I_Z<+2OL'X8?\DXT'_L'6_\
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MN<JO0^SU\ ?\$#?O_MI_]G3^./YV5 'W^**** &R_P"K;KTK\S?@9^TKX?\
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M(EG>V$(A*26RR^89&G'E?07_  2RF:\_8ST^23:6E\4>*V;:BHN3XDU,G"J
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MQQ_.RH ^_P"BBB@!'^[7XL_\$J?^4D/_  4>_P"RV^"/_4HOZ_:9_NU^+/\
MP2I_Y20_\%'O^RV^"/\ U*+^@#]I8_\ 5K]*=38_]6OTIU !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4'I
M110!_%)^UE>PQ_%[]HNW::-;B;XUQ2QQ%AO=%FU\,P'4@%U!/;</45_:TO?Z
MU_%#^UIHEG<?&O\ :&U&2VA:_L_C.MM#<%?WD<4L^N-(@/\ =9H8B1WV+Z5_
M:\O]: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "@]:*#UH AB^X/H**(ON#Z"B@#Y'_X(1_\ **SX4_\ <6_].]]7
MU]7R#_P0C_Y16?"G_N+?^G>^KZ^H **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6-U\0-0\'7RZ\+/PIJ$T-K=(FBP7EC'XBEBCM[R*WDMXP+= LD32R!D0QLB
M'ZZ6:M'(5V\*H//J>O\ *K51Q#]^_'8?UJ2@ IL_^J:G4V?_ %34 ? /_! K
M_F]/_LZGQS_[8U^@%?G_ /\ ! K_ )O3_P"SJ?'/_MC7Z 4 %%%% 'YX_M3_
M /*?_P#9]_Z]+'_TQ?$*OT.K\\?VI_\ E/\ _L^_]>EC_P"F+XA5^AU !111
M0!\0_P#!QK_RA5^/_P#V"+3_ -.%I7V#\,/^2<:#_P!@ZW_]%+7Q]_P<:_\
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MEZ!!;>$OBK-8E[:U918F.XU010P,J!8X"J-N3*DF*+:"$;;_ &SS_P"IDSN
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M'&O_ "A5^/\ _P!@BT_].%I7V#\,/^2<:#_V#K?_ -%+7Q]_P<:_\H5?C_\
M]@BT_P#3A:5]@_##_DG&@_\ 8.M__12T ;M%&X>M% #+C_4M]*^#/^"!O_(E
M_M4?]G*^-_\ T?;U]Y7# 0M]*^#?^"!WR^#/VJ >#_PTKXW_ /1]O0!][#I1
M0.E!;% !7Y^S_P#*TO\ ]VK?^[=7Z!%@HK\_9S_QU+?]VK ?^7=0!J?\%*_
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M@\>_]E,U;_TFL: /T8HHS10 5\ ?\$#?O_MI_P#9T_CC^=E7W^6Q7Y__ /!
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M ,SM>TP_M9^&5=F.D_$S+?\ 5.O$''_DC[T__AK;PS_T"?B9_P"&Z\0__(-
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M(F6XEDL6L[A)K/3[QI?+2&\0HX1?WZG+=!Y]_P (%^TG_P!$Y^'?_B1OB?\
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MM.:_KWAY;?0_ ?@VWM_$.CWFIZE!\:]>\02?V;!J-O/?P+9W&APQS-/:)<0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %?DS_P 'D/P7U#XC_P#!*S1_$FG:
M7:W?_"O_ !SI^IZE=OY:S6-C/!=61V$G>RO=7-FI1,DG:Q&(R1^LU?%G_!P[
M\/O^%E_\$9_CUIXTZZU1K;0HM4$%N&:0?9+N"Z,F%YVQK"9&R" J,3P#0!_/
M%_P2^U/7K']KOQH-4MO!7@73[73H/CC=76E6Z>;H?]G64VKZ5;:>O[Z)8'N+
MZR$MLZLQBB$89)$ /]:=CXMTU=7?3([VQDU2./S);2.=#<( ,@E =W0KU& "
M*_A436]2^&]_X7U[2M-O?#MU+9PW]A>2AY!?O!=.OVN$R*%P)[=D^7*JT#KG
M(8#^N;_@E_\ M&_ WP#_ ,$^?A/XPU75/@W\,=<\:>"]-\1Z\$ATKPP;^]-I
M'%?7KP1B)=K36T@W*NW9"H& H50#Z.\?_MD_#_X<>.9/"]UJFHZOXEMT\V\T
MGPYHM_XAOM-39&X>ZAL()WME=94*&8)Y@)*[@#CJK/XCOK'@:;6K#P_X@O)!
M;RSPZ6T"6=]=%0=D:I<O$JO(,!?,9%!^\RC)KY:^-/\ P7R_8W^ ;Z6NM_'W
MP+>?VJ9A;?\ ",33>)?+$>S(E_LV.X\G/F*5$NS<0VS=L8CYT\:?\'??[(WA
M737DL1\4/$<T<F!!8>'$AD<$_?'VB:)=H')RP.#T)R* /O#PC\8/BW\2KV[\
MOX2Z;X*TM+CRK=O%/BR%M4D58HW,QM=/CNX AE9HP#>!\1ERJY53TGQH\&_$
MG7UT\?#WQ=X)\*F,2B_/B#PK=:]]HSM\ORA#J-D(MI\S.X2AMRX";3N_&GX@
M_P#!Z#9ZIXC\10_"G]G'Q1XGT;2[:.>UU/6M>%K=1*PC0RW-G;V]PL:B>3RQ
MBZ.\&/E&?:OC=]_P=\_M0_$;Q-X:MO"'PI^"_AFQ\3>9!8S^*+BXCMKV:-B'
M(OIKRTMHT7Y5^<X#=6^8* #S?_@K3_P0=^,7Q>_X*Y^,O"/PETE?&E]XBT!?
MB#/=7NH:=IKZ@UQ<!+^Y('E(N[4)9L1MEE7 !*!:\U\&_P#!"?\ ;!_X)R^*
M]+^//B7X<PZ?X<^$-Y'XLUF6Q\7Z>MPUC:,)KF-?+G+'?"DB$ '(=@00<5]Y
M?\&U7QC^*W_!4+]NOQ;\>/BQ\7M3U'QI\)=&M_";Z%;65M8VNK:5=_;Y-DT-
MN(1^ZNPD@=HWY0*>0C)^HG_!9S:O_!*']HSIN;X=:W@?]N4M 'TQ/<+;IN/K
MBO,_#_Q[M_%G[2OC3P':K8R?\(;HVCZC=7$5VLKB>^FOU-K)&HS&Z16UO+@M
MEENX_E4;2^I\1_C[X=\$:D='COK/6/%S+');>'+*\A.JW(=L*RPLZE4QEF=R
MJ*BNS,%4FO.=#^#'B#X-7T/CJ&2X\1>*+JXOY_%-M96Z;=4@N6C:-85_=L\M
ME';6MO"Q8;[>.0.KRR(4 /CW_@Z&_8@O/CO^P;JGBCPG<:M'XT76/#>@R6W_
M  D^H6>GZI;3:M]EMH'LEE%C+*+S4E<33QAD7=B0;5%?B^O_  :P?MN2QJ4^
M%^E-$>0!XOTK:3TXQ<?6OZ"O^"FWQU\+_&;]@R^;P[K$5U=6OC;X?R7EA-NM
M]2TOSO%NC,L=W:R[9[64@.#',B.I1U*@J0/;_P!O7]JN3]A_]D3Q]\5H="_X
M2B/P-I3ZE_9/VS[&;W#(NP3;)/+^]G<4;IC!SD '\P?_ !"I_MN?]$MTK_PK
M=*_^2*/^(5/]MS_HENE?^%;I7_R17]+/PW_:Q\>>)_BGX9\'ZYX/\#Z#K$W]
MI#Q-$/&<UPVGFU=?*.G!M.0WZRQ212-YOV4Q*YX9E(,?A']NN^N_BSXX\/ZU
MX3MUT_PK9WU_;WOA_66U695L[H6KPZC#);P)8SW,C,]F@EF%Q':W;LT'DE7
M/YJ?^(5/]MS_ *);I/\ X5NE?_)%+_Q"J?MN?]$MTG_PK=*_^2*_I/\ "/[>
M&H:_\3[[P/>>%;6U\3>";K2+3X@1P:P9(-$;5LQZ>;"5H$^WK),4)+K:E(=T
MA D"V[UOV4?^"EFB_M3?%OPOX+L_#>O:+KFJ^"KWQCJMOJ2B&31XX=2BL+9"
MO_+1+O,]Q#(-N;>**1D3ST"@'\W/_$*E^VY_T2W2O_"MTK_Y(H_XA4OVW/\
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M31_PI[Q;_P!"OXB_\%LW_P 37][&P>@_*C8/0?E0!_!-_P *?\6_]"OXB_\
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M%_X+9O\ XFO[V=@]!^5&P>@_*@#^"?\ X4_XM_Z%?Q%_X+9O_B:/^%/>+?\
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ML;>45  5'], Z5&L"JWW%'?[M24 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %!ZT4'K0!#%]P?0441?<'T%% 'R/_P $(_\ E%9\*?\
MN+?^G>^KZ^KY!_X(1_\ **SX4_\ <6_].]]7U]0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5XQ_P4!^ EU^
MU)^QG\5OAOI\.C2:MX^\(:IH6G-J@;[)!=S6DRVTSE4D($<YC?<$+*0&4%@
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M@X_4<>]>X4S9\^=H^;@GO_GF@!XZ4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !0>M%!ZT 0Q?<'T%%$7W!]!10!\C_\$(_^
M45GPI_[BW_IWOJ^OJ^0?^"$?_**SX4_]Q;_T[WU?7U !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !0>M%!ZT 0Q?<'T%%$7W!]!10!\C_ /!"
M/_E%9\*?^XM_Z=[ZOKZOD'_@A'_RBL^%/_<6_P#3O?5]?4 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %!ZT4'K0!#%]P?0441?<'T%% 'R/_
M ,$(_P#E%9\*?^XM_P"G>^KZ^KY!_P""$?\ RBL^%/\ W%O_ $[WU?7U !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0>M%!ZT 0Q?<'T%%$7
MW!]!10!\C_\ !"/_ )16?"G_ +BW_IWOJ^OJ^0?^"$?_ "BL^%/_ '%O_3O?
M5]?4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!ZT4'K0!#%
M]P?0441?<'T%% 'R/_P0C_Y16?"G_N+?^G>^KZ^KY!_X(1_\HK/A3_W%O_3O
M?5]?4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!ZT4'K0!#
M%]P?0441?<'T%% 'R/\ \$(_^45GPI_[BW_IWOJ^OJ^0?^"$?_**SX4_]Q;_
M -.]]7U]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4'K10>
MM $,7W!]!11%]P?044 ?(_\ P0C_ .45GPI_[BW_ *=[ZOKZOD'_ ((1_P#*
M*SX4_P#<6_\ 3O?5]?4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %!ZT4'K0!#%]P?0441?<'T%% 'R/_P $(_\ E%9\*?\ N+?^G>^KZ^KY
M!_X(1_\ **SX4_\ <6_].]]7U]0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4'K10>M $,7W!]!11%]P?044 ?(__!"/_E%9\*?^XM_Z=[ZO
MKZOD'_@A'_RBL^%/_<6_].]]7U]0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4'K10>M $,7W!]!11%]P?044 ?(_P#P0C_Y16?"G_N+?^G>
M^KZ^KY!_X(1_\HK/A3_W%O\ T[WU?7U !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&;:,G@>IH 6BFB12N=RX]<T[- !12%P.]()5;.&7Y>O/2@!U%(K;ER.:4G%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*_:2\8:;X7\#Z)I%IKVF:1?26.MPV]A!$EY RV+*T4RH)$(9@5<8)ZU[_P#
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MQJ?[67_!87X.?%S]OOP?XBT7X<?$R!K_ .'=KJZ_8/"^GQK<#[%YJ3+B6Q#
M&17*>;Y]M/,6MY/WG]0&E16T5FBQ-"(UX0(/+4*#\H STQZ<'K0!H"B@'BB@
M K@_VF/#7CKQE\ _%VE_#/Q'8^#_ (@7VFRPZ!K5[:I=6^F79'[N9XG21753
MR048'T-=V&#=*6@#\=OVD_@;_P %2?V9OV=?'WQ(U/\ ;&^&^H:;\/\ PYJ'
MB2[M;;P/I@GN8K.VDN'CC+:8%W,L9 R0,GDXYK@/^"<5[_P4X_X*4?LB^&_B
M]X;_ &N/ ?A_1_$DUY##9:GX'TEKJ(V]U+;L6,>FE>6B)&#T(K]1O^"LO_*+
M3]I7_LE?BC_TT7-?-/\ P:H?\H1/A7_U_:W_ .G>[H \/_X*F?M#?MC?\$H?
M^"0D7BKQ9\<=#\2_&:\^)%O8Q^)M)\-Z>(%T>:RE(M#;RV:PAA+ SEQ$&P0-
MW45^IW[+WC+4OB+^S/\ #OQ!K-P+S6-=\,:;J%].(UC\Z>:UBDD?:H"KEF)P
MH &> !7YK?\ !Y*,_P#!)?2>G_)0M+/U_P!$OZYC]G'_ (+]?&KP+^SSX#T.
MS_X)^_M-Z]9Z/X=T^Q@U.ST>_:WU&.*VC19XR+ @HX4,I!((8<F@#Z>_X.*O
MVO\ XC?L,?\ !-+7OB%\+/$?_"+^+K+6M,LX;_\ L^UOMD<T^UQY=S')$<CC
ME<CJ"#7#_MT_MT_%7X-_\&V^E?'SP[XJ^P_%J\\!>#-<DU[^S;23-W?W.E+=
MR?9Y(FM_G6ZF^7R]J[_E52 1^?\ _P %Z/\ @KU\4/VQO^">>M>"?%7['OQT
M^#6CW>KZ=<OXE\4:;=P:= \4VY8V:2TB4,Y^5?G_  /2OJ;_ (*>%O\ B#V\
M/XZ?\*M^'>[C_IZT*@#/_9=^"O\ P5(_:C_9N\!_$K2?VQ?AOINF^/O#]CXA
MM+2[\#:89[>*Z@294DVZ85W*K@'!(R.*].\%_L4_\%0;+QGH]QKW[8OPQU+1
M+>^AEU"UB\$:>DES '!D16&F JS)D @@@GJ*\,_8"_X+K_&'X,?L,_![PCI7
M[!W[2'C33/#'@S2=*M/$&DZ1?26.MQ0V<4:7<#+8LICE50ZD,P*L,$]:^A?@
M=_P7=^,OQ>^-O@WPEJ7[!?[27@W3?%&N66DW>O:GH]ZEEHL,\Z1/=SLUDJK%
M$KF1BS* J$D@<@ _2R)-B8/6OF/_ (+*?'OQ=^RU_P $SOBY\1/ >K?V#XP\
M):,+W2M0^RPW7V67SXDW>5,CQ/\ *[##J1STKZ:MRQB&[KSU&*^-_P#@X4_Y
M0Q_M ?\ 8N#_ -*H* /A7]@W1O\ @IY^WQ^R#X.^+^@_M>?#_0]%\96T]Q;V
M&H^"=*-Q;K#<2VY#E--*\F(D$-T(S6IXU_X*%?MH_P#!&S]H#X<6'[5WB#X>
M?%_X(_$3Q FDW7C;2]/32[K16D505<0Q0)'Y.&FVM XEC68"4,/W?F/_  1Z
M_P""TOQ8_9B_X)K_  O\"^'OV*/V@?BAH_A^SNXK;Q3X?TJ\FTW50]]<2EX6
M2S=2%9RAPY&Z-A[#SG]O7]NGQ%_P65_;2^"OP"^._@74OV3/A7;ZW#K\L'CJ
MSOH=7\37&/LZPQ.\$(C$AEEA1OE1=[R/(658Z /W@_:[_:P\'_L8?LR>,OB=
MX\NKB'PKX-TXWEZ8(P\MVQ81QV\()"M++*\<* L%WR*&8#)'Y9_!_1?V_?\
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M6H7EUY1V(?)$]Q(L>Y0P0)NRV20#XU_X)H^(O^"F_P#P4W_90TGXM>&?VMO
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH'@WPRLR:;IYNI[O[,LL\D[CS)G>5LR2NWS,<;L<    _(7_ (+7?LU>,/\
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MI:-)&7C1Y([BRC5TC<LEM=R,OSR;&_>Z*UC@)*(J[@ <#J!TKYV_;=_X)9_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$G))/<GN:_IH_P"#*7_E&U\1_P#LIEU_Z:],K^9,U_39_P &4O\ RC:^(_\
MV4RZ_P#37IE '\XW[1IQ^T-X\_[&+4/_ $IDKZD_X(P?\%F?&W_!)?XX)=6W
MVKQ!\,?$$\?_  E/A@/D7*Y"_:[<,P5+I%X!.%D4!'Q\KI\M_M&_\G"^//\
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MCK_A#&\9"Z.C Z+J.H?;!;>2)O\ CTMY=FWSXOO[<[^,X. #Z$HKG?A-\5M
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M?V-X5\)V$FIZK??9I;G[);QJ6=_+B5I'P.R*2>P- '645\N^,?\ @LU^S9X
M_8Z\*?'[5_B0+3X1^.-4?1-%UW_A']4D^V7:-=HT?V9;8W"8:QNANDB5?W7!
M.Y=WD/\ Q%&_L*'_ )KE_P"69X@_^0* /T HK\_S_P '1/["N<_\+SZ\_P#(
MF^(/_D&OOZ.59/NG.W@T .HJIJFJ6^EV=Q-<W$5K#;QF265W"+"H!)9B>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MEX6TKQ.K:EI'A'2X=1N8Y+>"RG+6X>:\CNKAGV$9F&T*QE:3*_;;_9C\,_\
M!'3_ (+M?LF^/?@?!)X-T']H;Q)/X2\3^$M,E:VTJ4275G;2RB,,8_*/]J1R
M+;;!%')8QNFW(V '[D6!8VZLS,VXYRPP?RJQ5:Q#+:;F;=NRP[8'I^'X?05^
M?W[:'_!9GXH?LI?M.^)? /AG]C7X]?%G1]#^S-!XJ\,Z7=W&F:IYMI!._DM'
M:R*?+:4Q-AS\\9SSQ0!^A5%?-O\ P3G_ &V?%W[<GPLU;Q-XN^"?Q%^!FH:9
MK+:9%HOBZSEM;J\B$$4GVE%EAB9HRTA0$*?FC;D<X^DA0!^$_P"PM\$/!?Q\
M_P"#KK]KS1_'7A'PSXSTBV\-7EY#9:[I<&H6\4RW>B()5CF5E#A7=0P&0&89
MP37Z,?MI?\$OOV1-8_9J\7?\)[\+/A/X%\*V>FSW-]XBT[0;+1[K0U"$?:8K
MJ*-3'(F[<N<@MMRKC*G\E_ _[ >@_P#!1G_@YY_:L\$^(O&GQ'\#6.DZ7<ZV
ME_X+U:/3+^5TFTF$1/(\4H,1$Y8KMY9$.>.?JK]IG_@T=^'_ ,3_ (1ZAI>B
M_'_]H*X\0*HN-+/C#7[;7-)BG4CF2U6V@=BR,Z!DE0KYF[YP"C '4?\ !H7X
MO\4>(O\ @D=;VNO1R?V9X=\::KI_A[Y2H>P*P3L1G[R_;+B]&1M VXQD'=SO
M_!Q+XGU;]M/]JO\ 9E_8GT%5C7XJ:ZOBCQA+&T0N[71[1I )(FD<+@10ZE,1
MCS'-I&J$EGC;KO\ @VP_X*(ZE^T=^QWXO^'_ (R\/:5X5\2?LX7@T*_ET>RA
MM=*:Q(F,16.%L"5#;W*R;$VD)$X9G=POPC_P3Z_:F^.G[0'_  4U^/\ ^V;\
M*?V:=:^.FE^*M1N/!N@3-XDT_P .PZ#90K:F)9H769VO/L,5@A>.18QYMP#Y
M@D C /K;_@EUK7_#LS_@N1\?/V6;NXL+'P#\6,_$KX?VPM8+8+-)'YEQ;0I&
MQ952)9XA&X^[I8=$C5SO^VO^"S*_$:__ ."7OQL7X4QZH_CAO#-PMFNF@&^:
M#Y?M?D9_Y:_93<!0F92V/*_>%*_'W_@LY\?OVK_$7B/X4_M/>)/V1?\ A2^J
M_LXZDEXWB2[\56.N6VH6]S=6\<5I=QQ)%<M&+@A4*2@Q_:[@KM9_,3]N/$W[
M>'PG^'W['&D_'#Q=XCAT#X8>(-)T[5HM2O[.1E%KJ$<)M@\4:NWS>?&" " 6
M.<#H ?GO_P &KWQ__9IL/V#O"/@7PCK_ (+TOXV:I).GBK2[MXK/Q!K=U'-<
MSH5!VRWD,=L2R&+S%B0-NV$.*]0_X*>_\$0+C]J']IKX5_'OX"W/@;X9_&#P
M-K@UC4M3U"UE-EXE59%FC^U1VZDRRB0.I?*L\<SJS,!'LP?VB_\ @VW_ &1?
M^"E.C0_%+P?#KO@:Y^(EE#XCL-9\(7GV>QU);F!I8;EK*XB:-$D\R-V2)86;
M:"=C.Y;XE_:C^&W[67_!L+XQ\+_$G1OC)JGQR^"OB#4H]*U32M<NKB&-)VVS
M-$;6::=8998X91'<PERNQ_,7&P. ?4?_  >H'_C5IX!S_P!%4T[K_P!@C6*^
M_?A__P $X?V>;_P+HL]Q\!_@S//-8P2222>"M-=Y&,:DLS&'))/))Y-?F_\
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MC]G/]JW199;NYA@1ET?4+2[EM1,ZC=*6MB4:3;\C07Q8+)+"J+^['_!:R_\
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MNWT[Q;H>H? _X@:H=1\,>'(I+J:^T*1)7$>]Y0 3]G98G.7=S#$2WRDGYO\
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M-2^.7B6WU/Q88X89KC3M!MI0PF/FR(  8[B<!"'D;3]BMR5?[6_X)J_\$WO
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M8=3E^.7PCU^86*V>M0:-]JTN[@(NHVN&>%LYBB0+]HC4Q3W2D,TBUT7[)/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMHHEA'RKC/6GBOD;_A^S^RK_ -%2/_A-:O\ _(M'_#]G]E7_ **D?_":U?\
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M:U?_ .1: /KFBOD;_A^S^RK_ -%2/_A-:O\ _(M'_#]G]E7_ **D?_":U?\
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M:U?_ .1: /KFBOD;_A^S^RK_ -%2/_A-:O\ _(M'_#]G]E7_ **D?_":U?\
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M:U?_ .1: /KFBOD;_A^S^RK_ -%2/_A-:O\ _(M'_#]G]E7_ **D?_":U?\
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M:U?_ .1: /KFBOD;_A^S^RK_ -%2/_A-:O\ _(M'_#]G]E7_ **D?_":U?\
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M:U?_ .1: /KFBOD;_A^S^RK_ -%2/_A-:O\ _(M'_#]G]E7_ **D?_":U?\
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M:U?_ .1: /KFBOD;_A^S^RK_ -%2/_A-:O\ _(M'_#]G]E7_ **D?_":U?\
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*IT[6A]#10!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>image_31a.jpg
<TEXT>
begin 644 image_31a.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0 Z17AI9@  34T *@    @  U$0  $
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M1T__ .,U['10!XY_P[V^ _\ T1'X1?\ A(Z?_P#&:/\ AWM\!_\ HB/PB_\
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MO@/_ -$1^$7_ (2.G_\ QFC_ (=[? ?_ *(C\(O_  D=/_\ C->QT4 >.?\
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M /C->QT4 >.?\.]O@/\ ]$1^$7_A(Z?_ /&:/^'>WP'_ .B(_"+_ ,)'3_\
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M /1$?A%_X2.G_P#QFC_AWM\!_P#HB/PB_P#"1T__ .,U['10!XY_P[V^ _\
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M$CI__P 9H_X=[? ?_HB/PB_\)'3_ /XS7L=% 'CG_#O;X#_]$1^$7_A(Z?\
M_&:/^'>WP'_Z(C\(O_"1T_\ ^,U['10!XY_P[V^ _P#T1'X1?^$CI_\ \9H_
MX=[? ?\ Z(C\(O\ PD=/_P#C->QT4 >.?\.]O@/_ -$1^$7_ (2.G_\ QFC_
M (=[? ?_ *(C\(O_  D=/_\ C->QT4 >.?\ #O;X#_\ 1$?A%_X2.G__ !FC
M_AWM\!_^B(_"+_PD=/\ _C->QT4 >.?\.]O@/_T1'X1?^$CI_P#\9H_X=[?
M?_HB/PB_\)'3_P#XS7L=% 'CG_#O;X#_ /1$?A%_X2.G_P#QFC_AWM\!_P#H
MB/PB_P#"1T__ .,U['10!XY_P[V^ _\ T1'X1?\ A(Z?_P#&:/\ AWM\!_\
MHB/PB_\ "1T__P",U['10!XY_P .]O@/_P!$1^$7_A(Z?_\ &:/^'>WP'_Z(
MC\(O_"1T_P#^,U['10!XY_P[V^ __1$?A%_X2.G_ /QFC_AWM\!_^B(_"+_P
MD=/_ /C->QT4 >.?\.]O@/\ ]$1^$7_A(Z?_ /&:/^'>WP'_ .B(_"+_ ,)'
M3_\ XS7L=% 'CG_#O;X#_P#1$?A%_P"$CI__ ,9H_P"'>WP'_P"B(_"+_P )
M'3__ (S7L=% 'CG_  [V^ __ $1'X1?^$CI__P 9H_X=[? ?_HB/PB_\)'3_
M /XS7L=% 'CG_#O;X#_]$1^$7_A(Z?\ _&:/^'>WP'_Z(C\(O_"1T_\ ^,U[
M'10!XY_P[V^ _P#T1'X1?^$CI_\ \9H_X=[? ?\ Z(C\(O\ PD=/_P#C->QT
M4 >.?\.]O@/_ -$1^$7_ (2.G_\ QFC_ (=[? ?_ *(C\(O_  D=/_\ C->Q
MT4 >.?\ #O;X#_\ 1$?A%_X2.G__ !FC_AWM\!_^B(_"+_PD=/\ _C->QT4
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MZ?\ _&:/^'>WP'_Z(C\(O_"1T_\ ^,U['10!XY_P[V^ _P#T1'X1?^$CI_\
M\9H_X=[? ?\ Z(C\(O\ PD=/_P#C->QT4 >.?\.]O@/_ -$1^$7_ (2.G_\
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M)'3_ /XS7L=% 'CG_#O;X#_]$1^$7_A(Z?\ _&:/^'>WP'_Z(C\(O_"1T_\
M^,U['10!XY_P[V^ _P#T1'X1?^$CI_\ \9H_X=[? ?\ Z(C\(O\ PD=/_P#C
M->QT4 >.?\.]O@/_ -$1^$7_ (2.G_\ QFC_ (=[? ?_ *(C\(O_  D=/_\
MC->QT4 >.?\ #O;X#_\ 1$?A%_X2.G__ !FC_AWM\!_^B(_"+_PD=/\ _C->
MQT4 >.?\.]O@/_T1'X1?^$CI_P#\9H_X=[? ?_HB/PB_\)'3_P#XS7L=% 'C
MG_#O;X#_ /1$?A%_X2.G_P#QFC_AWM\!_P#HB/PB_P#"1T__ .,U['10!XY_
MP[V^ _\ T1'X1?\ A(Z?_P#&:/\ AWM\!_\ HB/PB_\ "1T__P",U['10!XY
M_P .]O@/_P!$1^$7_A(Z?_\ &:/^'>WP'_Z(C\(O_"1T_P#^,U['10!XY_P[
MV^ __1$?A%_X2.G_ /QFDD_X)\? <1M_Q9+X1]/^A0T__P",U[)39O\ 5M_N
MF@#\ ?\ @X>_9E^'WPT_;2\+6/A[P'X-T"SF\$6MQ);Z9HUK:0M(;_4%+%4C
M +;549.3A5&>!17=?\'+7_)]?A/_ +$.T_\ 3AJ-% 'ZR_\ !/O_ ),2^"/_
M &(&A?\ INMZ]AKQ[_@GW_R8E\$?^Q T+_TW6]>PT %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %-F_U;?[IIU-F_U;?[IH _#O\ X.6O^3Z_
M"?\ V(=I_P"G#4:*/^#EK_D^OPG_ -B':?\ IPU&B@#]9?\ @GW_ ,F)?!'_
M +$#0O\ TW6]>PUX]_P3[_Y,2^"/_8@:%_Z;K>O8: "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "FS?ZMO]TTZFS?ZMO]TT ?AW_P<M?\GU^$
M_P#L0[3_ -.&HT4?\'+7_)]?A/\ [$.T_P#3AJ-% 'ZR_P#!/O\ Y,2^"/\
MV(&A?^FZWKV&O'O^"??_ "8E\$?^Q T+_P!-UO7L- !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "FS?ZMO]TTZFS?ZMO\ =- 'X=_\'+7_ "?7X3_[
M$.T_].&HT4?\'+7_ "?7X3_[$.T_].&HT4 ?K+_P3[_Y,2^"/_8@:%_Z;K>O
M8:\>_P""??\ R8E\$?\ L0-"_P#3=;U[#0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4V;_5M_NFG4V;_5M_NF@#\._^#EK_ )/K\)_]B':?
M^G#4:*/^#EK_ )/K\)_]B':?^G#4:* /UE_X)]_\F)?!'_L0-"_]-UO7L->/
M?\$^_P#DQ+X(_P#8@:%_Z;K>O8: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "FS?ZMO]TTZFS?ZMO]TT ?AW_P '+7_)]?A/_L0[3_TX:C11
M_P '+7_)]?A/_L0[3_TX:C10!^LO_!/O_DQ+X(_]B!H7_INMZ]AKQ[_@GW_R
M8E\$?^Q T+_TW6]>PT %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FS
M?ZMO]TTZFS?ZMO\ =- 'X=_\'+7_ "?7X3_[$.T_].&HT4?\'+7_ "?7X3_[
M$.T_].&HT4 ?K+_P3[_Y,2^"/_8@:%_Z;K>O8:\>_P""??\ R8E\$?\ L0-"
M_P#3=;U[#0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4V;_5
MM_NFG4V;_5M_NF@#\._^#EK_ )/K\)_]B':?^G#4:*/^#EK_ )/K\)_]B':?
M^G#4:* /UE_X)]_\F)?!'_L0-"_]-UO7L->/?\$^_P#DQ+X(_P#8@:%_Z;K>
MO8: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FS?ZMO]TTZF
MS?ZMO]TT ?AW_P '+7_)]?A/_L0[3_TX:C11_P '+7_)]?A/_L0[3_TX:C10
M!^LO_!/O_DQ+X(_]B!H7_INMZ]AKQ[_@GW_R8E\$?^Q T+_TW6]>PT %%%%
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M;_QI_P#*:@#Z@HKY?_X;MUC_ *%'Q1_X;_QI_P#*:C_ANW6/^A1\4?\ AO\
MQI_\IJ /J"BOE_\ X;MUC_H4?%'_ (;_ ,:?_*:OGW]K#]OK]HJV^.'P[7X9
M>$_$7_"'R,O_  D@/PR\5R>4/[6TN)RYETG?*#9SWSK'$UNR"WDD,SLL=M*
M?I%17Y[_ +#O[>7QRG^%#2?&+PAXL_X2286LR!_ OBJ1HP]G TJG[/X>@12L
MYE4Q[9-A4@33+M:O:/\ ANW6/^A1\4?^&_\ &G_RFH ^H**^7_\ ANW6/^A1
M\4?^&_\ &G_RFH_X;MUC_H4?%'_AO_&G_P IJ /J"BOE_P#X;MUC_H4?%'_A
MO_&G_P IJ/\ ANW6/^A1\4?^&_\ &G_RFH ^H**^7_\ ANW6/^A1\4?^&_\
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MMSX8\6>;)$AC#NJ?V3N*H98@S 84R)G&X9 /LRBOCL?\%5-&/\#?^$GXN_\
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MP?F52"*ZM_B;XB'P=7Q)_P *Y\8MKGEY_P"$56[TK^U\^<$QO-[]BW;?WO\
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MW5-/\W[/H&HWND/J.IA(U=?*>WOIK5?,8E%,L\?SHQ8(A5V ._\ LO\ MO\
MI_A1]E_VW_3_  KPP?M3>/3"J_\ #,_QMSP#G6?".!^/]NDUWOQ6^)&O?#G1
MK6\T?X>^+O'DTTHB>ST*[TN.XMA@G>YOKRUC*# 7Y)'8LWW<#=0!VWV7_;?]
M/\*/LO\ MO\ I_A7F7PD^-7BKXB>);BSUGX1?$+P#:);&5+_ %Z^T*>WE<,B
MB)5L-2NI-[!BPW1JF(WRX)16S_&G[1/C'PGXKU#3K'X#_%CQ19VLFV+5-,U'
MPU#:7:[0=R+=:O#.!DD?O(D;(/&,$@'KOV7_ &W_ $_PH^R_[;_I_A7GGAOX
MM^)-=^&FI>(+SX8^-M#U*R=UB\-WM[H[:KJ(50P:)H;Z2T&XDJHEN8^5<L%&
MTMR-G^U/XZNWC#?LV_&J-9"!YC:KX1VH#W(77"<#KP"?0=J /<?LO^V_Z?X4
M?9?]M_T_PK@/B[\4O$7PP?3_ .Q?AKXX^(B78D$O_"/WND0-8[ FTR?VA?VN
M[?N;!CWG*-NVC;NK?";XS>)_B3KUQ::Q\)?B!\/[:W@,RWOB"^T.:&X;<!Y2
M+8:C=R;R"3ET10%;YLX4@'G'_!4&U_XL/X).]C_Q=SX=C:0".?&.C_0_K7GW
M_!#+P/H^J?\ !+;X6W%QI>GS3,VK,7>W0L3_ &O>C.2,DX &3GCCN:S/^"H'
MQZ\76_PS\.Z7_P *3^)TEGI_Q;\#-!JZ:AX=^QZIY/BW2GC$2-J@G!G9%2/S
M8HP&D4RF%=[+XC_P3G^&/P$^&?\ P1M\&?%;XB?!WX8Z]=0F^GU6YUG3O#]M
M>2L^N36R^9>ZG-!;AE\R-<RW"@XVJ79D1@#]-I?AYH,O_,)TX?2UB_/[M>-/
M^R)\*?CQXK\?:?X[^&?@#QM86/B:*:TM]>\.V>I0VSMI.G@LJS(P5CC&X $@
M]3V^3OAW^T=^R!\9O%5OH/A?]E[P!XBOKIAYZ>'H?AYXAN+"#>JM=26VG:M<
M7/DQ[@69(FQD  L54[GB71OV??A5XZ\6?V;^QS=_%".ZUL1I'X4^$FGR-HZ+
MIM@RK*MXMLR+*[RLJQAP2LC-LWKO /=/BG^R1^S?^RMX375K3X;MX#L;ZZCM
M#9_##1]3T^YU6=@Q0/9:"JRW3*JN0S1.44.<JN[-3X*>&/@]\5M8O-*\-Z=\
M=M/:&W:YE;Q)I/C+286Y50L<^JQHK288'RHG+$!FV?*Q'A4/A/X9_&GQ%H/]
M@_\ !//QAIL>AZE]JU&/6/ 7A#1?MEN]I<Q^6GVK4(Q-^\:-F5=P4*"V#LS[
M)X5_9*^'_C2UN)D_8M^'?A41_N3!XETOPU'-.#R6C%@UXGEY)&'D0[LG8>"0
M#F_BI<^$/#_CW4M-TSX@?M8>%8]-E:VEL="^"UUXDL#*A(>2*^N_#5^\RL>0
MT=R\1&"@ /.+\-]4U'PW\4O'7B>S\1:EKFBV'@[P\QG\3?!/4Y/%5VIU378A
MOTNRCL9RPD)^:*Q13'L8KM5Y7]&U7]A?P[<WC/9?LD_LLSP8 #:E+;V\V1QC
M;'HLR[?0[\^H%>2Z!_P3L_X2G]K'QI;1?#W]E'PO9KX4T&YBTB7X5CQ#96+/
M>:VNV.<W-EYDQ$>YW^SQY5XUVCRM\@!Z3X3_ &EX=?UNSTN*WU9;S4+A((VN
M/V9_&=G;([L%'F23(L<,8)!9I'"J"69@N2*GQW_:0^+G[/&J6<.I_ 'X8Z]9
MZA+-':W6@:GXHUF:5(BF9)[?3?"5XMHSK(K+'+,0?G57?8S5U&F?\$K? $NF
MQ_VMX+^!LM\P#3G3_A1I-O:%\8_=QR^=(JX P&E<^]<^?^"*_P -9+B1VN+.
M&.9V=H+;X>>!UC3>?F5"VALX7''+EL8Y)YH ZSX0_M=:'\=9]2AT#X!_&*SF
MTM4:?_A(_ \7AE7WY"^4^HO LS9&"(RQ7*EMH89\CT[]O7P=X9_;0\;:=J7P
M$^/EGLTG2M,N)8OA1>ZC;VLD5[JRO.SVD4PDMV+CRYH/,24))L+A0:[F#_@@
MU^R=;(H_X5#I[1QD$1OK>IR1G!W %6N=I&>Q!![UB>!/^"17[,=I^U'X@M8?
M@3\-9-/TCPYHEY9Q/H<$MO#-)=ZN)'5&4I\PBB5E((940%<#D Z3XI_\%-?V
M>_@5X#OO%7C;2?B%X1\,Z2(C?:QK/P6\46-C:"258HR\LFEJB[Y'1%RW+.JC
M)->5^'/^#B;]@/Q9XETW2;'XM^'5NM4NHK.)[WP=JEA;(\CA%:6XN+)(88P6
M!:25T1%!9F502/J"W_X)L_LYVR*W_"@_@HK+SE?!&F<?3]S5B+_@GG^SU)C;
M\"_@W\R[A_Q16F\@_P#;&@#RVP_X*A_LN^)?'L?ACPKXJT/XEZ]]A.IRV7P[
M\-7OC9[6U618FEE;2;2Y6("1U7$A4G>I ^84S_A?OA/XD_M+^&7\*_#+XC:L
MNG^%]:^V0ZAX#N/"K*'N])V,IUN*Q691M?=Y!D*97=L#+N]-N/\ @G=^SC-F
M.3X$_!5_+;&P^"=-;:QQV\GK\P_[Z'K7DOQ6_P""8G[-7BW]I#P/IUU\"_A+
M]A;P[KMU]GMO#-G9K+<)=:2D;,(XUW.JO*JELE0[@8W$T 9^I_\ !3SP%X>-
MZ-2_9]_:#TN'3&<7-W=_":]BLK>.,_/*]SY1A6)0&)E:0(%7<6"Y(]*\2:C\
M9K[7KE_"OP)^#,F@Y46K^)_B#+I6JM\J[O-MK30[Z"/Y]^W9=2;DV,=C,T:>
M'_MF?\$6?V7])_9E^)'B#3_@YX=T;4-(\)ZG=6QTVXN;&)9HK.5XY###*L;2
M!@O+J<@!3D*N.TC_ .")/P=TNYFCT&-?#^FL=T5D?"7A?6&B))+$W6IZ5=WD
MA9MS9EG?;NVKL141 #USPQX!^(OB'PW#>:UIGPA\*ZI-N6?2;+2KCQ':VI#L
MJ@7S-8/,&4*Y)M(@A<I\X7S&\U\4_"7QQ-^V)X#QKWPO\QO!_B5U*^!)S&BB
M^T(,KJ=1!8@[5# J% ;<K%@R.T7_ ()'?#71;6.'_A&?AGJ1A=B;O4_AEX;D
MO+E3D_.T%G!%QNP-D2<#!W'<[>2>,_\ @F;9V/[6_A'3;7PS^RK#8W7ACQ!=
MP)<_!%)5"QWFCJAN$344BEN )B%F41A<S!8]LI" 'T$_[!?B&4?\G"?%M=W.
MU?#W@D*/8?\ $A)Q]2>.N:[.^_8R\&:C 8Y9/%6U@RL4\0WL;8(P<,LH96QT
M92&!Y!%>-O\ L,Z<(_\ DTG]D>3W%^J[O?'_  CYQ],GZFM#5?V)/A_IVGS7
M9_9+^"^H?9T:4VFGZ;H[7=R%&?+A$MM#$9' VKYDL:;RNYT7+  ] U+_ ()X
M?"'Q#:-::YX;U/Q5I<G^OTKQ'XBU+7-+O .0LUG>7$MO*H;# 21L%9588901
MR\?[!_P1^ _QD\ ZGX#^#GPM\%ZI>:K/9W%YH'A+3M.N)H#IUZ[1,\,2,8V9
M$8J25)13C*C'!VGP<^$<%];G7/V$)/#.EL^V?49_!GA#5$MQM.";;3KZZO),
MG _<P2,,[B H9A3\=?!S]EN[\=?#^%?@'X;M8VUF99A<_!2ZM8Y5_LZ]95S)
MIRJQWA&"C)RN['RY !]@3_#;09TVG1]+^ALX<'C&"-O(]J23X<Z&BLRZ/INY
M0=B?9XPH./IS^.?I7S1XP\!_L5_#/2EU#Q=\.O@;X%TMI!"NH^+/ MGX?L7E
M.2(EN+VVBB:0@,0@8L0K$ A6(O\ P9^$G[$O[25SJ,/P]\,?LL^/9M)C26^C
M\.Z9H6J-9(Y(5I1 KE%8JP!; .TXZ&@#PJPBCA_X*;_LE^2JQP_:_C4L:( %
M51K5MMQC@#![<<5^CL/^IC^@_E7Y;>"OB)\/]._X*P_LN> _#NM>$;?5/!]Y
M\8;&Z\.Z?=6\=QHB/J4$MI"]JA#0*UO"[1H54&.)F4;5)'ZDP_ZF/Z#^5 #Z
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ ILW^K;_=-.ILW^K;_=- 'X=_\ !RU_R?7X3_[$.T_].&HT4?\ !RU_R?7X
M3_[$.T_].&HT4 ?K+_P3[_Y,2^"/_8@:%_Z;K>O8:\>_X)]_\F)?!'_L0-"_
M]-UO7L- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^=W[9GQC_:
M4TW]HKQK:_#/QUXCFTFSUU-)TOPKX;^&>D:]>VL,6BZ5=W%U+<W^JV*E#/J
M4*NYEW+P5&1Y9_PN;]N[^_\ ';_PRG@S_P":NOM/X1#_ (SR^(7_ &%]1_\
M3%X/KZ1H _!7_@IM\3_VO-6_9)\70^-9OB]_8,VAZREZ-2^%/A;3(3"=)O!,
M'FMO$5Q*J^27W,L3,B;F57951O9OV/M(^"OP!^"?@=?B1XRD\-WGQ.UOPQX;
MT$GP;H-Y#<ZA<^$/#\ZQ,[:5+Y*EYV7<[*G 9B79W;[._P""UWBBW\/_ /!,
MKXZ65Q#(TVN>!/$%K;/&H959=)NIB7R05&R)ER-Q)*C@$X^7_@=_P2X\$?\
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MV/B"W\-V-]X[T1O^)@)+FY@T?1/"^L63,[HVV076HS!FC";XU12!\Y?]UO\
MADOX@?\ 1SWQT_\ !7X-_P#E%7P'^T_^PJG[+'_!2/P)X@M_B=\3/%UU\0O"
MWQ*\2ZS%KTVEK;W%ZFBZ59NZQVEC J>9$MON5< M9PE=G[SS #PO_@EM_P &
MY/[-/[8?A'XS77B[3/&"W'P\^+WB;P-IKV.MM#YUA8W""W:4,K!I0LFTLH12
M$7Y=VYF^H?\ B$&_8]_Y\?B-_P"%$/\ XU7P_P#!ZX_;H\&?$+XR7'[.WQ6^
M'_A'P%XT_:-\8>&;/1]4TN&\OYM<5+F^=]SZ?/B*2*T6)&$@ D*EE1"[K[GX
M<\"_\%:_$GA30=27]HWX'VX\2>&I?%*6]SH]MYEO;(L#-&Y31F7S?])3A2R@
MAOG(P2 >^^#O^#3O]E;X>>,M#\0:"WQ(TS6/#>JVFL6,YUFWND2:VG290\-Q
M;212(QC"LKHP968<9!%WXT?$3]F7]GC]K^'X)_$'XE6?@/Q)<^%E\61ZOX@\
M-^"M+T,P-<-;K;BZGTY0;AFC=@FW!16(8D8IO_!/?7_^"@7A7XJS>'?C#XK^
M OQ.TF2+0M?O=1%W<Z9=Z3I5[-=1R):PVVF11SW.+69@LS*N[RQO"LVSU#]J
MC_@B5\'/VV/VZ+'XS_$ZS;Q@MCX17PO_ ,(O<Y6P+)<//'>!XV219%\V1""2
MK!\\'B@#\T_V^OB9^SG\0]>^*NA?#/XC7GQ N_#.E:[>:BRZ/X6?PI-+<_#C
MQ)]FETZ^TZPBGDFA>SMU:-IA$LTA*H\BEHOH3]@/_@JA_P $^OAS^PO\$]!\
M:>)_A5;^,-#\!:'IVN17G@^6>YBOXM/@2Y5Y/LC!V$J.&8,067.6SFOF+_@X
M4_X)>^#_ /@D?^S]+\9/@-KOBCX?WGCCXA:'I=OI>CWTEE%X?$&B:U',;:=6
M%Q^_W,S!GQEY,91PJ_HC\"_^"%V@^'OA-X=M='_:"_:6T'33I\5Q'8:7XATN
MVM8'E42OLC73MJ@N[-W)+$DDDD@&3_P^)_X)I_\ 0W?!_P#\(F7_ .0J/^'Q
M/_!-/_H;O@__ .$3+_\ (5>B?\.1['_HYG]J[_PJ]-_^5U9?B;_@@MX=\73:
M7-J7[07[36J3:+>KJ.G/>^(=)G.GW*HZ+/$6TTF.0))(H=<-M=UR QH X_\
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M7?\ A5Z;_P#*^@#SO_A\3_P33_Z&[X/_ /A$R_\ R%1_P^)_X)I_]#=\'_\
MPB9?_D*NLT;_ (((^&] \3ZQK%C^T!^TM8ZIX@>.35+VVU_28;K4GC18XFGD
M730TI2-512Y)55"C@#&Q_P .1['_ *.9_:N_\*O3?_E=0!X?\=?^"Q7_  3W
MA^#/BZ;P?XK^$<GBR'0[Y]%">!V<_;1"_P!G^62S*',FT?.".>>":_#3]E3]
MFG]F7XFZ3X/TOX@-\3M-\7>)/#USX@FU"#XC^$_#^BMLU;4+985&HQK]G;[/
M;VSJL\RRRM)(RQ+%Y+R_T8ZI_P $.=/U:RFM;C]I+]J6ZM;J-HIXKCQ1IDB2
MHPPRLITX@J02"#Q@]#TKS[3_ /@V,^!ES\;/!FO>*[SQ-\1O"O@KPB_A2T\/
M>*+H3Q.#>W-W',K6XA2!8OM31)!!&D2I&&VL[NQ /Y[/VF-.^"?[)OQTTG_A
M2>D_$#6/&7P[UC2O$$NI:_XHT#Q?X;F2/_2'B*Z9;F&=%D-HK-]H9,F>%XU9
M03_0Q'_P6'_X)JJBY\7?!_..?^**E_\ D.LG_B%C^!^E_'KX@>+?#/BSXA?#
M_P /^.M*AT0^%?"TUG#IL%F$@^TP3?;(+IKB.:>WCG*MM"L#PWR[?7%_X(D6
M94;OVF?VKMW?_BJ]-_\ E?0!YW_P^)_X)I_]#=\'_P#PB9?_ )"H_P"'Q/\
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MLE]XATFX^S74+!X9HP^F$+(C?,K@AE8 @YY !R/_  ^)_P"":?\ T-WP?_\
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MU+QQ\3M,\)^&)?#46A^*=0CN+6X4W4UQ!+F".'REA6>2-885CC($;;0WF&0
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MQ+AGM[R%U*/%)&UD4=&1F5E8$,"01@FM _\ !N5H?_1V_P"W-_X=&/\ ^0Z
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M?0\$5\H_\.COVF/^AX\8?^)&R?\ S#TU_P#@D;^TPRG_ (KCQAD]S^T9)_\
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M1110 4444 %%%% !39O]6W^Z:=39O]6W^Z: /P[_ .#EK_D^OPG_ -B':?\
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MXFJXMKI)"";+2B!\I."0CD>RD]J /C__ ()Y>%/'=_\ M=^(+W0=4T71V?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&Y@64?,,CIC
ML<\'/X5-39ON?B/YT ?CK_P;#^%-,\*_M&_M#6^EZ?8Z;#)\./@Q=O':0+"K
M37'@\W%Q(0H WRS.\CMU=W9F)+$G]B((!;KA=QX Y-?D/_P;1_\ )SG[0?\
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M "BBB@ HHHH **** "BBB@ HHHH *;-_JV_W33J;-_JV_P!TT ?AW_P<M?\
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M 'T-C_9_6C'^S^M?//\ P]D_9N_Z+1X$_P#!DE'_  ]D_9N_Z+1X$_\ !DE
M&E\,/^4_/P9_[)EX@_\ 1]O7E=I_RL]?M>?]BKX=_P#33I%;7['_ .TU\/\
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M.M5.<_\ 4"OOQK[>^#O_ "2[PW_V"+3_ -$)0!TU%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>^8QQ<
M;AU/&.3V_7%6*;-]S\1_.@#\;_\ @UVDUY_VAOVB/^$BATFUU#_A /@\L,>F
M7#W$+62^$W6S9W=5(E:U\AI% *K*TBJSHJNW[)5^0?\ P;1_\G.?M!_]DO\
M@?\ ^H2M?KY0!Y?^V[_R9?\ %[_L2]9_](9J],@50K8_B))^M<O\;_$NC^#O
M@QXLUCQ!9KJ&@Z3H]W>ZE;&!+C[1;1PN\J>6_P C[D5AM8A6S@D YK>T<[K=
MO[K'(QC;CMC P0>N>^: +K_=K\H/^#?C_DM>I?\ 9,(__5@>.:_5]_NU^4'_
M  ;\?\EKU+_LF$?_ *L#QS0!^L%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-F_U;?[II
MU-F_U;?[IH _#O\ X.6O^3Z_"?\ V(=I_P"G#4:*/^#EK_D^OPG_ -B':?\
MIPU&B@#]9?\ @GW_ ,F)?!'_ +$#0O\ TW6]>PUX]_P3[_Y,2^"/_8@:%_Z;
MK>O8: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!T.;PQX2TO39F:233[.*U:0+M5C&JIG'7G:2/8\UO44 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %-F_U;?[IIU-F_U;?[IH _#O_@Y:_P"3Z_"?_8AV
MG_IPU&BC_@Y:_P"3Z_"?_8AVG_IPU&B@#]9?^"??_)B7P1_[$#0O_3=;U[#7
MCW_!/O\ Y,2^"/\ V(&A?^FZWKV&@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ^;OA#_P GX_$+_L+ZA_Z8O"%?2-?-WPA_Y/Q^(7_87U#_ -,7
MA"OI&@#XS_X+IZQ<:;_P3E^*EO;W$D,-]X/\217,:,0LR#0-0<!AW 95;Z@&
MOFG7O'NM_##_ (( ?'[7_#>K:EH.N:;X.\/O::A87#6]S:LW@KPPA*2*0RMM
M8C<"",\5]5?\%M-'TV^_X)F_&RXO9%6[T_P)XCFL%\W89)6TF[1E"_QXC=V*
M_P"SN_A-?'_Q7_Y5T/VBO^Q+\/?^H7X6H _.CX!?LE>+/C'\6_@7J&H?M"_'
MR'6OB##-J4^JQ>*IOMVG3/X4TK4)&MY6+.I?[3]G9B26A@C4D[03]I_\.F_&
M'_1XO[77_A>S_P"%>-?L2?\ )3OV2_\ L$/_ .H!X>K]+\#T- 'QK_PZ;\8?
M]'B_M=?^%[/_ (4?\.F_&'_1XO[77_A>S_X5]E8'H:,#T- 'QK_PZ;\8?]'B
M_M=?^%[/_A1_PZ;\8?\ 1XO[77_A>S_X5]E8'H:,#T- 'QK_ ,.F_&'_ $>+
M^UU_X7L_^%>T?\$ =(\6_#+]M?\ :[^&_B+XH?$KXH:7X'3P6VE7?C'7I]4N
M;?[79ZA<3!-YVIN8H#M4;A&F<XS7L6!Z&O.O^",__*6+]NS_ *Y?#W_TU7U
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M/^2UZE_V3"/_ -6!XYH _6"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8U[XG>#/#+:)K>D?#[5]6\/2H_A+P_%N-Y:P2@A9+>5'$:L5:,J1D''Z,?\
M!4+4[*__ &*OBAX;U&Q-]8^*O"7B'3IQY[1[%31;VXS\OS'_ %6,93[V<D#G
MXM_;_P#^#<C]C7X$?L#?&SQOX8^#W]G^)_!_@'7=;TB]/BS7)OLMW:Z=/-!+
ML>\:-MLB*VUU93C!!!Q0!^6WA/7_ -KC]G34?".N?\*MAM]'^"=K<K/K6I?#
M;Q?'IVF6\/A^PL))K]_LZNB"ULXW)"H5<2.P6)D U?\ B(B^+?\ T-?[+_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5'.,IT[C^=25#>3>6GX9^F* /R)_
MX-I% _:;_:".!N_X5?\  _MZ^"5S7Z^5^.?_  ;#>*]/\5?M&?M#76F7UCJ5
MK'\.O@S823V=S'/''<6_A%K>>(LK$!XYHI(W7.Y'1E8!@17[&4 <S\7_ !Q8
M_##X2^*/$NJ07%UI?AW2;K5+R&!%>66&"%I'5%8JK,50@!F )X) K=T^)H8F
M!^[GY1Z#TZGOFN/_ &EO MY\3_V=/'WAG3Y+>+4/$7AS4-,MGN'V0I+/;21H
M7;!VJ&89.#@=C796LC,&5MI9>"5! S_G% $S_=K\H/\ @WX_Y+7J7_9,(_\
MU8'CFOU??[M?E!_P;\?\EKU+_LF$?_JP/'- 'ZP4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4V;_5M_NFG4V;_5M_NF@#\._^#EK_ )/K\)_]B':?^G#4:*/^#EK_ )/K
M\)_]B':?^G#4:* /UE_X)]_\F)?!'_L0-"_]-UO7L->/?\$^_P#DQ+X(_P#8
M@:%_Z;K>O8: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5CM-@#P(K%?*=6&W=M7[TKX__P""&L2I_P $VOA<<?>\)^&F^A_X1K2:^P*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU[#7CW_!/O\ Y,2^"/\ V(&A?^FZWKV&@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ^;OA#_P GX_$+_L+ZA_Z8O"%?2-?-WPA_Y/Q^(7_87U#_
M -,7A"OI&@#YG_X*@SS6W[,WB18Y9%CF\/>)5=%<JL@_X1W4VPP'W@#S@\9
M/4 UI?\ !5[_ )18?M*?]DK\4_\ IINJD_X*07.DP_LD?$)-1B=K^;PIXB72
MW )$<XT6^+$X/&81* 2".>@.#4?_  5>_P"46'[2G_9*_%/_ *:;J@#B?^"&
MW_*-KX6_]BCX9_\ 4:TBOKROB?\ X("Z5JNC?\$S?AG#JVK3:U<-X?T6>.X>
MUBM]D$FAZ;)!!MCX(AA:.$.<,XBW-EV8U]L4 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^2Y_
MY61+[_LHNB_^JQU^OUBL?^/?_@3?S-?CWX?\9S:Q_P '/_BS1Y(8TCT7X@^'
M7609W2^;\,/$1Y';&SC'7)]J_82Q_P"/?_@3?S- #-1_X]^/O9!'OCG'T.,'
MVKYP\6>#]4\#^._V?[/6+A;J[N/B]XDU&-Q(TFVWNM(\5W-NA+ $%(98U*@;
M5*E5)4 G+_X+$?MC^//V&/V08_''PYT72]>\2-XAT[2_LU]I%UJR);3R,L\J
MVUM-#+(Z1AF"K(OW3DXR1^>?C3_@M=XF\?\ BKP3JUYX_MUN/!_B.YU#2T@_
M9E\2JMS=_P!G7]A+ P;7]SE([JY8QJ0ZO$6+;49" ?>/["'_ ".ND_\ 8?\
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M3K]EU? ^AQ_'SX0:Y\._!=O!I]OX5_MO4;.WGLHHBB6_VJ/1O-C50HPP8MP
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M%% !1110 4444 %%%% !1156]U6UTYX5N+B&W:XD$40D<*97/15SU8X/ YH
MM455T_5K75TD:UN(;A8W,;F-PP1AU4XZ,.XZBK5 !1110 4444 %%%% !111
M0 4444 %%%% !1110 4456O-0ALGC6::.-IFV(&;EVP6P!W.U6/L%)Z T ?C
M-X*_Y6MOB3_V/OA/_P!5;XEK]G+'_CW_ .!-_,U^'NJ?&SP;\%_^#G;XJ>*O
M%_BSPSX5\+V'CSPF;K5]6U."SL;8?\*S\0P?/-(RHO[V2./DCYY$7JP!_42V
M_P""K_[+:0[6_:4^ *L"V0?B%I [G_IXH ]&^,:;_'7PP^[G_A)Y\9&?^8-J
MG]*\#T-"-8^!H#?ZSXZ>-QR,X'V?QEZUH>-O^"E/[.GCCX@_#V/1?C]\$]8?
M3=9O=2O%LO'&F7!M+6'1-4:6>0),=D4:_,SMA5')(%>)VO\ P4%^ NAWOP-N
MK[XW?"*SME^,'C'73+/XPT^./^SY5\80Q7FYI0/L\DLB1K+]QGD10Q+ $ ](
M_88LS<>,=*0R-_R'_C*,[0>/^$_4'KU]><\]<]*J_L?PD^-/V.OFQC]G?5ST
M]'\&5YK^PY^WS\"['Q-#>7'QJ^$\-IH^J?%?4+^>3Q=IZQV5M?>/8I+&>1C+
MA([A)8FA9B%E61"A8,,TOV:OV_?@3X"\<_LI)KGQJ^$VBMX?^ .HV&J"_P#%
M^GVYTZXN!X0F@AFWRCRY)8X9G17PSK$[*"%8@ ROA1:?\:D?%\F]MR_L8>%,
M=.AT?Q!Q].!QT..:]J^.-DJ_M[?$SYF^7P_\&L')R ?''B 8SG../SP>PKY#
M^&W[=_P/TW_@EYXL\.W'QD^%=OX@N/V2_#'AF+3)/%E@MY)JT6E:['+IXB,N
M\W4;RQ*T.-ZM(@*@LN?7?C-_P47_ &?=5_;3^(FKVOQT^#MQI-]H?PE@M[V+
MQGISV\\EEXRURXO%603;6:"":*64 YCCD1VVJP) /L_]EF#9\:/VB@2S8^(=
MH,Y/./"GA[FMSX'_  EOOAI\4_C!K%U/:W%O\0?%UOK]FD6_?;11Z#I.G%)-
MR@;C)I\C J2NUTYW;@/GG]F3_@I7^SG!\:OCEO\ C]\%5_X2+X@6DVE9\;Z9
MC4D/AO0K</!^^_>*9HI8LID;XY%^\K >H?LR?&FRUKXV?M"0ZCXJM[JSTOX@
M6EKI4=SJ :.SMCX5\/S-'"K-A(S/+.Y5< O)(V-S,2 ?0E(_W:S-&\7Z3XC:
M5=/U*QOO)QYGV>=9?+STW;2<9P<9ZX/H:O7-Q';0-)(ZQQJ-Q)X  Y)_*@#\
M4?\ @D3_ ,K3_P"VA_V!+_\ ].&F5^IVDR+^T)\7+G:T4W@;P#=>5"T-RS1:
MMKT4H+[D4!3'8,BK@R2(]T\FY(I+%&?\7OV*_CQI/PB_X.7/VN[Z\\9>&O!.
MF^(K2\TT>)=6U6ULK/3LWEA+N1KC,<TQ6)@D6"&(9F^16S^P'P\_;B_9K^&?
M@_2=!TOXY?!VWTG1;**RM8W\=6$K111JJ*K.]PSL=JC+,68D$LS$DD ]_@M!
M;6WEJS,J@@;N<#L/H.GT'.>M>9^,?"NI?!_5YO$GAN.XOM)N',VLZ%&&9B/G
MDDN[1%5B;AF.Z2(#]]\S+B7/F<I/_P %6/V7;2Y>&;]I'X"0S1,4=)/B!I*L
MC X((-QD$'M1!_P54_9=U">.&']I#X!W$TC )&GQ TEV=NP %QR: /9O#'BR
MQ\4Z';WVFSQWEG=1B6&6-B=Z$\'GD=^OI]<?D9_P:;_"+Q%\,+W]I+4M<T[[
M#9^.M:LO$&AR?:(I?MMC]NUNS\W",QC_ -(L[E-L@5_W>[;M96;[(\=?\%#?
MV>?@+XBN/$FB?'+X*_V/K$IDU;14\;Z3"))79&DO[<&7+3A58O""/-^\O[W*
MS?"O_!,3_@JO\"OV ?V?=%\0?$[QQ'H6E^,O"UO%I#VUA=7\MWL\5>,YF.RW
MB=EQ'+$<N%'[R/\ O< '[62_<;Z5^5?[1G_*Q?\ LN_]CM\0/_5=^'*^ZOV*
M_P!N_P"&/_!0?X47'CCX2^)CXF\-V^I2Z3/.UI<6CPW421N\31W"1R*0DL3?
M=P1(I!.2*^!OVM-<3PS_ ,'!7[-.H26]]>?9?&GCTB"SMWN+B8GX?>&EPB("
M21NR>P"D^Q /TQ_:#^(5U\)/@%XV\664$-U>>%_#]]J]O#/N\N62WMWE57VD
M':2@!P0<$UUEI!Y"M@YW'/3\/Z?YXKP[]I;XA7'Q/_9M\?>&='\,>-KK6/$7
MAO4-+LH6T&Y@22>>V>-%,CH%12S#+,< <DU[C:%L,6#<G(![>W^>^: +%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !39O]6W^Z:=39O]6W^Z: /P[_X.6O\ D^OP
MG_V(=I_Z<-1HH_X.6O\ D^OPG_V(=I_Z<-1HH _67_@GW_R8E\$?^Q T+_TW
M6]>PUX]_P3[_ .3$O@C_ -B!H7_INMZ]AH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "FS?ZMO]TTZFS?ZMO]TT ?AW_P '
M+7_)]?A/_L0[3_TX:C11_P '+7_)]?A/_L0[3_TX:C10!^LO_!/O_DQ+X(_]
MB!H7_INMZ]AKQ[_@GW_R8E\$?^Q T+_TW6]>PT %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ_G]*^/O^"ZHN9?^"=/BS['N^V'4])6#&,JXU"W*GYN!\V#S67X6\&_MO_\
M"/6?D^)?@0(C"I7SK+42X! /)5L$\\D #.>HY*HUO88FK2A!M:2TM9-Z/JM[
M7*Q>6K-N'\%F%>O"G.#J4O?;3E&')*+T3OR\[CZ)+H?<!;--;Y4/'8U\8_\
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M'QCD^$W[;7[.>AV]C!=P_$N\\0^';F624AK-8]*.J"5!@@L6TU$(.!ME9LY
M!^AIL^4V.N*_);]L^\^(WQ&_X+X?L\^$V^+'BC1?"]YXL\66^CV>F:5I D\-
M-9^!M.N9)+>:>SF:5IVU2Z5Q<>:JJPV!& 8 'Z:?%'XHQ?#/PDETT,VH:E>3
M)8Z;I\"LTVJ7<F1' FU6*[N6:1ALBC2261DBCD=5^ ?@'4/AG\+[/3]7NK>^
MUNXEN-2U6>WB,-L]]=3R7-SY$19VC@\^63RT:21E3:&=V!=J?PQ_9\TOX<ZQ
M;ZS)?:WXF\2+:M:S:YKFH27EY*LAC:<HIQ#;++)#$[Q6L<,!9$VQJJ(J^A4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !39O]6W^Z:=39O]6W^Z: /P[_X.6O\
MD^OPG_V(=I_Z<-1HH_X.6O\ D^OPG_V(=I_Z<-1HH _67_@GW_R8E\$?^Q T
M+_TW6]>PUX]_P3[_ .3$O@C_ -B!H7_INMZ]AH **** "BBB@ HHHH ****
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M8_\ ! OP3IW@7_@F1\,;/34N8[>;P]HFH.)KN:Y;SKK0]-NIB&D9F"F69RJ
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M/B-X;(// .O:9P/T]N,T ?3MOT;Z_P!!4E1V_1OK_05)0!X;^T#^VQ9_L_\
MC#Q%87O@SQCJFE^$_"T_BW5]:T^72?L=I;Q07D_D>5/>Q7<DSK92*HB@= TD
M99T7>R-^*/[;^G?"+QKXFLM7\*^*H_#?@K2[C5]?\5+)IK:9ID,%BU_(IM_M
M8U"5Q"JC]S:2+ND4;L!V6;X\_L0Z5^T!XP\0:EJ'BSQ1IMCXJ\+S^$]4TNRM
MM+:">VE@O(#*LTUG)=1RJM[(P\N98RT<>Y&7>K\S=?\ !-^R\37'BA?%GQ.^
M(7C;3_&UA=Z9KMAJMAH$"7]O<V)L743VFF0746(CE?)F3YAD[@SJP!H?$_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ ILW^K;_=-.ILW^K;_=- 'X=_\
M!RU_R?7X3_[$.T_].&HT4?\ !RU_R?7X3_[$.T_].&HT4 ?K+_P3[_Y,2^"/
M_8@:%_Z;K>O8:^0?^"$?_**SX4_]Q;_T[WU?7U !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!\W?"'_D_'XA?]A?4/\ TQ>$*^D:^;O&O_*1*T_[
M!WAO_P!$^,J^D: /G[_@H]XN'AW]DGXB6+6[2-KWA'Q%9JP8 1%=&O;C=[@B
M(J1P<D'/&#%_P5>_Y18?M*?]DK\4_P#IINJ]<^*'A&3QIIVGVJ7'V=K;5;*^
MSY>_(M[B.?'7/S;-N>@SGH*XO]@G_DQ?X,_]B-HG_IN@H \=_P""&\JG_@F]
M\+5S\W_"(^&>W_4M:1_G_P#57V!7Y9?\&FGA/2]#_P""87A.\L=.L;*[UJSF
MO=1FM[9(Y;^<:[K< EE8#,C^3;PQ;F)(2)%!PJ@?J:.E !1110 4444 %%%%
M !1110 5^)?[+G_!)+X%_P#!3'_@HY^V5<_%[PC<:]<^$_'A_LZ6TU*XTYU^
MT7>H"3>UNZ&3BWB WD[0#MQDU^VE?G#^SQQ_P<P_'K_LF]I_Z!H= 'DOQK_X
M-</V83\;?"_ASP;X8T_P_'J6AZGJ5RFLWFM:J+@V]Q81AD,>IVQCV"Z.=S,&
MWC"_*2&ZA_P:+?!J^TR>&!?!-E-/$T<=S!I7B$R6[,,"1 ^OLA9<[AN5ER.5
M(X/ZN?$CP=IOC_PC>:/JUI]LL=03RWC$K0L#U5UD0AXW1@K+(A#(RJRD,H->
M?Q^,?B#\*[VWT_4/#D_C[06+I'K&D7$$6IPC<S(+JSF:-& CVJTMO*S2/DB"
M)2* ./\ ^"6O_!/'0_\ @F+^RA9_#/1-2DUIEU"XU._U-[1;,W\\FU%<PHS)
M&1#'"A"'#-&6.69B?HZO"/V*O^"B/PQ_;Y7Q4/AUJVI7\W@N[2RU6*_TJXL9
M('=I44KYJ*)$9X)U#(2,Q-[5[J'&.H_.@!U9NL^*]-\-Z5<WVI7UOI]C9QF:
MXN+IQ## @&26=L* !UR>.]8?QE^(D_PS\%R:G:6<.HWDEQ;V%I;2S^1#-<W-
MQ';6ZR2!7:.,S2H&=4D95)(CD("U0^%WP0L? LDVM:C))KGC+5HD&J:Y=.TD
MTQVQAH8-Q(MK4,@9;:+;$&+.5,DDDC@':V%_#J=E'<6\T=Q;S(LD<L;!DD5@
M"K*PX(((((X-6*^=?^"8X6/]GWQ8HPO_ !=CXB #_N==:KZ)WK_>% 'QU_P5
MQ_X)(Z7_ ,%7OA]I.@WOC+4O MQIL5Q827]KIZ7QN;&XGL;J6V\MW55S<Z;8
MR;Q\P\DJ"%=PWYVS?\&0G@:W'S_M">*%R<#/ABWY]A_I'6OUR_;6_;A\!?L$
M_"^'QA\1-0U6QT6ZNS8P?V=I%QJ=Q)*+:XNW(B@1VV1VUI<3.[ *J0.Q88Q4
MMY\8/&WQ%:*Q\*>![S2H;V#SSX@\3&&+3K=&4E52WAF:ZGGY0["L,6TN?M =
M%BD /RZ_8I_X-2?V=_#WCOXD>'_'T_B'XMV/A^[T^QL]5EN+G0VM[QK=[BY@
M1+:;;)&L5Q8L)22-[RIP8VKSG]N']@;X/?\ !,K]LSX:>'?AGH,?A/P[?#3M
M8U&:\OY;IS(/&_@E69YYV9UC2-"0I;:A:0C&YB?V_P#A9\+-/^&^@7$-NUY?
M7NIW+7VIZG>E6OM7NF55:XG954%MJ(BA55(XHHHT5(XT1?CO_@I7XBL?^'C'
M[%.DS75O'J5UX\OKN&U:11+/%%H>I++(J9W%4::(,1D*94!QN&0#Z6U']HNT
M\7^)9O#?@%9/%6K*D;RW]O&[:)I2O)M;SKM<1/+&JLQM(W:XPT6Y8DE66NK^
M"GPNA^#G@"UT.">XO&C>2YNKNX8-/J%W/(\]S=2;0%#RSR2.50!%+8557"CJ
M!:QKM;)^4G'S$8S^-6,X% 'Y0_\ !XO_ ,HC+7_L?M+_ /1-[7ZN0_<KXC_X
M.-3G_@BI\?O^P/:?^G"TKUS_ (),_P#*+/\ 9K_[)7X7_P#31:T ?05%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5\T_P#!1;]ASQ%^V]HGP_L_#_Q(\0?#&?P1
MXI@\327NDHCW-\T$4GD0_O T05+DV\^)8I5+6Z_(&VNOTM10!^?_ (__ .":
M'[5FH:1:Q^%/VX/B)HM\MP#--JWAK1M3A>'!W*J1VMNP?.S#%V VM\IW KQX
M_P""6'[>&/\ E(AJ'_AKM/\ _CU?IA10!^:'_#J_]O#_ *2(W_\ X:[3_P#X
M]39/^"6G[>"#</\ @H9J$A'\'_"L=/3/X^:<?7!QZ'I7Z8T4 ?$,/_!-[]H%
MH_F_;,^,RMW'V/0#_P"XNG_\.V_C_P#]'G?&?_P"T#_Y65]MT4 ?$?\ P[<_
M: "\?MG?&;\;'0#_ .XNO+_$'_!+;]N&YU.ZDT__ (* ZY:V/VF0VL%S\.M-
MN9HH"?D1W5XU=P.&8(JMU"K]VOTLILQ_=-]#0!_+!_P2V_X(;^)/^"@GC#QW
MX9NO%7PZ\)WGP\\/^$->^U'PDVL'5+?Q#I3:G;;V:>W*31P",2##J9'D"LRJ
MK/\ 9W[.7_!L/XJ7XWSM)\?CINE_!S7;O3+>S\-^&FT>262_T>RN)9H7^URI
M"66ZB1_W;%UA()^9=GJ__!.<X_X.#_$1]/A-\0\_^'CUNOU.\/:/H<7Q=US4
MK>XB;Q+=:/I]M?PBX#216<4UZULS19RH:2:\ ?:-Y1AD[#0!\#I_P0*UYE^;
M]HWXS*QZC_A(&./_ "'1_P ."->_Z..^,W_@_;_XW7Z3+THH _//_@D+\,]%
M\)WGP_U;3X-875KC1O'?A[5;J_UZ]U,ZD^C>)K/3$N0L\C1P/+Y#2ND*(N9,
M8(5<?H97PE^S+_R=]\4/^SG+S_U6MI7W;0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-M?AQ_P<X_%"VNK'5+QO%G@^RT6![*W,J6DIM-,N!).<XCBVVS+O/!=XUZL
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M6K^"M8UIOV9?B/?>*9?#]S#+-!J-UH7BZZ$-]Y9+K=QP30(R2890JJ (P@H
M_;']O7]C#]J#]O7X*S>&?%6J>"KA-,M-9GTFVTGP0FBFYU"\T#5-(A6>ZD\1
MWWEVZ_VFSN4MW8^4N/0_I#X8T^32_#6GVLVWS;:VCB?!R-RJ <'\*L6T""/[
MOO4U  37Y.?\%&_C/8^/O^#B#]B7PO9Z=K4-QX&U/Q+!=WL]HR6-W)<Z/:7
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M?^4B5I_V#_#?_HGQE7TC7S7XZN%@_P""B%F9&5%^P>&AECCDQ>,0/S/%?2E
M'$_&W0KSQ%HNE6]G ;B2+7=+NG4, ?+AO899",]<(C'UXXYQ7+?L$'_C!?X,
M_P#8C:)_Z;H*Z_XM^*KCP=I>G7%O'#(UUK6GV;"5"RA)[J&%C@$?,%8E3S@@
M'!Q@_ECHW_!=#QW^R[X&TGX>^&?@'H'C+0/A/\/O!4VM>*-6^+&F>$;6%M4T
M>"6VC9;^(("S"2,%97/R9P,@4 >A?\&HO_*++P#_ -@FX_\ 4C\0U^GF:_*_
M_@U:GF\,_L63>"+KQ/\ #GQ%?>"8HK:1?"FOIJ_V%;B_U2Z$5V\>8A.))K@
MQ,\31K"R2/N)'ZH#I0 4444 %%%% !1110 4444 %?EC\-/@S8^._P#@Z4^+
M6O27E]9WOA[P!8W"+;^48[Q5BTE1%+O1FV;I=_[LHVZ-,G&5;]3J_.']G?\
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MU#4/"OQ2\,Z!\0/#DVFV5QX>BL=<\0>&)K?58[JR?,SVD#2J8(G,Q0 F/ @
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M]O\ _8Q;D'_A8=R.I[:#J^/\B@#4BM?V_ECPMQ^Q^J^\/B/C_P ?KEO$D?\
MP4VAUJ;^PV_83.F@*(3>+XJ$_P!T;LA<J/FSC!Z8SSFOO,0(?X%_*C[.G_/-
M/RH _*K]M3]D/_@I'^W7^S+XO^%GC"]_8CT_P_XRM([.^N='N?%,-Y$D<R3*
M8C+'+&&W( 28VR#CT(_0/]AKX-:M^SC^QC\)/AWKLVGW&M> ?!>C>'+^:QE:
M2WEN+.QAMY&C+*K%"T9*E@#@C(!XKU)K6-Q@QQ_E3HXEB'RC% #A1110 444
M4 %%%% !112%PIY(]: %HI X)QGGKBEH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB[6[75-!U:UGEN]1\N&14M]0T.VC6.-'BV7EJI99'VM^Q@Z4 %%%% !1110
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M:?V?]%M[[Q-\;OAO;PW4R00166L1ZG=3,TB1@K;VOF3,%9QN(0JH&2P4%A]
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ME^S+_P G??%#_LYR\_\ 5:VE?=M?"7[,O_)WWQ0_[.<O/_5:VE?=M !1110
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MEUQ#XJ\36BZ=%9"&1Q<O<"YAU".9W"(+272D9?,8O(,%:^4?V6?BGX[\-_\
M!=OX@>*/VB+7X?\ PYU^WT:R^WKIVK^9I%C"8M,6 M<S%1N92,YV_,V!D\D
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M(J6TK!&1TDG%K%\4?'3XD^'?BG_P4I^"6J>%]>T7Q)I;?'9T%YI=]%>6Y9?
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MU\)?LR_\G??%#_LYR\_]5K:5]VT %%%% !1110 4444 %%%% !1110 4444
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M_P!K>#)FM;J6/^T[Z"87$MKXATF55D>VB&R42>:;<.,>4<@'],?V-4VD9XX
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M "BBB@ HHHH **** "@]:*#UH AB^X/H**(ON#Z"B@#Y'_X(1_\ **SX4_\
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M@?E3J "BBB@"KJ0D\G]WSR"V.N!SQ^@^F>^*^'OV>_\ @G)\=?V5O@0WPU\
M_&WX7:9X<75KW55N;CX6W\FJO]KOWNYTDN(]>1=Y65H/,B2)Q'RC)(%D3[KH
M Q0!\MVW[.G[2GAWP=9:'H/Q<_9^\.Z?IL,5K9Q:7\&-2MULX(]H6*)?^$D*
M(FQ0F !A0-I!"D6O#_P(_:6\+6\S6?Q:^ (FN'\V>63X0ZS+/<OP SROXG+N
M0JJHW$[555& H%?35% 'R7X<_9I_::\/SZ]>K\:O@C<:MKDCO-J5Q\'M1:Z1
M [O;P1X\0JBQ6XD*Q)L8#+,YEEDED>'2?V3OVDM(TZ/3XOC-\$?[*PSW%FWP
MGUADOIG?>\TS_P#"2^9(Q.X$,^PAN4)VX^NJ* /E'QQ^R)\=?BOI'AGP_P"*
M?BI\'6\(Z+XG\/\ B.>R\/?"G4=-O)UTC5[/5([>&:7Q!/%")'LTC+&%P%8X
M4D#'U9$&6)<]<#-.HH ,U\L_\%H;G4?#W_!,?XM>(M"6=?$7@?3X/&6D30PB
MX>RO=)O(-2M[KRVRL@AEM8Y2K@QE8R'!0LI^IJ_/G_@KB/BI\6OCE\._V?\
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M1_\ **SX4_\ <6_].]]7U]7R#_P0C_Y16?"G_N+?^G>^KZ^H **** "BBB@
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M\G??%#_LYR\_]5K:5]VU\)?LR_\ )WWQ0_[.<O/_ %6MI7W;0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4'K10>M $,7W!]!11%]P?044 ?(_\ P0C_ .45GPI_[BW_
M *=[ZOKZOD'_ ((1_P#**SX4_P#<6_\ 3O?5]?4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !28]J6B@#XQ^/\ $R_MS+9W=]+HNF^#=9\%^/\
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M (I\[<R@MQ]D \4 %%&:* "B@G%!.* "BC-&<T &<49JO=7/DS1KE5\PGKW
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M\0>$;K5/#5UJ>I^89M3.GZG=V:7(,C.[1RQPH\;L[;HBC;CNR0#Z97I1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !4<[!8V_VN![FI*AO(!<0,K9VD'(Z9&.E 'Y#_ /!.J=8_^#@WQ$S-A?\
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M1_\ **SX4_\ <6_].]]7U]7R#_P0C_Y16?"G_N+?^G>^KZ^H **** "BBB@
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M-?\ A='['?Q<\&?:FL1XN\$ZSHOVD0>>+4W-A/#YNPD!MN_.W(SP..M>(_\
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M+S_U6MI7W;0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCP=)J'B[P'^RY\/9959?MNLRI=6%DVX1JV9K6U\Y0SQDJ&BRS!-P)#5\<?\
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M1(&GK_R\?LD?^'ZOA_[KE'_$2#I__/Q^R/\ ^'ZO?_F<H L^ OVS/A[\#/\
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M?7U?(/\ P0C_ .45GPI_[BW_ *=[ZOKZ@ HHHH **** "BBB@ HHHH ****
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MN#_H5?'/_@ED_P :;)\?(44_\4IXZ;T T63G]:[SRE_NBH+V/;;R;<+QP2.
M?7_Z^/SH X:S_: ANX Z^%/'')(&-&D(X/K39?VA88%RWA/QPO3!.C2!2<X
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MY!&>]6AP*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC=JEYLEBW6/BA?#5JR2K$DJ_8]'ALK1!(L$*R-' CR"*,NS,H( /I6\_:O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4'K10>M $,7W!]!11%]P?044 ?(__  0C
M_P"45GPI_P"XM_Z=[ZOKZOD'_@A'_P HK/A3_P!Q;_T[WU?7U !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#-OIJ^&]%B\.Z7--<37UQ8:=&L2"TBFN'DE6$BWMRR[OF,,9;<4&WTX+\N*
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M1T)%=Q10!GVN@1V-@MM'\L,:A H1>$  "XQ[?YXQ?4;5 I:* "BBB@ HHHH
M\Y\9?%"_\.?M'^$/"?\ 9BMI'B;0M6U"757! MKNSGT](+4'&-TL5W=R $YQ
M:.5! ?'HPZ5R'Q \&W'B/QCX5U&UOH;1M O9KJ:)X?,^UQO:3P^6"""A#R(^
MX9XC9<?-N7KQTH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M#UHH/6@"&+[@^@HHB^X/H** /D?_ ((1_P#**SX4_P#<6_\ 3O?5]?5\@_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *#UHH/6@"&+[@^@HHB^X/H** /D?_@A'_P H
MK/A3_P!Q;_T[WU?7U?(/_!"/_E%9\*?^XM_Z=[ZOKZ@ HHHH **** "BBB@
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M!P*DBLUB8$9PHP 3G_/_ -858HH !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !0>M%!ZT 0Q?<'T%%$7W!]!10!\C_P#!
M"/\ Y16?"G_N+?\ IWOJ^OJ^0?\ @A'_ ,HK/A3_ -Q;_P!.]]7U]0 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *#UHH/6@"
M&+[@^@HHB^X/H** /D?_ ((1_P#**SX4_P#<6_\ 3O?5]?5\@_\ !"/_ )16
M?"G_ +BW_IWOJ^OJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*YY '7T__74PX%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4'K10>M $,7W!]!11%]P?044 ?(__  0C
M_P"45GPI_P"XM_Z=[ZOKZOD'_@A'_P HK/A3_P!Q;_T[WU?7U !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !0>M%!ZT 0Q?<'T%%$7W!]!10!
M\C_\$(_^45GPI_[BW_IWOJ^OJ^0?^"$?_**SX4_]Q;_T[WU?7U !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !0>M%!ZT 0Q?<'T%%$7W!]!10
M!\C_ /!"/_E%9\*?^XM_Z=[ZOKZOD'_@A'_RBL^%/_<6_P#3O?5]?4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %!ZT4'K0!#%]P?0441?<'
MT%% 'R/_ ,$(_P#E%9\*?^XM_P"G>^KZ^KY!_P""$?\ RBL^%/\ W%O_ $[W
MU?7U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0>M%!ZT 0Q
M?<'T%%$7W!]!10!\C_\ !"/_ )16?"G_ +BW_IWOJ^OJ^0?^"$?_ "BL^%/_
M '%O_3O?5]?4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB=\2M<_X23QMXF?5VU+4OLEO9_:1!JU[:Q?NK>..)=L4$:_*HSMR2237;_\
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MIT#Q3;EC9I+2)0SGY5^?\#TKZF_X*>%O^(/;P_CI_P *M^'>[C_IZT*@#/\
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M>XL);FVM(=-GUO2=S+'>"VCCC0QK(C#?&@(2:W$BHS!Y/G7XU>-M)_X*7_\
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ML;^'[NVL]8^-7B2VU37[TNTC:)I<,XCBGF@4$M 9#<3L^X!%TULY!)0 X_\
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MJUT'MO#GAJVGC&H^);@;0R1*Q.V&/>AFE*D1C'#.T:/^3G_!PM^UQI_[!_\
MP<:? ?XO:KI=YKEGX'^&<-X+"V94DNY&N=?BBCW-PJF21 S<E5+$!B I^??V
M=?BSJ7[3/_!:WX3_ !-_X* ^&=6TSPS\4K'^U?A[:ZOYEIX:T]_-!TU3$S-B
MQWH08W^_)<02S[H97=P#]5/^"&OC3]LC]K^2;XZ?M!>.F\,?#GQ4&O/!OP]L
MO#NG6JWEM,I:.YDG:!KM+=4.85:7S90!(S>7M$OZ9CI5> 1L%; #L-V,8)Q[
M?E^GM5@=* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \[_ &IOVC_#?[)G[/GC7XC>+&F7P_X)T>XU>]6
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M#_\ !-/XL^%O@_\ \'1/[9NH>+/$F@>&+&YTR^MXKG5]1BL899#?Z:1&K2,
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MKPM\/VT?2_CI;W-IXXM(=;U$0:Q%.+A956,SE;8%;J91]F$957P"-JBO%_\
MB%V_89Q_R0IC_P!SIK__ ,GT ?8'A#]JSX8_$7Q##H_AWXB>!/$&KW@8P6.G
M^(+2ZN9MJEFVQI(7.%!8X!P%.<8KT(G*K]17QO\ LP_\$&/V5/V,?CQH/Q,^
M&?PK;POXU\,F?^SM1_X2;5[WR//MY+:7,5Q=21,&AFD7+*2-V1@@$?8D@?RL
M X;'4#^7^% 'XI?\&5G_ ":[\=?^QUM__22OTS_X*Q_\HL_VE/\ LE?BC_TT
M753?L5?\$YOA'_P3N\-:]H_P<\(R>$=-\27B:AJ4!U6]U#[7<*FP2%KJ:4J=
MO&$(7O@UZG\8_AAHOQO^$_B3P5XDL?[2\.^,-+N=%U6T\V2$75I<Q-#-&7C9
M74-&[C*,K#/!!Q0!^??_  :7?\H5_!/_ &'=:_\ 2Z2OM/\ ;R_Y,>^,O_8B
MZY_Z;YZL_LC?LA?#S]AOX)6/P[^%WAUO"_@_39IKJVL#?7-X4DF<R2,9+B22
M0[F)."Q [8Z5V7Q'\":=\3_ .L^&]:@:[T;Q!93:;J$"NT;3V\T;1R(&4AEW
M*Q&Y2",Y!! ( /R__P"#/#G_ ()"W(]?'6J_^B;.N._X,O\ PUI^L_\ !,#Q
M])>65G=2+\4;] \L*NP']DZ0<9([9/TR?6OTI_8[_8>^&_[ OPED\"_"7PTW
MA/PH^H2:FVGC4+N^'VB58UDD$EU+(_(1."Q4;3@=26?L/?L%?"O_ ()W?"W4
MO!?P@\+MX2\-:IJTFMW-HVHWE]YEY)%#"\@>ZEE< QV\2[0P7Y<XR22 >J6/
MA73]*N?,M;*QM7Z9B@6-B,YQD>^#^%?"?_!T;_R@J^.7_<!_]2#3*_0 <"O-
M?VL?V7O _P"V?\#M7^&GQ(T.3Q)X+\3/ -2T]+RXL_/$$\=S&?-@=)%VS0Q-
M\K#)'/&: /G_ /X)=_ME?"/PO_P3-_9UTS4OBE\.]/U+3OACX:M;JUN?$EG%
M-;2II5LKQNC2!E96!!4@$$$&O<I/VYO@P&79\6OA>^YL$?\ "5V"D\<8_>\\
MX%?*7_$+M^PR>OP+.?;QGK^/_2ZH[C_@UY_8<  C^!K(<\_\5AK[9Z_]/_IT
M]\=>A /G;_@Y8^)NL?M;_'?]G[]B3P;KFH:/J'QAUR#6?%-Y; RQVVF)*RP^
M= "IN$1H[BZ\MWC538Q$DY5X_H2V_P"#6S]AVX0L_P %[A6!Y \8ZYC_ -+/
M\*^EH/\ @G1\'Y/VVV_:&N/"+7OQ>6R_LZ'7;S4[VY%E!Y!MBEO;R2FV@S"7
M4F*)2?-E.299"WNZC"T ?@W^U3^S3X*_X-VO^"P?[./Q0^$WAW4?"_P7^)=O
M/X'\662ZI=7$2/)<*))I[JZ:8JJ^?:3I!\H?^RWPZDLR:O\ P7%^'&@_%K_@
MY _8W\,>*-%TG7O#^KZ;I]OJ&FWMLEQ:W<?]J7C>5)&V5=#A<H<AAD'()S^N
M'[9_["WPL_X* ?">'P3\7/"D?B[PU:ZA'JL%J;ZYLW@NHXY8TE22WDCD#".:
M5<;L$2-D&N4\:?\ !,+X,?$KX\?#3XF^(?"=YJWCSX265KIWA?5[K7=3>>PB
MMV9HM_\ I&VX?<[%GN!(S$DLS'D '-?\%;O^"6?A#_@J+^R7?> ]8-MI'B#3
M_P#2O#&NK91S7&B78"_<#$$Q2*@C>,,H92#D,J,OR9_P;L_\%0/%7Q#NO$G[
M*7Q]N[JT^/7P;FN-/C;4[EKF[UZTMIC')NF5?+DFMR8TW^:[7$;)*N[;)(?U
MA9=ZX:OG7XN?\$L_@?\ &7]KO0OCEK?@N9/BIX=2".R\1:5KFI:3=*(0ZIY@
MM+F))LQNT;&1&+Q;8V+1J$H ^C!TK\[?VZO^#:SX*_M^_M3^*OBYXM\?_&[1
M/$'BS[)]KLM URQMM.A^SVD%HGE1R64KKF.!&;<YRQ8C ( _1(<"B@#Y8_X)
M@?\ !)?P#_P2@\)>+-'\!^)_B%XFMO&%W!>7;^*M0M[R2!H49%$1AMX0H(<D
M@AB2!@BOJ<=*** /GW_@K+_RBT_:5_[)7XH_]-%S7S3_ ,&J'_*$3X5_]?VM
M_P#IWNZ^\/C'\*]$^.?PO\2>"_$UBVI>&?%VE76B:M:+<20?:;2YB:&:/?&P
M==R.RY4AADD'-<K^R1^R;X%_8D^">D_#KX9Z _AGP;H\D\MGIK7MS>?9VFF:
M:3]Y<22R-NDD=N7(&>.* /SO_P"#R?\ Y1+:3_V4+2__ $EOZ_13]BC_ ),T
M^$G_ &)>C_\ I##69^VC^P_\,?\ @H!\*[?P+\6?#+>*O"L.HQ:HMF+^ZL<7
M$:NL<F^WEC?@2N"N[!#'(.!CTWP-X/T[X>>"M'\/Z/;?8])T.QAT^RM_,>3R
M((HUCC3<Y+-A5 RQ).,DDT ?F[_P=Q_\H9?%'_8R:-_Z4UYO_P %/&Q_P9[>
M'Q_$WPM^'8'_ (%:$?Z5^E'[8'[''P]_;K^#]S\/_BEX>_X2GP;>7$-W-IWV
MZZL?-EA;=&QEMI(Y1M/( 8 GJ"*Q?B5^P5\,?C!^QU;_  "\1^%VU3X4VNDZ
M?HT>B-J-W"$M=/:W:TB\Y)EN"$:V@.?-W-Y9W,=QR >-?\$HOVQ/A+X1_P""
M8?[/6EZM\4/AWINI:=\.= M[JTNO$EG#-;R+I\ 9'1I RLK @J0"""#7OLG[
M<_P6 _Y*Y\,2W8?\)38\_CYOMC\1ZU\GP_\ !KK^PSL7/P+=CCJ?&6O@_P#I
M=1)_P:\?L-!?E^!CH>N?^$RU]L?^3Q!_*@#]!+:;[1;H_P OS*#\K;A^![U\
M;_\ !PI_RAC_ &@/^Q<'_I5!7V-IHVV$(VM'A -I.2O'2N+_ &DOV?\ PG^U
M/\%/$'P^\=:2VN^$?%%N+35+ 7,UM]JAWJQ7S(721>54Y5@>.N,T ?"'_!O-
M^UC\+/A]_P $9_@CHOB#XD> ]%U:RTZ_2YL;_P 06EO<09U.\8!XY) RY4@\
M@<'TKYL_X.P_VH/A7^T?^R=\//A+X!\0Z/\ $SXL:]XRM;W0](\+W":S=0Q)
M%/"[-]G9]IE>:.-$/SRMNVAMCE?K;_B%X_89Q_R0ML^O_"9:_P ^^/MP_05[
M%^QQ_P $:OV:?V%?%_\ PD?PQ^$NA>'_ !#"\C6VJW$]UJE_:>9$8I/)FO)9
MI(@T;%&"%0P)R/F.0#Y;_P""Z'_!-/QY^V5_P1V\+Z;:QZEXD^-'P?T_3=?C
M2!VO+O6;JWLU@U"%'(+S22J995QN>26")1S(=WO/_!(O_@KO\-O^"CO[._AF
M33?$-E:_$ZQLH;+Q1X6U"Y2VU6UOX84^T21P.^^:W9PS),HP5#!MLB/&OV+<
M6R^2Q6/<P.X <$GH/Q[9/\J^%_VV/^#=+]EW]NWX@7WBSQ)X)O/#GB[4[O[5
MJ.M>&+Y]+FU-V,K2&>(A[>1I'EWO*8A,Q109" 00"Y_P61_X*_> OV#OV;_%
MVBZ;XFM]0^-&N63Z-X6\-Z-/#>:U%J-U;M]EN)+8-OCB4M')O92#E0H=F5&\
M/_X)G_#&Y_X(+?\ ! 7Q#XX\=Z6O_"76ME>>.M9T@S?9IH]0N5C@LK!I'0^7
M+M6UAD)C;9*T@ D"C=[7^PA_P;T?LQ_L$^/+?Q9X<\"WGB#QAI]PTUAK?BF_
M_M2XTW*H1Y,85+>-D925E$7G*7?Y]I 'TA^V)^QC\/?V[_A1_P (%\4-%U#Q
M!X1DO(K^XT^WUB^TV.YEB),0E:UFB:1%8[]CDIN1&*[E0@ _)'_@B1_P0,^#
M_P"W)^Q-!\:_VEO"&K>//B)\7-<U'Q0M_=ZSJ>FW M9I0J^:L%Q&LKRR)-<B
M4J"RW2\$*K'TO_@I1_P:^?LTZ1^P[\3+SX,_#FZ\,_$O1]#DU?1+X:WJ^J,9
M+9A</;BWFNV1VN(XI(!E&*F;<%9E"G]8_AQ\.=$^$GP_T+PMX;TVWT?P_P"&
MM/M]*TRQ@SY5E:P1K%#$F>=J(JJ,\X%:TL2S?*PW<Y&>QH _&F+]NNX_X* ?
M\&GOQ$\5ZK=75UXM\.^$)?#'B2:ZNOM%Q=W]G);QFYD? +//"89SN (:8@E\
M;S]3?\&T5NLW_!#SX%EA&5:SU7<NW.?^)S?CZ?I7IOPU_P""./[._P (/@I\
M3/AOX;\ 3:3X%^+CI)XGT*+7M4^PW;*>L49N"+;.0&-MY1*I&I)6- OLW[+_
M .S)X+_8Y^!.@_#?X=Z.V@>#?#*S)INGFZGN_LRRSR3N/,F=Y6S)*[?,QQNQ
MP   #\A?^"UW[-7C#_@C[^U#H_[</[.]E'IOA^YOTLOBQX;MIFCLM76ZN8RU
MRZ,K(B7<A$,CH 4F^S2HK/)(R_>?[67[4/A+]L?_ ((9?&CXE>!+YM2\+^,O
M@[XEOK*5MHDA/]D78E@E"EECFBD#12)N.UXW7)VYKZA^+'PIT'XQ_#'7O!_B
M+3(=4\.^)-.FTG4K%P0MU:S(8Y(N.1E&(R"",Y!!&1XC\!?^"4/P+_9F_9]\
M<?"GP9X+U+2_AW\0K6YL==T*3Q-JMY:W$5S;O;W'E&>Y=X&EBD*.T+1L0 <[
ME4T ?%O_  :U_M0?#;X6?\$@/!^C>)OB!X(\.ZM#K>L2/9ZGKMK:3JK7CE6V
M2.&P1WQ@U[E_P57_ ."W?PA_9)_99\4+X3^('A_Q=\4/$6G2Z5X2T3PMJ=MJ
MVIMJ%S')':W#0QN=L*2C<SMG&T*%=V5#0_XA=OV&3_S0IO\ PL]?_P#D^O4?
MV6?^"(W[*_[&_C"/7OA_\%/#NEZY9W<=U:ZCJ$EQK-U92IRLEO+>RS/"5(!S
M&RX8 CF@#SG_ (-O_P!@#6?^"?/_  31T'0O%EG_ &=XW\:7TOBO7;%E99M.
M>X2-(;>16"E9(X(H@ZD?+(9%RP -? __  5;_:AU3_@D3_P6^^-7Q#:U6;0_
MCU\$[A;&%YYVM+C5XH!:6C21EXT>2.XLHU=(W+);7<C+\\FQOWNBM8X"2B*N
MX ' Z@=*^=OVW?\ @EG\#?\ @HGK'AN^^,G@9?&ESX/^T#2&.JW]BMH)C&9,
MI;31K+GRH_\ 6AA\N. Q! /.O^#?W]E&']C_ /X)0_";P^VGVUAK7B+2U\5:
MT4@\JXGNM0Q<C[1F*-VFBA>&W/F LBVZQ[F"+7Q?_P %@_C%<_\ !('_ (+$
M^%?VGM+T70[W0_BY\-?$'A358WC,4D^KZ=;"ZM&=T$:*\LR:9 )'>:1HH;A5
MCRD=?LQIMFMC:K%&H6./Y54<*H'0#V_.O$_VU/\ @GI\)?\ @H?X%TOPS\8?
M!Z^+M$T?4?[4L[8W]U9-#<"-XA();:6-^5D8%2=I^7(^4$ 'R)_P:U_">X^$
M7_!(;P]XDUJ.XM]6^)6NZKXQO[F\EF:>Z\V7[-'<RF7H)(K.%\J=K*4?)+DU
M\@?L _LA^ ?^#C#_ (*1?M(?'KXO6^L>*_A)X9N8_"'@;1+J^O+;:B/O2>.6
MWEA\E4B0RM;@,K2:K([$NN^3]J-%_9P\*Z!^S39_";3]/U#3? >G^'1X3M[&
MWU&ZCGM]-2V^RI$ERKBX4B' 602"0$ ALC-8O[&'[#WPO_8$^$__  A'PE\'
MP^#?#37LVHRVJ74]T\]S*(UDEDEGDDD=BL42@LY(6-5& HH ^5D_X-:OV'XG
M5E^#UT'5LAAXPUW(],?Z;VX]>E>$?\&MWQI\0?!-OCG^QWXXFN)O$'P#\47<
MVC3W,@A^U:=/<,DBPP$;EA^T)]I60/('&IKC 52_[ ]O\:\&T_\ X)S_  DT
MC]L[4/VA+/PG+;_%[5K,:;?Z[#K%_"M_;"!(!%+:K,+:11'%$!OA8YBC;[RJ
MR@'Y,_\ !HA\?? OP9^''[0T'B[QIX3\+SWGC"WE@BU?5[>Q>=!%,"R"5UW
M' )' S7[(:7^VA\(==U.WLK#XI_#F^OKR58(+:W\2V<DT\C,%5$02[F8D@
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M5@S%L8 )[T 6**!10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M",'_  69\;?\$E_C@EU;?:O$'PQ\03Q_\)3X8#Y%RN0OVNW#,%2Z1> 3A9%
M1\?*Z?+?[1O_ "<+X\_[&+4/_2F2N,H _L4L_P!DG]G[_@JY\7O@;^UUX!UB
MWF\1>#KR+4+76],"B35;9(Y!_9U]%GB2)WY+?O(V5T/RG:/N*TMOLJ;>O<G
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M-<QPOM9OF] ,U\;?MS?\%\/V7_\ @G[XYD\)^.?B%]L\86K*+O0M!LI=2O+
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M1^*/B_X^T7P3I-P_EVHNO,GO+]M\:,+>UA5YYRAD0N(HVV*=[84$CXL\&?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&G_"9?L[?%+X!OX7^P?91XSL;BU.N_:#<[OLXE@BR(?(4OC=_KTSM%?6@Z4
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M;_E!_P#!?_KMK_\ Z?+ZOHW_ (*O\?\ !*_]I3_LE/BC_P!-%U7SE_P:R_\
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MLR^5%<VEY-.D,B1AIB1',6C241!V5PH!]O?\&<OQ#\4>(OV%_B7X7N[RZO\
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M(. JJ.  . .PZ5<'2@=** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW9FSMZ<*3UXZ?C4]% 'X]_\ !3O]D?\ :JTC_@NE\,_VGO@?\&+'XIZ1\/\
MP1_9 AN_$VFZ1%<7,L6JV\J$3W"3 HEZKY52"0!NZX]*?]O+_@II#%D_L,^!
M551U/Q/TG _\G*_3JB@#Y[T'X3:O_P % /V!9/"O[2'P[T[POJWC_2+BP\3>
M%K:_@U*'36:1Q#)#.IDC\Z,+%/'*A)CD",,,@Q^;/PHU#]N__@@QIEU\/]'^
M$MQ^UI^SYHM])#X6NM+N9%\1Z?!*&:&W*0K--'$A5L@VTD:DX6549%'[544
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MX%^)+[Q-?V=QKEAI41=;K1[BVC9KF>(LLILI 3'N( YQQG]3J* /S'_X;O\
M^"FW_1B_@;_PYVD__)E>C_L?_M<_MT?$G]I#PYH?QA_91\*_#?X=WQN?[7\1
M6?CG3]2FT_;;2O!M@BN7=]\R11G"''F9. "1]XT4 ?C?_P %*?V.OVJ="_X+
MP^"/VHO@;\&;'XI:/X(\)KIL:7GBC3=)@N;B2WU"UF0K/<QS (EX&!"8)QR1
MFO5/^&\?^"FBP9_X89\#@;?O?\+-TH]O^OROT\HH _/C_@J-\&_CK_P4-_X(
M4>,/!<WPWM-'^.7C2WTF2;P=:ZU:-%;2P:W9SRHMY),+<@00M)N\W!Z#G KP
M+]CWXS_\%)OV1OV8O /POTW]BWP=K=GX"T.VT."^G^).D1R7:01A [!;S 8X
M.0. :_82B@#XT_8'_:>_;"^+?QCU+2_V@/V;_#7P?\'PZ-+<V.L6'C&RUF2Y
MOQ/ J6QB@GD95:)YWWE0!Y.,Y8 _8\T GC&XD=\BI** /R?_ ."DG_!-+]H;
MX)?\%/=._:\_9)M='\4>)]>L(=*\<^#=0OXK Z]#']GARDUPZQ!9((H0V'A:
M)K5)%,KR.!S"?\%T?VW_ (R:!'X4\(_\$]_B!X=\<:K;>19ZWK]S>V^BVESY
M1/G2K<V-O&L88$A)+I0?E7>Q()_8>B@#\^_^"$7_  2X\:?\$^OAK\1/%WQ9
M\16?B+XS?'+6E\1>+IK!Q+;VC@S21P[PJB282W-S)(ZJL8:78FX1B5^1_P""
M%?[!'Q:_8^_;5_;6\6?$3PC_ ,(YX=^+GC2'6?"=VVIV=T=5M5O]:E+^7;RR
M-%A+N D2A&_> 8R&Q^F5%  .E?'7_!=GP!\:OC)_P3A\9> O@-X=NO$?CCQ]
M)!H,R0ZG8Z>;/397S>2-)>311E9(4:V*J2_^E J!@LOV+10!\]_\$OOV.HOV
M&/V!OA7\,GM[6VU3PSH,"ZNML0\;ZE+F>\8/U8-<R2?-GD!< #BNF_;E_9ET
M?]L?]D[X@?"W60JVOC70KK3HYV&XV4Y3,%R!_>AF$4HR1\T:@\'!]>HH _.O
M_@B1^RA\5/"'_!+/4OV>?VFOAW)H<.F1ZGX;CADUFRO+?Q#H=ZKD@/9W#O$R
M>=/#C]WA/+();.SY&_9_\(_MO?\ !O7<Z_X)\._"K5/VJ/V=5U)I/#$&CW>W
M6-(,YEE 6&*.:X@5F)>9?L\L F0E'C:9R_[FT4 ?A[^TE<?MV?\ !?OPCI?P
MZ3X+ZG^RA\$[G5%B\8WOB74BVI:G&AMW*+;2PVUU-&BL9$184AF=-KS QD#]
M$/B=^P]%\'O^".7CK]GGX6Z?=:E+;_"S6/"'AVUN;B&.YU:\FTVXA1I9'*0H
M\\\A=F.V,/*3\HX'UE10!^*/_!-W5?\ @I!_P3F_8U\&?!C1?V-_"GBC3?!H
MOC#J-W\1M'AFN?M-]/>-N"7A4;6N&48ZA1WS7NP_;N_X*;'_ )L8\"X_[*?I
M/_R97Z<44 <?\#/$OBCQA\(/"FI>-M"MO"_C+4-&M+G7M&M[I;N+2;]X4:XM
MEF0LDBQRET#*2&"Y!(.:[ =*** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#QWX<_MM^!/BU^U?\4/@KI=]<?\ "<?">+3)M=M)X1$O
ME7]L+F%X6+9E4(R!RJX1I$!^\*MZ#^UAX,U'XE_$[PNVH#3K[X2VUE>^*+F^
MQ;6=E!=6SW,<OFLP7:(HW+,<! O)P*^3O$OP6\3>)/VB?VF/B9\-K*:_^+'P
MG^*-EJ.@:>FH+91^)+67P5X5&HZ+,[?N_+O+>,*C2 K%<PVD_'DD-\H?M,?&
MGP#^T;K/[2GCJ6^CU3X,>(O&7P6O?%4DPECA30S<Q+?1W2*!(AC :.6+"O'(
MC(0'4K0!]PZ3_P %Q/@UK5IINOMHWQ:LOASJLBO9>/[_ .'>KV?A62-E)6Y:
M\D@'EP$AAYS*$7[SE$!<>H?M.?\ !0;PG^S7J?@O3[CPW\1/']YX]TZ]U72[
M7P-X8G\0R36=H;-9KAU@W%8=U_; .>"9 ,^OLGC2YT&R^'^K+X@DTN/P[%I\
MQU%M0\O["EF(V,IEWXC\D1[MV[Y=H.> :_*3]BZT^*S>'OV2X_@<W@F.0> _
MB@^@-X_74Y+5O"9\5Z!_97EB,BYS]A_L[RO.)_<\-AL8 /MGX1?\%5/ OQ;^
M(J>"KSPK\5_A]XHU'3;C4="T[QMX,O="N/$B6RAKB.Q\] L\\:LKF%"9-I+!
M2JL5\_/_  6Z\"Q_$=/##?!_]J)O%$M@VKPZ0?A1J(OFLED2)[A(@F\PB1D!
M?!&YP"0,"N0_9MUGXN?M1?\ !0V+PE^T)XJ^''A3Q)^SUJ#^+_#_ (*\&V%W
MN\7PW5C+86^OM=7K,[6<*WE_:F&!05N"WFLH6'S?5=>_Y3T>&/\ L@>K?^I#
MIM 'LGP\_:L\,^-_C=9_#NWMM<T_Q3/X,M?''V#4-/:T:UL+F=K=$E5N8YUD
MC8-$?F4@YYKHM:^/&AZ+\?\ 1?AK(]S_ ,)-KWA^^\2VJ>3F$V=G<V=M.2^>
M&$E]  O<%CV-?$O[1<'QH?\ X+B70^"\OPQCU;_A1U@=0_X36.^DMC!_;U_C
MROLI#;]W7=Q@5M?!>W^.@_X*^>"?^%V2_"F2X;X/>*?[)'@=-1CC"?VWX:\W
MSQ=LV6R4V[,9&X'M0!]\#I0>M Z4'K0!#%]P?0441?<'T%% 'R/_ ,$(_P#E
M%9\*?^XM_P"G>^KZ^KY!_P""$?\ RBL^%/\ W%O_ $[WU?7U !7+_%KQ_P#\
M*M^'GB#Q%)";I-"TRYU(VX<*TZPQ/(RKQP2%QGMG.#@UU%<_\2_ D/Q/\#ZW
MX=O9IK?3]>T^?3YY("!,B31M&Q4L" P5B02#R!GC@@'Y"_LB?\$4_A[_ ,%0
M?^"=FD_';XE:AXDO?VC_ (M:=?>)(/',.N:A WAV\N+NXFM%M;59O)2W@W1Q
M^7L(*JVPIE2///V?_BEJ7_!;SQA^QO\ #KXT:MK&D_!W6/A3J/BG4+&74+FS
ME^*_B?3-2FT6ZLGO5GC\YHX[=+_RHLS)'<2F3(D66/UG]E[_ (*2^+/^"7G[
M!5I^SMXF^!GQBU_X\?"O3[[PYHJ>'_ MYJGAOQ3,ES<IIUY:W"R(\MG(AA>5
MF\J4_O@D88*M<Q\1/V3M,_81_8?_ &8/@G\=/V=-;^,OP;T70[B[\2>)/"]Q
M>7WB3X?^)KF66YN0OV".,M8R37H@C:.<$A#O+&*/SP#VW]G/PU\//^"7O_!8
MSPA^SG\%+C5]/\#_ !1\"ZAK^M^#;GQ!>:II_AF^MI0UO?VZW+RM'+<I'=12
MH)/GV0.0-BA_7OA?K_C#XQ?M-?M9?$OP3HWA[6/&'A$V7PM\ R:WF"RBDL;)
M;ZZ69@&F5#JFHR).\)598M/M@H9X=[?'?_!/K]FCP;X._:R\0_M)?"WX%^)O
MA7\!_@?X#UI='DUNVU"+Q=\1=9FABEN9FBN5GNWLH8(V@C )/G9*>9ODBC_1
MS_@E-\-O$'PM_P""=_PKM?& U4>-=;T?_A*/$ZZG;O;7J:SJTTFJ:BL\3?-'
M*+N[G#)A=K @*@&T 'QW_P $,/ACX\^#?_!4?]O#PY\2OB!<?$[QE8R>!;K4
M-?>W-K',UWIVHWGDPP%W\F"'[1Y,<8.U4B7"J,*/,?\ @JZWP'?_ (*P^(]+
M_;,OM8\:?#/4/!6FWWPW\.Z+J6HW,/AZ:*22._DO=.TR1+J.>9Y=T5S)&\3Q
MAT\[=$L2?5'_  3^\(ZMH_\ P6O_ &_M8O-+U&TTC7%^'9TZ^FM7CM]0$.A3
MI*89"-LFQOE;:3M)P<&O.?%GQDN/^"6O_!4/]H+X@?$CX>_$GQ9X-^.,>AW?
MA?Q9X7\/RZXFG&RLC;W&DW A+36[;@)D!'ER*'(P5- $G_!#KXG^&OA/^R/\
M>?%^C^)KAOV=O"/C/5KWP39WFM2:MJ'A30;.TC:2WEADDEN+51Y32QVDVV=5
M?<T:&4%J/P1_X)-3?MF_LW?!?_A;VL:A'\,]5T2\^(7C3P5IUS<V-YXN\6ZY
M.;R=M1O8I1)+8VL=Q)#;Q;EF4*GFW$RJ0/'[/P#XV^/W_"]/$D/@'X@>$OA[
M^V]\4_!_A;1_#=QIDUK=VGA^SB(UO6KBUBRUHFI007 9I?(D".)O,<A"WU!_
MP6._X*9>*/V-]=\&_#KX?Z3XJC\2>-[:XN-4\7V'@>]\36_@BQVO''<I;1!(
MKJ[DF5Q'"TH1#'OE0HR+( >1_!SX.>&O^":?_!4NX\!_LVMXBB^%.C_#74?$
MWQ4\'KK$^J:1H-Q$)&TGRY[II9+6]N6,Q,2R[I(E64Q! '/#?L??\$7_ (=_
M\%3_ /@GMI7QX^)M]XFU#]HGXM65_P"(K3QM'KVH0GPU=37UU-9K:6PF$,<%
MN&C01!-N Q7:2NWW?_@FO^TW\"?$OA^Y^!7P_P#"/QTTW5O&UKJ%]XB\4^+/
M!UY8WGB;4)8&^UZC?7\ZX>[FY(W# .U$"JJH/'/V6O\ @HWXJ_X)7?L*V/[.
M_B?X&_&;Q!\<OA;9WV@:$WA[P-=:GX;\62_;+E=.O+2X5T:>TD1H6D9A#*2L
MRJ@<!: .E_8[^ FI?\%W/V%?V:_&7QB\3ZU>?"+2_"MU#KWA"UU"ZM]0\:Z_
M:7<FF&\U&]BD5Y;4);2RK%'Y<GFSEGDD VB7X._!3PM_P3;_ ."K$W@']G'^
MWK?X5Z7\.-1\4_%?PB=4GU31=!GC5VTEXYKDR/;7ER[3%H4ER\2+)Y01=PXO
M6OCMXU_X(E?\$]?V=?V9?"VB^+(?B%JF@7%YXI\66_A*Z\7VWP^^UR3W5Q-%
M%:K%#>7'VV>>*WB\PJBP*TWF(R>;[?\ \$V/VH?@1XF\.W'P+\!^$?CM8ZQX
MX@O[[Q#XJ\6>"[RSNO$>H30,;O4;Z]F7:]W,1D9&T?(B*J*J@ \'_8X_X(T_
M#O\ X*H_\$^M)^/'Q.N?%&I?M#?%RTU#7K3QO!XCOX#X7N9KV[EM$M+59A#'
M! K1KY.PK@'9MR"OW'_P1 _:;UC]L+_@EG\&?'VOO?7&M:EH;:??W=U=?:9K
MZXL;B:PDN'DR2S2O;-*2<D&0@DL&KXP_99_X*)^*/^"6W["MK^SOXI^"/QI\
M0?&SX86=]H/A\^'O MUJGASQ6WVNZ73[NTN5D5IK5XVA,C,(9,B95C5@%K[F
M_P""/?[).I?L+_\ !.#X2_"_6VF77O#>B^;JT<EPEQ]GOKN:2\N85D3"LD<T
M[QJ1D;549<_,0#Z<'2B@=** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?^BI'_PFM7_^1: /KFBOD;_A^S^RK_T5(_\ A-:O_P#(M'_#]G]E7_HJ1_\
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M?^BI'_PFM7_^1: /KFBOD;_A^S^RK_T5(_\ A-:O_P#(M'_#]G]E7_HJ1_\
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M?^BI'_PFM7_^1: /KFBOD;_A^S^RK_T5(_\ A-:O_P#(M'_#]G]E7_HJ1_\
M":U?_P"1: /KFBOD;_A^S^RK_P!%2/\ X36K_P#R+1_P_9_95_Z*D?\ PFM7
M_P#D6@#ZYHKY&_X?L_LJ_P#14C_X36K_ /R+1_P_9_95_P"BI'_PFM7_ /D6
M@#ZYHKY&_P"'[/[*O_14C_X36K__ "+1_P /V?V5?^BI'_PFM7_^1: /KFBO
MD;_A^S^RK_T5(_\ A-:O_P#(M'_#]G]E7_HJ1_\ ":U?_P"1: /KFBOD;_A^
MS^RK_P!%2/\ X36K_P#R+1_P_9_95_Z*D?\ PFM7_P#D6@#ZYHKY&_X?L_LJ
M_P#14C_X36K_ /R+1_P_9_95_P"BI'_PFM7_ /D6@#ZYHKY&_P"'[/[*O_14
MC_X36K__ "+1_P /V?V5?^BI'_PFM7_^1: /KFBOD;_A^S^RK_T5(_\ A-:O
M_P#(M'_#]G]E7_HJ1_\ ":U?_P"1: /KFBOD;_A^S^RK_P!%2/\ X36K_P#R
M+1_P_9_95_Z*D?\ PFM7_P#D6@#ZYHKY&_X?L_LJ_P#14C_X36K_ /R+1_P_
M9_95_P"BI'_PFM7_ /D6@#ZYHKY&_P"'[/[*O_14C_X36K__ "+1_P /V?V5
M?^BI'_PFM7_^1: /KFBOD;_A^S^RK_T5(_\ A-:O_P#(M'_#]G]E7_HJ1_\
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M?^BI'_PFM7_^1: /KFBOD;_A^S^RK_T5(_\ A-:O_P#(M'_#]G]E7_HJ1_\
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M?^BI'_PFM7_^1: /KFBOD;_A^S^RK_T5(_\ A-:O_P#(M'_#]G]E7_HJ1_\
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+CIT[6A]#10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>image_32a.jpg
<TEXT>
begin 644 image_32a.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0 Z17AI9@  34T *@    @  U$0  $
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M1T__ .,U['10!XY_P[V^ _\ T1'X1?\ A(Z?_P#&:/\ AWM\!_\ HB/PB_\
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MO@/_ -$1^$7_ (2.G_\ QFC_ (=[? ?_ *(C\(O_  D=/_\ C->QT4 >.?\
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M /C->QT4 >.?\.]O@/\ ]$1^$7_A(Z?_ /&:/^'>WP'_ .B(_"+_ ,)'3_\
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M /1$?A%_X2.G_P#QFC_AWM\!_P#HB/PB_P#"1T__ .,U['10!XY_P[V^ _\
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M$CI__P 9H_X=[? ?_HB/PB_\)'3_ /XS7L=% 'CG_#O;X#_]$1^$7_A(Z?\
M_&:/^'>WP'_Z(C\(O_"1T_\ ^,U['10!XY_P[V^ _P#T1'X1?^$CI_\ \9H_
MX=[? ?\ Z(C\(O\ PD=/_P#C->QT4 >.?\.]O@/_ -$1^$7_ (2.G_\ QFC_
M (=[? ?_ *(C\(O_  D=/_\ C->QT4 >.?\ #O;X#_\ 1$?A%_X2.G__ !FC
M_AWM\!_^B(_"+_PD=/\ _C->QT4 >.?\.]O@/_T1'X1?^$CI_P#\9H_X=[?
M?_HB/PB_\)'3_P#XS7L=% 'CG_#O;X#_ /1$?A%_X2.G_P#QFC_AWM\!_P#H
MB/PB_P#"1T__ .,U['10!XY_P[V^ _\ T1'X1?\ A(Z?_P#&:/\ AWM\!_\
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MT4 >.?\ #O;X#_\ 1$?A%_X2.G__ !FC_AWM\!_^B(_"+_PD=/\ _C->QT4
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MZ?\ _&:/^'>WP'_Z(C\(O_"1T_\ ^,U['10!XY_P[V^ _P#T1'X1?^$CI_\
M\9H_X=[? ?\ Z(C\(O\ PD=/_P#C->QT4 >.?\.]O@/_ -$1^$7_ (2.G_\
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M)'3_ /XS7L=% 'CG_#O;X#_]$1^$7_A(Z?\ _&:/^'>WP'_Z(C\(O_"1T_\
M^,U['10!XY_P[V^ _P#T1'X1?^$CI_\ \9H_X=[? ?\ Z(C\(O\ PD=/_P#C
M->QT4 >.?\.]O@/_ -$1^$7_ (2.G_\ QFC_ (=[? ?_ *(C\(O_  D=/_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "FS?ZMO]TTZFS?ZMO]TT ?AW_P<M?\GU^$
M_P#L0[3_ -.&HT4?\'+7_)]?A/\ [$.T_P#3AJ-% 'ZR_P#!/O\ Y,2^"/\
MV(&A?^FZWKV&O'O^"??_ "8E\$?^Q T+_P!-UO7L- !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "FS?ZMO]TTZFS?ZMO\ =- 'X=_\'+7_ "?7X3_[
M$.T_].&HT4?\'+7_ "?7X3_[$.T_].&HT4 ?K+_P3[_Y,2^"/_8@:%_Z;K>O
M8:\>_P""??\ R8E\$?\ L0-"_P#3=;U[#0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4V;_5M_NFG4V;_5M_NF@#\._^#EK_ )/K\)_]B':?
M^G#4:*/^#EK_ )/K\)_]B':?^G#4:* /UE_X)]_\F)?!'_L0-"_]-UO7L->/
M?\$^_P#DQ+X(_P#8@:%_Z;K>O8: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "FS?ZMO]TTZFS?ZMO]TT ?AW_P '+7_)]?A/_L0[3_TX:C11
M_P '+7_)]?A/_L0[3_TX:C10!^LO_!/O_DQ+X(_]B!H7_INMZ]AKQ[_@GW_R
M8E\$?^Q T+_TW6]>PT %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !39O\ 5M_NFG4V;_5M_NF@#\._^#EK_D^OPG_V(=I_Z<-1HH_X.6O^3Z_"
M?_8AVG_IPU&B@#]9?^"??_)B7P1_[$#0O_3=;U[#7CW_  3[_P"3$O@C_P!B
M!H7_ *;K>O8: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FS
M?ZMO]TTZFS?ZMO\ =- 'X=_\'+7_ "?7X3_[$.T_].&HT4?\'+7_ "?7X3_[
M$.T_].&HT4 ?K+_P3[_Y,2^"/_8@:%_Z;K>O8:\>_P""??\ R8E\$?\ L0-"
M_P#3=;U[#0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4V;_5
MM_NFG4V;_5M_NF@#\._^#EK_ )/K\)_]B':?^G#4:*/^#EK_ )/K\)_]B':?
M^G#4:* /UE_X)]_\F)?!'_L0-"_]-UO7L->/?\$^_P#DQ+X(_P#8@:%_Z;K>
MO8: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FS?ZMO]TTZF
MS?ZMO]TT ?AW_P '+7_)]?A/_L0[3_TX:C11_P '+7_)]?A/_L0[3_TX:C10
M!^LO_!/O_DQ+X(_]B!H7_INMZ]AKQ[_@GW_R8E\$?^Q T+_TW6]>PT %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#?PA_P#+V@#W2BO")/VK_'D1PW[,_P </PU7PB?Y:[3_ /AJ?Q]_T;/\;_\
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M#?\ #,_QPP?^HOX0_P#E[0![K17A?_#4_C[_ *-G^-__ (-_"'_R]I@_:O\
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M1_AQ^U-XG\2R:?;A?)UN-6B5[.8D;ECD^4,R,K!=X!!*LH!N?L#_  ,^%?\
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M+\0O_")^'O\ \S5?8E% 'POXH_X(2^#?&?C+0=>U/XJ?$2ZU3PR96TV0>$_
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M6OC!\2IM(\06,^FWL=OX4\!VDLD$T;1R!)H?#J2QL5=L/&ZNIPRLK $?;U%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/_4;U.N:_P""0J*NG_M*;55?^+]^+>@Q_P M8*Z7_@J3_P FT^(/^P!XD_\
M4;U.N:_X)#?\@[]I/_LO?BW_ -&P4 ?7U%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?$O_  7.^'L/Q-_9
M&CTNXU+Q!H\8EUN\^T:1J$MC<DV_A37;D()(RK"-S"$D7.)(WD1AM<U[Q_P3
MYS_PPG\%SC@^ ]"Q_P""^#MVKRW_ (+$?\FU1?\ 7OXF_P#4*\25ZM_P3[_Y
M,-^"?_8A:%_Z;K>@#UZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 ?)/_  6(DS^S9"N?F:#Q-@=S
M_P 45XC_ ,:]8_X)^-_Q@=\%/;P%H7_INMZ\._X+>>%;CQ7^R;':V>MZIX>G
M8Z]/]LT^.W><+'X1\02M%BXBECV2JC1/\FX)(Y1D?:Z^W?\ !/B(1?L&_!7[
MOS> ]"/ Q_S#K?\ K0![#1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-F_U
M;?[IIU-F_P!6W^Z: /P[_P"#EK_D^OPG_P!B':?^G#4:*/\ @Y:_Y/K\)_\
M8AVG_IPU&B@#]9?^"??_ "8E\$?^Q T+_P!-UO7L->/?\$^_^3$O@C_V(&A?
M^FZWKV&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /F;_@
MJ3_R;3X@_P"P!XD_]1O4ZYK_ ()#-_H'[2B^GQ[\6_\ HV"NE_X*D_\ )M/B
M#_L >)/_ %&]3K@O^")_@JS^'7P]_: T'36U*33]'^./BFTMS?ZA<:A=%$>
M R7%P[S2OCJ\LCNQY+$\T ?:U%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 ?)?_  6(_P"3:HO^O?Q-_P"H
M5XDKU;_@GW_R8;\$_P#L0M"_]-UO7E/_  6(_P"3:HO^O?Q-_P"H5XDKU;_@
MGW_R8;\$_P#L0M"_]-UO0!Z]1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-
MF_U;?[IIU-F_U;?[IH _#O\ X.6O^3Z_"?\ V(=I_P"G#4:*/^#EK_D^OPG_
M -B':?\ IPU&B@#]9?\ @GW_ ,F)?!'_ +$#0O\ TW6]>PUX]_P3[_Y,2^"/
M_8@:%_Z;K>O8: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M ^9O^"I/_)M/B#_L >)/_4;U.N8_X)%3K#IW[26Y@N[X]^+<<]?WL%=-_P %
M2SC]FGQ!_P!@#Q)_ZC>J5^=/Q*^)?CV3_@F3^U%\9O@/\;/^$+M?!?QM\6^*
M!J6A6=MK%KXML':W184E9BBH6=)%FCW@A<8P=P /VLCNXY7*JW(J2ODC_@B]
M:?$O4?\ @G[\/?%7Q4^)U[\4_$GQ&TNR\8I?76CP:=)I=O?V-M<)8XB.V80L
M[_OF 9B^-JJ%4?6] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /F7_@J6=O[-/B#_ + 'B3_U
M&]4KA?\ @BIX@NO%?@7]H'4+[1=4\-WE]\<O%4\VE:B]O)=Z<[20$PRM;RS0
M,ZG@F*5TR.&8<UW?_!4K_DVGQ!_V /$G_J-ZG7,_\$AE L?VE&Q\W_"^_%@)
M]?WL% 'U_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*P5@>Q - $*_MH_"%Y=O_"T/AZ#C//B*SP/_ ")U]JD_X;+^$/\ T5/X=_\
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MX3_[$.T_].&HT4 ?K+_P3[_Y,2^"/_8@:%_Z;K>O8:\>_P""??\ R8E\$?\
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M[@1/,88$9@9)!%%(Y5 6VQNV,*2 #\)?^";^I^(M:_X+N:+=^,&U1O&%Y/\
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MRR*C"[B,D,:V<+@'TA_P1M_Y1._LW_\ 9-]"_P#2&*OI2OE/_@CYX_T+3_\
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MP37,RP1!_*U=W ,C 9520.:^U+0ML^;YO0^WI]??O0!8HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC?+N<@<L:_3 _L2^#SC&N?%S\?BIXG/_ +D*^*?^#?7_ )+U^WQ_V<5XA_\
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M_P#8AVG_ *<-1HH_X.6O^3Z_"?\ V(=I_P"G#4:* /UE_P""??\ R8E\$?\
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M[_A;&?!MY=2>']/\/F+5_#"WM]IR6L^I2B:PO1,K6LDG]I.K_NG#"&/&TY-
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MM@R,?>OS5_X)K?\ *3GQ1_V-'QK_ /4@\%4 ?J!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %-F_P!6W^Z:=39O]6W^Z: /P[_X.6O^3Z_"?_8AVG_IPU&B
MC_@Y:_Y/K\)_]B':?^G#4:* /UE_X)]_\F)?!'_L0-"_]-UO7L->/?\ !/O_
M ),2^"/_ &(&A?\ INMZ]AH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=U?1M[,_T=\+_"S@>CP?B<?E56.+KU*52+FU[T9<KNHQ>L7KVOJG?4_3X?\
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MX:LKP)<W,IGN9E\R([7FE)>1AS(WS-N)S6#_ ,.B?V5?^C;O@5_X0>E__&*
M-?\ X>9_LY_]' _!+_PM],_^/T?\/,_V<_\ HX'X)?\ A;Z9_P#'ZR/^'1/[
M*O\ T;=\"O\ P@]+_P#C%6-%_P""5/[,_A76K74M)_9[^"NFZE8RB:WN[3P7
MIUO/;..5='2$,K XP001US0!?_X>9_LY_P#1P/P2_P#"WTS_ ./T?\/,_P!G
M/_HX'X)?^%OIG_Q^NSB_9;^':1J&\$>%<@<XTR$#\MM._P"&7?AW_P!"/X5_
M\%L/_P 30!Q+?\%-/V<]O_)P'P1_#QOIG_Q^OB'_ ()3^+]+\>_\%$=8UK1=
M0L-8T?5M?^-%Y8W]A<I<VMY"^O>"61XY$9D=2N"&4E2""":_11_V7?AWM./!
M'A=3V/\ 9D/'_CM?G/\ \$F_ ^C_  T_X*"ZIX>\/Z3IF@Z)HNO_ !HL[#3M
M.MUM[2Q@CUWP0B11QJ JHJ@*%4  #I0!^JU%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4V;_5M_NFG4V;_5M_NF@#\._P#@Y:_Y/K\)_P#8AVG_ *<-1HH_
MX.6O^3Z_"?\ V(=I_P"G#4:* /UE_P""??\ R8E\$?\ L0-"_P#3=;U[#7CW
M_!/O_DQ+X(_]B!H7_INMZ]AH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#YE_X*EC=^S5X@_[ 'B3_ -1O5*Y?_@D=;)<Z;^TH&'WOCWXM
M!(.,_O8/\:ZG_@J3_P FT^(/^P!XD_\ 4;U.N:_X)#?\@[]I/_LO?BW_ -&P
M4 ?74=NL1^48ZU)110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P :'\%?MR.FW_A)O@"N>_V+4^/UKN^NS_Y]2_#_ #/F5PS2ZXVC_P"!2_\
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MGQ1_V-'QK_\ 4@\%5^G[_=K\P/\ @FM_RDY\4?\ 8T?&O_U(/!5 'Z@4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !39O]6W^Z:=39O]6W^Z: /P[_X.6O\
MD^OPG_V(=I_Z<-1HH_X.6O\ D^OPG_V(=I_Z<-1HH _67_@GW_R8E\$?^Q T
M+_TW6]>PUX]_P3[_ .3$O@C_ -B!H7_INMZ]AH **** "BBB@ HHHH ****
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M8?$ZW%C-X2U"YUGP<+J%E%]HUQ,9-RRXQ*5D<EF9@=TI7K&RI]V:_P"'=/\
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M_P"Q T+_ --UO7L->/?\$^_^3$O@C_V(&A?^FZWKV&@ HHHH **** "BBB@
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M** "BBB@ HHHH *;-_JV_P!TTZFS?ZMO]TT ?AW_ ,'+7_)]?A/_ +$.T_\
M3AJ-%'_!RU_R?7X3_P"Q#M/_ $X:C10!^LO_  3[_P"3$O@C_P!B!H7_ *;K
M>O8:^0?^"$?_ "BL^%/_ '%O_3O?5]?4 %%%% !1110 4444 %%%% !1110
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M/Q/^%+BWF\)R?$S1DW)!?:+J%I9:UDL6C$UI=-!:E%BPKW"709Y,%;559C&
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M^R1H7Q[\/^%Y_$UU9WW[._C"\EGU_7[S7+PR-=:&NP7%W+)*L8"Y";MJL[D
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MFW.[ ^%GA<#IC_D$VM 'T)10.E% !1110 4444 %%%% !1110 4444 %%%%
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M '%O_3O?5]?5\@_\$(_^45GPI_[BW_IWOJ^OJ "BBB@ HHHH **** "BBB@
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M-=2^'K24F*W24W ^SQ>1$TDL:!MT:J6 !H _13XR?#@_&#X,^+/"7VS^S?\
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M=+C?9+$RR1L59@'1E9<Y4@@&L/\ X(W?\D-^%G_9NGPP_P#2?5J /M2BBB@
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M/JU 'VI1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %!ZT4'K0!#%]P?0441?
M<'T%% 'R/_P0C_Y16?"G_N+?^G>^KZ^KY!_X(1_\HK/A3_W%O_3O?5]?4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y_^T/\ \BSH_P#V
M,FB_^G*WK\B? WQ"^$/PU_9<_:DOOC=#I=QX,N/ /PRM(([_ $J34HWU&3PD
M@L]L:1R%7\_9A\ *>2RC)K]=OVB/^18T?_L9-%_].5O7P;_P0%M?$,'Q6^.0
M\27>C7ET?#OP[>U;3+.2VC2R/AM#:HZR22%IE@\M9'!57=6940$*H!RW_!I+
MK/PMU;_@F%I=MX-L=)C^(NDWUU:^/[RWT:2UN+JX;4+Z:P6:Y:)5N2ME)$5"
MM((U8*=A)%?JW41MTR/D7Y>!\HX'I4HZ4 %%%% !1110 4444 %%%% !7Y4_
ML]?\K>GQZ_[(=;?^E&A5^JU?E3^SU_RMZ?'K_LAUM_Z4:%0!^JU?//\ P5B@
M+?\ !+S]I-U8_+\+?$[=3VTFZ/\ ,#U'7UKZ&KY^_P""L''_  2U_:6_[)7X
MH_'_ (E%U0!R_P"R?^RWJ'PV_8T^$\GAGQ7JUOXTT/P-IL$VI7%Q+)IWB*=+
M"$$WUI(\BD22JKF6(BXC 94F57D63S[]H/\ 8X\._MF>"O%7COP[\(OA7JVO
M?%CPM)IFI/XSMH;/6/"VJ0VUS9B1Y$M+HRSQ2>1;2()(Q#]@!1Y3M5?G7]F;
MQ#^W#'^S/X#\1>(OBI\)?"G@W6/#FEZCI&KV?@O4M:L+73Y[:,Q-?.;JWGM)
M8U(:9I;86\*$,UQ@2^5'\=/VE_V^/V&O"OQ"T?PAX+^#OQ*'P[8^(+N_7PY+
M9PZCI]ZDM[=:DQ?Q"LR$72WT9C%L1NM6VE5*+0!:^-__  6C\:?"C_@HY9?#
M[Q9XV\"_"3PJ_C&\\-7&B>(-&ELM0@TN$11VVLIJMR?(>&[DEDGCS:K;K#:3
MQ?:1-Y/G>8_M(Z#XK\1?\&N>CVG@G^UYO$DVE_#Q+-=+F:.X9S8^'-H4H0<B
M0ICG@D8[5]:>.OVKOB]\-OB$OAGQ5^U%^P5X;\51@HFE:KH5]9Z@H9OF AE\
M0B09*^@)*G/*UYW\'8U/_! 7P+PN6M_A<,XZY3PI0!\A_%+X1?';]FK]COXN
M:M\>O%,-QK&L?';P-J]CXPU2W6'1;^&/['%]M2%?(001QP0QN%\D%+?&5"@C
M]MOV4?B3JOQ<^#.DZYK3:7=7E[+=I'?:9$\-CK%M'<S16VH6Z%Y"L%W!'%<Q
MCS)<).HWN ';Y!_X+T^6_P"P%\/%<V7EO\0O!Q=;L+]G<?VE;9\T'/[OGYN,
M8SZU]A^"+KQC-IVC_88/ *Z#MB2)M.N9]@MAC_4@($P$'RX.WICB@#TKREQ4
M<-KY7]WJ23CKU_QI;0,(OG+;L]3U/%39H !TKY9_:R_Y2%?LN?\ 8=UG_P!1
MW5Z^IJ^6?VLO^4A7[+G_ &'=9_\ 4=U>@#ZBA_U7_ C_ #J2HX?]5_P(_P Z
MDH **** "BBB@ HHHH **** "OSO_P"#DW]F?XW_ +4_[%O@GP_\!++6KWQA
MI_Q)T?5KE=,U..PD@MHHKL1W+M))&I6*\>SD/+;#&LI $19?T0ICQ*Y^90V>
M.E 'YJ_\&^O[,?[0O[-?Q'_:DC_:"DU?4M<\3>.(M4M-<G*_8?$K%)4DO[1$
M(2*.1%MP(PB%%$<91/+V+^EHZ4T1JO11^5.H **** "BBB@ HHHH **** "B
MBB@ HHHH **** "OSQ_X.5_V<?C=^T]^PIX4T#X#V.O7_C"R^(.E:K<)I.K1
M:;-';PQW)CF,DDL0*Q7;6DG4^68UE.!"77]#J:T88_,H/U% 'YF_\&_?[*7[
M2'[-'Q;_ &IKC]HBXU'5K_Q?XSMK[3=;FO8I+/Q)(B3K-?6L$;8@B>%K,*GE
MQA%1(@J&W,:?IH.E-6)5/W5'T%.H **** "BBB@ HHHH **** "BBB@ HHHH
M **** "OC'_@OI\0OA'\/O\ @E]\2O\ A<"Z0VG:WIEYI?AK^T-(EU)1X@DL
MKEM/,:QQR&&42(2LQVJA'+J#S]G4QDWMRH..1[4 ?@+_ ,$PM-^%OC7_ (-S
MO#&EZ'X?T6?Q1+\6?"NC_$1VT%H_[3N#XXM)+>WNIGC5;P+87%N-H=UC68*=
MI8K7Z4_\$;O^2&_"S_LW3X8?^D^K5U/_  6!B5/V1=&5550?B;X"X Q_S-ND
MURW_  1N_P"2'?"S_LW3X8?^D^K4 ?:E%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS'\3[6">Y\/Z'>S'5/"_C2QMIM+DNK@)>(EQ;PM:V-LRVAD0&Q:413QS23(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %!ZT4'K0!#%]P?0441?<'T%% 'R/_P $(_\ E%9\
M*?\ N+?^G>^KZ^KY!_X(1_\ **SX4_\ <6_].]]7U]0 4444 %%%% !1110
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M5<X !\S>#OV-?VD/ OA/2]%L?VF/"?V+1[.&QMQ)\,69A'$@1?\ F*XSA1R
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MWXNTNZT75K,_#/58?M=I<Q/%-$7C\1*Z[HW==R,& /# \UQ__!!_QW=>,/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^5_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPO7P/)-\+]'GU7Q%?ZZ;B]AMY4L9KQ-.2VMGB8W+0K;R/YEQ$88;N"41S"5
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MAYC_ .!'^=25%:1O' JR%68?W1M&/I4M !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#SC]I:_ATSP9IMS-(L<-OXAT>1V(^ZHU& D]"?R
MK\T?^"3?[=_PB_9S^.?Q>M_B5\0/#?PON[OPM\/+2&Q\;S'PS>SR6GAJ*&?9
M!?"&1T5Q@2!=C JREE8,?TU_:/\ A[K7Q'^'#V.@QZ9<:E'J%E>1P:A>26=O
M.L-S%+(C3)%,T9*(P#"-L,1QC-?%GQ?_ ."3GBSXZ>&]=@\;63>*]2UCPPGA
M""YN/C+JVE6]K81+=>3%+9Z1H]C;WB*UW,2+F.1F#%2^TXH ^B_VFOCQ\&_B
MG\(O%7P_\0?%;P;X7_X3_P /:EI"W-QK-M;2K#-;^1+-%YKH&,?G1G /5ESC
M-?F7^S[I_CC0OAC8^//@EXB\3>%_%WQP^+^B0>,/%UCH.G75QX@TW5O"$/B2
M25HKNU%M'Y6J:A<06S;8@GFB%Y"2&7Z._8@^*VI_M^:+^RG\;_B!XJ\-ZI%\
M0?"OB70)=)M4;3RNJ2O:7$D%F8Y \AB71KK>CL[ 1EAPKE?'/!'CBZ^$^K_$
M[Q1KEXFAZ=H-WX5LM8\3:9YTUK%;>#OB9JEG=VQC7S)C/_8MQIC.BK^\6<';
MF;D ^PO#/["^F_$?]G/Q ;_XM?M#?%S^T('FMM/U[QI/X;NHKE+>6,V,_P#9
M2Z>RJS/Y<L5SO"LHW8V8'#Z__P $OO@W\1/%VAZ/X@^$O@V^^(GCHR:GXQO]
M5@EUR>/2+>=3)*&NY;M(+JZ<6MOE9S,J2W3P3,;9G'UC\4=+D^&ESJGQ \/>
M1!<6L)N-?TZ6:.UMM?@2-1YS2%3LN8HTQ'(2 ZH(9/D$<D$7[)UZWQ"\+WGQ
M"OH;VUUOQ@WER6=[#'#=:):6T]PMOILT:<+/;F299@7DQ</<!9#&(PH!^9/_
M  5P\ ^%?@/X9_;3\$^'-'M])L_$'P%\%ZG8:9ING0V]AI<-CJ^L6*P11Q[0
MGRR0E55=H^<9'R@\Y_P0(\2_%[]C;X]?#+]GCXN:QX@TYKCP%K,EAX1D-K):
M:%>#5GN859K7[S?9[>ZD:21W?-T(SL6,+7TI_P %^XM*E^&.M:=J_B:XT6#Q
M!\'/B+9:;I\"R;M3U>U@TK7+?HC(BI;Z+?$LY7(8A6WN ?%?A1^TOI_BO_@H
M/\#?$5X+K1$\:?V%X_M-7U^./=/HNL>%++28[6"3,CK-<ZY=V_F1H41I+9F+
M,V* /V(A&V%0!M  P ,8_"G4V ;8$ QC:,8&!^5.H **** "FF+<>=WYFG44
M 1I;K&V0OY]J=Y?S[N<_6G44 ->)9/O#I1M^7%.HH B-JC#E>/YTJVRJH R
M!@ $\?K4E% $?V=?]K_OH_XU\^_\%3/$%QX!_8%^(WC+3]#L_$U[\-[6W\=V
M^FW<YC@N9=%NX-57<P(.%:S#8!R=N "3@_0V:_-C_@L+;_%_XA?M@_"7X.Z+
M\8M/^&_P?_:#T76O!^O6EQHMGJ!FG6RNWE!\U5F'VE)+6WC\BYA97W$!F(%
M'V#^P5XP_P"$L_9DTJU\AHF\&ZIJ_@AG+Y-X=$U.[T?[3C V><+$3>6<^7YN
MS<^T.?9@,"OB?_@A!=Z#:?L<:GH'A_7O$7BFU\)>(%TF\U;6+B6Y>ZOO[)TV
M>[CBEE9G:&"XFEM5#$F/[,8LMY>]OM@=* "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X_\ ^"W4NMP?
ML01OX;CT^;7E\?\ @A]-BU*1XK&2Z'BG3/)$KQJSK&9-@8J"P RH)X.7_P $
M;O\ DAOPK_[-T^&'_I/JU=9_P6''_&(^B_\ 93? 7_J6Z37)_P#!&W_DAOPK
M_P"S<_AA_P"D^K4 ?:E%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4'K10>M
M $,7W!]!11%]P?044 ?(_P#P0C_Y16?"G_N+?^G>^KZ^KY!_X(1_\HK/A3_W
M%O\ T[WU?7U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M5M17,&<;F!R >A_Q_'C@59J.>,RKP=N.?YT ?F+\!O'>N:)>7#3:!I/B"S^#
M_P"U_KFE1W$&(9K'3_$+7N;B5F9RTD=UXF$?[L*'1$7:,.]?'_QP^&\?A/\
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M\.O'.E?$;PSI^L:+(;G3KU287>![>2-E+*\;Q2!9(98V5D>*15='5U8!@R@
M^./^",OPS^-WPZU/XV7OQ+\(ZGX)\.^//%]QXUT32-2AL5O+*]U&[O)]1@+V
MUW<^;'&&LDCE8P[PK$0J=V[[N7@49P** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y7_X+#,#^R1HX
M[CXF> B?;_BK=)KD_P#@C;_R0WX5_P#9N?PP_P#2?5JV_P#@M3HLVL_L76UO
M;W"VMQ>?$+P/;QRLKLL;-XKTH*Y".CG:3G"NAZX93S6)_P $;O\ DAOPK_[-
MS^&'_I/JU 'VI1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!ZT4'K0!#%]P
M?0441?<'T%% 'R/_ ,$(_P#E%9\*?^XM_P"G>^KZ^KY!_P""$?\ RBL^%/\
MW%O_ $[WU?7U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%!;% 'Y^_M:?".?XA_\%8]>\%&ZUC0=/\ C]^SEKGA/^TD#SV)N;2_51(\
M'FHDDEM'JC,N-IQ=,NX!S7P!^S/^P#KW_!2[XF>!?"OQJ\:>&?B\\_PY@\::
M3=>)M=\0>))_#'GVFB-(XBMM0TM((]0EOBT8<2 _V5+&N_R9)&_1_P#X*@_%
M/P]^RM^V3^RO\7/$VOZEH&B6'B'7?!>IR0V9O(+FUU71I9DB,4<4EP9FO]+T
MU8_)P?F=2&#G'R!_P3K^/'BGXG_M]^"?'.E6$>F^#%C?X:7U]I.@:C8Z=JN@
M:;>^)(;.X'VVPBC<M>7OAR-A:7#R1,K"6.))&CC ,3_@G+_P:;Z]^SG\8?%>
MK?%#XG>%]<\,ZYIDNGIIVA>$]/O)+EI),F1CJ=I/%:%%'R_9HQ("Y EC52LO
MH_BC_@S=_9?U>VTQ;'6OBUHJV5Q)-=&/6K:YFU"-A'B)MUMM14*.04 8^<V6
M;"!?UOLQLMH\8^[G ]ZFS0!\O_"?_@CK^R[\#_"-G9Z?\"_A?-)9V$-E+>ZE
MX:LKZZNO+4+OE9XR&E8C+, "S$US?Q-_8C\$Z]^U9HHUP>/+#PQJ'ARSTSPU
MIGA[QIK>A:!HMSILCD6XMK"\BMU\^">$1Q^24VZ9*>"^&]Z_:R\;7/PZ^"MQ
MJUOK7_"-I#JVD0WFJ%H5%A:2ZG:Q74I:96B15MWE)=P5098XQD?&_@'XX?$G
MXO?M#>$O"'C"SF\8?"7QAHUN(-1^PQ.)1]O\2?V;?RO#&&ADU#3+&RN'FC\E
M(9XX5CCA>Y2, 'T5\./^"77[-?P@NQJ7A7X$_"O3-26:"ZBNK;PU:&>&6-BT
M4L<A0E&5LL&0@Y ]!6[^P#J<>I_LP:78IHNG:%#X3U?6O"45G8N'MD32=6O-
M,1X_D0*CK:!P@4",/LRVW<8O%WPH^,NC2^;X)^*GA2/3VC60Q>-/!$FK7T4A
M/S*D]C?V""+:%PCPO(&W_O2K*J?//_!!?XS>)OC'X#_:,7Q58^&[#4O#WQOU
M_3&70EN([&X?R;*6:XC2>YN603SR2SE5F9%:9@F%P  ?>RC:N** >** "BBB
M@ HHHH **** "BBB@"-X5=B67/X5\\_'[X31>,/'6IP_#F&Z\._%"^"7EUXE
MTZ\ELK72Y!&D$5S?11Y@U*9(5CV6ERI\R.(*7A3;(OT0>,UXS\ -3TWPEX)U
MCQ5KVM6T-YXMU_4-0N[R\<6R,1.]O;6R@MM_<VEM;P@)C?\ 9S(P+R.Q -CX
M ?"+QG\*O#\UOXM^*GBSXH:A=!6-YJ^F:5IXM<;LB&*RM(!M)89$C2-A5PPP
MV_U!>E>/>(_V^_@AX4\7R^']1^,?PHT_7K>);F;3;KQ?80W<<3 %9#$9=X4A
MA@D '(]:]A'2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ^5_\ @L,?^,1]%_[*9X"_]2W2:Y/_ ((V
M_P#)#?A7_P!FY_##_P!)]6KJ/^"P\[)^R7I''RK\2_ 1!YY(\6Z43_3\SZ5R
M_P#P1N_Y(;\+/^S=/AA_Z3ZM0!]J4444 %%%% !1110 4444 %%%% !1110
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M"^MR:/=:EX%TQ_!TUUI2NME=?V1/)IBS1!QNV2"UW\X.6X4#@ 'T,**!THH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH ^0?^"VW@O3OB!^Q)%HNL6<-]I6L_$#P3I]Y;2C,=S!+XITR-T;V9
M78'V)]JR?^"-QS\#OA9_V;I\,/\ TGU:NL_X+#?\FCZ+_P!E,\!?^I;I-<G_
M ,$;?^2&_"O_ +-S^&'_ *3ZM0!]J4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !0>M%!ZT 0Q?<'T%%$7W!]!10!\C_ /!"/_E%9\*?^XM_Z=[ZOKZOD'_@
MA'_RBL^%/_<6_P#3O?5]?4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJWAN\\0:;XBBN+SP@FCZKJ%M+X>O-/U)_LLL.GJMP]S>L^3&@D*^8[.QW/\
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M#Q)XE+GP'^S5^T1XLCN $T^]U#2+'PO9SS?="31ZI=P7D$8D(W2M:8"AG02
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M*SX4_P#<6_\ 3O?5]?5\@_\ !"/_ )16?"G_ +BW_IWOJ^OJ "BBB@ HHHH
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M[3JU[;Z?XITR[N$C>0L(XX$T*!C&@C5IX<@R2_. ?;]%16LWG1[B5/;CI4M
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M_P#!"/\ Y16?"G_N+?\ IWOJ^OJ "BBB@ HHHH **** "BBB@ HHHH ****
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M]-;21I+9&;AF&<9SCVH DHHHH **** "BBF^>F\+O7<V<#/)QUH =11NHS0
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MJ>EVUK-#(\>3.+JW$X6+E8Q(-SHC$_II_P &^7[<7PWT_P#X(X_!F+Q9X\\
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M+[3/$4/A?PO#8:GXIOH5NGCNBXM=(L_-$4E[<LH^ZN7\J %7N9(F12B)//
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M2_9M\*VOB!1-86]_:?#FTN;E[ 2EXE:5O%T;INX=H1N17) 9_OGH_P#ANO\
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M2%6O_AM[7_YM:^YA_P $VOV=5Z? 3X+^G_(D:;_\9I?^';G[._\ T03X+_\
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MSQ>:/Q_I4E% 'G_PX^#%E\*O'OC[6;6XO+BX^(FOP^(;]96_=P3)IEAIH6/
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ML=2U[Q)J_A^T;4+W688!;W5R0L8C!,\<C*T:J%VH0J$!5]@_X*N?#Z'XB_\
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M7?%J<6.RW+&637+V.R>5WB=,C3U*1$(K8=Q7IWP(_P""0/Q4^%'CS3M4D_:
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M=JI(4(!Z8.E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0>M
M%!ZT 0Q?<'T%%$7W!]!10!\C_P#!"/\ Y16?"G_N+?\ IWOJ^OJ^0?\ @A'_
M ,HK/A3_ -Q;_P!.]]7U]0 4444 %%%% !1110 4444 %%%% !1110 4444
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M /PW\ ^"+6XG%T\.@^'K738Y)@ HE80HFZ0  !CR,#T%>E44 5C9[QRS <C
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0ZCI.M6<5_8W41S'<P2H'CD4^C*P(]C0!I4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4'K10>M $,7W!]!11%]P?044 ?(_\ P0C_ .45GPI_
M[BW_ *=[ZOKZOD'_ ((1_P#**SX4_P#<6_\ 3O?5]?4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 1S$JK8[ D<]:\C_8B\8MXR^
M\6ZV6V_X1O7==\*H V?.72M8O-,$V,?*9%M%DV<[=^W+;=Q]>;[IKF/ GC6W
M\2Z_XDT^&WN+9O#M^EE*9 H2=I+6VNC)'M8DK_I(!+ '>K_PX) .I' HH%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHH K&P5NK/G;CCCCZ=*(;!8'RK-^)_ \]?3KZ"K-%  .E%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!ZT4'K0!#%]P?04
M41?<'T%% 'R/_P $(_\ E%9\*?\ N+?^G>^KZ^KY!_X(1_\ **SX4_\ <6_]
M.]]7U]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5Y_\;/A=H?CGQ+\/?$&L:C=:;-\/?$IUG2_+F2.*YN[C3[[21%+N4EE9-3D"
MJI5O,$9R0"K>@5X[^WEXD_X0+]EKQ1XN?S7M_A^MOXSNH8SB6[M])N8M1F@C
M/022QVKQ+DXW2#.1F@#URR/^C+[?+S['%35';#;"OXXJ2@ HHHH **** "BF
MN^Q<X)^@J-;Q7X7EO3(R* )J*KRWZ0J?[P_AR.OI67XQ\>Z7\/\ PGJFO:Q<
M?8](T6UEOKVZ92RP01(SR2$ $D*JDG )XXSTH W**\]L/VD_#^IW\-M'IWCK
MS+AQ&&D\%:PD:,2!AW:U"H.>68A0,DD=:L_$+Q)XFTCQ5IMKX=\,V6L1ZC!,
M;J\O-8%A':&,Q[(\".1W=_,D(*+@")MQ&4R =S17$^ I?&NI7]\/$VA>%]%M
ME"_8SINNSZDTW7(E1[2W"8&#\KN#DC'&3SJ_"KXF:KKNLR:E\3-/L].FGD&D
MP:'X6BM9K*W+,4\Z2ZFNA-<*I4>8BPQ$H3Y/.  >L5'<,8XF([?Y]17&Z_\
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MM3T4  Z4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!ZT4'K0!#%]P?04
M41?<'T%% 'R/_P $(_\ E%9\*?\ N+?^G>^KZ^KY!_X(1_\ **SX4_\ <6_]
M.]]7U]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4'K10>M $,7W!]!11%]P?044 ?(__!"/_E%9
M\*?^XM_Z=[ZOKZOD'_@A'_RBL^%/_<6_].]]7U]0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4'K10>M $,7W!]!11%]P?044 ?(_P#P0C_Y
M16?"G_N+?^G>^KZ^KY!_X(1_\HK/A3_W%O\ T[WU?7U !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !0>M%!ZT 0Q?<'T%%$7W!]!10!\C_P#!
M"/\ Y16?"G_N+?\ IWOJ^OJ^0?\ @A'_ ,HK/A3_ -Q;_P!.]]7U]0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4'K10>M $,7W!]!11%]P?
M044 ?(__  0C_P"45GPI_P"XM_Z=[ZOKZOD'_@A'_P HK/A3_P!Q;_T[WU?7
MU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0>M%!ZT 0Q?<'
MT%%$7W!]!10!\C_\$(_^45GPI_[BW_IWOJ^OJ^0?^"$?_**SX4_]Q;_T[WU?
M7U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0>M%!ZT 0Q?<
M'T%%$7W!]!10!\C_ /!"/_E%9\*?^XM_Z=[ZOKZOD'_@A'_RBL^%/_<6_P#3
MO?5]?4 %%%% !11GFB@ HII?'=<#K3E;<,CH>E !111GF@ HH)Q3?-4'&Y=S
M=!GK0 ZBDS@<TN>: "BD9@@Y-+0 444 YH ** VZ@M@<T %%-$JEMNX;NN,T
MJN&Z'- "T4TRJ&VY7/IFA9%9<AAB@!U% .11F@ HHSBF^:O]Y?SH =10#D49
MQ0 444;N: "BBB@ HHHH ***1FVC)X'J: %HIHD4KG<N/7-.S0 44A<#O2"5
M6SAE^7KSTH =12*VY<CFE)Q0 44 YH)P* "B@'(IK2*HY8#ZT .HH#97/XYI
MHE5N0R\>] #J*:9D!^^OYTJN'Z'- "T4$XIOFJ3PR_G0 ZBC/%% !139)!$C
M,>-H)YIP.10 444TS*#C<N1VS0 ZBF^8N/O+^="R*W<?A0 ZBHVE42;2RAB,
MX/I_DU)0 44TR!3RR_G3MV!F@ HIAF4'!91N.!SUK*L+[5I/%E]#<6FGQZ.E
MM ]K<I=LUS+.SRB6-X?*"I&JK"5D$K%VDD!1!&K2 &Q130V%'\Z=0 449YH)
MQ0 44!LT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 44V8[8V/L:^(_\ @L5_P6T\ _\ !(WX8VLVJ11^
M*_B-XA3?H/A&*Z^SR740D"274TP1_(@7Y@&9"9'78OW9&0 ^UY+U8I=K?+R!
MDD8R3@#\:E$J^M?QL_\ !0/_ (+V?M(?\%!_'.KW&K>/M<\#^#=1@DLH_"'A
M;4;C3])%HZJK0SJCAKPM@L[3EN7<*$0B,>R?\$S_ /@W?^.W_!0_]ECQ/\4H
MM>N/!]G]A,G@FTU:6:/_ (2VY5T+%CD&&U:/>BS<[I",?*K&@#^KJ74%CR3'
M)M!(WX&/U.?_ -530SK,OR^F:_AIL?BQ\<OV"?CCK.FV7BKXD?"GQ]H,CZ7J
M<5IJEUI=[" Z,T$H1U+1LT<;%3N1PJ'##!K]NO\ @B__ ,'85W\5/B!H_P +
M?VE?[%T^YU-S::7\08$%C#<7#,BPQ:C;J&BA+DR;KF,I&I\L-&HWS4 ?O!13
M5D!"Y."1TIU !0>M%!ZT 0Q?<'T%%$7W!]!10!\C_P#!"/\ Y16?"G_N+?\
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MEM-%=6MQ\)_$TL$T3;TFC;1[DAE89!!!!!!P>WK7A_\ P:Y?\H+?@;_W'_\
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M/Q-X7TV[GTZZ:6Y=VC5H[252R$[6P_4=NE?1?[47_!?'XT?$/]F?XAZ!>_L
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MQ,NKN:XNKJY^*%Y+-+)*SM,[:9IA9F)^\222222<T =Y_P %A?\ @D/\+_\
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M_P#P0C_Y16?"G_N+?^G>^KZ^KY!_X(1_\HK/A3_W%O\ T[WU?7U !0**,YH
M_'O_ (-O/^4I'_!3/_LJ4?\ Z=_$=?L&W]*\5_9G_8'^%?[(_P 6?B?XT^'_
M (7;0?$GQBU7^VO%]V=1O+D:K=B6XF$@2:5XXOWEW<-B)4'SXQ@*![2.E 'X
MT_\ !NG_ ,I>_P#@I-_V4:?_ -/.NUP__!-/XL^%O@__ ,'1/[9NH>+/$F@>
M&+&YTR^MXKG5]1BL899#?Z:1&K2, 6(5C@'. 3C -?J[^SE_P3Z^%'[)_P 7
M_B7X\^'_ (5DT/Q5\7M3.K^+;XZE>7/]J71FGG9Q'-*R1?O+F9@(51?WF,8
M \9^.?\ P;W_ +(O[3'Q=\1>/?'7PA?7_%WBJ\?4-4U ^*=9M?M<S=6\N&\2
M-.@X557CI0!]"_\ #<_P5_Z*]\,?_"IL?_CM8_Q@_;O^&OPZ_9M^(GQ+L/%G
MA?Q3H/PZT:YU753I6M6]P%$<,DD<.]&8+)*R"-%/+,X #' /S-_Q"Z_L,_\
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MQ7%U)$P:&:1<LI(W9&" 1]B2!_*P#AL=0/Y?X4 ?BE_P96?\FN_'7_L=;?\
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MQR >-?\ !*+]L3X2^$?^"8?[/6EZM\4/AWINI:=\.= M[JTNO$EG#-;R+I\
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MWGA&\%KI7C'01)>^$M<2QBDN-.N=O_'MN8!EMY\(DBJR9\N)CGRUKU;XA?\
M!/+X2_%G]L3P?\>?$7A5M0^+'@2P73-$UL:E>PK8VP:X94^SI*MNYS=W'+QL
M3OZ_*H'N3()%^8 ]B#WH _+7_@W:_P""HGB?X_Z'XB_9S^.E[J$?[1/P7N+G
M3]3;4;G[1=Z]8V]P86EDF4&.2:"5T@=U=FF41REWW.U?J8.E?./Q%_X)8? W
MXE?M>Z5\>M2\$21_%W03 ;/Q'IVM:CILY$*M''YD5M<10S?NCY3>:CEX@(VW
M( H^AK59%5@S%L8 )[T 6**!10 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ'_[*9=?^FO3*_F3-?TV?\&4O_*-KXC_ /93+K_TUZ90!_.-^T:<?M#>//\
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M% 'R/_P0C_Y16?"G_N+?^G>^KZ^KY!_X(1_\HK/A3_W%O_3O?5]?4 %%%!-
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MXI:AX+^#OQ(_X2_Q-I>E2:Y<V?\ PC^J:?Y5G'+#"\N^ZMHD.))XEVABQWY
MP"0 ?45%>(_"'_@HK\'?CS^U+XV^"OA/QA_:OQ,^'4,D_B'1O[)OH/[/1)(X
MF/GR0K!)AYHQB.1B=V0" 2/;A0 45&\ZHWS-_G_(KXA_;<_X.%/V6/V&_B!<
M>#O%7Q"?6/%=A*T.HZ7X:LI=4FTM@TD;)/+'B&*57C96B:3S5)0F,*P:@#[B
MHKY'_8#_ ."U7[.__!2/7IM%^&OCZ.;Q5:Q?:)/#VK6\NFZDT>9!NBCE 6X
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MF>)OV?=+\6?:OB_X-TU-8UC0/[+O$^R6KQVLBR?:6B%N^4O+<[4E9OWG3Y6
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M50!P HZ 5I#@5''=1R_=922<?C4E !0>M%!ZT 0Q?<'T%%$7W!]!10!\C_\
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M+M%EY?\ ;5TQ8GC_ %-Q"?=G"]>* /VHM;C[2IY0[2!\IR.@-?C3_P 'K/\
MRCY^%_;_ (N)'CZ_V;>U^S,";$YK\9O^#UK_ )1\_"_=_P!%%CSS_P!0V^H
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MJG@SQ3>SF[U*>"-+N[BN'NGD,SP2+:WL9BG\R2.14166%1N &_M$_P#*Z1\
M?^Q%NO\ TS:]7[22?\>[?[AK\#O^"JO[+&E?MK?\'6'PI^&.M>(O&'A/3?$W
M@7][JOA:_6QU:S\BQUFY'DS/'(J[FA"ME#E'8<9S7UFW_!K#\+1!N_X:(_;
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M&C6(N?\ A.=?AU7[#]E,^S[-Y=O%Y9?[0V_.[=LC_N\@'PO^RI_RN:?M-?\
M9-;/_P!-WAJOV0K\;_V5#_QV9_M-?]DUL_\ TW>&J_9"@#\?_P#@]4_Y19^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX6<+(X^)NE-M7(R<?:^>,\5^EAO%\]DVN.>#QSVR.>W/7GC@4QM5A63;\RX
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M*=_$CQ%\2?#,</@*3P9J/AG1?$Z:I931ZPW]J:<]M(+:.X>XA62"V=PLB+L
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MHH _'WXE_L"_M&_\$=OVN_&WQ8_8W\+Z5\2O@_\ $#[5JGB?X4S7<6GKH]Z
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M]^U?\(=&NWLO!>K>%KPPZI8VYDN)%2:*&&YN5C*@';+$R0;EB6=E\M1^W%%
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M^U$WBB6P;5X=(/PHU$7S62R)$]PD03>81(R O@C<X!(&!7(?LVZS\7/VHO\
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M>&]%\W5HY+A+C[/?7<TEY<PK(F%9(YIWC4C(VJHRY^8@'TX.E% Z44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!R?@3X,Z'\./&/CC7M+AN$U#XA:O%KF
MLM)*766YCT^STY2@_@7[/8VXP.-RLW4FN!^$O[ 'PK^"GQ$^+GB30_#-K'<_
M'&[2]\86<JK)I^J2B*2-V-MCRP91+*TI(/F-*[,268GVJB@#XUT?_@A;\"]&
ML-.T-KKXM7_P]TIU-KX"O_B-K5YX4C1=Q6$V$EP4:$,S,8VRC98,&1F4_2S_
M  (\-?\ "V/#?C.&R:VUGPGH>H>&],$#>7;V]E>RZ?+-&(AA<!M,M-N.%"L!
M]XUVE% 'G_Q _9L\+_$GXR^!?'U]#J,'BKX=O>?V3=V=_-;*T5W"(KBWG1&"
M3POMB?9(#B2&-A@CF2Z_9U\,W?[2=I\6'AN_^$QL?#,_A**<7#"$6$UU#=.I
MCZ;S+"A#=0 1WKO** .#A_9W\,V_[2MQ\6%@NO\ A,;KPU%X3DF^T-Y)L([J
M2Z11'TW>;*YW=<<5:U'X'Z!JWQWT?XD2Q7)\4:'H-]X;M91,?*6SO+BSN9P8
M^C,9+"W(;J K ?>-=E10 "@]:*#UH AB^X/H**(ON#Z"B@#Y'_X(1_\ **SX
M4_\ <6_].]]7U]7Y4_\ !'G_ (*__L\?!'_@G3\.?#'BCX@?V;KFEOJ:W-M_
M86I3>5OU*[E7YH[=D.4D0\,<;L=<@?3H_P""[7[*I'_)4C_X36K_ /R+0!]<
MT=:^1?\ A^Q^ROCCXH$_]RWJ_P#\BU]1?#WQYI?Q2\":/XDT.Y^VZ+K]E#J-
MA<>6\?GV\T:R1OM<!EW(RG# $9P0#Q0!I-:1E]Q5LYS]X\?3T_"D^PQ;67;P
MP((!ZYZU/10!$+5$QQ]TY')XI8+=+:%8XUVJO0"I** (XH%A)*+MW')'K226
MT<Q^8,?^!'_&I:* *[V$,@*M&KJ1C##<"/I0FG0QLS+&-S  D]3C./YG\ZL4
M4 0BTC$F[:-P[C/2FMIL+*=T:MNZY[\8JQ10!&UI&R[=O'U- MHR?N\^V:DH
MH A6RC5L[1DG.?6GQPK']VGT4 %%%% !1110 45X+^TU_P %+?@Q^Q[\0[7P
MO\1?&'_".ZU?6"ZG#;_V5?7FZW:1XE?=!"Z#+Q2#:6W#9G&"#7 ?\/V?V51_
MS5$_^$UJ_P#\BT ?7-%?(W_#]G]E7_HJ1_\ ":U?_P"1:/\ A^S^RK_T5(_^
M$UJ__P BT ?7-%?(W_#]G]E7_HJ1_P#":U?_ .1:/^'[/[*O_14C_P"$UJ__
M ,BT ?7-%?(W_#]G]E7_ **D?_":U?\ ^1:/^'[/[*O_ $5(_P#A-:O_ /(M
M 'US17R-_P /V?V5?^BI'_PFM7_^1:/^'[/[*O\ T5(_^$UJ_P#\BT ?7-%?
M(W_#]G]E7_HJ1_\ ":U?_P"1:/\ A^S^RK_T5(_^$UJ__P BT ?7-%?(W_#]
MG]E7_HJ1_P#":U?_ .1:/^'[/[*O_14C_P"$UJ__ ,BT ?7-%?(W_#]G]E7_
M **D?_":U?\ ^1:/^'[/[*O_ $5(_P#A-:O_ /(M 'US17R-_P /V?V5?^BI
M'_PFM7_^1:/^'[/[*O\ T5(_^$UJ_P#\BT ?7-%?(W_#]G]E7_HJ1_\ ":U?
M_P"1:/\ A^S^RK_T5(_^$UJ__P BT ?7-%?(W_#]G]E7_HJ1_P#":U?_ .1:
M/^'[/[*O_14C_P"$UJ__ ,BT ?7-%?(W_#]G]E7_ **D?_":U?\ ^1:/^'[/
M[*O_ $5(_P#A-:O_ /(M 'US17R-_P /V?V5?^BI'_PFM7_^1:/^'[/[*O\
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M[*O_ $5(_P#A-:O_ /(M 'US17R-_P /V?V5?^BI'_PFM7_^1:/^'[/[*O\
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M[*O_ $5(_P#A-:O_ /(M 'US17R-_P /V?V5?^BI'_PFM7_^1:/^'[/[*O\
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M[*O_ $5(_P#A-:O_ /(M 'US17R-_P /V?V5?^BI'_PFM7_^1:/^'[/[*O\
MT5(_^$UJ_P#\BT ?7-%?(W_#]G]E7_HJ1_\ ":U?_P"1:/\ A^S^RK_T5(_^
M$UJ__P BT ?7-%?(W_#]G]E7_HJ1_P#":U?_ .1:/^'[/[*O_14C_P"$UJ__
M ,BT ?7-%?(W_#]G]E7_ **D?_":U?\ ^1:/^'[/[*O_ $5(_P#A-:O_ /(M
M 'US17R-_P /V?V5?^BI'_PFM7_^1:/^'[/[*O\ T5(_^$UJ_P#\BT ?7-%?
M(W_#]G]E7_HJ1_\ ":U?_P"1:/\ A^S^RK_T5(_^$UJ__P BT ?7-%?(W_#]
MG]E7_HJ1_P#":U?_ .1:/^'[/[*O_14C_P"$UJ__ ,BT ?7-%?(W_#]G]E7_
M **D?_":U?\ ^1:/^'[/[*O_ $5(_P#A-:O_ /(M 'US17R-_P /V?V5?^BI
M'_PFM7_^1:/^'[/[*O\ T5(_^$UJ_P#\BT ?7-%?(W_#]G]E7_HJ1_\ ":U?
M_P"1:/\ A^S^RK_T5(_^$UJ__P BT ?7-%?(W_#]G]E7_HJ1_P#":U?_ .1:
M/^'[/[*O_14C_P"$UJ__ ,BT ?7-%?(W_#]G]E7_ **D?_":U?\ ^1:/^'[/
M[*O_ $5(_P#A-:O_ /(M 'US17R-_P /V?V5?^BI'_PFM7_^1:/^'[/[*O\
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M[*O_ $5(_P#A-:O_ /(M 'US17R-_P /V?V5?^BI'_PFM7_^1:/^'[/[*O\
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@"BOD&;_@O'^RM9B,-\4@OF*&&?#FL=.G:T/H:* /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>image_34.jpg
<TEXT>
begin 644 image_34.jpg
MB5!.1PT*&@H    -24A$4@   R(    $" (   #],AR_    ,TE$051X7NW6
ML0T , @#0?9?.E0D$BVDNZLL>8&/  !@SRG]  !@XF7670  +))9  !?)+4(
2S#'DI#I.     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>image_37a.jpg
<TEXT>
begin 644 image_37a.jpg
MB5!.1PT*&@H    -24A$4@  !.(    $" (   "LM@>=    )TE$051X7NW!
M(0$    "(/^?UAL&( $             OA4   !N#%)+F"U5(V:)     $E%
&3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>image_42.jpg
<TEXT>
begin 644 image_42.jpg
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K?TR5H-O_V,.=DPJ=DPIQTOUZ3>>D0E]$&G$(W 'OO0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>image_48.jpg
<TEXT>
begin 644 image_48.jpg
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94_87D1]3F$*9-'M(0@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>image_63a.jpg
<TEXT>
begin 644 image_63a.jpg
MB5!.1PT*&@H    -24A$4@  #'    %)" (   #&FJP*   .\TE$051X7NW:
ML0V 0! #P>^_2G)$#8= FR!*^%E-Y!J\KO,           !@9M9_!0
M    V)!#%0          0!RJ            XE %           0ARH
M     ( X5 $          ,2A"@          ( Y5            <:@"
M      "(0Q4          $ <J@           .)0!0          $(<J
M      " .%0!          #$H0H          " .50           '&H @
M        B$,5          ! '*H           #B4 4          !"'*@
M        @#A4 0          Q*$*           @#E4           !QJ (
M         (A#%0          0!RJ            XE %           0ARH
M         ( X5 $          ,2A"@          ( Y5            <:@"
M          "(0Q4          $ <J@           .)0!0          $(<J
M          " .%0!          #$H0H          " .50           '&H
M @          B$,5          ! '*H           #B4 4          !"'
M*@          @#A4 0          Q*$*           @#E4           !Q
MJ (          (A#%0          0!RJ            XE %           0
MARH          ( X5 $          ,2A"@          ( Y5
M<:@"          "(0Q4          $ <J@           .)0!0
M$(<J          " .%0!          #$H0H          " .50
M '&H @          B$,5          ! '*H           #B4 4
M !"'*@          @#A4 0          Q*$*           @#E4
M  !QJ (          (A#%0          0!RJ            XE %
M   0ARH          ( X5 $          ,2A"@          ( Y5
M    <:@"          "(0Q4          $ <J@           .)0!0
M    $(<J          " .%0!          #$H0H          " .50
M     '&H @          B$,5          ! '*H           #B4 4
M     !"'*@          @#A4 0          Q*$*           @#E4
M      !QJ (          (A#%0          0!RJ            XE %
M       0ARH          ( X5 $          ,2A"@          ( Y5
M        <:@"          "(0Q4          $ <J@           .)0!0
M        $(<J          " .%0!          #$H0H          " .50
M         '&H @          B$,5          ! '*H           #B4 4
M         !"'*@          @#A4 0          Q*$*           @#E4
M          !QJ (          (A#%0          0!RJ            XE %
M           0ARH          ( X5 $          ,2A"@          ( Y5
M            <:@"          "(0Q4          $ <J@           .)0
M!0          $(<J          " .%0!          #$H0H          " .
M50           '&H @          B$,5          ! '*H           #B
M4 4          !"'*@          @#A4 0          Q*$*           @
M#E4           !QJ (          (A#%0          0!RJ
MXE %           0ARH          ( X5 $          ,2A"@
M( Y5            <:@"          "(0Q4          $ <J@
M .)0!0          $(<J          " .%0!          #$H0H
M " .50           '&H @          B$,5          ! '*H
M  #B4 4          !"'*@          @#A4 0          Q*$*
M   @#E4           !QJ (          (A#%0          0!RJ
M    XE %           0ARH          ( X5 $          ,2A"@
M    ( Y5            <:@"          "(0Q4          $ <J@
M     .)0!0          $(<J          " .%0!          #$H0H
M     " .50           '&H @          B$,5          ! '*H
M      #B4 4          !"'*@          @#A4 0          Q*$*
M       @#E4           !QJ (          (A#%0          0!RJ
M        XE %           0ARH          ( X5 $          ,2A"@
M        ( Y5            <:@"          "(0Q4          $ <J@
M         .)0!0          $(<J          " .%0!          #$H0H
M         " .50           '&H @          B$,5          ! .E0M
M29(D29(D29(D29(D2=HXARI)DB1)DB1)DB1)DB1)*H<J29(D29(D29(D29(D
M22J'*DF2)$F2)$F2)$F2)$FJSZ$*            ARH          ( X5 $
M         ,2A"@          ( Y5            <:@"          "(0Q4
M         $ <J@           .)0!0          $(<J          " .%0!
M          #$H0H          " .50           '&H @          B$,5
M          ! '*H           #B4 4          !"'*@          @#A4
M 0          Q*$*           @#E4           !QJ (          (A#
M%0          0!RJ            XE %           0ARH          ( X
M5 $          ,2A"@          ( Y5            <:@"          "(
M0Q4          $ <J@           .)0!0          $(<J          "
M.%0!          #$H0H          " .50           '&H @
MB$,5          ! '*H           #B4 4          !"'*@
M@#A4 0          Q*$*           @#E4           !QJ (
M (A#%0          0!RJ            XE %           0ARH
M ( X5 $          ,2A"@          ( Y5            <:@"
M  "(0Q4          $ <J@           .)0!0          $(<J
M  " .%0!          #$H0H          " .50           '&H @
M    B$,5          ! '*H           #B4 4          !"'*@
M    @#A4 0          Q*$*           @#E4           !QJ (
M     (A#%0          0!RJ            XE %           0ARH
M     ( X5 $          ,2A"@          ( Y5            <:@"
M      "(0Q4          $ <J@           .)0!0          $(<J
M      " .%0!          #$H0H          " .50           '&H @
M        B$,5          ! '*H           #B4 4          !"'*@
M        @#A4 0          Q*$*           @#E4           !QJ (
M         (A#%0          0!RJ            XE %           0ARH
M         ( X5 $          ,2A"@          ( Y5            <:@"
M          "(0Q4          $ <J@           .)0!0          $(<J
M          " .%0!          #$H0H          " =JI8D29(D29(D29(D
M29(D;9Q#E21)DB1)DB1)DB1)DB250Y4D29(D29(D29(D29(DE4.5)$F2)$F2
M)$F2)$F2)-7G4 4          ,!SJ!I)DB1)DB1)DB1)DB1)TML-%/KV;5J,
..M)\     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>image_87a.jpg
<TEXT>
begin 644 image_87a.jpg
MB5!.1PT*&@H    -24A$4@  "1X   !M" (   !"J7@?   $'4E$051X7NW9
ML0W"0!1$P>N_2G)$#=]"EX$$+[,MS6JB;>&MU_,!        _#8SZ_L%
M    /DAK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D$AK        D$AK        D$AK
M    D$AK        D$AK        D)R<UI:9F9F9F9F9F9F9F9G9Y;?;EK1F
M9F9F9F9F9F9F9F9F]F>[;9V<U@       . NI#4       !(WFEMS,S,S,S,
>S,S,S,S,S"SL !,47$.2F]/-     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>image_9.jpg
<TEXT>
begin 644 image_9.jpg
MB5!.1PT*&@H    -24A$4@  !+T    $" (   #DJ=I8    *$E$051X7NW!
M,0$   P"(/N7U@0[]P$)             #PH    W 84+"F<K:!P<     !)
'14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>imagea.jpg
<TEXT>
begin 644 imagea.jpg
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M0%(#UVXUV2X9!=MRL"_8.Z (V<*$B3LE#4 9<2W%-_\'L2WO1''I^^PSABX
M'>T1689L ]@!O)!_A#$9%TR'<,A-PA'?#D"83"$L;C;YY;^5,9A.^[_'P M=
MU@&E1F_'NO#M@[YWY!<)3?_'/Q)M: (K31 A"G@QB.&!!7X1!S!BDL/EZ3CA
MTO&I!P&2!V8&2H LC<" 2$@*1UU:@$>(@0X7VM(,VCX+CR-B>,I#3^C' <I(
MB;S##LX8;/7)0*\OK=]#$@.5+BW/(9^[I]=^I7HI"KTQACD Y<L.?(MRK8F!
MQQB_6, 'W+EXCFXT6?5J$'?8V?P8+M2Y.^U<V7%W:4,U>]Y]%9*MSR=6*]R!
MY[GD>>%8#;"J]ZX1QXT E:1 8K'',]H[&<!S?K%R.&91>JBUDODTB12->L#F
M.!#V(1Q%I!$#<+QZXEQB[IT4FO_A?^_FL09P[($#P*&!0QBB,3+-&T4,"H_X
M(K<FS C;FC\'&UH#4JT))O.#-IY@/KSC1MKF9[:%P\_>X\O$?_,W^@C+8VE:
M>N:/%@#-(P8_#)I"M)GPDP,(&-+ W])WCH$?R\=LBV/_6[,MF6#:A$]D&"@
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M?S.XQQL+&W0W-^@SX6EN\3;QS,W2B/\?=+?P)E0)BS%>Q+L#X !#08,6$ZT
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M_.XGKP<*BP@.1Q6.Q#XF!6!S'YEJ:/IR 8.T%]7T> _J'$;C3MIP2-5<E>/
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M7<>A9*?3:Y-F;8D\$0 .#1PG;UA*Y9 ")BA8^(\[PHCK,QZWJS&,V1^%?3<
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ML8L<Z@AK]#N]M2FVA#I[RBSM6,_ENE$=V[M(\Q?%/G$F:<FP.=JP-<>=Y04
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MBL2O PB)F_*"_\B!HR_4[.SL%ZSAQ8OQ_;<V(S+2TH0TN]LP692R7Z3VKR.
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MGV%Y!J6%A1A9IH,MH+6B#$\STL7Q[.@(4A,SH;<X<M#H]7B4GHF)*64.48
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M,#3TNR5X/_-PNW$/6:E%:&UI14YF/*X%1B&UH!@/$Q]LD'IV:!"A_F[(RZ]
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MJNNJD%MLT1T$D)S\"+$I"LAK;:Y$?LZFT?;'69D("W"$L\,==(TI>F3G#U_
M]6M.:&ILP:<_>0>W;]^"O8,SXAYG0I@[X3PF/+.:T5A1C\0(A9,X/]:#E.1(
MRST%^AHZ$1X4@*GY:82X^^+VS1NX?-L>D8^R,+^\@JKB7*RL+ N].SZK1MTJ
M]A_=C[1BQ=>MA_TM7/50_)ZF9*;!/5 !<)T-N? .CQ1^<FDVY+Z;.X;&%5_
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M.Q%$%@($GA>KO_)/%K69<M>KFB=#$:Y%94[D-]*2FWEMPX"LLBM>F>67U?
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M+<<IZV-*D;<$KK*,*&SCGRS'2]RE2]'Q;L)O ^ (>G<37A: XYCEN G@I!4
MGI/ 2IW'NH]:C19G3Y_!TS2%\\CKDZ/C&!]31%O\/3T[BRMVU]#<K.Q2Y+FA
M 45<:UW?\W[O%L"1DTH1:EV=HA,FQ_2\=E[W=2[>0B1)#P/<76!8PM/L3%3W
M#H+;&L@-8WC6W8.;=Z[@W-DO4%U!([$,9O3WU./ZQ2]P\8H=:EI[+;JS1I04
M%2(GOU LY$M+(X@)3\/*HE**WA12T]/0.] C@./JZ@J>)L5C;E;A>(Z,CB,[
MKT*(";FIH#CO"8[O/X 3QT[ P=X)\QH-.CK[4)U?@IJ21SAT:+_PTWG[GA/F
MEY8QV%".8X?WX^BI,SAZX@1B4]/16%V+(X<_Q[$3Q^#HZ8?1>07X$<KHUM<0
M&!" SLY>T=^AD1Z45!1C?GH<01[..'WN"^0UM(DQFTT:0A.,3<]B8J ?=85)
M.'#P$(Z?.(<CYRZBL+,-B0EA.';TL&C[MM,]3$\K'P(CS_K@X' 7IXZ?0UY)
M)8QF QXG).'V'1>L<#8R Y4Y^7"\ZXI%G<*E-*[-P,O#'D>.'\>)$R=P^>9]
M#$\M")#9TEB&^*2GEF_M=6B7IN#KZHS3I\^ALJ8.YG4MW!WOX/#1P]A_\"".
M'S^#XG+Z,35A8K(7T0^?8GY= 7T$R@1:H]T]B(^*$W?=;-3 U<$=QXX>P]'3
MIY!>5B_NKQGK0GKYFQ9Z;2 ^\9R\_']O =S+I^F>JO%-M ,GO6Y0'+/;( '<
M[CEPSP=P:J["\_JUUP"<! CJ!94 ;FY6V7DU,3V-^\XN6*.N!V<D\SH,ZQKX
M>;LA)6O3)RW%\C=NW! Z9 0?W VN#F\!G)H:OWFL!F=J ,?[0H M039_VPKE
MI67X]->?@(L]0W-#-<Z?.(:+%ZZAMKUK0\#4W-4!)Q=GZ"VJ!$.#+\9!W"V
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M(2R$XNYF\7MN>0T7/)S0U5X'7Q]_Q#Q)1UQRO,*1!Y"15H",',67*@NTE]3
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MZL"1"_-U"7)2?]'Q$,!)X+%=7=M=VTW;MNJQ=<Y6G3(?1:CL\XMPX,@5HCU
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MPK>M8/\8UV'4:S$U,8^^W@&4E!>CM+@,\^/*NT</$'H#;;U)."V&\DK_[2D
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M']@N^TN )OOIY.0$:P!"$23S_K9!?6\(X/@Q1 !)#J\4;TNZ;=46^S]+)]H
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M8)ZUTX$IMX#?K?[>A?1N\;S/ ' 0<@"<X\ Y(N$X<,]%J,\F@&,<.=V\  P
MTM&Q&CMVK!%WN;'VSHGG]Q__.C&0 \>[A@\UN&]PKY[5]8IVL0;CO@D##0Y
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M*QJ5OUY;-JU6>ND9DVU/]RUM7+%1>^,M\+A:G:=-VW:HP6_SW[%JD=*R#AD
M9D-"NEE;K ^61*I)/:HZE:,%B^V6D&184G12";LRU>-'F\JOZ'4;=/A D2G+
M.B>QK0GY.Y40NU%OO#5:)ZMKU.CWZ_TY\U5[[:8!?E*=XA9-U+[]!_3>[&C%
M;<U44O0F59:=U+S$_4HM/JTMVQ-L9I)V[]VKH_MCM"%BID:-^\#X]YNW8KV:
MVV]I^ZK)>NNMT9HU:Z9FSEFN'2G9\H=!7O&QHUJSP7*J5HT:K3='CM"LV;,T
M:<(,5=^P?O].'-ZAX2.&:'OJ$0/(C)Z8KU$;UT3J2"4B8WM4G+^@>6LB3?VO
MG\M41%24&B0UU]_4Q+=&:OH4ME&<H9^^.D3I.T\K9^LN#7GI)5/7F;,7J>K<
M596GI>KU'WW/A,V8L5"1FY/5WM:FW)Q,S5\P3Y,_F*HCN446$/LZM&G%<EVH
MLVYL&NOJ=#@U66=+3VC/_C3%[DQ7Y;E:)2;&*1#P*V)#K)(,Y@@H8W^,-J<?
M,7/E<NU%O?SJ3S1M]BQ3[LM#7E/6L3S7K$_D^M0".+[&,'+ LNG3!. @L"QP
M$&$LU-B6B^UI6/391<%[$H9/*;R?LP46ON\@!O=+"!"7LM<J"R#^WQ"GXBT=
M5Q-LN?7<"O79 G .O+GQ![!AZ(-?1,#^_0)\E_[Y]?&!-_K2 3C>6?[SKKLQ
M8>R>U?ZF#4A!V"^5=>.55UXQ:Q(?@^RRP,&ZA&$4^G[L\XSZ!A:GM;6U9G<&
MXCC0Q=4K,L4A,+L]L-8//+!NQ9DPOD"M,GU(H;":S<"X@_\'@01U:'^ZTHYD
M6S%IV#+1>?4RQ@%$"Z$5%][ ONVBUJY<J,/G+*<)#M6&Y5':%5=@BFF\6J0%
M:R)UL=.JLQ].6*]]Z9D&N!"A!WVRDDQ-7;%>30JH_%2NYB^U *[V?)5B8^)5
MWPSWC:-7*;MWZT!R3OA_4!WM];I]N]'\/WDD1I.FS3*;=C6TPKF;J6O7Z\-Q
M6[1UP8?:M^^@)DQ>KZ:Z3B6NGJ?(%4NT=.]!I115:'U\/X!+W+E-N9GQBET;
MH0W;=I@/_>SC^?+U-"I^PRRMWQ"G39LB]=KP,;K>:J$H!67N/Z!5ZZ-,F<M&
MS]>RU5$F[?SI,Q4?GV7"&Z^?U-OC1JCB=KOI!Z-CZ+^A=:LCE5':KR^)O\T-
MZ]>;--?.9BHB.EKT\HWZ&YH]?8J2]^Q21D:J9DZ=H:SMIY03LUOS9LTQY:4=
M/*JZVZTJWIVLV1,F:N_^_7KYY3=UM/",0J%NM;7>UNV69F5FI&G&] @=.G':
ME+-AT3P55U\T]X'.%N7MVZWM,3$JJ;FFC)QC6K%FDTI*J\WSE>SKFV7;E'4@
M2ILRCQI^;4W-68V9,$8IZ>E*3S^@R3-G*?W(<P!G.FW@#P .MCV+P-V,&)ZU
MA=%+A)V2\\2)$XU^&MPV=\)!XX0PH^/$ERA@C#3W0P@H!P(/]PV#!A9AP@!Q
MS@KUL\"!@XC2;OH-@H.?*J=,3MC#6J&2!R>$ZVXG<>AS%Y=QN%\NF:NWRQ_
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MEV_B7;E1K\2]!]3)!XB"RLG-5FEI"2^"$0?;G)_L[W, ]X3=D'@7=0?@("Z
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MAVV X+@ !NX7P$&DT<U$-(T8D[PXC3^EB@H31CC_R1\@QGGITB7S]0C!NE\
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M+[[XHN%4 93( U!RMW91/P@PW$FXE/058>A?HCS.B3L?Q&2X]H&8TR[B43X
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M:0!T<-  M(!'TCIP1;U=7H3QG+H@PF.C=/05R8>V44]7EDOC_C/_ 6?$=^,
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M"LATP)-W'2"%F-_%'WAE?-D!@7C$=^"-ON(C=V!\[W_*1/^/N*1E?:%L\@)
M\1PPY4W#/1Q8P#MSX&_^YF_,_..C@G&!0\N5.<F<P[T.8T@; ,E<T:7D0YRR
M ;CN<%RZ]O9V\Y&P:,EB'3QZ3'4WZU1_ZY9RLH]IQ<H5FKUHD1H;+8?*6HH^
M!,$D23B9N[5_^85,HRO'&5!O**C>GA8UUE]3>U>W3IXLUI+%44I)VJI]&3LT
M?MEZY>;FZ>CQ$VIJN:&2[#1]^$&4KE^_I8"OQ^CIK9DW0VE'#@Y2?PD  "
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M\'#,'B>  Q "="@+ ,<<9=[0?\Q;@"8<N;O-'Z\(U7'@F*> "8 /8 K  ZA
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M#\,.L^TD)K[QS&%VDPB/%W5A\P;&*SP/30T >\&0_,&0,(9QA[OS8&?SB#K
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MQ,&)\W+@ (/>-@R\IV^H)^ 2D$E=.0&*Z*3AHH3V8=&,_AI?\W"^B/,P.G
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MRKGG][H^52)4G",.-$NG 5X@]QS /3B 0]\'[@!$'.(,V/BS/_NSSP0'#N*
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MR>+U P>P<P .D37&!8\*X!P'CK(ADH@R'3B#RP:PPI<?  Z Q8D(#.M!.$N
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MU-!0E^[=NZO52T)UJ/RX>GI[=?1TI4+"-ZKQ1J/NM+<K/#%9^4>.FV=C^#8
MG&$Y8>?L,PUTS#,Z^048&#8'J!S0FLKR'0#C!^Y8/@?(O.6X>!S9B.-V%^:,
M&%Y4 .< @1.A\E7+TE:_]5N_I2]]Z4MFYYQ)"H_NG,/",.D!,AQ+\; !F,G,
M"^ <@&$R1QD9![\<$:\"%#^K.TK8]#7]Y?K>]1U]R>0Q$8!S<3DZ\/TL&#@
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MEY%M(T*UZ]E_2O!-^@7$2/R0O'N@QE-TXGZT'"<"<*XX;UU<&G</H/%9,&(
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M .  4>0+@ ,L/FT 1QF.@:/LI\' ?=H ;J)G\:CW $T\/])Q!&C!EL&2 9P
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M*SSTC1XDYIG*^CRO>;VH ,X9,. *@U4F>)8P=82S\^P!<=, [L%N1/A]?)8
M'.\Q3!<?G(C*86%Y)_[LS_[,N+/Y_.<_K\]][G/&50[N<F"'8=\!_NSH5#YL
M)QZZ;[A=0;^/CP?&%7;T"!&[\T&('J,+8\QAC&$,XAY6S.Q8-9,&,3P?!=QS
M6T_//2U:\('VYN9I3^$^):5G&#];SFO(1PL^-&,^\0WQX1).Q1'Z;01?<.1M
M]<>:ZAJT\KWWM"$I4M][8X%Z!KJ4EYNFA,*#?J;GMC8G)NE0I5U!H+6^7'$I
MB4*3;U-TE,*CUFGVO ^5LWNSCI3MT_I,Z^IB9,3OC%=22.1J_<=__9?YN)X]
M]QW57V]0S-9T%13E*77C>NTI*5/JQA0#A*5.96Z+TYZ <V&0;:^.E.5J9<A6
M'<T^I?512<HJ.:24;7NT(S];VQ-BE+0V7@BC+8=D.VMO]FZEK?<[V_7=4OS&
M6.6>K]#/WGE;+_W@^WKMU9?UUJNOJK&C5S6U%7K_@P6*CTW46Z_-TEU#.(VJ
MH#1?Z;G6-<R)?5N4GK7;#^!\&AR^H]1-.W0A]Z1>_N;W]<KKK^OK_^__HW7)
M&S6")3'+A)64Z]4WY^J39:&Z<<L:%6"@80 <9 \K8TSY@YZ*E^7YR>.9 3BW
MA!;@C7,&'K[D^%J<:.?K#Z#$D2]'K)F@\1DLW"+>3%KL, 7N_'&.+CW.3[T#
M% ..VQEXW #D_*O1%O;G :P * &8Z$:QBL,7OO %LZ02@[?;&81A,=&/FF;@
MGMP/W+-BX!R[ABB5<Y;28F+%XI1WE_?6O<.P=NC/(4*=9N#^QX ;?J.?10#G
M/B!I'Z),6#<<Y_+[QLT,'V^\"ZB>\([@:P[ QWCEQJZ)CHPIC-'D!S#D(Q?+
M4^\&VX837^]VY\X=XV*$,'S>,8Y[-]90Y5UV6T]OC\*CPM79URWU^;3LPV7J
M\8VIXZ]>$Z$3QRT#%Z"!7.(G/2(A\@T;JU'THX [)_:7*N23I:8OWY[UD4X>
M/:*BDEW:46X9N-'^NTJ)6:==Q8=TYGREAKJ:%9\4K;J65B5'Q2EJ;926+ENL
MY1&A.GZF0O'1.P*U/'WRE,X<JM"&'>DZ5W<E$,[)ZL0T[3M8JELMM7IKSBPM
M#ENG]@X@V%WM3$_2[N,7K*4GU=2@CAW*T:IE6W0R^[C6K8[4H&]$RU:$Z.7Y
M\U5:F*5M2>O5>!<+3NEV<Z-*CQ2H8'^Q-L?M,F%2C]8FKE/IQ2JMBHC5S6YK
M3)*:$*_,_&,Z5'Y(2Y?3#VLU9]:[.GC.,H#%I?G:D;/'Y-%PME3AL;$&*)IR
M6NJU:FV<KAZ\I,15L<:DHB0O6ZNBXS7H8W6&?>KLLCJ.V7G[M#PDPE\7:0CK
M6829HR/R^<73@9O3)_?UP#,!<+!O #=VSMFAUO'<[:CWB8XN'O0\R^@ /A )
M,.@@*D!LP)$!@O/'V9TB+GDR(>,?"OTC=@8_M[MK -[SQKXQ(#.84R\F*H <
M?0*8Q4*1'>8&]I!!GC;3WN<!>#[K.M#N%TV$Z@ <+ LZ;RRQQGN*6!QQH_<C
M9JH9.,I[5B)4WE':\K1%J'R,4=94Z<#Q3J'"X-R(7+QX\:G_OF#?O$",<U0\
M$&'"R '>$8^C\H%>&@#/Q2>,.C]L9SQA'.%C@'5JR1\ A\6I=W,K,7C# '&
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M:JH ');1B*<1$Z&?R5J83'8 $"9U^N%1 1R@Q>4!,P2[!B# #QP*XC!4E 5
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M@>.6Z'%%J+Q+WO' @2( $6,'8 M6GS)H)Z)$V#AO&N\Y (NZL"H&8)UWBW.
M)N<<>1:,4Y3EQB;*XQK#!>(%[^1%6L"4]\.4-+!J6.&[,KQI*1O&DGZ#8:;O
M>GKP@#^V\>ZC[\;F0)MCX@CC-\)8"@!Q#!SQ7%SB\)SC8J.U)255J9LW:?FJ
M53ISZK3)T_QAF2OCYL,+D,9N/^D9H,(($OU !&P$]#'^^#T CM)Q=V% ' #)
M_M>(@6C#MG)^0&;7;X6%@Z4"]5BP9^ 1^ 2+UU&[)).U$F55@0$#KPQ.Q6+3
MQ",A?M( >I1NXQAX8R,:L 8L TX9*&9\F[$"Q(#!05S:50/ZS$H")E\#SVS=
M#*XTG>BO[U@M+(XRA5%7\O0#-C^HM?#3(D0L1_%0AS6I[0R#/,U5P!+6U/D!
M3\RTU9_,G3\@VG20[8%I !<$X-S@RP + \>@A_X'@S#WO /M]/F+"^)XEH '
M0!)B-'2>T.MZV#-ED@3<PQ0YG4DF)[<2PU0OI06+!S/$>XC_/G2)8.*8X&'@
MF*P1T0'HT",C#I,[#!W@CW,FQHG:15_P?E,.$S@@AQTQ+<"1_ &FSI$O;!D
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M(^Y", S H2ZL'.\,0 4CAN?-"I7WVP$XKQ$#P!2=)?2>\ '&XNKX+ .L 6X
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M&:*.-L?6FC_#I 9NT&*O 3<<#I!QP [WQ -<\/1@3H &KJ L)<Y%L;)E$5K
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M$9MN*GRY-VGFESFT8 X0A\8<PN!0Y>SSJ7E^N>=Y:OX^W_Q9 (<A7]8^3)/
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MO__W__X!F0N&XGD .+O (N?QG>]\QU#@L&W$O7TV%;Y<&RD@#24%YI#3*C(
MRE%H((3R&AP<;-BIF$>P0/VSC)_RG/(0[K;E0JUE,WQ42I[]:'"W[5'JM6G<
M[Z,%I^ZXP&OD_^BS;:\MYV$A?:-MC ME6? ;6&[@/>D PXP'==EQ>E@][GC2
M4IZ=A\"R ^]MG]QEV/G]M#C24(>=JXGJL\\"^\V80+VE;N8[\&2\B'.73[O=
MY=@T@7GM_41C0/Z)ZK1EV7FR?;&A+<N6'1CR(</'-!0X#/FBT(!G!.(1)2%L
M;FXV[K(P#<)_BH.U'$H=VJLXN$<<ACB[QC]\6PO<%!' #XQ[>.X'GAALA&B_
MXV' \;>)O34_AC&&.=  ==KK\_7)JR'Y%3*-P5RJ=FR648;CYY7TE&HLZ3H.
M'(R--F,2US<\AI8<6(*9D4'CB_.!MN'-PH=I$.R]X?J)1CD'Y8_=&RU5QU:<
M>8I"@I<R \>$>V-HQ!9C7$BA%6I[;Q^0DIY@5X[GCE:IQV_EUU^NZ3?:P(P-
M1N^P%\>=X[,4+=E!C6C4U^T8#QYK#KW&M14I'=U:6R^AHU],S;1JP#RR[3'J
MLVZ,S0-_N4;/PM]G,V9F[,;'C(),;6C<CJ-_TPY,J\C+1P0YG6X.V:)-P8,2
M\^9_-4RB@!]:BSV[,81I]*2==R<@Z3.[?:$ '"^D56+ 2C>&'Y%!8L%P'U,
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M8>-AZW,_?]0V!N:U8^ANC[M<=[_=:=UI'G8-B 680:5&AI#\EDI'N3SG0P,
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M#&N5:PO>>)< RBAD_,JO_(H!<(]"@7O>_X%'K?^S !Q]AU(,@(-*RH'=MXE
M'.LY>\RS G!V+^OI:E-L[ &A6%EPH4#7KSF4-(]WT)C(0(G2F 6Q&[*O4Y&1
M:_3M[W_?L,6#5JV5;]BG:^<*M&CN7+T[?88.IF5K: 06[+#.9YW2M.D?ZKW9
M'RO[;(&*KU]64465O_IAG3F?KN2\0@,B,HZ=U)7":\8$R;W::PJ.WJTNCT^W
M+Q9HP=SY>O>]Z=I_)$N#0WTJ/)6DA!1'UJRS_K;F3?M EZL;#&5,OD'MC8_3
MT?,.6]?1DAU2U9TB+5FTV+1[7T*\^GJ[=*>\3(F[T_P"]T/*.I:LQ!-G_>WS
MZ7SA%67F%JJN^J[^[I6_UUMOHO#PKB[>*-&=HHO*R#JG'@-M1W3S0K9"]QPR
MS.+AKF8MF_F!3A<5ZL,YL_3=UU[5M _>4VS246."!:I79MIAO?:='YKVK I:
MIZK[3:A-:-&"F?KQFS_2V^^\HW<^F*O;%;7J;*_7O&4A:NT#1/<I?.D2%954
MJJ^K7GFY)]3AUQ@8ZF[2P91$[4G.4*Z?K>WS=&AG3)RNE->J_,9E+9\_6^_\
M]"<Z<#Q-;2,C1G'"F$-1FZ)V;%=RCC-NIXZ?5,CV/68L2JYE*R0AR:2MKZ]7
M4DJR1H8!<"V*VQ>OZ_<:S"C4EU_3H=3#:G\1E!@L:.-/92ER]L5_7J$;P&5G
M9S_0#.1NH,"QL-BO0!L^ZJ+TN.FF*' _&^!Q"L"-SR-C,07@)@9PEDW*>H$<
M)%0WY/T"UP_B\9_[F[_YF_]L )P= \8(C>3?_NW??L!B &S4RLI*XQ/5O8 _
M4P#'GH99"N^HH;"QQPT/#6MD>-1PU-C0,9$!U0N9>T.$@PKGZ9''UZ?.@0%U
M=_>HMZ??;P--&NSK5T?/N(R?M3G6V]NG7LLZIESH1IALP\Z:/.KW^ PP,"9&
M 'XCPQKU#1MV'7;@:-!@;Z]ZNIVRR>/S=3DL08<N:(;1 \40$QJC _)YAX4E
M.1_*&ICZ,';:I/ZA875W=HW90QLV>;!NXO>)ZO-IR(-+,T>I8VAH1)D9)]76
M@JLSCWI[NM7=TZ.>_@&=SDQ74UVC:>$@M6%N9<1O$\W/)L5PR,B(1X-]/>KI
M[5#_P)!&C5DYC'5XU#DPJ*ZN7HWZ91!'?2/R>(;,.';V]*JGJT>>X2')Y[#>
M8=9BN)E*F0[,BM W6NM(,8[(YQT5RJ7TS2A,,'^8?#&F4P8U/-QN^D'Z 6.&
MA;D8DL_'^"+UR(B;TDTEV/I#&YEPQ.?8R7/LRC&V#CP>9;P\@TX]&)8QYE4,
MV=;]BC^SZY^S[E!XL9_U5]&G];*GI\<L!GAD8'% 0Q"KWSA$QD83;%064DO*
MMR&;T=,\D9."E0";9,J0[S@(L(OYRQ). ;CQN9L"<,Y8, Z\OY8"9V4(B8<*
M9T-+D7/'D0\V*^8]?NF7?LDH=P!>D/=[W)-VD->&CUO.D^9#4QB%CE=??=6P
M4/EPAO5MRV4/P;XA,G"80+$$ =9W0)R;$@>!X%D". @V@#>OSZ^\P 9LM H=
MD2BT3]FT1WP^8QO,9ZB#V!)!<-V2X^@)6SFPPCG\V[Z]?;30V("E3#^(<N5"
MC<(YW'42,ZZ]ZDK^R)>4.NSNAV%K/I@=/,8Q.CB@03_ >C"%^\ZQ6.>. 5*9
MU@<TW7%Y9OOU8 ZO7V*06"<%\S-QV@=S/OS.4%$-4/LD%]%P[S#D.Z$!9'>9
M3E[*&G*UAWO H\%((%/*,= 4VX'N_,_V^N=0#>>P .YI@CA;!_4A'P$X ZA-
M=.((F44!F0D,IV);"*4&@!KVHS[\\$,C2 MU#MD83LCW]OKSAI2#LH2[#*X#
M3R@5V$0"P,V?/]\(OML%_64!+U/M=*@M3X.%RB9O@8 -&6_J0L/S4948R -5
M)U &SH((GMOR;4@<[R(;/C)<CRL#1UOM.VU#6Y_[GDW\<9484'P@+\H/E.GN
M W4%GOSO^4\_J0R<[8<M/[!>[ODPM%JH;@H<>6B'S>L>"_+Q#!#W&[_Q&_KR
ME[^L#S[XP#A^?_OMM\=";*FY[U%LX9[0?1)GT]KP8>G<\5R[[]UE/NXUK#1,
MATR;-LU\O%(.;;+A>^^]9Y1Z?NW7?LTXO<<K@UN)(1#$N?>!I[W=.=@%>&0W
M=39</UG';+R.(5_ AJ' 0-4!D& _SCNB[K9Z'3J<I>Y^-NQ!72^^H();%6;/
M'NEKUI7\'!46W=+"!8LT>\8LS9DU2RM6!ZNNIUUW[]W5BJ5+M&I%D$HK[YD\
MAB[GZQ?LSZMY>9HS=ZYBDP]H8+A?99>NJ+6]S0"9@ZDGE746K5"?RFZ6J*:R
M2&?/YBD[Z[R"ER_5S)D?:M;L69JW<)7NUK6IJ;%*:U8NU.J5ZU5QI\Z8OCA=
M4*"&SB[CXZ&VMD1Y)Z^:X>YL:5+8UBV:.W>VSE]%?JY?65F9NE_?X9^. 9V[
M<EXW2^]H2] *8RMSSKQYVA$3I;:>9H6%;M;<67,U9\Y<Q24>,.#79/2.ZG#"
M046%[QN;UKSL(\:NG*&FR:O<K-.Z7(RRA%<-]V\J.OJ@>L'%WE[=*KJBPO)J
ME5\MUO7SV<H^?UH?S)ZOV7,_UL*%RU5]]XY\WD$=33VLN7/G*"9IOP8](ZJ[
M6Z%C1PH,>]@X5?"-:.?.2,V9,TLSYR]0>NXY/_44JAU <=3(QY545"DB*D1S
M9L_4@CF+5'BI6)U]33IV.$W#CN$]U=R]H[,%EPQ(,Q\#@'!C#+K'\=S@$ G'
M^ONL+WX.2]G\H4"H]GP:(,Z63<@7&* ,;3ZL?-L3 ZE8 N>>$*%A@!M"L_;$
MZOM?_=5?&>H7AC;Y,MRY<Z?1$+/7W#_.B989<B^4@ZP+,BV$[I,VP\+]'__C
M?QA'S7R%LJ"[%W.[P$^%G]R(7Y0Q8<.=3 #'1F]-*O!.<,]F;M\-"^ PU<%'
MP*.,P\, '&53!N 'L$&]G+9,-P6)M($@Q::S(<_=+%2K40H@(;^EN)"&/I&>
M\TD '&9$9LR88>: =MBZZ(^[7\3SWR*<+ "'!B7]8IRHBVL[3M1%O#7#0KP=
MIT\+R4>YK%,8A0;4H+0":'>?;A!%/%2MP),/5+0]\18!$(?B3TA\8%KNB0=@
M85C7WD^4[DGC &WTB[;8]M V/$] ??OYG_]Y\]$Q/#QL."5N$&=EXA"->98
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MGCT?D,><30: LP"#CPUL84&E8#,%_//QP7/FF+J>1 O5B@L@AX6L%?;(\!8
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M&"K$9 (X%B0+R-B4V6A9U&&IN!=B]^)''IO/'3]U_>P!V><=<^9M,@$<H
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ME%$X4&( Q&$BRAYHHK:VMAH 9T5B[+,7(80A-@J+#.NP_CUY%),?.%L8<6A
MCO3:N)PXX )/#+#23"Q91ST:TJ!?_LW?,^^01@6@'3;F2D:Q&NP^4"3TCEN#
M,T;I_-),(T %VL3A\\CC<RR4T:)AZO8@V^7(=Y'$:<=X^0!,>X?XG6.2UBG.
M% D Q0 N6I;&*MZHL34\EFD\Z=B5SQ@$IDY&9%0^(QXUW@:3D$K]?2#P"G._
M?? DQ\KAPN/Q:= [[+1[+.-X$N\H-FII>)^\HSBY&C\&/>1[L+SQI\X5S6!N
MF2,LR##T36V-NG?/H32ZTX\8*JQ_#&WSO1@\'I(7KQUHGC+'8Z\ ==-O.\+N
MTI[^]0L'X!#@A:W 8;_>".TU\<C. . FDP+G7I"XQEP"5#\H&P@ELZC",G,O
MN/;:O<"Y%[ZIZ^<'T#YK[-E\I@#<%("#TN9FH?(_#Z2 ?=:[--%SNYZXG\%J
MY,,0>444I2Q[/7#]H'XHGF@R\XYR#UN7-2DPK051I+$*&'S8<FU/ ):['?::
MO*RA-EU@2/ML?8']8>TC/>WBHQLY3+<K+=9I0!RL4X";7<\!;ISN]=P\?-X_
M;.S&P0! 8=BTSY%T&@<'[-E M8<=!I,A:#6VN3NR<0]+3SQ)C2'=P&*]&/#U
M&GB$?!IM\XUZY?,,R6L\"3Q8J@\CM8''6#L"'UC0X<3['1Z8&W<S #V!!V#+
M@XS@! :&$?.?Z'BP%-/C3R2;L*DFZ; CDVAR8'+9;5[7*688Y8(QY<L'2Z)N
M6@4 ,\9W\=!EY/S'6S5DJ&A.6<3R?D[<$R>-J8&$I@@#^^V-D^ 9_KYP  ZA
M5]A/^,SC@!(7^*<'O#TM9_;NA8J%$,OB4.(0<L;T ."2A0T*!0NJ-7-@%\6I
M\,4%;>ZYF0)PX_-D-_(I"MPZ Y8F \#QKC&NK"=HIP)V$ 5!6QCV*760Q@(D
M][L)*QR92K1R"0%\ #ID] !<[K24S7K)A^9$=M[(BPRC!8LVK]6818DC,!^@
M%MMRL-#=X _01GLI"QD^TE ^\GIHW:*I#'61]=H>@#@\,1!RF,WQ*2G*V3H?
M*[3NJ3#CZ_=OB9>&2Q=S-'O&;*U;O5;W6UK5YQU1Z)8-FO7>3_7!^Q_JPYD?
M*2,G7WD7"M3;VR&T(^\4W=*5O%+=NW9-<S_\J3Z<.5/39LY4XI&3NG+IHF:_
M][[1#)TY<ZXN7B\WS6VIJ]*JI8OT\9(@W;Q=BUL$E=ZXI9:!4<=#!*#2&*$%
M6O2H^'J^YGTT7YLW[]! [["&!NNU,'BE9LR<J9DS9J?1#L4  "  241!5&KY
M^LWJ[6S1X8,9:FD95'55A98N6ZJ@I<O5VMJLYOK[6CEGL<IJZ@V([&FIT^H5
MRW6UHEH%!>=T[9;C_/WZV1S-F3Y+(5MVJ+FQPZ3%R$IW6[G6K%RL63-F:^:,
MC[7KX''#YCUSXH0^?/\#S9@QS;0C*_^<H3CF'#JNF3-G*>G820T/#RIFZT;-
MF/:AWGMWNF;,7*#\DR>5&+U9TV=,U[29L[1A:Z0Z>U$A&)$\?4HYG*Z2N_<-
MJ&UKJM:!0Z=TI?"&$@_L,XH&?!!<N'!)-XNN:./*Q<8?Z[L?S-"TCY;I2FF%
MH5SZ1@;DQ>*&06G2E?,Y2LD];>AG(YT=2MBZ727U#NZHJJW2N8)\U585:]K,
M]S5]YG2M#-ZD\GO-9@P<*J8#]&".&RSW6"_>DV5ZX0 <W>&+SI+B ZEO/+<
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MD89VL1=E#CK@4\*>:'TX<ZZFO?VVMH3$J+]K4,%S/U;9[=O:L"5"22=RM??
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M RI-68D!J'" 0VJ(83JS"1EHJ0<#H .< \BMNA&AK&Q +FU#VORYM)(VHZV
MH5L%.-Y5H,3S EC<C0@S'($W@*HE5F( X'"]0ML!BSCP;2K \3O$IQSMA0]
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M8* '$FFOILQ")2X0"-0 4+Z4%O7"CK.EEM+B.=%FM!UY44?4P[2M@Q9P?#,
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M:M$H99.)1>$LKL4+ &D 2YXU"2$=Q*Z-H%9?*Z<5,+I(#A%0Q5(G1+@:6MG
MDO:*^(H6L=)8>B%?:[DH?<_&TX@:R,I0!W"A'(0-[4?RG$69^,6HN%?O/(?Z
MS^OJ4!^$L]L"</[%Q9X7*"Y:O]E&0%3/%R@V)H#?TJ5+3<2/,UN.F[H!BDSU
MY\N<SH^-CBR^T='1>=(Q7^_+M!7>W@L+[W>;M +<>Y_)C0". 1Z5+/958\:,
M,94J:L]6@*MK2]K0-R1I2+607&$;AH$__062.. ,MQM\)"(!Y!J@A<0.Z +^
MF,'*A #6%HUO?_9G?V;7N8?+#NYY.,Z)AR^V;WWK6P:,7_C"%RP<]SQ\/#T_
M)AZ;GY,F$SR(0WI(7:D#=8EO2-TP:<$&D_Z1\#Z)P4!!TNG3I\W^S2<@^ >\
MW[_9_K]%P]NX#70P<(,5D<0I8H!:<*HM1 @7"*$V4!TQU(:+@T/MQ2A<!'!<
M)ECX9X$ #E-*UEYW"5: &@,G+IED,(@/L><*<0)<!=5L0)T <"%_+Q&@9*Y3
M+&"X2@L8J'$M@6J6-%U"1], 6Q58L8FI'@']P@0,Y[X ?I9ZA$J4(:BD/6\K
MB4GUHM1)-Q% $\L^D\9%<S6LKH$'HZ<3U</:)AR3$2D1S )%$M703@%HJ8D_
MW["/XEZU\S#QQ*\*\($YN2T 1VV!MOH@U]A6X,?N/WC4FO5MX/CR90.F;G7S
M-/C"9 D:!BW28I#RF6FH2[%I8<_F7]Q "1+%]QM.6O.O&U"OU1:M /?>-FH,
MP/%! \"AYL0FCM\%$->46:A([TB'[<.N0N5]H[] C0H _<[O_([-<,47&S[=
MF-@ V %H;!QCAH'4S7VP,9L4]>H':8O[F+M1N:@C'[6H3[V_IH_'G4A\$D/\
M7F/'@*:&NVHHMA/^U5VMNX1,"GP!/J()!LX#MM![900D'AO, G'">4B1_T"
M_W$>T4=M2"*$ZP'4/"Q[K@,\85\;U^@H0*.ESNU(<!4D8V@ZZTI#26VB@&EA
M'6 \[9"JR;HL7?*%!L&R&/R99 Z8"E*\, V%W)#Z,=TAE)1)'@':O/Q>:J -
MV[MDD/:1??S/UAL-;1UF2P27*>4J5Y(ET\B0REJQ0YM8$I'*EI)86_#/VN)J
M@+/[1$AZ_<F<P#P/0[V0=KQ,EEEMIE?=J3NQ M6=6IS8:>VAE;;VK+D/;AO
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MJ80M94L!')(P)M#@D!8I#A(;H 2@H@T88)M# D<^;BB/7S'.D38B+6- ;RK
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M4?>'_*[:P+#<_*O5W8F. !17I0);G!N1<-_N7!V%NIK$#@FE.3$QZ:+$6J>
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ME)Z1K56Y.5?%+UB7ISFIBVJO#>@_1NO6;;5S;!N-)^UMB@"N3BM;&Z>I!ZT
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MDWW0#>X_3#-F+=:[I_9K8*_)*KU($M7:MBE??=Z8;:TL7=#<F>/TRS8=-7#
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M_?A(H;^EC:@?]VCWI4N7VGO!.P#4?_K3G[[*9@U8<W<BWM^[[1OGI:6E%@]
M][_Y$T:HZRLOZ8D7>VE4RBR_K.-'C^J17S^BH^\$(_OF9A0 SB0VYMZ$9; N
MZ,+%=[5UURZ]O66[CAP)ZL[2TDOFP'?KVV_KK;>WZL3Q=Y4H+]>N/7OT]MMO
MZNWM;^MB>;0T%=[[JRMUXL1Q;=FV55O?VJH#QX-;D.K2R]I?LD=OO;5-F]_:
M;G9A%15G=*:BTI;]BGQ0Z/3)T]KZ]E9="1;[.G?FE+9OV:9+EX,S7%9YV+5[
MNXY&;D@2+"%E4J[F;J':1]%Z\ %J@?<%X.(B],:T13R\V\#AH9V.Q;\&?=_<
MG6']]/[7 %PD70OU9Q!@BZNH@+C& ARJ74^CH70BB=Y-0&;]Y]+8<]Z3Y@8X
M)C&@!D)2#!"PE!9Y-*<?.*0=;  <LY^1A %M&'RCX@(@44U2/P99RG&K$CC@
MC,W]P"&%0\)'ODC L4LB+WX+C0$X  ?)% N\?^(3G] ?_=$?V2Q+ !2((VTD
M/!S39DATJ!MUX#KWV9AIBPN?W__]W[=T[KSS3H,,E\3%P87WX5H 1]JT&=!%
MFD ITL;& %S]]XP\D$RA N:8]D<"AU2)]O$RW:[^*5X^!S6_UM@R>)F)1QI\
M2/".\WSH<X%Q/D+H@WG^S)3E/?S"%[Y@[1#OTU&;(HFC#^?/]QSSP4.[V0+W
MX:YZ/-Y.JPJRE5-4I.X]>QE415'5Y:5NUIX6M$['%DZ;^#\HOL**[Z&D5S1E
MXF#]Y/Y?JW/G%]2SUR"5[-BDE2OFZ<Y[?FTV>\]T?E:K,U;JS>)T_<_=]YG*
M_*G'.FCTN&FZ4!9LU*HN'='++W54NR>>TK.=GU7G%WIKU^&]6I>7J9]_[Q?J
MW/DY=>K\O ISEBIUT41-2,L)"K<:Z>*Y<QHZN*^>?+*MA@T?I].GSVGDD(%Z
M_/&G-7C,'%V^?$7[MA>H7Z^7U;W+Z]IWZ*3%K:RY6K78Q*9IC?X!;H'; G N
M?6/O7V <-^:/'WQ\UA&#4JL$[FI;,^^@K]['88OPC84M[-E0C=:I1T.Z=>D%
MB5FP@W,;MZOS#N5SR5H OQL#7)#J-:9NMQZ&0:RY 0X'M-@^(1D"4O[\S__<
M0 M[+08\V@8@:JH$#H ;/'BP&7LC#0&$R,_]M)$'>355 @=XN)T:L$:Y@1+@
MBGR1P"%=:JP$#@# 3QB+NR-=^Y=_^1>31#(AB#0H+W5S  7<J(M#*]?9N(9*
M]6__]F\MG<]][G-F1XLTB'K7!Y2& (XT@$%4N-AMT89 ""!'VU(6!V"D_:31
MT+OM^9$W\ =04UZN(X%#ND<[>ER@* Y&?KVE]D 6\(7DC!G3O(LWLQ''XP'1
M'&,:@%TB[SK2958!X?C?_NW?[!@)W)>^]"5[)P$S-MX?/B[XP$%*Q[N#U)A[
MJ.69H,"?RXLR%T_5W;^\2W??^ZC2T@I-%<D"[OSUZMU7Z6G!$6[SVQ6%=4$-
M%IG$D#BF:3-'*>-P<+!;LG&S7N_124M6+=&R+6%B@Q5*-5J[:H8F9*\/IY(&
M].RCG.W!#<6E8V]KTL31D>\W:=VJ/ T9/5B+5V=JSIBZ=6.QKYHV?KA>3ZUS
MRKMB6:IFS5QMZ8X<^88F3)R@U(7!_<;8*:G*79.K%5/&:.?;FY2_I43O7KBB
M:A:\CQNHU9:J]> WL05N"\#1</[E57_?F$;U.(0%X&[7+-2&.E<Z9088!J(/
MA@W<M6&F_H#F]8D/)(2)GUL8)CX@,6-B!!,4<L.>X^RL;.5DYT;7\Y2%#ZPH
M#=)B0Z45TO%XP-][ 2[DFZ7L[,Q()1O%:X1K%Z_+S>XI7W,#'%+A?_B'?S!W
M"DC?&,B05K NJ@_J@$-3 0ZP0-W'TE9(HE WLFP3 RS2+&"(^CF -$4"1UH8
MX+.\U;__^[_;Q +RQ3B? 9C? 75JC 2.9P3P,8#SNT%:0]K &.WC[Q^2-#S]
M PO$\?>)/1"(*I?U.0&P^._/X_O>WXF& (YRTU;DP8<@;4A;4K>;74H+>$/]
M"Z2P2@3Y40:@$-<:KD*E//7+YF7T/77T8_8W.H^'K7\,O'$-V&9E"%9\8&/2
MF&^T\[4VPO@]/Z:NM!M]+RI[[!>!7O)"0LM[B,H;"2U0AH0.UQWGSIW3I4N7
MM'OW;K-]9)4&KG%O^_;M%I:)#/R5GS^M9^__L3;LVJ0=.P_JB<>>U]EH47GN
M=^S\@O(+?&6#Q@D +.%&_:L6BZV;",L,^$]J_+C^NONQ3NK=N[_Z]^BO[>M7
M:>GRF?K1KY^P:[UZ#M'>O5M57+A0WW_@,?7HU4L]N[RH"1-FZ<1E)B%(51?W
MZ>4N3^K)+EW5HT=/]>L_3&_N>%NYF=FZ[[_:J7>O7AHX?*PN7#BIA5-':E3J
M"ENAH*SLLL9/GJ7I\XHLG;34V>KZ_#-:'0'LG&5+-''D6/7MW$W#APS7JZ\.
MTKYCQ\RXWGW"-:K:K8$^U"UPVP"N*:W4"G#7AK3ZG3?GN1$ ,6BPA<&@ 5!K
M:*"PN!%LY8:9?ME([[(BB5P$8ME 7!0_*S,X^?2RY#+[%:C+R8Y@+@!AML^4
M-2@,\;.R6!8)"*2L@-S-U?5FPU.NY@8X;+,>>N@AG3ESQ@8Y)!6T>W.J4($R
M8(?!D@\'5%JXVT -"$0PF )=M =A <BF !QPA@H58 2T4#N2+VDR0-\LP"%M
M W0 +Z"/Y\#R8SBG!<YH+R1&  - RGTVZL-]W'(@Q:%NE(5T;N2'L2& HXUH
M*]J,<M"&V#!2M\:H4+U,E(OG01L!EAQ3?NX[P-%&C7T_B>>V?+2%QR--KG,_
M?MWOL^<>&\> %NIJW)G0/IR[-,[+QSD;P,RU^,:U^'7"T69 &]"+U,S?0]J-
MY^IVR7S$D-:5*U=,;7KJ5'#]X7T_DQCXC?@?VA@FY) '?U57KFAPEV<T8MIX
MC1^?HIY=>NAB-'%@Q\Y=^N4##^N4K;.*O*YY 8Y%[Y/,%$789^+ LYHZ9:CZ
M#!^G-6NRM'4'2S-5:NG"2>K^ZG!E9^<I([M0Y\Z=4G[N/+W0]U6M3%^N^Q]H
MIYR-=39]96=W:<BK7;5@Z7(-[M=/S_<?874M6+9(W1[M:L]J94&QRLO/:.FL
M-]0O9;ZZ]NBC+B\\I_Z#1VGVDC I9,F\V>KYXBOF^H,$YBU;I'%#!VMHE-Z.
MO-6:-G>>6'H]R"LMF]9_O^$MT IP-PD,=,H?+ F<VY<%\ DN0)A!&CK]T/'G
M*#>OH+:C=PD9]WQPH.-E $"B9C-.#= "R/D $0#,X0Y'I( 9*E<D<F'0"?EE
M*S<O5YG,9BW(5R8#D$-=+5"&\M8.2@Q02/IN\GG<;'C*U]P U^K(]^5:>&SH
M>?",XQ(X[,-*2DIL[5.@#N  -'@V2(KB$C@@C!F]0"-JV%V[=AE$Q"5P#>7)
MM>L!W*W.0O7?@I<5E2#2*B#$[_WQ'_]QK03.K_G^6F6M?]U_C_6O-W3NOR'J
MBR20B1\L@<4YX<D[GA[GQ&'S<L7WGA[7@#7W#XBM'Y--<&0-5 -Z[(%P)I?\
MW=_]G?4GC)E\=./_S6>=^C5?B<$_RID( 9#C9):_BV</:LC(P1H\=+1.'K.U
MDNQZVR<>T^AQX^VX!O,;U[G:E:;_,R0T-QMU #=A\B@MV[0MEGB99LV?J;$+
MEMD$C-(KEU56=E9KTA=HY*(T"[=W^PYU[]Y#[U[ #8ETZ=U=&C5RF$Y6!#(<
M\MH;RBM"TIRFD:\&)[ A@TM*F3!4P^:O5**ZVDR-"O)S-&G\9!T\N%=#AXU6
M1D:NIDR:H/T'#VK4V$G:OKY8TR9.TL&CQ[5RX7PMRLC2V2M75&43'IJY@4(A
M6_]_P%J@%>!N$A@^# "7DYUI )>?GV>=;$$!,_4"'/G7M7?>^='ZAG3V!?D%
M*J33+RQ23D&1LI"VY>8K*[*?R\]GD,HW&,S*SC,H8PD9UL<K+"A046&1#60,
M9CEYN<K*S5%6'H"9HX+\/!46\+5/.<+@05F*"M<IOZ!(^931)'0M"W$,2JT
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M,QGD\?W;U>V%9S1N\CR5550K;46:=I?420 MT]9_O[$MT IPOV$ !QSEY>*
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M2_:T3,)7%SA<CYW;?>H6KV,X#FU4=XQ*M[G_?JN\O-P:QR5D+6&?0"-[^E0
M%2JJ&+X(O>.)[^F4^!($X,Z?/V^^H>(51]S/US.=!YTGG:OOXYW]S1S[ESYV
M'73<2-CH ,F'CHHO9O9\?;-QG0';O]!O)J_F#.L EYNS-CCO=1]K!?G*S\U6
M?DZF\O-RS<=; >HJ)!Z%..O-4E'^1F7ETWZKM2XW3_EYQ<K)S1/AUA5D*"<W
M0VNSBY61_Z;9TA6RL'7!6F7EK;!5%HH+"\V/6V[..JW+S=+JW"RM01V6G:><
MK!SEYJ]55M8:%11L4$Y>L7+S,I6?GZ7"7%R1K%/&NFW"9]VZ[%7*9YFN;!R/
M7ALTFJ/=>$^:>Q(#DF#6Y_S:U[ZFKW[UJV;XC1H053OO*.6^68#C?00>@$.@
M!L>W+$>$E)F5'LB+#6G5G_S)GYA$!',#!E/"$B=NPW6]MJ--'.  -K=O Q8P
M:O_*5[YB9@OD^]=__=?V[GN86P4X-SUP2&,/E#A0(-$A;;>S HXH)_GR ==8
M@*,-O/V M_W[]UM;X;.,#7<? .-?_,5?F 2>ML-_&W'H!_A]>QEY;U ONN/>
M^FV*.I%R(H$#VL@+?VDL+T4^Y,$,3S;208L A/(!RS$?A7P T!=R'<BD'_0P
M[-D(2]_IY_$/8/I&8)'R\P'J'\2$\?#U]]PC/0_K>7+^[6]_V\"-YT7[\7YA
M!XRY"9 -V.W=N]?\ [(V+6W%'^8O]2'.)7$W'G3CO7W3CLG+MQM)_OQ^/#RY
M<YUQT<9&FSV+/SL&[0!DMO*6 0YN1!BDF9%:K2133)FEF@S7 3@;SJ/TS"R<
MV:N65I2>C95< [Q"7/)))EDI(OC1\_2\9;R\(5Q(AWOQ<P_CXSOG'J9^.J$.
M(?Y[TT@HB9N3FNJH7I3-PS([-JD$;E>,:*DM;9 ([4&;T!;X!(P1KY?-\_7R
M^)[[B6C6,NE[_6N?@<-K5*?H$2B9B-JMIC(J;Y@I;.6+O1?6%H1-A+7::7B#
M;<*PKJP]HU GBFV\5QO?GJC5-[05X>K>#0>^\.SK -[KUM3];]$9\A<R]Q>P
MJ<E>'9^TXQL =_GR91.UXS/(-T3O !OWZ "PIV#Y%52G\3\Z*200S0EP# YT
M/BX)H!.C0\8A)AT7 X=O?%ES'/\ZK]^9WZYS5D) ?1H +M-61<AF":S\'.7G
MKE%15H8*F*!1O%%%@%1AH3+S5ZBX:(W6YVTTN,HK7*>U>6$2Q*;\ FTH*-:&
MHFP5K\M23OYZY15N479!L=8"%06YVI"?I:R\'&7E9UO:N9GY*B[*4>[Z0F4R
MJ20K4QMS\E6XOE %ZPI4R""87ZC<K#QM8%9>$1!9J-4YQ<K.*3"@RS5)#&LX
M?O@ #D@ IAA\&;R__.4OFQH5(W-_1V\6X'A_@ =4]Z3KJC:D3U__^M=-)0<D
MDA=YLT \4A/LLPA+'.RM2(-WF^U:[R3W'. 8]'FW>><9Z%G[DCP8G $=0 3X
M<.D2OT4 @/#72I_KA'<[*3Y^^%TY&%%&RDPZ2-E1 ?+;0C*&<3UE(PTD0*1S
M,Q(XV@!@(GVD1DB*4&?2AH I/MN8:<F&U,K;F3A(^"D'>2.9 ZSH%QPJO;[Q
MM@7@2),9ILS4Y)GP+#[RD8\8> -%2.%0-_*NL/W!'_R!V9]AT\9,3FS1XAMN
M0@C'-0_+WK=X6&:C4C>DBZA9Z\?U.#?:>UY(!6D3)'-\6+,'LME8_Q2)+!)#
M8([WD;;@CT',)S%P3O_/'P*#JBH ()S;Q1;\YW 4@()R4+;Z>7/.H.L@<O5X
M15D9L]A(CR6W&-B!"AN8;<#'GYO'<V@! ,(U#U<;)U"/DM5))1. 38 ;*P.E
MB=(,[01<5!G T50., YCM<#@;4H]$F$L)SYI)2AW#(2@$"\;8>)ID1Y_7 _Y
MAS:S5HHD390WM&UTS]J4-@'P2,_K3CF V6K+S^O%,R ^^8;RASI?_63"<^%^
MHCH<)Y+ &$*@I*JJRH5K%XJ42%0K03[4%^:R^10UJDGPKE4H:1!'.'O25L[:
M>@-<B; !<=2A]A[EINVX3IN2M[GW"R07P)HP_NR#ST!O[R"3#'D"GP'_FN^%
MKP6X^$O@#ZWYL@DO WG8PZ 5;_#'>GJ V^T".#IC.A^'.*1M2#_HP.F4N<Y&
M.,Z]\W[_][D1M(4%X7.S\Y696Z@U>9DJS%FE]6M7:L6R)9HP;8:F3)ZCI6FK
M5+@N71DK9FGVM+F:/'F.YLU?JLS\0EO*:LFLV9H^>:JF3IZL>7-F*G-MAI:E
MKM:JS%QE%V4I/RM+&8O7*CUGK=*R5BMK=88VY.9IX?RY2ID^4QFY>5I?F*?<
M)4LU9=H<39H^72G3IFI9^FJM6Y>K)0OG:LK4Z5J=4Z2U!>N4PPQBX"T+^[V6
M;U>><7-*X(!\WE.D(@"(@P@#-3:<W.>] 8INU@:.=P^(  !(F]FG[%'U8:/$
M1PS28!]8D5JQ 1DLS@Z\D$8<,!IZ7[D?!SA@$\D*]EY G-?))4:4B0\=ZG2K
M$CA C'8A7U9WP*:*<M"6N+L@?R1=&/P#L4 3X8D':+D$CC(T5">N47=,(H Q
MV@2U)1L@AKH8H ,2:4M D3!(SJBS QSEX/>.:A")/.E1]W@?X.W+=6QUD>Q1
MOOCVT8]^]*KS^+W?E&.@E-4@^&,,H:_'B2\3TOR:CRV^MQLM^ _U60"-N@'V
MO=G5#:P^#A+&H8:R,GCSQWU3C47J0 9T8P7"1[!F$J=$5="KQ@"N.IE4%6-@
M!&@ 5+(Z$>#&'?D"F$ "$J&(9JJK@3?4EI'$KQY@>9DIIVW)&E575M6R0BTT
MQ:#,X,TD976@5QO?TXF T.J/CSOJ&CU7*XO?IXY #V ;N2NFZ)9'\%+,"V'G
MM&$UP&5-'IZ-M6M4[ZC*UM:A GC5"Y!F(%53:<\"%J)-@,.@EP:5@$=K)H.Z
M '$\'1PP UGA'@M?5"4#\(4R!A@CLK>+/2<BA$1"W,CZSRT :7<#67,$&!79
MVCBT4Y1=D-A%4S_J0C7/T6\QK9L'% I3)WYMGN3K4HF_9'S)7.O/RW+APH5:
M@(O/;")>2TC@Z/#IE.F,Z8@Q;&: C'?6W&,08?-.FWCQXVL-)BUW'<E*GK+R
M,DVMF9-=J+4&1SDJQFW'RE3]ZN<_TQUW_5B_^-G]>J;3BUJ^;*Z>?/)!W7'7
MW;KOO@?UZWM^I:D3)VCZC&GZSO_W7?W\YP_HGI_=IRXO==:,E)'ZVE__'[TQ
M9HJ*WUZG)7/GZ-M?^YZ&CANG9WMTU=AA(S5GW&2U:_>X?O;+G^G%5WHK/[-
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M\R^2\GZ1@:-=$L&YM*=B2G;GTV3S.6!8!4Z*!!24=] SP7/R//,0/)!E>EP
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MR&31]HS @BP.Y9+Y87X"&MK+2;LX@HF'U6%]GNUEC#D^XPQ'(MO^J)1]HB,
M 1S+6\O;OT]0R+\; B_VAT&!R\I*T=/3C=;6%C0WMZ"MO1-5*C5>_=E_HZVU
M#6VM+6AK)?.HA*Y@/$BJ.:EBI1QZW%(NQXKU\=Y:U\OQ(-/*L2!SQ[$AD&/=
M'#..'=M/$$K;-8(JJ@:9EW9Q!",$ZVPOWP4$-;(>ULF_?0(PMHG.)+3CX[UE
M/MDFZ_RR?6P#'2>X\?[(\[+M7S: DVWF^/$YYWN.8TB01L:00)7/&P$>U:=D
MH_E^I T<@:S\$;"-CX\+E2K/$<3)]&$ 3I95T@=AV_UKBIS[QP_?ZZVIQ8V/
M+D"O-Z XLQ 9I2I%/2:<"PC>%*])MDVX",CE-K&$L @?_/SX9;BZN.'ZY3.P
MM;=#U]@$/CS[/NSM'>!VRPU]0[V86IR"^S5G;-U3)O3AR6D$AT5C1V_8X\2H
MENVN*D&-M@GYS5UP"@C: Z?:"BUB8Q)$)Z1]F&EG ,&A]O"X78#T+#5JRNN1
MD5X".R=7;!G7L:$W(R$I%=>NV2$Z(1E;!' $S@+OZK%V;QC^-SQ0DEV!TK)"
ME.?$(2LY&J[).5C87,2)MU[&N8L7\:,77T-3:[.H>W1Z"D'! ;#]X KJ*FN$
MO)G%>XB*C,2ELQ>14U NG!A8R:Y^!]O;]Y"1E8/S%Z[A=EH.>JL:\=[/WX.3
MLPO<O?TP,[^(]:%Q'/WIF[!EP&EG!Z06%J)G8!3>@8&@PEDO$!Q@TBF."K19
MVX*9[@C86IG'!X</X\.+'^('/_H%NGNZH2HJ1(1O(?J;FQ'GXXB0A$QDMO?#
M/SD=C=UW1#_6UE?A&1B,A7L* ]S>6@F;(Z_!V=D.@9Z!N'=O'=TC(PB+2<"N
M4*%N(R$Z'1H"N%O^B(\-07YY 8HK"L48^]Q,Q;BJ%\=^]C^XZ>P,%R\_3$[,
M">!I-!M@L-@P)F>FHJ*V4K0AS,D5[7<&Q#Z9T<ZN5KBX*_?8<O*)),\!W",
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M8H]645TOO%DUU71\*!? JTQ3+U@XJFNM 1Q5IL(+UL+Z$< QIAM90+:)+)X
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M_4)LS_@H;KIZH55; O^8. N  F87YN'G'XJ:DDJ$^X?))F!IMA/!T1'(+:W
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M]/@9-+3VB"F<8# \/AF)F8J')-M3%A>*U%1E90J8]##M3.+6K1A$QY:CM(R
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M$UH[%2<)PZX9AET#=@ENC%NH+%%CZNX&C+MZC/<V0%6M52RNS,"=Q@8L+LQ
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M .HU9:BNJ$:YJ@8CTXH#@$FWBGI5&6I;VH7/(@'IVMP*5C96E:6XC&;,+:Y
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M*='96<=W+WL_/AT[6@O>*M'6\*9I@&8P1QY^G'O)LS_.HX<[KAG7E,5.@7,
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MAZ.CH"-.U@[AAW8'N+#.A#T !\#@ !RT58 %0$AX,V'B9^%,@P4<943$X
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MY]I9.&:H^D#MEZ?_=[\$^B5P=Q+X3 "<7R7>E&TA7]YFT< ]"G S8.@'N'Z
MLWOAX_;<(S]MZ\ QB0$3&77VQWV9=LBT9-;)T^$;1 !Z=/"  1L 9TM[ &=
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M^!;/XO(< Q*^ ^(P5_JP EA8.&0,9  NA"5M-AS@"&SX< 9,H>&R-><(1WK
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M-.7_\ __H(D3)SK-&+!B#HT1VK1D<ZJO';*P0)QIX@ ;8(=CX,S: 9YQ@,%
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M^!:7NC-N['$!'&5#&X29BHT9D/YF_OXY^^V?X]E"4TE=Z)1Y40 ^DB<Q !M
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M8OT8,V:,FV7*&#?:'4REE!&9(#_JQI(AW$/V+/$\,'X9AUP /.J'\]MXY_$
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MQA_&%'7FW$AOU#$1DT(H%W7MZFK1I?IZ=;ME:4**]O0JQK(MB4F@X7A,?=%
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M^=6O?M5UZ"Q0C)G+0 #0,@>  44^B-'QTFFSQ^S%.4R*U)F.WQP@E@QQ=.8
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M#_2?WWU64Z;/5OW%XYJ07:Q@=%FOUB[*U_)MV]W,R<[F1BTH+=.X]\9IW98
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M!?^P 8Z.G,:'3H-&B4X<$."8KS PXXH!\+Q!)W?@R1#0?_QP(>W3Y,MUY&4
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M<P-(88)$VV//._[ %%H?WR0'3-'Q(B-SP F:&F#%W.U@ [_DB0T\Q\"+:>(
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M#BA!P:,T<8 !\YB $BQHYI /%A)@S!S 0+@0SLS:%$(<YX$2 Q" !(CB6OP
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M\A >WV^ X\&&X7(6,6 Y0=&C?&W8#Z5/&5&XYL=]"6@ L>'P&W"&@@=H@!'
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MSL;]["V7=)_M.3:8$;^OF5L"&?AY,]-02H/:EHUS<0-22U.K>OI9-\F>:,/
ML<OO4/[<ZDJRUGMC6#_8[$KLMMJ(INW?D!LG(X=ZD?=@AH)@SH]_ ^Z]H'Y'
M.:G'#;,C4& _2#OVQOW>W K/&U SDK![XX._EB@H%=N!1#NN!9GXZ?UZ1P .
M\7 C\K$.D XMG.-F<]W"^6\\D1*&#LP^O,:%%4_WH@7N-W_S-UUG9Q8XK#=
MQ]L90J6C1T8L[6>)/Q8WX U%A<+B/*_8^9W?^9U!2QQP0F=L0,1O^YA?""KO
M]W?R1/Z0%_G&LO3W?__W^K,_^S-GI:6\O..4^7X,EV+EY'C__?<[6&;2-:]&
M ]X(\VN_]FOZV[_]6S<G!ZL-EIJPW*03_KY9^>\&@ ."V,B7^PR'%0GK"_<@
M4,80)@K5+$&$06D"P,"068SP!T"8(X95$TC &9R%<,!W%/QP$!?"'O# (@8+
MQW4H>%[/Q(O/@4A@"$AA_SF[%H &@,AS"!OT*2'$D3\@ 4L5UJ%PA2EURG!C
MZ+#J8<4RH. <OX$OG($*,B1MZ\,X!\0A-ZQ;Y)ESR!49<H_Q((6CS(2C?S,+
M(.6GC 9PA -@&%*V^8>D;=8YSC'$R,:]A*%/#.N):ZACZLL<:23Z$1_R2H0X
M\A?*E;:"O,TZ9^!%&S!@)AWD0OO ZL\]8@Y8HP[HQP%TXB-MB\?D2OQ,[;#Y
MBVPO@OQQ%L;B?*^.$4)$<!601O35'T" 7C+EL\'!@9>'(0\QG.<]"ISC U#Q
M?H<(*@!#VU V"D)8%Z5[BX#'"Q<7UDJV#N.]#%SG]B2+) !H1N\)<+EQP.E7
ML[IDG=TJ2G^@VX=T <D'6^;RJBCB(EX?M[\.P.EV< ?4>N@A84N<069>Z\7J
M2\H9EC4J4'3@VD'TLDQ%>?"R(0LL*L J%J6A[NCWC1?[N"+(C>+B,!2_!S/\
MO,0I&G+K<2D0T,EYZ&PDR)_NPQT%."J)FYBG13HVGLQX K4/PU]\QX+ TSXW
M,M]M$U$V^T2!?OG+7W9F]GO% F=#J.\6P"$CY(BBPJK$W+I/?.(33G: #N!!
M1XN"88E_"'%<2ST 1GSGP_>;P<K[Z6] 998WRL@[&0$SMIIAN!WEC!)GV(HC
M"I1A.2Q*]]UWGU,4*$*4*HKQUW_]U_77?_W73E'2WDC#9'&K90T![DXO8B"/
MW#, '(L8#.#HI@ +%#+W(.T#Q<MP&@J9>Y/V@&('F+#2A'" A07  @;, 0=8
M:0 +<\ 880S.\.<[\1GLH<19Y4G>S,_"X1?&1U\! .!'?V%Y)8WAP,(FVQN,
M 6' A3GRRZ(&@T+\@0R&9Y&/ 0-6(2QH !I^YH_,L"XA0_,C'^2'!PA;T4NY
M&#HD#G.4&W .K8JT+>Y3BXNPY(TV&<H0.$,V[._'<"201AE)U^1%' 9Q)E?\
M2)=PYD<:Y!-9VG J?I0)B#.YXD<;""$./^*DG9BLD1_]!/<7[21TA*$_(<]6
M'I,=^;=ZXF&3]H5#]DS_"&42QOE>?7=L 2-$8.!^>ZT?*7]^>-CQ.,#W"&P<
M@6$=XE[@19<1Q3C0 G4\K !T[I3[Y[>N<.?XC>'/I^"!CA_40;3-!4D0UN4A
M[MXJ.F2G<RMH@95H.PR7GH]TP $DX.CSY.;YN3@]<KI8(ZCTH$0J">&#<@)P
ME((<@(*@W%#&708'?Y*D<V3%/H&?SV$T5NH %MM@%%\D#X(G7NK!.:JLP;+Z
M^A@$1[??F\-?7W:7&<[RN3?<'0,X;D9N5FY>NVG?3(1T1#:LP5 !0 ?(T>%]
M]:M?=<KV_P'<S8<LZ5!1Y%A-&";$"L>P&D_)*'G.<^0WEKC?_=W?=<.M7_K2
MEYR_69\,WNQXJQ#S7H8C+Y8?V@ P@.7M'__Q']T6*5C:V*05A6P.A85R"AT/
M$4R@-G^;?X,E#BLOU@X@#H5KZ=GQS<IW-P <*_NPNIJUQ\J-A04K$GD$V' H
M;  +R$79XPSL#.*X]VA+E-O\" <\H. YFL(%+@ &4]@6#@ !3K#>814S*#$
M(1S %D()?J0'-)$_JRL+%\(&_4H(%EP+@#$<RA$'P'%?8$&B3  &Y^AKR)=9
MEH (9 6PX6?]%W'@9Y8XZ\OP8T5E./Q)6Z']X) OPY&,-&!=,EE1!\B4^ S^
M"(^<$N?$(0= B.DC9F4S2V@(I 9LX8(%9$T>PG"DA[S"<,@5/[/$D4_Z;.K8
M9$C^\ < \0/@*"NR!)9#RQYAL3#2KUA[,!T0RA0Y,(R*/"D;\^"H\SON'#0
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MS"MOL,2%JU-1],1E\7"TN-\L_7?[G*5/O*1OY6'(E/; D_^__=N_N=679IW
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MGP;Q;0@(([!SBRAL$AQSXMQ+W'V\+C#)1+#IRNNJ$8O<T-8?D0A\TNX\7]V
ML9<%_WD=502J'MV8Q]?KS'T4H\?9 WEW5<R%,T@E;I<!WC?J:IA[D/P12P2X
M8?XP'SJ H]R^Y [DB&@P;R8ESKS!TT[>5<<[ G!OI\1T.BA-.A9[6K=X[D6
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M%T?[< T/3L\__[P+@_RX_RB[Q6='N]Z=>,M_ -#0?"Y' =$4?*>B^>>^ !:
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M=K\;<##$AG+YK__ZKQLL<<1'YXG2 XA^XS=^P[U+E6TW\+<A1+[?;MKO1GA
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M9]3F%G8 N -JOW)9>?GYVKQIBY\V^89V9N!FQS<$N",>=QW V<U)!T,G3T>
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M(,/A0"#.@,$)2'*K?MEV) 0=%#L*/H0-X '+30AG0 3QF>4,)0ZX$%<((%B
MB(^CY1'PX#X@/MH%T +()((*YP$?@Q>NYT/;#JU]E(<T@"Z<P1BR"2UQ@#EU
MCRQP%A]PAJSL.OQI%[0_YKX9H!$_\1&.,#C:62+$,<<R<9$6X2A?",?X(5?:
M&P 'Z"(GPAD4D0;?\0N!&1ER;0AQA*/]6SCR2/W<"L0A?\I!GG"4&<LX[UTV
M6,:?.(F/AR$@GBDAE(GK37XN@H1_E(N'-.1*G3)]@39FLK1CPF7#_FQOKM"L
MF1/=N0VY6U2RYY@?=G36*/8VBS &'>Q^ ,ZL)&W3YI*5VKC[@&NC?=T>/.?G
M+-#Z_8=4=NB$UJXKEBT?V;NB0+F9<[5RY1I=J*S1E98J'3U^0GUN$MQ5+<V9
MH_F;][E\'#IT4-NVK5/1HA0ES_9OGRBOK-&1_:7:EK],V<N'%MV<.'I4+?47
M=/CL62U?5ZR)8\:IKZ]?5UH;5+)MNSI<T^K3Q?)#RB]8I;[V*TH9/UHUG=[:
MEI&Y7!47F]7<>%[)R2G:N_.@QDQ9J,9V%ACT2O%.+4S-U-Y=?E-O,EB04:BU
MJS:ZO%95'%=:EK>65]<W:>KL] C[I*(U*[5[9XG6YV?HY'G__E]W$1;7PDQM
M.#;TUI:1/WA1Q\X<U;,O_4BG3OG7^ZU;MTE-#5=47U&NA<L6JR.Z^.#V[=IW
M8)?.U9S2G%FSM22G1-U76K5J39&:.^)*>7FR#AST^2U8OEHE^_S>@>5;#BM]
M=F8$U5)6WG*51"N^B7KKZHU:MYEW]<:U9^]V[2[ENKB.;BU1?OX&%6T[Z<J6
MMR1+FS8-+<8Y>O2XNKJZW8AY="M'.47X_\\"9W5^PY$A$3HV.D:&0$)WKUG@
M4/I !N5DV.LC'_F(6\# :CR>SK%^ '' '%!#>#[A$.:M@-%P88@'?QM.M84-
M*"^+'RC@-T!-W@ 3WH8!*-C0+O$0;K@T;M6/Z[%@$1YY8(%D-2S6089I6+!
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MZKC>JWD962JK/.\NBSD ]U'$&5J_D>"(./KX,'?Z_UUK@:-3H9-'0=SK%CC
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M2"E?;*B\\7X6P !P;"SL7;P'*[Z_II]^(9AOZ&1C<47'@7[V$.Q35[P7'G<
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M6C-TQ],FPWO\OMTX$L-;&1+]^0TT8"T!XEC4P# =<\2 $:" 5TL!$81!N;+
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MO0QPE#E4]D!4"'',B^/-"%A_4+AFX>$Z.CHZ5.0$C!C$ 09F 3)H( V^6_P
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M^4TY&8XEW^:L_='V[#OG[#??42SD!R7#X@=@CB$;Y,33/^4+VRX DFB)HYP
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MN/ #;)"C74=8@[W0+Q'V"$=](']K<[1[[E?N 4 -@&->&7."N0\ ..9R\H
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MT2_"?KZV7SO>[>ON]V[;OFU?V]UVNX?JH>:AJXJAF H0"(HJBE%,&A@$0H!
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M[S1:ML@>C1'K>@ $\ #"'6T5FQYP:+\ !K0_A_Z2!ILMN,>#-S1R@"WN  "
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MS4%W^-6/"U"#_O%]GG#^Q V^H1_Y]*>LE(]UJ6C\21>01_Y^NT%/VITQ@K&
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M&QH;J&?L@*9,:'[W=W_W(YL8&!,8&V@G*P_]A;[KY^NW3_QOXG$9?7C/Q ^
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M50Y3!UX*=P7IX=<-!<.=BG*D"ZF$PNKMB6W<B01F2_(,Q3Y3]I%THNWBXVD
M0',]T1Y%T,"Z=9"!)C(2BJHG%)0AH"3I1QQ] IZ+BL]D16*%)KEPQ!GE'7W<
M(2AN-\/GC^">&8![TLYEX1AP39MBQ.6.<$.PHXT!J#  ,X @7&P-"L]V\=[\
M$1!H>KA;/ MG=_SMG=WM'7?BDB]:%P-1!I[L^8NZF]!'>X& XFPW/@>%!HA#
M9=% ,;"; ^ !EGS!S>"(P/(!%K]I#W] !\0Q*/O"CM_X^7$1# @B0 2S94QC
MF)^X WXI)YH$WE%>-&P(=,Q, ".^>PMX0^O)9@ K/V5'BX4Y&Q!GVBSX![#%
MA?84(6:.L@"D,"VC,4  (*QPQG<6UNZ6%H*0WQ:..AF( WB2)NNM !^4#8'J
MFXD  )3%UVS 0]0!D(E6%(#*,0R RZ?A*>B*IN?K7_^Z*PO Q^A&O: #X HS
MFCGJ1YE]7J"^M!OK%N$I^)_V-8T1<8T>IHGCV?Q(ST"<Y0/XHWU]$SY !,TP
MFAF;+-'^''7CCP'D#UU\NL*3T-7G36@-((+/6,>'@U\)!RT8 S '4R_3TEKY
M:!]XR0<@YN>#+@-Q/IBEWM09TZN9UDF7"0?\XCN>;7)A-*.-" O=S4%7'P R
M:<0\Z_,U80&ZT)IR&?U)#]KZZ1$.P.:#/1_86;[T9<8!?])!GV4LA98X?M,^
M\!L;BW[S-W_3C8OD1[ZT@SG:!][!#^L):3^IHSZDZ=>-OLODB3'!0/Z3IO?X
M<)S-%IS/A@!FX;E#,Q\)'%4TW!/L+.SS1]BW*QKN-1U>WYM0[/PRYQ'@*@=$
M>$:\ASPHA9]+@=W[KE]ARXP!D;X4^W^$7 ECYXM14@"7O7: Q%7"?&+W($1?
MN+ZW\!M?<0@\,*$Z !<7D$? B-,E>:"'2H6B/>H)=[GSZ%PJT0Y%(_V3 LO*
M3S*&86-T!I 2BK*P:Y,Q/(CEX));EQ=+)>:/5BODS+V6^B?<^]+VPCB01IE)
M";K#9P[7*AJ<I^+ZDM-(1CH5IHZN'+T!Z -L1WH<CB9YHCBRT"RNHNPZI?2Q
M<_](VR> 5Y3/^O.9 ;@G+: -/LP _4'0X@/@.,@7S1):)(0@0L;N_(Z_ #;F
MY_\V/_]NZ?RR<,0QP/1% 3;R-4'/G8OR XHX+PD!SHR=W6& "K1O #9_IH\_
MPM(7$@S0"#$#-] >4,:@[(,S!G> G3]0$P<_"T=[ A@03,SV$3)H1J ?,WB$
M@@E!TD&313V86;-FC[4NIC4U$$+]T$( P@!/OC#P!WE H9G\C*\H"T +P 4H
M9,V<+YB-S[@3Q^+9LW]' &,> RA 5^@-R,"1)O2B/.8 !?"U+Q2)RV88-C=P
M]AW  F (J/VL_(5 !;0#@*$S](3^/BA!@-,6IBFBC)05 &+M@1_M27D OFC?
M$,(X W+N(?8/4&*:.*.; 3L_'/E"-P,6:&/@!4 =IF?,FTR>H L3,TL+>F ^
M@^X^#0T<&,^1%^\!:O"W.?@+32T $!!#VFCY:"<?  +8>(]FRQQ\ VCRP0+T
MPL\'PH1G7()>5F[\H /T,3_N/%N_XYF+9]KJX\(!X%@6 1\1UFA('O <M/4!
M+H"<,EKZ%NYQ((Y^Y,>E[1D'C-;0G[6<T L:03OHQN]__,=_U._\SN\X[2-Y
MX,<XX/,<Z0 ,V51%'_XTCO)35Z,+Y8<.F%(9(Y[:Q>B/YLJ9OL*=ZFR_K]J:
M*EV^6*DK5^H#\(4&3=*#^PVZ5'E)+>VV.!WI'-*#6S=U\5*E&CL"C5"HJT.-
M=QO5%@X[K8S"(37?OZ_.+K3_837>OJ/*RU7J[ 70 >*"3U9%01*A;G6WWU7-
MU2I=K*S4A<HJW6MJ4E?[ [6'NYSIE-&E]5&'@X,*=ZJEK5V=#H$"G@!Q/;IV
MI4:5M<':-0X$KJD^XP[OO7JU3A<KKZJ]DXT2W>KIZM##=M9JQ310;BV@=/O.
M#9VLK%([]D-71NZ]NEU7HYH+E<ZLV*->=0-N>J6VIC8'3L.11[K!(<A5U;I:
M6^?H\J"I2>V/.M73$:35VM2HBY<NZFYS /9#70_UJ+LSP'+1J+H[V]3>&P#!
MICMW=/G<9;7$CEYQ- I'U7C]ABY7GU=U_15=O%RMQH9&/6J^K2N5E3I;6:7[
M'8'EH_-1HZIKJG3V<J5N-<;.=HP$&D7H[NH=H-0^C6/P"#)#^XH6#I]@3:);
M,QE!6QG SH]@L[X'ZAE#G(YZG^^__^T G%6/#OI) .YQNU"_2"#U1>5M0IX[
MPAKAS0P=<RE:#<Y#0VMH#D##S-4$!_[$B0=Q"$/:P!>*_$88V(!.7, > SK"
MT097!FG\_+B$0[C[<0D?;VXA3;2&G.\&6&?!,B87TU88..7S60S>" ESI&<7
M?FBS$.(X7] A7%C/A8:'M8YH80S$$9^P?GA+W^X6AF?H"!@!.&,&Y1-?T B'
M8.>W#^( !0A*RF .4()6V;X%^WF84 %" $KJ"2  L &Z?(%J?CX H6[QFCAX
MFTD @I)W. L'"+%G[N1E(,Z]D%S; 2S,P0, 5=H..D-[VIE-')B?T<(!WN!?
M "X\0GZ4@W0 #<3U><EXTY]T$!<MK($2V@%@11D!=H!M^@R\"3#Q01QI Y)\
M>AGP\T$<?K0Q-/3Y D!*VN:,7D8__/&#?C8QL;#P.F4T'B0<S] !  =M*!?E
M(#[U(@P./]K9U[ 1CS(:'0A'>>G?OA_M0)W]N.0#B,,/'B=MP"STA[[P,?DS
M&?J]W_L]-UFP>D!#Q@'& ]^A:4=[][0..C"Y Y0_M8L)X9#3&G5)D6:M6+%0
M/W[Y=8T<.5H);P_1SN)2)[Y/GSJIF5.G:M3(D4I-6:"K=4$?.'/RB*9/GNHL
M"2F+,G3CYBW=OW!>W_J_OZ&B,\%Q%'>O5NJ[_^.[VG?PL*Y?.:O9,U,T<M0(
MK5B]0??Y,D%LK I,EATJW)"NYUYY52-&CM*(D6.T=_]!G3ZR5XLRE[DJ%Y24
M*#L_.""XY7:UQHX;J_,W,$E&%>UIUZY-&_7!A*D:.G:J"G:5Z<ZU<YHR8:1^
M\N,?Z0<_?DUCQD]SQXP 7_;N*M+LM,V!DBC *3J^NT23)H_3NR,3M&#A:MUJ
M8)E%K_;L*]7D\1/UWNAQRLQ>K<;65E>>*Z=.:/J$2;K3T:UPJ$M+YL]UX^QW
MO_]O>O?==[2_HEQS9BS7V>.W=.WJ527/F>'H-77F;-5>O:JJ4WOUDQ??4EU3
M8!DIS%VA?6>.JK[AMA;-GJ^QHT8I;>%\7;M[+]!R1:2MJ[(U>/";^L=_^6>]
M\VZ"MN3D:F;"2+WVZNMZ=^0834]?II:61]JQ9)%>>/$EUY[C)T[1N<N!%K@K
M%.A;^S#74S/3LTO@*P"W[Z/GJGU10.QI\D7#8F933'*L\V)A/T*778UHM7Q!
MA(8 $(=0, >(BP=V"$7 AB_83,.&GPD-!FH$A*^),X'J@SB;E?OA$" (98 -
MZ;$N"?"&-H;U5RS0-HT0(!5S*KMH^227#]X,)/G@"R#$FBJ<E=7N"&TT<0 \
M!!,F&1/,)A!-@!J-[,Y[/Q_HB"8/<(E0 8#:@:<&XORTJ#]T]04EFE)V\@$Z
M*<O3\ /@! W<G__YG[N[ 1T3J#Y811@CE,V/.E)6VL2 '77!K$O9T)Z:@Y:$
MBP=Q/,>#./P +\2!=YA4D"?A #  *W@(4S*;5P 2 "SR(SR:) Y]IJPX^)GP
ME-\<O.9/'(@+'0$PU)UVHZ] =]*F[0UDP0\ %9]?21N_>'X%^/CT@H?Q,SZE
M/)09FM&O?(<FSM> 0P^>;8)B?&*:..-KPD$G)EIHG:U-#<CY>5 'ORR\HPY^
M?\>/.L?[D:ZUIZ5)_>@;:(6MSU$_VL( '#NR,:%B/O9!H?&<3T-V9[-A[&D=
M(!!> ?3[IO_/DJ[3HCB+9(\4X1-9M[5ZW3(=N!:L"XT\N.MH?[2R1O/2EJK^
M9K"&[\+QHUHZ)U-7:RXH:?Y"U38%0.;"R0-:O&B%;NP_JI__R_>5713L3#R[
MNT0__-?G=6#?:<V?-%:'#@9'3FS:NEU[#UYR!P.#3 *#Z$/M7).FXS'MF=6K
MIZ=;60LRM&+A8DU+F:?:AX"=J"Z?.:+,C$SM+ ]X[E!QH59DK'#1, \6[MJA
MA[%#>8OR"[2YR(Z[($BG2O+S-'6Z?24CK&L7JY4Y8Y%:6X*3 PZ6'=&:16M4
M675(TQ>DJZ4[T"R5ENS2E9LLS>G2D=)U6IRY1,5'^H\$N7ZS7EDY $[T7#V:
M,F&!]NRZK*7IZ3I;5>/*=[ONJI:DS%%%^1;]]^_]7%.6YCN 5KAQ@4I.'M'\
M1=DJS0W6JY:7%FK'H6.!7BNVDS74>4LS4I?'SH63YHU\7S=O!9OE5F_9K!.G
MZE2<L5;'#@=GS5UKN*W9:0O4\JC- 5;T9%\!...PS^'.@/B5!N[)P"5"B-DP
M,UM,&6AR6"-H9@J$%@#!%SIH?0!L_F!MYE0;U$W8TA:^8.,W [FO[4 8Q,^V
M"8>09; WQX!.7'] 1Z BP%BWA<80\QF:$].>$1=S%Z 44R6:&1,DE!''W;_P
M0WBC"8EW)B0I'V")O !QK(\RLQEA+&T_/GZ\,Q!G82@_8)F-%)BO,>\:S1!^
MT,:$,>E1?\"! 1  %\ 5C1DF2]J4,GV6"X#.>C*^A<IF !\HDC> QC>=XD?Y
MK;Q67T $VA/*C; $] "B+*[5G;8PGK&X/!N(,WKC!XB#'VP3 VD!S.%1'+Q&
M/OC#H[;IAK*A*86.YBB;@0CS(VW* UT!<&QBL(F#SX>T$^">O,S!SP!'/QQ\
MC9^O18*>E,/O3X 6>-U +VG2[H X,S5:/H -VL!W@#A?*PYM 6ST3Z,SX=&L
M<AXB2P^,-] B,]'Q>0: A,84NA*.=X1CTF+:>B9]3)+@$=J5L/09^H.9S E+
M./H?X!' ;HZ^3!O35JS?9!,#]*1^/B_%@SC*QO*&IW70AC&/+ZZP<>2I'!HX
MS)RLOG)#2HNR,F?JM4$CG&9]\L39*BS=I](]>[0Z(_C"BFT'6)FT2%M69VKM
MCB(!I=@:$.UNU:JLC=JWOE#)8R<J:\T&W6U]I/Q-&S1MU&P=+SVG2V=.*&5.
MFB9,G*6"XG)UL/B=#0MA.S8DHNTKDO6+80/<9'Q:TBR=NQ),8%KJS^M;__4[
MVE82 *7>[EM:NVF3KE9?5]K,^6KM"FOURK4Z="A80F!?-PC,>=W:NG6'5N<%
MQXJP44!J5TG^=DU/6A<C8Z\*-FY2_JJ@7T;9SM'2J>S)L[1Z[6)M/'#0F7!C
MPZ^+TWSCHDKS5NGPZ?.:NWR3'L4V9URHN:CT[&P%.SY;E#P]55F9A=J\-L=]
M0]8,C$6K,I2Q-E435N5HQK(=.K)GG_;E+=>^D^=UN:I&"U-F:_S8,<K-V^&
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M)LZT6<RZ+9X):0MK=S0"F(!QQEL\(XPPQZ.!-$=YH2OF6NH+8,#1+Q#$:'0
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M\*;Q,/GB1[X^L/LX$$=<>-;BPP. 5-:.,0FQ30S4R6AH0 :P9[3!CPL:T,\
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M'16"'1K0-WW0#!\"N'CO.P $0,(?5SCZ!=.B[P 6Q(=O#  !"$QC1%CZ!1I
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M7NMP\5'-'P#'@(*CDUI'!93\NFUB8- #- $8,$4 WM#TH/%ATP*'7B*XC!:
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M"$(T:W_]UW_M=K^RC@V!A]!!@X+F!0TD&DJT=M0+31]T1:"A 9WX_@<ZL/^
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MV3H#-D(%#2%G70'B?-,I A"A: ,W:?.>>IKV##\T*81#L%G]$(J$,[!'.!Q
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M@\=.![/XJ-3TL%451P[IP4/2D>[=N^\V,0"JH+^U/>T4#T#@![3G!D"(3WC
M CQ"VQM@ ]# 6P M<Q8.+0WC  X^H"T,W.%'^O (?<$<X0 ,^!&7B[8!,%!6
M>($-*? (8XEO"J<OP%]^GX"/J)\!$-(E/?+U)PK\C@=Q !LF":;](BYT8,*
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M-''X<0$@T)(!X'C&T;^-?LXC!@Z@H;\FD35CMI3 PI$^P,+2QQ\0!U@!>!L
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MZAN05<B^MZN%V_[OA0.W!,"]EPP9+<(:0('P0-BCD!FI,YKE0%L6B_^V SC
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M4)A@Q1\K!!:I4#D!X@ :C(A1(J3'] ;.A"OO #Z NV3PY@B#?Q;& +:]0ID
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M)QQAZ2\,C!A(V/0A?J01\HLV1QJA'W'0?U@^$EJ>X3^\-4<Z@#KXPW=S6-P
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M2E.G/J_>O7MJ^2LK5!-O55U]D:8\/U,7,LMH)$I/W:OM>W=RR9A#?Q=/'M:
MOCW5M1MZN)\FC!VE"\=W:."(4>K5NX\&#ARFDQ>NN<G<90OFJ5?WGNK3JX]>
MG+N,V\.\T=)9Z1)MTS'Q]K_WS($/+8!CW1N6#92%63ZL<_XV SC &Y8JI@_8
ML, HF/5E #)&J@A\ !?O*#_  26'L&># =8Z4P@(1*9($9KF$$X ."Q!)JAY
M!PUQ$P8:%!C3,:3);Q.X)@0M+/S'6H<EC2E5UK-Q9,=G/_M9?>(3GW"6+=X!
M)E$LY(?O3"'RQ!K&E"3'#'!N&I^O?_WKSH)(O"@SP@/J #Y\QX\/?"$L<1D=
M\:/$L$JB@/%GBA<_P@)@[8E5X,X[[]27OO0EM_&%HQL  ? &*T;'CAV=@+_K
MKKO<66^\(T[\L=I!![_YS3NL;ASHBU+@'>T08 A?R1>;*%B#!S!G36.GIY_2
MHL6+M7C1(HT?-]X=L%M>4=&^_*.^ID8+9D_7T3=7:_:".>HQ*$4+EZS0]4NG
M-/>EUY1?5Z7BK,-ZXH%'](L'?JG9LV?JR-&3ZOAH7Z6,GJS].S9HW\ZMVGLL
M3?N/G%=+0[$FCWE.V5<+59BZ7QV?>%(__?DCFCMNJ@8-'J%\)R_K-6GTD[JW
M>P]=J?2 ?LK$9S5^XF(]W;&O7G]YG7J/&J/-;^[6]C=6:^.:%3IX/%5EU37N
MY'P4.VW6IDE-,0)\0A"'4@=8&!UMD#8&@,#?K,RT/<XM"W<"0PL(H*\ &LPQ
M"&#9 8YP.$ *X,=^XP>P(#SK-VT-'$ (T&U AVEO!A2 =FOKA 48D3_R;PX@
M!C@SX(H_8(]T#<3A!X@+P1Y^]&4 :KBQ =!"/\#?'+RA+X:#%OP <3:(HHQ8
MK9 #I!,Z\F>6..BH%WB=/)T*7_B8+(66^L0O="&(,W_D$/5!OLSA!R_I:UPF
MS^"3O-$>3-9 :_R'KU97R#P&0>;,WWZ_UZ>%MR>#6ZSN5D?X6[F3X\8TX.\)
MI6R5&MBYNU8NV:ST] Q=3DMW5M2"['0]V?%^[=E_2/W[C=2B5>O\!?!UY1K>
M\RG]VWW/J(I;WB6]NF2Q^@\=IO.IJ7KYE=<U?>IL5566Z=+%<QK4<Z!F37I1
MER]=5FU]@P,TM9GE>NR[C^AB7HF7#VW-.G;RB![O,5B[=V_7\>.']52?(=IV
MZ(@J2M(TL/OCVK9]HTZ?3E7_[J-T^)R_BB_U\&[]\]U?T]RE?NUH>7F6+IX]
MI"Z_?%!+UZS7M8PL+=ZX6;V&#E9==:5Z#1BK%U]:H=34BYKTW!Q-GKU0#16G
M]=G/?4KW/)7B ..Q[0LU<<84<:H<?*HIS]>EU//J\61OO3AGF:Y=NZ)C>U;H
MQYTZZTQZNK9NV:&^@\>KNKI0?1_IK0W+=BHU]8*>&YNB&0M>BVZP\+, R?5P
M^_=[X\"'%L!AS4# LFLP>92&XD09,Q7&%(A]/FP;&"@#>2-??$?Y )RX"!T!
M;J-UIE@X3!:EAM)"&&-Y !!A)6,:D-]8$0 +C%S-(9P ,Z$@1$@!X@ S)LR@
MQTH$T" _"#=39M"$'\*;4D.0,_7)QA% VY_^Z9^Z"Z.9+N'8 "Q7!JX />2/
MWWP <( I@!J !_ 'X&%:EGPP#<P3D&=@#! 'L"0,?GP 3(0Q.IZLIV.#@='@
M!Z]0;EC*^(VE$C]N66 *E;5KE./AAQ]VWUD+!P@E+A0/UW.1#KRDS!P2#+ $
M(*((^$ZY.+"7LE F\L\1)DS7L*N.>-AA.'+42$V=,56+%B]JS^/LV7-T_L(%
M?QEV5(&OO[Q(6]9SEMNKVG3XM#(S,U1;EJWA4V;J2F&^\J\<T9H5&W3ZY#E-
MGC1:&S=MU[SYKRDC/4T7SAW3HD5S]<:>PQHY?I9*BW/TW*296O?:=ET\NEW;
M#AW2H4-GM7C:<QH]+D6OO+%/^[>OT2LO/*OG%BS1V!GSM7_W%KTP9ZY>6K9>
M_7JDZ(N?^9ZFS)^I5S:LT*%#;^JEA2]J2,H,7<V\KM&C4QP@H&W01@V<\9LV
M@])&45N;0]&'=/A#A\('$(<.  '80,'3'Z %+(0 !&LH_8DV:>V5.* A'4L7
M/X 0@ \KG#D&/M0E>0#,(5< 6*0=6I9L.M4L1H0W$&=]%C\&5X"5$.PE@SAF
M#P"9@#,#<6S,8&! VF%8\D!\!MA(PT"<6>+(/X,/@*G16;GIS^'T)^7DMUGB
MK$_S&W]SA$\&>[PS.HL?/T!ZLB4._GWYRU]V%CAX3CKPGS*3!W.T%^K*_)AE
MP"J.PR],Q\+\.D^+G[I@4&5MX)W2()=N)C36XHX1&=]SK%8OWJMKU])TX5J&
MZNH!]$TZ=VR=/O_9+VO J$71JM-:73JS2<M6KM"\V>NU<\<15X[>G?OJQ%6_
MPQ9$5IA=H'C<#Y@6S%J@7>NBM7\.[[6I+KM$77_:2ZD%E9&5K5"3)T_4C-<3
MN]9W'3NLD1-&:O.K\S1V[M*(3JHL*%)I997:6NNUYM5%VKQYGT:-?4DE%=$4
M9EN+9@X9J9-7O)5VY9Y-&C-YI(X<W*'.@Z:UL[B\KDX#!P[0^3>7J&O?A_7U
MC@.T:NL)I1[<H.=>F">VROA;5GTY9DR<K:,'?/]*/;Y&]W?MKV/7TIP>FS)E
MGAJ;&C2FZQQEGR0?;2K.W:L'GDY1;F)Y<WO:M[_\>ASXT $XZWR,SE# "+G0
MPD0Q;V:!0[@#DCY,(,[ &WD"O&%Y0W"SS@H%$BH#A T @<T$"#X<[P$7 "]S
M\ <A'@(V% W  3!A#F$(@ O7Q!&6^ !$C+K?JT.98(4@+%.)@$24L3DL"J$B
M-/_P:58"_% 0ML,SI#'%%/J9 @O]#$"$?EA=;,1M_O *JR'39;030#)/-HY@
M+3-+"(H5?IEC;1P\I$Q80FA?./('<"3OI 7@Y)@5%!+ V Z[K6NJ4WWCC>M
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M#!R0?^@H9PCV\ ?,?N<[WW'6.+/, "  D4SW8C'%H610DI2'=*@+IH9(%U
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MSH%+]*];6\N_6ZE]Z "<L9>U*BP81Z B!$,'@.,L.$9T7-^"F1YA^'Z#M&1
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MJHE!D,]/7 W)3'"\(RSE#DMU^_NORX%; N#H./8)._0[91KAQU05RM< G'5
M%"9F;Y0K.R$!<&:! W3QP?IEW\,G_GP0-"@$GN9G8<*G?4^.PW[;>YY\B-/
M&[M(.?F?:38L9;S'40Z$*N /P&!3*2@AE [* X=5 F!V,TN<68J@8RH'RQZC
M?Q0 2@JABA_*)'GDZR)_'_Y9G1(5R@?%!Y VZY0IK/>2%$ 6)8UP-X=U F ;
M C'2,PN(T:$,41JF[/!'N:+$;,H)/Q1S,AWM$J5#.JQ!1/'B;$T<]45] -S@
M*3RV*6SJC#22^4R8&X %("[:,>G[@9=BA871"?@([$BPE9=5N74Y;$(P3\I
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MX)^4'[#J :(+V,X28N,/>J"@!W N20<-N3[,@T*'_QS0]3#S@Z[WW_;T;PF
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M^L9#_/&#%C_C P" ?D"^C!9P1/E"($892",$( !6T@C!&;R##R$=  2^AG0
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MAD7NMGL_.'!+ 5R888 5B^Z9TF"4B7#BB26)D3:C9ZQOK%'A@Q_ CBF/=^,
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MUML %N;-F^\$ M,J"$B$/D^F#A',A \_"$0^9\[XM3/L5&5*#\&"P$-HF.
MQ&5GOW5Z"B$3"Q: 5U3X<[<0B!86 (#00QB9,*NIL5UIB>,>S#K7V)A0G@@L
MT@B5)PH7OW $3MP(6S<RC4 5?B:4X1G\,(L!^2!_EI_D-LL[!+B!*-[S'1!G
MO'%K-]X!P*$@X#W3WEBD -^$YSMUAT)#"6-UH!Z@1R&AV-C=FW/=\YMTC9<W
MRZ>5Q6@,Y)H2 +C2#CQ0\3%  V" KRR1Q?$>X!3RNCDZ;#8<\4,'KZD;BD^Z
M !#\PCJAK0%664,%KW \KZ5Y:Y/E%W_J,]G:09O!#SK+X_5<KRC#L$7%_C@1
M^&2.LE-/H1\@!45+7BT\0"S98D<]F)_1 0H .J9028=V#0_#MD[YR3?I8/E!
MJ1LX"_EJ_ _Y15YIKRATTJ5>20_K6KB)@3@!1#RQFL%GTN06$WAMCJ44#.#"
MNB->\M;.UZB/\YO^$8(DZ,S:1!X8$%*?',<#6*>=(B\ 21R+0[NF+6-%Q@_@
M!9B#%CJFV 'U^#%0P8\PT&&1AHYR\AX_!C3$1=S,,C"]&SK:'_SW[=KSR]JF
M\9K\ FYMDY#U%>H$.4?]6QW#?]IPZ <];9.V8W3&0]I8LA_R)?0#Q"&[B0?'
M.]K15[_Z57W\XQ]OW\1 74)K=- 2/_5B?H3ET[%C1S=0"'EQJ[\#+9HI$S.]
MS7GJ]'1?;3@0S5 @3N*%ZMOM(8T:F:*?_>M/-&W%&K765:CCM[^KCH]W5I?.
M'?7#!Y_1V3P/HLG_J@DS](VO?]TM/?B7>WZ@^<O?4$W>&3W\P+_HD<Y=G?_,
MN0O55'5&_4?TUL(#9S2H;W]M6CA%<Q;/U]HCQS1I^C28[*='(Z:</[%;7_GG
MGZM3MS[JWK6S?OR][VK-P=-NNP.GK;75EZG7 _=HW*3A^O)W']26W6>4FWU-
M*7U&ZNB651K4JZMFSMRDY;-VZ^J^O7IVS@S9=JOU\V9J[H)5T<&_3.N7Z\*9
M"^K7>Y >>J*+UN[;K^JZ&@WM,ESGMZS6Y %=M&[_177K/DZ;GUNFF<_-U>7B
M OWHJU_65[[P>3W_\O((6#*(BZLQ.F#%;:"XU97\.YC>^P_@:.SA)_B!"=5>
MQ>)Q5=?4J*BX6"6EI2HM*W.C100& J>^ODXE)<5"X:)0*BLJ55)<XH3%\1,G
M N!V4J=.\?N$,_-BZCUSYI1;= WP0V C),*1K=5C37V]8C'67CCCKO-NJ*]6
M,U.TY#2Z'J2AH5[-S8E]1! V-#8Z9>3*XU>^.L';U&R'+*)\V]34W*1&=R M
ME'ZE9T-#HRN3Y8,G"A!AC8,2A[(C++];(V 5B[6HO+Q4966EJJWU.]-\B+<;
MTK@<NEA-8$;1NP?"M+H:H4]X0*!_^FD >!!2>\M636VMNQ*J*5JW H]1(,3E
M &%^OKA(W5Q5995RLG-45UOG%\;:"_>D320 #7G$N:=E/;(RP!_:#;S/N9ZM
MQD;.(TOD,1Z+WW /*/$T-S4[/Z+R-2)7OUXA)BR.\+^IR5\Q8X7F+E"K$Y<I
MUEZY$_^9^B0VSW,6^];6^#5,QBZ>M.^@""X*!Q(Y:RE8K SH"94:A/A1GI#_
MA T!''24 ]Z'CK(DT]TL+'XA@",._.AOH2,^^B1U:T#"M<W@>!?HR0?A0T<^
M#-19W1(' ,T<\0,*B).T^< /K&0V0($6:Q+Y2*X3:"U=2P-Z0"OTH;.\X _
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M (T%K^T SB'6"$@[D[D'/FWD)8K/ QT/>N"!!U;@/M\V7%VTM;F%NL3KVP]
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M?OIS?>USW]6^-]_4@0-[]2_?^=_ZX2\>TJ7L"_K'__9)=>TU2 ??)&_[M/?
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MIJ69VB/J(3^GY*Q>:S4O6=^S%;Y$ WE 8+=<@B?D;U1 WC_Q4'19_B$'/@.
MX^\1!G \A6@!'%M $CT$X#*P=<,R=!DULX3 G+?1Z-VE/6Y&QN+1U:.H7>EK
M1"5_/ FIL&GA)-1MU!Q#AGR' =^.1+<>/5#'N D>OGJ).0._P[KY:TOJI -1
M0P$>!7G#N$HG^(8* *=(>X;A-+$ZG"W)?^KH?O0:-9M-R9>83(/)F$4EU[0'
M*4\?H%=]?3A>NJ)-*MG['3-'XZ^J8^"08?CVVR$8-*@/JG[=#%<O7<..-:9H
MWG<B"+*I9:_0LVE=#)VV6F@3T)S-LW ![H9[X,[=",@5Q9AANA3K]_R&X];;
MT7? *+Z/O]MEU*G<"!==[5&_24/LMCW'Z9-&#D/[$9,@!.J%"+MV$OIM!L$K
M1@)"TL>0O[,].K5NA[2\8CR/#L$7^IUPXT$<WD2'H6V=VG#R%E*VXJ08--=O
M":OC <A*?8CF'3K P<VOI*T;3&=AV,3I>)WT&CT[=L!NUQMX\S0*#6M]C=\N
M"05=LJ3:N'8;',Y<0GI&,@8W[X"CI\\C*2X&78SJH$_??NC??Q"&#>L'?8.&
M6+OU,,+]KZ!Y^RZ(*6/!13<5W[,TW!3#Q_4@6K0?CN>I0G*I)>J,S6JTZMH=
MR:IBG+'=@89M!R!1">1EO$+GAO4P>,Q<'K#,M^]!F[8]\4X"FD['K-E8YIPD
MG7T7Y8$V35OCF)< <.3G3GQ\4(=*QYPQ?3!F[B;M;<5>E8)9/?M@U4?]CY1]
ME_X\!9VZ#\;;5&%!+,]/P/?#!V/8N*5(C7^*;]JWPX)5VR05 ^#I U\8-F@$
M\R.GD/[R,>KI-<:%"\+?TLKY,_"%?D>$Q+Z7[EO Y:C[\(<Z?U'3V<?OSH?D
MZLYT'-!QH P'!"H1TC&ME(C''2D/7:>-QE&!>DK D  S%+F ].=$(0(M=")\
M1U*B^-@JW8L/L!))'PLYZ!TN(R5C"U4"1R1V$X(ZX=2<K #H7I+.GA1EA@S5
MA.2-YF!:[I1+ $]2F]'(0?(UMGQG0P+A&)Z:(^Y!B42W@'92"TK<&8GE9:*/
MZ*01N1 J31'7Q^3P$K0 LJ*=)(TD]%?*!P;*.C4/J5/]^[O/".#$I,?=GA?>
M*5(!=0GJ+GE8LVP>FO08AC1)M/$RYC::-S&&W[V'B+QZDJWMVG8=A*%#AV#P
MX,$8,_$G^+M=14?#VMC]FP MU/S4E*<PTJ^&-=OW8^:P\="O7@N#AHW&X"$C
M,'CP*%P/(MTB%>[Y>Z*:7GUXWA1^:PK37Z)'\WI8N,-.XF(>]IIO09L!4]E5
MQ>Q1X]"OYUB>N,7BE,B6_"P*K:M71D-C8PP;/A)#!XW X"%#<-35%>.']<>,
MB3/*/)5<]._1!Y,'C\3RF1/0J-=8)+*+"#FNG"304!&VSIY\#W85IRS YB7C
M4*]N/0P;/@(=>@]%U*MD1(6YH7XM _3HT0<M6[7#I)^W(R<["8M^,H%QHV88
M.&@H#.KH8Y_#*4D"IT+0M1.H7*<=?.Y+1@S2@)+P, !MFABC4]<>Z-*I'?J,
MF('4 CF415F8:S(&=8V;8<C0(>C9N0.Z=AR*ITEY2'__ /H&M=&H>1L,'3(<
M _I]BU9MVN-&V!UDI\>C20-#;#XLGHFCO34:-VV&H4.'HD^/+JA211\6#J>0
MFI.*C@;&.'[\!/;MV(X.33M )M33>,3[9>TJU*_? <['#Z)RM>KHU.T;#!LQ
M H,&#\&*]=M05$R@A/J. E?.'42-NMT1]ECHZPEAKP:.YDM0W[@YTHJ+<-AR
M$ZH:=,"#!&'YY>OLR'W*RO$"GL0\1+.ZM="T12L,'SH49!7:=^Q,Q.4)5S'Q
M]WU@6-,(#E>$I(L>*-V9-TT.Q@WH@G[CYK&N)>F$L%Z()@M3>O=&K>JU,6CH
M2 P>,@R#AXR$?_@])+UZ@H%M6J)5ZTX8,G0H>G?OA);-.R(T^@U7Z7;*#O4-
M]-&Y[P ,&S8";9HUP_?CYR&W4(7XF$A4U*L(^X.NG#<]Z26:-VJ$ML.G(X/H
M5>?S<*C5@:%E"AK8:0#5;3H.Z#CP3W! >F5HIYVI:"\V.I+4@C@?C0C:48$2
M:'R2 !Q?U]8BE1.CO%0S9]!6+%[5CY)*+TI''URG$P);=']M_=H2XDN=<B@I
MN!=+W(38A*3S*HY_*A5C69MH!7OAU*Z8$#"4Y/A4/]^:_O":K+9^BA142)%A
M&= )5I!PAO1PM31]>D_7!<34TJS;_ZL<^$P CA:=!+JG1RAT!@CY2].*)@]7
M+YS"U@.'D,49-$A^^P;;=FS'B_@$Q#^ZCT5SYV+RQ,D8/WX<QIF,P]0%BW'E
MHC/V;5V#Z(3X,IU> >L]VV%K?PRG;!WQT[1I,)DP&>-^F(P??IB,@- (_E)Z
M_30:OYANPN,7[]BBL3CO'2QV_XISOD'2:UB ZWY7L<O.D;\:3ATZ#IO]QUCA
MGQ:EQ**@!GFI;[!K_2I,GCP18R?\"!.3'_'#>!,<<7;%^MUF\/;33OK4, W<
MSY^'U>9U<#QDC2W61R K)!TU-8H+4K!NPW+L.W2*5T_5/ #(4)SY#I8[MN"'
MB=,0&BDLEXB%]P-\,''\#]AAN1\9,@$T<K*3L7_?#IB8F.#W\Y=8/T*(8=2(
MC;V+E1MW(#8^J60J)[]D](+%W O#Y*F3L'3U6CQ_JS4X4"(O+1W;=^Z"B<E8
MK%JU 4_C).>5F<_QZX9UF#)Y!DQ^^!%SYBU$4-1#[G-YZ>^P9=MJ7+T5QJ\M
M)=[PNH)I/TS S*FS<2WD-M\_/S<+9K]NP_6@(%C_?A0'CYSB\D0O#2HQD;>Q
M;=5:^+I=P/*5*S!QXD283)B 'TQ,L&FGN8BCQU^G2CRXXX]5F_?B67*Z<)!+
MXX8:"/%QP;8=.U&H5"#LYE6LV+0;\>EY4J?+AK7Y)FS=8LWC4,+KQUB^?"[&
MFYA@M[4]GF?F"]U)C1H9"4^P?L,FA,:0P8L8L+B;$L6: CC8[\#!(V>YO0JH
M0$^#KI^TL<?,:5.8?S^,^Q'C3";"+U0LO1>FO8+5E@TP,1F/C;MVXU52,O.%
MG1Q#C2</[F#>G+D8_\,$'#]U&874)FB0]OHU5LQ=@8#P^U(_52+DQE5,6;0*
MT<^%51GEI*&<Y6X\MO.0*_BK^ZOC@(X#_Q0'&*N(-[]D[!2#B) FB<JTN>B,
MWGXQWO.UDM=/FZ[=_RT9)5D_N*3-_^FK(BN-2UH:M/D_J 2J#P <Y:?12NC&
MB<%$<O#.;:7K4CT$#+421XD/S @&<"*! )B&P!O?0VH^?TE_N"KR(46ZL[^:
M Y\!P%%7%PA;FE?%EXFJB,7#I&RI40D 0HTI(G%LB8+1GV^>6).GB>OO=7)1
MGTI#4QMU3O%711(*-5G.E$Y\H #"DOTJ]V.^2F;3M A&(F@BE.KX$QV4+19E
M4*M+1$Q2;=3Y2>N<XJ2*^],%XHE*70RU2B;&B=+<0DE4Z\*B3'J)T]PR:?S.
M<0@M20>-.4^TL[Q<O*!E(BQHB[)"*8.[O^6E!J0O)W3FM/EI3SF9)Q*LH#3A
ME+)L+G%,_8!$YQ]O!#K(Q%VI$:;O'U\O>\[AHY04VHQJ$\^ _C(HI0]?!CRB
M!.FA:!G) BE2$&%X(ZZ7VG>5WH%S\)A(M0I:Q?>U^.J@%&X#29.EC9X;&8RH
MU3)H/O6LI7P:.=VQ#(%2/Z14]CU%#D0_L6FH/TH10@1]%'VC]-E2$>Z21#=_
M,4L3#&76;3H.Z#CP3W" W_"2=Y\+BF&@I XA-:*7ZZ,+'YSSH""5H;S:_!^7
M$;7\;2H5+5NNY/;2@2A!?[4_<8'*?$B96-(55(M1BY9&)2D*9]?2)J1L7#.-
MT]J*Z8/Y@SHY1YF;T%A95NI(X]BGQS*)>-WN+^; 7P[@M/31HZ9'R1V'E*O5
MM%ZN$=(F A3J(B@X@@*%+R$%2B&UXQBAM)8OQ8 D!5%2K"Q2JB$G8,0_,?'3
M-9628F,6BU5[GJT)'!7Q.T"!UEEQE!S!2E"/Q;M4IUJ.8HU<@">.-5D \B7'
M;AFX3XK(!50E3;0,$,B,FL"IIE"$I>()G\S/BSD<EPB+1";A2O9:QNJ@DEH!
MO3@$-I2D.T *HW(29Q>#P"4KOFKU+AAKT4LF(B((![STG2.D@$0/T:A04SEA
M>D1\):"IDE.4!6J3$G(*-$_Q7"&'7%G,'U="298D@ 2$"*X2+71-"26%>Y+"
MF)$]!6,>!BMDN4H1$#0@',F@B>XE*:K*N2XI>+TT*!#PH#H)1U$Y6M934C[2
MOZ .0LUCBR<UY/Q5J&!S<^(QMX_$_@1HR?&P6L,.;^E9$OW\ 0!*I_BS)+Z7
M<UU*)6G< <54 ;572;H9U+<H,+P2Q:3PR\8(&LAIV9/:1K%BZ1G2\U"24C!Q
MI)@-%CC$&U,K#5K2,57/BR5D248Z'^H":%1D@B]9?C'M"E 8,'HFO*3)BKPJ
MY-,UJ0\3J"XF]$7 61NQ@1C,_85"B"F@8)T2:@\I2HO[40@U!H[$"_KQ$$MO
M&K6.WC:IPVE?1-U>QP$=!_X$!PBLT/M3!N!H\8T$8NB4QG&>0_B]DZK5#A%\
M2B>44UM7&4!4)COE^OA72J2X4QFD5.9NI3"R#'G2/4OK% 5*"1-Y15F^1@E\
M(.@L2PLG<U'Z(^;E#ZYKB_)'N<0O)EY+=VE+=$>?EP.?#< 1V5(79C!"DR/!
M&I8Z,( C8"!)&!A \6S':_8*MEBE24O%DR %BB]64:@JLHPA<$&OD/#9HY$K
M*)@I3[I4-X$IL-\;\1JQU)< !%WC_D7!ZD59.0HX,+R:7&\H9 QL* \%BR=)
M#X,#!G\TP5.#A)R#VD%AJ>A<F)'+1<!Y#DJN%!9*6K#'DS*5$#J!#(!HCB5!
M'+T5-($3T"*@* $GAFH<]U.2-8FW3Y)LDI62$@H"0XR0B!\L+*>@I\PCUD(@
MT$# 3%/,5E)T/WXF!&0(-!%/^ 4D-R;%4&JMD%AS0LWALYA/-&1Q.P5(%$Z
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M9&/.I!GXLDYSA-P-Q_#.M(RO!P.C1JAK(/K@ZET'X.?MAEH&1@A_\P;[UBY
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MV(XSESRQ>M52^ ?ZE53E[.:&0\=<L&'Y5O@$WV:0E/TV&04%N7B=E0,*%D6
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MP][Y%H]\%>=\/N3U^!EJ"G),%5D>;V.2_M[639=6 M=T6.M(BH BH @H HI
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M^9.3!8'*8 !!7EAO+ZVOWKT-1>T[XJ3O#A3_:WKCQVF$A/\#8!*5VP$>(*L
+    245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>zntl-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:zntl="http://www.zentalis.com/20210930">
    <link:schemaRef xlink:href="zntl-20210930.xsd" xlink:type="simple"/>
    <context id="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i686a0fdf3788449f8f91bd94b936f1fb_I20211109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <instant>2021-11-09</instant>
        </period>
    </context>
    <context id="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3c8ce9f01da84935a62e807401cc9cae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i66bf6807e17f4804bb968d10045ac403_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5479652c5e8948eea76ed85f21cb8d7e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibce0517364924372a750c28c212342ce_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i05e61bfa32a14e3187bb570193bd427c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib42d2e50a19640fd98f9685c1637127d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i73b610735c7347e8aaac83b4f7bc7c43_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i21152b916121449d97e5409f0cbc25b2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if7c1a20b82134c2996172b95f893e5d4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iab511672603b4a81a03caf2ab30bcf7c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3f0fe3d7eeb04c7899bcb9ae2088bdf4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie4021c98173a4dcba140ad00a72d452c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i98f6ab579d534d1bb65c5fe26ac9a269_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8acbfe477b1c4f3a815b95163a1b9152_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id08f2fc2050a4c44943d2e4a295e9e4b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9a274b3c002d4c999b3d4c6415451551_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9ee68a808a09462ab4fa007d6b40a836_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6caad814d88b42158fdc2cd280aab0ed_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i49952e4f44cf4702824e413a479ed8e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i08713a361b1540acb0726229b81829e1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5a86486294184f18889f9a3725de48f1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i609623d6091f4576a93d91b6acb32ee7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idc6dc347950a4b29af9da5a02d804ca9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if397f6a7f90548bcaa33a5c5cf1f88cb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i65a26d388f63425cb3a2dc35e2a31a4b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if1f3ce1f164345ed9ee96c629cc01c5d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie71fb05f111f4be48d0ccef2861d630f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib93e31ca1184485f94ea42f971abc9e0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iefaca15d6a7d4345a23fd191b8e32d62_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iadec20410c96469aaee44c0c733e3dc4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iaac40f72e56c4a298f6c8a19b70d2903_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4922676e6be541f3872e64b2464fb137_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2ab4533a3be14806b3b04f091b9ee6f3_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4aa9cf16c10047e38ad6329f8dc98d18_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i28c684747f014fc580d4d13ca452e467_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if603d442707c4674b05711009d838f40_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icfc558dbb30841d4b077a7adf6dba4a8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ica7568cfa246420a8555ccc29e4641d5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1b6093af831e491297bdfb820eba1bb4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iae5a70bb484d47a5966a3232feabc0a3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2b4a788eaa8d424898851941377c7408_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if9bfd239f78a4d1c9687ea22e1413f42_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i401925c54aed4e27af6b9f7bae761633_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ieea94c1751ea4ca9aafb6ed451e8026c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i84f4ac54c0c4412cad1de8c39c9f465f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icb096e42e3894e489f301e40bd55a89a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i37dfc4263719434b9b05fe487d9d50df_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4589566e63f84b7b9cccea38766a0eb1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1dffd747f1e14c5498e5f8b92e2018d7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i205664e670624f0d9706e05dfcffde81_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i72b30c6cbd624852b0a41e4ef1b61c9b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0b164794b9d4478db7c7a1f24b1a53e1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i36b0ac5aa6b94994b62d1befce371046_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7fafba9138604e4582aa3c16d8ca83cb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i172924960c934f48b9b4f68bfc2f1c46_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0020419724ac422c834b41878fbbf94b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib3d8bceefc7b40dc839ef2d3d293a13c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie807a0e24c7b451dae314257f1dd00e0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i20dba144ba4b4cc586cce30c51aaa503_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5015e220e18d463eab535a4b2752b5c2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5bcb52b9ccef496eb3fcb0a88b4d38ea_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i171029a8b8344ffcb4c0653ce2b78593_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie1d6083038da45c5aadfdf0aefeda452_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifd1fdb349c73430aa944980282c11963_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6eb313acd05f42ae9d92268c78a67bd4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i44bca96b50f545e98c95ba466913be25_D20171221-20171221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <startDate>2017-12-21</startDate>
            <endDate>2017-12-21</endDate>
        </period>
    </context>
    <context id="i53b0d350827a4825b36838126a07429a_I20200402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-02</instant>
        </period>
    </context>
    <context id="ibdac556512264baba2e3c86be867069c_D20200402-20200402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-02</startDate>
            <endDate>2020-04-02</endDate>
        </period>
    </context>
    <context id="i0daa24d503d64a52a0b1fa592bd6c4e8_D20200402-20200402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-02</startDate>
            <endDate>2020-04-02</endDate>
        </period>
    </context>
    <context id="id1b99cb5cf7d4b9bb0f68ae4525eab72_D20200407-20200407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-07</startDate>
            <endDate>2020-04-07</endDate>
        </period>
    </context>
    <context id="ie8cad8b83d3f432cafaa0e90fa7125e0_D20200407-20200407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-07</startDate>
            <endDate>2020-04-07</endDate>
        </period>
    </context>
    <context id="ib67a09c2cc4e4165b391d6ef5419f1b7_I20200407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-07</instant>
        </period>
    </context>
    <context id="i88c5a60307524479aa90649174075824_D20200407-20200407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <startDate>2020-04-07</startDate>
            <endDate>2020-04-07</endDate>
        </period>
    </context>
    <context id="i59959a77c7aa43129b028607068148f6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">zntl:ZenteraTherapeuticsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3a09ec80921740a8a5b68eddc9671099_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">zntl:ZenteraTherapeuticsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i36e1e114412b4a85a123b6bacd5ba04e_D20171221-20171221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">zntl:KalyraPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-21</startDate>
            <endDate>2017-12-21</endDate>
        </period>
    </context>
    <context id="ibe080c8b70bb4349ac04f51678c3abf1_I20171221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">zntl:KalyraPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-21</instant>
        </period>
    </context>
    <context id="i3da75022cc3d428d9e0424e542c47954_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iadfc04fccb134988b9f947350d9c04c9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2389c0a608534740bdcad0e2fa9bfcec_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie38dad6ada064a56894e848a9616b856_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1b8f9142cb4543f0a263ce89556879f5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa5cb2304d0444b389a997ad08e0c71e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia868940f58cc42b5b13f0fc8b51e01da_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9ad029fd87124e22a93cabf53bf1d8ad_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iec9f78113384472a9c1cd4490522fa4f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2cbe2ea503f244c28efc38eaf91c8231_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i37fa66f18165423bb7d922609186b948_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icc5bcd3985e645c3a401476d670729d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic46f09a640544a46acc118a2e3a87c79_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e4e6113e81b488f98011e1738519d49_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6170a569b9745a5ac1f31b8c185a532_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i89d1dfe44e99408ea6d011b126cf6fef_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3b74220aedf04b8caee6df508ef0f7ce_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3e82dd52a30f41459848f3a6b6b17f8e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i42e57e64fbf34e6da8033002ed837bad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if5fd90709dc74fd5a0cc52f2f2b7c1c0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i30534ad685e4405c91d0e95f607be899_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i96de234042a644fbab1614f7b8d810b0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i86bdaabffa344b98af6e3b49d1f8e9dd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0ec4099481c540d7af1b813bfb7d9ceb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6c547910054f4a26851d64a99c8cf16c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9732f080c4174fc4b7b9ebf4ed2bb7c1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4ecc7e181acf44b4a83f0b3df2cdf533_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6ebb15d5ad9e487694cef2cce04f74cc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib30cfbc3f8684fdaa1394520152b8204_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i32c0dcc014f347b3b166110a2b441716_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c8984afd47b4dd1b6aa58ef930f6c50_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i60a9b4ad23f4455bbd5483f1f3ba42b4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i47888dd151434e169157684d400b27a8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i315772c54c624f278fe0ed2cba140fa2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ideda6fd6619d423cacd820c6cb596396_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibd8cecb43fce44fabe382da208c94b9a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2424305fc33c47e180bdcca355f56217_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0249ef610edf412a8b7c3986cb8f4198_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec4ba4b40d1a4678a41ebfca352cd0cb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i197f8be1dab94341ab3cb7bec4da51ee_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9459160646db459cbb327815f2c0dfad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b05eb2946574576b40669621fb77cff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3044630795146b99483f1baf0d571ee_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4a5070fbecb84ab58845fe8229eb4e37_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i49e62a87a0124d07b9b303e1965c458e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i817a4309217c44a8b8dc4c083d2b3c28_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icc264132dfe94434b23a32e250ea3637_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zntl:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i61d571892c00485fac3e8c5f93914a1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zntl:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i69b3c5acd4d04eb0ad0b6255c633e023_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zntl:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0cdc5a844c7741f88f2ffc72efd90024_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zntl:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic372449226be422d8b31116aa2375ce9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i47a6b58f9a6844d89050368b6375eeb3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic01a05364dea4804a256c0dc000120f3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i90612704ec3a46e591ec1d86c1621300_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d749128b5cc4c058432e3008374c9f5_D20150901-20150930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-09-01</startDate>
            <endDate>2015-09-30</endDate>
        </period>
    </context>
    <context id="i791e20e9521c44e28152d01ddac1222b_I20150930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-09-30</instant>
        </period>
    </context>
    <context id="ibf2c9428be0742a0a000254f1421fc0d_I20160331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-31</instant>
        </period>
    </context>
    <context id="i8997c29134c6485eb8e9deb026d07200_D20160201-20160331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-02-01</startDate>
            <endDate>2016-03-31</endDate>
        </period>
    </context>
    <context id="i2dac0c6c83624d678d99d838917cfa5e_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i7e885190922f4e1d806613f4bfce9ffe_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i15fe047b039c40dfa459cd498a30878a_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i561f11c86d154f968f0d7b64cfa9bb70_D20180101-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="if4f7f71c7cf34041890690bb8f1b4f55_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i6cfdd80dc235471f94d955162c41ea8d_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4ae8f32d20e94dec87f494ef073bbaa1_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="id660983397b24d43bf35134f4a0c0395_D20200201-20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <context id="ic748b33ae7394b2b9c1ebfeb481ad01c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i662b4e7ea6f842119f8206ee5b4516c7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6bad6ea4eda8467f8d5d6a4850fc03d0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2494c11e1f6b40a3866cf410bc8a7cb8_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i0473a06af7ec44a996f1bca35660558f_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i69a08aa6ff634f5caab3972d78e1ddfa_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i7b2b52f5efb3462d8683dfdb2d599eac_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ia401f69705414c51916b97151f480785_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i6829f239f3964fc5b73c9f115f4efd4a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i773376c6e0a4414fba9a40b0fa6f57eb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i85105ad976e44ee3a9e3b01e44eee367_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if256d2dc23e54899b1bcec809c82546d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i90fe1d00c583463bb71b163aa4946d4b_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ibc382a9f642a48919cda5bcaa7020bfb_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i9a0fb89c534046e2a6262b44710848a6_D20200402-20200402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">zntl:CorporateConversionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-02</startDate>
            <endDate>2020-04-02</endDate>
        </period>
    </context>
    <context id="i398696456f95488dbba235847304fab6_I20200402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
        </entity>
        <period>
            <instant>2020-04-02</instant>
        </period>
    </context>
    <context id="ibac774a69e7b4afb9ca8e9498d26c25a_I20200407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-07</instant>
        </period>
    </context>
    <context id="i550ef246d4114b12b5ec6d79c50b321c_D20200407-20200407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-07</startDate>
            <endDate>2020-04-07</endDate>
        </period>
    </context>
    <context id="ie530cc1b51e14d3da1b54feb7ef48e78_D20200803-20200803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">zntl:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-03</startDate>
            <endDate>2020-08-03</endDate>
        </period>
    </context>
    <context id="ia99692ba60b24412a1dab4423fbdcce9_D20200803-20200803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-03</startDate>
            <endDate>2020-08-03</endDate>
        </period>
    </context>
    <context id="i59f99ff806c9400aa93e53bd0e0c2163_I20200803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">zntl:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-03</instant>
        </period>
    </context>
    <context id="i303787d7706b449b8fd82484ea7a63e8_D20200803-20200803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">zntl:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-03</startDate>
            <endDate>2020-08-03</endDate>
        </period>
    </context>
    <context id="ia6ddf0384ce84914b02bcf5b8a9a975f_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">zntl:FollowOnPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i462230a27f80426bb97a31bcd0bd3a57_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i599720d743104c59928244998d2e982a_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">zntl:FollowOnPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i26c9395499914bb6915eb0b50eb6531e_I20171221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zntl:A2017ProfitInterestPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-21</instant>
        </period>
    </context>
    <context id="i788f376ae39641539c7ea4298ff33b65_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zntl:A2020IncentiveAwardPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i40102d77fe8f40fa92901924ead82975_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zntl:A2020IncentiveAwardPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i9da50ea1ee9c4df0b7b30adef3d8867a_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zntl:A2020IncentiveAwardPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="ia728d556059a440da6322b57d7154e71_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zntl:A2020IncentiveAwardPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i181d83080b3f41ccb6787320f7d2229c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic4e4e5dca01c4b329a93274f8d739507_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8a7273c96f564c1e865eeb7eb0a5402f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i94593153cf8c498c8b518d4df370e8d5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4a677277d96a48bab6eb887dca74a45e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i607b537a79654bcfa5b76e79200ad79e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie98b88c9c000461eab4ed9980e58de2c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9e645d2454e44e4c90ab99b885f15b90_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0e9fbea9de0a48f9a2fd97d698309e42_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zntl:ZenteraStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iabd570ef2f9345599b057ad29b52f338_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zntl:ZenteraStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaf9822acfb464a6d891585e7be3a5ca0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:ProfitInterestAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i744b23fd24c6491ba42985404b428ca4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:ProfitInterestAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia2ec8dacbd2c4cc28e92de70f1d60be4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:ProfitInterestAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:ProfitInterestAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i22afa5cbdf1a42a4b3d45f2baa46d20a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4497e0e0b4ec4f1a8b88d44070441e38_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib9c306d1d813469a8be5c195343bbcce_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i587d0a5af8bc44d2be7b3c8da9f39a3f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id66b9433de164aa588c8902b962f4437_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie80c09b9267b4debab194f8e3b070f1d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i585f906916e24788950b045daf6006d0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:RestrictedStockAwardsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie1dc9e958a3743ed897181a2bcab4d8b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:RestrictedStockAwardsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8c866a3da3ee4c01869b06d7863723bb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:RestrictedStockAwardsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2c3c44f5e0b242eba976e925ee1e833c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:RestrictedStockAwardsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i20f31a36244b4706ade54e9ea17fc52f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">zntl:ProfitInterestAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i146ec30e5c904ad4934dfa43202cd322_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3721dc48f90f43aaaedb4b9e4701785a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i63c6b196f1234c5a926349599c036d07_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7d7f255a3d184998b0bc0e47acd7a4bf_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i660a769e8c324a2cbb4a2c3aaaf0e8ba_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if1ff576aa6cd420c9c34c4a3796b36df_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3f1a54d8ee624903a58ab6e4a97f47c3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i782b4959ffc945c6b1b065f0b433ec10_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5aa816b1a8094167b4936dcee3a759ea_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icc74194e61cc4c73a3ce9cb7361dcc5f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieeb7a874665d45dea6e7487809034f00_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3578222b355449619cf1a71155f3985c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i356de632612e431284fab49bb34efaca_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i004976abe339457d8797c8a3f4268c32_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia727e9eb512a4899be678569e4be9e04_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia84faaa12cb04eed88b3628a273183ce_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ida8eb8260bb84fffa3c3fc02e85ac4f2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic8cbc6c76d0e4128b4e08d37495dc609_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie48938e7777e45829bfd62b464670e1d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5379b3f1fc91468e8557d8d058d3aaa3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2f09d3ed0755408fa8b8594c78bbc16d_I20171221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">zntl:KalyraPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-21</instant>
        </period>
    </context>
    <context id="i05c84f48e4c9416e9b68315685186678_I20171221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">zntl:KalyraPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-21</instant>
        </period>
    </context>
    <context id="i2765153e500b4c2ea94087220a2f2cd0_D20171221-20171221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">zntl:KalyraPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-21</startDate>
            <endDate>2017-12-21</endDate>
        </period>
    </context>
    <context id="i4c0b35a7a7664cf0a904ddb853e834d5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">zntl:KalyraPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iffe291a882a04056a3a61eec999af54f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:LicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i10842b54d0d24a489e994b1893949958_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:LicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0db2a4af26634c05ae218afec38b427f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i18d34a087a6f45069ed7552aa3fc34b1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibf33597aac934769b0e7dc53e6692e7c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9b68177d9165436bb2788988bec1574e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifedec654804d4a048412181632ffca4d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2f9253d63b8a4572ac7ef410befd9a0b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i17387c8daecd44fd832424bd3dff82a8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0625dd931fe6420b9f8753010dae2784_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001725160</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">zntl:MasterServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="lease">
        <measure>zntl:lease</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80L2ZyYWc6ZTgwMTkyMjczYWNiNGUxNDlhOTdlNDg5ZTQxYTdlOTgvdGFibGU6MTU3Y2Y1ODZiNTViNGY2YTlkMDJjZDZlYzg4YzIyZjMvdGFibGVyYW5nZToxNTdjZjU4NmI1NWI0ZjZhOWQwMmNkNmVjODhjMjJmM18wLTEtMS0xLTE0NzQ1_a6e94eaf-3a9a-4b5d-b793-40f2ef4ad019">0001725160</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80L2ZyYWc6ZTgwMTkyMjczYWNiNGUxNDlhOTdlNDg5ZTQxYTdlOTgvdGFibGU6MTU3Y2Y1ODZiNTViNGY2YTlkMDJjZDZlYzg4YzIyZjMvdGFibGVyYW5nZToxNTdjZjU4NmI1NWI0ZjZhOWQwMmNkNmVjODhjMjJmM18xLTEtMS0xLTE0NzQ1_273f3ba1-709b-4369-91b2-c73918070db7">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80L2ZyYWc6ZTgwMTkyMjczYWNiNGUxNDlhOTdlNDg5ZTQxYTdlOTgvdGFibGU6MTU3Y2Y1ODZiNTViNGY2YTlkMDJjZDZlYzg4YzIyZjMvdGFibGVyYW5nZToxNTdjZjU4NmI1NWI0ZjZhOWQwMmNkNmVjODhjMjJmM18yLTEtMS0xLTE0NzQ1_d53229ea-c822-4c2b-847a-cde1b35acc35">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80L2ZyYWc6ZTgwMTkyMjczYWNiNGUxNDlhOTdlNDg5ZTQxYTdlOTgvdGFibGU6MTU3Y2Y1ODZiNTViNGY2YTlkMDJjZDZlYzg4YzIyZjMvdGFibGVyYW5nZToxNTdjZjU4NmI1NWI0ZjZhOWQwMmNkNmVjODhjMjJmM18zLTEtMS0xLTE0NzQ1_944dd580-d697-4156-9a95-a017c0fabc7c">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80L2ZyYWc6ZTgwMTkyMjczYWNiNGUxNDlhOTdlNDg5ZTQxYTdlOTgvdGFibGU6MTU3Y2Y1ODZiNTViNGY2YTlkMDJjZDZlYzg4YzIyZjMvdGFibGVyYW5nZToxNTdjZjU4NmI1NWI0ZjZhOWQwMmNkNmVjODhjMjJmM180LTEtMS0xLTE0NzQ1_429adb74-6b2f-481d-b1ea-15d87cea9b0f">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentType
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjgy_f90e1073-d8d6-4096-bbcb-f5d97d7851c9">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjgz_f68bad6e-e786-4f2d-affc-d0be4503236f">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjQ_1aaa4e30-fa69-48f0-8e3c-c800334f3af0">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjgw_d58cf542-7eba-4862-837c-6eb96820a549">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjg5_196b6e51-7f90-4316-acd1-c5b1914430af">001-39263</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjg1_9b672d61-f908-4db2-a39f-248775dbb297">Zentalis Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6YzhhYTEwNzdjMWIxNDk0ZDg4YjgxNjEwMTA3MGUwZTkvdGFibGVyYW5nZTpjOGFhMTA3N2MxYjE0OTRkODhiODE2MTAxMDcwZTBlOV8wLTAtMS0xLTE0NzQ1_dacf04bc-cc4d-4168-bad7-a6b30521121a">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6YzhhYTEwNzdjMWIxNDk0ZDg4YjgxNjEwMTA3MGUwZTkvdGFibGVyYW5nZTpjOGFhMTA3N2MxYjE0OTRkODhiODE2MTAxMDcwZTBlOV8wLTEtMS0xLTE0NzQ1_5d20e10c-dca8-4b69-88a8-e919f711882b">82-3607803</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6YzhhYTEwNzdjMWIxNDk0ZDg4YjgxNjEwMTA3MGUwZTkvdGFibGVyYW5nZTpjOGFhMTA3N2MxYjE0OTRkODhiODE2MTAxMDcwZTBlOV8zLTAtMS0xLTE0NzQ1_29f6b004-e7cf-4e60-8df6-5c63be984809">530 Seventh Avenue,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6YzhhYTEwNzdjMWIxNDk0ZDg4YjgxNjEwMTA3MGUwZTkvdGFibGVyYW5nZTpjOGFhMTA3N2MxYjE0OTRkODhiODE2MTAxMDcwZTBlOV80LTAtMS0xLTE0NzQ1_0a6b1f8d-4c23-49a8-93ee-726823a04d27">Suite 2201</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6YzhhYTEwNzdjMWIxNDk0ZDg4YjgxNjEwMTA3MGUwZTkvdGFibGVyYW5nZTpjOGFhMTA3N2MxYjE0OTRkODhiODE2MTAxMDcwZTBlOV81LTAtMS0xLTE0NzQ1_2f11b608-de18-4e6b-a517-de544fbb212f">New York,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6YzhhYTEwNzdjMWIxNDk0ZDg4YjgxNjEwMTA3MGUwZTkvdGFibGVyYW5nZTpjOGFhMTA3N2MxYjE0OTRkODhiODE2MTAxMDcwZTBlOV82LTAtMS0xLTE0NzQ1_54babf15-3e1d-4ed8-af5e-646413c280cd">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6YzhhYTEwNzdjMWIxNDk0ZDg4YjgxNjEwMTA3MGUwZTkvdGFibGVyYW5nZTpjOGFhMTA3N2MxYjE0OTRkODhiODE2MTAxMDcwZTBlOV82LTEtMS0xLTE0NzQ1_1990820d-76d7-4e36-8b2a-c6afd14e2bdb">10018</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjkw_6e2b78ab-ddaf-47f9-b566-c6cc34164809">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjkx_a26ba223-93db-4200-a65b-5c3b7068e21b">433-3791</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6NTM2YWMzMDQ4ZGU5NDBkYzkwNDkwNzdjYWQ2ZWRmOWQvdGFibGVyYW5nZTo1MzZhYzMwNDhkZTk0MGRjOTA0OTA3N2NhZDZlZGY5ZF8xLTAtMS0xLTE0NzQ1_4f29187b-8704-478f-8fdd-f4dd4e99480a">Common Stock,$0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6NTM2YWMzMDQ4ZGU5NDBkYzkwNDkwNzdjYWQ2ZWRmOWQvdGFibGVyYW5nZTo1MzZhYzMwNDhkZTk0MGRjOTA0OTA3N2NhZDZlZGY5ZF8xLTEtMS0xLTE0NzQ1_34395100-d7a5-44bf-aefb-f1df13784aa7">ZNTL</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6NTM2YWMzMDQ4ZGU5NDBkYzkwNDkwNzdjYWQ2ZWRmOWQvdGFibGVyYW5nZTo1MzZhYzMwNDhkZTk0MGRjOTA0OTA3N2NhZDZlZGY5ZF8xLTItMS0xLTE0NzQ1L3RleHRyZWdpb246ZThlNjY1NGVmNGVkNDI5MzlmMmZlYjRhMWUwYzQ0MzBfMjE5OTAyMzI1NTYzMw_f4d9c73a-cf2e-418f-9c2a-65f336517363">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjky_8e3280fb-160c-44e3-96b4-6516c91cd225">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjkz_bf61a475-7e56-4103-83f3-9da74a2cac14">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6M2E1MTAyZGI5OGFkNDRlMzg5NThmZGE5MDJmZDc2YTkvdGFibGVyYW5nZTozYTUxMDJkYjk4YWQ0NGUzODk1OGZkYTkwMmZkNzZhOV8xLTAtMS0xLTE0NzQ1_2cb5636c-8479-4a75-bcf6-73679b96e821">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6M2E1MTAyZGI5OGFkNDRlMzg5NThmZGE5MDJmZDc2YTkvdGFibGVyYW5nZTozYTUxMDJkYjk4YWQ0NGUzODk1OGZkYTkwMmZkNzZhOV8xLTQtMS0xLTE0NzQ1_bc95c1b2-016c-4a57-b1d0-5f1ad1e814cc">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGFibGU6M2E1MTAyZGI5OGFkNDRlMzg5NThmZGE5MDJmZDc2YTkvdGFibGVyYW5nZTozYTUxMDJkYjk4YWQ0NGUzODk1OGZkYTkwMmZkNzZhOV8yLTQtMS0xLTE0NzQ1_0090e636-334c-44b2-9e3a-0c62a9763528">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjg2_4c46b167-90c9-44a7-b221-7fc58de2a954">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjgx_f2392daa-332f-44e3-81e0-44676928a4c8">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i686a0fdf3788449f8f91bd94b936f1fb_I20211109"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8xL2ZyYWc6ZGFkMTBlODVhYWQ3NDM2YWIwZDZiYmVjODVjMjk2ODYvdGV4dHJlZ2lvbjpkYWQxMGU4NWFhZDc0MzZhYjBkNmJiZWM4NWMyOTY4Nl8yMjEy_7c60aadc-67b8-493b-bbd3-8bd3faa6223d"
      unitRef="shares">45305544</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNC0xLTEtMS0xNDc0NQ_9a1d5fbc-6a26-40e7-a04e-8748d70f9bd2"
      unitRef="usd">40807000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNC0zLTEtMS0xNDc0NQ_c6d1898d-bc14-4def-a7be-6caf76338325"
      unitRef="usd">54951000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNS0xLTEtMS0xNDc0NQ_b3f69078-ee33-430c-9bd5-48b6b7fb0307"
      unitRef="usd">325984000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNS0zLTEtMS0xNDc0NQ_c389cfed-30ae-435b-a7d6-c032b368a605"
      unitRef="usd">283554000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNi0xLTEtMS0xNDc0NQ_80ace361-5347-454f-8087-8389712e1d26"
      unitRef="usd">108000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNi0zLTEtMS0xNDc0NQ_61773737-d157-4f7f-ae60-1b3345445879"
      unitRef="usd">417000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNy0xLTEtMS0xNDc0NQ_8292ac3a-81bb-42e9-9c9e-34feffc41043"
      unitRef="usd">10423000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfNy0zLTEtMS0xNDc0NQ_07b35918-540f-47f1-8366-e7e73384ba63"
      unitRef="usd">6182000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfOC0xLTEtMS0xNDc0NQ_a5bb74ea-a31a-4268-8707-d58c4c33bea0"
      unitRef="usd">243000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfOC0zLTEtMS0xNDc0NQ_d839ec51-d526-4305-bba3-c75146d5c64a"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfOS0xLTEtMS0xNDc0NQ_9ddf0a15-3dee-458f-84de-a4d8ec7765df"
      unitRef="usd">377565000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfOS0zLTEtMS0xNDc0NQ_13bb204c-4a0a-44da-b2cb-8a28eae92a40"
      unitRef="usd">345104000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTAtMS0xLTEtMTQ3NDU_bef24cd6-5bee-40c3-b799-14761943ad51"
      unitRef="usd">4698000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTAtMy0xLTEtMTQ3NDU_ae4131fb-b131-4828-a68a-7d5b7338138a"
      unitRef="usd">1099000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTEtMS0xLTEtMTQ3NDU_5dd287b3-4fec-417b-bd6d-20e4350e3768"
      unitRef="usd">693000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTEtMy0xLTEtMTQ3NDU_c42f12e1-a7b6-4a3c-9dce-2cc30669e41a"
      unitRef="usd">2520000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTItMS0xLTEtMTQ3NDU_2cb543a3-f319-4965-bcf0-4175be868576"
      unitRef="usd">6042000</us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTItMy0xLTEtMTQ3NDU_01c1c32b-646e-4ad6-b15c-114203f5660e"
      unitRef="usd">2976000</us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent>
    <us-gaap:Goodwill
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTQtMS0xLTEtMTQ3NDU_1c5f8666-63f0-4f18-843c-0f25a14854d1"
      unitRef="usd">3736000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTQtMy0xLTEtMTQ3NDU_0be75ae2-e76c-4892-8a76-6d0c35a52836"
      unitRef="usd">3736000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTUtMS0xLTEtMTQ3NDU_160b4a26-28ab-4d1c-8299-ff7e35f3e59f"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTUtMy0xLTEtMTQ3NDU_812a8e9d-e03d-4a99-8746-90a86417e155"
      unitRef="usd">8800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:EquityMethodInvestments
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTYtMS0xLTEtMTg2NTI_7b581748-ae02-487f-a0c7-2172c50e70e5"
      unitRef="usd">39326000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTYtMy0xLTEtMTg2NTI_74e6a322-22e0-4417-af64-f994a0e28adb"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTYtMS0xLTEtMTQ3NDU_c598e7ab-2a1d-4c0b-b401-5f3ccb857462"
      unitRef="usd">3021000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTYtMy0xLTEtMTQ3NDU_64c91e65-eff2-43c9-8d12-2a5672298db0"
      unitRef="usd">1320000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:Assets
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTctMS0xLTEtMTQ3NDU_ca824d8d-38b2-4d90-bfe7-6de7b21c6e1c"
      unitRef="usd">435081000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMTctMy0xLTEtMTQ3NDU_f259581b-2b9e-4eb6-9003-427fcf52f6e3"
      unitRef="usd">365555000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjAtMS0xLTEtMTQ3NDU_13665f63-1803-4a96-8cd0-893cd4033166"
      unitRef="usd">8046000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjAtMy0xLTEtMTQ3NDU_e7d70a8e-db1b-4fbf-b1ce-d03cdc9334ae"
      unitRef="usd">8661000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjEtMS0xLTEtMTQ3NDU_99388628-8bd7-481e-b0a0-c4e74a83a529"
      unitRef="usd">31369000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjEtMy0xLTEtMTQ3NDU_17f80cab-109b-4d49-a889-59a5afbb7e4c"
      unitRef="usd">19940000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjItMS0xLTEtMTQ3NDU_83a7c6ee-fbd6-4ca2-99ce-d8f677764894"
      unitRef="usd">39415000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjItMy0xLTEtMTQ3NDU_92639f9e-0d97-4c44-8a00-391aa583d57e"
      unitRef="usd">28601000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjMtMS0xLTEtMTQ3NDU_04b8a829-ecc0-43be-804c-e97a2c41005e"
      unitRef="usd">1670000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjMtMy0xLTEtMTQ3NDU_297c4ac8-d7bd-47c5-9d0e-8e5cfffd93de"
      unitRef="usd">2480000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjQtMS0xLTEtMTQ3NDU_fb462883-87c7-4311-9003-80a2ac4659ae"
      unitRef="usd">0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjQtMy0xLTEtMTQ3NDU_b40adc68-2558-41f4-bb3f-7a22bfb89849"
      unitRef="usd">1097000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjUtMS0xLTEtMTQ3NDU_c9021c16-6f3d-485c-aa35-6bff3a0b3267"
      unitRef="usd">41085000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjUtMy0xLTEtMTQ3NDU_cf14046c-d76d-4e2c-8260-f29c8ffab951"
      unitRef="usd">32178000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjYtMS0xLTEtMTQ3NDU_bd8e36a9-7a28-4007-ab17-3e57927be3ef"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMjYtMy0xLTEtMTQ3NDU_c430a6ee-d3ac-479f-9aac-6ef3c687a15a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N18yMQ_376f5282-b172-4cd5-8e04-67a2ec944c81"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N18yMQ_3be04851-43a5-4480-87e8-904d7185457a"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N18zNQ_44413d30-e9aa-4215-abeb-0b599f5a85d9"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N18zNQ_b21aff87-66e3-4c6d-bd29-e1b49f53fe7b"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N181Nw_7c2e00e8-25f1-4f7d-b38c-e22955b9c116"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N181Nw_aaa082f4-0ac3-40ed-afdd-86355a6c63fe"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N181Nw_d7863ad4-2272-49fa-b008-3bdae87de3b4"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjowMWJlNDU1NjMwMWY0MDVhYjBhMzBhOWM4ZjU0NjM2N181Nw_f8270dc6-60fc-47c6-830d-a68a515945c8"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMS0xLTEtMTQ3NDU_b5ea6d29-7d58-42c7-a4ec-e20ecc975f13"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzEtMy0xLTEtMTQ3NDU_fc2bba37-79f8-4d98-afa2-29c92ae74f34"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl8xOA_b2a90d3f-49f3-47e2-9766-0366cff5fcb4"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl8xOA_d469acb2-60c8-4a9c-8132-f9af62134e69"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl8zMg_1404a944-26d9-4712-bc22-d4f34dc5fda1"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl8zMg_3b85beab-fd23-4952-bb69-f25bd2359f24"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl81NA_711b1c6a-4a6c-467d-bbce-88eb0dc9a337"
      unitRef="shares">45198528</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl81NA_7bb9f660-57ab-4643-b5a7-3c6f0998328c"
      unitRef="shares">45198528</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl82MQ_f17c97a2-61db-4847-aada-45771e6477da"
      unitRef="shares">41040286</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMC0xLTEtMTQ3NDUvdGV4dHJlZ2lvbjozOTNmOTYzMGM1ZTc0ZWI2OTI2MGMwMzMyYWY0MjNjMl82MQ_fec00b92-0956-4eaf-842d-63926158d904"
      unitRef="shares">41040286</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMS0xLTEtMTQ3NDU_20f6c75f-fd5b-4416-9fee-b3ef097cf00a"
      unitRef="usd">45000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzItMy0xLTEtMTQ3NDU_1b26066d-56e4-470e-95e9-28f25d11d688"
      unitRef="usd">41000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzMtMS0xLTEtMTQ3NDU_373bfff4-bcf9-4f12-b04a-0051f7778d50"
      unitRef="usd">702855000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzMtMy0xLTEtMTQ3NDU_ecc48dd4-f57f-45e8-9c30-10cf5fd3923c"
      unitRef="usd">509339000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzQtMS0xLTEtMTQ3NDU_5d7b2a21-933a-4854-98a2-f8edadd5432c"
      unitRef="usd">32000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzQtMy0xLTEtMTQ3NDU_9451a3a5-21c0-423c-9bcb-86be8c994687"
      unitRef="usd">36000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzUtMS0xLTEtMTQ3NDU_f824944d-c22f-498c-98b3-8f0f2765645b"
      unitRef="usd">-309500000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzUtMy0xLTEtMTQ3NDU_95636bd8-ea79-499e-8212-ebb5c8606487"
      unitRef="usd">-200834000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzYtMS0xLTEtMTQ3NDU_ac3574e1-e930-456d-ba49-7787196af85c"
      unitRef="usd">393432000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzYtMy0xLTEtMTQ3NDU_62379c68-acc6-48c8-a9b4-d56227fea2be"
      unitRef="usd">308582000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzctMS0xLTEtMTQ3NDU_91c757fc-a030-4775-9d18-4bb284a3d603"
      unitRef="usd">564000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzctMy0xLTEtMTQ3NDU_7883bf9f-a172-4e97-91ee-a0f257f7cc00"
      unitRef="usd">24795000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzgtMS0xLTEtMTQ3NDU_ee05580a-3b3b-4308-8b6e-4e64e124a16e"
      unitRef="usd">393996000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzgtMy0xLTEtMTQ3NDU_af5ab65f-2cb3-4d19-826e-ac1baf71356e"
      unitRef="usd">333377000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzktMS0xLTEtMTQ3NDU_3faa6c0c-e0bc-4c14-ac7d-226807b57c8e"
      unitRef="usd">435081000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yMi9mcmFnOmMyN2YwYWY5YTNlNjRhMjM4MzE4ZmJmMWIzZDI1YjUwL3RhYmxlOjQ1MzczZWU1MDZmMDQ0OGY5MjM0MzRmNDA1NzViNzg4L3RhYmxlcmFuZ2U6NDUzNzNlZTUwNmYwNDQ4ZjkyMzQzNGY0MDU3NWI3ODhfMzktMy0xLTEtMTQ3NDU_a0887cf9-9dc3-4788-bb86-e076af38b311"
      unitRef="usd">365555000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMy0xLTEtMS0xNDc0NQ_e9d61928-e7c6-4060-b8d0-b96aae228c1b"
      unitRef="usd">53998000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMy0zLTEtMS0xNDc0NQ_bea7bfa7-4e6f-4879-8083-1432056bfa1f"
      unitRef="usd">24670000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMy01LTEtMS0xNDc0NQ_0f7d2e57-0fa8-4091-8019-a959e2985cc0"
      unitRef="usd">137162000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMy03LTEtMS0xNDc0NQ_becc6651-3a78-4c0b-99d1-0fbe6afc14bb"
      unitRef="usd">55380000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNC0xLTEtMS0xNDc0NQ_3d53eda9-3c2c-439f-b6c7-15f521e77f22"
      unitRef="usd">8872000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNC0zLTEtMS0xNDc0NQ_6ea0e3a7-bb03-4aef-950a-d995f94e6e4d"
      unitRef="usd">10097000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNC01LTEtMS0xNDc0NQ_85c36a3d-3e36-440b-ba83-ace628163590"
      unitRef="usd">31187000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNC03LTEtMS0xNDc0NQ_0371ac7a-c1a7-4051-9bb5-15f1762f9318"
      unitRef="usd">23162000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNS0xLTEtMS0xNDc0NQ_7f4cf3ed-0d67-4356-888b-439a61caa093"
      unitRef="usd">62870000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNS0zLTEtMS0xNDc0NQ_bab71868-d276-4be0-a0c9-fdac518c5d7a"
      unitRef="usd">34767000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNS01LTEtMS0xNDc0NQ_013a4b3d-91d3-4441-97c8-6d66f4ac88cd"
      unitRef="usd">168349000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNS03LTEtMS0xNDc0NQ_c11eae79-0e75-439c-9972-cc24af7a5ac0"
      unitRef="usd">78542000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNi0xLTEtMS0xNDc0NQ_54c068cc-00d9-4cd7-914a-2d78da0149e9"
      unitRef="usd">-62870000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNi0zLTEtMS0xNDc0NQ_c4e11e3c-e021-4a3a-a3c3-77dd2b29a2d4"
      unitRef="usd">-34767000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNi01LTEtMS0xNDc0NQ_e8741745-5e6a-469a-b686-d70446e34031"
      unitRef="usd">-168349000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfNi03LTEtMS0xNDc0NQ_da284065-a311-4ebc-a000-5c7fb4f21549"
      unitRef="usd">-78542000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfOC0xLTEtMS0xNDc0NQ_50af70bb-d46b-4456-9d41-a42144457054"
      unitRef="usd">99000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfOC0zLTEtMS0xNDc0NQ_b0b7c9b3-6b45-4eff-a188-db065ccf7155"
      unitRef="usd">120000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfOC01LTEtMS0xNDc0NQ_8f9e4553-ee92-4a95-88ae-65310e63fbfe"
      unitRef="usd">313000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfOC03LTEtMS0xNDc0NQ_8bc2b0c9-2f76-4070-98ca-1258e2d49365"
      unitRef="usd">368000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtMS0xLTEtMjIwNDU_40a88a0f-c330-4cf4-b3a1-511b7939ed4b"
      unitRef="usd">51582000</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtMy0xLTEtMjIwNDU_e74bdc95-5b8a-45de-9864-2f13d2d31aae"
      unitRef="usd">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtNS0xLTEtMjIwNDU_7dd73cf0-ece2-4c6e-a992-35c18eb4e5d4"
      unitRef="usd">51582000</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtNy0xLTEtMjIwNDU_b6b5cefd-936e-4ed9-91b7-63f4052a0c03"
      unitRef="usd">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtMS0xLTEtMTQ3NDU_b806bc5c-54ae-4739-80be-f2302d7b1160"
      unitRef="usd">-11189000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtMy0xLTEtMTQ3NDU_46979cec-7930-4954-95db-fbb684f1b503"
      unitRef="usd">-34647000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtNS0xLTEtMTQ3NDU_de67936a-dc5f-4601-bb31-3cd66fefeeea"
      unitRef="usd">-116454000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTAtNy0xLTEtMTQ3NDU_199db44e-f3be-41dd-b48a-2df0f161dfcc"
      unitRef="usd">-78174000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTEtMS0xLTEtMTQ3NDU_23cb8926-441c-4578-9a91-d98b0a3c8a22"
      unitRef="usd">-697000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTEtMy0xLTEtMTQ3NDU_97529ea4-251e-49e2-821c-1ce6835c19de"
      unitRef="usd">18000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTEtNS0xLTEtMTQ3NDU_52b06729-cc21-44dc-b02e-55b9dd1ca90e"
      unitRef="usd">-456000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTEtNy0xLTEtMTQ3NDU_2599104d-0c9f-4282-83ea-7b5f402cb397"
      unitRef="usd">18000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTItMS0xLTEtMTQ3NDU_27aa6c4c-b4e4-4915-9b1f-9c017d958879"
      unitRef="usd">-10492000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTItMy0xLTEtMTQ3NDU_88e546e8-3d77-418f-8658-4f5fdd39e0a4"
      unitRef="usd">-34665000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTItNS0xLTEtMTQ3NDU_683ab1a1-d21a-4b72-b6b8-2765a1e17324"
      unitRef="usd">-115998000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTItNy0xLTEtMTQ3NDU_abaf28f6-5fea-4f77-b99b-3a6efd09151f"
      unitRef="usd">-78192000</us-gaap:ProfitLoss>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTMtMS0xLTEtMTQ3NDU_8bcd180d-6667-4486-89ef-17ed02386d92"
      unitRef="usd">-6301000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTMtMy0xLTEtMTQ3NDU_9d89abc9-44bd-4a6f-bb58-9457cd877467"
      unitRef="usd">-110000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTMtNS0xLTEtMTQ3NDU_be315c56-f6bc-4356-b71e-d4efaa7260ca"
      unitRef="usd">-7332000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTMtNy0xLTEtMTQ3NDU_1e6bc51f-e6cd-457c-9cba-797a47f0b59c"
      unitRef="usd">-654000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTQtMS0xLTEtMTQ3NDU_f13bff4d-1e65-479b-88e4-a37ce93b12b9"
      unitRef="usd">-4191000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTQtMy0xLTEtMTQ3NDU_49a1920f-ce94-44af-88a8-89ec12e5a88b"
      unitRef="usd">-34555000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTQtNS0xLTEtMTQ3NDU_b916f6dd-5996-4323-8749-ceec7e480970"
      unitRef="usd">-108666000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTQtNy0xLTEtMTQ3NDU_d2359ef9-6b76-4ca8-a5a6-da17a3e45bf4"
      unitRef="usd">-77538000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtMS0xLTEtMTQ3NDU_2b0b978e-174a-4107-bc17-3a5cc4f3f3a5"
      unitRef="usdPerShare">-0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtMS0xLTEtMTQ3NDU_b6ebfc08-94fd-47dc-9524-19b00a84af9e"
      unitRef="usdPerShare">-0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtMy0xLTEtMTQ3NDU_84a090c6-1bc7-42a5-9dce-17bc429dfd56"
      unitRef="usdPerShare">-0.91</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtMy0xLTEtMTQ3NDU_989aa5d0-c338-447b-a174-7b2bbf7fb781"
      unitRef="usdPerShare">-0.91</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtNS0xLTEtMTQ3NDU_11bb3597-2cd1-4bf9-84e8-a07c74d6e8ab"
      unitRef="usdPerShare">-2.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtNS0xLTEtMTQ3NDU_d3adbdf9-625b-4ddb-b0ac-fe1ad30b750b"
      unitRef="usdPerShare">-2.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtNy0xLTEtMTQ3NDU_21ecf7e9-a45c-441b-a25a-183d70213732"
      unitRef="usdPerShare">-3.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTUtNy0xLTEtMTQ3NDU_92d88857-ecda-494a-9184-9b29176d07fd"
      unitRef="usdPerShare">-3.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctMS0xLTEtMTQ3NDU_251943e7-c4ff-4e30-aceb-e0b0b097569a"
      unitRef="shares">44609000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctMS0xLTEtMTQ3NDU_7e48f6f3-6f3b-43db-9fc9-de74c5be139d"
      unitRef="shares">44609000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctMy0xLTEtMTQ3NDU_3b3feb87-0aba-4163-84ed-cb50991b3450"
      unitRef="shares">37959000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctMy0xLTEtMTQ3NDU_9774cd21-b11f-4141-a589-6f99c8effb38"
      unitRef="shares">37959000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctNS0xLTEtMTQ3NDU_6343a55f-ccd8-4a85-abf2-5eb87ae5eca4"
      unitRef="shares">41918000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctNS0xLTEtMTQ3NDU_d963b575-0235-4329-b4ba-7bb051189ddd"
      unitRef="shares">41918000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctNy0xLTEtMTQ3NDU_06eec7e6-084b-466a-aa6b-58faafb27330"
      unitRef="shares">24143000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNS9mcmFnOjU0MDcyODg4NDViZDRjOTNhNTY3NmMzYzQ1Y2RmODk3L3RhYmxlOmI4Y2E2ZTc3ODFhZjQwM2E5MmZjN2JhMWQ4MjA5YzE4L3RhYmxlcmFuZ2U6YjhjYTZlNzc4MWFmNDAzYTkyZmM3YmExZDgyMDljMThfMTctNy0xLTEtMTQ3NDU_87eea78e-68f4-4fe4-a6e9-618aa37a2db4"
      unitRef="shares">24143000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfMi0xLTEtMS0xNDc0NQ_27aa6c4c-b4e4-4915-9b1f-9c017d958879"
      unitRef="usd">-10492000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfMi0zLTEtMS0xNDc0NQ_88e546e8-3d77-418f-8658-4f5fdd39e0a4"
      unitRef="usd">-34665000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfMi01LTEtMS0xNDc0NQ_683ab1a1-d21a-4b72-b6b8-2765a1e17324"
      unitRef="usd">-115998000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfMi03LTEtMS0xNDc0NQ_abaf28f6-5fea-4f77-b99b-3a6efd09151f"
      unitRef="usd">-78192000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNC0xLTEtMS0xNDc0NQ_e12c1e32-eb3b-4de5-93af-fe9e5faed0a9"
      unitRef="usd">-45000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNC0zLTEtMS0xNDc0NQ_06199c77-9602-4161-b420-3a824cd4fa1a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNC01LTEtMS0xNDc0NQ_28aced20-f677-4695-bec2-c4c90e4e6895"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNC03LTEtMS0xNDc0NQ_e0d1e94a-5770-44c6-898d-14a96ef28ad5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNS0xLTEtMS0xNDc0NQ_a9bb767b-8493-4db0-ada2-4af0bf9356e8"
      unitRef="usd">-17000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNS0zLTEtMS0xNDc0NQ_f0bef178-68b7-4594-a9f3-7d0b08524f51"
      unitRef="usd">19000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNS01LTEtMS0xNDc0NQ_a80f1ab6-fde8-479e-9402-7e041bec4f3e"
      unitRef="usd">-4000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNS03LTEtMS0xNDc0NQ_5fba4d91-3065-48e8-8cf9-6f6c65b0e049"
      unitRef="usd">23000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNi0xLTEtMS0xNDc0NQ_f4c43b5b-0cea-4001-909e-199adb983fce"
      unitRef="usd">-10554000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNi0zLTEtMS0xNDc0NQ_3abc958c-2d65-433b-b014-852780d6bcc7"
      unitRef="usd">-34646000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNi01LTEtMS0xNDc0NQ_24ad24ca-b599-469d-b230-8d0eaaf783bc"
      unitRef="usd">-116002000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNi03LTEtMS0xNDc0NQ_22445d4d-ee79-4c5a-b279-c2e85d82fa96"
      unitRef="usd">-78169000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNy0xLTEtMS0xNDc0NQ_9802bde4-3562-438b-947f-962e761c3822"
      unitRef="usd">-6301000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNy0zLTEtMS0xNDc0NQ_ada79f2e-193f-40fd-bd20-61f0243a7890"
      unitRef="usd">-110000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNy01LTEtMS0xNDc0NQ_f9c8bbc9-7142-424b-9279-cd27872fcd34"
      unitRef="usd">-7332000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfNy03LTEtMS0xNDc0NQ_9af60984-666e-4149-814f-700dd5a028ca"
      unitRef="usd">-654000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfOC0xLTEtMS0xNDc0NQ_9e9c500c-aa6a-4d6c-a3bb-7030fdf1db72"
      unitRef="usd">-4253000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfOC0zLTEtMS0xNDc0NQ_15905471-5f20-4247-9d56-7967942e9e9f"
      unitRef="usd">-34536000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfOC01LTEtMS0xNDc0NQ_97092440-1f60-42b3-983b-cd59bf513975"
      unitRef="usd">-108670000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yOC9mcmFnOmUyYmZkZjgzOGY2ZDQ2NjQ5MWRkNTEyNDQzMzdhMTViL3RhYmxlOjAyMWY3MWIzOWMxNDRjNzlhMmZiN2EwNmQ2M2Q3NmNmL3RhYmxlcmFuZ2U6MDIxZjcxYjM5YzE0NGM3OWEyZmI3YTA2ZDYzZDc2Y2ZfOC03LTEtMS0xNDc0NQ_39034b85-55ce-4445-a2bd-86664beb4cd4"
      unitRef="usd">-77515000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMy0xLTEtMS0xNDc0NQ_97ab0bfa-fb46-4eb8-8fab-24debc07be70"
      unitRef="usd">-115998000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMy0zLTEtMS0xNDc0NQ_3ae128d3-dcca-4a0b-a75a-359debb9ae22"
      unitRef="usd">-78192000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNS0xLTEtMS0xNDc0NQ_53279301-e5ca-4d3a-b8a1-b1e91abd82fe"
      unitRef="usd">335000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNS0zLTEtMS0xNDc0NQ_c285ff90-fee6-49d3-9700-f0c0b64fddd0"
      unitRef="usd">127000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNi0xLTEtMS0yMDcwMg_72db40d7-e60d-4a3e-ae49-8b2001551de4"
      unitRef="usd">8800000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNi0zLTEtMS0yMDcwMg_6f34133d-08bc-4cd1-8c2e-34e044790285"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <zntl:RecognizedTaxGainOnIntangibleAssetImpairment
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNy0xLTEtMS0yMDcyOA_25771027-1c54-4698-8daf-3a1a2d6566b4"
      unitRef="usd">2462000</zntl:RecognizedTaxGainOnIntangibleAssetImpairment>
    <zntl:RecognizedTaxGainOnIntangibleAssetImpairment
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNy0zLTEtMS0yMDcyOA_ceaa69cd-315e-4974-9643-92b9db81a5b6"
      unitRef="usd">0</zntl:RecognizedTaxGainOnIntangibleAssetImpairment>
    <zntl:DeconsolidationGainLossAmountNet
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfOC0xLTEtMS0yMDcyOA_f0a9d5d3-3a88-45cb-a3ad-b859b21dfd30"
      unitRef="usd">49930000</zntl:DeconsolidationGainLossAmountNet>
    <zntl:DeconsolidationGainLossAmountNet
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfOC0zLTEtMS0yMDcyOA_f33b68f1-d885-4ef7-88e5-a2560fcace73"
      unitRef="usd">0</zntl:DeconsolidationGainLossAmountNet>
    <us-gaap:ShareBasedCompensation
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNi0xLTEtMS0xNDc0NQ_38b8c23e-278f-415f-9105-d28b4f38bb8a"
      unitRef="usd">27266000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNi0zLTEtMS0xNDc0NQ_fbea398d-63b6-4d5e-a5e1-fbb3b0d89e24"
      unitRef="usd">15259000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNy0xLTEtMS0xNDc0NQ_c9b0fd88-e43a-41a4-a61c-688085acd1dd"
      unitRef="usd">-15000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfNy0zLTEtMS0xNDc0NQ_06b0131f-7602-43c8-94b4-30eb881a530b"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:InvestmentIncomeAmortizationOfPremium
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfOC0xLTEtMS0xNDc0NQ_5515e6c9-9401-431d-b8b7-22cfc2767e90"
      unitRef="usd">712000</us-gaap:InvestmentIncomeAmortizationOfPremium>
    <us-gaap:InvestmentIncomeAmortizationOfPremium
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfOC0zLTEtMS0xNDc0NQ_8346fff7-d4af-45de-a74e-e34e95b55aad"
      unitRef="usd">224000</us-gaap:InvestmentIncomeAmortizationOfPremium>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTAtMS0xLTEtMTQ3NDU_70f235c0-8cbb-4c19-9826-fb95b10d256f"
      unitRef="usd">-309000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTAtMy0xLTEtMTQ3NDU_02a99458-c807-4d7d-8f71-4bdbbb05a6a6"
      unitRef="usd">-18000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTEtMS0xLTEtMTQ3NDU_75ada077-1b6b-4ce1-92cc-e9eef1444f34"
      unitRef="usd">-1696000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTEtMy0xLTEtMTQ3NDU_c1e89f90-43a5-40ce-9abd-e1ab9dd2f491"
      unitRef="usd">5784000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTItMS0xLTEtMTQ3NDU_d1d11daa-6e3a-4f7b-8f11-d57bc15e9285"
      unitRef="usd">12310000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTItMy0xLTEtMTQ3NDU_0843cd12-6c6b-4efe-b2c0-227d8804aee9"
      unitRef="usd">9049000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <zntl:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTMtMS0xLTEtMTQ3NDU_7c06fb20-d492-486d-a7ff-cc66fb733b20"
      unitRef="usd">-125000</zntl:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet>
    <zntl:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTMtMy0xLTEtMTQ3NDU_b31337af-abc4-4baf-8092-46c74cb8c50c"
      unitRef="usd">-169000</zntl:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTQtMS0xLTEtMTQ3NDU_449201fd-6714-40d8-aabf-c995cb1e5bca"
      unitRef="usd">-117072000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTQtMy0xLTEtMTQ3NDU_1a55bac2-1a5f-4d99-ad69-b49b6df4256b"
      unitRef="usd">-59468000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTYtMS0xLTEtMTQ3NDU_28d07dc8-0cc2-41bc-ad0c-a79eebf843b8"
      unitRef="usd">280285000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTYtMy0xLTEtMTQ3NDU_a91799f9-004b-4534-a914-89f24f2cc99f"
      unitRef="usd">304085000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTctMS0xLTEtMTQ3NDU_5373d9d9-048b-4b41-989e-373a4b57da62"
      unitRef="usd">237139000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTctMy0xLTEtMTQ3NDU_aec2f067-9ccf-48c6-bb21-86980daf751e"
      unitRef="usd">29000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:CashDivestedFromDeconsolidation
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjEtMS0xLTEtMjIxMDY_5073af31-9bb8-47f2-9bee-4935b2db285d"
      unitRef="usd">14320000</us-gaap:CashDivestedFromDeconsolidation>
    <us-gaap:CashDivestedFromDeconsolidation
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjEtMy0xLTEtMjIxMDg_dd2873df-ad0f-4335-a04e-c4ee02b94e06"
      unitRef="usd">0</us-gaap:CashDivestedFromDeconsolidation>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTgtMS0xLTEtMTQ3NDU_89b4a9a3-350a-4568-8ac0-6c2c99c40bdd"
      unitRef="usd">3916000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTgtMy0xLTEtMTQ3NDU_5dbecfaf-d32f-4022-bb9d-79974c19de01"
      unitRef="usd">97000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTktMS0xLTEtMTQ3NDU_f0496607-f35a-47e8-bc44-782372453ddb"
      unitRef="usd">-61382000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMTktMy0xLTEtMTQ3NDU_59d79458-52a6-4648-9f7d-5ae861aa7f5e"
      unitRef="usd">-275182000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjEtMS0xLTEtMTQ3NDU_d0a6a0d6-88f7-4fbf-9586-b775c0235e16"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjEtMy0xLTEtMTQ3NDU_60fdc34d-c7cb-46df-8145-68706d3fd0ed"
      unitRef="usd">172482000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjItMS0xLTEtMTQ3NDU_1912b122-d4c4-476a-978f-30d0d381bb19"
      unitRef="usd">4031000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjItMy0xLTEtMTQ3NDU_486a73ad-661a-4dd6-97f9-8823f1ce5740"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjMtMS0xLTEtMTQ3NDU_f3fdc842-c4eb-4d7c-a4c6-16b6c6db68d7"
      unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjMtMy0xLTEtMTQ3NDU_d2036ea3-393a-4ae4-b3fc-4cdd3e6027cc"
      unitRef="usd">18424000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjctMS0xLTEtMjEzMzA_967c035c-346c-469b-a7bb-80d0fdbd8dd9"
      unitRef="usd">162223000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjctMy0xLTEtMjEzMzA_092f1d0f-9309-46e6-9a49-d9f2d1f09d41"
      unitRef="usd">155899000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjQtMS0xLTEtMTQ3NDU_2961488d-494f-41d5-990d-59d89ae50217"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjQtMy0xLTEtMTQ3NDU_3c1b8046-75bc-4b10-b8eb-387edc7018c3"
      unitRef="usd">14228000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjYtMS0xLTEtMTQ3NDU_ec2dbd18-d133-4c09-8975-fdc9d5db583a"
      unitRef="usd">166254000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjYtMy0xLTEtMTQ3NDU_845ad266-d18b-46ad-84f8-23f7df572818"
      unitRef="usd">361033000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjctMS0xLTEtMTQ3NDU_dfb085cd-c751-4a13-9903-42321a1a95f9"
      unitRef="usd">-12200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjctMy0xLTEtMTQ3NDU_44e1c683-6f00-4817-a99e-dc5730bb0684"
      unitRef="usd">26383000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjgtMS0xLTEtMTQ3NDU_ef5373e8-43c2-43b1-9bf3-5ae180b00679"
      unitRef="usd">56271000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3c8ce9f01da84935a62e807401cc9cae_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjgtMy0xLTEtMTQ3NDU_89633d10-4b3c-4c5a-94e1-f8da58f10f80"
      unitRef="usd">67489000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjktMS0xLTEtMTQ3NDU_85c032aa-8e0a-4453-973a-a9b12b9c020a"
      unitRef="usd">44071000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i66bf6807e17f4804bb968d10045ac403_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMjktMy0xLTEtMTQ3NDU_b9d28641-585e-4b6e-9e57-5410f10c9e40"
      unitRef="usd">93872000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <zntl:StockIssuanceCostsIncurredButNotYetPaid
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMzMtMS0xLTEtMTQ3NDU_fa277454-98b2-4c16-8299-bd2034adfcdb"
      unitRef="usd">0</zntl:StockIssuanceCostsIncurredButNotYetPaid>
    <zntl:StockIssuanceCostsIncurredButNotYetPaid
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmI2Mjc5ZjcxNTI0ODRlNzA4Zjg0MGQ3YzQwZTUwNzZmL3RhYmxlcmFuZ2U6YjYyNzlmNzE1MjQ4NGU3MDhmODQwZDdjNDBlNTA3NmZfMzMtMy0xLTEtMTQ3NDU_5a4c575f-19f0-4489-99d8-41e012353ee1"
      unitRef="usd">594000</zntl:StockIssuanceCostsIncurredButNotYetPaid>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmM0ZDhmMWY3ODY1NTQ2OWY4OGY4Y2YwMjVkM2Y3ODY1L3RhYmxlcmFuZ2U6YzRkOGYxZjc4NjU1NDY5Zjg4ZjhjZjAyNWQzZjc4NjVfMi0xLTEtMS0xNDc0NQ_775db411-2bfe-4720-97d8-722887f1d24d"
      unitRef="usd">40807000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i66bf6807e17f4804bb968d10045ac403_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmM0ZDhmMWY3ODY1NTQ2OWY4OGY4Y2YwMjVkM2Y3ODY1L3RhYmxlcmFuZ2U6YzRkOGYxZjc4NjU1NDY5Zjg4ZjhjZjAyNWQzZjc4NjVfMi0zLTEtMS0xNDc0NQ_156e4837-770c-483f-a7d6-94f18fcf378f"
      unitRef="usd">92552000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmM0ZDhmMWY3ODY1NTQ2OWY4OGY4Y2YwMjVkM2Y3ODY1L3RhYmxlcmFuZ2U6YzRkOGYxZjc4NjU1NDY5Zjg4ZjhjZjAyNWQzZjc4NjVfMy0xLTEtMS0xNDc0NQ_449f145b-2069-46f7-a084-3e493111da38"
      unitRef="usd">3264000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i66bf6807e17f4804bb968d10045ac403_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmM0ZDhmMWY3ODY1NTQ2OWY4OGY4Y2YwMjVkM2Y3ODY1L3RhYmxlcmFuZ2U6YzRkOGYxZjc4NjU1NDY5Zjg4ZjhjZjAyNWQzZjc4NjVfMy0zLTEtMS0xNDc0NQ_99bdcb84-7b96-40a2-9ba8-496e7abc1163"
      unitRef="usd">1320000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmM0ZDhmMWY3ODY1NTQ2OWY4OGY4Y2YwMjVkM2Y3ODY1L3RhYmxlcmFuZ2U6YzRkOGYxZjc4NjU1NDY5Zjg4ZjhjZjAyNWQzZjc4NjVfNC0xLTEtMS0xNDc0NQ_a2e99c4b-b942-4a19-9e28-61cb67011202"
      unitRef="usd">44071000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i66bf6807e17f4804bb968d10045ac403_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zMS9mcmFnOjEzYzUxMWM1ODExMzRiOTViYjU2MDVhZmE1ZjhhZDg1L3RhYmxlOmM0ZDhmMWY3ODY1NTQ2OWY4OGY4Y2YwMjVkM2Y3ODY1L3RhYmxlcmFuZ2U6YzRkOGYxZjc4NjU1NDY5Zjg4ZjhjZjAyNWQzZjc4NjVfNC0zLTEtMS0xNDc0NQ_10c6ea5c-57d7-4d0a-8532-2234c56cd673"
      unitRef="usd">93872000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SharesIssued
      contextRef="i5479652c5e8948eea76ed85f21cb8d7e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNC0xLTEtMS0xNDc0NQ_a2d31575-99ca-478c-9908-10fdd70f7dcc"
      unitRef="shares">41315000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5479652c5e8948eea76ed85f21cb8d7e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNC0zLTEtMS0xNDc0NQ_eb54d6d1-7b7a-4df9-a2d9-231ab3d25d74"
      unitRef="usd">41000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibce0517364924372a750c28c212342ce_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNC01LTEtMS0xNDc0NQ_8c211389-af9d-441d-830e-d6bcb2d3a16d"
      unitRef="usd">529019000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i05e61bfa32a14e3187bb570193bd427c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNC03LTEtMS0xNDc0NQ_6c48fdf8-3286-4120-adf4-0c9339740ece"
      unitRef="usd">94000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib42d2e50a19640fd98f9685c1637127d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNC05LTEtMS0xNDc0NQ_ca5f1025-b864-4d6b-a996-1db4f15b725b"
      unitRef="usd">-305309000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73b610735c7347e8aaac83b4f7bc7c43_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNC0xMS0xLTEtMTQ3NDU_79c9ef15-a520-471f-b8ef-68ae5fa48671"
      unitRef="usd">23764000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i21152b916121449d97e5409f0cbc25b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNC0xMy0xLTEtMTQ3NDU_2cfc6d87-d7a3-4fa3-ab5c-3758da89d1a0"
      unitRef="usd">247609000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if7c1a20b82134c2996172b95f893e5d4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNS01LTEtMS0xNDc0NQ_537c8d24-27cb-431d-8ef5-f3c5bc9e85b9"
      unitRef="usd">7656000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNS0xMy0xLTEtMTQ3NDU_83aa391e-32ed-458e-8393-adde55f1a2e1"
      unitRef="usd">7656000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iab511672603b4a81a03caf2ab30bcf7c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNi03LTEtMS0xNDc0NQ_4eaf4b1e-8fe7-4b31-9e7e-9f3119a6efa6"
      unitRef="usd">-62000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNi0xMy0xLTEtMTQ3NDU_aade61c7-9016-4c6d-ae82-e482a5ebd312"
      unitRef="usd">-62000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i3f0fe3d7eeb04c7899bcb9ae2088bdf4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNy0xLTEtMS0xODgyNQ_e65ec44b-0853-46c5-b107-14be671ca69c"
      unitRef="shares">3565000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i3f0fe3d7eeb04c7899bcb9ae2088bdf4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNy0zLTEtMS0xODgyNQ_6cdc7521-e69c-4e5c-89cd-e2180f206ef1"
      unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if7c1a20b82134c2996172b95f893e5d4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNy01LTEtMS0xODgzMg_dc747c98-9982-4679-a3f2-65d4a2b44e8e"
      unitRef="usd">162219000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNy0xMy0xLTEtMTg4Mzk_cbab7f58-5eeb-4e4b-a1a2-dacd3bfbf18e"
      unitRef="usd">162223000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i3f0fe3d7eeb04c7899bcb9ae2088bdf4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfNy0xLTEtMS0xNDc0NQ_e9c461e3-776d-4e46-8ce0-a00e554192ea"
      unitRef="shares">170000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="ie4021c98173a4dcba140ad00a72d452c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfOS0xMS0xLTEtMjA4Nzg_7c2564a6-9300-487d-b414-57451f32e203"
      unitRef="usd">16899000</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfOS0xMy0xLTEtMjA4Nzg_11a55479-f612-4f46-9e95-836693695077"
      unitRef="usd">16899000</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3f0fe3d7eeb04c7899bcb9ae2088bdf4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfOC0xLTEtMS0xNDc0NQ_76e8c319-737e-4637-bf84-bc55ad81b24c"
      unitRef="shares">137000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if7c1a20b82134c2996172b95f893e5d4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfOC01LTEtMS0xNDc0NQ_b2260288-2057-4595-b999-e292ed7bb71e"
      unitRef="usd">3416000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfOC0xMy0xLTEtMTQ3NDU_e9f9c25a-8340-4ca1-b60f-b928610eb40b"
      unitRef="usd">3416000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i3f0fe3d7eeb04c7899bcb9ae2088bdf4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTAtMS0xLTEtMTkxNzM_99397e6d-20ea-4d22-8ec7-2f9274bc7f1c"
      unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="if7c1a20b82134c2996172b95f893e5d4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTAtNS0xLTEtMTkxODA_facc7572-0f6f-434f-aaf3-9c0b67d24dc2"
      unitRef="usd">545000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTAtMTMtMS0xLTE5MTgw_88f644f9-1137-484d-b33b-64fbb32e2d94"
      unitRef="usd">545000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="i3f0fe3d7eeb04c7899bcb9ae2088bdf4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfOS0xLTEtMS0xNDc0NQ_06cd6bc9-5a7f-4575-bc58-59a3678c2329"
      unitRef="shares">3000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie4021c98173a4dcba140ad00a72d452c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTAtMTEtMS0xLTE0NzQ1_12f3aa1a-670f-4749-a587-bb9d462df4b7"
      unitRef="usd">-6301000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTAtMTMtMS0xLTE0NzQ1_7ec8b9c8-e67b-49c4-bf43-79a3e1170f33"
      unitRef="usd">-6301000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i98f6ab579d534d1bb65c5fe26ac9a269_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTEtOS0xLTEtMTQ3NDU_fac8ec1a-8d38-42b0-86b2-951334059ada"
      unitRef="usd">-4191000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTEtMTMtMS0xLTE0NzQ1_69a80db4-5b68-4a11-a856-767e74f5de7a"
      unitRef="usd">-4191000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i8acbfe477b1c4f3a815b95163a1b9152_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTItMS0xLTEtMTQ3NDU_a0bc64b3-577f-47fa-a5ae-b8a84804276f"
      unitRef="shares">45199000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8acbfe477b1c4f3a815b95163a1b9152_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTItMy0xLTEtMTQ3NDU_f3993440-db00-437f-bb78-412a3404a7d3"
      unitRef="usd">45000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id08f2fc2050a4c44943d2e4a295e9e4b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTItNS0xLTEtMTQ3NDU_3927a831-984c-4b7d-8ef1-a254530004ef"
      unitRef="usd">702855000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9a274b3c002d4c999b3d4c6415451551_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTItNy0xLTEtMTQ3NDU_bb57ffc4-9383-4c97-8c6a-b9f0c77d5979"
      unitRef="usd">32000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ee68a808a09462ab4fa007d6b40a836_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTItOS0xLTEtMTQ3NDU_a7a8acf2-9f11-485f-b992-94706b7a71ac"
      unitRef="usd">-309500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6caad814d88b42158fdc2cd280aab0ed_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTItMTEtMS0xLTE0NzQ1_ff8cd371-042d-432b-b334-16653378f8c5"
      unitRef="usd">564000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjlhN2RmZjEwODYyYjQ0MGFhMjM3Nzc0MmU4Y2ZjOGRhL3RhYmxlcmFuZ2U6OWE3ZGZmMTA4NjJiNDQwYWEyMzc3NzQyZThjZmM4ZGFfMTItMTMtMS0xLTE0NzQ1_60f0feda-3218-4c21-be21-9839640a099f"
      unitRef="usd">393996000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i49952e4f44cf4702824e413a479ed8e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNC0xLTEtMS0xNDc0NQ_5240450c-859a-434d-ba4c-2df2a198fdec"
      unitRef="shares">41040000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i49952e4f44cf4702824e413a479ed8e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNC0zLTEtMS0xNDc0NQ_a232bdc1-1d90-4ebe-b232-cf36ddcee637"
      unitRef="usd">41000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i08713a361b1540acb0726229b81829e1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNC02LTEtMS0xNDc0NQ_c1e4ba49-db21-4724-a31b-a2301be7e16c"
      unitRef="usd">509339000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5a86486294184f18889f9a3725de48f1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNC04LTEtMS0xNDc0NQ_f5a8fc03-6b10-44a6-b9fa-06ea0f5a52b1"
      unitRef="usd">36000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i609623d6091f4576a93d91b6acb32ee7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNC0xMC0xLTEtMTQ3NDU_8c9f3204-8794-40a8-941e-8f534d304002"
      unitRef="usd">-200834000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idc6dc347950a4b29af9da5a02d804ca9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNC0xMi0xLTEtMTQ3NDU_9bdbfeb3-b916-4d32-a7ac-69ef73f5bed8"
      unitRef="usd">24795000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNC0xNC0xLTEtMTQ3NDU_4c3d9125-7e7a-4d69-bd14-4e79d01d8bad"
      unitRef="usd">333377000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if397f6a7f90548bcaa33a5c5cf1f88cb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNS02LTEtMS0xNDc0NQ_a71bfc3b-02d9-42ed-9e04-c533d484f8d2"
      unitRef="usd">27266000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNS0xNC0xLTEtMTQ3NDU_c8845cc7-25ce-4683-ad3e-c780dbe1d2ce"
      unitRef="usd">27266000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i65a26d388f63425cb3a2dc35e2a31a4b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNi04LTEtMS0xNDc0NQ_bdc0290a-7a9e-42dc-9a14-1db31a669421"
      unitRef="usd">-4000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNi0xNC0xLTEtMTQ3NDU_fd710705-e796-4b7d-abb1-b05f62d4038f"
      unitRef="usd">-4000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="if1f3ce1f164345ed9ee96c629cc01c5d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNy0xLTEtMS0xODg0Ng_12eef558-d9b3-4bc7-a470-f0f6cbcc5762"
      unitRef="shares">3565000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if1f3ce1f164345ed9ee96c629cc01c5d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNy0zLTEtMS0xODg0Ng_7b0f1475-4c13-4e70-be15-529b7e4d8e6e"
      unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if397f6a7f90548bcaa33a5c5cf1f88cb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNy02LTEtMS0xODg1Mw_2deb80a9-e444-4a0d-8414-00c63f43a5be"
      unitRef="usd">162219000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNy0xNC0xLTEtMTg4NTM_ae4c6fb9-8fe7-44b8-b70d-3eb27be52b21"
      unitRef="usd">162223000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="if1f3ce1f164345ed9ee96c629cc01c5d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfNy0xLTEtMS0xNDc0NQ_fa07c006-ecae-4b90-80d4-1e1410901030"
      unitRef="shares">442000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="ie71fb05f111f4be48d0ccef2861d630f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfOS0xMS0xLTEtMjA5NTA_bc9cb730-aaa6-4a2e-8cab-989aca98b722"
      unitRef="usd">16899000</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfOS0xMy0xLTEtMjA5NTA_ba2e85bb-4dc9-4045-978c-1f9c51e1fc25"
      unitRef="usd">16899000</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="if1f3ce1f164345ed9ee96c629cc01c5d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfOC0xLTEtMS0xNDc0NQ_e153d7ac-992f-4004-86dc-e11ec0842a9a"
      unitRef="shares">141000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if397f6a7f90548bcaa33a5c5cf1f88cb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfOC02LTEtMS0xNDc0NQ_a238a2fa-1f9b-4843-a43d-1d4c66ddd66d"
      unitRef="usd">3486000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfOC0xNC0xLTEtMTQ3NDU_20af8168-7eb1-4306-a641-3a25687b7801"
      unitRef="usd">3486000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="if1f3ce1f164345ed9ee96c629cc01c5d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTAtMS0xLTEtMTkxODc_70cebb8c-e845-4a12-b6a0-65e2c809a1a3"
      unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="if397f6a7f90548bcaa33a5c5cf1f88cb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTAtNi0xLTEtMTkxOTQ_1224ab3b-15b2-4112-aa8b-72e5d22a8faf"
      unitRef="usd">545000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTAtMTQtMS0xLTE5MTk0_5877edf2-b342-42cc-981b-f3f4e449c1ce"
      unitRef="usd">545000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="if1f3ce1f164345ed9ee96c629cc01c5d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfOS0xLTEtMS0xNDc0NQ_7e9b1bf7-6826-40ca-bfc3-6c83b625f047"
      unitRef="shares">4000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie71fb05f111f4be48d0ccef2861d630f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTAtMTItMS0xLTE0NzQ1_6389528a-b5c3-4d96-bb68-c98a479806e4"
      unitRef="usd">-7332000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTAtMTQtMS0xLTE0NzQ1_1d180fba-36f4-4df2-82a4-925ffcaea647"
      unitRef="usd">-7332000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ib93e31ca1184485f94ea42f971abc9e0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTEtMTAtMS0xLTE0NzQ1_f62e90ff-ee0d-4488-aa7b-fff5502a845c"
      unitRef="usd">-108666000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTEtMTQtMS0xLTE0NzQ1_f955d073-cfce-4ee6-9378-0b7429f6569c"
      unitRef="usd">-108666000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i8acbfe477b1c4f3a815b95163a1b9152_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTItMS0xLTEtMTQ3NDU_94a9ed15-5d78-43f0-9e32-35b26449dc65"
      unitRef="shares">45199000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8acbfe477b1c4f3a815b95163a1b9152_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTItMy0xLTEtMTQ3NDU_0643aa34-4587-4ab3-93a0-51c2761b0f3f"
      unitRef="usd">45000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id08f2fc2050a4c44943d2e4a295e9e4b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTItNi0xLTEtMTQ3NDU_d1934ff0-1e40-40fb-8a56-47ffc09a0d74"
      unitRef="usd">702855000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9a274b3c002d4c999b3d4c6415451551_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTItOC0xLTEtMTQ3NDU_969e7620-5dd6-4268-a3de-3b2a922ce7d6"
      unitRef="usd">32000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ee68a808a09462ab4fa007d6b40a836_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTItMTAtMS0xLTE0NzQ1_38079dba-29bf-4f6c-9b3d-204c966e7665"
      unitRef="usd">-309500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6caad814d88b42158fdc2cd280aab0ed_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTItMTItMS0xLTE0NzQ1_fd5911e4-095f-4854-9b61-32a548b702b1"
      unitRef="usd">564000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOmVjMDgyNGZmN2VhNzRmMjY4ZjcyMjU2YzcyMmQ1NGZkL3RhYmxlcmFuZ2U6ZWMwODI0ZmY3ZWE3NGYyNjhmNzIyNTZjNzIyZDU0ZmRfMTItMTQtMS0xLTE0NzQ1_3361080a-31b1-445a-a8eb-fb25e3179305"
      unitRef="usd">393996000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="iefaca15d6a7d4345a23fd191b8e32d62_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNC0xOC0xLTEtMTQ3NDU_a4b9e72f-5969-49aa-a52e-39d23767bf4f"
      unitRef="shares">35878000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iefaca15d6a7d4345a23fd191b8e32d62_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNC0yMC0xLTEtMTQ3NDU_fb26dd29-7099-4297-b28d-3b84f4463d5d"
      unitRef="usd">36000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iadec20410c96469aaee44c0c733e3dc4_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNC0yMi0xLTEtMTQ3NDU_30e64be8-e694-4e24-a701-90f0c6b708c6"
      unitRef="usd">339160000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaac40f72e56c4a298f6c8a19b70d2903_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNC0yNC0xLTEtMTQ3NDU_1c7fb2b1-6e92-4b4d-99a8-4a3eddad1836"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4922676e6be541f3872e64b2464fb137_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNC0yNi0xLTEtMTQ3NDU_3e0b1df0-9ee5-44d8-a3ad-01e13ef4a352"
      unitRef="usd">-125976000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2ab4533a3be14806b3b04f091b9ee6f3_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNC0yOC0xLTEtMTQ3NDU_361f9996-dc6f-4684-aa49-3323172b9f91"
      unitRef="usd">24701000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4aa9cf16c10047e38ad6329f8dc98d18_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNC0zMC0xLTEtMTQ3NDU_c3befeda-f13d-4af0-9184-89a5ebbedb7c"
      unitRef="usd">237925000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i28c684747f014fc580d4d13ca452e467_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNS0yMi0xLTEtMTQ3NDU_d76fafa7-0ada-49a5-9626-a9ea570a613f"
      unitRef="usd">7249000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNS0zMC0xLTEtMTQ3NDU_48010f39-110d-4260-8e7b-c90f7b9b3166"
      unitRef="usd">7249000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="if603d442707c4674b05711009d838f40_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNi0xOC0xLTEtMTQ3NDU_9684f1ae-1e89-4e4f-9b29-78d808c2e17d"
      unitRef="shares">4744000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if603d442707c4674b05711009d838f40_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNi0yMC0xLTEtMTQ3NDU_b12872ee-a35c-410b-8723-53991bd14303"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i28c684747f014fc580d4d13ca452e467_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNi0yMi0xLTEtMTQ3NDU_89df5f9b-6c7c-485d-ad3a-8d7a62d03856"
      unitRef="usd">155300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNi0zMC0xLTEtMTQ3NDU_a761e78e-e63c-4cc6-8add-49fa4dda7390"
      unitRef="usd">155305000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="if603d442707c4674b05711009d838f40_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfNy0xOC0xLTEtMTQ3NDU_25e09a30-d907-41b9-8005-57207ba45119"
      unitRef="shares">7000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="icfc558dbb30841d4b077a7adf6dba4a8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfOC0yNC0xLTEtMTQ3NDU_5f86a0b7-0b00-4cfe-b9ba-30354c405dc3"
      unitRef="usd">19000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfOC0zMC0xLTEtMTQ3NDU_04e01ad2-974d-4053-be4d-195a0c753b52"
      unitRef="usd">19000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i28c684747f014fc580d4d13ca452e467_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTEtMjItMS0xLTE0NzQ1_94613dc7-e5f0-42c6-9841-4e89092b55d2"
      unitRef="usd">-187000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ica7568cfa246420a8555ccc29e4641d5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTEtMjgtMS0xLTE0NzQ1_da9e6bae-2ff8-48f4-ac8c-8cc09bcfbd6f"
      unitRef="usd">77000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTEtMzAtMS0xLTE0NzQ1_a363acd4-6bf0-4877-9f08-866b993c08b3"
      unitRef="usd">-110000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i1b6093af831e491297bdfb820eba1bb4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTItMjYtMS0xLTE0NzQ1_88029d4b-d6ca-4816-8e0c-d2d2aec58ffc"
      unitRef="usd">-34555000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTItMzAtMS0xLTE0NzQ1_12bc6844-5985-472c-9761-cd5d5498de8b"
      unitRef="usd">-34555000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="iae5a70bb484d47a5966a3232feabc0a3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTMtMTgtMS0xLTE0NzQ1_2af3f6f5-8550-43a4-9f72-413918c661a5"
      unitRef="shares">40615000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iae5a70bb484d47a5966a3232feabc0a3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTMtMjAtMS0xLTE0NzQ1_dc1034ad-2fa6-4a6a-841c-936ac41f852a"
      unitRef="usd">41000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2b4a788eaa8d424898851941377c7408_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTMtMjItMS0xLTE0NzQ1_14556de6-341b-47cb-ae71-63a94f0317d3"
      unitRef="usd">501522000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if9bfd239f78a4d1c9687ea22e1413f42_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTMtMjQtMS0xLTE0NzQ1_e9f11ad6-909d-4437-86d3-2d89b1b2b22e"
      unitRef="usd">23000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i401925c54aed4e27af6b9f7bae761633_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTMtMjYtMS0xLTE0NzQ1_277f77ff-0b39-4ccf-a70f-031269c82d63"
      unitRef="usd">-160531000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieea94c1751ea4ca9aafb6ed451e8026c_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTMtMjgtMS0xLTE0NzQ1_96ff620a-7b42-4ded-86d4-b3a9f274a108"
      unitRef="usd">24778000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i66bf6807e17f4804bb968d10045ac403_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjUyYzk3ZjQ3ZWZlMTQzZWRhNzJlOTc2MjU2MjNmODNiL3RhYmxlcmFuZ2U6NTJjOTdmNDdlZmUxNDNlZGE3MmU5NzYyNTYyM2Y4M2JfMTMtMzAtMS0xLTE0NzQ1_75323082-daee-4154-9c8b-2f6611dc1381"
      unitRef="usd">365833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i84f4ac54c0c4412cad1de8c39c9f465f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0xLTEtMS0xNDc0NQ_318cd4ef-13f2-4c26-80e1-528d3b9373c8"
      unitRef="shares">9950000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i84f4ac54c0c4412cad1de8c39c9f465f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0zLTEtMS0xNDc0NQ_606640dc-73da-4d3d-a8de-3d51d96a0329"
      unitRef="usd">141706000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonUnitOutstanding
      contextRef="icb096e42e3894e489f301e40bd55a89a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0xMC0xLTEtMTQ3NDU_cd5a3f6d-311a-4fa2-858e-2a6f7e277557"
      unitRef="shares">5601000</us-gaap:CommonUnitOutstanding>
    <us-gaap:CommonUnitIssuanceValue
      contextRef="icb096e42e3894e489f301e40bd55a89a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0xMi0xLTEtMTQ3NDU_e2417f8f-e43b-41f9-b736-e41fb023fb2c"
      unitRef="usd">709000</us-gaap:CommonUnitIssuanceValue>
    <us-gaap:CommonUnitOutstanding
      contextRef="i37dfc4263719434b9b05fe487d9d50df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0xNC0xLTEtMTQ3NDU_53636111-1366-4429-999a-8a83cc822226"
      unitRef="shares">2671000</us-gaap:CommonUnitOutstanding>
    <us-gaap:CommonUnitIssuanceValue
      contextRef="i37dfc4263719434b9b05fe487d9d50df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0xNi0xLTEtMTQ3NDU_5f074a04-cf96-4a35-9f94-159b5b52379b"
      unitRef="usd">2178000</us-gaap:CommonUnitIssuanceValue>
    <us-gaap:SharesIssued
      contextRef="i4589566e63f84b7b9cccea38766a0eb1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0xOC0xLTEtMTQ3NDU_b644ee1d-ad85-4aa7-959b-dcdfe6a0a20c"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4589566e63f84b7b9cccea38766a0eb1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0yMC0xLTEtMTQ3NDU_54b9b2fd-dead-4948-8884-16faef5dd504"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1dffd747f1e14c5498e5f8b92e2018d7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0yMi0xLTEtMTQ3NDU_c7ee385a-ec19-4a05-8297-952a2f048d66"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i205664e670624f0d9706e05dfcffde81_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0yNC0xLTEtMTQ3NDU_a6e2b2ba-c946-4aa1-bb0c-9b5b5480ff1f"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i72b30c6cbd624852b0a41e4ef1b61c9b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0yNi0xLTEtMTQ3NDU_f2775f9a-1653-4ca2-b858-1693157f79c5"
      unitRef="usd">-82993000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b164794b9d4478db7c7a1f24b1a53e1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0yOC0xLTEtMTQ3NDU_dfd49c39-bbc5-453a-82cd-9545bb92a00c"
      unitRef="usd">6821000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c8ce9f01da84935a62e807401cc9cae_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNC0zMC0xLTEtMTQ3NDU_3826a03e-d5a9-462a-a0af-af0fef126c15"
      unitRef="usd">-73285000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i36b0ac5aa6b94994b62d1befce371046_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNS0wLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjVhMmI1YWUyZDY5NDQ0YTRhYjhjNGFiZTU4YTg0OThlXzU2_ca828861-84dd-4b4d-b045-b15aea36f097"
      unitRef="usdPerShare">17.50</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <zntl:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i7fafba9138604e4582aa3c16d8ca83cb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNS0xLTEtMS0xNDc0NQ_4510edb8-d963-47af-a7c5-25047cb6c83f"
      unitRef="shares">867000</zntl:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i7fafba9138604e4582aa3c16d8ca83cb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNS0zLTEtMS0xNDc0NQ_07027f82-c9c2-409d-bb13-5029003fb419"
      unitRef="usd">14228000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <zntl:StockCancelledDuringPeriodShares
      contextRef="i172924960c934f48b9b4f68bfc2f1c46_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNi0xNC0xLTEtMTQ3NDU_720f7f41-f7fb-44ec-bab9-e9c78ff18fa5"
      unitRef="shares">64000</zntl:StockCancelledDuringPeriodShares>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i0020419724ac422c834b41878fbbf94b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNy0xOC0xLTEtMTQ3NDU_9a72a95d-0945-4d87-a60e-9fa5f58f01bb"
      unitRef="shares">10589000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i0020419724ac422c834b41878fbbf94b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNy0yMC0xLTEtMTQ3NDU_3d0fdf81-2c30-4555-aed8-110956e6c2db"
      unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ib3d8bceefc7b40dc839ef2d3d293a13c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNy0yMi0xLTEtMTQ3NDU_f4483705-d7b8-4842-835e-e8b8560ca88c"
      unitRef="usd">172354000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ie807a0e24c7b451dae314257f1dd00e0_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfNy0zMC0xLTEtMTQ3NDU_8cd9ece7-9546-428b-a3f1-a251619e28a0"
      unitRef="usd">172365000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i20dba144ba4b4cc586cce30c51aaa503_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfOC0yOC0xLTEtMTQ3NDU_361c8170-9bde-406e-b767-b26460b63023"
      unitRef="usd">18424000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfOC0zMC0xLTEtMTQ3NDU_8d42a04a-cf25-4e3b-953c-a7408b280586"
      unitRef="usd">18424000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i172924960c934f48b9b4f68bfc2f1c46_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfOS0xNi0xLTEtMTQ3NDU_1cc5e53c-b671-4983-ac90-87bc62d44cdd"
      unitRef="usd">329000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5015e220e18d463eab535a4b2752b5c2_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfOS0yMi0xLTEtMTQ3NDU_bea0dade-c526-497a-8fab-95e2608e68b5"
      unitRef="usd">14930000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfOS0zMC0xLTEtMTQ3NDU_50e3a60a-2bc0-4982-b301-eba10b75ffe4"
      unitRef="usd">15259000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <zntl:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="i7fafba9138604e4582aa3c16d8ca83cb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTAtMS0xLTEtMTQ3NDU_49653451-fefc-4ed9-a4d8-f614ef77107c"
      unitRef="shares">10817000</zntl:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="i7fafba9138604e4582aa3c16d8ca83cb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTAtMy0xLTEtMTQ3NDU_81735eea-063a-425b-96f6-57860f8fcd73"
      unitRef="usd">-155934000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <zntl:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTAtMTgtMS0xLTE0NzQ1_6c6cdf46-7c7b-4ecd-b3ea-5c70f4c7ec7f"
      unitRef="shares">15011000</zntl:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTAtMjAtMS0xLTE0NzQ1_d83c7abe-f4eb-41fe-883d-c5b2cfe4be96"
      unitRef="usd">15000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="i5015e220e18d463eab535a4b2752b5c2_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTAtMjItMS0xLTE0NzQ1_0373ed4a-c134-4ff6-abf1-5a79ed67df10"
      unitRef="usd">155919000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTAtMzAtMS0xLTE0NzQ1_ff9dd71a-457a-46f3-b15d-d534e25615a3"
      unitRef="usd">155934000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="i5bcb52b9ccef496eb3fcb0a88b4d38ea_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMTAtMS0xLTE0NzQ1_9f5cbdb5-26bf-4365-a00f-92090e846b91"
      unitRef="shares">-5601000</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="i5bcb52b9ccef496eb3fcb0a88b4d38ea_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMTItMS0xLTE0NzQ1_58ad2fcf-c791-4466-8ebe-6c049be1c63f"
      unitRef="usd">-709000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="i172924960c934f48b9b4f68bfc2f1c46_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMTQtMS0xLTE0NzQ1_f61eadc6-aaa4-4a6a-a9ee-d529c46f2834"
      unitRef="shares">-2607000</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="i172924960c934f48b9b4f68bfc2f1c46_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMTYtMS0xLTE0NzQ1_f73d4b85-ae2a-47ad-a7c4-3b92336af9eb"
      unitRef="usd">-2507000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMTgtMS0xLTE0NzQ1_aa0b20c6-efea-428b-a62f-d3249250cdf1"
      unitRef="shares">10278000</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMjAtMS0xLTE0NzQ1_ec3fce94-f14e-47ec-a0a9-03bfb57524af"
      unitRef="usd">10000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="i5015e220e18d463eab535a4b2752b5c2_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMjItMS0xLTE0NzQ1_07ca6741-c25c-4b7d-a857-aff07ecf5b76"
      unitRef="usd">3206000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTEtMzAtMS0xLTE0NzQ1_288e0485-0c32-457e-9fe9-a3e7981089a2"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTItMTgtMS0xLTE5NTYz_581b3088-8660-474e-a459-d2ea9f4d43f3"
      unitRef="shares">4744000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTItMjAtMS0xLTE5NTYz_358bcef1-48ee-4867-a143-8caa15532922"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i5015e220e18d463eab535a4b2752b5c2_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTItMjItMS0xLTE5NTg4_ea82dbaf-a398-417c-a152-7bea8a484597"
      unitRef="usd">155300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTItMzAtMS0xLTE5NjI1_be450e7d-d36e-430f-b63f-38e223aa1040"
      unitRef="usd">155305000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="i44aa49493ba24d6b9e1afc3ae9445fb8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTMtMTgtMS0xLTE5NTYz_378732f1-72ed-4ffd-9656-d8448c67086d"
      unitRef="shares">7000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i171029a8b8344ffcb4c0653ce2b78593_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTItMjQtMS0xLTE0NzQ1_71dd312a-81c5-419e-afef-3beefaf9b119"
      unitRef="usd">23000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTItMzAtMS0xLTE0NzQ1_69e87a5e-550e-4cc0-aa74-ae8bbea6c554"
      unitRef="usd">23000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5015e220e18d463eab535a4b2752b5c2_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTMtMjItMS0xLTE0NzQ1_e17e1c7d-479f-4a69-98e7-1ad783f94345"
      unitRef="usd">-187000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i20dba144ba4b4cc586cce30c51aaa503_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTMtMjgtMS0xLTE0NzQ1_670c5139-d32c-4848-a061-0eeb9dc92dc3"
      unitRef="usd">-467000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTMtMzAtMS0xLTE0NzQ1_ed1a2399-21b2-4810-b80e-5b96da4ad222"
      unitRef="usd">-654000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ie1d6083038da45c5aadfdf0aefeda452_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTQtMjYtMS0xLTE0NzQ1_613c28a2-800c-4c11-97d6-ac9133262bf1"
      unitRef="usd">-77538000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTQtMzAtMS0xLTE0NzQ1_acf1dbbe-6c09-4302-b48b-9b11964063ca"
      unitRef="usd">-77538000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i36b0ac5aa6b94994b62d1befce371046_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMS0xLTEtMTQ3NDU_a277bb84-0f6c-42c6-935f-607fdc0803fc"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i36b0ac5aa6b94994b62d1befce371046_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMy0xLTEtMTQ3NDU_44753443-a432-4653-a972-d8968d84bfcb"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonUnitOutstanding
      contextRef="ifd1fdb349c73430aa944980282c11963_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMTAtMS0xLTE0NzQ1_f89995d0-3379-4324-af33-295a8efc1037"
      unitRef="shares">0</us-gaap:CommonUnitOutstanding>
    <us-gaap:CommonUnitIssuanceValue
      contextRef="ifd1fdb349c73430aa944980282c11963_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMTItMS0xLTE0NzQ1_b0d5342e-37d2-4c3d-85f0-284b6d0004a6"
      unitRef="usd">0</us-gaap:CommonUnitIssuanceValue>
    <us-gaap:CommonUnitOutstanding
      contextRef="i6eb313acd05f42ae9d92268c78a67bd4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMTQtMS0xLTE0NzQ1_7c04cd0f-3b13-4a31-8ac9-4cd3bb4f5847"
      unitRef="shares">0</us-gaap:CommonUnitOutstanding>
    <us-gaap:CommonUnitIssuanceValue
      contextRef="i6eb313acd05f42ae9d92268c78a67bd4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMTYtMS0xLTE0NzQ1_76fcc854-336d-4a1c-8a8e-a8861ddab0dd"
      unitRef="usd">0</us-gaap:CommonUnitIssuanceValue>
    <us-gaap:SharesIssued
      contextRef="iae5a70bb484d47a5966a3232feabc0a3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMTgtMS0xLTE0NzQ1_3cf363fb-9652-479f-915b-7895e71c38d0"
      unitRef="shares">40615000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iae5a70bb484d47a5966a3232feabc0a3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMjAtMS0xLTE0NzQ1_64d1858a-a725-4562-bdfa-d9aa9119de29"
      unitRef="usd">41000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2b4a788eaa8d424898851941377c7408_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMjItMS0xLTE0NzQ1_3b80a403-c729-4b32-ad2b-41c73f00d014"
      unitRef="usd">501522000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if9bfd239f78a4d1c9687ea22e1413f42_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMjQtMS0xLTE0NzQ1_8c3984cd-ff8d-47f4-a567-da2b9a0a62cc"
      unitRef="usd">23000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i401925c54aed4e27af6b9f7bae761633_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMjYtMS0xLTE0NzQ1_83d957a0-4b51-4a44-8254-c8f4c4f90b99"
      unitRef="usd">-160531000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieea94c1751ea4ca9aafb6ed451e8026c_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMjgtMS0xLTE0NzQ1_668d3124-3977-4fdc-9967-447746a45569"
      unitRef="usd">24778000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i66bf6807e17f4804bb968d10045ac403_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8zNC9mcmFnOjk3NDQxNzg3NWY1ZDQ2ZWI4NmUwYTg3ZWE1MWY4ZmFiL3RhYmxlOjJkYTdjNzQ1ZTJlMjQwZGNhNmM5NWY2MThhMzA2MWVhL3RhYmxlcmFuZ2U6MmRhN2M3NDVlMmUyNDBkY2E2Yzk1ZjYxOGEzMDYxZWFfMTUtMzAtMS0xLTE0NzQ1_ce7a8217-998b-40e5-95be-9773d91c4c72"
      unitRef="usd">365833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMzUzMQ_db64421d-cd37-4bdd-990f-124937efe199">Organization and Business&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Organization&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Zentalis Pharmaceuticals, Inc. (&#x201c;Zentalis&#x201d;, &#x201c;We&#x201d; or the &#x201c;Company&#x201d;) is a clinical-stage pharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. All of the Company&#x2019;s tangible assets are held in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company was formed and incorporated in the state of Delaware as Zeno Pharmaceuticals, Inc. on December&#160;23, 2014. Effective November&#160;21, 2017, Zeno Pharma, LLC was formed by the shareholders of Zeno Pharmaceuticals, Inc. On December&#160;21, 2017, Zeno Pharmaceuticals, Inc. became a wholly owned subsidiary of Zeno Pharma, LLC. In connection with this restructuring, the rights and preferences of the Preferred Stock of Zeno Pharmaceuticals, Inc. were exchanged for preferred units with similar rights and preferences of Zeno Pharma, LLC. As part of the restructuring, the employees, consultants and board members of Zeno Pharmaceuticals, Inc. exchanged their equity grants in Zeno Pharmaceuticals, Inc. stock for Class&#160;B common units in Zeno Pharma, LLC. Additionally, existing common stockholders of Zeno Pharmaceuticals, Inc. exchanged their common stock for Class&#160;A common units in Zeno Pharma, LLC. All exchanges were made on a&#160;one-for-one&#160;basis. The restructuring was accounted for as a common control transaction. In December 2019, the Company was renamed to Zentalis Pharmaceuticals, LLC. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Immediately prior to the effectiveness of the registration statement pertaining to the Company&#x2019;s initial public offering (&#x201c;IPO&#x201d;) on April 2, 2020, the Company converted from a Delaware limited liability company into a Delaware corporation, and changed its name to Zentalis Pharmaceuticals, Inc. Pursuant to the statutory corporate conversion, all of the outstanding units of Zentalis Pharmaceuticals, LLC converted into shares of common stock of Zentalis Pharmaceuticals, Inc. based upon the value of Zentalis Pharmaceuticals, Inc. at the time of the IPO with a value implied by the price of the shares of common stock sold in the IPO. Based on the IPO price of $18.00 per share, the outstanding converted units converted into 25,288,854 shares of common stock (including 1,160,277 shares of restricted common stock).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 7, 2020, the Company completed the IPO in which the Company issued and sold 10,557,000 shares&#160;of common stock (including 1,377,000 shares of common stock in connection with the full exercise of the underwriters&#x2019; option to purchase additional shares) at a public offering price of $18.00 per share. The Company&#x2019;s aggregate gross proceeds from the sale of shares in the IPO, including the sale of shares pursuant to the full exercise of the underwriters&#x2019; option to purchase additional shares, was $190.0&#160;million before fees and expenses of $17.6&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity&lt;/span&gt;&lt;/div&gt;Substantial doubt about an entity&#x2019;s ability to continue as a going concern exists when relevant conditions and events, considered in the aggregate, indicate that it is probable that the entity will be unable to meet its obligations as they become due within one year from the financial statement issuance date. The Company determined that there are no conditions or events that raise substantial doubt about its ability to continue as a going concern within one year after the date that the interim unaudited condensed consolidated financial statements for the quarter ended September&#160;30, 2021 are issued.</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <zntl:CommonStockConversionRatio
      contextRef="i44bca96b50f545e98c95ba466913be25_D20171221-20171221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMTQ0Nw_e9c6b5e1-3788-4ba0-8860-797896c64858"
      unitRef="number">1</zntl:CommonStockConversionRatio>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i53b0d350827a4825b36838126a07429a_I20200402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjI3Mw_9b4e4058-a4e9-43ab-aee5-913cae9ae708"
      unitRef="usdPerShare">18.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="ibdac556512264baba2e3c86be867069c_D20200402-20200402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjMzNA_f3e587ac-2cbe-4d92-9744-d8dab6fc9e64"
      unitRef="shares">25288854</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="i0daa24d503d64a52a0b1fa592bd6c4e8_D20200402-20200402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjM3MQ_33630794-b82a-4d8f-ba4b-16bd9f129fd0"
      unitRef="shares">1160277</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="id1b99cb5cf7d4b9bb0f68ae4525eab72_D20200407-20200407"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjQ5NQ_5e990466-d839-4d98-b6aa-88e2ed8486b0"
      unitRef="shares">10557000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ie8cad8b83d3f432cafaa0e90fa7125e0_D20200407-20200407"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjUzMg_842c8527-8931-446f-acd8-45da437bed4e"
      unitRef="shares">1377000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ib67a09c2cc4e4165b391d6ef5419f1b7_I20200407"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjY4NA_bac551d9-eb61-48fe-a39e-d97ba72378c8"
      unitRef="usdPerShare">18.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i88c5a60307524479aa90649174075824_D20200407-20200407"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjg5NQ_f52f3d87-45f0-432b-a874-f8a7fa65817e"
      unitRef="usd">190000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i88c5a60307524479aa90649174075824_D20200407-20200407"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80MC9mcmFnOjY4ZTc4NzFjZGVhMDRmOGU5YmQwMjljMjQzNDg3ZWMzL3RleHRyZWdpb246NjhlNzg3MWNkZWEwNGY4ZTliZDAyOWMyNDM0ODdlYzNfMjkyNg_56048be7-1868-4bcc-bcc5-750a7161ff15"
      unitRef="usd">17600000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80My9mcmFnOjM1MzA2YjAzNDZmNTRlY2M4ZTk5MzQ2NTJkYTQ0NWEyL3RleHRyZWdpb246MzUzMDZiMDM0NmY1NGVjYzhlOTkzNDY1MmRhNDQ1YTJfMjU2Mg_6cc04c03-9d5a-47e8-924b-5f2dc2d9bc5d">Interim Unaudited Financial Statements &lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) and with the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) related to a quarterly report on Form 10-Q. The year-end condensed consolidated balance sheet data was derived from the Company&#x2019;s audited financial statements but does not include all disclosures required by U.S. GAAP. These condensed consolidated financial statements and notes thereto should be read in conjunction with the Company&#x2019;s audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on March 25, 2021. The unaudited financial information for the interim periods presented herein reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of the financial condition and results of operation for the periods presented, with such adjustments consisting only of normal recurring adjustments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include our accounts and our wholly-owned subsidiaries and variable interest entity (&#x201c;VIE&#x201d;) for which we are the primary beneficiary. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate our ownership, contractual and other interests in entities that are not wholly-owned by us to determine if these entities are VIEs, and, if so, whether we are the primary beneficiary of the VIE. In determining whether we are the primary beneficiary of a VIE and therefore required to consolidate the VIE, we apply a qualitative approach that determines whether we have both (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of, or the rights to receive benefits from, the VIE that could potentially be significant to that VIE. We continuously assess whether we are the primary beneficiary of a VIE as changes to existing relationships or future transactions may result in the consolidation or deconsolidation, as the case may be, of such VIE.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The equity method is used to account for investments in which we have the ability to exercise significant influence, but not control, over the investee. Such investments are recorded on the balance sheet, and the share of net income or losses of equity investments is recognized on a one quarter lag in investment and other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates and judgments, which are based on historical and anticipated results and trends and on various other assumptions that management believes to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management&#x2019;s estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Though the impact of the COVID-19 pandemic to our business and operating results presents additional uncertainty, we continue to use the best information available to inform our critical accounting estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September 30, 2021, there have been no changes to the Company&#x2019;s significant accounting policies as described in its Annual Report on Form 10-K for the fiscal year ended December 31, 2020 outside of the equity method accounting for investments and adoption and pending adoption of recent accounting pronouncements mentioned below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Method Accounting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have significant influence, but not a controlling interest, in Zentera. From the deconsolidation of Zentera during July 2021 prospectively, this investment is accounted for using the equity method. Our share of earnings or losses of the investment entity are reported on the consolidated statement of operations through investment and other income, net, with a corresponding increase or decrease to the equity investment carried on the statement of financial position. This information is generally not received sufficiently timely for us to record our portion of earnings or loss in the current financial statements and therefore we report our portion of earnings or loss on a one quarter lag.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Adoption and Pending Adoption of Recent Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a brief description of recently issued accounting standards, those adopted in the current period and those not yet adopted:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.717%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.774%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.774%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect on the Financial&lt;br/&gt;Statements or Other&lt;br/&gt;Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In January 2020, the FASB issued ASU 2020-01, Investments &#x2013; Equity Securities (Topic 321)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This standard clarifies the interaction between accounting standards related to equity securities (ASC 321), equity method investments (ASC 323), and certain derivatives (ASC 815).&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of January 1, 2021, we did not hold equity securities, equity method investments or derivatives. The impact of this new accounting guidance in 2021 did not have a material impact to our consolidated financial statements at the time of adoption.&lt;br/&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of July 2021, we hold an equity method investment which is accounted for under ASC 323. The investment is recorded on the consolidated statement of financial position at fair value as of the date of deconsolidation. The Company&#x2019;s share of earnings or losses of the investment entity are reported on the consolidated statement of operations through investment and other income, net with a corresponding increase or decrease to the equity investment. &lt;br/&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80My9mcmFnOjM1MzA2YjAzNDZmNTRlY2M4ZTk5MzQ2NTJkYTQ0NWEyL3RleHRyZWdpb246MzUzMDZiMDM0NmY1NGVjYzhlOTkzNDY1MmRhNDQ1YTJfMjU2NA_cb9f146e-8635-4c3a-b74b-48e2035ef8b9">Basis of PresentationThe accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) and with the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) related to a quarterly report on Form 10-Q. The year-end condensed consolidated balance sheet data was derived from the Company&#x2019;s audited financial statements but does not include all disclosures required by U.S. GAAP. These condensed consolidated financial statements and notes thereto should be read in conjunction with the Company&#x2019;s audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on March 25, 2021. The unaudited financial information for the interim periods presented herein reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of the financial condition and results of operation for the periods presented, with such adjustments consisting only of normal recurring adjustments.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80My9mcmFnOjM1MzA2YjAzNDZmNTRlY2M4ZTk5MzQ2NTJkYTQ0NWEyL3RleHRyZWdpb246MzUzMDZiMDM0NmY1NGVjYzhlOTkzNDY1MmRhNDQ1YTJfMjU2NQ_d001237c-d80d-4df6-8db3-125d9a2ec826">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include our accounts and our wholly-owned subsidiaries and variable interest entity (&#x201c;VIE&#x201d;) for which we are the primary beneficiary. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate our ownership, contractual and other interests in entities that are not wholly-owned by us to determine if these entities are VIEs, and, if so, whether we are the primary beneficiary of the VIE. In determining whether we are the primary beneficiary of a VIE and therefore required to consolidate the VIE, we apply a qualitative approach that determines whether we have both (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of, or the rights to receive benefits from, the VIE that could potentially be significant to that VIE. We continuously assess whether we are the primary beneficiary of a VIE as changes to existing relationships or future transactions may result in the consolidation or deconsolidation, as the case may be, of such VIE.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The equity method is used to account for investments in which we have the ability to exercise significant influence, but not control, over the investee. Such investments are recorded on the balance sheet, and the share of net income or losses of equity investments is recognized on a one quarter lag in investment and other income (expense), net.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80My9mcmFnOjM1MzA2YjAzNDZmNTRlY2M4ZTk5MzQ2NTJkYTQ0NWEyL3RleHRyZWdpb246MzUzMDZiMDM0NmY1NGVjYzhlOTkzNDY1MmRhNDQ1YTJfMjU2Ng_88783c68-eb4e-430f-9a35-298e30e81a2b">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates and judgments, which are based on historical and anticipated results and trends and on various other assumptions that management believes to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management&#x2019;s estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Though the impact of the COVID-19 pandemic to our business and operating results presents additional uncertainty, we continue to use the best information available to inform our critical accounting estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80My9mcmFnOjM1MzA2YjAzNDZmNTRlY2M4ZTk5MzQ2NTJkYTQ0NWEyL3RleHRyZWdpb246MzUzMDZiMDM0NmY1NGVjYzhlOTkzNDY1MmRhNDQ1YTJfMjE5OTAyMzI2OTQxMg_ea4149f2-a7d0-4740-bf55-ac7e0c388c7a">Equity Method AccountingWe have significant influence, but not a controlling interest, in Zentera. From the deconsolidation of Zentera during July 2021 prospectively, this investment is accounted for using the equity method. Our share of earnings or losses of the investment entity are reported on the consolidated statement of operations through investment and other income, net, with a corresponding increase or decrease to the equity investment carried on the statement of financial position. This information is generally not received sufficiently timely for us to record our portion of earnings or loss in the current financial statements and therefore we report our portion of earnings or loss on a one quarter lag.</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80My9mcmFnOjM1MzA2YjAzNDZmNTRlY2M4ZTk5MzQ2NTJkYTQ0NWEyL3RleHRyZWdpb246MzUzMDZiMDM0NmY1NGVjYzhlOTkzNDY1MmRhNDQ1YTJfMjU2MA_729a10c3-79cf-4571-a113-86b709c480f7">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Adoption and Pending Adoption of Recent Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a brief description of recently issued accounting standards, those adopted in the current period and those not yet adopted:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.717%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.774%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.774%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect on the Financial&lt;br/&gt;Statements or Other&lt;br/&gt;Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In January 2020, the FASB issued ASU 2020-01, Investments &#x2013; Equity Securities (Topic 321)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This standard clarifies the interaction between accounting standards related to equity securities (ASC 321), equity method investments (ASC 323), and certain derivatives (ASC 815).&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of January 1, 2021, we did not hold equity securities, equity method investments or derivatives. The impact of this new accounting guidance in 2021 did not have a material impact to our consolidated financial statements at the time of adoption.&lt;br/&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of July 2021, we hold an equity method investment which is accounted for under ASC 323. The investment is recorded on the consolidated statement of financial position at fair value as of the date of deconsolidation. The Company&#x2019;s share of earnings or losses of the investment entity are reported on the consolidated statement of operations through investment and other income, net with a corresponding increase or decrease to the equity investment. &lt;br/&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80My9mcmFnOjM1MzA2YjAzNDZmNTRlY2M4ZTk5MzQ2NTJkYTQ0NWEyL3RleHRyZWdpb246MzUzMDZiMDM0NmY1NGVjYzhlOTkzNDY1MmRhNDQ1YTJfMjU2MQ_e3661b5e-f9ae-4dd8-8d26-fc13db9efcbd">&lt;div style="margin-bottom:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a brief description of recently issued accounting standards, those adopted in the current period and those not yet adopted:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.717%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.774%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.774%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect on the Financial&lt;br/&gt;Statements or Other&lt;br/&gt;Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In January 2020, the FASB issued ASU 2020-01, Investments &#x2013; Equity Securities (Topic 321)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;This standard clarifies the interaction between accounting standards related to equity securities (ASC 321), equity method investments (ASC 323), and certain derivatives (ASC 815).&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of January 1, 2021, we did not hold equity securities, equity method investments or derivatives. The impact of this new accounting guidance in 2021 did not have a material impact to our consolidated financial statements at the time of adoption.&lt;br/&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of July 2021, we hold an equity method investment which is accounted for under ASC 323. The investment is recorded on the consolidated statement of financial position at fair value as of the date of deconsolidation. The Company&#x2019;s share of earnings or losses of the investment entity are reported on the consolidated statement of operations through investment and other income, net with a corresponding increase or decrease to the equity investment. &lt;br/&gt;&lt;/span&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNzQ4Nzc5MDY5ODI3L2ZyYWc6MTc1NzIzZTdiZDZiNGZiOWI2OTNjYjJkN2RkMzdkNTYvdGV4dHJlZ2lvbjoxNzU3MjNlN2JkNmI0ZmI5YjY5M2NiMmQ3ZGQzN2Q1Nl8yNzQ4Nzc5MDc3MjMz_3b818d3c-e6a5-4fea-a7a9-e3db443ada3b">Significant Transactions&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Zentera Therapeutics&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, we became a majority common shareholder of Zentera Therapeutics, Ltd., a Shanghai-based clinical-stage biopharmaceutical company focused on developing cancer therapeutics (&#x201c;Zentera&#x201d;), concurrent with its Series A convertible preferred stock offering. The financial position and results of operations of Zentera have been included in our consolidated financial statements from the date of the initial investment as a result of our control of the entity. In July 2021, Zentera completed a Series B convertible preferred stock offering which diluted our investment to a position of less than majority owned. Upon review of the facts and circumstances, together with the authoritative accounting literature, we determined that consolidation of Zentera is no longer appropriate. After the July 2021 Series B convertible preferred offering in which we did not participate, our review concluded that we ceased to have a controlling financial interest in Zentera, an additional board member was added to the Zentera &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;board of directors and we concluded that we no longer have the power to direct the activities that most significantly affect Zentera&#x2019;s economic performance nor are we the primary beneficiary of Zentera.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in July 2021, the financial position and results of operations of Zentera are no longer included in our consolidated financial statements. An equity method investment of $39.3 million was recorded on our balance sheet representing the fair value of our common stock investment using the backsolve method with consideration for a lack of marketability at the time of deconsolidation. A corresponding deferred tax liability of $1.7 million representing the tax impact of the unrealized gain on deconsolidation was recorded during the three months ended September 30, 2021. A gain of $51.6 million, measured as the difference between the fair value of our retained noncontrolling interest together with the carrying amount of the Zentera noncontrolling interest, and the carrying amount of Zentera&#x2019;s assets and liabilities was recognized during the third quarter of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, each of our subsidiaries Zeno Alpha, Inc., K-Group Alpha, Inc., Zeno Management Inc., and K-Group Beta, Inc. entered into a collaboration and royalty-bearing license agreement with Zentera, which we refer to as the &#x201c;Zentera Sublicenses,&#x201d; pursuant to which we collaborate with Zentera on the development and commercialization of ZN-c3, ZN-c5 and ZN-d5, respectively, in the People&#x2019;s Republic of China, Macau, Hong Kong and Taiwan, which is referred to as the &#x201c;Zentera Collaboration Territory.&#x201d; Under each Zentera Sublicense, Zentera will lead development, and upon regulatory approval, the commercialization, of the collaboration products in the Zentera Collaboration Territory. &lt;/span&gt;&lt;/div&gt;Under the terms of the Zentera Sublicenses, Zentera is responsible for the costs of developing the Collaboration Products in the Zentera Collaboration Territory, and we are responsible for the costs of developing the Collaboration Products outside the Zentera Collaboration Territory, provided that Zentera will reimburse us for a portion of the costs for global data management, pharmacovigilance, safety database management, and chemistry, manufacturing and controls activities with respect to each Collaboration Product. Prior to the deconsolidation of Zentera, these costs were eliminated in consolidation. For the period subsequent to deconsolidation to September 30, 2021, the amounts incurred under this arrangement totaled $2.9 million and are presented as contra-research and development expense in the consolidated statement of operations. A corresponding receivable is recorded within prepaid expenses and other current assets on the consolidated balance sheet.</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNzQ4Nzc5MDY5ODI3L2ZyYWc6MTc1NzIzZTdiZDZiNGZiOWI2OTNjYjJkN2RkMzdkNTYvdGV4dHJlZ2lvbjoxNzU3MjNlN2JkNmI0ZmI5YjY5M2NiMmQ3ZGQzN2Q1Nl8xMDk5NTExNjM1Njgy_a99e07a8-ccc8-4a7d-9327-33979a2efd72"
      unitRef="usd">39300000</us-gaap:EquityMethodInvestments>
    <us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
      contextRef="i59959a77c7aa43129b028607068148f6_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNzQ4Nzc5MDY5ODI3L2ZyYWc6MTc1NzIzZTdiZDZiNGZiOWI2OTNjYjJkN2RkMzdkNTYvdGV4dHJlZ2lvbjoxNzU3MjNlN2JkNmI0ZmI5YjY5M2NiMmQ3ZGQzN2Q1Nl8xMDk5NTExNjM5NDkw_6f7e0b0b-7001-4489-8e22-6edef1a68c64"
      unitRef="usd">1700000</us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="i3a09ec80921740a8a5b68eddc9671099_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNzQ4Nzc5MDY5ODI3L2ZyYWc6MTc1NzIzZTdiZDZiNGZiOWI2OTNjYjJkN2RkMzdkNTYvdGV4dHJlZ2lvbjoxNzU3MjNlN2JkNmI0ZmI5YjY5M2NiMmQ3ZGQzN2Q1Nl8xMDk5NTExNjM1NzE1_863a4258-1072-4377-949b-eb0072349d3a"
      unitRef="usd">51600000</us-gaap:DeconsolidationGainOrLossAmount>
    <zntl:ResearchAndDevelopmentExpenseReimbursements
      contextRef="i3a09ec80921740a8a5b68eddc9671099_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV8yNzQ4Nzc5MDY5ODI3L2ZyYWc6MTc1NzIzZTdiZDZiNGZiOWI2OTNjYjJkN2RkMzdkNTYvdGV4dHJlZ2lvbjoxNzU3MjNlN2JkNmI0ZmI5YjY5M2NiMmQ3ZGQzN2Q1Nl8xMDk5NTExNjM1NzM1_43dbc703-15ba-4522-9ec2-17ae23cda3e4"
      unitRef="usd">2900000</zntl:ResearchAndDevelopmentExpenseReimbursements>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMTgyOA_5ad182b2-25d2-44d0-8f83-9deecd13636f">Business Combinations&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Kalyra Pharmaceuticals, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December&#160;21, 2017, we acquired $4.5&#160;million of Kalyra&#x2019;s Series B Preferred Stock representing a 25% equity interest in Kalyra for purposes of entering the analgesics therapeutic research space. The acquisition price was paid entirely in cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the authoritative guidance, we concluded that Kalyra is a business consisting of inputs, employees, intellectual property and processes capable of producing outputs. Additionally, we have concluded that Kalyra is a variable interest entity, we are the primary beneficiary and have the power to direct the activities that most significantly affect Kalyra&#x2019;s economic performance through common management and our board representation. Prior to the change of control, the Company and Kalyra transacted for the delivery of research and development services and support. The financial position and results of operations of Kalyra have been included in our consolidated financial statements from the date of the initial investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant with authoritative guidance, we have recorded the identifiable assets, liabilities and noncontrolling interests in the VIE at their fair value upon initial consolidation. The identified goodwill is comprised of the workforce and expected synergies from combining the entities. During the third quarter of 2021, Kalyra determined that they will no longer pursue the development of Kalyra&#x2019;s lead product candidate and ceased the associated clinical trial. The in-process research and development costs (&#x201c;IPR&amp;amp;D&#x201d;) recorded on Kalyra&#x2019;s balance sheet exclusively relates to this candidate. Management recorded an impairment charge of $8.8&#160;million within the research and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;development expense line item on the consolidated statement of operations during the third quarter of 2021, which resulted in a reduction of the IPR&amp;amp;D asset from $8.8&#160;million to zero. The impairment of IPR&amp;amp;D resulted in a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; reversal of the associated deferred tax liability of $2.4 million during the third quarter of 2021. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets and liabilities of Kalyra as of September&#160;30, 2021 and December&#160;31, 2020 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cdffcc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process&#160;research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The liabilities recognized as a result of consolidating Kalyra do not represent additional claims on our general assets. Pursuant to the authoritative guidance, the equity interest in Kalyra not owned by Zentalis is reported as a noncontrolling interest on our condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of equity (net assets) attributable to the noncontrolling interest (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.416%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i36e1e114412b4a85a123b6bacd5ba04e_D20171221-20171221"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfOTM_c4a02e29-534a-45b7-a46a-0dcd3c0cebdb"
      unitRef="usd">4500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="ibe080c8b70bb4349ac04f51678c3abf1_I20171221"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMTQ4_3c1914cf-f183-48b6-810d-d534e74af253"
      unitRef="number">0.25</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i3da75022cc3d428d9e0424e542c47954_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMjc0ODc3OTA4Mzg4NA_fcfdba02-4e84-410e-81a9-d49f55a3611d"
      unitRef="usd">8800000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iadfc04fccb134988b9f947350d9c04c9_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMjc0ODc3OTA4Mzg3MA_0207db94-a534-473c-a8e8-2bf6f37ccc9c"
      unitRef="usd">8800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2389c0a608534740bdcad0e2fa9bfcec_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMjc0ODc3OTA4Mzg5Nw_c1848802-cef5-43ab-8426-6275c22f26d5"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMjE5OTAyMzI3MTI0OQ_6de1292a-cf00-43f9-a3ef-e42e274de175"
      unitRef="usd">2400000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMTgyNg_47d3dae0-d98d-4ddf-ae5d-0766d4922156">Total assets and liabilities of Kalyra as of September&#160;30, 2021 and December&#160;31, 2020 are as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cdffcc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process&#160;research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie38dad6ada064a56894e848a9616b856_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfMi0xLTEtMS0xNDc0NQ_b9df5f8e-e651-4961-ba6a-34ac3aec533f"
      unitRef="usd">556000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfMi0zLTEtMS0xNDc0NQ_8838fb8e-329d-4173-8ef1-524c1ed6098f"
      unitRef="usd">417000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:OtherAssetsCurrent
      contextRef="ie38dad6ada064a56894e848a9616b856_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfMy0xLTEtMS0xNDc0NQ_e7a63ee4-bca9-4a1d-9500-1613e4f14104"
      unitRef="usd">107000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfMy0zLTEtMS0xNDc0NQ_993e000e-9b2d-49e9-9f3e-a3d71b7b5d74"
      unitRef="usd">82000</us-gaap:OtherAssetsCurrent>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie38dad6ada064a56894e848a9616b856_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfNC0xLTEtMS0xNDc0NQ_a3918868-ee55-4807-b753-2f5a06a73222"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfNC0zLTEtMS0xNDc0NQ_d962f764-b69e-4143-8129-5182d877464d"
      unitRef="usd">8800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Goodwill
      contextRef="ie38dad6ada064a56894e848a9616b856_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfNS0xLTEtMS0xNDc0NQ_320d4811-f8da-485b-9efc-22d97c75fa5d"
      unitRef="usd">3736000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfNS0zLTEtMS0xNDc0NQ_992cb0c5-bd15-4235-8efb-bea96a0be127"
      unitRef="usd">3736000</us-gaap:Goodwill>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="ie38dad6ada064a56894e848a9616b856_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfNy0xLTEtMS0xNDc0NQ_c8bdaa23-4884-42ca-bc57-eff9f0c7c54c"
      unitRef="usd">124000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfNy0zLTEtMS0xNDc0NQ_5d7a0170-19ac-4595-bc9e-f28b4807d29d"
      unitRef="usd">83000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ie38dad6ada064a56894e848a9616b856_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfOC0xLTEtMS0xNDc0NQ_e2a46b2d-ee12-4363-9f54-a29fc38a4f74"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfOC0zLTEtMS0xNDc0NQ_2847d6e3-1a0a-420c-a4de-bed33a1be4c0"
      unitRef="usd">2463000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:MinorityInterest
      contextRef="ie38dad6ada064a56894e848a9616b856_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfOS0xLTEtMS0xNDc0NQ_fcbab775-5444-413c-a449-8c2b2e8da8eb"
      unitRef="usd">564000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOjNmN2MwYWJmZmQwZTRkZTg4ZGYyN2QyMTdmMDNkZjY1L3RhYmxlcmFuZ2U6M2Y3YzBhYmZmZDBlNGRlODhkZjI3ZDIxN2YwM2RmNjVfOS0zLTEtMS0xNDc0NQ_87fe0542-ea5a-4521-bb8c-bd031fe2957e"
      unitRef="usd">6705000</us-gaap:MinorityInterest>
    <zntl:ReconciliationOfNoncontrollingInterestTableTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RleHRyZWdpb246OTk0N2M2ODI0YWZkNGYzNmEwOTk5NjI2OTRiMDZiNzZfMTgyNw_f110f72a-f498-4d6b-bbc5-a4fc563216b4">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of equity (net assets) attributable to the noncontrolling interest (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.416%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</zntl:ReconciliationOfNoncontrollingInterestTableTextBlock>
    <us-gaap:MinorityInterest
      contextRef="i1b8f9142cb4543f0a263ce89556879f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOmMyM2IyOGMzNDUyNDQwOTQ4YmEwNzIzZjNlOTIxOWZiL3RhYmxlcmFuZ2U6YzIzYjI4YzM0NTI0NDA5NDhiYTA3MjNmM2U5MjE5ZmJfMi0xLTEtMS0xNDc0NQ_39c37b87-b3d1-4dff-bba2-b7418ca485ff"
      unitRef="usd">6705000</us-gaap:MinorityInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ifa5cb2304d0444b389a997ad08e0c71e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOmMyM2IyOGMzNDUyNDQwOTQ4YmEwNzIzZjNlOTIxOWZiL3RhYmxlcmFuZ2U6YzIzYjI4YzM0NTI0NDA5NDhiYTA3MjNmM2U5MjE5ZmJfMy0xLTEtMS0xNDc0NQ_1865384f-be7d-4106-a658-13707c057c53"
      unitRef="usd">6141000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:MinorityInterest
      contextRef="ie38dad6ada064a56894e848a9616b856_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80Ni9mcmFnOjk5NDdjNjgyNGFmZDRmMzZhMDk5OTYyNjk0YjA2Yjc2L3RhYmxlOmMyM2IyOGMzNDUyNDQwOTQ4YmEwNzIzZjNlOTIxOWZiL3RhYmxlcmFuZ2U6YzIzYjI4YzM0NTI0NDA5NDhiYTA3MjNmM2U5MjE5ZmJfNC0xLTEtMS0xNDc0NQ_c3e55625-f32a-4efb-997f-77a5ac1647f6"
      unitRef="usd">564000</us-gaap:MinorityInterest>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RleHRyZWdpb246ZDM5NjNlMWUzY2VjNDY3YTkxMDVhYzBmYmE2YjMxNjlfMTQyNQ_aa05dc4e-99f7-4cb4-9cc1-644332c488d4">Fair Value Measurement&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale marketable securities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Government Agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Treasury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Government Agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Treasury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company regularly reviews the securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as the severity of the impairment, changes in underlying credit ratings, forecasted recovery, our intent to sell or the likelihood that we would be required to sell the investment before its anticipated recovery in market value and the probability that the scheduled cash payments will continue to be made. Based on our review of these marketable securities, we believe none of the unrealized loss is as a result of a credit loss as of September&#160;30, 2021, because we do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of their amortized cost basis. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual maturities of available-for-sale debt securities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.044%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After one but within five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes, by major security type, our cash equivalents and available-for-sale marketable securities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Government Agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers between Level&#160;1 and Level&#160;2 of the fair value hierarchy during the nine months ended September&#160;30, 2021. We had no instruments that were classified within Level&#160;3 as of September&#160;30, 2021 or December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RleHRyZWdpb246ZDM5NjNlMWUzY2VjNDY3YTkxMDVhYzBmYmE2YjMxNjlfMTQyNg_3290add7-41af-4c8b-a72f-24511bdc3426">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale marketable securities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Government Agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Treasury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Government Agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Treasury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia868940f58cc42b5b13f0fc8b51e01da_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMi0xLTEtMS0xNDc0NQ_14cd29d9-defb-4e50-9195-04a7669d1446"
      unitRef="usd">239391000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia868940f58cc42b5b13f0fc8b51e01da_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMi0zLTEtMS0xNDc0NQ_ecf4affa-fc08-40bb-bb65-d61ff8fa9252"
      unitRef="usd">23000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia868940f58cc42b5b13f0fc8b51e01da_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMi01LTEtMS0xNDc0NQ_028edc3e-8ca7-4421-a0b5-884b04675504"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia868940f58cc42b5b13f0fc8b51e01da_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMi03LTEtMS0xNDc0NQ_93b9e0db-864d-4844-8408-2ff5f3161e34"
      unitRef="usd">239412000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9ad029fd87124e22a93cabf53bf1d8ad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMy0xLTEtMS0xNDc0NQ_9587c614-a1db-4eb2-861b-c2c5d2bf7333"
      unitRef="usd">10145000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9ad029fd87124e22a93cabf53bf1d8ad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMy0zLTEtMS0xNDc0NQ_8f88a201-14b3-44d3-aebc-f4c62fc31df3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9ad029fd87124e22a93cabf53bf1d8ad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMy01LTEtMS0xNDc0NQ_e563b649-9214-452a-9e95-6ead5eadebc7"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9ad029fd87124e22a93cabf53bf1d8ad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfMy03LTEtMS0xNDc0NQ_312b1863-4e26-42f8-b0c1-70a68cc9592e"
      unitRef="usd">10142000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iec9f78113384472a9c1cd4490522fa4f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNC0xLTEtMS0xNDc0NQ_b5bf4ed0-721e-44a9-81d1-e9c6412f33cb"
      unitRef="usd">35731000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iec9f78113384472a9c1cd4490522fa4f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNC0zLTEtMS0xNDc0NQ_2aa4a67b-7d2a-41d6-9779-010a3ebef552"
      unitRef="usd">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iec9f78113384472a9c1cd4490522fa4f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNC01LTEtMS0xNDc0NQ_d98e944c-97c3-4be0-99ac-daf91b7ce5dd"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iec9f78113384472a9c1cd4490522fa4f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNC03LTEtMS0xNDc0NQ_f2c30418-acfe-4e12-8e41-bc42c75df93a"
      unitRef="usd">35737000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2cbe2ea503f244c28efc38eaf91c8231_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNS0xLTEtMS0xNDc0NQ_da0983e6-eb49-4545-bb54-a4626e3f7613"
      unitRef="usd">40685000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2cbe2ea503f244c28efc38eaf91c8231_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNS0zLTEtMS0xNDc0NQ_8661f488-972d-4ff5-9a12-7de98940b7fd"
      unitRef="usd">9000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2cbe2ea503f244c28efc38eaf91c8231_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNS01LTEtMS0xNDc0NQ_b11ccfc3-a963-46c0-91e1-50e339015a2e"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2cbe2ea503f244c28efc38eaf91c8231_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNS03LTEtMS0xNDc0NQ_082be041-03ca-4677-acd3-7d7b2aa18c74"
      unitRef="usd">40693000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNi0xLTEtMS0xNDc0NQ_90eb7d83-5175-4a5d-8b69-17a1780cda20"
      unitRef="usd">325952000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNi0zLTEtMS0xNDc0NQ_04584493-91d2-43ce-b73d-5ab4dd02b82d"
      unitRef="usd">38000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNi01LTEtMS0xNDc0NQ_5ec1b2df-5fd6-4474-9b81-c5435e2ebde5"
      unitRef="usd">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmI0MWVkOWU4OThiYjQ1ZjJiZjYyNGIxZTFlMzFlZWJlL3RhYmxlcmFuZ2U6YjQxZWQ5ZTg5OGJiNDVmMmJmNjI0YjFlMWUzMWVlYmVfNi03LTEtMS0xNDc0NQ_8c45bd62-b62f-4aa0-b37e-a43721de6ece"
      unitRef="usd">325984000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i37fa66f18165423bb7d922609186b948_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMi0xLTEtMS0xNDc0NQ_be70a868-9811-4340-a439-80ac62ca0ba5"
      unitRef="usd">147382000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i37fa66f18165423bb7d922609186b948_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMi0zLTEtMS0xNDc0NQ_96db6966-adae-41f3-9350-854751a16fb8"
      unitRef="usd">14000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i37fa66f18165423bb7d922609186b948_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMi01LTEtMS0xNDc0NQ_88483bbd-08c9-41de-856b-338d64c9ac6c"
      unitRef="usd">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i37fa66f18165423bb7d922609186b948_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMi03LTEtMS0xNDc0NQ_dca47de2-9c00-4bb9-a495-186ad9ee881c"
      unitRef="usd">147388000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="icc5bcd3985e645c3a401476d670729d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMy0xLTEtMS0xNDc0NQ_b0dd7434-5705-4128-96e5-fb68572c9cb9"
      unitRef="usd">23576000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icc5bcd3985e645c3a401476d670729d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMy0zLTEtMS0xNDc0NQ_2c5198b7-3c13-4f94-ab25-74293a6a8316"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icc5bcd3985e645c3a401476d670729d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMy01LTEtMS0xNDc0NQ_0c394936-05fb-4548-bd51-f333c2831990"
      unitRef="usd">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icc5bcd3985e645c3a401476d670729d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfMy03LTEtMS0xNDc0NQ_08289697-0cf2-4ec4-96d2-0524605a82e5"
      unitRef="usd">23571000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic46f09a640544a46acc118a2e3a87c79_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNC0xLTEtMS0xNDc0NQ_63cd1cf8-0b61-4f22-a45d-b965c365013b"
      unitRef="usd">81455000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic46f09a640544a46acc118a2e3a87c79_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNC0zLTEtMS0xNDc0NQ_5743fdd2-f7bd-45bd-ad67-3ad706aac1d8"
      unitRef="usd">32000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic46f09a640544a46acc118a2e3a87c79_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNC01LTEtMS0xNDc0NQ_0a1aa61c-19ec-4c57-b721-dd20c4287ced"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic46f09a640544a46acc118a2e3a87c79_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNC03LTEtMS0xNDc0NQ_931398fd-d19d-403a-bc7e-fdec7f74f75f"
      unitRef="usd">81486000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1e4e6113e81b488f98011e1738519d49_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNS0xLTEtMS0xNDc0NQ_d4bc011d-acef-420d-a91a-fde6a8a3b514"
      unitRef="usd">31105000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1e4e6113e81b488f98011e1738519d49_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNS0zLTEtMS0xNDc0NQ_880fae72-29c5-4cca-9018-1df30dc598c2"
      unitRef="usd">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1e4e6113e81b488f98011e1738519d49_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNS01LTEtMS0xNDc0NQ_cab826d1-c1f4-4817-844a-996b19431639"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1e4e6113e81b488f98011e1738519d49_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNS03LTEtMS0xNDc0NQ_89a90ff9-e5ff-430d-a97a-709bae5d5be6"
      unitRef="usd">31109000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNi0xLTEtMS0xNDc0NQ_518e5b47-aa57-4219-9158-75d2a1ffe645"
      unitRef="usd">283518000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNi0zLTEtMS0xNDc0NQ_83233bf3-a2e5-4e69-89cd-0fa7d0b137e9"
      unitRef="usd">51000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNi01LTEtMS0xNDc0NQ_abda31af-7670-4706-9d2b-3784c86e97d3"
      unitRef="usd">15000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjZjYWJiYWNiYzgzYzQwYWE4OWI5YzQxMzQzZGJkMzA1L3RhYmxlcmFuZ2U6NmNhYmJhY2JjODNjNDBhYTg5YjljNDEzNDNkYmQzMDVfNi03LTEtMS0xNDc0NQ_3a68e233-a4ad-4d46-8dce-c94dec7a32b0"
      unitRef="usd">283554000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RleHRyZWdpb246ZDM5NjNlMWUzY2VjNDY3YTkxMDVhYzBmYmE2YjMxNjlfMTQyMg_a0e0da6b-dbaa-4c5a-812a-4df44bdd3c15">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual maturities of available-for-sale debt securities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.044%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After one but within five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjk5NDliMzlmOGM1YjRjZTFiNjlmMjZlY2U4MjM0NmYwL3RhYmxlcmFuZ2U6OTk0OWIzOWY4YzViNGNlMWI2OWYyNmVjZTgyMzQ2ZjBfMy0xLTEtMS0xNDc0NQ_9d180bfc-8ac7-4620-94d4-2787f79d5137"
      unitRef="usd">315988000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjk5NDliMzlmOGM1YjRjZTFiNjlmMjZlY2U4MjM0NmYwL3RhYmxlcmFuZ2U6OTk0OWIzOWY4YzViNGNlMWI2OWYyNmVjZTgyMzQ2ZjBfMy0zLTEtMS0xNDc0NQ_df21e2de-ac53-4175-980c-292d7e4ee9a2"
      unitRef="usd">247455000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjk5NDliMzlmOGM1YjRjZTFiNjlmMjZlY2U4MjM0NmYwL3RhYmxlcmFuZ2U6OTk0OWIzOWY4YzViNGNlMWI2OWYyNmVjZTgyMzQ2ZjBfNC0xLTEtMS0xNDc0NQ_960a14b8-b563-4afd-a5bf-01c23c1d77f7"
      unitRef="usd">9996000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjk5NDliMzlmOGM1YjRjZTFiNjlmMjZlY2U4MjM0NmYwL3RhYmxlcmFuZ2U6OTk0OWIzOWY4YzViNGNlMWI2OWYyNmVjZTgyMzQ2ZjBfNC0zLTEtMS0xNDc0NQ_26ac2bfd-9ca7-4072-ade3-9faf33ea0285"
      unitRef="usd">36099000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjk5NDliMzlmOGM1YjRjZTFiNjlmMjZlY2U4MjM0NmYwL3RhYmxlcmFuZ2U6OTk0OWIzOWY4YzViNGNlMWI2OWYyNmVjZTgyMzQ2ZjBfNS0xLTEtMS0xNDc0NQ_706d7d4d-1437-46f8-83ef-d928cfd7dd14"
      unitRef="usd">325984000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOjk5NDliMzlmOGM1YjRjZTFiNjlmMjZlY2U4MjM0NmYwL3RhYmxlcmFuZ2U6OTk0OWIzOWY4YzViNGNlMWI2OWYyNmVjZTgyMzQ2ZjBfNS0zLTEtMS0xNDc0NQ_a118c8c0-2335-4b2f-8581-0740018239ca"
      unitRef="usd">283554000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RleHRyZWdpb246ZDM5NjNlMWUzY2VjNDY3YTkxMDVhYzBmYmE2YjMxNjlfMTQyMw_26365223-133a-4d30-a094-7c9c8925848f">The following table summarizes, by major security type, our cash equivalents and available-for-sale marketable securities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Government Agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id6170a569b9745a5ac1f31b8c185a532_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMy0xLTEtMS0xNDc0NQ_dc2519e7-1888-4fdd-b51f-02d19df7c407"
      unitRef="usd">25648000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i89d1dfe44e99408ea6d011b126cf6fef_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMy0zLTEtMS0xNDc0NQ_c4773ff5-a8d2-4fef-be98-df604f6f984b"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3b74220aedf04b8caee6df508ef0f7ce_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMy01LTEtMS0xNDc0NQ_36da52fe-8045-4cfa-8779-cdc52950fd6b"
      unitRef="usd">25648000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3e82dd52a30f41459848f3a6b6b17f8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMy03LTEtMS0xNDc0NQ_3abb2cac-0564-4156-b9a9-bdeb85888d9a"
      unitRef="usd">24016000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i42e57e64fbf34e6da8033002ed837bad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMy05LTEtMS0xNDc0NQ_ac88d188-4e50-4344-87a0-a62a28cd2418"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if5fd90709dc74fd5a0cc52f2f2b7c1c0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMy0xMS0xLTEtMTQ3NDU_e98a1850-1b52-4061-a764-f20218846f76"
      unitRef="usd">24016000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i30534ad685e4405c91d0e95f607be899_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNi0xLTEtMS0xNDc0NQ_3769a814-a265-45c2-a532-e051b4967b6e"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i96de234042a644fbab1614f7b8d810b0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNi0zLTEtMS0xNDc0NQ_8d969ae4-2232-4c3f-9839-b2400845a7b0"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i86bdaabffa344b98af6e3b49d1f8e9dd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNi01LTEtMS0xNDc0NQ_d538e48c-7ee5-4e39-a369-e332fe5a7750"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0ec4099481c540d7af1b813bfb7d9ceb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNi03LTEtMS0xNDc0NQ_ef25fae3-42e3-4929-acc6-fe866398439b"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6c547910054f4a26851d64a99c8cf16c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNi05LTEtMS0xNDc0NQ_3c98aeac-1c64-49ac-8e12-4a5a199967ac"
      unitRef="usd">4999000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9732f080c4174fc4b7b9ebf4ed2bb7c1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNi0xMS0xLTEtMTQ3NDU_d8b76acd-d6e7-4033-a0de-bb835b128f89"
      unitRef="usd">4999000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4ecc7e181acf44b4a83f0b3df2cdf533_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNy0xLTEtMS0xNDc0NQ_3505ee9d-8768-407f-be84-7657f41b7cd3"
      unitRef="usd">25648000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6ebb15d5ad9e487694cef2cce04f74cc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNy0zLTEtMS0xNDc0NQ_34af03c0-c21d-42f5-9855-7b793dd39f30"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNy01LTEtMS0xNDc0NQ_724b0340-9adb-434b-ac39-4486b18aeb91"
      unitRef="usd">25648000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib30cfbc3f8684fdaa1394520152b8204_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNy03LTEtMS0xNDc0NQ_d29992bb-90a7-4017-85bd-98ea5d14bd6b"
      unitRef="usd">24016000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i32c0dcc014f347b3b166110a2b441716_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNy05LTEtMS0xNDc0NQ_77242606-2064-4882-828e-c9de3f4c6a80"
      unitRef="usd">4999000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfNy0xMS0xLTEtMTQ3NDU_1bf163f1-c45e-47c4-81e4-3d33d7dff24f"
      unitRef="usd">29015000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8c8984afd47b4dd1b6aa58ef930f6c50_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTAtMS0xLTEtMTQ3NDU_55b02467-d18c-4ac7-a4c5-02c80f230a72"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i60a9b4ad23f4455bbd5483f1f3ba42b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTAtMy0xLTEtMTQ3NDU_23ce1d9d-91c0-49ff-9f58-da12385641b7"
      unitRef="usd">239412000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia868940f58cc42b5b13f0fc8b51e01da_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTAtNS0xLTEtMTQ3NDU_cd038f41-897b-4c8b-9b85-d7d0a1bda802"
      unitRef="usd">239412000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i47888dd151434e169157684d400b27a8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTAtNy0xLTEtMTQ3NDU_431c08fe-40c3-4087-8ff1-75e07a7f89e0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i315772c54c624f278fe0ed2cba140fa2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTAtOS0xLTEtMTQ3NDU_2a5e1097-0f7c-48c5-b510-2cf900784933"
      unitRef="usd">147388000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i37fa66f18165423bb7d922609186b948_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTAtMTEtMS0xLTE0NzQ1_f60217fa-a402-4f8a-a1ff-e772e5376f55"
      unitRef="usd">147388000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ideda6fd6619d423cacd820c6cb596396_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTEtMS0xLTEtMTQ3NDU_186276ca-286c-4d82-886a-a6f4ab0da21c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibd8cecb43fce44fabe382da208c94b9a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTEtMy0xLTEtMTQ3NDU_a04403b6-e119-40c9-b664-6a45037f8af6"
      unitRef="usd">10142000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9ad029fd87124e22a93cabf53bf1d8ad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTEtNS0xLTEtMTQ3NDU_f14bf57a-9294-4fdc-9bc2-0a8da315fbf5"
      unitRef="usd">10142000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2424305fc33c47e180bdcca355f56217_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTEtNy0xLTEtMTQ3NDU_bbd9c6bf-4cb5-4788-a690-c2ac78ba1c15"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0249ef610edf412a8b7c3986cb8f4198_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTEtOS0xLTEtMTQ3NDU_5aac36e7-519e-4a3b-ad22-a9c7f3248302"
      unitRef="usd">23571000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icc5bcd3985e645c3a401476d670729d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTEtMTEtMS0xLTE0NzQ1_3e9cdcc5-dddc-4f96-823b-1e97763ba955"
      unitRef="usd">23571000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iec4ba4b40d1a4678a41ebfca352cd0cb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTItMS0xLTEtMTQ3NDU_104097ab-f9f3-46bb-974a-88b85f13354e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i197f8be1dab94341ab3cb7bec4da51ee_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTItMy0xLTEtMTQ3NDU_32ed6ac4-1561-421a-8bab-235f39165cb3"
      unitRef="usd">35737000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iec9f78113384472a9c1cd4490522fa4f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTItNS0xLTEtMTQ3NDU_0dc59f06-2fd4-4bca-bd68-8c19e7436d0e"
      unitRef="usd">35737000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9459160646db459cbb327815f2c0dfad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTItNy0xLTEtMTQ3NDU_fb7f5f65-7db6-44dc-be5c-ce9412bdf69f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2b05eb2946574576b40669621fb77cff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTItOS0xLTEtMTQ3NDU_ba8a86b4-7ed2-4f13-a1da-97ebf6f15042"
      unitRef="usd">81486000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic46f09a640544a46acc118a2e3a87c79_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTItMTEtMS0xLTE0NzQ1_2696bc37-ab44-4f31-aef4-53dfc984f90e"
      unitRef="usd">81486000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia3044630795146b99483f1baf0d571ee_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTMtMS0xLTEtMTQ3NDU_bbf84daa-eafb-4991-8673-e10694278edf"
      unitRef="usd">40693000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4a5070fbecb84ab58845fe8229eb4e37_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTMtMy0xLTEtMTQ3NDU_89330a51-1dd4-41b3-a4e6-ec4b028c3f3b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2cbe2ea503f244c28efc38eaf91c8231_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTMtNS0xLTEtMTQ3NDU_0c34846f-24a5-4bc3-b58f-f2bb9aaa87e0"
      unitRef="usd">40693000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i49e62a87a0124d07b9b303e1965c458e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTMtNy0xLTEtMTQ3NDU_f0b7f20a-9982-4799-83a7-288bc93377f9"
      unitRef="usd">31109000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i817a4309217c44a8b8dc4c083d2b3c28_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTMtOS0xLTEtMTQ3NDU_b4bd1871-88f2-42b7-85f3-2c9a9b7b7c11"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1e4e6113e81b488f98011e1738519d49_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTMtMTEtMS0xLTE0NzQ1_799c9c35-2c88-4576-9bcd-8cbcfdf08fc1"
      unitRef="usd">31109000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4ecc7e181acf44b4a83f0b3df2cdf533_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTQtMS0xLTEtMTQ3NDU_20dcd1f4-adf9-41ac-8170-e2c21389ffdf"
      unitRef="usd">40693000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6ebb15d5ad9e487694cef2cce04f74cc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTQtMy0xLTEtMTQ3NDU_ef2c8c71-275f-4d75-bfef-275bc21af92f"
      unitRef="usd">285291000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTQtNS0xLTEtMTQ3NDU_f7845371-ce2d-4fe5-a475-d1fc434b3e98"
      unitRef="usd">325984000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib30cfbc3f8684fdaa1394520152b8204_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTQtNy0xLTEtMTQ3NDU_d7527320-432b-48fa-bd0b-ba7a7e75ec26"
      unitRef="usd">31109000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i32c0dcc014f347b3b166110a2b441716_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTQtOS0xLTEtMTQ3NDU_971b0aa8-b360-4565-b399-0ac97e90941a"
      unitRef="usd">252445000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTQtMTEtMS0xLTE0NzQ1_0b4d6d52-860e-444a-adfe-7ea7a86d11e1"
      unitRef="usd">283554000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4ecc7e181acf44b4a83f0b3df2cdf533_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTYtMS0xLTEtMTQ3NDU_c743320d-f487-4ac9-b276-2b4a16fc54af"
      unitRef="usd">66341000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6ebb15d5ad9e487694cef2cce04f74cc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTYtMy0xLTEtMTQ3NDU_3e3202d0-06de-43a5-806f-eccefef1596b"
      unitRef="usd">285291000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTYtNS0xLTEtMTQ3NDU_ca4da5ec-e0f2-403c-bf4c-99b10d4d58e6"
      unitRef="usd">351632000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib30cfbc3f8684fdaa1394520152b8204_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTYtNy0xLTEtMTQ3NDU_e6002d41-0cf5-4bdd-b08b-498db13caab0"
      unitRef="usd">55125000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i32c0dcc014f347b3b166110a2b441716_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTYtOS0xLTEtMTQ3NDU_58e890a4-0cf6-4ec9-b6f1-a3f414cab97c"
      unitRef="usd">257444000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV80OS9mcmFnOmQzOTYzZTFlM2NlYzQ2N2E5MTA1YWMwZmJhNmIzMTY5L3RhYmxlOmM4ZjU2ZTg5MmVlMzQxNzJiZGM0NDEzODkwNDQ1ZjQwL3RhYmxlcmFuZ2U6YzhmNTZlODkyZWUzNDE3MmJkYzQ0MTM4OTA0NDVmNDBfMTYtMTEtMS0xLTE0NzQ1_045f61bf-e56d-45c7-9842-b71a3b3aea80"
      unitRef="usd">312569000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:OtherAssetsDisclosureTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RleHRyZWdpb246ODM0MmUwZGExMDcxNGI0Nzg5ZTVjNmU0YjI0NjU2ZGJfMTIw_9a3bce96-1b77-4ed4-8398-fadb6ae82da4">Prepaid Expenses and Other Assets&lt;div style="margin-bottom:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid software licenses and maintenance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign R&amp;amp;D credit refund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest receivable &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Zentera receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaid expenses and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaid expenses and other assets, current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherAssetsDisclosureTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RleHRyZWdpb246ODM0MmUwZGExMDcxNGI0Nzg5ZTVjNmU0YjI0NjU2ZGJfMTIx_1b0e41af-b2ba-423e-b1d5-cea6bbeebb26">&lt;div style="margin-bottom:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid software licenses and maintenance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign R&amp;amp;D credit refund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest receivable &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Zentera receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaid expenses and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaid expenses and other assets, current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:PrepaidInsurance
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfMi0xLTEtMS0xNDc0NQ_f3ca2ba8-e540-43e0-aae9-0ea5d8567255"
      unitRef="usd">1661000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfMi0zLTEtMS0xNDc0NQ_3ba0a707-2c7d-4dbc-a86c-8c8249d1d356"
      unitRef="usd">1021000</us-gaap:PrepaidInsurance>
    <zntl:PrepaidSoftwareLicenseAndMaintenance
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfMy0xLTEtMS0xNDc0NQ_f9d8b5b7-c6af-4df3-a42f-0ab56d70cb28"
      unitRef="usd">207000</zntl:PrepaidSoftwareLicenseAndMaintenance>
    <zntl:PrepaidSoftwareLicenseAndMaintenance
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfMy0zLTEtMS0xNDc0NQ_76f9de9b-b0f5-4c56-815e-7e77a9e8977e"
      unitRef="usd">563000</zntl:PrepaidSoftwareLicenseAndMaintenance>
    <zntl:ForeignResearchAndDevelopmentCreditRefund
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNC0xLTEtMS0xNDc0NQ_8d1118cd-020d-4210-b773-3e63c3c0e288"
      unitRef="usd">1345000</zntl:ForeignResearchAndDevelopmentCreditRefund>
    <zntl:ForeignResearchAndDevelopmentCreditRefund
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNC0zLTEtMS0xNDc0NQ_fcfda1cd-3d2c-4019-aff5-94ff9517388b"
      unitRef="usd">692000</zntl:ForeignResearchAndDevelopmentCreditRefund>
    <zntl:PrepaidResearchAndDevelopmentCosts
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNS0xLTEtMS0xNDc0NQ_d4e49012-aa4a-4f86-a352-f567329bf8fd"
      unitRef="usd">9136000</zntl:PrepaidResearchAndDevelopmentCosts>
    <zntl:PrepaidResearchAndDevelopmentCosts
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNS0zLTEtMS0xNDc0NQ_d36a4f07-5926-4532-9837-a2123b1cf883"
      unitRef="usd">5963000</zntl:PrepaidResearchAndDevelopmentCosts>
    <us-gaap:InterestReceivable
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNi0xLTEtMS0xNDc0NQ_f57a6140-e7b6-4d94-a7be-45de0a563fad"
      unitRef="usd">288000</us-gaap:InterestReceivable>
    <us-gaap:InterestReceivable
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNi0zLTEtMS0xNDc0NQ_b6b73c66-65a0-4c00-bcca-9d4945d27fd9"
      unitRef="usd">478000</us-gaap:InterestReceivable>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNy0xLTEtMS0yMTAwMA_4ca8f4bb-30bf-481a-9f1e-2fccf7b3df1a"
      unitRef="usd">2940000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNy0zLTEtMS0yMTAwMA_15c77ede-28b4-4f27-8872-54cc98cd6b3f"
      unitRef="usd">0</us-gaap:DueFromRelatedPartiesCurrent>
    <zntl:OtherPrepaidExpense
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNy0xLTEtMS0xNDc0NQ_798d550f-b102-4be7-b848-77371ea40f1d"
      unitRef="usd">888000</zntl:OtherPrepaidExpense>
    <zntl:OtherPrepaidExpense
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfNy0zLTEtMS0xNDc0NQ_016103c8-300a-4219-86a5-d6eeb2a6207d"
      unitRef="usd">441000</zntl:OtherPrepaidExpense>
    <us-gaap:PrepaidExpenseAndOtherAssets
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfOC0xLTEtMS0xNDc0NQ_0defc1d0-5579-4cba-a780-8a0b48089731"
      unitRef="usd">16465000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfOC0zLTEtMS0xNDc0NQ_6f723c38-9aa0-4ff3-831a-725120f1b3b0"
      unitRef="usd">9158000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfOS0xLTEtMS0xNDc0NQ_e1a161d6-69a9-4201-b17b-33d023be9e83"
      unitRef="usd">6042000</us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfOS0zLTEtMS0xNDc0NQ_bbc2c6ae-f7c0-4f5a-ad2a-20ff99151f59"
      unitRef="usd">2976000</us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfMTAtMS0xLTEtMTQ3NDU_a063e037-5f20-4e9a-80f0-05d32f7ad925"
      unitRef="usd">10423000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81Mi9mcmFnOjgzNDJlMGRhMTA3MTRiNDc4OWU1YzZlNGIyNDY1NmRiL3RhYmxlOjA4MWNjYTQxZjZiNDQ4OGRiMzVjODY1MDhiMzE1ZmUxL3RhYmxlcmFuZ2U6MDgxY2NhNDFmNmI0NDg4ZGIzNWM4NjUwOGIzMTVmZTFfMTAtMy0xLTEtMTQ3NDU_af8697a8-4ab3-4858-8ed2-768139ac28c4"
      unitRef="usd">6182000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RleHRyZWdpb246MDVkZGM4NmE0YWM1NGNmNmE2MTljNzVlZmQxM2U0YjlfMzc4_e15c6856-b84e-4ed5-87da-cd5be0adcb53">Property and Equipment, net&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and Office Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lab Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold Improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in Progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense for the three months ended September&#160;30, 2021 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was approximately $137 thousand and $51 thousand, respectively. Depreciation and amortization expense for the nine months ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2021&lt;/span&gt; and 2020 was approximately $335 thousand and $127 thousand, respectively.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RleHRyZWdpb246MDVkZGM4NmE0YWM1NGNmNmE2MTljNzVlZmQxM2U0YjlfMzc3_159ec5fb-0c15-456f-8872-c0ab7d5addf1">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and Office Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lab Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold Improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in Progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="icc264132dfe94434b23a32e250ea3637_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfMi0xLTEtMS0xNDc0NQ_4f813354-d1d1-4e3e-9ff9-70ec6ad11f5b"
      unitRef="usd">563000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i61d571892c00485fac3e8c5f93914a1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfMi0zLTEtMS0xNDc0NQ_4e954d96-e854-4b99-88be-89250ac979e5"
      unitRef="usd">529000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i69b3c5acd4d04eb0ad0b6255c633e023_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfMy0xLTEtMS0xNDc0NQ_94eca40c-2485-435b-9a2d-52d20eb1dc8a"
      unitRef="usd">1883000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0cdc5a844c7741f88f2ffc72efd90024_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfMy0zLTEtMS0xNDc0NQ_53cf435a-93b5-4319-99e3-4d7fd124fdb5"
      unitRef="usd">424000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic372449226be422d8b31116aa2375ce9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNC0xLTEtMS0xNDc0NQ_c28a1866-2989-4f80-beb3-b7cf0df8174d"
      unitRef="usd">49000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i47a6b58f9a6844d89050368b6375eeb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNC0zLTEtMS0xNDc0NQ_53398081-1f6f-44c7-9258-6dfb973bb0bb"
      unitRef="usd">49000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic01a05364dea4804a256c0dc000120f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNS0xLTEtMS0xNDc0NQ_794a9a6b-e781-4bbb-86b6-a9063b5d9332"
      unitRef="usd">2787000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i90612704ec3a46e591ec1d86c1621300_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNS0zLTEtMS0xNDc0NQ_dc7be4df-0812-4aa1-b2d0-8e4c051c3364"
      unitRef="usd">347000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNi0xLTEtMS0xNDc0NQ_627d1621-bfb2-4819-81c5-f16a3239d076"
      unitRef="usd">5282000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNi0zLTEtMS0xNDc0NQ_22922beb-dbed-436a-a2fe-2ed3472bb781"
      unitRef="usd">1349000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNy0xLTEtMS0xNDc0NQ_158fff6a-341f-480b-a97a-f5d40f3cd401"
      unitRef="usd">584000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfNy0zLTEtMS0xNDc0NQ_d8600281-fea0-47d6-b7dd-8d4ea8ef42de"
      unitRef="usd">250000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfOC0xLTEtMS0xNDc0NQ_08fe767f-cbf8-41aa-a85f-67ac8f8ba0cc"
      unitRef="usd">4698000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RhYmxlOjkxNTVmOTVkOWVkMTRjZDFiNzM4M2JiZjQxZTljNjIyL3RhYmxlcmFuZ2U6OTE1NWY5NWQ5ZWQxNGNkMWI3MzgzYmJmNDFlOWM2MjJfOC0zLTEtMS0xNDc0NQ_ecb09e33-efdb-48b1-bc5b-139bb5d73f60"
      unitRef="usd">1099000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RleHRyZWdpb246MDVkZGM4NmE0YWM1NGNmNmE2MTljNzVlZmQxM2U0YjlfMjAy_c9e2f84d-f765-410f-aac1-87fc96001780"
      unitRef="usd">137000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RleHRyZWdpb246MDVkZGM4NmE0YWM1NGNmNmE2MTljNzVlZmQxM2U0YjlfMjE4_5fa6b046-609d-4d72-b253-7b3b04e13e83"
      unitRef="usd">51000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RleHRyZWdpb246MDVkZGM4NmE0YWM1NGNmNmE2MTljNzVlZmQxM2U0YjlfMzM1_a25188f5-ee95-4d9b-a7a6-1c440c8741fa"
      unitRef="usd">335000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81NS9mcmFnOjA1ZGRjODZhNGFjNTRjZjZhNjE5Yzc1ZWZkMTNlNGI5L3RleHRyZWdpb246MDVkZGM4NmE0YWM1NGNmNmE2MTljNzVlZmQxM2U0YjlfMzUx_10f4a9e1-3ca8-4519-9270-c7e9af415a71"
      unitRef="usd">127000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RleHRyZWdpb246ZmEzOGQ4NjY1M2U3NDM3MGFmODEwYmQ1ZTZhOTQ3NmVfODQ_05ea0fd9-837a-4227-aa6a-2d8b14a07d50">Accrued Expenses&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued employee expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RleHRyZWdpb246ZmEzOGQ4NjY1M2U3NDM3MGFmODEwYmQ1ZTZhOTQ3NmVfODM_1ec9a76a-495f-4ccc-9448-6a3a310bb647">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued employee expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <zntl:AccruedResearchAndDevelopmentCostsCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfMi0xLTEtMS0xNDc0NQ_4c7b8b2b-1454-4f02-9da8-d2f3d135e014"
      unitRef="usd">19589000</zntl:AccruedResearchAndDevelopmentCostsCurrent>
    <zntl:AccruedResearchAndDevelopmentCostsCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfMi0zLTEtMS0xNDc0NQ_69fa943c-0c0d-417f-b5d6-17c6edf6bf16"
      unitRef="usd">11947000</zntl:AccruedResearchAndDevelopmentCostsCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfMy0xLTEtMS0xNDc0NQ_c4a9e554-df65-4cd8-a1e9-c5e3efe8f9f4"
      unitRef="usd">7883000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfMy0zLTEtMS0xNDc0NQ_61fa9647-a597-466b-9200-10dafb441f5e"
      unitRef="usd">5649000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <zntl:AccruedGeneralAndAdministrativeCostsCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfNS0xLTEtMS0xNDc0NQ_56edc88f-528b-4396-822c-b4332de0c890"
      unitRef="usd">2268000</zntl:AccruedGeneralAndAdministrativeCostsCurrent>
    <zntl:AccruedGeneralAndAdministrativeCostsCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfNS0zLTEtMS0xNDc0NQ_32d276dd-f288-4f1e-a028-ead73ab37da7"
      unitRef="usd">996000</zntl:AccruedGeneralAndAdministrativeCostsCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfNi0xLTEtMS0xNDc0NQ_d66538e4-8c8a-47e5-93d5-1a5acbcfa9aa"
      unitRef="usd">862000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfNi0zLTEtMS0xNDc0NQ_6eafad93-5691-4109-9967-6e68f3233476"
      unitRef="usd">902000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfNy0xLTEtMS0xNDc0NQ_f968cdd6-dbc4-43ef-bbee-118c46bc40ed"
      unitRef="usd">767000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfNy0zLTEtMS0xNDc0NQ_cd76a2bc-84f2-4559-a7dc-1d0f2a16a9a2"
      unitRef="usd">410000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfOC0xLTEtMS0xNDc0NQ_bd3b7cb2-f67c-4317-b7bb-471bbd8e92d2"
      unitRef="usd">0</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfOC0zLTEtMS0xNDc0NQ_54ca7b9f-0622-4ddd-9149-64b633c31001"
      unitRef="usd">36000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfOS0xLTEtMS0xNDc0NQ_040beff2-cb92-41e7-9551-ea1a3e8e90e3"
      unitRef="usd">31369000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV81OC9mcmFnOmZhMzhkODY2NTNlNzQzNzBhZjgxMGJkNWU2YTk0NzZlL3RhYmxlOjVkNWMwZmNhYTg5YjRmNDA4MDE5MjczNjU2N2U4ODQwL3RhYmxlcmFuZ2U6NWQ1YzBmY2FhODliNGY0MDgwMTkyNzM2NTY3ZTg4NDBfOS0zLTEtMS0xNDc0NQ_bb746de2-61cb-4a30-a8c6-0b04ad8b8a41"
      unitRef="usd">19940000</us-gaap:AccruedLiabilitiesCurrent>
    <zntl:TemporaryEquityTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfODY0Mg_bbd3a882-289d-4dac-bdeb-989d3a441df7">Convertible Preferred Units&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Series A Convertible Preferred Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2015, Zeno Pharmaceuticals, Inc. entered into a Series A Preferred Stock Purchase Agreement (the &#x201c;Series A Preferred Agreement&#x201d;). Under the terms of the Series A Preferred Agreement, Zeno Pharmaceuticals, Inc. issued 1,293,104 shares of Series A convertible preferred stock at $11.60 per share for gross proceeds of $15.0&#160;million. The net proceeds of this financing were $14.9&#160;million after issuance costs of $0.1&#160;million. In February and March 2016, Zeno Pharmaceuticals, Inc. issued an aggregate of 286,205 additional shares of Series A convertible preferred stock at $11.60 per share for additional gross proceeds of $3.3&#160;million. The issuance costs of this additional financing were approximately thirty-nine thousand dollars. All Series A convertible preferred stock issued and outstanding by Zeno Pharmaceuticals, Inc. was converted into Series A convertible preferred units of Zentalis Pharmaceuticals, LLC in conjunction with the corporate restructuring and merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Series B Convertible Preferred Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, Zentalis Pharmaceuticals, LLC entered into a Series B Preferred Unit Purchase Agreement (the &#x201c;Series B Preferred Agreement&#x201d;). Under the terms of the Series B Preferred Agreement, Zentalis Pharmaceuticals, LLC issued 2,735,320 Series B preferred units at $12.43 per unit for gross proceeds of $34.0&#160;million. The net proceeds of this financing were $32.1&#160;million after issuance costs of $1.9&#160;million. In January and August 2018, Zentalis Pharmaceuticals, LLC issued an aggregate of 788,419 additional shares of Series B preferred units at $12.43 per unit for additional gross proceeds of $9.8&#160;million. The net proceeds of this additional financing were $9.5&#160;million after issuance costs of $0.3&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Series C Convertible Preferred Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2019, Zentalis Pharmaceuticals, LLC entered into a Series C Preferred Unit Purchase Agreement (the &#x201c;Series C Preferred Agreement&#x201d;). Under the terms of the Series C Preferred Agreement, Zentalis Pharmaceuticals, LLC issued 4,847,106 units of Series C convertible preferred units at $17.50 per unit for gross proceeds of $84.8&#160;million. The net proceeds of this financing were $81.9&#160;million after issuance costs of $2.9&#160;million. In February 2020, Zentalis Pharmaceuticals, LLC issued 867,194 additional units of Series C preferred units under the Series C Preferred Agreement. The units were issued for $17.50 per unit for gross proceeds of $15.2&#160;million. The net proceeds of this financing were $14.2&#160;million after issuance costs of $1.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no authorized, issued, or outstanding shares of convertible preferred units at September&#160;30, 2021 and December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During 2020, we reclassified the convertible preferred units from members&#x2019; equity to temporary equity because, in conjunction with the Series C convertible preferred units issuance, all units were now deemed to contain contingent liquidation features that are not solely within our control. During the year ended December&#160;31, 2020, we did not adjust the carrying values of the convertible preferred units to the deemed redemption values of such units since a liquidation event was not probable. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividends are payable if and when declared by the Board of Directors. No dividends have been declared through September&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Conversion&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each Series A preferred unit, Series B preferred unit and Series C preferred unit was convertible at the option of the holder thereof, at any time after the issuance of such unit, into Class&#160;A common units at a conversion price equal to the original purchase price (subject to anti-dilution adjustments, discussed below) which was $11.60, $12.43 and $17.50 per unit, respectively. The convertible preferred units automatically converted at the then applicable conversion rate upon the closing of a firm commitment underwritten public offering of shares of a successor corporations&#x2019; common stock, at a public offering price per share of equal to or greater than the Series C original purchase price (as adjusted for any stock splits, stock dividends, combinations or other similar recapitalization) resulting in aggregate gross cash proceeds of at least $75.0&#160;million (a &#x201c;Qualified IPO&#x201d;). Additionally, the convertible preferred unit would have automatically converted into common stock, at the then applicable conversion rate, upon written consent of a majority of the then outstanding Series A, Series B and Series C convertible preferred units (voting as a separate class on an as converted to Common Unit basis). In conjunction with our IPO on April 2, 2020, which constituted a Qualified IPO, all convertible preferred units were converted to common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Anti-dilution protection&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The holders of the convertible preferred units had proportional anti-dilution protection for unit splits, unit dividends and similar recapitalizations. Subject to certain exclusions, anti-dilution price protection for additional sales of securities by us for consideration per unit less than the applicable conversion price per unit of any series of convertible preferred stock, was on a broad-based weighted average basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Protective rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The holders of the convertible preferred units had certain protective rights, including, without limitation, regarding the authorization, alteration, redemption, or sale of Class&#160;B common units; commencement of a liquidation or deemed liquidation event; entrance into a joint venture or partnership; any incurrence of indebtedness; certain transactions that exceed a certain dollar threshold; changes to our governing documents; or the declaration of any dividends. Such actions were required to be approved by a majority of the then outstanding Series A, Series B and Series C convertible preferred unit holders (voting as a single class and on an&#160;as-converted&#160;basis), as specified in the amended and restated LLC agreement. An increase or decrease in the authorized number of Directors constituting the Board or the creation of a membership interest or equity security senior to or pari passu with Series C convertible preferred units was required to be approved by a majority of the then outstanding Series C convertible preferred Units (voting as a separate class on an as converted basis).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series A, Series B and Series C convertible preferred units were not redeemable except in the event of certain effected deemed liquidation events. As of immediately prior to our IPO on April 2, 2020, we had classified convertible preferred units as temporary equity in accordance with authoritative guidance for the classification and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;measurement of potentially redeemable securities whose redemption is based upon certain change in control events outside of our control, including liquidation, sale or transfer of control of the Company. We did not adjust the carrying value of the convertible preferred units to the deemed redemption values of such units since a liquidation event was not probable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidation preference&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event of the dissolution, liquidation, merger or winding up of the Company, the holders of Series C convertible preferred units were entitled to receive, on a pro rata basis in respect of each such Series C convertible preferred unit, a preference amount of $17.50 per Series C convertible unit (as adjusted for any unit splits, dividends, combinations, recapitalizations or the like).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the payment of the Series C convertible preferred unit preferences, Series A and Series B convertible preferred units were entitled to receive, on a pro rata basis in respect of each convertible preferred unit in proportion to the relative preference amount of each preferred unit, a preference amount of $11.60 and $12.43 per unit of Series A and Series B convertible preferred units (as adjusted for any units splits, dividend, combinations, recapitalizations of the like), respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the payment of the Series C, Series A and Series B convertible preferred unit preferences, Series A, Series B and Series C convertible preferred units are entitled to receive, on an as converted to common unit pro rata basis, an amount equal to distributions made to Class&#160;A common units prior to all unit classes sharing in distributions on a pro rata basis. Thereafter, Series A, Series B and Series C convertible preferred units and Series A and Series B common units were entitled to receive the remaining assets of the Company available for distribution to its unit holders pro rata based on the number of common units held by each holder, treating for these purposes as if all units had been converted to common.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Voting Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The holders of all units other than Class&#160;B common units that were unvested were to vote together as a single class. Each holder of Series A, Series B and Series C convertible preferred units were entitled to the number of votes calculated on an as converted to Class&#160;A common unit basis.&lt;/span&gt;&lt;/div&gt;</zntl:TemporaryEquityTextBlock>
    <zntl:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i9d749128b5cc4c058432e3008374c9f5_D20150901-20150930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzAz_796cad98-1fb2-4e76-be7c-8865bd80dfe5"
      unitRef="shares">1293104</zntl:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i791e20e9521c44e28152d01ddac1222b_I20150930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzU2_c99b6f4f-37cd-44a4-8338-82446b031144"
      unitRef="usdPerShare">11.60</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross
      contextRef="i9d749128b5cc4c058432e3008374c9f5_D20150901-20150930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzkx_1a494363-cd5e-4086-b7d8-82490757bbbc"
      unitRef="usd">15000000</zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="i9d749128b5cc4c058432e3008374c9f5_D20150901-20150930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNDM1_729e8fab-4d31-48da-aee3-4580c2e99ddf"
      unitRef="usd">14900000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i9d749128b5cc4c058432e3008374c9f5_D20150901-20150930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNDYy_a055d5c5-b1d4-46ff-8416-9e11c5b4e083"
      unitRef="usd">100000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="ibf2c9428be0742a0a000254f1421fc0d_I20160331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNTQ0_37ed9c05-3836-4be4-8949-ca222f0512c7"
      unitRef="shares">286205</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="ibf2c9428be0742a0a000254f1421fc0d_I20160331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNjA4_dd8dab72-d98d-40b1-a034-dc699f564e56"
      unitRef="usdPerShare">11.60</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross
      contextRef="i8997c29134c6485eb8e9deb026d07200_D20160201-20160331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNjU0_80898d42-70d4-4771-a68e-57f7a336a600"
      unitRef="usd">3300000</zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i8997c29134c6485eb8e9deb026d07200_D20160201-20160331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNzI1_29782a25-49f0-42ac-8bda-468122f99a01"
      unitRef="usd">39000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i2dac0c6c83624d678d99d838917cfa5e_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTI1MQ_8af4d82a-b5d5-43da-a6f1-e7ea1a43ffc8"
      unitRef="shares">2735320</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i2dac0c6c83624d678d99d838917cfa5e_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTI4Mg_1e417521-722d-4b9a-a2cc-cf0adda7aac8"
      unitRef="usdPerShare">12.43</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross
      contextRef="i7e885190922f4e1d806613f4bfce9ffe_D20171201-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTMxNg_f52862be-9e42-489a-9f8f-26632cf6f4b4"
      unitRef="usd">34000000</zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="i7e885190922f4e1d806613f4bfce9ffe_D20171201-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTM2MA_0d57660f-2059-4162-8489-1d852a5819e8"
      unitRef="usd">32100000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i7e885190922f4e1d806613f4bfce9ffe_D20171201-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTM4Nw_bb1ae05d-d142-45d1-9210-be14e8c8a757"
      unitRef="usd">1900000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i15fe047b039c40dfa459cd498a30878a_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTQ3Mg_b2ee0ec0-ee60-4583-9bfc-e64631ba9910"
      unitRef="shares">788419</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i15fe047b039c40dfa459cd498a30878a_I20180831"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTUyNA_d3d28b19-76f1-416b-a22e-5f287ba7d433"
      unitRef="usdPerShare">12.43</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross
      contextRef="i561f11c86d154f968f0d7b64cfa9bb70_D20180101-20180831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTU2OQ_06c5fca6-a70c-4c41-820d-f4b1a28d885d"
      unitRef="usd">9800000</zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="i561f11c86d154f968f0d7b64cfa9bb70_D20180101-20180831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTYyNA_be7b1ad7-cbb2-4b02-8070-dfcb7bcbf920"
      unitRef="usd">9500000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i561f11c86d154f968f0d7b64cfa9bb70_D20180101-20180831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTY1MQ_8f710d6e-0c39-4dd4-a9dc-2606e32d0e23"
      unitRef="usd">300000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="if4f7f71c7cf34041890690bb8f1b4f55_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTkyNw_80cd71e0-d211-4df6-ab89-caf7ac138bc2"
      unitRef="shares">4847106</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="if4f7f71c7cf34041890690bb8f1b4f55_I20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMTk3OQ_10ea0814-31b6-4be1-847f-73a9519a86a4"
      unitRef="usdPerShare">17.50</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross
      contextRef="i6cfdd80dc235471f94d955162c41ea8d_D20190901-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjAxMw_e0f05e32-33d1-4d67-95f2-7999dc1e2d9e"
      unitRef="usd">84800000</zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="i6cfdd80dc235471f94d955162c41ea8d_D20190901-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjA1Nw_a9166c6a-93fa-45ae-ba23-df03ada92716"
      unitRef="usd">81900000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i6cfdd80dc235471f94d955162c41ea8d_D20190901-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjA4NA_987f2558-06ce-4216-8787-5bab5b159f06"
      unitRef="usd">2900000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i4ae8f32d20e94dec87f494ef073bbaa1_I20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjE0Mw_aba7286f-11be-4c5a-8cc4-3617e16279d6"
      unitRef="shares">867194</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i4ae8f32d20e94dec87f494ef073bbaa1_I20200229"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjI1Nw_2b2a8368-e933-44db-a0de-d431b0c545df"
      unitRef="usdPerShare">17.50</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross
      contextRef="id660983397b24d43bf35134f4a0c0395_D20200201-20200229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjI5MQ_d709fd5e-7ee3-40d9-bba9-41282195f511"
      unitRef="usd">15200000</zntl:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="id660983397b24d43bf35134f4a0c0395_D20200201-20200229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjMzNQ_80a76af2-722a-45c9-ad9f-8d1edefe0a16"
      unitRef="usd">14200000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="id660983397b24d43bf35134f4a0c0395_D20200201-20200229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjM2Mg_a85b67af-b62d-4f5d-8ac9-b84b8f91abc9"
      unitRef="usd">1000000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjM3Nw_004fe5b8-c7a3-4029-8398-e350aa40ec9d"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjM3Nw_1a75bbef-2b0e-4460-83d9-0122bd2e5e4a"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjM3Nw_3ad8ba79-1540-43f3-a7ab-edea776e6780"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjM3Nw_761c4482-c287-4dac-9c25-a5a8cfc82f8d"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i973d4c68e1534b9e9776407fb3ef6a1d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjM3Nw_7bc02c0e-fd4c-4954-9656-5f77ba6ef8d9"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMjM3Nw_d131cb4d-ba95-4eaa-82b1-918b6a24ca79"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <zntl:ConvertiblePreferredStockDividendsPerShareDeclared
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzAyNw_0e33e916-f247-4312-a17b-2aed123afbc5"
      unitRef="usdPerShare">0</zntl:ConvertiblePreferredStockDividendsPerShareDeclared>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="ic748b33ae7394b2b9c1ebfeb481ad01c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzQxNA_5e27dd4e-dbcc-4021-8c3d-e17a5d2dfe5a"
      unitRef="usdPerShare">11.60</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="i662b4e7ea6f842119f8206ee5b4516c7_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzQxOA_3f5a7eec-9e2a-481d-992a-72e28bed910b"
      unitRef="usdPerShare">12.43</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="i6bad6ea4eda8467f8d5d6a4850fc03d0_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzQyNQ_1acea364-3dc0-4769-a25b-3498d8c01a8b"
      unitRef="usdPerShare">17.50</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <zntl:TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfMzkyNA_bd1d2366-56d1-4336-b3f7-df267af29149"
      unitRef="usd">75000000</zntl:TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="i6bad6ea4eda8467f8d5d6a4850fc03d0_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNjk4OA_26b95b96-2a70-49f4-a993-6108aadaf7ad"
      unitRef="usdPerShare">17.50</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="ic748b33ae7394b2b9c1ebfeb481ad01c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNzQzMQ_5e69eeba-0e6d-40a5-9f29-ec9d2b81c00e"
      unitRef="usdPerShare">11.60</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="i662b4e7ea6f842119f8206ee5b4516c7_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82MS9mcmFnOjU5MTZhMzYyNjliYjRlOTBiYmE2YzVjYTBlYTQ1ZDQ1L3RleHRyZWdpb246NTkxNmEzNjI2OWJiNGU5MGJiYTZjNWNhMGVhNDVkNDVfNzQzOA_41e07d3a-0d5c-409e-adbf-e0363d477658"
      unitRef="usdPerShare">12.43</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <zntl:ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTEwNjY_c4fdfc18-cfb3-4f65-a338-08b73026affd">Members&#x2019; Equity &lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2017, Zentalis Pharmaceuticals, LLC was formed in the state of Delaware. In conjunction with a corporate restructuring, Zeno Pharmaceuticals, Inc., a Delaware corporation formed in 2014, was acquired by the Company pursuant to a merger agreement and became a wholly owned subsidiary of the Company. Per the terms of the merger agreement, each share of Zeno Pharmaceuticals, Inc. common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive one Class&#160;A common unit and each share of Zeno Pharmaceuticals, Inc. Series A preferred stock issued and outstanding immediately prior to the effective date of the merger converted into the right to receive one Series A preferred unit. As of the effective time of the merger agreement, all outstanding options to purchase shares of Zeno Pharmaceuticals, Inc. common stock were cancelled and replaced with profits interest awards in the LLC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the December 2017 corporate restructuring, we amended and restated the LLC agreement, and as amended, the capital units of the Company consisted of 1,638,000 authorized Series A preferred units, 3,621,000 authorized Series B preferred units, 15,000,000 authorized Class&#160;A common units and 872,620 authorized Class&#160;B common units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Class&#160;A Common Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the corporate restructuring in December 2017, 5,187,554 shares of common stock issued and outstanding and 406,831 shares of common stock subject to future vesting provisions of Zeno Pharmaceuticals, Inc. were converted into an equal number of Class&#160;A common units of Zentalis Pharmaceuticals, LLC. In September &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2019, the number of authorized Class&#160;A common units was increased to 20,000,000. During the nine months ended September&#160;30, 2021 and 2020, we did not issue any Class A common units. As of September&#160;30, 2021 and 2020, there were no Class A common units subject to future vesting conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Class&#160;B Common Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the corporate restructuring in December 2017, 703,000 options exercisable into Zeno Pharmaceuticals, Inc. common stock were converted into an equal number of Class&#160;B Common Units of Zentalis Pharmaceuticals, LLC. In September 2019, the number of authorized Class&#160;B common units was increased to 3,458,522.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;IPO and Follow-on Offerings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 2, 2020 and immediately prior to the effectiveness of the Company&#x2019;s IPO, Zentalis Pharmaceuticals, LLC converted from a Delaware limited liability company into a Delaware corporation pursuant to a statutory conversion, and changed its name to Zentalis Pharmaceuticals, Inc. In order to consummate the corporate conversion, a certificate of conversion was filed with the Secretary of State of the State of Delaware. All of the outstanding units of Zentalis Pharmaceuticals, LLC converted into shares of common stock of Zentalis Pharmaceuticals, Inc. based upon the value of Zentalis Pharmaceuticals, Inc. at the time of the IPO with a value implied by the price of the shares of common stock sold in the IPO. No cash or fractional shares of common stock were issued in connection with the corporate conversion. Based on the IPO price of $18.00 per share of common stock, all of the outstanding units converted into an aggregate of 25,288,854 shares of common stock (including 1,160,277 shares of restricted common stock).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the completion of the IPO, the board and stockholders approved the certificate of incorporation to provide for 250,000,000 authorized shares of common stock with a par value of $0.001 per share and 10,000,000 authorized shares of preferred stock with a par value of $0.001 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 7, 2020, the Company completed an IPO in which the Company issued and sold 10,557,000 shares of common stock (including 1,377,000 shares of common stock in connection with the full exercise of the underwriters&#x2019; option to purchase additional shares) at a price of $18.00 per share. The Company&#x2019;s aggregate gross proceeds from the sale of shares in the IPO, including the sale of shares pursuant to the full exercise of the underwriters&#x2019; option to purchase additional shares, was $190.0&#160;million before fees and expenses of $17.6&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 3, 2020, the Company completed a follow-on offering in which the Company issued and sold 4,743,750 shares of common stock (including 618,750 shares of common stock in connection with the full exercise of the underwriters&#x2019; option to purchase additional shares) at a public offering price of $35.00 per share. The Company&#x2019;s aggregate gross proceeds from the sale of shares in the follow-on offering, including the sale of shares pursuant to the full exercise of the underwriters&#x2019; option to purchase additional shares, was $166.0&#160;million before fees and expenses of $10.8&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, the Company completed a follow-on offering in which the Company issued and sold 3,565,000 shares of common stock (including 465,000 shares of common stock in connection with the full exercise of the underwriters&#x2019; option to purchase additional shares) at a public offering price of $48.50 per share. The Company&#x2019;s aggregate gross proceeds from the sale of shares in the follow-on offering, including the sale of shares pursuant to the full exercise of the underwriters&#x2019; option to purchase additional shares, was $172.9&#160;million before fees and expenses of $10.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the Company&#x2019;s 2017 Profits Interest Plan (&#x201c;the Plan&#x201d;) as approved and adopted by the Board of Directors on December 21, 2017, the Company was authorized to issue up to 3,458,522 shares of Class B common units, (&#x201c;profits interest award units&#x201d;), subject to restrictions as described in the Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In April 2020, the Plan was terminated and the Company&#x2019;s board of directors adopted, and the Company&#x2019;s stockholders approved the 2020 Incentive Award Plan (&#x201c;the 2020 Plan&#x201d;), which became effective upon the corporate conversion and allows for grants to selected employees, consultants and non-employee members of the Board of Directors. We currently grant stock options and restricted stock units under the 2020 Plan. The number of common shares available for issuance under the 2020 Plan is the sum of (1) 5,600,000 shares of common stock; plus (2) any shares forfeited from the unvested restricted shares of our common stock issued upon conversion of unvested Class B common units (up to 1,250,000 shares); plus (3) an annual increase on the first day of each fiscal year beginning with the fiscal year ending December 31, 2021 and continuing to, and including, the fiscal year ending December 31, 2030, equal to the lesser of (a) 5% of the shares of common stock outstanding on the final day of the immediately preceding calendar year and (b) such smaller number of shares as determined by our board of directors. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2021, 4,418,484 shares were subject to outstanding awards and 2,237,052 shares were available for future grants of share-based awards. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total share-based compensation expense related to share based awards was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the deconsolidation during the third quarter of 2021, total share-based compensation expense includes $138&#160;thousand of share-based compensation expense for employees, consultants and directors of Zentera, for the nine months ended September&#160;30, 2021, compared to $187 thousand for the same period in 2020.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense by type of share-based award (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Profit Interest Award Units&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs and RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the profits interest awards is estimated using an option pricing model with the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Members&#x2019; equity value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Threshold amounts (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time to liquidity (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lack of marketability discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes option pricing model is used to estimate the fair value of each profits interest award on the date of grant. The members&#x2019; equity value was based on a recent enterprise valuation analysis performed. The threshold amounts are based on the discretion of the Board of Directors at the time of grant. The expected life of the Class&#160;B Common Unit awards granted during the period presented was determined based on an expected liquidation event under the plan. We apply the risk-free interest rate based on the U.S. Treasury yield in effect at the time of the grant consistent with the life of the award. The expected volatility is based on a peer group in the industry in which the Company does business consistent with the expected time to liquidity. The dividend yield was set at zero as the underlying security does not and is not expected to pay a dividend. The Finnerty model and the Asian Protective Put Model methods were used to estimate the discount for lack of marketability inherent to the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Class&#160;B common units issued have been classified as equity awards, and share-based compensation expense is based on the grant date fair value of the award. During the nine months ended September&#160;30, 2021 and 2020, we issued zero and 70,000 Class B common units, respectively. As of September&#160;30, 2021 and December&#160;31, 2020, there were no Class B common units outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options and Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The exercise price of stock options granted is equal to the closing price of the common stock on the date of grant. The fair value of each option award is estimated on the date of grant using the Black-Scholes model. Due to the Company&#x2019;s limited operating history and a lack of company specific historical and implied volatility data, the Company estimates expected volatility based on the historical volatility of a group of similar companies that are publicly traded. The historical volatility data was computed using the daily closing prices for the selected companies&#x2019; shares during the equivalent period of the calculated expected term of the stock-based awards. The Company uses the &#x201c;simplified method&#x201d; for estimating the expected term of employee options, whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option (generally 10 years). The risk-free interest rate is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The Company has not issued any dividends and does not expect to issue dividends over the life of the options. As a result, the Company has estimated the dividend yield to be zero. The fair value of the stock options granted during the nine months ended September&#160;30, 2021 and September&#160;30, 2020 was determined with the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.9% - 76.6%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.6% - 78.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2 - 6.2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7 - 6.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5% - 1.1%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4% - 0.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average assumptions used to estimate the fair value of stock purchase rights under the employee stock purchase plan (&#x201c;ESPP&#x201d;) are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.782%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.055%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.055%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.059%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the ESPP, the Company&#x2019;s employees may elect to have up to 20% of their compensation, up to a maximum of $21,250 per calendar year, withheld to purchase shares of the Company&#x2019;s common stock for a purchase price equal to 85% of the lower of the fair market value per share (at closing) of the Company&#x2019;s common stock on (i) the first trading day of a six-month offering period, or (ii) the applicable purchase date, defined as the last trading day of the six-month offering period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total unrecognized estimated compensation cost by type of award and the weighted average requisite service period over which such expense is expected to be recognized (in thousands, unless otherwise noted):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.256%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.881%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrecognized &lt;br/&gt;Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Remaining &lt;br/&gt;Weighted-Average Recognition Period &lt;br/&gt;(years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.05&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.84&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.29&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2021, we issued 0.1&#160;million shares of common stock in connection with the exercises of stock options. For the nine months ended September&#160;30, 2021, 0.3 million shares of &lt;/span&gt;&lt;/div&gt;common stock issued in conjunction with certain restricted stock awards vested. Outstanding stock options, unvested restricted stock awards, and unvested restricted stock units totaling approximately 4.1&#160;million shares, 0.4&#160;million shares and 0.4&#160;million shares of our common stock, respectively, were outstanding as of September&#160;30, 2021.</zntl:ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock>
    <us-gaap:PreferredUnitsAuthorized
      contextRef="i2494c11e1f6b40a3866cf410bc8a7cb8_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTE1NA_2f084b67-d20c-402d-b1f5-6d53a0c8e9cd"
      unitRef="shares">1638000</us-gaap:PreferredUnitsAuthorized>
    <us-gaap:PreferredUnitsAuthorized
      contextRef="i2dac0c6c83624d678d99d838917cfa5e_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTE5NA_cba0fd85-f23d-406e-baf8-4af331a58d39"
      unitRef="shares">3621000</us-gaap:PreferredUnitsAuthorized>
    <us-gaap:CommonUnitAuthorized
      contextRef="i0473a06af7ec44a996f1bca35660558f_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTIzNA_c2847e59-4cf1-4d8b-9224-0af7c877dd38"
      unitRef="shares">15000000</us-gaap:CommonUnitAuthorized>
    <us-gaap:CommonUnitAuthorized
      contextRef="i69a08aa6ff634f5caab3972d78e1ddfa_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTI3Mw_ca777176-4d16-4f32-9ac7-bd9da8ba4327"
      unitRef="shares">872620</us-gaap:CommonUnitAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7b2b52f5efb3462d8683dfdb2d599eac_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTM5Ng_4de6eb38-87a7-4d19-8821-eb57498feb98"
      unitRef="shares">5187554</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7b2b52f5efb3462d8683dfdb2d599eac_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTM5Ng_e072b66f-51c3-494a-ab1a-bf6f1a448772"
      unitRef="shares">5187554</us-gaap:CommonStockSharesIssued>
    <zntl:CommonStockSharesSubjectToFutureVestingProvisions
      contextRef="i7b2b52f5efb3462d8683dfdb2d599eac_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTQ0OQ_3fd0c3ea-0db8-44fe-b8bd-93f90fed1118"
      unitRef="shares">406831</zntl:CommonStockSharesSubjectToFutureVestingProvisions>
    <us-gaap:CommonUnitAuthorized
      contextRef="ia401f69705414c51916b97151f480785_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTcxOA_0a23a5ea-6be7-4fe1-9d66-8ea76c6fa2a6"
      unitRef="shares">20000000</us-gaap:CommonUnitAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i6829f239f3964fc5b73c9f115f4efd4a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTc2OA_09726f65-84b4-4c30-8b42-41cf246b8925"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i773376c6e0a4414fba9a40b0fa6f57eb_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTc2OA_2adc9d17-bef3-439e-aaaf-c52bdbb44b44"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <zntl:CommonUnitOutstandingSubjectToFutureVestingConditions
      contextRef="i85105ad976e44ee3a9e3b01e44eee367_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTgzMg_ef4a8c31-8d8a-4843-bafd-11cb88f02978"
      unitRef="shares">0</zntl:CommonUnitOutstandingSubjectToFutureVestingConditions>
    <zntl:CommonUnitOutstandingSubjectToFutureVestingConditions
      contextRef="if256d2dc23e54899b1bcec809c82546d_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTgzMg_fd837a84-4b00-4c2f-a467-9c430c2bb996"
      unitRef="shares">0</zntl:CommonUnitOutstandingSubjectToFutureVestingConditions>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="i90fe1d00c583463bb71b163aa4946d4b_D20171201-20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTk4MQ_ae9ac8f5-c737-49e3-9c3f-4c2332b99a6a"
      unitRef="shares">703000</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:CommonUnitAuthorized
      contextRef="ibc382a9f642a48919cda5bcaa7020bfb_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMjIyNQ_9c297798-3309-4819-aa3e-f33f8348f91a"
      unitRef="shares">3458522</us-gaap:CommonUnitAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i9a0fb89c534046e2a6262b44710848a6_D20200402-20200402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMjk3Mw_05e3725d-db10-4588-9e25-6c8218f925c5"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="ib67a09c2cc4e4165b391d6ef5419f1b7_I20200407"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzEwMg_be9eaa5c-c2c6-4c3c-ac77-4cba0dda83a5"
      unitRef="usdPerShare">18.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="ibdac556512264baba2e3c86be867069c_D20200402-20200402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzE5Mg_d00d65a9-89fe-4790-9c42-857e422681d7"
      unitRef="shares">25288854</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="i0daa24d503d64a52a0b1fa592bd6c4e8_D20200402-20200402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzIyOQ_b7f1d5bf-332c-4fc4-a898-77b33611d596"
      unitRef="shares">1160277</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i398696456f95488dbba235847304fab6_I20200402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzM5OA_4b3524cb-7038-4f47-9623-bc268a513fc4"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i398696456f95488dbba235847304fab6_I20200402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzQ1NQ_1e6cd625-1c77-473e-bf7c-22449243db43"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i398696456f95488dbba235847304fab6_I20200402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzQ3Mg_f83d2e44-cba7-4840-898b-ffb44bcef052"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i398696456f95488dbba235847304fab6_I20200402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzUzMg_6ddb2ab7-d7f1-4110-947f-3f7152cd0f38"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="id1b99cb5cf7d4b9bb0f68ae4525eab72_D20200407-20200407"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzYzMA_f6d3e894-529b-44b0-aa2e-b64e1e8501d8"
      unitRef="shares">10557000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ie8cad8b83d3f432cafaa0e90fa7125e0_D20200407-20200407"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzY2Nw_ac87c09e-8b1d-4577-9064-0b65bfeb4889"
      unitRef="shares">1377000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ibac774a69e7b4afb9ca8e9498d26c25a_I20200407"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMzgwMw_6b0e7194-48b8-47bf-a18d-bd9b6682f8f1"
      unitRef="usdPerShare">18.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i550ef246d4114b12b5ec6d79c50b321c_D20200407-20200407"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDAxNA_3fae32b0-f01c-4910-9e39-97492802a264"
      unitRef="usd">190000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i550ef246d4114b12b5ec6d79c50b321c_D20200407-20200407"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDA0NQ_a49bed56-3999-445c-9dbf-7134d5bc61c6"
      unitRef="usd">17600000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ie530cc1b51e14d3da1b54feb7ef48e78_D20200803-20200803"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDE0OA_d774b108-f0b9-4921-ba28-fdb0388adbe6"
      unitRef="shares">4743750</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ia99692ba60b24412a1dab4423fbdcce9_D20200803-20200803"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDE4NQ_e0c673ce-84dc-4865-9e62-c8147e91b0bd"
      unitRef="shares">618750</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i59f99ff806c9400aa93e53bd0e0c2163_I20200803"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDMzNw_221c1f28-9dd0-45bd-a67c-54481f9afa39"
      unitRef="usdPerShare">35.00</us-gaap:SaleOfStockPricePerShare>
    <zntl:ProceedsFromIssuanceOfCommonStockGross
      contextRef="i303787d7706b449b8fd82484ea7a63e8_D20200803-20200803"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDU2Mw_2d0c8329-48cd-4ace-a4e3-e876516bcc7a"
      unitRef="usd">166000000</zntl:ProceedsFromIssuanceOfCommonStockGross>
    <zntl:ExpensesAndFeesFromTheIssuanceOfCommonStock
      contextRef="i303787d7706b449b8fd82484ea7a63e8_D20200803-20200803"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDU5NA_8ffbf744-9a31-445b-bf4e-ca8b786a3140"
      unitRef="usd">10800000</zntl:ExpensesAndFeesFromTheIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ia6ddf0384ce84914b02bcf5b8a9a975f_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMjc0ODc3OTA4MTY4Mw_e5d8ae2e-87a8-4e30-a627-39f3139b463a"
      unitRef="shares">3565000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i462230a27f80426bb97a31bcd0bd3a57_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMjc0ODc3OTA4MTY5NA_4cc693f4-eba4-4da1-93fd-43f52841593e"
      unitRef="shares">465000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i599720d743104c59928244998d2e982a_I20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMjc0ODc3OTA4MTcxOQ_bf33062e-4dfd-44e5-aaea-ffc4164d2d88"
      unitRef="usdPerShare">48.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ia6ddf0384ce84914b02bcf5b8a9a975f_D20210701-20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMjc0ODc3OTA4MTcwMw_4d18d5f7-530b-4fdd-afe4-95a6f375b273"
      unitRef="usd">172900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <zntl:ExpensesAndFeesFromTheIssuanceOfCommonStock
      contextRef="ia6ddf0384ce84914b02bcf5b8a9a975f_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTA5OTUxMTY0MDU5Ng_0814031f-61ca-43a9-95ed-31b1f79f7a87"
      unitRef="usd">10700000</zntl:ExpensesAndFeesFromTheIssuanceOfCommonStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i26c9395499914bb6915eb0b50eb6531e_I20171221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNDkxMQ_684998a9-eb7c-4878-b9b8-ae639ae0b384"
      unitRef="shares">3458522</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i788f376ae39641539c7ea4298ff33b65_I20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNTUzNw_3cfce593-9f02-430f-b51b-d93a792307b5"
      unitRef="shares">5600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i40102d77fe8f40fa92901924ead82975_I20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNTcxMw_93d91e41-0477-4b18-8982-51edc4a2a1ba"
      unitRef="shares">1250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease
      contextRef="i9da50ea1ee9c4df0b7b30adef3d8867a_D20200401-20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNTk0OQ_32089459-6d5f-4d63-9629-7fc2746ab203"
      unitRef="number">0.05</zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="ia728d556059a440da6322b57d7154e71_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNjE0Mg_2f9cb229-fe7b-46bb-ae93-0849d98f0775"
      unitRef="shares">4418484</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ia728d556059a440da6322b57d7154e71_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNjE5MQ_c38dd377-9132-44d7-b4d5-6ffc86fa5b95"
      unitRef="shares">2237052</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTEwNjI_f7d85b7d-8063-40f1-a9bf-01a771f78798">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total share-based compensation expense related to share based awards was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense by type of share-based award (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Profit Interest Award Units&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs and RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i181d83080b3f41ccb6787320f7d2229c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMi0xLTEtMS0xNDc0NQ_079a3fc6-34fb-4544-8fce-8c6422bdda3f"
      unitRef="usd">3697000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic4e4e5dca01c4b329a93274f8d739507_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMi0zLTEtMS0xNDc0NQ_f2bee85b-8be7-41cd-a3e6-85c168f028f5"
      unitRef="usd">2180000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8a7273c96f564c1e865eeb7eb0a5402f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMi01LTEtMS0xNDc0NQ_295b585e-b1a1-4ad8-a44e-955a3d5486ab"
      unitRef="usd">10746000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i94593153cf8c498c8b518d4df370e8d5_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMi03LTEtMS0xNDc0NQ_13142bbd-a2d1-4a33-b805-3e95e2a7cad7"
      unitRef="usd">4606000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4a677277d96a48bab6eb887dca74a45e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMy0xLTEtMS0xNDc0NQ_a44d6296-c9a0-4a03-ae6d-768c18910c29"
      unitRef="usd">3959000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i607b537a79654bcfa5b76e79200ad79e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMy0zLTEtMS0xNDc0NQ_215ffffb-1680-4b50-b3cf-bc0e8aae74fa"
      unitRef="usd">5069000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie98b88c9c000461eab4ed9980e58de2c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMy01LTEtMS0xNDc0NQ_28112286-cd13-4765-9757-86c678c238b9"
      unitRef="usd">16520000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9e645d2454e44e4c90ab99b885f15b90_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfMy03LTEtMS0xNDc0NQ_bf45565d-d349-40f0-b022-e099c89b6641"
      unitRef="usd">10653000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfNC0xLTEtMS0xNDc0NQ_7c5122ec-e664-4c80-9a7d-3d65b20a1ace"
      unitRef="usd">7656000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfNC0zLTEtMS0xNDc0NQ_97da84c5-4ef1-4e87-b914-c19bcfb262c6"
      unitRef="usd">7249000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfNC01LTEtMS0xNDc0NQ_3a178572-2ff6-44f4-849e-4d86761f0d9b"
      unitRef="usd">27266000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjMwMWE5OGI0NzlhNDQyNmQ4Y2NlYmIwOGE3OTgwNDg3L3RhYmxlcmFuZ2U6MzAxYTk4YjQ3OWE0NDI2ZDhjY2ViYjA4YTc5ODA0ODdfNC03LTEtMS0xNDc0NQ_0e89953a-f401-4a65-b3cf-d34c175dd2f6"
      unitRef="usd">15259000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="i0e9fbea9de0a48f9a2fd97d698309e42_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNjQyNA_5dcf8c79-24d7-47d2-840c-ade9f3b9ef52"
      unitRef="usd">138000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="iabd570ef2f9345599b057ad29b52f338_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfNjY4OQ_d8a2bc9f-865d-4d32-b449-f3a7749957fa"
      unitRef="usd">187000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaf9822acfb464a6d891585e7be3a5ca0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMi0xLTEtMS0xNDc0NQ_36558fa2-a449-42dd-a7ec-28449bc21f58"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i744b23fd24c6491ba42985404b428ca4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMi0zLTEtMS0xNDc0NQ_9a235163-4a8b-438a-8c1f-493fc353a19d"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia2ec8dacbd2c4cc28e92de70f1d60be4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMi01LTEtMS0xNDc0NQ_79ee3d01-ac6b-4878-a7e5-1288b627f5cc"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMi03LTEtMS0xNDc0NQ_f14da5c9-d64b-428f-a492-2ef3c0967778"
      unitRef="usd">329000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i22afa5cbdf1a42a4b3d45f2baa46d20a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMy0xLTEtMS0xNDc0NQ_b3b49150-fe3e-4499-ba14-b223b3ba1832"
      unitRef="usd">5596000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4497e0e0b4ec4f1a8b88d44070441e38_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMy0zLTEtMS0xNDc0NQ_6e1dc116-6dff-4f9b-8808-a54eaa2d695f"
      unitRef="usd">2212000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMy01LTEtMS0xNDc0NQ_162a7276-f30a-4a62-a473-f73caefc5077"
      unitRef="usd">14267000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib9c306d1d813469a8be5c195343bbcce_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfMy03LTEtMS0xNDc0NQ_e82ee125-d111-41ba-a6ac-fcc59e52a0e8"
      unitRef="usd">3814000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i587d0a5af8bc44d2be7b3c8da9f39a3f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNC0xLTEtMS0xNDc0NQ_41e347f6-6ea7-4c3b-b6ab-a4901b1d4df5"
      unitRef="usd">103000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id66b9433de164aa588c8902b962f4437_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNC0zLTEtMS0xNDc0NQ_42c0816c-69bb-49b1-9f87-672a699cf01b"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNC01LTEtMS0xNDc0NQ_2c2f1a3a-f80f-45db-8152-339db535170d"
      unitRef="usd">213000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie80c09b9267b4debab194f8e3b070f1d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNC03LTEtMS0xNDc0NQ_22aef35f-e21a-4319-9553-fd31f4cc1e5b"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i585f906916e24788950b045daf6006d0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNS0xLTEtMS0xNDc0NQ_a4e8b54d-9ea0-492d-b2c3-6b5be242daa6"
      unitRef="usd">1957000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie1dc9e958a3743ed897181a2bcab4d8b_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNS0zLTEtMS0xNDc0NQ_80a44a77-f267-4bb9-8856-cceff40b3692"
      unitRef="usd">5037000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8c866a3da3ee4c01869b06d7863723bb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNS01LTEtMS0xNDc0NQ_19ec3e91-250b-441f-9d9f-66b4b9d06f33"
      unitRef="usd">12786000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2c3c44f5e0b242eba976e925ee1e833c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNS03LTEtMS0xNDc0NQ_897e240b-6c23-4fc3-ad14-b8e9fb13ba42"
      unitRef="usd">11116000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNi0xLTEtMS0xNDc0NQ_66b4f393-d758-445d-8609-f3277bd4261d"
      unitRef="usd">7656000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNi0zLTEtMS0xNDc0NQ_ffb4c2f2-5d10-480d-9193-ebb0bc58fef1"
      unitRef="usd">7249000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNi01LTEtMS0xNDc0NQ_5aa00415-5274-49ad-a266-732fa9d8f633"
      unitRef="usd">27266000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjNmMjc5ZWZmNjI2ZDQzZTc5NmJjOTU0NzNkMTkwMWM3L3RhYmxlcmFuZ2U6M2YyNzllZmY2MjZkNDNlNzk2YmM5NTQ3M2QxOTAxYzdfNi03LTEtMS0xNDc0NQ_dc3ab970-7dae-4b08-afdf-a59c24a98eca"
      unitRef="usd">15259000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTEwNjE_69995932-251b-404f-b6b9-fd941138d4e7">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the profits interest awards is estimated using an option pricing model with the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Members&#x2019; equity value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Threshold amounts (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time to liquidity (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lack of marketability discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The fair value of the stock options granted during the nine months ended September&#160;30, 2021 and September&#160;30, 2020 was determined with the following assumptions:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.9% - 76.6%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.6% - 78.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2 - 6.2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7 - 6.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5% - 1.1%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4% - 0.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:MembersEquity
      contextRef="i20f31a36244b4706ade54e9ea17fc52f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjhjYjc5ODc0ZTEyMTRmMzRhNTExMTk1MTM0ZjA1NmRiL3RhYmxlcmFuZ2U6OGNiNzk4NzRlMTIxNGYzNGE1MTExOTUxMzRmMDU2ZGJfMi0yLTEtMS0xNDc0NQ_8ca02148-8e20-4aaf-8fb5-55c7288307db"
      unitRef="usd">271207000</us-gaap:MembersEquity>
    <zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts
      contextRef="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjhjYjc5ODc0ZTEyMTRmMzRhNTExMTk1MTM0ZjA1NmRiL3RhYmxlcmFuZ2U6OGNiNzk4NzRlMTIxNGYzNGE1MTExOTUxMzRmMDU2ZGJfMy0yLTEtMS0xNDc0NQ_ab4bf645-6ee0-4dc5-9b23-6a52ed039528"
      unitRef="usd">309824000</zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjhjYjc5ODc0ZTEyMTRmMzRhNTExMTk1MTM0ZjA1NmRiL3RhYmxlcmFuZ2U6OGNiNzk4NzRlMTIxNGYzNGE1MTExOTUxMzRmMDU2ZGJfNC0yLTEtMS0xNDc0NQ_ebca9da5-4e20-447b-b4e0-85767e3f5fa9"
      unitRef="number">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjhjYjc5ODc0ZTEyMTRmMzRhNTExMTk1MTM0ZjA1NmRiL3RhYmxlcmFuZ2U6OGNiNzk4NzRlMTIxNGYzNGE1MTExOTUxMzRmMDU2ZGJfNS0yLTEtMS0xNDc0NQ_79bb9b16-f355-4a4b-909c-df7481bf4166"
      unitRef="number">0.750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity
      contextRef="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjhjYjc5ODc0ZTEyMTRmMzRhNTExMTk1MTM0ZjA1NmRiL3RhYmxlcmFuZ2U6OGNiNzk4NzRlMTIxNGYzNGE1MTExOTUxMzRmMDU2ZGJfNi0yLTEtMS0xNDc0NQ_fd448663-7757-4fc0-b4f8-52ebda36de3d">P1Y1M6D</zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity>
    <zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount
      contextRef="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjhjYjc5ODc0ZTEyMTRmMzRhNTExMTk1MTM0ZjA1NmRiL3RhYmxlcmFuZ2U6OGNiNzk4NzRlMTIxNGYzNGE1MTExOTUxMzRmMDU2ZGJfNy0yLTEtMS0xNDc0NQ_836b42b9-5ffc-4723-819b-cc800b24dd12"
      unitRef="number">0.265</zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3c5d816cd4334997a6825dec906fd15c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjhjYjc5ODc0ZTEyMTRmMzRhNTExMTk1MTM0ZjA1NmRiL3RhYmxlcmFuZ2U6OGNiNzk4NzRlMTIxNGYzNGE1MTExOTUxMzRmMDU2ZGJfOC0yLTEtMS0xNDc0NQ_d5a9f50d-0511-43d4-ad6c-3ca0299c187a"
      unitRef="usdPerShare">3.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i146ec30e5c904ad4934dfa43202cd322_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfODE1OA_f8e3de76-c754-4425-a6d5-b60357890034"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i3721dc48f90f43aaaedb4b9e4701785a_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfODE2NQ_65a9faa8-3927-4cc5-bc6c-dc34df88540f"
      unitRef="shares">70000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm
      contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfOTIwOQ_3b9c8962-0d08-4a70-898a-6c842e721d74">P10Y</zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMjc0ODc3OTA4MTcyNg_ecc76c38-8d8a-4dbc-8ab5-21674264ec69"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMS0xLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjA2MDVmYTc1Yjg2ZDQ0Y2ZiNjZhM2ZmOGNiYWFkMmZhXzIxOTkwMjMyNTU1NzQ_a6252d83-5ab2-4c0b-9bee-239ce8e067bb"
      unitRef="number">0.739</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMS0xLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjA2MDVmYTc1Yjg2ZDQ0Y2ZiNjZhM2ZmOGNiYWFkMmZhXzIxOTkwMjMyNTU1ODI_78f2b5eb-8c43-4fb7-a344-84636ccde367"
      unitRef="number">0.766</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="ib9c306d1d813469a8be5c195343bbcce_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMS0zLTEtMS0xNDc0NS90ZXh0cmVnaW9uOmQ2ZjFmZWY0ODkyNTRmNjZiZjk1YTQzZmU5ODliOWRjXzIxOTkwMjMyNTU1NzQ_e79349bf-087a-4ff2-9296-d58a35d04632"
      unitRef="number">0.766</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="ib9c306d1d813469a8be5c195343bbcce_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMS0zLTEtMS0xNDc0NS90ZXh0cmVnaW9uOmQ2ZjFmZWY0ODkyNTRmNjZiZjk1YTQzZmU5ODliOWRjXzIxOTkwMjMyNTU1ODI_0cbf5d12-f6e5-4c0a-b73d-6945fb790a59"
      unitRef="number">0.782</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i63c6b196f1234c5a926349599c036d07_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMi0xLTEtMS0xNDc0NS90ZXh0cmVnaW9uOmU2YjJhZDY2NDdmNjRkNGM4ZTU0YTA0MWE4NGU2OTliXzEwOTk1MTE2Mjc3ODY_3df07c2d-d457-4b09-a4e1-9f6a6166ade0">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i7d7f255a3d184998b0bc0e47acd7a4bf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMi0xLTEtMS0xNDc0NS90ZXh0cmVnaW9uOmU2YjJhZDY2NDdmNjRkNGM4ZTU0YTA0MWE4NGU2OTliXzIxOTkwMjMyNTU1NzY_715e8ebb-674f-4507-8408-f56b1d4834bd">P6Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i660a769e8c324a2cbb4a2c3aaaf0e8ba_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMi0zLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjQ1YjBkOTc2ODA0ZjRmYTJiMWY2NGEyOWM4NTUwZWMwXzIxOTkwMjMyNTU1Njg_db53bed8-9545-45f0-ba77-47d543805c1e">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="if1ff576aa6cd420c9c34c4a3796b36df_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMi0zLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjQ1YjBkOTc2ODA0ZjRmYTJiMWY2NGEyOWM4NTUwZWMwXzIxOTkwMjMyNTU1NzQ_c256ac31-3e6e-44ce-8d05-091517d8f577">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMy0xLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjZjMTAxMGIzMzMzYTQ5MjZhZGI3MjczOWFiM2IyZmRhXzQ5NDc4MDIzMjUwMTE_c904cf06-b03b-4338-99fa-49c72db87a89"
      unitRef="number">0.00005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMy0xLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjZjMTAxMGIzMzMzYTQ5MjZhZGI3MjczOWFiM2IyZmRhXzQ5NDc4MDIzMjUwMTg_ce749e09-4dc9-443e-8471-84548f459050"
      unitRef="number">0.00011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="ib9c306d1d813469a8be5c195343bbcce_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMy0zLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjdjOTg2N2NmNzMxYzRjZGU4MjIxMWI5YTk3Y2NkZjllXzQ5NDc4MDIzMjUwMTE_01f6a488-33f9-40c1-bfe2-10c263f0f72e"
      unitRef="number">0.00004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="ib9c306d1d813469a8be5c195343bbcce_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfMy0zLTEtMS0xNDc0NS90ZXh0cmVnaW9uOjdjOTg2N2NmNzMxYzRjZGU4MjIxMWI5YTk3Y2NkZjllXzQ5NDc4MDIzMjUwMTg_e065f07a-f738-42e0-86c7-8dc01b2a1a64"
      unitRef="number">0.00005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfNC0xLTEtMS0xNDc0NQ_64344223-3b93-470b-8224-faf9566bd6df"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ib9c306d1d813469a8be5c195343bbcce_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjA3ZGZmNzU1NDIxMjQzOTJiMGQ0OTVkMDY3NDMxZTc2L3RhYmxlcmFuZ2U6MDdkZmY3NTU0MjEyNDM5MmIwZDQ5NWQwNjc0MzFlNzZfNC0zLTEtMS0xNDc0NQ_b6b7e521-511a-4044-b507-a2851b731b8a"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTEwNjU_91155fee-9e4b-49bc-b7ec-c11c44f2def2">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average assumptions used to estimate the fair value of stock purchase rights under the employee stock purchase plan (&#x201c;ESPP&#x201d;) are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.782%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.055%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.055%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.059%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjkyYzc1ZWEyODZmYzQ5OWE4MDQ0NTM3YzhhMmU3NDRlL3RhYmxlcmFuZ2U6OTJjNzVlYTI4NmZjNDk5YTgwNDQ1MzdjOGEyZTc0NGVfMy0zLTEtMS0xNDc0NQ_0709a167-158f-4100-87b7-aed2ce8bc9a7"
      unitRef="number">0.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ie80c09b9267b4debab194f8e3b070f1d_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjkyYzc1ZWEyODZmYzQ5OWE4MDQ0NTM3YzhhMmU3NDRlL3RhYmxlcmFuZ2U6OTJjNzVlYTI4NmZjNDk5YTgwNDQ1MzdjOGEyZTc0NGVfMy01LTEtMS0xNDc0NQ_d69c5563-e451-4ce9-8884-e332fd27f378"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjkyYzc1ZWEyODZmYzQ5OWE4MDQ0NTM3YzhhMmU3NDRlL3RhYmxlcmFuZ2U6OTJjNzVlYTI4NmZjNDk5YTgwNDQ1MzdjOGEyZTc0NGVfNC0zLTEtMS0xNDc0NQ_a6c7c56e-904a-4150-ba1b-fc53c088dd36">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjkyYzc1ZWEyODZmYzQ5OWE4MDQ0NTM3YzhhMmU3NDRlL3RhYmxlcmFuZ2U6OTJjNzVlYTI4NmZjNDk5YTgwNDQ1MzdjOGEyZTc0NGVfNS0zLTEtMS0xNDc0NQ_9bdbab22-05c5-4a20-8a60-81a32147ceeb"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie80c09b9267b4debab194f8e3b070f1d_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjkyYzc1ZWEyODZmYzQ5OWE4MDQ0NTM3YzhhMmU3NDRlL3RhYmxlcmFuZ2U6OTJjNzVlYTI4NmZjNDk5YTgwNDQ1MzdjOGEyZTc0NGVfNS01LTEtMS0xNDc0NQ_8a1b566f-50da-4cc5-b39d-276e492cb41b"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjkyYzc1ZWEyODZmYzQ5OWE4MDQ0NTM3YzhhMmU3NDRlL3RhYmxlcmFuZ2U6OTJjNzVlYTI4NmZjNDk5YTgwNDQ1MzdjOGEyZTc0NGVfNi0zLTEtMS0xNDc0NQ_4d908738-6290-49bd-858a-6d122c1b8cf1"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ie80c09b9267b4debab194f8e3b070f1d_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOjkyYzc1ZWEyODZmYzQ5OWE4MDQ0NTM3YzhhMmU3NDRlL3RhYmxlcmFuZ2U6OTJjNzVlYTI4NmZjNDk5YTgwNDQ1MzdjOGEyZTc0NGVfNi01LTEtMS0xNDc0NQ_7e6f6392-3006-44f6-ae8f-5eb495911dfd"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="i3f1a54d8ee624903a58ab6e4a97f47c3_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfOTk1OA_7688659f-4abb-4c77-af7a-7c8492399953"
      unitRef="number">0.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount
      contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTAwMDM_f7a6a148-1575-47a9-94a6-90e0496221ee"
      unitRef="usd">21250</zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTAxMTM_213b380f-020a-4170-a4ff-b48824786773"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod
      contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTEwNjA_c67c8330-5043-4b4a-a6e4-2ebe050e46c6">P6M</zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod>
    <zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod
      contextRef="iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTEwNjg_d0d5e99b-0e11-4b22-ad7a-e282f8a8a84e">P6M</zntl:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTEwNjk_9356dc20-74e6-43af-abd9-65aa9ab06e8c">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total unrecognized estimated compensation cost by type of award and the weighted average requisite service period over which such expense is expected to be recognized (in thousands, unless otherwise noted):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.256%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.881%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrecognized &lt;br/&gt;Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Remaining &lt;br/&gt;Weighted-Average Recognition Period &lt;br/&gt;(years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.05&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.84&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.29&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i782b4959ffc945c6b1b065f0b433ec10_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOmY0NmJlMTVlZTJjNDQwYzM4YjEwMjczZTg4ZDIxYWM0L3RhYmxlcmFuZ2U6ZjQ2YmUxNWVlMmM0NDBjMzhiMTAyNzNlODhkMjFhYzRfMi0xLTEtMS0xNDc0NQ_ca0c1838-4c97-467e-9b9f-b380b845d512"
      unitRef="usd">65008000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOmY0NmJlMTVlZTJjNDQwYzM4YjEwMjczZTg4ZDIxYWM0L3RhYmxlcmFuZ2U6ZjQ2YmUxNWVlMmM0NDBjMzhiMTAyNzNlODhkMjFhYzRfMi0zLTEtMS0xNDc0NQ_0775f512-36f0-4538-8339-b545e3fe0831">P3Y18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i5aa816b1a8094167b4936dcee3a759ea_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOmY0NmJlMTVlZTJjNDQwYzM4YjEwMjczZTg4ZDIxYWM0L3RhYmxlcmFuZ2U6ZjQ2YmUxNWVlMmM0NDBjMzhiMTAyNzNlODhkMjFhYzRfMy0xLTEtMS0xNDc0NQ_071ead9e-2409-4ea9-90c8-9f7ead9bd349"
      unitRef="usd">1472000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="icc74194e61cc4c73a3ce9cb7361dcc5f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOmY0NmJlMTVlZTJjNDQwYzM4YjEwMjczZTg4ZDIxYWM0L3RhYmxlcmFuZ2U6ZjQ2YmUxNWVlMmM0NDBjMzhiMTAyNzNlODhkMjFhYzRfMy0zLTEtMS0xNDc0NQ_46691fbe-35e7-4c10-98fc-bf7273ded575">P1Y10M2D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="ieeb7a874665d45dea6e7487809034f00_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOmY0NmJlMTVlZTJjNDQwYzM4YjEwMjczZTg4ZDIxYWM0L3RhYmxlcmFuZ2U6ZjQ2YmUxNWVlMmM0NDBjMzhiMTAyNzNlODhkMjFhYzRfNC0xLTEtMS0xNDc0NQ_a73daded-3969-4ef3-92fb-e189f5cb075b"
      unitRef="usd">7793000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i3578222b355449619cf1a71155f3985c_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOmY0NmJlMTVlZTJjNDQwYzM4YjEwMjczZTg4ZDIxYWM0L3RhYmxlcmFuZ2U6ZjQ2YmUxNWVlMmM0NDBjMzhiMTAyNzNlODhkMjFhYzRfNC0zLTEtMS0xNDc0NQ_36fb7b3b-9dcd-485c-958d-4c0e543256a1">P2Y3M14D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i3f1a54d8ee624903a58ab6e4a97f47c3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RhYmxlOmY0NmJlMTVlZTJjNDQwYzM4YjEwMjczZTg4ZDIxYWM0L3RhYmxlcmFuZ2U6ZjQ2YmUxNWVlMmM0NDBjMzhiMTAyNzNlODhkMjFhYzRfNS0xLTEtMS0xNDc0NQ_b85eda11-df72-415c-bf76-2fa60e1f4176"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTA5OTUxMTY0MDQ5NQ_bb109aa5-d90a-4f4c-933e-9feeb611666e"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTA3NDk_7908ca49-c30c-466f-a9b9-b9a8e1813a3d"
      unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i782b4959ffc945c6b1b065f0b433ec10_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTA5NjI_955d81ec-be27-469b-b01f-c4f698abb86a"
      unitRef="shares">4100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i5aa816b1a8094167b4936dcee3a759ea_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTA5NzQ_7d583cd9-03eb-42cd-9a46-19a2ff41d9f3"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="ieeb7a874665d45dea6e7487809034f00_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82NC9mcmFnOjFhMmVkNGE2OGQzMzQ3Mjg4OWEyNjdiOThjOWQ2MGIwL3RleHRyZWdpb246MWEyZWQ0YTY4ZDMzNDcyODg5YTI2N2I5OGM5ZDYwYjBfMTA5ODg_08ff0988-05db-45c1-85b7-1eab4d86afdc"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RleHRyZWdpb246ZDZlNGRmZGI2MjEyNDRjZGIxMWQ3ZDEwNmQ2ZDhlZDZfMjE0OA_000d68c8-2fb8-4513-ac42-1a6d5735afee">Commitments and Contingencies&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Contingencies &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;From time to time, we may be involved in various disputes, including lawsuits and claims arising in the ordinary course of business, including actions with respect to intellectual property, employment, and contractual matters. Any of these claims could subject us to costly legal expenses. The Company records a liability in its consolidated financial statements for these matters when a loss is known or considered probable and the amount can be reasonably estimated. The Company reviews these estimates each accounting period as additional information is known and adjusts the loss provision when appropriate. If a matter is both probable to result in a liability and the amounts of loss can be reasonably estimated, the Company estimates and discloses the possible loss or range of loss to the extent necessary to make the consolidated financial statements not misleading. If the loss is not probable or cannot be reasonably estimated, a liability is not recorded in our consolidated financial statements. While we do generally believe that we have adequate insurance to cover many different types of liabilities, our insurance carriers may deny coverage, or our policy limits may be inadequate to fully satisfy any damage awards or settlement. If this were to happen, the payment of any such awards could have a material adverse effect on our consolidated results of operations and financial position. Additionally, any such claims, whether or not successful, could damage our reputation and business. We are currently not a party to any legal proceedings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our commitments include payments related to operating leases. Approximate annual future minimum operating lease payments as of September&#160;30, 2021 are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The weighted-average remaining lease term of our operating leases is approximately 0.8 years. As of September&#160;30, 2021, we had entered into two additional leases for real estate that have not yet commenced with total minimum lease payments of approximately $74.6 million. These leases are expected to commence in the fourth quarter of 2021 and have lease terms of 10 years and 11 years, respectively.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RleHRyZWdpb246ZDZlNGRmZGI2MjEyNDRjZGIxMWQ3ZDEwNmQ2ZDhlZDZfMjE0OQ_d6f11a82-9182-4268-9fee-c3d9f7645b60">Approximate annual future minimum operating lease payments as of September&#160;30, 2021 are as follows (in thousands): &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RhYmxlOmQ0ZWVlOGNlZTQ1YTQyY2ZhMDFlZmRlOWVlYzZlMjg2L3RhYmxlcmFuZ2U6ZDRlZWU4Y2VlNDVhNDJjZmEwMWVmZGU5ZWVjNmUyODZfMS0yLTEtMS0xNDc0NQ_bdd3f9ba-f6ac-476c-a516-3334cadc5b79"
      unitRef="usd">271000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RhYmxlOmQ0ZWVlOGNlZTQ1YTQyY2ZhMDFlZmRlOWVlYzZlMjg2L3RhYmxlcmFuZ2U6ZDRlZWU4Y2VlNDVhNDJjZmEwMWVmZGU5ZWVjNmUyODZfMi0yLTEtMS0xNDc0NQ_5e0b1d84-284f-42f2-aeba-82e684c2839e"
      unitRef="usd">637000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RhYmxlOmQ0ZWVlOGNlZTQ1YTQyY2ZhMDFlZmRlOWVlYzZlMjg2L3RhYmxlcmFuZ2U6ZDRlZWU4Y2VlNDVhNDJjZmEwMWVmZGU5ZWVjNmUyODZfNS0yLTEtMS0xNDc0NQ_267b0c72-cd36-43e0-ac4f-b84aeecd2c90"
      unitRef="usd">908000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RhYmxlOmQ0ZWVlOGNlZTQ1YTQyY2ZhMDFlZmRlOWVlYzZlMjg2L3RhYmxlcmFuZ2U6ZDRlZWU4Y2VlNDVhNDJjZmEwMWVmZGU5ZWVjNmUyODZfNi0yLTEtMS0xNDc0NQ_7af4559b-3872-4be4-bba1-69614080b093"
      unitRef="usd">46000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RhYmxlOmQ0ZWVlOGNlZTQ1YTQyY2ZhMDFlZmRlOWVlYzZlMjg2L3RhYmxlcmFuZ2U6ZDRlZWU4Y2VlNDVhNDJjZmEwMWVmZGU5ZWVjNmUyODZfNy0yLTEtMS0xNDc0NQ_ec9b164a-1681-4af7-95f3-950df825a706"
      unitRef="usd">862000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RleHRyZWdpb246ZDZlNGRmZGI2MjEyNDRjZGIxMWQ3ZDEwNmQ2ZDhlZDZfMTg3Nw_4414cf96-6db2-4e96-8e2b-9095d956c809">P0Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <zntl:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RleHRyZWdpb246ZDZlNGRmZGI2MjEyNDRjZGIxMWQ3ZDEwNmQ2ZDhlZDZfMTkxMQ_17cb6015-fd0a-440d-a3cd-d2780593e065"
      unitRef="lease">2</zntl:LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts>
    <zntl:LesseeOperatingLeaseLeaseNotYetCommencedLiability
      contextRef="ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RleHRyZWdpb246ZDZlNGRmZGI2MjEyNDRjZGIxMWQ3ZDEwNmQ2ZDhlZDZfMjAyNw_2f89f040-9767-45c0-ad2d-5a37c9bec7eb"
      unitRef="usd">74600000</zntl:LesseeOperatingLeaseLeaseNotYetCommencedLiability>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="i356de632612e431284fab49bb34efaca_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RleHRyZWdpb246ZDZlNGRmZGI2MjEyNDRjZGIxMWQ3ZDEwNmQ2ZDhlZDZfMjEyMw_7417b91a-2d82-4b04-b1c3-9cc3e42aa4f6">P10Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="i004976abe339457d8797c8a3f4268c32_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV82Ny9mcmFnOmQ2ZTRkZmRiNjIxMjQ0Y2RiMTFkN2QxMDZkNmQ4ZWQ2L3RleHRyZWdpb246ZDZlNGRmZGI2MjEyNDRjZGIxMWQ3ZDEwNmQ2ZDhlZDZfMjEzMA_6b8924ef-eb93-465c-aec5-c6caf139721b">P11Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RleHRyZWdpb246M2I5ZWQ1NmEyNjIxNGMyOGE3Mjk0NDMyZjE5ODFmMjFfNjEw_e7c3bfd3-6fe4-408f-9745-8f24c98eef9c">Net Loss Per Common Share/Class&#160;A Common Unit &lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net loss per common share/Class&#160;A common unit were calculated as follows (in thousands except per share and per unit amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to Zentalis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108,666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.09)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our potential and dilutive securities, which include outstanding stock options, unvested RSAs and unvested RSUs have been excluded from the computation of diluted net loss per common share as the effect would be anti-dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock equivalents have been excluded from the calculations of diluted net loss per common share because their inclusion would be antidilutive (in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.153%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested RSAs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested RSUs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RleHRyZWdpb246M2I5ZWQ1NmEyNjIxNGMyOGE3Mjk0NDMyZjE5ODFmMjFfNjEy_24b0c9f6-b8a8-48f7-bc93-27f84b722cbb">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net loss per common share/Class&#160;A common unit were calculated as follows (in thousands except per share and per unit amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to Zentalis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108,666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.09)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfMy0xLTEtMS0xNDc0NQ_f13bff4d-1e65-479b-88e4-a37ce93b12b9"
      unitRef="usd">-4191000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfMy0zLTEtMS0xNDc0NQ_49a1920f-ce94-44af-88a8-89ec12e5a88b"
      unitRef="usd">-34555000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfMy01LTEtMS0xNDc0NQ_b916f6dd-5996-4323-8749-ceec7e480970"
      unitRef="usd">-108666000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfMy03LTEtMS0xNDc0NQ_d2359ef9-6b76-4ca8-a5a6-da17a3e45bf4"
      unitRef="usd">-77538000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS0xLTEtMS0xNDc0NQ_251943e7-c4ff-4e30-aceb-e0b0b097569a"
      unitRef="shares">44609000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS0xLTEtMS0xNDc0NQ_7e48f6f3-6f3b-43db-9fc9-de74c5be139d"
      unitRef="shares">44609000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS0zLTEtMS0xNDc0NQ_3b3feb87-0aba-4163-84ed-cb50991b3450"
      unitRef="shares">37959000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS0zLTEtMS0xNDc0NQ_9774cd21-b11f-4141-a589-6f99c8effb38"
      unitRef="shares">37959000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS01LTEtMS0xNDc0NQ_6343a55f-ccd8-4a85-abf2-5eb87ae5eca4"
      unitRef="shares">41918000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS01LTEtMS0xNDc0NQ_d963b575-0235-4329-b4ba-7bb051189ddd"
      unitRef="shares">41918000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS03LTEtMS0xNDc0NQ_06eec7e6-084b-466a-aa6b-58faafb27330"
      unitRef="shares">24143000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNS03LTEtMS0xNDc0NQ_87eea78e-68f4-4fe4-a6e9-618aa37a2db4"
      unitRef="shares">24143000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi0xLTEtMS0xNDc0NQ_91216124-d3ab-474d-aa1d-522b52db9bc9"
      unitRef="usdPerShare">-0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi0xLTEtMS0xNDc0NQ_e6af426f-b8c3-4b42-a340-0966725302ef"
      unitRef="usdPerShare">-0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi0zLTEtMS0xNDc0NQ_13b36549-ce06-44ac-9ff8-6c705d42d23b"
      unitRef="usdPerShare">-0.91</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5125fc043bb14d4e9b6a0c120d94f900_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi0zLTEtMS0xNDc0NQ_cad090c2-068c-4149-94c0-c0f6468db205"
      unitRef="usdPerShare">-0.91</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi01LTEtMS0xNDc0NQ_05645293-a602-490e-bb2f-c28e594e0f13"
      unitRef="usdPerShare">-2.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi01LTEtMS0xNDc0NQ_b1d9dab1-5563-4864-879a-379c9f9acd0c"
      unitRef="usdPerShare">-2.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi03LTEtMS0xNDc0NQ_434ebcf0-d8b1-424d-832c-31a346456f86"
      unitRef="usdPerShare">-3.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOmQyM2JhNDNmN2Q2MjQ4MjRiMWZmNTdkMjUwYjkxNzM4L3RhYmxlcmFuZ2U6ZDIzYmE0M2Y3ZDYyNDgyNGIxZmY1N2QyNTBiOTE3MzhfNi03LTEtMS0xNDc0NQ_b699dde8-19b8-4480-9602-dba53a4107bd"
      unitRef="usdPerShare">-3.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RleHRyZWdpb246M2I5ZWQ1NmEyNjIxNGMyOGE3Mjk0NDMyZjE5ODFmMjFfNjE0_f6c57b44-bad2-4f50-9629-290b18e277fe">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock equivalents have been excluded from the calculations of diluted net loss per common share because their inclusion would be antidilutive (in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.153%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested RSAs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested RSUs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia727e9eb512a4899be678569e4be9e04_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfMi0xLTEtMS0xNDc0NQ_dcd351ec-ed9d-489a-864c-31376b50fbcd"
      unitRef="shares">4055000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia84faaa12cb04eed88b3628a273183ce_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfMi0zLTEtMS0xNDc0NQ_b7b71ce7-78ff-4f5e-990c-759ed92d0095"
      unitRef="shares">2783000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ida8eb8260bb84fffa3c3fc02e85ac4f2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfMy0xLTEtMS0xNDc0NQ_5dea2100-08d4-4b45-8543-8d6c2c62f5fd"
      unitRef="shares">447000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic8cbc6c76d0e4128b4e08d37495dc609_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfMy0zLTEtMS0xNDc0NQ_01dcfdbe-72ef-4181-8609-2561987da2b8"
      unitRef="shares">845000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie48938e7777e45829bfd62b464670e1d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfNC0xLTEtMS0xNDc0NQ_11c56b7b-e4c2-4842-ba22-112a3f82da5c"
      unitRef="shares">364000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5379b3f1fc91468e8557d8d058d3aaa3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfNC0zLTEtMS0xNDc0NQ_f836a35e-9a22-4a5a-a700-006b3da5fc5a"
      unitRef="shares">1102000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfNS0xLTEtMS0xNDc0NQ_6709dfa4-c6ac-4f87-bf86-4b2589121559"
      unitRef="shares">4866000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ifbde449dbf9a408483168c4a251023f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83MC9mcmFnOjNiOWVkNTZhMjYyMTRjMjhhNzI5NDQzMmYxOTgxZjIxL3RhYmxlOjhkNWU2MDVlMjg4MTQ1YjNhZDNkODVlM2M2OTMzOGIwL3RhYmxlcmFuZ2U6OGQ1ZTYwNWUyODgxNDViM2FkM2Q4NWUzYzY5MzM4YjBfNS0zLTEtMS0xNDc0NQ_6f471e79-614b-4464-8c55-8fdda16db219"
      unitRef="shares">4730000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i231496bb8d46467298acc8e2d1083d39_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMzE2Ng_0bfa9104-fcfa-4941-8358-7d16b88ce28a">Related Party Disclosures&lt;div style="text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Kalyra Pharmaceuticals, Inc. and Recurium IP Holdings, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December&#160;21, 2017, we acquired 17,307,692 shares of Series B preferred stock of Kalyra Pharmaceuticals, Inc. for a per share price of&#160;twenty-six&#160;cents ($0.26) or approximately $4.5&#160;million. The management team and stockholders of Kalyra are also stockholders of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the investment, we entered into a license agreement and a master services agreement with Kalyra. The license agreement was signed and commenced on December&#160;31, 2014 for the exclusive rights to develop and commercialize products derived from Kalyra&#x2019;s technology in the initial area of oncology. The license agreement and all rights were subsequently sold from Kalyra to Recurium IP Holdings, LLC (&#x201c;Recurium IP&#x201d;), an entity with common ownership to Kalyra prior to the Zentalis investment. Under the agreement, we have agreed to make payments to Recurium IP based on specific milestones. In addition, the Company shall pay mid to&#160;high-single&#160;digit percentage royalties on net product sales to Recurium IP and sublicense fees on any consideration paid to us by a sublicensor. All payments are based on Recurium Equity, LLC&#x2019;s, an affiliate company of Recurium IP, equity ownership stake in us as of December 2020. The license agreement will terminate upon the later of the last expiration of the patent rights or 15 years from the date of commencement. For the nine months ended &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2021 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we paid $10.0&#160;million and zero, respectively, in milestone payments to Recurium IP in connection with the commencement of Phase 2 trials for ZN-c3 and ZN-c5.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Master Services Agreement (&#x201c;MSA&#x201d;) was entered into in January 2015 and states that Kalyra may provide research and development services to us and that we shall reimburse such expenses on a time and materials basis based on the initial statements of work. For each of the three months ended September&#160;30, 2021 and 2020, we did not incur any expense with Kalyra. For the nine months ended September&#160;30, 2021 and 2020, we incurred approximately zero and seventeen thousand dollars of expense with Kalyra, respectively, that was eliminated in consolidation for research and development services provided. As of September&#160;30, 2021 and 2020, there was no balance due to Kalyra.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We entered into an Intercompany Services Agreement (&#x201c;ISA&#x201d;) with Kalyra in January 2018 which states that we may provide research and development services to Kalyra and that Kalyra shall reimburse such expenses on a time and materials basis. For the three and nine months ended September&#160;30, 2021 and 2020, we provided immaterial research and development services to Kalyra that were eliminated in consolidation, respectively. As of September&#160;30, 2021 and 2020, an immaterial amount was due from Kalyra and eliminated in consolidation, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Tempus&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Kimberly Blackwell, M.D., is a member of the Company's board of directors and is also the Chief Medical Officer of Tempus Labs, Inc. ("Tempus"). The Company entered into a Master Services Agreement with Tempus in December 2020 to provide data licensing and research services. There were $1.0&#160;million and zero fees incurred for services performed by Tempus for the nine months ended September&#160;30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Zentera&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Anthony Y. Sun, M.D., our President and Chief Executive Officer, serves as Chief Executive Officer and a member of the board of directors of Zentera, and Kevin D. Bunker, Ph.D., our Chief Operating Officer, serves as a member of the board of directors of Zentera. Accordingly, the Company identifies Zentera as a related party.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:24.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, we entered into the Zentera Sublicenses, pursuant to which we collaborate with Zentera on the development and comm&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ercialization of ZN-c3, ZN-c5 and ZN-d5, respectively, in the Zentera Collaboration Territory. Under the terms of the Zentera Sublicenses, Zentera is responsible for the costs of developing the Collaboration Products in the Zentera Collaboration Territory, and we are responsible for the costs of developing the Collaboration Products outside the Zentera Collaboration Territory, provided that Zentera will reimburse us for a portion of its costs for global data management, pharmacovigilance, safety database management, and chemistry, manufacturing and controls activities with respect to each Collaboration Product. Prior to the deconsolidation of Zentera during the three months ended September 30, 2021, these costs were eliminated in consolidation. For the three months ended September 30, 2021, the amounts incurred under this arrangement totaled $2.9 million and are presented as contra-research and development expense in the consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i2f09d3ed0755408fa8b8594c78bbc16d_I20171221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTI5_f20f34cf-618c-4800-af71-a86a6911b128"
      unitRef="shares">17307692</us-gaap:PreferredStockSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i05c84f48e4c9416e9b68315685186678_I20171221"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMjQy_285ea577-a74d-47a2-b1aa-9014641bdf0c"
      unitRef="usdPerShare">0.26</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates
      contextRef="i2765153e500b4c2ea94087220a2f2cd0_D20171221-20171221"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMjYz_8905abf5-1f1a-453e-917e-b26d916e3447"
      unitRef="usd">4500000</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <zntl:RelatedPartyAgreementTerm
      contextRef="i4c0b35a7a7664cf0a904ddb853e834d5_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTM3MA_a7d50359-596f-4a98-b40d-4280f800fa40">P15Y</zntl:RelatedPartyAgreementTerm>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="iffe291a882a04056a3a61eec999af54f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTQ2MQ_86764860-1f50-4e85-8d7a-14370623a826"
      unitRef="usd">10000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i10842b54d0d24a489e994b1893949958_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTQ2OA_918e4e01-2466-4e46-8101-8ce2787f1975"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i0db2a4af26634c05ae218afec38b427f_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTgzNg_648cb0c3-4c32-4f77-8f7a-8d6fd2cb2d43"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i18d34a087a6f45069ed7552aa3fc34b1_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTgzNg_ea988af6-9ecf-4fcc-b5eb-0eac8fb71b2a"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="ibf33597aac934769b0e7dc53e6692e7c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTkzMg_74fc50c5-0d8e-410f-8bb0-3c93ef75f0e2"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i9b68177d9165436bb2788988bec1574e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTkzOQ_5a8f90d0-6b8c-4b22-a970-ec4eed98a206"
      unitRef="usd">17000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="ifedec654804d4a048412181632ffca4d_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMjEwMA_5e66da83-3a12-4dcc-909c-f91e57e3b722"
      unitRef="usd">0</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="i2f9253d63b8a4572ac7ef410befd9a0b_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMjEwMA_be220812-cb12-43ce-a207-6b6635588667"
      unitRef="usd">0</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="i17387c8daecd44fd832424bd3dff82a8_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMzA2MA_c9a744de-b635-4482-83cd-fdda545a47f3"
      unitRef="usd">1000000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="i0625dd931fe6420b9f8753010dae2784_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMzA2Nw_e21b24a5-f20c-40b6-abbe-8aa0e11474b1"
      unitRef="usd">0</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <zntl:ResearchAndDevelopmentExpenseReimbursements
      contextRef="i3a09ec80921740a8a5b68eddc9671099_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1OWQ3NDgzZjg4YjQ0YWJhNmRmMjk1YjRiZTM3Y2RlL3NlYzozNTlkNzQ4M2Y4OGI0NGFiYTZkZjI5NWI0YmUzN2NkZV83My9mcmFnOmJkNjA4MTliMzg4MDQyZGNiMzgxOWQzMmU1NjdkN2MyL3RleHRyZWdpb246YmQ2MDgxOWIzODgwNDJkY2IzODE5ZDMyZTU2N2Q3YzJfMTA5OTUxMTYzNDk1OA_43dbc703-15ba-4522-9ec2-17ae23cda3e4"
      unitRef="usd">2900000</zntl:ResearchAndDevelopmentExpenseReimbursements>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064084180904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Nov. 09, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Zentalis Pharmaceuticals, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-3607803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">530 Seventh Avenue,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 2201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">433-3791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock,$0.001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ZNTL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,305,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001725160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064002255256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 40,807<span></span>
</td>
<td class="nump">$ 54,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">325,984<span></span>
</td>
<td class="nump">283,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable from government grants, net</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">10,423<span></span>
</td>
<td class="nump">6,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">377,565<span></span>
</td>
<td class="nump">345,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">4,698<span></span>
</td>
<td class="nump">1,099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease&#160;right-of-use&#160;assets</a></td>
<td class="nump">693<span></span>
</td>
<td class="nump">2,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent', window );">Prepaid expenses and other assets</a></td>
<td class="nump">6,042<span></span>
</td>
<td class="nump">2,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,736<span></span>
</td>
<td class="nump">3,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">In-process&#160;research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment in Zentera Therapeutics</a></td>
<td class="nump">39,326<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">3,021<span></span>
</td>
<td class="nump">1,320<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">435,081<span></span>
</td>
<td class="nump">365,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">8,046<span></span>
</td>
<td class="nump">8,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">31,369<span></span>
</td>
<td class="nump">19,940<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">39,415<span></span>
</td>
<td class="nump">28,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">1,670<span></span>
</td>
<td class="nump">2,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,097<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">41,085<span></span>
</td>
<td class="nump">32,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding at September&#160;30, 2021 and December 31, 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 250,000,000 shares authorized; 45,198,528 and 41,040,286 shares issued and outstanding at September&#160;30, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">702,855<span></span>
</td>
<td class="nump">509,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(309,500)<span></span>
</td>
<td class="num">(200,834)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">393,432<span></span>
</td>
<td class="nump">308,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">564<span></span>
</td>
<td class="nump">24,795<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">393,996<span></span>
</td>
<td class="nump">333,377<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 435,081<span></span>
</td>
<td class="nump">$ 365,555<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064084769368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (in shares)</a></td>
<td class="nump">45,198,528<span></span>
</td>
<td class="nump">41,040,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="nump">45,198,528<span></span>
</td>
<td class="nump">41,040,286<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064085213704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 53,998<span></span>
</td>
<td class="nump">$ 24,670<span></span>
</td>
<td class="nump">$ 137,162<span></span>
</td>
<td class="nump">$ 55,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">8,872<span></span>
</td>
<td class="nump">10,097<span></span>
</td>
<td class="nump">31,187<span></span>
</td>
<td class="nump">23,162<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">62,870<span></span>
</td>
<td class="nump">34,767<span></span>
</td>
<td class="nump">168,349<span></span>
</td>
<td class="nump">78,542<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(62,870)<span></span>
</td>
<td class="num">(34,767)<span></span>
</td>
<td class="num">(168,349)<span></span>
</td>
<td class="num">(78,542)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Income (Expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Investment and other income, net</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="nump">368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeconsolidationGainOrLossAmount', window );">Gain on deconsolidation of Zentera, net of tax</a></td>
<td class="nump">51,582<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">51,582<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="num">(11,189)<span></span>
</td>
<td class="num">(34,647)<span></span>
</td>
<td class="num">(116,454)<span></span>
</td>
<td class="num">(78,174)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">(697)<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="num">(456)<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(10,492)<span></span>
</td>
<td class="num">(34,665)<span></span>
</td>
<td class="num">(115,998)<span></span>
</td>
<td class="num">(78,192)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interests</a></td>
<td class="num">(6,301)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="num">(7,332)<span></span>
</td>
<td class="num">(654)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Zentalis</a></td>
<td class="num">$ (4,191)<span></span>
</td>
<td class="num">$ (34,555)<span></span>
</td>
<td class="num">$ (108,666)<span></span>
</td>
<td class="num">$ (77,538)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share outstanding, basic (USD per share)</a></td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.91)<span></span>
</td>
<td class="num">$ (2.59)<span></span>
</td>
<td class="num">$ (3.21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share outstanding, diluted (USD per share)</a></td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.91)<span></span>
</td>
<td class="num">$ (2.59)<span></span>
</td>
<td class="num">$ (3.21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Common shares used in computing net loss per share, basic (in shares)</a></td>
<td class="nump">44,609<span></span>
</td>
<td class="nump">37,959<span></span>
</td>
<td class="nump">41,918<span></span>
</td>
<td class="nump">24,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Common shares used in computing net loss per share, diluted (in shares)</a></td>
<td class="nump">44,609<span></span>
</td>
<td class="nump">37,959<span></span>
</td>
<td class="nump">41,918<span></span>
</td>
<td class="nump">24,143<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064002343256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (10,492)<span></span>
</td>
<td class="num">$ (34,665)<span></span>
</td>
<td class="num">$ (115,998)<span></span>
</td>
<td class="num">$ (78,192)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation effects</a></td>
<td class="num">(45)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive loss</a></td>
<td class="num">(10,554)<span></span>
</td>
<td class="num">(34,646)<span></span>
</td>
<td class="num">(116,002)<span></span>
</td>
<td class="num">(78,169)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interests</a></td>
<td class="num">(6,301)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="num">(7,332)<span></span>
</td>
<td class="num">(654)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss attributable to Zentalis</a></td>
<td class="num">$ (4,253)<span></span>
</td>
<td class="num">$ (34,536)<span></span>
</td>
<td class="num">$ (108,670)<span></span>
</td>
<td class="num">$ (77,515)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064002868104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Consolidated net loss</a></td>
<td class="num">$ (115,998)<span></span>
</td>
<td class="num">$ (78,192)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">335<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">IPR&amp;D impairment</a></td>
<td class="nump">8,800<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_RecognizedTaxGainOnIntangibleAssetImpairment', window );">Recognized tax gain on IPR&amp;D impairment</a></td>
<td class="num">(2,462)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_DeconsolidationGainLossAmountNet', window );">Gain on deconsolidation of Zentera, net of tax</a></td>
<td class="num">(49,930)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">27,266<span></span>
</td>
<td class="nump">15,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of equipment</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeAmortizationOfPremium', window );">Amortization of premiums on marketable securities, net</a></td>
<td class="nump">712<span></span>
</td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">309<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">1,696<span></span>
</td>
<td class="num">(5,784)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">12,310<span></span>
</td>
<td class="nump">9,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet', window );">Operating lease right-of-use assets and liabilities, net</a></td>
<td class="num">(125)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(117,072)<span></span>
</td>
<td class="num">(59,468)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="num">(280,285)<span></span>
</td>
<td class="num">(304,085)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturities of marketable securities</a></td>
<td class="nump">237,139<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashDivestedFromDeconsolidation', window );">Deconsolidation of Zentera cash</a></td>
<td class="num">(14,320)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(3,916)<span></span>
</td>
<td class="num">(97)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(61,382)<span></span>
</td>
<td class="num">(275,182)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of common stock in initial public offering, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">172,482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock under equity incentive plans</a></td>
<td class="nump">4,031<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Contributions from noncontrolling interest owners, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net</a></td>
<td class="nump">162,223<span></span>
</td>
<td class="nump">155,899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Proceeds from the issuance of Series C convertible preferred units, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,228<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">166,254<span></span>
</td>
<td class="nump">361,033<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase/(decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(12,200)<span></span>
</td>
<td class="nump">26,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">56,271<span></span>
</td>
<td class="nump">67,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">44,071<span></span>
</td>
<td class="nump">93,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of&#160;non-cash&#160;investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_StockIssuanceCostsIncurredButNotYetPaid', window );">Costs incurred in connection with initial public offering included in accounts payable and accrued expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">40,807<span></span>
</td>
<td class="nump">92,552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">3,264<span></span>
</td>
<td class="nump">1,320<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash reported in the Condensed Consolidated Statement of Cash Flows</a></td>
<td class="nump">$ 44,071<span></span>
</td>
<td class="nump">$ 93,872<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDivestedFromDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDivestedFromDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeAmortizationOfPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of purchase premium on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeAmortizationOfPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_DeconsolidationGainLossAmountNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deconsolidation, Gain (Loss), Amount, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_DeconsolidationGainLossAmountNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease Right-Of-Use Assets And Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_RecognizedTaxGainOnIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recognized Tax Gain on Intangible Asset Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_RecognizedTaxGainOnIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_StockIssuanceCostsIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issuance Costs Incurred But Not Yet Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_StockIssuanceCostsIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140063993458120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Members&#8217;/Stockholders&#8217; Equity(Deficit) and Changes in Redeemable Convertible Preferred Units - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>IPO</div></th>
<th class="th"><div>Convertible Preferred&#160;Units</div></th>
<th class="th"><div>Class&#160;A Common&#160;Units</div></th>
<th class="th"><div>Class&#160;B Common&#160;Units</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>IPO</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Class&#160;A Common&#160;Units</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Class&#160;B Common&#160;Units</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>IPO</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, beginning balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series C convertible preferred units at $17.50 per unit net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series C convertible preferred units at $17.50 per unit net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">867,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Conversion of convertible preferred units to common stock</a></td>
<td class="nump">$ 155,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (155,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of convertible preferred units to common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,817,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,011,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, ending balance at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="num">(73,285)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (82,993)<span></span>
</td>
<td class="nump">$ 6,821<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonUnitOutstanding', window );">Common units, beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,601,000<span></span>
</td>
<td class="nump">2,671,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonUnitIssuanceValue', window );">Common units, beginning balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 709<span></span>
</td>
<td class="nump">$ 2,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">15,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 329<span></span>
</td>
<td class="nump">14,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_StockCancelledDuringPeriodShares', window );">Cancellation of profit interest awards, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Cancellation of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
<td class="nump">4,744,000<span></span>
</td>
<td class="nump">10,589,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs</a></td>
<td class="nump">155,305<span></span>
</td>
<td class="nump">$ 172,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,300<span></span>
</td>
<td class="nump">$ 172,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Contributions from noncontrolling interest owners</a></td>
<td class="nump">18,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of convertible preferred units to common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,817,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,011,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Conversion of convertible preferred units to common stock</a></td>
<td class="nump">155,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (155,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of common and incentive units to common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,278,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,601,000)<span></span>
</td>
<td class="num">(2,607,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion of common and incentive units to common and restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (709)<span></span>
</td>
<td class="num">$ (2,507)<span></span>
</td>
<td class="nump">3,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interests</a></td>
<td class="num">(654)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(467)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Zentalis</a></td>
<td class="num">(77,538)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77,538)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonUnitOutstanding', window );">Common units, ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonUnitIssuanceValue', window );">Common units, ending balance at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,615,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">365,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">501,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="num">(160,531)<span></span>
</td>
<td class="nump">24,778<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, ending balance at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,878,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2020</a></td>
<td class="nump">237,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">339,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(125,976)<span></span>
</td>
<td class="nump">24,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">7,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Cancellation of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,744,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs</a></td>
<td class="nump">155,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interests</a></td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Zentalis</a></td>
<td class="num">(34,555)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,555)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonUnitOutstanding', window );">Common units, ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonUnitIssuanceValue', window );">Common units, ending balance at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,615,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">$ 365,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">501,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="num">(160,531)<span></span>
</td>
<td class="nump">24,778<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,040,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 333,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">509,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="num">(200,834)<span></span>
</td>
<td class="nump">24,795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">27,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock in connection with restricted stock unit vesting (in shares)</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">442,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation', window );">Deconsolidation event</a></td>
<td class="num">$ (16,899)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,899)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options, net (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options, net</a></td>
<td class="nump">$ 3,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Shares issued under employee stock purchase plan</a></td>
<td class="nump">545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Cancellation of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,565,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs</a></td>
<td class="nump">162,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interests</a></td>
<td class="num">(7,332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,332)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Zentalis</a></td>
<td class="num">(108,666)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(108,666)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,199,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 393,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">702,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="num">(309,500)<span></span>
</td>
<td class="nump">564<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2021</a></td>
<td class="nump">$ 247,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">529,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="num">(305,309)<span></span>
</td>
<td class="nump">23,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">7,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="num">(62)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock in connection with restricted stock unit vesting (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation', window );">Deconsolidation event</a></td>
<td class="num">(16,899)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,899)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options, net</a></td>
<td class="nump">3,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Shares issued under employee stock purchase plan</a></td>
<td class="nump">545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Cancellation of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,565,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs</a></td>
<td class="nump">162,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interests</a></td>
<td class="num">(6,301)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,301)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Zentalis</a></td>
<td class="num">(4,191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,199,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 393,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 702,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="num">$ (309,500)<span></span>
</td>
<td class="nump">$ 564<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonUnitIssuanceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stated value of common units of ownership issued by a limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonUnitIssuanceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonUnitOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common units of ownership outstanding of a limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonUnitOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90193-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationsOfTemporaryToPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares related to Restricted Stock Award forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_StockCancelledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Cancelled During Period, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_StockCancelledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, Conversion Of Units</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140063999157032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Members&#8217;/Stockholders&#8217; Equity(Deficit) and Changes in Redeemable Convertible Preferred Units (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion of common and incentive units to common and restricted stock | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred&#160;Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Par value per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 17.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000519944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Organization and Business</a></td>
<td class="text">Organization and Business<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Organization</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zentalis Pharmaceuticals, Inc. (&#8220;Zentalis&#8221;, &#8220;We&#8221; or the &#8220;Company&#8221;) is a clinical-stage pharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. All of the Company&#8217;s tangible assets are held in the United States.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was formed and incorporated in the state of Delaware as Zeno Pharmaceuticals, Inc. on December&#160;23, 2014. Effective November&#160;21, 2017, Zeno Pharma, LLC was formed by the shareholders of Zeno Pharmaceuticals, Inc. On December&#160;21, 2017, Zeno Pharmaceuticals, Inc. became a wholly owned subsidiary of Zeno Pharma, LLC. In connection with this restructuring, the rights and preferences of the Preferred Stock of Zeno Pharmaceuticals, Inc. were exchanged for preferred units with similar rights and preferences of Zeno Pharma, LLC. As part of the restructuring, the employees, consultants and board members of Zeno Pharmaceuticals, Inc. exchanged their equity grants in Zeno Pharmaceuticals, Inc. stock for Class&#160;B common units in Zeno Pharma, LLC. Additionally, existing common stockholders of Zeno Pharmaceuticals, Inc. exchanged their common stock for Class&#160;A common units in Zeno Pharma, LLC. All exchanges were made on a&#160;one-for-one&#160;basis. The restructuring was accounted for as a common control transaction. In December 2019, the Company was renamed to Zentalis Pharmaceuticals, LLC. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to the effectiveness of the registration statement pertaining to the Company&#8217;s initial public offering (&#8220;IPO&#8221;) on April 2, 2020, the Company converted from a Delaware limited liability company into a Delaware corporation, and changed its name to Zentalis Pharmaceuticals, Inc. Pursuant to the statutory corporate conversion, all of the outstanding units of Zentalis Pharmaceuticals, LLC converted into shares of common stock of Zentalis Pharmaceuticals, Inc. based upon the value of Zentalis Pharmaceuticals, Inc. at the time of the IPO with a value implied by the price of the shares of common stock sold in the IPO. Based on the IPO price of $18.00 per share, the outstanding converted units converted into 25,288,854 shares of common stock (including 1,160,277 shares of restricted common stock).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 7, 2020, the Company completed the IPO in which the Company issued and sold 10,557,000 shares&#160;of common stock (including 1,377,000 shares of common stock in connection with the full exercise of the underwriters&#8217; option to purchase additional shares) at a public offering price of $18.00 per share. The Company&#8217;s aggregate gross proceeds from the sale of shares in the IPO, including the sale of shares pursuant to the full exercise of the underwriters&#8217; option to purchase additional shares, was $190.0&#160;million before fees and expenses of $17.6&#160;million.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div>Substantial doubt about an entity&#8217;s ability to continue as a going concern exists when relevant conditions and events, considered in the aggregate, indicate that it is probable that the entity will be unable to meet its obligations as they become due within one year from the financial statement issuance date. The Company determined that there are no conditions or events that raise substantial doubt about its ability to continue as a going concern within one year after the date that the interim unaudited condensed consolidated financial statements for the quarter ended September&#160;30, 2021 are issued.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000522456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interim Unaudited Financial Statements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Interim Unaudited Financial Statements</a></td>
<td class="text">Interim Unaudited Financial Statements <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and with the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) related to a quarterly report on Form 10-Q. The year-end condensed consolidated balance sheet data was derived from the Company&#8217;s audited financial statements but does not include all disclosures required by U.S. GAAP. These condensed consolidated financial statements and notes thereto should be read in conjunction with the Company&#8217;s audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on March 25, 2021. The unaudited financial information for the interim periods presented herein reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of the financial condition and results of operation for the periods presented, with such adjustments consisting only of normal recurring adjustments. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include our accounts and our wholly-owned subsidiaries and variable interest entity (&#8220;VIE&#8221;) for which we are the primary beneficiary. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our ownership, contractual and other interests in entities that are not wholly-owned by us to determine if these entities are VIEs, and, if so, whether we are the primary beneficiary of the VIE. In determining whether we are the primary beneficiary of a VIE and therefore required to consolidate the VIE, we apply a qualitative approach that determines whether we have both (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the rights to receive benefits from, the VIE that could potentially be significant to that VIE. We continuously assess whether we are the primary beneficiary of a VIE as changes to existing relationships or future transactions may result in the consolidation or deconsolidation, as the case may be, of such VIE.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The equity method is used to account for investments in which we have the ability to exercise significant influence, but not control, over the investee. Such investments are recorded on the balance sheet, and the share of net income or losses of equity investments is recognized on a one quarter lag in investment and other income (expense), net.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates and judgments, which are based on historical and anticipated results and trends and on various other assumptions that management believes to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management&#8217;s estimates.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Though the impact of the COVID-19 pandemic to our business and operating results presents additional uncertainty, we continue to use the best information available to inform our critical accounting estimates.</span></div><div style="margin-bottom:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, there have been no changes to the Company&#8217;s significant accounting policies as described in its Annual Report on Form 10-K for the fiscal year ended December 31, 2020 outside of the equity method accounting for investments and adoption and pending adoption of recent accounting pronouncements mentioned below.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Accounting</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant influence, but not a controlling interest, in Zentera. From the deconsolidation of Zentera during July 2021 prospectively, this investment is accounted for using the equity method. Our share of earnings or losses of the investment entity are reported on the consolidated statement of operations through investment and other income, net, with a corresponding increase or decrease to the equity investment carried on the statement of financial position. This information is generally not received sufficiently timely for us to record our portion of earnings or loss in the current financial statements and therefore we report our portion of earnings or loss on a one quarter lag.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adoption and Pending Adoption of Recent Accounting Pronouncements </span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a brief description of recently issued accounting standards, those adopted in the current period and those not yet adopted:</span></div><div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.717%"><tr><td style="width:1.0%"/><td style="width:14.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.854%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.774%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.774%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Financial<br/>Statements or Other<br/>Significant Matters</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In January 2020, the FASB issued ASU 2020-01, Investments &#8211; Equity Securities (Topic 321)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This standard clarifies the interaction between accounting standards related to equity securities (ASC 321), equity method investments (ASC 323), and certain derivatives (ASC 815).&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 1, 2021, we did not hold equity securities, equity method investments or derivatives. The impact of this new accounting guidance in 2021 did not have a material impact to our consolidated financial statements at the time of adoption.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of July 2021, we hold an equity method investment which is accounted for under ASC 323. The investment is recorded on the consolidated statement of financial position at fair value as of the date of deconsolidation. The Company&#8217;s share of earnings or losses of the investment entity are reported on the consolidated statement of operations through investment and other income, net with a corresponding increase or decrease to the equity investment. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000547992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Significant Transactions</a></td>
<td class="text">Significant Transactions<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zentera Therapeutics</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we became a majority common shareholder of Zentera Therapeutics, Ltd., a Shanghai-based clinical-stage biopharmaceutical company focused on developing cancer therapeutics (&#8220;Zentera&#8221;), concurrent with its Series A convertible preferred stock offering. The financial position and results of operations of Zentera have been included in our consolidated financial statements from the date of the initial investment as a result of our control of the entity. In July 2021, Zentera completed a Series B convertible preferred stock offering which diluted our investment to a position of less than majority owned. Upon review of the facts and circumstances, together with the authoritative accounting literature, we determined that consolidation of Zentera is no longer appropriate. After the July 2021 Series B convertible preferred offering in which we did not participate, our review concluded that we ceased to have a controlling financial interest in Zentera, an additional board member was added to the Zentera </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">board of directors and we concluded that we no longer have the power to direct the activities that most significantly affect Zentera&#8217;s economic performance nor are we the primary beneficiary of Zentera.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in July 2021, the financial position and results of operations of Zentera are no longer included in our consolidated financial statements. An equity method investment of $39.3 million was recorded on our balance sheet representing the fair value of our common stock investment using the backsolve method with consideration for a lack of marketability at the time of deconsolidation. A corresponding deferred tax liability of $1.7 million representing the tax impact of the unrealized gain on deconsolidation was recorded during the three months ended September 30, 2021. A gain of $51.6 million, measured as the difference between the fair value of our retained noncontrolling interest together with the carrying amount of the Zentera noncontrolling interest, and the carrying amount of Zentera&#8217;s assets and liabilities was recognized during the third quarter of 2021.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, each of our subsidiaries Zeno Alpha, Inc., K-Group Alpha, Inc., Zeno Management Inc., and K-Group Beta, Inc. entered into a collaboration and royalty-bearing license agreement with Zentera, which we refer to as the &#8220;Zentera Sublicenses,&#8221; pursuant to which we collaborate with Zentera on the development and commercialization of ZN-c3, ZN-c5 and ZN-d5, respectively, in the People&#8217;s Republic of China, Macau, Hong Kong and Taiwan, which is referred to as the &#8220;Zentera Collaboration Territory.&#8221; Under each Zentera Sublicense, Zentera will lead development, and upon regulatory approval, the commercialization, of the collaboration products in the Zentera Collaboration Territory. </span></div>Under the terms of the Zentera Sublicenses, Zentera is responsible for the costs of developing the Collaboration Products in the Zentera Collaboration Territory, and we are responsible for the costs of developing the Collaboration Products outside the Zentera Collaboration Territory, provided that Zentera will reimburse us for a portion of the costs for global data management, pharmacovigilance, safety database management, and chemistry, manufacturing and controls activities with respect to each Collaboration Product. Prior to the deconsolidation of Zentera, these costs were eliminated in consolidation. For the period subsequent to deconsolidation to September 30, 2021, the amounts incurred under this arrangement totaled $2.9 million and are presented as contra-research and development expense in the consolidated statement of operations. A corresponding receivable is recorded within prepaid expenses and other current assets on the consolidated balance sheet.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000421608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Kalyra Pharmaceuticals, Inc.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;21, 2017, we acquired $4.5&#160;million of Kalyra&#8217;s Series B Preferred Stock representing a 25% equity interest in Kalyra for purposes of entering the analgesics therapeutic research space. The acquisition price was paid entirely in cash.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the authoritative guidance, we concluded that Kalyra is a business consisting of inputs, employees, intellectual property and processes capable of producing outputs. Additionally, we have concluded that Kalyra is a variable interest entity, we are the primary beneficiary and have the power to direct the activities that most significantly affect Kalyra&#8217;s economic performance through common management and our board representation. Prior to the change of control, the Company and Kalyra transacted for the delivery of research and development services and support. The financial position and results of operations of Kalyra have been included in our consolidated financial statements from the date of the initial investment.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant with authoritative guidance, we have recorded the identifiable assets, liabilities and noncontrolling interests in the VIE at their fair value upon initial consolidation. The identified goodwill is comprised of the workforce and expected synergies from combining the entities. During the third quarter of 2021, Kalyra determined that they will no longer pursue the development of Kalyra&#8217;s lead product candidate and ceased the associated clinical trial. The in-process research and development costs (&#8220;IPR&amp;D&#8221;) recorded on Kalyra&#8217;s balance sheet exclusively relates to this candidate. Management recorded an impairment charge of $8.8&#160;million within the research and </span></div><div style="margin-bottom:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development expense line item on the consolidated statement of operations during the third quarter of 2021, which resulted in a reduction of the IPR&amp;D asset from $8.8&#160;million to zero. The impairment of IPR&amp;D resulted in a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> reversal of the associated deferred tax liability of $2.4 million during the third quarter of 2021. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and liabilities of Kalyra as of September&#160;30, 2021 and December&#160;31, 2020 are as follows (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="background-color:#cdffcc;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process&#160;research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liabilities recognized as a result of consolidating Kalyra do not represent additional claims on our general assets. Pursuant to the authoritative guidance, the equity interest in Kalyra not owned by Zentalis is reported as a noncontrolling interest on our condensed consolidated balance sheets.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of equity (net assets) attributable to the noncontrolling interest (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.416%"><tr><td style="width:1.0%"/><td style="width:82.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.223%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140063999032744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurement</a></td>
<td class="text">Fair Value Measurement<div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale marketable securities consisted of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Government Agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Treasury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,952&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,984&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Government Agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Treasury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company regularly reviews the securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as the severity of the impairment, changes in underlying credit ratings, forecasted recovery, our intent to sell or the likelihood that we would be required to sell the investment before its anticipated recovery in market value and the probability that the scheduled cash payments will continue to be made. Based on our review of these marketable securities, we believe none of the unrealized loss is as a result of a credit loss as of September&#160;30, 2021, because we do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of their amortized cost basis. </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of available-for-sale debt securities are as follows (in thousands):</span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.044%"><tr><td style="width:1.0%"/><td style="width:51.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.256%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one but within five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,984&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,554&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes, by major security type, our cash equivalents and available-for-sale marketable securities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"/><td style="width:18.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total estimated fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents:</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,648&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,648&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,016&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Government Agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale marketable securities:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value<br/></span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,341&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,291&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,632&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,125&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,569&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between Level&#160;1 and Level&#160;2 of the fair value hierarchy during the nine months ended September&#160;30, 2021. We had no instruments that were classified within Level&#160;3 as of September&#160;30, 2021 or December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140063998815784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsDisclosureTextBlock', window );">Prepaid Expenses and Other Assets</a></td>
<td class="text">Prepaid Expenses and Other Assets<div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other assets consisted of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid software licenses and maintenance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign R&amp;D credit refund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zentera receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,465&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,158&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less long-term portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other assets, current</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,423&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,182&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000957208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, net</a></td>
<td class="text">Property and Equipment, net<div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and Office Equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold Improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in Progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,698&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense for the three months ended September&#160;30, 2021 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was approximately $137 thousand and $51 thousand, respectively. Depreciation and amortization expense for the nine months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span> and 2020 was approximately $335 thousand and $127 thousand, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140063998815784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text">Accrued Expenses<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,947&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,369&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,940&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064001086696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Units<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_TemporaryEquityTextBlock', window );">Convertible Preferred Units</a></td>
<td class="text">Convertible Preferred Units<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series A Convertible Preferred Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, Zeno Pharmaceuticals, Inc. entered into a Series A Preferred Stock Purchase Agreement (the &#8220;Series A Preferred Agreement&#8221;). Under the terms of the Series A Preferred Agreement, Zeno Pharmaceuticals, Inc. issued 1,293,104 shares of Series A convertible preferred stock at $11.60 per share for gross proceeds of $15.0&#160;million. The net proceeds of this financing were $14.9&#160;million after issuance costs of $0.1&#160;million. In February and March 2016, Zeno Pharmaceuticals, Inc. issued an aggregate of 286,205 additional shares of Series A convertible preferred stock at $11.60 per share for additional gross proceeds of $3.3&#160;million. The issuance costs of this additional financing were approximately thirty-nine thousand dollars. All Series A convertible preferred stock issued and outstanding by Zeno Pharmaceuticals, Inc. was converted into Series A convertible preferred units of Zentalis Pharmaceuticals, LLC in conjunction with the corporate restructuring and merger.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Convertible Preferred Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, Zentalis Pharmaceuticals, LLC entered into a Series B Preferred Unit Purchase Agreement (the &#8220;Series B Preferred Agreement&#8221;). Under the terms of the Series B Preferred Agreement, Zentalis Pharmaceuticals, LLC issued 2,735,320 Series B preferred units at $12.43 per unit for gross proceeds of $34.0&#160;million. The net proceeds of this financing were $32.1&#160;million after issuance costs of $1.9&#160;million. In January and August 2018, Zentalis Pharmaceuticals, LLC issued an aggregate of 788,419 additional shares of Series B preferred units at $12.43 per unit for additional gross proceeds of $9.8&#160;million. The net proceeds of this additional financing were $9.5&#160;million after issuance costs of $0.3&#160;million.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series C Convertible Preferred Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, Zentalis Pharmaceuticals, LLC entered into a Series C Preferred Unit Purchase Agreement (the &#8220;Series C Preferred Agreement&#8221;). Under the terms of the Series C Preferred Agreement, Zentalis Pharmaceuticals, LLC issued 4,847,106 units of Series C convertible preferred units at $17.50 per unit for gross proceeds of $84.8&#160;million. The net proceeds of this financing were $81.9&#160;million after issuance costs of $2.9&#160;million. In February 2020, Zentalis Pharmaceuticals, LLC issued 867,194 additional units of Series C preferred units under the Series C Preferred Agreement. The units were issued for $17.50 per unit for gross proceeds of $15.2&#160;million. The net proceeds of this financing were $14.2&#160;million after issuance costs of $1.0&#160;million.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no authorized, issued, or outstanding shares of convertible preferred units at September&#160;30, 2021 and December&#160;31, 2020. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2020, we reclassified the convertible preferred units from members&#8217; equity to temporary equity because, in conjunction with the Series C convertible preferred units issuance, all units were now deemed to contain contingent liquidation features that are not solely within our control. During the year ended December&#160;31, 2020, we did not adjust the carrying values of the convertible preferred units to the deemed redemption values of such units since a liquidation event was not probable. </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends are payable if and when declared by the Board of Directors. No dividends have been declared through September&#160;30, 2021. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Series A preferred unit, Series B preferred unit and Series C preferred unit was convertible at the option of the holder thereof, at any time after the issuance of such unit, into Class&#160;A common units at a conversion price equal to the original purchase price (subject to anti-dilution adjustments, discussed below) which was $11.60, $12.43 and $17.50 per unit, respectively. The convertible preferred units automatically converted at the then applicable conversion rate upon the closing of a firm commitment underwritten public offering of shares of a successor corporations&#8217; common stock, at a public offering price per share of equal to or greater than the Series C original purchase price (as adjusted for any stock splits, stock dividends, combinations or other similar recapitalization) resulting in aggregate gross cash proceeds of at least $75.0&#160;million (a &#8220;Qualified IPO&#8221;). Additionally, the convertible preferred unit would have automatically converted into common stock, at the then applicable conversion rate, upon written consent of a majority of the then outstanding Series A, Series B and Series C convertible preferred units (voting as a separate class on an as converted to Common Unit basis). In conjunction with our IPO on April 2, 2020, which constituted a Qualified IPO, all convertible preferred units were converted to common stock. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-dilution protection</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the convertible preferred units had proportional anti-dilution protection for unit splits, unit dividends and similar recapitalizations. Subject to certain exclusions, anti-dilution price protection for additional sales of securities by us for consideration per unit less than the applicable conversion price per unit of any series of convertible preferred stock, was on a broad-based weighted average basis.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective rights</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the convertible preferred units had certain protective rights, including, without limitation, regarding the authorization, alteration, redemption, or sale of Class&#160;B common units; commencement of a liquidation or deemed liquidation event; entrance into a joint venture or partnership; any incurrence of indebtedness; certain transactions that exceed a certain dollar threshold; changes to our governing documents; or the declaration of any dividends. Such actions were required to be approved by a majority of the then outstanding Series A, Series B and Series C convertible preferred unit holders (voting as a single class and on an&#160;as-converted&#160;basis), as specified in the amended and restated LLC agreement. An increase or decrease in the authorized number of Directors constituting the Board or the creation of a membership interest or equity security senior to or pari passu with Series C convertible preferred units was required to be approved by a majority of the then outstanding Series C convertible preferred Units (voting as a separate class on an as converted basis).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series A, Series B and Series C convertible preferred units were not redeemable except in the event of certain effected deemed liquidation events. As of immediately prior to our IPO on April 2, 2020, we had classified convertible preferred units as temporary equity in accordance with authoritative guidance for the classification and </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measurement of potentially redeemable securities whose redemption is based upon certain change in control events outside of our control, including liquidation, sale or transfer of control of the Company. We did not adjust the carrying value of the convertible preferred units to the deemed redemption values of such units since a liquidation event was not probable.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidation preference</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of the dissolution, liquidation, merger or winding up of the Company, the holders of Series C convertible preferred units were entitled to receive, on a pro rata basis in respect of each such Series C convertible preferred unit, a preference amount of $17.50 per Series C convertible unit (as adjusted for any unit splits, dividends, combinations, recapitalizations or the like).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the payment of the Series C convertible preferred unit preferences, Series A and Series B convertible preferred units were entitled to receive, on a pro rata basis in respect of each convertible preferred unit in proportion to the relative preference amount of each preferred unit, a preference amount of $11.60 and $12.43 per unit of Series A and Series B convertible preferred units (as adjusted for any units splits, dividend, combinations, recapitalizations of the like), respectively.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the payment of the Series C, Series A and Series B convertible preferred unit preferences, Series A, Series B and Series C convertible preferred units are entitled to receive, on an as converted to common unit pro rata basis, an amount equal to distributions made to Class&#160;A common units prior to all unit classes sharing in distributions on a pro rata basis. Thereafter, Series A, Series B and Series C convertible preferred units and Series A and Series B common units were entitled to receive the remaining assets of the Company available for distribution to its unit holders pro rata based on the number of common units held by each holder, treating for these purposes as if all units had been converted to common.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of all units other than Class&#160;B common units that were unvested were to vote together as a single class. Each holder of Series A, Series B and Series C convertible preferred units were entitled to the number of votes calculated on an as converted to Class&#160;A common unit basis.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_TemporaryEquityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_TemporaryEquityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140063999141592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Members&#8217; Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock', window );">Members&#8217; Equity</a></td>
<td class="text">Members&#8217; Equity <div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, Zentalis Pharmaceuticals, LLC was formed in the state of Delaware. In conjunction with a corporate restructuring, Zeno Pharmaceuticals, Inc., a Delaware corporation formed in 2014, was acquired by the Company pursuant to a merger agreement and became a wholly owned subsidiary of the Company. Per the terms of the merger agreement, each share of Zeno Pharmaceuticals, Inc. common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive one Class&#160;A common unit and each share of Zeno Pharmaceuticals, Inc. Series A preferred stock issued and outstanding immediately prior to the effective date of the merger converted into the right to receive one Series A preferred unit. As of the effective time of the merger agreement, all outstanding options to purchase shares of Zeno Pharmaceuticals, Inc. common stock were cancelled and replaced with profits interest awards in the LLC.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the December 2017 corporate restructuring, we amended and restated the LLC agreement, and as amended, the capital units of the Company consisted of 1,638,000 authorized Series A preferred units, 3,621,000 authorized Series B preferred units, 15,000,000 authorized Class&#160;A common units and 872,620 authorized Class&#160;B common units.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class&#160;A Common Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the corporate restructuring in December 2017, 5,187,554 shares of common stock issued and outstanding and 406,831 shares of common stock subject to future vesting provisions of Zeno Pharmaceuticals, Inc. were converted into an equal number of Class&#160;A common units of Zentalis Pharmaceuticals, LLC. In September </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019, the number of authorized Class&#160;A common units was increased to 20,000,000. During the nine months ended September&#160;30, 2021 and 2020, we did not issue any Class A common units. As of September&#160;30, 2021 and 2020, there were no Class A common units subject to future vesting conditions.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class&#160;B Common Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the corporate restructuring in December 2017, 703,000 options exercisable into Zeno Pharmaceuticals, Inc. common stock were converted into an equal number of Class&#160;B Common Units of Zentalis Pharmaceuticals, LLC. In September 2019, the number of authorized Class&#160;B common units was increased to 3,458,522.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IPO and Follow-on Offerings</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 2, 2020 and immediately prior to the effectiveness of the Company&#8217;s IPO, Zentalis Pharmaceuticals, LLC converted from a Delaware limited liability company into a Delaware corporation pursuant to a statutory conversion, and changed its name to Zentalis Pharmaceuticals, Inc. In order to consummate the corporate conversion, a certificate of conversion was filed with the Secretary of State of the State of Delaware. All of the outstanding units of Zentalis Pharmaceuticals, LLC converted into shares of common stock of Zentalis Pharmaceuticals, Inc. based upon the value of Zentalis Pharmaceuticals, Inc. at the time of the IPO with a value implied by the price of the shares of common stock sold in the IPO. No cash or fractional shares of common stock were issued in connection with the corporate conversion. Based on the IPO price of $18.00 per share of common stock, all of the outstanding units converted into an aggregate of 25,288,854 shares of common stock (including 1,160,277 shares of restricted common stock).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the completion of the IPO, the board and stockholders approved the certificate of incorporation to provide for 250,000,000 authorized shares of common stock with a par value of $0.001 per share and 10,000,000 authorized shares of preferred stock with a par value of $0.001 per share.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 7, 2020, the Company completed an IPO in which the Company issued and sold 10,557,000 shares of common stock (including 1,377,000 shares of common stock in connection with the full exercise of the underwriters&#8217; option to purchase additional shares) at a price of $18.00 per share. The Company&#8217;s aggregate gross proceeds from the sale of shares in the IPO, including the sale of shares pursuant to the full exercise of the underwriters&#8217; option to purchase additional shares, was $190.0&#160;million before fees and expenses of $17.6&#160;million.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 3, 2020, the Company completed a follow-on offering in which the Company issued and sold 4,743,750 shares of common stock (including 618,750 shares of common stock in connection with the full exercise of the underwriters&#8217; option to purchase additional shares) at a public offering price of $35.00 per share. The Company&#8217;s aggregate gross proceeds from the sale of shares in the follow-on offering, including the sale of shares pursuant to the full exercise of the underwriters&#8217; option to purchase additional shares, was $166.0&#160;million before fees and expenses of $10.8&#160;million.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed a follow-on offering in which the Company issued and sold 3,565,000 shares of common stock (including 465,000 shares of common stock in connection with the full exercise of the underwriters&#8217; option to purchase additional shares) at a public offering price of $48.50 per share. The Company&#8217;s aggregate gross proceeds from the sale of shares in the follow-on offering, including the sale of shares pursuant to the full exercise of the underwriters&#8217; option to purchase additional shares, was $172.9&#160;million before fees and expenses of $10.7 million.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Company&#8217;s 2017 Profits Interest Plan (&#8220;the Plan&#8221;) as approved and adopted by the Board of Directors on December 21, 2017, the Company was authorized to issue up to 3,458,522 shares of Class B common units, (&#8220;profits interest award units&#8221;), subject to restrictions as described in the Plan. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In April 2020, the Plan was terminated and the Company&#8217;s board of directors adopted, and the Company&#8217;s stockholders approved the 2020 Incentive Award Plan (&#8220;the 2020 Plan&#8221;), which became effective upon the corporate conversion and allows for grants to selected employees, consultants and non-employee members of the Board of Directors. We currently grant stock options and restricted stock units under the 2020 Plan. The number of common shares available for issuance under the 2020 Plan is the sum of (1) 5,600,000 shares of common stock; plus (2) any shares forfeited from the unvested restricted shares of our common stock issued upon conversion of unvested Class B common units (up to 1,250,000 shares); plus (3) an annual increase on the first day of each fiscal year beginning with the fiscal year ending December 31, 2021 and continuing to, and including, the fiscal year ending December 31, 2030, equal to the lesser of (a) 5% of the shares of common stock outstanding on the final day of the immediately preceding calendar year and (b) such smaller number of shares as determined by our board of directors. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, 4,418,484 shares were subject to outstanding awards and 2,237,052 shares were available for future grants of share-based awards. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense related to share based awards was comprised of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,656&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,249&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,259&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the deconsolidation during the third quarter of 2021, total share-based compensation expense includes $138&#160;thousand of share-based compensation expense for employees, consultants and directors of Zentera, for the nine months ended September&#160;30, 2021, compared to $187 thousand for the same period in 2020.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by type of share-based award (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.082%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit Interest Award Units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs and RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,786&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,656&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,249&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,259&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the profits interest awards is estimated using an option pricing model with the following assumptions:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"/><td style="width:77.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.880%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Members&#8217; equity value (in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Threshold amounts (in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to liquidity (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lack of marketability discount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of each profits interest award on the date of grant. The members&#8217; equity value was based on a recent enterprise valuation analysis performed. The threshold amounts are based on the discretion of the Board of Directors at the time of grant. The expected life of the Class&#160;B Common Unit awards granted during the period presented was determined based on an expected liquidation event under the plan. We apply the risk-free interest rate based on the U.S. Treasury yield in effect at the time of the grant consistent with the life of the award. The expected volatility is based on a peer group in the industry in which the Company does business consistent with the expected time to liquidity. The dividend yield was set at zero as the underlying security does not and is not expected to pay a dividend. The Finnerty model and the Asian Protective Put Model methods were used to estimate the discount for lack of marketability inherent to the awards.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class&#160;B common units issued have been classified as equity awards, and share-based compensation expense is based on the grant date fair value of the award. During the nine months ended September&#160;30, 2021 and 2020, we issued zero and 70,000 Class B common units, respectively. As of September&#160;30, 2021 and December&#160;31, 2020, there were no Class B common units outstanding. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options and Restricted Stock Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exercise price of stock options granted is equal to the closing price of the common stock on the date of grant. The fair value of each option award is estimated on the date of grant using the Black-Scholes model. Due to the Company&#8217;s limited operating history and a lack of company specific historical and implied volatility data, the Company estimates expected volatility based on the historical volatility of a group of similar companies that are publicly traded. The historical volatility data was computed using the daily closing prices for the selected companies&#8217; shares during the equivalent period of the calculated expected term of the stock-based awards. The Company uses the &#8220;simplified method&#8221; for estimating the expected term of employee options, whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option (generally 10 years). The risk-free interest rate is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The Company has not issued any dividends and does not expect to issue dividends over the life of the options. As a result, the Company has estimated the dividend yield to be zero. The fair value of the stock options granted during the nine months ended September&#160;30, 2021 and September&#160;30, 2020 was determined with the following assumptions:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.839%"><tr><td style="width:1.0%"/><td style="width:44.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.452%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9% - 76.6%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.6% - 78.2%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 - 6.2</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 - 6.0</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5% - 1.1%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4% - 0.5%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average assumptions used to estimate the fair value of stock purchase rights under the employee stock purchase plan (&#8220;ESPP&#8221;) are as follows:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.782%"><tr><td style="width:1.0%"/><td style="width:30.055%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.055%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.059%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the ESPP, the Company&#8217;s employees may elect to have up to 20% of their compensation, up to a maximum of $21,250 per calendar year, withheld to purchase shares of the Company&#8217;s common stock for a purchase price equal to 85% of the lower of the fair market value per share (at closing) of the Company&#8217;s common stock on (i) the first trading day of a six-month offering period, or (ii) the applicable purchase date, defined as the last trading day of the six-month offering period.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unrecognized estimated compensation cost by type of award and the weighted average requisite service period over which such expense is expected to be recognized (in thousands, unless otherwise noted):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.256%"><tr><td style="width:1.0%"/><td style="width:31.878%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.881%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized <br/>Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining <br/>Weighted-Average Recognition Period <br/>(years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,008&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.05</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.84</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.29</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, we issued 0.1&#160;million shares of common stock in connection with the exercises of stock options. For the nine months ended September&#160;30, 2021, 0.3 million shares of </span></div>common stock issued in conjunction with certain restricted stock awards vested. Outstanding stock options, unvested restricted stock awards, and unvested restricted stock units totaling approximately 4.1&#160;million shares, 0.4&#160;million shares and 0.4&#160;million shares of our common stock, respectively, were outstanding as of September&#160;30, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shareholders' Equity, Share-Based Payments, And Members' Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000426552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Contingencies </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we may be involved in various disputes, including lawsuits and claims arising in the ordinary course of business, including actions with respect to intellectual property, employment, and contractual matters. Any of these claims could subject us to costly legal expenses. The Company records a liability in its consolidated financial statements for these matters when a loss is known or considered probable and the amount can be reasonably estimated. The Company reviews these estimates each accounting period as additional information is known and adjusts the loss provision when appropriate. If a matter is both probable to result in a liability and the amounts of loss can be reasonably estimated, the Company estimates and discloses the possible loss or range of loss to the extent necessary to make the consolidated financial statements not misleading. If the loss is not probable or cannot be reasonably estimated, a liability is not recorded in our consolidated financial statements. While we do generally believe that we have adequate insurance to cover many different types of liabilities, our insurance carriers may deny coverage, or our policy limits may be inadequate to fully satisfy any damage awards or settlement. If this were to happen, the payment of any such awards could have a material adverse effect on our consolidated results of operations and financial position. Additionally, any such claims, whether or not successful, could damage our reputation and business. We are currently not a party to any legal proceedings.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commitments include payments related to operating leases. Approximate annual future minimum operating lease payments as of September&#160;30, 2021 are as follows (in thousands): </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The weighted-average remaining lease term of our operating leases is approximately 0.8 years. As of September&#160;30, 2021, we had entered into two additional leases for real estate that have not yet commenced with total minimum lease payments of approximately $74.6 million. These leases are expected to commence in the fourth quarter of 2021 and have lease terms of 10 years and 11 years, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000653640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share/Class&#160;A Common Unit<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Common Share/Class&#160;A Common Unit</a></td>
<td class="text">Net Loss Per Common Share/Class&#160;A Common Unit <div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per common share/Class&#160;A common unit were calculated as follows (in thousands except per share and per unit amounts):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Zentalis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,555)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108,666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.09)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.91)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.59)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.21)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our potential and dilutive securities, which include outstanding stock options, unvested RSAs and unvested RSUs have been excluded from the computation of diluted net loss per common share as the effect would be anti-dilutive. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents have been excluded from the calculations of diluted net loss per common share because their inclusion would be antidilutive (in thousands).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.153%"><tr><td style="width:1.0%"/><td style="width:58.359%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.269%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.269%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSAs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSUs </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,866&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140063999034632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Disclosures<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Disclosures</a></td>
<td class="text">Related Party Disclosures<div style="text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kalyra Pharmaceuticals, Inc. and Recurium IP Holdings, LLC</span></div><div style="text-indent:24.5pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;21, 2017, we acquired 17,307,692 shares of Series B preferred stock of Kalyra Pharmaceuticals, Inc. for a per share price of&#160;twenty-six&#160;cents ($0.26) or approximately $4.5&#160;million. The management team and stockholders of Kalyra are also stockholders of the Company.</span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the investment, we entered into a license agreement and a master services agreement with Kalyra. The license agreement was signed and commenced on December&#160;31, 2014 for the exclusive rights to develop and commercialize products derived from Kalyra&#8217;s technology in the initial area of oncology. The license agreement and all rights were subsequently sold from Kalyra to Recurium IP Holdings, LLC (&#8220;Recurium IP&#8221;), an entity with common ownership to Kalyra prior to the Zentalis investment. Under the agreement, we have agreed to make payments to Recurium IP based on specific milestones. In addition, the Company shall pay mid to&#160;high-single&#160;digit percentage royalties on net product sales to Recurium IP and sublicense fees on any consideration paid to us by a sublicensor. All payments are based on Recurium Equity, LLC&#8217;s, an affiliate company of Recurium IP, equity ownership stake in us as of December 2020. The license agreement will terminate upon the later of the last expiration of the patent rights or 15 years from the date of commencement. For the nine months ended </span></div><div style="margin-bottom:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we paid $10.0&#160;million and zero, respectively, in milestone payments to Recurium IP in connection with the commencement of Phase 2 trials for ZN-c3 and ZN-c5.</span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Master Services Agreement (&#8220;MSA&#8221;) was entered into in January 2015 and states that Kalyra may provide research and development services to us and that we shall reimburse such expenses on a time and materials basis based on the initial statements of work. For each of the three months ended September&#160;30, 2021 and 2020, we did not incur any expense with Kalyra. For the nine months ended September&#160;30, 2021 and 2020, we incurred approximately zero and seventeen thousand dollars of expense with Kalyra, respectively, that was eliminated in consolidation for research and development services provided. As of September&#160;30, 2021 and 2020, there was no balance due to Kalyra.</span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into an Intercompany Services Agreement (&#8220;ISA&#8221;) with Kalyra in January 2018 which states that we may provide research and development services to Kalyra and that Kalyra shall reimburse such expenses on a time and materials basis. For the three and nine months ended September&#160;30, 2021 and 2020, we provided immaterial research and development services to Kalyra that were eliminated in consolidation, respectively. As of September&#160;30, 2021 and 2020, an immaterial amount was due from Kalyra and eliminated in consolidation, respectively.</span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tempus</span></div><div style="text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kimberly Blackwell, M.D., is a member of the Company's board of directors and is also the Chief Medical Officer of Tempus Labs, Inc. ("Tempus"). The Company entered into a Master Services Agreement with Tempus in December 2020 to provide data licensing and research services. There were $1.0&#160;million and zero fees incurred for services performed by Tempus for the nine months ended September&#160;30, 2021 and 2020, respectively.</span></div><div style="text-indent:24.5pt"><span><br/></span></div><div style="text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Zentera</span></div><div style="text-indent:24.5pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony Y. Sun, M.D., our President and Chief Executive Officer, serves as Chief Executive Officer and a member of the board of directors of Zentera, and Kevin D. Bunker, Ph.D., our Chief Operating Officer, serves as a member of the board of directors of Zentera. Accordingly, the Company identifies Zentera as a related party.</span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we entered into the Zentera Sublicenses, pursuant to which we collaborate with Zentera on the development and comm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ercialization of ZN-c3, ZN-c5 and ZN-d5, respectively, in the Zentera Collaboration Territory. Under the terms of the Zentera Sublicenses, Zentera is responsible for the costs of developing the Collaboration Products in the Zentera Collaboration Territory, and we are responsible for the costs of developing the Collaboration Products outside the Zentera Collaboration Territory, provided that Zentera will reimburse us for a portion of its costs for global data management, pharmacovigilance, safety database management, and chemistry, manufacturing and controls activities with respect to each Collaboration Product. Prior to the deconsolidation of Zentera during the three months ended September 30, 2021, these costs were eliminated in consolidation. For the three months ended September 30, 2021, the amounts incurred under this arrangement totaled $2.9 million and are presented as contra-research and development expense in the consolidated statement of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064005189592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interim Unaudited Financial Statements (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of PresentationThe accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and with the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) related to a quarterly report on Form 10-Q. The year-end condensed consolidated balance sheet data was derived from the Company&#8217;s audited financial statements but does not include all disclosures required by U.S. GAAP. These condensed consolidated financial statements and notes thereto should be read in conjunction with the Company&#8217;s audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on March 25, 2021. The unaudited financial information for the interim periods presented herein reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of the financial condition and results of operation for the periods presented, with such adjustments consisting only of normal recurring adjustments.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include our accounts and our wholly-owned subsidiaries and variable interest entity (&#8220;VIE&#8221;) for which we are the primary beneficiary. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our ownership, contractual and other interests in entities that are not wholly-owned by us to determine if these entities are VIEs, and, if so, whether we are the primary beneficiary of the VIE. In determining whether we are the primary beneficiary of a VIE and therefore required to consolidate the VIE, we apply a qualitative approach that determines whether we have both (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the rights to receive benefits from, the VIE that could potentially be significant to that VIE. We continuously assess whether we are the primary beneficiary of a VIE as changes to existing relationships or future transactions may result in the consolidation or deconsolidation, as the case may be, of such VIE.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The equity method is used to account for investments in which we have the ability to exercise significant influence, but not control, over the investee. Such investments are recorded on the balance sheet, and the share of net income or losses of equity investments is recognized on a one quarter lag in investment and other income (expense), net.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates and judgments, which are based on historical and anticipated results and trends and on various other assumptions that management believes to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management&#8217;s estimates.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Though the impact of the COVID-19 pandemic to our business and operating results presents additional uncertainty, we continue to use the best information available to inform our critical accounting estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Accounting</a></td>
<td class="text">Equity Method AccountingWe have significant influence, but not a controlling interest, in Zentera. From the deconsolidation of Zentera during July 2021 prospectively, this investment is accounted for using the equity method. Our share of earnings or losses of the investment entity are reported on the consolidated statement of operations through investment and other income, net, with a corresponding increase or decrease to the equity investment carried on the statement of financial position. This information is generally not received sufficiently timely for us to record our portion of earnings or loss in the current financial statements and therefore we report our portion of earnings or loss on a one quarter lag.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Adoption and Pending Adoption of Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adoption and Pending Adoption of Recent Accounting Pronouncements </span></div><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a brief description of recently issued accounting standards, those adopted in the current period and those not yet adopted:</span></div><div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.717%"><tr><td style="width:1.0%"/><td style="width:14.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.854%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.774%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.774%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Financial<br/>Statements or Other<br/>Significant Matters</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In January 2020, the FASB issued ASU 2020-01, Investments &#8211; Equity Securities (Topic 321)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This standard clarifies the interaction between accounting standards related to equity securities (ASC 321), equity method investments (ASC 323), and certain derivatives (ASC 815).&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 1, 2021, we did not hold equity securities, equity method investments or derivatives. The impact of this new accounting guidance in 2021 did not have a material impact to our consolidated financial statements at the time of adoption.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of July 2021, we hold an equity method investment which is accounted for under ASC 323. The investment is recorded on the consolidated statement of financial position at fair value as of the date of deconsolidation. The Company&#8217;s share of earnings or losses of the investment entity are reported on the consolidated statement of operations through investment and other income, net with a corresponding increase or decrease to the equity investment. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140063999027096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interim Unaudited Financial Statements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Recently Issued Accounting Standards Adopted and Not Yet Adopted</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a brief description of recently issued accounting standards, those adopted in the current period and those not yet adopted:</span></div><div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.717%"><tr><td style="width:1.0%"/><td style="width:14.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.854%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.774%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.774%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Financial<br/>Statements or Other<br/>Significant Matters</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In January 2020, the FASB issued ASU 2020-01, Investments &#8211; Equity Securities (Topic 321)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This standard clarifies the interaction between accounting standards related to equity securities (ASC 321), equity method investments (ASC 323), and certain derivatives (ASC 815).&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 1, 2021, we did not hold equity securities, equity method investments or derivatives. The impact of this new accounting guidance in 2021 did not have a material impact to our consolidated financial statements at the time of adoption.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of July 2021, we hold an equity method investment which is accounted for under ASC 323. The investment is recorded on the consolidated statement of financial position at fair value as of the date of deconsolidation. The Company&#8217;s share of earnings or losses of the investment entity are reported on the consolidated statement of operations through investment and other income, net with a corresponding increase or decrease to the equity investment. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000507096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Assets and Liabilities of VIE</a></td>
<td class="text">Total assets and liabilities of Kalyra as of September&#160;30, 2021 and December&#160;31, 2020 are as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="background-color:#cdffcc;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process&#160;research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ReconciliationOfNoncontrollingInterestTableTextBlock', window );">Reconciliation of Equity Attributable to Noncontrolling Interest</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of equity (net assets) attributable to the noncontrolling interest (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.416%"><tr><td style="width:1.0%"/><td style="width:82.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.223%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6228884-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ReconciliationOfNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation Of Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ReconciliationOfNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000560632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Components of Available-for-sale Marketable Securities</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale marketable securities consisted of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Government Agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Treasury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,952&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,984&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Government Agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Treasury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Contractual Maturities of Available-for-sale Debt Securities</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of available-for-sale debt securities are as follows (in thousands):</span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.044%"><tr><td style="width:1.0%"/><td style="width:51.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.256%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one but within five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,984&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,554&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text">The following table summarizes, by major security type, our cash equivalents and available-for-sale marketable securities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"/><td style="width:18.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total estimated fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents:</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,648&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,648&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,016&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Government Agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale marketable securities:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value<br/></span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,341&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,291&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,632&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,125&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,569&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000590904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Summary of Prepaid Expenses and Other Assets</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other assets consisted of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid software licenses and maintenance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign R&amp;D credit refund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zentera receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,465&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,158&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less long-term portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other assets, current</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,423&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,182&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000491016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property and Equipment, net</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and Office Equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold Improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in Progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,698&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140063999054920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,947&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,369&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,940&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064005220904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Members&#8217; Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense related to share based awards was comprised of the following (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,656&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,249&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,259&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by type of share-based award (in thousands):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.082%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit Interest Award Units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs and RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,786&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,656&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,249&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,259&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Valuation Assumptions</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the profits interest awards is estimated using an option pricing model with the following assumptions:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"/><td style="width:77.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.880%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Members&#8217; equity value (in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Threshold amounts (in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to liquidity (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lack of marketability discount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div>The fair value of the stock options granted during the nine months ended September&#160;30, 2021 and September&#160;30, 2020 was determined with the following assumptions:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.839%"><tr><td style="width:1.0%"/><td style="width:44.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.452%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9% - 76.6%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.6% - 78.2%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 - 6.2</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 - 6.0</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5% - 1.1%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4% - 0.5%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Valuation Assumptions, ESPP</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average assumptions used to estimate the fair value of stock purchase rights under the employee stock purchase plan (&#8220;ESPP&#8221;) are as follows:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.782%"><tr><td style="width:1.0%"/><td style="width:30.055%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.055%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.059%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Share-based Compensation Expense by Type of Share-based Award</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unrecognized estimated compensation cost by type of award and the weighted average requisite service period over which such expense is expected to be recognized (in thousands, unless otherwise noted):</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.256%"><tr><td style="width:1.0%"/><td style="width:31.878%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.881%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized <br/>Expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining <br/>Weighted-Average Recognition Period <br/>(years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,008&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.05</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.84</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.29</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000487944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Operating Lease Payments</a></td>
<td class="text">Approximate annual future minimum operating lease payments as of September&#160;30, 2021 are as follows (in thousands): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000567128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share/Class&#160;A Common Unit (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Loss Per Unit</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per common share/Class&#160;A common unit were calculated as follows (in thousands except per share and per unit amounts):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Zentalis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,555)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108,666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.09)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.91)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.59)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.21)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Unit</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents have been excluded from the calculations of diluted net loss per common share because their inclusion would be antidilutive (in thousands).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.153%"><tr><td style="width:1.0%"/><td style="width:58.359%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.269%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.269%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSAs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSUs </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,866&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064002957176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Business (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 03, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 07, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 02, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Dec. 21, 2017</div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_CommonStockConversionRatio', window );">Exchange ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of common stock in initial public offering, net | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 190,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 172,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance fees and expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per sharee) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of common stock in initial public offering, net | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance fees and expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per sharee) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Number of shares converted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,288,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,557,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | Underwriters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per sharee) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold (in shares) | shares</a></td>
<td class="nump">465,000<span></span>
</td>
<td class="nump">618,750<span></span>
</td>
<td class="nump">1,377,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_RestrictedStockMember', window );">RSAs | IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Number of shares converted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,160,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_CommonStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_CommonStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064002363624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Transactions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment in Zentera Therapeutics</a></td>
<td class="nump">$ 39,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeconsolidationGainOrLossAmount', window );">Gain on deconsolidation of Zentera, net of tax</a></td>
<td class="nump">51,582<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">51,582<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=zntl_ZenteraTherapeuticsLtdMember', window );">Zentera</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates', window );">Deferred tax liability, deconsolidation of Zentera</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeconsolidationGainOrLossAmount', window );">Gain on deconsolidation of Zentera, net of tax</a></td>
<td class="nump">51,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ResearchAndDevelopmentExpenseReimbursements', window );">Contra-research and development expense</a></td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from investments in unconsolidated subsidiaries and investments in other affiliates which are not controlled nor consolidated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ResearchAndDevelopmentExpenseReimbursements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development Expense, Reimbursements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ResearchAndDevelopmentExpenseReimbursements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=zntl_ZenteraTherapeuticsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=zntl_ZenteraTherapeuticsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064002867944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 21, 2017</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">IPR&amp;D impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,800,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">In-process&#160;research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses', window );">Reversal of deferred tax liability due to IPR&amp;D impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">IPR&amp;D impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">In-process&#160;research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">VIE, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">In-process&#160;research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=zntl_KalyraPharmaceuticalsIncMember', window );">Kalyra Pharmaceuticals, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Cash payments to acquire interest</a></td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Ownership percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated impairment losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=zntl_KalyraPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=zntl_KalyraPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064002907688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations - Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 40,807<span></span>
</td>
<td class="nump">$ 54,951<span></span>
</td>
<td class="nump">$ 92,552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">In-process&#160;research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,736<span></span>
</td>
<td class="nump">3,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">1,670<span></span>
</td>
<td class="nump">2,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">564<span></span>
</td>
<td class="nump">24,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">VIE, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">556<span></span>
</td>
<td class="nump">417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">In-process&#160;research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,736<span></span>
</td>
<td class="nump">3,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">$ 564<span></span>
</td>
<td class="nump">$ 6,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064001687464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Rollforward of Noncontrolling Interest (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="nump">$ 6,301<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">7,332<span></span>
</td>
<td class="nump">$ 654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest at end of period</a></td>
<td class="nump">564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">VIE, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,141)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest at end of period</a></td>
<td class="nump">$ 564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInMinorityInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInMinorityInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064002866584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Components of Available-for-sale Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 325,952<span></span>
</td>
<td class="nump">$ 283,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale, fair value</a></td>
<td class="nump">325,984<span></span>
</td>
<td class="nump">283,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">239,391<span></span>
</td>
<td class="nump">147,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale, fair value</a></td>
<td class="nump">239,412<span></span>
</td>
<td class="nump">147,388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">10,145<span></span>
</td>
<td class="nump">23,576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale, fair value</a></td>
<td class="nump">10,142<span></span>
</td>
<td class="nump">23,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">US Government Agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">35,731<span></span>
</td>
<td class="nump">81,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale, fair value</a></td>
<td class="nump">35,737<span></span>
</td>
<td class="nump">81,486<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">40,685<span></span>
</td>
<td class="nump">31,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale, fair value</a></td>
<td class="nump">$ 40,693<span></span>
</td>
<td class="nump">$ 31,109<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064005256296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Contractual Maturities of Available-for-sale Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due within one year</a></td>
<td class="nump">$ 315,988<span></span>
</td>
<td class="nump">$ 247,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">After one but within five years</a></td>
<td class="nump">9,996<span></span>
</td>
<td class="nump">36,099<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total</a></td>
<td class="nump">$ 325,984<span></span>
</td>
<td class="nump">$ 283,554<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269825-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064084471128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Fair Value of Assets Measured on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 25,648<span></span>
</td>
<td class="nump">$ 29,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">325,984<span></span>
</td>
<td class="nump">283,554<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total fair value of assets</a></td>
<td class="nump">351,632<span></span>
</td>
<td class="nump">312,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">25,648<span></span>
</td>
<td class="nump">24,016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">40,693<span></span>
</td>
<td class="nump">31,109<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total fair value of assets</a></td>
<td class="nump">66,341<span></span>
</td>
<td class="nump">55,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">285,291<span></span>
</td>
<td class="nump">252,445<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total fair value of assets</a></td>
<td class="nump">285,291<span></span>
</td>
<td class="nump">257,444<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">239,412<span></span>
</td>
<td class="nump">147,388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">239,412<span></span>
</td>
<td class="nump">147,388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">10,142<span></span>
</td>
<td class="nump">23,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">10,142<span></span>
</td>
<td class="nump">23,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">US Government Agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">35,737<span></span>
</td>
<td class="nump">81,486<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">US Government Agencies | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">US Government Agencies | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">35,737<span></span>
</td>
<td class="nump">81,486<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">40,693<span></span>
</td>
<td class="nump">31,109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury securities | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">40,693<span></span>
</td>
<td class="nump">31,109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury securities | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">25,648<span></span>
</td>
<td class="nump">24,016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">25,648<span></span>
</td>
<td class="nump">24,016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064084914504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses and Other Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">$ 1,661<span></span>
</td>
<td class="nump">$ 1,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_PrepaidSoftwareLicenseAndMaintenance', window );">Prepaid software licenses and maintenance</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ForeignResearchAndDevelopmentCreditRefund', window );">Foreign R&amp;D credit refund</a></td>
<td class="nump">1,345<span></span>
</td>
<td class="nump">692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_PrepaidResearchAndDevelopmentCosts', window );">Prepaid research and development expenses</a></td>
<td class="nump">9,136<span></span>
</td>
<td class="nump">5,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest receivable</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Zentera receivable</a></td>
<td class="nump">2,940<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_OtherPrepaidExpense', window );">Other prepaid expenses</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">441<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Total prepaid expenses and other assets</a></td>
<td class="nump">16,465<span></span>
</td>
<td class="nump">9,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent', window );">Less long-term portion</a></td>
<td class="nump">6,042<span></span>
</td>
<td class="nump">2,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid expenses and other assets, current</a></td>
<td class="nump">$ 10,423<span></span>
</td>
<td class="nump">$ 6,182<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ForeignResearchAndDevelopmentCreditRefund">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign Research and Development Credit Refund</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ForeignResearchAndDevelopmentCreditRefund</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_OtherPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Prepaid Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_OtherPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_PrepaidResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Research And Development Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_PrepaidResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_PrepaidSoftwareLicenseAndMaintenance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Software License And Maintenance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_PrepaidSoftwareLicenseAndMaintenance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064084163864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, net - Summary (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">$ 5,282<span></span>
</td>
<td class="nump">$ 1,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(584)<span></span>
</td>
<td class="num">(250)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">4,698<span></span>
</td>
<td class="nump">1,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zntl_ComputerAndOfficeEquipmentMember', window );">Computer and Office Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">563<span></span>
</td>
<td class="nump">529<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zntl_LaboratoryEquipmentMember', window );">Lab Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">1,883<span></span>
</td>
<td class="nump">424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Subtotal</a></td>
<td class="nump">$ 2,787<span></span>
</td>
<td class="nump">$ 347<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zntl_ComputerAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=zntl_ComputerAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zntl_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=zntl_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140063998931144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, net - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 335<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064089896888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_AccruedResearchAndDevelopmentCostsCurrent', window );">Accrued research and development expenses</a></td>
<td class="nump">$ 19,589<span></span>
</td>
<td class="nump">$ 11,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued employee expenses</a></td>
<td class="nump">7,883<span></span>
</td>
<td class="nump">5,649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_AccruedGeneralAndAdministrativeCostsCurrent', window );">Accrued general and administrative expenses</a></td>
<td class="nump">2,268<span></span>
</td>
<td class="nump">996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liability</a></td>
<td class="nump">862<span></span>
</td>
<td class="nump">902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Taxes payable</a></td>
<td class="nump">767<span></span>
</td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 31,369<span></span>
</td>
<td class="nump">$ 19,940<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_AccruedGeneralAndAdministrativeCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued General And Administrative Costs, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_AccruedGeneralAndAdministrativeCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_AccruedResearchAndDevelopmentCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Research And Development Costs, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_AccruedResearchAndDevelopmentCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140063997760040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Units - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 07, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Net proceeds from issuance of convertible preferred units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 14,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs of financing</a></td>
<td class="nump">$ 17,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Units authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ConvertiblePreferredStockDividendsPerShareDeclared', window );">Dividends declared (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering', window );">Automatic conversion feature, minimum gross cash proceeds received in a public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Convertible preferred units issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,293,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Par value per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.60<span></span>
</td>
<td class="nump">$ 11.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross', window );">Gross proceeds from issuance of convertible preferred units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Net proceeds from issuance of convertible preferred units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs of financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Conversion price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Liquidation preference (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Par value per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,735,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">788,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross', window );">Gross proceeds from issuance of convertible preferred units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Net proceeds from issuance of convertible preferred units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs of financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Conversion price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Liquidation preference (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Par value per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.50<span></span>
</td>
<td class="nump">$ 17.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">867,194<span></span>
</td>
<td class="nump">4,847,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross', window );">Gross proceeds from issuance of convertible preferred units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,200<span></span>
</td>
<td class="nump">$ 84,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Net proceeds from issuance of convertible preferred units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,200<span></span>
</td>
<td class="nump">81,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs of financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Conversion price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Liquidation preference (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreferencePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ConvertiblePreferredStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Dividends Per Share, Declared</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ConvertiblePreferredStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Redeemable Convertible Preferred Stock, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Automatic Conversion Feature, Gross Cash Proceeds Minimum Amount Received In A Public Offering</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140063989819384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Members&#8217; Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Aug. 03, 2020</div></th>
<th class="th"><div>Apr. 07, 2020</div></th>
<th class="th"><div>Apr. 02, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 21, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,187,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,198,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,040,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,187,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,198,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,040,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_CommonStockSharesSubjectToFutureVestingProvisions', window );">Common stock subject to future vesting provisions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of common stock in initial public offering, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 190,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 172,482,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance fees and expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162,223,000<span></span>
</td>
<td class="nump">155,899,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Shares issued upon vesting of certain RSAs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm', window );">Generally expected vesting term of the option contract (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Non-Option equity instruments, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Non-Option equity instruments, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">ESPP maximum percent of compensation to contribute</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount', window );">Maximum contribution amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">ESPP purchase price of common stock, percent of market price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod', window );">Offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=zntl_ZenteraStockPlanMember', window );">Zentera Stock Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Employee benefits and share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138,000<span></span>
</td>
<td class="nump">$ 187,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per sharee)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of common stock in initial public offering, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance fees and expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=zntl_FollowOnOfferingMember', window );">Follow-On Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ProceedsFromIssuanceOfCommonStockGross', window );">Gross proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 166,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock', window );">Expenses and fees from the issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class&#160;A Common&#160;Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions', window );">Common units subject to future vesting conditions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonUnitAuthorized', window );">Common units, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class&#160;B Common&#160;Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonUnitAuthorized', window );">Common units, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">872,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,458,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Stock issued upon conversion of units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">703,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class&#160;B Common&#160;Units | The Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized to be issued under plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,458,522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class&#160;B Common&#160;Units | The 2020 Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized to be issued under plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | The 2020 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized to be issued under plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease', window );">Percent of common stock outstanding used as threshold to calculate shares available for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Non-Option equity instruments, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,418,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,237,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | Corporate Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Stock issued upon conversion of units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,288,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Stock issued (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,557,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per sharee)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | Underwriters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold (in shares)</a></td>
<td class="nump">465,000<span></span>
</td>
<td class="nump">618,750<span></span>
</td>
<td class="nump">1,377,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per sharee)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | Follow-On Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,743,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per sharee)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | Follow-On Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold (in shares)</a></td>
<td class="nump">3,565,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per sharee)</a></td>
<td class="nump">$ 48.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock', window );">Expenses and fees from the issuance of common stock</a></td>
<td class="nump">$ 10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net</a></td>
<td class="nump">$ 172,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_RestrictedStockMember', window );">RSAs | IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Stock issued upon conversion of units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,160,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance fees and expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredUnitsAuthorized', window );">Preferred units authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,638,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance fees and expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredUnitsAuthorized', window );">Preferred units authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,621,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonUnitAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum number of common units of ownership permitted to be issued by a limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonUnitAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for employee benefit and equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeBenefitsAndShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredUnitsAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of preferred units authorized to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 4.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187171-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredUnitsAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_CommonStockSharesSubjectToFutureVestingProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Shares, Subject to Future Vesting Provisions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_CommonStockSharesSubjectToFutureVestingProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_CommonUnitOutstandingSubjectToFutureVestingConditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Unit, Outstanding, Subject to Future Vesting Conditions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_CommonUnitOutstandingSubjectToFutureVestingConditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses and Fees from the Issuance of Common Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ProceedsFromIssuanceOfCommonStockGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Common Stock, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ProceedsFromIssuanceOfCommonStockGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Generally Expected Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Shares Authorized, Percent Threshold Used To Calculate Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Offering Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=zntl_ZenteraStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=zntl_ZenteraStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=zntl_FollowOnOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=zntl_FollowOnOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=zntl_A2017ProfitInterestPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=zntl_A2017ProfitInterestPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=zntl_A2020IncentiveAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=zntl_A2020IncentiveAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=zntl_CorporateConversionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=zntl_CorporateConversionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=zntl_FollowOnPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=zntl_FollowOnPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064091443128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Members&#8217; Equity - Share-based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 7,656<span></span>
</td>
<td class="nump">$ 7,249<span></span>
</td>
<td class="nump">$ 27,266<span></span>
</td>
<td class="nump">$ 15,259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">3,697<span></span>
</td>
<td class="nump">2,180<span></span>
</td>
<td class="nump">10,746<span></span>
</td>
<td class="nump">4,606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 3,959<span></span>
</td>
<td class="nump">$ 5,069<span></span>
</td>
<td class="nump">$ 16,520<span></span>
</td>
<td class="nump">$ 10,653<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064002460056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Members&#8217; Equity - Share-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 7,656<span></span>
</td>
<td class="nump">$ 7,249<span></span>
</td>
<td class="nump">$ 27,266<span></span>
</td>
<td class="nump">$ 15,259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=zntl_ProfitInterestAwardsMember', window );">Profit Interest Award Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">5,596<span></span>
</td>
<td class="nump">2,212<span></span>
</td>
<td class="nump">14,267<span></span>
</td>
<td class="nump">3,814<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember', window );">RSAs and RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 1,957<span></span>
</td>
<td class="nump">$ 5,037<span></span>
</td>
<td class="nump">$ 12,786<span></span>
</td>
<td class="nump">$ 11,116<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=zntl_ProfitInterestAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=zntl_ProfitInterestAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000366168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Members&#8217; Equity - Fair Value Assumptions for Profit Interest Awards (Details) - Profit Interest Awards<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MembersEquity', window );">Members&#8217; equity value (in thousands)</a></td>
<td class="nump">$ 271,207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts', window );">Threshold amounts (in thousands)</a></td>
<td class="nump">$ 309,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free rate (as a percent)</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility (as a percent)</a></td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity', window );">Time to liquidity (in years)</a></td>
<td class="text">1 year 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount', window );">Lack of marketability discount (as a percent)</a></td>
<td class="nump">26.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Grant date fair value (USD per share) | $ / shares</a></td>
<td class="nump">$ 3.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MembersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of ownership interest in limited liability company (LLC), attributable to the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125520817&amp;loc=d3e70258-108054<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70434-108055<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125520817&amp;loc=d3e70229-108054<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MembersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Lack of Marketability Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Threshold Amounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Time to Liquidity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=zntl_ProfitInterestAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=zntl_ProfitInterestAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064084776808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Members&#8217; Equity - Fair Value Assumptions for Stock Options (Details) - Stock Options<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">73.90%<span></span>
</td>
<td class="nump">76.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">76.60%<span></span>
</td>
<td class="nump">78.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum (as a percent)</a></td>
<td class="nump">0.005%<span></span>
</td>
<td class="nump">0.004%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum (as a percent)</a></td>
<td class="nump">0.011%<span></span>
</td>
<td class="nump">0.005%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Average expected term (in years)</a></td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Average expected term (in years)</a></td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064005105240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Members&#8217; Equity - Fair Value Assumptions for ESPP (Details) - Employee Stock Purchase Plan<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility (as a percent)</a></td>
<td class="nump">64.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Average expected term (in years)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free rate (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064084643928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Members&#8217; Equity - Unrecognized Compensation Cost (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized expense, stock options</a></td>
<td class="nump">$ 65,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Remaining Weighted-Average Recognition Period (years)</a></td>
<td class="text">3 years 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized expense, other than options</a></td>
<td class="nump">$ 1,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Remaining Weighted-Average Recognition Period (years)</a></td>
<td class="text">1 year 10 months 2 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized expense, other than options</a></td>
<td class="nump">$ 7,793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Remaining Weighted-Average Recognition Period (years)</a></td>
<td class="text">2 years 3 months 14 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized expense, other than options</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000563496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies - Future Minimum Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2021</a></td>
<td class="nump">$ 271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">637<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments:</a></td>
<td class="nump">908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 862<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064000344312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>lease</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease, weighted-average remaining lease term</a></td>
<td class="text">9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts', window );">Number of leases not yet commenced | lease</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability', window );">Total minimum lease payments on leases not yet commenced | $</a></td>
<td class="nump">$ 74.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Operating leases not yet commenced, term</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Operating leases not yet commenced, term</a></td>
<td class="text">11 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease not yet Commenced, Number of Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064006920792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share/Class&#160;A Common Unit - Calculation (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_EarningsPerShareNumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Zentalis</a></td>
<td class="num">$ (4,191)<span></span>
</td>
<td class="num">$ (34,555)<span></span>
</td>
<td class="num">$ (108,666)<span></span>
</td>
<td class="num">$ (77,538)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_EarningsPerShareDenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding, basic (in shares)</a></td>
<td class="nump">44,609<span></span>
</td>
<td class="nump">37,959<span></span>
</td>
<td class="nump">41,918<span></span>
</td>
<td class="nump">24,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares outstanding, diluted (in shares)</a></td>
<td class="nump">44,609<span></span>
</td>
<td class="nump">37,959<span></span>
</td>
<td class="nump">41,918<span></span>
</td>
<td class="nump">24,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share outstanding, basic (USD per share)</a></td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.91)<span></span>
</td>
<td class="num">$ (2.59)<span></span>
</td>
<td class="num">$ (3.21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share outstanding, diluted (USD per share)</a></td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.91)<span></span>
</td>
<td class="num">$ (2.59)<span></span>
</td>
<td class="num">$ (3.21)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_EarningsPerShareDenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share, Denominator</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_EarningsPerShareDenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_EarningsPerShareNumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share, Numerator</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_EarningsPerShareNumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064006594424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share/Class&#160;A Common Unit - Antidilutive Securities (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per unit (in shares)</a></td>
<td class="nump">4,866<span></span>
</td>
<td class="nump">4,730<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per unit (in shares)</a></td>
<td class="nump">4,055<span></span>
</td>
<td class="nump">2,783<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per unit (in shares)</a></td>
<td class="nump">447<span></span>
</td>
<td class="nump">845<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per unit (in shares)</a></td>
<td class="nump">364<span></span>
</td>
<td class="nump">1,102<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140064006084920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Disclosures (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 21, 2017</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Number of shares acquired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=zntl_ZenteraTherapeuticsLtdMember', window );">Zentera</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_ResearchAndDevelopmentExpenseReimbursements', window );">Contra-research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses from transactions with related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Master Services Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses from transactions with related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember', window );">Director | Master Services Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">VIE, Primary Beneficiary | Kalyra Pharmaceuticals, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates', window );">Cash payments to acquire interest</a></td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zntl_RelatedPartyAgreementTerm', window );">Agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">VIE, Primary Beneficiary | Series B Preferred Units | Kalyra Pharmaceuticals, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Number of shares acquired (in shares)</a></td>
<td class="nump">17,307,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_RelatedPartyAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related Party Agreement, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_RelatedPartyAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zntl_ResearchAndDevelopmentExpenseReimbursements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development Expense, Reimbursements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zntl_ResearchAndDevelopmentExpenseReimbursements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zntl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=zntl_ZenteraTherapeuticsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=zntl_ZenteraTherapeuticsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=zntl_LicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=zntl_LicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=zntl_MasterServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=zntl_MasterServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=zntl_KalyraPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=zntl_KalyraPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>99
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M,*JUC'O^?Z?ZO)%6JCCD+(]@NU#J8@+CU5G!PW7](\.Q.8/-^"PWPLH.AYM
M!?4"%13JOCI9>+C$?R17?2I3)=>1".RAQC$G+QBU.FMXN-A_I#:5&<@'>8W2
MX]\OCNB!*EY@W.JLX>%27\1P!.7U<2HX /4H1J1.%1ZN\P\2%!0$50HL5S2
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M_E>Q[5!L_>6RTOU_=+^UQ1.4=]K(>ML8%-1ELWGG#]M [#4@T4@#NFU 7]N
M;1NPOJ,;97VW+KCA9R=*WB-EK<&;O>ACT[>&WI2-'<9KH^#3$MJ9LW/9%# H
MHD!PI655%MS S7M>\287Z-HZUFB&OEQ?H!_>_(C>H+)!GU>RT[PI],G<@ ;K
M:9YOO^_]YOOHR/==B_8(,3Q%%%/B:7X>;GXA<FA.^N;X>?,Y]'S7?;KK/NW]
ML;'N=TJ)QB"N-?0SX)#M'++>833FD.L5@M"@W%Z(KUVYYA5\@S=4&U=)[\K.
MM_59A%.\.)FO]R/B6L51%I.=U3.=T4YG%-3Y@:L[8?A-)9 6>:=*4PH]17S-
MR\H^G<$*,=,@W:=[XSK>4\1HG*71@7#7C*8LCB._\GBG/ XJ?Y?GLH. PB*2
M"XBN[<)2R1K=RK5036V'\U9QL)BB1AB?_M@11G!Z(-ZUB<C"KSS9*4^"RJ^4
M:'E9(/'0VBFG^SR19B44S/3Q/-QH3CR:(\H.5+M6"4FI7_9B)WL1E/U):*/*
MW"X+-JE]XA;N2$>'TEP;[->5[G2E05V?I>'5*R*7NMFZ6,1)?*#/8Q;%$&._
MR&PG,GMAS(&XRCSV8VV7@]8FZ&AF9F[6)=EA:KI&!&>97R?! PAP4.E'T,E-
MV=RB2@ 7O_^.)/A860K.Y'+6/3T9C_/6_[/DRPZSP&-$8SJ2"62/8N3_3JV
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M^'PII7FZL6?ZN]]PSOX%4$L#!!0    ( 'H^:E-*>PCRW@(  +<)   8
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M,P ?JKPEE!,C"W?0+J2!8]L-,[A9464-8'\II=E-[-E=W]4F?P%02P,$%
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ML3: W_><JY<;_8+IK/GF_U!+ P04    " !Z/FI3[2XJ8Z8,  "33P  &
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M1\QZ\A'%7HB;O9SM/8838I(0R>X"HLFV*3$K*51G;X O"?H,8TT" G:Z3+P
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MNE$K:D#[BA2/J%RHR1)T!> TZ>:@& 3MJS \4+E0DR08<;M,NG$KK*9N3?]
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MMXL!AMVX%5O@CU4-@/36E /5 (9"^STYKM@!?T@U %1_'*@&A"0,N;[8@6J
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MBSB2ITMM(#^_R?/J_DW]][.V?X?OY&]02P,$%     @ >CYJ4Y/+L2NC @
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M&$X^.!#NO:82]=KW#$-NU](V#ZM;[=K23?,:WX\W/>V!Z367!@3F%!H-+XB
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M1!V[LM/VK,9'OR$M5XP-'62$?2!I$+DWE%$Y)R<F!URNX\.A>(LHQ98K?D>
MFLUQW)PFVVB)^/#A<IO6?-VPP"X55N?DHA/W$/BT3>"^,^XJS"E#%B!X*QR
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M&/$+ &#"83C!!45#2.U0N)C[4!K8%3!I0RTYL!8BS")L8E^IEH+G@0G&N1B
M@TEAV'8'+GDQPRT)U[N2.#I=Q;0>'_@41#KL_6^4K_&'VG%&%9I'P-Z. \01
M#4_H1\7(_73(>D?J4Q ;+I'B4@:ZCU(=//YU)/08C.=%W!9L<1P3V\FD!8#0
M8T".?ZF_(:N=7K84]=J452RDB(7+9=?$962..+#MAX?'C3D'4[),(R/U.],H
MXK=R?'/!$[: T0&2'QKXM<E7(G28:HM3R&=+2<8:C>(\"BDB/>H)G56)82U7
M2_(]!IE$@58X#MV:LG0K KV8+4!!M(E-&2>TX*S08P,VCJ69&9\U)9QG]AJI
M\QW?Q5P!XD*K#OONP'(0[E>)K^-(&,N8;1EK5YZD+##YD:\UV&H7.06MRFTY
M5(G16K^X;7.#;/DX^>[-W@-HJYK[V36K.*LEM$VX?/'[YZNWSR:O%%*5$Z,M
M3.,T+)K V)^B%J<=@:2H/DTY>)S' 0FF]6R7M"9D)!8)[(BMR3-%?_[3&VT*
MB:G,J?P@5AF?."2Q^\--SZ%Y#T+N.I^^;62.8I66N;N,1^PXT,[YV!0GVG1*
M'D;Z[$T?UO4A^:X9O(]B_1-8:X*<30+\6,3>8<)YQ."]Q,$#2QZ:OQ&@&G,;
MM4D\1.J>+3<16IHD=U4WT0*9\CAOIIN0R"QYPR4/)N;L1BG\%VMY2.(W52-U
M&?6_C_I[Z?B2(OH'@*];R"^Z(S5,EI'^7SQ*>SU2[]KCW0TR8XO3(I7'I/_6
M@(DYJVQXJ$C>9A4[SK$)?:S&5?*2D0RQXII?W0XID L5V=$',L-36C@DCSU/
MB>PT-T=Z2@#J;O(SC^ M;!Z<*AB+O+3L ]0BA)).&1Q"CZA5+B84*QBN*-%_
M_)T*^1;-81# L6-OX(%->X2O7#!Q^OX8 [GO8M-_+\$I3:,6'S&6/.Z03'IH
M7R0BA3I-9&!N:7B.4<KGS0!W@PU.1VS5O:2SGX&WU+UH^ /9=W$Z3BS]+KE.
M73+K=<F'V"5][#GL$J;U)4K:;:6F!.)0CQOT+8Q5"P1\F0#B1NOQ2 Q6.GRQ
MPPR3:Y\'+F.'9$K+1F3IQR8>0U,T>!UG8X>!)ZU_S>^11!)P9:_\4GB?A^.W
M3,3QLJV'_0LRG%-^TX POTLO N3Q;'[>6CR;?Y(GSXZ 55<]Z!'8G+QIL:+W
M3NG)1YS9,W4\Q8%""JMU564%J'H9SVGI2!JG7@!/O664OBM _1=/J=1#3]ML
M?B&ZAC<'W)ZQ:='QTS@\)EJ+KYKDK)26O)R\>#KJ(A+1>:)F@@<W[@HCYD;>
MS"@<-//;MCUDD;1QIST.Z'TF1]@L;?OQ6#4FOD.$X6)6IYP162LF4B]O8]+Q
MRSUVNHOC(?>RG&!24XQ:OUOT%8_%4XPZ]WF6IKK;2"P#5DI#<O< N&_._/>#
MZFT 8Q?DY0_/G<1$G?!;CLEN>9-CHOY;_/]_R0=_ AV,U%WO],>]+R<E^95\
M'^*W64A:_(C2W>T^0<WBEY?]\OC]ZKWV*P.?"EIBZ]'HEQ>#>$IO+VI7R7>8
MA:MK5\K/-6E4!"_ \Z7#@2)=L(+NP]S9_P!02P,$%     @ >CYJ4['W<$ZD
M!@  RP\  !D   !X;"]W;W)K<VAE971S+W-H965T,3$N>&ULK5=M;]LV$/XK
MA#<,&^#8B9/T-0F09-WZL@Q!DW; AGV@Q+/%A2)5DHKK_OH]1TJRW33IANU+
M(LGW^MP]Q^/1TOF;4!%%\;$V-AR/JAB;9]-I*"NJ99BXABQ^F3M?RXA7OYB&
MQI-42:DVT]GN[J-I+;4=G1RE;Y?^Y,BUT6A+EUZ$MJZE7YV1<<OCT=ZH__!6
M+ZK('Z8G1XU<T!7%=\VEQ]MTL*)T339H9X6G^?'H=._9V0'+)X'WFI9AXUEP
M)H5S-_SR2AV/=CD@,E1&MB#Q[Y;.R1@VA# ^=#9'@TM6W'SNK?^4<D<NA0QT
M[LQO6L7J>/1D)!3-96OB6[=\25T^AVRO=":DOV*990\?C439ANCJ3AD1U-KF
M__)CA\.&PI/=>Q1FG<(LQ9T=I2A_E%&>''FW%)ZE88T?4JI)&\%IRT6YBAZ_
M:NC%DRN]L'JN2VFCN/;2!IG0"D?3".LL,RT[2V?9TNP>2T_%A;.Q"N*%5:2V
M]:>(:@AMUH=V-GO0X!4U$[&_.Q:SW=G> _;VAU3WD[W]>^R]^-#JN!(7%"NG
MQ"M[2R&BO6(0TBKQVFE \![OK:<@_C@M0O0 X\\'/!\,G@^2YX/_ >0'+3%%
MGX5&EG0\ @<#^5L:W6M>_(YLR$MQ7>%O0VW494#BXD*N&%1 NR114"EK$A)=
M]9?SC%#IZAJ$"97T5#FCR LW_Z*QL?@EJLD8RE>5M(M*ZAVFB!(E D= 9B=$
M4%L4VC6P5B-PUI.&?332KL3<H<FA '^*;C$C&FT7 JF4\!HWX_[^NV^>S&:[
MS[LXTMO>\Q_&,&7+UGM\!G=B)30J>D5>HXJG_.,M^:@+0P*(S0F"2H!6Y0V2
MPBO<33@G,=<67C5B:US0>62@+X R"!X8 4Q"+S.R&WA4\I9!)"NT+4V+WL>#
M<*UGW\$9K63$M[5Y0!(I-][<NYJS%"S#1OD9R$66TT.'"HD>[2))@63CT6-<
M=$J00NDF7-W7K4GEW1L/,3+:AC@,V4-S]H^@$<M*EY50VK2LS8XWPHH.]@:T
M$(FA$!".M.MF<DM+:B+>-6F(W_*<[D*>HTTS]TKMR[8&+J@Z>BJZ!7'I<SE9
M5+;@+,Q)'N&8Y*5KD2_",YKS8\JF7E;(T6-*(E1$$3<JT 78 Z*#L$X89Q=P
M(YO&N\9KU& B3N<Q=]X:QZ]!-H"%NF>\.!2MX"**1D*^U V,CQ-^'0C<M;E;
M4J30*"E1!Z"FEI)]B0V;7K>/Y@Q0 ?;6I0,"HEF52G6 2.&D5Z*FNF 0N7F4
MRI8YKQZ#+ 50E/8X(YW/Q>!([L2V!BO%QF8:MV2@7*>>Z\1G+**@D#5KASC#
M>CP!4 FP(+W!XKW'SX,@^'2U+@4XEE8-M *\HCB>.(#DT6M>'$ V2["G^7E=
MTXDXHX6VMBO$!@OB?V WNU\G_Z\9CGZR@O+!4^>#9X,_\//M_M/)/@YV5!DA
M<:T IO,JCT3V44B3P,@[FJ<T]W/W9Q9I+VZE:6D]&?+X3D3>\-:&7J>0Y0WB
M1B&[F!+1.!FM.A PF(&],#(- ]#9WU"4A3:<B<S5CMC.4O_0%L\F:>R"&0&<
M5^Q3]4R)\B,HVYOA]/<FCX?L[^3&XAKG1!G[F=%:;)Y&?X*MA>0BV,^];V.H
M6C\8JSPAX;RC$.\HX'43,TGZ-8-CSX81V^'>Y%$?W!A0R=!R$C+DD:V9]L2E
M*2@N^0#X<CT\@$LCR8)6&Y0>B'QWWI72^Q7+R)HG79]]WY3W&!JGEKY'_W/"
MR1"H&[]]19BV/7J@[*?/\=,8%Q]:S+.\$&2\MM8)DAA^7=JA+=!.("F;A7<G
M3@V6@#$T2JP,;W9^]JYMMC\FL0MIL3.DELU?.<9>_ Q@9FF1$DI<3.<0-F$C
M"]>U;R*W6TD35SL%29\/BQ*W"4RI!3JA'O:%88@.LSM-]G2ZY5)O;Q[BJBTZ
M4V'<K2&B:7UH93X3!SOKD&C+%;=M:J&\\>0CGL]!,)<\CQ#]:7UD_;I3[H_3
MO\,DA2=U..;1U5"ZTYC5F <26[PDAX-^*/);:E*L;.>\PGP: ]U2MF/Q$@--
MO.$_;/):ZJ6T/0(ZB.%LNQ>$\RVXKR&M<82L)CT@[RSOC:DA[N*VWDR6H!?6
M!JDVP<@E;_/*L&B-9,OYF :S\D"_@]6X9\EV(T!'M;QH= A]+7[QI7U_NG'!
M@M=%ND8&D=:0?-<:O@XWU=-\05N+YVONA?0XI0)RGD-U=_+X<"1\OCKFE^B:
M=%TK7,3E+SU6P(<\"^#WN7.Q?V$'P_W]Y&]02P,$%     @ >CYJ4X0W7I/X
M!@  BA   !D   !X;"]W;W)K<VAE971S+W-H965T,3(N>&ULI5AM;]LV$/XK
MA-<5*^#Y1782KWD!DK;;BJ%MT'0=L&$?:(FVB%*D2E)QW%^_YXZ2[&1UBF%?
M')'BW3UW]]P=E;.-\Y]"J504=Y6QX7Q0QE@_'X]#7JI*AI&KE<6;E?.5C%CZ
M]3C47LF"A2HSSB:3XW$EM1U<G/'>M;\X<TTTVJIK+T)35=)OKY1QF_/!=-!M
MO-?K,M+&^.*LEFMUH^+O];7':MQK*72E;-#."J]6YX/+Z?.K.9WG Q^UVH2]
M9T&>+)W[1(O7Q?E@0H"447DD#1)_;M4+90PI HS/K<Y!;Y($]Y\[[3^S[_!E
M*8-ZX<P?NHCE^6 Q$(5:R<;$]V[SJVK].2)]N3.!?\4FG3V:#T3>A.BJ5A@(
M*FW37WG7QF%/8#$Y()"U AGC3H88Y4L9Y<69=QOAZ32TT0.[RM( IRTEY29Z
MO-60BQ=73<!.".*%JY;:2@I5.!M'J*8#X[Q5<Y749 ?4_"3>.!O+(%[90A7W
MY<> U./*.EQ7V:,*;U0]$K/)4&23;/J(OEGOYXSUS?Z#GT+:0ER& .I?YI\;
M'33O_G6Y#-&#+G\_8G?>VYVSW?G_C>^C:J@TGX=:YNI\@-H+RM^JP==UB]^D
MV7HIKDL)TN:JB3J7)@S%:YN/Q#LK7JI<54OE13:EZ$Y/AF*C4!T(@%>%>#(?
M'8%HQE HW*I5]_2[138].0WB1GFM@K@2UZ@>Y4GB)KK\$PJ4@=FH[5I(D1U]
M+Q14QJW0-BJ\BGCHP*&9B+KQM0O0!2.*CI!@+ '%2K-60>>!EE[6[(,@[=+G
MI> XC,2'LD7=IJWV.E=B(X.HI2Y()?PQ9%[D,I0C! #G<^<+:>F@CF4RU\32
M>1TEM0>Q;C2_YZ#DSN:F :%Q4,8.O [P;]G%'F>"#NPU'-&V;B*"K:K:N*U2
M>"3W#36A1AJ 1#OU" I1#XL<*A""7-9R:11IP&;1Y*RNB:1L)"Z+@EV4QFP9
M5REO'P5W*[UF?7WH*1HQ"4NOV&_$B]JP6"JK5CK7]$RH6#D?<!NP)#I1()!Y
M3,&B)@HP*B2KE8/RH-=60X6T$?&6JQ6=?L ;!;BN0AKA/H\2RD$LO6O6)5RI
M*F00FY@#Z/B1@;@&#==)7^RXQ10?@7O:,3*"E)?2KCET,!&],T/>1DW4TB:7
MVMB@J&V !P@9$9!.%<H@Z_ <XCW!2*10MQA8-8.A<@.W K\(35T['Q/_5J@Z
MB] AL:ZE(9V!)@P%9C:ENRW,OIA2B)=*622HS2%82OX2FYP!!1EDKSW <PY,
M$"OOJ@0=6Z23GK6%<9S3]A;9IH,(4N-#@Y0DIC_"<D:##*,RF$Q05Q!?5HE#
MDAHD>&RPU";EGIRTX%\*N"&V=E0+Y HI^?CZE9#,&NW%2N+G5II&B:9VM@>\
M\Y<3^V'/.+"LG2LV:$7$:G $C W8;7VF:8\TYHK1J+M:<6;#UBJ_)I <J9Q;
M8]=:N SP;B1>-GV_B:4&QSXWTL,#TDXC9]CEJE#8Q>#MZ@P26\&@K!/&@7K<
MRD*C6D+M>//O[FEP;6HK/*+H;<&99@=R)4,;?D3<(>WD38[84O\&=Q&N-D#V
MQ[9S'*9L[B@3/Y#A;'+Z^OK]4UG5IR]Y/3U]MDNWLP\Q+J7AXDQW0G4'@@9P
M!I6-=@I0(14>I:1S8"3>[$JW5RV19M2@]@D1YE$JTR>+T:*?,$3.EC 'G:'<
MVJ $#46A40B$FDM_OUKZ&GE0=L4W,[TI-:RFHDVE*+&B'+4SD&3[&*:"2.RZ
MYPK"\D5YUR9IYSD4[(0?6D'S"4AO:V0O\T4W7J.\ZVN/^]23;#3OC7[+.Z!Q
M$092%7-H]PMYUY,D+W#MBNEVT-V]6*2_,\SXSI!->(I 9(7J=QLPC7/HFH#3
MX=GS!WH>BD^3CA<8RXG[]$"W!70(;G)/Q-'1,7[GTQ/QCBX!N HC&#08DA_3
MR8E89!CIWRX%)G9V*A;#Q60B?NE:RFQX,CMN?R]Q+6C(;BVWJ>=!!^X*OE%%
MQS[8S.9B,8,S7TU,9R8;SH]GXNVAY@C/CN?X/1Z>3(Z8*?OIH-K!+/U"U1.8
M'\26=K9UC1+ZNM[DT(3B;CP*V=\4T#FDK@)5"LV5-8:\[VFP-QS:(7IH/'#3
M/'B-(^-N0ZUQN15_TGPV: N:_* 9V7EQ8%)TV/"NH @7]^OY7A\*[;QENK&2
M%!ZZ!"%XLJO4%NL/5G54>88AA.:Y;")GMO7W$*3'><S4/9!:FG5+M=;6ME=!
M="#MBC[5;X'(.!#U(9R#4(Z'T_GTV6/VE"WN62)J?>V;9;SW?5AA.O)7,(U4
MD#Y]*O:[_8?V9?J^W!U/7^EOT,6UI4FV@NAD='(T$#Y]^:9%=#5_;2Y=Q+<K
M/Y:8>LK3 ;Q?.1>[!1GH__UP\0]02P,$%     @ >CYJ4VH.)B5>!@  /A
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M/IM- ]"]GO8+JSJO81ME21']M*%?$&IG0.>U4O:X< [&G]KJ7U!+ P04
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M7LZF$=AA?0X"F2ZLK*TA7H#AV/ _#EKOP/;:&'H2?(+Q/VS]'U!+ P04
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M%FIT\[Q5$ =/@FM4U_5]C99NHT9UF'RQU$IRP!Z*0HWM'42^Y-]($P>W1_O
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M/)H4 >B^*?83JUK?B#;*4EOSPYK^(U"[#?1]JRA5AXDS</PS6?X#4$L#!!0
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MBD8BZ$U+90/K7X+E0A(?6K_RZ?;FI9R?A?;G]LK6C.,BHH-IT3QBM/R@'9/
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M4XU"S-%ITC*\:1B2$PQCN!>E3A6\*5=\]91^BLKU&I).PQMREN$#KUZ#[SI
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MFFU!\QBU,Z#S7"E[$%R XX2?_P502P,$%     @ >CYJ4Z-2LB3  @  S@4
M !D   !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL?51M;]HP$/XKIZR:6@DU
M(>$E88!$7Z9-6C74=MN':1],<A"K3IS93H%_O[,#@56%+\F=???<FY\;KZ5Z
MT3FB@4TA2CWQ<F.JD>_K-,>"Z6M984DW2ZD*9DA5*U]7"EGFG KAAT$P\ O&
M2V\Z=F=S-1W+V@A>XER!KHN"J>T-"KF>>%UO?_#(5[FQ!_YT7+$5/J'Y4<T5
M:7Z+DO$"2\UE"0J7$V_6'=WTK+TS^,EQK8]DL)4LI'RQRM=LX@4V(128&HO
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M10 "99Y0"FH0V[1JOJ*!EXQ3O",O' 5XAX&7#A,,AEX2)/2>5US!8 O <O!
MV.A90K<8 V\<CRGV@F1,8>+%V!<@23R@[_35*THAGKAW-!Q;93!([$08>Q'
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M[:BFP["B)HK&!]!^J;7;3WR"OBTO_@)02P,$%     @ >CYJ4U74@(&^ P
M8 @  !D   !X;"]W;W)K<VAE971S+W-H965T,S$N>&ULC599;^,V$/XK [4H
M8D"P;A^I;< YBA;HID&<=($6?:"EL46$$K4D%:?_OD-*OA8;=U_DX3'??'-Q
M/-M)]:I+1 /OE:CUW"N-::Z#0.<E5DP/98,UG6RDJIBAI=H&NE'("J=4B2 .
MPU%0,5Y[BYG;>U2+F6R-X#4^*M!M53'U[PT*N9M[D;??>.+;TMB-8#%KV!97
M:%Z:1T6KX(!2\ IKS64-"C=S;QE=WV3VOKOP)\>=/I'!>K*6\M4N?BOF7F@)
MH<#<6 1&/V]XBT)8(*+QI<?T#B:MXJF\1__%^4Z^K)G&6RD^\\*4<V_B08$;
MU@KS)'>_8N^/(YA+H=T7=OW=T(.\U496O3(QJ'C=_;+W/@[?HQ#W"K'CW1ER
M+.^888N9DCM0]C:A6<&YZK2)'*]M4E9&T2DG/;-XH+S_+K6&1U1P*ZN*(K4J
MF<+@5C"M?_HA&H4_+_<G+S4W</7,U@+U8!88(F!A@KPW=M,9BS\P-H5/LC:E
MAONZP.)</R#B!_;QGOU-?!%PA<T0DM"'.(RC"WC)(1J)PTL^P+MGJN;UMHN&
M"P/\O5QKHZAX_KF GQ[P4X>??L27>JIH!8+<P W3/ =6%W#'16NP@+-<V%!_
M*\*7#1Q!BQZT)E!A01L"S;LTZF."8;G?;&UN=T@NYTSDK6!6FVG82$&=J^&*
MUV!*V6I"UX#O.3;&@3HT9].N' RK9%L;/;B&YU(AGJ4='HCS^8[-GOV$)])#
M6Z%B1JIK%Q?G C-&\75K;/V!D? 7UH8)KN%'N$K]:!H-K)2D?I9E3HS"B3\:
MC9P\'OM9,AG '=:2&JF#_NRZUCKZ1M:V"'5;K<D+RL]IK#30>Z8-^4C5X=MG
MX*LHIZD_"J>0C/UI-H4T\J?1!&+BE"9'^E]GP+(*A^%TT D]_7B8=3O),(X&
M%XHN.Q1=]MU%MZP-=YSI*805YJWBAI-[]^^Y:&TJ-DI6MML;BK)[-DGIK"L^
MJLN+'.QHN=8-RW'NT>S0J-[06SR7V%<7H1\B8V3^"OBEY6],4'XUE)0;6"/6
MMNA.6)KR6*K$5%NJ_UOU!)2S5J/5Y@IX38ANP.QD*PHZI;2>A.BLZ =#"EEC
MT%7(_M7IJO6/8WGT'LBF(Y7Z899![(\G"<7N#;6E][1:TDDZADF:G>Z^:$A&
M*41^%,:D.1F-Z#M.0OA6&00GKS[URM;--DW>4NMU ^"P>QB?RVYJ'*]WL_<3
M4UM.9 5N2#4<CBF;JIMGW<+(QLV0M30TD9Q8TE\ 5/8"G6^D-/N%-7#X4['X
M#U!+ P04    " !Z/FI3]1)8HB4$  #=$   &0   'AL+W=O<FMS:&5E=',O
M<VAE970S,BYX;6S%6$UOXS84_"N$D$,"!)9(6Q]9V 82>[?)HNT:<=,>BAYH
MB;:)2*)*4G%:[(_OHZ1(CBUI?8C1'&)2>C-\CQP.38]W0CZK+6,:O29QJB;6
M5NOLDVVK<,L2J@8B8RF\60N94 U=N;%5)AF-"E 2V\1Q/#NA/+6FX^+90D['
M(M<Q3]E"(I4G"97_W+%8["86MMX>//+-5IL']G2<T0U;,OV4+23T[)HEX@E+
M%1<IDFP]L6[QIWM"#*"(^)VSG=IK(U/*2HAGTWF()I9C,F(Q"[6AH/#QPF8L
MC@T3Y/%W16K58QK@?ON-_4M1/!2SHHK-1/P'C_1V8@46BMB:YK%^%+M[5A7D
M&KY0Q*KXCW9EK.]:*,R5%DD%A@P2GI:?]+6:B#T <3H I *04P'#"C \  S]
M#L"H HP. 5TCN!7 /0#@40? JP#>80VX ^!7 /]40% !@F)UR^4HUG).-9V.
MI=@A::*!S30*011H6$*>&NTNM82W''!Z^DUN:,K_I:60T@C=Y0I"E$*7<Z8I
MC]45ND V4ELJF4(\14\IU^H:'D+[MZW(%:#4V-:0C*&TPVK@NW)@TC'PUSP>
M( =?(^(07+*WD,SZ26[S#9 ,"Q*GDV3^ Y), HE?DCPMY^CRXJHIN9/U\RFL
MI&0]@>Y+/]V<A0-$BNG"?@O\IW[XDF4#-'3*V:YJ;&&Y/YW%:66Q07ZU!DFM
M05+0#CMH9S$%O8DU6FH1/J,_?X;WZ$&S1/W5PSZLV8<%^ZB#_?-KN*7IAB%I
M1-XV\R7>+?#&ZU^F>&R_M PYJH<<]0ZYD")D+%)H+46"N%(Y34-F*@Q%DL!&
M4T6AL($X;"9.8Y3EJYB'$+%FDJ>;:Y3"L?4=7;2IN1S;VT_WQH&_.N=2$,=A
M!Q'W+40^&06DO7BW+M[M+?[AK=PU \,PEL)>X:15T.DHR#V>?]_;J^==&EZ=
MAM>?QN);CWC\FL4_@S2#FCWHS7%IS !EDL-L78(:(A''5"J4,5G:!;LR<U:;
M1YL+!<>+&+3/W$V=U<W_J-Z;X\5^K]YW.6.G.<><#Y9=1>B=ICN\=Z+BWDQF
MY2R5BOF.^H6(&Y/$YW!)W-@D[O?)#Q#CO!KB%#7BQDQQOYO^FB<KR $JK[Z$
MA")]85*SJ,BS?&ARZSFJ1T>J(RX)@L ==637N!WNM[NC[,R&@=2, I6(3\YQ
MCEMLT'%=OWMO-%:(^[WP0)%/:<3D3G+-I.J33F.2^!PNB1N;Q&?WR3D^W2AQ
MXY2XWRH_:O'O\+$MCCSWZ%"?M<1Y./#=@[AY2QP>^MU:(HW/DGZ??5S>JA^Z
M&FG,DN S2(?L?;4DYS:/:H1W<XD]A_C^P5S:>]<P<_'_A<H-3Q6*V1J0SL#<
ME&5YERX[6F3%S6PE--SSBN:64=B<)@#>KX70;QUSV:M_T9C^!U!+ P04
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M06CL".PPPSX2I-F WU="Z*>)$6@[T^D?4$L#!!0    ( 'H^:E.:$Y?]D ,
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M -\OE;)/'7?%K;^!QO\"4$L#!!0    ( 'H^:E/BU\[/, ,  !H+   9
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MEFBP8I!$:?F?_-(+L0. ;@< :0#J"\ :@/L"7 UP^P+&&C#N"YAHP*0OP-,
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MN0K5AN!%#U1,),O-)7_)I&H9S#!6?2/A&J">KQF3AXEV4'6BHY]02P,$%
M  @ >CYJ4\<;FZX] P  I0@  !D   !X;"]W;W)K<VAE971S+W-H965T-#@N
M>&ULC5;;;MLP#/T5PKN@!;KXDN;2+0G0KNU68 6*WO8P[$&QZ5B(;+F2W+3
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M\0UY9;GY<>/!2>U!M,.#([B4A<DTG!4))G_:^Z1&*TFTEN0DZ@2\P;('_>
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MT]JY86Z::91V@WD_%T)O)S9!TYZ/?@)02P,$%     @ >CYJ4V[[-KYM @
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MA78^^&5I!S)H%V"_;Y3"]XT;$MV(S]X 4$L#!!0    ( 'H^:E/3H7FCY@(
M +4(   9    >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;+5676_:,!3]*U=1
M'UJ)D@^^*T JL&F52E>5=7N8]F"2"UCU1V8;*-)^_&P'4B9!JCV4!V([ON<<
M'U_[IK^5ZD6O$ V\<B;T(%@9D]^$H4Y7R(FNRQR%?;.0BA-CNVH9ZEPAR7P0
M9V$21>V0$RJ"8=^//:IA7ZX-HP(?%>@UYT3M1LCD=A#$P6'@B2Y7Q@V$PWY.
MECA#\YP_*ML+2Y2,<A2:2@$*%X/@-KX9Q8D+\#.^4]SJHS:XI<RE?'&=NVP0
M1$X1,DR-@R#VL<$Q,N:0K([?>]"@Y'2!Q^T#^F>_>+N8.=$XENP'S<QJ$'0#
MR'!!ULP\R>T7W"^HY?!2R;3_AVTQM]T*(%UK(_D^V"K@5!1/\KHWXB@@:9\)
M2/8!WHBP(/(J)\2085_)+2@WVZ*YAE^JC[;BJ'"[,C/*OJ4VS@S'DG-JK,T&
MB,A@+(6A8HDBI:CA&AZ(4L3Y!I<3-(0R?0470 5,*6/65=T/C57AL,)TSS@J
M&),SC#V86I*5AD\BP^S?^-"J+Y>0')8P2BH!9YC7H1'5((F2^'DV@<N+*X9V
MIRJP&Z4]#8_=.(-]CUHCUN#>X=5@@CI5-/?Y]//>SH4[@US_JF!JEDQ-S]0\
MP_0U1^>T6 (KN+8^H3"[)AO[9HGV#+A35LX @XJ?LK^:IP>\L#_N0D9VND)Z
MJY3>JH1\6/,Y*I"+0I@&(0WL[(V2VN2RJ809_($3.U+(+;!;'MO=(9MAT@\W
M)^2T2SGM2CG?I"',G17*UWSO54YV+L<UV(VK$'EQ2F#!%D='"CO->JMW_#NM
MN%,J[E0JGA9:*[:B6R)U/SA?>R53[W_R]82?M;,96HT<1Q:'J*K,C*.WZRVJ
MMI:\OF-M?'15QA]L;IR\<24?9N\[T'%\WM_PJ))P5$M?+[4E70M3%)5RM*S)
MMT4E>IM>%/0I44LJM-6_L*%1O6./N"IJ9-$Q,O=U:2Z-K7*^N;+?%:C<!/M^
M(:4Y=!Q!^:4R_ M02P,$%     @ >CYJ4]6L$L-J P  J L  !D   !X;"]W
M;W)K<VAE971S+W-H965T-30N>&ULM59KC^(V%/TK5CJJ9J19\@XP!:09PJJ5
MNM5HZ72E?C/$$&L=F]K.L/WWO79"&L##H#Z^@!_G'/L>7SMWLA?RJRH)T>A;
MQ;B:>J76NP??5^N25%@-Q(YPF-D(66$-7;GUU4X27%A2Q?PH"#*_PI1[LXD=
M>Y:SB:@UHYP\2Z3JJL+RSR?"Q'[JA=YAX#/=EMH,^+/)#F_)DNB7W;.$GM^I
M%+0B7%'!D22;J?<8/BS&!F\!OU&R5[TV,I&LA/AJ.C\54R\P&R*,K+51P/#W
M2N:$,2,$V_BCU?2Z)0VQWSZH?[2Q0RPKK,A<L"^TT.74&WFH(!M<,_U9['\D
M;3RIT5L+INPOVK?8P$/K6FE1M638045Y\X^_M3[T"*#C)D0M(3HE)&\0XI80
M7[M"TA*2:U=(6X(-W6]BM\;E6./91(H]D@8-:J9AW;=L\(MRDR=++6&6 D_/
M?H%4_%DHA9Z)1'-157!XRQ)+XL\95NK[[\(L^.'Q,//"J48?T!RS=<VP/>G;
MG&A,F;J#\9=ECFYO[M -\I$R(@K1AJ3N>P._EJ)6F!<P>'/4G_@:0C(;\]?M
M]I^:[4=O;#]&GP37I4(+7I#"P<\O\\<7^#Y8V?D9'?Q\BBX*+LEN@.+@'D5!
M%#KV,[^>'KC"^7>K+_[QZD=FQ%URQ58O?BNYZHI(K(5\N""6=&*)%4LN9"HS
MF8JUEG15:[QB!&F!?B=<8T:=V=-(9E;2/)FOLP]). 9K7OMGXD#%29JFQ[#<
M 0N#499EQ[B% S<<IO&H@QW%GW;QIQ?-S D7\ "\9V?6R647[?QBGU!2(/P*
M9[0EB-?5"MX L4'KYK*W%Q8^+DK#[:1\>V_>9+I&M_0P>^<RO5DX[<6?)%DP
M/C']'!4/Q^D)*G=HP?F-3AP_1T5)F,1NPX>=0\/_P:&"LMJ0WO%H>)5'YRB7
M1PXMAT?GJ L>C3J/1M==RAT8TW?%F3;F^V" %N&TI5EMU+\ZP>#,%B?J]%;G
M#E0T.#5OX4#%@RATVS+N;!G_%[9TN?*^,>.KC'&BSHQQH!S&.% .8_Q>Z0&/
M_=;6? IBKKEN/A3=:%=6/MIJZF3\*7R8AX[Q',K0IFK\6[ZI83]AN:5<(48V
ML%0P&$)NRZ8N;#I:[&SALQ(:RBC;+*&4)M( 8'XCA#YTS )=<3[["U!+ P04
M    " !Z/FI3-_028_X"   $"P  &0   'AL+W=O<FMS:&5E=',O<VAE970U
M-2YX;6S-5EMOVC 8_2M6)DVMM#5WH!T@ >VT2NV&RKH]3'MPDP]B-;8SVRG=
MOY_MA'#/^L@+\>4[)^?X6.'K+[EXEAF 0J\T9W+@9$H55ZXKDPPHEA>\ *9W
MYEQ0K/14+%Q9","I!='<#3ROXU),F#/LV[6I&/9YJ7+"8"J0+"G%XN\8<KX<
M.+ZS6G@@BTR9!7?8+_ "9J >BZG0,[=A20D%)@EG2,!\X(S\JXD?&H"M^$%@
M*3?&R%AYXOS93&[3@>,919!#H@P%UH\7F$">&R:MXT]-ZC3O-,#-\8K]LS6O
MS3QA"1.>_R2IR@9.ST$IS'&9JP>^_ *UH=CP)3R7]A<MZUK/04DI%:<U6"N@
MA%5/_%H?Q 9 \QP&!#4@V 5$1P!A#; GYU;*K*UKK/"P+_@2"5.MV<S GHU%
M:S>$F1AG2NA=HG%J^%7?E#LN)9J"0!-.J3[:688%N),<2_G^G=_Q/HU6.X^,
M*/01C9@B*<E+DP":05(*H@A(='8-"I-<GNL::4CDZD$8^I[Q4F*6RKZKM'#S
M>C>I18XKD<$1D9?HGC.5273#4DBW\:XVW+@.5J['02OA#(H+%'H?4. %_@$]
MD[?#O18Y81-":/G"(WS'SO/F-<E+[1C-!:<F@Z)4V-Y^/D<W6##"%E5R-C+T
MZTX3HUL%5/YND14ULB(K*WJ+++F6!5NRDFU9L))5:%FEN2]G.OSJ&IP?BK[2
M$%L-YJ/S,HQZG4[??=G,XT!1-_2:HBU[<6,O;K4W4SQY1M\*HURV'%>GX>N<
M4HK=1E;W!%+L[@?DQ?%.BOM%0;<7'DZQU]CKM=I[F(W:PKML:"Y/*3S?6W^?
MO1.(KQ:QE5_4W8GO0%$OB@_'YV_\ ?G_"?"Q+4 _6!,%)Q7A^NONAZ<08;B7
M3MB)=B/<+_)]+]C)T-WH)RB(A6VSI%98,E7]R3:K32LWL@W,SOK8M'BV3UG3
M5/WA/18+PB3*8:XIO8NNEB2JEJN:*%[8KN6)*]T#V6&FVU00ID#OSSE7JXEY
M0=/X#O\!4$L#!!0    ( 'H^:E,\Z)V[/00  -H1   9    >&PO=V]R:W-H
M965T<R]S:&5E=#4V+GAM;+58VV[;.!#]%<+8AQ1(+9&^)85M(+:2;-!V8<1-
M%]C%/C#R*"8JB2I)VPG0C]^AI$AVH]!N"N<AUF7.&<Y%9R@--U)]TTL 0QZ3
M.-6CUM*8[(/GZ7 )"==MF4&*=R*I$F[P5#UX.E/ %SDHB3WF^WTOX2)MC8?Y
MM9D:#^7*Q"*%F2)ZE21</4T@EIM1B[:>+]R*AZ6Q%[SQ,.,/, =SE\T4GGD5
MRT(DD&HA4Z(@&K4NZ(=KUK6 W.*K@(W>.B8VE'LIO]F3F\6HY=L500RAL10<
M?]8PA3BV3+B.[R5IJ_)I@=O'S^Q7>? 8S#W7,)7QWV)AEJ/668LL(.*KV-S*
MS9]0!M2S?*&,=?Z?;$I;OT7"E38R*<&X@D2DQ2]_+!.Q!:#=5P"L!+!# 9T2
MT#D4T"T!W4,!O1+0.Q30+P']0P&#$C#(BU5D-R]-P T?#Y7<$&6MD<T>Y/7-
MT5@1D=I6G!N%=P7BS/@68FY@069<F2<2"!W&4J\4:'(2@.$BUN_(>W(W#\C)
M'^^&GD&7%NB%)?VDH&>OT <0M@FCIX3Y=-  G[KA<\C:I.-;.*,-\.!PN-\
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M"MT:,O2X=:&URE%VU,I,2WZ'R 2E27-1RLFRE^6JP80.?,?31FL%IFX)#E9
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M"^(M!'HKZJT$>BOJK01ZZ^AAFT!O1;V50&]%O95 ;T6]E4!O1;V50&]%O95
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " !Z/FI3F5R<(Q &  "<)P  $P
M            @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M 'H^:E,1(RSG<@4  *P6   8              " @0T(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " !Z/FI3+@![R8@&  #/&0  &
M            @(&U#0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#
M%     @ >CYJ4TI["/+> @  MPD  !@              ("!<Q0  'AL+W=O
M<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( 'H^:E/:TC#92 4  %T5
M   8              " @8<7  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q0
M2P$"% ,4    " !Z/FI3NDKA1*8#   )#   &               @($%'0
M>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ >CYJ4]U(WR>4
M!P  =QX  !@              ("!X2   'AL+W=O<FMS:&5E=',O<VAE970V
M+GAM;%!+ 0(4 Q0    ( 'H^:E/M+BICI@P  )-/   8              "
M@:LH  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !Z/FI3
MD\NQ*Z,"  "X!0  &               @(&'-0  >&PO=V]R:W-H965T<R]S
M:&5E=#@N>&UL4$L! A0#%     @ >CYJ4Y0'-?Q6!@  =Q   !@
M     ("!8#@  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (
M 'H^:E-$OBMQ1 H  *0;   9              " @>P^  !X;"]W;W)K<VAE
M971S+W-H965T,3 N>&UL4$L! A0#%     @ >CYJ4['W<$ZD!@  RP\  !D
M             ("!9TD  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"
M% ,4    " !Z/FI3A#=>D_@&  "*$   &0              @(%"4   >&PO
M=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( 'H^:E-J#B8E7@8
M #X0   9              " @7%7  !X;"]W;W)K<VAE971S+W-H965T,3,N
M>&UL4$L! A0#%     @ >CYJ4W223OL= P  X 8  !D              ("!
M!EX  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !Z/FI3
M?WE9D_,"  #/!@  &0              @(%:80  >&PO=V]R:W-H965T<R]S
M:&5E=#$U+GAM;%!+ 0(4 Q0    ( 'H^:E/^:OU?LP(  ,H%   9
M      " @81D  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%
M  @ >CYJ4VC+GC^?"P  E"<  !D              ("!;F<  'AL+W=O<FMS
M:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " !Z/FI3U=^E7J$0  !G-P
M&0              @(%$<P  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+
M 0(4 Q0    ( 'H^:E,^3>WM5 4  !,,   9              " @1R$  !X
M;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ >CYJ4QW/CJ;*
M P  I0@  !D              ("!IXD  'AL+W=O<FMS:&5E=',O<VAE970R
M,"YX;6Q02P$"% ,4    " !Z/FI3T\[9/&<(    %P  &0
M@(&HC0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( 'H^
M:E-3D"3%- H  #,<   9              " @4:6  !X;"]W;W)K<VAE971S
M+W-H965T,C(N>&UL4$L! A0#%     @ >CYJ4U''?H@R!   7PD  !D
M         ("!L:   'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
M    " !Z/FI3LC.K66T#   ?"   &0              @($:I0  >&PO=V]R
M:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( 'H^:E.GR.'1'04  /T-
M   9              " @;ZH  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL
M4$L! A0#%     @ >CYJ4RK)NQDI P  T@8  !D              ("!$JX
M 'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " !Z/FI3F7-0
M^<4"  #M!0  &0              @(%RL0  >&PO=V]R:W-H965T<R]S:&5E
M=#(W+GAM;%!+ 0(4 Q0    ( 'H^:E.C4K(DP (  ,X%   9
M  " @6ZT  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @
M>CYJ4[7MO6J=!0  2PX  !D              ("!9;<  'AL+W=O<FMS:&5E
M=',O<VAE970R.2YX;6Q02P$"% ,4    " !Z/FI3MC&)J9L"  "B!0  &0
M            @($YO0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4
M Q0    ( 'H^:E-5U("!O@,  & (   9              " @0O   !X;"]W
M;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ >CYJ4_426*(E!
MW1   !D              ("! ,0  'AL+W=O<FMS:&5E=',O<VAE970S,BYX
M;6Q02P$"% ,4    " !Z/FI3@N>YN$ #  "E"@  &0              @(%<
MR   >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( 'H^:E.:
M$Y?]D ,  (<-   9              " @=/+  !X;"]W;W)K<VAE971S+W-H
M965T,S0N>&UL4$L! A0#%     @ >CYJ4R^ VLJU P  #PT  !D
M     ("!FL\  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( 'H^:E,3+09W:@,  *\*   9              "
M@8?D  !X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ >CYJ
M4]L50#\J P  4 L  !D              ("!*.@  'AL+W=O<FMS:&5E=',O
M<VAE970T,2YX;6Q02P$"% ,4    " !Z/FI3:IUW1'D"  "M!@  &0
M        @(&)ZP  >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0
M   ( 'H^:E/(-<T'T@(  #P(   9              " @3GN  !X;"]W;W)K
M<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ >CYJ4RVI6'FJ!0  ^QP
M !D              ("!0O$  'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q0
M2P$"% ,4    " !Z/FI3=N.Y=:T*  #-/@  &0              @($C]P
M>&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( 'H^:E,O?J$T
M+0,  -H*   9              " @0<" 0!X;"]W;W)K<VAE971S+W-H965T
M-#8N>&UL4$L! A0#%     @ >CYJ4XE:=(68 P  E0X  !D
M ("!:P4! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " !Z
M/FI3QQN;KCT#  "E"   &0              @($Z"0$ >&PO=V]R:W-H965T
M<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( 'H^:E,&H:OL5@,  &<,   9
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M970U,RYX;6Q02P$"% ,4    " !Z/FI3U:P2PVH#  "H"P  &0
M    @(%U' $ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    (
M 'H^:E,W]!)C_@(   0+   9              " @18@ 0!X;"]W;W)K<VAE
M971S+W-H965T-34N>&UL4$L! A0#%     @ >CYJ4SSHG;L]!   VA$  !D
M             ("!2R,! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"
M% ,4    " !Z/FI3$"OR&QT#   N$@  #0              @ &_)P$ >&PO
M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( 'H^:E.7BKL<P    !,"   +
M      "  0<K 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( 'H^:E,( (ZWA@0
M ) E   /              "  ? K 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " !Z/FI3##^0_.4!  !_(0  &@              @ &C, $ >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !Z/FI3C^&W:=,!   V
M(0  $P              @ ' ,@$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    0 !  '<1  #$- $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>242</ContextCount>
  <ElementCount>333</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>54</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Members???/Stockholders??? Equity(Deficit) and Changes in Redeemable Convertible Preferred Units</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits</Role>
      <ShortName>Condensed Consolidated Statements of Members???/Stockholders??? Equity(Deficit) and Changes in Redeemable Convertible Preferred Units</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Members???/Stockholders??? Equity(Deficit) and Changes in Redeemable Convertible Preferred Units (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Members???/Stockholders??? Equity(Deficit) and Changes in Redeemable Convertible Preferred Units (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization and Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/OrganizationandBusiness</Role>
      <ShortName>Organization and Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Interim Unaudited Financial Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/InterimUnauditedFinancialStatements</Role>
      <ShortName>Interim Unaudited Financial Statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - Significant Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/SignificantTransactions</Role>
      <ShortName>Significant Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2108104 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2113105 - Disclosure - Fair Value Measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/FairValueMeasurement</Role>
      <ShortName>Fair Value Measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2118106 - Disclosure - Prepaid Expenses and Other Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/PrepaidExpensesandOtherAssets</Role>
      <ShortName>Prepaid Expenses and Other Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2121107 - Disclosure - Property and Equipment, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/PropertyandEquipmentnet</Role>
      <ShortName>Property and Equipment, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2125108 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2128109 - Disclosure - Convertible Preferred Units</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/ConvertiblePreferredUnits</Role>
      <ShortName>Convertible Preferred Units</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2130110 - Disclosure - Members??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/MembersEquity</Role>
      <ShortName>Members??? Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2139111 - Disclosure - Commitment and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/CommitmentandContingencies</Role>
      <ShortName>Commitment and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2143112 - Disclosure - Net Loss Per Common Share/Class??A Common Unit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnit</Role>
      <ShortName>Net Loss Per Common Share/Class??A Common Unit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2147113 - Disclosure - Related Party Disclosures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/RelatedPartyDisclosures</Role>
      <ShortName>Related Party Disclosures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Interim Unaudited Financial Statements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/InterimUnauditedFinancialStatementsPolicies</Role>
      <ShortName>Interim Unaudited Financial Statements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Interim Unaudited Financial Statements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/InterimUnauditedFinancialStatementsTables</Role>
      <ShortName>Interim Unaudited Financial Statements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.zentalis.com/role/InterimUnauditedFinancialStatements</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.zentalis.com/role/BusinessCombinations</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - Fair Value Measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/FairValueMeasurementTables</Role>
      <ShortName>Fair Value Measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.zentalis.com/role/FairValueMeasurement</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2319304 - Disclosure - Prepaid Expenses and Other Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsTables</Role>
      <ShortName>Prepaid Expenses and Other Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.zentalis.com/role/PrepaidExpensesandOtherAssets</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2322305 - Disclosure - Property and Equipment, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/PropertyandEquipmentnetTables</Role>
      <ShortName>Property and Equipment, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.zentalis.com/role/PropertyandEquipmentnet</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2326306 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.zentalis.com/role/AccruedExpenses</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2331307 - Disclosure - Members??? Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/MembersEquityTables</Role>
      <ShortName>Members??? Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.zentalis.com/role/MembersEquity</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2340308 - Disclosure - Commitment and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/CommitmentandContingenciesTables</Role>
      <ShortName>Commitment and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.zentalis.com/role/CommitmentandContingencies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2344309 - Disclosure - Net Loss Per Common Share/Class??A Common Unit (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitTables</Role>
      <ShortName>Net Loss Per Common Share/Class??A Common Unit (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnit</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Organization and Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/OrganizationandBusinessDetails</Role>
      <ShortName>Organization and Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zentalis.com/role/OrganizationandBusiness</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Significant Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/SignificantTransactionsDetails</Role>
      <ShortName>Significant Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zentalis.com/role/SignificantTransactions</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - Business Combinations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails</Role>
      <ShortName>Business Combinations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2411404 - Disclosure - Business Combinations - Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails</Role>
      <ShortName>Business Combinations - Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Business Combinations - Rollforward of Noncontrolling Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails</Role>
      <ShortName>Business Combinations - Rollforward of Noncontrolling Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Fair Value Measurement - Components of Available-for-sale Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails</Role>
      <ShortName>Fair Value Measurement - Components of Available-for-sale Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - Fair Value Measurement - Contractual Maturities of Available-for-sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails</Role>
      <ShortName>Fair Value Measurement - Contractual Maturities of Available-for-sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - Fair Value Measurement - Fair Value of Assets Measured on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurement - Fair Value of Assets Measured on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2420409 - Disclosure - Prepaid Expenses and Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails</Role>
      <ShortName>Prepaid Expenses and Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2423410 - Disclosure - Property and Equipment, net - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails</Role>
      <ShortName>Property and Equipment, net - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2424411 - Disclosure - Property and Equipment, net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/PropertyandEquipmentnetNarrativeDetails</Role>
      <ShortName>Property and Equipment, net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2427412 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/AccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zentalis.com/role/AccruedExpensesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2429413 - Disclosure - Convertible Preferred Units - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails</Role>
      <ShortName>Convertible Preferred Units - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2432414 - Disclosure - Members??? Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/MembersEquityNarrativeDetails</Role>
      <ShortName>Members??? Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2433415 - Disclosure - Members??? Equity - Share-based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/MembersEquitySharebasedCompensationDetails</Role>
      <ShortName>Members??? Equity - Share-based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2434416 - Disclosure - Members??? Equity - Share-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails</Role>
      <ShortName>Members??? Equity - Share-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2435417 - Disclosure - Members??? Equity - Fair Value Assumptions for Profit Interest Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails</Role>
      <ShortName>Members??? Equity - Fair Value Assumptions for Profit Interest Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2436418 - Disclosure - Members??? Equity - Fair Value Assumptions for Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails</Role>
      <ShortName>Members??? Equity - Fair Value Assumptions for Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2437419 - Disclosure - Members??? Equity - Fair Value Assumptions for ESPP (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails</Role>
      <ShortName>Members??? Equity - Fair Value Assumptions for ESPP (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - Members??? Equity - Unrecognized Compensation Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails</Role>
      <ShortName>Members??? Equity - Unrecognized Compensation Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2441421 - Disclosure - Commitment and Contingencies - Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Commitment and Contingencies - Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2442422 - Disclosure - Commitment and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails</Role>
      <ShortName>Commitment and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2445423 - Disclosure - Net Loss Per Common Share/Class??A Common Unit - Calculation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitCalculationDetails</Role>
      <ShortName>Net Loss Per Common Share/Class??A Common Unit - Calculation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2446424 - Disclosure - Net Loss Per Common Share/Class??A Common Unit - Antidilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails</Role>
      <ShortName>Net Loss Per Common Share/Class??A Common Unit - Antidilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="zntl-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2448425 - Disclosure - Related Party Disclosures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zentalis.com/role/RelatedPartyDisclosuresDetails</Role>
      <ShortName>Related Party Disclosures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zentalis.com/role/RelatedPartyDisclosures</ParentRole>
      <Position>56</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="zntl-20210930.htm">zntl-20210930.htm</File>
    <File>exhibit101-healthpeakhcpxz.htm</File>
    <File>zentalis10-qq32021ex3111.htm</File>
    <File>zentalis10-qq32021ex312.htm</File>
    <File>zentalis10-qq32021ex3211.htm</File>
    <File>zentalis10-qq32021ex3221.htm</File>
    <File>zntl-20210930.xsd</File>
    <File>zntl-20210930_cal.xml</File>
    <File>zntl-20210930_def.xml</File>
    <File>zntl-20210930_lab.xml</File>
    <File>zntl-20210930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>104
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "zntl-20210930.htm": {
   "axisCustom": 0,
   "axisStandard": 18,
   "contextCount": 242,
   "dts": {
    "calculationLink": {
     "local": [
      "zntl-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "zntl-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "zntl-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "zntl-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "zntl-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "zntl-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 413,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 5
   },
   "keyCustom": 35,
   "keyStandard": 298,
   "memberCustom": 14,
   "memberStandard": 34,
   "nsprefix": "zntl",
   "nsuri": "http://www.zentalis.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.zentalis.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Interim Unaudited Financial Statements",
     "role": "http://www.zentalis.com/role/InterimUnauditedFinancialStatements",
     "shortName": "Interim Unaudited Financial Statements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - Significant Transactions",
     "role": "http://www.zentalis.com/role/SignificantTransactions",
     "shortName": "Significant Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108104 - Disclosure - Business Combinations",
     "role": "http://www.zentalis.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113105 - Disclosure - Fair Value Measurement",
     "role": "http://www.zentalis.com/role/FairValueMeasurement",
     "shortName": "Fair Value Measurement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118106 - Disclosure - Prepaid Expenses and Other Assets",
     "role": "http://www.zentalis.com/role/PrepaidExpensesandOtherAssets",
     "shortName": "Prepaid Expenses and Other Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121107 - Disclosure - Property and Equipment, net",
     "role": "http://www.zentalis.com/role/PropertyandEquipmentnet",
     "shortName": "Property and Equipment, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125108 - Disclosure - Accrued Expenses",
     "role": "http://www.zentalis.com/role/AccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "zntl:TemporaryEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128109 - Disclosure - Convertible Preferred Units",
     "role": "http://www.zentalis.com/role/ConvertiblePreferredUnits",
     "shortName": "Convertible Preferred Units",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "zntl:TemporaryEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "zntl:ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130110 - Disclosure - Members\u2019 Equity",
     "role": "http://www.zentalis.com/role/MembersEquity",
     "shortName": "Members\u2019 Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "zntl:ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139111 - Disclosure - Commitment and Contingencies",
     "role": "http://www.zentalis.com/role/CommitmentandContingencies",
     "shortName": "Commitment and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143112 - Disclosure - Net Loss Per Common Share/Class\u00a0A Common Unit",
     "role": "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnit",
     "shortName": "Net Loss Per Common Share/Class\u00a0A Common Unit",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147113 - Disclosure - Related Party Disclosures",
     "role": "http://www.zentalis.com/role/RelatedPartyDisclosures",
     "shortName": "Related Party Disclosures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Interim Unaudited Financial Statements (Policies)",
     "role": "http://www.zentalis.com/role/InterimUnauditedFinancialStatementsPolicies",
     "shortName": "Interim Unaudited Financial Statements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Interim Unaudited Financial Statements (Tables)",
     "role": "http://www.zentalis.com/role/InterimUnauditedFinancialStatementsTables",
     "shortName": "Interim Unaudited Financial Statements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Business Combinations (Tables)",
     "role": "http://www.zentalis.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - Fair Value Measurement (Tables)",
     "role": "http://www.zentalis.com/role/FairValueMeasurementTables",
     "shortName": "Fair Value Measurement (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319304 - Disclosure - Prepaid Expenses and Other Assets (Tables)",
     "role": "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsTables",
     "shortName": "Prepaid Expenses and Other Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322305 - Disclosure - Property and Equipment, net (Tables)",
     "role": "http://www.zentalis.com/role/PropertyandEquipmentnetTables",
     "shortName": "Property and Equipment, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326306 - Disclosure - Accrued Expenses (Tables)",
     "role": "http://www.zentalis.com/role/AccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331307 - Disclosure - Members\u2019 Equity (Tables)",
     "role": "http://www.zentalis.com/role/MembersEquityTables",
     "shortName": "Members\u2019 Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesOutstanding",
       "us-gaap:PreferredStockSharesIssued",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340308 - Disclosure - Commitment and Contingencies (Tables)",
     "role": "http://www.zentalis.com/role/CommitmentandContingenciesTables",
     "shortName": "Commitment and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344309 - Disclosure - Net Loss Per Common Share/Class\u00a0A Common Unit (Tables)",
     "role": "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitTables",
     "shortName": "Net Loss Per Common Share/Class\u00a0A Common Unit (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i44bca96b50f545e98c95ba466913be25_D20171221-20171221",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "zntl:CommonStockConversionRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Organization and Business (Details)",
     "role": "http://www.zentalis.com/role/OrganizationandBusinessDetails",
     "shortName": "Organization and Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i44bca96b50f545e98c95ba466913be25_D20171221-20171221",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "zntl:CommonStockConversionRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - Significant Transactions (Details)",
     "role": "http://www.zentalis.com/role/SignificantTransactionsDetails",
     "shortName": "Significant Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i3a09ec80921740a8a5b68eddc9671099_D20210701-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DeconsolidationGainOrLossAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - Business Combinations - Narrative (Details)",
     "role": "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails",
     "shortName": "Business Combinations - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i3da75022cc3d428d9e0424e542c47954_D20210701-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411404 - Disclosure - Business Combinations - Assets and Liabilities (Details)",
     "role": "http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails",
     "shortName": "Business Combinations - Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ie38dad6ada064a56894e848a9616b856_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i973d4c68e1534b9e9776407fb3ef6a1d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Business Combinations - Rollforward of Noncontrolling Interest (Details)",
     "role": "http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails",
     "shortName": "Business Combinations - Rollforward of Noncontrolling Interest (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "zntl:ReconciliationOfNoncontrollingInterestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ifa5cb2304d0444b389a997ad08e0c71e_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Fair Value Measurement - Components of Available-for-sale Marketable Securities (Details)",
     "role": "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails",
     "shortName": "Fair Value Measurement - Components of Available-for-sale Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - Fair Value Measurement - Contractual Maturities of Available-for-sale Securities (Details)",
     "role": "http://www.zentalis.com/role/FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails",
     "shortName": "Fair Value Measurement - Contractual Maturities of Available-for-sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - Fair Value Measurement - Fair Value of Assets Measured on a Recurring Basis (Details)",
     "role": "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails",
     "shortName": "Fair Value Measurement - Fair Value of Assets Measured on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidInsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420409 - Disclosure - Prepaid Expenses and Other Assets (Details)",
     "role": "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails",
     "shortName": "Prepaid Expenses and Other Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidInsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423410 - Disclosure - Property and Equipment, net - Summary (Details)",
     "role": "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails",
     "shortName": "Property and Equipment, net - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424411 - Disclosure - Property and Equipment, net - Narrative (Details)",
     "role": "http://www.zentalis.com/role/PropertyandEquipmentnetNarrativeDetails",
     "shortName": "Property and Equipment, net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "zntl:AccruedResearchAndDevelopmentCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427412 - Disclosure - Accrued Expenses (Details)",
     "role": "http://www.zentalis.com/role/AccruedExpensesDetails",
     "shortName": "Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "zntl:AccruedResearchAndDevelopmentCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:TemporaryEquitySharesAuthorized",
       "us-gaap:TemporaryEquitySharesIssued",
       "us-gaap:TemporaryEquitySharesOutstanding",
       "us-gaap:TemporaryEquitySharesOutstanding",
       "us-gaap:TemporaryEquitySharesAuthorized",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429413 - Disclosure - Convertible Preferred Units - Narrative (Details)",
     "role": "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails",
     "shortName": "Convertible Preferred Units - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:TemporaryEquitySharesAuthorized",
       "us-gaap:TemporaryEquitySharesIssued",
       "us-gaap:TemporaryEquitySharesOutstanding",
       "us-gaap:TemporaryEquitySharesOutstanding",
       "us-gaap:TemporaryEquitySharesAuthorized",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesOutstanding",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i7b2b52f5efb3462d8683dfdb2d599eac_I20171231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432414 - Disclosure - Members\u2019 Equity - Narrative (Details)",
     "role": "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
     "shortName": "Members\u2019 Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesOutstanding",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i7b2b52f5efb3462d8683dfdb2d599eac_I20171231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433415 - Disclosure - Members\u2019 Equity - Share-based Compensation (Details)",
     "role": "http://www.zentalis.com/role/MembersEquitySharebasedCompensationDetails",
     "shortName": "Members\u2019 Equity - Share-based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i181d83080b3f41ccb6787320f7d2229c_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434416 - Disclosure - Members\u2019 Equity - Share-based Compensation Expense (Details)",
     "role": "http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails",
     "shortName": "Members\u2019 Equity - Share-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "iaf9822acfb464a6d891585e7be3a5ca0_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i20f31a36244b4706ade54e9ea17fc52f_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MembersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435417 - Disclosure - Members\u2019 Equity - Fair Value Assumptions for Profit Interest Awards (Details)",
     "role": "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails",
     "shortName": "Members\u2019 Equity - Fair Value Assumptions for Profit Interest Awards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i20f31a36244b4706ade54e9ea17fc52f_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MembersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436418 - Disclosure - Members\u2019 Equity - Fair Value Assumptions for Stock Options (Details)",
     "role": "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails",
     "shortName": "Members\u2019 Equity - Fair Value Assumptions for Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i540ddb3ca0df41eeb2c6de3a72cacd70_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "role": "http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437419 - Disclosure - Members\u2019 Equity - Fair Value Assumptions for ESPP (Details)",
     "role": "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails",
     "shortName": "Members\u2019 Equity - Fair Value Assumptions for ESPP (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "iff0bc2d120b04881bf89c97b3cd64dbe_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i782b4959ffc945c6b1b065f0b433ec10_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - Members\u2019 Equity - Unrecognized Compensation Cost (Details)",
     "role": "http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails",
     "shortName": "Members\u2019 Equity - Unrecognized Compensation Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i782b4959ffc945c6b1b065f0b433ec10_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441421 - Disclosure - Commitment and Contingencies - Future Minimum Lease Payments (Details)",
     "role": "http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails",
     "shortName": "Commitment and Contingencies - Future Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442422 - Disclosure - Commitment and Contingencies - Narrative (Details)",
     "role": "http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails",
     "shortName": "Commitment and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ifca4d5f92ab847edb29ab0e2bcc2216c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445423 - Disclosure - Net Loss Per Common Share/Class\u00a0A Common Unit - Calculation (Details)",
     "role": "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitCalculationDetails",
     "shortName": "Net Loss Per Common Share/Class\u00a0A Common Unit - Calculation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446424 - Disclosure - Net Loss Per Common Share/Class\u00a0A Common Unit - Antidilutive Securities (Details)",
     "role": "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails",
     "shortName": "Net Loss Per Common Share/Class\u00a0A Common Unit - Antidilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ic7e26115ab5b4a0bba07c095f7f7db9e_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448425 - Disclosure - Related Party Disclosures (Details)",
     "role": "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails",
     "shortName": "Related Party Disclosures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "iffe291a882a04056a3a61eec999af54f_D20210101-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "zntl:RecognizedTaxGainOnIntangibleAssetImpairment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i84f4ac54c0c4412cad1de8c39c9f465f_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Members\u2019/Stockholders\u2019 Equity(Deficit) and Changes in Redeemable Convertible Preferred Units",
     "role": "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
     "shortName": "Condensed Consolidated Statements of Members\u2019/Stockholders\u2019 Equity(Deficit) and Changes in Redeemable Convertible Preferred Units",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i84f4ac54c0c4412cad1de8c39c9f465f_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "ifbde449dbf9a408483168c4a251023f7_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodValueConversionOfUnits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Members\u2019/Stockholders\u2019 Equity(Deficit) and Changes in Redeemable Convertible Preferred Units (Parenthetical)",
     "role": "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical",
     "shortName": "Condensed Consolidated Statements of Members\u2019/Stockholders\u2019 Equity(Deficit) and Changes in Redeemable Convertible Preferred Units (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i36b0ac5aa6b94994b62d1befce371046_I20200930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization and Business",
     "role": "http://www.zentalis.com/role/OrganizationandBusiness",
     "shortName": "Organization and Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zntl-20210930.htm",
      "contextRef": "i231496bb8d46467298acc8e2d1083d39_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 54,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.zentalis.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r273",
      "r381",
      "r382",
      "r384",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "Affiliated Entity"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r106",
      "r225",
      "r230",
      "r236",
      "r332",
      "r333",
      "r342",
      "r343",
      "r387",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails",
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails",
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r106",
      "r225",
      "r230",
      "r236",
      "r332",
      "r333",
      "r342",
      "r343",
      "r387",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails",
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails",
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails",
      "http://www.zentalis.com/role/SignificantTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r238",
      "r250",
      "r276",
      "r278",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r421",
      "r482",
      "r483",
      "r497",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r238",
      "r250",
      "r276",
      "r278",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r421",
      "r482",
      "r483",
      "r497",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r238",
      "r250",
      "r265",
      "r276",
      "r278",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r421",
      "r482",
      "r483",
      "r497",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r238",
      "r250",
      "r265",
      "r276",
      "r278",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r421",
      "r482",
      "r483",
      "r497",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails",
      "http://www.zentalis.com/role/SignificantTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r447",
      "r473"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.",
        "label": "Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/AccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r40",
      "r390"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r26",
      "r166",
      "r167"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable from government grants, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r20",
      "r443",
      "r465"
     ],
     "calculation": {
      "http://www.zentalis.com/role/AccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.zentalis.com/role/AccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/AccruedExpensesDetails",
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r38",
      "r214"
     ],
     "calculation": {
      "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r56",
      "r57",
      "r58",
      "r467",
      "r488",
      "r489"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r55",
      "r58",
      "r65",
      "r66",
      "r67",
      "r108",
      "r109",
      "r110",
      "r340",
      "r484",
      "r485",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r27",
      "r304",
      "r390"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r301",
      "r302",
      "r303",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r279",
      "r281",
      "r307",
      "r308"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r281",
      "r297",
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationDetails",
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per unit (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r102",
      "r156",
      "r159",
      "r163",
      "r190",
      "r225",
      "r226",
      "r227",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r236",
      "r237",
      "r332",
      "r342",
      "r364",
      "r388",
      "r390",
      "r442",
      "r464"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r9",
      "r51",
      "r102",
      "r190",
      "r225",
      "r226",
      "r227",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r236",
      "r237",
      "r332",
      "r342",
      "r364",
      "r388",
      "r390"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r358"
     ],
     "calculation": {
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total fair value of assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r173"
     ],
     "calculation": {
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r174"
     ],
     "calculation": {
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r171",
      "r198"
     ],
     "calculation": {
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r175",
      "r176",
      "r460"
     ],
     "calculation": {
      "http://www.zentalis.com/role/FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "After one but within five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r175",
      "r177",
      "r461"
     ],
     "calculation": {
      "http://www.zentalis.com/role/FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r169",
      "r172",
      "r198",
      "r446"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Marketable securities, available-for-sale",
        "verboseLabel": "Debt securities, available-for-sale, fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails",
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r282",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails",
      "http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/InterimUnauditedFinancialStatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r275",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r275",
      "r277",
      "r320",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r322",
      "r323",
      "r324"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Cash payments to acquire interest"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r35",
      "r94"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails",
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r89",
      "r94",
      "r98"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash reported in the Condensed Consolidated Statement of Cash Flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r89",
      "r365"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase/(decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashDivestedFromDeconsolidation": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.",
        "label": "Cash Divested from Deconsolidation",
        "negatedTerseLabel": "Deconsolidation of Zentera cash"
       }
      }
     },
     "localname": "CashDivestedFromDeconsolidation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r101",
      "r102",
      "r125",
      "r126",
      "r127",
      "r129",
      "r131",
      "r141",
      "r143",
      "r144",
      "r190",
      "r225",
      "r230",
      "r231",
      "r232",
      "r236",
      "r237",
      "r248",
      "r249",
      "r252",
      "r253",
      "r364",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical",
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/OrganizationandBusinessDetails",
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails",
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r46",
      "r222",
      "r449",
      "r472"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r223",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Class\u00a0A Common\u00a0Units"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Class\u00a0B Common\u00a0Units"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r108",
      "r109",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r24",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r24",
      "r390"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value; 250,000,000 shares authorized; 45,198,528 and 41,040,286 shares issued and outstanding at September\u00a030, 2021 and December 31, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonUnitAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum number of common units of ownership permitted to be issued by a limited liability company (LLC).",
        "label": "Common Unit, Authorized",
        "terseLabel": "Common units, authorized (in shares)"
       }
      }
     },
     "localname": "CommonUnitAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonUnitIssuanceValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stated value of common units of ownership issued by a limited liability company (LLC).",
        "label": "Common Unit, Issuance Value",
        "periodEndLabel": "Common units, ending balance",
        "periodStartLabel": "Common units, beginning balance"
       }
      }
     },
     "localname": "CommonUnitIssuanceValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonUnitOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common units of ownership outstanding of a limited liability company (LLC).",
        "label": "Common Unit, Outstanding",
        "periodEndLabel": "Common units, ending balance (in shares)",
        "periodStartLabel": "Common units, beginning balance (in shares)"
       }
      }
     },
     "localname": "CommonUnitOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r61",
      "r63",
      "r64",
      "r72",
      "r454",
      "r478"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss attributable to Zentalis"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r61",
      "r63",
      "r71",
      "r329",
      "r330",
      "r351",
      "r453",
      "r477"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r61",
      "r63",
      "r70",
      "r328",
      "r351",
      "r452",
      "r476"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r100",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/InterimUnauditedFinancialStatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "auth_ref": [
      "r95",
      "r96",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Issued",
        "terseLabel": "Number of shares converted (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r248",
      "r249",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred\u00a0Units",
        "verboseLabel": "Convertible Preferred\u00a0Units"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r266",
      "r274",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Debt Securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails",
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Components of Available-for-sale Marketable Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeconsolidationGainOrLossAmount": {
     "auth_ref": [
      "r341"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.",
        "label": "Deconsolidation, Gain (Loss), Amount",
        "terseLabel": "Gain on deconsolidation of Zentera, net of tax"
       }
      }
     },
     "localname": "DeconsolidationGainOrLossAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.zentalis.com/role/SignificantTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Summary of Prepaid Expenses and Other Assets"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r310",
      "r311"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails",
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses": {
     "auth_ref": [
      "r313",
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated impairment losses.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses",
        "terseLabel": "Reversal of deferred tax liability due to IPR&amp;D impairment"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates": {
     "auth_ref": [
      "r313",
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments in unconsolidated subsidiaries and investments in other affiliates which are not controlled nor consolidated.",
        "label": "Deferred Tax Liabilities, Investment in Noncontrolled Affiliates",
        "terseLabel": "Deferred tax liability, deconsolidation of Zentera"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/SignificantTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r92",
      "r154"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.zentalis.com/role/PropertyandEquipmentnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r282",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "terseLabel": "Share-based Compensation Expense by Type of Share-based Award"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r5",
      "r16",
      "r25",
      "r104",
      "r228",
      "r230",
      "r231",
      "r235",
      "r236",
      "r237",
      "r382"
     ],
     "calculation": {
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due from Related Parties, Current",
        "terseLabel": "Zentera receivable"
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r104",
      "r228",
      "r230",
      "r231",
      "r235",
      "r236",
      "r237",
      "r382",
      "r448",
      "r474"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.",
        "label": "Due to Related Parties",
        "terseLabel": "Due to related parties"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r73",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r123",
      "r125",
      "r129",
      "r130",
      "r131",
      "r135",
      "r136",
      "r356",
      "r357",
      "r455",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per common share outstanding, basic (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitCalculationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r73",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r125",
      "r129",
      "r130",
      "r131",
      "r135",
      "r136",
      "r356",
      "r357",
      "r455",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per common share outstanding, diluted (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitCalculationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Common Share/Class\u00a0A Common Unit"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeBenefitsAndShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for employee benefit and equity-based compensation.",
        "label": "Employee Benefits and Share-based Compensation",
        "terseLabel": "Employee benefits and share-based compensation"
       }
      }
     },
     "localname": "EmployeeBenefitsAndShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.zentalis.com/role/AccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued employee expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "verboseLabel": "Remaining Weighted-Average Recognition Period (years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r298"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized expense, other than options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r298"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized expense, stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails",
      "http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails",
      "http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails",
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "EQUITY"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r65",
      "r66",
      "r67",
      "r108",
      "r109",
      "r110",
      "r112",
      "r119",
      "r121",
      "r140",
      "r192",
      "r255",
      "r262",
      "r301",
      "r302",
      "r303",
      "r315",
      "r316",
      "r355",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r484",
      "r485",
      "r486",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r36",
      "r157",
      "r186"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investment in Zentera Therapeutics"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.zentalis.com/role/SignificantTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Significant Transactions"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/SignificantTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r36",
      "r88",
      "r188",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Accounting"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/InterimUnauditedFinancialStatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r361",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r239",
      "r241",
      "r242",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r359",
      "r394",
      "r395",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r239",
      "r266",
      "r267",
      "r272",
      "r274",
      "r359",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r239",
      "r241",
      "r242",
      "r266",
      "r267",
      "r272",
      "r274",
      "r359",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r239",
      "r241",
      "r242",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r394",
      "r395",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r179",
      "r180",
      "r183",
      "r184",
      "r185",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r240",
      "r254",
      "r354",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails",
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r207",
      "r208",
      "r210",
      "r211",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r207",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r210",
      "r424"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "In-process\u00a0research and development"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails",
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Loss on disposal of equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r205",
      "r206",
      "r390",
      "r440"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails",
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r178",
      "r181",
      "r458",
      "r459"
     ],
     "calculation": {
      "http://www.zentalis.com/role/FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementContractualMaturitiesofAvailableforsaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r92",
      "r212"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "IPR&amp;D impairment"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r68",
      "r156",
      "r158",
      "r161",
      "r162",
      "r164",
      "r438",
      "r450",
      "r456",
      "r480"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Net loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r216",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r103",
      "r120",
      "r121",
      "r155",
      "r312",
      "r317",
      "r318",
      "r481"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestReceivable": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
        "label": "Interest Receivable",
        "terseLabel": "Interest receivable"
       }
      }
     },
     "localname": "InterestReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeAmortizationOfPremium": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization of purchase premium on nonoperating securities.",
        "label": "Investment Income, Amortization of Premium",
        "terseLabel": "Amortization of premiums on marketable securities, net"
       }
      }
     },
     "localname": "InvestmentIncomeAmortizationOfPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r76",
      "r153"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Investment and other income, net"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Contractual Maturities of Available-for-sale Debt Securities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "terseLabel": "Operating leases not yet commenced, term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Operating Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments:"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r42",
      "r102",
      "r160",
      "r190",
      "r225",
      "r226",
      "r227",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r236",
      "r237",
      "r333",
      "r342",
      "r343",
      "r364",
      "r388",
      "r389"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r102",
      "r190",
      "r364",
      "r390",
      "r445",
      "r470"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES\u00a0AND\u00a0STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r44",
      "r102",
      "r190",
      "r225",
      "r226",
      "r227",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r236",
      "r237",
      "r333",
      "r342",
      "r343",
      "r364",
      "r388",
      "r389",
      "r390"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MembersEquity": {
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r144",
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of ownership interest in limited liability company (LLC), attributable to the parent entity.",
        "label": "Members' Equity",
        "terseLabel": "Members\u2019 equity value (in thousands)"
       }
      }
     },
     "localname": "MembersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r49",
      "r102",
      "r190",
      "r225",
      "r230",
      "r231",
      "r232",
      "r236",
      "r237",
      "r364",
      "r444",
      "r469"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "periodEndLabel": "Noncontrolling interest at end of period",
        "periodStartLabel": "Noncontrolling interest at beginning of period",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails",
      "http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails",
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "terseLabel": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]"
       }
      }
     },
     "localname": "MovementInMinorityInterestRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r89",
      "r90",
      "r93"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r59",
      "r62",
      "r67",
      "r69",
      "r93",
      "r102",
      "r111",
      "r114",
      "r115",
      "r116",
      "r117",
      "r120",
      "r121",
      "r128",
      "r156",
      "r158",
      "r161",
      "r162",
      "r164",
      "r190",
      "r225",
      "r226",
      "r227",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r236",
      "r237",
      "r357",
      "r364",
      "r451",
      "r475"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss attributable to Zentalis",
        "totalLabel": "Net loss attributable to Zentalis"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitCalculationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r59",
      "r62",
      "r67",
      "r120",
      "r121",
      "r336",
      "r350"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net loss attributable to noncontrolling interest",
        "terseLabel": "Net loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails",
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Adoption and Pending Adoption of Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/InterimUnauditedFinancialStatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of\u00a0non-cash\u00a0investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation": {
     "auth_ref": [
      "r263",
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.",
        "label": "Noncontrolling Interest, Decrease from Deconsolidation",
        "negatedTerseLabel": "Deconsolidation event"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseFromDeconsolidation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": {
     "auth_ref": [
      "r263",
      "r331",
      "r338"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance",
        "terseLabel": "Contributions from noncontrolling interest owners"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r262",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other Income (Expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "terseLabel": "Operating Expenses"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r156",
      "r158",
      "r161",
      "r162",
      "r164"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://www.zentalis.com/role/AccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r372"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease\u00a0right-of-use\u00a0assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r376",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating lease, weighted-average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r107",
      "r122",
      "r152",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Organization and Business"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/OrganizationandBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r43"
     ],
     "calculation": {
      "http://www.zentalis.com/role/AccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r50",
      "r390"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Other Assets Disclosure [Text Block]",
        "terseLabel": "Prepaid Expenses and Other Assets"
       }
      }
     },
     "localname": "OtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r53",
      "r54",
      "r56"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized gain (loss) on marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Currency translation effects"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r60",
      "r63",
      "r328",
      "r329",
      "r339"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Underwriters"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Issuance fees and expenses",
        "verboseLabel": "Issuance costs of financing"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r78",
      "r80",
      "r170"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedTerseLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).",
        "label": "Payments to Acquire Businesses and Interest in Affiliates",
        "terseLabel": "Cash payments to acquire interest"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesAndInterestInAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r282",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r23",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "verboseLabel": "Number of shares acquired (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r23",
      "r390"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding at September\u00a030, 2021 and December 31, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredUnitsAuthorized": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of preferred units authorized to be issued.",
        "label": "Preferred Units, Authorized",
        "terseLabel": "Preferred units authorized (in shares)"
       }
      }
     },
     "localname": "PreferredUnitsAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.",
        "label": "Prepaid Expense and Other Assets",
        "totalLabel": "Total prepaid expenses and other assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r7",
      "r33",
      "r34"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "verboseLabel": "Total prepaid expenses and other assets, current"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent": {
     "auth_ref": [
      "r19",
      "r441",
      "r463"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Noncurrent",
        "terseLabel": "Prepaid expenses and other assets",
        "verboseLabel": "Less long-term portion"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidInsurance": {
     "auth_ref": [
      "r6",
      "r8",
      "r203",
      "r204"
     ],
     "calculation": {
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Insurance",
        "terseLabel": "Prepaid insurance"
       }
      }
     },
     "localname": "PrepaidInsurance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from issuance of common stock in initial public offering, net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock, net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.",
        "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock",
        "terseLabel": "Proceeds from the issuance of Series C convertible preferred units, net",
        "verboseLabel": "Net proceeds from issuance of convertible preferred units"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r84",
      "r300"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock under equity incentive plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r78",
      "r79",
      "r170"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Contributions from noncontrolling interest owners, net"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r2",
      "r59",
      "r62",
      "r67",
      "r87",
      "r102",
      "r111",
      "r120",
      "r121",
      "r156",
      "r158",
      "r161",
      "r162",
      "r164",
      "r190",
      "r225",
      "r226",
      "r227",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r236",
      "r237",
      "r328",
      "r335",
      "r337",
      "r350",
      "r351",
      "r357",
      "r364",
      "r456"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Consolidated net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r38",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r217",
      "r493",
      "r494",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PropertyandEquipmentnet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r37",
      "r213"
     ],
     "calculation": {
      "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Subtotal"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r17",
      "r18",
      "r215",
      "r390",
      "r462",
      "r471"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r17",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Summary of Property and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PropertyandEquipmentnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r17",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationsOfTemporaryToPermanentEquity": {
     "auth_ref": [
      "r245",
      "r353"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.",
        "label": "Reclassifications of Temporary to Permanent Equity",
        "terseLabel": "Conversion of convertible preferred units to common stock"
       }
      }
     },
     "localname": "ReclassificationsOfTemporaryToPermanentEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r273",
      "r381",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r273",
      "r381",
      "r382",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Expenses from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r273",
      "r381",
      "r384",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r379",
      "r380",
      "r382",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Disclosures"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r309",
      "r422",
      "r499"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r98",
      "r439",
      "r466"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r3",
      "r15",
      "r98"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r10",
      "r19",
      "r98",
      "r491"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "RSAs"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails",
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails",
      "http://www.zentalis.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails",
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r262",
      "r304",
      "r390",
      "r468",
      "r487",
      "r489"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r108",
      "r109",
      "r110",
      "r112",
      "r119",
      "r121",
      "r192",
      "r301",
      "r302",
      "r303",
      "r315",
      "r316",
      "r355",
      "r484",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares issued and sold (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Share price (in dollars per sharee)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/AccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Unit"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Basic and Diluted Net Loss Per Unit"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r281",
      "r296",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/SignificantTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r2",
      "r102",
      "r189",
      "r190",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/SignificantTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r358",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r113",
      "r116",
      "r138",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Recently Issued Accounting Standards Adopted and Not Yet Adopted"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/InterimUnauditedFinancialStatementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r38",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r282",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationDetails",
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails",
      "http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Valuation Assumptions, ESPP"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r47",
      "r101",
      "r141",
      "r143",
      "r243",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r332",
      "r333",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails",
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "terseLabel": "Schedule of Assets and Liabilities of VIE"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Preferred Units"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B Preferred Units"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series C preferred stock or outstanding series C preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series C Preferred Stock [Member]",
        "terseLabel": "Series C Preferred Units"
       }
      }
     },
     "localname": "SeriesCPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Grant date fair value (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, maximum (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, minimum (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationDetails",
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails",
      "http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "ESPP maximum percent of compensation to contribute"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r285",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "terseLabel": "Non-Option equity instruments, outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Shares authorized to be issued under plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for future grants (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r286",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r280",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails",
      "http://www.zentalis.com/role/MembersEquityUnrecognizedCompensationCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r291",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Average expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforESPPDetails",
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "ESPP purchase price of common stock, percent of market price"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Stock issued (in dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r99",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Interim Unaudited Financial Statements"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/InterimUnauditedFinancialStatements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r101",
      "r102",
      "r125",
      "r126",
      "r127",
      "r129",
      "r131",
      "r141",
      "r143",
      "r144",
      "r190",
      "r225",
      "r230",
      "r231",
      "r232",
      "r236",
      "r237",
      "r248",
      "r249",
      "r252",
      "r253",
      "r255",
      "r364",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical",
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/OrganizationandBusinessDetails",
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r48",
      "r65",
      "r66",
      "r67",
      "r108",
      "r109",
      "r110",
      "r112",
      "r119",
      "r121",
      "r140",
      "r192",
      "r255",
      "r262",
      "r301",
      "r302",
      "r303",
      "r315",
      "r316",
      "r355",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r484",
      "r485",
      "r486",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r140",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "auth_ref": [
      "r23",
      "r24",
      "r255",
      "r256",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "terseLabel": "Stock issued upon conversion of units (in shares)",
        "verboseLabel": "Conversion of common and incentive units to common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r23",
      "r24",
      "r255",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Shares issued under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r23",
      "r24",
      "r255",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": {
     "auth_ref": [
      "r23",
      "r24",
      "r255",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited",
        "negatedTerseLabel": "Cancellation of restricted stock awards (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r255",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "Shares issued upon vesting of certain RSAs (in shares)",
        "verboseLabel": "Issuance of common stock in connection with restricted stock unit vesting (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r23",
      "r24",
      "r255",
      "r262",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Issuance of common stock upon exercise of options, net (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "auth_ref": [
      "r48",
      "r255",
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Value, Conversion of Units",
        "terseLabel": "Conversion of common and incentive units to common and restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r23",
      "r24",
      "r255",
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Shares issued under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r23",
      "r24",
      "r255",
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock in connection with an offering, net of underwriting discounts, commissions and offering costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r48",
      "r255",
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of options, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r24",
      "r30",
      "r31",
      "r102",
      "r168",
      "r190",
      "r364",
      "r390"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r66",
      "r102",
      "r108",
      "r109",
      "r110",
      "r112",
      "r119",
      "r190",
      "r192",
      "r262",
      "r301",
      "r302",
      "r303",
      "r315",
      "r316",
      "r326",
      "r327",
      "r349",
      "r355",
      "r364",
      "r366",
      "r367",
      "r371",
      "r485",
      "r486",
      "r514"
     ],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails",
      "http://www.zentalis.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r225",
      "r230",
      "r231",
      "r232",
      "r236",
      "r237"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Temporary equity, ending balance",
        "periodStartLabel": "Temporary equity, beginning balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreferencePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Liquidation Preference Per Share",
        "terseLabel": "Liquidation preference (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreferencePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r14",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Par value per share (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnitsParenthetical",
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquityRedemptionPricePerShare": {
     "auth_ref": [
      "r14",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Redemption Price Per Share",
        "terseLabel": "Conversion price (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityRedemptionPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Units authorized (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Temporary equity ending balance (in shares)",
        "periodStartLabel": "Temporary equity beginning balance (in shares)",
        "terseLabel": "Shares outstanding (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of Series C convertible preferred units at $17.50 per unit net of issuance costs"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r179",
      "r180",
      "r183",
      "r184",
      "r185",
      "r240",
      "r254",
      "r354",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails",
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r105",
      "r266",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "US Government Agencies"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails",
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r105",
      "r266",
      "r274",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "US Treasury securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails",
      "http://www.zentalis.com/role/FairValueMeasurementFairValueofAssetsMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/InterimUnauditedFinancialStatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails",
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r332",
      "r333",
      "r342",
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "VIE, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsAssetsandLiabilitiesDetails",
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.zentalis.com/role/BusinessCombinationsRollforwardofNoncontrollingInterestDetails",
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r124",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Common shares used in computing net loss per share, diluted (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitCalculationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r123",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Common shares used in computing net loss per share, basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitCalculationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "zntl_A2017ProfitInterestPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Profit Interest Plan",
        "label": "2017 Profit Interest Plan [Member]",
        "terseLabel": "The Plan"
       }
      }
     },
     "localname": "A2017ProfitInterestPlanMember",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "zntl_A2020IncentiveAwardPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Incentive Award Plan",
        "label": "2020 Incentive Award Plan [Member]",
        "terseLabel": "The 2020 Plan"
       }
      }
     },
     "localname": "A2020IncentiveAwardPlanMember",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "zntl_AccruedGeneralAndAdministrativeCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.zentalis.com/role/AccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued General And Administrative Costs, Current",
        "label": "Accrued General And Administrative Costs, Current",
        "terseLabel": "Accrued general and administrative expenses"
       }
      }
     },
     "localname": "AccruedGeneralAndAdministrativeCostsCurrent",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_AccruedResearchAndDevelopmentCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.zentalis.com/role/AccruedExpensesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Research And Development Costs, Current",
        "label": "Accrued Research And Development Costs, Current",
        "terseLabel": "Accrued research and development expenses"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentCostsCurrent",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_CommonStockConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Conversion Ratio",
        "label": "Common Stock, Conversion Ratio",
        "terseLabel": "Exchange ratio"
       }
      }
     },
     "localname": "CommonStockConversionRatio",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "zntl_CommonStockSharesSubjectToFutureVestingProvisions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Shares, Subject to Future Vesting Provisions",
        "label": "Common Stock, Shares, Subject to Future Vesting Provisions",
        "terseLabel": "Common stock subject to future vesting provisions (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesSubjectToFutureVestingProvisions",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "zntl_CommonUnitOutstandingSubjectToFutureVestingConditions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Unit, Outstanding, Subject to Future Vesting Conditions",
        "label": "Common Unit, Outstanding, Subject to Future Vesting Conditions",
        "terseLabel": "Common units subject to future vesting conditions (in shares)"
       }
      }
     },
     "localname": "CommonUnitOutstandingSubjectToFutureVestingConditions",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "zntl_ComputerAndOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer And Office Equipment",
        "label": "Computer And Office Equipment [Member]",
        "terseLabel": "Computer and Office Equipment"
       }
      }
     },
     "localname": "ComputerAndOfficeEquipmentMember",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "zntl_ConvertiblePreferredStockDividendsPerShareDeclared": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock, Dividends Per Share, Declared",
        "label": "Convertible Preferred Stock, Dividends Per Share, Declared",
        "terseLabel": "Dividends declared (in dollars per share)"
       }
      }
     },
     "localname": "ConvertiblePreferredStockDividendsPerShareDeclared",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "zntl_CorporateConversionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Conversion",
        "label": "Corporate Conversion [Member]",
        "terseLabel": "Corporate Conversion"
       }
      }
     },
     "localname": "CorporateConversionMember",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "zntl_DeconsolidationGainLossAmountNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deconsolidation, Gain (Loss), Amount, Net",
        "label": "Deconsolidation, Gain (Loss), Amount, Net",
        "negatedTerseLabel": "Gain on deconsolidation of Zentera, net of tax"
       }
      }
     },
     "localname": "DeconsolidationGainLossAmountNet",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_EarningsPerShareDenominatorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share, Denominator",
        "label": "Earnings Per Share, Denominator [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "EarningsPerShareDenominatorAbstract",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitCalculationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "zntl_EarningsPerShareNumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share, Numerator",
        "label": "Earnings Per Share, Numerator [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "EarningsPerShareNumeratorAbstract",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/NetLossPerCommonShareClassACommonUnitCalculationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "zntl_ExpensesAndFeesFromTheIssuanceOfCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses and Fees from the Issuance of Common Stock",
        "label": "Expenses and Fees from the Issuance of Common Stock",
        "terseLabel": "Expenses and fees from the issuance of common stock"
       }
      }
     },
     "localname": "ExpensesAndFeesFromTheIssuanceOfCommonStock",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_FollowOnOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Follow-On Offering",
        "label": "Follow-On Offering [Member]",
        "terseLabel": "Follow-On Offering"
       }
      }
     },
     "localname": "FollowOnOfferingMember",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "zntl_FollowOnPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Follow-On Public Offering",
        "label": "Follow-On Public Offering [Member]",
        "terseLabel": "Follow-On Public Offering"
       }
      }
     },
     "localname": "FollowOnPublicOfferingMember",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "zntl_ForeignResearchAndDevelopmentCreditRefund": {
     "auth_ref": [],
     "calculation": {
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Research and Development Credit Refund",
        "label": "Foreign Research and Development Credit Refund",
        "terseLabel": "Foreign R&amp;D credit refund"
       }
      }
     },
     "localname": "ForeignResearchAndDevelopmentCreditRefund",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Lease Right-Of-Use Assets And Liabilities, Net",
        "label": "Increase (Decrease) In Operating Lease Right-Of-Use Assets And Liabilities, Net",
        "terseLabel": "Operating lease right-of-use assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_KalyraPharmaceuticalsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kalyra Pharmaceuticals, Inc.",
        "label": "Kalyra Pharmaceuticals, Inc. [Member]",
        "terseLabel": "Kalyra Pharmaceuticals, Inc."
       }
      }
     },
     "localname": "KalyraPharmaceuticalsIncMember",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsNarrativeDetails",
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "zntl_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory Equipment",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Lab Equipment"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/PropertyandEquipmentnetSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "zntl_LesseeOperatingLeaseLeaseNotYetCommencedLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Liability",
        "terseLabel": "Total minimum lease payments on leases not yet commenced"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiability",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease not yet Commenced, Number of Contracts",
        "label": "Lessee, Operating Lease, Lease not yet Commenced, Number of Contracts",
        "terseLabel": "Number of leases not yet commenced"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "zntl_LicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Agreement",
        "label": "License Agreement [Member]",
        "terseLabel": "License Agreement"
       }
      }
     },
     "localname": "LicenseAgreementMember",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "zntl_MasterServicesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Master Services Agreement",
        "label": "Master Services Agreement [Member]",
        "terseLabel": "Master Services Agreement"
       }
      }
     },
     "localname": "MasterServicesAgreementMember",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "zntl_OtherPrepaidExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Prepaid Expense",
        "label": "Other Prepaid Expense",
        "terseLabel": "Other prepaid expenses"
       }
      }
     },
     "localname": "OtherPrepaidExpense",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_PrepaidResearchAndDevelopmentCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Research And Development Costs",
        "label": "Prepaid Research And Development Costs",
        "terseLabel": "Prepaid research and development expenses"
       }
      }
     },
     "localname": "PrepaidResearchAndDevelopmentCosts",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_PrepaidSoftwareLicenseAndMaintenance": {
     "auth_ref": [],
     "calculation": {
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Software License And Maintenance",
        "label": "Prepaid Software License And Maintenance",
        "terseLabel": "Prepaid software licenses and maintenance"
       }
      }
     },
     "localname": "PrepaidSoftwareLicenseAndMaintenance",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/PrepaidExpensesandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_ProceedsFromIssuanceOfCommonStockGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Issuance Of Common Stock, Gross",
        "label": "Proceeds From Issuance Of Common Stock, Gross",
        "terseLabel": "Gross proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStockGross",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Issuance Of Redeemable Convertible Preferred Stock, Gross",
        "label": "Proceeds From Issuance Of Redeemable Convertible Preferred Stock, Gross",
        "verboseLabel": "Gross proceeds from issuance of convertible preferred units"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockGross",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_ProfitInterestAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Profit Interest Awards",
        "label": "Profit Interest Awards [Member]",
        "terseLabel": "Profit Interest Awards",
        "verboseLabel": "Profit Interest Award Units"
       }
      }
     },
     "localname": "ProfitInterestAwardsMember",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails",
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "zntl_RecognizedTaxGainOnIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recognized Tax Gain on Intangible Asset Impairment",
        "label": "Recognized Tax Gain on Intangible Asset Impairment",
        "negatedTerseLabel": "Recognized tax gain on IPR&amp;D impairment"
       }
      }
     },
     "localname": "RecognizedTaxGainOnIntangibleAssetImpairment",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_ReconciliationOfNoncontrollingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation Of Noncontrolling Interest",
        "label": "Reconciliation Of Noncontrolling Interest [Table Text Block]",
        "terseLabel": "Reconciliation of Equity Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "ReconciliationOfNoncontrollingInterestTableTextBlock",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "zntl_RelatedPartyAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Agreement, Term",
        "label": "Related Party Agreement, Term",
        "terseLabel": "Agreement term"
       }
      }
     },
     "localname": "RelatedPartyAgreementTerm",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "zntl_ResearchAndDevelopmentExpenseReimbursements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Expense, Reimbursements",
        "label": "Research and Development Expense, Reimbursements",
        "terseLabel": "Contra-research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseReimbursements",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails",
      "http://www.zentalis.com/role/SignificantTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_RestrictedStockAwardsAndRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Awards And Restricted Stock Units",
        "label": "Restricted Stock Awards And Restricted Stock Units [Member]",
        "terseLabel": "RSAs and RSUs"
       }
      }
     },
     "localname": "RestrictedStockAwardsAndRestrictedStockUnitsMember",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquitySharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Generally Expected Term",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Generally Expected Term",
        "terseLabel": "Generally expected vesting term of the option contract (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGenerallyExpectedTerm",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Lack of Marketability Discount",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Lack of Marketability Discount",
        "terseLabel": "Lack of marketability discount (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsLackOfMarketabilityDiscount",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Threshold Amounts",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Threshold Amounts",
        "terseLabel": "Threshold amounts (in thousands)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsThresholdAmounts",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Time to Liquidity",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Time to Liquidity",
        "terseLabel": "Time to liquidity (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeToLiquidity",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityFairValueAssumptionsforProfitInterestAwardsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Amount",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Amount",
        "terseLabel": "Maximum contribution amount"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Shares Authorized, Percent Threshold Used To Calculate Increase",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Shares Authorized, Percent Threshold Used To Calculate Increase",
        "terseLabel": "Percent of common stock outstanding used as threshold to calculate shares available for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentThresholdUsedToCalculateIncrease",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "zntl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Offering Period",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Offering Period",
        "terseLabel": "Offering period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "zntl_ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholders' Equity, Share-Based Payments, And Members' Equity",
        "label": "Shareholders' Equity, Share-Based Payments, And Members' Equity [Text Block]",
        "terseLabel": "Members\u2019 Equity"
       }
      }
     },
     "localname": "ShareholdersEquityShareBasedPaymentsAndMembersEquityTextBlock",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "zntl_StockCancelledDuringPeriodShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Cancelled During Period, Shares",
        "label": "Stock Cancelled During Period, Shares",
        "negatedLabel": "Cancellation of profit interest awards, net (in shares)"
       }
      }
     },
     "localname": "StockCancelledDuringPeriodShares",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "sharesItemType"
    },
    "zntl_StockIssuanceCostsIncurredButNotYetPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issuance Costs Incurred But Not Yet Paid",
        "label": "Stock Issuance Costs Incurred But Not Yet Paid",
        "terseLabel": "Costs incurred in connection with initial public offering included in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "StockIssuanceCostsIncurredButNotYetPaid",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Automatic Conversion Feature, Gross Cash Proceeds Minimum Amount Received In A Public Offering",
        "label": "Temporary Equity, Automatic Conversion Feature, Gross Cash Proceeds Minimum Amount Received In A Public Offering",
        "terseLabel": "Automatic conversion feature, minimum gross cash proceeds received in a public offering"
       }
      }
     },
     "localname": "TemporaryEquityAutomaticConversionFeatureGrossCashProceedsMinimumAmountReceivedInAPublicOffering",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "zntl_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, Conversion Of Units",
        "label": "Temporary Equity, Stock Issued During Period, Shares, Conversion Of Units",
        "negatedTerseLabel": "Conversion of convertible preferred units to common stock (in shares)",
        "terseLabel": "Conversion of convertible preferred units to common stock (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesConversionOfUnits",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits"
     ],
     "xbrltype": "sharesItemType"
    },
    "zntl_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "label": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of Series C convertible preferred units at $17.50 per unit net of issuance costs (in shares)",
        "verboseLabel": "Convertible preferred units issued (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/CondensedConsolidatedStatementsofMembersStockholdersEquityDeficitandChangesinRedeemableConvertiblePreferredUnits",
      "http://www.zentalis.com/role/ConvertiblePreferredUnitsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "zntl_TemporaryEquityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity",
        "label": "Temporary Equity [Text Block]",
        "terseLabel": "Convertible Preferred Units"
       }
      }
     },
     "localname": "TemporaryEquityTextBlock",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/ConvertiblePreferredUnits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "zntl_ZenteraStockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zentera Stock Plan",
        "label": "Zentera Stock Plan [Member]",
        "terseLabel": "Zentera Stock Plan"
       }
      }
     },
     "localname": "ZenteraStockPlanMember",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/MembersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "zntl_ZenteraTherapeuticsLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zentera Therapeutics Ltd.",
        "label": "Zentera Therapeutics Ltd. [Member]",
        "terseLabel": "Zentera"
       }
      }
     },
     "localname": "ZenteraTherapeuticsLtdMember",
     "nsuri": "http://www.zentalis.com/20210930",
     "presentation": [
      "http://www.zentalis.com/role/RelatedPartyDisclosuresDetails",
      "http://www.zentalis.com/role/SignificantTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e725-108305"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e765-108305"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70258-108054"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269825-111563"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.F)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90193-114008"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(1),(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3),(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r501": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r502": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r503": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r504": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r505": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r506": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r507": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r508": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r509": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r511": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r512": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r513": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>105
<FILENAME>0001725160-21-000220-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001725160-21-000220-xbrl.zip
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MD3CN-5R-3,8APW:&_%4BZHDLJT;3(=7'CIP%)^8%*M8C3PUY;&U13#P2"_@
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MY#2.TPC#= T;H%4UPPI!!2T_2I.S(<I6B<JASD.7&C=B3M.C2\5_@ODE[;2
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M55V[T(*-W"4\ZWVV\;%;'_*VQZ!O-C&WQZ2X^/W#A^GYOQ#T^LWTXNR$(Y5
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MW@(3M]9!;W3(TZ-D%+3VD?BKNJ^P6(>!R'&,-]!B1 9)91:>C<Z*+^#A8+>
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M.[M=T9JF]Z]8@J3[F%JQ21\85+KI36J+G?301.N[]B5:2449Q\O[*<?YS1N
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M4,"H,6?2;Y@*<=#"C6W#%!"UM1PAD1MGN.QJ\H^YE]6=M'P'C!$8 X J6*8
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M*U^^-4WS^=6UX4PZE340COLE"&]],;^2-CPY#E=7D;BB @O=QZJ=IFS+R?/
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M.N]]RE[ZKS<U_H<32\=&Q@[L+%22^2(VG* +)JDVDT'#>3P  >U,CCN3C_8
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ME2E7T!R]*J4Z62;@%]AIK,L2CX8II(LHF1M)$4]X62E3, %#<!S@*.*MCJY
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M.Y\X>/<68/(?_N-OB/B]>V6@B1\C]ZS,]<XG^CZ-7L\28$C7,)SZBJD5,.X
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M)3Z4]Y.>T:F$KRN7AX8X'&GF-JQ11]8N4>IMH"X./>[4!'&[(8<;GU-LCPM
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ME^\EI751 "7ET>.'QP/)K+XN'9V/" G1Q&H G\@<4BU5GQ<O0F ;(F:Y$["
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M@(]0@"[QJ;8,K@TF-)BNA\I9/_*7DMS_L+U^ZRJUOP('RI]AG[7W,52.V8Z
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M !\D@3^QUR7%Z*5LG#&'.4RN_%^@[+4O5 'KR-CGUD<[-'K_AIAZJD_[082
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M.4 /F$&TNG@3J'LO$=6R\QO\MFL,!6H,DA,@'&?.6COV@2-#<FG,IG]9I!C
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M1K*U06N^)$Z<];JKF,D(1%5S-/NX[8"]Q;148V%MR(K!@7LF@->-R@KUSO>
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MU!W'KG/NUBG: V8@=WR%4QAV,X'V< P"!7 )'*#V!D$W*!DYWJX?G?V)+65
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M!DW&''@T0J#R"D[>*-(.E^CD95JF8L^CC"6BB9U2IIXUO<=6W*\A&IF4GJ5
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M<L\-WU7/["1]/ %I+BB0;X#GZ0">;V&VQQ+V.'UT')'G,"IE6;0XSYK66JU
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M%Z?%QHL\/*];%O*M"F91CL8E):7\#-R6$(?4TQ9-O0]@P:8LS"0UTI#R@9;
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MMI7Z"2GE6XX0(EN Q,8]TZ&%S[-I66+S,AV8"&6*L1*<3F-5%/9,&%75B+6
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M[C7N/V_+W< <Q73LRS2@8\H923,\;S;H15_H>E#5(WA"[K&@QHKF;J4=Y*U
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M;NYJC4F@F5N U=9 N0,D@*C7MEA@NW-G5E30HQ?9_L(*=65QUK,B+Q_]*GC
MO6MLWZZ2"9B(#^VB R#<)A,F<]@7K2Y$01\E8.%"!WN+@E!IRNT7<#I<9[E;
M%X< )8]N4@)T!!-$4W=CK2*PN_U5ZG%4+(G'HB[2R <>S=T"E="H=A\A;!TG
MG<IL8SQJ(OG\688"A?T,=;@B/>%[SP@"QD?1CE0E$6UV'<UC!L&;O#1L$%.\
M,Y*'+-TV48$3^;PR&194HI3!LY(AQSCUTR\IBA4B#ISA?\JRV=K(H0W3:Y3
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MU>T;5U\+7_=HUP;#>"%T,RE1Y7?6>/DXR3YI%DY3M3."/]Z6U.1;#N!1@GH
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M_UW$BPF$)+%AS02/."YSV43B&^ G]X(![=5*1\ T(O((::1-XTM851Q1Y42
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MT+"^V >L/YG%-%6LOW'/3$^AGI2)U](?1/(]@N/-/83";X5F-RT<U<BXF?=
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M@W>K]"O"*!]N,-XR6,''-+S9V[^7>?ZQ(X0GWWV@NVL8_4<-@O6VAL!ZVPC
M>AC^ZN#PP,%?;1I9S0:_>=64F]'?_L#A_:CK_RQ'43D\'V_'W3UZ5'CP8N_U
M_MO-4>'SO8,[&A-G*FF.VPH;D=+ML<+W^Q[0S_<.7Q^ZYS.\H!?/?\[Q[+VY
M1U AVW^S=Z_\Y&-8GG&<8D+W=TQ3G^5Q0:PC=WN _8><<8<U0_!L_W#O=9,Q
MVW\>U<R9_=UC&+3]-R^_:] .*!GPUPU[:YM7;,?,!@3T]S :![7=\^)@[^TV
M6Y*#:F9P\]/](MO0OT(%N5.&$:67P2EV8S4X*/6=N]^P<_<?<^<>/'];@X)_
MQR5_E#+'(?CH;YY\]!\-WN]]6+[<"G>7#[2W!WN'FT^,KOBU/QRZ=J,5YE^]
MJ:5#UD</Z.TW/]U:PO>I4+[XE^_F>@PHPO[>RWJQP/SZUV<<[@O6&_S]X_#=
M\#SH_3P5['_)>4,,\+O3WNCH2^_X;[\6_;+M4W?Z^?QX>")*JJS&^3VS2>BJ
M[3";KY_,9M67>"41435T>]$0NKUH#-U>O'GQL$=X=;#!L=ZZA?7V^=/"NNO"
M>MFPL%X^+:P-"^OP:6'==6&]:EA8KYX6UH:%]>II8=UU8;UN6%BOGQ;6AH7U
M]FEAW75AO6E86&^>%E;CPCIX?O"TL.X4@-8ST?K;[H>?)N/Q;/\IY_&4\_A%
M\G&CT__!QO;Q\'P0G!WW3NXV?8>-M:C]MPU&_6VS43]\]5"C?OBO8M1?/AGU
MG[<M_S5.@H,G:W:_EKU/9Z>CWNB/8'S6ZP\> <3<9.8.&J =!\W0CL.W#S1S
M+_&+MYFY-UMBYO9?O?W7=UX;8&2M[9"#NYB6GU.]/OC!P;5&(G3[L'K/#A]D
M26JKP>O#?_N<D/>=6R'&ACZMD7L,RSMOGF;L#L-R@PW?C->/UPV'ZYN#AQZN
M^[<>KB]?<//E$Z+K5YV3&RRC/^S:LFB.+%\^.%WXHMNKXAZQY?X32.IG!DGU
M5B[SZRZX@'>++M\]91F?LHR_*BY'*IW@R^GH;\'QX/Q\,+I/^/VC\_=PBN[V
MJ+)(OU[HL+Z@*LEQ7"*C'Y.S6;%3DN>)<Z5USE(6;Q426E\HU5--=!G-D':^
M^7;PV[@H6(1[OE:I':2IN\HSHHUGJG<A79\A5:=PP"5%L8J-AN1MMR<UPP(5
M:5-D.(P*)IJ7"]PDR.))NHFS5:YD;-&T7!'G[6U/U2.M1A$P+(PP;,-SPB09
M=KPL#\:QROE<,!6B92%C,F!^#8LX8KD?Y.^^)FX[1SJSFPAQ\YC[[8T/8I(2
MUL_J\JJCDW3PMM7)D87,O6:6_(X9F#<M8?AM5);1]"HFQ8IN3NS@VU4R24KK
M>[0QOZ$CY'I'X]!L$.J?W7;K8)[SR3ILGJ27[1N'QL5W1[++ASCTC:WZG7-+
M[[W:!_WSX>E)<$>\Q2/)*3V_'\/!+R8)_6T<#$^&Y\/><= _/1F?CS[S')V^
M)WKY=\AA_^[S\/@(B>V'G\Y&I[\3 _WF5HE'F,-'5-UISZ7?W]L/@JXV#E:5
MZ]^ASV'T'+LC6E]1-#?^/Q% HW+S!NYGTGR_S+(9:3S"0.9(60?_34D:8&8D
M46;Q3$7M53!$+*TS"1A99#<1A2LDNNK-5N+,5K#3"3KU;KY.Y5AG+50*(PMX
M <MD*@S<W=01&*./C?K<^\]Z+?NQZO"+TF07%]O9'"[5A55F](\X/5'&B\))
MI&S#:OM%45/S6VU5/Z:+"_M3-DLN5':C"PN\6$W^%(4I<TQ^2M(L#_I744K*
M<)%H2F'*$#,&L_@B2<5^P Z8Q'"L[05#CEOC:U7UQG/V8@YF&3Y1WJ#Z5.?W
MRB^RS!W<*^C-=/[UM)P ZOS\_/LN7Y&?R>/K*)D[#K^1RJSJS*"]6Z M7C?X
MXN1]5%5\J+RP<,UWL--#=<=8M65F+")HI75ZRR78/U+V.8YNJ$A \H&FXJ(*
M@IXH('R*A7C*JR2?/6/I7);UB>8BU43"0&*6JR.8Q"(RQ.ZP(\%CA/PV>_9A
ML/-NE\LG:58&.\FNT2LU!1L8:Q'C3Z1R9A5TSE"_AE3'/Q=QM; B4LKXBXP.
M''@.Y\K@9^6<LKZ22$R^7X^C: I@+]C/7ZQ2>L!(-1TW?#'$;^XD\$PBX)CP
MF;7BX>IPX'/%NB!73W2QLI3NR[ETG&^<&SKCG$? 5P!O2-34)YP&)HVF$A>9
MY'4;;J**3'(7S[W<N#A9WQ+_+!I'V68"W#LIQ[UHS(.TE/;8Z>^J>!XN:3<'
M[JXAU5V"&!P)./7/.E>P0_T];.P""J;A.\PQ<.=%E*Y0"@$O 3N.U*R+981)
M_@AM"FUB5),VJQT6S6Y5!:UU9[/9A6O?SV2-\MO,CB.]B&^C3Q*+00\W.6Q9
M+PHKLF=35N"BBR\CV"KXYO,(WH*([I(%FS@E9#:&DLZAW$TMI<,E'C*98,,3
MS-0TVW%<!ZLTFTY72U1?HW6" Y?E1[I2\._Q:E*4$97!23-P'KL5Y\V341%H
M=VU[A"DD(U_F^.Z;RN6-5A ^+S)T<!8ADHJ.-!HS/10\.0D18VJ,96(=VT9#
MT%?!?W6^5#'Z.%/T"_=H8&U;N/L%;)M@Y^4N*G+!/KN@NAE\^J$3URP,QKX!
MR8-%O&)NHOG79U(N$IU>>7/Q'.7"89CF"6"N_LR2M 0#/R55>;C($LZ;JV?!
M/(%C"JPU(2;88N-A/HNO$W$0-/#A@IZ\QEM>O)Z1%JA@_01??;$3H>T13]<Z
M.,,)"8YA/KI@:BKIWCQ>1DG.1WF>TWYI2.6P0F'0\$AD WBO@%&*\RD?]ZYL
M(XP7K8I9P&H!R&?$U:;%R7JU[?YB!Z\;3_"#_==[II2A=8O70A#]:Q?'P2'*
MNVB=[*"EN E'<0=XV?VK42]JQ;E-6KS=+BT=[.UOEQ3O;265=@M,WDF#<I-P
M=I5S.;+!M,3/2KAA4/+'G%(/GZ;D:73#I'=UCL6MDY G6F2KM/0C)4&A!"_U
ML!RO%K!OU\%.Q4UBY"/Z9RI5OW>HWZ%8:M>X+:QC6T5%)FE"KLDL+F!;*X;2
M<[U,E."5]6S\""<&3$E,;@6$T<DW7BL=/.,;',CVUP%EF]-,DLV\[<RI3_D/
M,+@4&6*:)P(/?Y84DU5>R(M8PC]7^%@TYQN@<7CBEQEF9&2Y\>N+OTWC>%9\
MM\A;R8AS!OT[W\'L.H:E%ROT,%9E,B?<K!4:9L'@20P+5%(?)%^[\W.05Z_N
MQ'??T-R"!^6SP[V&3HT)["^VYNWZBKNP;5/T] HT$>[NI] 3X7WT:HY@%;6Y
M_?[K+V\/__I41?OO\V$O&%C5[%_W6FZOGL'<I.SEKU)2GF9349C0 Y>_6UL+
M-T2F8,PN5CFE?<E_+#CSD,?%4B(6K-7O!;U;E%BWCLQD_U^?7O9G=D=MBCM>
M=2F3VY2_I[-0\B%N MXD1;!Q(R_"((^F,;[\$+?*!2=(2,F.BR"S55+RW]CM
M;JAE_U:X@7J^FF-!.X\O5W-.T?!^A&U6YLE4?N-G&V6<"W.(8XX'DX'X 3C:
M9UC(@"FF <28# 8S0#"PB#-$)@4-Q[AO!HQ/( X&_HY2VDYIB(R+WD[OP]4@
M_Y+<N=(TW>C-:AO =_R/JPB35F#3%M$L=C+?9HIG,7QEYDXO7 8S]>"N8*3F
M>]CF4/VOO[Q\^U<S$V%PE=V@:0R]C'R(CW.38YX0O;L2^QC@5<J ESGJ;6EJ
M%&;*.[3/X994%+D$6Y?"(VN6$N<PCB""Q+%A%C*-;$9-^W-"LQHUM1HY=2V#
M!X2;PT+(,)&8KANGFMYJIBDGR@9&:&QJSCU^T"SW:41GQT3>-MT#W4Y:F>4J
MEZ"'RFWP.:F&U)*"?(\D=_*&\3=8@7@+;_82"%;@?2X$J4$W;7B:.T+#'R39
MV8C%?=/Q?,G!=N5+CIR89W,]H!OQ_1YX=]-X65(9!;V=&^S=JY1"&P.U\/M6
MS5HOF1'/< 8[<32E"A(;23]4--\EB^@&CHX-=+^"5FX:%\4N!&L0Q&DJP5JD
MQ"GZ8GJA4D/LAKM]VW0.\0':][[O(7KW,%GA'\GKOCYHTTYMSNR>16O7'%S$
MMMN69K673Z]@@4Y+KHMI08I^&J0PHS$Z9O)'].2RPO02Y[&!!OXR8.P#>]6"
MP[UVF]4V-V2%8H;HU9#U"=$9PG 0BZ(S<6JP).7V:9<Y)C+P'P;YL_$&F&+B
M-!9<*8@N+\$AILHFNZ$Q@E;PTO_G<._Y<\Q5@AL"UR5'$/Z6HS7+RJK_P3[M
MTBXPXT M!:X!TP:^4$[WA\O+$,J;#.^![5[!SL%_[NIUBRQPR_Q743[C=<=F
M$SYELZ[BJS=6NRNC,LL>W/Q5GM-9$)J%KM"C639=69?.@'; 5T(L@'S)JS8[
MQP&.:S7'"G:Q"8&U1!=1DAGLYUTGL+3<K>AUUQSE$1X>WM9K@.0^[;L'[SL*
M4>[H\3X61<>A(^4M!\>S=CW<S3XN GB<;;2<@^F87L73KR%5,Q()7R%H@UB)
M=YA;.-D,3KESP-#2K+C6Y!Z+Y)&2/ ]N6FS9 SF\;1VIE;TS8LFD9/X_>U_>
MG;B2[/E5<NY]?=N>0]&L-NXZ\\[!&%?QV@8WX*JN]Y\ 8:L+)*X6N^A//Q&1
MF=J%!09+V)K7<\N EEPB8X]?E-R:NX4&-$=\!G1FE5NY/'^+7*;X1!(4)38W
M:7",*NIMS-VR0 RA$T+S;@/Y:7FFM[A3A/;@MRG<9_V5DS5^*ZK/?. IV_"/
M#Z:--M+0 KG5>+ZB/_&UQ$:/E!<(B][!J->SZW*75P<2H"=KD3\8(SS]B83:
M//J0F>,Z:N;*U/;E?6.R(,I9+K8QXQ3%MC\)<*)8FD7U-/A0G!,\B;].)=B(
MF4:Y1XI4L!V3NWBD/U,5VC4EDTDR$ZXGG[(2U"<H+H GXA#2*Q7YI?#99$Q]
MS6VI3Y! / FY*<!!QY^?_G"W%2]E=.*Z^8Q9;L+Z'1A++DSX0XK3> "*>*6+
M+LV02L]2RDMY\N.=OZY/&=W6(*$>UL+H(K5-%!P<6E+%JBP7N><3YVEVP#V\
MKNTW<D#]?=(LW)1K53UV ZU1KI=K[\!$VX5PJ]5&#&.H9DJ5K22J'"D+H21@
M]-16?HE/8\P\9+4&*1$\[@9?9Z"8YE\SN$C%<WGL%30[F 79#7/'U#70W_!/
M[1?^(90U4 %6Q&A%@"V0NB5"O9ZWC+OYN#,K8S]?M;F-H^^0<<$CMG*JE21R
MPL \+^GDN\V+-$FW#^4%)+D+4QK*R3MS=+E!M:)#< H/XME%N157"U(MUT.2
MK%&G*S,N!JGGM!@D@%IV-6Q_[_6_I"P'J4=,C".M!ZD?6SW(B+*M!$?T!2X;
MY_&QDUR!D)DJ+\#4/8^0EZFV#F1X"4:?#\>!N\[9>P^H,IP[Y%X=-2,=*M^6
M6<:ALR0*/L%<3,414 PN>? T.+SB-.#:],=&\T'1;EI##BAZZ6#AKT#:\"6N
MQB5\^C/)?2>!@% 0(X+;)+ZE1R<V_CL3IX(7Y7O7RN^%?NKZNN&=WK;*0+F[
M:H2QPG,_W5RIG[KQC(JLE]<DZ_HSW^W\20;.F]!&B/<X2]!*#U>&2HSYSYA?
MME3XMF#<RX=.0["(/.4U+OGXA:QIC[CP@T"?B58Z8H$"O$R3\!@JG&Z!MZ]0
M=2-&W01JBZRQIZHY\2E^RDC'EJ/9(=2-/WYOU:KGGRV9+Q[-/M%534#G!%,L
M-KY-A(P\&A<I>QZ)(Y:&7!MW$')1-C]<\LJ%ICZY-ANEAXM<7[%^&L+$1*%*
M8QAK] 3"SLG+B)B&,AAQ ^^D\75@13F=G4BA1[!M)$.]E\1/83.J46)J-U&
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M8KW>0?WH$41^-S;R2^+">4!O?1$HZE6U_@50:P'46@"UOA-HJ3R>AW<(U'H
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M1PQ&4-W^0&+J&FY/P&9*_-PX#2Y6V3^KE_-EJS<V@ 7Q;GIH0MOK%<<&XHA
MU']*-GORP>!B.RJ\Z%&;/H)5 )^(8.D1'GTR<:A%A+ ]M3<K=:_J%U8 WQ;
MMP7P;9KJNMTP'%[H(Y%D+1U#H+D>!'O)% >6>'4'KH#GZLALF?6HF"M+:E;:
MG'RI[J]4;PW:0:O2_,RP;<L1-&@17:"\?JZ[X0;DLTAD+V'TC<G$>=M3#EB@
M:TN0]%/%G"J6M2-V<38[FH?,B606%.*XM</DMJ2%.E;L1WC5PUKHAY2\B:YC
MR[%6H$ISJPYT13^/RC?U$D>*<%'9J8ZM<,:@^<;RJ*V GM]A/<\>"/^B7$^+
MSI(=V0^!KB?* YO(CF(>9JH0R\D$Y DYBH0HCFU,%\H3S&S'KF0%'<71T7D,
MBE\L(56S*V7YZL CD%OJAO[ID3ZL3 [..UD8!MC5MF99#@;ET@;)8KH;9:H&
MG'#DF2G\0I8_2@4,%FZOXATOM1^5/E&M9^B3&IO*5&6=1W5I8"]R9:4Z,$'A
M+O*U2[\#$V@)ESJVYP.DU FZ[5FS,"WDP5F01:0DEXCEXIR0PH$H<=@??NE-
M*$F_2-FF+^KDS=#5N*%.$SV*3ZH^D]VX0%ETL(G6W(<EY9>2?CKPHU=MT4-K
M7P6Y%\VX6KZW*\AM1)'L,MWEY.2O*X.\]X_*$^QER TL\JVIU(V:VFG"H9]F
M,V.6H%8[ZKK.S96WM<RV]T?8AD^](572Z7>J LB.FOM&B4H23?5/1S/56?G(
MR(B7U;V8K%:/ 4VOM9KT;88K/W&P684L:J6(G!0.EC,!=F%'=B2)V;\,OY!T
M5RBIY&TRS>)#T<UCRP:X[U]UAU^& _B7C<:#8?M+EXW;_7^,V,G]:#PZ!=NX
MWOK,VI>#;]WXR]IX6;H0;"M5!+9V$2T,RS8$V]P0^<9T:5I/GE@#0X-5?E!Y
M>B4MHG5:XFU8XJ]H\RO0Q6!9QE0C77BEK50<A^7I6!BBE;<:<[92,2];=9:8
M>SUSIC9FA J]U*+'+:ACH$RV7IFJ16G9.@EN=L+3]TQ55Y_)R4%HP)R'TON
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M+?EQ3C!4?OMO#Q5$F_N)CC+Y\-&H&,6<.CKOI#5Y"4)>#Q3NW&8G\&0ZY8_
ML[U?);;(:0[41H^#=E%\<]NC@W1!7HM[G?][!\?65):LS<_=2>?^KGT:[$;$
M'C [2^<V$<HGMYNK96"2B&GS(%"9"5- 9 53SYA[[#R)7!6.'34]I>PF%'\&
MZP!_ J5)XT\6G[I>KU<8\%<53L4CNT(%PN;]7Y'1!1Y-']!7 NSHJ[)^!LY6
M8IVV?*[XBEVCX;;Q0;<X K02OJ%72MP>_#+V(;#KI>"3O RNX.1@A-Y/<=K
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M#9M,3 DT.(>7;R %TWL+Y]'+M3M(%''8%=;B#9V +P;<][!V@G>8FO73\B.
MNRLJ%W,/1V^7#+:X WN0YDNU5&0W FI1;."JI&T<KC-*HYRG6?>5Y383;A[]
MA,>:O?A86WREV-M,N'[T$QZK"W7U:.@OS#H?"0W;A/O.W6#$>TV#V%J$["=S
MNEJMEIM1QX'[]<&1OU^M4G;_];5WV1NSZV+9MEFVV_;P']TQ&W;[8];NMV]^
MC'HI<_9W8Y.1)6QDUX[P^R.E.G*+#+7(6\7\"<;PD##>[ !6G>D@2!W/R'/]
M!Y;P4$_DE:D[RNU4M1)KO#3.R^>QQDO X9<A(&)RM4->BUINNM_:<!RNVYWQ
M8#C*TN_'?4]__%YO?/;3)GV!,3ZJ9Y?V'Y7(ESR2A!EI+A(%%F A]H %%YXH
M&!&9/O(KN"N"#"UY 1IZEDIYDV IR>?G<[NZOQZUB69[?#^+?3J5#BK:F3XL
M7?=/!Y9V@:8VARX8@A)JB9WS7]Q!KYY)7K<QHA((>"+ZS;?]V2T^R B/]+)<
MY)1DK_[I(+J&<&'HND-171@NF/KT!R^/AZM,9-N&38W"9&VESPGJ^2.66%U)
M/EBQ<P,. #<&R8'EICP+VX\^4&(KQ[0<X:RT?1M+#FAGN70]$<*Q;3^KBR>5
MG51KIXCE".<.QJL9,,\E1P9!%\G*5*<JN5E).FFF9;.9LHX;UHGK .;N'2SN
M @UWAM*!!P+<%5LJ,W+AF.H<T_;)F0(OGZK$/J:/BOZ@2O@Z<M>@\]9D8N ^
MZO#)2TI[%74!]#S/L1Y/\<Q9R4V3]Z58_5,*(>,+=4/_9#F3!:<&_ 2W.<L)
MHD"*SW D,:B\P@;Q4V\0, ]9XDML\$^!L2=&<V>J2\T2PA\W3R.<61P,II-@
MPCJ;+PP,_)OL <N=* ??V_&2 !#RO1)5CA(/T@"U+/]J@8#7'] KY=TGD_M]
MM_&A:VY2@=R",".Y%,YXRSLRG B0,,@+/1?%MSF-C<J 12-3?B/09$X"Q]>"
MP5KSM7L&#5-], @ORM0H<N"=*UDK[NU1EEP\0=!D&]:$-3GE4@YITY(G/&&L
MWM*"98W,Q*82>SA;B2(WR(>#[RETFDWTDFD) <7Q:+,1II&7V1+OG<FZ:$-?
MK$,V&M]:P:8QP,D5*0R=GVBG(H9"P0$*6N"%J@64).* ;D)_//&5X"'B*<H2
M<^JIU3$(/S(/I8(AOQ!%BBM%<[GTIN?"@T5($>Y5?ZU4W>(#M)5?OD'Z\,9!
MU"BZD &DS">>&?R1#LD$#\4:>WG!3.5++#!(P2)8V(]4_HR+H&(2Y(9G\EB/
MP..RO4/)E0N>+*!@*1;6K.EP,KUK'8NOEF(9.CT68TNH"]&1C"R!)== I91&
M::MSX%RW!C;-F$6MVXGV=!J;%8$2&ND(DY\L+WC.Z[U]6;[T,GI/6"Z7D%2I
MIAR)59E.D4:X&P&XDN-J-.HOH4#XWU\2)7<E22Q^K4-"?/MN\ ]6$@*\=4PS
M*_$!NF^-?:.8UX02\)R5V%5JJ2L5(%S[A;(V'%?S"CR 1_)P0MB-#Y\G]& J
MAU^BCB64:L?6%G#X:==X<=2"(^H1(IO)+5(._6'YBISY;$YYUO4);)PXO<I$
M)I/XSKFW@AR^4:X*+850S7F.FZZ+$T1QP-B]Y,3B@<8\&L_JDTH-HT&-TL.\
MR#T!#Z QZSC\DRKG%%CA+\*=ONP W$LK4!9 ^36@R"L\RJMR -R):?Q4J:LZ
MJL$:331N#J'L#5+S!#/S!K!)KLX,O![^BV,2240B'V8M->^7!B:P9D[ ?A$&
M!%HO=&-PU[R=\E&N;X>2!IDP<4S3> !M6=3,\6CP+)3G,X\]]))UAK??XBJ)
MW[+A6RQS?SPS2IX,6I<9K^X37\DC7 H?,@J"*R:OCQ7M+.A9[CG9+#$.Z6.,
M]E=!!V,\0E1>/(S)M>_Y5._&W3[Z%T?=SOVP-_Z1O8,Q2NA>HW-*WA)4'TI?
M4BS.]%5,;'.QT2V#?PLLATN&DF#D'!1*9A&Z_) .,MBC(,P0T<92IXY)C=X]
MQ86#K5+M//!*COWPX"C(/=;<NN9O^*O%YV!,@$R%5C?C "LAOT&9C;@#U#^?
MH$-DLA8@8?)V(>=@%-'1X@6ZE&VP9%P& ;,QA*LJB:EQ-!7!_ 0X@+C.>POV
MH-%<_X18 S!?*-%/VC4X %?2I[P77BCVYH2G<?K@Q_RN(D^A$;T.YG/55$G[
MD.XK>/VGC:_WWL5KJC![DF=$\MFGRWG><^CD+-^<+>L\Z1TY6^_V;CCX1@!@
MK'US,_C>[G<RS9]&#$!2K?W1OJCS$G$F_%S"Y5R@K2$DH+UPC9N(-H$\R7=X
M7?W<-2L#UP8<F2-RZYWDPDOD=R&/>XA0R*>1O9NHY(F,I0)LWZ=3NVG3EH%^
M^Q5WGZKDS(;M(C63FCR0'Y;@:&3[EJ#3W#]C<L\"TS-GP8(8U]\@/ OM4^\=
MEK%4A2GYXN-=<TVR4$PAYU:NS.SD"9@G6EE%Z'"+L-_B;$!N(DDS\>221@0&
M%L;PE <%(]81[P?2JJ'[B-%_%+9>JQ,LSN+N:NK?@=P][;W^3'5W':B(3HQ7
MS,2M!B-+*VSTHAO1\,MIEUJ(#BR)??D@4EY5.M%FJ@TB)23FR+L;( K2^#@Y
M*(=&4$>7N#6XBS) ):)3 2>2+[,]]NDT],B$7QY5Q/?IA8\P!QCE=UJ9NS];
MHI5OB9O<."B?$K<SN+UK#]N7-UT7)3CCC 4$8P?"0\W7\[.+(*UTP&<OY^*B
M99G+.,$CEJK".:$<F6 OI"W+0AO+\Q0:6-M:$OXX[$?&KZ3P\*?I0L$:6! !
MFNU(D^X3UL[.I \.;GPQ1[1U+#FBU<J[SQ'=6P%"3#I>/,_.4W7, N2IR=LU
M>F<A%! ?&Z:IKMD=-?]8<L6&*M;\*$@E?YD;+R0SPXD!Z.(\X>X[X;R3R0D&
MK(ZF<PO7YVB4]7S4W66I_)N7MAL\R^K4333PG.QD\WM/P):SYI,V%:$/!20Z
MP5>5V7=40$VJJ2.!GN11<&>"6D-H78(,)>KV\05QR$LKZP1!W485(B$41SY-
MV,%2,'P0FIG$-U?1;X,J$T:U,%6#:DYXL$&F843#P"Z3=J$MN$*[\)4?R6M2
M*C6I3\S+!Z29;Z4FN0=6/I6:V^[XZ^!J<#/X\H-=#X9LV/W6ZW['!@CM_A7C
M*@]^&G_M,D\!^@#!\JW],<-V?]3N8)5EQEIA#WDC@14:/,_T/^K&B%2 Y\Y%
M"P0>LI3,A[,UF0D2R=]&AB+B<2^%O["3Q!."=R.;E/DA(B,+.3JY@GS&<RD8
M>$2P[G"^.+#0E2]?A9I-QO).@^O"G.UR+9"4/0(L@>&CP%$$?KGB59PGA8:P
M[%/$H6T!B&X:<!^LQULJW5L#+"3E[V2OD[O9!6ESDWQ9"CS=(8XR\!C0EF].
M#?$E79)9+YV4G&96B'A)CUIQ[$L<+U=@-"M6C.X21MRKPSV-^7^>74E(LUQ-
M$I7C1X%^@*#];DXQCX];6U")FVELFLH::(22?1?4.(!G*^/?3Q(I@@Z"31$K
M[!:3XK&^)!Q+6U*2')Q]3,/AV3JDCSF8HOR,T*DR?N,ZNEWDA87GN_:E 2"1
MNT7H&Q-V"%YYB8W53)DWB\\0CE3I%! 07+*CO1B.3 O"-X9X ZFKZ,BB[.3)
MFB_[(I(,E)"[Q"-S D-#I@_R9 5MZBV3F/&^5<E4< UI#;#\')I:TJ'!AD)S
M4Q797Y@ZI<$ %)-ZF$Q%&H:[F9SL86@^>IZI<*'/A*&?96J\[J4<K7E6>DE0
M$D_$HCMP3Z>*]8A9VL_NL8L[8H>T&XYU:^N;^"%?:V0<P45V>X2(=M[N;E*4
M&MNGH.\;FW8[ KY!5FK(WWB0PJWE:)4K?SF5=AY_:* R8$9:66#K.<^3>!<\
M&4ZRE4Q$7YHLFDRWNI'8@%5N9V1%2UBV ;M-42SO1)\$$P6]7$64#MP[Z=.@
M3V...R6F6"J%4:PX=C#3@&W8BW4)C02AV\ZPN27ONL/_Y!H1V!(:ZE(:YKC:
M+HF1,J91I$= 96*3 G3(\9P7QS1Y-[DHO9%BMA!<[83S(*RK< G[E&-*SAWR
M;1"#6^U=F.RK.#13HFMNXB_1$RPH@?B(LL0((^65*M.?<1Q=I@\]J8NHGA41
M]CYUG?)78UD2*"3(C'PU:&IHB+*,4F@VKH%*28L$=H-<BK.HQ_4*CP-O"<7'
MB?H+6JVNSB6GQ>/:0O:5:'[J+$75(3\$)P;7PHA;J]YUFINVY,O:(2,X=4+.
MATDT3&Y1G4_WS_VHRP;7K-\=,VS)]ZU]@QDY-]TV?#]LC[LC\J[Y0HCY\1?A
MZ4^NHWVI5D/6CB"7F'AMOX$/@]31T.OL-TX<"X\YI<<!O<'HS;4HV?/G/*,G
M1=$LCL&%HJO$4X'PD0O'$FYKOT^=RP77+R!2A%^H5_+G<8=R%M]1D*[^[H-T
MFQCBZ\&%L@<>"2,1[8K7\N5-\5K.SK)K\[II-8 /WR*KONF.Q]TA_M49=J]Z
MXS>%8LE.L/:&P^ZW08=DT&C<[E]=_H@L!>O?WUZ^62O<;1W8["7-X! @:WG:
MP='HOLNNVK+ST[O<I=W _W*V2]10OMW_QV9LN)=T]4JMG)W5..K=]#J#/@.%
M]J;[@V;#ZI5*G8W;H]MVGUT->]^ZNTZMWJR1'9)5,5/_BEW?# ;#$KMM]V[8
M:# <LZ_7M6J%C=K]<9MU;D!9QRYC-SV0&OU>FUTT*\W&5DK&+M9:1NMQV>UW
MKWN=7GOX8SN*S6B\X[M1A_7^56(W-YU=PP Q1-FHE[.;4X=2RP?L:[=],_YZ
MUVW_@]T-!W<(XMP=E5BOWRFSZD6M@A3;!P$^[';')0:L9MQEU5JEDO<]ZPV_
M]?I=ZMQW43NK1L]2SL;;'H_[7,S>=+^T;]A5%PSX,9;;O%<NT+Z[ Y8/_.]5
M4JO>R%)J_2_L#S#M$;O[VA[>MCO=^S%,Z48>H&8=.'SW&USTE;6_=<MPCKJL
M5JM47\%%LNJHUOW.?@R&_RBQ_@\&MGFU]88 VX$U.#^/<XN?75#A7U:T?#NX
M%X2<I([>C_ZK6JJ<GY4N6LURI<).!OTNN^W=W/1 Z^%$\N/3J/<O-OXZN!]A
M4EP?&!C[>M^_ EN)=7M?OL(%UZ %4<9<I4(,'':"W9='978UN $E8G1ZQ!T'
MXI>V^Z^[WI":"GBF2-(:C[IWXRY:E#DU53+%WRFQ6J56Y73WH]L>LNOAX);6
ME)(N;T#%&3&R^:[V0$7[RL2M5B\R(+U:O08K=G<#'!V]%1X-;B2_H"E&]8LC
MUD'.T!V.6'O,>F/XYW* 1_@*3O5H!&(>-F+4&])AOFU?M6^WA'%_2<ML-BD_
M*RLX7F!@W6'W\@?KCL;M2Y"47]G@?LC2.8<&(#"_7688M=ATF//7[0J4WC[(
M:%C>Z_:WP9 "07BRVQVB05Q9^BCU+M:]ONYVQBA1>K>WL.3 "FY^E-S[1O>W
ML =PV;\ZW2Y6H;&#B*S@AY. E#QEW[_V.E_Y >R.F-=9IB"&ERT*.FJ#:S"U
M^0:TO[5[-[RN\ <GE*MA^WI\,CK%/[[W87G9/3&J$6X=Z+!$!]*1+=W[R-IJ
ME<]M^K?Z&:X?MSM?8</I'1V*/?9[\!G>PN]'O "DGZM!YQY-FM$VW3EVD2-5
MD3H1:)!7S:XW;S)@-B[08-C[TNN#T4<G%*1PA!72RM[<L#:LWA6N(.P9V!C7
M\,./[3K=[)B$DM&Z_?'[1?7S>+U2&>:UPJ?Z[N[-\_W/HI7N(,+&X39?=<=P
M_D; .<=XIL F1-D(AXS.6=RVT_%$M0QX-J)OT)%R^7<9"6",SZ!+P"Z[ZHW@
M3CA]G1_LLCO^WNWV V].I"_^(J0R4@4CY,=?B0I0R7VP)T?POAC_;2GP;APG
M/''T%9?C#L0_?/MB^+M5/5SX6X!&RSNQDN73%%/,5I;Z=_G'YU!;=+IIEY R
MV*?-!KW<AI-GS^2+Q;C*]-/?[%GTM\99N56O)_Y<*5<3?]OTV'JY0DKN?I]*
M@VVF>NS?:"'X8L!R6RM%_W^_U7\+[0@* 2 "A '19@S/JCS7?Z^M?K%J,#".
M9S^\%WP;TA]]K""=F%H2XZJF._,\Y0-3)=N._6B8E-/FMN-RZ5XL4LS\Y2PK
M.,??-EYZW$MUY2L)\@CC;W327IN3<O;N<U(.63@>FW]ZWBQ7<P@+&(@I"=,;
M?1M70CI]Z<.?8&J."<*J1'_RZM,?9-8(X\C35;_W0$#W^J/Q\)XGSZ&8OARV
M.__H@A4_%J(;E5T0E]VK>(UV/RF_S8L,7=Q"V\?% ;NN.Q1+*<QZT?6SBRL"
M=H-O%TI@_^$J$9H2W2ET"\Q4/+F"R_ QEUU8;E!EP>1$C*,VZ#$,#+W[&]=<
M!4WD%I1C<@"B_G /YB ]I,2^MFDCV)"LE?& K!@P,KYSK8<[9?&F^]'5"6PE
MC/44=Q%ME.$5 ICQ79:O$0H2S .GA7$O83SQ07-RRKF/,8^6*'D>*Z2[]J]<
M_=%'*]R^<?7)$]<!T>ET1Z/!\%.O#_^#+>J.:)\#1I, J).TX=\R("Q!(B.P
MG-AM^P?0S#<P?TE_15L*-O2D V>>^T'0^X%7"YJG9P@KE],HO4'0%6B[HW%O
M?(\YMU?MV_87]$\0ZQ!VKQ@8C-<_54[=>!GY7_'"RV&W32/W47?X(7C>Z!31
M.%XX&,3R?$,==C&*.X)C>-?N7:&!3P_HW79=DP"/#@RJ+*9[L R^W,47!L-#
M<>U&.4O#>3>N33QUV.UT>VAMMMGW80]LP3[Z 7O<%QYCZ+D"MTOG:$"7(]UW
M_P7W7I';^T4O[[7+H9%Z;] Y#H/KP_O^-?[!3LXJIW#*?HP$+8,%V<-SP'F!
M+T;DG83@>Q()^[@<(H>CUDJV?IX=R14X%ZASO?$-7!U1 *[OR64FM8 TI"<4
MBH &<@T4C\[O:S@/WP8W\#1\\UT77HL4Y^DVY,C& S&\OQMW8-R#*Y13<!LI
MGI&?@BQ>/J=0/PKU(T[]X)$008S(II')TJ.N>J/;WFC4W:-D3YV\G&O6>.@*
M8!#QQV>8'9QGMM&C'<,H@?9).T:2!3*&M^_..MM?4*$=%_RSX)]9\\^"2[Y4
ML=[*,,\YMUR2?_H?;C"147_5[=["R_Q?%NZH[/G9F[*SDA!C(V%(U\^:DECB
M1.1V2EUUGV&!(B.@R @H,@**C( B(Z#("#BBC("+(B/@]1D!N0&.QQJY'E;+
M<1MM1(+G%N-K=S==E"DC+-#BX?LV2$7J7-6]RA-67%;U7(,QQKXI+"-QMT.E
M-JQWA1;0-:;R\JJ%)+6DE*!$<-%^">M^/Q[<MJDV[N:'" O!4S'3O-W'8@CR
M$,%&WG6'O<$5/D*6J90H1C^X'WO)KR4O="JV&,TGBJ%>WX_OA]&9W/<IH-3F
M2$EC=E;AP:1 % G^?Y]U[H=#?&#X"=]!:\=8UH_!/6O+<-@EAG._]$9H"USA
M&*0]><4+O>$;6+9AG_(3.H/[88]4^^$WRLCFOH9@/0B9>_&+^;T':\E]%MX*
M7G9_#(2.MFGX9=RZ_H!1SK[8EOBW)&^6>-6@,QX@9D>]BG94O5:6:>+\V7*=
MR/KQHH;]0?\3/6E$&B.N(MH_9%6[H6TW+=U_<'%W[DE1I9^$_8[G7!C ,J?'
M3>FA-<0WD'7E"V8&!B$'1Z04ASX TX)AW($AMMG$+PSO](8WG1XXGX)?8\%!
M;+26.,/]Z+^*M4V_MJ\)F2=7';CG"#F/[RR!48G5<;<<?2Y\8Z?3O1MS^+D!
M/F*[&H4C%JO(6*]@N?M7'(COKOWCUF.YE^CUX8'? (MSW8'_O.^A)''K9/"
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MU8VX5S<.\>IMDW*JK0S1C'SY6)C_BTE?W21-*N[:S,GOS4BZNI/C+%^(7$5
MK0BH'4?/XUJS\-V'F4DSPDPN:N7HR11?'KZI<3C $]?&UVM=3%Z&-OTW)<\Y
M*]>B39OEMTG3>U5^+.BF%]%7RF\/OZ)I&B.CBHA%3\1CTDVTUHQ7QYIQ.E$S
M5B=J5%N[$?_9Q5E0*]JC4([K6=UHO(V C=^:+_=@B]Y@X !MJ3L4'L+IO,5V
M[=;@J=98A;MRM'+8E<-K>HRN*HH"2"<\+5&R#,OO;).QLX?=:ZQE*/,9^P(E
M?\7:(7)+=#RO6U+7D93<JU:/\T)4*X1QG9O%JB<N%F9"NJ O5Z0Q\77KMWE2
M:2CW-I3&"8H6.9PZ[.2V_0]* PW&ID1:(-P824,<P;'=D#:77])K)*[F_>B_
M^.IY85'I5NPA2MP76)[1,4ZYN6'*HM?5AHE_!])*/>W8 W51]^*R.5B.L\3E
MB$9PB,\DEJO]U1=M$"=).%BYCYE#9;DA?(G>MC.[RA-1G6\46%<)$DM4NOF7
M[!A/5"M-[P>@#N3#.W'D8UR4B\1%B?>9\4-%)?2$?\9"E_&3Z%NP@X;"WL9A
MDS[BA1')?A>!*42J>GLTZHD:&Z_9!\<8X,B0UYCVP_'X,/&"PHV2+;GI0 ++
M#;A3H]+ZA'5:9[7S!@9_Y.?S\^K9JVLI"ZBVPH_W4?QX16)\D1A?),9GOU2'
M3(QOO7OG^N&3W[/2I5+U]^9F6SX3]=A+F7JYC D7OQ6_%;\5OQW3;_%Y+.]
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M-^'PSPZR!SR#@Y7A>/PWXF^^"=D?-8?[=L/596R/J_L;' Z.PH=@[!W\<SC
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M*\DA.BNH3K98>G/LWW\@EA80]JVZ65G[MZ,L??>;.OOKOM/_ U!+ P04
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M> [HX:Z@YR@XCJP?SIF&2D>T7*YY/,)MFP836NNG-['Y*&: 13.2SW"R5N@
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MG(X@[['FBQC+/NJVW><"*_0V+OL^W@"!_"!7O%W<%E3/G_9DZVN G8K]_MX
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M^2/HY,.*DR&TD5PH%TT"= 09Q3EWSA$-.AD(S^>/T!.)0DV$MM@*H)>)BN+
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M"K903FG%3/1 *N8]ML(8KD($U1<!J,Y 2.(E9&OTSDQ3VM88[24R&C"-)Q3
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M84)*/,&<:B>#842K&"D%9A@&/^=@>6>LZN%A_B-HH^/2D$[#ZIDI_ C\-X:
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M$\%1%+C3B!G/-&6IJB6%ESA/R2PE=TQ\5]ODM2>80$ _*4D'14:-,<%;9G4
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MWOQIB]?0:OVY;OSJ%8_?4OW32^L@P_9MMX Q-5RWU3(G95@9?OC#Y^5)RUS
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M9X^=5/#L:^/O^D4!_:H/MTA H&=Z_7(F]=-/+9)<_*4")0J!Y89Y=V#( VW
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MCEH3(D,AXP(5&-+2(H%Q%D$A)4$EFI*8!.Q);E^$5(VV1/,^C7GQ0'VZP"A
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M1EYX("@PRE&@4JB-3:%+E,4:0W4A4J+@>*XX'M,2CI&8(ZUS.JH 9J@#[5T
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MS"AJ.-$;FQ0WJ9BY(ET)8:POC!<E)@J,YP/C,3V!953(&0N):7.:$]-@E-+
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MF,G?AMZ'/&_FZX,D]QX6[9A>)XU;__)[?\\S](J[4>'N1W#WQ\F<-(NLEBH
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M;EE"&..>>0A!)@9U/'$I23\Y$A3WBD2CQ3"#4TP>K-:,0%]"(-B;"4]MP]R
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M[_@=V__S(]W;/CHYV$Z?V?;'^]N_M_</M^C^R>>X=T<&G306V6@@6B: !:M
M16.!,!^L0](&B>;1^7DJH*Q0*/Z+17[I_+QBR)\L714P49Z"=\X ,\B"D=Q
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MJ:"T2B@MHF<3)T%WMDDS$KDAU"@7DM,41V>)<WP1/7N!1.]S2GA1L!=2L-^
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M"%:^+I&JB2JGGCX!<9_7>98@ZR/H+_RVD/(#RDK/CD95@B&K*[/LI%,JV!V
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M#O.?DV?U3N"JE&(NG51E5:D+NA1<U1F!0=/K' QZT1_E4^OVXQ"$)+\+]"S
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M 'Q@0\R"95O/Q&5>K_Y1'N[9'5WNO 7%5N DN(A&>]#A+9?2$.8B%5FO)8K
MJH,FOTQ[P-YL_W[.!0:TX[,;['@P#*#,3E3@'_UQKTV?J^<MJ+^P#&4>_BM3
M_:E+"S\W-7;W'=X^_AR-!P0B04QI#6JLQ4AKB9$R2AL)ZJ$6>FUCT(]SSB@$
M8X_@BP9ZEPV)9F4])X\U4=K&>&AYH%Y:V^G6.AD[8Q"I4?/@FK(F])A9T72G
M%\KZ@< .-E/O] &V<T)03]HE+I#WM0Z^.8"N904(./YP6&6E8]"PVF29RB;
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MG_(_5VURO(W#.O5PAO,%<S@P@355EFLJ').::4*EQ8I38]O-#H[I'-7/;&@
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M8>CSU&AG[9G!V>V<D=L%%Q[.F/A+G<?=VK=TY6R=F:5:>V$E!@5)4,Y5+ER
M)3=$P;P4FO*?$"H2"_'IVW88?X=1G)0!>]-X<=[6LK?3BM[IW);/;F[OY>4W
M"9I8T K8,^%<=!J,8*TX2MJJ9*701&4R-7A]?FXW2RYHC+V,O8N #TRS&)O=
M@_C],(=TC7Y*:P\[4>Q)'5;6\MYDKKP<C,:C9SPWOIYL[WT6$G/MHD)$R^SP
M]A[!_P52 H,6)$E*1,#<4.ORZJDQ;[0L(4+KR]%H7*63U8V=^+/Z[U$%M'DR
M$^$V$W+R2(RXBR-E?A[Y\O[(9<=8[3[/L;2@_;C!$?SL=W+LPGAJ)6S=WDTX
M:!U>T^Q_[ U:KYJ/PWZSRS<""S'VP4KNQ6]YB<OQHU4;C9"IYUL6Z69#LX(%
M[FPG_'2YS8MGJ'Q>>,?[H)-5XQRM :NORP&XS6?U1D+=2- &8?%T>;ULOAYT
M#F(<-Y$0L)SLG85"P$TG>?]Y<! [ ;J0]4AX^: ?.R?1#L_6]0N"6VLKMXZ*
MR/&OYX,O MC(PX.J7QO*3>/R/OXP1]%.]W\P;+O?7#:T>;4?78)";O\UQWVV
M'W5<:-V1<#J(^:\J!TY6!WFD0#5I'!C7#NX]C1OY[Y$=YN='N#6<G:G9T$I[
ML":I>]\X!M;GY>KR_:SIF-7G$2G,EA$IS-DCCA1^P)A5>N<QJ^]AP*H$;-8?
MKW#PZ<E$B=DB.6GDXY=-4%8^'6SO_M7[2+= &?DJMGZ\H]N[.>GD'=[^Y_7)
MK!)3!Y2^^E1M@;*R??"1;/_Q]Y>//_9[.[M?X5D?29UT\NH=^;C[G^PMH%M[
MGZ7/U;XQ0R8(B[B*&AG*'1*)!D^#<5[,!72Z7$\-"VDC,3SYJ(UFT4O*O6".
M43L;?/JFY;P/IYSW^RFYO3\CMQN$HOZ\)>=;'J0 :]0J)3SG(6G#E9!!<P*W
M>QO%ST)15T9[NF.):8.Y9Z3EI/GYG"5F>_.S=R81+B/2DHE\H(9%3H'$<!AB
MS$1,VLV%:POGHR$N,"(ECRJ:?-*\U)YHE\\8E;,24X]_M@RGP^FOEH_'';%Y
ML7C_=-CJ2,\<$U0K@5D?NYU^M6^_1=!.07<^',9#VVK&^07#4"N>M=OS7.!L
M9R_VX["..8;KLB86)E%*K>L2WG+8@PLGX3 ?UM^O=_[8W'Q[&A23E?)3A^KP
MJ->Z"$ 5/^JUJG/KD*KO?1_]T1!TK/:RUVTD7=:%#T#?R\,W>=?[UR]/WU*K
M<$VHDYUHD-!JZ.@@AT#V.[\/A@<=@M&[1K7.>BR*_4M'T+6GNH_VLZX/G]G:
MZP4&!>B)X4R3G_/IM<!<B( [RDF%T+/^8-PZ\&(=7I/#OGN#T5'VW0US^.2P
M"4<Y'<VZT:.X$-YY^-HLNVPOU,$W@Z->R+8,*&VA=7I_.>K/>+T7ZM/\6]J.
MU<\?' T[FWV8][W.7W-0_-]3E;^V*AI]_WS$+R.3?<-4]>+41 +L\Z.V[-#O
M=ZAHC((&VC/I.&MPU6_\0KF?DY=.I.D0?@Y"-@!K.H+[<D>J;&*F7O2YCP"1
M#=GKT/2YWJ+L3NS*')Z?GPNSN(F2SQ=U&_,,.C,:Y:#C.J*ODVPUG+RG:4P[
M]<]:>FK.M5*2HW)K"3F-NC\+L)]M>+<-%CZ",9EN;VT+-_&Q@WZOCH#NY^'H
MP?-!VIIL@[/K?VY0W>T"?2[UJBS+V^\^!XP)!4L,!8T# N5.(AT<0X2*8"R-
M7M.Y9?:1+YI9DA=ANPF=9L9IEZB&G/('32H FDD%F*PQW^#7VK53M0G\$\_/
M9*'Y^\WKTX4F"U\3HG#<N&#:D,&#+.4.EDNPQ7*:01,(7C]Q$LPY%;W;!MDW
MB\STTAQS+&A_DL#AIR7A266Q_!,[,4=?ULDI@%"&9CC:KPZ[3; S#%->-&H
M\\)RBDV]"U;C4\76S]4XPL;G48;5\ZC.+S]UGG6JFFM'\>SV?"> .ZIC:;OY
M@M&@F_V+]2NO!GA"W7!_'8L]>4\=S7WM)]A\?]W->OFLMU%.-8#&+3>9^).W
M=>O''AYFI2RK.KUJ7'NO\F?#@:V#9V!43OL]FFY.,]-@2#O_(O]N&C8XCG7L
M=(!W^L:1ER?IMV:(SGK9//9@ /(Q.G,Z0"LJF-[MC:VDU&I#A+8/#F!]F$WY
M^A=MWGSF/:W5-C<:#%T'U*!FXZ@[2;!K<U[@$FA?K&I)R6,X;C9*N^?;YVL5
MYQ TDMKEV<LC/MW>9DL4+JQQ^R=.C)G!T2@/:)VGMCA^H\XDX0,>?YJ,TO@5
M 4&8U[5W-AV-C_+SIHG@P)ZTR_Q$H3@G]?FV$,]]U&U]S1V?]V?S_2YVZ]W?
MO/#G?CTEIL@+09M1= "H#$)VUM?YDGG2-$Q?LW+5_Q8G&L]I'-EDRM>S^LS;
M?;H7/CTS0$GL'>6$JFZMJ6=*:1,O8'2_Q8G6F-\2(U@J>;2G7VIKV<WFU%DH
M^#D[HCL1]&8GO=;#8FT)Y!T#Z,+IY)_T^%R?1O73H;T_FN?;VB,_<9?W;#80
MI^XX1Y[U&_[5[LO^NYO?NSZ_.35M@-^MCO=A%'?2:Q"3@VQG/D>M;N^SUDHS
M+S6*CD?$&4[(6"80C&=D.&IBJ5M,JUL9%]Z')LSD%."G1DB-!^74A+N.>IHO
MRLM@LZ68/2T3XWZRX(^F[,=ZF]%^!>J;#&$MSK ^'1T<-@M'H_O4R4X-O1TT
M2F_C\SBSOZ_G*3CG:*H-^CH!U^9MOV8WL,Y=JY6/<YK;^09^.0IU%GB^L";@
MS'-NDARS#POC8%@GG-?OA)775X=UPR:6;LV0P]@/K?;>K]5S6)U;*IL;@:DQ
M<Z ]QV_-(MPX.4:#9M.VCG5JULQJZ(\.\HZHSUW\[:1-^P2=^RAG=$QU9UAO
MGGZIQW>01Z+J[]=I][ @[PUC/<./\@YI3B$#5&L=$I;FO QW.ZT&.^E77J:;
MO/W&>736[#.%:?+J)[9^#X[V&J=-JRA.4OIW_G[S"A'3@=:&F!5%&.4\HUQ;
MOJ.9 *>% 28CV;H[1M.1:5,PU#/T=#<;'@FZ0K,49\MNVA%DO]FJ-]G3;[YH
M!";['^LY>N;JO R;V55S$7J^#V@6Y.VIW<3.V09)9[*?^)3FY:LF\3;/C'ZV
M#@_@COW1;-1!9Q)PT&VC+LY,]1Q[<:;T7^0XG58NI]WF[6AV:H=R+A_D&K;.
M)LTUO*6IRK%I%SE-.Q-_:9V45H736,_S"O146V85YYJ60QL&6I<9B$UFV^F'
M=8:*CS-=&H*MEX6P>4K^"==F,SSV!L<KFKFR6MN23;W)K1JA-V>(-/[/9Z<@
MOQ8[NYLG6S_>T)W==]^W]CY'RV&($T56!8RXXABY) 2R7D7LF=9>S>V(:^X<
M\4H&2A-7RD(SJ-98,!-!0/V<R[2!H--@,,5_5V].7AG5]_SBC?CE\48K$SIT
MX8;L;>,G5CQ<\V>RD%VR]>+V$Y>(G3A%>J=;TL!5W;88"OQEUSN_3[9'9SQ7
MDX1]N*@3FO7W/T>]DR:B#]:0T6%3N2&7=*G+[TQY,ZK9 AE'H\GZ?6YU [/E
M:'CF8(%%,KMD1^?=*V>>G/K9K;^_<>"TUM-@UAF7MPY.HS6G-^2R(3*LE=PK
MG"^URZ4[*3S@!T,8M<-!L[;"%=E6B:VOK_E]4LUBUA'4\78XK,X:>*Y-9^;=
MA#GRGF@]D&=Z;S6]KY\A;?VJ>6LD9=]FK-VZN69"[Z0=ZM;].A@V&RJ'337D
MBP;XU(MY-*QMI4LMSC.']W$\W:C_R;,O\GI=L%UYG[N5(+53H43G]* 26-2&
MXFU^AJ&U!-9II(Q/B M%D"6$(2V=PL9SC9-ZI+ZNS6EU^6VK+F].J<M_->KR
MM#UU7EV^S^GZWN_'<)23_:Z8N)O]\+(Q;=[TIZ^9A/L\Z\G\[G-D4A(G(DK&
MYEH002,=J$3)$Q:<B<F[N2*E"^@.E*^+U;.7L]LSP:H_.*Z7W=IO DOV-[ R
M<\: @S4IM>;LC*'8.TOA/Q.!NF2*'8917ND'=9[AX'"J;N%D^6B"7-H%(U^7
M%ZR3.)Y<_^+J^N?GU;&FU:=*=EW2'<:O9P]'\<7DEU]#-3KLV9,75;\>A?JF
M7\]C!OC,5G2O7]=\W2JJ1J\KHK)&ELN[GY6@;]78]5I9FRE/WW['UXTBEWZ-
MUV_ZG6'R1G=>U5A&UK7@=]!8I6[VU"M'5JP3QAY)8QE>%T)?Z['U"0+M-+O)
MJ2T7G)_2F)$/<US(W$I;VWSO6\Z8/=IA21U>M0-CFA#(BT^S>+(83]53+S _
M79C/:@F_ J.P(/W4D9YX*TZ3HVK?W%2"%%CX.]DCT'P^Y8+:LN-<H>+<>-UT
MM;OV*3X_FT7PA/OW[M7#^:;?^8_M'^7PL[."6K]OOO]MHF-OOO]0?X,PR34P
MS[9VZFTI\FNG]7)/)5K\:W=P"*8FHV3N*-!EG !WT3,N ^)185%[UB:&3,?W
M+#REB4IM8XG;BA<NCH_SCN%%YL]TYDKKZQM-(;/Y_F6-2W<V!FX*V/8B]N^V
M)&RS$][DJM3[#.TEFHA_KR^/?:X#\\*"^*CPGPABL^E*BNPL,':;M1]^9@3K
MV(U0U1E%G5R^?5XDKA*$VGU^.NF;;*#IF!.0UCZT?DH,]XZJ)O<-Y*7>A#A]
M>=X)L9T<\C&L$XC:&.?!=4.JSM<=GNR>KY_;DIH>][L;Z4M?><]03S9Z:I!K
M<',AD$O ;*/'YC=]ZD"NEO!:A,_M$<T&X%Z^?S._5Y)1JU.TFKK0]G2K*+1G
M:,QL9UU<UFLUMYZ6L/.TWGGHV7O988ES^_,7_#V_17^]TA<4OE7*8&DT/3LO
M[S$4GV!W7GSBDIB55Z?IK"NR47"2K]O^X<76JX]BY]4;]B?]=/+Q'R^W=CW9
M_O'FQZ?=4'UZ]:G:_N-3M?-/#CK9_O+QRW^^;M._OF[]"%^W=S]^"W_\S</_
M^4_O$^U]<U\&W[=_?&!;7[9[VQ2N.WB#/QV\$1^_?!1;=+O:.GC'/OWQ#M[_
MCFSWIM_O62XH_9DY371@'D5I!>(I6F25-2BR -.0V6"9FPMG,2)ZHJ5,QO.,
MD#'!2L:5@E^5C;-;#M-6U%0-T9L<B_;S5Y]O*L4\XN0$H8QQBX,5T1JG16*2
MY-,S'FYS[TJ)F<0F[$Z=G773V#4F'^YHC)P8/;$/C^/9D4@']LM@V)XO41<_
M/3N,:3HT8[K[W<Z?X[ .ED7G?=X1W+<5:L*Y9\XV<]7@&L>;31UG5A\R=OZ4
MLNFSU^#C2<YEG1(XV0^JE[$<*/D^U@F<FY,:^U6S(34Y/&ERKD13ZK%9J2]:
M\2])LAY-C\=9S.=L;OLUJEJ=AL*T.D2S_C>'BDPOVGD3K<T#RPUI'EZ?^C*)
MX:PUA3K7<$J7FK3QK):VG0S-;]<:FE;3"E4.+VNB.Z::5==3.!TM:$DO!V:/
M82J<3:8ZX7*]\R&?S3&,WRJ8Q).T=NO;8(]S8?==>.Q>FV$W2>BW1["(#$]3
M&<]4]%XN4-H&YV?K8*86VJ7Q15G9'X#>U=_+60,Y-?)P6-6EU39/RY>=!1_]
M9,A.!VLZL6QB*^13MMH\AFX]?NT@Y%G;S):ZI3DL/=HV<:VU+Z9#J::K%;1Y
MR&<Q5=FTGPYXGSZ?JSD\*(3FR;E?DS$H@8I7!"J*QQJH^-/%=;8PE'64:- L
M- D<1V.%UHPF4/><#3X\_&)\,4#-%,]65YV8/!@V3-)D=\P(UIFDGV9[_B2O
M^;)DYC:A:FH)NCR9N9^+>C3Q:U>D"$^B(A^A(O%;A(;U6]Z;6G3&MUA,V[*5
M+5P++ZA WU=X#1:L-^Q5I)(081T8?!8[$![EL1%))94#>>KRZ:WE<[[,\+7L
MH%4I(OS0YL_WK5=?Q?;NZ^_;T,_M+WLGGZTQ$2NKD0>3$W&K C*,*L284;F@
M20J*@@%KUME\5?5)T>GFA+LS;T^=.G:N;-,PMKEBDT#A*>?.J8YU[A2 TXET
M%ER<7;8P)8%5VNE6JRR3\K)G%7ELIV>;D\Q GK_&\23;?,83..="VIQQR82)
MSC&VWZ=.A%MP9@MCA+%*>64M9X0:AZF66&&I"==)7G=FOVI;LVN__]FVI<I1
M@9.!>M/?!C)NM1A8;U*"2YJ4[C+W9^>^V'[U]?BS3"IBAQT"&S2?8:$-TI%2
M)"- 3ZS4/I\D1=8O."1H,O7G)G:>*^>S*X_ZH+3TZE(!>[8NWCL7C'].@,)9
M.MQX/R>W_B0?+D_<YL&+34QFL8E>8T-S57>KK7!2QQ"\D0KFX\3KI,YYG:Z>
MH>=Z]0>T:6?XY^#_L_?N36WEROKP5W'QGG-J[RJ4K4OK-GL754S(Y&3.V$PR
M)"GX)Z4KF!C,SX9)X-._K66;BPT)%P,&5%-##+;7TI+T/.INM9X>#E>;\]!U
M'E[&P2=OV!>CA ,N#<'>Y@2$UL2"]21YBG\08*-P2RN272+Q/IF(R\B)KL3Y
MXD229%*:/*337<_+B7>0RB9E*A[4_GDOZ-3WF741R\&'YGCZZ*3[9*9/#(LK
M+G0FNG')]Z?-O$DU\?VS8IS%6)P@9:R]<0$K7312)Z<1\(H--IZ@J7<A9I2*
MBM!XH"[(937ECE=[!SMN5%]SN?5_Y.V@?W1P\8_-Q]IG!_-'?RV].OGXKSC\
MDP+,S4#%2:W3)@W7CXN<CDS*_K'K'1X3G]Q@%!$(1<6DY<HA_+W3H-"IIWSJ
MH#?N>Q/"&$W.B^&EUE]--9"F4,7R.-9TH7+*Z77.FI0NW&JR43,.:YUNOA2C
MHNC+%/X]BTMT2!#+S3^R^12^BG*Y&,SG3CV-LY__3/V#7CJ=EA_2:=6@UNL=
MM(J7L7>#.UIN_2^:T:W_*S_*)3=<]YO;7S[;/#L-8%S9":\O=/<&?KI;:L&^
MFG3(QV;#K9D0L_UV%GYJ1/)[157R7&>,AOQH%!=JY#Y+E=DF%H-<L#S>Y)KJ
MJ^4)KB].!/Q./ J'I\>+?M;^F\0^%A>55YQ4_*E#__%4[Z)$RX;35'E^YI\/
MF(W,T&$3_)J<-@^E',K(<CT-WHX.NY_O^#]O-CS+$U=^M.]YY[M.CKM?Z];C
M4POCZ,&%&3Q(W3V/%)#*D;>157_N.-I9P\I;V[V^+S45BC;L>>'/<1@<[['=
M;;R1Y=;0Y80V?/FH'VEVG=,);:HXI[U2GAH;AV\=E;#I:(D9L4FSJ W/1R\:
M%AHS1Y,Y5/!Y:=^\PA?GBF-??2!S>2R.-WK IF[]C\0(BR[!.1729IE MWP<
M,YZ^#?[I"DF%4]F:[BC$'T^U6LK>_V!03B&-(]&'KDC /HJQ>;)_V/OE W9/
MT9M=W8]K9R3W9J2I]6$R<ZKG?[75V69?0$0?-!6$2>\(2'1\<(@X8=HE+D)T
M(I4ZNJ_LU=Y/HU$Q2.<$>]UPK!I)!N,Q:CYT?ET>2Y_-:NQ=G5LQZYN/#LJ.
MM$+/^4[C^BB-*%3W7/6KLT2,R>[5V+Z\+,'C0NCB>C5-KEF[0]TI:^'&E9H>
M:>\6[CW;X=>Q+M'K_IXOM(BCLG"9#K33G1R)1."MQ=T2;L//[VVMX?5/MG8*
M(-<W-H\[NU_IYFXY,AGX])'(]8VOM,/;' D#V[;UM?-V\Z2S]^8;_EUV=@M)
M?.B6(Y.=DZW<WM@^7E_](EUDAGM.N(SH3$*DQ&13*F^D%"(32J@\O2^1 _J;
MSKD$6@'+RB@5N3<J*!^\Y#/G@2?]WSHW +=)9OCY?2^V$_^HJ$:2$HF"S<%8
MQJR1-"IC>1+PZ/LGEP/B_USO&.V:/R_LR@]'3M=S$G):WY\2C>=--BG3(Z'<
M,!;3O9'=H!)+C $P[L$9Z1@77N&31ERT**1"%DPS=)#(Y,4=ZA!>PBNOSX>7
MF]R=D1_'%L6P>'">6=]H?PG@*$_<$BF@V Y>$P?*$8I.CP@T)!]]60CD3\I5
MXBH_ L>I@WVZ_?_GJ<?<U(2\&&EU5Q>2WF\J-T]7YTW4T&"\IMZ#0,X)%+)D
M2IL@G,^L!.%G9P^_:GZLEJD\VFK[$UUF;!0Z$>OY4[\T[MU$'WMU/.%/9PKA
M+VRJM#?>PQ<1F&40,LD,ER$P7A'#:"01YT[2X#*7 NW,V:GRWV>)KV=9&&,N
M+6[?P='@H#]1Z6U*2(Q=4_3I>MMI6!*9SF4UM4XM4B3-,"[LY\Y&<ES_N408
M1\8C3K5!T5TI'I<;[CPKJGXW6V]F-O=GDI._?,E6_W@<NHWBP,0<.%_>(F._
M'1P5^=&T=]#K'Z<2X2@CV2NE/(JR7DD$2H.17.>HY'*3F8V&1F/7XQ5&H:;F
M<D>'Y6+H")QFWO1& I--FL$/&G=538'EGVF*EU;-*8=ABN,N36&8I(^/]T'/
MB:E.:B>,TC!.>7#L_5\(*HQ+](R$<$=ZV>?D$$=QWU'?3)3/Q]G\HXA$#T=]
ME"IQI?>&\^WO;AB[5,.C@Q*4N5U.W[@A#Y#2]ZR0^^<D+CXZ1G U8)N./?6,
MFYXI#X63LX'#R %>OK"[,BHA=.GFS6D\L5'9/QQK]9[;36J"RY.^O^1PQN3F
M91NTWX]-D*\[;+(E!]TF*W4T?-_Z@Z\X(\<5"HH'WTS2X?%^PK%*XT$/C85V
M*CLV+B/QJK7VDPVAY<FTNZ22Z[C [%E*3+,%D68V%F:-EB;</HZ+EWS:."H3
M,3H#.$HTW&EZO!^ZS6R>I.PB#+&[)J=GR)@$KT;?*"0XR<Y]]^>'_W%[!_]>
M.U=\ZRP+8ZJ-%Q,RTG?$VK#9ZAB?>QQKIY8AF3S J_,[1Z>7+O++2"?=P:A%
MZ-2,&.=&9GUT6E+.0Q 1N(D6_3D.20(/H*V$:X0#;V#6OSMM[GI&ZPPILD2X
M5QL _%:F;$-\\<5:].W=0-?7@EC?6(7VR39T5K_DD",Z6)Q ,D" T81&F[,D
MHMLMI1.*L;BT8EZ9GQCXXX!<4SWD_*2N^; _R(=53S4?=L[QF4=?:R\+6_>:
M D9H@=SH<.#/$A4F.\4C:VE<$!)_*RO*N3VO4\8?+=^CM? FQ.MB+JYO")ZA
M&VR,M]F"%CA$ME3HM>-L-'4GOAUQZA^%4Z?IMI,6)@_HL6E6M%>_4$Y+>BL0
MA\XPP8$(Q)ED"/=99:%#"#9<AV9QZ;[!).#"X&@[10W>50/U,;A($\_.^AQ2
MN#PE\5WGMXNS('>_ITA.TJ!_RPE 7_8$D)UO7P(S8 RNLR%E24 X3PQP1137
M,G">N8IR::7T\<P,.#M5/S;%D"/.^.$"D3S2F?.&0\L9G#08NM/34^?,X/ED
MV-X^=_P&G'8N_78TD?'%Y&^G&\_%.4Y%LW,UA,$1WN;,\ORC.7;^@KGO5$=>
MM#?>T?7W7U1,C%ON2,B4XM3/ECB1,DG $]> [VI9]I_AZOWGGZ;_M2Z;^8]N
M5CR8L.RG<>QK$I)^,_:37_(6:6?["^B(#FBB)%I3BKC&3%R2D5"M%#HXZ$I+
M-;WUZ#T:12Y'(5,"YY41.6;#BH\:,@,QO46Z49)DKLIB/8M^C90M3C-RQK66
MQVDYS?<N+\/<1"[=<*P#.VS]HW&R^D<X+>/PG[_,N8C[I<;^3WODH55>T:MY
M14>>S4UE7C5])>Y#XY2_PM7\'C1. 6[WS9\V]GJ"K'?5.+V+8-53D=P;57$Z
MGVIW*U6J$#-Z:R^OY\X74IJ+XN"34Z>\BXC9;97)%F\>/*2<VXOH37HW-(60
MTLW1]'CJ=J_=<!1Q+EOX34+!W^B [1\.IR?5SY[XVI. MAZ58J[9+_]U?\__
M[^E@\D(]^ T""TF8Z*)RT5$%3BICRVZ(<58QY8V\ZNBNF';(RAPLA3SPGS=G
M$W#U\/7X&-RGLH%Z&AH03],IV]G<^]Y;W^WLH3/V#=NSM[7W_MO6QH>O6QO;
ML/46/\_?'[<WXEY[#>^SN\DFW\%['6WQCPK;)C9/?L6_;>&]?NUUWG[HK:_M
ME#:*K;5WWSM\\UN;?]CK['[*[2[]_L?&F\/V7_1[9RW0SOLOWL8LLTDD*<D(
M^M",>*<<$>""<"E((?+2BI2S9R@O7V[GAH?R[@UQ<3,+\2(C3R]TE=<JKTWQ
M&O,F6P8\>) @,G5<B9",17 8;;-L>(TR+ECEM0?GM9,I7C-&F.R1UP2WD0#3
M@IB4&9$< DM146N0U_#O3X77'LB!>SR3<_V2@T97NC#\9@]^*0D_:3*:EY'5
M]/IH:^;UJ.LK\]R$>8YG+*JDG1(I ?'!60*.16(EI80I)A)D!HP6>11Z9^:Y
M'.#W:C1=-SKPXN$Y+UNAPO.N\)PV#*P5":=)(M9S- QLLL1FD8@343.OO8P:
MX6GX J'SV4>;WIWF\(XZ^:I$WEN9 Y=TQO/CF]N; W--3:J<]'-.ZKR>,1F<
ML,P894A*4A(P5!.OI2 \2QQ/IP7GO.QO&,[XO^?DL"Q0K*7"^.YFP_SS3"N6
MKX7E:?LB6L6S5FC^*YL(,!#$L'+DEQD>C=:@H!P!6#:4+A"2GWUTX>WX\%2-
M*-RO"?$3[ID,0V69F[#,7S,6@^ T@F&,9!PTM!BD)Z5L.^$\6AVTS$XBRXAE
M+>Z\<5/##(N+V0>Q%RIF;X?9V<@#CA,-DOC(T,KG0I8M"5]D0:URU"=6ZG,M
M&F9_8AE,LE"QL>G','^H3S[[:,GJJ+9,T=LX'IU)+WIRY>A$.M-NJZ&2^]XY
MF0S#GZ-1F!Q?2?&<SOPX9HOO=4XK0%4:O0F-SNZO!..C<[QHXI0SUCPXXH/4
M!&>NS33H("$LK3 ^>P"F!DJ>#8CGM;]20?PP()ZVA634CC)-";,N$) 6K:)@
M$\G<^!+_C-R6*,EL]90:(KDW^*U=>JRT!DP>:\]E,A[OFB+(%PO8U$#MS2AH
M?7;3)7$'JNP!)W2\" @E""X<0!RW.0CC()>-X#EMNM0@RN+B^$&"*!7,<P7S
MM#W!#>BHDB#,48=. 0W$04S$IRB$8SY!H$LK?!G4G4V*FMAQ?11VKE#%NXO]
M]DP3ZI]GSOR\@BWM[GY3JWDBR5#Y\B9\.;M_E(-W7FM))$ 1JBL*2@"6F, ]
M3SAF)OFE%:F>81"E<LTSY9H'L>,J$=V-B&;.Z>B<J 1.DI--.1U&O#>!^$@%
MRXE;J=/2BEK6]"I1_$>+!?VKD5RY3(;S.0@F%Y6T\^([Y\I'NF$CLEB4TL::
MV1/5XE++;RP4W&_M]\]5,&ZY4P7R5NBY[MYP4O)X.^VGP:GHSZO6G^<J&/Y(
M7+U1,+Y2Z;[<O/^MZ!3[XZ9"& [C<%3TJ&AO3Y[BJN*=_5,M[5BVT^(/2AT-
MIW2R[T>E:ES JRBV-P6*L2?7\T7S>D))&V5:OFBMJF]?,F,T:^Y(!FL(1.61
M5H)$(R<'J01'ZQ.FM:>> 6!'NE;-3!YA]/Q\:0H^C #SC_TT.6+WSY8[/!QT
M_=%(=6H,NJMP,2.8=9.J6@^K:V7D*V#J-K)6AK^26L]?*4J^XKPJ13V04E05
M/'II$CWL94GT7!%;*U4F?$*RW!_7DQG5-ZVZ/57?HOK/]^4_[[6/V_S=\?K;
M]DEG[>-Q9^T]&J?O81.-U*9([6ZGM[[Q[OOZYZWNM/^\B>]O[KZ#S9,V[6Q@
M&]=6\?X[V,[54J1VK\T_RB(#O+7W^V7Z/<(&H;W1Q(O(T-#-&0U=QXG7P$QP
M8&3.\_6?J]+%G9D;C>]>?SB<L;ROL+I?6 K&/V[ 6=G)X+F@$"D >&&LLU:[
M2$VB0;-TJ4=]:_+"@1OMWQ99\M5S@[?1O]P5K^QV$W:;S?5D1DEA #DMZ:+B
M0Q5Q2AK"A"YB]5*'4@11+3-@,^SVS[JC^[!69]J/=[8WQPZ^P.Z/_:-"B^61
MKEYS7I I>K>N66S*KSO*3XNJ+]$P""*AH\ ER8([ N5@$Z[$F6CMI M,@<YJ
MGCO*\T#%?+9_3FNQ7:@<<&EMMF9B"6FC!B.R,1[ >:=BYE9Z\$GH$-,7L$O7
MVT,:_ZEYRL>KTRY?M>ZY-,=OKCMH5!'7NL. EO/18'&*<:S_-8;KWOL3A.7)
MUL9OO38OUWG/._R-;&^LLLW/[6\(&[SGNY/VQJ:<WN#86FO+#D*S_?GCR2;_
MM-M9VQ2;&U^_M]<^[6R>_+J'\$68M[]W=GNE./1QD0QQ5,8 "4&6-0'TV8D-
M@1$%( 0/8+"[IXMQ:"%<X#Z(Z!0(KDWQ%!&M^&>J0D[3&R*EVUM-O[?:R95>
M'XGP_*A(QJ4U+WY^XXL-%:"48<)[I0V 9JZ$)3)ZL\D'@P]][[5@UI(__"N%
MHT&S][GZM^OV"MA_ZP_^PC5BH3;8'F7^;7\1W%)D4IQZS&6<?\83IWDF'"1C
M/@8!?*883%(Y)1&RY;&,*G@MDW,L26LM+@SJF6W(G4X;@BXF&>+$:>%3?$WC
M;;#3Z36I_WU6S/=L&^_V^VV7=<^3*2S#]"LP=OX[<.:5UK<M'O/@A65J8^^S
ML7(>&[$_/US!GO.&:^NFNVXWV9]^ EN3USVPO]?'QI3,J=?]'T1S;_CL+ZL/
MWPY*P/SC_B!A8TI7OG7=_:M5#FI?WJ0O1U4V:V?>IC/?# ^[>TU6X)F[]!B)
M"(_:":_[>^B(A:[KM0[0@!^T[B(_<H=@[Y..;#I3@IDT2Q,"<"\]$YEF]*PD
M2Y1%-Q<!MFE?=LK3G:Q49:'ZU:%7LC!AT5OZN>.PZ#O:_OSIZ_KGC["^L=/%
MMK&MW=^[6[N;QYVW[[XWUSKYK;?U^??>3%AT]_WWK<_OY=;&MEQ_^WNWL_9I
MK[WW^UYG%]NW^UOC,^.U>YM[E];781"*EH'%\<B>0)*46&8EH>"T4C8R0+]W
MA0N[+.SL'M:<=^@?XQC.SQMS%Y63RA4WY8H;T4$(1WM'O;*Z-3;#F<E0K*]?
M$_)..<I<.>)F'#%]!B:%#"YG1W*@A@#U)5E=21(5R]ED9[GDA2,J/;QH>KA)
M7LQC\T/Q*"H_W)(?V!0_4&Y2#"(1$YPF )P11[TDQH"GH+24I:+,;,6*ZV?
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MBNK%1?6#U*"OJ+XG5$_'^*UFGCIGB!<*H2T5VN#"6D)=L#I9:M'91AM<\F6
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M9>WN>-'=W<:%[_=>^^V''5QH17OC0[>S%F#]\T>&2W&O\_;=<6=MD^%]N[B
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M"T6RER_F/U^<FU$J@+HC2]]*H++"]];2E6WVQ7')C,F2I&21I:/UQ&FG" L
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MU6<?;-APW_%B!Z-#!S6<\  2E\7[>+<?^GNIZ?M*+K<@E]F=E&R5"3$J$GT
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M;)C5WEX#9-6@ QMTW#K[M3 $++-TQJW<3_D0'9!X!QCLU_'NY#'[E;)0W_8
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MBX_VJLWL)J+_FHA^]EPC^F^\HYB]T_ 4_E<*)SCAC!!'57!**B&"#DF2-<T
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MT%PH8D50F$UB7CM<F*:*#33,4<>'?($K0W#4.H6"RKE?A("JSA6H8DD107W
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MC&ORIZMPSTJR; :X9^7A!O<VN#?&O=QU)HK@+2:>.T:--8PJGG10S BLZA@
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M*S9)7LN:,?:/N^W0L*>P#M"W'P#E;PAJO7<@ZWIMX>V!?-'Z?@RL?H#RV;<
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M]TK,!(HXS['Q.+XL,=*RF-(HH;C ,<NB'W^17MW]')N:XW. "CR>&Y?%8I+
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M=U3:]<ML?B'/5L!B_167K*)>!SA@-$^HXI/G,?Q5K*H/GE ??!( 5##]E4I
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M ?A=0"=MA2;53@,P&P!6<SQNP$18"R-&I$C"0%_?1IH"]@>H7-(X;&XL9H7
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MTA30F=XDSLSXE44J=_'Y,_';L^]%[%ZE0*QDVFQV"!)GD>_-\G8Z %*08B*
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MI2_*G$]U5*H=A(#;XAS84Q?@F S(6I0"*)_MA,>5D/4'HUL K!?L"-@./#I
MP ;!P+TKP+[+C7\M$,7-)E!Q)Y#U;H5D_7 0[ C9X @@.W3O#K+73,PY\.30
M"X:Y@=6%2?]+<S"^@&A1YT*A)!KNB=%L.9-6\(3A<! VQ3[;6L"T,@@I'B%2
M%;-J+N3UGI_?^C%1+\AS>FA!O6TP"U77/#2PJMQ(5!C$CX" "ZI]I&E12DF5
M57I=+@6/MB<T&<H_$2XP#,E,*=^,CJ=:3&="YZ$#4%V'N'3_9=-9R9%@Z@),
MD2@*FCB-T*$4[R\LF]"VU(*!-N "=@VHBB*G CQ HCK8LR7+Y9"Q4BB.FM*H
M9N'4U89:"J@&TTE152I+%AF%^%OV6'% .6DXV):J!4,5+ A(P(/#@=TJ:OMN
M%#9<YIJ]&;JOK;9KV+ 5G1?3@CQ=S-=Y"OOU;]YQ19)EB$RLQ70ARD82CIG:
M<\$8[+&^/J+5/H97Q_#<XXCA'06CV")NFCB&'A@1W8=U]M$2!*N\I*8E^"_P
M=$[,-UV@@#A2WOH'%_)1-S.5A=EA8(+*-$$C6Q1!@2RB;O2+&$1.A7K>LM9M
M&Q?4:D<'F=]6\G-D%A@":*6Z=5<4K,PLRU+\\!5ODG.]NE]HKN9 ;$0$50K7
MC+33G _3=G^(5E6%EJG1.D13JC%U%0VF!&710B15UKT#3(-G%.AC$YSF4)1"
MP=;38$3^(MZ$!5DB+C@M4&WOV)RF2XM. *"$%+'(#1$OJK&=\M6DD5![6# [
M)XOAI-$#)U1IV1<B+X ^\G-J[6* BH3H?JX2V^OG&TM"/^8)/T?7# @/5+[)
M;R/R5R@97M8=:)62-5A4'@N.%T#LE9NDE9>@-#;#W8Z4-+6J0H*GH%.9 H2^
M+3'-$,L)J'VB!EZI#FH(*,M4D?$1]C8N-_)Q8:<6H51*J%&2&C^G#B5(YE2[
M*/I55J2-PGG4_$*'YV;>052+51&B,>6$D:DGG,!\U1$(RDJQ.+^0\?0)V8U<
M3O-+>#17SN/\G*I 99&'W+=4@E6^.>K6JL:C13^51D 26<B:4>^3AT"I?$V+
M;=6K3V(^JO(E;J%!28)4I#-&2E@C;B63ZED"N\&SFR!+T>J1)?6ASG_!<X*W
M@/B&@T*#F3K'8"+\3)A&8F (<L Y#L"D'&-)JHM<W4'V$V\6HN$/VD?="S%5
MAU11^K-:?)4 P0* J&V&@0F2N @RK)7(W=#A9ZW+CN1XR,RZ2G:HW >^)9@[
M8J]0-ILL"J!JU3F'3J*9^-QINA\60^@.9KTLRIEHG/02ZVY+]$X<^$8V)B>M
M.HJD;UJZQW!W=<T@ U-LPBX1>U508)*IG!I5I"J[==9WQO*L\ -Z'RI&L:8%
M*0MQ?8JJN0_VJ1&> >P8(SY?CVA=&X&.0V'AE9MOH#ZC?^C5J#@,5&,ENFXA
M.;1<D5BKO@N9)]2%!&L5Z)MN-&D%VC!E;+M3]SW;O,N(QW@>VH.-A['E7=SZ
M)CR.QX*OFT^8^/-BCG*9F.A'C.Y7QHE":RK+F!%*B$9)  %3W?7S3G>]W'[7
MRPG()/H@04; F'KVT86?6Q=$-9CX5T-XJN,V.S\O^;D<5>H&IAN&9ACXVQS,
MSQL]SS'!##/=T4B['Z>KEUDLPL+-8]^W:[4P3+4QCK2*=4?0,N"MJ$J&A;]\
M]Y^WKRQG;+P'B&#9^%%2Q$I^(8""LOLOBDM!&6J3,[E)2EA(4R[\[N3M!3.Q
M6'+4TE3HEHHO:K,1R_,RY9!MIS.0,2B;T7'5,*V:47<6[8@;1V$\H<(_X656
M[2@+ZA%9-?*':56+6&&L5J@KSO"EK*0!:74K.TD$ZG6XWCIX7?>^()Z)@6M1
M]K,TSN$3^>:(LE1244Q%2\TR*[!UQES5CU3Q!4\6%/A]E57E0GJ48T8-&^#!
M;F#0F0AI(<J=L%0?33LR6QOZ)16+XCJR1 !_Q(8'(LT(U"D%']$-A:P-] %<
M4 &;9LE6BPK--JG<B>0HH0#.ZT8AK1B ]H4ZN5CY>V6WD0Y[MB4$5Y%IV8%*
M:HLBSQ!IJFF#T]J,N&]@_"HAJQM0PKK2():R6/D 1-@?4W5:YUT?+#ZID$!V
MXE"]$5I2O671HYG1#5FR/%H.+LEXX#,-F95-MZ=F'V:WQP9MO@FUD\ SZ6B:
M!,N<RUI'N%4-GX$_=:NP:9BSE%8]PEC&4$KV#Q>YH$IU6=L7A3]K'JJT)L4"
MFL3BV^6%[DZ\\$$'&V-V8[8N7 J!6<(U6<.;L(.:.Y"MAL$MO%/>I4&]-IU1
MVLKF*S4(98@L1Z=+Q%6IF7(B 5ZD6(A&W33KAD<XJF1UN+T K4B9;[8@JKIP
M!8 7:!HKA:%V5I#3:D)>,VDPRWQ'U&(PJ"'F>30N(_(LE9DN:D@B+$IA&]8_
M)@T/-56[0:*D!OERC02$%Z_IF27KRK'(MYC*KL$LD5%M2O44$A 8/WZ--AO'
M-6W)/]KN0'BD*.<:#UQ[A_9E723*[E;B.:Q0%5 0E;^M7+_5AE..^^))DU.7
MO*PPTQ(T?%YWF)&)& U77F.]JT^L,.%&S H']6Z:CTK"!,AB*W[C[5NPJ[ 5
MH',RV*T]6%\_U\3>O&./O3V0.?.K\*PUPU $LGZL_:4OVV[6YKZ#,-7V3"+7
M9V?_;S%!FA5^D8=/K*74X;>MX3..+X0%\JRI"//+D3-S4IIJ 2)#\?JCHW;D
M'W\:K[XLV]8+7@VZD=7*HG&VC)G6QWC27"*58>/YTJ/:55.VE:[;O%'^ RC+
MHILP2,NOP%.IVQE8:)/D$LTSM2"4B5*!Z4[[)7*$([G,J>>):N<]$9:4OL@F
M$KCFP.;&2A>].MVWHUT$L7U,[I=ZD93.IM1;*'F'&J; HLGF[?)"*6 ( ,EC
M19,7%"GJ!5"K;92V4>L,E6HM+\JH:%2\Z+A>U36$=<,U.AL13U(-Z87I(LYL
M47>Q[P*RUCQ!K:6V'L1W6)-@E8CH!==.=8(V ZL*$;J0&M%V(# ,+&+-.,81
M5/R ["9T&)>9C K4+4!KO*47S; YI:S?E X#7B^]%;ZH3=SKMNDZ9"?/AMD$
MG70L8%@ <IPKA_:4?5X/]FBQ^BGV,)P3@ 3VH0,(D+DLEDQX(A#W,=M)I!Z(
M_+_/W9B[WFE?P:L&;$V)8N"']+J+MGIS#J<+3Z*]JC>FE/WR=&U-KYXQ9;68
M5D3SQZV<A!@!A.;3^O+1;3_#UW[G^TUBU4J"Q$: ='Q+OLT);!,02I0C;#P\
M\BR174']]>L-DX^C];DV+-%92V!$1UCWQB@U>9HE%CZ-5J>%$)Z@U7*>S='_
MB]HB:&.=R2#Q15$(-J_S*,P(0$<$*>3Y4B9LSL04JUU9V!IN=6] !$<QAQ^W
M#K>I-XET)! <0%9B_QH" V:A ZSNMM6112V"[TW<Z' 3&O;4K$!V%6"98%/8
M>B"R&M[W&LZTZ3.FQC8<[,ZO"B"]X5&I)H\.US2TK"G;D4I82RWK4+1RE2Z_
MKFC1J:XJ6=<XZIV5K29Q7_4NPRK9*Y2QSWEQ:5W(2L*K=;=FO!*U3))4&Z,R
M)10TVF!#Q>U#$",>V[^MC)?)I D/YGR&G%..(Y*Q+_PW]KH1&H&X(VT^U%X5
MMN\$II0771=925G=A882CJ,2%<\Z'Z&35UO=M,47PO.*F8G"\U3O4ZPWV?!)
MH59B)*-L,(.<2B43I6TUI/1YLG2U(P"L%\1C(1[Z0/"#3?QQ)3!9M'KC"3<7
M\NCF8:$*J(Z4L*-RV63@K\)YZ^S9)B*D\%CD%.G%!-+Q*8;1PD><P/2]8%/
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M_-3"(R,I>"4Z'U"H@YKK4:)+K5OF_+R@P@?9EXI*X&E**F*"3)Q>&_!%-,9
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MR2LPJ@V8)7B1Q#+1[01$8(6F$$X[/F?G0@O<R#K212ZLR1<]$MPS$M2\H68
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MJ)-PAJ9M!]VB]]9P@8["WOT@[@8Q-[*V)X/V5VA83PWW/7,X'O6H?Q>H?WC
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MW#%=-_C^(8!\F\:Z&QRXO!!S4(K;<6\=H3IZ\QFPCZI?^M %47J0_=*/;$[
M3>:0/BJ,\GQS--Q79/<8U6/49HLZ-!W;.T2,>@J1L%\QSYVZIC?9GKUQO:LF
M_J@(\;G0%O96T@^#K>^\F)M8;W?$UA\E-@E-H<>F'IMN YN$EG!@V/04)JN^
MI4K8NI)?-6/!RD(3B]QZS\(CCG:-QT\R\'H3V^P(H>RX3S.^_L3 _-QU=I>?
M]Q>R5F5Z>9'S[0#M[[SNG4_!D_$+END7N9%P; >!BE[=7?PORK]F=YKC^SCC
M=H%C!N&!Q.(?YPEC&T?'?7$81]P3PI,!4P_J0^5Y3\&K<,;GHL5.Q+'_CFKD
M-,=61;U'X4G& 9\[CNF$X[U-E,-P&/=1Y0/#)L\WA_X>X8<>FWILVIRCX)E^
M<,VL_P,+01RA9?^V5@[JSO+/95N]-?I^K&?P) L!G@_'^P>0>V/KF$#L[,M5
M>R@?(92?CYRC3OX_:-&@;.G>;GZ2NNESQS;]L=M;.KVE<UMV\W /9MUC4X]-
MVYHW.*,^M_^AG>RJFSRU39X71EZ 19W/<?84%@FJD0F]+?V85?"AZ=E[) #U
M=M8Q MEQ]J_?Z$%\5" >FL[X8>CX*1G3:S(3<\A@?4_&RKY18Z=V7UP/\"TI
M%GB0I+\]*A7WN;\?/=[B"=VO-77MI=Z"K7738^HI[3%0FN>;07!MUT1/:CVI
M]:2V8Y</V_2&_HW\-@]";J2A_D ZVT]'-:KL __"\\61CN/\ R<7)S0"40U=
MI!&(I=R4&AXVI]$RTX)&R_#V:!F!:_48-IK?VGG-/LZYJZTNVJ^T&<''/9E\
M4W/P]HCJ/8%_R4MN?!?X ]N )4]HZ"=-%R[A(3#%OG/]P4A=VO\#@$$X!Z^9
M]9S"&\<#KW[C):NT,>IR<*>ZG>;8P?'S$H>';QS]7.]?33.&5]#$4CA#9%_K
MHYTK.8.:)5]P&G&R<GLVXWC\ ^-M;B"G%+-0Y1#KW0^7QJ?&18[?QDFE\DVT
M(%Y_K9HODHR+\?"+LFS?"$BS2%D\7Y19/>-9S$R6]S:SI\5%A!"^48QXGK (
M)[$#OK%)-3!^SYNYYE>?9O/J:&E\YX2#L(::A!/00 :HDI7T8'P!Q"- K-];
M3VJ%?_^;398EH_J.T8O*>/O^P_^PZ>S%*Q,?<>M'<(IU<P9\.IL42SAS!5YY
M#"N3JIOE=HX0IRGC\#P<T+0].!SV_YVC+;C]=7%B*%,+$(?XZOJ$CI,[ZHU^
M3]K3VX^;/V[N8'P+'#(<C#<P2,<>.!IA$*'NSR.S"HLI&R;I:.30YI&KSC(D
M0L5>@45MP5>\^VJR%U]O>#X=9WMQ]F!87X9/TGAY(^7(Q&B@/:QAB3/?*SY'
MWJ&O4+S=T8D-^%LVH<G?]"U%Y3->3K-Y]0.^5S"S+!8KW('^GMP(9M]NGT4_
M@OD&H]Q;75C>41>6M[(+"_JLCY([7M5;AKC,=SHOVY]7KG#&&[U,:HXMO@-?
M@$.BE3(Y/!E_GQ3 HPV>IG):NXJQ&\#I<J%X9+1[U!U8)7@?P.HSE\.-.2A3
M@@%%;((*X7ZB_5Z!O*^TEY7ZKZZNU#^PC6[%YE>[R5FCEN)RLX0[>M<"G*HM
M,$ED9P!BG=.1 ;H%3B/G"!M!$<#G\T+B.6$/&MYS7?"#N@MOG('>C[^(*=[X
M9D+J0SWMO7DDE8E\8E^-]V7Q):L0I]8+10YLDU?.:Y^M[X4XEUXR*QCE<WLP
M^O[V6*43$F?;Y3W&!@8)&-8L?VW1UU!\LVU:)[X+?4YEA3W04](04TXF*=8.
M33(6H5*W%'Q[X#?JY(K9-B?W@ 5+![9;;=9/&T-S@Y*Y;0&Z/HOVZ'D.B$%$
M"9P@1[&!:K9:SB*'$YW0'?BJ<\E"Y^*T-[#11R,Q4,/Y54]QO]9VQ$\9(%@.
M+P[O4KW;2M5UC@%1+=AJP>T1K7<;KC%TL#6FGD[-N;[TAA(%Y2G=!_\ZW]"-
M1\/T'>U2H]EI%XVU_')76Y))5L6+"CTR+ )C=&#T]EICKSG';J\=,@][262:
M58)#G\%UXU0@_.M-"B(0] [WV8?*Y*]4;=)B G82,0%A]"RFR%"^H<=G44J.
M0MZ?ICEYS=2$$HMDGV2Q4)KGQ3DG&[(6F_$%R\\%;YA?%,C#X.SHSP2^S<KJ
MQQL?GERZHGX*;\;X\EG%?U3_>*&ZLF4Y'04]]*+]"9PMLQ+=I ^*RY*"QN'
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M%VS>?GA/_B<]9<"%6RQX5161D1O"QZVAF_8NYQ1KH2,CS$7@R#7)(]MUTRB
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M"=HT<?;_9^]=E]O(KJS!5T'TQ'QC1Z38I;J[*V8B9)7*5H=E54AR5\S\F4@
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M/6-54E$>?I^>HYD+.OE*,"]'&E4$&OZ.=#V7Q.1 9!1P\!%TR+A7@\KNL&K
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M-4N,ZQ!(/S(XDQN+(=R &S:>?3<:4]RDS0)#/Q7HF?@13[_?'EM ^+_/L;&
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MN^Q8YVD2.^%TV=*I'4FS%4GR)F6.L.ZJ$TUW)F7R*E9$A]""(R-YAT+ET;G
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M;C(0XY(PZ9PGY\$% 'W^/Z&R:B/:E:F-S/:?)_ 13:"U$.5<*ITQ4\\Q'GF
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MAKY@F#.3"-S)JJ3, RX<'0G=CA(F&0:OT^Q"BM;;^/X&9YS J*>9XH?2%W]
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M);5^N//;LI"3N2_RU[1-"5$VCD<<#CIMN\WX\S1,'&)Y+F=%5^V3FSF:[#0
M$B$<A:Y&/F03Q!FX 28AW S]0'BH3.V@1+V%HB,R,]4;58$&N"X"<VYUN5@H
MGD8NKDH8$3KA_)Q%N:58/J&GMWXK^2/A?3GK(LL@?9/[%E).(&NAH(0=>0&,
MN*?8P$&I+/$N>^#N.K8^#:B%C3!G:X"D74_]MMQ=46[6MR3%;E*9R$3M>1*6
M.-9YOJ.^T;PZM/ 8+3QA[G4:EC4J%GYS!*^6M.?9SH$"A5_/\#J%DSSD\N:B
MJK<4C19N268T6:+RNFLERXZ:GY="]4BH3%-3LR_-A;R:(.J)KGSE>.;G55.M
MZIWKJ94/>H+NK@Z>"S%)C$1)O%2HK@ZP<B-9VQJ=7/;A3S1_\HN2Z^"-Q8)Q
MR:J9F"3)N)([KYWH1[A6_F$\#OF-PN#.=,"A]Y;_/#S=<>M"<,K"6(I0.=4#
MJ>)&5/^,$UO7J^H)=<J'SXH,DVK=*T[H.ISQ/70'P]])8M!C(65A@9\C(HDC
M5'.VWP*F<ZYH647KJ].H:)W"'E6'=@"F'>\"M&XVSI\AS%T7=AC],<0 V[9N
MI N KE@M(:MLYM,^H;T:=""T#0!5X",Z> *8H=6-X24Z=4$$4XX^)7F<<L9+
M^CK%'%>:>.3[ZY?7![\QQ5;A)/O G",25BY#P%!ZU9NZ(X>WZP$R#)9J7B]%
M-F(#!@BT\_XD:<'MOB.BGW[J4"_RPTD%;3[V.B>U,3,LJCG^&P!RNG)96_!;
M;Z!$P[W2=)J'Q>8\:/FBC0=!G8@<Z,@L<$ D#1 A0*W6*Z@-\84HYAQ-V[/F
MMO50)S.9+A/)DLL=EB"AJ;EQNTD7XQTFXVXK[]Y7M0'-K]EC'IRZ9"AEU:I3
MGR0%0A@1CBM*>7/[C:0L\X?%(5&1U.#7[P&[G$UEZ3<"\Z/2^8@6\6N&J$KY
M6$6<(D&GAH,4LV\5M1=\4ARQJ&SE7C[<=-_O<3^.&RY1=Q"$"$6N;1?+ I==
MQ4\1W56&TX77"^:3_L*%L2+Q8A/!KL3+4Z>6A.-9D89=3R$-H(>@$1Z+OMNT
MOE2@]4@5#&&MZ1/BIK=?,'5/S \467/KS]#KG*@O^#,E;CA>JM[#A9_R_VYK
M-/ :H7 F5U6UG)>+]VGHA?Y8 F?%=(]D::IA9"PNZ?)H '&KZCV7]NG2+ALD
M$V>/&&L54N&SIMIEM4 FJ*6S@D!@:%P@B C9I+^'-\+@Y$9-!XVO2Z6S<%L*
MLY;(*+DRD:92/.[@8O:6,TQ"AW?[._:6I,9(V\OIJR19(7L9)GOZ%[U$U'7&
M^JAWRI.G@QJ"M;ZUM L%%H6&<?:9.-Q#*,_4$]N":=RCNO">0P>!4E<7EQ?!
M[I)'ZD)]V&WWN3\>D8"[=7Y@E[R88Y>\BDEKJ\*P]D&"*/6N8QTYS-C.)UT$
MTC=@*(7HN<6#\LX9$<X>&&%(I%'5Q(4B6=7X;M7*J)NHC1!^% @?0D\^$OLF
M0:S#EAJ#O "7MOW_]HMV>J8EBQRE>8//1ZG:CNN8+#0W[+TWBY-O RIRR1C"
M2Z$<Y$K)DU=PG(9$RF;8J&K'WK:Q$8L7S?D/] "<)FF$)#"84L&WGG'N6NC:
M:!H$J9\T%P"=,>1'/='C^T7DH[.=FF'A?2PDO+\8Z\KI\-Z>*$7@&G"S)I>=
MM<0P?0X%$H4SWI\W\!% 4 B2.D1O "E ^ RIS?\L0=+/7;NK(D7BLU4P]4N,
M[',:YV?,9\K?HY!^PVTWTCG^5XZK\%$ CL("YU7VIJ+:6Q@3_F=R'10;UNM*
MF0;I2L^>/RO0!+VEPOM2T_("(A8OR0Q9^ *%I1S6+="8U L%$#]<L$T<EWH4
M#+/C7I<,,H#<F2#',D6X/L)8MG2(!-.ZUT*\<C._K0&>V/5L(?CX9,\'JPCP
M:56I+#PS<[CI\W!.4N.X0)VOB/3,S+34Q$N$J]8=%@;I8O::L!9--:,.N5C
MQX.^W5/+/<&]@KM!B2!RKX1T%Z 3P?#H(\6[:@DVW,&ZR9(&F&Z/COG6TDYA
M2^_V;#U=F1)/:"$4<#K^F2RV)%\6<+1'LETB1??LS_0? T,T;M:LO,A^._D9
M/$C(!W5A27.G+#L]L+\_5?-N3R4AA5M8\>S9_I(:8^SWY&+YY%ML$9?D16S,
MA?@MLW+%0AS-7.+'O$,)*WUV>*A$N-?M<:#I.HN[A"K""DY+X:$D_\R^JE3
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M(JCT#8"[;%K,.V3)E<2HE\]QF;ML,!3J[XR.94+#%OF3:CH7OCI_!XQ:/86
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M)S+(4ZK.$WT1:::H^:2XKX>626BE/)-P+Z!$TJ/9)9@"4EAK6;5VME9<!.-
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M[X5%PO#U!TA^.^6_>&$*NZR^%@NGXO'$:V;$VXHNGBLR1 N[C!E$E5++R+&
MC,!%GH?^RU25J#/01?ZCWAZ'^NIUHAX1[OA-MWK&(_U?R&/7D)&H]_A$^/N?
M#^OP]_U$835CM'%>>!282\K>6TG;P2LJ%;3 ?"?\B *<]I)D4F^IM]3Z16._
M5;1]._ +GC2W_WS%P!?G40S\, 8T245/471")#S"KFY5Y0CI13"=[[>:U>&$
M-T>X8J=FFUO)T57BBE7 >+TZD^=,"91E$.V9)8GFB3Y:M$LS8.=9QL0)'&B
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MZ#'THNRSLXRRG=W(;"E:YHZG4[0Q68SLCT@V".H='D+8N-E8J!1<7Q3.&?S
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M/],O?GNFRQ!DIHHB$OYN%20N3?F.2%\I\3>-,Y4;U6"34GSAZQR5)3[1PD3
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M(UM(:M+(T8A4;E/R8%H,JUI$%&0DP4J5N@^163*E$:GF&U:::N>PNS3KNF"
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MLHF3N]40;1D+.(A* Q6;ZTUSX)S ^ 7](ESR+:^9F"K$ZWP3$ -CEDJ6\3?
M7,"D2=O7W$S*HA1K^2^,C)L):=!UDL4!SY#<V1"%LV,QFRQ!4R@&<-7ND;2T
M;(61L"8#KHZMNSLY\?HEJ5,D/0Y8@;?4%3.<,"]D4@ES8FUN )5@40,'4OI.
M-!P\R'5N*.*Q96BT@HDH'SG5++D?ZU3ICE)Z*>=J6^KW";M:+J8<IMTQ0I";
MW4V_/KI\SVP6#;!<MIY+7R,%WWAJ)<^^-7<_ ;?2RJ."^_P$#A]?A[-K.*I#
M\%"C_5#H '7E0S#O:(U%#-#A,T&41@5K\]#Y1OSFD6.)^EW&.V#/ZH,G+R.$
MX-0YC[4AB>>#K^H $V$FT3.B16'G0;+MAE2('>"<4=1:\;9]TVREM=E&]@D#
M:VU4D4LH,>%7:RJTAC BN:Y!J!USVR:\? N(Z].FZFU\''6*$U^'39TN5A_[
M+M.-A8=+=,'G&=5%6B_LWU_B+%0*$U!515E1_UX?[ZZ_[,-B>;EBOCJ9]RW3
MMA\OC4"N3O+\W.LD'TUH5C[-Q/V4VKDZ&2W:2M8#N.@\J%L@BY:W>=M.MH\Y
M&OGQ$<GWFDRY WB>C%B\UGLL*9WZAE!96!:BLFCCA/"[)4]Z+_$^8[HHSY(C
M++@0_+UW*B &:F<]95HSL_/-V-'-.5A4O2??PSYN#4C1)Y(J?@+<CBV!P0-R
MH?.%&NJ]\P.60+>(J@S49%P!FW88#U8\2$*E&3%V)@M?Q#5=%L$Y+P*$OZ62
MK=7M,XQ;7"R7&?Z 9I\&27H)'&W4$QN&UQ-/=.-CF>1#VL+D&HD?\UHNR^%]
M+X>VT%"0;']Z[N>__\*(5HK0#$)8D('8-C4R>JG-O\SJ>Y_5],PMGZ[J^J')
M3['T!1Q]RJ; N+:44R&C>KK,]P>63I<C6S#;RQ)J#@4.5+=JTQJ&*T&TIXQ,
M#('J#"'C\2#!# R=PGYRO+D+,@J42)Q=(QI]Q2?LZK\E38-2O;ZLL@_A'&HV
MP*"540*+49[- 14B[P=82!B[]2[<LA]B_GS430Y;] 3S#J0%CL^SS*K]<(=:
M15(3 D H#,)J-0VNO3DE))LAL]\]:\U'DYL5 B(UL5(_,B!4.C!S=)(BR@LN
MOU]TL7G)&PLY4?+6L&=7KX2C(&]0BM*Q(DK 8,'"-=/._FVKCTQGS+K>U;?:
MI9(AQC)"=&%1G+<)2W'M3//-CTPZ8/D#K$!]W[<BX\)#K@"X?':?-*]_ZA\:
M< 9Z6:KJ[;JRYR@L[1'*%T="AG??]FC??JM.,Q1GF9F,$=S; B_9LZOO<"%*
M;-@3PJ[2/6Z2WL2^N%CQY"?H-2C75C$4F%![1*^S8<T@]I?Z061_3C&.I'E=
M3?Y2B\9]Y'_2CND^H;%.O#7K2(^L-PD4H-Z1-\D82>5@J:["-KA3S ,S6+%(
M[ZP\K&RF/N)\4N>COL*<1U6+P![KK<Q<?E53!^/4@G?$"*;&C$DJ_/S-Z^]3
M)I'P>*^_3G\GU &1&4HZE<OL4,^N_C*%!6\0>9%00W47]*;RK2RXPZR>",Y9
M<ZU- .DF>2B08,<75V+?X#F6Q5*2=UMH5D4Q/?;N:?<XDTSMHLCYK@G'QAJF
MPE?["5<G?Z%%?J#"GV!'$E#[I*A6]]5E#IA+;=MJVR_.O;;]\9RE+\='S [A
MI6HZ5E%4[8=X!@FE+:/8QC=DG@C0HX[.:3:8^0'(O1D+I_3RH?SO4B(N-IUC
M]W,]E_DUO=0[XSLMQT^ZU_T:=VB)/"@< \2[<==$-K9,Q%RZ6IIUVAL  CA]
MT,S@^--+WQ9G<E&VYI&VP53:,F][IA;J1JQX6O(H<AL[VU3/[P;8D^N.B?S)
M-R?&G]!>P#7NZ$W P6U95M&6-#)'(R\^=2;8\-&S>BJ,4N+PQ +4H<\IJ];2
M0N28NO(Y3+P>HTR1!2(U9M^+XWN(LK%B!Y)IO,EA:09$KVO6!J"O,2",G0.
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M!6#8\C9\"EKLGZ\<_>FYEZ,_&CA?E&'S@FF*;$EXE(>$%,\!.G*T:$GYR:P
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M*E+!]TL&PH9PW2+G?H?:M*\ZE1:CK,!L61[Z$!A*^H&7);N=R=OP#84(68I
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M_#.U.*_% LA2AN8$$2>UFX8>!U[-+)I@?IKME@MQ#:6'PM'52)&*1@.A'+7
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MM]JY7X^GMUIFU@9T,DW_SU=Y^OVY5YX^'H.6@K"UZS9+G+E(PS7< DS= AB
M'78OI7EM!R*$_;I?3>BJ&<)AMFG(9APS/$K2+$XQHG#E>>@??3I:IX@<5>L5
M]^#\B?/,'A#!9*0Z."\;85G.WX8M7IJ*/<LCZS4RQ.UJAN0@B]0U#X2P:'@(
MNPEZ58UD?G1">9Z2\<=G^LZ[^T1;G+ARVJXO^MRN/=Y=>X'.IS[$Y=2W\-^U
M[YIP*TA])[09Q4> Z\=$IQ+84/1$G)I@8FG"&EBK<%=]E"G7P5AS*CK8X+Z;
M>YOIYREB[^A%@_MF':_* _?DE]8._'PI^B;AM]Q<CD1)R2E<Q:O0X6WEKC!R
MC!03HCG*&P6GACKS=CZ\"U_8-"-#=3 R2@F#MSA6DL81=Z46NEXXG!3%<$O#
M?E3F5J)FYOVO+\.MHN29TBL2J=11;DU>,V>*X#+' 2.@^9B42I0H0OM0DKC+
M59;0$<1 /8-]&]D%V0DW-_3 ,52K;\*+]IUV,_ [I33<Q=YV]0LXJ.)'9!)>
M$ZG/"*AC$,G%1G%@TC?Z1CPIJH$A;:)<Y"A8.';M=T8$^!%7"=B-3$M8FHQ%
M_<-Q+HC+C*SA0.G)L5F%N#:'4XB&U]P[?$AYML[TT,A%W*(=3+!SY8&*W?A3
MQVLV[.@W7?]P?=<_5#D)AYD1R[-X)EV@6(4*9+D7?E;\. #J'VS^?LP+0LG#
MBFQ-X2GC2\#5E?1:/ULK4>]4_09W4B@S^0)-,)M&RWGGES*D+JB_R$C4:-EP
M@1 H%H)E9ZT>UR;%J#BRN430,W#["[-)A%.934.\7>S#7D\HN3"/A)(H)KJ'
M*LAV1 ,6UQO]M02'O +V.D^AN;?W0UQ81'( %TH7FIW0A(6E6S:]H OYP2AB
M_LIZ^;3/WN1=*#_10A.#@U%^8KB'NW9$?3D\=LW"J?[A*+MNZ<GJI ).3!(I
MJAQM7ZY+)0OJM7(UP,"//(?K$W46,FHH7Y&W980P^H.W<WYXS]0J>2B$]\=H
MD83GHC[X&V&[@0A-W&G]H%6-1@%C[>A[D_R'20I:FEK5@3'U#2D1\2%<+DLH
MJ6-]R-@<,[N6E%@H3_G-)MUKTM_%$ -<@-,A5DK"%G/F6,& V59*\BNSH9&4
M SCRP>G(49(&5$\[Y$XC&!DIX[!BB7Z(X&<X\0-.ZL@ZNG%&+;ZWG0@G#F]O
M=8HGSI)5QGC-:!M3Q(L_ H=3!TQII/_6]&'AKAGI?);[,,K.+;0OZ3'\0,5'
M%B^^ RR=W%&5\\5FJ1UJQD1XXU**#5#Y]2:QU=%PJU;3XG';YX>_"42D[58G
M<=X?\[R\E,9T,(L_VCX_ZZ9*!ASN1-/=4I8?@(1FN$>4BMJ9>2-2>6E9C57N
MF5")+N/YODVL7>+BB%Z+[>;DL0:FK:50FIP5_A/5ORJU\UPFCY_9JTA1'S/O
M+ %D?V1BITY#,7O=0U\]SHZ0N3(>"-9[83?W!Q-CN6EP*BWNI"K;" !MQL'R
MD?3VF,(,YWLD6_^Q/!]W26(X^X4-(JB^^!>*5T54:;5M.5WV2UH*3<H/EO]#
M=@1BYE0GZ DL7<4>P*>T_!T2L?6W[OF#EGK6^)?Q'Q^:>O>6'8#_?$6%S\^]
MJ/ /'[AR<N7[=GPS7GT?F2&) _Q+<:!7( W_$=ZZ:GF?8P;I)TZ!\,%$$9]8
M:F7D1CH9!?LNSP#$H\'%%1'-RW!@VO(:T+_Z_CMRVJ/DEB(P,RR'QP"/AVEM
MQ"PI;SAL*=N8-&H2YSR:IRTE:(>!=/P.8MVU#DSV<3T=A&5IIS#Y%+7N6B<\
M_^_ DID\:M29$-'T)P/\4G? AKW$5,UOJ1LS*\O&2E"JU7;6B3HM<(35UQ+_
MQUZ5Q[=U5UJA%OW^JB7J.7/>\7+EZ_=T@B,FB,I]#'37&#<$ CVCMYH$&6\_
M*"\^'"V7OW1)+.X#R6G8G_:<EMH[#/V6VW(*+\Z[R$OP_84*#>'76P %Q$4P
MS4%I(0OALU9I:H+PK^[TZ?P3R8#!Y<?0"[]C5@W)VD8H5.W#\JP8\U<E^XS@
MQ4!<$NK'2#5'WR\AU0\;S-RHB'P$%N0]&G/ET1,#D6LL_M38+?SB<C@4LXTR
M8E&JVANDKU^]SC1X!7XS-/.*\A1B EBB2!$E1#?4"Z8I_GI01484[?QP.4(;
M4 =L3_0OH1_*>C9BA/0LG)W%*RJHBX<YO)CAYJ7K)\Q0<"#WS<HXPK BKC"V
MR @'1[Y;M?OR'N;/MHQHS\2I2U,K&P]3 ,<\&WJWQNAA.>^4=JDP"< A4G'E
MFU_BA#4EDRDQC^4FLMHV,5(;>]J\S+5^PN"!DLMQ$^>/(;WK?.QH5)=TCJ8U
M9LE0(=7>7!W[B3<N;&V<(EI<80S0NU]XVN ](+(I_8F+Z5[0IC9B[=(XSK>$
M+?TLXUR<A7"D,3I-S8I*0V--\W\Q/X1O6WW][>O9WM*\:IP=#Z0@%]%):ONG
M5=Q%O-Q\!H=P1M6'N47FK<[)R;"SN41?]".LS!U3RJ5NZ3D.2Z"<2WN$\<.1
M=;B2;HT^CL1FJ"=AZ+Y!?P(-Q3;V<Q:YK\*'[IIZ>[A;,=-W>U^OQ%RS2!Y#
M5\_4B;&NNH.0DI=<8IAPY(&3=(AFYVE_9'ZD',Z5,2?5V()ZIE09@89IPGJ'
MB.HYNK#"QXGO\KX7E.RRVSESP7\LK!7KFE4'CN<:$CN.E-/A;NE<SCVV+-_$
MS:T/=PS+/2:MN;*=D>G*=KQE@HI-V^:^9&D0XZ5O![6JZAM@-S5W]7:#P\7[
ME>GT]MF)(N/K>3R\#/&3TXN5U ]P\5\6ZF!4;K:2CCD=R;"<5@AE&O9)@#<#
MU&@M#T)/_M^3U"C()PS[EC:Q8$32@Q+74MXX-N<J(^O@5,Z$UNL[!7AX@Z[.
MWEB=BL\V#KI.BE[CPK&0=H-7;&/Y!95$7RI'OS2P2V?H"5%>@2MF&6?+Y2+;
M3A%VN\RBD9>Z%!<\&OV@T:2J_^JJ1NKO:)NQBT'=V"'BF"@]31M\@';V6=KQ
M[]0]9 R&\FM*>QNO#PV),JQ#+!YP.16=XD1G"3B8H9.XLE\JFHLAB+<G'J\X
M$_G]!0Z.LGWA438 2#$BS53NR/B'L)0RK4AUH<*+7LU-<["-+(G\4=!FP?M6
M;%=I3ST$*X0Z"DOS1"F*2C+(:(A2SWF+6LLMH\R4T^(F_&G3FBE<$;A 36O,
M0F_;L.?1KW.FBXNZU%Y]]Y_??'G]_ ]A;(,%VD&]V".#"1(XLA ! $ P-@B'
M)$TBY^TZZVTA+'\$NW%&0\R8)OMDLL43WQ"&5/H\*?D^3'LNC.-XQ*$;*P-N
M&6KWD 67 /B]53;ODK*WE/T?SCUE__'LKH@]D2Q/[HRZ:,<E_J)=74KF-E%A
M$J;NUIO:$-&$G<O\V;@<HRF"NQ:VZ>-JHS^$BZSN!/5$YP'%YC&JQQ6%(WY,
MPGUB_N$0"X[0F!3+H+'546? :BHT^P\ <=5&>1AE]92,!6#P&M3!X1'X)8"_
M>^B'-YG# C=@5%2N>-?$U!'[I-0XI98$GBC];MV,2(25<DM,U$@>:@Y,Q]B@
M(*HR3*LZW$8N3B9@N &K/C6PA<?>]O6:IX?.H[Y+AM-]<YSVW.\>GHQ\8<0^
M"LVDX)5=.\GH+JRU:(1YO.4@[OH(9C2@B 5^UCEMN0>3CQF97QXCG; P&^*$
M5[=.1O)5N\$24CH]/$XV@:7=7N<)IOZIL5"I@'@UKR1R234G<J*;?OGD\UG^
M8O*]7(=CX[$1B["0X /L=QMV1W@*@:;Y:,,TTMHQRWC[5U7/?Q17=WPS7Y7<
M?1*#V1 !2A!_8E1HM0[3[7BE@%;W+>3]*'IL]MR40<8LC<NQC"M#)C+U1MT.
M8BX2F=_96VM;\9EZB6%U2K ? 3X6C1!O0!W<]VFEFQ]]ZVK#G'%UBY<LVO;T
M?#%%05/B<RJLJK>N)5^K!I<]U!#WF3Q.2EGP-MLLWQJ1GI#J([SR-^&XH0XD
M&X1^N*T[_T8RZ-P!'';M-?B^,'8>(Y_I?V+?U ]F4T]&XL#2(!.TKB++#W<4
M"9:0D+?;YIH_I3,W:'E#6V!HS(<6X 3$F);/T48;>>P^\8G*^]1]0(Z415II
M]6"JJ$T;/0&AW(CT>Y4]!7FR_4#')2B=4BHY1OUCV[O7XH.L<I')2-<;]\J9
M[#(V4CM"ONPF+:P1C1L)/H+1C5+N%?=.JT+$HGT.T]QGFB#"912N:LG40CC'
M9^F8.SN4KN>]:(;4MF6!Z3B;,FNRGN5VN*A"[Z/-+9 F:44%QYA$-;3?D^2,
M_G3?#M,8$?ZUE.&P?SC\E%U-.2][58!0J7H!XFL$B6=L:Y?-U].LE\O&/773
M<7X;A1YEVRZ0NCIXI6OZBJU$876.='X2_X M^6(O3_'YLSC%'<<2FF080(N&
M[*9/OE<U]T"*CT2-H.TVB7/()?'%@G][JW6VYXCJ>MML)"B>KSS^58O$_K]=
M?_J[]X!"*Z]%Z)/_[@M]O_?_".EP??KBV6<T%CY+K[K97E4\=366#CYEA-'T
M_KBZ:]83658Z6-#2E8!X-B=Q%%2 YG8/U'M:+C K[YSMPJ0>)/W7R^=@!!UK
MK06\IK@ER<19T=V_RT%X014JXS>%RG9/EKK??7%9OA]@^:(AR/HGG%9RI"B6
M/Q*8AD[/9F2M>?:^1N.I'NIV%/:M_="*'A=Q$-SVE!35@Y86Q&6J/\14)[,+
M6@QEB*!3V6?O^J2"0QWYIX!;U'")M)HJW[%V(@=@X9/AK#2%Y.DR]Q]D[J69
MU^LL%Z92W+*Y\W*QSA^!<U&>LV68W@(DX#*3'WPFWXV;*-H7'.-?9O5#S.J.
M5%]OFJVRCEH&3M(75>P.1(G+4<'0U]'P&ESJ48%JH_!ORO?7#"5" 0V*#Y3H
M(]3132^%.&$X#?XWE9+6#.UNUB=6PS]='3D\V=D7DB_[]=?OU]GF=%M(8AMI
M.+ /M@?F06.8Z+:IU?ZF"5&N,\14; \N+VS8TKVHF;.]F0[6WJ YLN HKYF$
M5CQJ+J5VA)U-; >T;<9ZVP2S3^'SQ?1_$-,?6606**6?RH>#251RHF?GFBWV
M12(#/UD+%268J(,F;9_*1(D$N(^"!3#T0W,5H<76T* %ZNS+P9OJ-/V<L^S-
MVA@<.TRIBZ&@F!3&_2XYC:71<"6EM@WX;C-Q)B DEI*Z!4"-]^5//?,BWE>X
MA&1X<VF+S=( TN-(GTN"TO6>J6$C$.@3$4=/V;VB/VJ%$S)VJ\/R\VY\XP]+
M.%8.BI<-#_HA&F6#M(1_0?9M8QP&Z2R&?UE;6LZ#EJY@MW"1O8R,RR?&T)<A
MC,-*@>'6LJ"_B( 7&B[\EMRWR$R@[;TZ0/43>Z..L55/-,,$!!-?_RVQ' PW
M;1D5LAZXC>7H9<EP$#KX3<2,"6I^0X2<'A2V-#-IKX^#<B[BI:0\6"V7C!2#
MSG]9;"N@!B 164L:F2S-Z0*Y/"N6%78>C<S+H@!A.?!?A(I?.'-)6C!I#=E(
M:T+WMTF^45VMVOMV2Q7<,,H81RT5Q^HPO8=.H:3^9(2,>PZ ]EX)+,>F_3M
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MUQ^%NQ T9_H)PIQ;@8 _[9JRFL[Q2>>D>;);Q8]OR4D]EBUXZ=M8&W; J4)
MIITQ227@ 0DX#F=-8[G(,+T(OPM:+0@'P]&^$O34<!E8Z1^?$L7:2<BIZQ\X
M-+J3H4UZX,% B<5&=GS<%,QR!B:4>4J-UH@C;V?F@!>1=Q2NH%;WA9HJ:W?5
M,8/U:G>M<V*,BM.PR:#%U+\%/Z.#AH:MRRRP="LB3JPU0OOJVF %@%DN[I1Q
MGQVB#]]Q;F(&$7^F+J8RE1JLS'3J>NR<YB=I\/5S.-B=MQ!_:2^U1*JYQ9;1
ML.XPI35J""2P;;,FI*%F6/P<FFSIDR:"H)H0J.-<;VD4E,LCX*D_TL>A]$@B
MOLL7MG>I^JB[PCKRKM=.! C2J;J:%,"-5THYLB6LDN''^(G#C(;;2D!VGQNR
MEZEON( 7,%)@+A<)I DZ#A.3+#OW-)X5=4MJ<46Y> \G%PCOT+BN#2V4B)XW
MUD>'HL0Y(50(.C288!/>.)N!1_ZX_2Q1"D<YN7 N_0J5'1OLQC)VD=6YDUH
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M"\,[^39R#5GQ+DM/ORZ"H$++8M2,;#Y>>,' />(7-]RD=$E"H@U1C2**@7Z
MI?:R=!RC)A*]2:X\I'%H:)B#< AB:L1]P?Q$U!*..!SDV+!SA!_SR3$ Z!"I
M8J2]LWM"848.Z7\0Y2'T]HQ<-0<SO.E:Z)X6DN9"TH[W'9*V,[!<P!;_.0OS
MDCKS7"DX! V!(9!81554WK@%;PSXW*'>UW?,-FQ<X8(XA"6[!SR]BWG:3H!T
MV :#BISPH?3UD1VE;0%I8O,H6/4!JW,_)K[=.4Q^EZ$B=W-AY*6GVH![[32Y
MP2-19Z7:=B19X9:=%Z^(-AGH\Q!42+E70Q!D$,'&_K7 O4U[48#.]M/G&.W#
MWF!^3].^*8CF]#I#MF^?/K49O+=X$!O*EC:^V3RRI)G%GKD;#4!WL<NS3O:(
MV4E M ]R?Z;ZND#F+/K+[:1O>M*)B)?%5,5?K?!CD[0K$Q )M[U+"M<QD@N6
MKY%S^X60I4Z 3IC*I2C$270;"RO!8U/D5>>M-" %C8Q8M&$\1GF"91=KE];F
MLY+S1K*#,1 <X\1T@DE<6(T3GN/;.&,.H22\PQX]2(1-)3KHX(7SL<I)2 (Y
M74;Z3HX(BI)JAFDFHNZN$?082:]@NRHVOBHB*>*2P@A#I8H6*[7UJ;$X)U!(
M*P3-4HN8ZECB.0\K!5P+>K 9#U5,]31EXW$-5,K>S#9/$F+*UHY-#R]_>-ZN
MB6UT7J?+!)?Y/"\\L2)6.'*E-0!AARM&U(^<3"S3[8MT;J0F\ <JZ=3*#K6'
M^39AYQZ,F:+W)?2_2UNTVN+(YF?2L:]2)W%:0*5DLO_5$5INR[*)/YPJ+*LL
M EZY1824,2WHJE&"#AG+;P&_8 <M;'T^3=IQ:E.A'<S+S')(\(MZ5AVK@9>I
MK#S'[\HG6+2/0;C'N.#1@,LMP&*-.H;(F>MY#"8JA%8&T%YB(!&, Q=/<KA9
M1!*!Q%IK1=+,;3@IX'8'[R/)Q.4LSU$@2V\SX),!"#(R:<"+GOQ[5>#"6SQT
M.AJ^*A#5\66X$+.:B@::G6PLZN16E40']P"[<KZIHZ]D1G$3*"Y,@ L+B81-
M;M?!&9CS>C^MP"L<ZROM72A0$B/IO\%1)^@?]7N=P,E^((&#'B%4("6V4G1S
M&6[1,&6,[K=#3SVKW Z)(GCZHDG,(G>R#L <P8S"V'Y#Y'DRKSLGAN'HZW6>
MS=+H@$=LC/_]LJGQ"TXNNML[P)[]]?3?C6#6K$2L!=A OQ3YRM:EI>G?!<K8
M0@/O"+]L9'<#LMKIP;Z^H<*JU9Z4M ,6>*N7%TU'$1=C7GPBBI'-11S)%:E;
MN[>"=XC:"D&0L_8=*C<1R102)F8+[2S:$/H1.*+BX<NOM57^ETC51-EH9B(N
MXY)S,FVB\FM0AB0.\S'*N+IM9Y/P#X06Y%-2K=3!65I0.S",4$R/.T6QE)(;
MW?1AF(.MFJ5%IJTG]B:Z?.6DU<J)8[T156[5*SW#B*<44/)@L4^I!*V=/@B1
MB&>H3VS*#<%?PH*$A!S[R -*I7KY('>;ZP>'S88L1PNCC]+?6++5SQ.GJ"".
M]?^YD(/RE2AGZ5UZ$;TEMH+$+J'RCJ15S#9&],/1+1Q]!9L4[\WH^]6#U_K9
M"_=S@01&6!BF:!+/)M@6H42@*5X ^J(FDMZ3+O\'S&ZH#9N^C@<6J)NSYJ/C
M"8(%3EJPP .Y5U<"I P]J7>K&4IPY'HF*VX@F0T3Q!<Q( P<U>9J/\K_[:4;
M]-!#90J"Z(5.11/&@0Z)\(OK/X4LLE9WV\HM2T!JP5D-'0;T*4$Q.:*7JV%*
MGQRO8<D[\O$ZSA70'&E;$M6O$##+^H"$_C^I>3-P;0J'?LDPAB\S&.[>\3':
MSK.CGI#+Z\]?V4#RU8@'TKL2CASFO?B!";:5:&L0S0F9!_)S!9P$4>.%31QP
MHQ*"5F3I@>.+,G]B-_BG=F<A#NCX,W7O94(JOMB$WG%C"<'0V7Q"!S& +!HQ
MXW[+1/%;,<*V -X"\E!&&6N0T^$DSY!S;X+HL=M?Q6GCM7!PN12$-^7S2J^S
M6^6X.+ZO\+LB37!6*C:#'YK%N;"$W1MA^S[/%$8<^M5+"K"5=IS(_TG"U#(<
MHTNCOX7^'L;*$,:-8DFCV46=31EWPYXI/0TK'*Q<SWAIO)'D7H&)(("\!W!8
M.M,H_1Z@V2=](I8?%U25S=I"+4T+>RR4VX# #X@:S?JQ2(QV',0ED O:/LR*
M;M10/EUOC-:Q!7XZ9C=8..]YX'T)8ZS"U[ <6YA:%"<SX5"C\#9&@96*.V@$
MK)WL$K>L^UL3$C8I^.DWCHI"4ZX7F _'X6V6.]*YV#2[I^<FRU6BLFD=MS2'
MBR$R68(4/#0&J#"M '?I4[QH ?^2Q[<0.)$A@-[R86E;<UPS1+3D[M5FTX-Q
MGL&)(P +\L\3R%6FROX8)2J;J LJ$:?>5J]FUWJH(2]RA%?\QTQ;#LJ2W%$3
M=*)*.7#N<CCK4O-*$*_1D]<=PK\NGF_ZDGD8^Z:A.JK8.<HA*)M,$B,"-O<8
M%AB.6V8,JLW1=B@JLQ&\"0G%G. V 1MGD"NX6$G5EA5A8WW9J")CH.,>1AV(
M2@P!J"T[(MZ9MPI"YIV-UPVNX&"W75@^D[F[=RO1V\15$</WAF-17Z:DU8&R
MVI&^\C<DBJ&^6E<VS[R!['S+7HHA*#V\"Z\7J>N%B4*1:S--BPL2DF2+ZQ')
MEL.4$XSUR[)67JBBT^X8)&SGAX6PRC+A,7.=P]T)S$3&JB+V _&T8[W(;GE=
M%G?+[4$TXT!!KK'8N0ZE!.?EJ<V+7Q[R)7 8WMF<_)VJEQBW<3;GF"V8TJ'7
M!)]B/U/GX'%!$CN5]@8%22EX*28FHX:5>4=:'6 ;6[Y@H&U@OS,6 0J(&B!Z
M0")>+*3@,<<VU/-EZF\&GC6:#X*R5?T+9#IUU:$R6T':W^/OGK, ,LS:NBGC
M;_[CT^LK$X_@Z.DAIYZ:AF&&QILR3H(W:H0Y^V#0HW0]G5GZ%DE&BHMWELN=
M\>G-%\6]:^/*$J80,VQ20=$.]H1\:3HYA9NZ8<$8H^&O'#XDZ%BTR\8S,8VK
MJT6[;[$L3F;#F>>($NV3J8C6(0!:STZ)8A"@6TB^@;<NL-J$AVMP?'0LG5]7
M83X,]9EZ\.E;HF,:O1]:!,ON33#8'F<RK7,$EB72D39E=V!"/],.OV2+]6J$
MM(IP\4_@#F*V_'46YA'38).O!QQ1B(^"5:1]M7P2Y%EI/,P0D?()WSQS%QRS
MIHHY8C702C#HR78-LUEIKV#<7%O"MUF1=BUN'DU%W@@4QI*L0+?-\=7MFK'%
M:3=;U *GMC%I50^!W$K?]D/ !O.69NDP3GF#WL8%['JW\GN;<;ZD?H().%-3
M*982[37\&/4KPM&-#F1MF$7:ANH6G)=$H)C+9&>>8 WN=-]K<#L5(G#,Q6WQ
MF,TUR#GT^/69$ZV.EX:*$I@<8^>04J%V]$(YWCEF)0KNX>"[K'>#L((3R94Y
MW/FS(X\(BX/W6A1"R#=T2X1\,<0'"6G"G@9^OYFJDL1OG25!,50;L#Y""I#H
M*J$1U ^#^61M !'N89PD+%_H(Z[@6 _+75A50\ZP#.$O\A&(L%!Q2-*FCC+.
M[\N#.I-VC,#; Y@*HTWTL&0B&7BOIZV."X,8&Z).#YQD0":"VNE40)5.G4H0
M)PO\DY68TG5?O:AS#@1/#$&+J"JSCWF@S^#G%BX2%O(ZU/ZG"*0K."0Y-H=S
M:!G#O[[1Z_$.PF[]!T-8+!2I8P5+!:H4<O,)28L2Q,J!K6--*Z\RY;NJHJ!5
MB99EC+C>2.DK%\6/4FKLLJ7X=(\I@2&%U,_43JJC3GR?P8(P+*2V X#</>:<
M&B"#!]^J7 &V:Z34Q%J?;&9JLO9U 9@'N2O*$FE;D%X7;:9GXWY\ =2&4#_0
M:R,)BT*O78CL,5QW<93:S:#I)^Q?$DPP(6EFG[X!]@4M.AP:)0(.X21K@^I-
MSRM!</0$))2CJ9E0R.V;V8?/6&B+_1#VGH'?>AM"5W',M2*Y8CNQ&Y]83'8I
M$?.6>0*CBY.-;243B'*E3H'49Q!-N.4A_*S-Y#H1=7F7'6#1T3*9MDR+V^P1
MG^D8(-<7(2BUX)/TW/#\#I,P_:H/;37Z*C-,A7G(ZCH +&NER<>8D>YH/)$L
MJU>=ES(RU$V#YQC1?$VQ3P.<>+[U-(.6J&"J#03?^D6[0#9^A ,.C;14D5<O
M3N)R7K=W,61"F-Y488PU4:H4I$J[R;=LU6_B85SZ>4XJG6GW7B!&@)% FA"B
M\>"$:T'8RX5O"E$9I )2A.O*C+>6?:<F?32;"/'\;0;ST\[%]DY9>TQ6O65L
M)"/?%V/X=I:V&*U20QA$HY 6\4I/X/!"WW[*%43XMZ09!1;',YSC+ZG?CM+<
MU*)(J1@"CH<8S2(Z?#CW#U1L@4AGH6]]Y5AM*Y/;*2<38AL!!"H_P 9-\(B@
MS+C0S6BV-591G&2<Y19&IN+][/CV\)H,Q:&V[_[10&H"?V/BBTLG4?DAO#-P
MG9)3F9) -OU.;_YV^0%HI^D4@[" LN[)_  ;;4S&V4V!8K58I=?AM>BK6&:C
M4389"K<=@U ,6%EY->".T'5 59=ILH0L.[M6F%+$*\1$RV(Z?>Y2PK_"+X7(
M,RP@J9DK%3P?O CF*LRASXAZGJ-.T#LQ?==T.DLO*%9,I'R"H^5? RNE>(N(
MAY")R:5!V!*R<?L8O 64_B9JV:O/TD1RP[5#%Q>FTDT##+ED7LS45+NG^?57
MZ=QN49-V7I)P[TBV7<^45_] ^W[#FCR*X=YC2I@SMR/GS*DY>#%M3C$TM@ 1
MW2O2>LY2L#12):U:&J%[M,W&MLVXTDVVP*5 ]\,XW.L\QGY,[)+SR\#PIE!P
MYK+ -)S7MR.WY.4.%N)LW[$0.U.KI%-F94&,LYF%K2Q=ZA6*>_'R!AR\?-YX
M#H&=HYKV*-%F\!;[%WE/><0^&!X;?>&A*N^@;W16^, %TUY"%MG=W]7/B&R[
MY%K IQR2.(+3[_#'+"*>&_M8YB'P;+)<@@Y;A?"N8"O/9)ID<W7/>O7NV.MM
M37];1MP&O:W>&0!)P0-N)#!>AWUVB"U2**M!["0W83)N8^AM3!7/#W#9Y.+A
M)&$\@?T%)QN)/HSC:*8-&+ <SLJ6;G2W9BJ\UN>-#ES@&,NI%=H"LB@R6XD0
MXM-'LEEMMF)WYQ@/2.!D OZ'U/9>8(R8A@G0682Q=ANB;%3F]VSJWQV/ 0FS
MS(E^0">Z#?F@RDTNF5>K- TACD,VS-V11->LXI#1D&*O.?20&K_M.QPUPC 9
M=ZWCZ.4X=%_,WEYX>Y==T+H+6\$8QQ'$&)@R!> A:A=7O^]TENL(550)\#MW
MV*<\$J8UX9_/B3G+Y3%VV#QU$,H=X2#9ASA2[+CE+"OB[2.I0HG4"7!5R P1
MW04XSSGTM>>*!>0C!GLVSNPZ@$:J9L6ITV6HWW:6*FCU&2G\ 353AB.O15E?
M9I9[/<H9TH8513:*0R->IL<F2VZ97$66 #X93L(?>I2*B)O%_3 !5CNU&("2
M7*5Q_&.&X+:U7A$UW&;@$?NY VR91/M "[IHYKKAY-S;;YRS@)]AT@UW!$F0
MP(/396)FA,%4N(HP$8BSYQ&>.".N%_&2:&23AN3^7=11AN@U;A-/Y@Y<>HI;
M%8(1, ;LHE91[AU:^G_.\-O,J^#8'.TW8:,Z@)R!BA:NPXQXPNI>5=^#1!T4
MXX7- *:.&.CJ8+$_9M.]L[AW/EV6:]C2G*YJKR!KI("J%<AK0H"X0)01QA&)
MM83%S>(\+E!B(%;>+@-(%(SB*4$HB)"#N[,QJ&<N 17F*:(E.&GG<G]W+&T,
M,4=_FP*^WF8I3:(6.=UI'3JWI9>1S"/E(&O>1^X,B.I"D<6CIZ.#@9==A3&#
M7L9 L<&(XB%*!AP]$'<5<EJ\<16*Z8NIOXJY!1XH1;%B+>Z&[U)O8*2.XHI/
M+@[*KIA#HC/!0@R><:(2Y A8^/P<(DMU$T^1[3LV!#%(M^*EK=UR;(?I96HR
M;=3C1-1*=$8+B8T^ZX!ABQ@-KA52E9"A16H [ CDXXF^[NB$WNMXVG>;^ Z;
M+X6"3_]IG!Z%A#"E,N0-+L.LK5:(2FS31%NR)4_YRGJ6Q(8$4PV9 J:;*3H-
M:D="BE>JT4VJQ^@Z)J8YL8_&Q37R5=YC-RQ(>F%HJ$BL;&)5-+8F*_B=<]VT
M:+84TSJ41Y;OAE4)60(8CA%W4RY)YCSB'MFU<4.\)%B:J9%/<PD$P!BI"$]M
MXMJJL47M0,I NLCD6J=K$T/EY5CZ9VNDI"ZV/GC0= ,R@D;UP1 0-AE1V-)B
M:"DH9WNL(DOQ8PUW%$-&89:0K:\$O7"':[89T/6YCN38@TW7$RPQG^]7B7D?
M-Q1E;Y!ZQ@9@MHO19@M+]#$$E.01A(KR+NZU&/PD7).8,$'R/I-("1V7A,0"
MC']$J[.U>_73I(-5'GY6.W3RIXC+ M'LJA BSL<LY: 3+1KGU9P\#'"J8>0.
M7S61-]D5;5;!L6TGI6%2P&FN&>3JL8&0)^)W"W,:==X-#K[-)WY%>"5*P;#$
M1%CREZU6C+O_^'BK)=>U>GF8*>'VM54UK"<]LY2'='8)(2A+ $_?*J -1"MH
M' D3H>'\'-IY*%P"3MAM2C%S,@;D8B4Q05V&7V7R*W$<\GM"X#X>%ZH45US6
MF/MAFFM,U:)_B<G["A<I$87*+1?3&&BRE1?:2IZ+$A\=GY^<R&>!:]2AT>6D
M!)!T.\D*2U75X9\3L7^F)P(#<R\2X^$%MRM,KY&XEQ5EG.Y_2X+K2E5)AF8"
M%(PD7B/7=IGK^3V8,$.H,I)L1()G<8D_:DP&" EP7#BKA1XKUIYEG%>-+9!\
M8-6)$5"C$8)3,W<!N8O')9(#)M^\#"W#FY-2K69.:](Z2_?J#B7:G H;+IY(
M6PA@OF/M/,D'(WH: _5"A3E@,'*FN"N$&AY9X.5SS+9,%,-%HHBII_;;ED1M
M5G3\A#17-HV6187(!U<#DP Q[[U/'G__O._^9MM^O5F/$4F(M8V>EJG7F]F!
M<>7I8?SNBD5B9AW)#)=/8T5UP%[D[B8C"0E(FY*I6WL5+5M$DRQ222<0]:>%
MD-5;5U;*<&'QX2*OUW@<0W)/CILZB4HK15E=PW>,Y?P*-%IFW8(H9JI<%3L6
M:)#!&F%>&X>+*90(""!/8O<KC4^&H%(2A\V3.7/%XZV!Q DJW6PVY>@Q;$<T
M *:JS%*62T5XH!3D[TL47&O:E'MA*W^M81$DFM*PRNB$U.-Z -C[A]H]RP/8
MTQ/G%?)TU[8RAX%AN30<?%(F[56Q,+:X<(GKFFFJ*\S2#C* ;%HM*S3;'A>(
MT&D@ *:?O\FBZ.!=#FP&OP,.Y:K,8:]_@:KE!!_F4F]U2.\'G_.LY(8^(QSD
M7\%<->&(HOIL'\,B"O]T0#8.R,&QQ3G*%Y&U1M5GXMV[1*XQN*Z$0WJ+UGX6
MVTQLAMZ,J5<X2[1I39AL16P"%E9BZ_)VB&L=^SR0G8\>$!>Y2?%UJ!@TPH'B
M6@U\.YES)H-ORK+B7" OM+U3$WETWDDD"^CA2*3AO(Z[J6-JYZ@E1'V1'4=#
M%PL1S- O)E-P-U->3@NE\H5S@)YJ<0FM^6PF-> PPEG>66[N*23#J@_N6:XD
M"41(.TN<!<>HJP+,NX DDG)CR2*AY<)30,BU)F&D)'6Q]J41,>(,Z3 L8@J%
MLASA0$[N _$J^C25IT#=#&@*8[S9P[ZT<S+' %XBDL".%\"8E;4@Z&MHHCDN
MD&>NZ)DNS>'Q5\F^@_H'YO1P$3A=<I#4J**W%E1+UEF%K(:##5FI8JP<]IW:
M$I)):!%4#TOMH%<%_#VX0Q.(?8H:;O7"/P?E>1<-!R/9"'*"8>;WH+/VY;#R
M8G[<25B8#N\HQ#$FEPK:0E1)B3]:HU:HE9"T1NN+CT!G7V#GJA[IDK#5D@VC
M/KJJJH'1G<$'6L.:\Q[ ]$BM2??MN/#GK7I7U!)SE,K"?$[80[V/IX!G,ID*
MV$T(,-(W9*T6RL$EH?8QH4\:6&(@ST,9NLX"9VQLSDS!#4V17G8D (0LN65=
M;:$SA0K3-0@)P3@(<#2B\(A?"CGA]3O1_&#C2!;%=!S%Q4*&A%V3ZAS96,49
M>.GNA\O?Z&6E9/^0<"R(N=&CZ/,CH]UNN!DS;VF8Y\/KRFN366BK7;;:=;%?
MU:Z=,72(<R34*/N,%JKJ.N/T$1)YE,.U<IK@-ES#3'J)/P-7]36YK!O+[?>4
MTXSTW+#"Y&TUW^E7XFI.<#(-\%&_',=9Z0-.4V,0:$VDO"1M;/L+"NNADC<>
M4V[%'PTP0*ML*#C3X.4(K[US6YJ%!7L%@EH5<R4V-9P,8VWQ*): O2ZP^:KY
M).^+#$G',X9$34,G R+NL!JI^)BQ'7:UC04V12/:';ZS T[6S^LPT*$)DUX?
MF\&@8%05EW3JTN+E;E+!%E)F6UHT:&BI2<- @6!:]-$@[H01YZQ4%X9^5 #)
M\FEI]+ALJDE*#'X?LW=FV0>3KXF/,&;LJ4,9X+VC"1:==V1J>!X@O*P.,Q)B
M@ZVE>G79D3HD4#>BQ!=I%>=P]G-I%E57($,*-&:*FT@<A0?S*S)"]LY6$4*Z
M8KK!Z[D<Q>396)T7@+&B#'MA1YFR=F%=EF/!S7>]-1:IJ\M_C,!=(V9[2.F!
M9B2[YU:KSK>;P RB=VQ*:/60<J,V,>7628>LA5O&AG_51+)6"!#-'''#<R,'
M.7Y8?!G/DLK+T4J S(W7J )[_RWK[,%BY4MQ.<(^OI-"@\?'T!9:98A?!'G;
MH7N*\BW&GML3">(C6O#\/?C@1.H(E)!KP&CX,>/2/IL'LV*[D@TEB+;)>]O
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M-RKYZ9]P!R#]%8M9_\/?#3X#)B4<J1E.;]$)/GRX#)Z'CEXK:Q785BO&(;Z
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MQ+9I<L.GG%1M.) (%9$5T/_W[7>Q7[7]0.)&_M^C^1X956T^D-"0UFB]HGZ
M^XAZ)ZTS!K5?"ZEKG^XNB].]%AD_G')+^<T5^6!!607_4'M>)K:1IGK?67YV
MB4LDB'<;?M"_+WMV0IP\8B!<<HG2=(NV7$F67$R-9S1IZ)$0B.$7P7SJJ3+Y
M%/LJ9=Y/")&BO+W7<C* 86LPNH# /9B2S-!(>*(L4Y1P13';'5H9&P\PA^9-
MB*2@\.:@6V1KQE'U^CHXHA\7I/RT[;C.#"C8Z!;BL];Q==VQ@*49SYYE.>7P
MG+-';(3F G9(SLU^Q@)HX02>H8_DBHG- 9KG;,;5L:R].K@NR$%*T [?# I8
M3"Y\]K1!7&<<S7CN6=9^+3R!/]("=CC.K7Y-@B'AXEXR]_.$^1[\_O&OB,J7
M<U##I1*'WMD$AV,B:'A'/ (#X:%/@-NCJJ3AUP%4SH1SXGT"I3?G#9O6R^Q3
M^Y9U4,>G$BU_^/ZP:Q_\TLEJFUQ#L=8_)FK_A$!QE&B.:(CFNJ.,\FBF/=+J
M[SSVS3QC<Y7D5U/2[,L'EG789%_>XOKWEH]Q2+]H+<!VIQ&@3\J71D7D!G_H
MVI9MQX-_*ER?B8@3^"/+2:.8\MJ!<4XDIOYK,4FYF*!Q+/A7'AKT8\)TFWK,
M92@)I\&G$$<>A9AU0<'*+L7^/':51:H,*W-/ZMEZYF8!KH0KFK%%,[Z9^+I#
M+&OF 60@EY)-(C=C:4*P:SG=?(<KAR!DK43$KOLM6/Y!Y?M-0IDP- '9L_9Z
M]8&,!6P3C/=T'%*HV7 H'S@.!78KS;$5D9NCY;ZMYT<7(,IP0EE6.RPJEAUK
MN)C+C@,GG\>*D-G*JB,MN<Y8,(004JFSK*0U]Y1#6\\\+^ QJ_JR?+8<@FJI
MQL#!G%N.>OGNL1*.;4PEJZQZ@[E: 7DD%8-8*5[&4 8=)Y]D5F/51C/6NYB6
M&*4O!)$"!IE7% ^I3]6K$1O T,36#*?ME(R$<#V6HH?(&3D[;!,+W3'?'S'^
MA+G'1C<L=%DH@0B(Q[I0)D)N .H*4LS(0UFR5Q;YC% U<;DH%J5RM](3+C#E
MOV$_(M<$*RNJ(4]9?%?2&BL7NV?G45-LD.:#,HRV'(-JI8N!@[%TL9U>/AVN
MQF,;:Y=59E6K_"R,%VWZCQ NE%4@N CLDVO,/T,(@0OWQ(UXG?2X29'F +KG
MZ&7Q,M"WT5P%%4!G2K1!B[92 \WU0'-%=A%UAB"D&Q@@1]B_QC*Q3A[,#7M-
M39EFM]EW],IW6;>9Z8#F2A2XT,YO<AC.K@%NNGI-[GDLQ'?*7!P*F%,LZ"8<
MIKHPLZ<<.'I=N9RG9&XH[XA+]50!I%:VT$P'I)782B<9<#+%U/OX/%7+\VK(
M="LGA,?V*@N^F8FY@#NT\UDCX8=2AGJ(I5DF0.X BNU0K:@KP\I<W1WU\J/C
MM6!M8Z%G-'7%T%J*ES%R=BW'.JJ!VRX>KC3VG_8FH0-N._ V!9[>7O4"QE O
MBDU5*1"2TM,/1>3&! 8I+%^_IIPT+#->/R/@MH.C:M(R,3&FJZY:IJ\ S78F
MJI7FO8^" /.7RIFJ##-SM.LYME4%LS9*V.\BWMSB==?#RK(S0^@X=N[5&#.$
MV[TPUG=='I%9E5 6K&4R<YK:L_.#YX3#K(K87IM7RTFKB<VY:+^7'^<NVW\;
M$]"2+2L&K )J<WPZ<.S<ZQ5Y*+8P$&UB4U7UW4\0G [M_!!GMQG)"$G=%%^>
MH;D3'3EV;J'/M.=FVY-\LKDIWL!4%JQ%(F,?ZJEM-LN +.ZH2G9/;:O1J^7X
M5:3&#-\#"'(3 2L!V,8TOV#.NK'+S,08KWI=Q\Y-7:]&9Q>I,E:^GV!.U&>$
M/+5B#Z615NXUN)DYFD'L.79N0J<(1"VGK06AK*0=IJL12"K?S4.[Q-B,L./8
MN6%29803B3ND9ROP?2&B8*I?7QPQ/N!L1&7ZFF)?O<98=>#U6C%F+]AS[)*I
M=&&A/R,>@7P4*S!_'S-68><6!7CI#?>W\9]OX ZKV)O=8-^Q<W-6-=Q "T:)
MY!WZ!?!\O!\,W@#U+%LSV@>.G9L$J(&V$K@#^5/(B<O&(?VRF(S/6.6W[BOS
M-<-\Z'3+C5/A>E;:8HI7\K829;!"0*5:/%%?<&&AI.&8A%4VLQLXF&<8CNS\
MNLZ<6?PMEBR['2JTZLK"6C[&*0C'ZN47>4P(;>-,1+&)+R())KL&44$47!$8
M5PSPB]ZR7WF.M;X(8_!T;*=;J0NJ5*E%HD0FTD)1*G470JO!4_[5K]<)V7G!
M-_2"^DLKI3F:\>TZW=P"Y1I\MWO*\H9(]7G4 >'*3"S4,T-G/A:B'U]0:U!E
M82S'S%@J.3T[O\0,?/5'7!%P1C&G> JKHYG_\+V];_W23^\H(3L$%XU>K9:J
MPM)<5CF]_/)T=32WL=@JA<'97-.*$;<N>W/XW7.ZN:7M&G!#S)Y+WH7E(GCZ
MD,@\ZD<J>=7>K[@!26:?V(>DO!&?R"JQ[3L4[XBO/@,[P%R^S"U;&O0B<G-J
M/K#S+ZXDG)!FE;FU35,8!=:LV!'7<#%WLD.GFUO>+83F[]YCWG<6#^B*_UXX
MQ$L=X96<W*<A5*<'_:DCT.GR(FP?A@<P7%"/GK[,'TE&@'IA;-4$_J\D)!S[
M_HM:4G4!AP?"@Q;"0Z&W89^T1MA79QBID\Q.6E]#=$A]O<W[I"5YI$Y/4@<H
M'D\)I\Q[T.<;>5%\&D8+B0CTI#)2?_W*630]:<6/4TF 57P<4GPE);J$.XK-
M_-RTG('_A?T7C@?0D "[)-+?D!:7H1M/8F>-$VL8VV8=U<;;-3LI\MAC :9E
M6K91_!YH0![8%?TK@GRG7GG[&DZ3$_KMW:5V^Z[QLYJK^1A,??9"R#UHYW*J
MV]D/6*0^J[-IDY806<6@\;UA?/C02<OEQ%/#\ IVAL()@CQ_*6'G:RPDX?>$
M/U*7B/Z8$_V N5>N(6I"IQQPYA+BB0O.@DOP=&7+VY'YD_UZQ1N44%]V+_"1
MU[)]A1]X9/AV;G"%APSD,OXRVV5D=@$#01/@OR)"$)(<\12.]<2M_N^&R7\3
M]2D?>-XELR_=%0?:&IS6&R ^]55^Y;Y^P7R?/=V&@VCH4_=V!.X)+3+C;*9I
M M3]KF4?++XT-0!SFINUAJ@)[:J=CFXBU8C;D;XK^I&<,*Y>!8#QM@O//$S@
MJCH@Y!/0/;!TMH5 5<6)/EIST_GQU0J](1S36(<R?A;O=4H*['[H];T ABC*
M5&I60KU:(<XBKHY(*31A)1Y-#2,:QH7#<7*P"VC:XE8 \BQ/?<B#9N^JS_4-
M742F4LK81N7ZM##0<((7*T"]TTC&&6. J5=LA;+TC2TH5U=(R?QBW0(K3][4
M0JJP #RGC]0CH:=F6[5GGQ/7AQ_%OE"'U=M&2BVLE!'X5%6'23DL0( Y'1L(
MFI"*[V:OTSW@YU^!YC:\5,O58X6-_G+,93"%<75@BOW5F#2V?]]!J<2I*Q-?
MC%\.A\"\=%UO7S2#7H=3$[RA=AV45L\#K>[FZZQE_M]^%B?=%PZH7A"B@_K#
MA*R,ZX7FJ,2CN6DA74Z[C:0JVCS Z3X:_I>X\H'%KQG]!GX/5]6A?WKBNSA)
MUN16H:"L8 6AJ_H2-O@/42,MK)%:/T(K>KH)$2#C<O&89K7MH99YI*($DI4X
M?6,4KZBKNF/)F<*BIYN 8O(U.$@W!'-W O'EG#P2GTWCS_8*::I2UY/6'[Z]
M:21*)W2J3?\T<>)'9<<(8@18']0#1RLY=;F>KB&M2R/#O"B^4T++!),<R1O5
M M.HU( @UDEYM^\3[SR:5REQU#./AXV$;]2PTO%PU79-L_^9*)K@>>F\&XPJ
M]<_+<''V^XZ.)_)V]$G$HQ95F&4.<KDAQ4.@#7!N:H'W$?,0FI$9DH<L4&>?
M,-Y/C%'D#Z5(W\K-I>I1Y6<_#1FOY-QG&0Y-G?E,TOX]&TGHM20M;D+O&GJ6
M).K0RN+I\W+$#:T:^EVK:T'WA8OTD>B856J1Q434A%BWT=<HKK#[^7:4'L&A
M%P/5FU=O\])!904:L8CR0 (UT1>O&LN7V73WJMQ^0Y[TK>+JH":W;UTR)$/;
MAPG\-]4O-8DKZ94:#A?0_.VZTFQ-,'Z!QE @OJW4QD[#+A<--U% >)UJ8P7A
MMZXURKYRD:XKI\?;%'O)*SB^D3%4RA\3ON&0.1_V014=?X)R Z%S!==O'4)7
M5Y')5/$=H<$PXB(^.-RP(%.!1V,#P1*0_4A"P(;T, ?M@J@CGXA>.#W#8I(N
ML2:[6N-8=T=< D6:=QGV%U_U*>M!;R"XJ6.]"\8)'8<%(QF-]AT916'Q$D\%
M#@T=$*C5S-"%$E/;_[;@#%&]=6_]NQ_UF#7DE0]]?LCBD26%#5WY;$,17NK?
MZU$L)F@(4N?*S03SJ:=EJ35XM1$MCD.F>:OUA(U-#]F=1;-5&.-V% /%5UQ0
MUOMVA#LA ?[PW?\ 4$L#!!0    ( 'H^:E,\^9@.%1P  *(. 0 5    >FYT
M;"TR,#(Q,#DS,%]C86PN>&ULY7U;<UNWLN;[_A4>G]=!C/LEM;-/.7:\)U5V
MG+*=L\\\L1I P^*$(CTD)5O[UT^#E&1)%BV*!*BE3"HE2S*]U@?TA[ZAT?C[
M?WXYGCPYQ?EB/)O^]%3\P)\^P6F:Y?'TXT]/__CPBOFG__F/O_WM[_^#L?_^
M^=WK)R]GZ>08I\LG+^8(2\Q//H^71T_^E7'QYY,RGQT_^==L_N?X%!C[Q^H?
MO9A].IN//QXMGT@NQ<V_G?^(22E>>&#"<<VTC)'Y$A/#@DZ[)*2+Z7]^_#$E
MC,8'8$;FR+3RG 5E$W-6BB"S,R6KU4,GX^F?/]8O$1;XA 8W7:Q^_.GIT7+Y
MZ<=GSSY__OS#ESB?_#";?WPF.5?/+C[]]/SC7[[Y_&>U^K0((3Q;_>WE1Q?C
MVSY(CQ7/_OO-Z_?I"(^!C:>+)4Q3?<%B_.-B]<O7LP3+U9S?B>O)QD_4G]C%
MQUC]%1.2*?'#ET5^^H^_/7FRGH[Y;(+OL#RI?_[Q[M=KK_PWR1(FX\4/:7;\
MK'[@V8O9-.-T@9F^6<PFXUS%_#-,Z@C>'R$N%S2.U7.79Y_PIZ>+\?&G"5[\
M[FB.Y:>G_YXN)ZP*G ?%*YK_V.*IS[XB3C!))Y/5!+VFG\^?7>$U!H]?EDC_
M8CU;%V^?S-*U#TVJK&;SBW\Y@8B3U6]')POV$>#3Z/UREOX\FDTR+:1?_N_)
M>'GVZS1-3NHJ^GTVK\-XOES.Q_%D"7&"'V:_S6B-39<$F9[X\=?I$N>X6(Y*
M 9JOI(G;OC!MDV/>HF<A2,E1H/3)7I_H.AD+FHT5+PHLXHH<Y[">50D\P\ER
M<?&;E4P8%^<<^8^V^-<2W'T6WXRGL_GJW>?S(93@X))G"$1MS9-D0>?,= RV
MN"($5[K+?-Q$<GUD5]CY?)Z>S.8T;:0[GS[YC%73G:O1-2R8IV]H>WT1GW_B
MV>+D^'CU3#9>XO'%OZ\Z]<&YMIPU%-2:#33J?>GR[42,A$8N(2$S19.9 )\(
MARW,&VG1Y*2D"P=:0-M01O[_0YD]A=6,-*_'$,>3\7*,BQ<G\SD9D%%U,I*+
MAOD(G&D3:%A@'9-92QE$MD7[+J3Y%LN^HWN>TNQDNES\#F=5DA<CY*Y ]B8Q
M"6!H>5IRLD 59C"GD@VM4N.ZC/!V/$/2IGORX2;-&PB@&=4)R_P$\RTCM!)1
MIB*85/1%D_O,HI>."56\Y<;*!'WLZD9(0]*6[2G10 P]K29:Z:Q2E@%*R;0C
M;1QC+/1C,9@R@ SR0:SF_4?W8G9\/)NNGOM?,#G!D2&SDDT2#'VFE0=),8_&
MLX)96X&Z"(Q=QG83R9"4WIX<N,GPO2:]&;'?X1+&4\R_P'Q*7LN"UMW)<9UC
MS"^QC--X.=*E<$%^*GDL&9B60;&8K644V"-W %&5/O'5W=B&I  ;TZ.Q8-K9
MQYS'=39@\CN,\Z_3%_!IO(3)"$/60D7%+.>!:4VPP$?.5.): BGM!-C'.MX.
M:!MJJ,=)C18B:,:'WTF62)8Y7]%DWL=HLR,FYIIWU +)1(=*45M].@6"]PDH
M;P&S#0_TX^3!OE/?TF>^T$UOET<X)]/V:8Y'.%V,3Y&"YMDQOIXM%K_A\FWY
M %]&&<'93(-6PBIR# TPR,*Q:*-W/$:12B==<3^@VW#'/$[N]!19.UXM%KB\
M=/PS63E1W7UABF4:=2!JJT0QA?;"&J.+2WU8<Q5&JV3#.TPX/JWA+LWQ9<0;
M,03%+?->>)*H+2RH3+.L(QGU&&+"TC7E<!NJ(?G@NS-B4\YA;SFT8_LIC"<5
MR*O9_#U,\#VFD_DJ]'V)<?GUIY%,2@J/A,E;6.=%@LN%<:M3" *,Q$Z)B"T1
M#LDM;\B8'O)IZ8=](F_PER^?ZD[>\^E:K5\??41(A=/H+7B*, 4ZYHOF+ %-
M2BXB(N]#G"W #<E?;\>9UE)I1I<7L#@B./6/ZDV<$I])&3Y?OH#Y_(SBS;4W
M"3)GP*28BH4\#&\T\]9J)E!QZ1)&G_N8W*W@#<FU;T>9]I)IF"Q:+.?C1#YC
M17<Q6.T+ZFPD^9V8F2Y2,2^E9BE%[4R @)%W(<FM<(;DL[<CQ?XSWV,OD&AZ
M6UABE.6(A,H3-&U$8E&*PCS//AF+J%*??;.[D+7?!-AI0S@4GE&0<YF4JMM:
M@:3F34W8B&B#3B+Z/DY^CWJ5P>Q#[L_%NS??NXN[G7F?'1^/E\<KRS&M95U+
M@H335-W3H()0$#R3!1/I(4#2&@X91?%D.60POO3AWW= #2EBZ$JJ5H+IH<Y'
M(%QV29,!R<8Q#=DS2,$Q#@)0ZY!M[+/3<P7$D.* KDS8=>(;9]=&H%61->A0
MB7.FDR3X-B:6N2@HG(RQ4R'/^OUM?=*J@\^=HY*5,4K1:P'(.4()%%9QQ:2P
MGOPE$HW/!W!+OR(:DN'<0?;?=TEWG/A.J>)8*]L3T+H,G#1I ,ZB%HXY:UR0
MU@D3^]0OW#NE<=@TV%X"WWV*FTGYU7A*PWP]/L5,_A5,/X[)\UKC^@TI'M+H
ME*(H* @L% ]Q63,IAI400 <L@L*D+F+_/JXAF;0&/&@HA(;9S]DGG"_/?I_
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M^!5\7F*V47E6.SHP\F@*\Q2[,Z6BESQAHO\/2=);, XJ:?+H2;HO"1Y"D[J
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MN7,\\$Z7K#>!/R0+W96I-[7KX87?S&A__PSLE9-?3@8;/+K:*D%1%.(, UF
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MH6BZVL?S]N$74=(>!G'#DUI8P&U MBJ&^J:=^H5G+*U (D)FV0?+M#'D&?/
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MP=.&*T7B(8!44?FU+)FM'K__[6IW&MRQ:]H+O<'=U0+HMS!Y,WD_J_<=7:X
M8>X #VQ.Y,"1+'BIP4P4FL6B' O2J21K0W/?)C=L38!/F3TM==&B G*!YQVA
MYT0?.$\>O_.9I2)=M> S\TYDYD 'G;C4"1L5-*X&=8+4V%KF/1K&W9Y'-EA"
MS--?2 85#HP2OBGO,".>UU#TLA.]$\O\XCY(\NQJEG^2ND[R,)'%;) E+7E
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M*(/@Q4+2Z4:M;1:?]Y1UWDJL2U2_=6BTP_CSGY]Q-,4Z1OD7Q [JAT^X%.T
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M52R>"9?(!S+(&6CN&$@A:A^'E!K5ARR%\^2UOKN0>^P">FVQ/#!XPQ<O0Q#
M8N<#1U\3ZPF?U4J#2T*G5E?/1S[I9!<6]"7P!JT^'QJ\(4T2KM#Y8SCO)JM+
M%H2S->?2EZ3 ^%97)4<^Z61W+NPN\!;-/R_B=)B',/EZJPE'Y\E 22ZGX%@1
MG?UI! L6)-DIT8"U!K4Q;9BP"M+)17]ZD7V+%N.W6O7 .?WU5FN>R]=A'81-
MHT&/8SQ0=*@?I3[0/*E'C;08G;0&4H-%*J<8U,&D6EK#O..U?%5;\GT%!VRT
MLQR(,X]%DPY&F0T4T?^0BTF=/CS#FS[&ER=B,9(.Q5#;E89,J!+Y2! 2LT*8
MVLDT1UPOI6SE(_9O4/2MC''ODFP03'KU]LTE$)0&11T<C02"@- "@2=D8()T
M5N62?)N@X36$DU'Y;L)ML.&_(<X].SL;SVH\?'X_?@DL(GBCG6'<8B0W1Y-M
M9)6I&3VE% RJ-"JE6PGIY%C0C_![-"&['>F7,4'ZX\WH*B7U$I+)O+HZMC:2
M)1>*O!L6O- L2\#:E1P=7Z_4;?GGGXQR^Y)AW\-DKB#=;;5W"4RXC+142XX0
M)[[Q5$T5$9B 5"3G(I(4-E+NLJ><IHIWEF>#&-';,QC5!<^'/B<3@J$E99F)
M="F9>;\-(RWM*T";2:,[O]LH3LW[WUK"#:+#5UBN!K.O@::I<W\7SV$<^>WU
MLT+1.PBW@=FV@"H;!"LDF0NI&I&._A;12#(<8IVY+ EL&Y]\'ZI^Q/]NI>E-
M9-JW>_U,DIWP=C(NP]FKT0PG.)U5=-<N@_+".\&$J764M2FF!P\L@HI0,A3P
M8JW#^L''[/^TWD4!XR;2Z]&MOD(F^:M1+2 <?L%YI>$M9-%:;XBWF,$Q73,*
M/&I@RLE(%DJV)JTWN._!QSQIO?8DO;[?U_^+E6<P+Q"]@03)"V=0D[D?0QWI
MI5BT9&46KR2&9*R#LI9"EW_^T]5D#_+JT>N=3F:#=[5V8!ZU%=8:$8 E9>H@
MG>AI:[":Q1 CBJ"M5&O=I].GWCI'Z:O%,_3.8T_%/MY>ECVZ0=<@KGBU!HQ-
M+.+U5=O_B_JX";R#"A:5N(/\>MQB%^%$'CP9=9'Y8I!.<$645,(Q98+@W-!>
MM!B).F8UKC!O^]?B)F+K67N7O4$N@83HT):0:'//M*\4 -IAHF8 !8W/*<>X
M5H_LM?1WY]'[.S%W$OZX#\DUN!+J3*X/],L=)^N@.4B<,V4UG=9T5C"(9 *8
M$J-P.A@(;2X([L XE8-S=QFWR"]ZK-)RNJK4\F89H[Q@-:ZSIK;))PU6=9@H
MUPYDV;2F=E^:;I'4TF)MT7MNB\\U([B.HK#U*D?6WNV^2.T#>GV@!L]'P]Y'
M G='3MY-%-R M-=]U&Y:N5S5G"A50LR.F1JVTD;0Z<)%9CP7E3*@)S^\"?-6
M0CK Q=[!-;ZB)>YNZFI@LRVO9R  PG)9Z!VK;0X,]P0J*F;0 8 F:[*T:6AQ
M)$4C1\>?W=748 ]: -7U>7GW_O<KE\:BC'42N<S2,<VK6\)K=0PY-MYB$=ZW
M*39X$-9W+O6HM@;9Z7<VRJLM,M!BK?7DT?+:7SZ2YQ0S9U)!D:G0"^#;%"TN
M ?.=/SNK:&6*P[__M"#4U_1E]X/N^U5H[[#\4/_[^[M7UP+^XX\__O(O6C.<
M#:=_2>/SGSKISH%-YU,XEC?Z?(DS&)Y-[^*:#FEY"YU/[E^[;/#I/]VLX.[*
M+A]QARS]K@7_G.$H8_[QAV'^VX]#K4&(Z+6()6L=7;32AV0AD=$1HC&##9YS
MH!9<KZ^[_%B;)/D$F>EH+-.:3L'@H ;0!$8MN4ZFS::P._:=XVQGW>_@BJD*
MEQ,3!TIY3]K5S-I"EJ5%RZ*7EH'@V:/V22VFVO<5@%L+WQ'NI/VR[E[HKG^U
M-7 (;@4NMSYXYF%.(7PH8) A"84L"<@LU$H7.BB"CV@2V:IMWM"^EK"O/F8'
M)N9A5'XL+=)>C>B<Q>NF/Z_K/ZB+KE$G+966#A,KLHC:\ ?)& ;)HC+<N<*U
MMFT.F0= '<&-QCY9LE@9TY.V&KC#*Z!=6MSK@&MZK?$@O,/<3_2FS/5(LH,F
M]DZ7[*50MB0&I::K&4WOB'>99>N#(FN=4#<JJML_31ZY"#@,2S910)O8&M('
M?B+7_25^P;/QYXKQTD:\RKOQ5I3B-"M)&3KX,RT>N&4%M()HP0H033BR!KC]
M6_<]JO-^P*Q7732PVB_GE1'"9_F<1#V=3:!FP=X%J6+4121.>@UUW)X,#&*,
MS'AE+>JB56AS-;06O%.B3/_Z6+G'[#MJ=KF$ML&SA8?L)X;VT,H60FF%@P=;
MC"%[57LN B]*%.")6YU\P75":0N/.WA$38:,W.D:N84:$S:&16<YRP*!<^U]
MS&OEW9UN1"V1UGWTG '6MGY1:!:+,TQ&B"%[E#&TZ8Q[PA&U35BW941M$[4=
M=40-1,+@A6$J2F2T[V@&M.,P%027RI3L8QN#[UN,J.U"S,.H_%@B:G<SMU22
M,?D,S E-9I13D8%QD5F1Z*BT/*9&C4*.+0]XGTQX,&MX$XT\E7S+==;T/6MX
MBZSAC<BRC\3+;33]5%CLHQ0FV\"D]5T!1V'!D'\HK @N.B@^?\\:WB!K^.C(
MNXF"^ZY"OEORWH&<7A5'H^-<I)J^H\(\C.I#M@RXU]9XFR,/CWGUCSSC")V3
MY@H<]R_]!O[)ZMQD+H3.-CH69"TK3**P&+QEV>CDBA=6^S:FVZFGDF_#HG[5
MU;HDX:H9.CJ=:DI@,;+F!8)FOH3:2"O:#*(DD'M@T'?N]*2BOGL)+IL5.Z4E
M+TM1OLI/]B$AQ,)DHD5K(3.17/(*UT/ K)U6:QU5FS_[&R;0/K1U@+S@7V X
M^0><7>"SZ?3B?#[^LXPGR\[JONX[MGADW[<?NZYZ,:W8N)QRD%Z*K'71P0*
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M&ZU"AFBYY1Y2A"-+(NY;!-_?OQ.@YOUWU.[ZCC;2TF5);2K1*2&9\JX.%,+
M0O:2<0"3 @2G+#9Y[5JN:E_)PD?]_AP-;8XSNQATQIBE94Z;S+0C(8=B"TM<
M1I>\Y#RTZ3)V%-G%QT..!Q..-U'24TG57&=-WQ..MT@XWH@L^\C9W$;33X7%
M(M<R4Z&9-;5^WCO.@E>9_'A1)TY&KD*CBJ(GP]Z-$HZ/CKR;*'B/"<=&)&.R
MUJSXDFL+F,B",Y'VBLR-,LF+Z+\G'&^LP#43CC>1_LI[_KUG9=U*>&V=C;7L
M47O*PGITE0O95^ 5>BU5 ,^U%L9SU )"=#$&@0[7RKY:]M"C]'9O?"I:-3E.
M9),F32:JYE'7I'E@ :*3:*3)BU<1Q^WQONXKZVH/%UR_$OO/+\X'TF7.7>U-
MV-T,6XVT+27%)&TB/)B4BSRR8-_&:SS!:-XF;\X!;D^W(5>+JOT]K'0^O&F@
M,\]& #+K4@T/J<@\&,U(,S)!1I5DF[82^UOC]]?H*9"KE==ZK_7-_97&35;Z
M 2?G8L"UTT4:9"9[S>IE,XL)"@-E=2:SF6ML$_-NMZ;OK\DQDN?8D]J69>U=
MG:*F6%FT42PE7KM&>,,\3XXI5Z>?NV3XHJ-]C&?+ RO\_LH</[%ZS'';WSHO
MST\>>0DR<68XKS41=8AU\37=R0.X@$JH-M4]^UKA]Q?H^(G58_9<4Q/TY?#+
M,.,H=UFP)G/CC"7+T]3Y09KT4<M!F55@C.?.*O>$H@.WE_;]E3EB*C5(KVMZ
MS8X9)&!V==1'9CK49/':NJ'X6 1(G9UM4ZGS/76G\7MQ-+0YSM0=%X,J:,G[
M@DP'H*8W.V!1+&N4GL<2,YYP8\#C(<>#J3N;*.FI)#VLLZ;OJ3M;I.YL1)9]
M9#]LH^FGPF*5I.,^)2:0+"&-*K.@4#,ZDQ"S5IG; ]T:' U[-TK=.3KR;J+@
MUNV\[O09"TKH $XR--"-+5 L6CIL.'I3@N-!)=Z$>:?>%FXCC:_=%FX3=?5X
MD3J=S ;OJC2ZMVONP!G'I(W=J&K.@E"2[&C%%21;E%V+,_2IM_A"7RURY<YC
MOQMWXUV5T>/EQS6(2V*N V,3.VQ];O2_:SQN,NV@@D4E[B"_'@^*13@AZF"L
M#,S)0+RLTTN#BX*9$"U:Q!A@K>E"QZ'&%;9#_UK<1&P]:^_R+N>*3B(JX\CB
M48+[VJN U_:A@GF(J9I#RL6UY@6OI;\[C][?\;V3\,=]2*[G$_;R-N&JW6(6
M2 OAC#N'M=UB85ZB8*@QY>AUB:*_4_;.HY^@"K>6W %&<:W(V_WY_=NWC5.A
M;S]B3RG0*U>UD/HL R3#M>9<HDX^Q))XC (+&L$3EK52GV\_["AO"6[%HB-7
MIF;L!P- AE^T9,@GS[R2T9!"N-!M<CF^ISSC( +QRMO O.&2:56WF5(*RT(4
MU%P'K=O,3OS>(JKUNW*(%E&;T*E5=G.;S#JR?&44P3 TWC -M*B@(;'H/2JI
MZ;1N&9?\GI:YI_?C\.1YDGTY:]%\$<6QZ+AC6CMR%7@ 9I7V9&DZKN,32(KY
M1OIR'LTALC.5CCV%>6G6#[ERPEK-:V9VG4=!BO BUY[4NAB)7IM&PT.^)Y ]
MX7=E9RHUR%9N>A_@4S+9TV*2%#43VT42.C=,BN)MS $4M+F.^YY UOB].!K:
M'&<"F2])2U":C$5'!V#6)%7A/),^@K)!T$O?9EKBZ2>0;42.!Q/(-E'24TF]
M66=-WQ/(MD@@VX@L>YG7N86FGPJ+(P@I:Y=R79N\Z202 ]"*R>BB J&</52K
MUJ-A[T8)9$='WDT4O*=YD*!\$=X[LH9$KE6#@7EM/:M7Y5EX)UUI<X5QNO,@
M-]+R&O,@-U'1 9I#_5Y-F/''T?!?=Z7X8CR=]745NLXS^KX+W7A=BY>A3CC+
M$;QT7*?D(%I!S C 10@FB\'&3SM0>.C&=0(;E2*/B6&=SZ0U1Q:@&T<&7A=P
M$:,ZS 'U*/;>]DZ<?!DF7 Z(S/DO.*T]K[OF;A_&Q*]%9?XVGOU_.'MWK>S;
MG;X&)JE</"+SQ!>FB2H,A 66:!>)T@27<^-$WI;+.\+]O5_.K]S-CX8T#6XN
MVRWR^I/F_VBQW?P@2HO)DE9$2JDF^R46G53,^^Q!.AL,7RL_[HC>ED>6_/T-
M.DIRM;35^U[X?#C#+^/)Y;?J[XE!T8)[IPO#)&@/*<(RX I9I+^*4+ DWZ;M
M\'[7^?W].1X:M;@!39\P7YSAF[*]8W<9;D69.!I%R,G3TD84!CD7%FTH)7(3
M56YTT]G7$O9U7W-@@A]&Y<=Y_4*6'L^%Y&@SUK8U0;"0HF.8K9%6!9Y5F_Y[
M1W']<B F/'C7LHE&GDJ4>ITU?;]KV>*N92.R["-<O8VFGPJ+=4JZ&*SV?)T(
M*^FX 4\;C2\Y)BN2T+I-M_*GP]Z-[EJ.CKR;*'BOQ?I:1_(A+3(9-0'+RC.0
MH;!L4#OAZ8S1;=*Q3[U8?R.-KUVLOXFZ&D37WI%C-AG6]+G;5T(.BM/.<H81
M:HF=U&2<B*KQ4H>$88FAC:6W%,YW_O2@I@9[T *HWTDKTW?O?[\$IW3BT7%)
MMJT53 ,D%CS4E.5L"5@.QK7IH_H@K.]<ZE%M#4(LRRZHL^(1H !S7@+3"LE?
MBF"9REDX]%84W3AX^'TOZE%%*].M>\TA(&&=#V=5%C BR8UF0Q+7* UQ^AN0
M[&;#+[A#]L &G]Y#WL"V:UG(&%!.6>]E2<5Z78KRQJND8I*%\^A+&FSPG-W>
M\M<XG2*^1F+L2YRFR?#SI5 N(W:)BRA*\*PXLO%UT9EY:2S92,6%@L+9V,:&
M?038KKO;F\]8Q3CZV#UA88+U.ZROYM4/+\OC7$V\58)9P"H(!PQTJ!UQHXO<
MDQABFT-T4Z3[WQ?[Y-#B%M=43SU:\=W<O[D@[D+N_IC?J=27FEYBS+]=5(&^
M*?7%GD":30<ZH^82)/,FTUGOK&$QD["$YDZ2^2CL8C[]BJ&,6T,X#=KL40T]
MFO$;H;XJ-?@Z4(8; \'0V5XLTQX$"XYS5F(J08D8E7>]DN;ZT=\@6;83>P.[
M?%W =3N\X;88N&B<@4268*R&IA?(  S6"P^O1;1:-KKXWQ+P:7!LGUIK4#VY
M7"27S1!U0&--(4^#W!=-IBP+9,<RG5"Z@L7SV*8MRP.@]G47WIXJN\O\T%?7
M"_WZ-!0I,C(;=1V&)S*K3:.8<D)F"$GE]3**GT87TMYTN+R)Z :R;-AU<AT8
M)]M$=!,5K&HBNH7\&JK3E!)<X)E!*9SI>O41HPN,@XF0.)TXN%:!T'&H<;TF
MHCUH<1.Q-6TBBJ#)))":N2@+.2^%@"AMF.$>0O2)=IK8F_Z.I(GH1L)?V41T
M$\DU;2*J(,4"EC (2P>""+5K!M=D_'&P 14='&OE*CRE)J);JW!KR>VGB>AO
M.'L]GD[?XJ0:]^-1=S/PX@RFTV?S;]3KGF>CV3 /SRYJ0/=][0_0M1#8(1S>
MPU-[")/WO?:%\#DW(6M>;T@TK_:3=TJ97'2P)FIES:"'Y^^8KKGTLW_^,YU=
MT#)^H9>A7B%=S+H;I#?E9YC4,&8%W$&]<220!V,4U'>7)^)UU QB#,S2J\&=
M)L67-I7B?:U@Y\37W7 \.Q]?C&8#\K<T^=&6A:[&(W*RN;T2C+[2&B/2#M&F
MGK$7^/L/A1R$O_<R;/>N^A;M/J^3E7=<SJ7S*#W9JR*2 #76I #%()$!F]&Y
MZ%V":!K-Q.UU'?N*TQP%CP](@4/'@'K2P_.ORS^@<^(L@,W9.A9JU9[VQM41
MD9:!3\HZGP681L,,VRWJ\*45^Z=JO[M_;Y1ID*ZW'-FMI*!U\#6MO'@,X8&J
M*(Z%$FM1=4=]'H)W41=M')URUI#OK#$ BY(7YD+A6%RJ#=)/B&^/U3T\5;IM
MHL:]5D1 R+2RS&F9N49I9&*^$+#$4RI"&V7$'O)'#UL1T:_VUJYNV$3T>ZMN
M"*'.BRF!*57[MJ58"%2BI8I@$Z+)%MJXY4=2W="4"[N+?.^5"N!M[1*M&!9?
M^ZHG9-X(R;A'GQVW3BGX%BH5]LF+'52P,KNIUT#Z.SR#6<VGG\R^OAQ.J]MZ
M,=DI2/[()_80 -\$\T)PVR>KR5O2F?Y7"VZZX5HB!A>$<C'%P2.?O>O[>?/A
M'R8PFD*ZF]F"UIM0?& Q&6*>5\! $EV*+DI9"-XT>T4?1K;KSO26P.)D<OE6
M=!;<]-5T>H%Y@(#2"A49Y_3*:6LE Q2*693DW%IC,[99\VI,^]^3>F7&XI[4
MD_ ;&"[/+Z:TPNGT6?KOB^&TDW$'[RUMH3C0SKOH ]8)B))I"(%YA[1Y)F.2
M3,KI1N'8!V&=&#GZ4T$#@^:RS&OZ8=S!([?O$BW6OO!74V->C9Z5,CP;DI"F
M@^R="K$69HG:.RGG3$>L4\S+@C84*^C_VFPG&V,],28U5E:/V=Y=;OIM63S[
M.,$N)E\SA ?>1U/J?/H4;63:.<\"JCJX7NLL?%#1J\>LH(<?<2*:[U&.#=*K
M5RRYSM$9$2=KB.G6MZ?_.9Q]NOU/!AK QUJO$KI1ABD;YC'10KQUPH6ZBC8[
MR8[ 3X1<AU#C?1;J75GX\@(_C&\!(E?SQ0498Z/9?'!)FG\Q4'7"+[>UJKC4
M"8%)T"[HD&5"GR.0;XAMV+8FP!-C50NUW&>/V?&$FB)]VB="]!*_X-GX<]U:
M+XG_#H?G\6(RG=?&#QR98VC1L< SI[U6>I**)Y8'*TS@ICB(:YY9:S_T1"C1
M5-;W.6'[2WI9(8[I\Z]W?M+=%NOLO HF,RLL@>9(ECSMC"Q(2>>T50%%FR[/
M6\'=5PI+TSVFO:(.G8%24X5?T#K&9\-<E_'S:'9S"R<<;9(N)):CJ?T?O620
MZFJ\0"PBHE?]Y5NO0G'X7(]FNA_WK(.>ZR>68;H,L*^#JO?:IM5X]E_JU(^^
M'B' #L+>(Q6RD49FVEIE;1++38T 0&"FA!PLSP;C6K,.CY("#Y1)[94!&\BX
M01#O'S 9UMWM*@+4H?OZ=C(\A\G7YS@B8:<A_?7JCHQS@%HGYFQQ9';;PGP.
MD<40M'&H1&R4<;@9SOW6]/2EW?'>5-,BVWM&RZ_F2E=L\J9TUQGSER9SP47U
M\7GU[#$IYH4AB-%AJFTG(V\S,74EI-.W._K52H->'K?Q7+\KCR-JFOIY']-A
MDCU[4MJXB<0;G$%+D"&=J(#(6?&J<EXC\XZV-8,^*,5M%*)->M2^./!( N;>
M*+")H%OT/<<)'9;/[UZ"7W66U:$H*PH+UM?:9$G&EG&1.:>3L3+)Y-LT 'X
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M]0?,NYS:>M!(/ .ES*7KX%9J\*N6&Y2"6]X]&X!OQNAN(1V8FQV@V2>9GB%
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MPT1(TZU'N^&IL44C&]#"F6\L]K"ZO)'HB\#0QQ%&REMM$TYIVFM;L-?0:-N
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M)GZ\P%S35".S;B (8"8$8(1(@#42++/EB)C3@:&3M+$M 48QS]2J;C!=/=I
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MH;",3)5;&'=ZWB5,KVT0QVRV^+.Z7=+V2*?N4_%AL3* -G:$(T87M(+27:?
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MES&X(=3LS$L'CC>[;-9IT%G'9_MYCV<+%CQ_F,[5^[5Z7$TRBDF9"0%*R#F
M18D HPP#+0K*F,9002\W\(J\L4W^"U4YGI/?K<I)I;/G;=,UQ-T\M( X1B:'
MVR#T]I0<@0GJ\ER3.:COX@C L1/B^MBM19<N%'.H"_TPB$O$N#VD(RF &1:
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MGGI;?. P]7]+CQ7F?['9\Y)],@O6H_D>;=93P6:K]W/1U$YG,H,%)!+D2'
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M?0790/VQ/;#I;(OM\I[ANF%[6'70!-OGN7[^U:^+N7K^E2W_4.MWF[E<-3L
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M"H86\;HMAVB?^(/:B@Z&/+8A[:[86W5U==%_HO[ DW)U\0]02P,$%     @
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MULH>I?:[*^ZF^H[3FT>)<&3UO\-TOB3H<A'?3]<SG-AZ+9/H[)+*$P/!>R#
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M$7:4.GI$UL7!;YU'VA8.!$939\+0P5^302QQQ0I];U6;%^^/$#1NTNSTB#I
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M7D,M!"\$ I*08O!"9YV: .=)LL9-NPP/HN%TT .@4CH_.Y_5V.>Q(?,7C.G
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MZ5@F+\37<=E*68@V:1 Y*JN-B2&WJ58>\.$1_RZNL!HHK',O\L8K*BYM,L%
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MJBE_=543RM%*:169#8.<_ RIP26*=VIPXSD&YTRC]P$[T]A+-XG!C\7&ZNH
MB(_P,Q$A)ENT T%>+NU2&R&:E"#ER'/.1GC>)E1XA*#./:\#];];VF,O972
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MS;3Q/0D=-P9H!IC=@7FT]CH Y\OYIL'X:O5P==/E7$V#K!XVX$OTVYC*RUR
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MK2/H]ULJV-S*),SSC6>Y ]=N/K5$LS+.G?D:Z1$%\YD;5X!;[T%%LH^.9W(
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MZ4X_% 6=N@W#@'84,1\.;[^&]PQ_KRMMJT%_P>N)<<1*E9%VIR3CML@,+MD
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M.@;O;JZ7UV&6R=V>Q(S&N4(V*3<(2GD.$:T#B\A-]A)%:=-._ULK&W>H[)F
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M2GL9L,QF!<DZ\.*.<ZOO_!"6F&]C-*]F^1%O[VM)K'966EJ@-SK5P!]"2"Y
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MZ/3#*1$3G60N#DF3)$N*(!!^ S<!DDH\"DUN:V[<?;@E>9U[8@-C]B6]WPV
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M.L22,(-).8)"[=?Y<ZA3P,!$E(U*]P]<Z#B*<$Q$#B*R+C#Y;*!GXC!'2S8
M%+0:E$T"G$D12C%"9D8K:82\9Y<S[C7\H ?M<&SOX'1]LOG6NV(B"Y>8E01F
MBR3SE"/X9! *<:<4C]SD-A;\"PL:]YK\+/@YAO47'99Z/I#7.D*U^ZWG"U8=
M0'WKN!4IJ>)\X*!#376,F4,,C-Q(9T+D3I:2V]1RM[^_.C58O$Z"%HYGY!%,
M4%@'UTBR4C-"1O*NG4TAZC9'Z;!T=!I$.P1][6X%#A9T!X?WB33_\/7Y!ZQJ
MQTP()F=CP=>FZLII^BQ$ \$E::S+/.@V X4;$M7+,-CS8W5[(FPGP.EV#SV8
M21554=J2>C*:*7(':WZ18 6L+PR+3;Q@F\+\;ZULY+FOO4!H+V@?*<\.\/GR
M6-'@,W$B,V)+KK5Y(H$K]7*=I52XTE+S,\RBZV<B[+"2WWNZZR%BZ !/SX\*
M]1XU9\63XVHMJ!0+$9&(-=R;A*BS"6W&QG4XW;4ICDYG?W\8VAKS&9R)*4@)
M6!P1HQ*"TUP <^BR9<9*V:;?9\>36L^)J1/$T0&V3K0KWMZ5KB#S6LM0@<)2
M;5*J(,3HR5Q.C%G%F6_4H&XH"GJ9AWGIWLIQD+C\K;#I.&E-5%8' WXU)RTR
M!]Y)#O254AC1HVQSM ^R_!Y-RM;(&Q;^1\"@UUN%#WA5^YJ^#XOKK_<-T(ZZ
M*GCI48/$__=:YT!!_8?O^K@(LV5(J_F(=^%546JG)X$@<]*@//G17LM</V-,
M!ZT)@XW,L=TK.]T*??[YS\]U*B;)Y(%.&B(]8()@K82D!2J;HMZS&=1@3.AN
M)->@.'IJH;81U84IJA.N-K_QQ)9JJ^65Y#=1)YD/RCD)PM1^V6;5PDXI,"E%
M^BHF9]I$7UMKKWO[^J4W_?#UT4]69K3*UDFO,QAN&"A6AS.%0$>Y$,Y%(SWR
M-J-RCEINYQKM$&R]?/'82GPC=]/[D4B87TUSI> GLD#O@O/<YN"L3Y!CK8S6
M3I G5PEQ'+'PB$X.UUCOI57T<I/73/CS@271(9HVD2^>M= BTP:D;4ALT74B
M0O"@B\_>L*PQ[E5V>32>QKQ-&TZ^WP#,$<SN( +RC["8UKWS9D;/Q.7UBIJO
M[Q?3SV'Q]0><89FF*7UZ&^ID+(3:X-::8D%)4VJ6<(3HO=(6)8^-<A8.6V=?
M4#L&&?.SB:D#$/Y*LEE-<U]E\+TKJR#[>H-FQAD/ CQ+-5,\27"\5G-%B\EE
M@Y$UJAA_:4F]Q(Q;GXO#RJ8#D#U<_V9'(NGY@+7FP<G*%X7@+&T8C<Y+R4SD
MO$W@]NE:1C:WAA'R]F3PTSC> 69^Q07I[Q_>W[[^X8VR5;Y(PPMXXVK?;D&V
M@[81K%5)&Y%$<FU&V>U8U,C#-$Z4][;F&8CY'>!H/V6]VG""&:U-])!4Y*""
M5_74)APD)Z0,KEC;YL3;?XWC7O2?_PAL)+W.<+G9L8IEKE(.D+ R*D8+(2H/
MQF7&5"&K=;_@PTGXZ^%,;"7U'> Z0@0C1QU>E3*]FMXY.[?^!]J0C.,"4JBC
M$9RSX%66D,A@4"HE3&HO-W&OB,/S:^@'/,=(=3XHBT<&R>OI A/]>+/RPGWT
M/%E@R.OE%EF3SGI&SC#JR+5*P0XW+^CQN\=UW@8$Q0DL[>S8>:!:5[I4>N&R
M#PD")JP68X:HN0-"N<O(+:G3-CG7.Q8U;FEL-P;/P?+I%VJ;[:<%!LV-!1/,
MRKLE]Z3VXA9%QYK,*0([:^9&QW;/X<+?#U1'2&+L%DMOIPEG2WSU^P)709.[
M%',E4^ <M'0)5)*DA#T1XQ-+5B.I=+%E.;\T@>'9YW>)BF.D-Q^6E6.CX>]A
M24_Z%1=?B);E-B5&9PS*< C.!W(-$H,HE .,UG!%1[,+>B]0['Q-/W;-@-@8
MCK$=G$,_W"RGLSJD/OW'S70YO=.H&&3)%A%BSF2YR2+!L\S QABEYEK20=WD
M!'IA0>,.>3^_J3.$7#J%5_V4]LQF&SITAM4#VUD;Z]@M14S2A SOM1$B5'_C
M;$![M+1Q#[9! + 'J(Z7QM@'W/\-5U\7X?VGL/@<$MY<3U.X6KZ9I8TBYDB[
M+GD%V2.=U25[VGBDET64RCN7;%1NKQ-N]WOZ0\D)$IVW8>_(<9X'C?&)-352
M=?UIGM_,ON!R-6+]Z7<1:X'>:K\QGZ/11H'P]48G*P8^.P^QR)!$U-G+X:)"
MIZQT+R":RS\ASRK1D9'[$AVWMY@^:28E^;F1-J(*G(@P@?:@5T)KYHW3>TT?
MV0N;N]<R7F;3^; P;R*8L8_1?\>:NQ4^?J(/?ZST_/+M==YH^12"8L8;,+[.
MD<\L5?X4T,FB-%&S%/>+'>QZRWC8&5*,\Q8\[<"$?T&?O[VO<"0V^%(W3=+$
M)2<#!"$E%%6D-,$[W:SJ?_?*]L*5O?P3L8FD.D#>XPR;=;O>-\OE#6;R@I",
M31F!,=J/RA@! ;D$@P)YU>@9VV#NY35U&0<]4O;S)H+HHF7R,Q[3BJ#WBVFB
M[6>=C<XCU-E7-6."MA]I9<"D=1))6M6HW^/.97491AT&6L.)HP>%%;Y6BW/Y
M<;YQPF^IP^6K6;[-D7\SNTN=6$ZRL])'+! XK\9 KLGW5H(3!8TOAM._-HKL
MX+6.FU[75L&U%=S8)OZCQ+#;^XHZ?'E"-H4N$A6D6"]!K"5+ V4"A4IE[KR,
M3NYEW[_XBG%S%)J@9D">=J"T7F#13W_^46] E[7+R$.C]5^GUY\>_LE$D7D:
M1<W$UXQT=,H:'-:<?&<LM[Y2?=;$F'T7/NZ-4E-U=DZ1=H#@US?X<?Z @"DN
M?[Q95"F0\OYE/DOK+R8R1H[,U(&/1=>K64[:VB)DHC;'P(S%-DC=<X'C1G";
M(K*%B,8_59=(;_]4!^OB%[R:_[$*-ZXWV0><?HXW])Z573&Q9*ZB0;N^JU-U
ME$U,CG:4-UQ[IHL-<<]S=N^7CAO^:'GRMN%[^Y8RFQ_4#S$L\?_\C_\/4$L!
M A0#%     @ >CYJ4Y9J1Y['X@$ "?8. !X              ( !     &5X
M:&EB:70Q,#$M:&5A;'1H<&5A:VAC<'AZ+FAT;5!+ 0(4 Q0    ( 'H^:E/?
M'1*E"@@  #@H   <              "  0/C 0!Z96YT86QI<S$P+7%Q,S(P
M,C%E>#,Q,3$N:'1M4$L! A0#%     @ >CYJ4RT L$SH!P  !BD  !L
M         ( !1^L! 'IE;G1A;&ES,3 M<7$S,C R,65X,S$R+FAT;5!+ 0(4
M Q0    ( 'H^:E-)?F15,04  #<4   <              "  6CS 0!Z96YT
M86QI<S$P+7%Q,S(P,C%E>#,R,3$N:'1M4$L! A0#%     @ >CYJ4R@)N-(=
M!0  PA4  !P              ( !T_@! 'IE;G1A;&ES,3 M<7$S,C R,65X
M,S(R,2YH=&U02P$"% ,4    " !Z/FI3)X4N +LC P":5QX $0
M    @ $J_@$ >FYT;"TR,#(Q,#DS,"YH=&U02P$"% ,4    " !Z/FI3Z1FH
M?)(/  !9I0  $0              @ $4(@4 >FYT;"TR,#(Q,#DS,"YX<V10
M2P$"% ,4    " !Z/FI3//F8#A4<  "B#@$ %0              @ '5,04
M>FYT;"TR,#(Q,#DS,%]C86PN>&UL4$L! A0#%     @ >CYJ4T+T#G,24
MKHX# !4              ( !'4X% 'IN=&PM,C R,3 Y,S!?9&5F+GAM;%!+
M 0(4 Q0    ( 'H^:E,=4EDV[;\  !D("  5              "  6*>!0!Z
M;G1L+3(P,C$P.3,P7VQA8BYX;6Q02P$"% ,4    " !Z/FI3./S<]Q6"  "3
M] 4 %0              @ &"7@8 >FYT;"TR,#(Q,#DS,%]P<F4N>&UL4$L%
3!@     +  L _0(  ,K@!@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
